FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Clement, B
   Grimaud, JA
   Deleuze, JF
   Postaire, E
AF Clement, B
   Grimaud, JA
   Deleuze, JF
   Postaire, E
CA Participants Round Table Three Gi
TI The Human Biological Resource Centres network - A key infrastructure for
   biomedical research in Europe
SO THERAPIE
LA English
DT Article; Proceedings Paper
CT 20th National Clinical Pharmacology Workshop
CY OCT 03-05, 2004
CL Giens, FRANCE
SP French Inst Med Res, French Agcy Hlth Products, Paris Pubicl Hosp Network, Natl Public Hlth Insurance, French Soc Pharmacol, Marseille Public Hosp Network, Leem-Rech
DE biotechnology; biological resources; drugs; diagnosis
AB Continuing advances in life sciences and medical research are the result of the remarkable achievements of cell and molecular biology. In the post-sequencing era, the quality of the huge amount of data continuously generated by biotechnology, i.e. genomics, proteomics and high-throughput screening, depends on the quality assurance and the traceability of the original biological materials, including the annotations linked to these materials. Thus, biological resource centres are key infrastructures supporting biotechnology, bioprocessing and the development of new approaches in the prevention, diagnosis and treatment of diseases.
C1 INSERM Transfert, Paris, France.
   Univ Paris 06, CNRS, UMR 7623, Paris, France.
   Sanofi Aventis, Evry, France.
   INSERM, Direct Animat & Partenariats Sci, Paris, France.
RP Clement, B (reprint author), Univ Rennes 1, Fac Med & Pharm, INSERM, U620, 2 Ave Leon Bernard, Rennes, France.
EM bruno.clement@rennes.inserm.fr
RI Deplanque, Dominique/E-4901-2015; Clement, Bruno/E-5546-2016
OI Deplanque, Dominique/0000-0002-4995-584X; Clement,
   Bruno/0000-0001-8827-146X
CR *DECL INT DONN GEN, 2003, C GEN UNESCO 32 SESS
   *OECD, 2001, CTR RESS BIOL FOND D
   SCHWARTZENBERG MRG, 2001, INSTALLATION COMITE
NR 3
TC 0
Z9 0
U1 0
U2 0
PU ADIS INTERNATIONAL LTD
PI AUCKLAND
PA 41 CENTORIAN DR, PRIVATE BAG 65901, MAIRANGI BAY, AUCKLAND 1311, NEW
   ZEALAND
SN 0040-5957
J9 THERAPIE
JI Therapie
PD JUL-AUG
PY 2005
VL 60
IS 4
BP 355
EP 357
DI 10.2515/therapie:2005050
PG 3
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 976MS
UT WOS:000232738300004
OA Green Published
DA 2018-10-19
ER

PT J
AU Geringer, J
   Forest, B
   Combrade, P
AF Geringer, J
   Forest, B
   Combrade, P
TI Fretting-corrosion of materials used as orthopaedic implants
SO WEAR
LA English
DT Article
DE fretting-corrosion; orthopaedic implants; PMMA; 316L
ID INTERFACE; SURFACES
AB In the biomedical field, about 6% of hip total joint prostheses have to be replaced after 9 years because of a loosening of the femoral stem. One of the main causes of a new surgical intervention is attributed to the phenomenon of fretting-corrosion, i.e. wear under small movements (lower than 100 mu m) in corrosive aqueous medium.
   To understand this degradation, the fretting between 316L steel and PMMA has been investigated to simulate the fretting between femoral stem and bone cement.
   First, fretting in air has been studied as a reference environment. No significant wear was observed on the stainless steel. PMMA suffers a wear that exhibits a linear evolution as a function of the cumulated dissipated energy. Third body evolution could explain the particular W shape of the active wear track in PMMA, in dry conditions.
   In aerated Ringer's solution, at free corrosion potential, stainless steel suffers significant wear damage, and the wear volume increases linearly with time but not with dissipated energy. Moreover the optical observations and three-dimensional (3-D) profilometry show a 'W' shape of the wear track of 316L. A corrosion mechanism involving a crevice effect enhanced by fretting allows to explain the location of the maximum damage zones.
   Finally, the effect of electrochemical potential on the behaviour of 316L/PMMA contacts has been studied by recording current intensity and cumulated dissipated energy under potentiodynamic conditions. Dissipated energy exhibited a reproducible variation with potential. Lubrication regimes and effect of potential on the surface charges could account for such a behaviour. (c) 2005 Elsevier B.V. All rights reserved.
C1 CNRS, Ecole Natl Super Mines St Etienne, UMR 5146, F-42023 St Etienne, France.
   ANP, Ctr Tech Framatome, F-71205 Le Creusot, France.
RP Geringer, J (reprint author), CNRS, Ecole Natl Super Mines St Etienne, UMR 5146, 158 Cours Fauriel, F-42023 St Etienne, France.
EM geringer@emse.fr
RI yang, lin/G-6662-2011
OI geringer, jean/0000-0002-4843-2844
CR BESSON J, 1984, PRECIS THERMODYNAMIQ, P102
   Exartier C, 2004, CORROS SCI, V46, P1777, DOI 10.1016/j.corsci.2003.10.012
   Fouvry S, 1997, WEAR, V203, P393, DOI 10.1016/S0043-1648(96)07436-4
   HERBERTS P, 1989, CLIN ORTHOP RELAT R, V249, P487
   Hertz H., 1881, ANGEW MATH, V92, P156
   HILLS DA, 1993, MECH ELASTIC CONTACT, P53
   Huq MZ, 1997, WEAR, V212, P151, DOI 10.1016/S0043-1648(97)00167-1
   Johnson K. L., 1985, CONTACT MECH, P84
   KOVACS P, 1992, AM SOC TEST MATER, V1144, P160, DOI 10.1520/STP14863S
   LANDOLT D, 1997, LAUSANNE, P386
   Le Bozec N, 2001, CORROS SCI, V43, P765, DOI 10.1016/S0010-938X(00)00113-X
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   RUBIN PJ, 1993, J BIOMECH, V26, P725, DOI 10.1016/0021-9290(93)90035-D
   Tritschler B, 1999, TRIBOL INT, V32, P587, DOI 10.1016/S0301-679X(99)00099-7
   Walker SL, 2002, LANGMUIR, V18, P2193, DOI 10.1021/la011284j
   WATERHOUSE RB, 1982, ASTM SPECIAL TECHNIC, V780, P3
NR 16
TC 78
Z9 81
U1 2
U2 26
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0043-1648
EI 1873-2577
J9 WEAR
JI Wear
PD JUL-AUG
PY 2005
VL 259
SI SI
BP 943
EP 951
DI 10.1016/j.wear.2004.11.027
PN 2
PG 9
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA 943QX
UT WOS:000230370300019
DA 2018-10-19
ER

PT J
AU Mandl, S
   Attenberger, W
   Stritzker, B
   Rauschenbach, B
AF Mandl, S
   Attenberger, W
   Stritzker, B
   Rauschenbach, B
TI Disorder formation in rutile during ion assisted deposition
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 13th International Conference on Surface Modification of Materials by
   Ion Beams
CY SEP 21-26, 2003
CL San Antonio, TX
SP SW Res Inst
DE ion implantation; rutile; TEM; XRD
ID OXIDE-FILMS; TITANIUM; IMPLANTATION; TIO2; BIOCOMPATIBILITY
AB Ion assisted deposition (IAD) is a well-known method for obtaining dense and well adhering surface layers. Conventional IAD operates with evaporated metal atoms and energetic gaseous ions whereas metal plasma immersion ion implantation and deposition (MePIIID) draws energetic metallic ions from a cathodic arc which may additionally ionise the background gas. TiO2 is a widely investigated material for biomedical, optical and catalysis applications. MePIIID is employed to deposit TiO2 films onto Si substrates at different pulse voltages up to 10 kV X-ray diffraction (XRD) and transmission electron microscopy (TEM) studies are performed to investigate the changing film properties as a function of pulse voltage and to estimate the barrier efficiency against diffusion through the layer. (c) 2004 Elsevier B.V. All rights reserved.
C1 Leibniz Inst Oberflachenmodifizierung, D-04303 Leipzig, Germany.
   Univ Augsburg, Inst Expt Phys 4, D-8900 Augsburg, Germany.
RP Mandl, S (reprint author), Leibniz Inst Oberflachenmodifizierung, Permoserstr 15, D-04303 Leipzig, Germany.
EM stephan.maendl@iom-leipzig.de
CR Alvarez-Herrero A, 1999, THIN SOLID FILMS, V349, P212, DOI 10.1016/S0040-6090(99)00145-5
   ANDERSSON S, 1959, ACTA CHEM SCAND, V13, P989, DOI 10.3891/acta.chem.scand.13-0989
   Attenberger W, 2001, SURF COAT TECH, V142, P412, DOI 10.1016/S0257-8972(01)01080-5
   Bilek MMM, 2003, IEEE T PLASMA SCI, V31, P939, DOI 10.1109/TPS.2003.818409
   Escobar-Alarcon L, 1999, APPL SURF SCI, V137, P38, DOI 10.1016/S0169-4332(98)00486-3
   HOFER F, 1995, ULTRAMICROSCOPY, V59, P15, DOI 10.1016/0304-3991(95)00015-S
   HOSTENPILLER PAM, 1996, J CRYST GROWTH, V106, P779
   Huang N, 1994, J Biomater Appl, V8, P404, DOI 10.1177/088532829400800406
   LARSSON C, 1994, BIOMATERIALS, V15, P1062, DOI 10.1016/0142-9612(94)90092-2
   Lee BH, 1999, APPL PHYS LETT, V74, P3143, DOI 10.1063/1.124089
   Leng YX, 2002, THIN SOLID FILMS, V420, P408, DOI 10.1016/S0040-6090(02)00814-3
   Mandl S, 2002, NUCL INSTRUM METH B, V190, P728, DOI 10.1016/S0168-583X(02)00448-2
   Mandl S, 2002, SURF COAT TECH, V156, P276, DOI 10.1016/S0257-8972(02)00085-3
   Mandl S, 2001, NUCL INSTRUM METH B, V178, P148, DOI 10.1016/S0168-583X(01)00513-4
   MANDL S, 2002, GENET ANAL-BIOMOL E, V19, P131
   MANDL S, 2003, P 26 INT C PHEN ION
   Pan J, 1998, J BIOMED MATER RES, V40, P244, DOI 10.1002/(SICI)1097-4636(199805)40:2<244::AID-JBM9>3.0.CO;2-L
   Pham MT, 2000, SURF COAT TECH, V128, P313, DOI 10.1016/S0257-8972(00)00593-4
   THORNTON JA, 1974, SURF FILMS, V4, P666
NR 19
TC 2
Z9 2
U1 0
U2 3
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD JUN 22
PY 2005
VL 196
IS 1-3
BP 76
EP 80
DI 10.1016/j.surfcoat.2004.08.100
PG 5
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 929VV
UT WOS:000229375600015
DA 2018-10-19
ER

PT J
AU Fuchter, MJ
   Beall, LS
   Baum, SM
   Montalban, AG
   Sakellariou, EG
   Mani, NS
   Miller, T
   Vesper, BJ
   White, AJP
   Williams, DJ
   Barrett, AGM
   Hoffman, BM
AF Fuchter, MJ
   Beall, LS
   Baum, SM
   Montalban, AG
   Sakellariou, EG
   Mani, NS
   Miller, T
   Vesper, BJ
   White, AJP
   Williams, DJ
   Barrett, AGM
   Hoffman, BM
TI Synthesis of porphyrazine-octaamine, hexamine and diamine derivatives
SO TETRAHEDRON
LA English
DT Article
DE porphyrazine; aminoporphyrazine; nickel porphyrazines; Linstead
   macrocyclization; UV-vis spectroscopy; electrochemistry
ID METAL-ION BINDING; SPECTROSCOPIC INVESTIGATIONS;
   SOLITAIRE-PORPHYRAZINES; SECO-PORPHYRAZINES; HYDROGEN-CYANIDE;
   COMPLEXES; CORE; TETRAKIS(THIADIAZOLE)PORPHYRAZINES;
   BIS(DIMETHYLAMINO)PORPHYRAZINES; GENERATION
AB The syntheses of a variety of substituted diaminomaleonitriles, with variable nitrogen substituents, were undertaken. Linstead macrocyclization of the resulting diaminomaleonitriles gave access to a wide range of functionalized porphyrazine-octaamines and hexamines and norphthalocyaninediamines. Conversion of these macrocycles into metallic derivatives and studies of their electronic absorption, solubility and electrochemistry are described. These flexible tetraazaporphyrins show potential in a range of applications including biomedical agents, novel charge-transfer complexes, chemical sensors, novel electronic materials and non-linear optics. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ London Imperial Coll Sci Technol & Med, Dept Chem, London SW7 2AZ, England.
   Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA.
   Northwestern Univ, Dept Chem, Evanston, IL 60208 USA.
RP Barrett, AGM (reprint author), Univ London Imperial Coll Sci Technol & Med, Dept Chem, London SW7 2AZ, England.
EM agmb@imperial.ac.uk; bmh@northwestern.edu
OI Fuchter, Matthew/0000-0002-1767-7072
CR Ahmed M, 2003, ORG LETT, V5, P669, DOI 10.1021/ol027406w
   ANANTANARAYAN A, 1986, J ORG CHEM, V51, P752, DOI 10.1021/jo00355a037
   Anderson ME, 1999, INORG CHEM, V38, P6143, DOI 10.1021/ic990410s
   Anderson ME, 2000, J INORG BIOCHEM, V80, P257, DOI 10.1016/S0162-0134(00)00084-2
   Angeloni S, 2001, J PORPHYR PHTHALOCYA, V5, P881, DOI 10.1002/jpp.558
   Bauer EM, 1999, INORG CHEM, V38, P6114, DOI 10.1021/ic990855g
   Bauer EM, 1999, J PORPHYR PHTHALOCYA, V3, P371, DOI 10.1002/(SICI)1099-1409(199906)3:5<371::AID-JPP140>3.0.CO;2-F
   Baum SM, 2003, J ORG CHEM, V68, P1665, DOI 10.1021/jo026484u
   BAUMANN TF, 1994, J AM CHEM SOC, V116, P2639, DOI 10.1021/ja00085a062
   Baumann TF, 1996, J AM CHEM SOC, V118, P10479, DOI 10.1021/ja9619115
   Baumann TF, 1997, INORG CHEM, V36, P5661, DOI 10.1021/ic9701367
   Beall LS, 1998, J ORG CHEM, V63, P5806, DOI 10.1021/jo9802574
   BEGLAND RW, 1974, J ORG CHEM, V39, P2341, DOI 10.1021/jo00930a004
   BOYER JH, 1976, J AM CHEM SOC, V98, P1099, DOI 10.1021/ja00421a008
   BOYER JH, 1970, CHEM COMMUN, P1204
   COOK AH, 1949, J CHEM SOC, P2337, DOI 10.1039/jr9490002337
   CUELLAR EA, 1981, INORG CHEM, V20, P3766, DOI 10.1021/ic50225a039
   Dolphin D., 1978, PORPHYRINS, VI
   Donzello MP, 2003, J AM CHEM SOC, V125, P14190, DOI 10.1021/ja0344361
   Ehrlich LA, 2000, INORG CHEM, V39, P3963, DOI 10.1021/ic991033m
   Eichhorn D. M., 1995, CHEM COMMUN, P1703
   FERRIS JP, 1972, J AM CHEM SOC, V94, P6968, DOI 10.1021/ja00775a018
   Forsyth TP, 1998, J ORG CHEM, V63, P331, DOI 10.1021/jo971683c
   Fuchter MJ, 2005, J ORG CHEM, V70, P2793, DOI 10.1021/jo047792q
   Goldberg DP, 1998, INORG CHEM, V37, P2873, DOI 10.1021/ic970624e
   Goldberg DP, 1998, INORG CHEM, V37, P2100, DOI 10.1021/ic971498h
   Gouterman M., 1978, PORPHYRINS, V3, P1
   GROVES JT, 1989, J AM CHEM SOC, V111, P4998, DOI 10.1021/ja00195a074
   HAMMER ND, 2005, UNPUB CHARGE DEPENDE
   Hochmuth DH, 2000, EUR J INORG CHEM, P593
   KATRITZKY AR, 1992, SYNTHESIS-STUTTGART, P911
   KHANA N, 1994, J ORG CHEM, V59, P4832
   Lange SJ, 1998, INORG CHEM, V37, P6435, DOI 10.1021/ic980791u
   Lee SW, 2003, PHOTOCHEM PHOTOBIOL, V77, P18, DOI 10.1562/0031-8655(2003)077<0018:TTSOQY>2.0.CO;2
   LEZNOFF CC, 1989, PHTHALOCYANINES PROP, V1
   LINSTEAD RP, 1952, J CHEM SOC, P4839, DOI 10.1039/jr9520004839
   Loiseau FA, 2004, J ORG CHEM, V69, P639, DOI 10.1021/jo035042v
   MAJNI NS, 1994, CHEM COMMUN, P2095
   MARQUIS D, 1995, J ORG CHEM, V60, P7984, DOI 10.1021/jo00129a045
   Michel SLJ, 2001, PROG INORG CHEM, V50, P473
   MOI MK, 1988, J AM CHEM SOC, V110, P6266, DOI 10.1021/ja00226a063
   Montalban AG, 1999, J PHYS CHEM A, V103, P4352, DOI 10.1021/jp9905068
   Montalban AG, 1997, J ORG CHEM, V62, P9284, DOI 10.1021/jo971599x
   Montalban AG, 2000, J ORG CHEM, V65, P2472, DOI 10.1021/jo991646g
   MONTALBAN AG, 2003, J CHEM SOC DA, P2093
   MOORE WJ, 1995, TETRAHEDRON LETT, V36, P6599, DOI 10.1016/00404-0399(50)1349M-
   Nie HL, 1999, J ORG CHEM, V64, P6791, DOI 10.1021/jo9907890
   Sakellariou EG, 2000, J PHOTOCH PHOTOBIO A, V136, P185, DOI 10.1016/S1010-6030(00)00343-9
   Sakellariou EG, 2003, TETRAHEDRON, V59, P9083, DOI 10.1016/j.tet.2003.09.060
   Sakellariou EG, 2002, INORG CHEM, V41, P2182, DOI 10.1021/ic0111583
   Savage SA, 1998, J ORG CHEM, V63, P10048, DOI 10.1021/jo981505z
   Stuzhin P.A., 2003, PORPHYRIN HDB, P263, DOI DOI 10.1016/B978-0-08-092389-5.50011-0
   Stuzhin PA, 1998, INORG CHEM, V37, P1533, DOI 10.1021/ic9609259
   Trabanco AA, 2000, SYNLETT, P1010
   VILLANUEVA A, 1994, J PHOTOCH PHOTOBIO B, V23, P49, DOI 10.1016/1011-1344(93)06982-9
   WIBERG KB, 1957, J AM CHEM SOC, V79, P3160, DOI 10.1021/ja01569a046
   Zhao M, 2003, ANGEW CHEM INT EDIT, V42, P462, DOI 10.1002/anie.200390140
   Zhao M, 2004, INORG CHEM, V43, P3377, DOI 10.1021/ic035402x
NR 58
TC 37
Z9 37
U1 2
U2 9
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0040-4020
J9 TETRAHEDRON
JI Tetrahedron
PD JUN 20
PY 2005
VL 61
IS 25
BP 6115
EP 6130
DI 10.1016/j.tet.2005.03.090
PG 16
WC Chemistry, Organic
SC Chemistry
GA 934PZ
UT WOS:000229722000013
DA 2018-10-19
ER

PT J
AU Sannino, A
   Nicolais, L
AF Sannino, A
   Nicolais, L
TI Concurrent effect of microporosity and chemical structure on the
   equilibrium sorption properties of cellulose-based hydrogels
SO POLYMER
LA English
DT Article
DE hydrogel; swelling; ionic strength
ID SWELLING EQUILIBRIA; CROSS-LINKING; POLYMER GELS; RELEASE; COMPOSITES;
   PHASES
AB Polyelectrolite hydrogels are crosslinked polymers which display high sorption capacity in water and water solutions. They are widely used in the marked of personal hygiene products, as well as in other biomedical and industrial applications. In the most industrial application they are not biodegradable and prepared starting from acrylamide.
   In this work, the chemical-physical analysis of a novel class of natural polymers-based microporous superabsorbent hydrogels has been presented. The main focus is the definition of the relationship between material's chemical-physical structure and its equilibrium sorption properties.
   The effect of the variation of the degree of crosslinking, the polyelectrolyte nature of the backbone and the hydrogel microporosity on its swelling properties has been analysed, and a good agreement with the theoretical statements has been displayed.
   The effect of the ionic strength and the pH of the external solution in contact with the hydrogel on its equilibrium sorption properties has also been assessed, and an high sensitivity to these variations was detected for all the tested chemical compositions and physical structures.
   This work have to be considered part of the efforts towards the reduction of the environmental impact of the large scale consumption industrial polymer based products. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Lecce, Dept Engn Innovat, I-73100 Lecce, Italy.
   Univ Naples Federico II, Dept Mat & Prod Engn, I-80125 Naples, Italy.
RP Sannino, A (reprint author), Univ Lecce, Dept Engn Innovat, Via Monteroni, I-73100 Lecce, Italy.
EM alessandro.sannino@unile.it
OI Sannino, Alessandro/0000-0001-8959-4412
CR ANBERGEN U, 1990, POLYMER, V31, P1854, DOI 10.1016/0032-3861(90)90006-K
   Antonietti M, 1998, LANGMUIR, V14, P2670, DOI 10.1021/la971054y
   Antonietti M, 1999, MACROMOLECULES, V32, P1383, DOI 10.1021/ma9812478
   BAKER JP, 1992, MACROMOLECULES, V25, P1955, DOI 10.1021/ma00033a019
   Beebe DJ, 2000, NATURE, V404, P588, DOI 10.1038/35007047
   Bergbreiter DE, 1998, MACROMOLECULES, V31, P6053, DOI 10.1021/ma980836a
   BRANNONPEPPAS L, 1990, ABSORBENT POLYM TECH, P67
   Capitani D, 2000, MACROMOLECULES, V33, P430, DOI 10.1021/ma9914117
   Chen J, 2000, J CONTROL RELEASE, V64, P39, DOI 10.1016/S0168-3659(99)00139-X
   Chen J, 2000, CARBOHYD POLYM, V41, P259, DOI 10.1016/S0144-8617(99)00144-7
   Chen J, 2000, J CONTROL RELEASE, V65, P73, DOI 10.1016/S0168-3659(99)00238-2
   DELNOBILE MA, 2003, Patent No. 66304422
   Esposito F, 1996, J APPL POLYM SCI, V60, P2403
   Flory J., 1953, PRINCIPLES POLYM CHE
   GROSS JR, 1990, ABSORBENT POLYM TECH
   HARSH DC, 1990, ABSORBENT POLYM TECH, P103
   Holtz JH, 1997, NATURE, V389, P829
   HOOPER HH, 1990, MACROMOLECULES, V23, P1096, DOI 10.1021/ma00206a031
   Ichikawa H, 2000, J CONTROL RELEASE, V63, P107, DOI 10.1016/S0168-3659(99)00181-9
   IRIE Y, 1990, Patent No. 4920202
   Kang HW, 1999, BIOMATERIALS, V20, P1339, DOI 10.1016/S0142-9612(99)00036-8
   Lenzi F, 2003, POLYMER, V44, P1577, DOI 10.1016/S0032-3861(02)00939-4
   Makino K, 2001, COLLOID SURFACE B, V20, P341, DOI 10.1016/S0927-7765(00)00201-0
   MASUDA F, 1987, SUPERABSORBENT POLYM
   MENSITIERI G, 2001, Patent No. 0168713
   OVERBEEK J T, 1956, Prog Biophys Biophys Chem, V6, P57
   Park TG, 1999, BIOMATERIALS, V20, P517, DOI 10.1016/S0142-9612(98)00197-5
   Pradas MM, 2001, POLYMER, V42, P4667
   Takeda H, 1985, US Patent, Patent No. [4,525,527, 4525527]
NR 29
TC 41
Z9 44
U1 0
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
J9 POLYMER
JI Polymer
PD JUN 17
PY 2005
VL 46
IS 13
BP 4676
EP 4685
DI 10.1016/j.polymer.2005.03.072
PG 10
WC Polymer Science
SC Polymer Science
GA 933XW
UT WOS:000229667200019
DA 2018-10-19
ER

PT J
AU Lv, Q
   Cao, CB
   Zhang, Y
   Ma, XL
   Zhu, HS
AF Lv, Q
   Cao, CB
   Zhang, Y
   Ma, XL
   Zhu, HS
TI Preparation of insoluble fibroin films without methanol treatment
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE conformational analysis; mechanical properties; structure
ID MORI SILK FIBROIN; PHYSICAL-PROPERTIES; CASTING TEMPERATURE;
   HEAT-TREATMENT; CONFORMATION; MORPHOLOGY; MEMBRANE
AB Insoluble fibroin films were prepared without methanol treatment. A 15 wt % fibroin solution was obtained through concentration, and then, the insoluble film was achieved by the adjustment of the drying temperature and rate. These films were examined through Fourier transform infrared-attenuated total reflection, X-ray diffraction, and scanning electron microscopy to determine the structure of the silk fibroin. The physical and mechanical properties were investigated to discover the feasibility of using these films as biomedical materials. When fibroin films were dried above 60 degrees C, abundant beta-sheet crystals existed in the fibroin films, and many globule-containing micelles aggregated and interacted with each other, which resulted in excellent mechanical properties of the regenerated fibroin films in the wet state. Interestingly, the amide III band of the random coil structure in the fibroin films dried at 70 and 80 degrees C was shifted to a lower frequency, 1228 cm(-1), which meant that a partly orientated structure formed. This may have also affected the mechanical properties of the fibroin films. The tensile strength and breaking elongation of the films dried at 70 degrees C were 29.8 MPa and 59.6%,, which is distinctly superior to fibroin films treated with methanol. If the drying temperature was raised to 60 degrees C, the stability of the films in water was also excellent. (c) 2005 Wiley Periodicals, Inc.
C1 Beijing Inst Technol, Res Ctr Mat Sci, Beijing 100081, Peoples R China.
RP Cao, CB (reprint author), Beijing Inst Technol, Res Ctr Mat Sci, Beijing 100081, Peoples R China.
EM cbcao@bit.edu.cn
RI Cao, Chuanbao/J-5396-2013
OI Cao, Chuanbao/0000-0003-2830-4383
CR Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   DEMURA M, 1991, J MEMBRANE SCI, V59, P39, DOI 10.1016/S0376-7388(00)81220-X
   Freddi G, 1997, J POLYM SCI POL PHYS, V35, P841, DOI 10.1002/(SICI)1099-0488(19970415)35:5<841::AID-POLB13>3.0.CO;2-A
   He SJ, 1999, INT J BIOL MACROMOL, V24, P187, DOI 10.1016/S0141-8130(99)00004-5
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Kweon H, 2001, J APPL POLYM SCI, V81, P2271, DOI 10.1002/app.1667
   Kweon H, 2001, J APPL POLYM SCI, V80, P928, DOI 10.1002/app.1172
   MAGOSHI J, 1985, J POLYM SCI POL PHYS, V23, P227, DOI 10.1002/pol.1985.180230120
   MAGOSHI J, 1977, POLYMER, V18, P643, DOI 10.1016/0032-3861(77)90229-4
   MASUHIRO T, 1994, J POLYM SCI POL LETT, V32, P961
   Mathur AB, 1997, BIOPOLYMERS, V42, P61, DOI 10.1002/(SICI)1097-0282(199707)42:1<61::AID-BIP6>3.0.CO;2-#
   Nam J, 2001, J APPL POLYM SCI, V81, P3008, DOI 10.1002/app.1751
   Noishiki Y, 2002, J APPL POLYM SCI, V86, P3425, DOI 10.1002/app.11370
   NORIHIKO M, 1990, POLYMER, V31, P265
   Petrini P, 2001, J MATER SCI-MATER M, V12, P849, DOI 10.1023/A:1012847301850
   Putthanarat S, 2002, POLYMER, V43, P3405, DOI 10.1016/S0032-3861(02)00161-1
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Tretinnikov ON, 2001, LANGMUIR, V17, P7406, DOI 10.1021/la010791y
   Tsuboi Y, 2001, APPL PHYS A-MATER, V73, P637, DOI 10.1007/s003390100984
   Wilson D, 2000, BIOPHYS J, V78, P2690, DOI 10.1016/S0006-3495(00)76813-5
   YOSHIMIZU H, 1990, J APPL POLYM SCI, V40, P1745, DOI 10.1002/app.1990.070400928
NR 21
TC 28
Z9 29
U1 0
U2 29
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD JUN 15
PY 2005
VL 96
IS 6
BP 2168
EP 2173
DI 10.1002/app.21682
PG 6
WC Polymer Science
SC Polymer Science
GA 921PF
UT WOS:000228776100022
DA 2018-10-19
ER

PT J
AU Laroussi, M
AF Laroussi, M
TI Low temperature plasma-based sterilization: Overview and
   state-of-the-art
SO PLASMA PROCESSES AND POLYMERS
LA English
DT Article
DE atmospheric pressure glow discharges (APGD); bacteria spores; cold
   plasma; non-thermal plasma; ozone; radicals; sterilization; UV-photon
ID ATMOSPHERIC-PRESSURE PLASMAS; GLOW-DISCHARGE PLASMA; DECONTAMINATION;
   INACTIVATION; BACTERIA; SURFACES; VOLUME; ROLES
AB Low temperature, high pressure, non-equilibrium plasmas are now routinely used in several material processing applications, and in some cases are competing with low pressure plasmas in areas where these have historically been dominant. Etching and deposition are examples of such applications. Amongst the novel applications of non-equilibrium plasmas, biomedical applications such as electrosurgery, surface modification of biocompatible materials, and the sterilization of heat-sensitive medical tools are particularly interesting. In this paper, first a brief overview of recent research on reduced-pressure plasma-based sterilization/ decontamination methods is given. Then a detailed review and discussion on the effects of atmospheric pressure non-equilibrium plasmas on the cells of bacteria is presented. This includes the evaluation of the inactivation kinetics and the roles of the various plasma agents in the inactivation process. Measurements of the plasma temperature, the UV emission, and concentrations of various reactive species for the case of air plasma are presented. Plasma sub-lethal effects are also briefly discussed, and the prospects of the use of "cold" plasmas in the biomedical field are outlined.
C1 Old Dominion Univ, Dept Elect & Comp Engn, Norfolk, VA 23529 USA.
   Old Dominion Univ, Ctr Bioelect, Norfolk, VA 23529 USA.
RP Laroussi, M (reprint author), Old Dominion Univ, Dept Elect & Comp Engn, 231 Kaufman Hall, Norfolk, VA 23529 USA.
EM mlarouss@odu.edu
CR BETTLEHIM FA, 1995, INTRO GEN ORGANIC BI, P525
   BIRMINGHAM J, 2003, P EL C VER ENG INC S, P16
   BLAKELY EA, 2002, P IEEE INT C PLASM S, P253
   BLOCK SS, 1992, ENCY MICROBIOLOGY, V4, P87
   Bol'shakov AA, 2004, AIAA J, V42, P823, DOI 10.2514/1.9562
   ELIASSON B, 1991, IEEE T PLASMA SCI, V19, P1063, DOI 10.1109/27.125031
   Herrmann HW, 1999, PHYS PLASMAS, V6, P2284, DOI 10.1063/1.873480
   KANAZAWA S, 1988, J PHYS D APPL PHYS, V21, P838, DOI 10.1088/0022-3727/21/5/028
   Kelly-Wintenberg K, 1998, J IND MICROBIOL BIOT, V20, P69, DOI 10.1038/sj.jim.2900482
   Kogelschatz U, 2002, IEEE T PLASMA SCI, V30, P1400, DOI 10.1109/TPS.2002.804201
   KOINUMA H, 1992, APPL PHYS LETT, V60, P816, DOI 10.1063/1.106527
   Kunhardt EE, 2000, IEEE T PLASMA SCI, V28, P189, DOI 10.1109/27.842901
   Laroussi M, 1999, IEEE T PLASMA SCI, V27, P34, DOI 10.1109/27.763016
   Laroussi M, 2003, NEW J PHYS, V5, DOI 10.1088/1367-2630/5/1/341
   Laroussi M, 2004, INT J MASS SPECTROM, V233, P81, DOI 10.1016/j.ijms.2003.11.016
   Laroussi M, 2002, APPL PHYS LETT, V81, P772, DOI 10.1063/1.1494863
   Laroussi M, 2002, IEEE T PLASMA SCI, V30, P158, DOI 10.1109/TPS.2002.1003972
   Laroussi M, 2000, IEEE T PLASMA SCI, V28, P184, DOI 10.1109/27.842899
   Laroussi M, 2002, IEEE T PLASMA SCI, V30, P1409, DOI 10.1109/TPS.2002.804220
   Laroussi M, 2004, P IEEE INT C PLASM S, P122
   MASSINES E, 1992, P INT C GAS DISCH TH, P730
   Mendis DA, 2000, IEEE T PLASMA SCI, V28, P1304, DOI 10.1109/27.893321
   Moisan M, 2001, INT J PHARMACEUT, V226, P1, DOI 10.1016/S0378-5173(01)00752-9
   MOISAN M, 1991, J PHYS D APPL PHYS, V24, P1025, DOI 10.1088/0022-3727/24/7/001
   MOISAN M, 2003, 5 INT WORKSH MICR DI, P210
   Montie TC, 2000, IEEE T PLASMA SCI, V28, P41, DOI 10.1109/27.842860
   Moreau S, 2000, J APPL PHYS, V88, P1166, DOI 10.1063/1.373792
   NORMAN A, 1954, J CELL COMPAR PHYSL, V44, P1, DOI 10.1002/jcp.1030440102
   Philip N, 2002, IEEE T PLASMA SCI, V30, P1429, DOI 10.1109/TPS.2002.804203
   SANCHEZESTRADA FS, 2002, P IEEE INT C PLASM S, P254
   Schoenbach KH, 1996, APPL PHYS LETT, V68, P13, DOI 10.1063/1.116739
   Scutze A, 1998, IEEE T PLASMA SCI, V26, P1685
   Smulders EHWM, 1998, IEEE T PLASMA SCI, V26, P1476, DOI 10.1109/27.736042
   Stalder K. R., 2003, P GAS EL C SAN FRANC, P16
   Stoffels E, 2002, PLASMA SOURCES SCI T, V11, P383, DOI 10.1088/0963-0252/11/4/304
   Stoffels E, 2002, HIGH TEMP MATER P-US, V6, P191
   Stoffels E, 2003, P GAS EL C SAN FRANC, P16
   YAMAMOTO M, 2001, P 15 INT S PLASM CHE, V2, P743
NR 38
TC 616
Z9 639
U1 14
U2 222
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1612-8850
J9 PLASMA PROCESS POLYM
JI Plasma Process. Polym.
PD JUN 14
PY 2005
VL 2
IS 5
BP 391
EP 400
DI 10.1002/ppap.200400078
PG 10
WC Physics, Applied; Physics, Fluids & Plasmas; Physics, Condensed Matter;
   Polymer Science
SC Physics; Polymer Science
GA 943WK
UT WOS:000230385400003
DA 2018-10-19
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Varian unveils expandable MRI
SO CHEMICAL & ENGINEERING NEWS
LA English
DT News Item
AB Varian have launched a new magnetic resonance imaging system for biomedical and materials science applications.This new system initially offers up to four transmitter and eight receiver channels. The scanner was designed to improve the rate of implementation of magnetic resonance imaging experiments.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0009-2347
J9 CHEM ENG NEWS
JI Chem. Eng. News
PD JUN 13
PY 2005
VL 83
IS 24
BP 29
EP 29
PG 1
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA 936JE
UT WOS:000229850500049
DA 2018-10-19
ER

PT J
AU Bayari, S
   Severcan, F
AF Bayari, S
   Severcan, F
TI FTIR study of biodegradable biopolymers: P(3HB), P(3HB-co-4HB) and
   P(3HB-co-3HV)
SO JOURNAL OF MOLECULAR STRUCTURE
LA English
DT Article; Proceedings Paper
CT 27th European Congress on Molecular Spectroscopy
CY SEP 05-10, 2004
CL AGH Univ Sci & Technol, Cracow, POLAND
SP AGH Univ Sci & Technol, Fac Mat Sci Ceram
HO AGH Univ Sci & Technol
DE poly(3-hydroxybutyrate); poly(3-hydroxybutyrate-co-3-hydroxyvalerate);
   poly(3-hydroxybutyrate-co-4-hydroxybutyrate); FTIR; crystallinity
ID TRANSFORM INFRARED-SPECTROSCOPY; ENZYMATIC DEGRADATION;
   POLY(3-HYDROXYBUTYRATE-CO-3-HYDROXYVALERATE); POLYHYDROXYALKANOATES;
   BACTERIAL; POLYESTERS; PLASMA; FILM
AB Biodegradable materials have various important applications in the biomedical field. Poly(hydroxyalkanoate)s are a family of microbially synthesized polymers and known to degrade in vitro and vivo, as well as in microorganism. The structure, crystallization and melting of three types of poly(hyroxyalkanoate)s namely poly(3-hydroxybutyrate) homopolymer, P(3HB), poly(3-hydroxybutyrate-co-3-hydroxyvalerate) copolymer, P(3HB-co-3HV, and poly(3-hydroxybutyrate-co-4-hydroxybutyrate) copolymer, P(3HB-co-4HB) were investigated using Fourier transform infrared (FTIR) spectroscopy. P(3HB-co-3HV) and P(3HB-co-4HB) were studied in the presence of different molar ratio of 3HV and 4HB, respectively. The FTIR spectra of samples in solution and as cast film were compared at room temperature, in the region of 4000-400 cm(-1) which showed significant differences between the two phases. Furthermore, the temperature dependent variations of these polymers were also studied between 25 and 200 degrees C. The heating and cooling FTIR experiments of the samples showed that P(3HB-co-3HV) and P(3HB-co-4HB) are reversible while P(3HB) is irreversible. The absorbance variances of the crystalline and the amorphous bands revealed that the structure, crystallinity and thermal behavior of, P(3HB), P(3HB-co-4HB) and P(3HB-co-3HV) are different from each other. This study also allowed us the identification of the bands which are sensitive to crystallinity. For example, the bands at 1185, 1278 and 1724 cm(-1) were found to be sensitive to crystallinity. In the present study, P(3HB) and P(3HB-co-3HV) samples which were modified by applying oxygen plasma to create hydrophilic surfaces were also analyzed. The shifting in the frequency of some infrared bands (i.e. C-O and C-O-C) and the appearance of some bands may indicate some modification on the structure of the polymers. (c) 2005 Elsevier B.V. All rights reserved.
C1 Hacettepe Univ, Fac Educ, Dept Phys, TR-06532 Ankara, Turkey.
   Middle E Tech Univ, Dept Biol Sci, TR-06531 Ankara, Turkey.
RP Bayari, S (reprint author), Hacettepe Univ, Fac Educ, Dept Phys, TR-06532 Ankara, Turkey.
EM bayari@hacettepe.edu.tr
RI Bayari, Sevgi/N-9506-2018
OI Severcan, Feride/0000-0002-1717-2517
CR BARHAM PJ, 1986, J POLYM SCI POL PHYS, V24, P69, DOI 10.1002/polb.1986.180240108
   BLOEMBERGEN S, 1986, MACROMOLECULES, V19, P2865, DOI 10.1021/ma00165a034
   Fei B, 2003, EUR POLYM J, V39, P1939, DOI 10.1016/S0014-3057(03)00114-9
   KAMIYA N, 1991, MACROMOLECULES, V24, P2178, DOI 10.1021/ma00009a006
   KAMIYA N, 1990, MACROMOLECULES, V23, P1313, DOI 10.1021/ma00207a015
   KUNIOKA M, 1990, MACROMOLECULES, V23, P1933, DOI 10.1021/ma00209a009
   KUNIOKA M, 1989, MACROMOLECULES, V22, P694, DOI 10.1021/ma00192a031
   Lara L.M., 1991, MICROBIOL MOL BIOL R, V63, P21
   Lee SY, 1996, BIOTECHNOL BIOENG, V49, P1
   Mas A, 1996, MACROMOL CHEM PHYS, V197, P2331, DOI 10.1002/macp.1996.021970723
   NAKAMURA K, 1994, POLYMER, V35, P193, DOI 10.1016/0032-3861(94)90071-X
   Randriamahefa S, 2003, BIOMACROMOLECULES, V4, P1092, DOI 10.1021/bm034104o
   Ryou JH, 2003, MACROMOL BIOSCI, V3, P44, DOI 10.1002/mabi.200390004
   Spyros A, 1996, MACROMOLECULES, V29, P2479, DOI 10.1021/ma951549z
   Steinbuchel A, 1998, TRENDS BIOTECHNOL, V16, P419, DOI 10.1016/S0167-7799(98)01194-9
   Sudesh K, 2000, PROG POLYM SCI, V25, P1503, DOI 10.1016/S0079-6700(00)00035-6
   Tian G, 2002, J POLYM SCI POL PHYS, V40, P649, DOI 10.1002/polb.10126
   Wu Q, 2001, J APPL POLYM SCI, V82, P934, DOI 10.1002/app.1925.abs
   Xu J, 2002, POLYMER, V43, P6893, DOI 10.1016/S0032-3861(02)00615-8
   Yoshie N, 2002, BIOMACROMOLECULES, V3, P1320, DOI 10.1021/bm020077a
   Yoshie N, 1999, MACROMOL CHEM PHYSIC, V200, P977, DOI 10.1002/(SICI)1521-3935(19990501)200:5<977::AID-MACP977>3.0.CO;2-Y
   1998, NATO SCI STABILITY P
NR 22
TC 34
Z9 34
U1 0
U2 22
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-2860
EI 1872-8014
J9 J MOL STRUCT
JI J. Mol. Struct.
PD JUN 3
PY 2005
VL 744
SI SI
BP 529
EP 534
DI 10.1016/j.molstruc.2004.12.029
PG 6
WC Chemistry, Physical
SC Chemistry
GA 933UF
UT WOS:000229657700071
DA 2018-10-19
ER

PT J
AU Marvin, JS
   Zhu, ZP
AF Marvin, JS
   Zhu, ZP
TI Recombinant approaches to IgG-like bispecific antibodies
SO ACTA PHARMACOLOGICA SINICA
LA English
DT Review
DE bispecific antibodies; single chain Fv; diabody; immunoglobulin G;
   biomedical engineering
ID SINGLE-DOMAIN ANTIBODIES; METASTATIC BREAST-CANCER; GROWTH-FACTOR
   RECEPTOR; NON-HODGKINS-LYMPHOMA; MONOCLONAL-ANTIBODY; ANTIGEN-BINDING;
   IN-VITRO; EFFICIENT ROUTE; DIABODIES; FRAGMENTS
AB One of the major obstacles in the development of bispecific antibodies (BsAb) has been the difficulty of producing the materials in sufficient quality and quantity by traditional technologies, such as the hybrid hybridoma and chemical conjugation methods. In contrast to the rapid and significant progress in the development of recombinant BsAb fragments (such as diabody and tandem single chain Fv), the successful design and production of full length IgG-like BsAb has been limited. Compared to smaller fragments, IgG-like BsAb have long serum half-life and are capable of supporting secondary immune functions, such as antibody-dependent cellular cytotoxicity and complement-mediated cytotoxicity. The development of IgG-like BsAb as therapeutic agents will depend heavily on our research progress in the design of recombinant BsAb constructs (or formats) and production efficiency. This review will focus on recent advances in various recombinant approaches to the engineering and production of IgG-like BsAb.
C1 ImClone Syst Inc, Dept Antibody Technol, New York, NY 10014 USA.
RP Zhu, ZP (reprint author), ImClone Syst Inc, Dept Antibody Technol, New York, NY 10014 USA.
EM zhenping.zhu@imclone.com
OI Marvin, Jonathan/0000-0003-2294-4515
CR Alt M, 1999, FEBS LETT, V454, P90, DOI 10.1016/S0014-5793(99)00782-6
   Atwell S, 1997, J MOL BIOL, V270, P26, DOI 10.1006/jmbi.1997.1116
   Baeuerle PA, 2003, CURR OPIN MOL THER, V5, P413
   BRENNAN M, 1985, SCIENCE, V229, P81, DOI 10.1126/science.3925553
   Cao Y, 2003, ADV DRUG DELIVER REV, V55, P171, DOI 10.1016/S0169-409X(02)00178-3
   Carter P, 1995, J Hematother, V4, P463, DOI 10.1089/scd.1.1995.4.463
   Chang CH, 2002, MOL CANCER THER, V1, P553
   Clynes RA, 2000, NAT MED, V6, P443
   Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639
   Colby DW, 2004, METHOD ENZYMOL, V388, P348
   COLCHER D, 1990, J NATL CANCER I, V82, P1191, DOI 10.1093/jnci/82.14.1191
   Coloma MJ, 1997, J IMMUNOL, V158, P733
   Conrath KE, 2001, J BIOL CHEM, V276, P7346
   Corvalan J R, 1988, Int J Cancer Suppl, V2, P22
   DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001
   EIGENBROT C, 1993, J MOL BIOL, V229, P969, DOI 10.1006/jmbi.1993.1099
   Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381
   Ferrini S, 2001, METH MOL B, V166, P177
   FitzGerald K, 1997, PROTEIN ENG, V10, P1221, DOI 10.1093/protein/10.10.1221
   Ford CHJ, 2001, INT J CANCER, V92, P851, DOI 10.1002/ijc.1262
   Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2
   HOLLIGER P, 1993, P NATL ACAD SCI USA, V90, P6444, DOI 10.1073/pnas.90.14.6444
   Ichikawa K, 2001, NAT MED, V7, P954, DOI 10.1038/91000
   James ND, 2001, BRIT J CANCER, V85, P152, DOI 10.1054/bjoc.2001.1878
   JUNG SH, 1994, PROTEINS, V19, P35, DOI 10.1002/prot.340190106
   Kipriyanov Sergey M, 2002, Methods Mol Biol, V178, P317
   Kipriyanov SM, 1999, J MOL BIOL, V293, P41, DOI 10.1006/jmbi.1999.3156
   Kipriyanov SM, 2002, J IMMUNOL, V169, P137, DOI 10.4049/jimmunol.169.1.137
   KNIGHT DM, 1993, MOL IMMUNOL, V30, P1443, DOI 10.1016/0161-5890(93)90106-L
   Kontermann RE, 2005, ACTA PHARMACOL SIN, V26, P1, DOI 10.1111/j.1745-7254.2005.00008.x
   LI S, 2005, IN PRESS CANC CELL
   Lipovsek D, 2004, J IMMUNOL METHODS, V290, P51, DOI 10.1016/j.jim.2004.04.008
   Lu D, 2004, J BIOL CHEM, V279, P2856, DOI 10.1074/jbc.M310132200
   Lu D, 1999, J IMMUNOL METHODS, V230, P159, DOI 10.1016/S0022-1759(99)00135-0
   Lu D, 2003, J IMMUNOL METHODS, V279, P219, DOI 10.1016/S0022-1759(03)00251-5
   Lu D, 2002, J IMMUNOL METHODS, V267, P213, DOI 10.1016/S0022-1759(02)00148-5
   Lu D, 2001, CANCER RES, V61, P7002
   LU D, 2005, IN PRESS J BIOL 0309
   Maynard JA, 2002, NAT BIOTECHNOL, V20, P597, DOI 10.1038/nbt0602-597
   McLaughlin P, 1998, J CLIN ONCOL, V16, P2825, DOI 10.1200/JCO.1998.16.8.2825
   Merchant AM, 1998, NAT BIOTECHNOL, V16, P677, DOI 10.1038/nbt0798-677
   Miller K, 2003, J IMMUNOL, V170, P4854, DOI 10.4049/jimmunol.170.9.4854
   MILSTEIN C, 1983, NATURE, V305, P537, DOI 10.1038/305537a0
   MUYLDERMANS S, 1994, PROTEIN ENG, V7, P1129, DOI 10.1093/protein/7.9.1129
   Nowakowski A, 2002, P NATL ACAD SCI USA, V99, P11346, DOI 10.1073/pnas.172229899
   Ridgway JBB, 1996, PROTEIN ENG, V9, P617, DOI 10.1093/protein/9.7.617
   Riechmann L, 1999, J IMMUNOL METHODS, V231, P25, DOI 10.1016/S0022-1759(99)00138-6
   SIDHUA SS, 2005, PHAGE DISPLAY BIOTEC
   Silverman DH, 2004, CANCER TREAT REV, V30, P165, DOI 10.1016/j.ctrv.2003.07.006
   Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101
   Todorovska A, 2001, J IMMUNOL METHODS, V248, P47, DOI 10.1016/S0022-1759(00)00342-2
   Worn A, 2001, J MOL BIOL, V305, P989, DOI 10.1006/jmbi.2000.4265
   Xie ZG, 2005, J IMMUNOL METHODS, V296, P95, DOI 10.1016/j.jim.2004.11.005
   Xiong DS, 2002, CANCER LETT, V177, P29, DOI 10.1016/S0304-3835(01)00758-3
   Yagita H, 2004, CANCER SCI, V95, P777, DOI 10.1111/j.1349-7006.2004.tb02181.x
   Zhu ZP, 1997, PROTEIN SCI, V6, P781
   Zhu ZP, 1996, BIO-TECHNOL, V14, P192, DOI 10.1038/nbt0296-192
   Zuo Z, 2000, PROTEIN ENG, V13, P361, DOI 10.1093/protein/13.5.361
NR 58
TC 68
Z9 69
U1 0
U2 17
PU ACTA PHARMACOLOGICA SINICA
PI SHANGHAI
PA 294 TAI-YUAN RD, SHANGHAI, 200031, PEOPLES R CHINA
SN 1671-4083
EI 1745-7254
J9 ACTA PHARMACOL SIN
JI Acta Pharmacol. Sin.
PD JUN
PY 2005
VL 26
IS 6
BP 649
EP 658
DI 10.1111/j.1745-7254.2005.00119.x
PG 10
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 937IL
UT WOS:000229917700002
PM 15916729
OA Bronze
DA 2018-10-19
ER

PT J
AU Delen, D
   Walker, G
   Kadam, A
AF Delen, D
   Walker, G
   Kadam, A
TI Predicting breast cancer survivability: a comparison of three data
   mining methods
SO ARTIFICIAL INTELLIGENCE IN MEDICINE
LA English
DT Article
DE breast cancer survivability; data mining; k-fold-cross-validation; SEER
ID ARTIFICIAL NEURAL-NETWORKS; PROGNOSIS; PROGRAM; TREES
AB Objective: The prediction of breast cancer survivability has been a challenging research problem for many researchers. Since the early dates of the related research, much advancement has been recorded in several related fields. For instance, thanks to innovative biomedical technologies, better explanatory prognostic factors are being measured and recorded; thanks to Low cost computer hardware and software technologies, high volume better quality data is being collected and stored automatically; and finally thanks to better analytical methods, those voluminous data is being processed effectively and efficiently. Therefore, the main objective of this manuscript is to report on a research project where we took advantage of those available technological advancements to develop prediction models for breast cancer survivability.
   Methods and material: We used two popular data mining algorithms (artificial neural networks and decision trees) along with a most commonly used statistical method (Logistic regression) to develop the prediction models using a Large dataset (more than 200,000 cases). We also used 10-fold cross-validation methods to measure the unbiased estimate of the three prediction models for performance comparison purposes.
   Results: The results indicated that the decision tree (C5) is the best predictor with 93.6% accuracy on the holdout sample (this prediction accuracy is better than any reported in the literature), artificial neural networks came out to be the second with 91.2% accuracy and the logistic regression models came out to be the worst of the three with 89.2% accuracy.
   Conclusion: The comparative study of multiple prediction models for breast cancer survivability using a large dataset along with a 10-fold cross-validation provided us with an insight into the relative prediction ability of different data mining methods. Using sensitivity analysis on neural network models provided us with the prioritized importance of the prognostic factors used in the study. &COPY; 2004 Elsevier B.V. All rights reserved.
C1 Oklahoma State Univ, Dept Management Sci & Informat Syst, Tulsa, OK 74106 USA.
RP Delen, D (reprint author), Oklahoma State Univ, Dept Management Sci & Informat Syst, 700 N Greenwood Venue, Tulsa, OK 74106 USA.
EM delen@okstate.edu
CR Abbass HA, 2002, ARTIF INTELL MED, V25, P265, DOI 10.1016/S0933-3657(02)00028-3
   Abu-Hanna A, 2003, ARTIF INTELL MED, V29, P5, DOI 10.1016/S0933-3657(03)00047-2
   Berman JJ, 2002, ARTIF INTELL MED, V26, P25, DOI 10.1016/S0933-3657(02)00050-7
   Bostwick DG, 2001, CANCER, V91, P1643, DOI 10.1002/1097-0142(20010415)91:8+<1643::AID-CNCR1177>3.0.CO;2-I
   Breiman L., 1984, CLASSIFICATION REGRE
   Brenner H, 2002, EUR J CANCER, V38, P690, DOI 10.1016/S0959-8049(02)00003-5
   Bundred NJ, 2001, CANCER TREAT REV, V27, P137, DOI 10.1053/ctrv.2001.0207
   Burke HB, 1997, CANCER, V79, P857, DOI 10.1002/(SICI)1097-0142(19970215)79:4<857::AID-CNCR24>3.0.CO;2-Y
   Burke HB, 1995, ADV NEURAL INFORMATI, P1063
   Calle J., 2004, BREAST CANC FACTS FI, P1
   Cios KJ, 2002, ARTIF INTELL MED, V26, P1, DOI 10.1016/S0933-3657(02)00049-0
   Cox DR, 1984, ANAL SURVIVAL DATA
   D'Eredita G, 2001, EUR J CANCER, V37, P591, DOI 10.1016/S0959-8049(00)00435-4
   Edwards BK, 2002, CANCER, V94, P2766, DOI 10.1002/cncr.10593
   Hankey BF, 1999, CANCER EPIDEM BIOMAR, V8, P1117
   Hastie T, 2001, ELEMENTS STAT LEARNI
   Hornik K., 1990, NEURAL NETWORKS, V3, P359
   HYAKIN S, 1998, NEURAL NETWORKS COMP
   Jerez-Aragones JM, 2003, ARTIF INTELL MED, V27, P45, DOI 10.1016/S0933-3657(02)00086-6
   Jimenez-Lee R, 2003, AM J SURG, V186, P404, DOI 10.1016/S0002-9610(03)00283-6
   Kohavi R., 1995, 14 INT JOINT C ART I, P1137
   Lavrac N, 1999, ARTIF INTELL MED, V16, P3, DOI 10.1016/S0933-3657(98)00062-1
   Lundin M, 1999, ONCOLOGY-BASEL, V57, P281, DOI 10.1159/000012061
   *NCI SURV RES PROG, 1973, SEER CANC STAT REV S
   Ohno-Machado L, 2001, J BIOMED INFORM, V34, P428, DOI 10.1006/jbin.2002.1038
   OMALLEY CD, 2003, SOCIOECONOMIC STATUS, P1303
   Pendharkar PC, 1999, EXPERT SYST APPL, V17, P223, DOI 10.1016/S0957-4174(99)00036-6
   Principe J. C., 2000, NEURAL ADAPTIVE SYST
   Quinlan J. R., 1986, Machine Learning, V1, P81, DOI 10.1007/BF00116251
   Quinlan JR, 1993, C4 5 PROGRAMS MACHIN
   Rampaul RS, 2001, EUR J SURG ONCOL, V27, P229, DOI 10.1053/ejso.2001.1114
   Richards G, 2001, ARTIF INTELL MED, V22, P215, DOI 10.1016/S0933-3657(00)00110-X
   RITTER M, 2003, TULSA WORLD     0616, pD8
   ROSS E, 2003, ASS PRESS
   Santos-Garcia G, 2004, ARTIF INTELL MED, V30, P61, DOI 10.1016/S0933-3657(03)00059-9
   SHEARER C, 2000, J DATA WAREHOUSING, V5, P13
   Warren J, 2003, WEBMD MED NEWS
   BREAST CANC Q A FACT
NR 38
TC 363
Z9 372
U1 10
U2 90
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0933-3657
J9 ARTIF INTELL MED
JI Artif. Intell. Med.
PD JUN
PY 2005
VL 34
IS 2
BP 113
EP 127
DI 10.1016/j.artmed.2004.07.002
PG 15
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Medical Informatics
SC Computer Science; Engineering; Medical Informatics
GA 932NA
UT WOS:000229559200002
PM 15894176
DA 2018-10-19
ER

PT J
AU Yoo, HJ
   Kim, HD
AF Yoo, HJ
   Kim, HD
TI Characteristics of crosslinked blends of Pellethene((R)) and multiblock
   polyurethanes containing phospholipid
SO BIOMATERIALS
LA English
DT Article
DE polyurethane; phospholipid; biomaterials; platelet adhesion
ID PLATELET-ADHESION; SEGMENTED POLYURETHANE; GLYCOL) METHACRYLATE;
   POLY(ETHYLENE OXIDE); SURFACE MODIFICATION; BLOOD COMPATIBILITY; PROTEIN
   ADSORPTION; BACTERIAL ADHESION; POLYMER; PHOSPHORYLCHOLINE
AB A series of segmented multiblock polyurethanes (MPUs) were synthesized by polyaddition reaction using hexamethylene diisocyanate (HDI)/poly(ethylene oxide) (PEO, as a hydrophilic component)/ poly(tetramethylene oxide) (PTMO)/ poly(butadiene diol)(PBD)/1,4-butanediol(BD)/{2-[bis(2-hydroxyethyl) methyl ammonio]ethyl stearyl phosphate) [BESP, as a phospholipids component: 0-42mol% (0-9wt%)]. To improve the blood compatibility of biomedical grade polyurethane (Pelletheneg), the Pellethenee was blended with MPUs and then crosslinked using dicumyl peroxide as a crosslinking agent. Effects of BESP content [0-42mol% (0-9wt%)] in MPUs on the properties of MPUs and blend (Pellethene(g)/MPUs) films were investigated. The X-ray photoelectron spectra indicated that the BESP moieties were located at the surface of the crosslinked blend (Pellethene(R)/MPUS) films. As the BESP content in MPUs increased, the water contact angle on the surfaces of corsslinked blend film was decreased but the water absorption and mechanical properties were markedly increased. By the test of platelet adhesion on the surfaces of corsslinked blend film, it was found that the platelet adhesion on the surface was significantly decreased from 70% to 6% by increasing BESP content from 0 to 42 mol% (0-9 wt%) in MPUs. These results suggest that crosslinked blend films may have more potential as a new material for biomedical applications, which are directly in contact with blood. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Pusan Natl Univ, Dept Text Engn, Coll Engn, Pusan 609735, South Korea.
RP Kim, HD (reprint author), Pusan Natl Univ, Dept Text Engn, Coll Engn, 30 Changjeon Dong, Pusan 609735, South Korea.
EM kimhd@pusan.ac.kr
CR Abraham GA, 2002, BIOMATERIALS, V23, P1625, DOI 10.1016/S0142-9612(01)00289-7
   BAILEY FE, 1976, POLYETHYLENE OXIDE, P20
   BOATS JGF, 1987, BR POLYM J, V19, P527
   BOATS JGF, 1986, BIOMATERIALS, V7, P393
   BRINKMAN E, 1989, INT J ARTIF ORGANS, V12, P390
   DURRANI AA, 1986, BIOMATERIALS, V7, P121, DOI 10.1016/0142-9612(86)90068-2
   EDMUNDSON RS, 1962, CHEM IND-LONDON, V20, P828
   Flemming RG, 1999, J BIOMAT SCI-POLYM E, V10, P679, DOI 10.1163/156856299X00874
   FUJIMOTO K, 1993, J BIOMED MATER RES, V27, P1559, DOI 10.1002/jbm.820271213
   Han DK, 1998, J BIOMAT SCI-POLYM E, V9, P163
   Ho SP, 2003, BIOMATERIALS, V24, P5121, DOI 10.1016/S0142-9612(03)00450-2
   Korematsu A, 2002, BIOMATERIALS, V23, P263, DOI 10.1016/S0142-9612(01)00104-1
   KOREMATSU A, 1999, J MATER RES, V14, P378
   Lee JH, 2000, BIOMATERIALS, V21, P683, DOI 10.1016/S0142-9612(99)00197-0
   Lee JH, 1997, POLYM-KOREA, V21, P332
   LELAH MD, 1986, POLYURETHANES MED, P57
   Li YJ, 1997, J BIOMATER APPL, V12, P167, DOI 10.1177/088532829701200205
   LI YJ, 1995, MACROMOL CHEM PHYS, V196, P143
   LOGEARTAVRAMOGLOU, 1999, J BIOMED MATER RES, V48, P578
   MARCONI W, 1995, BIOMATERIALS, V16, P449, DOI 10.1016/0142-9612(95)98817-X
   Morimoto N, 2002, BIOMATERIALS, V23, P4881, DOI 10.1016/S0142-9612(02)00246-6
   Park KD, 1998, BIOMATERIALS, V19, P851, DOI 10.1016/S0142-9612(97)00245-7
   Qiu YX, 1996, J APPL POLYM SCI, V61, P2373, DOI 10.1002/(SICI)1097-4628(19960926)61:13<2373::AID-APP17>3.0.CO;2-5
   Strel'tsov A. I., 1989, Izvestiya Vysshikh Uchebnykh Zavedenii, Energetika, P100
   Uyama Y, 1998, ADV POLYM SCI, V137, P3
   Yoo HJ, 2004, J APPL POLYM SCI, V91, P2348, DOI 10.1002/app.13377
   Yung LYL, 1998, BIOMATERIALS, V19, P31, DOI 10.1016/S0142-9612(97)00220-2
NR 27
TC 15
Z9 17
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2005
VL 26
IS 16
BP 2877
EP 2886
DI 10.1016/j.biomaterials.2004.09.001
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 892UM
UT WOS:000226675500010
PM 15603783
DA 2018-10-19
ER

PT J
AU Genove, E
   Shen, C
   Zhang, SG
   Semino, CE
AF Genove, E
   Shen, C
   Zhang, SG
   Semino, CE
TI The effect of functionalized self-assembling peptide scaffolds on human
   aortic endothelial cell function
SO BIOMATERIALS
LA English
DT Article
DE self-assembly; biomimetic material; cell proliferation; extracellular
   matrix; endotheliar monolayer
ID CAPILLARY-LIKE STRUCTURES; LAMININ GAMMA-1 CHAIN; BASEMENT-MEMBRANE; IV
   COLLAGEN; COMPLEMENTARY OLIGOPEPTIDE; ADHESION PEPTIDES; IDENTIFICATION;
   BINDING; DIFFERENTIATION; MATRICES
AB A class of designed self-assembling peptide nanofiber scaffolds with more than 99% water content has been shown to be a good biological material for cell culture. Here, we report the functionalization of one of these peptide scaffolds, RAD16-I (AcN-RADARADARADARADA-CONH2) by direct solid phase synthesis extension at the amino terminal with three short-sequence motifs. These motifs are present in two major protein components of the basement membrane, laminin I (YIGSR, RYVVLPR) and collagen IV (TAGSCLRKFSTM). These motifs have been previously shown to promote specific biological activities including endothelial cell adhesion, spreading, and tubular formation. Therefore, the generic functionalized peptide developed was AcN-X-GG-RADARADARADARADA-CONH2 with each motif represented by "X". We show in this work that these tailor-made peptide scaffolds enhance the formation of confluent cell monolayers of human aortic endothelial cells (HAEC) in culture. Moreover, additional assays designed to evaluate endothelial cell function showed that HAEC monolayers obtained on these scaffolds not only maintained LDL uptake activity but also enhanced nitric oxide release and elevated laminin 1 and collagen IV deposition. These results suggest that this new scaffold provide a better physiological substrate for endothelial cell culture and suggest its further application for biomedical research, cancer biology and regenerative biology. (C) 2004 Elsevier Ltd. All rights reserved.
C1 MIT, Ctr Biomed Engn, Cambridge, MA 02139 USA.
   Harvard Univ, Cambridge, MA 02138 USA.
   MIT, Ctr Biotechnol Proc Engn, Cambridge, MA 02139 USA.
RP Semino, CE (reprint author), MIT, Ctr Biomed Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
EM shuguang@mit.edu; semino@mit.edu
CR Ardini E, 2002, CANCER RES, V62, P1321
   BECK K, 1990, FASEB J, V4, P148
   Bell SE, 2001, J CELL SCI, V114, P2755
   Bogenrieder T, 2003, ONCOGENE, V22, P6524, DOI 10.1038/sj.onc.1206757
   BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211
   CHARONIS AS, 1985, J CELL BIOL, V100, P1848, DOI 10.1083/jcb.100.6.1848
   Davis GE, 2000, IN VITRO CELL DEV-AN, V36, P513
   Davis GE, 2002, ANAT RECORD, V268, P252, DOI 10.1002/ar.10159
   ENGEL J, 1992, BIOCHEMISTRY-US, V31, P10643, DOI 10.1021/bi00159a001
   FERENCZY A, 1979, AM J OBSTET GYNECOL, V133, P859, DOI 10.1016/0002-9378(79)90302-8
   Gloe T, 1999, J BIOL CHEM, V274, P15996, DOI 10.1074/jbc.274.23.15996
   GRAF J, 1987, BIOCHEMISTRY-US, V26, P6896, DOI 10.1021/bi00396a004
   GRANT DS, 1989, CELL, V58, P933, DOI 10.1016/0092-8674(89)90945-8
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   IWAMOTO Y, 1987, SCIENCE, V238, P1132, DOI 10.1126/science.2961059
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   KLEINMAN HK, 1989, ARCH BIOCHEM BIOPHYS, V272, P39, DOI 10.1016/0003-9861(89)90192-6
   KOLIAKOS GG, 1989, J BIOL CHEM, V264, P2313
   KREIS T, 1999, GUIDEBOOK EXTRACELLU
   KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589
   LIN HB, 1994, J BIOMED MATER RES, V28, P329, DOI 10.1002/jbm.820280307
   Malinda KM, 1999, FASEB J, V13, P53
   MASSIA SP, 1993, J BIOL CHEM, V268, P8053
   MASSIA SP, 1991, J BIOMED MATER RES, V25, P223, DOI 10.1002/jbm.820250209
   PAULSSON M, 1987, EUR J BIOCHEM, V166, P11, DOI 10.1111/j.1432-1033.1987.tb13476.x
   Ponce ML, 1999, CIRC RES, V84, P688, DOI 10.1161/01.RES.84.6.688
   Poschl E, 1996, EMBO J, V15, P5154, DOI 10.1002/j.1460-2075.1996.tb00899.x
   Reed MJ, 1996, CURR TOP MICROBIOL, V213, P81
   Sagnella SM, 2004, BIOMATERIALS, V25, P1249, DOI 10.1016/S0142-9612(03)00634-3
   SAKAMOTO N, 1991, CANCER RES, V51, P903
   Schmedlen KH, 2002, BIOMATERIALS, V23, P4325, DOI 10.1016/S0142-9612(02)00177-1
   Semino CE, 2004, TISSUE ENG, V10, P643, DOI 10.1089/107632704323061997
   Semino CE, 2003, DIFFERENTIATION, V71, P262, DOI 10.1046/j.1432-0436.2003.7104503.x
   SILVA GA, 2004, SCI EXPRESS
   SKUBITZ APN, 1990, CANCER RES, V50, P7612
   TSILIBARY EC, 1990, J CELL BIOL, V111, P1583, DOI 10.1083/jcb.111.4.1583
   YURCHENCO PD, 1994, METHOD ENZYMOL, V245, P489
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
NR 41
TC 211
Z9 225
U1 3
U2 68
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2005
VL 26
IS 16
BP 3341
EP 3351
DI 10.1016/j.biomaterials.2004.08.012
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 892UM
UT WOS:000226675500057
PM 15603830
DA 2018-10-19
ER

PT J
AU Kim, HK
   Kim, K
   Byun, Y
AF Kim, HK
   Kim, K
   Byun, Y
TI Preparation of a chemically anchored phospholipid monolayer on an
   acrylated polymer substrate
SO BIOMATERIALS
LA English
DT Article
DE phospholipid monolayer; in situ photopolymerization; acrylated polymer
   substrate; blood compatibility
ID LANGMUIR-BLODGETT MONOLAYER; IN-SITU PHOTOPOLYMERIZATION; CYTOMIMETIC
   BIOMATERIALS; TERMINATED SUBSTRATE; BLOOD COMPATIBILITY;
   PROTEIN-ADSORPTION; ALKYLATED SURFACE; MEMBRANES; BILAYER; BLEND
AB This paper describes a strategy for designing a chemically anchored phospholipid monolayer that could be used as coating materials for biomedical implants. To make a chemically anchored phospholipid monolayer on the polymer substrate, we prepared the mono-acrylated phospholipid (1-palmitoyl-2-[12-(acryloyloxy)-dodecanoyl]-sn-glycero-3-phosphocholine; acryloyl-PC) and the acrylated polymer (poly(octadecylacrylate-co-4-acryloyloxy butylacrylate)), which was synthesized by the acrylation of poly(octadecyl acrylate-co-hydroxybutyl acrylate, poly(OA-co-HA)) with acryloyl chloride. The chemically anchored phospholipid monolayer was prepared by using in situ photopolymerization of a pre-assembled phospholipid monolayer, produced by lipid vesicle fusion, onto the acrylated polymer coated silicon wafer. Optimal condition of vesicle fusion and irradiation time was determined from the degree of hydrophilicity rendered by the polymerized phospholipid surface. The physicochemical properties of polymerized phospholipid monolayer on the substrate were evaluated using water contact angle, field-emission scanning electron micrograph (FE-SEM), atomic force microscopy (AFM) and X-ray photoelectron spectroscopy (XPS). These results confirmed that the polymerized phospholipid monolayer was chemically anchored on the acrylated polymer substrate. The chemically anchored phospholipid monolayer was stable in aqueous condition for 2 weeks, but the physically adsorbed phospholipid monolayer got removed within I day. Moreover, the polymerized phospholipid monolayer also suppressed albumin absorption and platelet adhesion, in vitro. This polymerized phospholipid monolayer provides a new biomimetic system for coating medical devises. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Gwangju Inst Sci & Technol, Ctr Cell & Macromol Therapy, Dept Mat Sci & Engn, Kwangju 500712, South Korea.
RP Byun, Y (reprint author), Gwangju Inst Sci & Technol, Ctr Cell & Macromol Therapy, Dept Mat Sci & Engn, 1 Oryong Dong, Kwangju 500712, South Korea.
EM yrbyun@gist.ac.kr
RI BYUN, YOUNG RO/D-5735-2013
CR CHAPMAN D, 1993, LANGMUIR, V9, P39, DOI 10.1021/la00025a012
   Hasegawa T, 2001, BIOMATERIALS, V22, P243, DOI 10.1016/S0142-9612(00)00180-0
   HAYWARD JA, 1984, BIOMATERIALS, V5, P135, DOI 10.1016/0142-9612(84)90047-4
   HENCH LL, 1980, J BIOMED MATER RES, V14, P803, DOI 10.1002/jbm.820140611
   Iwasaki Y, 2002, BIOMATERIALS, V23, P3897, DOI 10.1016/S0142-9612(02)00135-7
   Kim K, 2003, J BIOMAT SCI-POLYM E, V14, P887, DOI 10.1163/156856203322381393
   Kim K, 2004, LANGMUIR, V20, P5396, DOI 10.1021/la049959g
   Kim K, 2001, LANGMUIR, V17, P5066, DOI 10.1021/la0102096
   Kim K, 2000, J BIOMED MATER RES, V52, P836, DOI 10.1002/1097-4636(20001215)52:4<836::AID-JBM30>3.3.CO;2-W
   KIM K, 2004, BIOMATERIALS, V25, P233
   Korematsu A, 2002, BIOMATERIALS, V23, P263, DOI 10.1016/S0142-9612(01)00104-1
   Lewis AL, 2001, BIOMATERIALS, V22, P99, DOI 10.1016/S0142-9612(00)00083-1
   LIM F, 1994, BIOMATERIALS, V15, P408, DOI 10.1016/0142-9612(94)90218-6
   Marra KG, 1997, MACROMOLECULES, V30, P6483, DOI 10.1021/ma970481f
   Morimoto N, 2002, BIOMATERIALS, V23, P4881, DOI 10.1016/S0142-9612(02)00246-6
   Orban JM, 2000, MACROMOLECULES, V33, P4205, DOI 10.1021/ma9915780
   PLANT AL, 1994, BIOPHYS J, V67, P1126, DOI 10.1016/S0006-3495(94)80579-X
   Ross EE, 2001, LANGMUIR, V17, P2305, DOI 10.1021/la010752
   Sackmann E, 1996, SCIENCE, V271, P43, DOI 10.1126/science.271.5245.43
   SPINKE J, 1992, BIOPHYS J, V63, P1667, DOI 10.1016/S0006-3495(92)81742-3
   UEDA T, 1992, POLYM J, V24, P1259, DOI 10.1295/polymj.24.1259
   Ulman A., 1991, INTRO ULTRATHIN ORGA
NR 22
TC 21
Z9 21
U1 1
U2 21
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2005
VL 26
IS 17
BP 3435
EP 3444
DI 10.1016/j.biomaterials.2004.09.066
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 896XQ
UT WOS:000226968200007
PM 15621232
DA 2018-10-19
ER

PT J
AU Gupta, AK
   Gupta, M
AF Gupta, AK
   Gupta, M
TI Synthesis and surface engineering of iron oxide nanoparticles for
   biomedical applications
SO BIOMATERIALS
LA English
DT Review
DE magnetic nanoparticles; MRI; drug delivery; surface modification;
   hyperthermia; cell labelling; iron oxide
ID MODIFIED SUPERPARAMAGNETIC NANOPARTICLES; PHYSIOLOGICAL PHARMACOKINETIC
   MODEL; MAGNETIC ALBUMIN MICROSPHERES; TRANSFERRIN RECEPTOR GENE;
   SELF-ASSEMBLED MONOLAYERS; TARGETED DRUG-DELIVERY;
   FINE-PARTICLE-SYSTEMS; IN-VIVO TRACKING; POLY(ETHYLENE GLYCOL); CONTRAST
   AGENTS
AB Superparamagnetic iron oxide nanoparticles (SPION) with appropriate surface chemistry have been widely used experimentally for numerous in vivo applications such as magnetic resonance imaging contrast enhancement, tissue repair, immunoassay, detoxification of biological fluids, hyperthermia, drug delivery and in cell separation, etc. All these biomedical and bioengineering applications require that these nanoparticles have high magnetization values and size smaller than 100 nm with overall narrow particle size distribution, so that the particles have uniform physical and chemical properties. In addition, these applications need special surface coating of the magnetic particles, which has to be not only non-toxic and biocompatible but also allow a targetable delivery with particle localization in a specific area. To this end, most work in this field has been done in improving the biocompatibility of the materials, but only a few scientific investigations and developments have been carried out in improving the quality of magnetic particles, their size distribution, their shape and surface in addition to characterizing them to get a protocol for the quality control of these particles. Nature of surface coatings and their subsequent geometric arrangement on the nanoparticles determine not only the overall size of the colloid but also play a significant role in biokinetics and biodistribution of nanoparticles in the body. The types of specific coating, or derivatization, for these nanoparticles depend on the end application and should be chosen by keeping a particular application in mind, whether it be aimed at inflammation response or anti-cancer agents. Magnetic nanoparticles can bind to drugs, proteins, enzymes, antibodies, or nucleotides and can be directed to an organ, tissue, or tumour using an external magnetic field or can be heated in alternating magnetic fields for use in hyperthermia. This review discusses the synthetic chemistry, fluid stabilization and surface modification of superpararnagnetic iron oxide nanoparticles, as well as their use for above biomedical applications. (C) 2004 Elsevier Ltd. All rights reserved.
C1 So Gen Hosp, Crusade Labs Ltd, Glasgow G51 4TF, Lanark, Scotland.
   Univ Glasgow, Div Biochem & Mol Biol, IBLS, Glasgow G12 8QQ, Lanark, Scotland.
RP Gupta, AK (reprint author), So Gen Hosp, Crusade Labs Ltd, 1345 Govan Rd, Glasgow G51 4TF, Lanark, Scotland.
EM akgupta25@hotmail.com
RI sadeghi, meisam/K-2389-2018
OI sadeghi, meisam/0000-0002-8448-0149
CR Akiyoshi K., 1996, SUPRAMOL SCI, V3, P157
   Arbab AS, 2003, RADIOLOGY, V229, P838, DOI 10.1148/radiol.2293021215
   Babes L, 1999, J COLLOID INTERF SCI, V212, P474, DOI 10.1006/jcis.1998.6053
   Babincova M, 2001, Z NATURFORSCH C, V56, P909
   Bagwe RP, 2001, CRIT REV THER DRUG, V18, P77
   BAILEY RL, 1983, J MAGN MAGN MATER, V39, P178, DOI 10.1016/0304-8853(83)90428-6
   Baker ME, 1998, FEBS LETT, V439, P9, DOI 10.1016/S0014-5793(98)01346-5
   Banfield JF, 2000, SCIENCE, V289, P751, DOI 10.1126/science.289.5480.751
   BEAN CP, 1959, J APPL PHYS, V30, P1976, DOI 10.1063/1.1735100
   Berry CC, 2004, INT J PHARM, V269, P211, DOI 10.1016/j.ijpharm.2003.09.042
   Berry CC, 2003, BIOMATERIALS, V24, P4551, DOI 10.1016/S0142-9612(03)00237-0
   Berry CC, 2003, J PHYS D APPL PHYS, V36, pR198, DOI 10.1088/0022-3727/36/13/203
   Bhadriraju K, 2000, BIOMATERIALS, V21, P267, DOI 10.1016/S0142-9612(99)00175-1
   BHANDARKAR S, 1990, J COLLOID INTERF SCI, V139, P541, DOI 10.1016/0021-9797(90)90127-A
   Bhorade R, 2000, BIOCONJUGATE CHEM, V11, P301, DOI 10.1021/bc990168d
   BILBAO G, 1998, TARGETED ADENOVIRAL, P365
   Binh VT, 1998, APPL SURF SCI, V130, P803, DOI 10.1016/S0169-4332(98)00158-5
   BOISTELLE R, 1988, J CRYST GROWTH, V90, P14, DOI 10.1016/0022-0248(88)90294-1
   Bonnemain B, 1998, J DRUG TARGET, V6, P167, DOI 10.3109/10611869808997890
   Bourke SL, 2003, ADV DRUG DELIVER REV, V55, P447, DOI 10.1016/S0169-409X(03)00038-3
   BOYLE MDP, 1985, J IMMUNOL, V134, P564
   BRADBURY A, 1984, IEEE T MAGN, V20, P1846, DOI 10.1109/TMAG.1984.1063338
   BRANDLEY BK, 1988, ANAL BIOCHEM, V172, P270, DOI 10.1016/0003-2697(88)90442-3
   Bulte JWM, 2001, NAT BIOTECHNOL, V19, P1141, DOI 10.1038/nbt1201-1141
   Bulte JWM, 1999, P NATL ACAD SCI USA, V96, P15256, DOI 10.1073/pnas.96.26.15256
   Burugapalli K, 2004, J BIOMED MATER RES A, V68A, P210, DOI 10.1002/jbm.a.10117
   Capek I, 2001, ADV COLLOID INTERFAC, V92, P195, DOI 10.1016/S0001-8686(00)00072-5
   Carpenter EE, 2001, J MAGN MAGN MATER, V225, P17, DOI 10.1016/S0304-8853(00)01222-1
   CHAN DCF, 1993, J MAGN MAGN MATER, V122, P374
   CHARLES SW, 1980, IEEE T MAGN, V16, P172, DOI 10.1109/TMAG.1980.1060584
   CHARLES SW, 1992, N-HOLLAND D, P267
   Chatterjee J, 2003, J MAGN MAGN MATER, V257, P113, DOI 10.1016/S0304-8853(02)01066-1
   Chatterjee J, 2001, J MAGN MAGN MATER, V225, P21, DOI 10.1016/S0304-8853(00)01223-3
   Chemseddine A, 1999, EUR J INORG CHEM, P235, DOI 10.1002/(SICI)1099-0682(19990202)1999:2<235::AID-EJIC235>3.0.CO;2-N
   CHEN C, 1986, MAGNETISM METALLURGY
   CHEN GH, 1993, BIOCONJUGATE CHEM, V4, P509, DOI 10.1021/bc00024a013
   Chen M, 2003, J APPL PHYS, V93, P7551, DOI 10.1063/1.1555312
   Chilkoti A, 2002, ADV DRUG DELIVER REV, V54, P1093, DOI 10.1016/S0169-409X(02)00060-1
   CHOI SW, 2003, J DISPERSION SCI TEC, V24, P2003
   Chouly C, 1996, J MICROENCAPSUL, V13, P245, DOI 10.3109/02652049609026013
   COEY JMD, 1971, PHYS REV LETT, V27, P1140, DOI 10.1103/PhysRevLett.27.1140
   Contag PR, 1998, NAT MED, V4, P245, DOI 10.1038/nm0298-245
   Cornelis K, 1977, MANUAL MINERALOGY
   Cornell R. M., 1991, IRON OXIDES LAB PREP
   COTTER TG, 1995, TRENDS BIOTECHNOL, V13, P150, DOI 10.1016/S0167-7799(00)88926-X
   Cotton FA, 1988, ADV INORGANIC CHEM
   CREPON B, 1991, BIOMATERIALS, V12, P550, DOI 10.1016/0142-9612(91)90049-G
   CUATRECASAS P, 1983, RECEPTOR MEDIATED EN
   Curtis A, 2001, TRENDS BIOTECHNOL, V19, P97, DOI 10.1016/S0167-7799(00)01536-5
   D'Souza AJM, 2004, J CONTROL RELEASE, V94, P91, DOI 10.1016/j.jconrel.2003.09.014
   Debelle L, 1999, INT J BIOCHEM CELL B, V31, P261, DOI 10.1016/S1357-2725(98)00098-3
   Deng Y, 2003, J MAGN MAGN MATER, V257, P69, DOI 10.1016/S0304-8853(02)00987-3
   Denizot B, 1999, J COLLOID INTERF SCI, V209, P66, DOI 10.1006/jcis.1998.5850
   Dormann JL, 1997, ADV CHEM PHYS, V98, P283, DOI 10.1002/9780470141571.ch4
   Dresco PA, 1999, LANGMUIR, V15, P1945, DOI 10.1021/la980971g
   ELLIOTT SR, 1998, PHYSICS CHEM SOLIDS
   Enochs WS, 1999, JMRI-J MAGN RESON IM, V9, P228, DOI 10.1002/(SICI)1522-2586(199902)9:2<228::AID-JMRI12>3.3.CO;2-B
   FARQUHAR MG, 1978, J CELL BIOL, V77, pR35, DOI 10.1083/jcb.77.3.R35
   FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664
   FENDLER JH, 1987, CHEM REV, V87, P877, DOI 10.1021/cr00081a002
   Florence AT, 1997, PHARM RES-DORDR, V14, P259, DOI 10.1023/A:1012029517394
   FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628
   FRANCIS G, 1997, BLOOD, V89, P3778
   Frazier RA, 1997, LANGMUIR, V13, P7115, DOI 10.1021/la970382v
   FREEMAN JA, 1965, AM J DIG DIS, V10, P1004, DOI 10.1007/BF02233375
   Fried NM, 1999, LASER SURG MED, V25, P291, DOI 10.1002/(SICI)1096-9101(1999)25:4<291::AID-LSM4>3.0.CO;2-#
   FURUSAWA K, 1994, COLLOID POLYM SCI, V272, P1104, DOI 10.1007/BF00652379
   GALLO JM, 1989, J PHARMACOKINET BIOP, V17, P305, DOI 10.1007/BF01061899
   GALLO JM, 1989, J PHARM SCI, V78, P190, DOI 10.1002/jps.2600780303
   GALLO JM, 1993, J PHARMACOKINET BIOP, V21, P575, DOI 10.1007/BF01059115
   GHINEA N, 1985, J CELL BIOL, V100, P606, DOI 10.1083/jcb.100.2.606
   GILCHRIST RK, 1957, ANN SURG, V146, P596, DOI 10.1097/00000658-195710000-00007
   Gomez-Lopera SA, 2001, J COLLOID INTERF SCI, V240, P40, DOI 10.1006/jcis.2001.7579
   GORDON RT, 1979, MED HYPOTHESES, V5, P83, DOI 10.1016/0306-9877(79)90063-X
   Goya GF, 2003, J APPL PHYS, V94, P3520, DOI 10.1063/1.1599959
   Gruttner C, 1997, SCIENTIFIC AND CLINICAL APPLICATIONS OF MAGNETIC CARRIERS, P53
   Gupta AK, 2003, IEEE T NANOBIOSCI, V2, P255, DOI 10.1109/TNB.2003.820279
   Gupta AK, 2004, J MATER SCI-MATER M, V15, P493, DOI 10.1023/B:JMSM.0000021126.32934.20
   Gupta AK, 2004, IEEE T NANOBIOSCI, V3, P66, DOI 10.1109/TNB.2003.820277
   Gupta AK, 2004, BIOMATERIALS, V25, P3029, DOI 10.1016/j.biomaterials.2003.09.095
   GUPTA AK, 2003, P 30 ANN S CONTR REL, V30, P788
   GUPTA PK, 1989, LIFE SCI, V44, P175, DOI 10.1016/0024-3205(89)90593-6
   Gupta PK, 1993, MICROSPHERES REGIONA, P71
   HADJIPANAYIS GC, 1993, NATO ASI SERIES AP E, V260
   Hafeli U., 1997, SCI CLIN APPL MAGNET
   Hamley IW, 2003, ANGEW CHEM INT EDIT, V42, P1692, DOI 10.1002/ange.200200546
   Hampdenn-Smith M. J, 1999, AEROSOL PROCESSING M
   HAN DH, J MAGN MAGN MAT, V136, P176
   Handgretinger R, 1998, BONE MARROW TRANSPL, V21, P987, DOI 10.1038/sj.bmt.1701228
   HAYAT MA, 1991, COLLOIDAL GOLD PRINC, V1, P14
   Held GA, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.012408
   Hirao K, 2003, INT J ONCOL, V22, P1065
   Holland NB, 1998, NATURE, V392, P799
   Igartua M, 2002, INT J PHARM, V233, P149, DOI 10.1016/S0378-5173(01)00936-X
   ISABELLE B, 1997, CYTOTECHNOLOGY, V25, P231
   Ito A, 2001, CANCER GENE THER, V8, P649, DOI 10.1038/sj.cgt.7700357
   Janik J, 1997, LANGMUIR, V13, P4466, DOI 10.1021/la960452i
   Jeong YI, 1999, DRUG DEV IND PHARM, V25, P917, DOI 10.1081/DDC-100102252
   Jiles D., 1991, INTRO MAGNETISM MAGN
   JOHNSON GA, 1993, MAGN RESON QUART, V9, P1
   Jordan A, 1999, J MAGN MAGN MATER, V194, P185, DOI 10.1016/S0304-8853(98)00558-7
   Jordan A, 2001, J MAGN MAGN MATER, V225, P118, DOI 10.1016/S0304-8853(00)01239-7
   JOSEPHSON L, 1990, MAGN RESON IMAGING, V8, P637, DOI 10.1016/0730-725X(90)90143-P
   Josephson L, 1999, BIOCONJUGATE CHEM, V10, P186, DOI 10.1021/bc980125h
   Kaneo Y, 2001, J CONTROL RELEASE, V70, P365, DOI 10.1016/S0168-3659(00)00368-0
   Kataby G, 1998, LANGMUIR, V14, P1512, DOI 10.1021/la970978i
   Kawaguchi H, 1996, COLLOID SURFACE A, V109, P147, DOI 10.1016/0927-7757(95)03482-X
   KEMMNER W, 1992, J IMMUNOL METHODS, V147, P197, DOI 10.1016/S0022-1759(12)80008-1
   KHALAFALLA SE, 1980, IEEE T MAGN, V16, P178, DOI 10.1109/TMAG.1980.1060578
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kiessling AA, 2003, HUMAN EMBRYONIC STEM
   Kim DK, 2001, SCRIPTA MATER, V44, P1713, DOI 10.1016/S1359-6462(01)00870-3
   Kim DK, 2001, J MAGN MAGN MATER, V225, P30, DOI 10.1016/S0304-8853(00)01224-5
   KLEIN J, 1991, NATURE, V352, P143, DOI 10.1038/352143a0
   KRONICK P, 1986, J BIOCHEM BIOPH METH, V12, P73, DOI 10.1016/0165-022X(86)90052-7
   Krotz F, 2003, MOL THER, V7, P700, DOI 10.1016/S1525-0016(03)00065-0
   Krotz F, 2003, J VASC RES, V40, P425, DOI 10.1159/000073901
   Kubo T, 2000, INT J ONCOL, V17, P309
   Kubo T, 2001, INT J ONCOL, V18, P121
   KWEI GH, 1990, J MOL STRUCT, V223, P383, DOI 10.1016/0022-2860(90)80482-Y
   Lauffenburger DA, 1993, RECEPTORS MODELS BIN
   LAWRENCE MJ, 1994, EUR J DRUG METAB PH, V19, P257, DOI 10.1007/BF03188929
   LAWRENCE MJ, ADV DRUG DELIV REV, V45, P89
   Lee CS, 2001, APPL PHYS LETT, V79, P3308, DOI 10.1063/1.1419049
   Lee J, 1996, J COLLOID INTERF SCI, V177, P490, DOI 10.1006/jcis.1996.0062
   Lefebure S, 1998, J MATER RES, V13, P2975, DOI 10.1557/JMR.1998.0407
   Lewin M, 2000, NAT BIOTECHNOL, V18, P410
   Li JK, 1997, J PHARM SCI-US, V86, P891, DOI 10.1021/js970084i
   Li SC, 2000, COLLOID SURFACE A, V174, P275, DOI 10.1016/S0927-7757(00)00538-0
   Li YQ, 2002, APPL PHYS LETT, V80, P4644, DOI 10.1063/1.1487921
   Lin J, 2001, J SOLID STATE CHEM, V159, P26, DOI 10.1006/jssc.2001.9117
   Liz-Marzan L. M., 2003, NANOSCALE MAT
   Lobel B, 2000, LASER SURG MED, V26, P4, DOI 10.1002/(SICI)1096-9101(2000)26:1<4::AID-LSM3>3.0.CO;2-J
   LUDERER AA, 1983, RADIAT RES, V94, P190, DOI 10.2307/3575874
   Luisi P. L., 1983, BIOL TECHNOLOGICAL R, P73
   Massia SP, 2000, BIOMATERIALS, V21, P2253, DOI 10.1016/S0142-9612(00)00151-4
   Mendenhall GD, 1996, J COLLOID INTERF SCI, V184, P519, DOI 10.1006/jcis.1996.0647
   Messersmith P, 2001, ENCY MAT SCI TECHNOL, P602
   MEYERS PH, 1966, AMER J ROENTGENOL RA, V96, P913, DOI 10.2214/ajr.96.4.913
   MILLER CR, 1988, BIOCHEMISTR, V37, P12875
   MILLER ES, 1983, J MEMBRANE SCI, V14, P79, DOI 10.1016/S0376-7388(00)81375-7
   Moghimi SM, 2001, PHARMACOL REV, V53, P283
   Moore A, 1998, BBA-MOL CELL RES, V1402, P239, DOI 10.1016/S0167-4889(98)00002-0
   Moore A, 2001, RADIOLOGY, V221, P244, DOI 10.1148/radiol.2211001784
   Morawski AM, 2004, MAGN RESON MED, V51, P480, DOI 10.1002/mrm.20010
   MULLER BW, 1984, J PHARM SCI, V73, P919, DOI 10.1002/jps.2600730714
   Mulvaney P, 2000, J MATER CHEM, V10, P1259, DOI 10.1039/b000136h
   Munshi N, 1997, J COLLOID INTERF SCI, V190, P387, DOI 10.1006/jcis.1997.4889
   MUTSAERS SE, 1988, J LEUKOCYTE BIOL, V44, P17
   Najafi F, 2003, BIOMATERIALS, V24, P1175, DOI 10.1016/S0142-9612(02)00487-8
   NAKAJIMA K, 1990, POLYM J, V22, P985, DOI 10.1295/polymj.22.985
   Nam JM, 2003, SCIENCE, V301, P1884, DOI 10.1126/science.1088755
   Nam JM, 2002, J AM CHEM SOC, V124, P3820, DOI 10.1021/ja0178766
   Ng V, 2002, NANOTECHNOLOGY, V13, P554, DOI 10.1088/0957-4484/13/5/302
   Nielsen OS, 2001, EUR J CANCER, V37, P1587, DOI 10.1016/S0959-8049(01)00193-9
   Nunn AVW, 1996, FEBS LETT, V392, P295, DOI 10.1016/0014-5793(96)00839-3
   Okamura Y, 2001, J BIOL CHEM, V276, P48183, DOI 10.1074/jbc.M106408200
   Olsen D, 2003, ADV DRUG DELIVER REV, V55, P1547, DOI 10.1016/j.addr.2003.08.008
   OLSVIK O, 1994, CLIN MICROBIOL REV, V7, P43
   OSTERBERG E, 1993, COLLOID SURFACE A, V77, P159, DOI 10.1016/0927-7757(93)80112-R
   Otsuka H, 2003, ADV DRUG DELIVER REV, V55, P403, DOI 10.1016/S0169-409X(02)00226-0
   Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201
   Panyam J, 2003, ADV DRUG DELIVER REV, V55, P329, DOI 10.1016/S0169-409X(02)00228-4
   Pauser S, 1997, ANTI-CANCER DRUG DES, V12, P125
   Penn RL, 1998, SCIENCE, V281, P969, DOI 10.1126/science.281.5379.969
   Penn RL, 1999, GEOCHIM COSMOCHIM AC, V63, P1549, DOI 10.1016/S0016-7037(99)00037-X
   Pierres A, 1996, J IMMUNOL METHODS, V196, P105, DOI 10.1016/0022-1759(96)00103-2
   Poptani H, 1998, CANCER GENE THER, V5, P101
   Portet D, 2001, J COLLOID INTERF SCI, V238, P37, DOI 10.1006/jcis.2001.7500
   Pratsinis SE, 1996, POWDER TECHNOL, V88, P267, DOI 10.1016/S0032-5910(96)03130-0
   Qian ZM, 2002, PHARMACOL REV, V54, P561, DOI 10.1124/pr.54.4.561
   Reimer P, 1996, RADIOLOGE, V36, P153, DOI 10.1007/s001170050053
   REIMERS GW, 1972, PREPARING MAGNETIC F, P59
   Rishton SA, 1997, MICROELECTRON ENG, V35, P249, DOI 10.1016/S0167-9317(96)00107-4
   Roberts MJ, 2002, ADV DRUG DELIVER REV, V54, P459, DOI 10.1016/S0169-409X(02)00022-4
   ROSENSWE.RE, 1969, J COLLOID INTERF SCI, V29, P680, DOI 10.1016/0021-9797(69)90220-3
   Rosensweig R. E., 1985, FERROHYDRODYNAMICS
   RUIZ JM, 1991, J CONTROL RELEASE, V16, P177, DOI 10.1016/0168-3659(91)90041-B
   Sahoo Y, 2001, LANGMUIR, V17, P7907, DOI 10.1021/la010703+
   SALZMAN EW, 1983, AM J SOC ARTIF INTER, V6, P60
   Santra S, 2001, LANGMUIR, V17, P2900, DOI 10.1021/la0008636
   SATO T, 1987, J MAGN MAGN MATER, V65, P252, DOI 10.1016/0304-8853(87)90044-8
   Sauzedde F, 1999, COLLOID POLYM SCI, V277, P1041, DOI 10.1007/s003960050488
   Sauzedde F, 1999, COLLOID POLYM SCI, V277, P846, DOI 10.1007/s003960050461
   Scherer F, 2002, GENE THER, V9, P102, DOI 10.1038/sj/gt/3301624
   Schoepf U, 1998, BIOTECHNIQUES, V24, P642, DOI 10.2144/98244rr01
   SCHOLTEN PC, 1978, THERMODYNAMICS MAGNE
   Schwertmann U, 1991, IRON OXIDES LAB PREP
   SCHWICK HG, 1969, BIBL HAEMATOL, P111
   Shan GB, 2003, BIOTECHNOL LETT, V25, P1977, DOI 10.1023/B:BILE.0000004388.15751.8c
   Shepherd P. G., 1970, Journal of Physics D (Applied Physics), V3, P1985, DOI 10.1088/0022-3727/3/12/430
   Shibli SM, 2001, BRAZ J PHYS, V31, P418, DOI 10.1590/S0103-97332001000300012
   Siegel R. W., 1999, NANOSTRUCTURE SCI TE
   Sinha A, 2000, CURR SCI INDIA, V79, P646
   SJOGREN CE, 1994, MAGNET RESON MED, V31, P268, DOI 10.1002/mrm.1910310305
   SNEED PK, 1996, THERMORADIOTHERAPY T, V2
   Sokolov K, 2003, CANCER RES, V63, P1999
   Sorensen CM, 2001, NANOSCALE MATERIALS IN CHEMISTRY, P169, DOI 10.1002/0471220620.ch6
   STOLNIK S, 1995, ADV DRUG DELIVER REV, V16, P195, DOI 10.1016/0169-409X(95)00025-3
   Storhoff JJ, 1999, CHEM REV, V99, P1849, DOI 10.1021/cr970071p
   STORM G, 1995, ADV DRUG DELIVER REV, V17, P31, DOI 10.1016/0169-409X(95)00039-A
   SUGIMOTO T, 1987, ADV COLLOID INTERFAC, V28, P65, DOI 10.1016/0001-8686(87)80009-X
   Tadmor R, 2000, LANGMUIR, V16, P9117, DOI 10.1021/la0009137
   Tang J, 2003, J PHYS CHEM B, V107, P7501, DOI 10.1021/jp027048e
   Tanji N, 2001, ARCH ANDROLOGY, V47, P1
   Tartaj P, 2003, J PHYS D APPL PHYS, V36, pR182, DOI 10.1088/0022-3727/36/13/202
   Tartaj P, 2002, LANGMUIR, V18, P4556, DOI 10.1021/la025566a
   Tartaj P, 2001, ADV MATER, V13, P1620, DOI 10.1002/1521-4095(200111)13:21<1620::AID-ADMA1620>3.0.CO;2-Z
   Taylor AP, 2001, J MICROSC-OXFORD, V201, P84, DOI 10.1046/j.1365-2818.2001.00760.x
   Tchikov V, 2001, J MAGN MAGN MATER, V225, P285, DOI 10.1016/S0304-8853(00)01252-X
   Tepper T, 2003, J APPL PHYS, V93, P6948, DOI 10.1063/1.1540033
   THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464
   Tillotson TM, 2001, J NON-CRYST SOLIDS, V285, P338, DOI 10.1016/S0022-3093(01)00477-X
   TORCHILIN VP, 1995, ADV DRUG DELIVER REV, V16, P141, DOI 10.1016/0169-409X(95)00022-Y
   TOURINHO F, 1989, PROG COLL POL SCI S, V79, P128
   Uchegbu IF, 1996, DRUG SAFETY, V14, P39, DOI 10.2165/00002018-199614010-00005
   UGELSTAD J, 1993, BLOOD PURIFICAT, V11, P349, DOI 10.1159/000170129
   Ulman A, 1996, CHEM REV, V96, P1533, DOI 10.1021/cr9502357
   Varanda LC, 2002, J APPL PHYS, V92, P2079, DOI 10.1063/1.1496124
   VERGES MA, 1990, J CHEM SOC FARADAY T, V86, P959, DOI 10.1039/ft9908600959
   Vladimir S., 1999, J COLLOID INTERF SCI, V212, P49
   Voit W., 2001, MATER RES SOC S P, V676
   Wada S, 2003, ORAL DIS, V9, P218, DOI 10.1034/j.1601-0825.2003.02839.x
   Wang XX, 2000, CHAOS SOLITON FRACT, V11, P2319, DOI 10.1016/S0960-0779(99)00151-4
   Weissleder R, 1997, J MAGN RESON IMAGING, V7, P258, DOI 10.1002/jmri.1880070140
   WEISSLEDER R, 1995, ADV DRUG DELIVER REV, V16, P321, DOI 10.1016/0169-409X(95)00033-4
   WEISSLEDER R, 1997, MAGN RESON IMAGING, V7, P258
   Weissleder Ralph, 2000, Nature Medicine, V6, P351, DOI 10.1038/73219
   WIDDER KJ, 1980, CANCER RES, V40, P3512
   WILBANKS GA, 1990, IMMUNOLOGY, V71, P566
   Wilhelm C, 2003, BIOMATERIALS, V24, P1001, DOI 10.1016/S0142-9612(02)00440-4
   Wilkinson J M, 2003, Med Device Technol, V14, P29
   WINOTOMORBACH S, 1994, J CLIN LAB ANAL, V8, P400, DOI 10.1002/jcla.1860080610
   Xu HHK, 2004, BIOMATERIALS, V25, P4615, DOI 10.1016/j.biomaterials.2003.12.058
   XU HK, 1992, J MATER RES, V7, P712, DOI 10.1557/JMR.1992.0712
   YAACOB II, 1994, J COLLOID INTERF SCI, V168, P289, DOI 10.1006/jcis.1994.1423
   YAACOB II, 1995, J COLLOID INTERF SCI, V171, P73, DOI 10.1006/jcis.1995.1152
   YAMAZAKI M, 1990, BIOCHEMISTRY-US, V29, P1309, DOI 10.1021/bi00457a029
   Yee C, 1999, LANGMUIR, V15, P7111, DOI 10.1021/la990663y
   YEH TC, 1993, MAGN RESON MED, V30, P617, DOI 10.1002/mrm.1910300513
   Yu J., 2003, REV ADV MATER SCI, V4, P55
   YUEN S, 1974, PROCESS BIOCHEM, V9, P7
   Zhang Y, 2002, BIOMATERIALS, V23, P1553, DOI 10.1016/S0142-9612(01)00267-8
   Zhao M, 2002, BIOCONJUGATE CHEM, V13, P840, DOI 10.1021/bc0255236
   Zhao M, 2001, NAT MED, V7, P1241, DOI 10.1038/nm1101-1241
   Zhao X, 1998, J PHARM SCI, V87, P1450, DOI 10.1021/js980065o
   Zhou WL, 2001, EUR PHYS J D, V16, P289, DOI 10.1007/s100530170112
   Zhou WL, 2001, J APPL PHYS, V89, P7398, DOI 10.1063/1.1358831
   ZIMMERMANN U, 1980, BIOELECTROCH BIOENER, V7, P553, DOI 10.1016/0302-4598(80)80014-6
   ZIOLO RF, 1992, SCIENCE, V257, P219, DOI 10.1126/science.257.5067.219
   ZOLA H, 1994, IMMUNOLOGIST, V2, P47
NR 251
TC 4114
Z9 4242
U1 226
U2 3909
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2005
VL 26
IS 18
BP 3995
EP 4021
DI 10.1016/j.biomaterials.2004.10.012
PG 27
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 899KR
UT WOS:000227143800024
PM 15626447
DA 2018-10-19
ER

PT J
AU Fortman, JL
   Sherman, DH
AF Fortman, JL
   Sherman, DH
TI Utilizing the power of microbial genetics to bridge the gap between the
   promise and the application of marine natural products
SO CHEMBIOCHEM
LA English
DT Review
DE biosynthesis; genomics; heterologous expression; marine natural
   products; secondary metabolites
ID CYANOBACTERIUM LYNGBYA-MAJUSCULA; LARGE-SCALE SYNTHESIS; PSEUDOPTEROSIN
   DITERPENE CYCLASE; ASCIDIAN LISSOCLINUM-PATELLA; SPONGE
   DISCODERMIA-DISSOLUTA; POLYKETIDE SYNTHASE; ANTITUMOR-ACTIVITY;
   IN-VITRO; HETEROLOGOUS EXPRESSION; ANTINEOPLASTIC AGENTS
AB Marine organisms are a rich source of secondary metabolites. They have yielded thousands of compounds with a broad range of biomedical applications. Thus for, samples required for preclinical and clinical studies have been obtained by collection from the wild, by moriculture, and by total chemical synthesis. However, for a number of complex marine metabolites, none of these options is feasible for either economic or environmental reasons. In order to proceed with the development of many of these promising therapeutic compounds, a reliable and renewable source must be found. Over the last twenty years, the study of microbial secondary metabolites has greatly advanced our understanding of how nature utilizes simple starting materials to yield complex small molecules. Much of this work has focused on polyketides and nonribosomol peptides, two classes of molecules that are prevalent in marine micro- and mocroorganisms. The lessons learned from the study of terrestrial metabolite biosynthesis are now being applied to the marine world. As techniques for cloning and heterologous expression of biosynthetic pathways continue to improve, they may provide our greatest hope for bridging the gap between the promise and application of many marine natural products.
C1 Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA.
   Univ Michigan, Dept Med Chem, Inst Life Sci, Ann Arbor, MI 48109 USA.
   Univ Michigan, Dept Chem, Inst Life Sci, Ann Arbor, MI 48109 USA.
   Univ Michigan, Dept Microbiol & Immunol, Inst Life Sci, Ann Arbor, MI 48109 USA.
RP Sherman, DH (reprint author), Univ Minnesota, Dept Microbiol, 1460 Mayo Bldg,420 Delaware St SE, Minneapolis, MN 55455 USA.
EM davidhs@umich.edu
FU NCI NIH HHS [CA 83155]
CR Ahaidar A, 2003, J ORG CHEM, V68, P10020, DOI 10.1021/jo035332b
   AICHER TD, 1992, J AM CHEM SOC, V114, P3162, DOI 10.1021/ja00034a086
   ARAI T, 1977, J ANTIBIOT, V30, P1015
   Bangera MG, 1999, J BACTERIOL, V181, P3155
   Baz JP, 1997, J ANTIBIOT, V50, P738, DOI 10.7164/antibiotics.50.738
   Belarbi E, 2003, BIOMOL ENG, V20, P333, DOI 10.1016/S1389-0344(03)00043-1
   BERGMANN W, 1950, J AM CHEM SOC, V72, P2809, DOI 10.1021/ja01162a543
   BERGMANN W, 1951, J ORG CHEM, V16, P981, DOI 10.1021/jo01146a023
   BERGMANN W, 1955, J ORG CHEM, V20, P1501, DOI 10.1021/jo01128a007
   Bewley CA, 1996, EXPERIENTIA, V52, P716, DOI 10.1007/BF01925581
   Blunt JW, 2003, NAT PROD REP, V20, P1, DOI 10.1039/b207130b
   Blunt JW, 2004, NAT PROD REP, V21, P1, DOI 10.1039/b305250h
   Brady SF, 2001, ORG LETT, V3, P1981, DOI 10.1021/ol015949k
   Brakmann S, 2001, CHEMBIOCHEM, V2, P865, DOI 10.1002/1439-7633(20011203)2:12<865::AID-CBIC865>3.0.CO;2-6
   Burgett AWG, 2003, ANGEW CHEM INT EDIT, V42, P4961, DOI 10.1002/anie.200352577
   Burja AM, 2002, J MICROBIOL METH, V48, P207, DOI 10.1016/S0167-7012(01)00324-4
   CARDANI C, 1965, TETRAHEDRON LETT, P2537
   Chang ZX, 2004, J NAT PROD, V67, P1356, DOI 10.1021/np0499261
   Chang ZX, 2002, GENE, V296, P235, DOI 10.1016/S0378-1119(02)00860-0
   Coleman AC, 1999, ORG LETT, V1, P2173, DOI 10.1021/ol991120i
   Coleman AC, 2000, TETRAHEDRON, V56, P9569, DOI 10.1016/S0040-4020(00)00930-3
   Connon SA, 2002, APPL ENVIRON MICROB, V68, P3878, DOI 10.1128/AEM.68.8.3878-3885.2002
   CORLEY DG, 1988, J ORG CHEM, V53, P3644, DOI 10.1021/jo00250a053
   Courtois S, 2003, APPL ENVIRON MICROB, V69, P49, DOI 10.1128/AEM.69.1.49-55.2003
   CREWS P, 1986, TETRAHEDRON LETT, V27, P2797, DOI 10.1016/S0040-4039(00)84645-6
   CREWS P, 1994, J ORG CHEM, V59, P2932, DOI 10.1021/jo00090a008
   Cropp TA, 2000, NAT BIOTECHNOL, V18, P980
   Cuevas C, 2000, ORG LETT, V2, P2545, DOI 10.1021/ol0062502
   Cundliffe E, 2001, ANTON LEEUW INT J G, V79, P229, DOI 10.1023/A:1012065300116
   DAMBROSIO M, 1987, HELV CHIM ACTA, V70, P2019, DOI 10.1002/hlca.19870700807
   DAURIA MV, 1993, TETRAHEDRON, V49, P8657, DOI 10.1016/S0040-4020(01)96271-4
   DAURIA MV, 1993, CHEM REV, V93, P1839, DOI 10.1021/cr00021a010
   Davidson SK, 2001, APPL ENVIRON MICROB, V67, P4531, DOI 10.1128/AEM.67.10.4531-4537.2001
   de Caralt S, 2003, BIOMOL ENG, V20, P339, DOI 10.1016/S1389-0344(03)00045-5
   DEARRUDA M, 1995, CANCER RES, V55, P3085
   DEGNAN BM, 1989, J MED CHEM, V32, P1354, DOI 10.1021/jm00126a035
   DEGNAN BM, 1989, J MED CHEM, V32, P1349, DOI 10.1021/jm00126a034
   DELL A, 1975, J AM CHEM SOC, V97, P2497, DOI 10.1021/ja00842a029
   DESILVA ED, 1992, TETRAHEDRON LETT, V33, P1561, DOI 10.1016/S0040-4039(00)91674-5
   Dewick PM, 2002, NAT PROD REP, V19, P181, DOI 10.1039/b002685i
   Dittmann E, 2001, APPL MICROBIOL BIOT, V57, P467
   DONADIO S, 1993, P NATL ACAD SCI USA, V90, P7119, DOI 10.1073/pnas.90.15.7119
   DORDICK JS, 1992, TRENDS BIOTECHNOL, V10, P287, DOI 10.1016/0167-7799(92)90246-R
   Duckworth AR, 2003, MAR BIOTECHNOL, V5, P519, DOI 10.1007/s10126-002-0111-0
   Duckworth AR, 2003, AQUACULTURE, V217, P139, DOI 10.1016/S0044-8486(02)00038-8
   Dupont E, 2002, CLIN EXP METASTAS, V19, P145, DOI 10.1023/A:1014546909573
   Edler MC, 2002, BIOCHEM PHARMACOL, V63, P707, DOI 10.1016/S0006-2952(01)00898-X
   Edwards DJ, 2004, J AM CHEM SOC, V126, P11432, DOI 10.1021/ja047876g
   Edwards DJ, 2004, CHEM BIOL, V11, P817, DOI 10.1016/j.chembiol.2004.03.030
   El-Sayed AK, 2003, CHEM BIOL, V10, P419, DOI 10.1016/S1074-5521(03)00091-7
   Eppelmann K, 2001, J BIOL CHEM, V276, P34824, DOI 10.1074/jbc.M104456200
   Erickson KL, 1997, J ORG CHEM, V62, P8188, DOI 10.1021/jo971556g
   Faulkner DJ, 2000, ANTON LEEUW INT J G, V77, P135, DOI 10.1023/A:1002405815493
   Faulkner DJ, 2000, NAT PROD REP, V17, P1, DOI 10.1039/a909113k
   Faulkner DJ, 2002, NAT PROD REP, V19, P1, DOI 10.1039/b009029h
   Feling RH, 2003, ANGEW CHEM INT EDIT, V42, P355, DOI 10.1002/anie.200390115
   FELING RH, 2003, ANGEW CHEM, V115, P369
   FERNANDEZ AM, 1999, PURE APPL CHEM, V70, P2130
   Flowers AE, 1998, CELL TISSUE RES, V292, P597, DOI 10.1007/s004410051089
   Freemantle M, 2004, CHEM ENG NEWS, V82, P33, DOI 10.1021/cen-v082n009.p033
   FRINCKE JM, 1982, J AM CHEM SOC, V104, P265, DOI 10.1021/ja00365a048
   Fu X, 2003, NAT BIOTECHNOL, V21, P1467, DOI 10.1038/nbt909
   FURUSAKI A, 1968, TETRAHEDRON LETT, P6301
   FURUSAKI A, 1978, J CHEM SOC CHEM COMM, P800, DOI 10.1039/c39780000800
   FUSETANI N, 1992, J ORG CHEM, V57, P3828, DOI 10.1021/jo00040a021
   GARSON MJ, 1992, LIPIDS, V27, P378, DOI 10.1007/BF02536153
   Garson MJ, 1998, CELL TISSUE RES, V293, P365, DOI 10.1007/s004410051128
   Gerwick WH, 2001, ALKALOIDS, V57, P75, DOI 10.1016/S0099-9598(01)57003-0
   GERWICK WH, 1994, J ORG CHEM, V59, P1243, DOI 10.1021/jo00085a006
   Gillespie DE, 2002, APPL ENVIRON MICROB, V68, P4301, DOI 10.1128/AEM.68.9.4301-4306.2002
   Gillor O, 2000, MAR BIOTECHNOL, V2, P213, DOI 10.1007/s101260000026
   GINER JL, 1993, CHEM REV, V93, P1735, DOI 10.1021/cr00021a004
   Goldspiel BR, 1997, PHARMACOTHERAPY, V17, pS110
   GOUIFFES D, 1988, TETRAHEDRON, V44, P451, DOI 10.1016/S0040-4020(01)85836-1
   GUELLA G, 1989, HELV CHIM ACTA, V72, P237, DOI 10.1002/hlca.19890720207
   GULAVITA NK, 1992, J NAT PROD, V55, P506, DOI 10.1021/np50082a019
   GUNASEKERA SP, 1991, J ORG CHEM, V56, P4830, DOI 10.1021/jo00016a006
   GUNASEKERA SP, 1990, J ORG CHEM, V55, P4912, DOI 10.1021/jo00303a029
   HAMANN MT, 1993, J AM CHEM SOC, V115, P5825, DOI 10.1021/ja00066a061
   Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9
   Hanson JR, 2003, NAT PROD REP, V20, P70, DOI 10.1039/b108963n
   Harrigan GG, 1998, J NAT PROD, V61, P1075, DOI 10.1021/np980321c
   Henne A, 1999, APPL ENVIRON MICROB, V65, P3901
   Hirama M, 2001, SCIENCE, V294, P1904, DOI 10.1126/science.1065757
   Hoffmeister D, 2003, P NATL ACAD SCI USA, V100, P13184, DOI 10.1073/pnas.2235011100
   Holloway GA, 2003, J ORG CHEM, V68, P2200, DOI 10.1021/jo026798h
   Hooper GJ, 1998, J NAT PROD, V61, P529, DOI 10.1021/np970443p
   Hopwood DA, 1997, CHEM REV, V97, P2465, DOI 10.1021/cr960034i
   IKEDA Y, 1983, J ANTIBIOT, V36, P1284, DOI 10.7164/antibiotics.36.1284
   IRSCHIK H, 1988, J ANTIBIOT, V41, P993, DOI 10.7164/antibiotics.41.993
   ISHIBASHI M, 1986, J ORG CHEM, V51, P5300, DOI 10.1021/jo00376a047
   ITO S, 1972, TETRAHEDRON LETT, P1185
   Jansen R, 1996, LIEBIGS ANN, P285
   Jennewein S, 2004, CHEM BIOL, V11, P379, DOI 10.1016/j.chembiol.2004.02.022
   Jennewein S, 2001, APPL MICROBIOL BIOT, V57, P13
   Jou G, 1997, J ORG CHEM, V62, P354, DOI 10.1021/jo961932h
   Julien B, 2002, ANTIMICROB AGENTS CH, V46, P2772, DOI 10.1128/AAC.46.9.2772-2778.2002
   Kaeberlein T, 2002, SCIENCE, V296, P1127, DOI 10.1126/science.1070633
   KASHMAN Y, 1980, TETRAHEDRON LETT, V21, P3629, DOI 10.1016/0040-4039(80)80255-3
   Kato Y, 2002, J AM CHEM SOC, V124, P5268, DOI 10.1021/ja0127483
   Kelecom A, 2002, AN ACAD BRAS CIENC, V74, P151, DOI 10.1590/S0001-37652002000100012
   Khosla C, 1999, ANNU REV BIOCHEM, V68, P219, DOI 10.1146/annurev.biochem.68.1.219
   KINNEL RB, 1992, J ORG CHEM, V57, P6327, DOI 10.1021/jo00049a049
   KOBAYASHI J, 1988, TETRAHEDRON LETT, V29, P1177, DOI 10.1016/S0040-4039(00)86681-2
   KOBAYASHI M, 1994, TETRAHEDRON LETT, V35, P7969, DOI 10.1016/0040-4039(94)80024-3
   Kohl AC, 2004, ARCH BIOCHEM BIOPHYS, V424, P97, DOI 10.1016/j.abb.2004.01.019
   Kohl AC, 2003, J IND MICROBIOL BIOT, V30, P495, DOI 10.1007/s10295-003-0076-7
   KONISHI K, 1968, AGR BIOL CHEM TOKYO, V32, P678, DOI 10.1080/00021369.1968.10859118
   Kunze B, 1998, J ANTIBIOT, V51, P1075, DOI 10.7164/antibiotics.51.1075
   Kuzuyama T, 2003, NAT PROD REP, V20, P171, DOI 10.1039/b109860h
   LEE MD, 1987, J AM CHEM SOC, V109, P3466, DOI 10.1021/ja00245a051
   Li AY, 2002, CHEM BIOL, V9, P1017, DOI 10.1016/S1074-5521(02)00223-5
   Li CW, 1998, SCIENCE, V279, P879, DOI 10.1126/science.279.5352.879
   Li J, 2001, ANGEW CHEM INT EDIT, V40, P4770, DOI 10.1002/1521-3773(20011217)40:24<4770::AID-ANIE4770>3.0.CO;2-T
   LI J, 2001, ANGEW CHEM, V113, P4901
   Liao XB, 2003, ANGEW CHEM INT EDIT, V42, P1648, DOI 10.1002/anie.200351145
   Lindel T, 1997, J AM CHEM SOC, V119, P8744, DOI 10.1021/ja9717828
   LINDQUIST N, 1991, EXPERIENTIA, V47, P504, DOI 10.1007/BF01959957
   LINDQUIST N, 1991, J AM CHEM SOC, V113, P2303, DOI 10.1021/ja00006a060
   LOOK SA, 1986, J ORG CHEM, V51, P5140, DOI 10.1021/jo00376a016
   Lopanik N, 2004, OECOLOGIA, V139, P131, DOI 10.1007/s00442-004-1487-5
   Lopez JV, 2004, MOL GENET GENOMICS, V270, P420, DOI 10.1007/s00438-003-0937-9
   Lopez-Macia A, 2001, J AM CHEM SOC, V123, P11398, DOI 10.1021/ja0116728
   Luesch H, 2001, J NAT PROD, V64, P907, DOI 10.1021/np010049y
   Magarvey NA, 2004, APPL ENVIRON MICROB, V70, P7520, DOI 10.1128/AEM.70.12.7520-7529.2004
   Mao YQ, 1999, CHEM BIOL, V6, P251, DOI 10.1016/S1074-5521(99)80040-4
   Martinez A, 2004, APPL ENVIRON MICROB, V70, P2452, DOI 10.1128/AEM.70.4.2452-2463.2004
   MATSUMOTO T, 1968, TETRAHEDRON LETT, P6297
   Mayer AMS, 1998, LIFE SCI, V62, pPL401, DOI 10.1016/S0024-3205(98)00229-X
   McDonald LA, 1996, J AM CHEM SOC, V118, P10898, DOI 10.1021/ja961122n
   MEEKS JC, 2001, PHOTOSYN RES, V70
   Mendola D, 2003, BIOMOL ENG, V20, P441, DOI 10.1016/S1389-0344(03)00075-3
   Mickel SJ, 2004, ORG PROCESS RES DEV, V8, P92, DOI 10.1021/op034130e
   Mickel SJ, 2004, ORG PROCESS RES DEV, V8, P122, DOI 10.1021/op034134j
   Mickel SJ, 2004, ORG PROCESS RES DEV, V8, P113, DOI 10.1021/op034133r
   Mickel SJ, 2004, ORG PROCESS RES DEV, V8, P101, DOI 10.1021/op0341317
   Mickel SJ, 2004, ORG PROCESS RES DEV, V8, P107, DOI 10.1021/op034132z
   Mincer TJ, 2002, APPL ENVIRON MICROB, V68, P5005, DOI 10.1128/AEM.68.10.5005-5011.2002
   MIYAZAKI K, 1995, CHEM PHARM BULL, V43, P1706
   Mochizuki S, 2003, MOL MICROBIOL, V48, P1501, DOI 10.1046/j.1365-2958.2003.03523.x
   MOODY CJ, 1992, TETRAHEDRON, V48, P3589, DOI 10.1016/S0040-4020(01)88497-0
   Moore BS, 1999, NAT PROD REP, V16, P653, DOI 10.1039/a805873c
   MOORE KS, 1993, P NATL ACAD SCI USA, V90, P1354, DOI 10.1073/pnas.90.4.1354
   Mootz HD, 2002, CHEMBIOCHEM, V3, P490, DOI 10.1002/1439-7633(20020603)3:6<490::AID-CBIC490>3.0.CO;2-N
   Morita M, 1996, BIOSCI BIOTECH BIOCH, V60, P288, DOI 10.1271/bbb.60.288
   Muller WEG, 2000, J NAT PROD, V63, P1077, DOI 10.1021/np000003p
   MULLER WEG, 1986, J HISTOCHEM CYTOCHEM, V34, P1687, DOI 10.1177/34.12.3782777
   Muller WEG, 2004, MAR BIOTECHNOL, V6, P105, DOI 10.1007/s10126-002-0098-6
   Mydlarz LD, 2003, CHEM BIOL, V10, P1051, DOI 10.1016/j.chembiol.2003.10.012
   NATORI T, 1993, TETRAHEDRON LETT, V34, P5591, DOI 10.1016/S0040-4039(00)73889-5
   Natsume T, 2003, CANCER SCI, V94, P826, DOI 10.1111/j.1349-7006.2003.tb01526.x
   Nazi I, 2004, ANAL BIOCHEM, V324, P100, DOI 10.1016/j.ab.2003.09.005
   Newman DJ, 2000, NAT PROD REP, V17, P215, DOI 10.1039/a902202c
   Newman DJ, 2004, CURR MED CHEM, V11, P1693, DOI 10.2174/0929867043364982
   Nicolaou KC, 1999, CHEM PHARM BULL, V47, P1199
   Nieman JA, 2003, J NAT PROD, V66, P183, DOI 10.1021/np020375t
   OKAICHI T, 1962, AGR BIOL CHEM TOKYO, V26, P224, DOI 10.1080/00021369.1962.10857963
   Oku N, 2003, J AM CHEM SOC, V125, P2044, DOI 10.1021/ja0296780
   ORJALA J, 1995, J AM CHEM SOC, V117, P8281, DOI 10.1021/ja00136a031
   Osinga R, 2003, J BIOTECHNOL, V100, P141, DOI 10.1016/S0168-1656(02)00257-2
   Osinga R, 1999, MAR BIOTECHNOL, V1, P509, DOI 10.1007/PL00011807
   OTSUKA H, 1965, TETRAHEDRON, V21, P2931, DOI 10.1016/S0040-4020(01)98379-6
   Peng JN, 2003, J AGR FOOD CHEM, V51, P2246, DOI 10.1021/jf0207880
   PERRY NB, 1994, TETRAHEDRON, V50, P3987, DOI 10.1016/S0040-4020(01)89673-3
   PERRY NB, 1988, J AM CHEM SOC, V110, P4850, DOI 10.1021/ja00222a067
   Pettit GR, 1998, ANTI-CANCER DRUG DES, V13, P47
   PETTIT GR, 1987, J AM CHEM SOC, V109, P6883, DOI 10.1021/ja00256a070
   PETTIT GR, 1981, J NAT PROD, V44, P482, DOI 10.1021/np50016a016
   PETTIT GR, 1982, J AM CHEM SOC, V104, P6846, DOI 10.1021/ja00388a092
   Pettit GR, 1996, J NAT PROD, V59, P812, DOI 10.1021/np9604386
   PETTIT GR, 1989, J ORG CHEM, V54, P6005, DOI 10.1021/jo00287a003
   PETTIT GR, 1997, PROG CH ORG NAT PROD, V70, P1
   Pfeifer BA, 2001, SCIENCE, V291, P1790, DOI 10.1126/science.1058092
   Piel J, 2004, CHEMBIOCHEM, V5, P93, DOI 10.1002/cbic.200300782
   Piel J, 2002, P NATL ACAD SCI USA, V99, P14002, DOI 10.1073/pnas.222481399
   Pomponi SA, 1999, J BIOTECHNOL, V70, P5, DOI 10.1016/S0168-1656(99)00053-X
   QUINOA E, 1988, J ORG CHEM, V53, P3642, DOI 10.1021/jo00250a052
   Reetz Manfred T., 2000, Science Progress, V83, P157
   Regentin R, 2002, J IND MICROBIOL BIOT, V28, P12, DOI 10.1038/sj/jim/7000208
   Remiszewski SW, 2003, CURR MED CHEM, V10, P2393, DOI 10.2174/0929867033456675
   Remiszewski SW, 2003, J MED CHEM, V46, P4609, DOI 10.1021/jm030235w
   RINEHART KL, 1988, J AM CHEM SOC, V110, P8557, DOI 10.1021/ja00233a049
   RINEHART KL, 1990, J ORG CHEM, V55, P4512, DOI 10.1021/jo00302a007
   RINEHART KL, 1981, J AM CHEM SOC, V103, P1857, DOI 10.1021/ja00397a055
   Rix U, 2002, NAT PROD REP, V19, P542, DOI 10.1039/b103920m
   Romero F, 1997, J ANTIBIOT, V50, P734, DOI 10.7164/antibiotics.50.734
   Rottmayr EM, 2001, ZOOMORPHOLOGY, V120, P159, DOI 10.1007/s004350000032
   SAKAI M, 1969, Review of Plant Protection Research, V2, P17
   SAKEMI S, 1988, J AM CHEM SOC, V110, P4851, DOI 10.1021/ja00222a068
   Salomon CE, 2002, J NAT PROD, V65, P689, DOI 10.1021/np010556f
   Salomon CE, 2001, MAR BIOL, V139, P313
   Sandmann G, 2001, ARCH BIOCHEM BIOPHYS, V385, P4, DOI 10.1006/abbi.2000.2170
   SASSE F, 1993, J ANTIBIOT, V46, P741, DOI 10.7164/antibiotics.46.741
   Sauder DN, 2002, J AM ACAD DERMATOL, V47, P535, DOI 10.1067/mjd.2002.124702
   Schmidt EW, 2000, MAR BIOL, V136, P969, DOI 10.1007/s002270000273
   Schmidt-Dannert C, 2000, CURR OPIN BIOTECH, V11, P255, DOI 10.1016/S0958-1669(00)00093-8
   Schroeder H. C., 2003, P163
   Schwarzer D, 2003, NAT PROD REP, V20, P275, DOI 10.1039/b111145k
   Sears P, 1996, P NATL ACAD SCI USA, V93, P12086, DOI 10.1073/pnas.93.22.12086
   SHIGEMORI H, 1992, J ORG CHEM, V57, P4317, DOI 10.1021/jo00041a053
   Snyder RV, 2003, MAR BIOTECHNOL, V5, P1, DOI 10.1007/s10126-002-0077-y
   Staats PS, 2004, JAMA-J AM MED ASSOC, V291, P63, DOI 10.1001/jama.291.1.63
   Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g
   Stinear TP, 2004, P NATL ACAD SCI USA, V101, P1345, DOI 10.1073/pnas.0305877101
   Tabata H, 2004, ADV BIOCHEM ENG BIOT, V87, P1
   Taglialatela-Scafati O, 2002, ORG LETT, V4, P4085, DOI 10.1021/ol026831m
   TALPIR R, 1994, TETRAHEDRON LETT, V35, P4453, DOI 10.1016/S0040-4039(00)73382-X
   Tanaka J, 1996, CHEM LETT, P255, DOI 10.1246/cl.1996.255
   Tang L, 2000, SCIENCE, V287, P640, DOI 10.1126/science.287.5453.640
   terHaar E, 1996, BIOCHEMISTRY-US, V35, P243, DOI 10.1021/bi9515127
   Tincu JA, 2000, BIOCHEM BIOPH RES CO, V270, P421, DOI 10.1006/bbrc.2000.2449
   TRIMURTULU G, 1994, J AM CHEM SOC, V116, P4729, DOI 10.1021/ja00090a020
   UEMURA D, 1985, J AM CHEM SOC, V107, P4796, DOI 10.1021/ja00302a042
   UNSON MD, 1993, EXPERIENTIA, V49, P349, DOI 10.1007/BF01923420
   Uriz MJ, 1996, MAR BIOL, V124, P583, DOI 10.1007/BF00351039
   Uriz MJ, 1996, CELL TISSUE RES, V285, P519, DOI 10.1007/s004410050668
   Vera MD, 2002, MED RES REV, V22, P102, DOI 10.1002/med.10003
   Walsh CT, 2002, CHEMBIOCHEM, V3, P125
   Wang GYS, 2000, ORG LETT, V2, P2401, DOI 10.1021/ol005860z
   WANI MC, 1971, J AM CHEM SOC, V93, P2325, DOI 10.1021/ja00738a045
   Warabi K, 2003, J ORG CHEM, V68, P2765, DOI 10.1021/jo0167910
   Wender PA, 1999, MED RES REV, V19, P388
   Wender PA, 2002, J AM CHEM SOC, V124, P4956, DOI 10.1021/ja0258428
   Wender PA, 1998, P NATL ACAD SCI USA, V95, P6624, DOI 10.1073/pnas.95.12.6624
   Wender PA, 1998, J AM CHEM SOC, V120, P4534, DOI 10.1021/ja9727631
   Wender PA, 1998, TETRAHEDRON LETT, V39, P8625, DOI 10.1016/S0040-4039(98)01955-8
   WENDER PA, 2001, GASSMAN MEMORIAL LEC
   West LM, 2000, J ORG CHEM, V65, P445, DOI 10.1021/jo991296y
   Willetts A, 1997, TRENDS BIOTECHNOL, V15, P55, DOI 10.1016/S0167-7799(97)84204-7
   WILLOUGHBY R, 2000, IN VITRO CELL DEV-AN, V36, P194
   Wipf P, 1996, J ORG CHEM, V61, P6556, DOI 10.1021/jo960845m
   WOOLLACOTT RM, 1981, MAR BIOL, V65, P155, DOI 10.1007/BF00397080
   WRIGHT AE, 1990, J ORG CHEM, V55, P4508, DOI 10.1021/jo00302a006
   Yun JM, 2003, J ORG CHEM, V68, P7675, DOI 10.1021/jo034755a
   ZABRISKIE TM, 1986, J AM CHEM SOC, V108, P3123, DOI 10.1021/ja00271a062
   Zazopoulos E, 2003, NAT BIOTECHNOL, V21, P187, DOI 10.1038/nbt784
   Zengler K, 2002, P NATL ACAD SCI USA, V99, P15681, DOI 10.1073/pnas.252630999
   Zhang DH, 2003, ORG LETT, V5, P3257, DOI 10.1021/o1035062j
   Zhang YX, 2002, NATURE, V415, P644, DOI 10.1038/415644a
   Zhu G, 2002, GENE, V298, P79, DOI 10.1016/S0378-1119(02)00931-9
NR 240
TC 47
Z9 50
U1 0
U2 3
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1439-4227
EI 1439-7633
J9 CHEMBIOCHEM
JI ChemBioChem
PD JUN
PY 2005
VL 6
IS 6
BP 960
EP 978
DI 10.1002/cbic.200400428
PG 19
WC Biochemistry & Molecular Biology; Chemistry, Medicinal
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA 934SZ
UT WOS:000229730000002
PM 15880675
DA 2018-10-19
ER

PT J
AU Worth, A
   Mucalo, M
   Horne, G
   Bruce, W
   Burbidge, H
AF Worth, A
   Mucalo, M
   Horne, G
   Bruce, W
   Burbidge, H
TI The evaluation of processed cancellous bovine bone as a bone graft
   substitute
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE biomaterials; bovine hydroxyapatite; composite bone grafting;
   histomorphometry; ovine condylar defect; xenografting; xenoimplant
ID ANIMAL-DERIVED BONE; BIOMEDICAL APPLICATIONS; YIELD MATERIALS;
   BIO-OSS(R); IMPLANTS; DEFECTS; AUGMENTATION; HUMANS
AB Objective: To determine the ability of a novel bovine cancellous bone xenoimplant to act as an osteoconductive graft in an ovine femoral defect model. An autograft harvested from the xenoimplant site was placed in a contralateral limb defect for comparison.
   Material and methods: The xenoimplant used had been rendered immunologically inert by a novel defatting and deproteinating process. Following surgical implantation of cores into condylar cancellous bone defects, fluorochrome labels were administered to 12 sheep at 2 1/2, 4 1/2 and 8 weeks. Incorporation of the xenoimplants and autografts into the host bone was compared radiographically and histomorphometrically at 10 weeks.
   Results: Radiographically, the degree of osteointegration was comparable. Histomorphometric data, consisting of labelled surface (LS) estimates, confirmed osteoconductive properties of both the xenoimplants and autografts. Remodelling activity was greatest in the xenoimplants at 2 1/2, weeks. At 4 1/2 weeks, there was more activity in the autograft, but by 8 weeks they were performing similarly. Xenoimplant-LS estimates were comparable or greater than those of the autograft at all times.
   Conclusions: Processed bovine cancellous bone xenoimplants were osteoconductive in this model and show promise for development as a biomaterial in human and veterinary orthopaedic surgery.
C1 Massey Univ, Vet Teaching Hosp, Ctr Compan Anim Hlth, Palmerston North, New Zealand.
   Univ Waikato, Dept Chem, Hamilton, New Zealand.
   Univ Otago, Wellington Sch Med, Wellington, New Zealand.
   Adelaide Vet Specialist & Referral Ctr, Vet Specialist Orthopaed Serv, Adelaide, SA, Australia.
RP Worth, A (reprint author), Massey Univ, Vet Teaching Hosp, Ctr Compan Anim Hlth, Private Bag 11-222, Palmerston North, New Zealand.
EM A.J.Worth@massey.ac.nz
RI Mucalo, Michael/E-5263-2013
OI Mucalo, Michael/0000-0002-7655-9885
CR Anderson JC, 2001, AM J ARCHAEOL, V105, P371, DOI 10.2307/507312
   Anderson LA, 2000, J MATER SCI-MATER M, V11, P743
   Berglundh T, 1997, CLIN ORAL IMPLAN RES, V8, P117, DOI 10.1034/j.1600-0501.1997.080206.x
   Eriksen E, 1994, BONE HISTOMORPHOMETR, P33
   Hallman M, 2001, CLIN ORAL IMPLAN RES, V12, P135, DOI 10.1034/j.1600-0501.2001.012002135.x
   Hollinger J O, 1990, J Craniofac Surg, V1, P60, DOI 10.1097/00001665-199001000-00011
   Johnson GS, 2000, J MATER SCI-MATER M, V11, P427, DOI 10.1023/A:1008987908917
   KERWIN SC, 1991, COMP CONT EDUC PRACT, V13, P1558
   KLINGE B, 1992, J ORAL MAXIL SURG, V50, P241, DOI 10.1016/0278-2391(92)90320-Y
   Ladd A L, 1999, J Am Acad Orthop Surg, V7, P279
   Merkx MAW, 1999, BIOMATERIALS, V20, P639, DOI 10.1016/S0142-9612(98)00219-1
   OHASHI H, 1994, J MATER SCI-MATER M, V5, P225, DOI 10.1007/BF00121093
   Piattelli M, 1999, INT J ORAL MAX IMPL, V14, P835
   Richardson CR, 1999, J CLIN PERIODONTOL, V26, P421, DOI 10.1034/j.1600-051X.1999.260702.x
   Salama R, 1973, J Bone Joint Surg Br, V55, P402
   Schlegel AK, 1998, J LONG-TERM EFF MED, V8, P201
   Wolff J., 1986, LAW BONE REMODELLING
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
NR 18
TC 19
Z9 23
U1 0
U2 4
PU BLACKWELL MUNKSGAARD
PI FREDERIKSBERG C
PA 1 ROSENORNS ALLE, DK-1970 FREDERIKSBERG C, DENMARK
SN 0905-7161
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD JUN
PY 2005
VL 16
IS 3
BP 379
EP 386
DI 10.1111/j.1600-0501.2005.01113.x
PG 8
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 924FR
UT WOS:000228964900015
PM 15877759
DA 2018-10-19
ER

PT J
AU Chang, K
   Chiu, JJ
AF Chang, K
   Chiu, JJ
TI Clinical applications of nanotechnology in atherosclerotic diseases
SO CURRENT NANOSCIENCE
LA English
DT Article
DE atherosclerosis; diagnosis; nanotechnology; prevention; treatment
ID LOW-DENSITY-LIPOPROTEIN; ARTERIAL GENE-TRANSFER; LIPID-BASED SYSTEMS;
   IN-VIVO; DELIVERY-SYSTEMS; HEART-DISEASE; CARDIOVASCULAR-DISEASE;
   BIOLOGICAL DETECTION; ENDOTHELIAL-CELLS; QUANTUM DOTS
AB Nanotechnology can be defined as the science and engineering involved in the design, synthesis, characterization, and application of materials and devices whose smallest functional organization in at least one dimension is on the nanometer scale or one billionth of a meter. One of the great promises of nanotechnology is the application to biology and medicine. In medicine, the cardiovascular field is one of the most technically advanced disciplines. Engineering achievements have helped us develop novel diagnostic and therapeutic technologies that provide safe and efficient solutions for cardiovascular patients. In spite of such progress, cardiovascular disease remains a major cause of death, morbidity, and disability in Occidental and Oriental societies. To address this formidable public health issue, substantial advances will be needed, and in particular, some important technological hurdles need to be overcome. The burgeoning new field of nanotechnology might open up a brand new approach in addressing some of these technical challenges. In fact, recent rapid advances in nanotechnology and nanoscience offer a wealth of new opportunities for diagnosis, prevention, and therapy of cardiovascular diseases, especially atherosclerosis. The aim of this article is to provide a brief survey at promising, important targets for nanotechnology in atherosclerosis. We review some of the main advances in the field of nanotechnology over the past few years, explore the prospects of clinical application in atherosclerosis, and discuss the concepts, issues, approaches, and challenges, with the goal of triggering the interest of biomedical scientists in the field of extremely tiny world.
C1 Natl Hlth Res Inst, Div Med Engn Res, Zhunan Town 350, Miaoli, Taiwan.
RP Chiu, JJ (reprint author), Natl Hlth Res Inst, Div Med Engn Res, 35 Keyan Rd, Zhunan Town 350, Miaoli, Taiwan.
EM jjchiu@nhri.org.tw
RI Chiu, Jeng-Jiann/E-3980-2010
CR AMBROSE JA, 1996, SYNDROMES ATHEROSCLE, P105
   BARR E, 1994, GENE THER, V1, P51
   Bonnemain B, 1998, J DRUG TARGET, V6, P167, DOI 10.3109/10611869808997890
   BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297
   Bryant LH, 1999, JMRI-J MAGN RESON IM, V9, P348, DOI 10.1002/(SICI)1522-2586(199902)9:2<348::AID-JMRI30>3.0.CO;2-J
   BULTE JW, 2001, MOL IMAGING, V1, P225
   Chan WCW, 2002, CURR OPIN BIOTECH, V13, P40, DOI 10.1016/S0958-1669(02)00282-3
   CHANG MY, 1992, ARTERIOSCLER THROMB, V12, P1088, DOI 10.1161/01.ATV.12.9.1088
   Chesebro James H, 2004, Am Heart Hosp J, V2, P21
   Chilton Robert J, 2004, J Am Osteopath Assoc, V104, pS5
   Couvreur P, 1986, POLYM NANOPARTICLES
   Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+
   Davda J, 2002, INT J PHARM, V233, P51, DOI 10.1016/S0378-5173(01)00923-1
   De Smedt SC, 2000, PHARMACEUT RES, V17, P113, DOI 10.1023/A:1007548826495
   Demos SM, 1999, J AM COLL CARDIOL, V33, P867, DOI 10.1016/S0735-1097(98)00607-X
   Deshpande D, 1998, PHARMACEUT RES, V15, P1340, DOI 10.1023/A:1011933117509
   DINSMORE R, 1996, SYNDROMES ATHEROSCLE, P277
   EIGLER DM, 1990, NATURE, V344, P524, DOI 10.1038/344524a0
   Farmer JA, 1997, HEART DIS TXB CARDIO, P1126
   FELDMAN LJ, 1995, J CLIN INVEST, V95, P2662, DOI 10.1172/JCI117968
   French BA, 1998, CURR OPIN CARDIOL, V13, P205
   Fruchart JC, 2004, CIRCULATION, V109, P15, DOI 10.1161/01.CIR.0000131513.33892.5b
   Garas SM, 2001, PHARMACOL THERAPEUT, V92, P165, DOI 10.1016/S0163-7258(01)00168-1
   Garnett MC, 1999, CRIT REV THER DRUG, V16, P147
   Gnatenko D, 1997, J INVEST MED, V45, P87
   GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333
   GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8
   GUZMAN PJ, 1993, CIRCULATION, V88, P2838
   Haes AJ, 2004, EXPERT REV MOL DIAGN, V4, P527, DOI 10.1586/14737159.4.4.527
   HANAFUSA S, 1995, CLIN ORTHOP RELAT R, V315, P262
   Herreros R, 1999, PALLIATIVE MED, V13, P83, DOI 10.1177/026921639901300114
   Hirko A, 2003, CURR MED CHEM, V10, P1185, DOI 10.2174/0929867033457412
   Iwata A, 2001, CIRCULATION, V103, P2753
   Jneid Hani, 2003, Expert Opin Emerg Drugs, V8, P349, DOI 10.1517/eoed.8.2.349.21131
   KOHLER T, 1996, SYNDROMES ATHEROSCLE, P205
   Kooi ME, 2003, CIRCULATION, V107, P2453, DOI 10.1161/01.CIR.0000068315.98705.CC
   KOPFLER WP, 1994, CIRCULATION, V90, P1319, DOI 10.1161/01.CIR.90.3.1319
   KOTTKE BA, 1986, MAYO CLIN PROC, V61, P313, DOI 10.1016/S0025-6196(12)61947-8
   KREUTER J, 1994, DRUGS PHARM SCI, V66, P219
   KUBOTA R, 1994, J NUCL MED, V35, P104
   Labarrere CA, 2004, AM J MED, V117, P499, DOI 10.1016/j.amjmed.2004.03.039
   Laitinen M, 2000, HUM GENE THER, V11, P263, DOI 10.1089/10430340050016003
   Lanza GM, 1996, CIRCULATION, V94, P3334, DOI 10.1161/01.CIR.94.12.3334
   LEES AM, 1988, ARTERIOSCLEROSIS, V8, P461, DOI 10.1161/01.ATV.8.5.461
   LEMARCHAND P, 1993, CIRC RES, V72, P1132, DOI 10.1161/01.RES.72.5.1132
   Lenter MC, 2004, PHARM RES, V21, P683, DOI 10.1023/B:PHAM.0000022416.33048.81
   Lynch CM, 1997, CIRC RES, V80, P497
   Lyon LA, 1998, ANAL CHEM, V70, P5177, DOI 10.1021/ac9809940
   Ma QG, 2001, J AM CHEM SOC, V123, P4627, DOI 10.1021/ja0156542
   MANNINEN V, 1988, JAMA-J AM MED ASSOC, V260, P641, DOI 10.1001/jama.260.5.641
   MATSUSUE Y, 1995, CLIN ORTHOP RELAT R, P246
   Maurer N, 1999, MOL MEMBR BIOL, V16, P129, DOI 10.1080/096876899294869
   MILLER NE, 1987, AM HEART J, V113, P589, DOI 10.1016/0002-8703(87)90638-7
   Moghimi SM, 2001, PHARMACOL REV, V53, P283
   Monfardini C, 1998, BIOCONJUGATE CHEM, V9, P418, DOI 10.1021/bc970184f
   Noon WH, 2002, P NATL ACAD SCI USA, V99, P6466, DOI 10.1073/pnas.022532599
   OLIGINO TJ, 2000, CLIN ORTHOP S, V379, pS17
   Paoletti R, 2004, CIRCULATION, V109, P20, DOI 10.1161/01.CIR.0000131514.71167.2e
   PARKER SE, 1995, HUM GENE THER, V6, P575, DOI 10.1089/hum.1995.6.5-575
   Peppas LB, 1995, INT J PHARMACEUT, V116, P1
   PIRICH C, 1995, ANN NY ACAD SCI, V748, P613
   Qian HS, 1999, CIRCULATION, V99, P2979, DOI 10.1161/01.CIR.99.23.2979
   Rader DJ, 1997, INT J CLIN LAB RES, V27, P35, DOI 10.1007/BF02827240
   Ranney DF, 2000, BIOCHEM PHARMACOL, V59, P105, DOI 10.1016/S0006-2952(99)00316-0
   Rasmussen Henrik Sandvad, 2002, Cardiovasc Radiat Med, V3, P114, DOI 10.1016/S1522-1865(02)00158-0
   Roessler BJ, 2001, BIOCHEM BIOPH RES CO, V283, P124, DOI 10.1006/bbrc.2001.4690
   ROSEN JM, 1990, J NUCL MED, V31, P343
   ROSS R, 1997, HEART DIS TXB CARDIO, P1105
   Schultz DA, 2003, CURR OPIN BIOTECH, V14, P13, DOI 10.1016/S0958-1669(02)000150
   Shah Svati H, 2003, Cardiol Rev, V11, P169, DOI 10.1097/01.CRD.0000077906.74217.6E
   Sipkins DA, 1998, NAT MED, V4, P623, DOI 10.1038/nm0598-623
   Smith AM, 2004, ANALYST, V129, P672, DOI 10.1039/b404498n
   SMITH LC, 1995, ADV EXP MED BIOL, V369, P79
   STEG PG, 1994, CIRCULATION, V90, P1648, DOI 10.1161/01.CIR.90.4.1648
   STEINBERG D, 1989, NEW ENGL J MED, V320, P915
   STEINBRECHER UP, 1989, J BIOL CHEM, V264, P15216
   Stephan DJ, 1996, HUM GENE THER, V7, P1803, DOI 10.1089/hum.1996.7.15-1803
   Torchilin VP, 1998, J MICROENCAPSUL, V15, P1, DOI 10.3109/02652049809006831
   Toussaint JF, 1996, CIRCULATION, V94, P932, DOI 10.1161/01.CIR.94.5.932
   TOUSSAINT JF, 1995, ARTERIOSCL THROM VAS, V15, P1533
   Tsimikas S, 1999, J NUCL CARDIOL, V6, P41, DOI 10.1016/S1071-3581(99)90064-8
   Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u
   VALLABHAJOSULA S, 1990, SEMIN NUCL MED, V20, P68, DOI 10.1016/S0001-2998(05)80177-1
   Vallabhajosula S., 1996, Journal of Nuclear Medicine, V37, p38P
   VALLABHAJOSULA S, 1988, J NUCL MED, V29, P1237
   VANDER A, 1998, HUMAN PHYSL MECH BOD
   VIRGOLINI I, 1991, EUR J NUCL MED, V18, P948
   WIENER EC, 1994, MAGNET RESON MED, V31, P1, DOI 10.1002/mrm.1910310102
   WILSON JM, 1989, SCIENCE, V244, P1344, DOI 10.1126/science.2734614
   Zaric V, 2004, J GENE MED, V6, P176, DOI 10.1002/jgm.484
   ZIMMER A, 1995, ADV DRUG DELIVER REV, V16, P61, DOI 10.1016/0169-409X(95)00017-2
NR 91
TC 0
Z9 0
U1 0
U2 8
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1573-4137
EI 1875-6786
J9 CURR NANOSCI
JI Curr. Nanosci.
PD JUN
PY 2005
VL 1
IS 2
BP 107
EP 115
DI 10.2174/1573413054065349
PG 9
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology;
   Materials Science, Multidisciplinary
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics; Materials Science
GA 992OY
UT WOS:000233894700002
DA 2018-10-19
ER

PT J
AU Herodin, F
   Thullier, P
   Garin, D
   Drouet, M
AF Herodin, F
   Thullier, P
   Garin, D
   Drouet, M
TI Nonhuman primates are relevant models for research in hematology,
   immunology and virology
SO EUROPEAN CYTOKINE NETWORK
LA English
DT Review
DE nonhuman primate model; hematopoiesis; stem cell; immunology; virology;
   cytokines; AIDS; vaccine
ID COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM-CELLS; LETHALLY IRRADIATED
   BABOONS; EX-VIVO EXPANSION; HUMAN MEGAKARYOCYTE GROWTH; AUTOLOGOUS
   BONE-MARROW; TOTAL-BODY IRRADIATION; GLYCOSYLATED HUMAN INTERLEUKIN-6;
   CD34(+) PROGENITOR CELLS; PERIPHERAL-BLOOD STEM
AB Nonhuman primates have been used for biomedical research for several decades. They have proved to be models that are relevant to humans because of the high level of gene homology which underlies physiological and biochemical similarities. The similarity of monkeys to humans has been used to investigate pathophysiological mechanisms in hematology, immunology and virology. New therapeutic procedures can be assessed in primates by using materials, in particular pharmacological reagents, and methods designed for humans. The relevance of these models also relies on the use of species-specific pathogens and the availability of recombinant, homologous cytokines. The introduction of more and more sophisticated cell and gene therapy protocols in hematopoietic cell transplantation and immunotherapy requires the development of preclinical trials similar to clinical settings. For several decades now, baboons and cynomolgus/rhesus monkeys have been the most useful primate models in experimental hematology, and this has contributed to numerous therapeutic advances. Primate models of AIDS have been developed to study the pathogenesis, transmission and immune responses to infection, and to test vaccines and drugs. Primate research should be restricted in quantity, and mainly designed with the aim of removing uncertainty as to the safety and clinical benefit to the patient, of new biomedical protocols.
C1 Ctr Rech, Serv Sante Armees, F-38702 La Tronche, France.
RP Herodin, F (reprint author), Ctr Rech, Serv Sante Armees, 24 Ave Maquis Gresivaudan,BP 87, F-38702 La Tronche, France.
EM fherodin@crssa.net
CR ADAMSON RH, 1975, BIBL HAEMATOL, V40, P723
   Amsellem S, 2003, NAT MED, V9, P1423, DOI 10.1038/nm953
   ANDREWS RG, 1995, BLOOD, V85, P15
   ANDREWS RG, 1992, BLOOD, V80, P1693
   Andrews RG, 2000, EXP HEMATOL, V28, P508, DOI 10.1016/S0301-472X(00)00137-5
   Andrews RG, 1999, STEM CELLS, V17, P210, DOI 10.1002/stem.170210
   ANDRISWIHOPF J, 2001, PHAGE DISPLAY LAB MA
   Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X
   BERENSON RJ, 1988, J CLIN INVEST, V81, P951, DOI 10.1172/JCI113409
   Berg SL, 1999, J PEDIAT HEMATOL ONC, V21, P26, DOI 10.1097/00043426-199901000-00008
   Bertho JM, 2001, INT J RADIAT BIOL, V77, P703, DOI 10.1080/09553000110043711
   Brandt JE, 1999, BLOOD, V94, P106
   Brown JM, 2004, EXP HEMATOL, V32, P693, DOI 10.1016/j.exphem.2004.07.001
   Bugelski PJ, 2000, HUM EXP TOXICOL, V19, P230, DOI 10.1191/096032700678815783
   Carlsson HE, 2004, AM J PRIMATOL, V63, P225, DOI 10.1002/ajp.20054
   Chassagne S, 2004, MOL IMMUNOL, V41, P539, DOI 10.1016/j.molimm.2004.03.040
   Chenuaud P, 2004, BLOOD, V103, P3303, DOI 10.1182/blood-2003-11-3848
   CIVIN CI, 1984, J IMMUNOL, V133, P157
   Coates PTH, 2003, BLOOD, V102, P2513, DOI 10.1182/blood-2002-09-2929
   Cosimi AB, 2004, TRANSPLANTATION, V77, P943, DOI 10.1097/01.TP.0000117779.23431.3F
   DeJong MO, 1997, STEM CELLS, V15, P275, DOI 10.1002/stem.150275
   DEREVEL T, 2000, C SFGM MARS
   Devine SM, 2001, EXP HEMATOL, V29, P244, DOI 10.1016/S0301-472X(00)00635-4
   Devine SM, 2003, BLOOD, V101, P2999, DOI 10.1182/blood-2002-06-1830
   DONAHUE RE, 1986, NATURE, V321, P872, DOI 10.1038/321872a0
   Donahue RE, 2000, BLOOD, V95, P445
   DORSSERS LCJ, 1994, GROWTH FACTORS, V11, P93, DOI 10.3109/08977199409001051
   Drouet M, 1999, STEM CELLS, V17, P273, DOI 10.1002/stem.170273
   Drouet M, 2004, BLOOD, V103, P878, DOI 10.1182/blood-2003-05-1400
   Drouet M, 2003, EXP HEMATOL, V31, P180
   Drouet M, 2001, STEM CELLS, V19, P436, DOI 10.1634/stemcells.19-5-436
   Earl PL, 2004, NATURE, V428, P182, DOI 10.1038/nature02331
   EVES EM, 1989, EXP HEMATOL, V17, P73
   Farese AM, 1996, J CLIN INVEST, V97, P2145, DOI 10.1172/JCI118652
   FARESE AM, 1995, BLOOD, V86, P54
   Fisher JW, 1996, BRIT J HAEMATOL, V95, P27, DOI 10.1046/j.1365-2141.1996.d01-1864.x
   Fry TJ, 2003, BLOOD, V101, P2294, DOI 10.1182/blood-2002-07-2297
   Gao CJ, 2003, MOL THER, V8, P974, DOI 10.1016/j.ymthe.2003.08.017
   GILLIO AP, 1990, J CLIN INVEST, V85, P1560, DOI 10.1172/JCI114605
   Glamann J, 1998, J VIROL, V72, P585
   Gomes APM, 2001, INT ENDOD J, V34, P93, DOI 10.1046/j.1365-2591.2001.00353.x
   Gorman S D, 1990, Semin Immunol, V2, P457
   Gottlieb AB, 2004, CLIN IMMUNOL, V111, P28, DOI 10.1016/j.clim.2004.01.006
   Gruber A, 2003, BLOOD, V102, P953, DOI 10.1182/blood-2003-01-0324
   Haig D, 1999, AM J PRIMATOL, V49, P285, DOI 10.1002/(SICI)1098-2345(199912)49:4<285::AID-AJP1>3.3.CO;2-O
   Hanawa H, 2004, BLOOD, V103, P4062, DOI 10.1182/blood-2004-01-0045
   Hanazono Y, 2001, STEM CELLS, V19, P12, DOI 10.1634/stemcells.19-1-12
   Harker LA, 1998, BLOOD, V91, P4427
   Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489
   HARRISON MR, 1989, LANCET, V2, P1425
   Hartong SCC, 2000, EXP HEMATOL, V28, P753, DOI 10.1016/S0301-472X(00)00171-5
   HERODIN F, 1992, BLOOD, V80, P688
   HILLYER CD, 1993, EXP HEMATOL, V21, P1455
   Hirsch V M, 2000, Adv Pharmacol, V49, P437
   Honig GR, 2004, BLOOD CELL MOL DIS, V32, P5, DOI 10.1016/j.bcmd.2003.09.008
   Horn PA, 2003, BLOOD, V102, P4329, DOI 10.1182/blood-2003-01-0082
   Hu JJ, 2000, J VIROL, V74, P6087, DOI 10.1128/JVI.74.13.6087-6095.2000
   JAHRLING PB, 2000, EMERG INFECT DIS, V4, P187
   Kaufman DS, 2004, BLOOD, V103, P1325, DOI 10.1182/blood-2003-03-0799
   Keckesova Z, 2004, P NATL ACAD SCI USA, V101, P10780, DOI 10.1073/pnas.0402474101
   Kennedy AD, 2003, BLOOD, V101, P1071, DOI 10.1182/blood-2002-03-0876
   King AG, 2001, BLOOD, V97, P1534, DOI 10.1182/blood.V97.6.1534
   Kitchener S, 2004, VACCINE, V22, P2103, DOI 10.1016/j.vaccine.2004.01.026
   KOTZE HF, 1985, THROMB HAEMOSTASIS, V53, P408
   Kuramoto K, 2004, BLOOD, V103, P4070, DOI 10.1182/blood-2003-08-2934
   Laterveer L, 1996, BLOOD, V87, P781
   Laukkanen MO, 2005, BLOOD, V105, P1010, DOI 10.1182/blood-2004-04-1498
   Lefranc MP, 2004, MOL IMMUNOL, V40, P647, DOI 10.1016/j.molimm.2003.09.006
   LEWIS AP, 1993, DEV COMP IMMUNOL, V17, P549, DOI 10.1016/S0145-305X(05)80010-2
   Lifson JD, 2004, AIDS RES HUM RETROV, V20, P772, DOI 10.1089/0889222041524661
   LUCCIANI P, 1998, PRIMATOLOGIE, V1, P285
   MacVittie TJ, 2000, BLOOD, V95, P837
   MacVittie TJ, 1996, BLOOD, V87, P4129
   MacVittie TJ, 1999, EXP HEMATOL, V27, P1557, DOI 10.1016/S0301-472X(99)00092-2
   Mahmud N, 2001, BLOOD, V97, P3061, DOI 10.1182/blood.V97.10.3061
   Marchevsky RS, 2003, VIROLOGY, V316, P55, DOI 10.1016/S0042-6822(03)00583-X
   MESTRIES JC, 1994, EUR CYTOKINE NETW, V5, P275
   Michelson AD, 1996, P NATL ACAD SCI USA, V93, P11877, DOI 10.1073/pnas.93.21.11877
   MONROY RL, 1987, BLOOD, V70, P1696
   MONROY RL, 1988, EXP HEMATOL, V16, P344
   Morris JC, 2004, BLOOD, V103, P492, DOI 10.1182/blood-2003-07-2324
   Muller MC, 2003, FRONT BIOSCI, V8, pD1170, DOI 10.2741/1130
   Mychaliska GB, 1997, J PEDIATR SURG, V32, P976, DOI 10.1016/S0022-3468(97)90381-X
   Nakatsuji Norio, 2002, ScientificWorldJournal, V2, P1762
   Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263
   Neelis KJ, 1997, BLOOD, V90, P2565
   NEWMAN R, 1992, BIO-TECHNOL, V10, P1455, DOI 10.1038/nbt1192-1455
   NIBLACK GD, 1976, CLIN EXP IMMUNOL, V23, P536
   Norol F, 2003, BLOOD, V102, P4361, DOI 10.1182/blood-2003-03-0685
   Norol F, 2002, BRIT J HAEMATOL, V117, P924, DOI 10.1046/j.1365-2141.2002.03531.x
   Norol F, 2000, BRIT J HAEMATOL, V109, P162, DOI 10.1046/j.1365-2141.2000.01995.x
   Ozwara H, 1997, J MED PRIMATOL, V26, P164, DOI 10.1111/j.1600-0684.1997.tb00048.x
   Papayannopoulou T, 1997, BLOOD, V90, P620
   PAPAYANNOPOULOU T, 1993, P NATL ACAD SCI USA, V90, P9374, DOI 10.1073/pnas.90.20.9374
   Prilliman K, 1996, TRANSPLANTATION, V61, P989, DOI 10.1097/00007890-199604150-00001
   Ramsburg E, 2004, J VIROL, V78, P3930, DOI 10.1128/JVI.78.8.3930-3940.2004
   Rey M, 1966, B SOC MED AFR NOIRE, V11, P560
   Rosenzweig M, 1999, BLOOD, V94, P2271
   Rubenstein JL, 2003, BLOOD, V101, P466, DOI 10.1182/blood-2002-06-1636
   Sablinski T, 1999, TRANSPLANTATION, V67, P972, DOI 10.1097/00007890-199904150-00007
   Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102
   SCHERMAN FJ, 1996, STEM CELLS, V14, P517
   Schmidt M, 2002, BLOOD, V100, P2737, DOI 10.1182/blood-2002-02-0407
   Shields LE, 2003, STEM CELLS, V21, P304, DOI 10.1634/stemcells.21-3-304
   Slungaard A, 2003, BLOOD, V102, P146, DOI 10.1182/blood-2002-11-3529
   Sopper S, 1997, CYTOMETRY, V29, P351
   Staprans Silvija I, 2004, Expert Rev Vaccines, V3, pS5, DOI 10.1586/14760584.3.4.S5
   Stittelaar KJ, 2002, VACCINE, V21, P155, DOI 10.1016/S0264-410X(02)00453-X
   STORB R, 1977, BLOOD, V50, P537
   STORB R, 1994, BLOOD, V83, P3384
   Storek J, 2003, BLOOD, V101, P4209, DOI 10.1182/blood-2002-08-2671
   Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343
   Thiebot H, 2005, BLOOD, V105, P2403, DOI 10.1182/blood-2004-01-0025
   Tisdale JF, 1998, BLOOD, V92, P1131
   Umeda K, 2004, DEVELOPMENT, V131, P1869, DOI 10.1242/dev.01065
   VANGILS FCJM, 1994, EXP HEMATOL, V22, P248
   Vetillard J, 1999, J HEMATOTH STEM CELL, V8, P365, DOI 10.1089/152581699320126
   VILLINGER F, 1995, J IMMUNOL, V155, P3946
   Vrana KE, 2003, P NATL ACAD SCI USA, V100, P11911, DOI 10.1073/pnas.2034195100
   WELTE K, 1987, J EXP MED, V165, P941, DOI 10.1084/jem.165.4.941
   WEN D, 1993, BLOOD, V82, P1507
   *WHO, 1998, WHO TECH REP SER, V872, P30
   WIENER A S, 1974, Haematologia, V8, P195
   Wild MA, 2003, NAT BIOTECHNOL, V21, P1305, DOI 10.1038/nbt891
   Williams Douglas E., 1993, Biotechnology Therapeutics, V4, P17
   Winkler A, 1999, HUM GENE THER, V10, P667, DOI 10.1089/10430349950018742
   WOLD DP, 2004, BIOL REPROD, V71, P1766
   Wu T, 2000, MOL THER, V1, P285, DOI 10.1006/mthe.2000.0034
   Yap MW, 2005, CURR BIOL, V15, P73, DOI 10.1016/j.cub.2004.12.042
   2002, EUROPEAN PHARM
NR 130
TC 35
Z9 38
U1 0
U2 3
PU JOHN LIBBEY EUROTEXT LTD
PI MONTROUGE
PA 127 AVE DE LA REPUBLIQUE, 92120 MONTROUGE, FRANCE
SN 1148-5493
J9 EUR CYTOKINE NETW
JI Eur. Cytokine Netw.
PD JUN
PY 2005
VL 16
IS 2
BP 104
EP 116
PG 13
WC Biochemistry & Molecular Biology; Cell Biology; Immunology
SC Biochemistry & Molecular Biology; Cell Biology; Immunology
GA 937CG
UT WOS:000229901600002
PM 15941681
DA 2018-10-19
ER

PT J
AU Balasubramanian, A
   Bhuva, B
   Mernaugh, R
   Haselton, FR
AF Balasubramanian, A
   Bhuva, B
   Mernaugh, R
   Haselton, FR
TI Si-based sensor for virus detection
SO IEEE SENSORS JOURNAL
LA English
DT Article
DE Analog integrated circuits; biomedical transducers; capacitance
   measurement; dielectric material; differential amplifiers
ID BIOSENSOR; DNA; SIGNAL
AB This paper describes the development of a sensor for the detection of viruses. The detection scheme uses sense and dummy capacitors and a sense amplifier circuit to compare capacitance values. The presence of sufficient biological material within the sense capacitor alters the sense amplifier output. This promising approach has the potential to more rapidly test for the presence of virus using an IC platform.
C1 Vanderbilt Univ, Dept Elect Engn & Comp Sci, Nashville, TN 37235 USA.
   Vanderbilt Univ, Dept Biochem, Nashville, TN 37235 USA.
   Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA.
RP Balasubramanian, A (reprint author), Vanderbilt Univ, Dept Elect Engn & Comp Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.
EM bhuva@vuse.vanderbilt.edu
CR ANDERSON GP, 1994, IEEE ENG MED BIOL, V13, P358, DOI 10.1109/51.294007
   ANDLE JCV, 1990, IEEE 4 TECH DIG SOL
   Baselt DR, 1997, P IEEE, V85, P672, DOI 10.1109/5.573755
   BERGAUD CC, 2001, IEEE 8 INT C TECHN F
   Berggren C, 1998, BIOSENS BIOELECTRON, V13, P1061, DOI 10.1016/S0956-5663(98)00058-X
   BONE S, 1995, BBA-GENE STRUCT EXPR, V1260, P85, DOI 10.1016/0167-4781(94)00181-2
   BONINCONTRO A, 1993, BIOCHIM BIOPHYS ACTA, V1171, P288, DOI 10.1016/0167-4781(93)90067-N
   DHANG SHL, 1988, IEEE J, V23, P34
   Dumitrascu G, 2001, IEEE T MAGN, V37, P2932, DOI 10.1109/20.951351
   GEIB H, 1992, IEEE J SOLID-ST CIRC, V27, P1028, DOI 10.1109/4.142598
   HAFEMAN DG, 1992, Patent No. 5164319
   HELLER MJ, 1994, Patent No. 5632957
   JUNG CM, 2002, 15 TECH DIG OPT FIB
   KARLSSON N, 1994, IEEE 10 INT C INSTR
   KARLSSON NJ, 1993, IEEE 9 INT C INSTR M
   Kawabata T, 2001, IEEE T IND APPL, V37, P1625, DOI 10.1109/28.968170
   KOSSLINGER CR, 1981, INT C SOL STAT SENS
   KOTHARI MW, 1988, IEEE INT C ENG MED B
   KOUFAS DF, 1998, IEEE 24 ANN NE BIOEN
   Laurent DG, 2002, IEEE T CIRCUITS-I, V49, P269, DOI 10.1109/81.989159
   Machida K, 2001, IEEE T ELECTRON DEV, V48, P2273, DOI 10.1109/16.954466
   Moore SK, 2001, IEEE SPECTRUM, V38, P54, DOI 10.1109/6.908856
   PACE SJ, 1990, Patent No. 4908112
   SAKAI GO, 1997, INT C SOL STAT SENS
   SARPESHKAR RW, 1991, IEEE INT S CIRC SYST
   Souteyrand E, 1997, J PHYS CHEM B, V101, P2980, DOI 10.1021/jp963056h
   SUEHIRO JN, 2001, IEEE 36 IAS ANN M IN
   1989, Patent No. 4822566
NR 28
TC 19
Z9 19
U1 0
U2 2
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 1530-437X
J9 IEEE SENS J
JI IEEE Sens. J.
PD JUN
PY 2005
VL 5
IS 3
BP 340
EP 344
DI 10.1109/JSEN.2005.844543
PG 5
WC Engineering, Electrical & Electronic; Instruments & Instrumentation;
   Physics, Applied
SC Engineering; Instruments & Instrumentation; Physics
GA 925WQ
UT WOS:000229084500002
DA 2018-10-19
ER

PT J
AU Fridman, G
   Li, MY
   Lelkes, PI
   Friedman, G
   Fridman, A
   Gutsol, AF
AF Fridman, G
   Li, MY
   Lelkes, PI
   Friedman, G
   Fridman, A
   Gutsol, AF
TI Nonthermal plasma bio-active liquid micro and nano-xerography
SO IEEE TRANSACTIONS ON PLASMA SCIENCE
LA English
DT Article
DE biomedical equipment; plasma applications; plasma materials-processing
   applications
AB Method of biochemical patterning which allows for micro- and nano-scale resolution on nonplanar substrates is presented. Utilizing this method, bio-molecules (including DNA, proteins, and enzymes) can be delivered to charged locations on surfaces by charged water buffer droplets. Charging of water droplets is accomplished using dielectric barrier discharge (DBD) plasma. DBD was effectively stabilized in the presence of high concentration of micron-size water droplets. The concepts of the proposed method, as well as first experimental results supporting the idea are discussed in this paper.
C1 Drexel Univ, Sch Biomed Engn, Sci & Hlth Syst, Philadelphia, PA 19104 USA.
   Drexel Univ, Dept Elect & Comp Engn, Philadelphia, PA 19104 USA.
RP Fridman, G (reprint author), Drexel Univ, Sch Biomed Engn, Sci & Hlth Syst, Philadelphia, PA 19104 USA.
EM gf33@drexel.edu; mengyan.li@drexel.edu; pilelkes@drexel.edu;
   gary@ece.drexel.edu; fridman@drexel.edu; gutsol@drexel.edu
OI Fridman, Gregory/0000-0003-4006-4722
CR Babaeva NY, 1996, J PHYS D APPL PHYS, V29, P2423, DOI 10.1088/0022-3727/29/9/029
   DJERMOUNE D, 1995, 11 INT C GAS DISCH T, V2, P484
   FORTOV VE, 2000, CHARGE COUPLING ORDE
   FRIDMAN A, 2003, FUNDAMENTALS PLASMS
   Kogelschatz U., 1988, PROCESS TECHNOLOGIES, P87
   Kogelschatz U., 2003, PLASMA CHEM PLASMA P
   KOZYREV AV, 2001, USPEKHI FIZICHESKIKH
   KULIKOVSKY AA, 1994, J PHYS D APPL PHYS, V27, P2556, DOI 10.1088/0022-3727/27/12/017
   Kunchardt E. E., 1988, PHYS REV A, VA38, P1410
   MORAVEJ M, 2004, J APPL PHYS
   RAIZER PR, 1991, GAS DISCHARE PHYS
   SIRIGNANO WA, 1999, FLUID DYNAMICS TRANS
NR 12
TC 3
Z9 4
U1 0
U2 6
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 0093-3813
J9 IEEE T PLASMA SCI
JI IEEE Trans. Plasma Sci.
PD JUN
PY 2005
VL 33
IS 3
BP 1061
EP 1065
DI 10.1109/TPS.2005.848602
PG 5
WC Physics, Fluids & Plasmas
SC Physics
GA 935TR
UT WOS:000229806800010
DA 2018-10-19
ER

PT J
AU Pound, MW
   May, DB
AF Pound, MW
   May, DB
TI Proposed mechanisms and preventative options of Jarisch-Herxheimer
   reactions
SO JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
LA English
DT Article
DE antibiotics; cytokines; endotoxin; Jarisch-Herxheimer reactions;
   spirochete
ID BORNE RELAPSING FEVER; TUMOR-NECROSIS-FACTOR; BORRELIA-RECURRENTIS
   INFECTION; TREPONEMA-PALLIDUM; ENDOTOXEMIA; PENICILLIN; TETRACYCLINE;
   MODEL
AB Objective: To review the aetiologies and preventative methods associated with Jarisch-Herxheimer reactions (JHR).
   Data sources: Ovid Medline((R)) (1966-June Week 1 2004) was utilized to assess biomedical literature; a review of the bibliographies of articles was also performed.
   Data synthesis: JHR often occurs with the treatment of spirochete infections. However, the mechanism by which the reaction takes place is not clearly defined.
   Conclusion: Studies suggest with conflicting evidence that the JHR is caused by release of endotoxin-like material from the spirochete as well as cytokine elevation in the body. It appears the type of drug and the rate of spirochete clearance from the body have little effect on the incidence of the reaction. Many pretreatment options have been explored with limited efficacy with the exception of anti-tumour necrosis factor antibodies.
C1 Campbell Univ, Sch Pharm, Dept Pharm Practice, Buies Creek, NC 27506 USA.
   Cape Fear Valley Hlth Syst, Dept Pharm, Fayetteville, NC USA.
   Duke Univ, Med Ctr, Dept Pharm, Durham, NC USA.
RP Pound, MW (reprint author), Campbell Univ, Sch Pharm, Dept Pharm Practice, POB 1090, Buies Creek, NC 27506 USA.
EM mpound@capefearvalley.com
CR BRYCESON AD, 1972, CLIN SCI, V43, P343, DOI 10.1042/cs0430343
   BUTLER T, 1978, J INFECT DIS, V137, P573, DOI 10.1093/infdis/137.5.573
   Cooper PJ, 2000, J INFECT DIS, V181, P203, DOI 10.1086/315183
   Dworkin MS, 1998, CLIN INFECT DIS, V26, P122, DOI 10.1086/516273
   ELIN RJ, 1975, NEW ENGL J MED, V293, P521, DOI 10.1056/NEJM197509112931102
   ELIN RJ, 1973, J INFECT DIS, V128, P349, DOI 10.1093/infdis/128.3.349
   Fekade D, 1996, NEW ENGL J MED, V335, P311, DOI 10.1056/NEJM199608013350503
   GALLOWAY RE, 1977, AM J MED, V63, P933, DOI 10.1016/0002-9343(77)90548-4
   GEBREHIWOT T, 1992, ETHIOPIAN MED J, V30, P175
   GELFAND JA, 1976, NEW ENGL J MED, V295, P211, DOI 10.1056/NEJM197607222950409
   Griffin GE, 1998, J ANTIMICROB CHEMOTH, V41, P25, DOI 10.1093/jac/41.suppl_1.25
   GUDJONSSON H, 1968, ACTA DERM-VENEREOL, V48, P15
   HARDY PH, 1983, P SOC EXP BIOL MED, V174, P47
   Herxheimer K, 1902, DEUT MED WOCHENSCHR, V28, P895, DOI 10.1055/s-0028-1139096
   Jarisch A., 1895, WIEN MED WOCHENSCHR, V45, P721
   Maloy A L, 1998, J Emerg Med, V16, P437, DOI 10.1016/S0736-4679(98)00011-0
   Meislin H W, 1976, JACEP, V5, P779, DOI 10.1016/S0361-1124(76)80309-7
   NADELMAN RB, 1992, ANN INTERN MED, V117, P273, DOI 10.7326/0003-4819-117-4-273
   NEGUSSIE Y, 1992, J EXP MED, V175, P1207, DOI 10.1084/jem.175.5.1207
   RADOLF JD, 1991, J IMMUNOL, V147, P1968
   REMICK DG, 1986, J INFECT DIS, V174, P627
   ROSEN T, 1989, ARCH DERMATOL, V125, P77, DOI 10.1001/archderm.125.1.77
   SHENEP JL, 1986, JAMA-J AM MED ASSOC, V256, P388, DOI 10.1001/jama.256.3.388
   TEKLU B, 1983, LANCET, V1, P835
   VAUGHAN C, 1994, POSTGRAD MED J, V70, P118, DOI 10.1136/pgmj.70.820.118
   WARRELL DA, 1983, J INFECT DIS, V147, P898, DOI 10.1093/infdis/147.5.898
   YOUNG EJ, 1982, J INFECT DIS, V146, P606, DOI 10.1093/infdis/146.5.606
   1967, BRIT MED J, V1, P384
NR 28
TC 52
Z9 53
U1 0
U2 6
PU BLACKWELL PUBLISHING LTD
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND
SN 0269-4727
J9 J CLIN PHARM THER
JI J. Clin. Pharm. Ther.
PD JUN
PY 2005
VL 30
IS 3
BP 291
EP 295
DI 10.1111/j.1365-2710.2005.00631.x
PG 5
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 927DX
UT WOS:000229173700014
PM 15896248
DA 2018-10-19
ER

PT J
AU Zhang, M
   James, SP
AF Zhang, M
   James, SP
TI Synthesis and properties of melt-processable hyaluronan esters
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Article
ID DERIVATIVES; ACID
AB A series of melt-processable hyaluronan ( HA) esters were synthesized for potential biomedical applications ( e. g., hot molding with thermoplastic ultra high molecular weight polyethylene for total joint replacements or molding tissue engineering scaffold). A silylated complex of HA with cetyltrimethylammonium cations ( silyl HA-CTA) was used as the starting material. The reactions were performed with acid chlorides as the acylation agents in xylenes or no solvent other than the acid chloride. The disappearance of all characteristic FT-IR vibration bands associated with the - OSi(CH3)(3) groups and the appearance of the strong ester carbonyl peak at 1753 cm(-1) demonstrated the success of esterification. Thermoplasticity was achieved when the length of aliphatic chains in the HA esters was equal to or greater than 10 carbon atoms. It was found that the longer the ester chain, the lower the melting point; thus, to meet various needs different melting temperatures can be obtained by adjusting the acid chloride chain length. (C) 2005 Springer Science + Business Media, Inc.
C1 Colorado State Univ, Dept Mech Engn, Biomed Engn Program, Ft Collins, CO 80523 USA.
RP James, SP (reprint author), Colorado State Univ, Dept Mech Engn, Biomed Engn Program, Ft Collins, CO 80523 USA.
EM sjames@lamar.colostate.edu
CR Balazs E. A., 1970, CHEMISTRY MOLECULAR, P1241
   BALAZS EA, 1989, CIBA F SYMP, V143, P265
   BALAZS EA, 1984, COSMET TOILETRIES, V99, P65
   BALAZS EA, 2000, SCARLESS WOUND HEALI, P143
   BARBUCCI R, 1993, J BIOMAT SCI-POLYM E, V4, P245, DOI 10.1163/156856293X00555
   Brun P, 2000, INT CONGR SER, V1196, P269
   Della Valle F, 1989, U.S. Patent, Patent No. [4,851,521, 4851521, 4851521A]
   FAVIA P, 1998, PLASMAS POLYM, V3, P77, DOI DOI 10.1023/B:PAPO.0000005940.30092.58
   Grigolo B, 2001, BIOMATERIALS, V22, P2417, DOI 10.1016/S0142-9612(00)00429-4
   Heinegard D, 1998, WENN GR INT, V72, P113
   Hoekstra D., 1999, MED DEVICES DIAGNOST, P51
   KENNEDY JF, 2002, HYALURONAN 2000, V2, P3461
   Klemm D, 1998, COMPREHENSIVE CELLUL, V2, P164
   KLEMM D, 1998, COMPREHENSIVE CELLUL, V1, P235
   LAURENT TC, 2003, GLYCOFORUM SCI HYALU
   LAURENT TC, 1970, CHEM MOL BIOL INTERC, P703
   Moulder J. F., 1992, HDB XRAY PHOTOELECTR
   Ogston AG, 1970, CHEMISTRY MOLECULAR, P1231
   SCOTT J. E., 1960, METHODS BIOCHEM ANAL, V8, P145
   SHIRAISHI N, 1979, J APPL POLYM SCI, V24, P2361, DOI 10.1002/app.1979.070241204
   SMITH B, 1998, INFRARED SPECTRAL IN, P158
   STEIN A, 1988, MAKROMOL CHEM-RAPID, V9, P569
   Weiss C, 1998, WENN GR INT, V72, P255
   YUI N, 2002, Patent No. 20020143171
   Yun YH, 2004, BIOMATERIALS, V25, P147, DOI 10.1016/S0142-9612(03)00467-8
   ZHANG M, 2004, INSTRU SOC AM, V40, P13
   ZHANG M, UNPUB POLYMER
   ZHANG M, 2004, THESIS COLORADO STAT
NR 28
TC 4
Z9 4
U1 0
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0022-2461
EI 1573-4803
J9 J MATER SCI
JI J. Mater. Sci.
PD JUN
PY 2005
VL 40
IS 11
BP 2937
EP 2943
DI 10.1007/s10853-005-2432-7
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 936TN
UT WOS:000229878400026
DA 2018-10-19
ER

PT J
AU Barralet, JE
   Wang, L
   Lawson, M
   Triffitt, JT
   Cooper, PR
   Shelton, RM
AF Barralet, JE
   Wang, L
   Lawson, M
   Triffitt, JT
   Cooper, PR
   Shelton, RM
TI Comparison of bone marrow cell growth on 2D and 3D alginate hydrogels
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 7th World Biomaterials Congress
CY MAY 17-21, 2004
CL Sydney, AUSTRALIA
ID STROMAL CELLS
AB Calcium cross-linked sodium alginate hydrogels have several advantageous features making them potentially suitable as tissue engineering scaffolds and this material has been previously used in many biomedical applications. 3D cell culture systems are often very different from 2D petri dish type cultures. in this study the effect of alginate hydrogel architecture was investigated by comparing rat bone marrow cell proliferation and differentiation on calcium cross linked sodium alginate discs and 1mm internal diameter tubes. It was found that bone marrow cell proliferation was diminished as the concentration of alginate in the 2D hydrogel substrates increased, yet proliferation was extensive on tubular alginate constructs with high alginate contents. Alginate gel thickness was found to be an important parameter in determining cell behaviour and the different geometries did not generate significant alterations in BMC differentiation profiles. (C) 2005 Springer Science + Business Media, Inc.
C1 McGill Univ, Fac Dent, Montreal, PQ H3A 2B2, Canada.
   Univ Birmingham, Sch Dent, Biomat Unit, Birmingham B4 6NN, W Midlands, England.
   Univ Oxford, Nuffield Dept Orthopaed Surg, Oxford OX3 7LD, England.
RP Barralet, JE (reprint author), McGill Univ, Fac Dent, 3640 Univ St, Montreal, PQ H3A 2B2, Canada.
RI barralet, jake/A-5820-2008
OI barralet, jake/0000-0003-3543-6042; Cooper, Paul/0000-0003-1305-7287
CR Dhiman HK, 2005, BIOMATERIALS, V26, P979, DOI 10.1016/j.biomaterials.2004.04.012
   Eiselt P, 2000, BIOMATERIALS, V21, P1921, DOI 10.1016/S0142-9612(00)00033-8
   HARRIS AK, 1980, SCIENCE, V208, P177, DOI 10.1126/science.6987736
   HAUSELMANN HJ, 1994, J CELL SCI, V17, P107
   Hishikawa K, 2004, BIOCHEM BIOPH RES CO, V317, P1103, DOI 10.1016/j.bbrc.2004.03.165
   Jacks T, 2002, CELL, V111, P923, DOI 10.1016/S0092-8674(02)01229-1
   Lawson MA, 2004, TISSUE ENG, V10, P1480, DOI 10.1089/ten.2004.10.1480
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   Lysaght MJ, 2001, TISSUE ENG, V7, P485, DOI 10.1089/107632701753213110
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   Marler JJ, 2000, PLAST RECONSTR SURG, V105, P2049, DOI 10.1097/00006534-200005000-00020
   MATTHEW IR, 1995, BIOMATERIALS, V16, P275, DOI 10.1016/0142-9612(95)93254-B
   TAYLOR KA, 1992, ANAL BIOCHEM, V201, P190, DOI 10.1016/0003-2697(92)90194-C
   Tonnesen HH, 2002, DRUG DEV IND PHARM, V28, P621, DOI 10.1081/DDC-120003853
   Wang L, 2003, BIOMATERIALS, V24, P3475, DOI 10.1016/S0142-9612(03)00167-4
NR 15
TC 53
Z9 53
U1 3
U2 24
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 2005
VL 16
IS 6
BP 515
EP 519
DI 10.1007/s10856-005-0526-z
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 931SI
UT WOS:000229505100005
PM 15928866
DA 2018-10-19
ER

PT J
AU Kuo, SM
   Wang, YJ
   Weng, CL
   Lu, HE
   Chang, SJ
AF Kuo, SM
   Wang, YJ
   Weng, CL
   Lu, HE
   Chang, SJ
TI Influence of alginate on type II collagen fibrillogenesis
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 7th World Biomaterials Congress
CY MAY 17-21, 2004
CL Sydney, AUSTRALIA
ID IN-VITRO; FIBRIL FORMATION; CHONDROCYTES; INVITRO; TISSUE; CELLS
AB Collagen II is the majority of extracellular matrix components in articular cartilage, which with the major functions of preventing expansion of the tissue and distributing the load of body weight. To obtain man-made ECM, the reconstitution of collagen could be conducted in the presence of negatively charged polysaccharide, such as alginate. Alginate is an anionic polysaccharide capable of eversible gelated in calcium ion solution to prepare different shapes of biomaterials. Its well-known biocompatibility makes it an ideal material in biomedical applications. Thus, the aim of this study was to evaluate the effects of alginate on the fibrillogenesis of type II collagen. The preliminary results revealed that inclusion of alginate into soluble type II collagen solution could inhibit the development of turbidity of collagen solution, and the apparent rate constants in lag and growth phases decreased during collagen formation period, both rate constants decreased to about one-third of the original constants, respectively. From TEM observations, the collagen fibrils were significantly thicker in 0.05% and 0.1% alginate as compared with pure collagen solution. Furthermore, the D-periods of collagen fibers kept unchanged significantly under all reconstituted conditions, which meant the packing of collagen monomer was probably not affected by adding these amounts of alginate. (C) 2005 Springer Science + Business Media, Inc.
C1 I SHOU Univ, Dept Biomed Engn, Kaohsiung, Taiwan.
   Natl Yang Ming Univ, Inst Biomed Engn, Taipei 112, Taiwan.
RP Chang, SJ (reprint author), I SHOU Univ, Dept Biomed Engn, Kaohsiung, Taiwan.
EM sjchang@isu.edu.tw
RI Liu, Yifei/L-7828-2014
OI Liu, Yifei/0000-0002-1087-9827
CR Beekman B, 1997, EXP CELL RES, V237, P135, DOI 10.1006/excr.1997.3771
   BIRK DE, 1984, ARCH BIOCHEM BIOPHYS, V235, P178, DOI 10.1016/0003-9861(84)90266-2
   BROKAW JL, 1985, INT J BIOL MACROMOL, V7, P135, DOI 10.1016/0141-8130(85)90015-7
   de Vos P, 2003, BIOMATERIALS, V24, P305, DOI 10.1016/S0142-9612(02)00319-8
   Delorenzi NJ, 1996, INT J BIOL MACROMOL, V19, P15, DOI 10.1016/0141-8130(96)01094-X
   Fried A, 1996, J CELL BIOCHEM, V61, P246
   GELMAN RA, 1980, J BIOL CHEM, V255, P8098
   Goh MC, 1997, PHYSICA A, V239, P95, DOI 10.1016/S0378-4371(96)00472-4
   Gregory KE, 1999, EXP CELL RES, V246, P98, DOI 10.1006/excr.1998.4291
   Kobayashi S, 2000, SURG NEUROL, V54, P66
   Lee CH, 2004, ARTIF ORGANS, V28, P537, DOI 10.1111/j.1525-1594.2004.00051.x
   Lee CR, 2003, J BIOMED MATER RES A, V64A, P560, DOI 10.1002/jbm.a.10443
   Nehrer S, 1997, J BIOMED MATER RES, V38, P95
   Ohno T, 2004, MAT SCI ENG C-BIO S, V24, P407, DOI 10.1016/j.msec.2003.11.011
   Okada N, 1997, BIOCHEM BIOPH RES CO, V230, P524, DOI 10.1006/bbrc.1996.5996
   Peirone M, 1998, J BIOMED MATER RES, V42, P587, DOI 10.1002/(SICI)1097-4636(19981215)42:4<587::AID-JBM15>3.0.CO;2-X
   PIEZ KA, 1984, EXTRACELLULAR MATRIX, P1
   PROCKOP DJ, 1994, EXTRACELLULAR MATRIX, P90
   RADA JA, 1993, EXP EYE RES, V56, P635, DOI 10.1006/exer.1993.1081
   ROMANIC AM, 1992, J BIOL CHEM, V267, P22265
   SCOTT PG, 1995, BBA-GEN SUBJECTS, V1244, P121, DOI 10.1016/0304-4165(94)00209-G
   SILVER FH, 1979, BIOPOLYMERS, V18, P2523, DOI 10.1002/bip.1979.360181011
   SILVER FH, 1983, COLLAGEN REL RES, V3, P393
   SILVER FH, 1981, J BIOL CHEM, V256, P4973
   TRELSTAD RL, 1976, P NATL ACAD SCI USA, V73, P4027, DOI 10.1073/pnas.73.11.4027
   TSUHIYA K, 2001, MAT SCI ENG C-BIO S, V17, P79
   Veis A., 1994, EXTRACELLULAR MATRIX, P15
   WI WN, 2003, J ORTHOP RES, V21, P282
   Wu TJ, 2004, BIOMATERIALS, V25, P651, DOI 10.1016/S0142-9612(03)00576-3
NR 29
TC 9
Z9 10
U1 1
U2 9
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 2005
VL 16
IS 6
BP 525
EP 531
DI 10.1007/s10856-005-0528-x
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 931SI
UT WOS:000229505100007
PM 15928868
DA 2018-10-19
ER

PT J
AU Silva, SS
   Santos, MI
   Coutinho, OP
   Mano, JF
   Reis, RL
AF Silva, SS
   Santos, MI
   Coutinho, OP
   Mano, JF
   Reis, RL
TI Physical properties and biocompatibility of chitosan/soy blended
   membranes
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 7th World Biomaterials Congress
CY MAY 17-21, 2004
CL Sydney, AUSTRALIA
ID SOYBEAN PROTEIN; FILMS; TENSILE
AB Blends of polysaccharides and proteins are a source for the development of novel materials with interesting and tailorable properties, with potential to be used in a range of biomedical applications. in this work a series of blended membranes composed by chitosan and soy protein isolate was prepared by solvent casting methodology. in addition, cross-linking was performed in situ with glutaraldehyde solutions in the range 5 x 10(-3) -0.1 M. Furthermore, the influence of the composition and cross-linking on the degradation behaviour, water uptake and cell adhesion was investigated. The obtained results showed that the incorporation of chitosan, associated to network formation by cross linking, promoted a slight decrease of water absorption and a slower degradability of the membranes. Moreover, direct contact biocompatibility studies, with L929 cells, indicate that the cross-linking enhances the capability of the material to support cell growth. (C) 2005 Springer Science + Business Media, Inc.
C1 3Bs Res Grp Biomat Biodegradables & Biomimet, P-4710057 Braga, Portugal.
   Univ Minho, Dept Polymer Engn, P-4800058 Guimaraes, Portugal.
   Univ Minho, Dept Biol, P-4710057 Braga, Portugal.
RP Silva, SS (reprint author), 3Bs Res Grp Biomat Biodegradables & Biomimet, Campus Gualtar, P-4710057 Braga, Portugal.
EM simonesilva@dep.uminho.pt
RI Coutinho, Olga/K-7155-2013; Reis, Rui L./A-8938-2008; Group,
   3Bs/E-4374-2012; Mano, Joao/A-4418-2009; Silva, Simone/F-9757-2011
OI Reis, Rui L./0000-0002-4295-6129; Group, 3Bs/0000-0002-5195-3456; Mano,
   Joao/0000-0002-2342-3765; Silva, Simone/0000-0003-4268-9419; Coutinho,
   Olga/0000-0002-0647-080X
CR [Anonymous], 1992, 10993 ISO 5
   BAKOS D, 2001, NATO SCI SERIES, P55
   Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   Demirgoz D, 2000, POLYM DEGRAD STABIL, V70, P161, DOI 10.1016/S0141-3910(00)00102-6
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Hua YF, 2003, FOOD HYDROCOLLOID, V17, P889, DOI 10.1016/S0268-005X(03)00110-3
   Khan TA, 2003, J PHARM PHARM SCI, V6, P20
   Mi FL, 2001, BIOMATERIALS, V22, P165, DOI 10.1016/S0142-9612(00)00167-8
   Mi FL, 2003, J MEMBRANE SCI, V212, P237, DOI 10.1016/S0376-7388(02)00505-7
   Mo XQ, 2001, IND CROP PROD, V14, P1, DOI 10.1016/S0926-6690(00)00083-2
   Pawlak A, 2003, THERMOCHIM ACTA, V396, P153, DOI 10.1016/S0040-6031(02)00523-3
   Rhim JW, 2000, J AGR FOOD CHEM, V48, P4937, DOI 10.1021/jf0005418
   Rhim JW, 1998, IND CROP PROD, V8, P195, DOI 10.1016/S0926-6690(98)00003-X
   Silva RM, 2004, J MATER SCI-MATER M, V15, P523, DOI 10.1023/B:JMSM.0000021132.60475.79
   SILVA RM, 2003, UNPUB J MAT SCI MAT
   Subirade M, 1998, INT J BIOL MACROMOL, V23, P241, DOI 10.1016/S0141-8130(98)00052-X
   Vaz CM, 2003, J BIOMED MATER RES A, V65A, P60, DOI 10.1002/jbm.a.10416
   Were L, 1999, J FOOD SCI, V64, P514, DOI 10.1111/j.1365-2621.1999.tb15074.x
NR 18
TC 77
Z9 83
U1 1
U2 28
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 2005
VL 16
IS 6
BP 575
EP 579
DI 10.1007/s10856-005-0534-z
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 931SI
UT WOS:000229505100013
PM 15928874
DA 2018-10-19
ER

PT J
AU Zhang, M
   James, SP
AF Zhang, M
   James, SP
TI Synthesis and properties of melt-processable hyaluronan esters
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 7th World Biomaterials Congress
CY MAY 17-21, 2004
CL Sydney, AUSTRALIA
ID DERIVATIVES; ACID
AB A series of melt-processable hyaluronan (HA) esters were synthesized for potential biomedical applications (e.g., hot molding with thermoplastic ultra high molecular weight polyethylene for total joint replacements or molding tissue engineering scaffold). A silylated complex of HA with cetyltrimethylammonium cations (silyl HA-CTA) was used as the starting material. The reactions were performed with acid chlorides as the acylation agents in xylenes or no solvent other than the acid chloride. The disappearance of all characteristic FT-IR vibration bands associated with the -OSi(CH3)(3) groups and the appearance of the strong ester carbonyl peak at 1753 cm(-1) demonstrated the success of esterification. Thermoplasticity was achieved when the length of aliphatic chains in the HA esters was equal to or greater than 10 carbon atoms. It was found that the longer the ester chain, the lower the melting point; thus, to meet various needs different melting temperatures can be obtained by adjusting the acid chloride chain length. (C) 2005 Springer Science + Business Media, Inc.
C1 Colorado State Univ, Dept Mech Engn, Biomed Engn Program, Ft Collins, CO 80523 USA.
RP James, SP (reprint author), Colorado State Univ, Dept Mech Engn, Biomed Engn Program, Ft Collins, CO 80523 USA.
EM sjames@lamar.colostate.edu
CR Balazs E. A., 1970, CHEMISTRY MOLECULAR, P1241
   BALAZS EA, 1989, CIBA F SYMP, V143, P265
   BALAZS EA, 1984, COSMET TOILETRIES, V99, P65
   BALAZS EA, 2000, SCARLESS WOUND HEALI, P143
   BARBUCCI R, 1993, J BIOMAT SCI-POLYM E, V4, P245, DOI 10.1163/156856293X00555
   Brun P, 2000, INT CONGR SER, V1196, P269
   Della Valle F, 1989, U.S. Patent, Patent No. [4,851,521, 4851521, 4851521A]
   FAVIA P, 1998, PLASMAS POLYM, V3, P77, DOI DOI 10.1023/B:PAPO.0000005940.30092.58
   Grigolo B, 2001, BIOMATERIALS, V22, P2417, DOI 10.1016/S0142-9612(00)00429-4
   Heinegard D, 1998, WENN GR INT, V72, P113
   Hoekstra D., 1999, MED DEVICES DIAGNOST, P51
   KENNEDY JF, 2002, HYALURONAN 2000, V2, P3461
   Klemm D, 1998, COMPREHENSIVE CELLUL, V2, P164
   KLEMM D, 1998, COMPREHENSIVE CELLUL, V1, P235
   LAURENT TC, 2003, GLYCOFORUM SCI HYALU
   LAURENT TC, 1970, CHEM MOL BIOL INTERC, P703
   Moulder J. F., 1992, HDB XRAY PHOTOELECTR
   Ogston AG, 1970, CHEMISTRY MOLECULAR, P1231
   SCOTT J. E., 1960, METHODS BIOCHEM ANAL, V8, P145
   SHIRAISHI N, 1979, J APPL POLYM SCI, V24, P2361, DOI 10.1002/app.1979.070241204
   SMITH B, 1998, INFRARED SPECTRAL IN, P158
   STEIN A, 1988, MAKROMOL CHEM-RAPID, V9, P569
   Weiss C, 1998, WENN GR INT, V72, P255
   YUI N, 2002, Patent No. 20020143171
   Yun YH, 2004, BIOMATERIALS, V25, P147, DOI 10.1016/S0142-9612(03)00467-8
   ZHANG M, 2004, INSTRU SOC AM, V40, P13
   ZHANG M, UNPUB POLYMER
   ZHANG M, 2004, THESIS COLORADO STAT
NR 28
TC 6
Z9 6
U1 0
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 2005
VL 16
IS 6
BP 587
EP 593
DI 10.1007/s10856-005-0536-x
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 931SI
UT WOS:000229505100015
PM 15928876
DA 2018-10-19
ER

PT J
AU Autiero, M
   Liuzzi, R
   Riccio, P
   Roberti, G
AF Autiero, M
   Liuzzi, R
   Riccio, P
   Roberti, G
TI Determination of the concentration scaling law of the scattering
   coefficient of water solutions of Intralipid at 832 nm by comparison
   between collimated detection measurements and Monte Carlo Simulations
SO LASERS IN SURGERY AND MEDICINE
LA English
DT Article
DE photon transport; scattering media; Intralipid; Monte Carlo simulations;
   parallel computing; transmittance measurements; optical
   transillumination; optical parameters; absorption coefficient;
   scattering coefficient
ID INFRARED OPTICAL-PROPERTIES; TURBID MEDIA; BIOLOGICAL TISSUES; INVERSION
   TECHNIQUE; LIGHT DOSIMETRY; PHANTOM; INVIVO; STATE
AB Background and Objectives: Intralipid (IP) is a scatterer extensively used in the building of phantoms for Biomedical Optics measurements. Recently, deviations from the linearity have been shown for the concentration scaling law of the scattering coefficient of IP water solutions at visible wavelengths. In this work this scaling law was determined at 832 nm.
   Study Design/Materials and Methods: Space resolved transmittance measurements of a laser beam at 832 nm through water solutions of IP and ink were performed and compared with the corresponding results of Monte Carlo simulations.
   Results: The comparison provides a quadratic dependence of mu'(S) on the volume-to-volume scatterer concentration, C-IP, in the range of C-IP values (0.0024 < C-IP < 0.0075). These deviations from the linear behavior are related to the failure of the independent scatterer approximation.
   Conclusion: The quadratic dependence of mu'(S) on C-IP is in agreement with recent results obtained by other groups with different experimental techniques and is validated by a recent theoretical work. (c) 2005 Wiley-Liss, Inc.
C1 Univ Naples Federico II, Dipartimento Sci Fis, I-80126 Naples, Italy.
   Ist Nazl Fis Mat, I-80126 Naples, Italy.
   Consiglio Nazl Ist Ric Biostrutture & Bioimmagini, I-80131 Naples, Italy.
   Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol, I-80131 Naples, Italy.
RP Roberti, G (reprint author), Univ Naples Federico II, Dipartimento Sci Fis, Complesso Univ Mt S Angelo,Via Cintia, I-80126 Naples, Italy.
EM Roberti@unina.it
OI liuzzi, raffaele/0000-0002-2350-6691
CR Barajas O, 1997, PHYS MED BIOL, V42, P1675, DOI 10.1088/0031-9155/42/9/001
   Beek JF, 1997, PHYS MED BIOL, V42, P2255, DOI 10.1088/0031-9155/42/11/017
   Bondani M, 2003, J OPT SOC AM B, V20, P2383, DOI 10.1364/JOSAB.20.002383
   CHEONG WF, 1990, IEEE J QUANTUM ELECT, V26, P2166, DOI 10.1109/3.64354
   Choukeife JE, 1999, LASER MED SCI, V14, P286, DOI 10.1007/s101030050096
   Colasanti A, 2000, COMPUT PHYS COMMUN, V132, P84, DOI 10.1016/S0010-4655(00)00138-7
   COLASANTI A, 1998, SPIE, V3255, P118
   COLASANTI A, 1998, SPIE, V3566, P73
   COLASANTI A, 1997, SPIE, V3194, P471
   Cubeddu R, 1997, PHYS MED BIOL, V42, P1971, DOI 10.1088/0031-9155/42/10/011
   de Jode ML, 1999, PHYS MED BIOL, V44, P3027, DOI 10.1088/0031-9155/44/12/312
   FARRELL TJ, 1992, MED PHYS, V19, P879, DOI 10.1118/1.596777
   FLOCK ST, 1992, LASER SURG MED, V12, P510, DOI 10.1002/lsm.1900120510
   FURUTSU K, 1994, PHYS REV E, V50, P3634, DOI 10.1103/PhysRevE.50.3634
   Giusto A, 2003, APPL OPTICS, V42, P4375, DOI 10.1364/AO.42.004375
   GRAAFF R, 1993, APPL OPTICS, V32, P435, DOI 10.1364/AO.32.000435
   HASEGAWA Y, 1991, APPL OPTICS, V30, P4515, DOI 10.1364/AO.30.004515
   Hebden JC, 2003, J BIOMED OPT, V8, P87, DOI 10.1117/1.1528206
   Iizuka MN, 1999, LASER SURG MED, V25, P159, DOI 10.1002/(SICI)1096-9101(1999)25:2<159::AID-LSM10>3.3.CO;2-M
   Jacques SL, 1995, OPTICAL THERMAL RESP, P73
   JENTINK HW, 1991, APPL OPTICS, V29, P2371
   KEIZJER M, 1989, LASER SURG MED, V9, P148
   Kumar D, 2003, MED BIOL ENG COMPUT, V41, P310, DOI 10.1007/BF02348436
   MADSEN SJ, 1992, PHYS MED BIOL, V37, P985, DOI 10.1088/0031-9155/37/4/012
   Nakai T, 1997, PHYS MED BIOL, V42, P2541, DOI 10.1088/0031-9155/42/12/017
   Nomura Y, 1997, PHYS MED BIOL, V42, P1009, DOI 10.1088/0031-9155/42/6/002
   Nomura Y, 1989, Adv Exp Med Biol, V248, P77
   NOMURA Y, 1991, J BIOCHEM-TOKYO, V109, P455, DOI 10.1093/oxfordjournals.jbchem.a123403
   Ripley PM, 1999, PHYS MED BIOL, V44, P2451, DOI 10.1088/0031-9155/44/10/307
   Simpson CR, 1998, PHYS MED BIOL, V43, P2465, DOI 10.1088/0031-9155/43/9/003
   VANSTAVEREN HJ, 1991, APPL OPTICS, V30, P4507, DOI 10.1364/AO.30.004507
   WILSON B C, 1986, Lasers in Medical Science, V1, P235, DOI 10.1007/BF02032418
   Zaccanti G, 2003, APPL OPTICS, V42, P4023, DOI 10.1364/AO.42.004023
NR 33
TC 3
Z9 3
U1 0
U2 2
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0196-8092
J9 LASER SURG MED
JI Lasers Surg. Med.
PD JUN
PY 2005
VL 36
IS 5
BP 414
EP 422
DI 10.1002/lsm.20157
PG 9
WC Dermatology; Surgery
SC Dermatology; Surgery
GA 941CE
UT WOS:000230191500012
PM 15900560
DA 2018-10-19
ER

PT J
AU Sanghvi, AB
   Miller, KPH
   Belcher, AM
   Schmidt, CE
AF Sanghvi, AB
   Miller, KPH
   Belcher, AM
   Schmidt, CE
TI Biomaterials functionalization using a novel peptide that selectively
   binds to a conducting polymer
SO NATURE MATERIALS
LA English
DT Article
ID DYNAMIC FORCE SPECTROSCOPY; ENERGY LANDSCAPES; POLYPYRROLE; SURFACE;
   ADHESION; FILMS; SPECIFICITY; MICROSCOPE; ATTACHMENT; TITANIUM
AB The goal in biomaterial surface modification is to retain a material's bulk properties while modifying only its surface to possess desired recognition and specificity. Here we develop a unique strategy for surface functionalization of an electrically conductive polymer, chlorine-doped polypyrrole (PPyCl), which has been widely researched for various electronic and biomedical applications. An M13 bacteriophage library was used to screen 109 different 12-mer peptide inserts against PPyCl. A binding phage (phi T59) was isolated, and its binding stability and specificity to PPyCl was assessed using fluorescence microscopy and titer count analysis. The relative binding strength and mechanism of the corresponding 12-mer peptide and its variants was studied using atomic force microscopy and fluorescamine assays. Further, the T59 peptide was joined to a cell adhesive sequence and used to promote cell attachment on PPyCl. This strategy can be extended to immobilize a variety of molecules to PPyCl for numerous applications. In addition, phage display can be applied to other polymers to develop bioactive materials without altering their bulk properties.
C1 Univ Texas, Dept Chem Engn, Austin, TX 78712 USA.
   Univ Texas, Dept Biomed Engn, Austin, TX 78712 USA.
   MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.
   MIT, Dept Bioengn, Cambridge, MA 02139 USA.
RP Sanghvi, AB (reprint author), Univ Texas, Dept Chem Engn, Austin, TX 78712 USA.
EM schmidt@che.utexas.edu
RI Schmidt, Christine/P-1613-2016
CR ADEY NB, 1995, GENE, V156, P27, DOI 10.1016/0378-1119(95)00058-E
   Allison DP, 2002, CURR OPIN BIOTECH, V13, P47, DOI 10.1016/S0958-1669(02)00283-5
   BARLTROP JA, 1991, BIOORG MED CHEM LETT, V1, P611, DOI 10.1016/S0960-894X(01)81162-8
   Barrett GC, 1998, AMINO ACIDS PEPTIDES
   Berglund J, 1998, ANAL COMMUN, V35, P3, DOI 10.1039/a708046h
   Blackburn S., 1978, AMINO ACID DETERMINA, P121
   Collier JH, 2000, J BIOMED MATER RES, V50, P574, DOI 10.1002/(SICI)1097-4636(20000615)50:4<574::AID-JBM13>3.0.CO;2-I
   Cook AD, 1997, BIOMATERIALS, V18, P1417, DOI 10.1016/S0142-9612(97)00075-6
   Cui XY, 2001, SENSOR ACTUAT A-PHYS, V93, P8, DOI 10.1016/S0924-4247(01)00637-9
   Dammer U, 1996, BIOPHYS J, V70, P2437, DOI 10.1016/S0006-3495(96)79814-4
   DIAZ AF, 1981, J ELECTROANAL CHEM, V129, P115, DOI 10.1016/0368-1874(81)87387-X
   Evans E, 1998, FARADAY DISCUSS, V111, P1
   Flynn CE, 2003, J MATER CHEM, V13, P2414, DOI 10.1039/b307593a
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   HRKACH J, 1999, J MAT SCI RES, V78, P92
   JOZEFONVICZ J, 1990, Journal of Biomaterials Science Polymer Edition, V1, P147
   Kontturi K, 1998, J ELECTROANAL CHEM, V453, P231, DOI 10.1016/S0022-0728(98)00246-0
   Kubies D, 2000, BIOMATERIALS, V21, P529, DOI 10.1016/S0142-9612(99)00219-7
   Labrou NE, 2003, J CHROMATOGR B, V790, P67, DOI 10.1016/S1570-0232(03)00098-9
   LEE GU, 1994, LANGMUIR, V10, P354, DOI 10.1021/la00014a003
   Lee SW, 2002, SCIENCE, V296, P892, DOI 10.1126/science.1068054
   Levy R, 2002, NANOTECHNOLOGY, V13, P33, DOI 10.1088/0957-4484/13/1/307
   MASSIA SP, 1990, ANN NY ACAD SCI, V589, P261, DOI 10.1111/j.1749-6632.1990.tb24251.x
   Merkel R, 1999, NATURE, V397, P50, DOI 10.1038/16219
   MORI T, 2004, CURR PHARM DESIGN, V19, P2335
   MOY VT, 1994, COLLOID SURFACE A, V93, P343, DOI 10.1016/0927-7757(94)02933-4
   Nakamura C, 2004, BIOPOLYMERS, V76, P48, DOI 10.1002/bip.10572
   *NEW ENGL BIOL, 2004, TECHN B NEW ENGL B E, V8120, P1
   *NEW ENGL BIOL, 2004, TECHN B NEW ENGL B E, V8100
   *NEW ENGL BIOL, 2004, TECHN B NEW ENGL B E, V8110, P1
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Rowley Merrill J, 2004, Biotechnol Annu Rev, V10, P151, DOI 10.1016/S1387-2656(04)10006-9
   Sano KI, 2003, J AM CHEM SOC, V125, P14234, DOI 10.1021/ja038414q
   Sarikaya M, 2003, NAT MATER, V2, P577, DOI 10.1038/nmat964
   Sarikaya M, 2004, ANNU REV MATER RES, V34, P373, DOI 10.1146/annurev.matsci.34.040203.121025
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Shakesheff KM, 1998, J BIOMAT SCI-POLYM E, V9, P507, DOI 10.1163/156856298X00596
   Silk T, 1998, SYNTHETIC MET, V93, P59, DOI 10.1016/S0379-6779(98)80131-8
   Sutar D, 2002, THIN SOLID FILMS, V417, P40, DOI 10.1016/S0040-6090(02)00649-1
   Tamm J, 1997, ELECTROCHIM ACTA, V42, P2929, DOI 10.1016/S0013-4686(97)00114-X
   Tong YW, 1998, J BIOMED MATER RES, V42, P85, DOI 10.1002/(SICI)1097-4636(199810)42:1<85::AID-JBM11>3.3.CO;2-R
   Undenfriend S, 1972, SCIENCE, V178, P871
   VALENTINI RF, 1992, BIOMATERIALS, V13, P183, DOI 10.1016/0142-9612(92)90069-Z
   Valuev IL, 1998, BIOMATERIALS, V19, P41, DOI 10.1016/S0142-9612(97)00147-6
   Vidal JC, 1999, ANAL CHIM ACTA, V385, P213, DOI 10.1016/S0003-2670(98)00838-1
   Wang LX, 2001, REACT FUNCT POLYM, V47, P125, DOI 10.1016/S1381-5148(00)00079-1
   Whaley SR, 2000, NATURE, V405, P665
   Xiao SJ, 1998, LANGMUIR, V14, P5507, DOI 10.1021/la980257z
   Zhang SG, 1999, REACT FUNCT POLYM, V41, P91, DOI 10.1016/S1381-5148(99)00031-0
NR 49
TC 263
Z9 269
U1 7
U2 148
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1476-1122
J9 NAT MATER
JI Nat. Mater.
PD JUN
PY 2005
VL 4
IS 6
BP 496
EP 502
DI 10.1038/nmat1397
PG 7
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 931RL
UT WOS:000229502700019
PM 15895095
DA 2018-10-19
ER

PT J
AU Coffer, JL
   Whitehead, MA
   Nagesha, DK
   Mukherjee, P
   Akkaraju, G
   Totolici, M
   Saffie, RS
   Canham, LT
AF Coffer, JL
   Whitehead, MA
   Nagesha, DK
   Mukherjee, P
   Akkaraju, G
   Totolici, M
   Saffie, RS
   Canham, LT
TI Porous silicon-based scaffolds for tissue engineering and other
   biomedical applications
SO PHYSICA STATUS SOLIDI A-APPLICATIONS AND MATERIALS SCIENCE
LA English
DT Article; Proceedings Paper
CT 4th International Conference on Porous Semiconductors - Science and
   Technology (PSST-2004)
CY MAR 14-19, 2004
CL Cullera, SPAIN
ID BONE
AB This work describes the formation of porous composite materials based on a combination of bioactive mesoporous silicon and bioerodible polymers such as poly-caprolactone (PCL). The fabrication of a range of composites prepared by both salt leaching and microemulsion techniques are discussed. Particular attention to the influence of Si content in the composite on in vitro calcification assays are assessed. For each system, cytotoxicity and cellular proliferation are explicitly evaluated through fibroblast cell culture assays. (c) 2005 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
C1 Texas Christian Univ, Dept Chem, Ft Worth, TX 76129 USA.
   Texas Christian Univ, Dept Biol, Ft Worth, TX 76129 USA.
   PSi Medica Ltd, Malvern, Worcs, England.
RP Coffer, JL (reprint author), Texas Christian Univ, Dept Chem, Ft Worth, TX 76129 USA.
EM j.coffer@tcu.edu
RI Nagesha, Dattatri/O-3111-2013; Coffer, Jeffery/G-5686-2011
OI Nagesha, Dattatri/0000-0001-7277-4513; Coffer,
   Jeffery/0000-0003-0267-9646
CR Anderson SHC, 2003, PHYS STATUS SOLIDI A, V197, P331, DOI [10.1002/pssa.200306519, 10.1002/7pssa.200306519]
   Bellet D, 1996, J APPL PHYS, V80, P3772, DOI 10.1063/1.363305
   Bowditch AP, 1999, MATER RES SOC SYMP P, V536, P149
   CANHAM LT, Patent No. 9706101
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   LANZA RP, 2000, PRINCIPLES TISSUE EN
   Wagner R. S., 1970, WHISKER TECHNOLOGY, P47
NR 10
TC 92
Z9 92
U1 0
U2 18
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0031-8965
J9 PHYS STATUS SOLIDI A
JI Phys. Status Solidi A-Appl. Mat.
PD JUN
PY 2005
VL 202
IS 8
BP 1451
EP 1455
DI 10.1002/pssa.200461134
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied; Physics,
   Condensed Matter
SC Materials Science; Physics
GA 941HW
UT WOS:000230206900024
DA 2018-10-19
ER

PT J
AU Ahlqvist, T
AF Ahlqvist, T
TI From information society to biosociety? On societal waves, developing
   key technologies, and new professions
SO TECHNOLOGICAL FORECASTING AND SOCIAL CHANGE
LA English
DT Article
DE information society; biosociety; transition; technology; profession
AB The article discusses the possible societal transition from information society toward biosociety. Furthermore, the impacts of this possible transition on professional and educational branches (PEBs) are examined. It is based on the study completed in Lahti Center at the Helsinki University of Technology between years 2001-2003. In the study, the most important developing key technologies were defined and their impacts on professions analysed through the application of Delphi technique. The developing key technology groups were information and communication technology, biotechnology, and material and nanotechnology. In addition, combinations of these technologies, that is, so-called fusion technologies, were also subjects for analysis. The first empirical aim was to analyse the plausibility and the timing of the so-called technological theses. The following technologies (technological theses) were deemed to be the most important ones: highly selective drugs, sensors, integrated technology, biomedical materials, photonic materials, 3G technology, intelligent materials, diagnostics, and virtual reality. The second empirical objective of the study was to analyze the professional and educational impacts of these technologies. Moreover, the article takes an experimental glance into the future through the creation and evaluation of "future professions". (c) 2004 Elsevier Inc. All rights reserved.
C1 Turku Univ, Dept Geog, FIN-20014 Turku, Finland.
RP Ahlqvist, T (reprint author), Turku Univ, Dept Geog, FIN-20014 Turku, Finland.
EM toni.ahlqvist@utu.fi
CR AHLQVIST T, 2003, KEYS FUTURES SOC REF
   BELL D, 1973, COMING POST IND SOC
   Castells M., 1996, RISE NETWORK SOC
   Drucker P, 1993, POST CAPITALIST SOC
   FUKUYAMA F., 2002, OUR POSTHUMAN FUTURE
   Gershuny J., 1978, EMERGING SELF SERVIC
   KODAMA F, 1992, HARVARD BUSINESS JUL, P70
   Kuusi O., 1999, EXPERTISE FUTURE USE
   Latour Bruno, 1993, WE HAVE NEVER BEEN M
   MANNERMAA M, 2003, BIOSOCIETY HUMAN BEN
   MANNERMAA M, 1996, FUTURA, V15, P17
   MASUDA Y, 1983, INFORMATION SOC POST
   NEGROPONTE N, 2003, MITS TECHNOL REV
   Paterson J, 2002, FUTURIST, V36, P9
   Rifkin J., 1998, BIOTECH CENTURY HARN
   SCHIENSTOCK D, 2001, SITRA REPORTS SERIES, V7
   SCHWARTZ P, 1999, LONG BOOM VISION COM, P191
   Stock G, 2002, REDESIGNING HUMANS O
   STONIER T, 1983, WEALTH INFORMATION P
   2003, EXPERT MED BIOTECHNO
   2003, MITS TECHNOL REV
NR 21
TC 7
Z9 7
U1 1
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0040-1625
J9 TECHNOL FORECAST SOC
JI Technol. Forecast. Soc. Chang.
PD JUN
PY 2005
VL 72
IS 5
BP 501
EP 519
DI 10.1016/j.techfore.2004.06.001
PG 19
WC Business; Planning & Development
SC Business & Economics; Public Administration
GA 927DI
UT WOS:000229172200001
DA 2018-10-19
ER

PT J
AU Yang, Q
   Xu, ZK
   Dai, ZW
   Wang, JL
   Ulbricht, M
AF Yang, Q
   Xu, ZK
   Dai, ZW
   Wang, JL
   Ulbricht, M
TI Surface modification of polypropylene microporous membranes with a novel
   glycopolymer
SO CHEMISTRY OF MATERIALS
LA English
DT Article
ID MICROFILTRATION MEMBRANES; GRAFT-POLYMERIZATION; ULTRAFILTRATION
   MEMBRANES; CHEMOENZYMATIC SYNTHESIS; SYNTHETIC GLYCOPOLYMERS;
   POLY(ETHYLENE GLYCOL); CONCANAVALIN-A; SUGAR; POLYMERS; BEHAVIOR
AB Membrane-based biomedical processes have increased considerably in recent years. However, the natural disadvantages of common membrane materials, such as hydrophobic surface and poor biocompatibility, cause many side effects in use and cumber further applications. In this work, to meet the requirements of biomedical applications, a novel sugar-containing monomer (D-gluconamidoethyl methacrylate (GAMA)) was grafted on polypropylene microporous membrane (PPMM) with an UV-induced polymerization to improve both the surface hydrophilicity and hemocompatibility. Fourier transform infrared spectroscopy, X-ray photoelectron spectroscopy, and scanning electron microscopy were employed to confirm the surface modification on the membranes. Water contact angle, protein adsorption, and platelet adhesion measurements were used to evaluate the anti-fouling property and the hemocompatibility of the membranes. It was found that the GAMA grafting degree increases reasonably with the increase of GAMA monomer concentration, and then the increase slows down when the GAMA concentration exceeds 40 g/L. At the same time, a 20-25-min UV irradiation is enough for the grafting polymerization. The water contact angle of the modified membrane decreases from 149 to 64 degrees with the increase of GAMA grafting degree from 0 to 6.18 wt %, which indicates a hydrophilic variation of the membrane surface by the grafting of GAMA. Furthermore, the modified membranes show higher water and protein solution fluxes, lower BSA adsorption, and better flux recovery after cleaning than those of the original PPMM. Platelet adhesion experiment also reveals that a more hemocompatible interface can be obtained between the membrane and the biomolecules.
C1 Zhejiang Univ, Inst Polymer Sci, Hangzhou 310027, Peoples R China.
   Zhejiang Univ Technol, Coll Chem Engn & Mat, Hangzhou 310014, Peoples R China.
   Univ Duisberg, Inst Tech Chem, D-45117 Essen, Germany.
RP Xu, ZK (reprint author), Zhejiang Univ, Inst Polymer Sci, Hangzhou 310027, Peoples R China.
EM xuzk@ipsm.zju.edu.cn
RI Yang, Qian/F-6704-2011; Ulbricht, Mathias/L-5844-2015; Xu,
   Zhi-Kang/B-1462-2009
OI Yang, Qian/0000-0002-7925-6775; Ulbricht, Mathias/0000-0002-2094-0708; 
CR Albertin L, 2004, BIOMACROMOLECULES, V5, P255, DOI 10.1021/bm034199u
   ARTURSSON P, 1990, J POLYM SCI POL CHEM, V28, P2651, DOI 10.1002/pola.1990.080281006
   Bahulekar R, 1998, CARBOHYD POLYM, V37, P71, DOI 10.1016/S0144-8617(98)00027-7
   BELFORT G, 1994, J MEMBRANE SCI, V96, P1, DOI 10.1016/0376-7388(94)00119-7
   CHEN XM, 1995, MACROMOLECULES, V28, P6014, DOI 10.1021/ma00122a005
   Deng HT, 2004, J MOL CATAL B-ENZYM, V28, P95, DOI 10.1016/j.molcatb.2004.01.004
   Deppisch R, 1998, SEP PURIF TECHNOL, V14, P241, DOI 10.1016/S1383-5866(98)00079-3
   GarciaOteiza MC, 1997, MACROMOL CHEM PHYSIC, V198, P2237, DOI 10.1002/macp.1997.021980718
   GOLDSTEIN IJ, 1965, BIOCHEMISTRY-US, V4, P876, DOI 10.1021/bi00881a013
   Gupta B, 2003, ADV POLYM SCI, V162, P35
   Karamuk E, 1999, ARTIF ORGANS, V23, P881, DOI 10.1046/j.1525-1594.1999.06308.x
   KELLY ST, 1993, J MEMBRANE SCI, V80, P175, DOI 10.1016/0376-7388(93)85142-J
   KIM KJ, 1992, J MEMBRANE SCI, V68, P79
   KITA H, 1994, J MEMBRANE SCI, V87, P139, DOI 10.1016/0376-7388(93)E0098-X
   Kobayashi K, 1997, MACROMOLECULES, V30, P2016, DOI 10.1021/ma961681e
   Kou RQ, 2003, LANGMUIR, V19, P6869, DOI 10.1021/la0345486
   Ladmiral V, 2004, EUR POLYM J, V40, P431, DOI 10.1016/j.eurpolymj.2003.10.019
   LIU FP, 1995, LANGMUIR, V11, P2674, DOI 10.1021/la00007a056
   Liu ZM, 2005, J MEMBRANE SCI, V249, P21, DOI 10.1016/j.memsci.2004.10.001
   Liu ZM, 2004, EUR POLYM J, V40, P2077, DOI 10.1016/j.eurpolymj.2004.05.020
   Ma HM, 2000, J MEMBRANE SCI, V173, P191, DOI 10.1016/S0376-7388(00)00360-4
   Narain R, 2003, BIOMACROMOLECULES, V4, P1746, DOI 10.1021/bm034166e
   Nie FQ, 2003, LANGMUIR, V19, P9889, DOI 10.1021/la035315h
   Okada M, 2001, PROG POLYM SCI, V26, P67, DOI 10.1016/S0079-6700(00)00038-1
   OKAHATA Y, 1987, J CHEM SOC PERK T 2, P1317, DOI 10.1039/p29870001317
   Patankar NA, 2003, LANGMUIR, V19, P1249, DOI 10.1021/la026612+
   Richey T, 2000, BIOMATERIALS, V21, P1057, DOI 10.1016/S0142-9612(99)00281-1
   SMITH DA, 1970, J POLYM SCI A1, V8, P783, DOI 10.1002/pol.1970.150080321
   Steen ML, 2002, J MEMBRANE SCI, V204, P341, DOI 10.1016/S0376-7388(02)00061-3
   Tanaka M, 2002, BIOMACROMOLECULES, V3, P36, DOI 10.1021/bm010072y
   Taniguchi M, 2003, CHEM MATER, V15, P3805, DOI 10.1021/cm020283p
   Thom VH, 2000, LANGMUIR, V16, P2756, DOI 10.1021/la990303a
   TRACEY EM, 1994, J COLLOID INTERF SCI, V167, P104, DOI 10.1006/jcis.1994.1338
   Ulbricht M, 1998, COLLOID SURFACE A, V138, P353, DOI 10.1016/S0927-7757(98)00236-2
   Wang Q, 2002, CHEM MATER, V14, P3232, DOI 10.1021/cm0200137
   Wavhal DS, 2003, LANGMUIR, V19, P79, DOI 10.1021/la020653o
   Xu ZK, 2004, LANGMUIR, V20, P1481, DOI 10.1021/la035930l
   Xu ZK, 2003, J MEMBRANE SCI, V214, P71, DOI 10.1016/S0376-7388(02)00536-7
   Xu ZK, 2002, J MEMBRANE SCI, V196, P221, DOI 10.1016/S0376-7388(01)00600-7
   YASUDA T, 1992, LANGMUIR, V8, P1425, DOI 10.1021/la00041a030
   ZEMAN LJ, 1983, J MEMBRANE SCI, V15, P213, DOI 10.1016/S0376-7388(00)82300-5
   Zhou WJ, 1999, J POLYM SCI POL CHEM, V37, P1393, DOI 10.1002/(SICI)1099-0518(19990515)37:10<1393::AID-POLA1>3.3.CO;2-Z
NR 42
TC 184
Z9 199
U1 6
U2 142
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0897-4756
J9 CHEM MATER
JI Chem. Mat.
PD MAY 31
PY 2005
VL 17
IS 11
BP 3050
EP 3058
DI 10.1021/cm048012x
PG 9
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 933TO
UT WOS:000229656000037
DA 2018-10-19
ER

PT J
AU Nuti, F
   Hildenbrand, S
   Chelli, M
   Wodarz, R
   Papini, AM
AF Nuti, F
   Hildenbrand, S
   Chelli, M
   Wodarz, R
   Papini, AM
TI Synthesis of DEHP metabolites as biomarkers for GC-MS evaluation of
   phthalates as endocrine disrupters
SO BIOORGANIC & MEDICINAL CHEMISTRY
LA English
DT Article
DE DEHP metabolites; phthalates; GC-MS analytes; endocrine disrupters;
   plasticizers
ID DI(2-ETHYLHEXYL) PHTHALATE; DI-(2-ETHYLHEXYL) PHTHALATE; DIETHYLHEXYL
   PHTHALATE; EXCHANGE-TRANSFUSION; NEWBORN-INFANTS; HUMAN URINE; EXPOSURE;
   RATS; CHROMATOGRAPHY; OXIDATION
AB Phthalates are used primarily as plasticizers to make polyvinyl chloride (PVC) soft and flexible. In recent years the phthalate esters have attracted increasing attention as environmental and biomedical pollutants and, because of their toxicological characteristics. In particular, they are more and more recognized as endocrine disrupters. In this context, we describe herein an efficient synthetic pathway leading to a series of metabolites of di(2-ethylhexyl) phthalate (DEHP). Mono(2-ethylhexenyl) phthalate was used as starting material to obtain these products in good yield, large scale and GC-MS purity. The metabolites of DEHP were synthesized, for the first time, as biomarkers to verify their quantitative determination in human urine and serum by GC-MS analysis for studying the exposure to phthalates and establishing reference values. &COPY; 2005 Elsevier Ltd. All rights reserved.
C1 Univ Tubingen, Dept Occupat & Social Med, D-72074 Tubingen, Germany.
   Univ Florence, Dept Organ Chem, Lab Peptide & Prot Chem & Biol, I-50019 Florence, Italy.
   CNR, ICCOM, I-50019 Florence, Italy.
RP Hildenbrand, S (reprint author), Univ Tubingen, Dept Occupat & Social Med, Wilhelmstr 27, D-72074 Tubingen, Germany.
EM sibylle.hildenbrand@med.uni-tuebingen.de; annamaria.papini@unifi.it
RI Nuti, Francesca/L-6282-2015; Chelli, Mario/L-7389-2015
OI Nuti, Francesca/0000-0001-9908-5996; Chelli, Mario/0000-0003-2939-6961;
   Papini, Anna Maria/0000-0002-2947-7107
CR Albro P. W., 1987, REV BIOCHEM TOXICOL, V8, P73
   ALBRO PW, 1973, J CHROMATOGR, V76, P321, DOI 10.1016/S0021-9673(01)96915-8
   ARBIN A, 1980, J CHROMATOGR, V193, P405, DOI 10.1016/S0021-9673(00)87740-7
   Baczko K, 2000, J CHEM SOC PERK T 2, P521, DOI 10.1039/a907987d
   deBoer T. J., 1956, ORG SYNTH, V36, P16
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P555, DOI 10.1007/BF00517700
   EISENBRAUN EJ, 1973, ORG SYNTH, V5, P310
   EMA M, 1995, TOXICOL LETT, V78, P101, DOI 10.1016/0378-4274(94)03241-X
   Gilsing HD, 2003, MONATSH CHEM, V134, P1207, DOI 10.1007/s00706-003-0044-y
   Gray LE, 1999, TOXICOL IND HEALTH, V15, P94, DOI 10.1191/074823399678846664
   HILDENBRAND S, 2002, PERSPEKTIVEN KLIN AR, P535
   Kambia K, 2001, INT J PHARM, V229, P139, DOI 10.1016/S0378-5173(01)00840-7
   Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P15, DOI 10.1078/1438-4639-00270
   Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202
   Li LH, 2000, TOXICOL APPL PHARM, V166, P222, DOI 10.1006/taap.2000.8972
   LISS GM, 1985, SCAND J WORK ENV HEA, V11, P381, DOI 10.5271/sjweh.2209
   MEINWALD J, 1973, ORG SYNTH, V5, P866
   Mettang T, 1996, PERITON DIALYSIS INT, V16, P58
   Mettang T, 1996, NEPHROL DIAL TRANSPL, V11, P2439, DOI 10.1093/oxfordjournals.ndt.a027211
   MORIARTY RM, 1989, ORG SYNTH, V68, P175
   PLONAIT SL, 1993, TRANSFUSION, V33, P598, DOI 10.1046/j.1537-2995.1993.33793325058.x
   SCHMID P, 1985, XENOBIOTICA, V15, P251, DOI 10.3109/00498258509045356
   SHARMAN M, 1994, FOOD ADDIT CONTAM, V11, P375, DOI 10.1080/02652039409374236
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8
   SJOBERG POJ, 1985, TRANSFUSION, V25, P424, DOI 10.1046/j.1537-2995.1985.25586020115.x
   SUZUKI T, 2001, ENVIRON SCI TECHNOL, V35, P3563
   TSUJI J, 1984, SYNTHESIS-STUTTGART, P369
   WAMS TJ, 1987, SCI TOTAL ENVIRON, V66, P1, DOI 10.1016/0048-9697(87)90072-6
   WARD JM, 1986, ENVIRON HEALTH PERSP, V65, P279, DOI 10.2307/3430195
NR 30
TC 13
Z9 13
U1 1
U2 23
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0968-0896
J9 BIOORGAN MED CHEM
JI Bioorg. Med. Chem.
PD MAY 16
PY 2005
VL 13
IS 10
BP 3461
EP 3465
DI 10.1016/j.bmc.2005.03.005
PG 5
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry,
   Organic
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry
GA 926PW
UT WOS:000229136100016
PM 15848759
DA 2018-10-19
ER

PT J
AU Ellman, PI
   Reece, TB
   Maxey, TS
   Tache-Leon, C
   Taylor, JL
   Spinosa, DJ
   Pineros-Fernandez, AC
   Rodeheaver, GT
   Kern, JA
AF Ellman, PI
   Reece, TB
   Maxey, TS
   Tache-Leon, C
   Taylor, JL
   Spinosa, DJ
   Pineros-Fernandez, AC
   Rodeheaver, GT
   Kern, JA
TI Evaluation of an absorbable cyanoacrylate adhesive as a suture line
   sealant
SO JOURNAL OF SURGICAL RESEARCH
LA English
DT Article
DE vascular surgery; anastomosis; PTFE; cyanoacrylate; biomedical
   engineering; tissue adhesives; glue; oxidized cellulose; hemostasis;
   vascular research
ID DISSECTION; TRIAL; GLUE
AB Background. Previous formulations of cyanoacrylate, though very effective, proved to have too high a tissue reactivity to be used internally. A novel cyanoacrylate compound with less tissue reactivity was recently developed. The objective of this study was to assess this novel cyanoacrylate compound for the use as vascular suture line sealant.
   Materials and methods. Twelve adult female sheep received a 6 mm PTFE interposition graft in each iliac artery, for a total of 24 grafts. Using oxidized cellulose (Surgicel) as a control, two formulations of a new cyanoacrylate compound (named "compound A" and "compound B") were assessed during this trial. Hemostatic efficiency was measured at the time of operation by the assessment of bleeding time and amount of blood loss. Long-term graft patency was assessed angiographically at 4, 6, and 18 months. Tissue reaction at 2 weeks, 1, 6, and 18 months was assessed grossly by vascular surgeons and microscopically by a blinded pathologist.
   Results. Average time to hemostasis was 37.6, 50.6, and 219 s in g-roup A, group B, and oxidized cellulose control groups, respectively (P <= 0.001 for both compounds versus control). There were no significant differences between groups with regards to graft patency. Histopathology analysis demonstrated mild to moderate tissue reaction at 2 weeks and 1 month in the cyanoacrylate groups compared with controls at 1 month (ANOVA P = 0.004). Mild tissue reaction was seen at 6 months and 18 months, with no significant differences between groups (ANOVA P = 0.08, 0.62, respectively).
   Conclusions. The novel cyanoacrylate compound examined in this study is a highly effective suture line sealant with only mild tissue reactivity and no significant effects on graft patency when studied over an 18 month period. (c) 2005 Elsevier Inc. All rights reserved.
C1 Univ Virginia, Dept Surg, Charlottesville, VA USA.
   Univ Virginia, Dept Radiol, Charlottesville, VA USA.
   Univ Virginia, Dept Plast Surg, Charlottesville, VA USA.
   Univ Utah, Anim Resources Ctr, Salt Lake City, UT USA.
RP Ellman, PI (reprint author), Bldg MR4,POB 801359, Charlottesville, VA 22908 USA.
EM pie8y@virginia.edu
CR Barbalinardo R J, 1986, J Vasc Surg, V4, P220
   Bavaria JE, 2002, ANN THORAC SURG, V74, pS1848, DOI 10.1016/S0003-4975(02)04128-0
   CITRIN P, 1985, J VASC SURG, V2, P488, DOI 10.1067/mva.1985.avs0020488
   Coover H, 1959, J SOC PLAST SURG ENG, V15, P5
   GIUNTA J, 1972, ARCH ORAL BIOL, V17, P617, DOI 10.1016/0003-9969(72)90188-4
   Glickman M, 2002, ARCH SURG-CHICAGO, V137, P326, DOI 10.1001/archsurg.137.3.326
   Hile J. P, 1978, FED REGISTER, V43, P1131
   Hino M, 2000, BRIT J HAEMATOL, V108, P194, DOI 10.1046/j.1365-2141.2000.01818.x
   *I LAB AN RES COLS, 1996, GUID CAR US LAB AN
   KUNG H, 1986, EVALUATION UNDESIRAB
   MCCREADY RA, 1992, J VASC SURG, V15, P661, DOI 10.1016/0741-5214(92)90012-W
   Miller DC, 2002, ANN THORAC SURG, V74, pS1857, DOI 10.1016/S0003-4975(02)04263-7
   REITER A, 1987, Zeitschrift fuer Experimentelle Chirurgie Transplantation und Kuenstliche Organe, V20, P55
   Spotnitz WD, 1999, TRANSFUSION THERAPY, P199
   Switzer EF, 2003, AM SURGEON, V69, P434
   VINTERS HV, 1985, NEURORADIOLOGY, V27, P279, DOI 10.1007/BF00339559
NR 16
TC 24
Z9 31
U1 1
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0022-4804
J9 J SURG RES
JI J. Surg. Res.
PD MAY 15
PY 2005
VL 125
IS 2
BP 161
EP 167
DI 10.1016/j.jss.2004.12.014
PG 7
WC Surgery
SC Surgery
GA 922AR
UT WOS:000228808500007
PM 15854669
DA 2018-10-19
ER

PT J
AU Niewold, TA
   Kerstens, HHD
   van der Meulen, J
   Smits, MA
   Hulst, MM
AF Niewold, TA
   Kerstens, HHD
   van der Meulen, J
   Smits, MA
   Hulst, MM
TI Development of a porcine small intestinal cDNA micro-array:
   characterization and functional analysis of the response to
   enterotoxigenic E-coli
SO VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
LA English
DT Article
DE genomics; micro-array; pig; mucosa; small intestine; enterotoxigenic
   Escherichia coli
ID ACID-BINDING PROTEIN; GENE DISCOVERY; PIGS; GENERATION; GENOMICS;
   ADHESION; LIBRARY; PLASMA; HEALTH; EST
AB The intestine is a complex and dynamic ecosystem, in which nutrients, exogenous compounds and micro-flora interact, and its condition is influenced by the complex interaction between these factors and host genetic elements. Furthermore, interactions of immune cells with the other components of the intestinal mucosa are essential in the defense against pathogens. The outcomes of these complex interactions determine resistance to infectious diseases. The development of genomic tools and techniques allows for analysis of multiple and complex host responses.
   We have constructed a porcine small intestinal micro-array, based on cDNA from jejunal mucosal scrapings. Material from two developmental distinct stages (4- and 12-week-old pigs) was used in order to assure a reasonably broad representation of mucosal transcripts. The micro-array consists of 3468 cDNAs spotted in quadruplicate. Comparison of the 4-week-old versus 12-week-old pigs revealed a differential expression in at least 300 spots. Furthermore, we report the early gene expression response of pig small intestine jejunal mucosa to infection with enterotoxigenic E. coli (ETEC) using the small intestinal segment perfusion (SISP) technique. A response pattern was found in which a marker for innate defense dominated, demonstrating the strength of this applied technology. Further analysis of these response patterns will contribute to a better understanding of enteric health and disease in pigs. The great similarity between pig and human suggest results from these continuing studies should be applicable for both agricultural and human biomedical purposes. (c) 2005 Elsevier B.V. All rights reserved.
C1 Wageningen UR, Anim Sci Grp, Res Cluster Anim Physiol & Hlth, NL-8200 AB Lelystad, Netherlands.
   Anim Genom, NL-8200 AB Lelystad, Netherlands.
RP Niewold, TA (reprint author), Wageningen UR, Anim Sci Grp, Res Cluster Anim Physiol & Hlth, POB 65, NL-8200 AB Lelystad, Netherlands.
EM theo.niewold@wur.nl
RI smits, mari/J-4892-2013
OI smits, mari/0000-0002-3493-291X; Niewold, Theo/0000-0001-8838-750X
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   BOERSMA WJA, IN PRESS WELFARE PIG
   Chuaqui RF, 2002, NAT GENET, V32, P509, DOI 10.1038/ng1034
   Desjeux A, 2002, GASTROEN CLIN BIOL, V26, P23
   DIEKGRAEFE BK, 2000, PHYSIOL GENOMICS, V4, P1
   Dudoit S, 2002, STAT SINICA, V12, P111
   Fahrenkrug SC, 2002, MAMM GENOME, V13, P475, DOI 10.1007/s00335-001-2072-4
   Glatz JFC, 1996, PROG LIPID RES, V35, P243, DOI 10.1016/S0163-7827(96)00006-9
   Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709
   KARSTEN SL, 2002, NUCLEIC ACIDS RES, V30, P4
   Kiers J. L., 2001, P261, DOI 10.1079/9780851995175.0261
   MONTROSE MH, 2003, AM J PHYSIOL-GASTR L, V284, P547
   NABUURS MJA, 1993, RES VET SCI, V55, P108, DOI 10.1016/0034-5288(93)90043-F
   NABUURS MJA, 1993, RES VET SCI, V55, P78, DOI 10.1016/0034-5288(93)90038-H
   Niewold TA, 2004, RES VET SCI, V77, P89, DOI 10.1016/j.rvsc.2004.02.006
   Pelsers MMAL, 2003, CLIN BIOCHEM, V36, P529, DOI 10.1016/S0009-9120(03)00096-1
   REID G, 2003, J CLIN GASTROENTEROL, V7, P105
   Roberts MA, 2001, CURR OPIN BIOTECH, V12, P516, DOI 10.1016/S0958-1669(00)00256-1
   Rothschild MF, 2003, COMP FUNCT GENOM, V4, P266, DOI 10.1002/cfg.261
   Sambrook J, 1989, MOL CLONING LAB MANU
   SELLWOOD R, 1975, J MED MICROBIOL, V8, P405, DOI 10.1099/00222615-8-3-405
   Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498
   Van Dijk AJ, 2002, J VET MED A, V49, P81, DOI 10.1046/j.1439-0442.2002.jv415.x
   van Hemert S, 2003, ANIM BIOTECHNOL, V14, P133, DOI 10.1081/ABIO-120026483
   van Ommen B, 2002, CURR OPIN BIOTECH, V13, P517, DOI 10.1016/S0958-1669(02)00349-X
   van Zijderveld FG, 1998, VET QUART, V20, pS73
   Verburg M, 2002, J HISTOCHEM CYTOCHEM, V50, P1525, DOI 10.1177/002215540205001113
   Wintero AK, 1996, MAMM GENOME, V7, P509, DOI 10.1007/s003359900153
   Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100
   Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15
NR 30
TC 45
Z9 50
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-2427
J9 VET IMMUNOL IMMUNOP
JI Vet. Immunol. Immunopathol.
PD MAY 15
PY 2005
VL 105
IS 3-4
BP 317
EP 329
DI 10.1016/j.vetimm.2005.02.010
PG 13
WC Immunology; Veterinary Sciences
SC Immunology; Veterinary Sciences
GA 918ZZ
UT WOS:000228589400012
PM 15808309
DA 2018-10-19
ER

PT J
AU Cibula, E
   Donlagic, D
AF Cibula, E
   Donlagic, D
TI Miniature fiber-optic pressure sensor with a polymer diaphragm
SO APPLIED OPTICS
LA English
DT Article
ID BIOMEDICAL APPLICATIONS; MEDICAL PRESSURE; OPTICAL-FIBER;
   INTERFEROMETER; STRAIN
AB The fabrication and experimental investigation of a miniature optical fiber pressure sensor for biomedical and industrial applications are described. The sensor measures only 125 mu m in diameter. The essential element is a thin polymer diaphragm that is positioned inside the hollow end of an optical fiber. The cavity at the fiber end is made by a simple and effective micromachining process based on wet etching in diluted HF acid. Thus a Fabry-Perot interferometer is formed between the inner fiber-cavity interface and the diaphragm. The fabrication technique is described in detail. Different sensor prototypes were fabricated upon 125 mu m-diameter optical fiber that demonstrated pressure ranges from 0 to 40 and from 0 to 1200 kPa. A resolution of less than 10 Pa was demonstrated in practice. The fabrication technique presented facilitates production of simple and low-cost disposable pressure sensors by use of materials with that ensure the required biocompatibility. (c) 2005 Optical Society of America.
C1 Univ Maribor, Fac Elect Engn & Comp Sci, SLO-2000 Maribor, Slovenia.
RP Donlagic, D (reprint author), Univ Maribor, Fac Elect Engn & Comp Sci, Smetanova 17, SLO-2000 Maribor, Slovenia.
EM ddonlagic@uni-mb.si
RI Donlagic, Denis/E-4621-2011
OI Donlagic, Denis/0000-0002-0247-503X
CR Abeysinghe DC, 2001, IEEE PHOTONIC TECH L, V13, P993, DOI 10.1109/68.942671
   BEHEIM G, 1987, REV SCI INSTRUM, V89, P1655
   BELLEVILLE C, 1995, Patent No. 5392117
   BELOVOLOV MI, 1999, Patent No. 9966299
   CHAN MA, 1994, SENSOR ACTUAT A-PHYS, V43, P196, DOI 10.1016/0924-4247(93)00694-Y
   Chatzandroulis S, 1997, SENSOR ACTUAT A-PHYS, V62, P551, DOI 10.1016/S0924-4247(97)01567-7
   De Brabander GN, 1998, APPL OPTICS, V37, P3264, DOI 10.1364/AO.37.003264
   Druzhinin A, 1999, SENSOR ACTUAT B-CHEM, V58, P415, DOI 10.1016/S0925-4005(99)00121-5
   Ezbiri A, 1997, OPT COMMUN, V133, P62, DOI 10.1016/S0030-4018(96)00445-2
   HE G, 1993, P 9 OPT FIB SENS C F, P463
   JI J, 1992, IEEE T ELECTRON DEV, V39, P2260, DOI 10.1109/16.158797
   JOHANNESEN K, 1999, Patent No. 9945352
   Katsumata T., 2000, Transactions of the Institute of Electrical Engineers of Japan, Part E, V120-E, P58
   KAYOUN P, 1981, ELECTRON LETT, V17, P400, DOI 10.1049/el:19810278
   Koysal O, 2002, OPT COMMUN, V205, P1, DOI 10.1016/S0030-4018(02)01203-8
   LEE CE, 1991, J LIGHTWAVE TECHNOL, V9, P129, DOI 10.1109/50.64932
   LEE CE, 1989, OPT LETT, V14, P1225, DOI 10.1364/OL.14.001225
   LEE YS, 1982, IEEE T ELECTRON DEV, V29, P42, DOI 10.1109/T-ED.1982.20656
   LI TC, 1995, OPT LETT, V20, P785, DOI 10.1364/OL.20.000785
   Liu T, 2000, REV SCI INSTRUM, V71, P1275, DOI 10.1063/1.1150453
   Narendran N, 1996, ASAIO J, V42, pM500, DOI 10.1097/00002480-199609000-00037
   Potter J, 1997, OPT COMMUN, V140, P11, DOI 10.1016/S0030-4018(97)00133-8
   RAO YJ, 1993, OPT LETT, V18, P2153, DOI 10.1364/OL.18.002153
   SADKOWSKI R, 1995, APPL OPTICS, V34, P5861, DOI 10.1364/AO.34.005861
   SANTOS JL, 1992, APPL OPTICS, V31, P7361, DOI 10.1364/AO.31.007361
   Schmidt M, 1999, OPT LETT, V24, P599, DOI 10.1364/OL.24.000599
   SIRKIS J, 1995, J LIGHTWAVE TECHNOL, V13, P1256, DOI 10.1109/50.400690
   Stropnik C, 1996, J APPL POLYM SCI, V61, P1821, DOI 10.1002/(SICI)1097-4628(19960906)61:10<1821::AID-APP24>3.0.CO;2-3
   Tohyama O, 1998, SENSOR ACTUAT A-PHYS, V66, P150, DOI 10.1016/S0924-4247(97)01764-0
   WOLTHUIS RA, 1991, IEEE T BIO-MED ENG, V38, P974, DOI 10.1109/10.88443
   WU N, 1993, SENSOR ACTUAT A-PHYS, V35, P197
   Yoshino T., 1982, IEEE Transactions on Microwave Theory and Techniques, VMTT-30, P1612
   Zaatar Y, 2000, MAT SCI ENG B-SOLID, V74, P296, DOI 10.1016/S0921-5107(99)00579-6
NR 33
TC 74
Z9 79
U1 1
U2 29
PU OPTICAL SOC AMER
PI WASHINGTON
PA 2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA
SN 1559-128X
EI 2155-3165
J9 APPL OPTICS
JI Appl. Optics
PD MAY 10
PY 2005
VL 44
IS 14
BP 2736
EP 2744
DI 10.1364/AO.44.002736
PG 9
WC Optics
SC Optics
GA 925IN
UT WOS:000229046900006
PM 15943325
DA 2018-10-19
ER

PT J
AU Nguyen, B
   Bowers, RM
   Wahlund, TM
   Read, BA
AF Nguyen, B
   Bowers, RM
   Wahlund, TM
   Read, BA
TI Suppressive subtractive hybridization of and differences in gene
   expression content of calcifying and noncalcifying cultures of Emiliania
   huxleyi strain 1516
SO APPLIED AND ENVIRONMENTAL MICROBIOLOGY
LA English
DT Article
ID INORGANIC CARBON; COCCOLITH FORMATION; CALCIFICATION; PHOTOSYNTHESIS;
   IDENTIFICATION; PROTEIN; BIOMINERALIZATION; PRYMNESIOPHYCEAE;
   PHOSPHORUS; SHELL
AB The marine coccolithophorid Emiliania huxleyi is a cosmopolitan alga intensely studied in relation to global carbon cycling, biogeochemistry, marine ecology, and biomineralization processes. The biomineralization capabilities of coccolithophorids have attracted the attention of scientists interested in exploiting this ability for the development of materials science and biomedical and biotechnological applications. Although it has been well documented that biomineralization in E. huxleyi is promoted by growth under phosphate-limited conditions, the genes and proteins that govern the processes of calcification and coccolithogenesis remain unknown. Suppressive subtractive hybridization (SSH) libraries were constructed from cultures grown in phosphate-limited and phosphate-replete media as tester and driver populations for reciprocal SSH procedures. Positive clones from each of the two libraries were randomly selected, and dot blotting was performed for the analysis of expression patterns. A total of 513 clones from the phosphate-replete library and 423 clones from the phosphate-limited library were sequenced, assembled, and compared to sequences in GenBank using BIASTX. Of the 103 differentially expressed gene fragments from the phosphate-replete library, 34% showed significant homology to other known proteins, while only 23% of the 65 differentially expressed gene fragments from the phosphate-limited library showed homology to other proteins. To further assess mRNA expression, real-time RT-PCR analysis was employed and expression profiles were generated over a 14-day time course for three clones from the phosphate-replete library and five clones from the phosphate-limited library. The fragments isolated provide the basis for future cloning of full-length genes and functional analysis.
C1 Calif State Univ San Marcos, Dept Biol Sci, San Marcos, CA 92096 USA.
RP Read, BA (reprint author), Calif State Univ San Marcos, Dept Biol Sci, 333 S Twin Oaks Valley Rd, San Marcos, CA 92096 USA.
EM bread@csusm.edu
FU NIGMS NIH HHS [GM 059833, S06 GM059833]
CR ANDERSEN OK, 1981, THESIS U OSLO OSLO
   BALCH WM, 1992, CONT SHELF RES, V12, P1353, DOI 10.1016/0278-4343(92)90059-S
   BROWN CW, 1994, J GEOPHYS RES-OCEANS, V99, P7467, DOI 10.1029/93JC02156
   Buitenhuis ET, 1999, J PHYCOL, V35, P949, DOI 10.1046/j.1529-8817.1999.3550949.x
   Corstjens PLAM, 1998, J PHYCOL, V34, P622, DOI 10.1046/j.1529-8817.1998.340622.x
   Cramer RA, 2004, FUNGAL GENET BIOL, V41, P115, DOI 10.1016/j.fgb.2003.10.009
   DEVRINDDEJONG EW, 1997, GEOMICROBIOLOGY INTE, P267
   Diatchenko L, 1999, METHOD ENZYMOL, V303, P349
   Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025
   Gotliv BA, 2003, CHEMBIOCHEM, V4, P522, DOI 10.1002/cbic.200200548
   Guillard R. R. L, 1975, CULTURE MARINE INVER, P29, DOI DOI 10.1007/978-1-4615-8714-9_3
   Happe T, 2002, EUR J BIOCHEM, V269, P1022, DOI 10.1046/j.0014-2956.2001.02743.x
   Henriksen K, 2003, AM MINERAL, V88, P2040, DOI 10.2138/am-2003-11-1248
   HOLLIGAN PM, 1993, GLOBAL BIOGEOCHEM CY, V7, P879, DOI 10.1029/93GB01731
   Illies MR, 2002, DEV GENES EVOL, V212, P419, DOI 10.1007/s00427-002-0261-0
   Kim M, 2001, MOL CELLS, V11, P213
   Laguna R, 2001, APPL ENVIRON MICROB, V67, P3824, DOI 10.1128/AEM.67.9.3824-3831.2001
   Liao H, 2003, GENE, V318, P103, DOI 10.1016/S0378-1119(03)00764-9
   Mahalingam R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r20
   Marsh ME, 2003, COMP BIOCHEM PHYS B, V136, P743, DOI 10.1016/S1096-4959(03)00180-5
   Moyano E, 1998, PLANT PHYSIOL, V117, P711, DOI 10.1104/pp.117.2.711
   Ozaki N, 2001, BIOSCI BIOTECH BIOCH, V65, P2330, DOI 10.1271/bbb.65.2330
   Paasche E, 1998, EUR J PHYCOL, V33, P33, DOI 10.1017/S0967026297001480
   PAASCHE E, 1994, PHYCOLOGIA, V33, P324, DOI 10.2216/i0031-8884-33-5-324.1
   Palenik B, 1997, LIMNOL OCEANOGR, V42, P1544, DOI 10.4319/lo.1997.42.7.1544
   SEKINO K, 1994, PLANT CELL PHYSIOL, V35, P353
   Shen XY, 1997, J BIOL CHEM, V272, P32472, DOI 10.1074/jbc.272.51.32472
   Shiraiwa Y, 2003, COMP BIOCHEM PHYS B, V136, P775, DOI 10.1016/S1096-4959(03)00221-5
   SIKES CS, 1980, LIMNOL OCEANOGR, V25, P248, DOI 10.4319/lo.1980.25.2.0248
   Stoll HM, 2002, PHILOS T R SOC A, V360, P719, DOI 10.1098/rsta.2001.0966
   Strommer Judith, 1993, P49
   Tyrrell T, 1996, J MARINE SYST, V9, P83, DOI 10.1016/0924-7963(96)00019-X
   VANBLEIJSWIJK JDL, 1995, MAR ECOL PROG SER, V121, P271, DOI 10.3354/meps121271
   VANDERWAL P, 1983, PROTOPLASMA, V118, P157, DOI 10.1007/BF01293073
   VANEMBURG PR, 1989, THESIS LEIDEN U LEID
   Wahlund TM, 2004, MAR BIOTECHNOL, V6, P278, DOI 10.1007/s10126-003-0035-3
   WAHLUND TM, 2004, J MICROPALEONTOL, V51, P145
   Wang XB, 2002, GENE, V297, P93, DOI 10.1016/S0378-1119(02)00870-3
   Weiss IM, 2000, BIOCHEM BIOPH RES CO, V267, P17, DOI 10.1006/bbrc.1999.1907
   Wustman BA, 2002, BIOPOLYMERS, V65, P362, DOI 10.1002/bip.10274
   Young JR, 1999, J STRUCT BIOL, V126, P195, DOI 10.1006/jsbi.1999.4132
   Zhang B, 2000, BIOPOLYMERS, V54, P464, DOI 10.1002/1097-0282(200011)54:6<464::AID-BIP90>3.0.CO;2-N
   Zhang XN, 2002, DNA SEQUENCE, V13, P195, DOI 10.1080/1042517021000003905
NR 43
TC 23
Z9 23
U1 0
U2 7
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0099-2240
J9 APPL ENVIRON MICROB
JI Appl. Environ. Microbiol.
PD MAY
PY 2005
VL 71
IS 5
BP 2564
EP 2575
DI 10.1128/AEM.71.5.2564-2575.2005
PG 12
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA 926EH
UT WOS:000229105300047
PM 15870347
OA Bronze, Green Published
DA 2018-10-19
ER

PT J
AU Morra, M
AF Morra, M
TI Engineering of biomaterials surfaces by hyaluronan
SO BIOMACROMOLECULES
LA English
DT Review
ID MOLECULAR-DYNAMICS SIMULATIONS; ATOMIC-FORCE MICROSCOPY; SOLID-PHASE
   ASSAY; ANGIOGENIC OLIGOSACCHARIDES; CARTILAGE PROTEOGLYCANS;
   AQUEOUS-SOLUTION; IN-VIVO; POLYELECTROLYTE MULTILAYERS;
   EXTRACELLULAR-MATRIX; TERTIARY STRUCTURES
AB This review addresses the area of study that defines the field of surface modification of biomedical materials and devices by hyaluronan (HA), as related to the exploitation of HA biological properties. To provide a comprehensive view of the subject matter, initial sections give a quick introduction to basic information on HA-protein and HA-cell interactions, together with some discussion on the bioactive role of HA in wound healing and related phenomena. This is followed by a description of current theories that correlate HA properties to its molecular structure in aqueous media, underlying how HA molecular details are crucial for its biological interaction and role. Finally, existing approaches to surface modification by HA are reviewed, stressing the need for HA-surface engineering founded on the knowledge and control of the surface-linked HA molecular conformation at the solid/aqueous interface.
C1 Nobil Bio Ricerche Srl, I-14018 Villafranca Asti, Italy.
RP Morra, M (reprint author), Nobil Bio Ricerche Srl, Str S Rocco 36, I-14018 Villafranca Asti, Italy.
CR ABATANGELO G, 2000, REDEFINING HYALURONA
   Almond A, 1998, GLYCOBIOLOGY, V8, P973, DOI 10.1093/glycob/8.10.973
   Almond A, 1997, GLYCOBIOLOGY, V7, P597, DOI 10.1093/glycob/7.5.597
   Almond A, 2000, J PHYS CHEM B, V104, P5634, DOI 10.1021/jp000402t
   Bajorath J, 1998, J BIOL CHEM, V273, P338, DOI 10.1074/jbc.273.1.338
   BALAZS EA, 1970, CHEM MOL BIOL INTERC, V2
   BALAZS EA, 1970, CHEM MOL BIOL INTERC, V3
   BALL V, 2003, SURFACTANT SCI SER, V110, P295
   Banerji S, 1998, PROTEIN EXPRES PURIF, V14, P371, DOI 10.1006/prep.1998.0971
   Barbucci R, 2003, BIOMATERIALS, V24, P915, DOI 10.1016/S0142-9612(02)00425-8
   Beavers E. M., 1987, US America Patent, Patent No. 4663233
   Benz M, 2004, J BIOMED MATER RES A, V71A, P6, DOI 10.1002/jbm.a.30123
   BOSKEY AL, 1991, CALCIFIED TISSUE INT, V49, P389, DOI 10.1007/BF02555848
   Burke SE, 2003, BIOMACROMOLECULES, V4, P1773, DOI 10.1021/bm034184w
   Butt HJ, 1999, LANGMUIR, V15, P2559, DOI 10.1021/la981503+
   Cassinelli C, 2000, J BIOMAT SCI-POLYM E, V11, P961, DOI 10.1163/156856200744138
   Catterall JB, 1997, GLYCOCONJUGATE J, V14, P867, DOI 10.1023/A:1018598223579
   Cen L, 2002, LANGMUIR, V18, P8633, DOI 10.1021/la025979b
   Chajara A, 1998, PATHOL BIOL, V46, P561
   Chen L, 2004, BIOMACROMOLECULES, V5, P238, DOI 10.1021/bm0344102
   CHEN WYJ, 1999, WOUND REPAIR REGEN, P79
   CHEN WYJ, 2002, HYALURONAN, P147
   COMPER WD, 1978, PHYSIOL REV, V58, P255
   DAGOSTINO R, 1995, PLASMA DEPOSITION TR
   Day AJ, 1999, BIOCHEM SOC T, V27, P115, DOI 10.1042/bst0270115
   Day AJ, 2001, CURR OPIN STRUC BIOL, V11, P617, DOI 10.1016/S0959-440X(00)00256-6
   DeFife KM, 1999, J BIOMED MATER RES, V44, P298, DOI 10.1002/(SICI)1097-4636(19990305)44:3<298::AID-JBM8>3.0.CO;2-N
   DELPECH B, 1985, ANAL BIOCHEM, V149, P555, DOI 10.1016/0003-2697(85)90613-X
   Entwistle J, 1996, J CELL BIOCHEM, V61, P569, DOI 10.1002/(SICI)1097-4644(19960616)61:4<569::AID-JCB10>3.0.CO;2-B
   Evanko SP, 1999, ARTERIOSCL THROM VAS, V19, P1004, DOI 10.1161/01.ATV.19.4.1004
   EVERED D, 1989, BIOL HYALURONAN
   Fagerholm P, 1987, Acta Ophthalmol Suppl, V182, P110
   Fieber C, 2004, J CELL SCI, V117, P359, DOI 10.1242/jcs.00831
   Ghatak S, 2002, J BIOL CHEM, V277, P38013, DOI 10.1074/jbc.M202404200
   GOETINCK PF, 1987, J CELL BIOL, V105, P2403, DOI 10.1083/jcb.105.5.2403
   Gribbon P, 1999, BIOPHYS J, V77, P2210, DOI 10.1016/S0006-3495(99)77061-X
   Gribbon P, 2000, BIOCHEM J, V350, P329, DOI 10.1042/0264-6021:3500329
   Grigoreas GHA, 2003, ANAL BIOCHEM, V320, P179, DOI 10.1016/S0003-2697(03)00386-5
   GROVER J, 1994, BIOCHEM J, V300, P317, DOI 10.1042/bj3000317
   Guo MML, 1996, ANAL BIOCHEM, V233, P216, DOI 10.1006/abio.1996.0031
   HALPERN G, 1991, Patent No. 5037677
   Halpern G., 1989, US Patent, Patent No. 4801475
   HARDINGHAM TE, 1972, BIOCHIM BIOPHYS ACTA, V279, P401, DOI 10.1016/0304-4165(72)90160-2
   HARDINGHAM TE, 1973, BIOCHEM J, V135, P905, DOI 10.1042/bj1350905
   HASCALL VC, 1974, J BIOL CHEM, V249, P4242
   HASCALL VC, 1974, J BIOL CHEM, V249, P4232
   HEINEGARD D, 1974, J BIOL CHEM, V249, P4250
   HERSH LS, 1972, J BIOMED MATER RES, V6, P85, DOI 10.1002/jbm.820060408
   Heublein B, 2002, INT J ARTIF ORGANS, V25, P1166
   HOEKSTRA D, 1999, MED DEVICE DIAGN FEB, P23
   Huang L, 2003, J BIOMED MATER RES A, V66A, P880, DOI 10.1002/jbm.a.10535
   Huang WJ, 2001, BIOCHEMISTRY-US, V40, P2359, DOI 10.1021/bi0024254
   ILER RK, 1966, J COLLOID INTERF SCI, V21, P569, DOI 10.1016/0095-8522(66)90018-3
   JACKSON DG, 2002, HYALURONAN, V1, P335
   Jacoboni I, 1999, J STRUCT BIOL, V126, P52, DOI 10.1006/jsbi.1999.4090
   Jha BK, 2003, J BIOL CHEM, V278, P27464, DOI 10.1074/jbc.M206696200
   JOHNSTON JB, MALE INFERTILITY
   KENNEDY JF, 2002, HYALURONAN
   Kito H, 1996, J BIOMED MATER RES, V30, P321
   Kohda D, 1996, CELL, V86, P767, DOI 10.1016/S0092-8674(00)80151-8
   KUJAWA MJ, 1986, DEV BIOL, V114, P504, DOI 10.1016/0012-1606(86)90214-9
   Larsen NE, 1998, WENN GR INT, V72, P267
   LARSSON R, 1987, ACTA OTO-LARYNGOL, P44
   LAURENT TC, 1957, ARK KEMI, V11, P487
   LAURENT TC, 1964, BIOCHEM J, V93, P106, DOI 10.1042/bj0930106
   Laurent TC, 1998, CHEM BIOL MED APPL H
   Lee JY, 2000, CURR OPIN CELL BIOL, V12, P581, DOI 10.1016/S0955-0674(00)00135-6
   LEES VC, 1995, LAB INVEST, V73, P259
   Lesley J, 2004, J BIOL CHEM, V279, P25745, DOI 10.1074/jbc.M313319200
   Lesley J, 2002, J BIOL CHEM, V277, P26600, DOI 10.1074/jbc.M201068200
   LESLEY J, 2002, HYALURONAN, V1, P341
   LISE M, 2000, REDEFINING HYALURONA, P339
   Liu DC, 1996, P NATL ACAD SCI USA, V93, P7832, DOI 10.1073/pnas.93.15.7832
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Lokeshwar VB, 2000, J BIOL CHEM, V275, P27641
   Lovekamp J, 2001, J BIOMED MATER RES, V56, P478, DOI 10.1002/1097-4636(20010915)56:4<478::AID-JBM1119>3.0.CO;2-C
   LOWRY KM, 1994, J BIOMED MATER RES, V28, P861, DOI 10.1002/jbm.820280804
   Markovic-Housley Z, 2000, STRUCTURE, V8, P1025, DOI 10.1016/S0969-2126(00)00511-6
   Mason M, 2000, BIOMATERIALS, V21, P31, DOI 10.1016/S0142-9612(99)00129-5
   Meyer K, 1934, J BIOL CHEM, V107, P629
   Mohamadzadeh M, 1998, J CLIN INVEST, V101, P97, DOI 10.1172/JCI1604
   Montesano R, 1996, LAB INVEST, V75, P249
   Morra M, 1998, SURF INTERFACE ANAL, V26, P742, DOI 10.1002/(SICI)1096-9918(199809)26:10<742::AID-SIA417>3.0.CO;2-P
   Morra M, 2003, J COLLOID INTERF SCI, V259, P236, DOI 10.1016/S0021-9797(02)00204-7
   Morra M, 2000, J BIOMAT SCI-POLYM E, V11, P547, DOI 10.1163/156856200743869
   Morra M, 2001, WATER BIOMATERIALS S
   MORRA M, 2000, Patent No. 6129956
   Nasreen N, 2001, ONCOL RES, V13, P71
   NICHOL LW, 1967, BIOCHEM J, V102, P407, DOI 10.1042/bj1020407
   OGSTON AG, 1966, J BIOL CHEM, V241, P17
   Ohri R, 2004, J BIOMED MATER RES A, V70A, P328, DOI 10.1002/jbm.a.30088
   PEACH RJ, 1993, J CELL BIOL, V122, P257, DOI 10.1083/jcb.122.1.257
   PESSAC B, 1972, SCIENCE, V175, P898, DOI 10.1126/science.175.4024.898
   Picart C, 2001, LANGMUIR, V17, P7414, DOI 10.1021/la010848g
   Picart C, 2002, P NATL ACAD SCI USA, V99, P12531, DOI 10.1073/pnas.202486099
   Pitt WG, 2004, J BIOMED MATER RES A, V68A, P95, DOI 10.1002/jbm.a.10170
   Plant AL, 2003, LANGMUIR, V19, P1449, DOI 10.1021/la024035z
   Ponnuraj K, 2000, J MOL BIOL, V299, P885, DOI 10.1006/jmbi.2000.3817
   POUYANI T, 1992, J AM CHEM SOC, V114, P5972, DOI 10.1021/ja00041a010
   POUYANI T, 1994, J AM CHEM SOC, V116, P7515, DOI 10.1021/ja00096a007
   PRESTI D, 1994, CELL BIOCHEM FUNCT, V12, P281, DOI 10.1002/cbf.290120409
   PRESTON BN, 1965, BIOCHEM J, V96, P449, DOI 10.1042/bj0960449
   Ranganathan S, 1995, CELL MOL BIOL RES, V41, P467
   RATNER BD, 1993, J BIOMED MATER RES, V27, P283, DOI 10.1002/jbm.820270302
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   Richert L, 2004, BIOMACROMOLECULES, V5, P284, DOI 10.1021/bm0342281
   ROWEN JW, 1956, BIOCHIM BIOPHYS ACTA, V19, P480, DOI 10.1016/0006-3002(56)90471-1
   SATTAR A, 1994, J INVEST DERMATOL, V103, P576, DOI 10.1111/1523-1747.ep12396880
   Savani RC, 2001, J BIOL CHEM, V276, P36770, DOI 10.1074/jbc.M102273200
   Savani RC, 1995, INT J TISSUE REACT, V17, P141
   Scott JE, 1999, P NATL ACAD SCI USA, V96, P4850, DOI 10.1073/pnas.96.9.4850
   Scott JE, 2002, BIOMACROMOLECULES, V3, P547, DOI 10.1021/bm010170j
   Scott JE, 1998, WENN GR INT, V72, P7
   Sengupta K, 2003, BIOPHYS J, V84, p381A
   Sengupta K, 2003, LANGMUIR, V19, P1775, DOI 10.1021/la026146o
   Slevin M, 2002, J BIOL CHEM, V277, P41046, DOI 10.1074/jbc.M109443200
   Slevin M, 1998, LAB INVEST, V78, P987
   Stile RA, 2002, J BIOMED MATER RES, V61, P391, DOI 10.1002/jbm.10154
   SUH KP, IN PRESS J BIOMED B
   Suh KY, 2004, ADV MATER, V16, P584, DOI 10.1002/adma.200306180
   Sweeney DF, 2003, INVEST OPHTH VIS SCI, V44, P3301, DOI 10.1167/iovs.02-0561
   Taylor KR, 2004, J BIOL CHEM, V279, P17079, DOI 10.1074/jbc.M310859200
   TENGBLAD A, 1979, Biochimica et Biophysica Acta, V578, P281
   Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858
   Thierry B, 2003, BIOMACROMOLECULES, V4, P1564, DOI 10.1021/bm0341834
   Thierry B, 2004, BIOMATERIALS, V25, P3895, DOI 10.1016/j.biomaterials.2003.10.068
   TOOLE BP, 1971, DEV BIOL, V25, P57, DOI 10.1016/0012-1606(71)90019-4
   Toole BP, 2000, J CLIN INVEST, V106, P335, DOI 10.1172/JCI10706
   TOOLE BP, 1972, P NATL ACAD SCI USA, V69, P1384, DOI 10.1073/pnas.69.6.1384
   TURLEY EA, 1989, J BIOL CHEM, V264, P8951
   TURLEY EA, 1982, BIOCHEM BIOPH RES CO, V108, P1016, DOI 10.1016/0006-291X(82)92101-5
   UNDERHILL C, 1978, EXP CELL RES, V117, P155, DOI 10.1016/0014-4827(78)90438-X
   UNDERHILL C, 1992, J CELL SCI, V103, P293
   UNDERHILL CB, 1980, J BIOL CHEM, V255, P4544
   UNDERHILL CB, 1979, J CELL BIOL, V82, P475, DOI 10.1083/jcb.82.2.475
   Verheye S, 2000, ARTERIOSCL THROM VAS, V20, P1168, DOI 10.1161/01.ATV.20.4.1168
   Vogler EA, 1996, J ELECTRON SPECTROSC, V81, P237, DOI 10.1016/0368-2048(96)02526-1
   Vyavahare N, 1999, J BIOMED MATER RES, V46, P44
   WAN B, 1999, SOC BIOMATERIALS T, V22, P228
   Watanabe H, 1997, J BIOL CHEM, V272, P28057, DOI 10.1074/jbc.272.44.28057
   Weber E, 2004, LYMPHOLOGY, V37, P15
   WEIGEL PH, 1988, INT J TISSUE REACT, V10, P355
   WEST DC, 1989, EXP CELL RES, V183, P179, DOI 10.1016/0014-4827(89)90428-X
   WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340
   WEST DC, 2002, HYALURONAN, V2, P165
   WEST RH, 1995, J MATER SCI-MATER M, V6, P63, DOI 10.1007/BF00120408
   WIGHT TN, 2002, HYALURONAN, V2, P173
   Wisniewski HG, 1996, J IMMUNOL, V156, P1609
   Xu HP, 2002, J BIOL CHEM, V277, P17308, DOI 10.1074/jbc.M112371200
   Zhang SW, 1998, J BIOL CHEM, V273, P11342, DOI 10.1074/jbc.273.18.11342
NR 150
TC 130
Z9 135
U1 0
U2 27
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAY-JUN
PY 2005
VL 6
IS 3
BP 1205
EP 1223
DI 10.1021/bm049346i
PG 19
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 926QY
UT WOS:000229138900008
PM 15877335
DA 2018-10-19
ER

PT J
AU Stevens, MM
   Allen, S
   Davies, MC
   Roberts, CJ
   Sakata, JK
   Tendler, SJB
   Tirrell, DA
   Williams, PM
AF Stevens, MM
   Allen, S
   Davies, MC
   Roberts, CJ
   Sakata, JK
   Tendler, SJB
   Tirrell, DA
   Williams, PM
TI Molecular level investigations of the inter- and intramolecular
   interactions of pH-responsive artificial triblock proteins
SO BIOMACROMOLECULES
LA English
DT Article
ID ATOMIC-FORCE MICROSCOPE; LEUCINE-ZIPPER; SENSITIVE HYDROGELS;
   SPECTROSCOPY; PEPTIDE; ELASTICITY; ADHESION; DOMAINS; DESIGN; HELIX
AB Intelligent materials that can undergo physical gelation in response to environmental stimuli have potential impacts in the bioengineering and biomedical fields where the entrapment of cellular or molecular species is desired. Here, we utilize atomic force microscopy (AFM) to perform molecular level investigations of designer artificial proteins that undergo physical gelation. These are engineered as triblock copolymers with independent interchain binding and solvent retention functions, namely, two terminal leucine zipper-like peptide sequences and a central alanylglycine rich sequence, respectively. AFM force measurements between probes and surfaces functionalized with molecules of this triblock protein revealed adhesive interactions that increased in average force and frequency as the pH was lowered from pH 11.2 to 7.4 to 4.5, reflecting an increase in the numbers of interacting molecular strands. In bulk solution, lowering the pH results in a viscous liquid to gel transition. The modular design of the triblock protein was also exploited for single molecule force spectroscopy investigations, which revealed altered intramolecular interactions in response to changes in pH. An increased understanding of the inter- and intramolecular forces involved in biomolecule driven gelation processes is not only of great fundamental interest in the study of the biomolecular systems involved but may also prove key in enabling the rational design of new generations of intelligent hydrogel systems.
C1 Univ Nottingham, Sch Pharm, Lab Biophys & Surface Anal, Nottingham NG7 2RD, England.
   Univ Massachusetts, Dept Polymer Sci & Engn, Amherst, MA 01003 USA.
   CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.
RP Allen, S (reprint author), Univ Nottingham, Sch Pharm, Lab Biophys & Surface Anal, Nottingham NG7 2RD, England.
EM stephanie.allen@nottingham.ac.uk
RI Williams, Philip/C-6947-2009; Roberts, Clive/C-6970-2009
OI Williams, Philip/0000-0002-1822-2133; Roberts,
   Clive/0000-0001-9443-3445; Allen, Stephanie/0000-0001-5384-2998; Davies,
   Martyn/0000-0001-7695-0596
CR Adamson J. Gordon, 1993, Current Opinion in Biotechnology, V4, P428, DOI 10.1016/0958-1669(93)90008-K
   Alber T, 1992, Curr Opin Genet Dev, V2, P205, DOI 10.1016/S0959-437X(05)80275-8
   Allen S, 1997, BIOCHEMISTRY-US, V36, P7457, DOI 10.1021/bi962531z
   BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175
   Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694
   DeSilva TM, 1997, BIOCHEMISTRY-US, V36, P3991, DOI 10.1021/bi962412j
   Durr E, 1999, BIOCHEMISTRY-US, V38, P870, DOI 10.1021/bi981891e
   Evans E, 1999, FARADAY DISCUSS, V111, P1
   FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628
   FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C
   Gombotz WR, 1998, ADV DRUG DELIVER REV, V31, P267, DOI 10.1016/S0169-409X(97)00124-5
   HEGNER M, 1993, SURF SCI, V291, P39, DOI 10.1016/0039-6028(93)91474-4
   Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/S0169-409X(01)00240-X
   Hodges RS, 1996, BIOCHEM CELL BIOL, V74, P133, DOI 10.1139/o96-015
   HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970
   KOHN WD, 1995, PROTEIN SCI, V4, P237
   KRYLOV D, 1994, EMBO J, V13, P2849, DOI 10.1002/j.1460-2075.1994.tb06579.x
   Merkel R, 1999, NATURE, V397, P50, DOI 10.1038/16219
   Miyata T, 1999, NATURE, V399, P766, DOI 10.1038/21619
   Miyata T, 2002, ADV DRUG DELIVER REV, V54, P79, DOI 10.1016/S0169-409X(01)00241-1
   Oberhauser AF, 1998, NATURE, V393, P181
   Oesterhelt F., 1999, NEW J PHYS, P1
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   Pope LH, 2001, EUR BIOPHYS J BIOPHY, V30, P53, DOI 10.1007/s002490000107
   Qiu Y, 2001, ADV DRUG DELIVER REV, V53, P321, DOI 10.1016/S0169-409X(01)00203-4
   Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109
   Rief M, 1997, SCIENCE, V275, P1295, DOI 10.1126/science.275.5304.1295
   Rief M, 1998, PHYS REV LETT, V81, P4764, DOI 10.1103/PhysRevLett.81.4764
   Rief M, 1999, J MOL BIOL, V286, P553, DOI 10.1006/jmbi.1998.2466
   Stevens MM, 2004, BIOMATERIALS, V25, P887, DOI 10.1016/j.biomaterials.2003.07.002
   Stevens MM, 2004, LANGMUIR, V20, P7747, DOI 10.1021/la030440e
   Stevens MM, 2004, J ORTHOPAED RES, V22, P1114, DOI 10.1016/j.orthres.2003.12.021
   Stevens MM, 2004, ADV MATER, V16, P915, DOI 10.1002/adma.200306430
   Stevens MM, 2002, LANGMUIR, V18, P6659, DOI 10.1021/la0202024
   Stevens MM, 2000, ANALYST, V125, P245, DOI 10.1039/a907741c
   STEVENS MM, 2004, UNPUB LANGMUIR
   Wang C, 1999, NATURE, V397, P417, DOI 10.1038/17092
   Willemsen OH, 1999, BIOPHYS J, V76, P716, DOI 10.1016/S0006-3495(99)77238-3
   WILLIAMS PM, 2002, HOUCHES ECOLE ETE PH
NR 39
TC 28
Z9 29
U1 2
U2 21
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAY-JUN
PY 2005
VL 6
IS 3
BP 1266
EP 1271
DI 10.1021/bm049369x
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 926QY
UT WOS:000229138900014
PM 15877341
DA 2018-10-19
ER

PT J
AU Shingel, KI
   Faure, MP
AF Shingel, KI
   Faure, MP
TI Structure-property relationships in poly(ethylene glycol)-protein
   hydrogel systems made from various proteins
SO BIOMACROMOLECULES
LA English
DT Article
ID BIOARTIFICIAL POLYMERIC MATERIAL; PEG HYDROGEL; ALBUMIN; GLYCOL);
   FRACTIONS; PEPTIDE; WATER; GELS
AB A series of poly(ethylene glycol)-protein hydrogels were synthesized with different proteins, and the resultant structures were characterized in terms of swelling behavior and mechanical, optical, and drug release properties. Irrespectively of the protein involved in polymerization with poly(ethylene glycol), all studied systems were found to be loosely cross-linked networks, where both polymer and protein are completely solvated, enabling as high as 96% water content. Changes in the apparent transparency of the hydrogels synthesized with different proteins were attributed to the ability of the protein component to self-associate via hydrophobic interactions. The polyelectrolyte nature of the protein component governs the pH responsiveness of the network, which manifested itself in a pH-dependent mechanism of swelling and drug release. It was demonstrated that there is great opportunity to modulate the final characteristics of the hydrogel system to fit the need of specific biomedical application.
C1 Bioartificial Gel Technol Inc, Montreal, PQ H3A 1L4, Canada.
RP Shingel, KI (reprint author), Bioartificial Gel Technol Inc, 400 Maisonneuve W,Suite 1156, Montreal, PQ H3A 1L4, Canada.
EM kirill.shingel@bagtech.com
CR DAIS M, 1999, INT J PHARM, V182, P41
   DURSO EM, 1994, BIOTECHNOL TECH, V8, P71, DOI 10.1007/BF00152843
   DURSO EM, 1994, J BIOACT COMPAT POL, V9, P367, DOI 10.1177/088391159400900402
   Flory PJ, 1943, J CHEM PHYS, V11, P521, DOI 10.1063/1.1723792
   FORTIER G, 1993, BIOTECHNOL APPL BIOC, V17, P115
   FORTIER G, 1998, METHODS BIOTECHNOLOG, V1
   Fortier G., 1998, U.S. Patent, Patent No. [5733563, 5,733,563]
   Gayet JC, 1998, J BIOACT COMPAT POL, V13, P179, DOI 10.1177/088391159801300302
   Gayet JC, 1996, J CONTROL RELEASE, V38, P177, DOI 10.1016/0168-3659(95)00118-2
   HETTIARACHCHY NS, 1998, FUNCTIONAL PROPERTIE, V708, P80
   Hoffman A. S., 2002, ADV DRUG DELIVERY RE, V43, P3, DOI DOI 10.1016/S0169-409X(01)00239-3
   HORKAY F, 1982, MACROMOLECULES, V15, P1306, DOI 10.1021/ma00233a018
   JAKUBEK M, 1979, J GENET POL, V20, P369
   Lu BY, 2000, J SCI FOOD AGR, V80, P1964, DOI 10.1002/1097-0010(200010)80:13<1964::AID-JSFA737>3.0.CO;2-J
   Malin EL, 2001, J PROTEIN CHEM, V20, P391, DOI 10.1023/A:1012232804665
   NAKAI S, 1996, FOOD PROTEINS PROPER, P122
   NOZAWA I, 1991, J BIOMED MATER RES, V25, P243, DOI 10.1002/jbm.820250210
   PERRIER E, 1994, Patent No. 9418944
   REFOJO MF, 1965, J APPL POLYM SCI, V9, P3417, DOI 10.1002/app.1965.070091019
   Renkema JMS, 2002, J AGR FOOD CHEM, V50, P6064, DOI 10.1021/jf020061b
   Riblett AL, 2001, J AGR FOOD CHEM, V49, P4983, DOI 10.1021/jf0105081
   ROBERT M, 2003, APGI S
   Roberts MJ, 2002, ADV DRUG DELIVER REV, V54, P459, DOI 10.1016/S0169-409X(02)00022-4
   Sanborn TJ, 2002, BIOMATERIALS, V23, P2703, DOI 10.1016/S0142-9612(02)00002-9
   Stubbe BG, 2002, MACROMOLECULES, V35, P2501, DOI 10.1021/ma011408z
   ZALIPSKY S, 1995, BIOCONJUGATE CHEM, V6, P150, DOI 10.1021/bc00032a002
NR 26
TC 15
Z9 15
U1 2
U2 9
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAY-JUN
PY 2005
VL 6
IS 3
BP 1635
EP 1641
DI 10.1021/bm0492475
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 926QY
UT WOS:000229138900061
PM 15877388
DA 2018-10-19
ER

PT J
AU Liu, ZF
   Wu, X
   Yang, XY
   Liu, DP
   Jun, C
   Sun, RM
   Liu, XP
   Li, FX
AF Liu, ZF
   Wu, X
   Yang, XY
   Liu, DP
   Jun, C
   Sun, RM
   Liu, XP
   Li, FX
TI Synthesis and characterization of novel blood-compatible soluble
   chemically cross-linked polyurethanes with excellent mechanical
   performance for biomedical applications
SO BIOMACROMOLECULES
LA English
DT Article
ID CHAIN ALKYL-GROUPS; PHOSPHATIDYLCHOLINE POLAR HEADGROUPS; SIDE-CHAINS;
   SEGMENTED POLYURETHANES; MAIN CHAINS; POLY(URETHANE UREA); ALBUMIN
   ADSORPTION; SIZE DETERMINATION; ANALOGS; SURFACE
AB A controlled cross-linking polymerization system was designed, and soluble chemically cross-linked polyurethane was synthesized using laurylamine, n-octylamine, n-pentylamine, and ethylenediamine chain extenders. The mechanical analysis showed that the polyurethane materials synthesized in this paper have very excellent mechanical properties with a breaking elongation of 1914% and a tensile strength of 4303 N/cm(2). Such good mechanical properties must enable it to have good longevity when used as biomaterials. The polyurethane materials with n-pentylamine and n-octylamine chain extenders show reduced platelet adhesion than that with an ethylenediamine chain extender after sustaining 200 000 times of load cycles, indicating that polyurethanes introduced with an alkyl side chain onto the hard segments keep good antithrombogenic properties after sustaining load cycles. This might be because the hard segments are shielded by the alkyl side chain when the micro- phase- separation structure is destroyed in the repeated deformation of the polyurethane materials. The present investigation reveals that the influence of introducing long alkyl side chains into the backbone of the polyurethane macromolecule has been shown to reduce platelet deposition and to enhance in vitro albumin adsorption. However, in this paper, it has been observed that the polyurethane material introduced with a proper-length alkyl side chain onto the hard segment has the best antithrombogenic properties after the fatigue test.
C1 State Key Lab Funct Polymer Mat Adsorpt & Separat, Tianjin 300071, Peoples R China.
   Nankai Univ, Dept Chem, Tianjin 300071, Peoples R China.
   Tianjin Med Univ, Pharmaceut Coll, Tianjin 300070, Peoples R China.
RP Li, FX (reprint author), State Key Lab Funct Polymer Mat Adsorpt & Separat, Tianjin 300071, Peoples R China.
EM lifangxing@nankai.edu.cn
CR COURY AJ, 1984, ADV URETHANE SCI TEC, V9, P130
   Dai XH, 2004, MACROMOLECULES, V37, P5615, DOI 10.1021/ma049900g
   EBERHART RC, 1987, ARTIF ORGANS, V11, P375
   Garrett JT, 2001, MACROMOLECULES, V34, P7066, DOI 10.1021/ma0102114
   GRASEL TG, 1987, J BIOMED MATER RES, V21, P815, DOI 10.1002/jbm.820210702
   HEARN MJ, 1988, MACROMOLECULES, V21, P2950, DOI 10.1021/ma00188a011
   Jayabalan M, 2000, POLYM INT, V49, P88, DOI 10.1002/(SICI)1097-0126(200001)49:1<88::AID-PI298>3.0.CO;2-7
   JAYABALAN M, 1998, VINOY THOMAS MACOMOL, P617
   Korematsu A, 1997, POLYM BULL, V38, P133, DOI 10.1007/s002890050029
   Lelah M. D., 1986, POLYURETHANES MED
   Li F, 1999, CHIN J INORG CHEM, V15, P55
   Li FX, 1998, EUR POLYM J, V34, P59, DOI 10.1016/S0014-3057(97)00077-3
   Li FX, 2001, EUR POLYM J, V37, P193, DOI 10.1016/S0014-3057(00)00082-3
   Li FX, 2005, MACROMOLECULES, V38, P69, DOI 10.1021/ma0491558
   Li FX, 2004, MACROMOLECULES, V37, P764, DOI 10.1021/ma034593k
   LI FX, 1994, J POLYM SCI A, V52, P1939
   Li YJ, 1996, CHEM MATER, V8, P1441, DOI 10.1021/cm960014x
   Li YJ, 1998, CHEM MATER, V10, P1596, DOI 10.1021/cm9707869
   Li YJ, 1996, MACROMOL RAPID COMM, V17, P737, DOI 10.1002/marc.1996.030171009
   Li YJ, 1999, CHEM MATER, V11, P763, DOI 10.1021/cm9806432
   Li YJ, 1997, CHEM MATER, V9, P1570, DOI 10.1021/cm960615o
   LI YJ, 1995, MACROMOL RAPID COMM, V16, P253, DOI 10.1002/marc.1995.030160404
   Li YJ, 1996, MACROMOL CHEM PHYSIC, V197, P2827, DOI 10.1002/macp.1996.021970920
   Marand E, 1996, MACROMOLECULES, V29, P2555, DOI 10.1021/ma950569y
   MARCONI W, 1995, BIOMATERIALS, V16, P449, DOI 10.1016/0142-9612(95)98817-X
   MARCONI W, 1994, MACROMOL CHEM PHYS, V195, P875, DOI 10.1002/macp.1994.021950306
   MUNRO MS, 1983, ASAIO J, V6, P65
   PITT WG, 1988, BIOMATERIALS, V9, P36, DOI 10.1016/0142-9612(88)90067-1
   Planck H, 1987, PROGR BIOMEDICAL ENG
   POLLACK SK, 1992, MACROMOLECULES, V25, P2381, DOI 10.1021/ma00035a014
   RAHMAN R, 1989, J POLYM SCI POL CHEM, V27, P2673, DOI 10.1002/pola.1989.080270815
   SOLOMON DH, 1972, STEP GROWTH POLYM, pCH3
   STRIZINAR I, 1992, J BIOMED MATER RES, V26, P577
   TAKAHARA A, 1985, POLYMER, V26, P978, DOI 10.1016/0032-3861(85)90217-4
   Teo LS, 1997, MACROMOLECULES, V30, P1793, DOI 10.1021/ma961035f
   Thomas V, 2001, BIOMACROMOLECULES, V2, P588, DOI 10.1021/bm010044f
   Tomita T, 1999, CHEM MATER, V11, P2155, DOI 10.1021/cm9901257
   YAMADA M, 1995, MACROMOL RAPID COMM, V16, P25, DOI 10.1002/marc.1995.030160105
   YAMADA M, 1995, J MACROMOL SCI PURE, VA32, P1235, DOI 10.1080/10601329508009351
   ZUO J, 1994, PRINCIPLES APPL LASE, P65
NR 40
TC 15
Z9 18
U1 0
U2 7
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAY-JUN
PY 2005
VL 6
IS 3
BP 1713
EP 1721
DI 10.1021/bm049173x
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 926QY
UT WOS:000229138900071
PM 15877398
DA 2018-10-19
ER

PT J
AU Watanabe, J
   Ishihara, K
AF Watanabe, J
   Ishihara, K
TI Cell engineering biointerface focusing on cytocompatibility using
   phospholipid polymer with an isomeric oligo(lactic acid) segment
SO BIOMACROMOLECULES
LA English
DT Article
ID PHOSPHORYLCHOLINE; WATER; STEREOCOMPLEX; COPOLYMERS; SUBSTRATE;
   ADHESION; ASSAY
AB Initial contact between a biological environment and a biomaterial ultimately decides the in vivo performance. Therefore, the fabrication of a delicate biointerface is important because it can be utilized as a platform for novel biomaterials. For the preparation of advanced biomedical devices such as biochips, nanoparticles, and cell engineering devices, the surface properties may be modified by the design of polymeric biomaterials. Anomalous phospholipid polymers with an isomeric oligo(lactic acid) segment were designed and evaluated as a biointerface. The phospholipid polymer containing 2-methacryloyloxyethyl phosphorylcholine was easily copolymerized with isomeric oligo(lactic acid) macromonomers, and the obtained polymer could easily form thin coating membranes as biointerfaces. The oligo(lactic acid) involves three kinds of isomers: DL-, D-, and L-forms. The favorable characteristic on the surface provides regulation of cell-material interactions on the biointerface. The oligo(lactic acid) segment could form hydrophobic domains, which were considered to be located on the interface, to enhance protein adsorption and cell adhesion. The most favorable characteristics on the biointerface were dual functions of cytocompatibility by the phospholipid polymer and cell adhesion property by the oligo(lactic acid) segment. In this study, we focused on the biological responses such as protein adsorption and cell adhesion by change in the oligo(lactic acid) component. The cell viability on the confluent stage was evaluated in terms of metabolic activity.
C1 Univ Tokyo, Sch Engn, Dept Mat Engn, Bunkyo Ku, Tokyo 1138656, Japan.
RP Ishihara, K (reprint author), Univ Tokyo, Sch Engn, Dept Mat Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.
EM ishihara@bmw.t.u-tokyo.ac.jp
CR Baskin A, 1980, J BIOMED MATER RES, V14, P393
   Biran I, 2002, ANAL CHEM, V74, P3046, DOI 10.1021/ac020009e
   Cheng XH, 2004, J BIOMED MATER RES A, V70A, P159, DOI 10.1002/jbm.a.30053
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   Ishihara K, 1999, J BIOMAT SCI-POLYM E, V10, P1047, DOI 10.1163/156856299X00676
   ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355
   Kitano H, 2003, LANGMUIR, V19, P10260, DOI 10.1021/la0349673
   Kitano H, 2000, J PHYS CHEM B, V104, P11425, DOI 10.1021/jp000429c
   Konno T, 2004, BIOMACROMOLECULES, V5, P342, DOI 10.1021/bm034356p
   MATSUDA T, 1994, J JAPANESE SOC BIOMA, V12, P187
   Miyamoto D, 2004, BIOMATERIALS, V25, P71, DOI 10.1016/S0142-9612(03)00474-5
   Miyazawa K, 2002, MACROMOLECULES, V35, P2440, DOI 10.1021/ma011898v
   Nakayama GR, 1997, J IMMUNOL METHODS, V204, P205, DOI 10.1016/S0022-1759(97)00043-4
   Oki A, 2001, ELECTROPHORESIS, V22, P341, DOI 10.1002/1522-2683(200101)22:2<341::AID-ELPS341>3.0.CO;2-W
   Park J, 2004, ANAL CHEM, V76, P2649, DOI 10.1021/ac035321i
   Sawada S, 2003, J BIOMED MATER RES A, V64A, P411, DOI 10.1002/jbm.a.10433
   Takei K, 2004, BIOMACROMOLECULES, V5, P858, DOI 10.1021/bm0344250
   Watanabe J, 2003, ARTIF ORGANS, V27, P242, DOI 10.1046/j.1525-1594.2003.07015.x
   Watanabe J, 2003, CHEM LETT, V32, P192, DOI 10.1246/cl.2003.192
   Watanabe J, 2002, BIOMACROMOLECULES, V3, P1109, DOI 10.1021/bm025586r
   Whelan DM, 2000, HEART, V83, P338, DOI 10.1136/heart.83.3.338
   YONEYAMA T, 2002, BIOMATERIALS, V23, P1445
NR 22
TC 21
Z9 23
U1 1
U2 10
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAY-JUN
PY 2005
VL 6
IS 3
BP 1797
EP 1802
DI 10.1021/bm050138f
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 926QY
UT WOS:000229138900080
PM 15877407
DA 2018-10-19
ER

PT J
AU Frost, MC
   Reynolds, MM
   Meyerhoff, ME
AF Frost, MC
   Reynolds, MM
   Meyerhoff, ME
TI Polymers incorporating nitric oxide releasing/generating substances for
   improved biocompatibility of blood-contactincy medical devices
SO BIOMATERIALS
LA English
DT Review
DE nitric oxide; blood compatible polymers; anti-platelet activity
ID MUSCLE-CELL-PROLIFERATION; IN-STENT RESTENOSIS; VASCULAR ACCESS
   DYSFUNCTION; SIROLIMUS-ELUTING STENT; S-NITROSOTHIOLS;
   PLATELET-ADHESION; NEOINTIMAL HYPERPLASIA; NITROGEN(II) OXIDE; CHEMICAL
   SENSORS; RELEASE POLYMERS
AB The current state-of-the-art with respect to the preparation, characterization and biomedical applications of novel nitric oxide (NO) releasing or generating polymeric materials is reviewed. Such materials show exceptional promise as coatings to prepare a new generation of medical devices with superior biocompatiblity. Nitric oxide is a well-known inhibitor of platelet adhesion and activation, as well as a potent inhibitor of smooth muscle cell proliferation. Hence, polymers that release OF generate NO locally at their surface exhibit greatly enhanced thromboresistivity and have the potential to reduce neointimal hyperplasia caused by device damage to blood vessel walls. In this review, the use of diazeniumdiolates and nitrosothiols as NO donors within a variety polymeric matrixes are summarized. Such species can either be doped as discrete NO donors within polymeric films, or covalently baked to polymer backbones and/or inorganic polymeric filler particles that are often employed to enhance the strength of biomedical polymers (e.g., fumed silica or titanium dioxide). In addition, very recent efforts to create catalytic polymers posssessing immobilized Cu(II) sites capable of generating NO from endogenous oxidized forms of NNO already present in blood and other physiological fluids (nitrite and nitrosothiols) are discussed. Preliminary literature data illustrating the efficacy of the various NO release/ generating polymers as coatings for intravascular sensors, extracorporeal blood loop circuits. and arteriovenous grafts/shunts are reviewed. circle * 2004 Elsevier Ltd. All rights reserved.
C1 Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.
RP Meyerhoff, ME (reprint author), Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.
EM mmeyerho@umich.edu
CR Annich GM, 2000, CRIT CARE MED, V28, P915, DOI 10.1097/00003246-200004000-00001
   BAMFORD CH, 1992, INT J ARTIF ORGANS, V15, P71
   Batchelor MM, 2003, J MED CHEM, V46, P5153, DOI 10.1021/jm030286t
   BATCHELOR MM, 2004, THESIS U MICHIGAN, P157
   Bohl KS, 2000, BIOMATERIALS, V21, P2273, DOI 10.1016/S0142-9612(00)00153-8
   Braybrook J.H., 1997, BIOCOMPATIBILITY ASS
   Bruemmer D, 2003, BIOCHEM BIOPH RES CO, V303, P251, DOI 10.1016/S0006-291X(03)00343-7
   Chandrasekar B, 2000, J AM COLL CARDIOL, V35, P555, DOI 10.1016/S0735-1097(99)00596-3
   Chaux A, 1998, J THORAC CARDIOV SUR, V115, P604, DOI 10.1016/S0022-5223(98)70325-3
   Chen CY, 1997, J SURG RES, V67, P26, DOI 10.1006/jsre.1996.4915
   COLMAN RW, 1993, CARDIOVASC PATHOL, V2, pS23
   Degertekin M, 2003, J AM COLL CARDIOL, V41, P184, DOI 10.1016/S0735-1097(02)02704-3
   Dicks AP, 1996, CHEM SOC P2, V4, P481
   DRAGO RS, 1960, J AM CHEM SOC, V82, P96, DOI 10.1021/ja01486a021
   DRAGO RS, 1961, J AM CHEM SOC, V83, P1819, DOI 10.1021/ja01469a012
   Duan XB, 2002, BIOMATERIALS, V23, P1197, DOI 10.1016/S0142-9612(01)00234-4
   EspadasTorre C, 1997, J AM CHEM SOC, V119, P2321, DOI 10.1021/ja963054a
   Etchenique R, 2000, J AM CHEM SOC, V122, P3967, DOI 10.1021/ja9939845
   Feng J., 2000, POLYM PREPR, V41, P16
   Frost MC, 2004, J AM CHEM SOC, V126, P1348, DOI 10.1021/ja039466i
   Frost MC, 2003, MICROCHEM J, V74, P277, DOI 10.1016/S0026-265X(03)00033-X
   Frost MC, 2002, ANAL CHEM, V74, P5942, DOI 10.1021/ac025944g
   Gabikian P, 2002, STROKE, V33, P2681, DOI 10.1161/01.STR.0000033931.62992.B1
   GOLDSTEIN S, 1995, J AM CHEM SOC, V117, P12078, DOI 10.1021/ja00154a007
   GROVES PH, 1995, CARDIOVASC RES, V30, P87, DOI 10.1016/S0008-6363(95)00009-7
   Groves PH, 2000, BIOMATERIALS, V21, P2273
   Gruberg L, 2000, EXPERT OPIN INV DRUG, V9, P2555, DOI 10.1517/13543784.9.11.2555
   Hoffmann R, 2000, EUR HEART J, V21, P1739, DOI 10.1053/euhj.2000.2153
   HOLMES AJ, 2000, CHEM SOC P2, V8, P1639
   HRABIE JA, 1993, J ORG CHEM, V58, P1472, DOI 10.1021/jo00058a030
   Jourd'heuil D, 2000, FREE RADICAL BIO MED, V28, P409, DOI 10.1016/S0891-5849(99)00257-9
   KELLY BS, 2002, KIDNEY INT, V262, P2272
   Makrides SC, 1998, THROMBOSIS HEMORRHAG, P295
   Marxer SM, 2003, CHEM MATER, V15, P4193, DOI 10.1021/cm034347n
   Masters KSB, 2002, WOUND REPAIR REGEN, V10, P286, DOI 10.1046/j.1524-475X.2002.10503.x
   Mowery KA, 2000, BIOMATERIALS, V21, P9, DOI 10.1016/S0142-9612(99)00127-1
   Mowery KA, 1999, ELECTROANAL, V11, P681, DOI 10.1002/(SICI)1521-4109(199907)11:10/11<681::AID-ELAN681>3.3.CO;2-R
   Oh BK, 2003, J AM CHEM SOC, V125, P9552, DOI 10.1021/ja035775x
   OH BK, 2004, BIOMATERIALS, V23, P283
   Parzuchowski PG, 2002, J AM CHEM SOC, V124, P12182, DOI 10.1021/ja020268l
   Pulfer SK, 1997, J BIOMED MATER RES, V37, P182, DOI 10.1002/(SICI)1097-4636(199711)37:2<182::AID-JBM6>3.0.CO;2-N
   RADOMSKI MW, 1987, BRIT J PHARMACOL, V92, P639, DOI 10.1111/j.1476-5381.1987.tb11367.x
   RADOMSKI MW, 1987, BIOCHEM BIOPH RES CO, V148, P1482, DOI 10.1016/S0006-291X(87)80299-1
   Regar E, 2001, BRIT MED BULL, V59, P227, DOI 10.1093/bmb/59.1.227
   Roy-Chaudhury P, 2001, KIDNEY INT, V59, P2325, DOI 10.1046/j.1523-1755.2001.0590062325.x
   Roy-Chaudhury P, 2003, BLOOD PURIFICAT, V21, P99, DOI 10.1159/000067863
   Roy-Chaudhury P, 2002, ADV RENAL REPLACE TH, V9, P74, DOI 10.1053/jarr.2002.33519
   ROYCHAUDHURY P, 2002, J INVASIVE CARDIOL, V14, pE25
   Saavedra JE, 1999, J ORG CHEM, V64, P5124, DOI 10.1021/jo9901539
   Saavedra JE, 1996, J MED CHEM, V39, P4361, DOI 10.1021/jm960616s
   SARKAR R, 1995, THESIS U MICHIGAN
   Schoenfisch MH, 2002, ANAL CHEM, V74, P5937, DOI 10.1021/ac026075y
   Schoenfisch MH, 2000, ANAL CHEM, V72, P1119, DOI 10.1021/ac991370c
   SCHWARTZ RS, 1992, J AM COLL CARDIOL, V20, P1284, DOI 10.1016/0735-1097(92)90389-5
   Sefton MV, 2000, J BIOMAT SCI-POLYM E, V11, P1165
   Shishido SM, 2003, BIOMATERIALS, V24, P3543, DOI 10.1016/S0142-9612(03)00153-4
   Shishido SM, 2000, PHOTOCHEM PHOTOBIOL, V71, P273, DOI 10.1562/0031-8655(2000)071<0273:PGMRTR>2.0.CO;2
   SINEY L, 1992, EUR J PHARMACOL, V229, P223, DOI 10.1016/0014-2999(92)90559-M
   Singh RJ, 1996, J BIOL CHEM, V271, P18596, DOI 10.1074/jbc.271.31.18596
   Smith DJ, 1996, J MED CHEM, V39, P1148, DOI 10.1021/jm950652b
   Smith DJ, 1998, J CONTROL RELEASE, V51, P153, DOI 10.1016/S0168-3659(97)00161-2
   SNEDDON JM, 1988, P NATL ACAD SCI USA, V85, P2800, DOI 10.1073/pnas.85.8.2800
   Sousa JE, 2003, CIRCULATION, V107, P24, DOI 10.1161/01.CIR.0000047063.22006.41
   Tierney TS, 2001, NEUROSURGERY, V49, P945, DOI 10.1097/00006123-200110000-00028
   Tyurin VA, 2002, METHOD ENZYMOL, V352, P347
   VAUGHN M, 1998, AM J PHYSIOL, V274, P2163
   Williams DLH, 1999, ACCOUNTS CHEM RES, V32, P869, DOI 10.1021/ar9800439
   WISE DL, 2000, BIOMATERIALS ENV DEV, V1
   Zhang HP, 2003, J AM CHEM SOC, V125, P5015, DOI 10.1021/ja0291538
   Zhang HP, 2002, BIOMATERIALS, V23, P1485, DOI 10.1016/S0142-9612(01)00274-5
NR 70
TC 206
Z9 214
U1 5
U2 85
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2005
VL 26
IS 14
BP 1685
EP 1693
DI 10.1016/j.biomaterials.2004.06.006
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 892PZ
UT WOS:000226663800009
PM 15576142
DA 2018-10-19
ER

PT J
AU Rimmer, S
   German, MJ
   Maughan, J
   Sun, Y
   Fullwood, N
   Ebdon, J
   MacNeil, S
AF Rimmer, S
   German, MJ
   Maughan, J
   Sun, Y
   Fullwood, N
   Ebdon, J
   MacNeil, S
TI Synthesis and properties of amphiphilic networks 3: preparation and
   characterization of block conetworks of poly(butyl
   methacrylate-block-(2,3 propandiol-1-methacrylate-stat-ethandiol
   dimethacrylate))
SO BIOMATERIALS
LA English
DT Article
DE ampiphilic network; hydrogel; fibroblast; cell proliferation;
   methacrylate
ID BIOMEDICAL APPLICATIONS; TELECHELIC OLIGOMERS; POLYMER COMPOSITION;
   MAIN-CHAIN; HYDROGELS; RELEASE; DEGRADATION; COPOLYMERS; SCAFFOLDS;
   ADHESION
AB Amphiphilic conetwork polymers were prepared and studied as substrates in the culture of dermal fibroblasts. Both block and random conetworks polymers were produced by radical polymerization of either low-molecular weight monomers or oligomeric macromonomers. The oligomeric macromonomers were prepared by methacrylation of biscarboxy oligo(butyl methacrylates) (OBMA). The latter were synthesized by ozononolysis of poly(butyl methacrylate-co-butadiene) materials. The hydrophilic component was derived from copolymerization with 2,3 propandiol-l-methacrylate and cross-linking was provided by inclusion of ethandiol dimethacrylate (EDMA). None of the synthesized materials showed indications of cytotoxicity to human dermal fibroblasts. All of the block conetworks were highly phase separated and possessed pores on the micron length scale. The equilibrium water contents of the latter could be controlled by addition of EDMA. Block conetworks that did not contain EDMA were highly swollen and had smoother surfaces than those that contained EDMA. The former were poor substrates for cell proliferation (as measured by monitoring DNA content) whilst the latter class gave increasing levels of DNA during culture; an indicator proliferation. The performance of these materials in cell culture was also dependent on the fraction of OBMA in the formulation. Increasing the fractions of BMA, either in the random terpolymer or block networks, system had the effect of increasing both cell proliferation and viability (as measured by the Alamar Blue assay). (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Sheffield, Dept Chem, Ctr Polymer, Polymer & Biomat Chem Labs, Sheffield S3 7HF, S Yorkshire, England.
   Univ Sheffield, Dept Chem, Polymer & Biomat Chem Labs, CTEB, Sheffield S3 7HF, S Yorkshire, England.
   Univ Lancaster, Dept Phys, Lancaster LA1 4YB, Lancs, England.
   Univ Lancaster, Dept Sci Biol, Lancaster LA1 4YQ, England.
   Univ Sheffield, Dept Mat Engn, Sheffield S1 3JD, S Yorkshire, England.
   No Gen Hosp, Div Clin Sci, Sheffield S5 7AU, S Yorkshire, England.
RP Rimmer, S (reprint author), Univ Sheffield, Dept Chem, Ctr Polymer, Polymer & Biomat Chem Labs, Sheffield S3 7HF, S Yorkshire, England.
EM s.rimmer@sheffield.ac.uk
RI German, Matthew/R-5269-2018
OI German, Matthew/0000-0002-3910-6377; Fullwood, Nigel
   James/0000-0002-9405-8515; Ebdon, John/0000-0003-4176-3912
CR AHMED SA, 1994, J IMMUNOL METHODS, V170, P211
   Bae YH, 2000, J CONTROL RELEASE, V64, P3, DOI 10.1016/S0168-3659(99)00126-1
   Barakat I, 1999, J POLYM SCI POL CHEM, V37, P2401, DOI 10.1002/(SICI)1099-0518(19990715)37:14<2401::AID-POLA14>3.0.CO;2-9
   Bellesia F, 1998, TETRAHEDRON, V54, P7849, DOI 10.1016/S0040-4020(98)00419-0
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P19, DOI 10.1016/s0939-6411(03)00161-9
   BLEZER R, 1995, POLYM BULL, V34, P101, DOI 10.1007/BF00294894
   CHEN D, 1989, J BIOMED MATER RES, V23, P1327, DOI 10.1002/jbm.820231109
   Cunliffe D, 2002, DES MONOMERS POLYM, V5, P233, DOI 10.1163/156855502760157953
   Cunliffe D, 2001, MACROMOLECULES, V34, P3882, DOI 10.1021/ma001313h
   DAVID G, 2002, EUR POLYM J, V39, P77
   EBDON J, 1991, NEW METHODS POLYM SY, pCH7
   Ebdon JR, 1997, J POLYM SCI POL CHEM, V35, P3255, DOI 10.1002/(SICI)1099-0518(19971115)35:15<3255::AID-POLA19>3.3.CO;2-K
   EBDON JR, 1995, MACROMOL REP A, V32, P603
   GOEGAN P, 1995, TOXICOL IN VITRO, V9, P257, DOI 10.1016/0887-2333(95)00004-R
   Guan Y, 2002, MACROMOL CHEM PHYSIC, V203, P900, DOI 10.1002/1521-3935(20020401)203:5/6<900::AID-MACP900>3.0.CO;2-E
   GUAN Y, 1999, HUAXUE JINZHAN, V11, P86
   Haigh R, 2002, BIOMATERIALS, V23, P3509, DOI 10.1016/S0142-9612(02)00081-9
   Haigh R, 2000, BIOMATERIALS, V21, P735, DOI 10.1016/S0142-9612(99)00245-8
   Higham MC, 2003, TISSUE ENG, V9, P919, DOI 10.1089/107632703322495565
   Isayeva IS, 2002, POLYM BULL, V48, P475, DOI 10.1007/s00289-002-0062-7
   Ivan B, 2001, MACROMOLECULES, V34, P1579, DOI 10.1021/ma000062+
   Ivan B, 1996, MACROMOL SYMP, V102, P81, DOI 10.1002/masy.19961020112
   IVAN B, 1990, POLYM PREPR, V31, P217
   Kennedy J. P., 2001, MACROMOL S, V172, P56
   KENNEDY JP, 1994, J MACROMOL SCI PURE, VA31, P1771, DOI 10.1080/10601329408545881
   KENNEDY JP, 1993, TRENDS POLYM SCI, V1, P381
   KENNEDY JP, 2000, POLYM PREPR AM CHEM, V41, P710
   KESZLER B, 1993, J CONTROL RELEASE, V25, P115, DOI 10.1016/0168-3659(93)90100-J
   LIMA V, 2003, POLYM PREPR, V44, P812
   Lovell P. A., 1997, EMULSION POLYM EMULS
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Nakayama Y, 2000, J BIOMED MATER RES, V51, P520, DOI 10.1002/1097-4636(20000905)51:3<520::AID-JBM29>3.0.CO;2-A
   Patrickios CS, 2003, CURR OPIN COLLOID IN, V8, P76, DOI 10.1016/S1359-0294(03)00005-0
   Rimmer S, 1996, J POLYM SCI POL CHEM, V34, P3573, DOI 10.1002/(SICI)1099-0518(199612)34:17<3573::AID-POLA12>3.0.CO;2-B
   Rimmer S, 1995, REACT FUNCT POLYM, V26, P145, DOI 10.1016/1381-5148(95)00014-7
   Simmons MR, 2000, MACROMOLECULES, V33, P3176, DOI 10.1021/ma991720x
   TOLNAI M, 1998, POLYM MAT SCI ENG, V79, P250
   Triftaridou AI, 2002, MACROMOLECULES, V35, P2506, DOI 10.1021/ma0114077
   Yoon JJ, 2001, J BIOMED MATER RES, V55, P401, DOI 10.1002/1097-4636(20010605)55:3<401::AID-JBM1029>3.0.CO;2-H
   YU H, 1995, J CONTROL RELEASE, V34, P117, DOI 10.1016/0168-3659(94)00127-G
   Zhang ZR, 1999, THERMOCHIM ACTA, V336, P133, DOI 10.1016/S0040-6031(99)00127-6
NR 41
TC 51
Z9 51
U1 0
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2005
VL 26
IS 15
BP 2219
EP 2230
DI 10.1016/j.biomaterials.2004.07.013
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 893DB
UT WOS:000226698400003
PM 15585223
DA 2018-10-19
ER

PT J
AU De Aza, PN
   De Aza, AH
   De Aza, S
AF De Aza, PN
   De Aza, AH
   De Aza, S
TI Crystalline bioceramic materials
SO BOLETIN DE LA SOCIEDAD ESPANOLA DE CERAMICA Y VIDRIO
LA English
DT Review
DE alumina; zirconia; zirconia-toughened alumina; graphite; hydroxyapatite;
   bioactive silicates; bioeutectic; tricalcium phosphate
ID TOUGHENED ALUMINA CERAMICS; TRICALCIUM PHOSPHATE BIOEUTECTIC(R);
   TRANSMISSION ELECTRON-MICROSCOPY; CRACK-GROWTH RESISTANCE; PULSED-LASER
   DEPOSITION; CALCIUM-PHOSPHATE; PROSTHETIC APPLICATIONS; BIOMEDICAL
   APPLICATION; JOINT REPLACEMENT; HIGH-RESOLUTION
AB A strong interest in the use of ceramics for biomedical engineering applications developed in the late 1960's. Used initially as alternatives to metallic materials in order to increase the biocoinpatibility of implants, bioceramics have become a diverse class of biomaterials, presently including three basic types: relatively bioinert ceramics; bioactive or surface reactive bioceramics and bioresorbable ceramics.
   This review will only refer to bioceramics "sensus stricto", it is to say, those ceramic materials constituted for nonmetallic inorganic compounds, crystallines and consolidated by thermal treatments of powders to high temperatures. Leaving bioglasses, glass-ceramics and biocements apart, since, although all of them are obtained by thermal treatments to high temperatures, the first are amorphous, the second are obtained by desvitrification of a glass and in them vitreous phase normally prevails on the crystalline phases and the third are consolidated by means of a hydraulic or chemical reaction to room temperature.
   A review of the composition, physiochemical properties and biological behaviour of the principal types of crystalline bioceramics is given, based on the literature data and on the own experience of the authors.
C1 Univ Miguel Hernandez, Inst Bioingn, Alicante, Spain.
   CSIC, Inst Ceram & Vidrio, Madrid, Spain.
RP De Aza, PN (reprint author), Univ Miguel Hernandez, Inst Bioingn, Alicante, Spain.
RI De Aza, Piedad/A-7621-2015; de Aza, Antonio/G-4626-2015
OI De Aza, Piedad/0000-0001-9316-4407; de Aza, Antonio/0000-0002-1655-3932
CR Abe Y, 1975, Shika Rikogaku Zasshi, V16, P196
   AKAO M, 1982, J MATER SCI, V17, P343, DOI 10.1007/BF00591468
   ANDERSSON OH, 1990, J NON-CRYST SOLIDS, V119, P290, DOI 10.1016/0022-3093(90)90301-2
   ASHBROOK RL, 1977, J AM CERAM SOC, V60, P428, DOI 10.1111/j.1151-2916.1977.tb15527.x
   BAILEY A, 1971, AM J SCI, V27, P464
   BAKO Z, 1992, CERAM INT, V18, P373, DOI 10.1016/0272-8842(92)90068-O
   BERGER G, 1989, P 15 INT C GLASS A, V3, P120
   BLENKE BA, 1973, LANGENBECHS ARCH CHI, V107
   Bragdon CR, 1997, J ARTHROPLASTY, V12, P119, DOI 10.1016/S0883-5403(97)90057-7
   BROWN L, 2004, 7 WORLD BIOM C SIDN
   BUTLER EP, 1985, MATER SCI TECH SER, V1, P417, DOI 10.1179/mst.1985.1.6.417
   CHEUNG HS, 1989, BIOMATERIALS, V10, P63, DOI 10.1016/0142-9612(89)90012-4
   Chevalier J, 2000, ADV MATER, V12, P1619, DOI 10.1002/1521-4095(200011)12:21<1619::AID-ADMA1619>3.0.CO;2-O
   Christel P., 1988, BIOCERAMICS MAT CHAR, V523, P237
   CLARK A, 1991, ENG MAT HDB, V4, P1091
   Cleries L, 2000, J BIOMED MATER RES, V49, P43, DOI 10.1002/(SICI)1097-4636(200001)49:1<43::AID-JBM6>3.0.CO;2-G
   Cui FZ, 2000, SURF COAT TECH, V131, P481, DOI 10.1016/S0257-8972(00)00809-4
   DAUSKARDT RH, 1993, INTRO BIOCERAMICS, P261
   De Aza AH, 2003, J AM CERAM SOC, V86, P115
   De Aza AH, 2002, KEY ENG MAT, V206-2, P1535, DOI 10.4028/www.scientific.net/KEM.206-213.1535
   De Aza AH, 2002, BIOMATERIALS, V23, P937, DOI 10.1016/S0142-9612(01)00206-X
   De Aza P. N., 1995, ADV SCI TECHNOLOGY, P19
   De Aza PN, 2004, BIOMATERIALS, V25, P1983, DOI 10.1016/j.biomaterials.2003.08.036
   De Aza PN, 1998, ANALYST, V123, P681, DOI 10.1039/a708445e
   De Aza PN, 1999, J DENT, V27, P107, DOI 10.1016/S0300-5712(98)00029-3
   De Aza PN, 2001, J MICROSC-OXFORD, V201, P33, DOI 10.1046/j.1365-2818.2001.00779.x
   De Aza PN, 1998, ACTA MATER, V46, P2541, DOI 10.1016/S1359-6454(98)80038-4
   de Aza PN, 1998, J MICROSC-OXFORD, V189, P145
   De Aza PN, 2000, BIOMATERIALS, V21, P1735, DOI 10.1016/S0142-9612(00)00058-2
   de Aza PN, 2000, J MICROSC-OXFORD, V197, P60
   De Groot K, 1988, Ann N Y Acad Sci, V523, P227
   De Groot K., 1990, HDB BIOACTIVE CERAMI, P3
   De Santis E, 2000, KEY ENG MAT, V192-1, P995
   DeAza PN, 1997, BIOMATERIALS, V18, P1285, DOI 10.1016/S0142-9612(97)00063-X
   DEAZA PN, 1994, SCRIPTA METALL MATER, V31, P1001, DOI 10.1016/0956-716X(94)90517-7
   DeAza PN, 1996, J MICROSC-OXFORD, V182, P24, DOI 10.1111/j.1365-2818.1996.tb04794.x
   DeAza PN, 1996, J MATER SCI-MATER M, V7, P399, DOI 10.1007/BF00122007
   DEAZA PN, 1995, J AM CERAM SOC, V78, P1653
   DEAZA PN, 1998, CERAMIC MICROSTRUCTU, P761
   DEAZA PN, 1999, ADV SCI TECHN 28 MAT, P25
   DEER WA, 1972, INTRO ROCK FORMING B, V5
   DEGROOT K, 1988, BIOCERAMICS MAT CHAR, P227
   DEGROOT K, 1991, CENTENNIAL MEMORIAL, V99, P943
   DEGROOT K, 1988, BIOCERAMICS MAT CHAR, P268
   Dubok VA, 2000, POWDER METALL MET C+, V39, P381, DOI 10.1023/A:1026617607548
   Dufrane D, 2003, J MATER SCI-MATER M, V14, P33, DOI 10.1023/A:1021545302732
   ELLIOTT R, 1977, INT METALS REV, P161
   Fernandez-Pradas JM, 2002, BIOMATERIALS, V23, P2057, DOI 10.1016/S0142-9612(01)00335-0
   Fernandez-Pradas JM, 2002, BIOMATERIALS, V23, P1989, DOI 10.1016/S0142-9612(01)00327-1
   Frondel C, 1941, AM MINERAL, V26, P145
   GARVIE RC, 1984, J MATER SCI, V19, P3224, DOI 10.1007/BF00549808
   Glasmacher B, 1999, MATERIALWISS WERKST, V30, P806, DOI 10.1002/(SICI)1521-4052(199912)30:12<806::AID-MAWE806>3.3.CO;2-6
   GROSS U, 1988, CRC CRITICAL REV BIO, V4, P2
   GROSS UM, 1982, CLIN APPLICATIONS BI, P237
   GROSS UM, 1993, INTRO BIOCERAMICS, P105
   HAYASHI K, 1992, BIOMATERIALS, V13, P195, DOI 10.1016/0142-9612(92)90184-P
   HAYEK E, 1963, INORG SYN, V7, P63, DOI 10.1002/9780470132388.ch17
   Hench L.L., 1981, FUNDAMENTAL ASPECTS
   HENCH LL, 1975, ANNU REV MATER SCI, V5, P279, DOI 10.1146/annurev.ms.05.080175.001431
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   HENCH LL, 1978, J NON-CRYST SOLIDS, V28, P83, DOI 10.1016/0022-3093(78)90077-7
   HENCH LL, 1988, BIOCERAMICS MAT CHAR, V523, P54
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   HOLMES R, 1984, CLIN ORTHOP RELAT R, P252
   HOWLETT CR, 1994, J MATER SCI-MATER M, V5, P715, DOI 10.1007/BF00120363
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   Hulbert S. F., 1987, HIGH TECH CERAMICS, P189
   HULBERT SF, 1983, CERAMICS SURGERY, P3
   Hulbert SF, 1993, INTRO BIOCERAMICS, P25
   JACKSON SA, 1978, CALC TISS RES, V25, P217, DOI 10.1007/BF02010772
   Josset Y, 2000, KEY ENG MAT, V192-1, P329
   KARLSSON KH, 1989, J NON-CRYST SOLIDS, V112, P69, DOI 10.1016/0022-3093(89)90495-X
   KAWAHARA H, 1980, J BIOMED MATER RES, V14, P597, DOI 10.1002/jbm.820140506
   KEREBEL B, 1976, J ULTRA MOL STRUCT R, V57, P266, DOI 10.1016/S0022-5320(76)80116-5
   KOKUBO T, 1986, J MATER SCI, V21, P536, DOI 10.1007/BF01145520
   KOKUBO T, 1993, 3 EUROCERAMICS, V3, P1
   Kokubo T., 1993, INTRO BIOCERAMICS, P75
   Kurz W., 1984, FUNDAMENTAL SOLIDIFI
   Lancaster JG, 1997, P I MECH ENG H, V211, P17, DOI 10.1243/0954411971534647
   Lee SY, 2000, BIOMATERIALS, V21, P1315, DOI 10.1016/S0142-9612(99)00217-3
   LEGEROS RZ, 1993, INTRO BIOCERAMICS, P139
   LEWANDOWSKASZUMIEL, 1997, J MATER SCI-MATER M, V8, P485
   Miake Y, 1995, J DENT RES, V74, P1756, DOI 10.1177/00220345950740110701
   *MIN SANTE FAM PER, 2002, J OFFICIEL NOR  0722
   Mitura S, 1996, DIAM RELAT MATER, V5, P1185, DOI 10.1016/0925-9635(95)00525-0
   NEO M, 1992, J BIOMED MATER RES, V26, P255, DOI 10.1002/jbm.820260210
   Nkamgueu EM, 2000, J BIOMED MATER RES, V52, P587, DOI 10.1002/1097-4636(20001215)52:4<587::AID-JBM2>3.3.CO;2-T
   NONAMI T, 1995, J SOC MAT ENG RESOUR, V8, P12
   NURSE RW, 1969, J CHEM SOC, P1077
   OHURA K, 1992, J MATER SCI-MATER M, V3, P95, DOI 10.1007/BF00705275
   PASCUAL C, 1983, J AM CERAM SOC, V66, P23, DOI 10.1111/j.1151-2916.1983.tb09961.x
   PERNOT F, 1979, J MATER SCI, V14, P1694, DOI 10.1007/BF00569292
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   ROY DM, 1974, NATURE, P274
   SANTOS C, 1994, THESIS U SANTIAGO SP
   Sarmento C, 2004, J BIOMED MATER RES A, V69A, P351, DOI 10.1002/jbm.a.30012
   Schulte W, 1984, QUINTESSENCE INT, V15, P1
   Sedel L, 2000, KEY ENG MAT, V192-1, P969
   Serra E, 2002, BIOMATERIALS, V23, P1131, DOI 10.1016/S0142-9612(01)00227-7
   Shackelford JF, 1999, MATER SCI FORUM, V293, P99, DOI 10.4028/www.scientific.net/MSF.293.99
   Sivakumar M, 1996, BIOMATERIALS, V17, P1709, DOI 10.1016/0142-9612(96)87651-4
   Stevens R., 1986, INTRO ZIRCONIA
   TAEISHI T, 1987, B MECH ENG LAB, V45, P1
   TENCER AF, 1990, HDB BIOACTIVE CERAMI, V2, P209
   Vallet-Regis M., 2001, J CHEM SOC DA, V2, P97
   Van der Woude A., 1980, P INT C IMPLANTOLOGY, P157
   Villora JM, 2002, BOL SOC ESP CERAM V, V41, P443, DOI 10.3989/cyv.2002.v41.i5.663
   WELCH JH, 1961, J CHEM SOC, P4442, DOI 10.1039/jr9610004442
   Williams D. F., 1987, DEFINITIONS BIOMATER
   WILLIAMS DF, 1987, J MATER SCI, V22, P3421, DOI 10.1007/BF01161439
   Williams DF., 1985, BIOCOMPATIBILITY TIS, VII, P43
   YAMAGAMI A, 1988, P 1 INT S CER MED, P332
   Young RA, 1975, C INT CNRS, V230, P21
   YUBAO L, 1994, J MAT SCI MAT ME, P26
   2000, ENCY BRITANICA MICRO, V12, P324
NR 116
TC 60
Z9 62
U1 1
U2 44
PU SOCIEDAD ESPANOLA CERAMICA VIDRIO
PI MADRID
PA ANTIGUA CTRA MADRID-VALENCIA, KM 24,300, ARGANDA DEL REY, 28500 MADRID,
   SPAIN
SN 0366-3175
J9 BOL SOC ESP CERAM V
JI Bol. Soc. Esp. Ceram. Vidr.
PD MAY-JUN
PY 2005
VL 44
IS 3
BP 135
EP 145
DI 10.3989/cyv.2005.v44.i3.382
PG 11
WC Materials Science, Ceramics
SC Materials Science
GA 936ZW
UT WOS:000229895300002
DA 2018-10-19
ER

PT J
AU Ho, C
   Soolaman, DM
   Yu, HZ
AF Ho, C
   Soolaman, DM
   Yu, HZ
TI 2004 Fred Beamish Award Lecture - Analytical - materials chemistry on
   old CDs - Beyond self-assembly
SO CANADIAN JOURNAL OF CHEMISTRY-REVUE CANADIENNE DE CHIMIE
LA English
DT Article
DE compact disc-recordable (CD-R); self-assembled monolayers (SAMs);
   electrochemical analysis; material micro- and (or) nanostructures;
   biomedical diagnosis
ID ELECTRON-TRANSFER KINETICS; ZIRCONIA THIN-FILMS; GOLD ELECTRODES;
   RECORDABLE CDS; AMPEROMETRIC DETERMINATION; COMPACT DISCS; FLOW CELL;
   MONOLAYERS; FABRICATION; MICROARRAYS
AB This review describes a variety of new chemistry that has been established in our research laboratory and by other scientists worldwide related to optical compact disc (CD) technology. In particular, we have discovered that gold substrates from CD-Rs can be used to prepare high-quality, self-assembled monolayers (SAMs) after removing the protective polymer films with concentrated nitric acid. It was proven that these substrates are feasible for electrochemical, spectroscopic, and surface wetting studies. We have also demonstrated that CD-R gold films are ideal micropatterned conductive substrates for the "customized" fabrication of material microstructures. In addition, we have been working on the micropatterning of DNA probes on CD-R substrates, and exploring the possibility of using the CD-R writing/reading system for biochip fabrication and gene analysis.
C1 Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada.
RP Yu, HZ (reprint author), Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada.
EM hzyu@sfu.ca
CR Alexandre I, 2002, BIOTECHNIQUES, V33, P435, DOI 10.2144/02332pf01
   Alexandre I, 2001, ANAL BIOCHEM, V295, P1, DOI 10.1006/abio.2001.5176
   Angnes L, 2000, ANAL CHEM, V72, P5503, DOI 10.1021/ac000437p
   Banks JT, 2002, J PHYS CHEM B, V106, P3538, DOI 10.1021/jp013970x
   Birkett D, 2002, J CHEM EDUC, V79, P1081, DOI 10.1021/ed079p1081
   CHAIM R, 1991, J ELECTROCHEM SOC, V138, P1942, DOI 10.1149/1.2085905
   Daniel D, 2003, ELECTROCHEM COMMUN, V5, P782, DOI 10.1016/j.elecom.2003.07.004
   Daniel D, 2001, ELECTROANAL, V13, P681, DOI 10.1002/1521-4109(200105)13:8/9<681::AID-ELAN681>3.0.CO;2-F
   Drummond TG, 2003, NAT BIOTECHNOL, V21, P1192, DOI 10.1038/nbt873
   FINKLEA HO, 1992, J AM CHEM SOC, V114, P3173, DOI 10.1021/ja00035a001
   FOJTA M, 2002, ELECTROANAL, V14, P1149
   Hamels S, 2001, BIOTECHNIQUES, V31, P1364, DOI 10.2144/01316md04
   Hazarika P, 2003, LAB CHIP, V3, P128, DOI 10.1039/b302563m
   Helt JM, 2004, J AM CHEM SOC, V126, P628, DOI 10.1021/ja035142i
   Khoshtariya DE, 2003, J AM CHEM SOC, V125, P7704, DOI 10.1021/ja034719t
   Kido H, 2000, ANAL CHIM ACTA, V411, P1, DOI 10.1016/S0003-2670(00)00776-5
   KUHN KJ, 2003, AUDIO COMPACT DISK I
   KUMAR A, 1993, APPL PHYS LETT, V63, P2002, DOI 10.1063/1.110628
   La Clair JJ, 2003, ORG BIOMOL CHEM, V1, P3244, DOI 10.1039/b306391g
   Lai S, 2004, ANAL CHEM, V76, P1832, DOI 10.1021/ac0348322
   Madou MJ, 2001, BIOMED MICRODEVICES, V3, P245, DOI 10.1023/A:1011419515576
   Munoz RAA, 2001, J PHARM SCI, V90, P1972, DOI 10.1002/jps.1148
   PICKNETT RG, 1977, J COLLOID INTERF SCI, V61, P336, DOI 10.1016/0021-9797(77)90396-4
   Pohlman Kenneth, 1992, COMPACT DISC HDB
   Richter EM, 2000, FRESEN J ANAL CHEM, V366, P444, DOI 10.1007/s002160050090
   Richter EM, 2003, QUIM NOVA, V26, P839, DOI 10.1590/S0100-40422003000600011
   Richter EM, 2001, ELECTROANAL, V13, P760, DOI 10.1002/1521-4109(200105)13:8/9<760::AID-ELAN760>3.0.CO;2-N
   SAKAI H, 1998, LANGMUIR, V14, P2008
   Shacham R, 2004, CHEM-EUR J, V10, P1936, DOI 10.1002/chem.200305469
   Su L, 2004, ANAL CHEM, V76, P5953, DOI 10.1021/ac0494331
   Templeton AC, 2000, ACCOUNTS CHEM RES, V33, P27, DOI 10.1021/ar9602664
   Therese GHA, 2000, CHEM MATER, V12, P1195, DOI 10.1021/cm990447a
   Ulman A., 1991, INTRO ULTRATHIN ORGA
   Vercoutere W, 2002, CURR OPIN CHEM BIOL, V6, P816, DOI 10.1016/S1367-5931(02)00395-2
   Westbroek P, 2002, ANAL CHEM, V74, P915, DOI 10.1021/ac0104072
   Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153
   Yu HZ, 2004, CHEM COMMUN, P2633, DOI 10.1039/b412784f
   Yu HZ, 2004, CHEMPHYSCHEM, V5, P1035, DOI 10.1002/cphc.200301042
   Yu HZ, 2003, ANAL CHEM, V75, P3902, DOI 10.1021/ac034318w
   Yu HZ, 2002, ANAL CHEM, V74, P5742, DOI 10.1021/ac025686n
   Yu HZ, 2001, ANAL CHEM, V73, P4743, DOI 10.1021/ac015521z
   Yu HZ, 1996, LANGMUIR, V12, P2843, DOI 10.1021/la950632c
NR 42
TC 5
Z9 7
U1 0
U2 8
PU NATL RESEARCH COUNCIL CANADA
PI OTTAWA
PA RESEARCH JOURNALS, MONTREAL RD, OTTAWA, ONTARIO K1A 0R6, CANADA
SN 0008-4042
J9 CAN J CHEM
JI Can. J. Chem.-Rev. Can. Chim.
PD MAY
PY 2005
VL 83
IS 5
BP 403
EP 412
DI 10.1139/V05-006
PG 10
WC Chemistry, Multidisciplinary
SC Chemistry
GA 930KO
UT WOS:000229414900001
DA 2018-10-19
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Engineering biomedical materials from corn and wool
SO CHEMICAL ENGINEERING PROGRESS
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER INST CHEMICAL ENGINEERS
PI NEW YORK
PA 3 PARK AVE, NEW YORK, NY 10016-5901 USA
SN 0360-7275
EI 1945-0710
J9 CHEM ENG PROG
JI Chem. Eng. Prog.
PD MAY
PY 2005
VL 101
IS 5
BP 10
EP 11
PG 2
WC Engineering, Chemical
SC Engineering
GA 926XA
UT WOS:000229155800009
DA 2018-10-19
ER

PT J
AU Hollaus, K
   Biro, O
   Gerstenberger, C
   Preis, K
   Stollberger, R
   Wagner, B
AF Hollaus, K
   Biro, O
   Gerstenberger, C
   Preis, K
   Stollberger, R
   Wagner, B
TI Effect of stray capacitances on bio-impedances in quasi-static electric
   field
SO IEEE TRANSACTIONS ON MAGNETICS
LA English
DT Article; Proceedings Paper
CT 11th IEEE Biennial Conference on Electromagnetic Field Computation
CY JUN 06-09, 2004
CL Seoul, SOUTH KOREA
SP IEEE Magnet Soc, Seoul Natl Univ
DE biomedical computing; capacitance; dielectric materials; electric
   fields; finite-element method
ID HZ
AB Evaluating bio-impedances, inevitable stray capacitances have considerable impact on the measurement data. If the stray capacitances are not considered when simulating the electric impedance tomography problem, incorrect conductivities are reconstructed. To study the effect of the stray capacitances, a finite-element model of a test person in surroundings exposed to a quasi-static electric field is used to simulate the measuring setup. Results clearly demonstrate that the displacement currents at high frequencies in air have to be modeled appropriately.
C1 IGTE, Inst Fundamentals & Theory Elect Engn, A-8010 Graz, Austria.
RP Hollaus, K (reprint author), IGTE, Inst Fundamentals & Theory Elect Engn, A-8010 Graz, Austria.
RI Biro, Oszkar/F-9812-2015
OI Biro, Oszkar/0000-0003-0792-8955
CR Gabriel S, 1996, PHYS MED BIOL, V41, P2251, DOI 10.1088/0031-9155/41/11/002
   HOLLAUS K, 2003, P 72 ICB SEM REC ACH
   KANAI H, 1987, MED PROG TECHNOL, V12, P159
   Morucci JP, 1996, CRIT REV BIOMED ENG, V24, P599, DOI 10.1615/CritRevBiomedEng.v24.i4-6.50
   ROSELL J, 1988, IEEE T BIO-MED ENG, V35, P649, DOI 10.1109/10.4599
   Scharfetter H, 1998, PHYSIOL MEAS, V19, P247, DOI 10.1088/0967-3334/19/2/012
   Webster JG, 1990, ELECT IMPEDANCE TOMO
   ZIENKIEWICZ OC, 1994, FINITE ELEMENT METHO
NR 8
TC 1
Z9 2
U1 1
U2 3
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 0018-9464
J9 IEEE T MAGN
JI IEEE Trans. Magn.
PD MAY
PY 2005
VL 41
IS 5
BP 1940
EP 1943
DI 10.1109/TMAG-2005.846218
PG 4
WC Engineering, Electrical & Electronic; Physics, Applied
SC Engineering; Physics
GA 925WN
UT WOS:000229084200147
DA 2018-10-19
ER

PT J
AU Kim, SY
   Park, J
   Kwon, DS
AF Kim, SY
   Park, J
   Kwon, DS
TI The real-time haptic simulation of a biomedical volumetric object with
   shape-retaining chain linked model
SO IEICE TRANSACTIONS ON INFORMATION AND SYSTEMS
LA English
DT Article
DE medical simulation; modeling; haptic; biomedical volumetric object;
   virtual reality
ID SURGERY SIMULATION; FORCE
AB This paper presents a new model which computes the deformation and the feedback force of high-resolution biomedical volumetric objects consisting of hundreds of thousands of volume elements. The main difficulty in the simulation of these high-resolution volumetric objects is to compute and generate stable feedback force from the objects within a haptic update time (1 msec). In our model, springs are used in order to represent material properties of volume elements and cylinders are used to activate corresponding springs according to the amount of deformation. Unlike in a mass-spring model, springs in our model have constraint conditions. In our model, the deformation is calculated locally and then is propagated outward through object's volume as if a chain is pulled or pushed. The deformed configuration is then used to compute the object's internal potential energy that is reflected to the user. The simple nature of our model allows the much faster calculation of the deformation and the feedback force from the volumetric deformable object than the conventional model (an FEM or a mass-spring model). Experiments are conducted with homogenous and non-homogenous volumetric cubic objects and a volumetric human liver model obtained from CT data at a haptic update rate of 1000 Hz and a graphic update rate of 100 Hz to show that our model can be utilized in the real-time volume haptic rendering. We verify that our model provides a realistic haptic feeling for the user in real time through comparative study.
C1 Informat & Commun Univ, Sch Engn, Taejon, South Korea.
   Korea Adv Inst Sci & Technol, Dept ME, Taejon 305701, South Korea.
EM sangyoun7.kim@samsung.com; jinah@icu.ac.kr; kwonds@kaist.ac.kr
RI Park, Jinah/I-6949-2016; Kwon, Dong-Soo/C-1540-2011
OI Park, Jinah/0000-0003-4676-9862; 
CR Astley OR, 1998, IEEE INT CONF ROBOT, P989, DOI 10.1109/ROBOT.1998.677216
   BALANIUK R, 2003, INT S SURG SIMULATIO, P48
   BASDOGAN C, 2002, HDB VIRTUAL ENV, pCH6
   Bro-Nielsen M, 1998, P IEEE, V86, P490, DOI 10.1109/5.662874
   CAVUSOGLU MC, 2000, IEEE INT C ROB AUT, P2458
   Costa IF, 2001, IEEE INT CONF ROBOT, P2337, DOI 10.1109/ROBOT.2001.932971
   Cotin S, 1999, IEEE T VIS COMPUT GR, V5, P62, DOI 10.1109/2945.764872
   CUGINI U, 1999, EUROGRAPHICS99 STAT
   DAULIGNAC R, 2000, IEEE INT C ROB AUT, P2452
   Frisken-Gibson SF, 1999, IEEE T VIS COMPUT GR, V5, P333, DOI 10.1109/2945.817350
   HANNAFORD B, 2001, P USC WORKSH HAPT IN
   Ho CH, 2000, INT J ROBOT RES, V19, P668
   Jones L.A., 2000, KINESTHETIC SENSING
   JONES LA, 1986, PSYCHOL BULL, V100, P29, DOI 10.1037/0033-2909.100.1.29
   KIM SY, 2003, INT S SURG SIM SOFT, P108
   Kruse SA, 2000, PHYS MED BIOL, V45, P1579, DOI 10.1088/0031-9155/45/6/313
   MASS H, 1999, 13 INT C COMP ASS RA, P865
   Mendoza CA, 2001, P IEEE VIRT REAL ANN, P264, DOI 10.1109/VR.2001.913795
   Nedel LP, 1998, COMPUTER GRAPHICS INTERNATIONAL, PROCEEDINGS, P156, DOI 10.1109/CGI.1998.694263
   Park J, 2002, IEEE/ACM SIGGRAPH SYMPOSIUM ON VOLUME VISUALIZATION AND GRAPHICS 2002, PROCEEDINGS, P65, DOI 10.1109/SWG.2002.1226511
   PARK J, 2004, INT S MED SIM CAMBR, P144
   Picinbono G, 2001, IEEE INT CONF ROBOT, P1370, DOI 10.1109/ROBOT.2001.932801
   Tokumoto S, 1999, ICRA '99: IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOLS 1-4, PROCEEDINGS, P767, DOI 10.1109/ROBOT.1999.770067
   Wu XL, 2001, COMPUT GRAPH FORUM, V20, pC349
   Zilles C., 1995, IEEE INT C INT ROB S, V3, P146, DOI DOI 10.1109/IROS.1995.525876
NR 25
TC 11
Z9 12
U1 0
U2 1
PU IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG
PI TOKYO
PA KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011,
   JAPAN
SN 1745-1361
J9 IEICE T INF SYST
JI IEICE Trans. Inf. Syst.
PD MAY
PY 2005
VL E88D
IS 5
BP 1012
EP 1020
DI 10.1093/ietisy/e88-d.5.1012
PG 9
WC Computer Science, Information Systems; Computer Science, Software
   Engineering
SC Computer Science
GA 928EF
UT WOS:000229253200030
DA 2018-10-19
ER

PT J
AU Gou, ZG
   Chang, J
   Zhai, WY
   Wang, JY
AF Gou, ZG
   Chang, J
   Zhai, WY
   Wang, JY
TI Study on the self-setting property and the in vitro bioactivity of
   beta-Ca2SiO4
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE beta-dicalcium silicate; self-setting; bioactivity; injectability; cell
   proliferation; bone cement
ID BETA-DICALCIUM SILICATE; LOADED BONE-CEMENT; HUMAN OSTEOBLASTS; CALCIUM
   PHOSPHATES; IONIC PRODUCTS; EXPRESSION; HYDRATION; BEHAVIOR; RELEASE;
   REPAIR
AB This study sought to investigate the physical and chemical properties of &beta;-dicalcium silicate (&beta;-Ca2SiO4) in order to evaluate its use as an injectable bioactive cement filler. Workable &beta;-Ca2SiO4 pastes with a liquid-to-powder (LIP) ratio of 1.0-1.2 could be injected for 10-30 min (nozzle diameter 2.0 mm) and enabled initial setting times of 60-180 min. The setting process yielded cellular structures with compressive strengths of 4.8-28.8 MPa after 2-28 days. The paste was soaked in simulated body fluid (SBF), and the results demonstrated that it exhibited a moderate degradation and could induce carbonated hydroxyapatite formation. The ionic products of the paste dissolution enhanced a proliferative response of fibroblasts compared with the cells cultured alone, and this cement could also support adhesion and spreading of the mesenchymal stem cells. Finally, with the use of gentamicin as a model drug, it was found that a high dose of drug release from the paste was maintained for 14 days, and there was a sustained release over 4 weeks. This combination of properties indicates that the novel &beta;-Ca2SiO4 cement might be suitable for potential applications in the biomedical field, preferentially as materials for bone/dental repair and controlled drug-delivery systems. &COPY; 2005 Wiley Periodicals, Inc.
C1 Chinese Acad Sci, Shanghai Inst Ceram, Biomat & Tissue Engn Res Ctr, Shanghai 200050, Peoples R China.
   Chinese Acad Sci, Grad Sch, Shanghai 200050, Peoples R China.
   E China Normal Univ, Sch Biol Sci, Shanghai 200062, Peoples R China.
RP Chang, J (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, Biomat & Tissue Engn Res Ctr, Dingxi Rd 1295, Shanghai 200050, Peoples R China.
EM jchang@mail.sic.ac.cn
CR Blom EJ, 2000, J BIOMED MATER RES, V50, P67, DOI 10.1002/(SICI)1097-4636(200004)50:1<67::AID-JBM10>3.0.CO;2-E
   BOHNER M, 2002, P 17 EUR C BIOM BARC, P124
   BORDER WA, 1992, J CLIN INVEST, V90, P1, DOI 10.1172/JCI115821
   BRUNAUER S, 1958, J AM CHEM SOC, V80, P761, DOI 10.1021/ja01537a001
   CARLISLE EM, 1970, SCIENCE, V167, P279, DOI 10.1126/science.167.3916.279
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   Constantz BR, 1998, J BIOMED MATER RES, V43, P451, DOI 10.1002/(SICI)1097-4636(199824)43:4<451::AID-JBM13>3.0.CO;2-Q
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   FUJII K, 1979, J AM CERAM SOC, V62, P16
   FUJITA Y, 1991, J BIOMED MATER RES, V25, P991, DOI 10.1002/jbm.820250806
   GHOSH SN, 1979, J MATER SCI, V14, P1554, DOI 10.1007/BF00569274
   GIBSON IR, 1999, P 12 INT S CER MED N, P191
   Gou ZG, 2004, J EUR CERAM SOC, V24, P93, DOI 10.1016/S0955-2219(03)00320-0
   Gough JE, 2004, BIOMATERIALS, V25, P2039, DOI 10.1016/j.biomaterials.2003.07.001
   Hench LL, 1996, LIFE CHEM REPORTS, V13, P187
   Hendriks JGE, 2004, BIOMATERIALS, V25, P545, DOI 10.1016/S0142-9612(03)00554-4
   HOLLINGER JO, 1986, CLIN ORTHOP RELAT R, P290
   Hong SH, 1999, J AM CERAM SOC, V82, P1681, DOI 10.1111/j.1151-2916.1999.tb01986.x
   Ijima T., 1992, GYPSUM LIME, V238, P159
   ISHIDA H, 1992, J AM CERAM SOC, V75, P359, DOI 10.1111/j.1151-2916.1992.tb08187.x
   Ishida H., 1992, J AM CERAM SOC, V72, P2779
   JAWED I, 1983, STRUCTURE PERFORMANC, P237
   Kamegai Akihide, 1994, Bio-Medical Materials and Engineering, V4, P291
   Kenny SM, 2003, J MATER SCI-MATER M, V14, P923, DOI 10.1023/A:1026394530192
   Khairoun I, 1998, J MATER SCI-MATER M, V9, P425, DOI 10.1023/A:1008811215655
   Knabe C, 2004, J BIOMED MATER RES A, V69A, P145, DOI 10.1002/jbm.a.20131
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   KOKUBO T, 1992, BONE BONDING BIOMATE, P31
   Laffargue P, 2000, J BIOMED MATER RES, V49, P415, DOI 10.1002/(SICI)1097-4636(20000305)49:3<415::AID-JBM15>3.3.CO;2-Q
   Li YW, 2000, J BIOMED MATER RES, V52, P164, DOI 10.1002/1097-4636(200010)52:1<164::AID-JBM21>3.0.CO;2-R
   LIDGREN L, 2002, Patent No. 2002005861
   Liu XY, 2002, BIOMATERIALS, V23, P963, DOI 10.1016/S0142-9612(01)00210-1
   Lu J. X., 1999, BONE S, V25, P41
   Malafaya PB, 2002, CURR OPIN SOLID ST M, V6, P283, DOI 10.1016/S1359-0286(02)00075-X
   MASRI BA, 1995, J ARTHROPLASTY, V10, P453, DOI 10.1016/S0883-5403(05)80145-7
   Ohura K, 1999, J BIOMED MATER RES, V44, P168, DOI 10.1002/(SICI)1097-4636(199902)44:2<168::AID-JBM7>3.0.CO;2-4
   Patel N, 2002, J MATER SCI-MATER M, V13, P1199, DOI 10.1023/A:1021114710076
   Phan PV, 2003, J BIOMED MATER RES A, V67A, P1001, DOI 10.1002/jbm.a.10162
   Pittet C, 2000, J BIOMED MATER RES, V53, P769, DOI 10.1002/1097-4636(2000)53:6<769::AID-JBM19>3.0.CO;2-P
   Ringe J, 2002, CELL TISSUE RES, V307, P321, DOI 10.1007/s00441-002-0525-z
   Sarda S, 2001, J MATER SCI-MATER M, V12, P905, DOI 10.1023/A:1012832325957
   Schildhauer TA, 1999, J ORTHOPAED RES, V17, P67, DOI 10.1002/jor.1100170111
   SCHWARZ K, 1972, NATURE, V239, P333, DOI 10.1038/239333a0
   Silver IA, 2003, MATERIALWISS WERKST, V34, P1069, DOI 10.1002/mawe.200300710
   Sivakumar M, 2002, BIOMATERIALS, V23, P3175, DOI 10.1016/S0142-9612(02)00066-2
   TAYLOR HFW, 1950, J CHEM SOC, P3682, DOI 10.1039/jr9500003682
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   Yoshikawa T, 2001, MAT SCI ENG C-BIO S, V17, P19, DOI 10.1016/S0928-4931(01)00330-7
   ZHANG XC, 1994, J PHARM PHARMACOL, V46, P718, DOI 10.1111/j.2042-7158.1994.tb03890.x
   CHUNG HUA KOU CHIANG, V25, P216
NR 51
TC 64
Z9 65
U1 4
U2 24
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD MAY
PY 2005
VL 73B
IS 2
BP 244
EP 251
DI 10.1002/jbm.b.30203
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 923UR
UT WOS:000228935300006
PM 15793821
DA 2018-10-19
ER

PT J
AU Neuberger, T
   Schopf, B
   Hofmann, H
   Hofmann, M
   von Rechenberg, B
AF Neuberger, T
   Schopf, B
   Hofmann, H
   Hofmann, M
   von Rechenberg, B
TI Superparamagnetic nanoparticles for biomedical applications:
   Possibilities and limitations of a new drug delivery system
SO JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS
LA English
DT Article; Proceedings Paper
CT 5th International Conference on Scientific and Clinical Applications of
   Magnetic Carriers
CY MAY 20-22, 2004
CL Lyon, FRANCE
DE superparamagnetic iron oxide nanoparticles (SPION); nanoparticles;
   magnetic drug targeting (MDT); immunomagnetic cell sorting (IMS);
   magnetic hyperthermia; toxicity; hyperthermia; review; contrast agent;
   nanoparticle functionalization; nanoparticle application
ID IRON-OXIDE NANOPARTICLES; MAGNETIC FLUID HYPERTHERMIA; IN-VIVO; PROTEIN
   ADSORPTION; CONTRAST AGENTS; TRIAMCINOLONE ACETONIDE; HYPERLIPIDEMIC
   RABBITS; ACID) NANOPARTICLES; POLYMER PARTICLES; CANCER-TREATMENT
AB Nanoparticles can be used in biomedical applications, where they facilitate laboratory diagnostics, or in medical drug targeting. They are used for in vivo applications such as contrast agent for magnetic resonance imaging (MRI), for tumor therapy or cardiovascular disease. Very promising nanoparticles for these applications are superparamagnetic nanoparticles based on a core consisting of iron oxides (SPION) that can be targeted through external magnets. SPION are coated with biocompatible materials and can be functionalized with drugs, proteins or plasmids. In this review, the characteristics and applications of SPION in the biomedical sector are introduced and discussed. (c) 2005 Elsevier B.V. All rights reserved.
C1 Univ Zurich, Fac Vet, Musculoskeletal Res Unit, CH-8057 Zurich, Switzerland.
   Ecole Polytech Fed Lausanne, Swiss Fed Inst Technol, Inst Mat, Lab Powder Technol, CH-1015 Lausanne, Switzerland.
   MatSearch Pully, CH-1009 Pully, Switzerland.
RP von Rechenberg, B (reprint author), Univ Zurich, Fac Vet, Musculoskeletal Res Unit, Winterthurerstr 260, CH-8057 Zurich, Switzerland.
EM bvonrechenberg@vetclinics.unizh.ch
RI Xu, Qingguo/C-1962-2014
OI Xu, Qingguo/0000-0003-3191-0771
CR Abe Y, 2000, Radiat Med, V18, P97
   Alexiou C, 2000, CANCER RES, V60, P6641
   Allen LM, 1997, SCIENTIFIC AND CLINICAL APPLICATIONS OF MAGNETIC CARRIERS, P481
   Altman RD, 1998, OSTEOARTHR CARTILAGE, V6, P22, DOI 10.1016/S1063-4584(98)80007-1
   Armstrong TI, 1997, J DRUG TARGET, V4, P389, DOI 10.3109/10611869709017896
   Artemov D, 2003, MAGNET RESON MED, V49, P403, DOI 10.1002/mrm.10406
   Babes L, 1999, J COLLOID INTERF SCI, V212, P474, DOI 10.1006/jcis.1998.6053
   Bacri JC, 1997, SCIENTIFIC AND CLINICAL APPLICATIONS OF MAGNETIC CARRIERS, P597
   Barratt G, 2003, CELL MOL LIFE SCI, V60, P21, DOI 10.1007/s000180300002
   Barratt G., 2002, POLYM BIOMATERIALS, P753
   BAZILE DV, 1992, BIOMATERIALS, V13, P1093, DOI 10.1016/0142-9612(92)90142-B
   BECK PH, 1993, THESIS J W GOETHE U
   Beckmann N, 2003, MAGNET RESON MED, V49, P459, DOI 10.1002/mrm.10387
   Blankenstein G, 1997, SCIENTIFIC AND CLINICAL APPLICATIONS OF MAGNETIC CARRIERS, P233
   BLUNK T, 1993, ELECTROPHORESIS, V14, P1382, DOI 10.1002/elps.11501401214
   BLUNK T, 1994, THESIS U KIEL
   Bonnemann H, 2001, EUR J INORG CHEM, P2455
   Borchard G, 1993, J DRUG TARGET, V1, P15, DOI 10.3109/10611869308998760
   Borchard G, 1996, PHARMACEUT RES, V13, P1055, DOI 10.1023/A:1016010808522
   BORCHARD G, 1993, THESIS J W GOETHE U
   Bordat C, 2000, J MAGN RESON IMAGING, V12, P505, DOI 10.1002/1522-2586(200009)12:3<505::AID-JMRI18>3.0.CO;2-A
   Bosnes M, 1997, SCIENTIFIC AND CLINICAL APPLICATIONS OF MAGNETIC CARRIERS, P269
   Brauer M, 2003, PROG NEURO-PSYCHOPH, V27, P323, DOI 10.1016/S0278-5846(03)00026-5
   Bulte JWM, 1997, SCIENTIFIC AND CLINICAL APPLICATIONS OF MAGNETIC CARRIERS, P527
   CANET E, 1995, AM HEART J, V130, P949, DOI 10.1016/0002-8703(95)90193-0
   Chalmers JJ, 1998, BIOTECHNOL PROGR, V14, P141, DOI 10.1021/bp970140l
   CHAMBON C, 1993, MAGN RESON IMAGING, V11, P509, DOI 10.1016/0730-725X(93)90470-X
   CHAN DCF, 1993, J MAGN MAGN MATER, V122, P374
   Chan DCF, 1997, SCIENTIFIC AND CLINICAL APPLICATIONS OF MAGNETIC CARRIERS, P607
   Chastellain M, 2004, ADV ENG MATER, V6, P235, DOI 10.1002/adem.200300574
   Chouly C, 1996, J MICROENCAPSUL, V13, P245, DOI 10.3109/02652049609026013
   Dardzinski BJ, 2001, MAGN RESON IMAGING, V19, P1209, DOI 10.1016/S0730-725X(01)00448-9
   DAVIS S S, 1986, Acta Pharmaceutica Technologica, V32, P4
   Davis SS, 1997, TRENDS BIOTECHNOL, V15, P217, DOI 10.1016/S0167-7799(97)01036-6
   Dodd CH, 2001, J IMMUNOL METHODS, V256, P89, DOI 10.1016/S0022-1759(01)00433-1
   Dousset V, 1999, MAGNET RESON MED, V41, P329, DOI 10.1002/(SICI)1522-2594(199902)41:2<329::AID-MRM17>3.0.CO;2-Z
   Ehrlich P, 1906, COLLECTED STUDIES IM
   EVERETT ED, 1991, PERITON DIALYSIS INT, V11, P206
   Fattal E., 1993, STP PHARMA SCI, V3, P11
   Fleige G, 2001, NEOPLASIA, V3, P489, DOI 10.1038/sj.neo.7900176
   Frisbie DD, 1997, EQUINE VET J, V29, P349, DOI 10.1111/j.2042-3306.1997.tb03138.x
   FUSSEL F, 1997, THESIS TECHNISCHE HO
   Gruttner C, 1999, J MAGN MAGN MATER, V194, P8, DOI 10.1016/S0304-8853(98)00561-7
   GUIMARAES R, 1994, AM J ROENTGENOL, V162, P201, DOI 10.2214/ajr.162.1.8273666
   Hilger I, 2001, RADIOLOGY, V218, P570, DOI 10.1148/radiology.218.2.r01fe19570
   HSU MJ, 1982, BIOCHIM BIOPHYS ACTA, V720, P411, DOI 10.1016/0167-4889(82)90120-3
   Johansson LO, 2001, J MAGN RESON IMAGING, V13, P615, DOI 10.1002/jmri.1086
   Jordan A, 1999, J MAGN MAGN MATER, V194, P185, DOI 10.1016/S0304-8853(98)00558-7
   Jordan A, 1999, J MAGN MAGN MATER, V201, P413, DOI 10.1016/S0304-8853(99)00088-8
   Jordan A, 1997, SCIENTIFIC AND CLINICAL APPLICATIONS OF MAGNETIC CARRIERS, P569
   Jordan A, 2001, J MAGN MAGN MATER, V225, P118, DOI 10.1016/S0304-8853(00)01239-7
   KARINO A, 1987, J PHARM SCI, V76, pS273
   Kawcak CE, 1998, EQUINE VET J, V30, P66, DOI 10.1111/j.2042-3306.1998.tb04090.x
   Kim DK, 2003, CHEM MATER, V15, P1617, DOI 10.1021/cm021349j
   Kissel T, 1991, P INT S CONTR REL BI, V18, P275
   Krause M, 2002, OPHTHALMIC RES, V34, P241, DOI 10.1159/000063883
   Kresse M, 1997, SCIENTIFIC AND CLINICAL APPLICATIONS OF MAGNETIC CARRIERS, P545
   KREUTER J, 1983, PHARM ACTA HELV, V58, P196
   KREUTER J, 1981, THESIS FEDERAL I TEC
   KREUTER J, 1985, DRUG TARGETING
   Kroft LJM, 1998, MAGN RESON IMAGING, V16, P755, DOI 10.1016/S0730-725X(98)00091-5
   Kuznetsov AA, 1997, SCIENTIFIC AND CLINICAL APPLICATIONS OF MAGNETIC CARRIERS, P379
   Lacava ZGM, 1999, J MAGN MAGN MATER, V194, P90, DOI 10.1016/S0304-8853(98)00583-6
   Lacava ZGM, 1999, J MAGN MAGN MATER, V201, P431, DOI 10.1016/S0304-8853(99)00002-5
   Laissy J P, 2000, J Magn Reson Imaging, V12, P278, DOI 10.1002/1522-2586(200008)12:2<278::AID-JMRI10>3.0.CO;2-V
   LEROUX JC, 1995, LIFE SCI, V57, P695, DOI 10.1016/0024-3205(95)00321-V
   Lewin M, 2000, NAT BIOTECHNOL, V18, P410
   Liberti PA, 2001, J MAGN MAGN MATER, V225, P301, DOI 10.1016/S0304-8853(00)01254-3
   Lind K, 2002, J DRUG TARGET, V10, P221, DOI 10.1080/10611860290022651
   Litovsky S, 2003, CIRCULATION, V107, P1545, DOI 10.1161/01.CIR.0000055323.57885.88
   Lubbe AS, 1996, CANCER RES, V56, P4686
   Lubbe AS, 1997, SCIENTIFIC AND CLINICAL APPLICATIONS OF MAGNETIC CARRIERS, P457
   Lubbe AS, 2001, J SURG RES, V95, P200, DOI 10.1006/jsre.2000.6030
   Lubbe AS, 1999, J MAGN MAGN MATER, V194, P149, DOI 10.1016/S0304-8853(98)00574-5
   LUCK M, 1997, THESIS FU BERLIN
   MAHMUDOV SY, 1997, SCI CLIN APPL MAGNET, P495
   McCloskey KE, 2001, BIOTECHNOL BIOENG, V75, P642, DOI 10.1002/bit.10040
   MENIK K, 2001, BIOTECHNOL PROGR, V17, P907
   Meza M, 1997, SCIENTIFIC AND CLINICAL APPLICATIONS OF MAGNETIC CARRIERS, P303
   Moghimi SM, 2001, PHARMACOL REV, V53, P283
   Moore A, 2000, RADIOLOGY, V214, P568, DOI 10.1148/radiology.214.2.r00fe19568
   Muller RH, 1996, J DRUG TARGET, V4, P161, DOI 10.3109/10611869609015973
   Muller RH, 1997, SCIENTIFIC AND CLINICAL APPLICATIONS OF MAGNETIC CARRIERS, P135
   MULLER RH, 1990, DAZ, V130, P1509
   Muller RH, 1996, ZETAPOTENTIAL PARTIK, V37
   MULTHOFF G, 1995, INT J CANCER, V61, P272, DOI 10.1002/ijc.2910610222
   Nanz D, 2000, MAGNET RESON MED, V43, P645, DOI 10.1002/(SICI)1522-2594(200005)43:5<645::AID-MRM5>3.0.CO;2-E
   NEUBERGER T, 2002, THESIS U ZURICH
   NORDE W, 1986, J COLLOID INTERF SCI, V112, P447, DOI 10.1016/0021-9797(86)90113-X
   NORMAN ME, 1993, BIOMATERIALS, V14, P193, DOI 10.1016/0142-9612(93)90023-U
   OLSVIK O, 1994, CLIN MICROBIOL REV, V7, P43
   OPPENHEIM RC, 1981, INT J PHARM, V8, P217, DOI 10.1016/0378-5173(81)90100-9
   Oswald P, 1997, MAGN RESON IMAGING, V15, P1025, DOI 10.1016/S0730-725X(97)00004-0
   PAPATHEOFANIS FJ, 1991, J BIOMED MATER RES, V25, P761, DOI 10.1002/jbm.820250606
   PATEL HM, 1992, CRIT REV THER DRUG, V9, P39
   POLIQUEN D, 1991, J MAGN RESON IMAGING, V9, P275
   Portet D, 2001, J COLLOID INTERF SCI, V238, P37, DOI 10.1006/jcis.2001.7500
   POSTE G, 1984, LIPOSOME TECHNOLOGY, P1
   Prestvik WS, 1997, SCIENTIFIC AND CLINICAL APPLICATIONS OF MAGNETIC CARRIERS, P11
   REIMER P, 1990, RADIOLOGY, V177, P729, DOI 10.1148/radiology.177.3.2243978
   RINCK PA, 1992, ROFO FORTSCHR RONTG, V157, P533, DOI 10.1055/s-2008-1033058
   RINCK PA, 1991, RADIOLOGY, V178, P775, DOI 10.1148/radiology.178.3.1994417
   ROGERS JM, 1994, MAGN RESON IMAGING, V12, P1161, DOI 10.1016/0730-725X(94)90081-2
   Rousseau V, 1997, MAGN RESON MATER PHY, V5, P213, DOI 10.1007/BF02594584
   Rudge S, 2001, J CONTROL RELEASE, V74, P335, DOI 10.1016/S0168-3659(01)00344-3
   RUDT S, 1992, THESIS U KIEL
   Ruehm SG, 2001, CIRCULATION, V103, P415
   Sbarbati A, 2000, NEUROIMAGE, V12, P418, DOI 10.1006/nimg.2000.0618
   Scherer F, 2002, GENE THER, V9, P102, DOI 10.1038/sj/gt/3301624
   Schmidt RF, 1995, PHYSL MENSCHEN, P515
   Schmitz SA, 2000, INVEST RADIOL, V35, P460, DOI 10.1097/00004424-200008000-00002
   Schutt W, 1999, ARTIF ORGANS, V23, P98, DOI 10.1046/j.1525-1594.1999.06278.x
   Schutt W, 1997, HYBRIDOMA, V16, P109, DOI 10.1089/hyb.1997.16.109
   SCOTT G, 1999, J MAGN MAGN MATER, V194, P132
   SENETERRE E, 1991, RADIOLOGY, V179, P529, DOI 10.1148/radiology.179.2.2014305
   Sezaki H, 1984, Crit Rev Ther Drug Carrier Syst, V1, P1
   SHINKAI M, 1995, BIOTECHNOL APPL BIOC, V21, P125, DOI 10.1111/j.1470-8744.1995.tb00329.x
   Sinclair B, 1998, SCIENTIST, V12, P16
   STROM G, 1995, ADV DRUG DELIV REV, V17, P31
   Strom V, 2004, NANOTECHNOLOGY, V15, P457, DOI 10.1088/0957-4484/15/5/009
   SUZUKI M, 1995, BIOTECHNOL APPL BIOC, V21, P335
   TANIMOTO A, 1994, JMRI-J MAGN RESON IM, V4, P653, DOI 10.1002/jmri.1880040506
   Tobin T., 1981, DRUGS PERFORMANCE HO, P132
   Torchilin VP, 2000, EUR J PHARM SCI, V11, pS81, DOI 10.1016/S0928-0987(00)00166-4
   TORCHILIN VP, 1988, HAEMOSTASIS, V18, P113
   TRELEAVEN JG, 1984, LANCET, V1, P70
   TROSTER S, 1990, THESIS J W GOETHE U
   UGELSTAD J, 1993, BLOOD PURIFICAT, V11, P349, DOI 10.1159/000170129
   UGELSTAD J, 1992, PROG POLYM SCI, V17, P87, DOI 10.1016/0079-6700(92)90017-S
   van Ewijk GA, 1999, J MAGN MAGN MATER, V201, P31, DOI 10.1016/S0304-8853(99)00080-3
   VANBEERS B, 1995, J RADIOL, V76, P991
   WEISE K, 1993, MEAS SCI TECHNOL, V4, P1, DOI 10.1088/0957-0233/4/1/001
   WEISSLEDER R, 1990, AM J ROENTGENOL, V155, P1161, DOI 10.2214/ajr.155.6.2122660
   WEISSLEDER R, 1989, AM J ROENTGENOL, V152, P167, DOI 10.2214/ajr.152.1.167
   WEISSLEDER R, 1995, ADV DRUG DELIVER REV, V16, P321, DOI 10.1016/0169-409X(95)00033-4
   Wen Ge, 2002, Di Yi Jun Yi Da Xue Xue Bao, V22, P451
   Widder K J, 1979, Adv Pharmacol Chemother, V16, P213, DOI 10.1016/S1054-3589(08)60246-X
   Ye Q, 2002, KIDNEY INT, V61, P1124, DOI 10.1046/j.1523-1755.2002.00195.x
   Zhang YQ, 2000, KIDNEY INT, V58, P1300, DOI 10.1046/j.1523-1755.2000.00286.x
NR 139
TC 1103
Z9 1130
U1 24
U2 546
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-8853
EI 1873-4766
J9 J MAGN MAGN MATER
JI J. Magn. Magn. Mater.
PD MAY 1
PY 2005
VL 293
IS 1
SI SI
BP 483
EP 496
DI 10.1016/j.jmmm.2005.01.064
PG 14
WC Materials Science, Multidisciplinary; Physics, Condensed Matter
SC Materials Science; Physics
GA 933VQ
UT WOS:000229661400074
DA 2018-10-19
ER

PT J
AU Cazalbou, S
   Eichert, D
   Ranz, X
   Drouet, C
   Combes, C
   Harmand, MF
   Rey, C
AF Cazalbou, S
   Eichert, D
   Ranz, X
   Drouet, C
   Combes, C
   Harmand, MF
   Rey, C
TI Ion exchanges in apatites for biomedical application
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 7th World Biomaterials Congress
CY MAY 17-21, 2004
CL Sydney, AUSTRALIA
ID CALCIUM-PHOSPHATE; BONE; HYDROXYAPATITE; CARBONATE; ADHESION
AB The modification of the composition of apatite materials can be made by several processes corresponding to ion exchange reactions which can conveniently be adapted to current coatings and ceramics and are an alternative to setting up of new synthesis methods. In addition to high temperature thermal treatments, which can partly or almost totally replace the monovalent OH- anion of stoichiometric hydroxyapatite by any halogen ion or carbonate, aqueous processes corresponding to dissolution-reprecipitation reactions have also been proposed and used. However, the most interesting possibilities are provided by aqueous ion exchange reactions involving nanocrystalline apatites. These apatites are characterised by the existence on the crystal surface of a hydrated layer of loosely bound mineral ions which can be easily exchanged in solution. This layer offers a possibility to trap mineral ions and possibly active molecules which can modify the apatite properties. Such processes are involved in mineralised tissues and could be used in biomaterials for the release of active mineral species. (C) 2005 Springer Science + Business Media, Inc.
C1 Inst Natl Polytech Toulouse, ENSIACET, CIRIMAT, CNRS,UMR 5085, F-31077 Toulouse, France.
RP Cazalbou, S (reprint author), Inst Natl Polytech Toulouse, ENSIACET, CIRIMAT, CNRS,UMR 5085, 118 Route Narbonne, F-31077 Toulouse, France.
EM Christian.Rey@ensiacet.fr
RI Drouet, Christophe/A-8023-2008; CAZALBOU, sophie/G-5683-2012; Drouet,
   Christophe/S-1680-2018
OI Drouet, Christophe/0000-0002-8471-8719; Drouet,
   Christophe/0000-0002-8471-8719
CR BESHAH K, 1990, J SOLID STATE CHEM, V84, P71, DOI 10.1016/0022-4596(90)90185-Z
   BONEL G, 1972, ANN CHIM FRANCE, V7, P127
   Buehler J, 2001, BONE, V29, P176, DOI 10.1016/S8756-3282(01)00484-7
   CAZALBOU S, 2000, THESIS INPT TOULOUSE
   Daculsi G, 1997, INT REV CYTOL, V172, P129, DOI 10.1016/S0074-7696(08)62360-8
   Denissen HW, 1996, INT J PROSTHODONT, V9, P142
   EICHERT D, 2003, P CIMTEC 2002 6, P23
   EICHERT D, 2001, THESIS INPT TOULOUSE
   ELLIOTT JC, 1967, NATURE, V214, P904, DOI 10.1038/214904b0
   ELLIOTT JC, 1973, SCIENCE, V180, P1055, DOI 10.1126/science.180.4090.1055
   Feng B, 2002, BIOMATERIALS, V23, P173, DOI 10.1016/S0142-9612(01)00093-X
   Glimcher M.J., 1992, DISORDERS BONE MINER, P265
   Li YW, 2000, J BIOMED MATER RES, V52, P164, DOI 10.1002/1097-4636(200010)52:1<164::AID-JBM21>3.0.CO;2-R
   NEUMAN WF, 1968, CALC TISS RES, V2, P262, DOI 10.1007/BF02279214
   Porter AE, 2004, BIOMATERIALS, V25, P3303, DOI 10.1016/j.biomaterials.2003.10.006
   Ranz X., 1996, THESIS INPT TOULOUSE
   REDEY S, 2000, J BONE MINER RES, V353
   Redey SA, 1999, J BIOMED MATER RES, V45, P140, DOI 10.1002/(SICI)1097-4636(199905)45:2<140::AID-JBM9>3.3.CO;2-9
   Rey C, 1995, CELL MATER, V5, P345
   REY C, 1994, B I OCEANOGRAPHIQUE, V14, P55
   SAMEC F, 1966, CR ACAD SCI C CHIM, V262, P837
   Sfihi H., 2002, NATO ASI SER, VII, P409
   TROMBE JC, 1974, CR ACAD SCI C CHIM, V278, P1227
   Webster TJ, 2002, J BIOMED MATER RES, V59, P312, DOI 10.1002/jbm.1247
NR 24
TC 97
Z9 100
U1 4
U2 45
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAY
PY 2005
VL 16
IS 5
BP 405
EP 409
DI 10.1007/s10856-005-6979-2
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 924IY
UT WOS:000228973700006
PM 15875249
DA 2018-10-19
ER

PT J
AU Boehlert, C
   Niinomi, M
   Ikeda, M
AF Boehlert, C
   Niinomi, M
   Ikeda, M
TI Selected papers presented at the Materials Science and Technology 2004
   Meeting: Titanium for Biomedical, Dental and Healthcare Applications -
   Introduction
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Editorial Material
C1 Michigan State Univ, Coll Engn, Dept Chem Engn & Mat Sci, E Lansing, MI 48824 USA.
   Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418580, Japan.
   Kansai Univ, Dept Mat Sci & Engn, Suita, Osaka 5648680, Japan.
RP Boehlert, C (reprint author), Michigan State Univ, Coll Engn, Dept Chem Engn & Mat Sci, 2527 Engn Bldg, E Lansing, MI 48824 USA.
EM boehlert@egr.msu.edu; niinomi@sp-Mac4.tutpse.tut.ac.jp;
   hikoik@ipcku.kansai-u.ac.jp
RI Niinomi, Mitsuo/B-5965-2011
NR 0
TC 6
Z9 6
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD MAY
PY 2005
VL 25
IS 3
BP 247
EP 247
DI 10.1016/j.msec.2004.12.008
PG 1
WC Materials Science, Multidisciplinary
SC Materials Science
GA 948SC
UT WOS:000230735000001
DA 2018-10-19
ER

PT J
AU Atwood, RC
   Lee, PD
   Curtis, RV
   Di Silvio, L
AF Atwood, RC
   Lee, PD
   Curtis, RV
   Di Silvio, L
TI Multiscale modeling of titanium investment cast dental prostheses
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT Materials and Science Technology Meeting 2004
CY SEP 26-29, 2004
CL New Orleans, LA
SP The Mat Soc
DE dental prostheses; titanium; investment casting; multiscale modeling;
   mold-metal interfacial reactions
ID SOLIDIFICATION; ALLOY; CONTAMINATION; PREDICTION; SIMULATION; POROSITY;
   SURFACE
AB Titanium alloys are attractive materials for biomedical applications due to their superior biocompatibility. However, the use of titanium alloys for dental and maxillofacial prostheses is particularly challenging because each prosthesis has a unique, complex shape. A multiscale model for the processing of Ti prostheses was developed that combines a commercial macrocode for process simulation with an in-house code to explicitly track the development of the microstructure including surface reactions. The model was applied to simulate the dental titanium investment casting process. The macroscopic heat transfer model is coupled with a microscale simulation incorporating the release and diffusion of impurity elements at the mold-metal interface. The penetration depth of impurity species was simulated to determine the amount of alpha-case formed. The microstructural modeling results indicate that the critical factor is the time for which liquid Ti is in contact with the mold and that the incorporation of silicon from the mold increases this time by depressing the solidus temperature. (c) 2005 Elsevier B.V. All rights reserved.
C1 Univ London Imperial Coll Sci & Technol, Dept Mat, London SW7 2BP, England.
   Kings Coll London, Guys Kings & St Thomas Dent Inst, Dept Dent Biomat, London, England.
RP Lee, PD (reprint author), Univ London Imperial Coll Sci & Technol, Dept Mat, Prince Consort Rd, London SW7 2BP, England.
EM p.d.lee@imperial.ac.uk
RI Lee, Peter/R-2323-2016
OI Lee, Peter/0000-0002-3898-8881; Di Silvio, Lucy/0000-0003-2554-2052
CR Anderson D.A., 1984, COMPUTATIONAL FLUID
   Atwood RC, 2005, DENT MATER, V21, P178, DOI 10.1016/j.dental.2004.02.010
   Atwood RC, 2003, ACTA MATER, V51, P5447, DOI 10.1016/S1359-6454(03)00411-7
   Atwood RC, 2002, METALL MATER TRANS B, V33, P209, DOI 10.1007/s11663-002-0006-5
   Beckermann C, 2002, INT MATER REV, V47, P243, DOI 10.1179/095066002225006557
   BIRD RB, 1960, TRANSPORT PHENOMENA
   Boettinger WJ, 2000, METALL MATER TRANS B, V31, P1419, DOI 10.1007/s11663-000-0026-y
   BRIDGES PJ, 1997, TITANIUM, V2, P1
   Brunette D. M., 2001, TITANIUM MED, P145
   CAMPBELL J, 1991, CATINGS
   DURHAM DR, 1974, AFS T, V74, P101
   KUMAR TSP, 1991, METALL T B, V22
   KURZ W, 1986, ACTA METALL MATER, V34, P823, DOI 10.1016/0001-6160(86)90056-8
   Lee P.D., 2001, J LIGHT METALS, V1, P15, DOI DOI 10.1016/S1471-5317(00)00003-1
   Lee PD, 2004, MAT SCI ENG A-STRUCT, V365, P57, DOI 10.1016/j.msea.2003.09.007
   LEE PD, 1999, ISIJ INT, P97
   MAIJER DM, 2004, UNPUB METALL T A
   MAJOR JF, 1994, VEHICLE SUSPENSION S, P117
   Mills K. C., 2001, RECOMMENDED VALUES T
   Nishido S, 2002, INT J CAST METAL RES, V15, P325
   Okabe T, 1998, JOM-J MIN MET MAT S, V50, P24, DOI 10.1007/s11837-998-0410-7
   Papadopoulos T, 1999, J MATER SCI, V34, P3639, DOI 10.1023/A:1004639002688
   Pollock TM, 1996, METALL MATER TRANS A, V27, P1081, DOI 10.1007/BF02649777
   Rafii-Tabar H, 2002, PHYS REP, V365, P145, DOI 10.1016/S0370-1573(02)00028-5
   Veeck S, 2002, ADV MATER PROCESS, V160, P59
   Wu M, 2001, JOM-J MIN MET MAT S, V53, P36, DOI 10.1007/s11837-001-0146-0
   Wu MH, 1998, DENT MATER, V14, P321, DOI 10.1016/S0109-5641(98)00045-1
NR 27
TC 5
Z9 5
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD MAY
PY 2005
VL 25
IS 3
BP 255
EP 262
DI 10.1016/j.msec.2005.01.019
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA 948SC
UT WOS:000230735000003
DA 2018-10-19
ER

PT J
AU He, G
   Hagiwara, M
AF He, G
   Hagiwara, M
TI Bimodal structured Ti-base alloy with large elasticity and low Young's
   modulus
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT Materials and Science Technology Meeting 2004
CY SEP 26-29, 2004
CL New Orleans, LA
SP The Mat Soc
DE biomaterials; Young's modulus; Martensite transformation; Ti alloys;
   superelasticity
ID NANOSTRUCTURE-DENDRITE COMPOSITE; MECHANICAL-PROPERTIES;
   TITANIUM-ALLOYS; BIOMEDICAL APPLICATIONS; ENHANCED PLASTICITY;
   MICROSTRUCTURE; TRANSFORMATION
AB A bimodal structured Ti60Cu14Ni12Sn4Nb10 alloy has been fabricated by different methods. The as-prepared microstructure is composed of a dendritic bcc-beta-Ti(Nb,Sn) phase and a nano/ultrafine structured matrix. Except for beta-Ti, gamma-TiCu and a few intermetallics the matrix also contains the B2 structure, which acts as a parent phase for a reversible phase transformation around room temperature. Annealing induces precipitation of intermetallics, which significantly increases the yield strength and the Young's modulus, but does not change the reversible phase transformation. The alloy exhibits very high yield strength, large elasticity and low Young's modulus, providing an advantage for biomedical application. The reversible phase transformation provides potential applications as a smart material. (c) 2005 Elsevier B.V. All rights reserved.
C1 Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan.
RP He, G (reprint author), Natl Inst Mat Sci, 1-2-1 Sengen, Tsukuba, Ibaraki 3050047, Japan.
EM he.guo@nims.go.jp
CR Breme HJ, 1998, METALS BIOMATERIALS, P1
   Dai QL, 2004, J MATER RES, V19, P2557, DOI 10.1557/JMR.2004.0332
   FUKUDA T, 1995, MATER T JIM, V36, P1244, DOI 10.2320/matertrans1989.36.1244
   FURUYA Y, 1990, MATER T JIM, V31, P504, DOI 10.2320/matertrans1989.31.504
   He G, 2004, ACTA MATER, V52, P3035, DOI 10.1016/j.actamat.2004.03.006
   He G, 2004, MATER TRANS, V45, P1120, DOI 10.2320/matertrans.45.1120
   He G, 2003, ACTA MATER, V51, P5223, DOI [10.1016/S1359-6454(03)00386-0, 10.1016/s1359-6454(03000386-0]
   He G, 2002, J MATER RES, V17, P3015, DOI 10.1557/JMR.2002.0439
   He G, 2003, NAT MATER, V2, P33, DOI 10.1038/nmat792
   HE G, 2003, BIOMATERIALS, V24, P2115
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Ratner B. D., 2001, TITANIUM MED, P1
   SUN BB, UNPUB ACTA MAT
   Takahashi E, 2002, MATER TRANS, V43, P2978, DOI 10.2320/matertrans.43.2978
   ZHANG ZF, 2003, PHYS REV LETT, V91, DOI UNSP 045501-045505
NR 19
TC 26
Z9 27
U1 1
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD MAY
PY 2005
VL 25
IS 3
BP 290
EP 295
DI 10.1016/j.msec.2005.03.001
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 948SC
UT WOS:000230735000007
DA 2018-10-19
ER

PT J
AU Gunawarman, B
   Niinomi, M
   Akahori, T
   Souma, T
   Ikeda, M
   Toda, H
AF Gunawarman, B
   Niinomi, M
   Akahori, T
   Souma, T
   Ikeda, M
   Toda, H
TI Mechanical properties and microstructures of low cost beta titanium
   alloys for healthcare applications
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT Materials and Science Technology Meeting 2004
CY SEP 26-29, 2004
CL New Orleans, LA
SP The Mat Soc
DE mechanical properties; microstructure; healthcare; wheelchair; titanium
   alloys; Ti-4.3Fe-7.1Cr; Ti-4.3Fe-7.1Cr-3.0Al
AB Titanium alloys are the best choice of metallic materials for biomedical and healthcare applications due to the combination of their excellent mechanical properties and biocompatibility. However, the usage of titanium alloys is limited due to its high cost. In order to reduce their cost, two new titanium alloys, Ti-4.3Fe-7.1Cr (TFC alloy) and Ti-4.3Fc-7.1Cr-3.0Al (TFCA alloy), for healthcare goods such as wheelchairs have been recently developed using low cost ferro-chrom elements. The microstructure and mechanical properties of both alloys subjected to solution treatment in the beta field or thermomechanical treatment were investigated, and then evaluated for their potential to be used as wheelchair materials.
   The specific strength and fatigue ratio of TFC and TFCA alloys are much greater than those of the existing wheelchair materials. Unrecrystallized grains obtained in the alloys at low solution treatment temperature can be eliminated by increasing solution treatment temperature or by conducting thermomechanical treatment. The latter method is recommended because it also gives a better strength and ductility balance as a result, mainly, of grain refinement. However, TFCA alloy seems to have more potential to be used as wheelchair materials compared to TFC alloy because of its better workability and post thermomechanical treatment ductility. (c) 2005 Elsevier B.V. All rights reserved.
C1 Toyohashi Univ Technol, Toyohashi, Aichi 4418580, Japan.
   Andalas Univ, W Sumatera, Indonesia.
   Kansai Univ, Suita, Osaka 5648680, Japan.
RP Gunawarman, B (reprint author), Toyohashi Univ Technol, 1-1 Hibarigaoka, Toyohashi, Aichi 4418580, Japan.
EM gunawarman@ft.unand.ac.id
RI Niinomi, Mitsuo/B-5965-2011
OI Gunawarman, Gunawarman/0000-0002-2291-5514
CR Boyer R., 1994, MAT PROPERTIES HDB T, P685
   Ikeda M, 2004, MATER TRANS, V45, P1566, DOI 10.2320/matertrans.45.1566
   IKEDA M, 2001, PRICM, V4, P213
   IKEDA M, 2001, LIMAT 2001, P73
   Niinomi M., 2003, Science and Technology of Advanced Materials, V4, P445, DOI 10.1016/j.stam.2003.09.002
   SOUMA T, 2004, THESIS TOYOHASHI U T
   Weiss I, 1998, MAT SCI ENG A-STRUCT, V243, P46, DOI 10.1016/S0921-5093(97)00783-1
NR 7
TC 31
Z9 36
U1 1
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD MAY
PY 2005
VL 25
IS 3
BP 304
EP 311
DI 10.1016/j.msec.2004.12.015
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA 948SC
UT WOS:000230735000009
DA 2018-10-19
ER

PT J
AU Nyberg, E
   Miller, M
   Simmons, K
   Weil, KS
AF Nyberg, E
   Miller, M
   Simmons, K
   Weil, KS
TI Microstructure and mechanical properties of titanium components
   fabricated by a new powder injection molding technique
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT Materials and Science Technology Meeting 2004
CY SEP 26-29, 2004
CL New Orleans, LA
SP The Mat Soc
ID BIOMEDICAL APPLICATIONS; ALLOY
AB A powder injection molding (PIM) binder system has been developed for reactive metals such as titanium that employs an aromatic compound as the primary component to facilitate easy binder removal and mitigate problems with carbon contamination. In the study presented here, we examined the densification behavior, microstructure, and mechanical properties of titanium specimens formed by this process using naphthalene as the principle binder constituent. In general, it was found that tensile strengths could be achieved comparable to wrought titanium in the PIM-formed specimens, but that maximum elongation was less than expected. Chemical and microstructural analyses indicate that this process does not add oxygen to the material, suggesting that the use of higher purity powder and further process optimization should lead to significant improvements in ductility. (c) 2005 Published by Elsevier B.V.
C1 Battelle Mem Inst, Richland, WA 99352 USA.
RP Nyberg, E (reprint author), Battelle Mem Inst, Richland, WA 99352 USA.
EM Eric.Nyberg@pnl.gov
CR *AM SOC MET, 1980, MET HDB, P372
   ANDERMANN HH, 1995, MATER MANUF PROCESS, V10, P439
   Breme J, 2000, ADV ENG MATER, V2, P270, DOI 10.1002/(SICI)1527-2648(200005)2:5<270::AID-ADEM270>3.0.CO;2-9
   CIOMEK A, 1991, Patent No. 5064463
   CONACHIE MJ, 2000, TITANIUM TECHNICAL G
   Fricke J, 1998, J SOL-GEL SCI TECHN, V13, P299, DOI 10.1023/A:1008663908431
   German R.M., 1997, INJECTION MOLDING ME
   GERMAN RM, 1992, METALL TRANS A, V23, P1455, DOI 10.1007/BF02647329
   GERMAN RM, 1993, REV PARTICUL MATER, V1, P109
   Guillemot F, 2004, MED BIOL ENG COMPUT, V42, P137, DOI 10.1007/BF02351023
   Huang CT, 1996, POWDER METALL, V39, P119, DOI 10.1179/pom.1996.39.2.119
   KANEKO Y, 1990, J JAPAN SOC POWDER P, V37, P13
   Kato K., 1999, J JAPAN SOC POWDER P, V46, P865
   Kyogoku H, 1993, J JPN SOC POWDER POW, V40, P439
   LEDBETTER H, 1995, REV PROGR QUANTITATI, P1663
   LEE YT, 1990, POWDER METALL INT, V22, P11
   Niinomi M., 2003, Science and Technology of Advanced Materials, V4, P445, DOI 10.1016/j.stam.2003.09.002
   Niinomi M, 2002, MATER TRANS, V43, P2970, DOI 10.2320/matertrans.43.2970
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   NYBERG E, 2005, TRENDS MAT MANUFACTU
   Oh IH, 2003, SCRIPTA MATER, V49, P1197, DOI 10.1016/j.scriptamat.2003.08.018
   Ouchi C, 1998, MAT SCI ENG A-STRUCT, V243, P186, DOI 10.1016/S0921-5093(97)00799-5
   VANNOORT R, 1987, J MATER SCI, V22, P3801, DOI 10.1007/BF01133326
   Wang H., 1999, P M SCI TECH BRIEFS, V1, P16
   Wasz ML, 1996, INT MATER REV, V41, P1
   Zu YS, 1996, J MATER ENG PERFORM, V5, P609, DOI 10.1007/BF02646090
NR 26
TC 39
Z9 43
U1 1
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD MAY
PY 2005
VL 25
IS 3
BP 336
EP 342
DI 10.1016/j.msec.2005.04.006
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 948SC
UT WOS:000230735000013
DA 2018-10-19
ER

PT J
AU Koike, M
   Ohkubo, C
   Sato, H
   Fujii, H
   Okabe, T
AF Koike, M
   Ohkubo, C
   Sato, H
   Fujii, H
   Okabe, T
TI Evaluation of cast Ti-Fe-O-N alloys for dental applications
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT Materials and Science Technology Meeting 2004
CY SEP 26-29, 2004
CL New Orleans, LA
SP The Mat Soc
DE titanium alloys; dental alloys; tensile testing; corrosion studies;
   grindability; mold filling
ID TITANIUM
AB Good mechanical properties, biocompatibility and corrosion resistance make titanium an excellent material for biomedical applications. However, when better mechanical properties than those offered by commercially pure titanium (CPTi) are needed, Ti-6Al-4V is sometimes a good alternative. Some new titanium alloys, developed as industrial structural materials, aim at an intermediate range of strength between that of CP Ti and Ti-6Al-4V Two of these alloys are Super-TIX800 (TM) (Ti-1% Fe-0.35% O-0.01% N) and Super-TIX800N (TM) (Ti-1% Fe-0.3% O-0.04% N) (both produced by Nippon Steel Corp., Japan). Besides being stronger than CP Ti, the cost of manufacturing these alloys is reportedly lower than for Ti-6Al-4V since they do not contain any expensive elements. In addition, they are not composed of elements such as aluminum or vanadium, which have caused biocompatibility concerns in medical and dental appliances. To evaluate these alloys as candidates for dental use, it is helpful to compare them to CP Ti (ASTM Grade 2) and Ti-6Al-4V (ASTM Grade 5), which have already been employed in dentistry. We evaluated the tensile properties, mold filling capacity, corrosion characteristics and grindability of these industrial alloys prepared by investment casting. Compared to the strengths of cast CPTi, the yield strength and tensile strength of these cast alloys were more than 20% and approximately 30% higher, respectively. On the other hand, both of these properties were 30% lower than for Ti-6Al-4V. Better grindability and wear resistance were additional benefits of these new alloys for dental applications. (c) 2005 Elsevier B.V All rights reserved.
C1 Texas A&M Univ, Syst Hlth Sci Ctr, Baylor Coll Dent, Dallas, TX 75246 USA.
   Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 8528588, Japan.
   Tsurumi Univ, Sch Dent Med, Tsurumi Ku, Yokohama, Kanagawa 2308501, Japan.
   Tohoku Univ, Grad Sch Dent, Sendai, Miyagi 9808575, Japan.
   Nippon Steel Corp Ltd, Futtsu, Chiba 2938511, Japan.
RP Okabe, T (reprint author), Texas A&M Univ, Syst Hlth Sci Ctr, Baylor Coll Dent, 3302 Gaston Ave, Dallas, TX 75246 USA.
EM tokabe@bcd.tamhsc.edu
CR BOYER R, 1994, MAT PROPERTIES HDB, P1065
   Donachie MJ, 2000, TITANIUM TECHNICAL G, P126
   EWERS GJ, 1985, J ORAL REHABIL, V12, P469, DOI 10.1111/j.1365-2842.1985.tb01293.x
   FUJII H, 1996, TITANIUM 95, P2309
   FUJII H, 2001, TITANIUM, V49, P171
   *ICDD, 1998, POWD DIFFR FIL SET 1
   Kikuchi M, 2003, DENT MATER J, V22, P191, DOI 10.4012/dmj.22.191
   Koike M, 2003, BIOMATERIALS, V24, P4541, DOI 10.1016/S0142-9612(03)00063-2
   MAREK M, 1990, J DENT RES, V69, P1167, DOI 10.1177/00220345900690050901
   MILLER I, 1985, PROBABILITY STAT ENG, P188
   MURRAY JL, 1984, PHASE DIAGRAMS BINAR
   OBrien WJ, 2002, DENT MAT THEIR SELEC
   OHKUBO C, 2004, J DENT RES, V83
   Okabe T, 1998, JOM-J MIN MET MAT S, V50, P24, DOI 10.1007/s11837-998-0410-7
   Okabe T, 2004, COST-AFFORDABLE TITANIUM, P177
   Okazaki Y, 1998, BIOMATERIALS, V19, P1197, DOI 10.1016/S0142-9612(97)00235-4
   Shimizu H, 2002, BIOMATERIALS, V23, P2275, DOI 10.1016/S0142-9612(01)00357-X
   Siegel S, 1988, NONPARAMETRIC STAT B
   Stem M., 1957, J ELECTROCHEM SOC, V104, P56
   Watanabe I, 1997, J DENT RES, V76, P773, DOI 10.1177/00220345970760031001
NR 20
TC 21
Z9 26
U1 3
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD MAY
PY 2005
VL 25
IS 3
BP 349
EP 356
DI 10.1016/j.msec.2005.04.002
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA 948SC
UT WOS:000230735000015
DA 2018-10-19
ER

PT J
AU Sakaguchi, N
   Niinomi, M
   Akahori, T
   Takeda, J
   Toda, H
AF Sakaguchi, N
   Niinomi, M
   Akahori, T
   Takeda, J
   Toda, H
TI Relationships between tensile deformation behavior and microstructure in
   Ti-Nb-Ta-Zr system alloys
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT Materials and Science Technology Meeting 2004
CY SEP 26-29, 2004
CL New Orleans, LA
SP The Mat Soc
DE Ti-Nb-Ta-Zr system titanium alloy; biomedical applications; Mechanical
   properties; elastic modulus; stress-induced martensite; super elastic
   behavior; shape memory effect
ID TITANIUM-ALLOY; MECHANICAL-PROPERTIES; BIOMEDICAL APPLICATIONS;
   SHAPE-MEMORY; MO ALLOYS; TI-29NB-13TA-4.6ZR; FATIGUE
AB Ti-Nb-Ta-Zr system alloys are receiving more attention for biomedical material component applications. However, the deformation behavior of the Ti-Nb-Ta-Zr system has not been evaluated to date. Therefore, the deformation behavior of Ti-Nb-Ta-Zr alloys with different Nb contents was investigated in this study.
   The behaviors of loading-unloading stress-strain curves of Ti-20Nb-10Ta-5Zr and Ti-25Nb-10Ta-5Zr air-cooled after final heating of the manufacturing process are similar to that obtained in metastable beta type titanium alloys that have the shape memory effect. Therefore, the shape memory effect was expected in Ti-20Nb-10Ta-5Zr and Ti-25Nb-10Ta-5Zr alloys. The elastic deformation of Ti-30Nb-10Ta-5Zr disobeyed Hooke's law. However, stress or strain-induced martensite (SIM) is not observed on the loading-unloading stress-strain curve. The deformation mechanism of Ti-25Nb-10Ta-5Zr changes with varying its microstructure. In Ti-25Nb-10Ta-5Zr air-cooled after final heating, the microstructure consisted of an omega phase in a beta phase. The stress for inducing martensite in a phase, am, was nearly equal to the yielding stress, sigma(y). Therefore, stress-induced martensitic transformation and movement of dislocations occurred together. In Ti-25Nb-10Ta-5Zr water-quenched after final heating of the manufacturing process, the microstructure consisted of a single phase, where am is lower than ay, Therefore, stress-induced martensitic transformation occurred before yielding. (c) 2005 Elsevier B.V. All rights reserved.
C1 Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418580, Japan.
   Toyohashi Univ Technol, Toyohashi, Aichi 4418580, Japan.
RP Niinomi, M (reprint author), Toyohashi Univ Technol, Dept Prod Syst Engn, 1-1 Hibarigaoka, Toyohashi, Aichi 4418580, Japan.
EM Niinomi@sp-Mac4.tutpse.tut.ac.jp
RI Niinomi, Mitsuo/B-5965-2011
CR Akahori T, 2004, MATER TRANS, V45, P1540, DOI 10.2320/matertrans.45.1540
   Grosdidier T, 2000, METALL MATER TRANS A, V31, P1095, DOI 10.1007/s11661-000-0105-3
   HANADA S, 1985, METALL TRANS A, V16, P789, DOI 10.1007/BF02814829
   HIDA M, 1980, J JPN I MET, V44, P436, DOI 10.2320/jinstmet1952.44.4_436
   Karasevskaya OP, 2003, MAT SCI ENG A-STRUCT, V354, P121, DOI 10.1016/S0921-5093(02)00935-8
   Kasuga T, 2003, BIOMATERIALS, V24, P283, DOI 10.1016/S0142-9612(02)00316-2
   Kasuga T, 2001, BIOMATERIALS, V22, P577, DOI 10.1016/S0142-9612(00)00216-7
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Li SJ, 2002, MATER TRANS, V43, P2964, DOI 10.2320/matertrans.43.2964
   Maeshima T, 2004, MATER TRANS, V45, P1101, DOI 10.2320/matertrans.45.1101
   Meng XL, 2002, MATER LETT, V55, P111, DOI 10.1016/S0167-577X(01)00631-0
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Niinomi M, 2002, MATER TRANS, V43, P2970, DOI 10.2320/matertrans.43.2970
   OHMORI Y, 2001, MAT SCI ENG A-STRUCT, V321, P182
   OKA M, 1978, J JPN I MET, V42, P814, DOI 10.2320/jinstmet1952.42.8_814
   Sakaguch N, 2004, MATER TRANS, V45, P1113, DOI 10.2320/matertrans.45.1113
   SAKAGUCHI N, 2003, P ATEM 03 JAP SOC ME
   YOSHITANI S, 2000, P 2000 POWD MET WORL, V2, P1085
NR 18
TC 78
Z9 87
U1 2
U2 42
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD MAY
PY 2005
VL 25
IS 3
BP 363
EP 369
DI 10.1016/j.msec.2004.12.014
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 948SC
UT WOS:000230735000017
DA 2018-10-19
ER

PT J
AU Niinomi, M
   Akahori, T
   Takeuchi, T
   Katsura, S
   Fukui, H
   Toda, H
AF Niinomi, M
   Akahori, T
   Takeuchi, T
   Katsura, S
   Fukui, H
   Toda, H
TI Mechanical properties and cyto-toxicity of new beta type titanium alloy
   with low melting points for dental applications
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT Materials and Science Technology Meeting 2004
CY SEP 26-29, 2004
CL New Orleans, LA
SP The Mat Soc
DE beta titanium alloy; casting; melting point; surface reaction layer;
   tensile properties; biocompatibility
ID BIOMEDICAL APPLICATIONS; FATIGUE PROPERTIES; TI-29NB-13TA-4.6ZR
AB Beta stabilized new alloys such as Ti-29Nb-13Zr-2Cr, Ti-29Nb-15Zr-1.5Fe, Ti-29Nb-10Zr-0.5Si, Ti-29Nb-10Zr-0.5Cr-0.5Fe and Ti-29Nb-18Zr-2Cr-0.5Si have been developed for dental applications. These alloys were designed based on master alloy Ti-29Nb-13Ta-4.6Zr (TNTZ) for biomedical applications. In this research, high melting temperature element Ta was replaced with beta stabilizing elements such as Cr, Fe and Si to lower the melting temperature of the alloy.
   Their melting points, mechanical properties, surface reaction layers and cyto-toxicity were investigated in this study.
   Melting points of designed alloys fall by about 50 K to 370 K as compared with that of TNTZ, and Ti-29Nb-13Zr-2Cr has the lowest melting point of around 2050 K. Vickers hardness of the surface of each designed alloy cast into modified magnesia based investment material is in the range of 400 Hv to 500 Hv, which is lower than that of TNTZ (around 560 Hv).
   Balances of strength and ductility of cast Ti-29Nb-13Zr-2Cr, Ti-29Nb-15Zr-1.5Fe and Ti-29Nb-10Zr-0.5Cr-0.5Fe are nearly equal to that of cast TNTZ.
   Cell viability of each cast designed alloy is excellent. (c) 2005 Elsevier B.V. All rights reserved.
C1 Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418580, Japan.
   Takauchikatan Ltd, Toyohashi, Aichi 4418132, Japan.
   Yamahachi Dent Co, Aichi 4430105, Japan.
   Aichi Gakuin Univ, Dept Dent Mat Sci, Sch Dent, Nagoya, Aichi 4648650, Japan.
RP Niinomi, M (reprint author), Toyohashi Univ Technol, Dept Prod Syst Engn, 1-1 Hibarigaoka, Toyohashi, Aichi 4418580, Japan.
EM Niinomi@sp-Mac4.tutpse.tut.ac.jp
RI Niinomi, Mitsuo/B-5965-2011
CR Akahori T, 2003, J JPN I MET, V67, P652, DOI 10.2320/jinstmet1952.67.11_652
   Akahori T, 2002, J JPN I MET, V66, P715, DOI 10.2320/jinstmet1952.66.7_715
   DOI H, 1999, J J SOC DENT MAT DEV, V18, P122
   KATO A, 1993, CURRENT ADV MAT PROC, V6, P1584
   Kawahara H., 1992, B JAPAN I METALS, V31, P1033
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   MORINAGA M, 1992, J JPN I LIGHT MET, V42, P416
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Niinomi M., 2003, Science and Technology of Advanced Materials, V4, P445, DOI 10.1016/j.stam.2003.09.002
   Niinomi M, 2004, TETSU TO HAGANE, V90, P154, DOI 10.2355/tetsutohagane1955.90.3_154
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Niinomi M., 2004, BIOMATERIALS ORTHOPE, P41
   NIINOMI M, 2002, MAT T, V43, P2877
   NIINOMI M, 2001, J J FOUNDRY ENG SOC, V73, P798
   Okazaki Y., 1997, MAT JAPAN, V36, P1092
   OUCHI C, 1998, MAT JAPAN, V37, P22
   Steinemann S. G., 1980, EVALUATION BIOMATERI, P1
   TAKAHASHI J, 1995, J J SOC BIOMATERIALS, V13, P131
NR 18
TC 32
Z9 32
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD MAY
PY 2005
VL 25
IS 3
BP 417
EP 425
DI 10.1016/j.msec.2005.01.024
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA 948SC
UT WOS:000230735000024
DA 2018-10-19
ER

PT J
AU Steller, S
   Angenendt, P
   Cahill, DJ
   Heuberger, S
   Lehrach, H
   Kreutzberger, J
AF Steller, S
   Angenendt, P
   Cahill, DJ
   Heuberger, S
   Lehrach, H
   Kreutzberger, J
TI Bacterial protein microarrays for identification of new potential
   diagnostic markers for Neisseria meningitidis infections
SO PROTEOMICS
LA English
DT Article
DE opacity proteins; pathogen; phase variation; protein chip; vaccine
ID COMPLETE GENOME SEQUENCE; OUTER-MEMBRANE PROTEIN; PHASE-VARIABLE GENES;
   STRAIN MC58; SEROGROUP-B; MENINGOCOCCAL MENINGITIS; MOLECULAR
   MECHANISMS; ENDOTHELIAL-CELLS; SUPPORT MATERIALS; EXPRESSION
AB Neisseria meningitidis is the most common cause of meningitis and causes epidemic outbreaks. One trait of N. meningitidis, which is associated with most of the currently recognized virulence determinants, is the presence of phase-variable genes that are suspected to enhance its ability to cause an invasive disease. To detect the immune responses to phase-variable expressed proteins, we applied protein microarray technology for the screening of meningitis patient sera. We amplified all 102 known phase-variable genes from N. meningitidis serogroup B strain MC58 by polymerase chain reaction and subcloned them for expression in Escherichia coli. With this approach, we were able to express and purify 67 recombinant proteins representing 66 % of the annotated genes. These were spotted robotically onto coated glass slides to generate protein microarrays, which were screened using 20 sera of patients suffering from meningitis, as wen as healthy controls. From these screening experiments, 47 proteins emerged as immunogenic, exhibiting a variable degree of seroreactivity with some of the patient sera. Nine proteins elicited an immune response in more than three patients, with one of them, the phase-variable opacity protein OpaV (NMB0442), showing responses in 11 patient sera. This is the first time that protein microarray technology has been applied for the investigation of genetic phase variation in pathogens. The identification of disease-specific proteins is a significant target in biomedical research, as such proteins may have medical, diagnostic, and commercial potential as disease markers.
C1 Max Planck Inst Mol Genet, D-14195 Berlin, Germany.
   Ruhr Univ Bochum, Med Proteome Ctr, D-4630 Bochum, Germany.
   PROTAGEN AG, Dortmund, Germany.
   Royal Coll Surgeons Ireland, Ctr Human Proteom, Dublin 2, Ireland.
   AGES BSU Graz, Natl Referenzzentrale Meningokokken, Graz, Austria.
RP Kreutzberger, J (reprint author), Max Planck Inst Mol Genet, Ihnestr 73, D-14195 Berlin, Germany.
EM kreutzbg@molgen.mpg.de
CR Angenendt P, 2005, PROTEOMICS, V5, P420, DOI 10.1002/pmic.200400955
   Angenendt P, 2004, ANAL CHEM, V76, P2916, DOI 10.1021/ac035357a
   Angenendt P, 2003, J CHROMATOGR A, V1009, P97, DOI 10.1016/S0021-9673(03)00769-6
   Angenendt P, 2002, ANAL BIOCHEM, V309, P253, DOI 10.1016/S0003-2697(02)00257-9
   Bacarese-Hamilton T, 2002, BIOTECHNIQUES, P24
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Bussow K, 1998, NUCLEIC ACIDS RES, V26, P5007, DOI 10.1093/nar/26.21.5007
   Courtney HS, 2003, INFECT IMMUN, V71, P5097, DOI 10.1128/IAI.71.9.5097-5103.2003
   Freissler E, 2000, CELL MICROBIOL, V2, P69, DOI 10.1046/j.1462-5822.2000.00036.x
   Glokler J, 2003, J CHROMATOGR B, V797, P229, DOI 10.1016/j.jchromb.2003.08.034
   Haab BB, 2001, GENOME BIOL, V2
   Hammerschmidt S, 1996, MOL MICROBIOL, V20, P1211, DOI 10.1111/j.1365-2958.1996.tb02641.x
   Hiller R, 2002, FASEB J, V16, P414, DOI 10.1096/fj.01-0711fje
   Jennings MP, 1999, MICROBIOL-UK, V145, P3013, DOI 10.1099/00221287-145-11-3013
   Jennings MP, 1998, MOL MICROBIOL, V29, P975, DOI 10.1046/j.1365-2958.1998.00962.x
   Jennings MP, 1995, MOL MICROBIOL, V18, P729, DOI 10.1111/j.1365-2958.1995.mmi_18040729.x
   Kotilainen P, 1998, J CLIN MICROBIOL, V36, P2205
   KRISTIANSEN BE, 1991, LANCET, V337, P1568, DOI 10.1016/0140-6736(91)93262-8
   Lewis LA, 1999, MOL MICROBIOL, V32, P977, DOI 10.1046/j.1365-2958.1999.01409.x
   Lueking A, 2003, MOL CELL PROTEOMICS, V2, P1342, DOI 10.1074/mcp.T3000010-MCP200
   MacBeath G, 2000, SCIENCE, V289, P1760
   Mahler E, 2004, CLIN EXP IMMUNOL, V136, P527, DOI 10.1111/j.1365-2249.2004.02480.x
   Martin P, 2003, MOL MICROBIOL, V50, P245, DOI 10.1046/j.1365-2958.2003.03678.x
   Michaud GA, 2003, NAT BIOTECHNOL, V21, P1509, DOI 10.1038/nbt910
   MOXON ER, 1994, CURR BIOL, V4, P24, DOI 10.1016/S0960-9822(00)00005-1
   MURALIDHARAN K, 1987, A VAN LEEUW J MICROB, V53, P435, DOI 10.1007/BF00415499
   Pandey A, 2000, NATURE, V405, P837, DOI 10.1038/35015709
   Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816
   Robinson WH, 2002, NAT MED, V8, P295, DOI 10.1038/nm0302-295
   Rowe CA, 1999, ANAL CHEM, V71, P433, DOI 10.1021/ac980798t
   SARKARI J, 1994, MOL MICROBIOL, V13, P207, DOI 10.1111/j.1365-2958.1994.tb00416.x
   Saunders NJ, 2000, MOL MICROBIOL, V37, P207, DOI 10.1046/j.1365-2958.2000.02000.x
   Snyder LAS, 2001, MICROBIOL-SGM, V147, P2321, DOI 10.1099/00221287-147-8-2321
   Sun YH, 2000, NAT MED, V6, P1269
   Templin MF, 2003, PROTEOMICS, V3, P2155, DOI 10.1002/pmic.200300600
   Templin MF, 2002, TRENDS BIOTECHNOL, V20, P160, DOI 10.1016/S0167-7799(01)01910-2
   Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809
   Tikhomirov Eugene, 1997, World Health Statistics Quarterly, V50, P170
   TRAMONT EC, 1977, J IMMUNOL, V118, P1843
   VANDERENDE A, 1995, J BACTERIOL, V177, P2475, DOI 10.1128/jb.177.9.2475-2480.1995
   VANPUTTEN JPM, 1995, MOL MICROBIOL, V16, P847
   Virji M, 1995, MOL MICROBIOL, V18, P741, DOI 10.1111/j.1365-2958.1995.mmi_18040741.x
   VIRJI M, 1993, MOL MICROBIOL, V10, P499, DOI 10.1111/j.1365-2958.1993.tb00922.x
   Wren BW, 2000, NAT REV GENET, V1, P30, DOI 10.1038/35049551
   Zhu H, 2000, NAT GENET, V26, P283
NR 45
TC 49
Z9 55
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1615-9853
EI 1615-9861
J9 PROTEOMICS
JI Proteomics
PD MAY
PY 2005
VL 5
IS 8
BP 2048
EP 2055
DI 10.1002/pmic.200401097
PG 8
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 932LJ
UT WOS:000229554900006
PM 15852346
DA 2018-10-19
ER

PT J
AU Fisher, JK
   Cummings, JR
   Desai, KV
   Vicci, L
   Wilde, B
   Keller, K
   Weigle, C
   Bishop, G
   Taylor, RM
   Davis, CW
   Boucher, RC
   O'Brien, ET
   Superfine, R
AF Fisher, JK
   Cummings, JR
   Desai, KV
   Vicci, L
   Wilde, B
   Keller, K
   Weigle, C
   Bishop, G
   Taylor, RM
   Davis, CW
   Boucher, RC
   O'Brien, ET
   Superfine, R
TI Three-dimensional force microscope: A nanometric optical tracking and
   magnetic manipulation system for the biomedical sciences
SO REVIEW OF SCIENTIFIC INSTRUMENTS
LA English
DT Article
ID MITOTIC SPINDLE; BEAT PATTERN; CILIARY BEAT; TWEEZERS; MOVEMENT;
   MICROMANIPULATION; MOTILITY; CELLS; RESOLUTION; FLAGELLA
AB We report here the development of a three-dimensional (3D) magnetic force microscope for applying forces to and measuring responses of biological systems and materials. This instrument combines a conventional optical microscope with a free-floating or specifically bound magnetic bead used as a mechanical probe. Forces can be applied by the bead to microscopic structures of interest (specimens), while the reaction displacement of the bead is measured. This enables 3D mechanical manipulations and measurements to be performed on specimens in fluids. Force is generated by the magnetically permeable bead in reaction to fields produced by external electromagnets. The displacement is measured by interferometry using forward light scattered by the bead from a focused laser beam. The far-field interference pattern is imaged on a quadrant photodetector from which the 3D displacement can be computed over a limited range about the focal point. The bead and specimen are mounted on a 3D translation stage and feedback techniques are used to keep the bead within this limited range. We demonstrate the system with application to beads attached to cilia in human lung cell cultures. &COPY; 2005 American Institute of Physics.
C1 Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC 27599 USA.
   Univ N Carolina, Dept Comp Sci, Chapel Hill, NC 27599 USA.
   Univ N Carolina, Med Cyst Fibrosis Ctr, Chapel Hill, NC 27599 USA.
   Univ N Carolina, Dept Phys & Astron, Chapel Hill, NC 27599 USA.
RP Fisher, JK (reprint author), Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC 27599 USA.
RI Superfine, Richard/A-1968-2012
OI Superfine, Richard/0000-0002-2569-071X
CR Allersma MW, 1998, BIOPHYS J, V74, P1074, DOI 10.1016/S0006-3495(98)74031-7
   Amblard F, 1996, REV SCI INSTRUM, V67, P818, DOI 10.1063/1.1146816
   ASHKIN A, 1986, OPT LETT, V11, P288, DOI 10.1364/OL.11.000288
   Assi F, 2002, J APPL PHYS, V92, P5584, DOI 10.1063/1.1509086
   Baker AA, 2000, BIOPHYS J, V79, P1139, DOI 10.1016/S0006-3495(00)76367-3
   Barbic M, 2001, APPL PHYS LETT, V79, P1897, DOI 10.1063/1.1402963
   BLOCK SM, 1989, NATURE, V338, P514, DOI 10.1038/338514a0
   BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0
   Boucher RC, 2004, EUR RESPIR J, V23, P146, DOI 10.1183/09031936.03.00057003
   Braga P. C., 2003, METHODS MOL BIOL, V242
   Chilvers MA, 2000, THORAX, V55, P314, DOI 10.1136/thorax.55.4.314
   CRAMER LP, 1994, CURR OPIN CELL BIOL, V6, P82, DOI 10.1016/0955-0674(94)90120-1
   CRICK FHC, 1950, EXP CELL RES, V1, P37, DOI 10.1016/0014-4827(50)90048-6
   DAI JW, 1995, BIOPHYS J, V68, P988, DOI 10.1016/S0006-3495(95)80274-2
   Davey MJ, 2002, NAT REV MOL CELL BIO, V3, P826, DOI 10.1038/nrm949
   DENK W, 1990, APPL OPTICS, V29, P2382, DOI 10.1364/AO.29.002382
   Ellison V, 2001, CELL, V106, P655, DOI 10.1016/S0092-8674(01)00498-6
   Endow SA, 2003, BIOESSAYS, V25, P1212, DOI 10.1002/bies.10358
   Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105
   Florin EL, 1998, APPL PHYS A-MATER, V66, pS75, DOI 10.1007/s003390051103
   Gittes F, 1998, OPT LETT, V23, P7, DOI 10.1364/OL.23.000007
   Gosse C, 2002, BIOPHYS J, V82, P3314, DOI 10.1016/S0006-3495(02)75672-5
   Haber C, 2000, REV SCI INSTRUM, V71, P4561, DOI 10.1063/1.1326056
   HARADA Y, 1998, LASER TWEEZERS CELL, V55, P99
   Hirakawa E, 2000, P NATL ACAD SCI USA, V97, P2533, DOI 10.1073/pnas.050585297
   Hosu BG, 2003, REV SCI INSTRUM, V74, P4158, DOI 10.1063/1.1599066
   Huang H, 2002, BIOPHYS J, V82, P2211, DOI 10.1016/S0006-3495(02)75567-7
   HUANG HD, 2002, BIOPHYS J, V82, P2008
   HUITOREL P, 1988, BIOL CELL, V63, P249, DOI 10.1016/0248-4900(88)90062-7
   Kachynski AV, 2003, OPT LETT, V28, P2288, DOI 10.1364/OL.28.002288
   KISHINO A, 1988, NATURE, V334, P74, DOI 10.1038/334074a0
   KUO SC, 1993, SCIENCE, V260, P232, DOI 10.1126/science.8469975
   Lang MJ, 2003, AM J PHYS, V71, P201, DOI 10.1119/1.1532323
   Mark W. R., 1996, Computer Graphics Proceedings. SIGGRAPH '96, P447
   Matsui H, 1998, J CLIN INVEST, V102, P1125, DOI 10.1172/JCI2687
   Mermall V, 1998, SCIENCE, V279, P527, DOI 10.1126/science.279.5350.527
   Morio D, 2000, J DENT RES, V79, P468
   NICKLAS RB, 1983, J CELL BIOL, V97, P542, DOI 10.1083/jcb.97.2.542
   Peterman EJG, 2003, BIOPHYS J, V84, P1308, DOI 10.1016/S0006-3495(03)74946-7
   Pralle A, 1999, MICROSC RES TECHNIQ, V44, P378, DOI 10.1002/(SICI)1097-0029(19990301)44:5<378::AID-JEMT10>3.0.CO;2-Z
   Pralle A, 1998, APPL PHYS A-MATER, V66, pS71, DOI 10.1007/s003390051102
   RAUTIAINEN M, 1992, ACTA OTO-LARYNGOL, V112, P845, DOI 10.3109/00016489209137483
   RIEDER CL, 1994, J CELL BIOL, V124, P223, DOI 10.1083/jcb.124.3.223
   Rief M, 2000, P NATL ACAD SCI USA, V97, P9482, DOI 10.1073/pnas.97.17.9482
   RUBIN BK, 2002, RESP CARE, V23, P761
   SANDERSON MJ, 1981, J CELL SCI, V47, P331
   Schmitz KA, 2000, BIOPHYS J, V79, P468, DOI 10.1016/S0006-3495(00)76308-9
   Scholey JM, 2003, NATURE, V422, P746, DOI 10.1038/nature01599
   Signor D, 2000, Essays Biochem, V35, P89
   Skibbens RV, 1997, EXP CELL RES, V235, P314, DOI 10.1006/excr.1997.3691
   STOSSEL TP, 1993, SCIENCE, V260, P1086, DOI 10.1126/science.8493552
   Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835
   TEUNIS PFM, 1994, BIOPHYS J, V67, P381, DOI 10.1016/S0006-3495(94)80493-X
   VALBERG PA, 1985, J CELL BIOL, V101, P130, DOI 10.1083/jcb.101.1.130
   VICCI L, 2001, DEPT COMPUTER SCI U, pTR1
   Visscher K, 1999, NATURE, V400, P184
   Wallace RA, 1981, BIOL SCI LIFE
   Wilson KS, 1998, CELL, V92, P337, DOI 10.1016/S0092-8674(00)80927-7
   Wintermeyer W, 2000, Essays Biochem, V35, P117
   YIN H, 1995, SCIENCE, V270, P1653, DOI 10.1126/science.270.5242.1653
   ZIEMANN F, 1994, BIOPHYS J, V66, P2210, DOI 10.1016/S0006-3495(94)81017-3
   1996, ANN BOOK STANDARDS
NR 62
TC 26
Z9 26
U1 0
U2 19
PU AMER INST PHYSICS
PI MELVILLE
PA CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1,
   MELVILLE, NY 11747-4501 USA
SN 0034-6748
J9 REV SCI INSTRUM
JI Rev. Sci. Instrum.
PD MAY
PY 2005
VL 76
IS 5
AR 053711
DI 10.1063/1.1914777
PG 11
WC Instruments & Instrumentation; Physics, Applied
SC Instruments & Instrumentation; Physics
GA 925PF
UT WOS:000229064300037
DA 2018-10-19
ER

PT J
AU Feili, D
   Schuettler, M
   Doerge, T
   Kammer, S
   Stieglitz, T
AF Feili, D
   Schuettler, M
   Doerge, T
   Kammer, S
   Stieglitz, T
TI Encapsulation of organic field effect transistors for flexible
   biomedical microimplants
SO SENSORS AND ACTUATORS A-PHYSICAL
LA English
DT Article
DE organic field effect transistor; polyimide; microimplants; parylene;
   encapsulation; neural prostheses
ID THIN-FILM TRANSISTORS; MICROELECTRODE ARRAY; PENTACENE; MOBILITY
AB Biomedical microimplants are used as neural prostheses to restore body functions after paraplegia by means of functional electrical stimulation (FES). This paper describes an approach of the integration of organic transistors into flexible biomedical microimplant for FES use. Encapsulation is used to ensure the electrical functionality of implants (insulation) and to protect them from the harsh environments in the human body. So far, biomedical microdevices have been fabricated using silicon or polyimide substrate, respectively. Highly flexible polyimide based microdevices that have been interfaced with nerves as neural prostheses showed excellent properties as implant material [1-3]. Therefore, we have developed transistors on polyimide, which is used as flexible substrate. Gold was sputtered as gate, drain and source. Silicon oxide formed the gate insulator and pentacene (C14H22) was evaporated at ultra high vacuum (UHV) and 75 degrees C substrate temperature as active layer in an organic field effect transistor (OFET). Parylene is used as encapsulation material. First transistors have been fabricated and characterized. So far, they are still in low scale integration. The first investigation on the electrical properties of the OFETs before and after encapsulation with Parylene at room temperature led to promising results. (c) 2004 Elsevier B.V. All rights reserved.
C1 Fraunhofer Inst Biomed Engn, Neural Prosthet Grp, D-66386 St Ingbert, Germany.
   UCL, Dept Med Phys, London WC1E 6JA, England.
   UCL, Bioengn Implanted Devices Grp, London WC1E 6JA, England.
RP Feili, D (reprint author), Fraunhofer Inst Biomed Engn, Neural Prosthet Grp, Ensheimer Str 48, D-66386 St Ingbert, Germany.
EM dara.feili@ibmt.fraunhofer.de
RI Stieglitz, Thomas/C-7916-2013
OI Stieglitz, Thomas/0000-0002-7349-4254
CR Dimitrakopoulos CD, 2001, IBM J RES DEV, V45, P11, DOI 10.1147/rd.451.0011
   Dimitrakopoulos CD, 1996, J APPL PHYS, V80, P2501, DOI 10.1063/1.363032
   Dimitrakopoulos CD, 1999, SCIENCE, V283, P822, DOI 10.1126/science.283.5403.822
   GORHAM WF, 1966, J POLYM SCI A1, V4, P3027, DOI 10.1002/pol.1966.150041209
   Gundlach DJ, 1997, IEEE ELECTR DEVICE L, V18, P87, DOI 10.1109/55.556089
   Horowitz G, 1998, ADV MATER, V10, P365, DOI 10.1002/(SICI)1521-4095(199803)10:5<365::AID-ADMA365>3.0.CO;2-U
   IHANTOLA HKJ, 1964, SOLID STATE ELECTRON, V7, P423, DOI 10.1016/0038-1101(64)90039-5
   Jackson TN, 1998, IEEE J SEL TOP QUANT, V4, P100, DOI 10.1109/2944.669475
   KENNEDY DP, 1973, IBM J RES DEV, V17, P1, DOI 10.1147/rd.171.0002
   Lin YY, 1997, IEEE T ELECTRON DEV, V44, P1325, DOI 10.1109/16.605476
   Lin YY, 1997, IEEE ELECTR DEVICE L, V18, P606, DOI 10.1109/55.644085
   MATSUO Y, 2000, SYNTHETIC MET, V121, P408
   MINAKATA T, 1993, J APPL PHYS, V74, P1079, DOI 10.1063/1.354955
   Nelson SF, 1998, APPL PHYS LETT, V72, P1854, DOI 10.1063/1.121205
   PHILIPPOW E, 1987, TASCHENBUCH ELEKTROT, V2, P920
   Sandison M, 2002, J NEUROSCI METH, V114, P63, DOI 10.1016/S0165-0270(01)00509-X
   Schwarz M, 2000, SENSOR ACTUAT A-PHYS, V83, P40, DOI 10.1016/S0924-4247(00)00290-9
   Steiger J, 2001, SYNTHETIC MET, V122, P49, DOI 10.1016/S0379-6779(00)01359-X
   Stieglitz T, 1997, SENSOR ACTUAT A-PHYS, V60, P240, DOI 10.1016/S0924-4247(97)01494-5
   Suaning GJ, 2003, SENSOR ACTUAT A-PHYS, V108, P155, DOI 10.1016/j.sna.2003.07.002
   Swiggers ML, 2001, APPL PHYS LETT, V79, P1300, DOI 10.1063/1.1394952
   Takahashi H, 2003, IEEE T BIO-MED ENG, V50, P510, DOI 10.1109/TBME.2003.809483
   Thompson RW, 2003, INVEST OPHTH VIS SCI, V44, P5035, DOI 10.1167/iovs.03-0341
   Ulman A., 1991, INTRO ULTRATHIN ORGA
   WANG J, 1999, 41 EL MAT C SANT BAR, P16
NR 25
TC 47
Z9 48
U1 0
U2 29
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0924-4247
J9 SENSOR ACTUAT A-PHYS
JI Sens. Actuator A-Phys.
PD APR 29
PY 2005
VL 120
IS 1
BP 101
EP 109
DI 10.1016/j.sna.2004.11.021
PG 9
WC Engineering, Electrical & Electronic; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA 921NG
UT WOS:000228770700014
DA 2018-10-19
ER

PT J
AU Mano, JF
AF Mano, JF
TI Viscoelastic properties of bone: Mechanical spectroscopy studies on a
   chicken model
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT Conference of the NATO-Advanced-Study-Institute on Learning from Nature
   How to Design New Implantable Biomaterials
CY OCT 13-24, 2003
CL Alvor, PORTUGAL
DE biocomposites; bone viscoelasticity; complex modulus; DMA
ID HUMAN CORTICAL BONE; DEMINERALIZED BONE; COMPACT-BONE; COLLAGEN; BOVINE;
   ATTENUATION; TEMPERATURE; BEHAVIOR
AB The mechanical behaviour of bone exhibits a time-dependent response, as a consequence of its viscoelastic character. New materials for biomedical applications should have similar time-dependent mechanical behaviour as bone (viscoelastic biocompatibility). Hence, it is important to evaluate the properties of bone and to understand the underlying mechanism responsible for its damping features. In this work the solid-state theological properties were studied in chicken bone. Fresh ulna specimens were tested using dynamic mechanical analysis in the temperature range -50 to 80 &DEG; C, at a constant frequency of 1 Hz. A broad tan 6 peak was found between -50 and 30 &DEG; C, that was attributed to melting of water and molecular mobility involving collagen molecules. A minimum in the loss factor was detected at physiological temperature, which is consistent with isothermal results previously reported. It was hypothesised that this behaviour would have a physiological significance and could be associated to some damage process occurring within the organic phase caused by energy absorption during cyclic loading. This minimum is not detected in the demineralised bone or in collagen, indicating that the specific interactions between the collagen molecules and the apatite crystals, as well as the complex hierarchical organisation of the bone structure, are designed to reduce damping at functional time scales. A broad loss process was observed at low temperature in collagen. Local molecular motions at low temperatures occurring in collagen molecules could enhance bone toughness. Creep tests also revealed bone viscoelasticity features, and are useful to monitor irrecoverable strain upon static loads, which could be mainly a consequence of structural damage, rather than pure-viscous flow. &COPY; 2005 Elsevier B.V All rights reserved.
C1 Univ Minho, Dept Polymer Engn, P-4800058 Guimaraes, Portugal.
   Univ Minho, 3Bs Res Grp Biomat Biodegradable & Biomimet, P-4710057 Braga, Portugal.
RP Mano, JF (reprint author), Univ Minho, Dept Polymer Engn, Campus Azurem, P-4800058 Guimaraes, Portugal.
EM jmano@dep.uminho.pt
RI Group, 3Bs/E-4374-2012; Mano, Joao/A-4418-2009
OI Group, 3Bs/0000-0002-5195-3456; Mano, Joao/0000-0002-2342-3765
CR BONAR LC, 1970, J ULTRA MOL STRUCT R, V32, P545, DOI 10.1016/S0022-5320(70)80027-2
   Bowman SM, 1999, J BIOMECH ENG-T ASME, V121, P253, DOI 10.1115/1.2835112
   Buechner PM, 2001, ANN BIOMED ENG, V29, P719, DOI 10.1114/1.1385813
   CHIEN JCW, 1972, BIOPOLYMERS, V11, P2015, DOI 10.1002/bip.1972.360111003
   CURREY J, 1984, MECH ADAPTATION BONE
   Evans F. G., 1973, MECH PROPERTIES BONE
   Ferry J. D., 1980, VISCOELASTIC PROPERT
   Fois M, 2001, J APPL POLYM SCI, V79, P2527, DOI 10.1002/1097-4628(20010401)79:14<2527::AID-APP1061>3.0.CO;2-J
   FONDRK M, 1988, J BIOMECH, V21, P623, DOI 10.1016/0021-9290(88)90200-X
   Gao HJ, 2003, P NATL ACAD SCI USA, V100, P5597, DOI 10.1073/pnas.0631609100
   Garner E, 2000, J BIOMECH ENG-T ASME, V122, P166, DOI 10.1115/1.429638
   Johari GP, 1996, SCIENCE, V273, P90, DOI 10.1126/science.273.5271.90
   LAKES R, 1986, J BIOMED ENG, V8, P143, DOI 10.1016/0141-5425(86)90049-X
   LAKES R, 1979, SCIENCE, V204, P503
   LAKES RS, 1979, J BIOMECH, V12, P657, DOI 10.1016/0021-9290(79)90016-2
   LAKES RS, 1979, J BIOMECH, V12, P679, DOI 10.1016/0021-9290(79)90017-4
   LANDIS WJ, 1995, BONE, V16, P533, DOI 10.1016/8756-3282(95)00076-P
   LEE S, 1981, CALCIFIED TISSUE INT, V33, P591
   Mano J. F., 2002, POLYM BASED SYSTEMS
   Mano JF, 2004, POLYM TEST, V23, P423, DOI 10.1016/j.polymertesting.2003.09.011
   Nalla RK, 2003, NAT MATER, V2, P164, DOI 10.1038/nmat832
   NGUYEN AL, 1974, BIOPOLYMERS, V13, P1023, DOI 10.1002/bip.1974.360130516
   Oliveira AL, 2003, CURR OPIN SOLID ST M, V7, P309, DOI 10.1016/j.cossms.2003.10.009
   Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1
   Schaller R, 2004, MAT SCI ENG A-STRUCT, V370, P569, DOI 10.1016/j.msea.2003.08.107
   Smith BL, 1999, NATURE, V399, P761, DOI 10.1038/21607
   Thompson JB, 2001, NATURE, V414, P773, DOI 10.1038/414773a
   Toyras J, 2002, BONE, V31, P503, DOI 10.1016/S8756-3282(02)00843-8
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Weiner S, 1997, J MATER CHEM, V7, P689, DOI 10.1039/a604512j
   WOLFF J, 1892, GESETZ TRANFORMATION
   Woo L, 1996, THERMOCHIM ACTA, V284, P57, DOI 10.1016/0040-6031(96)02890-0
   WOO L, 1994, POLYM ENG SCI, V34, P420, DOI 10.1002/pen.760340507
   Yamashita J, 2002, J BIOMED MATER RES, V63, P31, DOI 10.1002/jbm.10086
   Yamashita J, 2001, J BIOMED MATER RES, V58, P47, DOI 10.1002/1097-4636(2001)58:1<47::AID-JBM70>3.0.CO;2-U
NR 35
TC 35
Z9 36
U1 0
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD APR 28
PY 2005
VL 25
IS 2
BP 145
EP 152
DI 10.1016/j.msec.2005.01.017
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA 932EA
UT WOS:000229535800007
DA 2018-10-19
ER

PT J
AU Silva, GA
   Pedro, A
   Costa, FJ
   Neves, NM
   Coutinho, OP
   Reis, RL
AF Silva, GA
   Pedro, A
   Costa, FJ
   Neves, NM
   Coutinho, OP
   Reis, RL
TI Soluble starch and composite starch Bioactive Glass 45S5 particles:
   Synthesis, bioactivity, and interaction with rat bone marrow cells
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT Conference of the NATO-Advanced-Study-Institute on Learning from Nature
   How to Design New Implantable Biomaterials
CY OCT 13-24, 2003
CL Alvor, PORTUGAL
DE starch-based; bioactive glass; rat bone marrow cells; bioactivity; Ca-P
   layer; cytotoxicity
ID IN-VITRO SYNTHESIS; BIOMATERIALS; PROLIFERATION; TISSUE;
   DIFFERENTIATION; HYDROXYAPATITE; DEGRADATION; OSTEOBLASTS; SCAFFOLDS;
   POLYMERS
AB For many biomedical applications, biodegradable and simultaneously bioactive materials are desired. These materials should at the same time be able to support cell function and co-exist with the organism without triggering a relevant immune response.
   In this work, the synthesis as well as the bioactivity evaluation of newly developed polymer soluble potato starch and composite (with Bioactive Glass 45S5) micron-size particles are reported. An extremely interesting result is that although with different properties, both polymer and composite particles were able to form a calcium phosphate layer at their surface, which is a clear indication of their bioactivity.
   The cytotoxicity and the ability to support cell attachment and growth of the developed materials were also studied, and both polymer and composite materials were shown to be non-cytotoxic. Preliminary results show that both types of materials were found to allow rat bone marrow cells to attach and to proliferate on their surface and to express osteogenic markers, such as alkaline phosphatase and osteopontin.
   The obtained results indicate that the developed carriers might be used as substrates for cell culture in vitro, in order to form constructs that might be used as a part of a tissue engineering strategy. &COPY; 2005 Elsevier B.V. All rights reserved.
C1 Univ Minho, 3Bs Res Grp Biomat Biodegradables Biomimet, P-4710057 Braga, Portugal.
   Univ Minho, Dept Polymer Engn, P-4800058 Guimaraes, Portugal.
   Univ Minho, Dept Biol, P-4710057 Braga, Portugal.
RP Silva, GA (reprint author), Univ Minho, 3Bs Res Grp Biomat Biodegradables Biomimet, Campus Gualtar, P-4710057 Braga, Portugal.
EM gsilva@dep.uminho.pt
RI Pedro, Adriano/B-5519-2012; Group, 3Bs/E-4374-2012; Coutinho,
   Olga/K-7155-2013; silva, gabriela/F-4409-2012; Neves, Nuno/B-4685-2008;
   Reis, Rui L./A-8938-2008
OI Pedro, Adriano/0000-0002-1653-1725; Group, 3Bs/0000-0002-5195-3456;
   silva, gabriela/0000-0001-5946-1918; Neves, Nuno/0000-0003-3041-0687;
   Reis, Rui L./0000-0002-4295-6129; Coutinho, Olga/0000-0002-0647-080X
CR Azevedo HS, 2003, BIOMACROMOLECULES, V4, P1703, DOI 10.1021/bm0300397
   Cenni E, 1999, TOXICOL IN VITRO, V13, P801, DOI 10.1016/S0887-2333(99)00058-2
   DUCHEYNE P, 1994, J CELL BIOCHEM, V56, P162, DOI 10.1002/jcb.240560207
   ELGHANNAM A, 1995, J BIOMED MATER RES, V29, P359, DOI 10.1002/jbm.820290311
   Gomes ME, 2003, J BIOMED MATER RES A, V67A, P87, DOI 10.1002/jbm.a.10075
   Kirkpatrick CJ, 2002, BIOMOL ENG, V19, P211, DOI 10.1016/S1389-0344(02)00019-9
   Knabe C, 1997, BIOMATERIALS, V18, P1339, DOI 10.1016/S0142-9612(97)00078-1
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Leonor IB, 2003, J MATER SCI-MATER M, V14, P435, DOI 10.1023/A:1023214918592
   Leonor IB, 2003, BIOMATERIALS, V24, P579, DOI 10.1016/S0142-9612(02)00371-X
   LI PJ, 1993, BIOMATERIALS, V14, P963, DOI 10.1016/0142-9612(93)90186-6
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   Marques AP, 2002, BIOMATERIALS, V23, P1471, DOI 10.1016/S0142-9612(01)00272-1
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   OHGUSHI H, 1994, MAT SCI ENG C-BIOMIM, V1, P139, DOI 10.1016/0928-4931(94)90045-0
   Oliveira AL, 2003, BIOMATERIALS, V24, P2575, DOI 10.1016/S0142-9612(03)00060-7
   Oliveira AL, 1999, J MATER SCI-MATER M, V10, P827, DOI 10.1023/A:1008900428325
   Reis RL, 1997, ADV POLYM TECH, V16, P263, DOI 10.1002/(SICI)1098-2329(199711)16:4<263::AID-ADV2>3.0.CO;2-T
   Reis RL, 1999, MOD PLAST, V76, P73
   Rosa AL, 2003, DENT MATER, V19, P768, DOI 10.1016/S0109-5641(03)00024-1
   Salgado AJ, 2002, MAT SCI ENG C-BIO S, V20, P27, DOI 10.1016/S0928-4931(02)00009-7
   Schroeder A, 2000, BIOMATERIALS, V21, P449, DOI 10.1016/S0142-9612(99)00135-0
   Silva GA, 2004, J BIOMED MATER RES A, V70A, P442, DOI 10.1002/jbm.a.30099
   Silva GA, 2003, J MATER SCI-MATER M, V14, P1055, DOI 10.1023/B:JMSM.0000004002.11278.30
   SLATER TF, 1963, BIOCHIM BIOPHYS ACTA, V77, P383, DOI 10.1016/0006-3002(63)90513-4
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Tanahashi M, 1997, J BIOMED MATER RES, V34, P305
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
   Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183
NR 29
TC 20
Z9 20
U1 0
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD APR 28
PY 2005
VL 25
IS 2
BP 237
EP 246
DI 10.1016/j.msec.2005.01.012
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA 932EA
UT WOS:000229535800018
DA 2018-10-19
ER

PT J
AU Matousek, P
   Clark, IP
   Draper, ERC
   Morris, MD
   Goodship, AE
   Everall, N
   Towrie, M
   Finney, WF
   Parker, AW
AF Matousek, P
   Clark, IP
   Draper, ERC
   Morris, MD
   Goodship, AE
   Everall, N
   Towrie, M
   Finney, WF
   Parker, AW
TI Subsurface probing in diffusely scattering media using spatially offset
   Raman spectroscopy
SO APPLIED SPECTROSCOPY
LA English
DT Article
DE Raman spectroscopy; Confocal microscopy; diffuse scattering; turbid
   media; photon migration; optical tomography
ID TARGET ENTROPY MINIMIZATION; PHOTON MIGRATION; FLUORESCENCE; BTEM;
   SPECTRA; REJECTION; MIXTURES
AB We describe a simple methodology for the effective retrieval of Raman spectra of subsurface layers in diffusely scattering media. The technique is based on the collection of Raman scattered light from surface regions that are laterally offset away from the excitation laser spot on the sample. The Raman spectra obtained in this way exhibit a variation in relative spectral intensities of the surface and subsurface layers of the sample being investigated. The data set is processed using a multivariate data analysis to yield pure Raman spectra of the individual sample layers, providing a method for the effective elimination of surface Raman scatter. The methodology is applicable to the retrieval of pure Raman spectra from depths well in excess of those accessible with conventional confocal microscopy. In this first feasibility study we have differentiated between surface and subsurface Raman signals within a diffusely scattering sample composed of two layers: trans-stilbene powder beneath a I rum thick over-layer of PMMA (poly(methyl methacrylate)) powder. The improvement in contrast of the subsurface trans-stilbene layer without numerical processing was 19 times. The potential applications include biomedical subsurface probing of specific tissues through different overlying tissues such as assessment of bone quality through skin, providing an effective noninvasive means of screening for bone degeneration, other skeletal disease diagnosis, and dermatology studies, as well as materials and catalyst research.
C1 Rutherford Appleton Lab, CCLRC, Cent Laser Facil, Didcot OX11 0QX, Oxon, England.
   Univ London Royal Vet Coll, Hatfield AL9 7TA, Herts, England.
   Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.
   Wilton Res Ctr, ICI PLC, Redcar TS10 4RF, Cleveland, England.
RP Matousek, P (reprint author), Rutherford Appleton Lab, CCLRC, Cent Laser Facil, Didcot OX11 0QX, Oxon, England.
RI Parker, Anthony/G-5445-2011; Morris, Michael/A-9327-2009; Matousek,
   Pavel/D-5750-2011
OI Parker, Anthony/0000-0003-3094-9762; Matousek, Pavel/0000-0003-0912-5339
FU NIAMS NIH HHS [P30 AR46024]
CR Brenan CJH, 1996, J RAMAN SPECTROSC, V27, P561, DOI 10.1002/(SICI)1097-4555(199608)27:8<561::AID-JRS7>3.3.CO;2-0
   Carden A, 2000, J BIOMED OPT, V5, P259, DOI 10.1117/1.429994
   Chew W, 2002, ORGANOMETALLICS, V21, P1982, DOI 10.1021/om0108752
   Das BB, 1997, REP PROG PHYS, V60, P227, DOI 10.1088/0034-4885/60/2/002
   Everall N, 2004, APPL SPECTROSC, V58, P591, DOI 10.1366/000370204774103426
   Everall N, 2001, APPL SPECTROSC, V55, P1701, DOI 10.1366/0003702011954053
   Koizumi H, 1999, J BIOMED OPT, V4, P403, DOI 10.1117/1.429959
   Li CZ, 2003, J CATAL, V213, P126, DOI 10.1016/S0021-9517(02)00009-X
   Lieber CA, 2003, APPL SPECTROSC, V57, P1363, DOI 10.1366/000370203322554518
   Matousek P, 2001, J RAMAN SPECTROSC, V32, P983, DOI 10.1002/jrs.784
   Matousek P, 1999, APPL SPECTROSC, V53, P1485, DOI 10.1366/0003702991945993
   MATOUSEK P, 2005, APPL SPECTROSC, V59, P300
   TUCHIN V, 2000, TISSUE OPTICS LIGHT, P3
   Widjaja E, 2003, APPL SPECTROSC, V57, P1353, DOI 10.1366/000370203322554509
   Widjaja E, 2002, ORGANOMETALLICS, V21, P1991, DOI 10.1021/om010933j
   Widjaja E, 2003, ANAL CHEM, V75, P4499, DOI 10.1021/ac0263622
   WU J, 1995, APPL OPTICS, V34, P3425, DOI 10.1364/AO.34.003425
NR 17
TC 268
Z9 270
U1 9
U2 91
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0003-7028
EI 1943-3530
J9 APPL SPECTROSC
JI Appl. Spectrosc.
PD APR
PY 2005
VL 59
IS 4
BP 393
EP 400
DI 10.1366/0003702053641450
PG 8
WC Instruments & Instrumentation; Spectroscopy
SC Instruments & Instrumentation; Spectroscopy
GA 914NP
UT WOS:000228234900001
PM 15901323
DA 2018-10-19
ER

PT J
AU Niinomi, M
   Hanawa, T
   Narushima, T
AF Niinomi, M
   Hanawa, T
   Narushima, T
TI Japanese research and development on metallic biomedical, dental, and
   healthcare materials
SO JOM
LA English
DT Article
ID SURFACE OXIDE-FILM; QUASI-BIOLOGICAL ENVIRONMENTS; AUSTENITIC
   STAINLESS-STEEL; NB-TA-ZR; SHAPE-MEMORY; MECHANICAL-PROPERTIES; FATIGUE
   PROPERTIES; TITANIUM-ALLOY; CYTOTOXICITY EVALUATION; CRYSTAL ORIENTATION
AB There is considerable demand for metallic materials for use in medical and dental devices. Metals and alloys are widely used as biomedical materials and are indispensable in the medical field. In dentistry, metal is used for restorations, orthodontic wires, and dental implants. This article describes R&D on metallic biomaterials primarily conducted by the members of the Japan Institute of Metals.
C1 Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418580, Japan.
   Tokyo Med & Dent Univ, Tokyo, Japan.
   Tohoku Univ, Sendai, Miyagi 980, Japan.
RP Niinomi, M (reprint author), Toyohashi Univ Technol, Dept Prod Syst Engn, 1-1 Hibarigaoka,Tempaku Cho, Toyohashi, Aichi 4418580, Japan.
EM niinomi@sp-Mac4.tutpse.tut.ac.jp
RI Niinomi, Mitsuo/B-5965-2011
CR Akahori T, 2004, MATER TRANS, V45, P1540, DOI 10.2320/matertrans.45.1540
   Akahori T, 2003, J JPN I MET, V67, P652, DOI 10.2320/jinstmet1952.67.11_652
   Akahori T, 2002, J JPN I MET, V66, P715, DOI 10.2320/jinstmet1952.66.7_715
   Chiba A, 2005, MATER SCI FORUM, V475-479, P2317, DOI 10.4028/www.scientific.net/MSF.475-479.2317
   CLEMOW AJT, 1980, WEAR, V61, P219, DOI 10.1016/0043-1648(80)90287-2
   COOPER CV, 1989, J TRIBOL-T ASME, V111, P668, DOI 10.1115/1.3261993
   HANAWA T, 1991, BONE-BIOMATERIAL INTERFACE, P49
   Hanawa T, 2004, MATER TRANS, V45, P1635, DOI 10.2320/matertrans.45.1635
   Hanawa T, 2002, MATER TRANS, V43, P3088, DOI 10.2320/matertrans.43.3088
   Hanawa T, 2002, MATER TRANS, V43, P3000, DOI 10.2320/matertrans.43.3000
   HANAWA T, 1992, J JPN I MET, V56, P1168, DOI 10.2320/jinstmet1952.56.10_1168
   HANAWA T, 1992, APPL SURF SCI, V55, P269, DOI 10.1016/0169-4332(92)90178-Z
   HANAWA T, 1991, BIOMATERIALS, V12, P767, DOI 10.1016/0142-9612(91)90028-9
   Hanawa T, 2001, APPL SURF SCI, V183, P68, DOI 10.1016/S0169-4332(01)00551-7
   HANAWA T, P 4 AS INT S BIOM AI, P67
   Hiromoto S, 2004, BIOMATERIALS, V25, P979, DOI 10.1016/S0142-9612(03)00620-3
   Hiromoto S, 2002, ELECTROCHIM ACTA, V48, P387, DOI 10.1016/S0013-4686(02)00684-9
   Hiromoto S, 2002, MATER TRANS, V43, P261, DOI 10.2320/matertrans.43.261
   Hiromoto S, 2002, CORROS SCI, V44, P955, DOI 10.1016/S0010-938X(01)00110-X
   Hiromoto S, 2001, MATER TRANS, V42, P656, DOI 10.2320/matertrans.42.656
   Hiromoto S, 2001, CORROS SCI, V43, P1767, DOI 10.1016/S0010-938X(00)00168-2
   HOSODA H, 2004, J JPN SOC MECH ENG, V107, P509
   Hosoda H, 2001, T MRS J, V26, P243
   Ikeda M, 2004, MATER TRANS, V45, P1566, DOI 10.2320/matertrans.45.1566
   Ikeda M, 2004, MATER TRANS, V45, P1106, DOI 10.2320/matertrans.45.1106
   Inamura T, 2004, MATER TRANS, V45, P1083, DOI 10.2320/matertrans.45.1083
   Inoue A, 2000, ACTA MATER, V48, P279, DOI 10.1016/S1359-6454(99)00300-6
   Inoue K, 2003, KEY ENG MATER, V240-2, P513, DOI 10.4028/www.scientific.net/KEM.240-242.513
   Kasuga T, 2001, BIOMATERIALS, V22, P577, DOI 10.1016/S0142-9612(00)00216-7
   KAWASAKI H, 2003, P FALL M JPN I MET, P130
   Kim HY, 2004, MATER TRANS, V45, P1090, DOI 10.2320/matertrans.45.1090
   Kuroda D, 2002, MATER TRANS, V43, P3100, DOI 10.2320/matertrans.43.3100
   Kuroda D, 2002, MATER TRANS, V43, P3093, DOI 10.2320/matertrans.43.3093
   Li SJ, 2004, WEAR, V257, P869, DOI 10.1016/j.wear.2004.04.001
   Maeshima T, 2004, MATER TRANS, V45, P1101, DOI 10.2320/matertrans.45.1101
   Maeshima T, 2004, MATER TRANS, V45, P1096, DOI 10.2320/matertrans.45.1096
   Mano T, 2004, MATER TRANS, V45, P1601, DOI 10.2320/matertrans.45.1601
   MARUYAMA N, 1999, J JPN SOC BIOMATER, V17, P172
   Mizumoto T, 2002, MATER TRANS, V43, P3160, DOI 10.2320/matertrans.43.3160
   MRUYAMA N, 2000, J JPN I BIOMATERIALS, V18, P17
   Mu Y, 2000, J BIOMED MATER RES, V49, P238, DOI 10.1002/(SICI)1097-4636(200002)49:2<238::AID-JBM12>3.0.CO;2-J
   Nakano T, 2002, BONE, V31, P479, DOI 10.1016/S8756-3282(02)00850-5
   Nakano T, 2004, MATER SCI FORUM, V449-4, P1289, DOI 10.4028/www.scientific.net/MSF.449-452.1289
   Nakazawa K, 1999, J JPN I MET, V63, P1600, DOI 10.2320/jinstmet1952.63.12_1600
   Niinomi M, 2005, MATER SCI FORUM, V475-479, P2303, DOI 10.4028/www.scientific.net/MSF.475-479.2303
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   NIINOMI M, 2002, MAT T, V43
   NIINOMI M, 2002, J IRON STEEL I JPN, V88, P553
   Niinomi M., 2004, BIOMATERIALS ORTHOPE, P41
   NIINOMI M, IN PRESS MAT SCI ENG
   NIINOMI M, 2002, J IRON STEEL I JPN, V88, P567
   Niinomi M, 2003, SCI TECHNOL ADV MAT, V4, P445, DOI 10.1016/j.stam.2003.09.002
   NINOMI M, 2002, P FAT 2002, V3, P2073
   Nishio K, 2004, MATER TRANS, V45, P1613, DOI 10.2320/matertrans.45.1613
   NITTA K, 2001, STRUCTURAL BIOMATERI
   Ogata Y, 2004, MATER TRANS, V45, P1070, DOI 10.2320/matertrans.45.1070
   Ohtsu N, 2004, MATER TRANS, V45, P1778, DOI 10.2320/matertrans.45.1778
   OKAZAKI M, 2004, MAT JAPAN, V43, P182
   Okazaki Y, 2000, MATER T JIM, V41, P1247, DOI 10.2320/matertrans1989.41.1247
   Okazaki Y, 2004, BIOMATERIALS, V25, P5913, DOI 10.1016/j.biomaterials.2004.01.064
   Okazaki Y, 2002, MATER TRANS, V43, P3134, DOI 10.2320/matertrans.43.3134
   Okazaki Y, 2005, BIOMATERIALS, V26, P11, DOI 10.1016/j.biomaterials.2004.02.005
   OKAZAKI Y, 2002, MAT T, V43, P2936
   Okido M, 2002, SOLID STATE IONICS, V151, P47, DOI 10.1016/S0167-2738(02)00603-3
   Okuyama M, 2004, MATER TRANS, V45, P1045, DOI 10.2320/matertrans.45.1045
   OU A, 2003, P ANN M JPN I MET SE, P326
   OZAWA A, 2001, J JPN SOC DENT MAT D, V38, P20
   Sakaguch N, 2004, MATER TRANS, V45, P1113, DOI 10.2320/matertrans.45.1113
   SRRIMANEEPONG V, P 4 AS INT S BIOM AI, P237
   Takahashi S., 2000, J JAPANESE SOC DENT, V19, P162
   Takamura R, 1997, J DENT RES, V76, P1177
   Tamura Y, 2002, MATER TRANS, V43, P3043, DOI 10.2320/matertrans.43.3043
   TOYOSHIMA K, 2003, P ANN M JPN I MET SE, P130
   Ueda K, 2005, MATER SCI FORUM, V475-479, P2333, DOI 10.4028/www.scientific.net/MSF.475-479.2333
   UENISHI K, 2002, MAT T, V43, P3065
   UGGOWITZER PJ, 1997, P ADV POWDER METAL P, V3
   van Dijk K, 1998, J BIOMED MATER RES, V41, P624, DOI 10.1002/(SICI)1097-4636(19980915)41:4<624::AID-JBM15>3.0.CO;2-E
   Yamamoto A, 2004, MAT SCI ENG C-BIO S, V24, P737, DOI 10.1016/j.msec.2004.08.017
   Yamamoto A, 1998, J BIOMED MATER RES, V39, P331, DOI 10.1002/(SICI)1097-4636(199802)39:2<331::AID-JBM22>3.0.CO;2-E
   Yamamoto A, 2004, J BIOMED MATER RES A, V68A, P244, DOI 10.1002/jbm.a.20020
   Yamamoto A, 2002, J BIOMED MATER RES, V59, P176, DOI 10.1002/jbm.1231
   YAMAMOTO A, 1995, P 4 JPN INT SAMPE S, P638
   YONEYAMA T, P 4 AS INT S BIOM AI, P241
   Yoshinari M, 2002, METALL MATER TRANS A, V33, P511, DOI 10.1007/s11661-002-0113-6
   Zhou YL, 2004, MATER TRANS, V45, P1549, DOI 10.2320/matertrans.45.1549
   Zhou YL, 2004, MAT SCI ENG A-STRUCT, V371, P283, DOI 10.1016/j.msea.2003.12.011
   ZHOU YL, 2003, P ATEM 03
NR 87
TC 39
Z9 41
U1 0
U2 8
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1047-4838
EI 1543-1851
J9 JOM-US
JI JOM
PD APR
PY 2005
VL 57
IS 4
BP 18
EP 24
DI 10.1007/s11837-005-0076-3
PG 7
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Mineralogy; Mining & Mineral Processing
SC Materials Science; Metallurgy & Metallurgical Engineering; Mineralogy;
   Mining & Mineral Processing
GA 914WU
UT WOS:000228259600002
DA 2018-10-19
ER

PT J
AU Fare, S
   Valtulina, V
   Petrini, P
   Alessandrini, E
   Pietrocola, G
   Tanzi, MC
   Speziale, P
   Visai, L
AF Fare, S
   Valtulina, V
   Petrini, P
   Alessandrini, E
   Pietrocola, G
   Tanzi, MC
   Speziale, P
   Visai, L
TI In vitro interaction of human fibroblasts and platelets with a
   shape-memory polyurethane
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE polyurethane; shape memory; cytocompatibility; fibroblasts; platelets;
   extracellular matrix (ECM) proteins
ID OLIGO(EPSILON-CAPROLACTONE) SEGMENTS; POLYCARBONATE URETHANES;
   BIOMEDICAL APPLICATIONS; SOFT-SEGMENT; POLYETHER; PROLIFERATION;
   FIBRONECTIN; STABILITY; INTEGRINS; POLYMERS
AB Physicochernical and mechanical properties, in vitro cytotoxicity, cytocompatibility, and platelet adhesion were investigated on a shape-memory polyether-based polyurethane (MM-5520 SMPu) using the polyether-based Pellethane 2363-80AE (Pell-2363 SPU) as reference. MM5520 SMPu and Pell-2363 SPU showed similar average molecular weights and different surface properties, with a higher hydrophilicity and roughness for the SMPu. By tensile tests and dynamic mechanical analysis, the peculiar characteristics of the MM-5520 SMPu were evidenced: strong temperature-dependent behavior for SMPu compared with SPU, and a high shape recovery. MM-5520 SMPu did not show any cytotoxic effect on the adhesion and proliferation of human skin fibroblasts and gingival fibroblasts, and a good cytocompatibility was observed with both cell types, as demonstrated by cell counting and scanning electron microscopy observations. SMPu compared with SPU showed higher adsorption of extracellular matrix proteins such as fibronectin, fibrinogen, and collagens. Proteins adsorbed onto SMPu significantly enhanced the adhesion and proliferation of human fibroblasts. The interaction of SMPu with platelets was studied with platelet rich plasma. Fewer platelets adhered to the SMPu, with minor morphological variations than onto the SPU. The cytocompatibility and hemocompatibility of MM-5520 SMPu combined with its unique properties such as change in shape or in stiffness, depending on practical requirements, make this shape-memory material potentially advantageous for biomedical applications. (c) 2005 Wiley Periodicals, Inc.
C1 Univ Pavia, Dept Biochem, I-27100 Pavia, Italy.
   Politecn Milan, Dept Bioengn, Biomat Lab, I-20133 Milan, Italy.
RP Visai, L (reprint author), Univ Pavia, Dept Biochem, Via Taramelli 3-B, I-27100 Pavia, Italy.
EM lvisai@unipv.it
RI Fare', Silvia/F-6484-2013; Tanzi, Maria Cristina/I-4620-2013; Petrini,
   Paola/A-3150-2013
OI Tanzi, Maria Cristina/0000-0002-4913-6633; Petrini,
   Paola/0000-0002-5081-5254; Fare', Silvia/0000-0002-0303-1131;
   PIETROCOLA, GIAMPIERO/0000-0002-7069-8155
CR Altankov G, 1996, J BIOMAT SCI-POLYM E, V8, P299
   AYAD S, 1994, EXTRACELLULAR MATRIX, P104
   FARE S, 2002, ADV MAT BIOMEDICAL A, P133
   FLATAU AB, 2000, ENG STRUCT, V224, P261
   GABEL K, 1991, BIOMATERIALS, V12, P597
   GOODMAN SL, 1984, SEM 1984, V1, P279
   GRAY AJ, 1993, J CELL SCI, V104, P409
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   Hayashi S, 1992, Patent No. [5145935, US 5,145,935 A]
   Hayashi S., 1993, INT PROGR URETHANES, V6, P90
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   ITO Y, 1989, CRIT REV BIOCOMPAT, V5, P45
   Jahangir AR, 2002, J BIOMED MATER RES, V60, P135, DOI 10.1002/jbm.10033
   JAHANGIR AR, 1986, BIOMED MAT RES, V20, P589
   Jeong HM, 2000, POLYMER, V41, P1849, DOI 10.1016/S0032-3861(99)00334-1
   Kim BK, 1998, POLYMER, V39, P2803, DOI 10.1016/S0032-3861(97)00616-2
   Kim BK, 1996, POLYMER, V37, P5781, DOI 10.1016/S0032-3861(96)00442-9
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lamba N. M. K., 1998, POLYURETHANES BIOMED
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lendlein A, 2002, ANGEW CHEM INT EDIT, V41, P2034, DOI 10.1002/1521-3773(20020617)41:12<2034::AID-ANIE2034>3.0.CO;2-M
   Lendlein A, 2001, P NATL ACAD SCI USA, V98, P842, DOI 10.1073/pnas.031571398
   LI F, 1996, J APPL POLYM SCI, V64, P1511
   Li FK, 1996, J APPL POLYM SCI, V62, P631, DOI 10.1002/(SICI)1097-4628(19961024)62:4<631::AID-APP6>3.0.CO;2-U
   Li FK, 1998, POLYMER, V39, P6929, DOI 10.1016/S0032-3861(98)00099-8
   Li Y, 1997, J APPL POLYM SCI, V63, P1173, DOI 10.1002/(SICI)1097-4628(19970228)63:9<1173::AID-APP9>3.0.CO;2-E
   LIPSCOMB P, 1996, APPL SHAPE MEMORY AL
   Metcalfe A, 2003, BIOMATERIALS, V24, P491, DOI 10.1016/S0142-9612(02)00362-9
   Monkman GJ, 2000, MECHATRONICS, V10, P489, DOI 10.1016/S0957-4158(99)00068-9
   NA GC, 1986, BIOCHEMISTRY-US, V25, P958, DOI 10.1021/bi00353a003
   OTSUDA K, 1998, SHAPE MEMORY MAT
   Park JC, 2000, J BIOMED MATER RES, V52, P669, DOI 10.1002/1097-4636(20001215)52:4<669::AID-JBM11>3.3.CO;2-L
   PARK K, 1986, J BIOMED MATER RES, V20, P589, DOI 10.1002/jbm.820200506
   Planck H, 1987, PROGR BIOMEDICAL ENG
   REESE CA, 1981, BIOCHEMISTRY-US, V20, P5443, DOI 10.1021/bi00522a014
   Rickert D, 2003, J BIOMED MATER RES B, V67B, P722, DOI 10.1002/jbm.b.10069
   RUOSLAHTI E, 1994, CELL, V77, P477, DOI 10.1016/0092-8674(94)90209-7
   Tanzi MC, 1997, J BIOMED MATER RES, V36, P550, DOI 10.1002/(SICI)1097-4636(19970915)36:4<550::AID-JBM14>3.0.CO;2-E
   Tanzi MC, 2000, J BIOMATER APPL, V14, P325, DOI 10.1106/7TJU-H1YA-4NYT-XL84
   TOBUSHI H, 1997, J INTELL MAT SYS AUG, P24
   TUCCI V, 1995, ANTEC 95 - THE PLASTICS CHALLENGER: A REVOLUTION IN EDUCATION, CONFERENCE PROCEEDINGS, VOLS I-III, P2102
   TUSZYNSKI GP, 1990, ANAL BIOCHEM, V184, P184
   van Wachem PB, 2002, BIOMATERIALS, V23, P1401, DOI 10.1016/S0142-9612(01)00174-0
   Visai L, 2002, J BIOMATER APPL, V16, P191, DOI 10.1106/088532802021175
   VUENTO M, 1979, BIOCHEM J, V183, P331, DOI 10.1042/bj1830331
   Wache HM, 2003, J MATER SCI-MATER M, V14, P109, DOI 10.1023/A:1022007510352
   Wang MT, 1998, EUR POLYM J, V34, P1, DOI 10.1016/S0014-3057(97)00082-7
   WARD RS, 1985, MD DI            AUG, P24
   Zdrahala RJ, 1999, J BIOMATER APPL, V14, P67, DOI 10.1177/088532829901400104
NR 49
TC 28
Z9 28
U1 2
U2 19
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR 1
PY 2005
VL 73A
IS 1
BP 1
EP 11
DI 10.1002/jbm.a.30193
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 906ZR
UT WOS:000227684500001
PM 15704114
DA 2018-10-19
ER

PT J
AU Day, RM
   Boccaccini, AR
AF Day, RM
   Boccaccini, AR
TI Effect of particulate bioactive glasses on human macrophages and
   monocytes in vitro
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE bioactive glass; cytokines; inflammation; macrophage
ID TISSUE ENGINEERING APPLICATIONS; OSTEOBLAST-LIKE CELLS;
   TUMOR-NECROSIS-FACTOR; MECHANICAL-PROPERTIES; MOLECULAR-MECHANISMS;
   BIOMEDICAL MATERIALS; COMPOSITES; BIOLOGY; SYSTEM; ZINC
AB Bioactive glasses, originally developed to promote tissue adhesion, are finding an increasing array of biomedical applications. The aim of the current study was to assess the ability of silicate- and zinc phosphate-based bioactive glasses to modulate the secretion of cytokines from activated human macrophages and monocytes. Human macrophages and monocytes were isolated and cultured on surfaces coated with a range of quantities of the bioactive glasses. Nontoxic concentrations of the glasses were selected and assessed further for their ability to modulate the secretion of tumor necrosis factor (TNF)-alpha, interleukin (IL)-10 and -6, in the presence or absence of the stimulant lipopolysaccharide. 45S5 glass produced a significant reduction to the amount of TNF-alpha (p < 0.05) and IL-6 (p < 0.01) secreted by stimulated cells compared with cells stimulated in the absence of bioactive glass. A significant reduction in IL-6 secretion was also observed with the other silicate- and zinc phosphate-based glasses tested. IL-10 secretion was increased (but not significantly) in presence of all glasses tested. TNF-alpha and IL-6 secretion from stimulated cells was lower in presence of the silicate glasses compared with the zinc phosphate glasses, indicating that this system of bioactive glass might be of clinical use in conditions associated with inflammation. (c) 2005 Wiley Periodicals, Inc.
C1 Univ London Kings Coll, Burdett Inst Gastrointestinal Nursing, Biomat & Tissue Engn Grp, Harrow HA1 3UJ, Middx, England.
   St Marks Hosp, Harrow HA1 3UJ, Middx, England.
   Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2BP, England.
   Univ London Imperial Coll Sci Technol & Med, Ctr Tissue Engn & Regenerat Med, London SW7 2BP, England.
RP Day, RM (reprint author), Univ London Kings Coll, Burdett Inst Gastrointestinal Nursing, Biomat & Tissue Engn Grp, Watford Rd, Harrow HA1 3UJ, Middx, England.
EM richard.day@kcl.ac.uk
RI Day, Richard/C-5725-2009; Boccaccini, Aldo/C-7905-2013
CR Ahmed I, 2004, BIOMATERIALS, V25, P491, DOI 10.1016/S0142-9612(03)00546-5
   Bendall SP, 1998, J BIOMED MATER RES, V41, P392, DOI 10.1002/(SICI)1097-4636(19980905)41:3<392::AID-JBM8>3.0.CO;2-7
   BENNETT S, 1992, J IMMUNOL METHODS, V153, P201, DOI 10.1016/0022-1759(92)90323-L
   Boccaccini AR, 2003, COMPOS SCI TECHNOL, V63, P2417, DOI 10.1016/S0266-3538(03)00275-6
   Bosetti M, 2002, J BIOMED MATER RES, V60, P79, DOI 10.1002/jbm.1282
   Braat H, 2003, EXPERT OPIN BIOL TH, V3, P725, DOI 10.1517/14712598.3.5.725
   DALLMAN M, 2000, HAEMATOPOIETIC LYMPH, P123
   DAY R, 2004, IN PRESS ASSESSMENT
   Ebisawa Y, 1997, BIOMATERIALS, V18, P1277, DOI 10.1016/S0142-9612(97)00067-7
   Falchuk KH, 1998, MOL CELL BIOCHEM, V188, P41, DOI 10.1023/A:1006808119862
   Fujibayashi S, 2003, BIOMATERIALS, V24, P1349, DOI 10.1016/S0142-9612(02)00511-2
   Fujihara M, 2003, PHARMACOL THERAPEUT, V100, P171, DOI 10.1016/j.pharmthera.2003.08.003
   Hashimoto SI, 2003, SCAND J INFECT DIS, V35, P619, DOI 10.1080/00365540310015926
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hench LL, 1997, CURR OPIN SOLID ST M, V2, P604, DOI 10.1016/S1359-0286(97)80053-8
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Ishihara K, 2002, CYTOKINE GROWTH F R, V13, P357, DOI 10.1016/S1359-6101(02)00027-8
   Ito Hiroaki, 2003, Current Drug Targets - Inflammation and Allergy, V2, P125, DOI 10.2174/1568010033484296
   Jones JR, 2001, MATER SCI TECH SER, V17, P891, DOI 10.1179/026708301101510762
   Kamimura D, 2003, Rev Physiol Biochem Pharmacol, V149, P1
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Lopes MA, 2000, BIOMATERIALS, V21, P1165, DOI 10.1016/S0142-9612(00)00007-7
   Lu HH, 2003, J BIOMED MATER RES A, V64A, P465, DOI 10.1002/jbm.a.10399
   Rectenwald JE, 2002, SHOCK, V17, P135, DOI 10.1097/00024382-200202000-00009
   Riches DWH, 1996, IMMUNOBIOLOGY, V195, P477, DOI 10.1016/S0171-2985(96)80017-9
   Roether JA, 2002, BIOMATERIALS, V23, P3871, DOI 10.1016/S0142-9612(02)00131-X
   Schrooten J, 2000, BIOMATERIALS, V21, P1461, DOI 10.1016/S0142-9612(00)00027-2
   Sepulveda P, 2002, J BIOMED MATER RES, V59, P340, DOI 10.1002/jbm.1250
   Verrier S, 2004, BIOMATERIALS, V25, P3013, DOI 10.1016/j.biomaterials.2003.09.081
   VILCEK J, 1991, J BIOL CHEM, V266, P7313
   Wellinghausen N, 1998, J LEUKOCYTE BIOL, V64, P571
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   Yokota S, 2003, CURR OPIN RHEUMATOL, V15, P581, DOI 10.1097/00002281-200309000-00010
   Zanotti S, 2002, EXPERT OPIN INV DRUG, V11, P1061, DOI 10.1517/13543784.11.8.1061
   Zhang K, 2004, BIOMATERIALS, V25, P2489, DOI 10.1016/j.biomaterials.2003.09.033
   Zoli A, 1998, CLIN RHEUMATOL, V17, P378, DOI 10.1007/BF01450895
NR 37
TC 51
Z9 52
U1 5
U2 13
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR 1
PY 2005
VL 73A
IS 1
BP 73
EP 79
DI 10.1002/jbm.a.30262
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 906ZR
UT WOS:000227684500009
PM 15714504
DA 2018-10-19
ER

PT J
AU Bomati-Miguel, O
   Leconte, Y
   Morales, MP
   Herlin-Boime, N
   Veintemillas-Verdaguer, S
AF Bomati-Miguel, O
   Leconte, Y
   Morales, MP
   Herlin-Boime, N
   Veintemillas-Verdaguer, S
TI Laser pyrolysis preparation of SiO2-coated magnetic nanoparticles for
   biomedical applications
SO JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS
LA English
DT Article; Proceedings Paper
CT Joint European Magnetic Symposia (JEMS 04)
CY SEP 05-10, 2004
CL Dresden, GERMANY
DE composites materials; laser; magnetisation curves; nanoparticles;
   surface; exchange enhancement
AB The encapsulation of magnetic particles into silica has been achieved efficiently in a single and continuous process by laser-induced pyrolysis of ferrocene and TEOS aerosols. This process results in rather homogeneous iron/magnetite particles smaller than 10 nm in diameter surrounded by a SiO2 coating of about 20 nm. Interactions between the metal core and the passivation layer dominates the coercivity at low temperature in these systems. (c) 2004 Elsevier B.V. All rights reserved.
C1 Inst Ciencia Mat Madrid, Madrid 28049, Spain.
   CEA Saclay, CNRS, CEA, URA 2453,SPAM, F-91191 Gif Sur Yvette, France.
RP Veintemillas-Verdaguer, S (reprint author), Inst Ciencia Mat Madrid, Sor Juana Ines Cruz S-N, Madrid 28049, Spain.
EM sabino@icmm.csic.es
RI Bomati Miguel, Oscar/B-5206-2012; Morales Herrero, Maria del
   Puerto/A-4558-2011; Veintemillas, Sabino/A-7276-2012
OI Bomati Miguel, Oscar/0000-0003-4787-6061; Morales Herrero, Maria del
   Puerto/0000-0002-7290-7029; Veintemillas, Sabino/0000-0002-3015-1470
CR Bate G., 1980, FERROMAGNETIC MAT
   BOMATIMIGUEL O, 2002, IEEE T MAGN, V38, P2616
   Carpenter EE, 2001, J MAGN MAGN MATER, V225, P17, DOI 10.1016/S0304-8853(00)01222-1
   GANGOPADHYAY S, 1992, PHYS REV B, V45, P9778, DOI 10.1103/PhysRevB.45.9778
   Kuhn LT, 2002, J PHYS-CONDENS MAT, V14, P13551, DOI 10.1088/0953-8984/14/49/311
   LesliePelecky DL, 1996, CHEM MATER, V8, P1770, DOI 10.1021/cm960077f
   Tartaj P, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.094401
   Ulman A, 1996, CHEM REV, V96, P1533, DOI 10.1021/cr9502357
NR 8
TC 15
Z9 15
U1 1
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-8853
J9 J MAGN MAGN MATER
JI J. Magn. Magn. Mater.
PD APR
PY 2005
VL 290
SI SI
BP 272
EP 275
DI 10.1016/j.jmmm.2004.11.207
PN 1
PG 4
WC Materials Science, Multidisciplinary; Physics, Condensed Matter
SC Materials Science; Physics
GA 922KU
UT WOS:000228837600066
DA 2018-10-19
ER

PT J
AU Kim, JI
   Kim, HY
   Hosoda, H
   Miyazaki, S
AF Kim, JI
   Kim, HY
   Hosoda, H
   Miyazaki, S
TI Shape memory behavior of Ti-22Nb-(0.5-2.0)O(at%) biomedical alloys
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE shape memory alloy; superelasticity; biomaterials; smart material;
   titanium based alloy; titanium-niobium-oxygen; interstitial element
ID MECHANICAL-PROPERTIES; MO ALLOYS
AB In order to develop new biomedical shape memory alloys, mechanical properties and shape memory behavior of Ti-22Nb-(0.5-2.0)O(at%) alloys were investigated by tensile tests at various temperatures and X-ray diffraction measurement. The Ti-Nb-O alloys were fabricated by an arc melting method and then homogenized at 1273 K for 7.2 ks. The ingots were cold-rolled with a reduction up to 98.5% in thickness and solution treated at 1173 K for 1.8 ks. The fracture stress of both as-rolled specimen and Solution treated specimen increased with increasing oxygen content. A fracture stress of 1.37GPa was obtained in the as-rolled Ti-22Nb-2O alloy. The martensitic transformation temperature decreased by 160 K per I at% increase of oxygen content. Superior shape memory effect and superelastic behavior were observed at room temperature in the Ti-22Nb-(0.5-1.5)O alloys. The addition of oxygen stabilized superelastic behavior of Ti-Nb alloys by increasing the critical stress for permanent deformation. The maximum shape recovery strain of 4.0% and the critical stress of 900 MPa for permanent deformation were obtained in the Ti-22Nb-0.5O and Ti-22Nb-1.5O alloys, respectively.
C1 Univ Tsukuba, Inst Mat Sci, Tsukuba, Ibaraki 3058573, Japan.
   Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 2268503, Japan.
RP Miyazaki, S (reprint author), Univ Tsukuba, Inst Mat Sci, Tsukuba, Ibaraki 3058573, Japan.
EM miyazaki@ims.tsukuba.ac.jp
RI Miyazaki, Shuichi/A-3113-2012; Kim, Hee Young/F-6065-2011
OI Miyazaki, Shuichi/0000-0003-3849-4176; Kim, Hee
   Young/0000-0003-1981-6678
CR ANNAKA S, 2004 FALL M JAP I ME, P333
   Baker C., 1971, Metal Science Journal, V5, P92
   DEURIG TW, 1982, ACTA METALL, V30, P2161
   Grosdidier T, 2000, MAT SCI ENG A-STRUCT, V291, P218, DOI 10.1016/S0921-5093(00)00921-7
   Ho WF, 1999, BIOMATERIALS, V20, P2115, DOI 10.1016/S0142-9612(99)00114-3
   Hosoda H, 2001, T MRS J, V26, P243
   HOSODA H, 2003, MATER SCI FORUM, V425, P3121
   Kim HY, 2004, MATER TRANS, V45, P2443, DOI 10.2320/matertrans.45.2443
   Kim HY, 2004, MATER TRANS, V45, P1090, DOI 10.2320/matertrans.45.1090
   KIM HY, 2004 SPR M JAP I MET, P327
   KIM JI, 2003 FALL M JAP I ME, P149
   Maeshima T, 2004, MATER TRANS, V45, P1101, DOI 10.2320/matertrans.45.1101
   Maeshima T, 2004, MATER TRANS, V45, P1096, DOI 10.2320/matertrans.45.1096
   MIYAZAKI T, 2004 FALL M JAP I ME, P466
   Nitta K, 2001, STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY, P25
   OHMATSU Y, 2003 SPR M JAP I MET, P144
   OSHIKA N, 2004 FALL M JAP I ME, P330
   OSHIKA N, 2003 FALL M JAP I ME, P149
   OSHIKA N, UNPUB
   Saito T, 2003, SCIENCE, V300, P464, DOI 10.1126/science.1081957
   Shabalovskaya S., 1994, P 1 INT C SHAP MEM S, P209
   YONEZAWA M, UNPUB
NR 22
TC 133
Z9 139
U1 1
U2 34
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD APR
PY 2005
VL 46
IS 4
BP 852
EP 857
DI 10.2320/matertrans.46.852
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 933CP
UT WOS:000229601900017
OA Bronze
DA 2018-10-19
ER

PT J
AU Mills, CA
   Escarre, J
   Engel, E
   Martinez, E
   Errachid, A
   Bertomeu, J
   Andreu, J
   Planell, JA
   Samitier, J
AF Mills, CA
   Escarre, J
   Engel, E
   Martinez, E
   Errachid, A
   Bertomeu, J
   Andreu, J
   Planell, JA
   Samitier, J
TI Micro- and nanostructuring of poly(ethylene-2,6-naphthalate) surfaces,
   for biomedical applications, using polymer replication techniques
SO NANOTECHNOLOGY
LA English
DT Article
ID NANOIMPRINT LITHOGRAPHY; ADHESION
AB Here we investigate the formation of superficial micro- and nanostructures in poly(ethylene-2,6-naphthalate) (PEN), with a view to their use in biomedical device applications, and compare its performance with a polymer commonly used for the fabrication of these devices, poly(methyl methacrylate) (PMMA). The PEN is found to replicate both micro- and nanostructures in its surface, albeit requiring more forceful replication conditions than PMMA, producing a slight increase in surface hydrophilicity. This ability to form micro/nanostructures, allied to biocompatibility and good optical transparency, suggests that PEN could be a useful material for production of, or for incorporation into, transparent devices for biomedical applications. Such devices will be able to be autoclaved, due to the polymer's high temperature stability, and will be useful for applications where forceful experimental conditions are required, due to a superior chemical resistance over PMMA.
C1 CREBEC, Lab Nanobioengn, Ctr Reference Bioengn Catalonia, Barcelona 08028, Spain.
   Univ Barcelona, Fac Fis, E-08028 Barcelona, Spain.
   Tech Univ Catalonia, Div Biomat & Biomech, Dept Mat Sci & Met, Ctr Reference Bioengn Catalonia, Barcelona 08028, Spain.
RP Mills, CA (reprint author), CREBEC, Lab Nanobioengn, Ctr Reference Bioengn Catalonia, Parc Cientific Barcelona,C-Josep Samitier 1-5, Barcelona 08028, Spain.
EM cmills@pcb.ub.es
RI Bertomeu, Joan/N-1846-2013; Martinez, Elena/C-6008-2009; Andreu,
   Jordi/I-3543-2014; Engel, Elisabeth/D-4365-2014; MARTINEZ,
   ELENA/F-7572-2014; Mills, Christopher/C-5535-2009
OI Bertomeu, Joan/0000-0003-0903-6192; Andreu, Jordi/0000-0001-9446-8242;
   Engel, Elisabeth/0000-0003-4855-8874; Mills,
   Christopher/0000-0002-2906-4978
CR Becker H, 2002, TALANTA, V56, P267, DOI 10.1016/S0039-9140(01)00594-X
   BESSUEILLE F, 2005, UNPUB BIOSENS BIOELE
   CHOU SY, 1995, APPL PHYS LETT, V67, P3114, DOI 10.1063/1.114851
   Chou SY, 1996, J VAC SCI TECHNOL B, V14, P4129, DOI 10.1116/1.588605
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   de Mello A, 2002, LAB CHIP, V2, p31N, DOI 10.1039/b203828p
   Eaton PJ, 2000, LANGMUIR, V16, P7887, DOI 10.1021/la000159p
   Heidari B, 2000, J VAC SCI TECHNOL B, V18, P3557, DOI 10.1116/1.1326923
   HEKELE M, 2004, J MICROMECH MICROENG, V14, pR1
   Higashioji T, 2003, TRIBOL INT, V36, P437, DOI 10.1016/S0301-679X(02)00232-3
   Jakeways R, 1996, POLYMER, V37, P3761, DOI 10.1016/0032-3861(96)00113-9
   Jaszewski RW, 1998, MICROELECTRON ENG, V42, P575, DOI 10.1016/S0167-9317(98)00135-X
   Jokinen E, 2002, MICROELECTRON RELIAB, V42, P1913, DOI 10.1016/S0026-2714(02)00100-2
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   Ouchi I, 2003, NUCL INSTRUM METH B, V199, P270, DOI 10.1016/S0168-583X(02)01586-0
   Speranza G, 2004, BIOMATERIALS, V25, P2029, DOI 10.1016/j.biomaterials.2003.08.061
   Tonelli AE, 2002, POLYMER, V43, P637, DOI 10.1016/S1089-3156(00)00028-3
   Torres CMS, 2003, MAT SCI ENG C-BIO S, V23, P23, DOI 10.1016/S0928-4931(02)00221-7
   Zhu YB, 2004, J BIOMED MATER RES A, V69A, P436, DOI 10.1002/jbm.a.30007
NR 19
TC 22
Z9 23
U1 0
U2 9
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0957-4484
EI 1361-6528
J9 NANOTECHNOLOGY
JI Nanotechnology
PD APR
PY 2005
VL 16
IS 4
BP 369
EP 375
DI 10.1088/0957-4484/16/4/007
PG 7
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA 923ZX
UT WOS:000228949300016
DA 2018-10-19
ER

PT J
AU Kuzuya, M
   Kondo, S
   Sasai, Y
AF Kuzuya, M
   Kondo, S
   Sasai, Y
TI Recent advances in plasma techniques for biomedical and drug engineering
SO PURE AND APPLIED CHEMISTRY
LA English
DT Article; Proceedings Paper
CT 16th International Symposium on Plasma Chemistry
CY JUN, 2003
CL Taormina, ITALY
ID IRRADIATED PHARMACEUTICAL AIDS; ELECTRON-SPIN-RESONANCE; INDUCED SURFACE
   RADICALS; DELIVERY SYSTEM; CONTROLLED-RELEASE; WALL MATERIAL; CELLULOSE
   DERIVATIVES; THEOPHYLLINE; SPECTROCHEMISTRY; IMMOBILIZATION
AB Plasma-induced surface radicals formed on a variety of organic polymers have been studied by electron spin resonance (ESR), making it possible to provide a sound basis for future experimental design of polymer surface processing (i.e., plasma treatment). On the basis of the findings from such studies on the nature of radical formation and radical reactivity, several novel bioapplications in the field of biomedical and drug engineering have been developed. Applications derived from the nature of plasma-induced surface radical formation include the preparation of a reservoir-type drug delivery system (DDS) of sustained and delayed release, and a floating drug delivery system (FDDS) possessing gastric retention capabilities, the combined findings leading to preparation of a novel "patient-tailored DDS" administered under consideration of the fact that the environment (pH and transit time, etc.) in the gastrointestinal (GI) tract varies with each patient. Applications derived from the reactivity of plasma-induced surface radicals include the preparation of composite powders applicable to a matrix-type DDS by making a mechanical application to the surface radical-containing polymer powders with drug powders, plasma-assisted immobilization of oligo-nucleotides (DNA) onto polymer surfaces applicable to constructing a DNA diagnosis system, and basic study of plasma-assisted preparation of a novel functionalized chemo-embolic agent of non-crosslinked hydrogel, vinyl alcohol-sodium acrylate copolymer (PVA-PAANa).
C1 Gifu Pharmaceut Univ, Lab Pharmaceut Phys Chem, Gifu 5025858, Japan.
RP Kuzuya, M (reprint author), Gifu Pharmaceut Univ, Lab Pharmaceut Phys Chem, 5-6-1 Mitahora Higashi, Gifu 5025858, Japan.
CR Halliwell CM, 2001, ANAL CHEM, V73, P2476, DOI 10.1021/ac0010633
   HORI S, 1996, JPN J INTERVENT RADI, V11, P375
   INABA F, 1996, INTERVENTIONAL RADIO, V11, P108
   ISHIKAWA M, 1993, CHEM PHARM BULL, V41, P1626
   Ishikawa M, 1995, CHEM PHARM BULL, V43, P2215
   Ishikawa M, 1996, CHEM PHARM BULL, V44, P1232
   Ito K, 2001, CHEM PHARM BULL, V49, P1615, DOI 10.1248/cpb.49.1615
   Jiaqi Y, 1996, Nihon Igaku Hoshasen Gakkai Zasshi, V56, P19
   Kondo S, 2003, J PHOTOPOLYM SCI TEC, V16, P71, DOI 10.2494/photopolymer.16.71
   KONDO S, 2000, DDS, V17, P127
   Kuzuya M, 1999, J PHYS CHEM B, V103, P8051, DOI 10.1021/jp984278d
   Kuzuya M., 1997, Plasmas and Polymers, V2, P133, DOI 10.1007/BF02766028
   Kuzuya M, 2002, THIN SOLID FILMS, V407, P144, DOI 10.1016/S0040-6090(02)00029-9
   Kuzuya M, 2002, J PHOTOPOLYM SCI TEC, V15, P331, DOI 10.2494/photopolymer.15.331
   KUZUYA M, 1991, MACROMOLECULES, V24, P6612, DOI 10.1021/ma00025a010
   Kuzuya M., 1997, Plasmas and Polymers, V2, P79, DOI 10.1007/BF02766025
   Kuzuya M, 1995, CHEM PHARM BULL, V43, P2037
   KUZUYA M, 1994, J PHYS CHEM-US, V98, P11301, DOI 10.1021/j100095a011
   KUZUYA M, 1991, J PHYS CHEM-US, V95, P2398, DOI 10.1021/j100159a052
   Kuzuya M, 1996, CHEM PHARM BULL, V44, P192
   Kuzuya M, 2001, CHEM PHARM BULL, V49, P1586, DOI 10.1248/cpb.49.1586
   Kuzuya M, 1998, MACROMOLECULES, V31, P3230, DOI 10.1021/ma970937t
   KUZUYA M, 1993, MACROMOLECULES, V26, P1990, DOI 10.1021/ma00060a030
   KUZUYA M, 1991, DDS, V6, P119
   Kuzuya M., 2001, PLASMAS POLYM, V6, P145
   Kuzuya M., 1999, J PHOTOPOLYM SCI TEC, V12, P75
   Kuzuya M., 2001, J PHOTOPOLYM SCI TEC, V14, P87
   KUZUYA M, 1993, DDS, V8, P149
   KUZUYA M, 1991, DDS, V6, P437
   KUZUYA M, 1996, MOL CRYST LIQ CRYST, V277, P343
   Phimister B, 1999, NAT GENET, V21, P1, DOI 10.1038/4423
   Ramsay G, 1998, NAT BIOTECHNOL, V16, P40, DOI 10.1038/nbt0198-40
   Singh BN, 2000, J CONTROL RELEASE, V63, P235, DOI 10.1016/S0168-3659(99)00204-7
   YAMAKAWA I, 1993, BIOL PHARM BULL, V16, P182
   Yamauchi Y, 1999, CHEM PHARM BULL, V47, P273
NR 35
TC 7
Z9 7
U1 0
U2 3
PU INT UNION PURE APPLIED CHEMISTRY
PI RES TRIANGLE PK
PA 104 TW ALEXANDER DR, PO BOX 13757, RES TRIANGLE PK, NC 27709-3757 USA
SN 0033-4545
J9 PURE APPL CHEM
JI Pure Appl. Chem.
PD APR
PY 2005
VL 77
IS 4
BP 667
EP 682
DI 10.1351/pac200577040667
PG 16
WC Chemistry, Multidisciplinary
SC Chemistry
GA 925JW
UT WOS:000229050400001
DA 2018-10-19
ER

PT J
AU Martin, T
   Rayne, K
   Kemp, NJ
   Hart, J
   Diller, KR
AF Martin, T
   Rayne, K
   Kemp, NJ
   Hart, J
   Diller, KR
TI Teaching for adaptive expertise in biomedical engineering ethics
SO SCIENCE AND ENGINEERING ETHICS
LA English
DT Article
DE engineering ethics; stem cell research; adaptive expertise;
   instructional methods; ethical decision making; undergraduate
   engineering education
ID STAKEHOLDERS; LESSONS
AB This paper considers an approach to teaching ethics in bioengineering based on the How People Learn (HPL) framework. Curricula based on this framework have been effective in mathematics and science instruction from the kindergarten to the college levels. This framework is well suited to teaching bioengineering ethics because it helps learners develop "adaptive expertise". Adaptive expertise refers to the ability to use knowledge and experience in a domain to learn in unanticipated situations. It differs from routine expertise, which requires using knowledge appropriately to solve routine problems. Adaptive expertise is an important educational objective for bioengineers because the regulations and knowledge base in the discipline are likely to change significantly over the course of their careers. This study compares the performance of undergraduate bioengineering students who learned about ethics for stem cell research using the HPL method of instruction to the performance of students who learned following a standard lecture sequence. Both groups learned the factual material equally well, but the HPL group was more prepared to act adaptively when presented with a novel situation.
C1 Univ Texas, Dept Curriculum & Instruct, Austin, TX 78712 USA.
   Univ Texas, Dept Educ Psychol, Austin, TX 78712 USA.
   Univ Texas, Dept Biomed Engn, Austin, TX USA.
RP Martin, T (reprint author), Univ Texas, Dept Curriculum & Instruct, 1 Univ Stn,D5700, Austin, TX 78712 USA.
EM taylormartin@mail.utexas.edu
CR *ADV COMM NAT SCI, 1998, SHAP FUT, V2
   ANDERSON JR, 1982, PSYCHOL REV, V89, P369, DOI 10.1037//0033-295X.89.4.369
   Barron BJS, 1998, J LEARN SCI, V7, P271, DOI 10.1207/s15327809jls0703&4_2
   BELL J, 2003, BALTIMORE SUN   1111
   Bransford J.D, 2000, PEOPLE LEARN MIND BR
   BRANSFORD JD, 1989, SIMILARITY AND ANALOGICAL REASONING, P470, DOI 10.1017/CBO9780511529863.022
   BROPHYS S, 2002, P AM SOC ENG ED CD R, V2273
   Chase W. G., 1973, COGNITIVE PSYCHOL, V1, P33
   Cognition and Technology Group at Vanderbilt, 1997, JASP PROJ LESS CURR
   Cognition and Technology Group at Vanderbilt University, 1990, ED RES, V19, P2, DOI DOI 10.3102/0013189X019006002
   COLLINS J, 2002, P AM SOC ENG ED CD R, V2164
   DAVIS M, 2003, TEACHING ETHICS ENG
   Fisher F. T., 2001, P 2001 AM SOC ENG ED
   Freeman R. E, 1984, STRATEGIC MANAGEMENT
   GICK ML, 1983, COGNITIVE PSYCHOL, V1, P1
   Harris TR, 2002, ANNU REV BIOMED ENG, V4, P29, DOI 10.1146/annurev.bioeng.4.091701.125502
   Harrison JS, 1999, ACAD MANAGE J, V42, P479, DOI 10.2307/256971
   Hatano G., 1986, CHILD DEV ED JAPAN, P262, DOI DOI 10.1002/CCD.10470
   Hatano G., 2003, ED RES, V32, P26, DOI DOI 10.3102/0013189X032008026
   Hatano Giyoo, 1999, INT J EDUC RES, V31, P645, DOI DOI 10.1016/S0883-0355(99)00029-4
   Hays W. L, 1994, STATISTICS
   Herkert J. R., 2000, European Journal of Engineering Education, V25, P303, DOI 10.1080/03043790050200340
   LAVE J, 1991, SITUATED LEARNING
   Mongoven AM, 2003, BIOETHICS, V17, P319, DOI 10.1111/1467-8519.00348
   PALIWODA J, 2002, BEHAV HLTH MANAGEMEN, V22, P44
   PANDY MG, 2005, UNPUB J ENG ED
   Pintrich P. R., 1996, MOTIVATION ED THEORY
   SADLER DR, 1989, INSTR SCI, V18, P119, DOI 10.1007/BF00117714
   Scaife M, 1996, INT J HUM-COMPUT ST, V45, P185, DOI 10.1006/ijhc.1996.0048
   Schwartz DL, 2004, COGNITION INSTRUCT, V22, P129, DOI 10.1207/s1532690xci2202_1
   Schwartz DL, 1999, ETR&D-EDUC TECH RES, V47, P39, DOI 10.1007/BF02299464
   Schwartz DL, 1998, COGNITION INSTRUCT, V16, P475, DOI 10.1207/s1532690xci1604_4
   SCHWARTZ DL, 2005, UNPUB TRANSFER
   *U TEX AUST ETH GR, 2005, ETH LEARN MOD
   VYE N, 1998, METACOGNITION ED THE
   Weiss J., 2003, BUSINESS ETHICS STAK
   Williams S. M., 1992, J LEARN SCI, V2, P367, DOI DOI 10.1207/S15327809JLS0204_2
NR 37
TC 35
Z9 35
U1 0
U2 16
PU OPRAGEN PUBLICATIONS
PI GUILDFORD
PA PO BOX 54, GUILDFORD GU1 2YF, SURREY, ENGLAND
SN 1353-3452
J9 SCI ENG ETHICS
JI Sci. Eng. Ethics
PD APR
PY 2005
VL 11
IS 2
BP 257
EP 276
DI 10.1007/s11948-005-0045-9
PG 20
WC Ethics; Engineering, Multidisciplinary; History & Philosophy Of Science;
   Multidisciplinary Sciences; Philosophy
SC Social Sciences - Other Topics; Engineering; History & Philosophy of
   Science; Science & Technology - Other Topics; Philosophy
GA 927PL
UT WOS:000229205900010
PM 15915863
DA 2018-10-19
ER

PT J
AU Amer, MS
   El-Ashry, MA
   Dosser, LR
   Hix, KE
   Maguire, JF
   Irwin, B
AF Amer, MS
   El-Ashry, MA
   Dosser, LR
   Hix, KE
   Maguire, JF
   Irwin, B
TI Femtosecond versus nanosecond laser machining: comparison of induced
   stresses and structural changes in silicon wafers
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Raman spectroscopy; laser machining; micromachining; silicon
   amorphization; induced stress; femtosecond laser machining
ID MICRO-RAMAN SPECTROSCOPY; PHASE-TRANSFORMATIONS; MECHANICAL-STRESS;
   SEMICONDUCTORS; DEVICES; MATTER
AB Laser micromachining has proven to be a very successful tool for precision machining and microfabrication with applications in microelectronics, MEMS, medical device, aerospace, biomedical, and defense applications. Femtosecond (FS) laser micromachining is usually thought to be of minimal heat-affected zone (HAZ) local to the micromachined feature. The assumption of reduced HAZ is attributed to the absence of direct coupling of the laser energy into the thermal modes of the material during irradiation. However, a substantial HAZ is thought to exist when machining with lasers having pulse durations in the nanosecond (NS) regime. In this paper, we compare the results of micromachining a single crystal silicon wafer using a 150-femtosecond and a 30-nanosecond lasers.
   Induced stress and amorphization of the silicon single crystal were monitored using micro-Raman spectroscopy as a function of the fluence and pulse duration of the incident laser. The onset of average induced stress occurs at lower fluence when machining with the femtosecond pulse laser. Induced stresses were found to maximize at fluence of 44 J cm(-2) and 8 J cm(-2) for nanosecond and femtosecond pulsed lasers, respectively. In both laser pulse regimes, a maximum induced stress is observed at which point the induced stress begins to decrease as the fluence is increased. The maximum induced stress was comparable at 2.0 GPa and 1.5 GPa for the two lasers. For the nanosecond pulse laser, the induced amorphization reached a plateau of approximately 20% for fluence exceeding 22 J cm(-2). For the femtosecond pulse laser, however, induced amorphization was approximately 17% independent of the laser fluence within the experimental range. These two values can be considered nominally the same within experimental error. For femtosecond laser machining, some effect of the laser polarization on the amount of induced stress and amorphization was also observed. (C) 2004 Elsevier B.V. All rights reserved.
C1 Wright State Univ, Dept Mech & Mat Engn, Dayton, OH 45435 USA.
   Mound Laser & Photon Ctr Inc, Miamisburg, OH 45342 USA.
   Sciperio Inc, Stillwater, OK 74075 USA.
RP Amer, MS (reprint author), Wright State Univ, Dept Mech & Mat Engn, 3640 Colonel Glenn HWY, Dayton, OH 45435 USA.
EM maher.amer@wright.edu
RI Amer, Maher/A-1802-2009
CR AHN SJ, 1999, APPL PHYS A, V69, P527
   Amer MS, 2002, APPL SURF SCI, V187, P291, DOI 10.1016/S0169-4332(01)01043-1
   AMIMOTO ST, SPIE, V3512, P123
   Bergmann HW, 1996, APPL SURF SCI, V96-8, P287, DOI 10.1016/0169-4332(95)00432-7
   Dauer S, 1999, SENSOR ACTUAT A-PHYS, V76, P381, DOI 10.1016/S0924-4247(99)00029-1
   DeWolf I, 1996, MICROELECTRON RELIAB, V36, P1751, DOI 10.1016/0026-2714(96)00190-4
   DEWOLF I, 1993, J APPL PHYS, V74, P4490, DOI 10.1063/1.354365
   Domnich V, 2000, APPL PHYS LETT, V76, P2214, DOI 10.1063/1.126300
   Gogotsi Y, 1999, SEMICOND SCI TECH, V14, P936, DOI 10.1088/0268-1242/14/10/310
   *ICALEO, 2000, LAS MICR SESS OCT 2
   Jandeleit J, 1998, APPL SURF SCI, V127, P885, DOI 10.1016/S0169-4332(97)00762-9
   Kimura Y, 1997, APPL SURF SCI, V117, P790, DOI 10.1016/S0169-4332(97)80184-5
   Li J, 2001, J MICROMECH MICROENG, V11, P38, DOI 10.1088/0960-1317/11/1/307
   MARINOV M, 1997, PHYS REV B, V55, P2939
   Marowsky G, 1998, APPL PHYS B-LASERS O, V66, P475, DOI 10.1007/s003400050422
   READY JF, 1997, IND APPL LASERS, P394
   Simon P, 1996, APPL PHYS A-MATER, V63, P505, DOI 10.1007/BF01571681
   Xu W, 1998, J PHYS-CONDENS MAT, V10, P6105, DOI 10.1088/0953-8984/10/27/011
NR 18
TC 91
Z9 95
U1 1
U2 36
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD MAR 31
PY 2005
VL 242
IS 1-2
BP 162
EP 167
DI 10.1016/j.apsusc.2004.08.029
PG 6
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 904OU
UT WOS:000227508400020
DA 2018-10-19
ER

PT J
AU Sinani, VA
   Gheith, MK
   Yaroslavov, AA
   Rakhnyanskaya, AA
   Sun, K
   Mamedov, AA
   Wicksted, JP
   Kotov, NA
AF Sinani, VA
   Gheith, MK
   Yaroslavov, AA
   Rakhnyanskaya, AA
   Sun, K
   Mamedov, AA
   Wicksted, JP
   Kotov, NA
TI Aqueous dispersions of single-wall and multiwall carbon nanotubes with
   designed amphiphilic polycations
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID FIELD-EFFECT TRANSISTORS; NONCOVALENT FUNCTIONALIZATION;
   ELECTRONIC-STRUCTURE; OPTICAL-ABSORPTION; ORGANIC POLYMER; PURIFICATION;
   WATER; SOLUBILIZATION; COMPOSITES; FILMS
AB Poor solubility of single-walled and multiwalled carbon nanotubes (NTs) in water and organic solvents presents a considerable challenge for their purification and applications. Macromolecules can be convenient solubilizing agents for NTs and a structural element of composite materials for them. Several block copolymers with different chemical functionalities of the side groups were tested for the preparation of aqueous NT dispersions. Poly(N-cetyl-4-vinylpyridinium bromide-co-N-ethyl-4-vinylpyridinium bromideco-4-vinylpyridine) was found to form exceptionally stable NT dispersions. It is suggested that the efficiency of macromolecular dispersion agents for NT solubilization correlates with the topological and electronic similarity of polymer-NT and NT-NT interactions in the nanotube bundles. Raman spectroscopy and atomic force and transmission electron microcopies data indicate that the polycations are wrapped around NTs forming a uniform coating 1.0-1.5 nm thick. The ability to wind around the NT originates in the hydrophobic attraction of the polymer backbone to the graphene surface and topological matching. Tetraalkylammonium functional groups in the side chains of the macromolecule create a cloud of positive charge around NTs, which makes them hydrophilic. The prepared dispersions could facilitate the processing of the nanotubes into composites with high nanotube loading for electronic materials and sensing. Positive charge on their surface is particularly important for biological and biomedical applications because it strengthens interactions with negatively charged cell membranes. A high degree of spontaneous bundle separation afforded by the polymer coating can also be beneficial for NT sorting.
C1 Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.
   Moscow MV Lomonosov State Univ, Dept Chem, Moscow 119899, Russia.
   Oklahoma State Univ, Dept Phys, Stillwater, OK 74078 USA.
   Univ Michigan, Electron Microbeam Anal Lab, Ann Arbor, MI 48109 USA.
   Nomad Inc, Stillwater, OK 74074 USA.
RP Kotov, NA (reprint author), Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.
EM kotov@umich.edu
RI 李, 府中/H-4357-2011
OI Kotov, Nicholas/0000-0002-6864-5804
CR Abatemarco T, 1999, J PHYS CHEM B, V103, P3534, DOI 10.1021/jp984020n
   Ago H, 1999, SYNTHETIC MET, V103, P2494, DOI 10.1016/S0379-6779(98)01062-5
   Ajayan PM, 1999, CHEM REV, V99, P1787, DOI 10.1021/cr970102g
   Alvarez L, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.153401
   Alvaro M, 2002, CHEM COMMUN, P3004, DOI 10.1039/b209225p
   Bahr JL, 2001, J AM CHEM SOC, V123, P6536, DOI 10.1021/ja010462s
   Bahr JL, 2001, CHEM MATER, V13, P3823, DOI 10.1021/cm0109903
   Bandow S, 1997, J PHYS CHEM B, V101, P8839, DOI 10.1021/jp972026r
   Banerjee S, 2002, J PHYS CHEM B, V106, P12144, DOI 10.1021/jp026304k
   Banerjee S, 2002, J AM CHEM SOC, V124, P8940, DOI 10.1021/ja026487o
   Brown SDM, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.073403
   Carrillo A, 2003, NANO LETT, V3, P1437, DOI 10.1021/nl034376x
   Caruso F, 2001, ADV MATER, V13, P11, DOI 10.1002/1521-4095(200101)13:1<11::AID-ADMA11>3.0.CO;2-N
   CARUSO F, 2001, MRS BULL, V26, P992
   Chen J, 2001, J PHYS CHEM B, V105, P2525, DOI 10.1021/jp002596i
   Chen RJ, 2003, P NATL ACAD SCI USA, V100, P4984, DOI 10.1073/pnas.0837064100
   Dalton AB, 2000, J PHYS CHEM B, V104, P10012, DOI 10.1021/jp002857o
   Dalton AB, 2001, SYNTHETIC MET, V121, P1217, DOI 10.1016/S0379-6779(00)00861-4
   Dalton AB, 1999, SYNTHETIC MET, V102, P1176, DOI 10.1016/S0379-6779(98)01067-4
   Dieckmann GR, 2003, J AM CHEM SOC, V125, P1770, DOI 10.1021/ja029084x
   Dresselhaus M.S., 1996, SCI FULLERENES CARBO, P965
   Dresselhaus MS, 2002, CARBON, V40, P2043, DOI 10.1016/S0008-6223(02)00066-0
   Dyke CA, 2003, J AM CHEM SOC, V125, P1156, DOI 10.1021/ja0289806
   Dyke CA, 2003, NANO LETT, V3, P1215, DOI 10.1021/nl034537x
   FUOSS RM, 1948, J POLYM SCI, V3, P246, DOI 10.1002/pol.1948.120030211
   Gartstein YN, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.045503
   Georgakilas V, 2002, CHEM COMMUN, P3050, DOI 10.1039/b209843a
   GUAN W, 2002, HUAZHONG KEJI DAXUE, V30, P114
   Guo YZ, 2002, PHYSICA B, V323, P235, DOI 10.1016/S0921-4526(02)00975-4
   Hamon MA, 1999, ADV MATER, V11, P834, DOI 10.1002/(SICI)1521-4095(199907)11:10<834::AID-ADMA834>3.0.CO;2-R
   HIURA H, 1995, ADV MATER, V7, P275, DOI 10.1002/adma.19950070304
   Hu H, 2004, NANO LETT, V4, P507, DOI 10.1021/nl035193d
   Islam MF, 2003, NANO LETT, V3, P269, DOI 10.1021/nl025924u
   Jacquemin R, 2000, SYNTHETIC MET, V115, P283, DOI 10.1016/S0379-6779(00)00318-0
   Javey A, 2003, NATURE, V424, P654, DOI 10.1038/nature01797
   Jin ZX, 2003, SYNTHETIC MET, V135, P735, DOI 10.1016/S0379-6779(02)00824-X
   JISHI RA, 1993, CHEM PHYS LETT, V209, P77, DOI 10.1016/0009-2614(93)87205-H
   Kim OK, 2003, J AM CHEM SOC, V125, P4426, DOI 10.1021/ja029233b
   KIRSH YE, 1970, VYSOKOMOL SOEDIN A, V12, P186
   Kong J, 2000, SCIENCE, V287, P622, DOI 10.1126/science.287.5453.622
   Krstic V, 1998, CHEM MATER, V10, P2338, DOI 10.1021/cm980207f
   Kukovecz A, 2002, EUR PHYS J B, V28, P223, DOI 10.1140/epjb/e2002-00224-8
   Kuzmany H, 2001, EUR PHYS J B, V22, P307, DOI 10.1007/s100510170108
   Li B, 2001, CHEM LETT, P598, DOI 10.1246/cl.2001.598
   Liu J, 1998, SCIENCE, V280, P1253, DOI 10.1126/science.280.5367.1253
   Mamedov AA, 2002, NAT MATER, V1, P190, DOI 10.1038/nmat747
   Martel R, 1998, APPL PHYS LETT, V73, P2447, DOI 10.1063/1.122477
   Maser WK, 2003, MAT SCI ENG C-BIO S, V23, P87, DOI 10.1016/S0928-4931(02)00235-7
   Matthews MJ, 1999, PHYS REV B, V59, pR6585, DOI 10.1103/PhysRevB.59.R6585
   Mickelson ET, 1999, J PHYS CHEM B, V103, P4318, DOI 10.1021/jp9845524
   Moore VC, 2003, NANO LETT, V3, P1379, DOI 10.1021/nl034524j
   Nativ-Roth E, 2002, J POLYM ENG, V22, P353
   O'Connell MJ, 2001, CHEM PHYS LETT, V342, P265, DOI 10.1016/S0009-2614(01)00490-0
   Pimenta MA, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.041401
   Rao AM, 1997, SCIENCE, V275, P187, DOI 10.1126/science.275.5297.187
   Rouse JH, 2003, NANO LETT, V3, P59, DOI 10.1021/nl025780j
   Rueckes T, 2000, SCIENCE, V289, P94, DOI 10.1126/science.289.5476.94
   Saito R, 1998, PHYS REV B, V57, P4145, DOI 10.1103/PhysRevB.57.4145
   SAITO R, 1998, PHYS CARBON NANOTUBE, P200
   Sancho MPL, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.165419
   Sauvajol JL, 2002, CARBON, V40, P1697, DOI 10.1016/S0008-6223(02)00010-6
   SCHREUDERGIBSON H, 2000, P ELECT SOC, V2000, P210
   Star A, 2002, ANGEW CHEM INT EDIT, V41, P2508, DOI 10.1002/1521-3773(20020715)41:14<2508::AID-ANIE2508>3.0.CO;2-A
   Star A, 2001, ANGEW CHEM INT EDIT, V40, P1721, DOI 10.1002/1521-3773(20010504)40:9<1721::AID-ANIE17210>3.0.CO;2-F
   Stephan C, 2000, SYNTHETIC MET, V108, P139, DOI 10.1016/S0379-6779(99)00259-3
   Strano MS, 2003, SCIENCE, V301, P1519, DOI 10.1126/science.1087691
   Strano MS, 2003, J NANOSCI NANOTECHNO, V3, P81, DOI 10.1166/jnn.2003.194
   Tans SJ, 1997, NATURE, V386, P474, DOI 10.1038/386474a0
   Tans SJ, 1998, NATURE, V393, P49
   VANHOVE L, 1953, PHYS REV, V89, P1189, DOI 10.1103/PhysRev.89.1189
   Venema LC, 1999, SCIENCE, V283, P52, DOI 10.1126/science.283.5398.52
   Wildoer JWG, 1998, NATURE, V391, P59, DOI 10.1038/34139
   Yaroslavov AA, 1999, COLLOID SURFACE B, V16, P29, DOI 10.1016/S0927-7765(99)00059-4
   Yudasaka M, 2000, APPL PHYS A-MATER, V71, P449, DOI 10.1007/s003390000688
   Zengin H, 2002, ADV MATER, V14, P1480, DOI 10.1002/1521-4095(20021016)14:20<1480::AID-ADMA1480>3.0.CO;2-O
   Zhang J, 2003, NANO LETT, V3, P403, DOI 10.1021/nl025952c
   Zhang NY, 2003, SMART MATER STRUCT, V12, P260, DOI 10.1088/0964-1726/12/2/314
   Zhang XF, 2003, NANO LETT, V3, P1285, DOI 10.1021/nl034336t
   Zhao B, 2001, J AM CHEM SOC, V123, P11673, DOI 10.1021/ja010488j
   Zhao W, 2002, J AM CHEM SOC, V124, P12418, DOI 10.1021/ja027861n
NR 80
TC 298
Z9 303
U1 4
U2 143
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD MAR 16
PY 2005
VL 127
IS 10
BP 3463
EP 3472
DI 10.1021/ja045670+
PG 10
WC Chemistry, Multidisciplinary
SC Chemistry
GA 906GD
UT WOS:000227627800053
PM 15755166
DA 2018-10-19
ER

PT J
AU Kang, YL
   Zyryanov, GV
   Rudkevich, DM
AF Kang, YL
   Zyryanov, GV
   Rudkevich, DM
TI Towards supramolecular fixation of NOx gases: Encapsulated reagents for
   nitrosation
SO CHEMISTRY-A EUROPEAN JOURNAL
LA English
DT Article
DE calixarenes; molecular recognition; nitrogen oxides; structure-activity
   relationships; supramolecular chemistry
ID ALKYL-N-NITROSOAMIDES; NITRIC-OXIDE; NITROGEN-DIOXIDE; MOLECULAR
   ENCAPSULATION; RECOVERABLE CATALYSTS; DINITROGEN TETROXIDE; SOLUBLE
   POLYMERS; AMIDES; CHEMISTRY; CONVERSION
AB the use of simple calix[4]arenes for chemical conversion of NO2/ N2O4 gases is demonstrated in solution and in the solid state. Upon reacting with these gases, calixarenes 1 encapsulate nitrosonium (NO+) cations within their cavities with the formation of stable calixarene-NO+ complexes 2. These complexes act as encapsulated nitrosating reagents; cavity effects control their reactivity and selectivity. Complexes 2 were effectively used for nitrosation of secondary amides 5, including chiral derivatives. Unique size-shape selectivity was observed, allowing for exclusive nitrosation of less crowded N-Me amides 5a-e (up to 95% yields). Bulkier N-Alk (Alk > Me) substrates 5 did not react due to the hindered approach to the encapsulated NO+ reagents. Robust, silica gel based calixarene material 3 was prepared, which reversibly traps NO2/ N2O4 with the formation of NO'-storing silica gel 4. With material 4, similar size-shape selectivity was observed for nitrosation. The N-Me-N-nitroso derivatives 6d,e were obtained with similar to 30% yields, while bulkier amides were nitrosated with much lower yields (< 8%). Enantiomerically pure encapsulating reagent 2d was tested for nitrosation of racemic amide 5t, showing modest but reproducible stereoselectivity and similar to 15% ee. Given high affinity to NO+ species, which can be generated by a number of NOx gases, these supramolecular reagents and materials may be useful for NOx entrapment and separation in the environment and biomedical areas.
C1 Univ Texas, Dept Chem & Biochem, Arlington, TX 76019 USA.
RP Rudkevich, DM (reprint author), Univ Texas, Dept Chem & Biochem, Arlington, TX 76019 USA.
EM rudkevich@uta.edu
CR ADDISON CC, 1980, CHEM REV, V80, P21, DOI 10.1021/cr60323a002
   ANDERSON JE, 1991, J ORG CHEM, V56, P1731, DOI 10.1021/jo00005a016
   Antonovic DG, 1997, J MOL STRUCT, V408, P421, DOI 10.1016/S0022-2860(96)09743-8
   Aronica LA, 2001, EUR J ORG CHEM, P4321
   AUERBACH J, 1976, J ORG CHEM, V41, P725, DOI 10.1021/jo00866a038
   BEDENBAUGH AO, 1979, J ORG CHEM, V44, P4703, DOI 10.1021/jo00393a051
   BERENGUER R, 1989, SYNTHESIS-STUTTGART, P305
   Bergbreiter DE, 2002, CHEM REV, V102, P3345, DOI 10.1021/cr010343v
   BIANCHI F, 2003, NEW J CHEM, P502
   Birney DM, 2004, ORG LETT, V6, P851, DOI 10.1021/ol049867i
   Borodkin GI, 2001, RUSS CHEM REV, V70, P211
   BOSCH E, 1994, J ORG CHEM, V59, P3314, DOI 10.1021/jo00091a018
   BUTLER AR, 1993, CHEM SOC REV, V22, P233, DOI 10.1039/cs9932200233
   CASNATI A, 1995, J AM CHEM SOC, V117, P2767, DOI 10.1021/ja00115a012
   CHALLIS BC, 1984, J CHEM SOC CHEM COMM, P1050, DOI 10.1039/c39840001050
   Chen J, 2002, NATURE, V415, P385, DOI 10.1038/415385b
   Cram D. J., 1994, CONTAINER MOL THEIR
   D'Alelio GF, 1937, J AM CHEM SOC, V59, P109, DOI 10.1021/ja01280a025
   Darbeau RW, 2002, J ORG CHEM, V67, P2942, DOI 10.1021/jo011002k
   Darbeau RW, 2001, J ORG CHEM, V66, P5027, DOI 10.1021/jo001741l
   Darbeau RW, 2000, J ORG CHEM, V65, P1121, DOI 10.1021/jo9916378
   Dickerson TJ, 2002, CHEM REV, V102, P3325, DOI 10.1021/cr010335e
   Espey MG, 2001, J BIOL CHEM, V276, P30085, DOI 10.1074/jbc.M101723200
   EVANS DA, 1997, TETRAHEDRON LETT, V38, P54353
   Fujita M, 2001, CHEM COMMUN, P509, DOI 10.1039/b008684n
   GARCIA J, 1984, TETRAHEDRON, V40, P3121, DOI 10.1016/S0040-4020(01)82437-6
   GARCIA J, 1984, J ORG CHEM, V49, P3322, DOI 10.1021/jo00192a014
   GARCIA J, 1982, TETRAHEDRON LETT, V23, P1127, DOI 10.1016/S0040-4039(00)87040-9
   Glatzhofer DT, 2002, ORG LETT, V4, P2349, DOI 10.1021/ol026051d
   Granik VG, 2002, RUSS CHEM B+, V51, P1375, DOI 10.1023/A:1020994402835
   GUTSCHE CD, 1990, ORG SYNTH, V68, P234
   Hof F, 2002, ANGEW CHEM INT EDIT, V41, P1488, DOI 10.1002/1521-3773(20020503)41:9<1488::AID-ANIE1488>3.0.CO;2-G
   Hof F., 2002, ANGEW CHEM, V114, P1556
   Hoffmann D, 2001, CHEM RES TOXICOL, V14, P767, DOI 10.1021/tx000260u
   HOOD DB, 1993, ARCH BIOCHEM BIOPHYS, V304, P17, DOI 10.1006/abbi.1993.1316
   HUISGEN R, 1956, LIEBIGS ANN CHEM, V599, P161
   IKEDA A, 1994, J CHEM SOC CHEM COMM, P2375, DOI 10.1039/c39940002375
   IKEDA A, 1994, TETRAHEDRON LETT, V35, P8417, DOI 10.1016/S0040-4039(00)74422-4
   Ikeda A, 1997, J ORG CHEM, V62, P3568, DOI 10.1021/jo962040k
   IKEDA A, 1994, J AM CHEM SOC, V116, P3102, DOI 10.1021/ja00086a045
   Ito H, 2000, CHEM LETT, P598, DOI 10.1246/cl.2000.598
   Itoh T, 1997, TETRAHEDRON LETT, V38, P5017, DOI 10.1016/S0040-4039(97)01074-5
   Jasat A, 1999, CHEM REV, V99, P931, DOI 10.1021/cr960048o
   JOHNSTONE RAW, 1979, TETRAHEDRON, V35, P2169, DOI 10.1016/0040-4020(79)87035-0
   KAKUDA Y, 1980, J AGR FOOD CHEM, V28, P584, DOI 10.1021/jf60229a036
   Kang JM, 1998, J AM CHEM SOC, V120, P7389, DOI 10.1021/ja980927n
   Kang YL, 2004, TETRAHEDRON, V60, P11219, DOI 10.1016/j.tet.2004.08.063
   KARANEWSKY DS, 1991, J ORG CHEM, V56, P3744, DOI 10.1021/jo00011a064
   Kavallieratos K, 2000, ANAL CHEM, V72, P5258, DOI 10.1021/ac0005971
   KELLY TR, 1989, J AM CHEM SOC, V111, P4522, DOI 10.1021/ja00194a071
   KELLY TR, 1993, J AM CHEM SOC, V115, P5843, DOI 10.1021/ja00066a070
   KIM YH, 1990, TETRAHEDRON LETT, V31, P3893
   Kirsch M, 2002, BIOL CHEM, V383, P389, DOI 10.1515/BC.2002.043
   Korner SK, 2000, CHEM-EUR J, V6, P187, DOI 10.1002/(SICI)1521-3765(20000103)6:1<187::AID-CHEM187>3.0.CO;2-I
   KRAWCZYK W, 1989, J CHROMATOGR, V463, P297, DOI 10.1016/S0021-9673(01)84484-8
   KUHN LP, 1967, J AM CHEM SOC, V89, P3858, DOI 10.1021/ja00991a030
   LINKE S, 1978, SYNTHESIS-STUTTGART, P303
   Liu CQ, 2004, MACROMOL RAPID COMM, V25, P804, DOI 10.1002/marc.200300277
   McNamara CA, 2002, CHEM REV, V102, P3275, DOI 10.1021/cr0103571
   Megson IL, 2002, EXPERT OPIN INV DRUG, V11, P587
   MIRVISH SS, 1995, CANCER LETT, V93, P17, DOI 10.1016/0304-3835(95)03786-V
   Mogck O, 1996, J CHEM SOC PERK T 1, P1711, DOI 10.1039/p19960001711
   NAUMOV YA, 1974, ZH PRIKL KHIM, V47, P1888
   Nicolaou K. C., 1996, CLASSICS TOTAL SYNTH, P130
   NIKOLAIDES N, 1990, TETRAHEDRON LETT, V31, P1113, DOI 10.1016/S0040-4039(00)88739-0
   NIKOLAIDES N, 1990, TETRAHEDRON LETT, V31, P6009, DOI 10.1016/S0040-4039(00)98015-8
   OLAH GA, 1965, J ORG CHEM, V30, P2386, DOI 10.1021/jo01018a066
   Pariiskii G. B., 2000, RUSS CHEM REV, V69, P985
   POUR PM, 1984, IARC SCI PUBL, V57, P683
   Rathore R, 2000, ANGEW CHEM INT EDIT, V39, P2123, DOI 10.1002/1521-3773(20000616)39:12<2123::AID-ANIE2123>3.0.CO;2-4
   Rathore R., 2000, ANGEW CHEM, V112, P2207
   ROMEA P, 1991, J ORG CHEM, V56, P7038, DOI 10.1021/jo00025a017
   Rudkevich DA, 2002, B CHEM SOC JPN, V75, P393, DOI 10.1246/bcsj.75.393
   Rudkevich DM, 2004, AUST J CHEM, V57, P713, DOI 10.1071/CH04102
   Rudkevich DM, 2004, ANGEW CHEM INT EDIT, V43, P558, DOI 10.1002/anie.200300606
   RUDKEVICH DM, 2004, ANGEW CHEM, V116, P568
   SAAVEDRA JE, 1979, J ORG CHEM, V44, P860, DOI 10.1021/jo01319a046
   SCHWAIER R, 1966, Z VEREBUNGSL, V98, P309, DOI 10.1007/BF00895261
   Sergeeva MV, 2000, BIOTECHNOL LETT, V22, P1419, DOI 10.1023/A:1005621117392
   Stepanov AV, 2003, USP KHIM+, V72, P363
   TEMPE J, 1968, CR ACAD SCI C CHIM, V266, P834
   THATCHER GRJ, 1908, CHEM SOC REV, V27, P331
   TORRA N, 1989, TETRAHEDRON, V45, P863, DOI 10.1016/0040-4020(89)80118-8
   USKOKOVI M, 1970, J AM CHEM SOC, V92, P203, DOI 10.1021/ja00704a036
   Vysotsky M, 2000, ADV SUPR CH, V7, P139
   Wang PG, 2002, CHEM REV, V102, P1091, DOI 10.1021/cr000040l
   Warmuth R, 2001, EUR J ORG CHEM, P423
   Warmuth R, 2003, J ORG CHEM, V68, P2077, DOI 10.1021/jo026649z
   WEBSTER FX, 1986, TETRAHEDRON LETT, V27, P4941, DOI 10.1016/S0040-4039(00)85102-3
   WHITE EH, 1955, J AM CHEM SOC, V77, P6008, DOI 10.1021/ja01627a063
   WHITE EH, 1955, J AM CHEM SOC, V77, P6014, DOI 10.1021/ja01627a065
   WUDL F, 1971, J AM CHEM SOC, V93, P271, DOI 10.1021/ja00730a058
   YOSHIZAWA M, 2000, ANGEW CHEM INT EDIT, V39, P4119
   YOSHIZAWA M, 2000, ANGEW CHEM, V112, P4285
   YUREV YK, 1959, ZH OBSHCH KHIM+, V29, P2594
   Zyryanov GV, 2004, J AM CHEM SOC, V126, P4264, DOI 10.1021/ja0392869
   Zyryanov GV, 2003, ORG LETT, V5, P1253, DOI 10.1021/ol0342195
   Zyryanov GV, 2003, J AM CHEM SOC, V125, P2997, DOI 10.1021/ja029166l
NR 98
TC 23
Z9 23
U1 0
U2 15
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0947-6539
J9 CHEM-EUR J
JI Chem.-Eur. J.
PD MAR 4
PY 2005
VL 11
IS 6
BP 1924
EP 1932
DI 10.1002/chem.200400939
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA 906SK
UT WOS:000227662900024
PM 15674979
DA 2018-10-19
ER

PT J
AU Lynn, AK
   Bonfield, W
AF Lynn, AK
   Bonfield, W
TI A novel method for the simultaneous, titrant-free control of pH and
   calcium phosphate mass yield
SO ACCOUNTS OF CHEMICAL RESEARCH
LA English
DT Review
ID SELF-ORGANIZATION MECHANISM; BONE TISSUE; SUBSTITUTED HYDROXYAPATITE;
   BIOMEDICAL APPLICATIONS; CHITOSAN HYDROGELS; IN-VIVO; COLLAGEN;
   MINERALIZATION; NANOCOMPOSITES; REGENERATION
AB Calcium phosphate (Cap) bioceramics have long been of interest for the unique properties that they exhibit as bone substitute materials. By harnessing the unique bone-bonding capacity of CaP's, biomaterials scientists have made great strides over the past 2 decades to produce novel materials to assist in the treatments of defects caused by trauma, disease, or both. In recent years, however, it has become apparent that the traditional set of techniques used to produce calcium phosphates does not satisfy all of the requirements necessary to meet the challenges of emerging applications. In particular, recent interest in (i) the synthesis of coprecipitated CaP/bioorganic composites and (ii) the investigation of the mechanisms of biomineralization has highlighted the need for new methods to control pH and Cap mass yield.
C1 Univ Cambridge, Cambridge Ctr Med Mat, Dept Mat Sci & Met, Cambridge CB2 1TP, England.
RP Lynn, AK (reprint author), Univ Cambridge, Cambridge Ctr Med Mat, Dept Mat Sci & Met, Pembroke St, Cambridge CB2 1TP, England.
EM akl28@cam.ac.uk
CR BENEBASSATH H, 1994, CELLS MAT, V4, P37
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P19, DOI 10.1016/s0939-6411(03)00161-9
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P35, DOI 10.1016/s0939-6411(03)00160-7
   BIANCHI E, 1967, J BIOL CHEM, V242, P1361
   BODEN SD, 1995, SPINE S, V20, P113
   Bohner M, 2000, Injury, V31 Suppl 4, P37
   BONFIELD W, 1981, BIOMATERIALS, V2, P185, DOI 10.1016/0142-9612(81)90050-8
   CARTER DR, 1978, CLIN ORTHOP RELAT R, P192
   CHRISTIANSEN DL, 1993, CELL MATER, V3, P177
   Doll B, 2001, CRIT REV EUKAR GENE, V11, P173
   DRIESSENS FCM, 1994, J MATER SCI-MATER M, V5, P164, DOI 10.1007/BF00053338
   Du C, 2000, J BIOMED MATER RES, V50, P518, DOI 10.1002/(SICI)1097-4636(20000615)50:4<518::AID-JBM7>3.0.CO;2-W
   Ferreira A, 2003, J CRYST GROWTH, V252, P599, DOI 10.1016/S0022-0248(03)00899-6
   GERHART TN, 1989, J BIOMED MATER RES, V23, P1, DOI 10.1002/jbm.820230102
   Geyer G, 1999, HNO, V47, P77, DOI 10.1007/s001060050363
   Gibson IR, 2002, J BIOMED MATER RES, V59, P697, DOI 10.1002/jbm.10044
   Gibson IR, 1999, J BIOMED MATER RES, V44, P422, DOI 10.1002/(SICI)1097-4636(19990315)44:4<422::AID-JBM8>3.0.CO;2-#
   Green D, 2002, BONE, V30, P810, DOI 10.1016/S8756-3282(02)00727-5
   Hasegawa K, 1998, ARCH ORTHOP TRAUM SU, V117, P175, DOI 10.1007/s004020050223
   Hing KA, 2000, KEY ENG MATER, V192-1, P373
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Kikuchi M, 2004, COMPOS SCI TECHNOL, V64, P819, DOI 10.1016/j.compscitech.2003.09.002
   Kikuchi M, 2004, KEY ENG MAT, V254-2, P561, DOI 10.4028/www.scientific.net/KEM.254-256.561
   KLEIN CPAT, 1983, J BIOMED MATER RES, V17, P769, DOI 10.1002/jbm.820170505
   Kumar RR, 2000, KEY ENG MAT, V192-1, P19
   Lawson AC, 1998, P I MECH ENG H, V212, P413, DOI 10.1243/0954411981534187
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Lynn AK, 2004, KEY ENG MATER, V254-2, P593, DOI 10.4028/www.scientific.net/KEM.254-256.593
   Moreira-Gonzalez A, 2003, PLAST RECONSTR SURG, V111, P1808, DOI 10.1097/01.PRS.0000055432.20074.93
   Ong JL, 2000, CRIT REV BIOMED ENG, V28, p667A
   OVERGAARD S, 2000, ACTA ORTHOP SCAND, V71, pU1
   Rhee SH, 2001, BIOMATERIALS, V22, P2843, DOI 10.1016/S0142-9612(01)00028-X
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   SYLVESTER MF, 1989, THROMB RES, V55, P135, DOI 10.1016/0049-3848(89)90463-5
   YANNAS IV, 1972, J MACROMOL SCI R M C, VC  7, P49, DOI 10.1080/15321797208068160
   Zeng HT, 2000, J BIOMED MATER RES, V50, P248, DOI 10.1002/(SICI)1097-4636(200005)50:2<248::AID-JBM20>3.3.CO;2-9
NR 36
TC 34
Z9 35
U1 0
U2 17
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0001-4842
J9 ACCOUNTS CHEM RES
JI Accounts Chem. Res.
PD MAR
PY 2005
VL 38
IS 3
BP 202
EP 207
DI 10.1021/ar040234d
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA 907XL
UT WOS:000227751400006
PM 15766239
DA 2018-10-19
ER

PT J
AU Chen, AS
   Taguchi, T
   Okamoto, H
   Danjo, K
   Sakai, K
   Matahira, Y
   Wang, MW
   Miwa, I
AF Chen, AS
   Taguchi, T
   Okamoto, H
   Danjo, K
   Sakai, K
   Matahira, Y
   Wang, MW
   Miwa, I
TI Pharmacokinetics of chitobiose and chitotriose administered
   intravenously or orally to rats
SO BIOLOGICAL & PHARMACEUTICAL BULLETIN
LA English
DT Article
DE chitobiose; chitotriose; pharmacokinetic; chitooligosaccharide
ID CHITOSAN OLIGOSACCHARIDE; OLIGOMER
AB Chitooligosaccharides have attracted much attention as new biomedical materials. The biologic availability of each of these chitooligosaccharides, however, has not yet been studied. In the present study, we found that chitobiose and chitotriose appeared in the blood of rats with maximum plasma concentrations at around 1 h after administration when given orally at a dose of 30 mg/kg. However, chitotetraose and chitopentaose did not appear in the blood when given at a dose of 300 mg/kg. Pharmacokinetic analysis of chitobiose and chitotriose after intravenous administration at 100 mg/kg revealed that both sugars were eliminated from the body following a one-compartment model and that the former relative to the latter was higher for both the total body clearance (224 +/- 43 vs. 155 +/- 26 ml/h/kg) and the distribution volume (107 +/- 15 vs. 65 +/- 9 ml/kg). The absolute oral bioavailability of chitobiose was higher than that of chitotriose at all doses (30, 100, and 300 mg/kg) examined. The first-order absorption rate constants for chitobiose and chitotriose at all doses were less than 1.0 h(-1) and smaller than the elimination rate constants (2.2 +/- 0.3, 2.7 +/- 0.1 h(-1), respectively). The absorption was slow, resulting in flip-flop kinetics. This study indicates that among various chitooligosaccharides, only chitobiose and chitotriose can be appreciably absorbed from the gastrointestinal tract.
C1 Meijo Univ, Fac Pharm, Dept Pathobiochem, Tempaku Ku, Nagoya, Aichi 4688503, Japan.
   Meijo Univ, Fac Pharm, Dept Ind Pharm, Nagoya, Aichi 4688503, Japan.
   Yaizu Suisan Kagaku Ind Co, Yaizu 4258750, Peoples R China.
   Shenyang Pharmaceut Univ, Sch Pharm, Dept Pharmacol, Shenyang 110016, Peoples R China.
RP Miwa, I (reprint author), Meijo Univ, Fac Pharm, Dept Pathobiochem, Tempaku Ku, Nagoya, Aichi 4688503, Japan.
EM miwaichi@ccmfs.meijo-u.ac.jp
CR Chen AS, 2003, BIOL PHARM BULL, V26, P1326, DOI 10.1248/bpb.26.1326
   Choi BK, 2001, INT J ANTIMICROB AG, V18, P553, DOI 10.1016/S0924-8579(01)00434-4
   HIRANO S, 1989, AGR BIOL CHEM TOKYO, V53, P3065, DOI 10.1080/00021369.1989.10869777
   Je JY, 2004, FOOD CHEM TOXICOL, V42, P381, DOI 10.1016/j.fct.2003.10.001
   KENDRA DF, 1984, EXP MYCOL, V8, P276, DOI 10.1016/0147-5975(84)90013-6
   Nam KS, 2001, BIOTECHNOL LETT, V23, P971, DOI 10.1023/A:1010519224254
   Pae HO, 2001, LEUKEMIA RES, V25, P339, DOI 10.1016/S0145-2126(00)00138-7
   Shon YH, 2002, BIOL PHARM BULL, V25, P1161, DOI 10.1248/bpb.25.1161
   Xue CH, 1998, BIOSCI BIOTECH BIOCH, V62, P206, DOI 10.1271/bbb.62.206
   Yasuno S, 1999, BIOSCI BIOTECH BIOCH, V63, P1353, DOI 10.1271/bbb.63.1353
NR 10
TC 10
Z9 12
U1 0
U2 9
PU PHARMACEUTICAL SOC JAPAN
PI TOKYO
PA 2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN
SN 0918-6158
J9 BIOL PHARM BULL
JI Biol. Pharm. Bull.
PD MAR
PY 2005
VL 28
IS 3
BP 545
EP 548
DI 10.1248/bpb.28.545
PG 4
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 907GW
UT WOS:000227705300030
PM 15744088
OA Bronze
DA 2018-10-19
ER

PT J
AU Arimura, H
   Ohya, Y
   Ouchi, T
AF Arimura, H
   Ohya, Y
   Ouchi, T
TI Formation of core-shell type biodegradable polymeric micelles from
   amphiphilic poly(aspartic acid)-block-polylactide diblock copolymer
SO BIOMACROMOLECULES
LA English
DT Article
ID BLOCK-COPOLYMERS; POLY(ETHYLENE GLYCOL); DEGRADATION
AB Poly(aspartic acid)-block-polylactide diblock copolymers (PA.sp-b-PLAs) having both hydrophilic and hydrophobic segments of various lengths were synthesized. These PAsp-b-PLA diblock copolymers formed polymeric micelles consisting of a hydrophobic PLA core and a hydrophilic, pH-sensitive PAsp shell in aqueous solution. The effects of the segment length of both the PLA and the PAsp portions and the pH of the solution on the shapes and sizes of the PAsp-b-PLA polymeric micelles were investigated. The results indicated a balance between the effects of electrostatic repulsion, hydrogen bonding in the PAsp shell layer, and hydrophobic interactions in the PLA core determine the sizes of the PAsp-b-PLA polymeric micelles. Moreover, the PAsp-b-PLA polymeric micelles did not possess any cytotoxic activity against L929 fibroblast cells. The obtained polymeric micelle should be useful for biodegradable biomedical materials such as drug delivery vehicle.
C1 Kansai Univ, Fac Engn & High Technol Res Ctr, Dept Appl Chem, Suita, Osaka 5648680, Japan.
RP Ohya, Y (reprint author), Kansai Univ, Fac Engn & High Technol Res Ctr, Dept Appl Chem, Suita, Osaka 5648680, Japan.
EM yohya@ipcku.kansai-u.ac.jp; touchi@ipcku.kansai-u.ac.jp
CR Arimura H, 2004, MACROMOL RAPID COMM, V25, P743, DOI 10.1002/marc.200300259
   Forster S, 1998, ADV MATER, V10, P195, DOI 10.1002/(SICI)1521-4095(199802)10:3<195::AID-ADMA195>3.0.CO;2-V
   HAMLEY IW, 1998, PHYS BLOCK COPOLYMER, P332
   Iijima M, 1999, MACROMOLECULES, V32, P1140, DOI 10.1021/ma9815962
   Jeong B, 2002, ADV DRUG DELIVER REV, V54, P37, DOI 10.1016/S0169-409X(01)00242-3
   KWON G, 1996, ADV DRUG DEL REV, V16, P107
   Li SM, 2003, MACROMOLECULES, V36, P8008, DOI 10.1021/ma034734i
   Li SM, 2002, BIOMACROMOLECULES, V3, P525, DOI 10.1021/bm010168s
   Nagasaki Y, 1998, MACROMOLECULES, V31, P1473, DOI 10.1021/ma971294k
   Ouchi T, 2003, BIOMACROMOLECULES, V4, P477, DOI 10.1021/bm020118t
   Ouchi T, 2002, J POLYM SCI POL CHEM, V40, P1426, DOI 10.1002/pola.10226
   WILHELM M, 1991, MACROMOLECULES, V24, P1033, DOI 10.1021/ma00005a010
   Xiong XY, 2004, MACROMOLECULES, V37, P3425, DOI 10.1021/ma049662p
   Yoo HS, 2002, J CONTROL RELEASE, V82, P17, DOI 10.1016/S0168-3659(02)00088-3
NR 14
TC 117
Z9 121
U1 1
U2 39
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAR-APR
PY 2005
VL 6
IS 2
BP 720
EP 725
DI 10.1021/bm0494491
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 907AT
UT WOS:000227687800028
PM 15762635
DA 2018-10-19
ER

PT J
AU Masuko, T
   Minami, A
   Iwasaki, N
   Majima, T
   Nishimura, SI
   Lee, YC
AF Masuko, T
   Minami, A
   Iwasaki, N
   Majima, T
   Nishimura, SI
   Lee, YC
TI Thiolation of chitosan. Attachment of proteins via thioether formation
SO BIOMACROMOLECULES
LA English
DT Article
ID N-CARBOXYBUTYL CHITOSAN; WATER-SOLUBLE CHITOSAN; IN-VITRO EVALUATION;
   CONTROLLED-RELEASE; SUCCINYL-CHITOSAN; GENE DELIVERY; TISSUE;
   NANOPARTICLES; SCAFFOLDS; CHITIN
AB Chitosan has a variety of biological functions through conjugating of other compounds to their amino and hydroxyl groups. To further expand applicability of chitosan, we have modified the amino group of chitosan with 2-iminothiolane to bestow thiol groups and obtained about 20% yield, which is equivalent to 913 mu equiv SH/g chitosan or 457 nequiv SH/nmol chitosan. Bovine serum albumin (BSA) was reacted with N-(c-maleimidocaproyloxy)sulfosuccinimide ester (sulfo-EMCS), and maleimide-modified BSA (MaINBSA) was obtained. The yield of sulfo-EMCS addition was 12.8-36.8 mol MaIN/mol BSA. When the chitosan-SH was reacted with MalN-BSA via thioether, 97.8% of the maleimide group was reacted, and 37.2% of the SH group was consumed. The remaining SH group was quenched by bromoacetamide. This is the first report of covalent conjugation of a protein to chitosan. Our method should find many applications in developing new chitosan-based biomedical materials containing other components such as growth factors and cell adhesion molecules, known to be crucial to cells. Our thiolated chitosan will facilitate conjugation of such biomedical components to provide new types of materials for tissue engineering.
C1 Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.
   Hokkaido Univ, Sch Med, Dept Orthopaed Surg, Kita Ku, Sapporo, Hokkaido 0608638, Japan.
   Hokkaido Univ, Frontier Res Ctr Postgenom Sci & Technol, Grad Sch Sci, Div Biol Sci,Lab Biomacromol Chem,Kita Ku, Sapporo, Hokkaido 0010021, Japan.
RP Lee, YC (reprint author), Johns Hopkins Univ, Dept Biol, 3400 N Charles St, Baltimore, MD 21218 USA.
EM yclee@jhu.edu
RI Nishimura, Shinichiro/F-5277-2011; Iwasaki, Norimasa/D-6448-2012;
   Majima, Tokifumi/E-2412-2012
CR Aiedeh K, 1997, J MICROENCAPSUL, V14, P567, DOI 10.3109/02652049709006810
   Bernkop-Schnurch A, 2003, INT J PHARM, V260, P229, DOI 10.1016/S0378-5173(03)00271-0
   BIAGINI G, 1991, BIOMATERIALS, V12, P287, DOI 10.1016/0142-9612(91)90036-A
   BIAGINI G, 1991, BIOMATERIALS, V12, P281, DOI 10.1016/0142-9612(91)90035-9
   Brown CD, 2001, J CONTROL RELEASE, V72, P35, DOI 10.1016/S0168-3659(01)00260-7
   Chen XG, 2002, BIOMATERIALS, V23, P4609, DOI 10.1016/S0142-9612(02)00207-7
   Cui YL, 2003, BIOMATERIALS, V24, P3859, DOI 10.1016/S0142-9612(03)00209-6
   Degim Z, 2002, AMINO ACIDS, V22, P187, DOI 10.1007/s007260200007
   Elcin AE, 1998, NEUROL RES, V20, P648
   Elcin YM, 1998, ARTIF ORGANS, V22, P837
   Elcin YM, 1999, ARTIF ORGANS, V23, P146, DOI 10.1046/j.1525-1594.1999.06222.x
   ELKAMEL A, 2002, PHARMSCI, V4, pE44
   ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   Erbacher P, 1998, PHARMACEUT RES, V15, P1332, DOI 10.1023/A:1011981000671
   HIRANO S, 1989, BIOMATERIALS, V10, P574, DOI 10.1016/0142-9612(89)90066-5
   Huang M, 2002, PHARM RES-DORDR, V19, P1488, DOI 10.1023/A:1020404615898
   Illum L, 1998, PHARMACEUT RES, V15, P1326
   Ishihara M, 2003, J BIOMED MATER RES A, V64A, P551, DOI 10.1002/jbm.a.10427
   Iwasaki N, 2004, BIOMACROMOLECULES, V5, P828, DOI 10.1021/bm0400067
   JENNINGS CD, 1988, P SOC EXP BIOL MED, V189, P13
   Kato Y, 2000, BIOMATERIALS, V21, P1579, DOI 10.1016/S0142-9612(00)00044-2
   Kato Y, 2004, BIOMATERIALS, V25, P907, DOI 10.1016/S0142-9612(03)00598-2
   Khan TA, 2000, J PHARM PHARM SCI, V3, P303
   Kumar G, 1999, BIOTECHNOL BIOENG, V63, P154, DOI 10.1002/(SICI)1097-0290(19990420)63:2<154::AID-BIT4>3.3.CO;2-I
   Lahiji A, 2000, J BIOMED MATER RES, V51, P586
   Liu WG, 2003, BIOCONJUGATE CHEM, V14, P782, DOI 10.1021/bc020051g
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   MACLAUGHLIN FC, 1998, CONTROLLED RELEASE, V56, P259
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Mitra S, 2001, J CONTROL RELEASE, V74, P317, DOI 10.1016/S0168-3659(01)00342-X
   MUZZARELLI R, 1990, ANTIMICROB AGENTS CH, V34, P2019, DOI 10.1128/AAC.34.10.2019
   MUZZARELLI R, 1989, BIOMATERIALS, V10, P598, DOI 10.1016/0142-9612(89)90113-0
   MUZZARELLI RAA, 1993, BIOMATERIALS, V14, P39, DOI 10.1016/0142-9612(93)90073-B
   Nettles DL, 2002, TISSUE ENG, V8, P1009, DOI 10.1089/107632702320934100
   Nishikawa H., 2001, SILICON BASED MAT DE, V2, P93
   NISHIOKA Y, 1992, CHEM PHARM BULL, V40, P267, DOI 10.1248/cpb.40.267
   NISHIOKA Y, 1990, CHEM PHARM BULL, V38, P2871, DOI 10.1248/cpb.38.2871
   Onishi H, 1999, BIOMATERIALS, V20, P175, DOI 10.1016/S0142-9612(98)00159-8
   PANGBURN SH, 1982, BIOMATERIALS, V3, P105, DOI 10.1016/0142-9612(82)90043-6
   Park YJ, 2000, BIOMATERIALS, V21, P153
   PARTIS MD, 1983, J PROTEIN CHEM, V2, P263, DOI 10.1007/BF01025358
   Qin CQ, 2002, INT J BIOL MACROMOL, V31, P111, DOI 10.1016/S0141-8130(02)00064-8
   Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m
   Richardson SCW, 1999, INT J PHARMACEUT, V178, P231, DOI 10.1016/S0378-5173(98)00378-0
   Roy K, 1999, NAT MED, V5, P387
   SANZGIRI YD, 1990, PHARMACEUT RES, V7, P418, DOI 10.1023/A:1015887910184
   Schipper NGM, 1997, PHARMACEUT RES, V14, P923, DOI 10.1023/A:1012160102740
   Sechriest VF, 2000, J BIOMED MATER RES, V49, P534, DOI 10.1002/(SICI)1097-4636(20000315)49:4<534::AID-JBM12>3.0.CO;2-#
   SOSA MAG, 1991, BIOCHEM BIOPH RES CO, V174, P489, DOI 10.1016/0006-291X(91)91443-G
   SUGANO M, 1980, AM J CLIN NUTR, V33, P787
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Suzuki M, 2003, J NEUROSCI RES, V72, P646, DOI 10.1002/jnr.10589
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   Tommeraas K, 2001, CARBOHYD RES, V336, P291, DOI 10.1016/S0008-6215(01)00275-0
   Ueno H, 1999, BIOMATERIALS, V20, P1407, DOI 10.1016/S0142-9612(99)00046-0
   Varum KM, 1997, CARBOHYD RES, V299, P99, DOI 10.1016/S0008-6215(96)00332-1
   Vongchan P, 2002, CARBOHYD RES, V337, P1239, DOI 10.1016/S0008-6215(02)00098-8
   Wang XH, 2003, BIOMATERIALS, V24, P3213, DOI 10.1016/S0142-9612(03)00170-4
   Xu YM, 2003, INT J PHARM, V250, P215, DOI 10.1016/S0378-5173(02)00548-3
   Xu YM, 2003, BIOMATERIALS, V24, P5015, DOI 10.1016/S0142-9612(03)00408-3
   Yamane S, 2005, BIOMATERIALS, V26, P611, DOI 10.1016/j.biomaterials.2004.03.013
   Zhu HG, 2002, J BIOMED MATER RES, V62, P532, DOI 10.1002/jbm.10313
NR 62
TC 42
Z9 42
U1 1
U2 26
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAR-APR
PY 2005
VL 6
IS 2
BP 880
EP 884
DI 10.1021/bm049352e
PG 5
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 907AT
UT WOS:000227687800047
PM 15762654
DA 2018-10-19
ER

PT J
AU Cheng, FY
   Su, CH
   Yang, YS
   Yeh, CS
   Tsai, CY
   Wu, CL
   Wu, MT
   Shieh, DB
AF Cheng, FY
   Su, CH
   Yang, YS
   Yeh, CS
   Tsai, CY
   Wu, CL
   Wu, MT
   Shieh, DB
TI Characterization of aqueous dispersions of Fe3O4 nanoparticles and their
   biomedical applications
SO BIOMATERIALS
LA English
DT Article
DE MRI; nanoparticle; cytotoxicity
ID SUPERPARAMAGNETIC IRON-OXIDE; POOL CONTRAST-MEDIUM; MAGNETITE
   NANOPARTICLES; MR-ANGIOGRAPHY; CLINICAL-APPLICATION; PARTICLES VSOP;
   MAST-CELLS; PHASE-I; AGENTS; LIVER
AB A newly developed non-polymer coated Fe3O4 nanoparticles showing well-dispersion were synthesized using Fe(II) and Fe(III) salt chemical coprecipitation with tetramethylammonium hydroxide (N(CH3)(4)OH) in an aqueous solution. Transmission electron microscopy (TEM), X-ray diffraction (XRD), Fourier transform infrared spectrometer (FT-IR), X-ray photoelectron spectrometer (XPS) and superconducting quantum interference measurement device (SQUID) measurements were employed to investigate the iron oxide properties. The resulting iron oxide particles were manipulated to be as small as 9 nm diameter in size. Based on FT-IR and X-ray photoelectron spectrometer results, it is suggested that the surfaces of the magnetite (Fe3O4) particles are covered with hydroxide (-OH) groups incorporated with (CH3)(4)N+ through electrostatic interaction. The in vitro cytotoxicity test revealed that the magnetite particles exhibited excellent biocompatibility, suggesting that they may be further explored for biomedical applications. NMR measurements revealed significantly reduced water proton relaxation times T1 and T2. The MR images of the nanoparticles in water, serum, and whole blood were investigated using a 1.5T clinical MR imager. Significant reduction of the background medium signal was achieved in the T2-weighted and the T2*-weighted sequence especially in the serum and whole blood. Combining the advantage of MRI signal contrast, the non-polymer-coated surface chemistry for distinct bioconjugation and the homogenous nanometer size for better controlled biodistribution, these preliminary experiments demonstrated the potential of the as-synthesized magnetite material in functional molecular imaging for biomedical research and clinical diagnosis. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Natl Cheng Kung Univ, Dept Chem, Tainan 701, Taiwan.
   Natl Cheng Kung Univ, Dept Biochem, Tainan 701, Taiwan.
   Kaohsiung Vet Gen Hosp, Dept Radiol, Kaohsiung 813, Taiwan.
   Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan.
   Natl Cheng Kung Univ, Dept Dent, Tainan 701, Taiwan.
   Natl Cheng Kung Univ, Ctr Biosci & Biotechnol, Tainan 701, Taiwan.
RP Yeh, CS (reprint author), Natl Cheng Kung Univ, Dept Chem, Tainan 701, Taiwan.
EM csyeh@mail.ncku.edu.tw; wumolbio@mail.ncku.edu.tw;
   dshieh@mail.ncku.edu.tw
RI Wu, Chao-Liang/K-5272-2013; Yeh, Chen-Sheng/H-4347-2011
OI Wu, Chao-Liang/0000-0001-7821-9406; 
CR ATKINSON TP, 1988, J IMMUNOL, V141, P1302
   Bean C., 1959, J APPL PHYS, V30, P120
   Bellin MF, 2000, EUR J RADIOL, V34, P257, DOI 10.1016/S0720-048X(00)00204-7
   Bergemann C, 1999, J MAGN MAGN MATER, V194, P45, DOI 10.1016/S0304-8853(98)00554-X
   Bonnemain B, 1998, J DRUG TARGET, V6, P167, DOI 10.3109/10611869808997890
   CHAN DCF, 1993, J MAGN MAGN MATER, V122, P374
   Chouly C, 1996, J MICROENCAPSUL, V13, P245, DOI 10.3109/02652049609026013
   Closmann C, 1996, AM MINERAL, V81, P1321
   Cornell R.M., 1996, IRON OXIDE STRUCTURE
   Dyal A, 2003, J AM CHEM SOC, V125, P1684, DOI 10.1021/ja021223n
   ENNIS M, 1986, AGENTS ACTIONS, V18, P235, DOI 10.1007/BF01988029
   FINN P, 1972, INORG CHEM, V11, P893, DOI 10.1021/ic50110a051
   Fu L, 2001, APPL SURF SCI, V181, P173, DOI 10.1016/S0169-4332(01)00388-9
   HAHN PF, 1990, RADIOLOGY, V174, P361, DOI 10.1148/radiology.174.2.2296646
   Harris LA, 2003, CHEM MATER, V15, P1367, DOI 10.1021/cm020994n
   HARVEY DT, 1981, ANAL CHEM, V53, P1684, DOI 10.1021/ac00234a030
   INCORVIA MJ, 1989, J ELECTROCHEM SOC, V136, P2493, DOI 10.1149/1.2097443
   Jordan A, 1999, J MAGN MAGN MATER, V194, P185, DOI 10.1016/S0304-8853(98)00558-7
   JUNG CW, 1995, MAGN RESON IMAGING, V13, P675, DOI 10.1016/0730-725X(95)00023-A
   Kim DK, 2001, J MAGN MAGN MATER, V225, P256, DOI 10.1016/S0304-8853(00)01255-5
   Kim DK, 2001, J MAGN MAGN MATER, V225, P30, DOI 10.1016/S0304-8853(00)01224-5
   Knag YS, 1996, CHEM MATER, V8, P2209
   Koenig S H, 1987, Magn Reson Annu, P263
   Lind K, 2002, J DRUG TARGET, V10, P221, DOI 10.1080/10611860290022651
   Lubbe AS, 1996, CANCER RES, V56, P4686
   MANN S, 1988, J COLLOID INTERF SCI, V122, P326, DOI 10.1016/0021-9797(88)90368-2
   MCLACHLAN SJ, 1994, JMRI-J MAGN RESON IM, V4, P301, DOI 10.1002/jmri.1880040313
   MULLER N, 1990, METEORITICS, V25, P1
   NOLTE H, 1988, AM J PEDIAT HEMATOL, V10, P308
   Qu SC, 1999, J COLLOID INTERF SCI, V215, P190, DOI 10.1006/jcis.1999.6185
   Reimer P, 2003, EUR RADIOL, V13, P1266, DOI 10.1007/s00330-002-1721-7
   REIMER P, 1992, JMRI-J MAGN RESON IM, V2, P177, DOI 10.1002/jmri.1880020210
   Reynolds CH, 2000, J AM CHEM SOC, V122, P8940, DOI 10.1021/ja001426g
   SAINI S, 1988, RADIOLOGY, V169, P656, DOI 10.1148/radiology.169.3.3186987
   Schnorr J, 2002, ACAD RADIOL, V9, pS307, DOI 10.1016/S1076-6332(03)80211-8
   Shen LF, 1999, LANGMUIR, V15, P447, DOI 10.1021/la9807661
   STARK DD, 1988, RADIOLOGY, V168, P297, DOI 10.1148/radiology.168.2.3393649
   Sun SH, 2002, J AM CHEM SOC, V124, P8204, DOI 10.1021/ja026501x
   Taupitz M, 2002, RADIOLOGY, V222, P120, DOI 10.1148/radiol.2221001452
   Taupitz M, 2000, J MAGN RESON IMAGING, V12, P905, DOI 10.1002/1522-2586(200012)12:6<905::AID-JMRI14>3.0.CO;2-5
   Thode K, 1997, J DRUG TARGET, V5, P35, DOI 10.3109/10611869708995856
   Vijayakumar R, 2000, MAT SCI ENG A-STRUCT, V286, P101, DOI 10.1016/S0921-5093(00)00647-X
   Wagner S, 2002, INVEST RADIOL, V37, P167, DOI 10.1097/00004424-200204000-00002
   WEISSLEDER R, 1990, RADIOLOGY, V175, P489, DOI 10.1148/radiology.175.2.2326474
   Zhang Y, 2002, BIOMATERIALS, V23, P1553, DOI 10.1016/S0142-9612(01)00267-8
NR 45
TC 459
Z9 486
U1 52
U2 630
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2005
VL 26
IS 7
BP 729
EP 738
DI 10.1016/j.biomaterials.2004.03.016
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 860DK
UT WOS:000224319300005
PM 15350777
DA 2018-10-19
ER

PT J
AU Alarcon, CDH
   Pennadam, S
   Alexander, C
AF Alarcon, CDH
   Pennadam, S
   Alexander, C
TI Stimuli responsive polymers for biomedical applications
SO CHEMICAL SOCIETY REVIEWS
LA English
DT Review
ID SCHIZOPHRENIC DIBLOCK COPOLYMER; CROSS-LINKED MICELLES; CONTACT-ANGLE
   MEASUREMENTS; SELF-ASSEMBLED MONOLAYERS; CELL-CULTURE MEMBRANES;
   TARGETED DRUG-DELIVERY; PROTEINS IN-VIVO; THERMORESPONSIVE POLYMER;
   BLOCK-COPOLYMERS; AQUEOUS-SOLUTION
AB Polymers that can respond to external stimuli are of great interest in medicine, especially as controlled drug release vehicles. In this critical review, we consider the types of stimulus response used in therapeutic applications and the main classes of responsive materials developed to date. Particular emphasis is placed on the wide-ranging possibilities for the biomedical use of these polymers, ranging from drug delivery systems and cell adhesion mediators to controllers of enzyme function and gene expression (134 references).
C1 Univ Portsmouth, Sch Pharm & Biomed Sci, Portsmouth PO1 2DT, Hants, England.
RP Alexander, C (reprint author), Univ Portsmouth, Sch Pharm & Biomed Sci, St Michaels Bldg,White Swan Rd, Portsmouth PO1 2DT, Hants, England.
EM cameron.alexander@port.ac.uk
RI Alexander, Cameron/N-7729-2014
OI Alexander, Cameron/0000-0001-8337-1875
CR ALEXANDRIDIS P, 1995, COLLOID SURFACE A, V96, P1, DOI 10.1016/0927-7757(94)03028-X
   ALEXANDRIDIS P, 1995, LANGMUIR, V11, P1468, DOI 10.1021/la00005a011
   Arotcarena M, 2002, J AM CHEM SOC, V124, P3787, DOI 10.1021/ja012167d
   Arvidsson P, 2001, J CHROMATOGR B, V753, P279, DOI 10.1016/S0378-4347(00)00558-2
   BAE YH, 1991, PHARMACEUT RES, V8, P624, DOI 10.1023/A:1015860824953
   BAE YH, 1989, J CONTROL RELEASE, V9, P271, DOI 10.1016/0168-3659(89)90096-5
   Barker SLR, 2000, ANAL CHEM, V72, P5925, DOI 10.1021/ac0008690
   BRONDSTED H, 1992, ACS SYM SER, V480, P285
   Cadee JA, 2002, J CONTROL RELEASE, V78, P1, DOI 10.1016/S0168-3659(01)00483-7
   Caliceti P, 2003, ADV DRUG DELIVER REV, V55, P1261, DOI 10.1016/S0169-409X(03)00108-X
   Callow ME, 2000, APPL ENVIRON MICROB, V66, P3249, DOI 10.1128/AEM.66.8.3249-3254.2000
   Cellesi F, 2002, MACROMOL CHEM PHYSIC, V203, P1466, DOI 10.1002/1521-3935(200207)203:10/11<1466::AID-MACP1466>3.0.CO;2-P
   Chao HM, 1998, J CHROMATOGR B, V715, P307, DOI 10.1016/S0378-4347(98)00172-8
   Chen GP, 1998, J BIOMED MATER RES, V42, P38, DOI 10.1002/(SICI)1097-4636(199810)42:1<38::AID-JBM6>3.0.CO;2-P
   Chilkoti A, 2002, ADV DRUG DELIVER REV, V54, P613, DOI 10.1016/S0169-409X(02)00041-8
   Chilkoti A, 2002, ADV DRUG DELIVER REV, V54, P1093, DOI 10.1016/S0169-409X(02)00060-1
   Crommelin DJA, 2003, J CONTROL RELEASE, V87, P81, DOI 10.1016/S0168-3659(03)00014-2
   Cunliffe D, 2003, LANGMUIR, V19, P2888, DOI 10.1021/la026358l
   Cunliffe D, 2000, BIOTECHNOL LETT, V22, P141, DOI 10.1023/A:1005622424821
   Di Zio K, 2003, MACROMOLECULES, V36, P1553, DOI 10.1021/ma0256587
   Ding ZL, 1998, J BIOMED MATER RES, V39, P498, DOI 10.1002/(SICI)1097-4636(19980305)39:3<498::AID-JBM22>3.0.CO;2-5
   Donini C, 2002, INT J PHARM, V245, P83, DOI 10.1016/S0378-5173(02)00335-6
   Dreher MR, 2003, J CONTROL RELEASE, V91, P31, DOI 10.1016/S0168-3659(03)00216-5
   Duncan R, 2003, NAT REV DRUG DISCOV, V2, P347, DOI 10.1038/nrd1088
   DUNCAN R, 1994, CLIN PHARMACOKINET, V27, P290, DOI 10.2165/00003088-199427040-00004
   ELSAYED M, 2001, PHARM RES, V18, P223
   Fu Q, 2003, ADV MATER, V15, P1262, DOI 10.1002/adma.200305165
   Galaev IY, 1999, TRENDS BIOTECHNOL, V17, P335, DOI 10.1016/S0167-7799(99)01345-1
   Gan DJ, 2001, J AM CHEM SOC, V123, P7511, DOI 10.1021/ja010609f
   Gao J, 2003, LANGMUIR, V19, P5212, DOI 10.1021/la0269762
   Garrigues A, 2002, MOL PHARMACOL, V62, P1288, DOI 10.1124/mol.62.6.1288
   Goldmints I, 1997, LANGMUIR, V13, P6130, DOI 10.1021/la970534m
   Grabstain V, 2003, BIOTECHNOL PROGR, V19, P1728, DOI 10.1021/bp034161t
   Graham NB, 1998, PURE APPL CHEM, V70, P1271, DOI 10.1351/pac199870061271
   Greish K, 2003, CLIN PHARMACOKINET, V42, P1089, DOI 10.2165/00003088-200342130-00002
   Haider M, 2004, J CONTROL RELEASE, V95, P1, DOI 10.1016/j.jconrel.2003.11.011
   Harimoto M, 2003, MACROMOL SYMP, V195, P231, DOI 10.1002/masy.200390127
   HELLER J, 1993, ADV DRUG DELIVER REV, V10, P163, DOI 10.1016/0169-409X(93)90047-8
   Hinrichs WLJ, 1999, J CONTROL RELEASE, V60, P249, DOI 10.1016/S0168-3659(99)00075-9
   Hoffmann J, 1999, SENSOR ACTUAT A-PHYS, V77, P139, DOI 10.1016/S0924-4247(99)00080-1
   Ista LK, 1999, APPL ENVIRON MICROB, V65, P1603
   Ista LK, 2001, LANGMUIR, V17, P2552, DOI 10.1021/la001257d
   Ista LK, 1998, J IND MICROBIOL BIOT, V20, P121, DOI 10.1038/sj.jim.2900490
   Kaneko Y, 1996, MACROMOL SYMP, V109, P41, DOI 10.1002/masy.19961090105
   Kaneko Y, 1999, J BIOMAT SCI-POLYM E, V10, P1079, DOI 10.1163/156856299X00757
   KANEKO Y, 1995, J MEMBRANE SCI, V101, P13, DOI 10.1016/0376-7388(94)00268-4
   Kato N, 2003, B CHEM SOC JPN, V76, P543, DOI 10.1246/bcsj.76.543
   Kiick KL, 2002, P NATL ACAD SCI USA, V99, P19, DOI 10.1073/pnas.012583299
   Kikuchi A, 2002, ADV DRUG DELIVER REV, V54, P53, DOI 10.1016/S0169-409X(01)00243-5
   Kim B, 2003, J APPL POLYM SCI, V89, P1606, DOI 10.1002/app.12337
   Kim SJ, 2003, J APPL POLYM SCI, V89, P890, DOI 10.1002/app.12331
   Kirshenbaum K, 2002, CHEMBIOCHEM, V3, P235, DOI 10.1002/1439-7633(20020301)3:2/3<235::AID-CBIC235>3.0.CO;2-7
   Kishi R, 2003, J APPL POLYM SCI, V89, P75, DOI 10.1002/app.11996
   Koh AYC, 2002, PHYS CHEM CHEM PHYS, V4, P96, DOI 10.1039/b105990b
   Kost J, 2001, ADV DRUG DELIVER REV, V46, P125, DOI 10.1016/S0169-409X(00)00136-8
   Kuckling D, 2003, MACROMOL MATER ENG, V288, P144, DOI 10.1002/mame.200390007
   Kuckling D, 2002, LANGMUIR, V18, P4263, DOI 10.1021/la015758q
   Kurisawa M, 2000, J CONTROL RELEASE, V68, P1, DOI 10.1016/S0168-3659(00)00246-7
   Kurisawa M, 2000, J CONTROL RELEASE, V69, P127, DOI 10.1016/S0168-3659(00)00297-2
   Kwok SC, 2004, J BIOL CHEM, V279, P21576, DOI 10.1074/jbc.M401074200
   Kwon I, 2003, J AM CHEM SOC, V125, P7512, DOI 10.1021/ja0350076
   Kwon OH, 2000, J BIOMED MATER RES, V50, P82, DOI 10.1002/(SICI)1097-4636(200004)50:1<82::AID-JBM12>3.3.CO;2-Z
   Kwon OH, 2003, BIOMATERIALS, V24, P1223, DOI 10.1016/S0142-9612(02)00469-6
   Kyriakides TR, 2002, J CONTROL RELEASE, V78, P295, DOI 10.1016/S0168-3659(01)00504-1
   Lee J, 2001, J BIOMAT SCI-POLYM E, V12, P229, DOI 10.1163/156856201750180942
   LEHR CM, 1992, PHARMACEUT RES, V9, P70, DOI 10.1023/A:1018931811189
   Li SK, 2001, J CONTROL RELEASE, V75, P55, DOI 10.1016/S0168-3659(01)00365-0
   Liu SY, 2002, ANGEW CHEM INT EDIT, V41, P1413, DOI 10.1002/1521-3773(20020415)41:8<1413::AID-ANIE1413>3.0.CO;2-K
   Liu SY, 2003, LANGMUIR, V19, P4432, DOI 10.1021/la020951l
   Liu SY, 2002, LANGMUIR, V18, P8350, DOI 10.1021/la020496t
   Liu SY, 2001, J AM CHEM SOC, V123, P9910, DOI 10.1021/ja011206i
   Lowman AM, 1999, J PHARM SCI, V88, P933, DOI 10.1021/js980337n
   Lustig SR, 2001, MACROMOLECULES, V34, P2364, DOI 10.1021/ma001393p
   Maeda H, 2001, J CONTROL RELEASE, V74, P47, DOI 10.1016/S0168-3659(01)00309-1
   Maeda H, 2003, INT IMMUNOPHARMACOL, V3, P319, DOI 10.1016/S1567-5769(02)00271-0
   Maeda H, 2001, ADV DRUG DELIVER REV, V46, P169, DOI 10.1016/S0169-409X(00)00134-4
   MAKINO K, 1990, J CONTROL RELEASE, V12, P235, DOI 10.1016/0168-3659(90)90104-2
   MATSUMURA Y, 1986, CANCER RES, V46, P6387
   Megeed Z, 2004, J CONTROL RELEASE, V94, P433, DOI 10.1016/j.jconrel.2003.10.027
   Megeed Z, 2002, ADV DRUG DELIVER REV, V54, P1075, DOI 10.1016/S0169-409X(02)00063-7
   Meyer DE, 2001, J CONTROL RELEASE, V74, P213, DOI 10.1016/S0168-3659(01)00319-4
   Murata M, 2003, CHEM LETT, V32, P986, DOI 10.1246/cl.2003.986
   Murata M, 2003, BIOORG MED CHEM LETT, V13, P3967, DOI 10.1016/j.bmcl.2003.08.062
   Murthy KS, 2003, J MATER CHEM, V13, P2785, DOI 10.1039/b304166b
   Nagarsekar A, 2002, J BIOMED MATER RES, V62, P195, DOI 10.1002/jbm.10272
   Nakamura K, 1999, J CONTROL RELEASE, V61, P329, DOI 10.1016/S0168-3659(99)00150-9
   Nishida K, 2003, INVEST OPHTH VIS SCI, V44, pU127
   Noguchi Y, 1998, JPN J CANCER RES, V89, P307, DOI 10.1111/j.1349-7006.1998.tb00563.x
   OKANO T, 1995, J CONTROL RELEASE, V36, P125, DOI 10.1016/0168-3659(95)00054-C
   PARK TG, 1993, ENZYME MICROB TECH, V15, P476, DOI 10.1016/0141-0229(93)90079-H
   Peppas NA, 1999, J CONTROL RELEASE, V62, P81, DOI 10.1016/S0168-3659(99)00027-9
   Peppas NA, 1997, CURR OPIN COLLOID IN, V2, P531, DOI 10.1016/S1359-0294(97)80103-3
   Pinkrah VT, 2003, LANGMUIR, V19, P585, DOI 10.1021/la0262831
   Poortinga AT, 2001, LANGMUIR, V17, P2851, DOI 10.1021/la001673y
   RAMKISSOONGANORKAR, 1999, J CONTROL RELEASE, V59, P287
   Raucher D, 2001, CANCER RES, V61, P7163
   Raula J, 2003, LANGMUIR, V19, P3499, DOI 10.1021/la026872r
   Saunders BR, 1999, ADV COLLOID INTERFAC, V80, P1, DOI 10.1016/S0001-8686(98)00071-2
   SCHILD HG, 1992, PROG POLYM SCI, V17, P163, DOI 10.1016/0079-6700(92)90023-R
   Schmitt FJ, 1998, LANGMUIR, V14, P2838, DOI 10.1021/la9709195
   Sharma N, 2000, FEBS LETT, V467, P37, DOI 10.1016/S0014-5793(00)01120-0
   SHIINO D, 1994, BIOMATERIALS, V15, P121, DOI 10.1016/0142-9612(94)90261-5
   Shiino D, 1995, J CONTROL RELEASE, V37, P269, DOI 10.1016/0168-3659(95)00084-4
   Shimizu T, 2003, BIOMATERIALS, V24, P2309, DOI 10.1016/S0142-9612(03)00110-8
   Shimoboji T, 2002, P NATL ACAD SCI USA, V99, P16592, DOI 10.1073/pnas.262427799
   Shiroyanagi Y, 2003, TISSUE ENG, V9, P1005, DOI 10.1089/107632703322495646
   Sosnik A, 2004, BIOMATERIALS, V25, P2851, DOI 10.1016/j.biomaterials.2003.09.057
   STAYTON PS, 1995, NATURE, V378, P472, DOI 10.1038/378472a0
   Stile RA, 2001, BIOMACROMOLECULES, V2, P185, DOI 10.1021/bm0000945
   Stile RA, 2003, LANGMUIR, V19, P1853, DOI 10.1021/la026256v
   Sun YM, 1999, J BIOMED MATER RES, V45, P125, DOI 10.1002/(SICI)1097-4636(199905)45:2<125::AID-JBM7>3.0.CO;2-B
   Thurmond KB, 1996, J AM CHEM SOC, V118, P7239, DOI 10.1021/ja961299h
   Thurmond KB, 1999, NUCLEIC ACIDS RES, V27, P2966, DOI 10.1093/nar/27.14.2966
   Twaites BR, 2004, J CONTROL RELEASE, V97, P551, DOI 10.1016/j.jconrel.2004.03.032
   Uchida K, 2000, BIOMATERIALS, V21, P923, DOI 10.1016/S0142-9612(99)00260-4
   Ulbrich K, 1996, MACROMOL SYMP, V103, P177
   Urry DW, 1999, TRENDS BIOTECHNOL, V17, P249, DOI 10.1016/S0167-7799(99)01306-2
   Urry DW, 1998, BIOPOLYMERS, V47, P167, DOI 10.1002/(SICI)1097-0282(1998)47:2<167::AID-BIP6>3.0.CO;2-S
   Urry DW, 2002, PHILOS T R SOC B, V357, P169, DOI 10.1098/rstb.2001.1023
   Urry DW, 1998, J BIOMAT SCI-POLYM E, V9, P1015, DOI 10.1163/156856298X00316
   van der Weert M, 2000, J CONTROL RELEASE, V68, P31, DOI 10.1016/S0168-3659(00)00227-3
   van Hest JCM, 2001, CHEM COMMUN, P1897, DOI 10.1039/b105185g
   Von Recum HA, 1999, EXP EYE RES, V69, P97, DOI 10.1006/exer.1999.0682
   Wang P, 2003, J AM CHEM SOC, V125, P6900, DOI 10.1021/ja0298287
   Weaver JVM, 2002, CHEM COMMUN, P2122, DOI 10.1039/b207251n
   Weaver JVM, 2004, ANGEW CHEM INT EDIT, V43, P1389, DOI 10.1002/anie.200352428
   Wu JZ, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.048304
   Yamato M, 2002, BIOMATERIALS, V23, P561, DOI 10.1016/S0142-9612(01)00138-7
   Yamato M, 2001, J BIOMED MATER RES, V55, P137, DOI 10.1002/1097-4636(200104)55:1<137::AID-JBM180>3.0.CO;2-L
   Yamato M, 2001, TISSUE ENG, V7, P473, DOI 10.1089/10763270152436517
   YOSHIDA R, 1995, NATURE, V374, P240, DOI 10.1038/374240a0
   Youngster S, 2002, CURR PHARM DESIGN, V8, P2139, DOI 10.2174/1381612023393242
NR 132
TC 1024
Z9 1035
U1 59
U2 877
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0306-0012
EI 1460-4744
J9 CHEM SOC REV
JI Chem. Soc. Rev.
PD MAR
PY 2005
VL 34
IS 3
BP 276
EP 285
DI 10.1039/b406727d
PG 10
WC Chemistry, Multidisciplinary
SC Chemistry
GA 908HV
UT WOS:000227779000019
PM 15726163
DA 2018-10-19
ER

PT J
AU Schroeder, C
   Regli, WC
   Shokoufandeh, A
   Sun, W
AF Schroeder, C
   Regli, WC
   Shokoufandeh, A
   Sun, W
TI Computer-aided design of porous artifacts
SO COMPUTER-AIDED DESIGN
LA English
DT Article
DE computer-aided design; representation; heterogeneous models; solid
   modeling; porous models; biomedical applications
ID SYNTHETIC MICROSTRUCTURES; SEDIMENTARY-ROCK; 2-PHASE FLOW; RANDOM-MEDIA;
   RECONSTRUCTION
AB Heterogeneous structures represent an important new frontier for 21st century engineering. Human tissues, composites, 'smart' and multimaterial objects are all physically manifest in the world as three-dimensional (31)) objects with varying surface, internal and volumetric properties and geometries. For instance, a tissue engineered structure, such as bone scaffold for guided tissue regeneration, can be described as a heterogeneous structure consisting of 3D extra-cellular matrices (made from biodegradable material) and seeded donor cells and/or growth factors.
   The design and fabrication of such heterogeneous structures requires new techniques for solid models to represent 3D heterogeneous objects with complex material properties. This paper presents a representation of model density and porosity based on stochastic geometry. While density has been previously studied in the solid modeling literature, porosity is a relatively new problem. Modeling porosity of bio-materials is critical for developing replacement bone tissues. The paper uses this representation to develop an approach to modeling of porous, heterogeneous materials and provides experimental data to validate the approach. The authors believe that their approach introduces ideas from the stochastic geometry literature to a new set of engineering problems. It is hoped that this paper stimulates researchers to find new opportunities that extend these ideas to be more broadly applicable for other computational geometry, graphics and computer-aided design problems. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Drexel Univ, Dept Comp Sci, Coll Engn, Philadelphia, PA 19104 USA.
   Drexel Univ, Coll Engn, Dept Mech Engn & Mech, Philadelphia, PA 19104 USA.
RP Regli, WC (reprint author), Drexel Univ, Dept Comp Sci, Coll Engn, Philadelphia, PA 19104 USA.
EM regli@drexel.edu
CR ADZHIEV V, 2002, P 7 ACM S SOL MOD AP
   BARNDORFFNIELSE.O, 1999, STOCKHASTIC GEOMETRY
   Biswal B, 1998, PHYSICA A, V255, P221, DOI 10.1016/S0378-4371(98)00111-3
   Biswal B, 1999, PHYSICA A, V273, P452, DOI 10.1016/S0378-4371(99)00248-4
   Biswal B, 1999, PHYSICA A, V266, P307, DOI 10.1016/S0378-4371(98)00607-4
   BOWYER A, 1999, SVLIS INTRO USER MAN
   CHO W, 2000, P NSF DES MAN GRANT
   CHO W, 2002, P NSF DES  SERV MAN
   Corney J., 2001, 3D MODELING ACIS
   DAVIS D, 1999, GITGVU9913, P99
   Flake G. W., 1998, COMPUTATIONAL BEAUTY
   HILFER R, 1991, PHYS REV B, V44, P60, DOI 10.1103/PhysRevB.44.60
   Hilfer R, 2000, GRANUL MATTER, V2, P137
   HILFER R, 1992, PHYS REV B, V45, P7115, DOI 10.1103/PhysRevB.45.7115
   Hilfer R, 2002, J PHYS-CONDENS MAT, V14, P2297, DOI 10.1088/0953-8984/14/9/318
   Hilfer R, 1997, PHYSICA A, V241, P105, DOI 10.1016/S0378-4371(97)00067-8
   Hilfer R, 2000, PHYSICA B, V279, P125, DOI 10.1016/S0921-4526(99)00694-8
   Hilfer R, 1998, PHYS REV E, V58, P2090, DOI 10.1103/PhysRevE.58.2090
   Hilfer R., 1996, ADV CHEM PHYS, P299
   HILFER R, 2000, LECTURE NOTES PHYS, V31, P203
   HILFER R, 2001, PHYS REV E, P64
   Jackson T. R., 2000, THESIS MIT
   Jackson TR, 1999, MATER DESIGN, V20, P63, DOI 10.1016/S0261-3069(99)00011-4
   JACKSON TR, 2002, J COMPUT INFORM SCI, V2
   Johnsen T, 1997, PHYS REV E, V55, P5433, DOI 10.1103/PhysRevE.55.5433
   Kumar V, 1999, COMPUT AIDED DESIGN, V31, P541, DOI 10.1016/S0010-4485(99)00051-2
   KUMAR V, 1997, 4 ACM S SOL MOD
   KUMAR V, 1998, GEOM MOD WORKSH
   LIU H, 2000, P ASME IDETC CIE
   Liu H, 2000, THESIS MIT
   Manwart C, 1999, PHYS REV E, V59, P5596, DOI 10.1103/PhysRevE.59.5596
   Manwart C, 2000, PHYS REV E, V62, P893, DOI 10.1103/PhysRevE.62.893
   PARK SM, 2001, S SOL MOD APPL
   PATIL O, 2000, P ASME C
   Pratt MJ, 2002, COMPUT AIDED DESIGN, V34, P1111, DOI 10.1016/S0010-4485(01)00189-0
   QIAN X, 2003, ASME T, V125, P416
   Qian XP, 2003, COMPUT GRAPH-UK, V27, P943, DOI 10.1016/j.cag.2003/08.001
   Russell S., 1995, ARTIFICIAL INTELLIGE
   *SPAT TECHN INC, 1997, ACIS 3 D TOOLK GETT
   Stoyan D, 1987, STOCHASTIC GEOMETRY
   *STRUCT DYN RES CO, EXPL I DEAS GEN MACH
   Sun W, 2002, COMPUT AIDED DESIGN, V34, P481, DOI 10.1016/S0010-4485(01)00131-2
   Tscheschel A, 2000, PHYSICA A, V284, P46, DOI 10.1016/S0378-4371(00)00116-3
   VOELCKER H, 1978, P 5 ANN C COMP GRAPH
   Yeong CLY, 1998, PHYS REV E, V58, P224, DOI 10.1103/PhysRevE.58.224
NR 45
TC 49
Z9 52
U1 1
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0010-4485
J9 COMPUT AIDED DESIGN
JI Comput.-Aided Des.
PD MAR
PY 2005
VL 37
IS 3
BP 339
EP 353
DI 10.1016/j.cad.2004.03.008
PG 15
WC Computer Science, Software Engineering
SC Computer Science
GA 878XA
UT WOS:000225679500005
DA 2018-10-19
ER

PT J
AU Huang, C
AF Huang, C
TI Designing high-quality interactive multimedia learning modules
SO COMPUTERIZED MEDICAL IMAGING AND GRAPHICS
LA English
DT Article
DE educational media; interactive teaching for biology and medicine;
   instructional web design; physiology modules; multimedia module design
AB Modem research has broadened scientific knowledge and revealed the interdisciplinary nature of the sciences. For today's students, this advance translates to teaming a more diverse range of concepts, usually in less time, and without supporting resources. Students can benefit from technology-enhanced learning supplements that unify concepts and are delivered on-demand over the Internet. Such supplements, like imaging informatics databases, serve as innovative references for biomedical information, but could improve their interaction interfaces to support teaming. With information from these digital datasets, multimedia teaming tools can be designed to transform teaming into an active process where students can visualize relationships over time, interact with dynamic content, and immediately test their knowledge. This approach bridges knowledge gaps, fosters conceptual understanding, and builds problem-solving and critical thinking skills-all essential components to informatics training for science and medicine. Additional benefits include cost-free access and ease of dissemination over the Intemet or CD-ROM. However, current methods for the design of multimedia learning modules are not standardized and lack strong instructional design.
   Pressure from administrators at the top and students from the bottom are pushing faculty to use modern technology to address the teaming needs and expectations of contemporary students. Yet, faculty lack adequate support and training to adopt this new approach. So how can faculty learn to create educational multimedia materials for their students? This paper provides guidelines on best practices in educational multimedia design, derived from the Virtual Labs Project at Stanford University. The development of a multimedia module consists of five phases: (1) understand the teaming problem and the users needs; (2) design the content to harness the enabling technologies; (3) build multimedia materials with web style standards and human factors principles; (4) user testing; (5) Evaluate and improve design. (c) 2004 Elsevier Ltd. All rights reserved.
C1 Stanford Univ, Sch Med, SUMMIT, Stanford, CA 94305 USA.
RP Huang, C (reprint author), Stanford Univ, Sch Med, SUMMIT, Wallenberg Hall,450 Serra Mall,Bldg 160, Stanford, CA 94305 USA.
CR Alessi S, 2001, MULTIMEDIA LEARNING
   *AM ASS HIGH ED TE, FLASHLIGHT TOOL KIT
   [Anonymous], RES BASED WEB DESIGN
   Bransford J. D., 2000, PEOPLE LEARN BRAIN M, P39
   Clark R. C., 2003, E LEARNING SCI INSTR, P322
   COOPER A, 1995, FACE ESSENTIALS USER, P580
   Creswell J. W, 2003, RES DESIGN QUALITATI, P246
   DICK W, 1996, SYSTEMATIC DESIGN IN
   Fogg BJ, 2002, PERSUASIVE TECHNOLOG
   HARVEY J, 1998, LEARNING TECHNOLOGY
   HUANG C, 2003, JCMIG, V27, P157
   HUANG C, 2003, CELL MOL BIOL, V49, P9
   HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837
   KELLOGG WK, 1998, KELLOGG FDN EV HDB 1
   KOZMA RB, 1991, REV EDUC RES, V61, P179, DOI 10.2307/1170534
   LEPPER M, 1987, APTITUDE LEARNING IN, V3, P256
   LYNCH PJ, 2001, WEB STYLE GUIDE, P223
   NIELSEN J., 1999, DESIGNING WEB USABIL
   Nielsen J., 1999, USABILITY ENG
   RETTIG M, 1994, COMMUN ACM, V37, P21, DOI 10.1145/175276.175288
   ROGERS G, 2001, MAT DEV ATE PROGRAM
   SHNEIDERMAN B, 1997, DESIGNING USER INTER
   STRUNK W, 1992, ELEMENTS STYLE
   Tufte E. R., 1990, ENVISIONING INFORMAT, P126
   WICKENS C, 2000, ENG PSYCHOL HUMAN PE, P350
   RES BASED WEB DESIGN, V2004
NR 27
TC 33
Z9 33
U1 1
U2 15
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0895-6111
J9 COMPUT MED IMAG GRAP
JI Comput. Med. Imaging Graph.
PD MAR-APR
PY 2005
VL 29
IS 2-3
BP 223
EP 233
DI 10.1016/j.compmedimag.2004.09.017
PG 11
WC Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging
SC Engineering; Radiology, Nuclear Medicine & Medical Imaging
GA 910VZ
UT WOS:000227961600012
PM 15755539
DA 2018-10-19
ER

PT J
AU Fernandes, AJS
   Salgueiredo, E
   Oliveira, FJ
   Silva, R
   Costa, FM
AF Fernandes, AJS
   Salgueiredo, E
   Oliveira, FJ
   Silva, R
   Costa, FM
TI Directly MPCVD diamond-coated Si3N4 disks for dental applications
SO DIAMOND AND RELATED MATERIALS
LA English
DT Article; Proceedings Paper
CT 15th European Conference on Diamond, Diamond-Like Materials, Carbon
   Nanotubes, Nitrides, and Silicon Carbide
CY SEP 12-17, 2004
CL Riva del Garda, ITALY
SP Aixtron AG, Diamond Business-Magazine, Elsevier Ltd, Iplas Innovat Plasma Syst GmbH, Roth & Rau AG, Seki Technotron Corp
DE abrasion; diamond film; plasma CVD; biomedical applications
ID DEPOSITION; TOOLS
AB Embedded diamond grains in a metal matrix, generally Ni, constitutes a very common material for abrasive machining, namely, in dentistry. Its replacement with CVD diamond in high added-value technological areas is desirable, since metal contamination from the binder matrix can thus be eliminated, and the tool life can be extended. This was already reported in dental burs but has never been attempted in abrasive disks.
   In this work, silicon nitride (Si3N4) substrates were sintered, disk shaped (circle divide 16 mm x 0.35 mm), laser patterned and diamond coated by microwave plasma CVD (MPCVD). For a performance comparison with an electroplated diamond commercial disk in the grinding of two materials used in dentistry (Opaque Dentine 900 ceramic and Luna metal alloy), CVD, diamond-coated disks having distinct surface roughness were prepared.
   Laser patterning was successful for increasing the Si3N4 surface roughness, but this feature was less important for the grinding efficiency than the CVD diamond grain size and shape. A CVD diamond disk removed 1.7 times more material in the ceramic grinding than the commercial one, which evidenced wear by extensive grain pullout in the grinding of the metal alloy. (c) 2004 Elsevier B.V. All rights reserved.
C1 Univ Aveiro, Dept Fis, P-3810193 Aveiro, Portugal.
   Univ Aveiro, CICECO, Dept Ceram & Glass Engn, P-3810193 Aveiro, Portugal.
RP Fernandes, AJS (reprint author), Univ Aveiro, Dept Fis, Campus Santiago, P-3810193 Aveiro, Portugal.
EM toze2@fis.ua.pt
RI Universidade Aveiro, Departamento Fisica/E-4128-2013; Costa,
   Florinda/J-4345-2013; Oliveira, Filipe/H-2618-2013
OI Costa, Florinda/0000-0001-8729-714X; Oliveira,
   Filipe/0000-0001-7956-6565; Silva, Rui/0000-0002-2584-1792
CR Amaral M, 2003, SURF ENG, V19, P410, DOI [10.1179/026708403225010136, 10.1179/02670840322510136]
   Belmonte M, 2003, J AM CERAM SOC, V86, P749, DOI 10.1111/j.1151-2916.2003.tb03369.x
   FLOTER A, 1995, DIAM RELAT MATER, V4, P930, DOI 10.1016/0925-9635(94)00253-3
   Sein H, 2004, THIN SOLID FILMS, V447, P455, DOI 10.1016/j.tsf.2003.08.044
   Sein H, 2002, DIAM RELAT MATER, V11, P731, DOI 10.1016/S0925-9635(01)00579-9
   TANG L, 1995, BIOMATERIALS, V16, P483, DOI 10.1016/0142-9612(95)98822-V
   TravaAiroldi VJ, 1996, DIAM RELAT MATER, V5, P857, DOI 10.1016/0925-9635(95)00516-1
NR 7
TC 1
Z9 1
U1 0
U2 12
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-9635
J9 DIAM RELAT MATER
JI Diam. Relat. Mat.
PD MAR-JUL
PY 2005
VL 14
IS 3-7
SI SI
BP 626
EP 630
DI 10.1016/j.diamond.2004.11.017
PG 5
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 935AP
UT WOS:000229751400074
DA 2018-10-19
ER

PT J
AU Hirakuri, KK
   Kuwashima, K
   Tatsuta, K
   Sato, K
AF Hirakuri, KK
   Kuwashima, K
   Tatsuta, K
   Sato, K
TI Etching of diamond-like carbon films deposited on polyethylene
   terephthalate
SO DIAMOND AND RELATED MATERIALS
LA English
DT Article; Proceedings Paper
CT 15th European Conference on Diamond, Diamond-Like Materials, Carbon
   Nanotubes, Nitrides, and Silicon Carbide
CY SEP 12-17, 2004
CL Riva del Garda, ITALY
SP Aixtron AG, Diamond Business-Magazine, Elsevier Ltd, Iplas Innovat Plasma Syst GmbH, Roth & Rau AG, Seki Technotron Corp
DE diamond-like carbon; etching; chemical vapor deposition; microscopy
ID INTEGRATED-CIRCUIT FABRICATION; BIOMEDICAL APPLICATIONS; POLYMERIC
   MATERIALS
AB Recently, the diamond-like carbon (DLC) films are deposited in the wall of the polyethylene terephthalate (PET) bottles because of the protection for carbon dioxide gas penetration and deterioration against ultraviolet irradiation. However the DLC films fall into the contamination through the recycling process of PET bottle. In order to recycle the PET bottles deposited in DLC films, it is quite necessary to remove the DLC films at the early stage of recycling process. The DLC films were chemically etched by the glow discharge plasma of oxygen gas because carbon films were greatly reacted by the oxygen radicals and ions in the plasma. The etching of the DLC films deposited on the PET materials has been investigated using Raman spectroscopy. The complete removal of the DLC films was confirmed by Raman spectra. The etching depth increases with the etching time and the etching rate at optimum condition is approximately 50 nm/min. Atomic force microscopy observation was relieved surface condition of the PET after the etching treatment at different etching time. The surface roughness of the PET completely removed DLC films is almost same as the pure PET substrate without the exposure of oxygen plasma. (c) 2005 Elsevier B.V All rights reserved.
C1 Tokyo Denki Univ, Fac Sci & Engn, Dept Elect & Comp Engn, Hatoyama, Saitama 3500394, Japan.
RP Kuwashima, K (reprint author), Tokyo Denki Univ, Fac Sci & Engn, Dept Elect & Comp Engn, Hatoyama, Saitama 3500394, Japan.
EM hirakuri@f.dendai.ac.jp; kuwaman@agate.plala.or.jp
CR Alanazi A, 2000, ARTIF ORGANS, V24, P624, DOI 10.1046/j.1525-1594.2000.06576.x
   HATTA A, 2004, NEW DIAMOND, V20, P20
   HIRAKURI KK, 1995, VACUUM, V46, P57, DOI 10.1016/0042-207X(93)E0008-9
   Hirakuri KK, 2003, DIAM RELAT MATER, V12, P1013, DOI 10.1016/S0925-9635(02)00379-5
   Hirakuri KK, 1997, THIN SOLID FILMS, V302, P5, DOI 10.1016/S0040-6090(97)00022-9
   KOBAYASHI K, 1988, THIN SOLID FILMS, V158, P233, DOI 10.1016/0040-6090(88)90025-9
   Komatsu Y, 1999, DIAM RELAT MATER, V8, P2018, DOI 10.1016/S0925-9635(99)00138-7
   Ohgoe Y, 2004, SURF COAT TECH, V184, P263, DOI 10.1016/j.surfcoat.2003.10.009
   Ohgoe Y, 2003, ASAIO J, V49, P701, DOI 10.1097/01.MAT.0000093970.59796.40
   Pelletier MJ., 1999, ANAL APPL RAMAN SPEC
   ROBERTSON J, 1986, ADV PHYS, V35, P317, DOI 10.1080/00018738600101911
   SHIRAKURA A, 2000, NEW DIAMOND, V57, P32
   TANAKA K, 2003, SEN-I GAKKAISHI, V59, P202
   Vasquez S, 1997, DIAM RELAT MATER, V6, P551, DOI 10.1016/S0925-9635(96)00659-0
   von Keudell A, 2002, DIAM RELAT MATER, V11, P969, DOI 10.1016/S0925-9635(01)00553-2
NR 15
TC 5
Z9 5
U1 2
U2 5
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-9635
J9 DIAM RELAT MATER
JI Diam. Relat. Mat.
PD MAR-JUL
PY 2005
VL 14
IS 3-7
SI SI
BP 1067
EP 1072
DI 10.1016/j.diamond.2004.12.032
PG 6
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 935AP
UT WOS:000229751400156
DA 2018-10-19
ER

PT J
AU Park, GE
   Webster, TJ
AF Park, Grace E.
   Webster, Thomas J.
TI A Review of Nanotechnology for the Development of Better Orthopedic
   Implants
SO JOURNAL OF BIOMEDICAL NANOTECHNOLOGY
LA English
DT Review
DE Nanophase; Ceramics; Metals; Polymers; Composites; Orthopedic Implants;
   Tissue Engineering
AB Over the past 9 decades of administering bioimplants to humans, most synthetic prostheses consist of material particles and/or grain sizes with conventional dimensions (on the order of 1 to 10(4) mu m). But the lack of sufficient bonding of synthetic implants to surrounding body tissues have, in recent years, led to the investigations of novel material formulations. One such classification of materials, nanomaterials (or materials with constituent components less than 100 nm in at least one direction), can be used to synthesize implants with similar surface roughness to that of natural tissues. Natural tissues have numerous nanometer features available for cellular interactions, since they are composed of many nanostructures (specifically, proteins). Several nanophase biomedical implants are currently being investigated, and are likely to gain approval for clinical use in the near future. The critical factor for this drive is the increasingly documented special, biologically improved material properties of nanophase implants compared to conventional grain-size formulations of the same material chemistry. In this manner, this review paper highlights a novel property of nanophase materials that makes them attractive for use as implants: enhanced cytocompatibility leading to increased tissue regeneration. Active works are focused in the domains of orthopedic, dental, bladder, neurologic, vascular, cartilage, and cardiovascular applications. However, only orthopedic applications, which are the closest to clinical applications, will be emphasized herein. This entry will briefly articulate the seeming revolutionary changes and the potential gains nanostructured materials can make for bone implant technology.
C1 [Park, Grace E.; Webster, Thomas J.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.
   [Webster, Thomas J.] Purdue Univ, Sch Mat Engn, W Lafayette, IN 47907 USA.
RP Webster, TJ (reprint author), Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.
CR AYAD S, 1994, EXTRACELLULAR MATRIX, P29
   Baraton MI, 1997, NANOSTRUCT MATER, V8, P435, DOI 10.1016/S0965-9773(97)00189-X
   Bordji K, 1996, BIOMATERIALS, V17, P929, DOI 10.1016/0142-9612(96)83289-3
   Brunette D M, 1988, Int J Oral Maxillofac Implants, V3, P231
   Brunette DM, 2001, TITANIUM MED, P486
   Buser D, 1999, J BIOMED MATER RES, V45, P75, DOI 10.1002/(SICI)1097-4636(199905)45:2<75::AID-JBM1>3.0.CO;2-P
   Chun AL, 2004, NANOTECHNOLOGY, V15, pS234, DOI 10.1088/0957-4484/15/4/022
   COWIN R, 1987, HDB BIOENGINEERING
   Dalby MJ, 2002, BIOMATERIALS, V23, P2945, DOI 10.1016/S0142-9612(01)00424-0
   DANILOV YN, 1989, EXP CELL RES, V182, P186, DOI 10.1016/0014-4827(89)90290-5
   Dee KC, 1996, BIOMATERIALS, V17, P209, DOI 10.1016/0142-9612(96)85765-6
   Dowson D, 2001, P I MECH ENG H, V215, P335, DOI 10.1243/0954411011535939
   Elias KL, 2002, BIOMATERIALS, V23, P3279, DOI 10.1016/S0142-9612(02)00087-X
   Guidi V., 1999, P 12 EUR C SOL STAT, V1, P501
   Gutwein LG, 2002, J NANOPART RES, V4, P231, DOI 10.1023/A:1019920105207
   HENCH LL, 1975, ADV BIOMED ENG, V5, P35
   Horbett Thomas A., 1996, P133
   HUGHES RC, 1979, EXP CELL RES, V121, P307, DOI 10.1016/0014-4827(79)90009-0
   HUMPHRIES MJ, 1986, J CELL BIOL, V103, P2637, DOI 10.1083/jcb.103.6.2637
   Kay S, 2002, TISSUE ENG, V8, P753, DOI 10.1089/10763270260424114
   Klabunde KJ, 1996, J PHYS CHEM-US, V100, P12141
   LARSSON C, 1994, BIOMATERIALS, V15, P1325
   Lerouge S, 1996, J BIOMED MATER RES, V32, P627, DOI 10.1002/(SICI)1097-4636(199612)32:4<627::AID-JBM16>3.0.CO;2-A
   Li PJ, 2003, J BIOMED MATER RES A, V66A, P79, DOI 10.1002/jbm.a.10519
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   LITSY AS, 1994, ORTHOPEDIC BASIC SCI, P482
   MALSCH I, 2001, LECT COST NANOSTAG C
   MALSCH I, 2002, IND PHYS
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   Miller DC, 2004, BIOMATERIALS, V25, P53, DOI 10.1016/S0142-9612(03)00471-X
   MININO AM, 2001, NATL VITAL STAT REP, V49, P12
   Nikolovski J, 2000, BIOMATERIALS, V21, P2025, DOI 10.1016/S0142-9612(00)00079-X
   Oparaugo PC, 2001, ACTA ORTHOP SCAND, V72, P22, DOI 10.1080/000164701753606644
   Park GE, 2005, BIOMATERIALS, V26, P3075, DOI 10.1016/j.biomaterials.2004.08.005
   PATTISON M, 2004, BIOMATERIALS, V26, P2491
   Price RL, 2003, J BIOMED MATER RES A, V67A, P1284, DOI 10.1002/jbm.a.20011
   Price RL, 2003, BIOMATERIALS, V24, P1877, DOI 10.1016/S0142-9612(02)00609-9
   Price RL, 2004, NANOTECHNOLOGY, V15, P892, DOI 10.1088/0957-4484/15/8/004
   Roco M. C., 1999, NANOTECHNOLOGY RES D
   SATO M, 2005, 29 INT C ADV CER COM
   Schakenraad J.M., 1996, BIOMATERIALS SCI INT, P141
   Siegel R. W., 1999, NANOSTRUCTURE SCI TE
   Siegel RW, 1995, NANOSTRUCT MATER, V6, P205, DOI 10.1016/0965-9773(95)00044-5
   SIEGEL RW, 1994, NATO ADV SCI INST SE, V260, P233
   Siegel RW, 1996, SCI AM, V275, P42
   Simon SP, 1994, ORTHOPAEDIC BASIC SC, P127
   SINGER II, 1987, J CELL BIOL, V104, P573, DOI 10.1083/jcb.104.3.573
   SMITH TA, 2005, J BIOMED MA IN PRESS
   Thapa A, 2003, J BIOMED MATER RES A, V67A, P1374, DOI 10.1002/jbm.a.20037
   Thull R, 2001, TITANIUM MED, P284
   UNDERWOOD PA, 1989, J CELL SCI, V93, P641
   Urban RM, 2000, J BONE JOINT SURG AM, V82A, P457, DOI 10.2106/00004623-200004000-00002
   Webster T. J., 2000, BIOCERAMICS, V13, P321
   Webster T.J., 1998, BIOCERAMICS, P273
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 1999, NANOSTRUCT MATER, V12, P983, DOI 10.1016/S0965-9773(99)00283-4
   Webster TJ, 2004, BIOMATERIALS, V25, P4731, DOI 10.1016/j.biomaterials.2003.12.002
   Webster TJ, 2001, SCRIPTA MATER, V44, P1639, DOI 10.1016/S1359-6462(01)00873-9
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   Webster TJ, 2001, TISSUE ENG, V7, P291, DOI 10.1089/10763270152044152
   Webster TJ, 2001, BIOMATERIALS, V22, P1327, DOI 10.1016/S0142-9612(00)00285-4
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Webster TJ, 2001, ADV CHEM ENG, V27, P125
   Wen HB, 1998, J MATER SCI-MATER M, V9, P121, DOI 10.1023/A:1008859417664
   Wu SJ, 1996, J AM CERAM SOC, V79, P2207, DOI 10.1111/j.1151-2916.1996.tb08962.x
   Zhang RY, 1999, J BIOMED MATER RES, V45, P285
NR 67
TC 30
Z9 32
U1 0
U2 24
PU AMER SCIENTIFIC PUBLISHERS
PI STEVENSON RANCH
PA 25650 NORTH LEWIS WAY, STEVENSON RANCH, CA 91381-1439 USA
SN 1550-7033
J9 J BIOMED NANOTECHNOL
JI J. Biomed. Nanotechnol.
PD MAR
PY 2005
VL 1
IS 1
BP 18
EP 29
DI 10.1166/jbn.2005.003
PG 12
WC Nanoscience & Nanotechnology; Materials Science, Biomaterials
SC Science & Technology - Other Topics; Materials Science
GA V85AQ
UT WOS:000205747600003
DA 2018-10-19
ER

PT J
AU Kino-Oka, M
   Maeda, Y
   Yamamoto, T
   Sugawara, K
   Taya, M
AF Kino-Oka, M
   Maeda, Y
   Yamamoto, T
   Sugawara, K
   Taya, M
TI A kinetic modeling of chondrocyte culture for manufacture of
   tissue-engineered cartilage
SO JOURNAL OF BIOSCIENCE AND BIOENGINEERING
LA English
DT Review
DE biomedical engineering; tissue-engineered cartilage; collagen-embedded
   culture; chondrocytes; kinetic model
ID HUMAN ARTICULAR CHONDROCYTES; COLLAGEN-GEL; IN-VITRO; BOVINE
   CHONDROCYTES; MATRIX SYNTHESIS; QUALITY-ASSURANCE; OXYGEN-TENSION;
   TACTILE SENSOR; CELL YIELD; TRANSPLANTATION
AB For repairing articular cartilage defects, innovative techniques based on tissue engineering have been developed and are now entering into the practical stage of clinical application by means of grafting in vitro cultured products. A variety of natural and artificial materials available for scaffolds, which permit chondrocyte cells to aggregate, have been designed for their ability to promote e cell growth and differentiation. From the viewpoint of the manufacturing process for tissue-engineered cartilage, the diverse nature of raw materials (seeding cells) and end products (cultured cartilage) oblige us to design a tailor-made process with less reproducibility, which is an obstacle to establishing a production doctrine based on bioengineering knowledge concerning growth kinetics and modeling as well as designs of bioreactors and culture operations for certification of high product quality. In this article, we review the recent advances in the manufacturing of tissue-engineered cartilage. After outlining the manufacturing processes for tissue-engineered cardlage in the first section, the second and third sections, respectively, describe the three-dimensioual culture of chondrocytes with Aterocollagen gel and kinetic model consideration as a tool for evaluating this culture process. In the final section, culture strategy is discussed in terms of the combined processes of monolayer growth (ex vivo chondrocyte cell expansion) and three-dimensioinal growth (construction of cultured cartilage in the gel).
C1 Osaka Univ, Grad Sch Engn Sci, Div Chem Engn, Toyonaka, Osaka 5608531, Japan.
   Japan Tissue Engn Co Ltd, Gamagori, Aichi 4430022, Japan.
   Osaka Univ, Grad Sch Frontier Biosci, Toyonaka, Osaka 5608531, Japan.
RP Taya, M (reprint author), Osaka Univ, Grad Sch Engn Sci, Div Chem Engn, 1-3 Machikaneyama, Toyonaka, Osaka 5608531, Japan.
EM taya@cheng.es.osaka-u.ac.jp
OI Kino-oka, Masahiro/0000-0002-4912-5811
CR Barbero A, 2003, ARTHRITIS RHEUM, V48, P1315, DOI 10.1002/art.10950
   BENYA PD, 1978, CELL, V15, P1313, DOI 10.1016/0092-8674(78)90056-9
   Blunk T, 2002, TISSUE ENG, V8, P73, DOI 10.1089/107632702753503072
   Boyce ST, 2004, BIOCHEM ENG J, V20, P107, DOI 10.1016/j.bej.2003.09.017
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Brittberg M, 2001, CLIN ORTHOP RELAT R, pS337
   Chen G, 2003, FEBS LETT, V542, P95, DOI 10.1016/S0014-5793(03)00354-5
   Darling EM, 2003, TISSUE ENG, V9, P9, DOI 10.1089/107632703762687492
   du Moulin GC, 2000, MAT SCI ENG C-BIO S, V13, P15, DOI 10.1016/S0928-4931(00)00171-5
   Enmon RM, 2002, BIOTECHNOL BIOENG, V80, P580, DOI 10.1002/bit.10394
   Frondoza C, 1996, BIOMATERIALS, V17, P879, DOI 10.1016/0142-9612(96)83283-2
   Fuchs JR, 2001, ANN THORAC SURG, V72, P577, DOI 10.1016/S0003-4975(01)02820-X
   Gagne TA, 2000, J ORTHOPAED RES, V18, P882, DOI 10.1002/jor.1100180606
   Galban CJ, 1999, BIOTECHNOL BIOENG, V64, P633, DOI 10.1002/(SICI)1097-0290(19990920)64:6<633::AID-BIT1>3.0.CO;2-6
   GALBAN CJ, 1999, BIOTECHNOL BIOENG, V65, P122
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Haisch A, 2002, EUR ARCH OTO-RHINO-L, V259, P316, DOI 10.1007/s00405-002-0446-1
   Hesse F, 2000, TRENDS BIOTECHNOL, V18, P173, DOI 10.1016/S0167-7799(99)01420-1
   Heywood HK, 2004, TISSUE ENG, V10, P1467, DOI 10.1089/ten.2004.10.1467
   Homicz MR, 2002, OTOLARYNG HEAD NECK, V127, P398, DOI 10.1067/mhn.2002.129730
   Hunzinker E. B., 2001, OSTEOARTHR CARTILAGE, V10, P432
   Iwasa J, 2003, ARTIF ORGANS, V27, P249, DOI 10.1046/j.1525-1594.2003.07073.x
   Kang KA, 2002, ANN NY ACAD SCI, V961, P216, DOI 10.1111/j.1749-6632.2002.tb03088.x
   KAVALKOVICH KW, 2002, IN VITRO CELL DEV, V38, P1071
   Kawasaki K, 1999, J CELL PHYSIOL, V179, P142, DOI 10.1002/(SICI)1097-4652(199905)179:2<142::AID-JCP4>3.0.CO;2-Q
   Kino-Oka M, 2005, TISSUE ENG, V11, P597, DOI 10.1089/ten.2005.11.597
   Kino-Oka M, 2000, J BIOSCI BIOENG, V89, P285, DOI 10.1016/S1389-1723(00)88836-2
   Kinoshita N, 2004, GENES CELLS, V9, P1, DOI 10.1111/j.1365-2443.2004.00696.x
   Kremer M, 2000, BRIT J PLAST SURG, V53, P459, DOI 10.1054/bjps.2000.3368
   Lindahl A, 2001, KNEE SURG SPORT TR A, V9, P358, DOI 10.1007/s001670100209
   Lysaght MJ, 2004, TISSUE ENG, V10, P309, DOI 10.1089/107632704322791943
   MacArthur BD, 2004, BIOCHEM BIOPH RES CO, V313, P825, DOI 10.1016/j.bbrc.2003.11.171
   Malda J, 2004, OSTEOARTHR CARTILAGE, V12, P306, DOI 10.1016/j/joca.2003.12.001
   Malda J, 2004, BIOTECHNOL BIOENG, V86, P9, DOI 10.1002/bit.20038
   Mandl EW, 2004, TISSUE ENG, V10, P109, DOI 10.1089/107632704322791754
   Marijnissen WJCM, 2000, BIOMATERIALS, V21, P571, DOI 10.1016/S0142-9612(99)00218-5
   Martin I, 2004, TRENDS BIOTECHNOL, V22, P80, DOI 10.1016/j.tibtech.2003.12.001
   Masuda K, 2003, J ORTHOPAED RES, V21, P139, DOI 10.1016/S0736-0266(02)00109-2
   Mauck RL, 2003, OSTEOARTHR CARTILAGE, V11, P879, DOI 10.1016/j.joca.2003.08.006
   Miyaji K, 1997, CANCER, V80, P1920, DOI 10.1002/(SICI)1097-0142(19971115)80:10<1920::AID-CNCR8>3.0.CO;2-R
   Mizuno S, 2002, J CELL PHYSIOL, V193, P319, DOI 10.1002/jcp.10180
   Mizuno S, 1998, MAT SCI ENG C-BIO S, V6, P301, DOI 10.1016/S0928-4931(98)00068-X
   MOW VC, 1992, BIOMATERIALS, V13, P67, DOI 10.1016/0142-9612(92)90001-5
   Murphy CL, 2001, TISSUE ENG, V7, P791, DOI 10.1089/107632701753337735
   Nehrer S, 1997, BIOMATERIALS, V18, P769, DOI 10.1016/S0142-9612(97)00001-X
   NEWMANGAGE H, 1995, CELL TRANSPLANT, V4, P447, DOI 10.1016/0963-6897(95)00033-T
   NOLL T, 2002, ADV BIOCH ENG BIOTEC, V74, P112
   Obradovic B, 1999, J ORTHOP RES, V17, P130
   Ochi M, 2004, ARTIF ORGANS, V28, P28, DOI 10.1111/j.1525-1594.2004.07317.x
   Omata S, 2004, SENSOR ACTUAT A-PHYS, V112, P278, DOI 10.1016/j.sna.2004.01.038
   Peterson L, 2000, CLIN ORTHOP RELAT R, P212
   Rahfoth B, 1998, OSTEOARTHR CARTILAGE, V6, P50, DOI 10.1053/joca.1997.0092
   Ratcliffe A, 2002, ANN NY ACAD SCI, V961, P210, DOI 10.1111/j.1749-6632.2002.tb03087.x
   Robinson D, 2001, CELL TRANSPLANT, V10, P203
   Ronziere MC, 2003, BIOMATERIALS, V24, P851, DOI 10.1016/S0142-9612(02)00418-0
   Saha AK, 2003, IEEE T NANOBIOSCI, V2, P89, DOI 10.1109/TNB.2003.813921
   Saha AK, 2003, IEEE T NANOBIOSCI, V2, P158, DOI 10.1109/TNB.2003.816226
   SCHUMAN L, 1995, BIOMATERIALS, V16, P809, DOI 10.1016/0142-9612(95)99644-2
   Tay AG, 2004, TISSUE ENG, V10, P762, DOI 10.1089/1076327041348572
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Uchio Y, 2000, J BIOMED MATER RES, V50, P138, DOI 10.1002/(SICI)1097-4636(200005)50:2<138::AID-JBM7>3.0.CO;2-K
   WAKITANI S, 1989, J BONE JOINT SURG BR, V71, P74
   Yamamoto T, 2002, TISSUE ENG, V8, P119, DOI 10.1089/107632702753503117
   Yashiki S, 2004, KAGAKU KOGAKU RONBUN, V30, P515, DOI 10.1252/kakoronbunshu.30.515
   YASUI N, 1982, EXP CELL BIOL, V50, P92
   Yoshida T, 2004, BIOCHEM ENG J, V20, P99, DOI 10.1016/j.bej.2003.10.004
NR 66
TC 41
Z9 47
U1 3
U2 16
PU SOC BIOSCIENCE BIOENGINEERING JAPAN
PI OSAKA
PA OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871,
   JAPAN
SN 1389-1723
J9 J BIOSCI BIOENG
JI J. Biosci. Bioeng.
PD MAR
PY 2005
VL 99
IS 3
BP 197
EP 207
DI 10.1263/jbb.99.197
PG 11
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA 925KP
UT WOS:000229052300002
PM 16233778
DA 2018-10-19
ER

PT J
AU Neuse, EW
AF Neuse, EW
TI Macromolecular ferrocene compounds as cancer drug models
SO JOURNAL OF INORGANIC AND ORGANOMETALLIC POLYMERS AND MATERIALS
LA English
DT Review
DE aerospace materials; antiproliferative activity; cancer research;
   carrier-drug conjugation; cell culture test; ferrocene; metallocene;
   water solubility
ID WATER-SOLUBLE POLYAMIDOAMINES; ELECTRON-TRANSFER REACTIONS; METALLOCENE
   POLYMERS; BIOMEDICAL APPLICATIONS; ANTITUMOR-ACTIVITY;
   SUPEROXIDE-DISMUTASE; DIFERRICENIUM MU-OXO-BIS<TRICHLOROFERRATE(III)>;
   ANTINEOPLASTIC ACTIVITY; MOLECULAR STRUCTURE; ION DERIVATIVES
C1 Univ Witwatersrand, Sch Chem, Johannesburg, South Africa.
RP Neuse, EW (reprint author), Univ Witwatersrand, Sch Chem, Johannesburg, South Africa.
EM neuse@aurum.wits.ac.za
CR ANDERSON JD, 1969, AIAA J, V7, P1665, DOI 10.2514/3.5373
   ARMSTRON.AT, 1967, J CHEM PHYS, V46, P4321, DOI 10.1063/1.1840547
   Babin V. N., 1995, MENDELEEV CHEM J, V17, P39
   BEDNARIK L, 1980, J ORG CHEM, V45, P2032, DOI 10.1021/jo01298a067
   BLAIR AH, 1983, J IMMUNOL METHODS, V59, P129
   BLOM NF, 1987, TRANSIT METAL CHEM, V12, P301, DOI 10.1007/BF01024018
   BOEYENS JC, 1984, S AFR J CHEM, V37, P32
   BOEYENS JCA, 1984, S AFR J CHEM, V37, P187
   BOHN RK, 1966, J ORGANOMET CHEM, V5, P470, DOI 10.1016/S0022-328X(00)82382-7
   BUBLITZ DE, 1969, ORG REACTIONS, V17, P1
   Cais M., 1966, ORGANOMET CHEM REV, V1, P435
   CALDWELL G, 1993, J APPL POLYM SCI, V50, P393, DOI 10.1002/app.1993.070500303
   Caldwell G, 1998, APPL ORGANOMET CHEM, V12, P793
   Caldwell G, 2000, J INORG ORGANOMET P, V10, P93, DOI 10.1023/A:1009475909111
   CALDWELL G, 1992, S AFR J CHEM-S-AFR T, V45, P93
   CARLSON BW, 1984, J AM CHEM SOC, V106, P7233, DOI 10.1021/ja00335a062
   CARLSON BW, 1983, J AM CHEM SOC, V105, P7453, DOI 10.1021/ja00363a047
   CARNEY MJ, 1984, J AM CHEM SOC, V106, P2565, DOI 10.1021/ja00321a013
   Casas JS, 2004, J INORG BIOCHEM, V98, P1009, DOI 10.1016/j.jinorgbio.2004.02.019
   CHEN SC, 1980, J ORGANOMET CHEM, V202, P183, DOI 10.1016/S0022-328X(00)90515-1
   CHU BCF, 1977, MOL PHARMACOL, V13, P80
   DANUSSO F, 1970, POLYMER, V11, P88, DOI 10.1016/0032-3861(70)90029-7
   DIACONIS NS, 1965, 16 INT ASTR C ATH SE, V16, P397
   DOMBROWSKI KE, 1986, J ORGANOMET CHEM, V302, P281, DOI 10.1016/0022-328X(86)80097-3
   Drobnik J., 1979, J POLYM SCI PS, V66, P65
   EPTON R, 1977, J ORGANOMET CHEM, V134, pC23, DOI 10.1016/S0022-328X(00)81426-6
   Ferruti P., 1996, POLYM MAT ENCY, V5, P3334
   FIORINA VJ, 1978, J MED CHEM, V21, P393, DOI 10.1021/jm00202a016
   FRIDOVICH I, 1975, ANNU REV BIOCHEM, V44, P147, DOI 10.1146/annurev.bi.44.070175.001051
   Gopal YNV, 2000, ARCH BIOCHEM BIOPHYS, V376, P229
   Greenwald RB, 2000, CRIT REV THER DRUG, V17, P101
   GRUNDFEST IJ, 1964, ENCY POLYM SCI TECH, V1, P1
   Halliwell B, 1985, FREE RADICALS BIOL M
   HANZLIK RP, 1979, J MED CHEM, V22, P424, DOI 10.1021/jm00190a013
   Hartinger CG, 2002, NEW J CHEM, V26, P671, DOI 10.1039/b200701k
   HENDRY SP, 1993, ANAL CHIM ACTA, V281, P453, DOI 10.1016/0003-2670(93)85002-2
   HILL DT, 1989, INORG CHEM, V28, P3529, DOI 10.1021/ic00317a027
   HOES CJT, 1989, DRUG CARRIER SYSTEMS, P57
   HOULTON A, 1991, J ORGANOMET CHEM, V418, P107, DOI 10.1016/0022-328X(91)86350-Y
   HURWITZ E, 1983, BIOPOLYMERS, V22, P557, DOI 10.1002/bip.360220168
   *ISR AC SCI HUM, 1971, JER S QUANT CHEM BIO, V3, P96
   Johnson D, 2002, ENTERTAIN DES, V36, P1
   Johnson MT, 2003, J INORG ORGANOMET P, V13, P255, DOI 10.1023/A:1026148211721
   Johnson MT, 2003, J INORG ORGANOMET P, V13, P55, DOI 10.1023/A:1024103629830
   JOY AM, 1989, INT J RADIAT ONCOL, V16, P1053, DOI 10.1016/0360-3016(89)90914-0
   KEALY TJ, 1951, NATURE, V168, P1039, DOI 10.1038/1681039b0
   KENSLER TW, 1983, SCIENCE, V221, P75, DOI 10.1126/science.6857269
   KENSLER TW, 1983, BIOCHEM PHARMACOL, V32, P3485, DOI 10.1016/0006-2952(83)90382-9
   KOOPF H, 1979, ANGEW CHEM INT EDIT, V18, P477
   KOOPFMAIER P, 1988, STRUCT BOND, V70, P103
   KOOPFMAIER P, 1984, J CANCER RES CLIN, V108, P336
   KOOPFMAIER P, 1984, ANGEW CHEM, V96, P446
   KORNICKER WA, 1968, ANN NY ACAD SCI, V153, P689
   KOVACIC P, 1988, ANTI-CANCER DRUG DES, V3, P205
   Kovjazin R, 2003, FASEB J, V17, P467, DOI 10.1096/fj.02-0558fje
   LOGAN SR, 1983, J CHEM SOC PERK T 2, P1781, DOI 10.1039/p29830001781
   LOGAN SR, 1990, Z PHYS CHEM NEUE FOL, V167, P41, DOI 10.1524/zpch.1990.167.Part_1.041
   MADDOX ML, 1965, ADV ORGANOMETALLIC C, V3, P1
   MAEDA H, 1991, ADV DRUG DELIVER REV, V6, P181, DOI 10.1016/0169-409X(91)90040-J
   Mason RW, 1999, APPL ORGANOMET CHEM, V13, P163, DOI 10.1002/(SICI)1099-0739(199903)13:3<163::AID-AOC821>3.0.CO;2-K
   Matson PA, 1987, GLOBAL BIOGEOCHEM CY, V1, P163, DOI 10.1029/GB001i002p00163
   Matthews SE, 1996, ADV DRUG DELIVER REV, V18, P219, DOI 10.1016/0169-409X(95)00098-R
   MCDOWELL MS, 1984, INORG CHEM, V23, P2232, DOI 10.1021/ic00183a007
   Meirim MG, 1997, J INORG ORGANOMET P, V7, P71, DOI 10.1023/A:1021488110997
   Meirim MG, 1998, J INORG ORGANOMET P, V8, P225, DOI 10.1023/A:1021436126927
   Minges M. L., 1969, High Temperatures - High Pressures, V1, P607
   MULVANEY JE, 1962, J POLYM SCI, V62, P59, DOI 10.1002/pol.1962.1206217305
   NERI P, 1973, J MED CHEM, V16, P893, DOI 10.1021/jm00266a006
   NERI P, 1982, MACROMOL SYNTHESES, V8, P25
   Neuse E. W., 1970, METALLOCENE POLYM
   Neuse E. W., 1988, APPL ORGANOMET CHEM, V2, P53
   Neuse E. W., 1990, INORGANIC METAL CONT, P139
   NEUSE EW, 1981, J MACROMOL SCI CHEM, VA16, P3, DOI 10.1080/00222338108082042
   NEUSE EW, 1977, POLYM ENG SCI, V17, P821, DOI 10.1002/pen.760171202
   NEUSE EW, 1972, J MATER SCI, V7, P708, DOI 10.1007/BF00549384
   NEUSE EW, 1966, B CHEM SOC JPN, V39, P1508, DOI 10.1246/bcsj.39.1508
   NEUSE EW, 1985, J ORGANOMET CHEM, V286, P329, DOI 10.1016/0022-328X(85)80049-8
   NEUSE EW, 1979, MACROMOLECULES, V12, P187, DOI 10.1021/ma60068a005
   NEUSE EW, 1985, TRANSIT METAL CHEM, V10, P135, DOI 10.1007/BF00641583
   NEUSE EW, 1990, APPL ORGANOMET CHEM, V4, P19, DOI 10.1002/aoc.590040105
   NEUSE EW, 1963, J AM CHEM SOC, V85, P1952, DOI 10.1021/ja00896a013
   NEUSE EW, 1982, ADV POLYM SCI, V47, P1
   NEUSE EW, 1965, J POLYM SCI PART A, V3, P1499, DOI 10.1002/pol.1965.100030418
   Neuse EW, 1999, J INORG ORGANOMET P, V9, P221, DOI 10.1023/A:1021706123621
   NEUSE EW, 1986, MACROMOLECULES, V19, P269, DOI 10.1021/ma00156a004
   NEUSE EW, 1984, TRANSIT METAL CHEM, V9, P12, DOI 10.1007/BF00620720
   NEUSE EW, 1968, ENCYCL POLYM SCI TEC, V8, P667
   NEUSE EW, 1985, METAL CONTAINING POL, P99
   NEUSE EW, 1989, POLYM MAT SCI ENG, V61, P94
   NEUSE EW, 1967, Patent No. 3341495
   NEUSE EW, 1966, Patent No. 3238185
   NEUSE EW, 1987, APPL ORGANOMET CHEM, V1, P499
   NEUSE EW, 1977, SYNTHESIS-STUTTGART, P479
   NEUSE EW, 1968, MACROMOLECULES, V1, P751
   NEUSE EW, 1968, ADV MACROMOL CHEM, V1, P1
   NEUSE EW, 1990, INORGANIC METAL CONT, P394
   OBERLEY LW, 1979, CANCER RES, V39, P1141
   OBRIEN PJ, 1985, ENVIRON HEALTH PERSP, V64, P219, DOI 10.2307/3430012
   Osella D, 2000, INORG CHIM ACTA, V306, P42, DOI 10.1016/S0020-1693(00)00147-X
   PALENIK GJ, 1970, INORG CHEM, V9, P2424, DOI 10.1021/ic50093a008
   PLADZIEWICZ JR, 1985, INORG CHEM, V24, P1450, DOI 10.1021/ic00204a009
   PLADZIEWICZ JR, 1982, J AM CHEM SOC, V104, P3544, DOI 10.1021/ja00376a068
   POPOVA LV, 1993, APPL ORGANOMET CHEM, V7, P85, DOI 10.1002/aoc.590070203
   POPOVA LV, 1994, Patent No. 2025125
   POWIS G, 1989, FREE RADICAL BIO MED, V6, P63, DOI 10.1016/0891-5849(89)90162-7
   Putnam D, 1995, ADV POLYM SCI, V122, P55
   Pytela J, 1998, J BIOACT COMPAT POL, V13, P198, DOI 10.1177/088391159801300303
   Ringsdorf H., 1975, J POLYM SCI POLYM S, V51, P135
   ROSATO DV, 1968, ENV EFFECTS POLYM MA, V1, P487
   ROSENBLUM M, 1967, ADV CHEM SER, V62, P532
   Sachdeva M S, 1998, Expert Opin Investig Drugs, V7, P1849, DOI 10.1517/13543784.7.11.1849
   SCHLOGL K, 1966, FORTSCHR CHEM FORSCH, V6, P479
   SCHMIDT DL, 1960, MOD PLAST, V37, P147
   SCHMIDT DL, 1960, MOD PLAST, V37, P131
   SEVILLA MD, 1983, BIOCHEM BIOPH RES CO, V115, P800, DOI 10.1016/S0006-291X(83)80005-9
   Shen W., UNPUB
   Swarts JC, 2001, ANTICANCER RES, V21, P2033
   SWARTS JC, 1994, J INORG ORGANOMET P, V4, P143
   Takakura Y, 1996, ADV DRUG DELIVER REV, V19, P377, DOI 10.1016/0169-409X(96)00010-5
   Togni A., 1994, FERROCENES
   Togni A., 1998, METALLOCENES
   Top S, 2001, J ORGANOMET CHEM, V637, P500, DOI 10.1016/S0022-328X(01)00953-6
   TRIFAN DS, 1960, TETRAHEDRON LETT, V13, P1
   Troll W, 1982, Carcinog Compr Surv, V7, P593
   TROUET A, 1982, P NATL ACAD SCI-BIOL, V79, P626, DOI 10.1073/pnas.79.2.626
   WATTS WE, 1967, ORGANOMET CHEM REV, V2, P231
   Waud W.R., 1995, CANC CHEMOTHERAPEUTI, P121
   WENZEL M, 1988, Z NATURFORSCH C, V43, P963
   YASHCHENKO GN, 1978, KHIM FARM ZH+, V12, P68
NR 129
TC 126
Z9 127
U1 0
U2 51
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1574-1443
J9 J INORG ORGANOMET P
JI J. Inorg. Organomet. Polym. Mater.
PD MAR
PY 2005
VL 15
IS 1
BP 3
EP 32
DI 10.1007/s10904-004-2371-9
PG 30
WC Polymer Science
SC Polymer Science
GA 935JV
UT WOS:000229778500002
DA 2018-10-19
ER

PT J
AU Jenkins, GL
   Sugarman, J
AF Jenkins, GL
   Sugarman, J
TI The importance of cultural considerations in the promotion of ethical
   research with human biologic material
SO JOURNAL OF LABORATORY AND CLINICAL MEDICINE
LA English
DT Review
ID UMBILICAL-CORD-BLOOD; HEMATOPOIETIC STEM; PLACENTAL-BLOOD; UNRELATED
   DONORS; ORGAN DONATION; BODY PARTS; TRANSPLANTATION; BANKING; ATTITUDES;
   CELLS
AB Although ethical consideration has been given to a wide variety of issues that arise in the collection and storage of human biologic material for research, little attention has been focused on the ethical implications of the diverse cultural meanings often associated with these materials. We explore the rich social meanings of the placenta across cultures and contrast these meanings with the assumption that the placenta is typically considered waste tissue that may find value in biomedical research. We suggest that the incorporation of sensitivity to the cultural meanings people give human biologic material and the use of empirical research, where necessary, to delineate these meanings should enhance the ability to craft and conduct ethically appropriate research.
C1 Johns Hopkins Univ, Phoebe R Berman Bioeth Inst, Baltimore, MD 21205 USA.
   Johns Hopkins Univ, Dept Med, Baltimore, MD 21205 USA.
   Univ Kansas, Dept Anthropol, Lawrence, KS 66045 USA.
   Univ Kansas, Womens Studies Program, Lawrence, KS 66045 USA.
RP Sugarman, J (reprint author), Johns Hopkins Univ, Phoebe R Berman Bioeth Inst, Hampton House 351,624 N Broadway, Baltimore, MD 21205 USA.
EM jsugarm1@jhmi.edu
CR AGINKSY BW, 1939, AM SOCIOL REV, V8, P4
   ALPERT S, 1999, RES INVOLVING HUMAN, V2, pA1
   Annas GJ, 1999, NEW ENGL J MED, V340, P1521, DOI 10.1056/NEJM199905133401923
   Ballen KK, 2002, TRANSFUSION, V42, P1279, DOI 10.1046/j.1537-2995.2002.00191.x
   BELLERHANN I, 1999, CONCEIVING PERSONS E, P113
   BROXMEYER HE, 1992, BONE MARROW TRANSPL, V9, P7
   Campbell C.S., 1999, RES INVOLVING HUMAN, V2, pC1
   CANESSA A, 1999, CONCEIVING PERSONS, P69
   CARSTEN J, 1995, AM ETHNOL, V22, P223, DOI 10.1525/ae.1995.22.2.02a00010
   CEDERCREUTZ S, 1999, CONCEIVING PERSONS E, P89
   CLAYTON EW, 1995, JAMA-J AM MED ASSOC, V274, P1786, DOI 10.1001/jama.274.22.1786
   Conklin BA, 1996, ETHOS, V24, P657, DOI 10.1525/eth.1996.24.4.02a00040
   *CTR HLTH POL STUD, 1999, RES INV HUM BIOL MAT, V2, pG4
   Dame L, 2001, J PEDIAT HEMATOL ONC, V23, P409, DOI 10.1097/00043426-200110000-00003
   Danzer E, 2003, TRANSFUSION, V43, P604, DOI 10.1046/j.1537-2995.2003.00375.x
   DAVIDSON JR, 1985, CULT MED PSYCHIAT, V9, P75
   Doran C, 1997, WOMEN HIST REV, V6, P29
   Downey GL, 1997, SCH AM RES, P5
   Eiseman E., 1999, RES INVOLVING HUMAN, V2, pD1
   EISENBRUCH M, 1997, PSYCHOL ASPECTS GEOG, P109
   Fox M, 2000, HEALTH CARE ANAL, V8, P83, DOI 10.1023/A:1009498810174
   Fruzzetti Lina M., 1984, KINSHIP RITUAL BENGA
   Furness PN, 2001, J PATHOL, V195, P277
   Gluckman E, 1997, NEW ENGL J MED, V337, P373, DOI 10.1056/NEJM199708073370602
   GRANQUIST H, 1947, BIRTH CHILDHOOD AMON
   Hilger M. I., 1951, CHIPPEWA CHILD LIFE
   Hogle LF, 1996, MED ANTHROPOL Q, V10, P675, DOI 10.1525/maq.1996.10.4.02a00150
   KEELER C, 1957, B GEORGIA ACAD SCI, V15, P97
   KEYER GG, 1986, MEXICAN AM ANGLO MID
   KOHLIKUMAR M, 1993, BRIT J HAEMATOL, V85, P419, DOI 10.1111/j.1365-2141.1993.tb03192.x
   Kurtzberg J, 1996, NEW ENGL J MED, V335, P157, DOI 10.1056/NEJM199607183350303
   Laderman Carol, 1983, WIVES MIDWIVES CHILD
   Lam WA, 2000, CLIN TRANSPLANT, V14, P449, DOI 10.1034/j.1399-0012.2000.140502.x
   Leith-Ross Sylvia, 1965, AFRICAN WOMEN STUDY
   LIAMPUTTONG RP, 1999, AUSMED PUBLICATIONS, P117
   MARSHALL PA, 1992, MED ANTHROPOL Q, V6, P49, DOI 10.1525/maq.1992.6.1.02a00040
   MARSHALL PA, 1996, MED ANTHR CONT THEOR, P349
   MARTIN E, 1992, AM ETHNOL, V19, P121, DOI 10.1525/ae.1992.19.1.02a00070
   Martin E, 1987, WOMAN BODY CULTURAL
   Maschke KJ, 2004, THEOR MED BIOETH, V25, P143, DOI 10.1023/B:META.0000033773.44765.7c
   MERZ J, 1997, RISK HLTH SAFETY ENV, V8, P235
   Morgan Lynn M, 2002, Med Anthropol, V21, P247, DOI 10.1080/01459740214079
   Munzer SR, 2001, J PEDIAT HEMATOL ONC, V23, P203, DOI 10.1097/00043426-200105000-00004
   OBER WB, 1979, B NEW YORK ACAD MED, V55, P591
   OUDSHOORN N, 1990, SOC STUD SCI, V20, P5, DOI 10.1177/030631290020001001
   SARGENT C, 1984, MED ANTHROPOL Q, V16, P7
   Saura B, 2002, J POLYNESIAN SOC, V111, P127
   Seligman CG, 1938, MAN, V38, P20, DOI 10.2307/2790004
   Siminoff LA, 2000, KENNEDY INST ETHIC J, V10, P59
   SPENCER RF, 1977, CULTURE DIS HEALING, P289
   Sugarman J, 1997, JAMA-J AM MED ASSOC, V278, P938, DOI 10.1001/jama.278.11.938
   SUGARMAN J, 1995, JAMA-J AM MED ASSOC, V274, P1783, DOI 10.1001/jama.274.22.1783
   Sugarman J, 1998, J WOMENS HEALTH, V7, P747, DOI 10.1089/jwh.1998.7.747
   Surbek DV, 1998, SCHWEIZ MED WSCHR, V128, P689
   Vawter DE, 2002, TRANSFUSION, V42, P1268, DOI 10.1046/j.1537-2995.2002.00227.x
   WAGNER JE, 1995, LANCET, V346, P214, DOI 10.1016/S0140-6736(95)91268-1
   Wagner JE, 1996, BLOOD, V88, P795
   Yuen CC, 1998, J NATL MED ASSOC, V90, P13
   1999, RES INVOLVING HUMAN, V1
NR 59
TC 13
Z9 13
U1 1
U2 6
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-2143
J9 J LAB CLIN MED
JI J. Lab. Clin. Med.
PD MAR
PY 2005
VL 145
IS 3
BP 118
EP 124
DI 10.1016/j.lab.2005.01.001
PG 7
WC Medical Laboratory Technology; Medicine, General & Internal; Medicine,
   Research & Experimental
SC Medical Laboratory Technology; General & Internal Medicine; Research &
   Experimental Medicine
GA 913TC
UT WOS:000228175100001
PM 15871302
DA 2018-10-19
ER

PT J
AU Brunke, O
   Odenbach, S
   Fritsche, C
   Hilger, I
   Kaiser, WA
AF Brunke, O
   Odenbach, S
   Fritsche, C
   Hilger, I
   Kaiser, WA
TI Determination of magnetic particle distribution in biomedical
   applications by X-ray microtomography
SO JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS
LA English
DT Article; Proceedings Paper
CT 10th International Conference on Magnetic Fluids
CY AUG 02-06, 2004
CL Guaruja, BRAZIL
SP FINEP, FAPESP, CNPq, CAPES, ICTP
DE X-ray microtomography; biodistribution of magnetic particles; biomedical
   application
AB In biomedical application of ferrofluids the resulting biodistribution of the magnetic nanoparticles is a crucial parameter for the effect of the therapeutic approach. Usually the biodistribution is determined by histological cuts of the investigated specimen, a technique which provides only a very local information about the overall distribution of the magnetic material, e.g. in a tumor. Here we will introduce X-ray microtomography as a tool for a three-dimensional analysis of the distribution of magnetic nanoparticles in biological applications. Within the experiments presented here a spatial resolution of 80 mu m could be achieved which can be enhanced to approximately 2 pm by the use of a synchrotron as X-ray radiation source. (c) 2004 Elsevier B.V. All rights reserved.
C1 Univ Bremen, ZARM, D-28359 Bremen, Germany.
   FSU Jena, Inst Diagnost & Interventionelle Radiol, D-07740 Jena, Germany.
RP Odenbach, S (reprint author), Univ Bremen, ZARM, Am Fallturm, D-28359 Bremen, Germany.
EM odenbach@zarm.uni-bremen.de
RI Odenbach, Stefan/D-4542-2009
CR Alexiou C, 2003, J DRUG TARGET, V11, P139, DOI 10.1080/1061186031000150791
   BRUNKE O, UNPUB EUR PHYS J APP
   FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612
   Hilger I, 2002, INVEST RADIOL, V37, P580, DOI 10.1097/00004424-200210000-00008
   Winter PM, 2003, CANCER RES, V63, P5838
NR 5
TC 16
Z9 16
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-8853
J9 J MAGN MAGN MATER
JI J. Magn. Magn. Mater.
PD MAR
PY 2005
VL 289
BP 428
EP 430
DI 10.1016/j.jmmm.2004.11.120
PG 3
WC Materials Science, Multidisciplinary; Physics, Condensed Matter
SC Materials Science; Physics
GA 912YU
UT WOS:000228117100121
DA 2018-10-19
ER

PT J
AU Verne, E
   Brovarone, C
   Moisescu, C
AF Verne, E
   Brovarone, C
   Moisescu, C
TI Glazing of alumina by a fluoroapatite-containing glass-ceramic
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Article
ID BIOACTIVE GLASSES; COATINGS; HYDROXYAPATITE; BIOCERAMICS
AB Glazing of alumina substrates was performed in order to prepare bioactive glass-ceramic coatings for biomedical applications. The coating material was a fluoroapatite-containing glass-ceramic (SAF) with a good degree of bioactivity. A careful optimisation of the coating conditions was carried out. The obtained coatings were characterized by means of scanning electron microscopy (SEM), compositional analysis (EDS), X-Ray diffraction (XRD), and in vitro tests (soaking into a simulated body fluid). Direct firing of SAF powders on the ceramic substrates gave unsatisfactory results in terms of crack propagation and bioactivity, due to the nucleation of a non-bioactive Al-rich phase (leucite) with high linear expansion coefficient. The use of an intermediate layer based on a SiO(2)-CaO glass (SC) was necessary in order to avoid Al ions diffusion through the coating and thus the formation of undesired additional phases. The coatings obtained with the optimised processing parameters resulted to be adherent, defect-free, and characterized by unchanged composition and structure as well as unmodified bioactivity if compared with the bulk SAF glass-ceramic. (C) 2005 Springer Science + Business Media, Inc.
C1 Politecn Torino, Dept Mat Sci & Chem Engn, Turin, Italy.
   Johnson Matthey BV, NL-6222 NZ Maastricht, Netherlands.
RP Verne, E (reprint author), Politecn Torino, Dept Mat Sci & Chem Engn, Turin, Italy.
EM enrica.verne@polito.it
RI Vitale Brovarone, Chiara/G-9630-2012
OI Vitale Brovarone, Chiara/0000-0003-2413-5594; Verne,
   Enrica/0000-0002-8649-4739
CR Bosetti M, 2003, J BIOMED MATER RES A, V66A, P615, DOI 10.1002/jbm.a.10030
   Brovarone CV, 2001, J EUR CERAM SOC, V21, P2855
   Ferraris M, 2000, BIOMATERIALS, V21, P765, DOI 10.1016/S0142-9612(99)00209-4
   Ferraris M, 1996, J EUR CERAM SOC, V16, P421, DOI 10.1016/0955-2219(95)00114-X
   Gomez-Vega JM, 2000, BIOMATERIALS, V21, P105, DOI 10.1016/S0142-9612(99)00131-3
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hench LL, 1999, MATER SCI FORUM, V293, P37, DOI 10.4028/www.scientific.net/MSF.293.37
   Holand W, 1997, J NON-CRYST SOLIDS, V219, P192, DOI 10.1016/S0022-3093(97)00329-3
   Hulbert S. F., 1993, INTRO BIOCERAMICS, V1, P25
   Kim CY, 2003, J EUR CERAM SOC, V23, P1803, DOI 10.1016/S0955-2219(02)00444-2
   KOKUBO T, 1990, J NON-CRYST SOLIDS, V120, P138, DOI 10.1016/0022-3093(90)90199-V
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   LEVIN EM, 1964, PHASE DIAGRAMS CERAM, P1969
   Moisescu C, 1999, J NON-CRYST SOLIDS, V248, P169, DOI 10.1016/S0022-3093(99)00239-2
   Moisescu C, 1999, J NON-CRYST SOLIDS, V248, P176, DOI 10.1016/S0022-3093(99)00240-9
   MOISESCU C, 2000, THESIS FSU JENA
   RAVAGLIOLI A, 1992, INTERCERAM, V41, P69
   Rawlings Rees D., 1993, Clinical Materials, V14, P155, DOI 10.1016/0267-6605(93)90038-9
   TOSHITAKA O, 1993, J AM CERAM SOC, V76, P2379
   Verne E, 2000, J EUR CERAM SOC, V20, P473, DOI 10.1016/S0955-2219(99)00181-8
   Verne E, 2002, BIOMATERIALS, V23, P3395, DOI 10.1016/S0142-9612(02)00040-6
   VERNE E, 1999, BIOCERAMICS, V12, P491
   VERNE E, 1997, BIOCERAMICS, V12, P491
NR 24
TC 6
Z9 7
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0022-2461
J9 J MATER SCI
JI J. Mater. Sci.
PD MAR
PY 2005
VL 40
IS 5
BP 1209
EP 1215
DI 10.1007/s10853-005-6939-8
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 910TT
UT WOS:000227955800022
DA 2018-10-19
ER

PT J
AU Pritsos, C
   Kontonasaki, E
   Chatzistavrou, X
   Papadopoulou, L
   Pappas, F
   Koidis, P
   Paraskevopoulos, KM
AF Pritsos, C
   Kontonasaki, E
   Chatzistavrou, X
   Papadopoulou, L
   Pappas, F
   Koidis, P
   Paraskevopoulos, KM
TI Studying morphological characteristics of thermally treated bioactive
   glass ceramic using image analysis
SO JOURNAL OF THE EUROPEAN CERAMIC SOCIETY
LA English
DT Article
DE electron microscopy; optical microscopy; glass ceramics; biomedical
   applications image analysis
ID SIMULATED BODY-FLUID; HYDROXYAPATITE; TEMPERATURE; BIOGLASS(R);
   PARTICLES; BEHAVIOR; SIZE
AB Bioactive glass ceramics are materials which develop a strong bond with living tissues through a carbonate-containing hydroxyapatatite layer, similar to that of bone. Recently, the use of thermally treated bioactive glass in dental restorations has been proposed, as it could provide a bioactive surface, which in combination with a tissue regenerative technique could lead to periodontal tissues attachment. The purpose of this study was the investigation of the qualitative and quantitative alterations of thermally treated bioactive glasses after incubation in simulated body fluid (SBF) for different time intervals, through the use of Image Analysis methods. There is a remarkable decrease in the dimensions of bioactive glass particles-their shape being more elongated-with the immersion time in SBF and the depth from the surface. The influence on particles morphology in deeper layers is recognizable and the species in the coating, present bioactivity on the surface and in the volume. (c) 2004 Elsevier Ltd. All rights reserved.
C1 Aristotle Univ Thessaloniki, Dept Fixed Prosthesis & Implant Proshtodont, Sch Dent, Thessaloniki 54124, Greece.
   Aristotle Univ Thessaloniki, Dept Phys, Thessaloniki 54124, Greece.
   Aristotle Univ Thessaloniki, Dept Geol, Thessaloniki 54124, Greece.
RP Paraskevopoulos, KM (reprint author), Aristotle Univ Thessaloniki, Dept Fixed Prosthesis & Implant Proshtodont, Sch Dent, Thessaloniki 54124, Greece.
EM kpar@auth.gr
RI Papadopoulou, Lambrini/R-3341-2017; Paraskeuopoulos,
   Konstantinos/F-9926-2011
CR ANDERSON OH, 1990, J NONCRYST SOLIDS, V112, P290
   Arcos D, 2002, CHEM MATER, V14, P1515, DOI 10.1021/cmO11119p
   Chatzistavrou X, 2004, PHYS STATUS SOLIDI A, V201, P944, DOI 10.1002/pssa.200306776
   Clupper DC, 2002, BIOMATERIALS, V23, P2599, DOI 10.1016/S0142-9612(01)00398-2
   Filho OP, 1996, J BIOMED MATER RES, V30, P509
   FUJIU T, 1983, J NON-CRYST SOLIDS, V56, P417, DOI 10.1016/0022-3093(83)90505-7
   Gomez-Vega JM, 2000, BIOMATERIALS, V21, P105, DOI 10.1016/S0142-9612(99)00131-3
   Greenspan D. C., 1994, BIOCERAMICS, V7, P55
   GUMMEL J, 1988, Z KLIN MED, V43, P1971
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   HYAKUNA K, 1990, J BIOMED MATER RES, V24, P471, DOI 10.1002/jbm.820240406
   KELLERHALS R, 1975, J GEOL, V83, P79, DOI 10.1086/628046
   Khajotia SS, 1999, DENT MATER, V15, P390, DOI 10.1016/S0109-5641(99)00062-7
   Kokubo T., 1982, Bulletin of the Institute for Chemical Research, Kyoto University, V60, P260
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Kontonasaki E, 2003, J ORAL REHABIL, V30, P893, DOI 10.1046/j.1365-2842.2003.01072.x
   KRAJEWSKI A, 1985, AM CERAM SOC BULL, V64, P679
   LeGeros RZ, 1991, CALCIUM PHOSPHATES O, P4
   Legeros Z. R., 1991, CALCIUM PHOSPHATES O, P82
   MacNeill SR, 1999, J CLIN PERIODONTOL, V26, P239, DOI 10.1034/j.1600-051X.1999.260407.x
   Merwin GE, 1990, HDB BIOACTIVE CERAMI, V1, P323
   NAKAMURA T, 1994, BIOCERAMICS, V7, P145
   OHURA K, 1991, J BIOMED MATER RES, V25, P357, DOI 10.1002/jbm.820250307
   Oonishi H, 1997, CLIN ORTHOP RELAT R, P316
   Papadopoulou L, 2003, PHYS STATUS SOLIDI A, V198, P65, DOI 10.1002/pssa.200306588
   Peterson TD, 1996, CONTRIB MINERAL PETR, V124, P395, DOI 10.1007/s004100050199
   Pryce RS, 2003, KEY ENG MAT, V240-2, P201, DOI 10.4028/www.scientific.net/KEM.240-242.201
   Shi DL, 2002, J BIOMED MATER RES, V63, P71, DOI 10.1002/jbm.10087
   TUOMINEN U, 1993, BIOCERAMICS, V6, P151
   Vogel M, 2001, BIOMATERIALS, V22, P357, DOI 10.1016/S0142-9612(00)00191-5
   WANG SA, 1989, J ORAL REHABIL, V16, P229
   WILSON J, 1994, BIOCERAMICS, V7, P415
   Zamet JS, 1997, J CLIN PERIODONTOL, V24, P410, DOI 10.1111/j.1600-051X.1997.tb00205.x
   Zhong J. P., 1998, BIOCERAMICS, V11, P415
NR 34
TC 5
Z9 5
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0955-2219
J9 J EUR CERAM SOC
JI J. European Ceram. Soc.
PD MAR
PY 2005
VL 25
IS 6
BP 891
EP 897
DI 10.1016/j.jeurceramsoc.2004.04.004
PG 7
WC Materials Science, Ceramics
SC Materials Science
GA 908XB
UT WOS:000227822400014
DA 2018-10-19
ER

PT J
AU Herr, HW
AF Herr, HW
TI A history of partial nephrectomy for renal tumors
SO JOURNAL OF UROLOGY
LA English
DT Article
DE kidney; kidney neoplasms; nephrectomy; history of medicine
ID NEPHRON SPARING SURGERY; 10-YEAR FOLLOW-UP; CELL CARCINOMA;
   ADENOCARCINOMA; KIDNEY
AB Purpose: This article records the history of nephron sparing surgery for renal tumors.
   Materials and Methods: Multiple biomedical databases were queried. Original sources were reviewed to document the history of partial nephrectomy.
   Results: For more than a century partial nephrectomy evolved as treatment for renal tumors, first by accident, then rejected as a planned procedure in favor of radical nephrectomy, later in mandatory cases of solitary kidney, poor renal function or bilateral renal tumors and then to an accepted elective procedure in cases with a healthy opposite kidney. Partial nephrectomy became widely accepted only recently for many renal tumors due to parallel advances in tumor biology, radiological imaging and surgical technology.
   Conclusions: The history of partial nephrectomy is a timely story setting important precedents for understanding current and future strategies to treat changing patterns of renal neoplasms.
C1 Mem Sloan Kettering Canc Ctr, Dept Urol, New York, NY USA.
RP Herr, HW (reprint author), Mem Hosp, 1275 York Ave, New York, NY 10021 USA.
EM herrh@mskcc.org
CR Bell ET, 1938, J UROLOGY, V39, P238, DOI 10.1016/S0022-5347(17)71856-3
   ENGEN DE, 1981, BR J UROL, V53, P378
   Fergany AF, 2000, J UROLOGY, V163, P442, DOI 10.1016/S0022-5347(05)67896-2
   FLEMING JOSEPH P., 1964, BRIT J UROL, V36, P313, DOI 10.1111/j.1464-410X.1964.tb09515.x
   Goldstein AE, 1937, J UROLOGY, V38, P15, DOI 10.1016/S0022-5347(17)71922-2
   Gregoire W, 1903, B MED SOC ANAT PARIS, V78, P764
   GROSS R, 1985, AM J MED SCI, V90, P79
   Herczel E., 1890, BRUNS BEITR KLIN CHI, V6, P485
   Herr HW, 1999, J UROLOGY, V161, P33, DOI 10.1016/S0022-5347(01)62052-4
   HESS E, 1950, J UROLOGY, V64, P175, DOI 10.1016/S0022-5347(17)68617-8
   LICHT MR, 1993, J UROLOGY, V149, P1
   MARBERGER M, 1981, BRIT J UROL, V53, P528, DOI 10.1111/j.1464-410X.1981.tb03254.x
   Newman D., 1901, LANCET, V23, P149
   NOVICK AC, 1977, J UROLOGY, V118, P932, DOI 10.1016/S0022-5347(17)58254-3
   PUIGVERT A, 1976, European Urology, V2, P70
   ROBSON CJ, 1963, J UROLOGY, V89, P37, DOI 10.1016/S0022-5347(17)64494-X
   Simon G., 1876, CHIRURG NIEREN, V2, P314
   VERMOOTEN V, 1950, J UROLOGY, V64, P200, DOI 10.1016/S0022-5347(17)68620-8
   Wells S, 1884, Br Med J, V1, P758
   Wharton LR, 1939, J UROLOGY, V42, P713, DOI 10.1016/S0022-5347(17)71567-4
   WICKHAM JEA, 1975, BRIT J UROL, V47, P25, DOI 10.1111/j.1464-410X.1975.tb03914.x
NR 21
TC 39
Z9 45
U1 1
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD MAR
PY 2005
VL 173
IS 3
BP 705
EP 708
DI 10.1097/01.ju.0000146270.65101.1d
PG 4
WC Urology & Nephrology
SC Urology & Nephrology
GA 898KK
UT WOS:000227075500009
PM 15711247
DA 2018-10-19
ER

PT J
AU Mills, CA
   Martinez, E
   Bessueille, F
   Villanueva, G
   Bausells, J
   Samitier, J
   Errachid, A
AF Mills, CA
   Martinez, E
   Bessueille, F
   Villanueva, G
   Bausells, J
   Samitier, J
   Errachid, A
TI Production of structures for microfluidics using polymer imprint
   techniques
SO MICROELECTRONIC ENGINEERING
LA English
DT Article; Proceedings Paper
CT 30th International Conference on Micro and Nano Engineering
CY SEP 19-22, 2004
CL Rotterdam, NETHERLANDS
DE hot embossing; nanoimprint lithography; micromoldin; micromechanisation;
   polymers
ID MASS-SPECTROMETRY; DEVICES
AB We present a technology for the fabrication of three dimensional microfluidic channels in optically transparent substrates consisting of polymers with different properties. The microstructures are fabricated using polymer replication techniques with a view to the production of microfluidic devices with characteristics suitable for biomedical applications. The replication processes can be used to fabricate large numbers of highly precise, complex microchannels via replication from a single similarly precise master, containing microstructures fabricated from silicon-based materials using lithographic micromachining techniques. Silicon oxide and silicon nitride-based masters have been used, due to their anti-adhesion properties, to produce microchannels, in the transparent polymers, that are suitable for channel profiling measurements and optical studies of fluid flow. (c) 2005 Elsevier B.V. All rights reserved.
C1 CREBEC, Nanobioengn Lab, E-08028 Barcelona, Spain.
   CSIC, IBM, Ctr Nacl Microelect, E-08193 Barcelona, Spain.
RP Mills, CA (reprint author), CREBEC, Nanobioengn Lab, Barcelona Sci Pk,Josep Samitier 1-5, E-08028 Barcelona, Spain.
EM cmills@pcb.ub.es
RI Mills, Christopher/C-5535-2009; Bausells, Joan/K-1808-2014; MARTINEZ,
   ELENA/F-7572-2014; Villanueva, Luis Guillermo/C-4904-2009; Martinez,
   Elena/C-6008-2009
OI Mills, Christopher/0000-0002-2906-4978; Bausells,
   Joan/0000-0003-3706-4975; Villanueva, Luis
   Guillermo/0000-0003-3340-2930; 
CR Becker H, 2002, TALANTA, V56, P267, DOI 10.1016/S0039-9140(01)00594-X
   Bendix D, 1998, POLYM DEGRAD STABIL, V59, P129, DOI 10.1016/S0141-3910(97)00149-3
   BESSUEILLE F, UNPUB BIOSENS BIOELE
   BRYUNG HJ, 2000, J MICROELECTROMECH S, V9, P76
   FREEMANTLE M, 1999, CHEM ENG NEWS, V22, P27
   HEKELE M, 2004, J MICROMECH MICROENG, V14, pR1
   Higashioji T, 2003, TRIBOL INT, V36, P437, DOI 10.1016/S0301-679X(02)00232-3
   Liu HH, 2000, ANAL CHEM, V72, P3303, DOI 10.1021/ac000115l
   Meng ZJ, 2001, ANAL CHEM, V73, P1286, DOI 10.1021/ac000984a
   MILLS CA, UNPUB J BIOMED MAT R
   MILLS CA, IN PRESS NANOTECHNOL
   Ouchi I, 2003, NUCL INSTRUM METH B, V199, P270, DOI 10.1016/S0168-583X(02)01586-0
   RENAUD P, 1998, MICRO TOTAL ANAL SYS, P17
   Torres CMS, 2003, MAT SCI ENG C-BIO S, V23, P23, DOI 10.1016/S0928-4931(02)00221-7
   Wen J, 2000, ELECTROPHORESIS, V21, P191, DOI 10.1002/(SICI)1522-2683(20000101)21:1<191::AID-ELPS191>3.0.CO;2-M
   Xue QF, 1997, ANAL CHEM, V69, P426, DOI 10.1021/ac9607119
   Yuan CH, 2001, ANAL CHEM, V73, P1080, DOI 10.1021/ac001305z
NR 17
TC 52
Z9 54
U1 0
U2 20
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-9317
EI 1873-5568
J9 MICROELECTRON ENG
JI Microelectron. Eng.
PD MAR
PY 2005
VL 78-79
SI SI
BP 695
EP 700
DI 10.1016/j.mee.2004.12.087
PG 6
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology;
   Optics; Physics, Applied
SC Engineering; Science & Technology - Other Topics; Optics; Physics
GA 919AC
UT WOS:000228589700113
DA 2018-10-19
ER

PT J
AU Georg, C
   Welker, V
   Eidam, H
   Alfkel, H
AF Georg, C
   Welker, V
   Eidam, H
   Alfkel, H
TI Aortic stentgraft movement detection using digital roentgen
   stereophotogrammetric analysis on plane film radiographs - Initial
   results of a phantom study
SO ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER
   BILDGEBENDEN VERFAHREN
LA English
DT Article
DE stentgraft movement; roentgen stereophotogrammetric analysis; RSA
ID RADIOSTEREOMETRIC ANALYSIS RSA; TOTAL KNEE ARTHROPLASTY; RECONSTRUCTION;
   MIGRATION; ACCURACY; ENDOGRAFTS; FIXATION; ANEURYSM; LIGAMENT; HIP
AB Purpose: To evaluate the feasibility of aortic stentgraft micromovement detection using digital roentgen stereophotogrammetric analysis on plane film radiographs. Material and Methods: An aortic stentgraft used for demonstration purposes was marked with 10 tantalum markers of 0.8 mm in diameter. The stentgraft was placed on a Plexiglas phantom with 5 tantalum markers of 1 mm in diameter simulating a fixed segment needed for mathematical analysis. In a subsequent step, the stentgraft was placed onto an orthopaedic spine model to simulate in vivo conditions in a next step. Two radiographs taken simultaneously from different angles were used for simulating different stentgraft movement, e.g. translation, angulation, aortic pulsation and migration in the spine model. Movement of the stentgraft markers was analysed using a commercially available digital RSA setup (UmRSA(R) 4.1, RSA Biomedical, Umea, Sweden). Results: Our study shows the feasibility of measuring aortic stentgraft movement and changes in stentgraft shape in the submillimeter range using digital roentgen stereophotogrammetric analysis. Translation along the 3 cardinal axes, change in stentgraft shape, simulation of aortic pulsation and simulation of in vivo conditions could be described precisely. Conclusion: Aortic stentgraft movement detection using digital roentgen stereophotogrammetric analysis on plane film radiographs is a very promising, precise method.
C1 Hosp Luedenscheid, Dept Diagnost & Intervent Radiol, D-58515 Luedenscheid, Germany.
   Univ Marburg, Dept Diagnost Radiol, Marburg, Germany.
   Univ Marburg, Dept Math, Marburg, Germany.
   Univ Marburg, Dept Tech Serv, Marburg, Germany.
RP Alfkel, H (reprint author), Hosp Luedenscheid, Dept Diagnost & Intervent Radiol, Paulmannshoher Str 14, D-58515 Luedenscheid, Germany.
EM alfke@klinikum-luedenscheid.de
CR Chuter TAM, 2002, CARDIOVASC SURG, V10, P7, DOI 10.1016/S0967-2109(01)00120-X
   Flora HS, 2001, J ENDOVASC THER, V8, P511, DOI 10.1583/1545-1550(2001)008<0511:MATAAN>2.0.CO;2
   Fukuoka S, 2000, J BONE JOINT SURG BR, V82B, P222, DOI 10.1302/0301-620X.82B2.9461
   GALLAND RB, 1991, BRIT J SURG, V78, P1259, DOI 10.1002/bjs.1800781036
   Jorn LP, 1997, ACTA ORTHOP SCAND, V68, P427, DOI 10.3109/17453679708996256
   Kramer SC, 2001, J ENDOVASC THER, V8, P34, DOI 10.1583/1545-1550(2001)008<0034:GCIAEO>2.0.CO;2
   LOFVENBERG R, 1994, ACTA ORTHOP SCAND, V65, P401, DOI 10.3109/17453679408995479
   MALCHAU H, 1995, ACTA ORTHOP SCAND, V66, P418, DOI 10.3109/17453679508995578
   Nilsson KG, 1996, J BONE JOINT SURG BR, V78B, P1
   Parodi J C, 1991, Ann Vasc Surg, V5, P491, DOI 10.1007/BF02015271
   Regner L, 2000, J ARTHROPLASTY, V15, P681, DOI 10.1054/arth.2000.8103
   RYD L, 1995, J BONE JOINT SURG BR, V77B, P377
   RYD L, 1992, CLIN ORTHOP RELAT R, P56
   Ryd L, 2000, ACTA ORTHOP SCAND, V71, P403, DOI 10.1080/000164700317393420
   SELVIK G, 1990, ACTA RADIOL, V31, P113
   Valstar ER, 2000, J BIOMECH, V33, P1593, DOI 10.1016/S0021-9290(00)00138-X
   Vrooman HA, 1998, J BIOMECH, V31, P491, DOI 10.1016/S0021-9290(98)00025-6
   Yuan XH, 2000, J BIOMECH, V33, P493, DOI 10.1016/S0021-9290(99)00182-7
NR 18
TC 2
Z9 2
U1 0
U2 0
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 1438-9029
J9 ROFO-FORTSCHR RONTG
JI Rofo-Fortschr. Gebiet Rontgenstrahlen Bildgeb. Verfahr.
PD MAR
PY 2005
VL 177
IS 3
BP 321
EP 325
DI 10.1055/s-2005-857964
PG 5
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 903BV
UT WOS:000227401300003
PM 15719292
DA 2018-10-19
ER

PT J
AU Ludlage, E
   Murphy, CL
   Davern, SM
   Solomon, A
   Weiss, DT
   Glenn-Smith, D
   Dworkin, S
   Mansfield, KG
AF Ludlage, E
   Murphy, CL
   Davern, SM
   Solomon, A
   Weiss, DT
   Glenn-Smith, D
   Dworkin, S
   Mansfield, KG
TI Systemic AA amyloidosis in the common marmoset
SO VETERINARY PATHOLOGY
LA English
DT Article
DE AA amyloid; amyloidosis; common marmoset
ID PROTEIN AA; PATHOGENESIS; PATHOLOGY; CATS; SAA
AB The common marmoset (Callithrix jacchus) is a small New World primate native to Brazil that has been used extensively in biomedical research. A retrospective analysis of archived hematoxylin and eosin-stained tissue sections and clinical records was conducted at the New England primate Research Center on 86 marmosets more than I year of age that were euthanized during the past decade because of morbidity and failure to thrive. Approximately 17% (15 of 86) were found to have amyloid deposits in one or more organs, including the liver, adrenal glands, kidneys, and intestine. This material was shown by amino acid sequence analysis to be composed of serum amyloid A (SAA)-related protein. This type of amyloidosis, designated AA or "secondary," is associated typically with an inflammatory process that induces elevated levels of the SAA amyloidogenic precursor molecule. Notably, there were no significant pathologic differences or other distinguishing features in animals with amyloid versus those without; furthermore, on the basis of the limited number of serum specimens available for analysis, the SAA concentrations in the two groups were comparable, thus Suggesting the possible inheritable nature of the disorder. In this respect, the common marmoset provides a unique experimental model for Study of the pathogenesis and treatment of AA and other forms of systemic amyloidosis.
C1 Harvard Univ, Sch Med, New England Reg Primate Res Ctr, Southborough, MA 01772 USA.
   Univ Tennessee, Grad Sch Med, Dept Med, Human Immunol & Canc Program, Knoxville, TN 37996 USA.
   Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA.
RP Ludlage, E (reprint author), Harvard Univ, Sch Med, New England Reg Primate Res Ctr, Southborough, MA 01772 USA.
EM elisabeth_ludlage@hms.harvard.edu
FU NCRR NIH HHS [P51RR000168-41]; NCI NIH HHS [CA10056]
CR ABE M, 1993, HYBRIDOMA, V12, P475, DOI 10.1089/hyb.1993.12.475
   BENDITT EP, 1971, FEBS LETT, V19, P169, DOI 10.1016/0014-5793(71)80506-9
   Benson M. D., 2001, METABOLIC MOL BASES, P5345
   Benson MD, 1996, CIBA F SYMP, V199, P104
   BLANCHARD JL, 1986, VET PATHOL, V23, P425, DOI 10.1177/030098588602300412
   Booth DR, 1998, AMYLOID, V5, P262, DOI 10.3109/13506129809007299
   BOYCE JT, 1984, VET PATHOL, V21, P33, DOI 10.1177/030098588402100106
   CHALIFOUX LV, 1982, VET PATHOL, V19, P141, DOI 10.1177/030098588201907s11
   DIBARTOLA SP, 1989, J VET INTERN MED, V3, P31, DOI 10.1111/j.1939-1676.1989.tb00326.x
   Hubbard GB, 2001, J MED PRIMATOL, V30, P260, DOI 10.1034/j.1600-0684.2001.d01-58.x
   HUSBY G, 1994, AMYLOID, V1, P119, DOI 10.3109/13506129409148635
   Johan K, 1998, P NATL ACAD SCI USA, V95, P2558, DOI 10.1073/pnas.95.5.2558
   Johnson KH, 1997, AMYLOID, V4, P171, DOI 10.3109/13506129709014381
   Johnson KH, 1996, AMYLOID, V3, P270, DOI 10.3109/13506129609014375
   Lundmark K, 2002, P NATL ACAD SCI USA, V99, P6979, DOI 10.1073/pnas.092205999
   Mansfield KG, 2001, AM J PATHOL, V159, P693, DOI 10.1016/S0002-9440(10)61740-3
   Mensua C, 2003, VET PATHOL, V40, P71, DOI 10.1354/vp.40-1-71
   Murphy CL, 2001, AM J CLIN PATHOL, V116, P135
   PRAS M, 1968, J CLIN INVEST, V47, P924
   Rocken C, 2002, VIRCHOWS ARCH, V440, P111, DOI 10.1007/s00428-001-0582-9
   SKINNER M, 1977, LAB INVEST, V36, P420
   SLATTUM MM, 1989, LAB ANIM SCI, V39, P567
   Solomon A, 1999, AM J PATHOL, V154, P1267, DOI 10.1016/S0002-9440(10)65378-3
   Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x
   WESTERMARK GT, 1990, AM J PATHOL, V137, P377
   YAMAMOTO M, 1998, REV TOXICOL, V2, P5
NR 26
TC 19
Z9 19
U1 0
U2 3
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0300-9858
EI 1544-2217
J9 VET PATHOL
JI Vet. Pathol.
PD MAR
PY 2005
VL 42
IS 2
BP 117
EP 124
DI 10.1354/vp.42-2-117
PG 8
WC Pathology; Veterinary Sciences
SC Pathology; Veterinary Sciences
GA 901RU
UT WOS:000227300400001
PM 15753464
DA 2018-10-19
ER

PT J
AU Ghoroghchian, PP
   Frail, PR
   Susumu, K
   Blessington, D
   Brannan, AK
   Bates, FS
   Chance, B
   Hammer, DA
   Therien, MJ
AF Ghoroghchian, PP
   Frail, PR
   Susumu, K
   Blessington, D
   Brannan, AK
   Bates, FS
   Chance, B
   Hammer, DA
   Therien, MJ
TI Near-infrared-emissive polymersomes: Self-assembled soft matter for in
   vivo optical imaging
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE porphyrin; vesicles; nanoscale; diblock copolymer
ID FLUORESCENT CONTRAST AGENTS; BLOCK-COPOLYMERS; MOLECULAR-WEIGHT;
   DRUG-DELIVERY; VESICLES; SURFACTANTS; MICROSCOPY; SYSTEMS; TUMORS; LIGHT
AB We demonstrate that synthetic soft materials can extend the utility of natural vesicles, from predominantly hydrophilic reservoirs to functional colloidal carriers that facilitate the biomedical application of large aqueous-insoluble compounds. Near-infrared (NIR)emissive polymersomes (50-nm- to 50-mum-diameter polymer vesicles) were generated through cooperative self assembly of amphiphilic diblock copolymers and conjugated multi(porphyrin)based NIR fluorophores (NIRFs). When compared with natural vesicles comprised of phospholipids, polymersomes were uniquely capable of incorporating and uniformly distributing numerous large hydrophobic NIRFs exclusively in their lamellar membranes. Within these sequestered compartments, long polymer chains regulate the mean fluorophore-fluorophore interspatial separation as well as the fluorophore-localized electronic environment. Porphyrin-based NIRFs manifest photophysical properties within the polymersomal matrix akin to those established for these high-emission dipole strength fluorophores in organic solvents, thereby yielding uniquely emissive vesicles. Furthermore, the total fluorescence emanating from the assemblies gives rise to a localized optical signal of sufficient intensity to penetrate through the dense tumor tissue of a live animal. Robust NIR-emissive polymersomes thus define a soft matter platform with exceptional potential to facilitate deep-tissue fluorescence-based imaging for in vivo diagnostic and drug-delivery applications.
C1 Univ Penn, Dept Chem, Philadelphia, PA 19104 USA.
   Univ Penn, Sch Engn & Appl Sci, Inst Med & Engn, Philadelphia, PA 19104 USA.
   Univ Penn, Sch Med, Johnson Res Fdn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.
   Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA.
RP Therien, MJ (reprint author), Univ Penn, Dept Chem, Philadelphia, PA 19104 USA.
EM hammer@seas.upenn.edu; therien@sas.upenn.edu
OI Bates, Frank/0000-0003-3977-1278
FU NCI NIH HHS [R33-NO1-CO-29008]; NIBIB NIH HHS [EB003457-01, R01
   EB003457]
CR Achilefu S, 2000, INVEST RADIOL, V35, P479, DOI 10.1097/00004424-200008000-00004
   Antonietti M, 2003, ADV MATER, V15, P1323, DOI 10.1002/adma.200300010
   BANGHAM AD, 1965, J MOL BIOL, V13, P238, DOI 10.1016/S0022-2836(65)80093-6
   Becker A, 2001, NAT BIOTECHNOL, V19, P327, DOI 10.1038/86707
   Bellomo EG, 2004, NAT MATER, V3, P244, DOI 10.1038/nmat1093
   Bermudez H, 2002, MACROMOLECULES, V35, P8203, DOI 10.1021/ma020669l
   Chance B, 1998, ANN NY ACAD SCI, V838, P29, DOI 10.1111/j.1749-6632.1998.tb08185.x
   Deming TJ, 1997, NATURE, V390, P386, DOI 10.1038/37084
   Dinsmore AD, 2002, SCIENCE, V298, P1006, DOI 10.1126/science.1074868
   Discher BM, 1999, SCIENCE, V284, P1143, DOI 10.1126/science.284.5417.1143
   Discher DE, 2002, SCIENCE, V297, P967, DOI 10.1126/science.1074972
   Franceschini MA, 1997, P NATL ACAD SCI USA, V94, P6468, DOI 10.1073/pnas.94.12.6468
   Gu YQ, 2002, REV SCI INSTRUM, V73, P172, DOI 10.1063/1.1424907
   Hamley IW, 2003, ANGEW CHEM INT EDIT, V42, P1692, DOI 10.1002/ange.200200546
   Hawrysz DJ, 2000, NEOPLASIA, V2, P388, DOI 10.1038/sj.neo.7900118
   Intes X, 2003, MED PHYS, V30, P1039, DOI 10.1118/1.1573791
   Jain RK, 2002, NAT REV CANCER, V2, P266, DOI 10.1038/nrc778
   Jain S, 2003, SCIENCE, V300, P460, DOI 10.1126/science.1082193
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   KALER EW, 1989, SCIENCE, V245, P1371, DOI 10.1126/science.2781283
   Kim S, 2004, NAT BIOTECHNOL, V22, P93, DOI 10.1038/nbt920
   Kimizuka N, 2003, CURR OPIN CHEM BIOL, V7, P702, DOI 10.1016/j.cbpa.2003.10.010
   Langer R, 1998, NATURE, V392, P5
   Lin JJ, 2004, LANGMUIR, V20, P5493, DOI 10.1021/la036417a
   Lin VSY, 1995, CHEM-EUR J, V1, P645, DOI 10.1002/chem.19950010913
   LIN VSY, 1994, SCIENCE, V264, P1105, DOI 10.1126/science.8178169
   Meng FH, 2003, MACROMOLECULES, V36, P3004, DOI 10.1021/ma034040+
   Moghimi SM, 2001, PHARMACOL REV, V53, P283
   Najafi F, 2003, BIOMATERIALS, V24, P1175, DOI 10.1016/S0142-9612(02)00487-8
   Napoli A, 2004, NAT MATER, V3, P183, DOI 10.1038/nmat1081
   Photos PJ, 2003, J CONTROL RELEASE, V90, P323, DOI 10.1016/S0168-3659(03)00201-3
   Riess G, 2003, PROG POLYM SCI, V28, P1107, DOI 10.1016/S0079-6700(03)00015-7
   Rubtsov IV, 2003, J AM CHEM SOC, V125, P2687, DOI 10.1021/ja021157p
   Sevick-Muraca EM, 2002, CURR OPIN CHEM BIOL, V6, P642, DOI 10.1016/S1367-5931(02)00356-3
   Stupp SI, 1997, SCIENCE, V276, P384, DOI 10.1126/science.276.5311.384
   Susumu K, 2002, J AM CHEM SOC, V124, P8550, DOI 10.1021/ja0203925
   Torchilin V. P., 2003, PRACTICAL APPROACH S, V264, P1
   Weissleder R, 1999, NAT BIOTECHNOL, V17, P375, DOI 10.1038/7933
   Weissleder R, 2003, NAT MED, V9, P123, DOI 10.1038/nm0103-123
   Won YY, 2002, J PHYS CHEM B, V106, P3354, DOI 10.1021/jp013639d
   Zaheer A, 2001, NAT BIOTECHNOL, V19, P1148, DOI 10.1038/nbt1201-1148
   Zhang SG, 2002, CURR OPIN CHEM BIOL, V6, P865, DOI 10.1016/S1367-5931(02)00391-5
NR 42
TC 272
Z9 276
U1 5
U2 95
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD FEB 22
PY 2005
VL 102
IS 8
BP 2922
EP 2927
DI 10.1073/pnas.0409394102
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 900RQ
UT WOS:000227232400046
PM 15708979
OA Bronze, Green Published
DA 2018-10-19
ER

PT J
AU Deville, S
   Gremillard, L
   Chevalier, J
   Fantozzi, G
AF Deville, S
   Gremillard, L
   Chevalier, J
   Fantozzi, G
TI A critical comparison of methods for the determination of the aging
   sensitivity in biomedical grade yttria-stabilized zirconia
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE aging; hip replacement prosthesis; yttria-stabilized zirconia
ID ATOMIC-FORCE MICROSCOPY; Y-TZP CERAMICS; DEGRADATION; ALUMINA
AB Since the recent failure events of two particular series of zirconia femoral heads for total hip replacement prosthesis, a large decrease in the use of zirconia ceramics for orthopaedic implants has been observed. In spite of the biomedical success of this material during the last 10 years, this decrease in use was required for safety reasons, until the cause of the failures is known. It has been shown that these failures were related to the low temperature hydrothermal degradation (also known as aging). Thus, it is crucial to better understand the aging behavior, in order to be able to assess its importance and then control it if required. In this study, various techniques relevant to assess the hydrothermal degradation sensitivity of biomedical grade yttria-stabilized zirconia are discussed and compared. The expected outputs of conventional methods, that is, X-ray diffraction and scanning electron microscopy are examined. More recent methods like optical interferometry and atomic force microscopy are presented, with their respective benefits and drawbacks. An up-to-date comparison of these different techniques is provided, and their use for ensuring the long-term reliability of a particular batch of zirconia in terms of aging degradation is demonstrated. (C) 2004 Wiley Periodicals, Inc.
C1 Inst Natl Sci Appl, Etud Met Phys & Phys Mat Grp, Dept Mat Sci, Associate Res Unit 5510, F-69621 Villeurbanne, France.
   LBNL, Div Sci Mat, Berkeley, CA 94720 USA.
RP Chevalier, J (reprint author), Inst Natl Sci Appl, Etud Met Phys & Phys Mat Grp, Dept Mat Sci, Associate Res Unit 5510, 20 Av A Einstein, F-69621 Villeurbanne, France.
EM jerome.chevalier@insa-lyon.fr
OI Gremillard, Laurent/0000-0001-7258-6483; Deville,
   Sylvain/0000-0002-3363-3184
CR Affatato S, 1999, BIOMATERIALS, V20, P1925, DOI 10.1016/S0142-9612(99)00093-9
   Burlington D. B., 1997, STEAM RESTERILIZATIO
   Chevalier J, 1999, J AM CERAM SOC, V82, P2150
   Christian J. W., 1965, THEORY TRANSFORMATIO, P1
   Deville S, 2003, J AM CERAM SOC, V86, P2225, DOI 10.1111/j.1151-2916.2003.tb03639.x
   Fullman R.L., 1953, J MET, V5, P447
   GARVIE RC, 1972, J AM CERAM SOC, V55, P303, DOI 10.1111/j.1151-2916.1972.tb11290.x
   Gremillard L, 2004, J EUR CERAM SOC, V24, P3483, DOI 10.1016/j.jeurceramsoc.2003.11.025
   Hannink RHJ, 2000, J AM CERAM SOC, V83, P461
   HIRANO M, 1991, J MATER SCI, V26, P5047, DOI 10.1007/BF00549890
   KOBAYASHI K, 1981, SOLID STATE IONICS, V3-4, P489, DOI 10.1016/0167-2738(81)90138-7
   LANGE FF, 1986, J AM CERAM SOC, V69, P237, DOI 10.1111/j.1151-2916.1986.tb07415.x
   LAWSON S, 1995, J EUR CERAM SOC, V15, P485, DOI 10.1016/0955-2219(95)00035-S
   MCKELLOP H, 1992, P 38 ANN M ORTH RES, P402
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Piconi C, 1998, BIOMATERIALS, V19, P1489, DOI 10.1016/S0142-9612(98)00064-7
   Tsubakino H, 1999, J AM CERAM SOC, V82, P2921
   *UK MED DEV AG SAF, 2001, REC SPEC BATCH ZIRC
   Willmann G, 1996, J MATER PROCESS TECH, V56, P168, DOI 10.1016/0924-0136(96)85101-6
   WURST JC, 1972, J AM CERAM SOC, V55, P109, DOI 10.1111/j.1151-2916.1972.tb11224.x
   YOSHIMURA M, 1987, J MATER SCI LETT, V6, P465, DOI 10.1007/BF01756800
NR 21
TC 95
Z9 95
U1 0
U2 16
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD FEB 15
PY 2005
VL 72B
IS 2
BP 239
EP 245
DI 10.1002/jbm.b.30123
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 892GS
UT WOS:000226638700003
PM 15654702
OA Green Published
DA 2018-10-19
ER

PT J
AU Jiang, GQ
   Mishler, D
   Davis, R
   Mobley, JP
   Schulman, JH
AF Jiang, GQ
   Mishler, D
   Davis, R
   Mobley, JP
   Schulman, JH
TI Zirconia to Ti-6Al-4V braze joint for implantable biomedical device
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE zirconia; titanium alloys; mechanical properties; biocompatibility/soft
   tissue
ID MICROSTRUCTURE
AB A strong, hermetic, reliable, and biocompatible ceramic-to-metal seal is essential for many implantable medical devices. Yttria-stabilized tetragonal zirconia polycrystals (Y-TZPs) and a titanium alloy Ti-6AI-4V were selected as the ceramic and metal components of the seal because both materials have excellent mechanical properties and favorable biocompatibility. A brazing method using titanium nickel (TiNi)-clad braze filler material is presented to bond the components together forming a seal. Laboratory tests show that the ceramic-to-metal seal is hermetic, strong, and resistant to electrochemical corrosion. Twenty-eight microstimulators utilizing the ceramic-to-metal seals were implanted in seven sheep to stimulate the hypoglossal nerve. When the tissue was evaluated by gross inspection at necropsy and examined histologically by a pathologist, there were no signs of local hemorrhage, infection, or hypoglossal nerve tissue damage. (C) 2004 Wiley Periodicals, Inc.
C1 Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA.
   Alfred E Mann Fdn Sci Res, Santa Clarita, CA 91355 USA.
RP Jiang, GQ (reprint author), Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA.
EM jiang@aemf.org
CR Agathopoulos S, 2002, KEY ENG MAT, V206-2, P487, DOI 10.4028/www.scientific.net/KEM.206-213.487
   AGATHOPOULOS S, 1997, CERAMIC T, V77, P75
   AGATHOPOULOS S, 2002, ADV JOINING CERAMICS, P135
   ARCOS I, 2001, ARTIF ORGANS, V26, P228
   Bogdanski D, 2002, BIOMATERIALS, V23, P4549, DOI 10.1016/S0142-9612(02)00200-4
   Correia RN, 1998, J MATER SCI, V33, P215, DOI 10.1023/A:1004378520526
   KUBASCHEWSKI O, 1955, J I MET, V84, P440
   PARK E, 1991, METAL CERAMIC JOININ, P1676
   PEYTOUR C, 1990, J MATER SCI LETT, V9, P1129, DOI 10.1007/BF00721864
   SANTELLA ML, 1993, WELDING RES S, P165
   Uo M, 1999, BIOMATERIALS, V20, P747, DOI 10.1016/S0142-9612(98)00224-5
NR 11
TC 15
Z9 17
U1 0
U2 8
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD FEB 15
PY 2005
VL 72B
IS 2
BP 316
EP 321
DI 10.1002/jbm.b.30161
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 892GS
UT WOS:000226638700014
PM 15497165
DA 2018-10-19
ER

PT J
AU Li, XD
   Wang, XN
   Bondokov, R
   Morris, J
   An, YHH
   Sudarshan, TS
AF Li, XD
   Wang, XN
   Bondokov, R
   Morris, J
   An, YHH
   Sudarshan, TS
TI Micro/nanoscale mechanical and tribological characterization of SiC for
   orthopedic applications
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE SiC; biomaterials; orthopedic; nanoindentation; mechanical properties;
   tribology
ID SILICON-CARBIDE; IN-VITRO; RETRIEVAL; PARTICLES; DIAMOND; FILMS
AB Micro/nanomechanical and tribological characterization of SiC has been carried out. For comparison, measurements on SiC, CoCrMo, Ti-6Al-4V, and stainless steel have also been made. Hardness and elastic modulus of these materials were measured by nanoindentation using a nanoindenter. The nanoindentation impressions were imaged using an atomic force microscope (AFM). Scratch, friction, and wear properties were measured using an accelerated microtribometer. Scratch and wear damages were studied using a scanning electron microscope (SEM). It is found that SiC exhibits higher hardness, elastic modulus, scratch resistance as well as lower friction with fewer and smaller debris particles compared to other materials. These results show that SiC possesses superior mechanical and tribological properties that make it an ideal material for use in orthopedic and other biomedical applications. (C) 2004 Wiley Periodicals, Inc.
C1 Univ S Carolina, Dept Mech Engn, Columbia, SC 29208 USA.
   Univ S Carolina, Dept Elect Engn, Columbia, SC 29208 USA.
   Med Univ S Carolina, Orthopaed Res Lab, Charleston, SC 29425 USA.
RP Li, XD (reprint author), Univ S Carolina, Dept Mech Engn, 300 Main St, Columbia, SC 29208 USA.
EM lixiao@engr.sc.edu
RI Li, Xiaodong/B-6530-2008
CR ALLEN M, 1995, BIO-MED MATER ENG, V5, P151
   Aspenberg P, 1996, BIOMATERIALS, V17, P807, DOI 10.1016/0142-9612(96)81418-9
   Bessette BIJ, 2003, CAN J SURG, V46, P257
   Bhushan B, 2003, INT MATER REV, V48, P125, DOI 10.1179/095066003225010227
   Bhushan B., 1999, PRINCIPLES APPL TRIB
   BHUSHAN B, 1998, TRIBOLOGY ISSUES OPP, P407
   BHUSHAN B, 2003, HIGH PRESSURE SURFAC, P321
   Cherednichenko DI, 2004, J CRYST GROWTH, V262, P175, DOI 10.1016/j.jcrysgro.2003.09.048
   Friedman RJ, 1996, J ORTHOPAED RES, V14, P455, DOI 10.1002/jor.1100140316
   Goodman SB, 1998, CLIN ORTHOP RELAT R, P25
   Kadoya Y, 1998, Acta Orthop Scand Suppl, V278, P1
   Kalnins Uldis, 2002, Med Sci Monit, V8, pPI16
   Kotzar G, 2002, BIOMATERIALS, V23, P2737, DOI 10.1016/S0142-9612(02)00007-8
   LEMONS J, 2002, BONEZONE         FAL
   Li XD, 2003, ULTRAMICROSCOPY, V97, P481, DOI 10.1016/S0304-3991(03)00077-9
   Li XD, 2002, MATER CHARACT, V48, P11
   Li XD, 1999, THIN SOLID FILMS, V340, P210, DOI 10.1016/S0040-6090(98)01153-5
   McGee MA, 2000, WEAR, V241, P158, DOI 10.1016/S0043-1648(00)00370-7
   MCLAUGHLIN J, 2000, SIC SUBRETINAL APPL, P34
   Monnink SHJ, 1999, J INVEST MED, V47, P304
   Nordsletten L, 1996, BIOMATERIALS, V17, P1521, DOI 10.1016/0142-9612(96)89777-8
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Santavirta S, 1998, ARCH ORTHOP TRAUM SU, V118, P89, DOI 10.1007/s004020050319
   Sneddon IN, 1965, INT J ENG SCI, V3, P47, DOI DOI 10.1016/0020-7225(65)90019-4
NR 24
TC 50
Z9 51
U1 0
U2 14
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD FEB 15
PY 2005
VL 72B
IS 2
BP 353
EP 361
DI 10.1002/jbm.b.30168
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 892GS
UT WOS:000226638700020
PM 15538716
DA 2018-10-19
ER

PT J
AU Kitano, H
   Kawasaki, A
   Kawasaki, H
   Morokoshi, S
AF Kitano, H
   Kawasaki, A
   Kawasaki, H
   Morokoshi, S
TI Resistance of zwitterionic telomers accumulated on metal surfaces
   against nonspecific adsorption of proteins
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article; Proceedings Paper
CT 53rd Symposium of the Society-of-Polymer-Science on Macromolecules
CY SEP, 2004
CL Sapporo, JAPAN
SP Soc Polymer Sci
DE cyclic voltammetry Iniferter; nonspecific adsorption; protein
   adsorption; self-assembled monolayer; surface plasmon resonance;
   Telomerization; Zwitterionic telomer
ID SELF-ASSEMBLED MONOLAYERS; LIVING-RADICAL POLYMERIZATION; ORGANIZED
   MOLECULAR ASSEMBLIES; RESONANCE RAMAN-SPECTROSCOPY; GOLD COLLOID
   MONOLAYERS; ATOMIC-FORCE MICROSCOPY; AG ISLAND FILMS; INTERFACIAL
   RECOGNITION; THIOLATED CYCLODEXTRIN; BENZYL N,N-DIETHYLDITHIOCARBAMATE
AB Telomers of N,N-dimethyl-N-(3-sulfopropyl)(-3')-methacryloylaminopropanaminium inner salt (SPB), 2-methacryloyloxyethyl phosphorylcholine (MPC), and N,N-dimethyl-N-(1-carboxymethyl)-2-methacryloyloxylethanaminium inner salt (CMB) were prepared by UV irradiation in the presence of N,N,N',N'-tetraethylthiuram disulfide and a disulfide-group-carrying iniferter (a compound which pursues initiation, chain transfer, and termination). Cys-BDC, which had been prepared by coupling N.N-diethyldithiocarbamoylmethylbenzoic acid succinimidyl ester with cystamine dihydrochloride. The telomers formed a self-assembled rnonolayer (SAM) on a gold electrode and a monolayer of colloidal gold deposited on a glass plate, as confirmed by the increase in potential difference (DeltaE(p)) of the voltammogram for hydroquinone as a probe using cyclic voltammetry (CV) and the increase in absorbance using localized surface plasmon resonance (LSPR) absorption spectroscopy, respectively. Nonspecific adsorption of various proteins onto the surfaces of various telomer SAMs was examined from the decrease in peak current (DeltaI) using CV and the absorption increase at 550 nm using LSPR absorption spectroscopy. The zwitterionic telomer SAM in general did not adsorb proteins significantly, suggesting the usability of zwitterionic polymer SAMs and brushes to coat various materials used in biomedical fields. The correlation between the structure of water in the vicinity of zwitterionic telomers and the resistance of the zwitterionic telomer SAMs against the nonspecific adsorption of proteins was discussed. (C) 2004 Elsevier Inc. All rights reserved.
C1 Toyama Univ, Dept Chem & Biochem Engn, Toyama 9308555, Japan.
RP Kitano, H (reprint author), Toyama Univ, Dept Chem & Biochem Engn, Toyama 9308555, Japan.
EM kitano@eng.toyama-u.ac.jp
CR ANUFRIEVA EV, 1968, J POLYM SCI POL SYM, P3519
   Baethge H, 1997, MACROMOL RAPID COMM, V18, P911, DOI 10.1002/marc.1997.030181003
   Bain C. D., 1989, ADV MATER, V1, P506
   BAIN CD, 1989, J AM CHEM SOC, V111, P321, DOI 10.1021/ja00183a049
   Beulen MWJ, 1998, LANGMUIR, V14, P7463, DOI 10.1021/la981031z
   Cheng SF, 2003, ANAL CHEM, V75, P16, DOI 10.1021/ac020310v
   Chi QJ, 2000, J AM CHEM SOC, V122, P4047, DOI 10.1021/ja993174t
   CHIDSEY CED, 1990, LANGMUIR, V6, P682, DOI 10.1021/la00093a026
   DALY WH, 1988, TETRAHEDRON LETT, V29, P5859, DOI 10.1016/S0040-4039(00)82209-1
   Dirix Y, 1999, ADV MATER, V11, P223, DOI 10.1002/(SICI)1521-4095(199903)11:3<223::AID-ADMA223>3.0.CO;2-J
   DOI T, 1994, J POLYM SCI POL CHEM, V32, P2911, DOI 10.1002/pola.1994.080321512
   DUBOIS LH, 1992, ANNU REV PHYS CHEM, V43, P437, DOI 10.1146/annurev.pc.43.100192.002253
   Emory SR, 1998, J PHYS CHEM B, V102, P493, DOI 10.1021/jp9734033
   Flink S, 1998, J AM CHEM SOC, V120, P4652, DOI 10.1021/ja9734713
   FREEMAN RG, 1995, SCIENCE, V267, P1629, DOI 10.1126/science.267.5204.1629
   Fukuda T, 1999, LANGMUIR, V15, P1887, DOI 10.1021/la981269n
   Fukuda T, 1996, MACROMOLECULES, V29, P3050, DOI 10.1021/ma951792y
   GARRETT RH, 1995, BIOCHEMISTRY
   GENNIS RB, 1989, BIOMEMBRANES MOL STR
   Gorman CB, 1998, LANGMUIR, V14, P3312, DOI 10.1021/la9803023
   Grabar KC, 1997, ANAL CHEM, V69, P471, DOI 10.1021/ac9605962
   GRABAR KC, 1995, ANAL CHEM, V67, P735, DOI 10.1021/ac00100a008
   Guo SR, 2001, POLYMER, V42, P1017, DOI 10.1016/S0032-3861(00)00472-9
   Haes AJ, 2002, J AM CHEM SOC, V124, P10596, DOI 10.1021/ja020393x
   Hansson KM, 2005, BIOMATERIALS, V26, P861, DOI 10.1016/j.biomaterials.2004.03.036
   Hawker CJ, 1996, MACROMOLECULES, V29, P2686, DOI 10.1021/ma9515137
   HILL W, 1993, J PHYS CHEM-US, V97, P9451, DOI 10.1021/j100139a032
   Holmlin RE, 2001, LANGMUIR, V17, P2841, DOI 10.1021/la0015258
   Horton H. R., 2002, PRINCIPLES BIOCH
   Huisman BH, 1996, ADV MATER, V8, P561, DOI 10.1002/adma.19960080704
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   ISHIHARA K, 1990, J BIOMED MATER RES, V24, P1077
   Jensen TR, 2000, APPL SPECTROSC, V54, P371, DOI 10.1366/0003702001949654
   Jeon NL, 1997, LANGMUIR, V13, P3382, DOI 10.1021/la970166m
   Ji J, 2000, POLYMER, V41, P3713, DOI 10.1016/S0032-3861(99)00556-X
   Jonsson B., 1998, SURFACTANTS POLYM AQ
   Jun Z., 2003, COLLOID SURFACE B, V28, P1
   Kaifer A. E., 1996, COMPREHENSIVE SUPRAM, V8, P499
   Kanayama N, 2000, J PHYS CHEM B, V104, P271, DOI 10.1021/jp990884c
   Kanayama N, 2000, LANGMUIR, V16, P577, DOI 10.1021/la990182e
   Kitamura T, 2002, J TEMPORAL DESIGN AR, V2, P13
   KITANO H, 1989, J AM CHEM SOC, V111, P6809, DOI 10.1021/ja00199a048
   Kitano H, 2004, J COLLOID INTERF SCI, V273, P106, DOI 10.1016/j.jcis.2004.01.027
   Kitano H, 2003, LANGMUIR, V19, P10260, DOI 10.1021/la0349673
   Kitano H, 2002, J PHYS CHEM B, V106, P11391, DOI 10.1021/jp020185r
   Kitano H, 2001, LANGMUIR, V17, P1878, DOI 10.1021/la000869v
   KITANO H, 1994, LANGMUIR, V10, P4131, DOI 10.1021/la00023a036
   Kitano H, 1999, LANGMUIR, V15, P2709, DOI 10.1021/la981250k
   Kitano H, 2000, J PHYS CHEM B, V104, P11425, DOI 10.1021/jp000429c
   Kitano H, 1998, LANGMUIR, V14, P165, DOI 10.1021/la9704260
   Kitano H, 2000, ANAL CHEM, V72, P2976, DOI 10.1021/ac000074t
   KITANO H, UNPUB
   Ko YG, 2001, BIOMATERIALS, V22, P2115, DOI 10.1016/S0142-9612(00)00400-2
   Kroeze E, 1996, MACROMOLECULES, V29, P8599, DOI 10.1021/ma961131g
   KROSCHWITZ JI, 1994, GLASS, V12, P569
   LAIBINIS PE, 1991, J AM CHEM SOC, V113, P7152, DOI 10.1021/ja00019a011
   LASCHEWSKY A, 1995, POLYMER, V36, P3045, DOI 10.1016/0032-3861(95)94357-Y
   Lee HJ, 1999, MACROMOLECULES, V32, P6989, DOI 10.1021/ma990566b
   LOPEZ GP, 1993, J AM CHEM SOC, V115, P5877, DOI 10.1021/ja00066a087
   MAEDA Y, 1995, J PHYS CHEM-US, V99, P487, DOI 10.1021/j100002a004
   Maeda Y, 1997, LANGMUIR, V13, P4187, DOI 10.1021/la9701384
   MAEDA Y, 1995, J PHYS CHEM-US, V99, P4837, DOI 10.1021/j100013a063
   Matyjaszewski K, 1997, MACROMOL RAPID COMM, V18, P1057, DOI 10.1002/marc.1997.030181209
   Meriaudeau F, 1998, APPL OPTICS, V37, P8030, DOI 10.1364/AO.37.008030
   Morokoshi S, 2004, LANGMUIR, V20, P8897, DOI 10.1021/la049201x
   Nakayama Y, 1996, MACROMOLECULES, V29, P8622, DOI 10.1021/ma9606014
   Nakayama Y, 1999, LANGMUIR, V15, P1667, DOI 10.1021/la981169h
   Nath N, 2002, ANAL CHEM, V74, P504, DOI 10.1021/ac015657x
   NUZZO RG, 1990, J AM CHEM SOC, V112, P558, DOI 10.1021/ja00158a012
   NUZZO RG, 1987, J AM CHEM SOC, V109, P2358, DOI 10.1021/ja00242a020
   NUZZO RG, 1983, J AM CHEM SOC, V105, P4481, DOI 10.1021/ja00351a063
   Okamoto T, 2000, OPT LETT, V25, P372, DOI 10.1364/OL.25.000372
   OKAWARA M, 1964, KOGYO KAGAKU ZASSHI, V67, P2108
   OTSU T, 1989, EUR POLYM J, V25, P643, DOI 10.1016/0014-3057(89)90023-2
   OTSU T, 1986, MACROMOLECULES, V19, P287, DOI 10.1021/ma00156a007
   OTSU T, 1982, MAKROMOL CHEM-RAPID, V3, P127
   Patten TE, 1996, SCIENCE, V272, P866, DOI 10.1126/science.272.5263.866
   Pipino ACR, 1996, PHYS REV B, V53, P4162, DOI 10.1103/PhysRevB.53.4162
   PORTER MD, 1987, J AM CHEM SOC, V109, P3559, DOI 10.1021/ja00246a011
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   Sawamato M, 1999, CHEMTECH, V29, P30
   SAWAMOTO M, 1999, MAT SCI TECHNOLOGY S, pCH6
   SCHIERBAUM KD, 1994, SCIENCE, V265, P1413, DOI 10.1126/science.265.5177.1413
   Schonherr H, 1997, LANGMUIR, V13, P1567, DOI 10.1021/la961084l
   Senoo M, 1999, MACROMOLECULES, V32, P8005, DOI 10.1021/ma9909814
   SPINKE J, 1993, LANGMUIR, V9, P1821, DOI 10.1021/la00031a033
   Takei H, 2002, OPT LETT, V27, P342, DOI 10.1364/OL.27.000342
   Tarcha PJ, 1999, APPL SPECTROSC, V53, P43, DOI 10.1366/0003702991945443
   TSUJI S, 2004, LANGMUIR, V20, P2499
   Tsuruta T., 1993, BIOMEDICAL APPL POLY
   VANDUYNE RP, 1993, J CHEM PHYS, V99, P2101, DOI 10.1063/1.465276
   VEREGIN RPN, 1993, MACROMOLECULES, V26, P5316, DOI 10.1021/ma00072a007
   Voet D., 1995, BIOCHEMISTRY
   Wadayama T, 1999, APPL PHYS A-MATER, V69, P77, DOI 10.1007/s003390050974
   WANG JS, 1995, MACROMOLECULES, V28, P7901, DOI 10.1021/ma00127a042
   WANG JS, 1995, J AM CHEM SOC, V117, P5614, DOI 10.1021/ja00125a035
   West SL, 2004, BIOMATERIALS, V25, P1195, DOI 10.1016/j.biomaterials.2003.08.010
   Yamamoto H, 1997, J PHYS CHEM B, V101, P6855, DOI 10.1021/jp963916u
   Yang WH, 1996, J CHEM PHYS, V104, P4313, DOI 10.1063/1.471241
   Yoshizumi A, 1999, LANGMUIR, V15, P482, DOI 10.1021/la980374u
   Yuan J, 2003, POLYM INT, V52, P1869, DOI 10.1002/pi.1277
   Yuan YL, 2004, POLYM INT, V53, P121, DOI 10.1002/pi.1122
   YUAN YL, 2003, J BIOMAT SCI-POLYM E, V13, P1081
   YUKI H, 1956, NIPPON KAGAKU ZASSHI, V77, P44
NR 104
TC 74
Z9 76
U1 5
U2 56
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD FEB 15
PY 2005
VL 282
IS 2
BP 340
EP 348
DI 10.1016/j.jcis.2004.08.157
PG 9
WC Chemistry, Physical
SC Chemistry
GA 885TB
UT WOS:000226178700011
PM 15589539
DA 2018-10-19
ER

PT J
AU Benabderrahmane, S
   Bousalem, S
   Mangeney, C
   Azioune, A
   Vaulay, MJ
   Chehimi, MM
AF Benabderrahmane, S
   Bousalem, S
   Mangeney, C
   Azioune, A
   Vaulay, MJ
   Chehimi, MM
TI Interfacial physicochemical properties of functionalized conducting
   polypyrrole particles
SO POLYMER
LA English
DT Article; Proceedings Paper
CT 5th Conference on Polymers in Dispersed Media
CY 2004
CL Lyon, FRANCE
DE polypyrrole dispersions; reactivity; protein
ID COATED POLYSTYRENE LATEX; RAY PHOTOELECTRON-SPECTROSCOPY; BIOMEDICAL
   APPLICATIONS; COMPOSITES; IMMOBILIZATION; PROTEINS
AB Polypyrrole-coated polystyrene latex particles bearing reactive N-succinimidyl ester functional groups (PS-PPyNSE75) were prepared by the in situ copolymerization of pyrrole 1 and the active N-succinimidyl ester-functionalized pyrrole 2 (pyrroleNSE), with initial 1:2 fractions of 25:75 (%) in the presence of sterically stabilized polystyrene (PS) latex particles. PS particles were prepared by dispersion polymerization leading to particles having a diameter of 600 +/- 10 nm. The PS-PPyNSE75 particles were characterized in terms of surface morphology and chemical composition. Surface analysis of the colloidal materials by X-ray photoelectron spectroscopy (XPS) and scanning electron microscopy (SEM) indicated a substantial coating of PS by the reactive conducting copolymer. Infrared spectroscopy permitted to detect pyrroleNSE repeat units at the surface of the particles indicating that 1 and 2 did indeed copolymerise.
   Reactivity of the PS-PPyNSE75 particles has been investigated using 2-aminoethanol and 2-mercaptoethanol, two model molecules bearing functional groups borne by proteins. Incubation of the particles with these model molecules clearly showed that the particles are highly reactive towards amine and thiol groups. The functionalized particles were then tested as bioadsorbents. PS-PPyNSE75 particles were found to be effective in attaching an aminated biotin. The Biotin-decorated PS-PPyNSE75 latex particles were incubated with avidin with a result of a significant change in the surface composition that is in line with the attachment of the protein by specific binding to biotin. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Paris 07, CNRS, UMR 7086, Itodys, F-75005 Paris, France.
RP Chehimi, MM (reprint author), Univ Paris 07, CNRS, UMR 7086, Itodys, 1 Rue Guy Brosse, F-75005 Paris, France.
EM chehimi@paris7.jussieu.fr
CR Azioune A, 2004, LANGMUIR, V20, P3350, DOI 10.1021/la030407s
   Beamson G., 1992, HIGH RESOLUTION XPS
   Bousalem S, 2004, COLLOID SURFACE A, V249, P91, DOI 10.1016/j.colsurfa.2004.08.056
   Bousalem S, 2004, COLLOID POLYM SCI, V282, P1301, DOI 10.1007/s00396-004-1065-8
   Bousalem S, 2003, POLYM ADVAN TECHNOL, V14, P820, DOI 10.1002/pat.401
   Cairns DB, 1999, LANGMUIR, V15, P8059, DOI 10.1021/la990443k
   CAIRNS DB, 2003, CHEM MATER, V15, P223
   CHEHIMI MM, 2003, SURFACTANT SCI SER, V115, P245
   Chen RJ, 2001, J AM CHEM SOC, V123, P3838, DOI 10.1021/ja010172b
   GUBITZ G, 1988, J CHROMATOGRAPHY L A, V39, pCH3
   HUIJIS FM, 2000, THESIS NETHERLANDS
   Lascelles SF, 1997, J MATER CHEM, V7, P1339, DOI 10.1039/a700237h
   Omastova M, 1998, POLYMER, V39, P6559, DOI 10.1016/S0032-3861(97)10178-1
   Omastova M, 1996, EUR POLYM J, V32, P681, DOI 10.1016/0014-3057(95)00206-5
   Perruchot C, 1996, LANGMUIR, V12, P3245, DOI 10.1021/la960057s
   Skotheim T.A, 1998, HDB CONDUCTING POLYM
   WANG C, SURFACTANT SCI SER, V115, P93
   WIERSMA AE, 1995, SYNTHETIC MET, V71, P2269, DOI 10.1016/0379-6779(94)03254-4
   YASSAR A, 1987, POLYM COMMUN, V28, P103
NR 19
TC 35
Z9 35
U1 1
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
J9 POLYMER
JI Polymer
PD FEB 7
PY 2005
VL 46
IS 4
BP 1339
EP 1346
DI 10.1016/j.polymer.2004.11.066
PG 8
WC Polymer Science
SC Polymer Science
GA 893BS
UT WOS:000226694900036
DA 2018-10-19
ER

PT J
AU Es-Souni, M
   Es-Souni, M
   Fischer-Brandies, H
AF Es-Souni, M
   Es-Souni, M
   Fischer-Brandies, H
TI Assessing the biocompatibility of NiTi shape memory alloys used for
   medical applications
SO ANALYTICAL AND BIOANALYTICAL CHEMISTRY
LA English
DT Review
DE NiTi shape memory alloys; corrosion; biocompatibility; genotoxicity; Ni
   release
ID IN-VITRO BIOCOMPATIBILITY; FIXED ORTHODONTIC APPLIANCES; NICKEL-TITANIUM
   ALLOY; CORROSION BEHAVIOR; CALCIUM-PHOSPHATE; STAINLESS-STEEL; TI ALLOY;
   CYTOTOXICITY; RESISTANCE; TOXICITY
AB The present paper reviews aspects related to the biocompatibility of NiTi shape memory alloys used for medical applications. These smart metallic materials which are characterised by outstanding mechanical properties, have been gaining increasing importance over the last two decades in many minimal invasive surgery and diagnostic applications, as well as for other uses, such as in orthodontic appliances. Due to the presence of high amounts of Ni, the cytotoxicity of such alloys is under scrutiny. In this review paper we analyse work published on the biocompatibility of NiTi alloys, considering aspects related to: (1) corrosion properties and the different methods used to test them, as well as specimen surface states; (2) biocompatibility tests in vitro and in vivo; (3) the release of Ni ions. It is shown that NiTi shape memory alloys are generally characterised by good corrosion properties, in most cases superior to those of conventional stainless steel or Co-Cr-Mo-based biomedical materials. The majority of biocompatibility studies suggest that these alloys have low cytotoxicity (both in vitro and in vivo) as well as low genotoxicity. The release of Ni ions depends on the surface state and the surface chemistry. Smooth surfaces with well-controlled structures and chemistries of the outermost protective TiO2 layer lead to negligible release of Ni ions, with concentrations below the normal human daily intake.
C1 Univ Appl Sci Kiel, Inst Mat & Surface Technol, D-24149 Kiel, Germany.
   Univ Kiel, Fac Med, Dept Orthodont, D-24149 Kiel, Germany.
RP Es-Souni, M (reprint author), Univ Appl Sci Kiel, Inst Mat & Surface Technol, D-24149 Kiel, Germany.
EM me@fh-kiel.de
RI Fischer-Brandies, Prof. Dr., Helge/E-9480-2010
CR Agaoglu G, 2001, ANGLE ORTHOD, V71, P375
   ASSAD M, 1994, ANN CHIR, V48, P731
   Assad M, 2002, BIO-MED MATER ENG, V12, P339
   Assad M, 2002, BIO-MED MATER ENG, V12, P225
   Assad M, 1998, J BIOMED MATER RES, V41, P154, DOI 10.1002/(SICI)1097-4636(199807)41:1<154::AID-JBM18>3.3.CO;2-0
   Assad M, 1999, BIO-MED MATER ENG, V9, P1
   Barceloux DG, 1999, J TOXICOL-CLIN TOXIC, V37, P239, DOI 10.1081/CLT-100102423
   BASS JK, 1993, AM J ORTHOD DENTOFAC, V103, P280, DOI 10.1016/0889-5406(93)70009-D
   BISHARA SE, 1993, AM J ORTHOD DENTOFAC, V103, P115, DOI 10.1016/S0889-5406(05)81760-3
   Bogdanski D, 2004, BIOMATERIALS, V25, P4627, DOI 10.1016/j.biomaterials.2003.12.001
   Bogdanski D, 2002, BIOMATERIALS, V23, P4549, DOI 10.1016/S0142-9612(02)00200-4
   Choi J, 2003, BIOMATERIALS, V24, P3689, DOI 10.1016/S0142-9612(03)00241-2
   COUNTS AL, 2001, J OROFACIAL ORTHOP, V63, P509
   Denkhaus E, 2002, CRIT REV ONCOL HEMAT, V42, P35, DOI 10.1016/S1040-8428(01)00214-1
   DUERIG TW, 1995, MATER RES SOC SYMP P, V360, P497
   DUNLAP CL, 1989, J AM DENT ASSOC, V118, P449, DOI 10.14219/jada.archive.1989.0174
   El Medawar L, 2002, BIOMOL ENG, V19, P153, DOI 10.1016/S1389-0344(02)00041-2
   Es-Souni M, 2002, BIOMATERIALS, V23, P2887, DOI 10.1016/S0142-9612(01)00416-1
   Es-Souni M, 2001, BIOMATERIALS, V22, P2153, DOI 10.1016/S0142-9612(00)00406-3
   Es-Souni Martha, 2003, J Orofac Orthop, V64, P16, DOI 10.1007/s00056-003-0235-5
   Faccioni F, 2003, AM J ORTHOD DENTOFAC, V124, P687, DOI 10.1016/j.ajodo.2003.09.010
   Filip P, 2001, BIOMATERIALS, V22, P2131, DOI 10.1016/S0142-9612(00)00404-X
   Gil FJ, 1999, J BIOMED MATER RES, V48, P682, DOI 10.1002/(SICI)1097-4636(1999)48:5<682::AID-JBM12>3.0.CO;2-M
   Kerosuo H, 1996, AM J ORTHOD DENTOFAC, V109, P148, DOI 10.1016/S0889-5406(96)70175-0
   Kim H, 1999, ANGLE ORTHOD, V69, P39
   Kujala S, 2004, BIOMATERIALS, V25, P353, DOI 10.1016/S0142-9612(03)00488-5
   Kujala S, 2003, BIOMATERIALS, V24, P4691, DOI 10.1016/S0142-9612(03)00359-4
   Kuphasuk C, 2001, J PROSTHET DENT, V85, P195, DOI 10.1067/mpr.2001.113029
   Lamberti M, 2004, TOXICOL APPL PHARM, V195, P321, DOI 10.1016/j.taap.2003.09.022
   Melton KN, 1998, SHAPE MEMORY MAT, P220
   Menne T, 1996, ANN CLIN LAB SCI, V26, P133
   Mockers O, 2002, DENT MATER, V18, P311, DOI 10.1016/S0109-5641(01)00055-0
   MonteroOcampo C, 1996, J BIOMED MATER RES, V32, P583, DOI 10.1002/(SICI)1097-4636(199612)32:4<583::AID-JBM11>3.0.CO;2-F
   NIELSEN NH, 1992, ACTA DERM-VENEREOL, V72, P456
   PELTONEN L, 1979, CONTACT DERMATITIS, V5, P27, DOI 10.1111/j.1600-0536.1979.tb05531.x
   Prymak O, 2004, MATERIALWISS WERKST, V35, P346, DOI 10.1002/mawe.200400753
   Rahilly G, 2003, J Orthod, V30, P171, DOI 10.1093/ortho/30.2.171
   Rhalmi S, 1999, BIO-MED MATER ENG, V9, P151
   Rondelli G, 2000, J BIOMED MATER RES, V51, P47, DOI 10.1002/(SICI)1097-4636(200007)51:1<47::AID-JBM7>3.3.CO;2-G
   Rondelli G, 1996, BIOMATERIALS, V17, P2003, DOI 10.1016/0142-9612(95)00352-5
   Rondelli G, 1999, BIOMATERIALS, V20, P785, DOI 10.1016/S0142-9612(98)90233-2
   Rose E C, 1998, J Orofac Orthop, V59, P253, DOI 10.1007/BF01321792
   Ryhanen J, 1997, J BIOMED MATER RES, V35, P451
   Ryhanen J, 1998, J BIOMED MATER RES, V41, P481, DOI 10.1002/(SICI)1097-4636(19980905)41:3<481::AID-JBM19>3.0.CO;2-L
   Ryhanen J, 1999, BIOMATERIALS, V20, P1309, DOI 10.1016/S0142-9612(99)00032-0
   Saburi T, 1998, SHAPE MEMORY MAT, P49
   Schuster Gabriele, 2004, J Orofac Orthop, V65, P48, DOI 10.1007/s00056-004-0312-4
   Shabalovskaya SA, 1996, BIO-MED MATER ENG, V6, P267
   SHI ZC, 1994, SCI TOTAL ENVIRON, V148, P293, DOI 10.1016/0048-9697(94)90406-5
   SPECK KM, 1980, J DENT RES, V59, P1590, DOI 10.1177/00220345800590100601
   SUZUKI Y, 1992, MAT SMART SYSTEMS, P403
   Tan L, 2003, BIOMATERIALS, V24, P3931, DOI 10.1016/S0142-9612(03)00271-0
   TEMPLETON DM, 1994, SCI TOTAL ENVIRON, V148, P243, DOI 10.1016/0048-9697(94)90400-6
   Trepanier C, 1998, J BIOMED MATER RES, V43, P433, DOI 10.1002/(SICI)1097-4636(199824)43:4<433::AID-JBM11>3.0.CO;2-#
   Uthus EO, 1996, BIOL TRACE ELEM RES, V52, P23, DOI 10.1007/BF02784087
   Veien N., 1989, NICKEL SKIN IMMUNOLO, P165
   Venugopalan R, 2000, MINIM INVASIV THER, V9, P67, DOI 10.3109/13645700009063052
   Wever DJ, 1998, BIOMATERIALS, V19, P761, DOI 10.1016/S0142-9612(97)00210-X
   WILLIAMS DF, 1998, ADV BIOMATER, P11
   WINTERMANTEL E, 1998, BIOKOMPATIBLE WERKST, P7
   Zhou DJ, 1998, CANCER RES, V58, P2182
NR 61
TC 146
Z9 160
U1 3
U2 57
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1618-2642
J9 ANAL BIOANAL CHEM
JI Anal. Bioanal. Chem.
PD FEB
PY 2005
VL 381
IS 3
BP 557
EP 567
DI 10.1007/s00216-004-2888-3
PG 11
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 907EE
UT WOS:000227697400006
PM 15660223
DA 2018-10-19
ER

PT J
AU Bunescu, R
   Ge, RF
   Kate, RJ
   Marcotte, EM
   Mooney, RJ
   Ramani, AK
   Wong, YW
AF Bunescu, R
   Ge, RF
   Kate, RJ
   Marcotte, EM
   Mooney, RJ
   Ramani, AK
   Wong, YW
TI Comparative experiments on learning information extractors for proteins
   and their interactions
SO ARTIFICIAL INTELLIGENCE IN MEDICINE
LA English
DT Article
DE information extraction; text mining; machine learning; protein
   interactions; Medline
ID GENES; MODELS
AB Objective: Automatically extracting information from biomedical text holds the promise of easily consolidating large amounts of biological knowledge in computer-accessible form. This strategy is particularly attractive for extracting data relevant to genes of the human genome from the 11 million abstracts in Medline. However, extraction efforts have been frustrated by the lack of conventions for describing human genes and proteins. We have developed and evaluated a variety of learned information extraction systems for identifying human protein names in Medtine abstracts and subsequently extracting information on interactions between the proteins.
   Methods and Material: We used a variety of machine learning methods to automaticatly develop information extraction systems for extracting information on gene/ protein name, function and interactions from Medline abstracts. We present crossvalidated results on identifying human proteins and their interactions by training and testing on a set of approximately 1000 manuatly-annotated Medline abstracts that discuss human genes/proteins. Results: We demonstrate that machine learning approaches using support vector machines and maximum entropy are able to identify human proteins with higher accuracy than several previous approaches. We also demonstrate that various rule induction methods are able to identify protein interactions with higher precision than manually-developed rules.
   Conclusion: Our results show that it is promising to use machine learning to automatically build systems for extracting information from biomedical text. The results also give a broad picture of the relative strengths of a wide variety of methods when tested on a reasonably large human-annotated corpus. (c) 2004 Elsevier B.V. All rights reserved.
C1 Univ Texas, Dept Comp Sci, Austin, TX 78712 USA.
   Univ Texas, Inst Cellular & Mol Biol, Austin, TX 78712 USA.
   Univ Texas, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA.
RP Mooney, RJ (reprint author), Univ Texas, Dept Comp Sci, Austin, TX 78712 USA.
EM razvan@cs.utexas.edu; grf@cs.utexas.edu; rjkate@cs.utexas.edu;
   marcotte@icmb.utexas.edu; mooney@cs.utexas.edu; arun@icmb.utexas.edu;
   ywwong@cs.utexas.edu
CR Berger AL, 1996, COMPUT LINGUIST, V22, P39
   Bikel DM, 1999, MACH LEARN, V34, P211, DOI 10.1023/A:1007558221122
   Blaschke C, 2002, IEEE INTELL SYST, V17, P14, DOI 10.1109/MIS.2002.999215
   Blaschke C, 2001, COMPAR FUNCT GENOM, V2, P196, DOI 10.1002/cfg.91
   Brill E, 1995, COMPUT LINGUIST, V21, P543
   Califf ME, 1999, SIXTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE (AAAI-99)/ELEVENTH INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE (IAAI-99), P328
   CALIFF ME, 1999, AAAI1999 WORKSH MACH
   Cardie C, 1997, AI MAG, V18, P65
   CESTNIK B, 1990, P 9 EUR C ART INT, P147
   CHARRAS C, 1998, SEQUENCE COMPAR LAB
   COLLIER N, 2000, P 18 INT C COMP LING, P201
   Collins M., 2002, P ANN M ASS COMP LIN
   COLLINS M, 1999, P C EMP METH NAT LAN
   Cowie J, 1996, COMMUN ACM, V39, P80, DOI 10.1145/234173.234209
   Craven M, 1999, Proc Int Conf Intell Syst Mol Biol, P77
   DARROCH JN, 1972, ANN MATH STAT, V43, P1470, DOI 10.1214/aoms/1177692379
   Duda R. O., 1973, PATTERN CLASSIFICATI
   ELIASSIRAD T, 2001, P 18 INT C MACH LEAR
   Freitag D, 2000, SEVENTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE (AAAI-2001) / TWELFTH INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE CONFERENCE (IAAI-2000), P577
   Freund Y, 1996, P 13 INT C MACH LEAR
   Friedman C, 2001, Bioinformatics, V17 Suppl 1, pS74
   Fukuda K, 1998, Pac Symp Biocomput, P707
   GUSFIELD D, 1997, AGLORITHMS STRINGS
   Hahn Udo, 2002, Pac Symp Biocomput, P338
   HUMPHREYS K, 2000, PAC S BIOC, P502
   JOACHIMS T, 1998, P 10 EUR C MACH LEAR, P137
   Kubat M, 1998, MACH LEARN, V30, P195, DOI 10.1023/A:1007452223027
   Kudoh Taku, 2000, P CONLL 2000 LLL 200, P142
   KUSHMERICK N, 1997, P 15 INT JOINT C ART, P729
   LAFFERTY J, 2001, PROBABLISTIC MODELS
   Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062
   Leonard JE, 2002, BIOINFORMATICS, V18, P1515, DOI 10.1093/bioinformatics/18.11.1515
   Levenshtein V, 1966, SOV PHYS DOKL, V10, P707
   MACCALLUM A, P 1N INT C MACH LEAR
   Marcotte EM, 2001, BIOINFORMATICS, V17, P359, DOI 10.1093/bioinformatics/17.4.359
   Marcus M.P., 1993, COMPUTATIONAL LINGUI, V19, P313, DOI DOI 10.1080/07494460903404410
   *NAT I STAND TECH, ACE AUT CONT EXTR
   Park J C, 2001, Pac Symp Biocomput, P396
   Pearl J., 1988, PROBABILISTIC REASON
   Perez-Iratxeta C, 2002, NAT GENET, V31, P316, DOI 10.1038/ng895
   Proux D., 2000, Proceedings. Eighth International Conference on Intelligent Systems for Molecular Biology, P279
   PROUX D, 1998, GENOME INFORM SER WO, V9, P72
   Pustejovsky J, 2002, Pac Symp Biocomput, P362
   RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626
   Ramshaw L. A., 1995, P 3 WORKSH VER LARG
   RAY S, 2001, P 17 INT JOINT C ART, P1273
   Raychaudhuri S, 2002, GENOME RES, V12, P203, DOI 10.1101/gr.199701
   RINDFLESCH TC, 2000, PAC S BIOC 2000, P515
   ROTH D, 2002, P 6 C NAT LANG LEARN
   Tanabe L, 2002, BIOINFORMATICS, V18, P1124, DOI 10.1093/bioinformatics/18.8.1124
   Thomas J, 2000, Pac Symp Biocomput, P541
   THOMPSON CA, 1999, P 16 INT C MACH LEAR, P406
   Vapnik V, 1995, NATURE STAT LEARNING
   Vapnik V N, 1998, STAT LEARNING THEORY
   Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040
   Xenarios I, 2001, NUCLEIC ACIDS RES, V29, P239, DOI 10.1093/nar/29.1.239
NR 56
TC 128
Z9 137
U1 2
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0933-3657
EI 1873-2860
J9 ARTIF INTELL MED
JI Artif. Intell. Med.
PD FEB
PY 2005
VL 33
IS 2
BP 139
EP 155
DI 10.1016/j.artmed.2004.07.016
PG 17
WC Computer Science, Artificial Intelligence; Engineering, Biomedical;
   Medical Informatics
SC Computer Science; Engineering; Medical Informatics
GA 920FC
UT WOS:000228673800004
PM 15811782
DA 2018-10-19
ER

PT J
AU Tettamanti, M
   Tralamazza, S
   Berati, M
   Molteni, M
   Gamba, N
AF Tettamanti, M
   Tralamazza, S
   Berati, M
   Molteni, M
   Gamba, N
TI Human research tissue banks: The ATRA Project for establishing a human
   research tissue bank in Switzerland
SO ATLA-ALTERNATIVES TO LABORATORY ANIMALS
LA English
DT Article
DE cadaveric donor; donor card; human cell culture; legislation; surplus
   surgical tissue; tissue bank; tissue and organ donation
ID RECOMMENDATIONS; HEPATOCYTES; WORKSHOP; CELLS; MODEL
AB A large number of experiments in biomedical research are carried out on tissues, but, even though the results should be applicable to humans, these tissues are mainly of animal origin. The difficulty encountered in obtaining human organs and tissues is an acknowledged problem: not enough human tissues are available to meet research needs. We are introducing the ATRA Project, with the purpose of supporting progress in biomedical research in Switzerland through the establishment of one or more human tissue banks, which will be able to find, treat, preserve and supply human material. Where similar projects have already been launched, concerns have been expressed that donation for research purposes might compete with donation for transplantation, but most organs and tissues are in any case non-transplantable. Surplus surgical tissue is considered "sanitary waste", and must be treated according to specific regulations for collection, packaging, transport, treatment and disposal. A human tissue bank would not only abate the costs of treating sanitary waste, but would actually turn what is now considered waste into a resource which could be used to save human and animal lives.
C1 ATRA, Schweizer Vereinigung Abschaffung Tierversuche, CH-6900 Lugano, Switzerland.
   NoVivisez Working Grp, Turin, Italy.
RP Tettamanti, M (reprint author), ATRA, Schweizer Vereinigung Abschaffung Tierversuche, Via Capelli 28, CH-6900 Lugano, Switzerland.
EM massimo.tettamanti@gmail.com
CR *AAVV, 1993, HUM CELLS VITR PHARM
   Anderson R, 1998, ATLA-ALTERN LAB ANIM, V26, P763
   Anderson R, 2001, ATLA-ALTERN LAB ANIM, V29, P125
   Bach PH, 1996, ATLA-ALTERN LAB ANIM, V24, P893
   Bader A, 1996, EXP CELL RES, V226, P223, DOI 10.1006/excr.1996.0222
   CHESNE C, 1993, HEPATOLOGY, V18, P406, DOI 10.1016/0270-9139(93)90026-J
   DON M, 1992, CRYOBIOLOGY, V29, P454
   *EUR COMM, 2003, 3 COMM COUNC EUR PAR
   FENTEM JH, 1994, HUM EXP TOXICOL, V13, P445, DOI 10.1177/096032719401300614
   GUILLOUZO A, 1992, IN VITRO METHODS TOX, P133
   GURNEY J, 1993, HUMAN CELLS IN IN VITRO PHARMACO-TOXICOLOGY, P315
   HAWKSWORTH GM, 1994, HUM EXP TOXICOL, V13, P568, DOI 10.1177/096032719401300811
   HIREL B, 1994, IN VITRO CELL DEV-AN, V30A, P372
   Lloyd TDR, 2003, ATLA-ALTERN LAB ANIM, V31, P483
   MORGAN R, 1997, MANAGING BIOL CHEM R
   *NHS EX, 1996, GUID MICR SAF HUM TI
   Nuffield Council on Bioethics, 1995, HUM TISS ETH LEG ISS
   Orr Samantha, 2002, Cell and Tissue Banking, V3, P133, DOI 10.1023/A:1022811232250
   SKETT P, 1995, BIOCHEM PHARMACOL, V50, P280, DOI 10.1016/0006-2952(95)90011-X
   Start RD, 1996, BRIT MED J, V313, P1366, DOI 10.1136/bmj.313.7069.1366
   Ward RK, 1998, TOXICOL IN VITRO, V12, P163, DOI 10.1016/S0887-2333(97)00098-2
   Ward SL, 1997, TOXICOL IN VITRO, V11, P121, DOI 10.1016/S0887-2333(96)00068-9
   2003, TIERVERSUCHE SCHWEIZ
NR 23
TC 4
Z9 4
U1 0
U2 1
PU FRAME
PI NOTTINGHAM
PA RUSSELL & BURCH HOUSE 96-98 NORTH SHERWOOD ST, NOTTINGHAM NG1 4EE,
   NOTTS, ENGLAND
SN 0261-1929
J9 ATLA-ALTERN LAB ANIM
JI ATLA-Altern. Lab. Anim.
PD FEB
PY 2005
VL 33
IS 1
BP 29
EP 36
PG 8
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 907WP
UT WOS:000227749100008
PM 15804215
DA 2018-10-19
ER

PT J
AU Keselowsky, BG
   Garcia, AJ
AF Keselowsky, BG
   Garcia, AJ
TI Quantitative methods for analysis of integrin binding and focal adhesion
   formation on biomaterial surfaces
SO BIOMATERIALS
LA English
DT Article
DE cell adhesion; integrin; focal adhesion; vinculin; talin
ID CELL-ADHESION; FIBRONECTIN; ACTIVATION; POLYSTYRENE
AB Integrin binding and focal adhesion assembly are critical to cellular responses to biomaterial surfaces in biomedical and biotechnological applications. While immunostaining techniques to study focal adhesion assembly are well established, a crucial need remains for quantitative methods for analyzing adhesive structures. We present simple yet robust approaches to quantify integrin binding and focal adhesion assembly on biomaterial surfaces. Integrin binding to fibronectin and a RGD-containing synthetic peptide was quantified by sequentially cross-linking integrin ligand complexes via a water-soluble homo-bifunctional cross-linker, extracting bulk cellular components in detergent, and detecting bound integrins by ELISA. Focal adhesion components (vinculin, talin, alpha-actinin) localized to adhesion plaques were isolated from bulk cytoskeletal and cytoplasmic components by mechanical rupture at a plane close to the basal cell surface and quantified by Western blotting. These approaches represent simple and efficient methodologies to analyze structure-function relationships in cell-material interactions. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
   Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
RP Garcia, AJ (reprint author), Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
EM andres.garcia@me.gatech.edu
RI Keselowsky, Benjamin/A-8000-2009
CR Allen LT, 2003, P NATL ACAD SCI USA, V100, P6331, DOI 10.1073/pnas.1031426100
   ANDERSON JM, 1995, J BIOMAT SCI-POLYM E, V7, P159, DOI 10.1163/156856295X00670
   Andersson H, 2001, J APPL ELECTROCHEM, V31, P1, DOI 10.1023/A:1004105622558
   AOTA S, 1994, J BIOL CHEM, V269, P24756
   BRANDS R, 1988, EXP CELL RES, V176, P309, DOI 10.1016/0014-4827(88)90333-3
   BRODBECK WG, 2003, P NATL ACAD SCI USA, V99, P10287
   Clark RA, 1990, J INVEST DERMATOL, V94, p128S
   ENOMOTOIWAMOTO M, 1993, CELL ADHES COMMUN, V1, P191, DOI 10.3109/15419069309097253
   Garcia AJ, 2002, CRIT REV EUKAR GENE, V12, P151, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i2.50
   Garcia AJ, 1999, BIOMATERIALS, V20, P2427, DOI 10.1016/S0142-9612(99)00170-2
   Garcia AJ, 1998, J BIOL CHEM, V273, P34710, DOI 10.1074/jbc.273.52.34710
   Garcia AJ, 2002, BIOCHEMISTRY-US, V41, P9063, DOI 10.1021/bi025752f
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Gorbet MB, 2001, J LAB CLIN MED, V137, P345, DOI 10.1067/mlc.2001.114677
   HAIMOVICH B, 1991, CELL REGUL, V2, P271
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   KESCLOWSKY BG, 2003, J BIOMED MATER RES, V66, P247
   KESELOWSKY BG, IN PRESS BIOMATERIAL
   PLOPPER G, 1993, BIOCHEM BIOPH RES CO, V193, P571, DOI 10.1006/bbrc.1993.1662
   Sastry SK, 2000, EXP CELL RES, V261, P25, DOI 10.1006/excr.2000.5043
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   Tziampazis E, 2000, BIOMATERIALS, V21, P511, DOI 10.1016/S0142-9612(99)00212-4
NR 26
TC 60
Z9 62
U1 3
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2005
VL 26
IS 4
BP 413
EP 418
DI 10.1016/j.biomaterials.2004.02.050
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 857RG
UT WOS:000224135400007
PM 15275815
DA 2018-10-19
ER

PT J
AU LaVan, DA
   Padera, RF
   Friedmann, TA
   Sullivan, JP
   Langer, R
   Kohane, DS
AF LaVan, DA
   Padera, RF
   Friedmann, TA
   Sullivan, JP
   Langer, R
   Kohane, DS
TI In vivo evaluation of tetrahedral amorphous carbon
SO BIOMATERIALS
LA English
DT Article
DE biocompatibility; amorphous diamond; amorphous carbon; thin film; in
   vivo testing
ID BIOMEDICAL APPLICATIONS; DIAMOND; FILMS; BIOCOMPATIBILITY; COATINGS;
   MACROPHAGES; ACTIVATION; ADHESION; VITRO
AB The in vivo behavior and tissue reaction to tetrahedral amorphous carbon (ta-C) has been evaluated for periods of up to 6 months in SV129 mice. Two sample types were tested-silicon die coated with ta-C (n=53) and micromachined particles (n=40). The coated samples were compared to uncoated silicon die (n=22). Die samples were implanted subcutaneously, and tissue reaction and capsule formation were evaluated at various time points. Micromachined particles of 1, 3 10, and 30 mum were injected adjacent to the sciatic nerve, and tissue samples were examined histologically at various time points (4 days-6 months).
   Tissue reaction to ta-C was mild and was localized to the area of the injection or implantation. Samples with a higher ratio of 3-fold bonding appeared to shed material during the experiments; this was not observed on samples with a higher level of 4-fold bonding. nor on uncoated silicon die. The results strongly suggest that films with greater 4-fold bonding character (more diamondlike) are more resistant to in vivo fragmentation than films with higher 3-fold character (more graphitic) (C) 2004 Elsevier Ltd. All rights reserved.
C1 Massachusetts Gen Hosp, Pediat Intens Care Unit, Dept Pediat, Boston, MA 02114 USA.
   Yale Univ, Dept Mech Engn, New Haven, CT 06520 USA.
   MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
   Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA.
   Sandia Natl Labs, Albuquerque, NM 87185 USA.
   MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
RP Kohane, DS (reprint author), Massachusetts Gen Hosp, Pediat Intens Care Unit, Dept Pediat, Ellison 317,55 Fruit St, Boston, MA 02114 USA.
EM dkohane@partners.org
RI LaVan, David/C-3943-2012
OI LaVan, David/0000-0002-1952-0028
FU NIGMS NIH HHS [GM00684]
CR Alanazi A, 2000, ARTIF ORGANS, V24, P624, DOI 10.1046/j.1525-1594.2000.06576.x
   ALEKSOV A, 2003, P EL SOC, P2003
   ALEKSOV A, STATE OF THE ART PRO, V3, P146
   Allen M, 2001, J BIOMED MATER RES, V58, P319, DOI 10.1002/1097-4636(2001)58:3<319::AID-JBM1024>3.0.CO;2-F
   ALLEN M, 1995, BIO-MED MATER ENG, V5, P151
   Carlisle J. A., 2003, Electrochemical Society Interface, V12, P28
   DAVIDSON JL, 1997, P 5 INT S DIAM MAT, P635
   DAVIDSON JL, 1998, P EL SOC, P97
   De Scheerder I, 2000, J INVASIVE CARDIOL, V12, P389
   Du C, 1998, BIOMATERIALS, V19, P651, DOI 10.1016/S0142-9612(97)00159-2
   Ferrari AC, 2000, PHYS REV B, V61, P14095, DOI 10.1103/PhysRevB.61.14095
   Friedmann TA, 1997, APPL PHYS LETT, V71, P3820, DOI 10.1063/1.120515
   Grill A, 2003, DIAM RELAT MATER, V12, P166, DOI 10.1016/S0925-9635(03)00018-9
   Gruen DM, 1999, ANNU REV MATER SCI, V29, P211, DOI 10.1146/annurev.matsci.29.1.211
   Kohane DS, 2003, PHARM RES-DORDR, V20, P1533, DOI 10.1023/A:1026162628965
   Kohane DS, 2003, PAIN, V104, P415, DOI 10.1016/S0304-3959(03)00049-6
   Kohane DS, 2002, J BIOMED MATER RES, V59, P450, DOI 10.1002/jbm.1261
   Kornu R, 1996, J ORTHOPAED RES, V14, P871, DOI 10.1002/jor.1100140605
   KOSKINEN J, 1993, SURF COAT TECH, V62, P356, DOI 10.1016/0257-8972(93)90267-R
   LAVAN DA, 2000, MATER RES SOC S P, P295
   Linder S, 2002, BIOMATERIALS, V23, P767, DOI 10.1016/S0142-9612(01)00182-X
   PACCAGNELLA A, 1986, INT J ARTIF ORGANS, V9, P127
   Sullivan JP, 2001, MRS BULL, V26, P309, DOI 10.1557/mrs2001.68
   SULLIVAN JP, 2001, MAT RES SOC S P
   TABATA Y, 1990, ADV POLYM SCI, V94, P107
   THOMSON LA, 1991, BIOMATERIALS, V12, P37
   Veerasamy VS, 2003, THIN SOLID FILMS, V442, P1, DOI 10.1016/S0040-6090(03)00929-5
   Yang P, 2003, BIOMATERIALS, V24, P2821, DOI 10.1016/S0142-9612(03)00091-7
   Yang WS, 2002, NAT MATER, V1, P253, DOI 10.1038/nmat779
NR 29
TC 25
Z9 26
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2005
VL 26
IS 5
BP 465
EP 473
DI 10.1016/j.biomaterials.2004.02.071
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 857RJ
UT WOS:000224135700001
PM 15276354
DA 2018-10-19
ER

PT J
AU Khan, M
   Smith, N
   Jones, E
   Finch, DS
   Cameron, RE
AF Khan, M
   Smith, N
   Jones, E
   Finch, DS
   Cameron, RE
TI Analysis and evaluation of a biomedical polycarbonate urethane tested in
   an in vitro study and an ovine arthroplasty model. Part I: materials
   selection and evaluation
SO BIOMATERIALS
LA English
DT Article
DE hip replacement prosthesis; polyurethane elastomer; compliance;
   biocompatibihty; animal model
ID SEGMENTED POLYURETHANES; ARTIFICIAL-HEART; STRESS CRACKING;
   BIOSTABILITY; CALCIFICATION; POLYETHER; INVIVO; BIODEGRADATION;
   STABILITY; ELASTOMERS
AB The polyurethane elastomer (PU) Corethane 80A (Corvita) is being considered as the acetabular bearing material in a novel total replacement hip joint. The biostability of Corethane 80A was investigated in vitro (this work) and in vivo (reported separately) in a fully functioning ovine total hip arthroplasty (THA) model, with the PU as the bearing layer in a prototype compliant layer acetabular cup. The in vitro studies assessed the resistance of Corethane 80A to the main degradation mechanisms observed in PUs: hydrolysis, environmental stress cracking (ESC), metal ion oxidation (MIO) and calcification. The performance of the polycarbonate PU Corethane 80A was assessed alongside three other commercially available biomedical PUs: polyether PUs Pellethane 2363-80A (DOW Chemical) and PHMO-PU (CSIRO, not supplied as a commercial material) as well as polycarbonate PU ChronoFlex AL-80A (CardioTech). Chemical and structural variables that affect the properties of the materials were analysed with particular attention to the nature of the material's hard and soft segments. PU degradation was probed using a range of analytical tools and physical-testing methods, including mechanical testing, differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy (FTIR) and environmental scanning microscopy (ESEM). Corethane 80A displayed the best overall resistance to hydrolysis, ESC, MIO and calcification, followed by ChronoFlex 80A and PHMO-PU. Pellethane 80A was the least stable. This study provides compelling evidence for the biostability and effectiveness of Corethane 80A and points to its suitability for use as a compliant bearing layer in hip arthroplasty, and possibly also other joints. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Cambridge, Dept Mat Sci & Met, Cambridge CB2 3QZ, England.
   Stryker Howmedica Osteon, Staines, England.
   Stryker Europe, CASA Grp, Limerick, Ireland.
   Univ Colorado, Dept Mech Engn, Boulder, CO 80309 USA.
RP Cameron, RE (reprint author), Univ Cambridge, Dept Mat Sci & Met, New Museums Site,Pembroke St, Cambridge CB2 3QZ, England.
EM rec11@cam.ac.uk
OI Cameron, Ruth/0000-0003-1573-4923
CR Bernacca GM, 1997, J BIOMED MATER RES, V34, P371
   Boretos J W, 1971, J Biomed Mater Res, V5, P373, DOI 10.1002/jbm.820050408
   COLEMAN DL, 1981, T AM SOC ART INT ORG, V27, P708
   COURY AJ, 1987, LIFE SUPPORT SYST, V5, P25
   COURY AJ, 1984, ADV URETHANE SCI TEC, V9, P130
   COURY AJ, 1996, BIOMATERIALS SCI INT
   COVALOS GC, 1977, SPE NAT TECHN C DENV, P5558
   DREYER B, 1959, J APPL PHYSIOL, V14, P475
   Gunatillake PA, 2003, AUST J CHEM, V56, P545, DOI 10.1071/CH02168
   GUNATILLAKE PA, 1998, Patent No. 9800546
   HARASAKI H, 1979, T AM SOC ART INT ORG, V25, P305
   HERGENROTHER RW, 1993, BIOMATERIALS, V14, P449, DOI 10.1016/0142-9612(93)90148-U
   HOFFMAN D, 1993, CLIN MATER, V13, P95
   KHAN I, 2002, THESIS U CAMBRIDGE
   KHAN I, IN PRESS BIOAMTERIAL
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   KWEI TK, 1982, J APPL POLYM SCI, V27, P2891, DOI 10.1002/app.1982.070270815
   Lamba N. M. K., 1998, POLYURETHANES BIOMED
   LEMM W, 1984, POLYURETHANES BIOMED, P103
   MANDARINO MP, 1960, ARCH SURG-CHICAGO, V80, P623, DOI 10.1001/archsurg.1960.01290210091019
   MANDARINO MP, 1958, ORTHOP SURG, V9, P762
   Mathur AB, 1997, J BIOMED MATER RES, V36, P246, DOI 10.1002/(SICI)1097-4636(199708)36:2<246::AID-JBM14>3.3.CO;2-9
   McLean RS, 1997, MACROMOLECULES, V30, P8314, DOI 10.1021/ma970350e
   MIRKOVITCH V, 1962, T AM SOC ART INT ORG, V8, P79
   PANGMAN WJ, 1965, Patent No. 921
   PANGMAN WJ, 1958, Patent No. 775
   PARINS DJ, 1985, ASTM STP, V859, P322
   Phillips R E, 1988, J Biomater Appl, V3, P207, DOI 10.1177/088532828800300204
   PHILLIPS RE, 1987, POLYURETHANES BIOMED, V2, P91
   PINCHUK L, 1993, Patent No. 9431
   PINCHUK L, 1992, Patent No. 742
   PINCHUK L, 1996, T SOC BIOM 19 M BIRM, P22
   Rabek J. F, 1995, POLYM PHOTODEGRADATI
   RAPOPORT NY, 1985, DEV POLYM DEGRADATIO, V6, P207
   REVENKO I, 1999, SOC BIOM 25 ANN M T, P354
   SANTERRE JP, 1994, J BIOMED MATER RES, V28, P1187, DOI 10.1002/jbm.820281009
   SCHOEN FJ, 1988, J BIOMED MATER RES-A, V22, P11
   SINGH PI, 1985, MECH ETIOLOGY CALCIF, P104
   STOKES K, 1990, Journal of Biomaterials Science Polymer Edition, V1, P207
   Stokes K, 1987, J Biomater Appl, V1, P411
   STOKES K, 1995, J BIOMATER APPL, V9, P321, DOI 10.1177/088532829500900402
   STOKES K, 1982, BIOMATERIALS, V3, P225, DOI 10.1016/0142-9612(82)90024-2
   STOKES K, 1987, POLYURETHANES BIOMED, V2, P109
   STOKES K, 1984, POLYURETHANES BIOMED, P243
   Stokes KB, 1987, ADV BIOMEDICAL POLYM, P147
   SZYCHER M, 1991, BLOOD COMPATIBLE MAT, P3385
   Szycher Michael, 1994, P233
   TAKAHARA A, 1991, J BIOMED MATER RES, V25, P341, DOI 10.1002/jbm.820250306
   Tang YW, 2001, J BIOMED MATER RES, V56, P516, DOI 10.1002/1097-4636(20010915)56:4<516::AID-JBM1123>3.0.CO;2-B
   Tanzi MC, 1997, J BIOMED MATER RES, V36, P550, DOI 10.1002/(SICI)1097-4636(19970915)36:4<550::AID-JBM14>3.0.CO;2-E
   Tanzi MC, 2000, J BIOMATER APPL, V14, P325, DOI 10.1106/7TJU-H1YA-4NYT-XL84
   Thoma R J, 1987, J Biomater Appl, V1, P449
   THOMA RJ, 1986, T SOC BIOMATER, V9, P47
   Ward R. S., 2000, MED DEVICE DIAGN IND, V22, P68
   WARD RS, 1994, T 20 ANN M SOC BIOM
   WARD RS, 1996, Patent No. 5589563
   WILLIAMS DF, 1982, J MATER SCI, V17, P1233, DOI 10.1007/BF00752233
   WILLIAMS DF, 1984, POLYURETHANES BIOMED, P98
   WISMAN CB, 1982, T AM SOC ART INT ORG, V28, P164
   Yang MJ, 1999, J BIOMED MATER RES, V48, P648, DOI 10.1002/(SICI)1097-4636(1999)48:5<648::AID-JBM8>3.0.CO;2-6
   Zdrahala RJ, 1996, J BIOMATER APPL, V11, P37, DOI 10.1177/088532829601100102
   ZHAO Q, 1990, J BIOMED MATER RES, V24, P621, DOI 10.1002/jbm.820240508
   ZHAO QH, 1995, J BIOMED MATER RES, V29, P467, DOI 10.1002/jbm.820290406
   ZHAO QH, 1993, J BIOMED MATER RES, V27, P379, DOI 10.1002/jbm.820270311
NR 64
TC 100
Z9 107
U1 1
U2 31
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2005
VL 26
IS 6
BP 621
EP 631
DI 10.1016/j.biomaterials.2004.02.065
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 857RK
UT WOS:000224135800005
PM 15282140
DA 2018-10-19
ER

PT J
AU Khan, M
   Smith, N
   Jones, E
   Finch, DS
   Cameron, RE
AF Khan, M
   Smith, N
   Jones, E
   Finch, DS
   Cameron, RE
TI Analysis and evaluation of a biomedical polycarbonate urethane tested in
   an in vitro study and an ovine arthroplasty model. Part II: in vivo
   investigation
SO BIOMATERIALS
LA English
DT Article
DE hip replacement prostheses; polyurethane; elstomer; compliance;
   biocompatibility; animal model
ID MOLECULAR-WEIGHT POLYETHYLENE; TOTAL HIP-REPLACEMENT; ENZYME-INDUCED
   BIODEGRADATION; JOINT FORCES; WEAR DEBRIS; POLYURETHANES; DEGRADATION;
   MORPHOLOGY; SHEEP; CHOLESTEROL
AB The polyurethane (PU) elastomer Corethane 80A (Corvita) is being considered as the acetabular bearing material in a novel total replacement hip joint. Its biostability was investigated in vitro (Analysis and evaluation of a biomedical polycarbonate urethane tested in an in vitro study and an ovine arthroplasty model. Part 1: material selection and evaluation, Biomaterials, in press) together with three other commercially available biomedical PUs: Pellethane 2363-80A (DOW Chemical), a polyhexamethylene oxide based PU, PHMO-PU (CSIRO, not supplied as a commercial product) and ChronoFlex AL-80A (CardioTech). From the in vitro studies, Corethane 80A displayed the best overall resistance to hydrolysis, ESC, MIO and calcification, followed by ChronoFlex 80A and PHMO-PU, with Pellethane 80A being the least stable. Building on the in vitro investigation, the follow-up ill vivo study (reported here) assessed Corethane 80A as the bearing layer in a prototype compliant layer acetabular cup, in a fully functioning ovine total hip arthoplasty (THA) model. PU degradation in the retrieved cups was analysed using a range of analytical and physical-testing methods including mechanical testing, differential scanning calorimetry, Fourier transform infrared spectroscopy and environmental scanning electron microscopy. The Corethane 80A functioned well in the THA model, with the bearing surfaces of the retrieved hip cups showing no significant evidence of biodegradation or wear damage after 3 years in vivo. The findings in this study provide compelling evidence for the biostability and effectiveness of acetabular cups incorporating a Corethane 80A compliant bearing layer. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Cambridge, Dept Mat Sci & Met, Cambridge CB2 3QZ, England.
   Stryker Howmedica Osteon, Staines, England.
   Stryker Europe, CASA Grp, Limerick, Ireland.
   Univ Colorado, Dept Mech Engn, Boulder, CO 80309 USA.
RP Cameron, RE (reprint author), Univ Cambridge, Dept Mat Sci & Met, New Museums Site,Pembroke St, Cambridge CB2 3QZ, England.
EM recll@cam.ac.uk
OI Cameron, Ruth/0000-0003-1573-4923
CR ALEXANDER JW, 1999, T 45 ANN M ORTH RES, P906
   Bergmann G, 1999, J BIOMECH, V32, P769, DOI 10.1016/S0021-9290(99)00068-8
   BERGMANN G, 1984, J BIOMECH, V17, P907, DOI 10.1016/0021-9290(84)90004-6
   Brumby SA, 1998, CLIN ORTHOP RELAT R, P229
   Bruns DP, 1996, VET COMP ORTHOPAED, V9, P158
   CARAVIA L, 1993, WEAR, V160, P191, DOI 10.1016/0043-1648(93)90420-Q
   CARBONE A, VET J BIOMATER DRAFT
   Cooper R A, 1992, J Arthroplasty, V7, P285, DOI 10.1016/0883-5403(92)90050-Z
   Dillon J., 1989, INFRARED SPECTROSCOP
   DOWSON D, 1986, FLUID FILM LUBRICATI
   DOWSON D, 1991, P I MECH ENG H, V205, P52
   DOWSON D, 1983, P 9 CAN C APPL MECH, P15
   Eisenbach C., 1986, ADV ELASTOMERS RUBBE
   Field JR, 2001, VET COMP ORTHOPAED, V14, P32
   HU WC, 1994, J POLYM SCI POL PHYS, V32, P437, DOI 10.1002/polb.1994.090320304
   James SP, 1999, J BIOMED MATER RES, V48, P374, DOI 10.1002/(SICI)1097-4636(1999)48:3<374::AID-JBM23>3.0.CO;2-O
   KELLOP HA, 1999, T 45 ANN M ORTH RES, P76
   KHAN I, IN PRESS BIOMATERIAL
   Kurtz SM, 1999, BIOMATERIALS, V20, P1659, DOI 10.1016/S0142-9612(99)00053-8
   LABOW RS, 1994, J BIOMAT SCI-POLYM E, V6, P169, DOI 10.1163/156856294X00293
   LABOW RS, 1999, BIOMATERIALS, V32, P769
   LAURENT MP, 2000, T 26 ANN M SOC BIOM, P851
   LAURENT MP, 2000, T 25 ANN M SOC BIOM, P874
   LI S, 1994, J BONE JOINT SURG AM, V76A, P1080, DOI 10.2106/00004623-199407000-00020
   Mai MT, 1996, J BONE JOINT SURG AM, V78A, P505, DOI 10.2106/00004623-199604000-00004
   MALCHAU H, 1998, REVISION REREVISION
   MANLEY MT, 1994, CLIN ORTHOP RELAT R, P137
   Martin DJ, 1997, J APPL POLYM SCI, V64, P803, DOI 10.1002/(SICI)1097-4628(19970425)64:4<803::AID-APP20>3.0.CO;2-T
   McKellop H, 1999, CLIN ORTHOP RELAT R, P73
   McKellop H, 1999, J ORTHOP RES, V17, P157, DOI 10.1002/jor.1100170203
   MOODY J, 1999, T 45 ANN M ORTH RES, P278
   Muratoglu OK, 2001, J ORTHOPAED RES, V19, P1210, DOI 10.1016/S0736-0266(01)00059-6
   MURATOGLU OK, 1999, T 4 ANN M ORTH RES S, P77
   Naidu SH, 1997, ORTHOPEDICS, V20, P137
   OKUMURA Y, 1999, T 45 ANN M ORTH RES, P928
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   SANTERRE JP, 1994, J BIOMED MATER RES, V28, P1187, DOI 10.1002/jbm.820281009
   SANTERRE JP, 1993, J BIOMED MATER RES, V27, P97, DOI 10.1002/jbm.820270113
   Santerre JP, 1997, J BIOMED MATER RES, V36, P223
   SHANBHAG AS, 1994, J BONE JOINT SURG BR, V76B, P60
   Shaw JH, 1997, EFFECT GAMMA IRRADIA
   SHINDE A, 1985, J POLYM SCI POL PHYS, V23, P1681, DOI 10.1002/pol.1985.180230819
   SMITH R, 1987, J BIOMED MATER RES, V21, P991, DOI 10.1002/jbm.820210805
   SMITN N, 1996, Patent No. 698382
   Tang YW, 2002, J BIOMAT SCI-POLYM E, V13, P463, DOI 10.1163/156856202320253965
   Tang YW, 2001, J BIOMED MATER RES, V57, P597, DOI 10.1002/1097-4636(20011215)57:4<597::AID-JBM1207>3.0.CO;2-T
   Tang YW, 2001, J BIOMED MATER RES, V56, P516, DOI 10.1002/1097-4636(20010915)56:4<516::AID-JBM1123>3.0.CO;2-B
   THANNER J, 1999, ACTA ORTHOP SCAND S, V286, P141
   Unsworth A, 1995, TRIBOL INT, V28, P485, DOI 10.1016/0301-679X(95)00027-2
   VERONROBERTS B, 1997, I ETHICS COMMITTEE G
   WU Y, 1992, J APPL POLYM SCI, V46, P201, DOI 10.1002/app.1992.070460202
NR 51
TC 62
Z9 63
U1 3
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2005
VL 26
IS 6
BP 633
EP 643
DI 10.1016/j.biomaterials.2004.02.064
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 857RK
UT WOS:000224135800006
DA 2018-10-19
ER

PT J
AU Fenderson, BA
AF Fenderson, BA
TI Strategies for teaching pathology to graduate students and allied health
   professionals
SO HUMAN PATHOLOGY
LA English
DT Article
DE pathology education; graduate students; allied health professionals
ID BASIC SCIENCE
AB Pathology is an essential course for many students in the biomedical sciences and allied health professions. These students learn the language of pathology and medicine, develop an appreciation for mechanisms of disease, and understand the close relationship between basic research and clinical medicine. We have developed 3 pathology courses to meet the needs of our undergraduates, graduate students, and allied health professionals. Through experience, we have settled on an approach to teaching pathology that takes into account the diverse educational backgrounds of these students. Educational resources such as assigned reading, online homework, lectures, and review sessions are carefully balanced to adjust course difficulty. Common features of our pathology curricula include a web-based computer laboratory and review sessions on the basis of selected pathology images and open-ended study questions. Lectures, computer-guided homework, and review sessions provide the core educational content for undergraduates. Graduate students, using the same computer program and review material, rely more heavily on assigned reading for core educational content. Our experience adapting a pathology curriculum to the needs of divergent groups of students suggests a general strategy for monitoring course difficulty. We hypothesize that course difficulty is proportional to the information density of specific learning resources (eg, lecture or textbook) multiplied by the weight of those learning resources placed on examinations. This formula allows educators to match the difficulty of a course with the educational needs of students, and provides a useful tool for longitudinal studies of curriculum reform. (c) 2005 Elsevier Inc. All rights reserved.
C1 Thomas Jefferson Univ, Jefferson Med Coll, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA.
RP Fenderson, BA (reprint author), Thomas Jefferson Univ, Jefferson Med Coll, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA.
EM bruce.fenderson@jefferson.edu
CR ARIAS IM, 1989, NEW ENGL J MED, V321, P972, DOI 10.1056/NEJM198910053211412
   Damjanov I, 2000, PATHOLOGY HLTH RELAT
   E Rubin, 2001, ESSENTIAL PATHOLOGY
   FENDERSON BA, 1999, PATHOL ED, V24, P17
   FENDERSON BA, 2001, PATHOL ED, V25, P25
   FENDERSON BA, 1999, PATHOL ED, V23, P21
   GRAY ML, 2003, NAT MED, V8, P433
   Kemp JD, 2004, HUM PATHOL, V35, P785, DOI 10.1016/j.humpath.2004.03.014
   Mallon WT, 2003, ACAD MED, V78, P302, DOI 10.1097/00001888-200303000-00014
NR 9
TC 9
Z9 9
U1 0
U2 4
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399 USA
SN 0046-8177
J9 HUM PATHOL
JI Hum. Pathol.
PD FEB
PY 2005
VL 36
IS 2
BP 146
EP 153
DI 10.1016/j.humpath.2004.09.022
PG 8
WC Pathology
SC Pathology
GA 905UL
UT WOS:000227595800003
PM 15754291
DA 2018-10-19
ER

PT J
AU Robertson, SW
   Imbeni, V
   Wenk, HR
   Ritchie, RO
AF Robertson, SW
   Imbeni, V
   Wenk, HR
   Ritchie, RO
TI Crystallographic texture for tube and plate of the
   superelastic/shape-memory alloy nitinol used for endovascular stents
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE nitinol; texture; stents
ID POLYCRYSTALLINE NITI; STRAIN; TENSION
AB The superelastic/shape-memory material, Nitinol, an approximately equiatomic alloy of Ni and Ti, is rapidly becoming one of the most important metallic implant materials in the biomedical industry, in particular for the manufacture of endovascular stents. As such stents are invariably laser-machined from Nitinol tubes or sheets rolled into tubes, it is important to fully understand the physical phenomena that may affect the mechanical behavior of this material. With tubing and plate, one major issue is crystallographic texture, which can play a key role in influencing the mechanical properties of Nitinol. In this article, we present a study on how geometry and heat treatment can affect the texture of Nitinol, with specific quantification of the texture of Nitinol tube used for the production of endovascular stents. (C) 2004 Wiley Periodicals, Inc.
C1 Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA.
   SRI Int, Menlo Pk, CA 94025 USA.
   Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA.
RP Ritchie, RO (reprint author), Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA.
EM roritchie@lbl.gov
RI Ritchie, Robert/A-8066-2008
OI Ritchie, Robert/0000-0002-0501-6998
CR Duerig T, 1999, MAT SCI ENG A-STRUCT, V273, P149, DOI 10.1016/S0921-5093(99)00294-4
   Gall K, 1999, INT J PLASTICITY, V15, P69, DOI 10.1016/S0749-6419(98)00060-6
   Gao S, 2003, MAT SCI ENG A-STRUCT, V362, P107, DOI 10.1016/S0921-5093(03)00585-9
   Hornbogen E, 2002, Z METALLKD, V93, P3, DOI 10.3139/146.020003
   Inoue H, 1996, ACTA MATER, V44, P4825, DOI 10.1016/S1359-6454(96)00120-6
   KITAMURA K, 1997, P INT C SHAP MEM SUP, P47
   Kocks U. F., 1998, TEXTURE ANISOTROPY, P195
   LI DY, 1990, ACTA METALL MATER, V38, P19, DOI 10.1016/0956-7151(90)90130-9
   MATTHIES S, 1982, PHYS STATUS SOLIDI B, V112, pK111, DOI 10.1002/pssb.2221120254
   McNaney JM, 2003, MECH MATER, V35, P969, DOI 10.1016/S0167-6636(02)00310-1
   MIYAZAKI S, 1989, ACTA METALL, V37, P1837
   MONASEVICH LA, 1979, MET SCI HEAT TREAT+, V21, P735, DOI 10.1007/BF00708647
   MULDER JH, 1993, Z METALLKD, V84, P501
   PELTON AR, 2000, MIN INVAS THER APPL, V200, P107
   Shu YC, 1998, ACTA MATER, V46, P5457, DOI 10.1016/S1359-6454(98)00184-0
   Sitepu H, 2002, APPL PHYS A-MATER, V74, pS1676, DOI 10.1007/s003390201934
   Vaidyanathan R, 2001, METALL MATER TRANS A, V32, P777
   WENK HR, 1987, METALL TRANS A, V18, P1083, DOI 10.1007/BF02668557
   Wenk HR, 1998, J APPL CRYSTALLOGR, V31, P262, DOI 10.1107/S002188989700811X
   Yuan WQ, 1999, MAT SCI ENG A-STRUCT, V271, P439, DOI 10.1016/S0921-5093(99)00311-1
NR 20
TC 29
Z9 30
U1 0
U2 12
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB 1
PY 2005
VL 72A
IS 2
BP 190
EP 199
DI 10.1002/jbm.a.30214
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 887TF
UT WOS:000226327700008
PM 15625682
DA 2018-10-19
ER

PT J
AU Weldon, LM
   McHugh, PE
   Carroll, W
   Costello, E
   O'Bradaigh, C
AF Weldon, LM
   McHugh, PE
   Carroll, W
   Costello, E
   O'Bradaigh, C
TI The influence of passivation and electropolishing on the performance of
   medical grade stainless steels in static and fatigue loading
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CORROSION-FATIGUE; MECHANICAL-PROPERTIES; SURFACE-ROUGHNESS; IMPLANT
   MATERIALS; BIOMATERIALS; TECHNOLOGY; BEHAVIOR; METALS; COPPER; BODY
AB The effects of surface passivation and electropolishing on the mechanical performance of a group of biomedical grade stainless steels have been investigated. Surface roughness measurements showed that the treatments had a significant effect on the final surface finish. However, static mechanical testing demonstrated no difference in static mechanical properties, regardless of surface treatment. High cycle fatigue testing was carried out at a frequency of 120 Hz with a load ratio of R = 0.1, in both air and a simulated in vivo wet corrosive environment. 316LVM (cold worked) proved superior to 316L (annealed) in fatigue performance, in both dry and wet environments. The fatigue performance of both materials did depend on the surface treatment, with electropolishing resulting in better performance than passivation. The fatigue performance of both materials was significantly better in the dry environment in comparison to the wet environment. The dry-to-wet deterioration in fatigue performance was. somewhat dependent on the surface treatment for the 316L material but almost independent of surface treatment for the 316LVM material. Significant surface pitting and damage was evident for 316L during fatigue in the wet environment, whereas almost no pitting and damage was observed for 316LVM. (C) 2005 Springer Science + Business Media, Inc.
C1 Natl Univ Ireland Univ Coll Galway, Dept Mech & Biomed Engn, Galway, Ireland.
   Natl Univ Ireland Univ Coll Galway, Dept Chem, Galway, Ireland.
   Natl Univ Ireland Univ Coll Galway, Natl Ctr Biomed Engn Sci, Galway, Ireland.
RP McHugh, PE (reprint author), Natl Univ Ireland Univ Coll Galway, Dept Mech & Biomed Engn, Galway, Ireland.
EM peter.mchugh@nuigalway.ie
RI O Bradaigh, Conchur/G-5347-2013
OI O Bradaigh, Conchur/0000-0002-8048-4222
CR ASKELAND D, 1985, SCI ENG MAT, P507
   BASINSKI SJ, 1969, PHILOS MAG, V19, P899, DOI 10.1080/14786436908225856
   Bertrand OF, 1998, J AM COLL CARDIOL, V32, P562, DOI 10.1016/S0735-1097(98)00289-7
   Collins J. A, 1993, FAILURE MAT MECH DES, P374
   COSTELLO E, 2003, THESIS NUI GALWAY IR
   FIELD M, 1971, STC S, V20, P107
   FORREST FG, 1962, FATIGUE METALS
   FROST NE, 1974, METAL FATIGUE, P121
   Gough HJ, 1932, J I MET, V49, P17
   HAYASHI K, 1987, JSME INT J, V30, P1517, DOI 10.1299/jsme1987.30.1517
   HAYASHI K, 1994, J SOC MAT SCI JPN, V43, P1502
   HIGO Y, 1994, AM SOC TEST MATER, V1173, P148, DOI 10.1520/STP18101S
   HIGO Y, 1993, CORROS SCI, V35, P587
   HULTQUIST G, 1980, CORROSION-US, V36, P126, DOI 10.5006/0010-9312-36.3.126
   KAKAJIMA M, 1998, FAT FRACT ENG MAT ST, V21, P35
   KHANI MK, 1996, METAL T A, V27, P133
   Landgraf RW, 1988, ASTM STP, P1
   LANDGRAF RW, 1975, ASTM STP, V569, P130
   LUKAS P, 1996, ASM HDB, V19, P97
   MAIYA PS, 1975, METALL TRANS A, V6, P1761, DOI 10.1007/BF02642305
   MANSON SS, 1971, ASTM STP, V495, P254
   Marsland LC, 2000, ELECTROCHEM COMMUN, V2, P591, DOI 10.1016/S1388-2481(00)00084-9
   *MAT INF SOC ASM I, 1985, MET HDB, P1214
   MAYER H, 1994, INT MATER REV, V44, P1
   MCADAM DJ, 1941, P ASTM, V41, P696
   MEULLER MP, 1982, MET TECHNOL, V9, P587
   MORITA M, 1992, ANN BIOMED ENG, V20, P505, DOI 10.1007/BF02368170
   MORITA M, 1988, J BIOMED MATER RES, V22, P529, DOI 10.1002/jbm.820220608
   Murphy BP, 2003, ANN BIOMED ENG, V31, P686, DOI 10.1114/1.1569268
   Murtaza G, 2000, ENG FRACT MECH, V67, P461, DOI 10.1016/S0013-7944(00)00057-6
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Palmaz JC, 1997, TEX HEART I J, V24, P156
   Papakyriacou M, 2000, INT J FATIGUE, V22, P873, DOI 10.1016/S0142-1123(00)00057-8
   QIAN YR, 1977, CORROS SCI, V53, P129
   RYU JH, 1989, INT J FATIGUE, V11, P433, DOI 10.1016/0142-1123(89)90183-7
   SALVAGO G, 1994, CORROS SCI, V36, P733, DOI 10.1016/0010-938X(94)90077-9
   SCHULZE V, 1996, P ICSP, V6, P403
   Shih CC, 2000, J BIOMED MATER RES, V52, P323
   Suresh S., 1988, FATIGUE MAT
   SZKLARSKASMIALO.Z, 1986, PITTING CORROSION ME
   TAIRA M, 1992, J BIOMED MATER RES, V26, P1131, DOI 10.1002/jbm.820260903
   Teoh SH, 2000, INT J FATIGUE, V22, P825, DOI 10.1016/S0142-1123(00)00052-9
   THOMPSON N, 1956, PHILOS MAG, V1, P113, DOI 10.1080/14786435608238086
   Wareing J., 1979, Metal Science, V13, P1
   WELDON LM, 2001, THESIS NUI GALWAY IR
   Wescott B.B., 1938, Mechanical Engineering, V60, P813
   WILSON AD, 1996, ASM HDB, V19, P591
   WOOD DS, 1980, FATIGUE ENG MATER, V3, P39, DOI 10.1111/j.1460-2695.1980.tb01103.x
NR 48
TC 15
Z9 15
U1 1
U2 12
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2005
VL 16
IS 2
BP 107
EP 117
DI 10.1007/s10856-005-5922-x
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 901KW
UT WOS:000227282400003
PM 15744598
DA 2018-10-19
ER

PT J
AU Sivakumar, K
   Panchapakesan, B
AF Sivakumar, K
   Panchapakesan, B
TI Electric field-assisted deposition of nanowires on carbon nanotubes for
   nanoelectronics and sensor applications
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Article
DE carbon nanotubes; single-walled carbon nanotubes; nanowires;
   electrostatic double layer; supercapacitor; nanoelectrochemical cell;
   electrophoresis
ID QUANTUM CONFINEMENT; SILVER NANOWIRES; ROOM-TEMPERATURE; SILICON;
   NANOMATERIALS; CONDUCTIVITY; WIRES
AB Manipulation and control of matter at the nanoscale and atomic scale levels are crucial for the success of nanoscale sensors and actuators. The ability to control and synthesize multilayer structures using carbon nanotubes that will enable the building of electronic devices within a nanotube is still in its infancy. In this paper, we present results on selective electric field-assisted deposition of metals on carbon nanotubes realizing metallic nanowire structures. Silver and platinum nanowires have been fabricated using this approach for their applications in chemical sensing as catalytic materials to sniff toxic agents and in the area of biomedical nanotechnology for construction of artificial muscles. Electric field-assisted deposition allows the deposition of metals with a high degree of selectivity on carbon nanotubes by manipulating the charges on the surface of the nanotubes and forming electrostatic double-layer supercapacitors. Deposition of metals primarily occurred due to electrochemical reduction, electrophoresis, and electro-osmosis inside the walls of the nanotube. SEM and TEM investigations revealed silver and platinum nanowires between 10 nm and 100 nm in diameter. The present technique is versatile and enables the fabrication of a host of different types of metallic and semiconducting nanowires using carbon nanotube templates for nanoelectronics and a myriad of sensor applications.
C1 Univ Delaware, Dept Elect & Comp Engn, Newark, DE 19716 USA.
RP Panchapakesan, B (reprint author), Univ Delaware, Dept Elect & Comp Engn, Newark, DE 19716 USA.
CR Avouris P, 2002, CHEM PHYS, V281, P429, DOI 10.1016/S0301-0104(02)00376-2
   Barbic M, 2002, J APPL PHYS, V91, P9341, DOI 10.1063/1.1476071
   Cheng YH, 2004, NANOTECHNOLOGY, V15, P171, DOI 10.1088/0957-4484/15/1/033
   Constantin C, 2000, J APPL PHYS, V88, P141, DOI 10.1063/1.373634
   Cui Y, 2003, NANO LETT, V3, P149, DOI 10.1021/nl025875l
   Dai HJ, 1996, SCIENCE, V272, P523, DOI 10.1126/science.272.5261.523
   DRESSELHAUS G, 1998, NANOTECHNOLOGY CARBO
   DRESSELHAUS MS, 1998, NANOTECHNOLOGY
   Ebbesen TW, 1996, NATURE, V382, P54, DOI 10.1038/382054a0
   Emmenegger C, 2000, APPL SURF SCI, V162, P452, DOI 10.1016/S0169-4332(00)00232-4
   Feng SQ, 2000, J CRYST GROWTH, V209, P513, DOI 10.1016/S0022-0248(99)00608-9
   Fujiwara A, 2002, APPL PHYS LETT, V80, P4567, DOI 10.1063/1.1487451
   Huang MH, 2001, SCIENCE, V292, P1897, DOI 10.1126/science.1060367
   Huber TE, 2004, APPL PHYS LETT, V84, P1326, DOI 10.1063/1.1650038
   Hulteen JC, 1997, J MATER CHEM, V7, P1075, DOI 10.1039/a700027h
   Ijima S., 1991, NATURE, V354, P56
   Johnson JC, 2002, NAT MATER, V1, P106, DOI 10.1038/nmat728
   Karpus V, 1997, SEMICOND SCI TECH, V12, P781, DOI 10.1088/0268-1242/12/7/005
   Klemic JF, 2001, NAT BIOTECHNOL, V19, P924, DOI 10.1038/nbt1001-924
   Krapf D, 2003, PHYS STATUS SOLIDI A, V197, P566, DOI 10.1002/pssa.200306564
   Li C, 2003, APPL PHYS LETT, V82, P1613, DOI 10.1063/1.1559438
   Liu CY, 1999, ELECTROCHEM SOLID ST, V2, P577, DOI 10.1149/1.1390910
   MADOU MJ, 2001, FUNDAMENTALS MICROFA
   MEYAYAPPAN M, 2003, HDB NANOSCIENCE TECH
   Mulligan RF, 2003, J APPL POLYM SCI, V89, P1058, DOI 10.1002/app.12250
   Shtyrkov EI, 2003, RADIAT EFF DEFECT S, V158, P125, DOI 10.1080/1042015021000052412
   Thostenson ET, 2001, COMPOS SCI TECHNOL, V61, P1899, DOI 10.1016/S0266-3538(01)00094-X
   XIA Y, 2003, ADV MATER, P15
   Zhang DB, 2001, CHEM MATER, V13, P2753, DOI 10.1021/cm0105007
NR 29
TC 4
Z9 4
U1 2
U2 27
PU AMER SCIENTIFIC PUBLISHERS
PI STEVENSON RANCH
PA 25650 NORTH LEWIS WAY, STEVENSON RANCH, CA 91381-1439 USA
SN 1533-4880
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD FEB
PY 2005
VL 5
IS 2
BP 313
EP 318
DI 10.1166/jnn.2005.050
PG 6
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 908KO
UT WOS:000227786100022
PM 15853154
DA 2018-10-19
ER

PT J
AU Bova, GS
   Eltoum, IA
   Kiernan, JA
   Siegal, GP
   Frost, AR
   Best, CJM
   Gillespie, JW
   Su, GH
   Emmert-Buck, MR
AF Bova, GS
   Eltoum, IA
   Kiernan, JA
   Siegal, GP
   Frost, AR
   Best, CJM
   Gillespie, JW
   Su, GH
   Emmert-Buck, MR
TI Optimal molecular profiling of tissue and tissue components - Defining
   the best processing and microdissection methods for biomedical
   applications
SO MOLECULAR BIOTECHNOLOGY
LA English
DT Article
DE tissue processing; tissue fixation; tissue staining; molecular
   profiling; microdissection; laser capture microdissection; proteomics;
   DNA analysis; RNA analysis; cytology; phenotype-genotype correlation
ID LASER-CAPTURE MICRODISSECTION; GENE-EXPRESSION; PROTEOMIC ANALYSIS;
   ARCHIVAL TISSUE; ASSISTED MICRODISSECTION; ARRAY HYBRIDIZATION; GENOMIC
   DNA; SECTIONS; RNA; CELLS
AB Isolation of well-preserved pure cell populations is a prerequisite for sound studies of the molecular basis of any tissue-based biological phenomenon. This article reviews current methods for obtaining anatomically specific signals from molecules isolated from tissues, a basic requirement for productive linking of phenotype and genotype. The quality of samples isolated from tissue and used for molecular analysis is often glossed over or omitted from publications, making interpretation and replication of data difficult or impossible. Fortunately, recently developed techniques allow life scientists to better document and control the quality of samples used for a given assay, creating a foundation for improvement in this area. Tissue processing for molecular studies usually involves some or all of the following steps: tissue collection, gross dissection/identification, fixation, processing/embedding, storage/archiving, sectioning, staining, microdissection/annotation, and pure analyte labeling/identification and quantification. We provide a detailed comparison of some current tissue microdissection technologies, and provide detailed example protocols for tissue component handling upstream and downstream from microdissection. We also discuss some of the physical and chemical issues related to optimal tissue processing, and include methods specific to cytology specimens. We encourage each laboratory to use these as a starting point for optimization of their overall process of moving from collected tissue to high quality, appropriately anatomically tagged scientific results. In optimized protocols is a source of inefficiency in current life science research. Improvement in this area will significantly increase life science quality and productivity. The article is divided into introduction, materials, protocols, and notes sections. Because many protocols are covered in each of these sections, information relating to a single protocol is not contiguous. To get the greatest benefit from this article, readers are advised to read through the entire article first, identify protocols appropriate to their laboratory for each step in their workflow, and then reread entries in each section pertaining to each of these single protocols.
C1 Johns Hopkins Univ Hosp, PELICAN Lab, Dept Pathol, Baltimore, MD 21287 USA.
   Johns Hopkins Univ Hosp, PELICAN Lab, Dept Oncol, Baltimore, MD 21287 USA.
   Johns Hopkins Univ Hosp, PELICAN Lab, Inst Med Genet, Baltimore, MD 21287 USA.
   Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA.
   Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA.
   Univ Alabama, Dept Surg, Birmingham, AL 35294 USA.
   Univ Alabama, UAB Comprehens Canc Ctr, Birmingham, AL 35294 USA.
   Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada.
   NCI, Pathogenet Unit, NIH, Bethesda, MD 20892 USA.
   NCI, Sci Applicat Int Corp, Bethesda, MD 20892 USA.
   Columbia Univ, Coll Phys & Surg, Dept Otolaryngol, New York, NY USA.
   Columbia Univ, Coll Phys & Surg, Dept Pathol, New York, NY USA.
RP Bova, GS (reprint author), Johns Hopkins Univ Hosp, PELICAN Lab, Dept Pathol, Carnegie 628, Baltimore, MD 21287 USA.
EM gbov@jhmi.edu
OI Kiernan, John/0000-0002-3324-1092
CR Ahram M, 2003, PROTEOMICS, V3, P413, DOI 10.1002/pmic.200390056
   Bancroft JD, 2002, THEORY PRACTICE HIST
   Beltinger C. P., 1998, Molecular Pathology, V51, P233
   Best C J, 2001, Expert Rev Mol Diagn, V1, P53, DOI 10.1586/14737159.1.1.53
   Brockhoff G, 1999, CYTOMETRY, V38, P184, DOI 10.1002/(SICI)1097-0320(19990815)38:4<184::AID-CYTO5>3.0.CO;2-W
   Burgemeister R, 2003, PATHOL RES PRACT, V199, P431, DOI 10.1078/0344-0338-00442
   Carson FL, 2003, HISTOTECHNOLOGY SELF
   Cohen CD, 2002, KIDNEY INT, V61, P125, DOI 10.1046/j.1523-1755.2002.00112.x
   Craven RA, 2002, METHOD ENZYMOL, V356, P33
   Curran S, 2000, J CLIN PATHOL-MOL PA, V53, P64
   Eltoum IA, 2002, ADV ANAT PATHOL, V9, P316, DOI 10.1097/00125480-200209000-00006
   Emmert-Buck MR, 2000, MOL CARCINOGEN, V27, P158, DOI 10.1002/(SICI)1098-2744(200003)27:3<158::AID-MC2>3.0.CO;2-2
   EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998
   Englert CR, 2000, CANCER RES, V60, P1526
   Fend F, 1999, AM J PATHOL, V154, P61, DOI 10.1016/S0002-9440(10)65251-0
   Fink L, 2002, AM J PATHOL, V160, P81, DOI 10.1016/S0002-9440(10)64352-0
   GASSMANN M, 2003, QUALITY ASSURANCE RN
   Gillespie JW, 2002, AM J PATHOL, V160, P449, DOI 10.1016/S0002-9440(10)64864-X
   Gillespie JW, 2001, CANCER J, V7, P32
   GOELZ SE, 1985, BIOCHEM BIOPH RES CO, V130, P118, DOI 10.1016/0006-291X(85)90390-0
   Goldsworthy SM, 1999, MOL CARCINOGEN, V25, P86, DOI 10.1002/(SICI)1098-2744(199906)25:2<86::AID-MC2>3.3.CO;2-W
   Guerrero RB, 1997, DIAGN MOL PATHOL, V6, P277, DOI 10.1097/00019606-199710000-00005
   Gupta SK, 1997, J CLIN PATHOL-MOL PA, V50, P218
   Harsch M, 2001, AM J PATHOL, V158, P1985, DOI 10.1016/S0002-9440(10)64669-X
   Horobin RW, 2002, CONNS BIOL STAINS HD
   Ikeda K, 1998, J HISTOCHEM CYTOCHEM, V46, P397, DOI 10.1177/002215549804600314
   Inoue K, 2003, VIRCHOWS ARCH, V442, P159, DOI 10.1007/s00428-002-0719-5
   KIERNAN JA, 2002, MICROSCOPY HISTOLOGY
   Kiernan JA, 2001, HISTOLOGICAL HISTOCH
   Kleeberger W, 2000, PATHOBIOLOGY, V68, P196, DOI 10.1159/000055923
   Lawrie L. C., 2001, Molecular Pathology, V54, P253, DOI 10.1136/mp.54.4.253
   Lee JY, 1998, VIRCHOWS ARCH, V433, P305, DOI 10.1007/s004280050253
   Luzzi V, 2003, J MOL DIAGN, V5, P9, DOI 10.1016/S1525-1578(10)60445-X
   Maitra A, 1999, NAT MED, V5, P459
   Mori M, 2002, SURGERY, V131, pS39, DOI 10.1067/msy.2002.119292
   Moskaluk CA, 1997, AM J PATHOL, V150, P1547
   Nakazono M, 2003, PLANT CELL, V15, P583, DOI 10.1105/tpc.008102
   Novelli M, 2000, CLIN EXP DERMATOL, V25, P423, DOI 10.1046/j.1365-2230.2000.00680.x
   Ohyama H, 2000, BIOTECHNIQUES, V29, P530, DOI 10.2144/00293st05
   Ornstein DK, 2000, ELECTROPHORESIS, V21, P2235, DOI 10.1002/1522-2683(20000601)21:11<2235::AID-ELPS2235>3.3.CO;2-1
   Pertoft H, 2000, J BIOCHEM BIOPH METH, V44, P1, DOI 10.1016/S0165-022X(00)00066-X
   Simone NL, 2000, AM J PATHOL, V156, P445, DOI 10.1016/S0002-9440(10)64749-9
   Srinivasan M, 2002, AM J PATHOL, V161, P1961, DOI 10.1016/S0002-9440(10)64472-0
   Tai YT, 2000, J IMMUNOL METHODS, V235, P11, DOI 10.1016/S0022-1759(99)00199-4
   Zhang ZQ, 1997, ANAL QUANT CYTOL, V19, P514
   ZHUANG ZP, 1995, AM J PATHOL, V146, P620
NR 46
TC 13
Z9 14
U1 0
U2 6
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 1073-6085
J9 MOL BIOTECHNOL
JI Mol. Biotechnol.
PD FEB
PY 2005
VL 29
IS 2
BP 119
EP 152
DI 10.1385/MB:29:2:119
PG 34
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 905UK
UT WOS:000227595700004
PM 15699569
DA 2018-10-19
ER

PT J
AU Vavere, AL
   Laforest, R
   Welch, MJ
AF Vavere, AL
   Laforest, R
   Welch, MJ
TI Production, processing and small animal PET imaging of titanium-45
SO NUCLEAR MEDICINE AND BIOLOGY
LA English
DT Article
DE titanium-45; microPET; ion chromatography
ID TITANOCENE DICHLORIDE; RADIOPHARMACEUTICALS; CYCLOTRON; ISOTOPES; CANCER
AB Introduction: Titanium-45 was prepared as a tool for elucidation of the mechanism of action of titanium anticancer drugs in vivo using microPET imaging.
   Methods: Titanium-45 was produced by the Sc-45(p,n)Ti-45 nuclear reaction using 14.5 MeV protons. Sufficient yields of 45Ti were produced and separated from the target material with 99.8% radionuclidic purity using a simple, efficient separation procedure.
   Results: A typical bombardment of 5 mu A for 1 h produced an average of 2105 +/- 150 MBq (56.9 +/- 4.0 mCi) at the end of bombardment (EOB), well within acceptable range of the calculated theoretical yields of 2165 MBq and 433 MBq mu A(-1) h(-1) (58.5 mCi and 11.7 mCi mu A(-1) h(-1)). This amount of activity is sufficient for the radiosynthesis of target compounds as well as imaging studies. MicroPET images of a miniature Derenzo phantom show excellent resolution where rods of 1.25 mm were separated by four times their diameter.
   Conclusions: Titanium-45 can be easily produced on a biomedical cyclotron with excellent yields as compared to calculated theoretical values with imaging studies demonstrating that the decay properties of titanium-45 are well suited for microPET. (c) 2005 Elsevier Inc. All rights reserved.
C1 Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA.
   Washington Univ, Sch Med, Alvin J Siteman Canc Ctr, St Louis, MO 63110 USA.
   Washington Univ, Dept Chem, St Louis, MO 63104 USA.
RP Welch, MJ (reprint author), Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA.
EM welchm@mir.wustl.edu
CR Christodoulou CV, 1998, J CLIN ONCOL, V16, P2761, DOI 10.1200/JCO.1998.16.8.2761
   Clark R.J.H., 1968, CHEM TITANIUM VANADI
   DEAN JA, 1992, LANGES HDB CHEM
   DELL GF, 1965, NUCL PHYS, V64, P513, DOI 10.1016/0029-5582(65)90576-6
   DERENZO SE, 1981, IEEE T NUCL SCI, V28, P81, DOI 10.1109/TNS.1981.4331144
   Guo ML, 2000, BIOCHEMISTRY-US, V39, P10023, DOI 10.1021/bi000798z
   Harding MM, 2000, CURR MED CHEM, V7, P1289, DOI 10.2174/0929867003374066
   ISHIWATA K, 1991, APPL RADIAT ISOTOPES, V42, P707
   ISHIWATA K, 1982, J LABELLED COMPD RAD, V19, P11
   KAWAMURA M, 1986, J LABELLED COMPD RAD, V23, P1360
   Knoess C, 2003, EUR J NUCL MED MOL I, V30, P737, DOI 10.1007/s00259-002-1052-6
   Koepf-Maier P., 1994, European Journal of Clinical Pharmacology, V47, P1
   KOEPF-MAIER P, 1989, Cancer Chemotherapy and Pharmacology, V23, P225
   KOEPF-MAIER P, 1986, Anticancer Research, V6, P33
   KOEPFMAIER P, 1981, CANCER CHEMOTHER PHA, V5, P237
   Laforest R, 2002, IEEE T NUCL SCI, V49, P2119, DOI 10.1109/TNS.2002.803685
   LEDERER CM, 1978, TABLE ISOTOPES
   Levkovskij V. N., 1991, ACTIVATION CROSS SEC
   Lewis MR, 2002, NUCL MED BIOL, V29, P701, DOI 10.1016/S0969-8051(02)00330-X
   McCarthy DW, 1997, NUCL MED BIOL, V24, P35, DOI 10.1016/S0969-8051(96)00157-6
   MERRILL JC, 1978, INT J APPL RADIAT IS, V29, P115, DOI 10.1016/0020-708X(78)90033-9
   TONEY JH, 1985, J AM CHEM SOC, V107, P947, DOI 10.1021/ja00290a033
NR 22
TC 18
Z9 18
U1 1
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0969-8051
J9 NUCL MED BIOL
JI Nucl. Med. Biol.
PD FEB
PY 2005
VL 32
IS 2
BP 117
EP 122
DI 10.1016/j.nucmedbio.2004.10.003
PG 6
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 907BF
UT WOS:000227689100002
PM 15721756
DA 2018-10-19
ER

PT J
AU Moreau, C
   Bisson, JF
   Lima, RS
   Marple, BR
AF Moreau, C
   Bisson, JF
   Lima, RS
   Marple, BR
TI Diagnostics for advanced materials processing by plasma spraying
SO PURE AND APPLIED CHEMISTRY
LA English
DT Article; Proceedings Paper
CT 16th International Symposium on Plasma Chemistry
CY JUN, 2003
CL Taormina, ITALY
DE particle diagnostics; plasma spraying; optical sensors; particle
   flattening; nanostructured coatings
ID PARTIALLY-STABILIZED ZIRCONIA; FLIGHT PARTICLE PARAMETERS; THERMAL
   SPRAY; SUBSTRATE SURFACE; SPLAT FORMATION; DROPLETS; TEMPERATURE;
   IMPACT; FLUCTUATIONS; COLD
AB Advanced coatings deposited by plasma spraying are used in a large variety of industrial applications. The sprayed coatings are employed typically in industry to protect parts from severe operating conditions or to produce surfaces with specific functions. Applications are found in many industrial sectors such as aerospace, automobile, energy generation, and biomedical implants.
   Coatings are built by the successive deposition of molten or partially molten particles that flatten and solidify upon contact on the substrate, forming lamellae. The coating properties are intimately linked to the properties of these lamellae, which in turn depend on in-flight particle properties as well as substrate temperature during spraying. Consequently, the development of diagnostic tools for monitoring and controlling these spray parameters will help provide the necessary information to study the coating formation process, optimize the coating properties, and, eventually, control the spray process in production.
   In this paper, a review of some recent developments of optical diagnostic techniques applied to monitor plasma-sprayed particles is presented. In the first part of the paper, two different sensing techniques for in-flight particle measurement are described. First, time-resolved diagnostics on individual particles is described. This technique is used to study the instabilities of the particle characteristics associated with the plasma fluctuations. Secondly, a technique adapted for use in an industrial production environment for measuring the particle jet characteristics as an ensemble is presented. In the second part of the paper, the use of an optical system to study the influence of the substrate temperature on the flattening and solidification of sprayed particles impacting on a flat substrate is described. The last part of this paper describes the optimization of nanostructured coatings based on a tight control of the temperature and velocity of the plasma-sprayed particles.
C1 Natl Res Council Canada, Inst Ind Mat, Boucherville, PQ J4B 6Y4, Canada.
RP Moreau, C (reprint author), Natl Res Council Canada, Inst Ind Mat, 75 Mortagne, Boucherville, PQ J4B 6Y4, Canada.
EM christian.moreau@cnrc-nrc.gc.ca
CR Beck M.S., 1987, CROSS CORRELATION FL
   Bianchi L, 1997, THIN SOLID FILMS, V305, P35, DOI 10.1016/S0040-6090(97)80005-3
   Bisson JF, 2003, J THERM SPRAY TECHN, V12, P38, DOI 10.1361/105996303770348483
   Bisson JF, 2003, J THERM SPRAY TECHN, V12, P258, DOI 10.1361/105996303770348375
   Bisson JF, 2001, THERMAL SPRAY 2001: NEW SURFACES FOR A NEW MILLENNIUM, P705
   Blain J., 1997, Surface Engineering, V13, P420
   BLAIN J, 2003, THERMAL SPRAY 2003 A, P1131
   BOURQUE G, 2000, SURFACE ENG VIA APPL, P45
   COULOMBE S, 1995, PLASMA CHEM PLASMA P, V15, P653, DOI 10.1007/BF01447065
   CRAIG JE, 2003, THERMAL SPRAY 2003 A, P1107
   DUAN Z, 2000, THERMAL SPRAY SURFAC, P1
   Escure C, 2003, PLASMA CHEM PLASMA P, V23, P185, DOI 10.1023/A:1022976914185
   Fauchais P, 2001, J THERM SPRAY TECHN, V10, P44, DOI 10.1361/105996301770349510
   FINCKE J, 1993, MEAS SCI TECHNOL, V4, P449
   FINCKE JR, 1988, J PHYS E SCI INSTRUM, V21, P367, DOI 10.1088/0022-3735/21/4/005
   Fincke JR, 2001, SURF COAT TECH, V146, P537, DOI 10.1016/S0257-8972(01)01432-3
   FINCKE JR, 2003, THERMAL SPRAY 2003 A, P1093
   Friis M, 2003, J THERM SPRAY TECHN, V12, P44, DOI 10.1361/105996303770348492
   Fukumoto M, 2002, SURF COAT TECH, V161, P103, DOI 10.1016/S0257-8972(02)00471-1
   Fukumoto M, 1999, SURF COAT TECH, V120, P131, DOI 10.1016/S0257-8972(99)00349-7
   Gougeon P, 2001, J THERM SPRAY TECHN, V10, P76, DOI 10.1361/105996301770349538
   Gougeon P, 1995, ADVANCES IN THERMAL SPRAY SCIENCE AND TECHNOLOGY, P149
   Jiang XY, 2001, THIN SOLID FILMS, V385, P132, DOI 10.1016/S0040-6090(01)00769-6
   Leblanc L, 2002, J THERM SPRAY TECHN, V11, P380, DOI 10.1361/105996302770348772
   LEBLANC L, 1997, THERMAL SPRAY UNITED, P567
   Lima RS, 2002, MAT SCI ENG A-STRUCT, V327, P224, DOI 10.1016/S0921-5093(01)01530-1
   Lima RS, 2001, MAT SCI ENG A-STRUCT, V313, P75, DOI 10.1016/S0921-5093(01)01146-7
   LYAGUSHKIN VP, S P INT S PLASM CHEM
   MADEJSKI J, 1976, INT J HEAT MASS TRAN, V19, P1009, DOI 10.1016/0017-9310(76)90183-6
   MADEJSKI J, 1983, INT J HEAT MASS TRAN, V26, P1095, DOI 10.1016/S0017-9310(83)80137-9
   MISHIN J, 1987, J PHYS E SCI INSTRUM, V20, P620, DOI 10.1088/0022-3735/20/6/008
   Miyayama M., 1991, ENG MAT HDB, V4, P748
   MOREAU C, 1994, THERMAL SPRAY IND AP, P431
   MOREAU C, 1998, THERMAL SPRAY M CHAL
   Mostaghimi J, 2002, PLASMA CHEM PLASMA P, V22, P59, DOI 10.1023/A:1012940515065
   Pawlowski L, 1995, SCI ENG THERMAL SPRA
   PFENDER E, 1988, SURF COAT TECH, V34, P1, DOI 10.1016/0257-8972(88)90083-7
   VARDELLE M, 1983, AICHE J, V29, P236, DOI 10.1002/aic.690290210
   Vardelle M, 2001, J THERM SPRAY TECHN, V10, P267, DOI 10.1361/105996301770349367
   Vattulainen J, 2001, J THERM SPRAY TECHN, V10, P94, DOI 10.1361/105996301770349556
   WUTZKE S, 1967, AIAA, V5, P1216
NR 41
TC 33
Z9 33
U1 0
U2 8
PU INT UNION PURE APPLIED CHEMISTRY
PI RES TRIANGLE PK
PA 104 TW ALEXANDER DR, PO BOX 13757, RES TRIANGLE PK, NC 27709-3757 USA
SN 0033-4545
J9 PURE APPL CHEM
JI Pure Appl. Chem.
PD FEB
PY 2005
VL 77
IS 2
BP 443
EP 462
DI 10.1351/pac200577020443
PG 20
WC Chemistry, Multidisciplinary
SC Chemistry
GA 908CP
UT WOS:000227765200010
DA 2018-10-19
ER

PT J
AU Karabanova, LV
   Mikhalovsky, SV
   Lloyd, AW
   Boiteux, G
   Sergeeva, LM
   Novikova, TI
   Lutsyk, ED
   Meikle, S
AF Karabanova, LV
   Mikhalovsky, SV
   Lloyd, AW
   Boiteux, G
   Sergeeva, LM
   Novikova, TI
   Lutsyk, ED
   Meikle, S
TI Gradient semi-interpenetrating polymer networks based on polyurethane
   and poly(vinyl pyrrolidone)
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID TEMPERATURE TRANSITIONS; FABRICATION; BEHAVIOR
AB Gradient semi-interpenetrating polymer networks (gradient semi-IPNs) were synthesized using polyurethane (PU) and poly(vinyl pyrrolidone) (PVP). The materials were characterized with respect to thermodynamic miscibility, IR-spectroscopy, mechanical properties and morphological structure. The positive values of Gibbs free energy indicated that the polymeric systems were thermodynamically immiscible. The gradient semi-IPNs were shown to have unique mechanical properties dependent on the composition and the subsequent degree of microphase separation. Given the ability to control both the mechanical properties and surface chemistry, these materials offer the potential for further development as biocompatible biomedical materials for the fabrication of medical implants.
C1 Univ Brighton, Sch Pharm & Biomol Sci, Biomed Mat Res Grp, Brighton BN2 4GJ, E Sussex, England.
   Natl Acad Sci Ukraine, Inst Macromol Chem, UA-253660 Kiev, Ukraine.
   Univ Lyon 1, CNRS, UMR 5627, Lab Mat Polymers & Biomat, F-69622 Villeurbanne, France.
RP Lloyd, AW (reprint author), Univ Brighton, Sch Pharm & Biomol Sci, Biomed Mat Res Grp, Brighton BN2 4GJ, E Sussex, England.
EM a.w.lloyd@brighton.ac.uk
RI Lloyd, Andrew/D-1369-2011; Meikle, Steven/A-8268-2012
OI Lloyd, Andrew/0000-0003-2778-8195; Meikle, Steven/0000-0002-3846-5001
CR Akovali G, 1999, J APPL POLYM SCI, V73, P1721, DOI 10.1002/(SICI)1097-4628(19990829)73:9<1721::AID-APP12>3.0.CO;2-U
   Bershtein VA, 1999, J POLYM SCI POL PHYS, V37, P429, DOI 10.1002/(SICI)1099-0488(19990301)37:5<429::AID-POLB3>3.0.CO;2-E
   DROR M, 1981, J APPL POLYM SCI, V26, P1741, DOI 10.1002/app.1981.070260601
   HARRIC HJ, 1967, INTERNAL REFLECTION, P287
   HEDVIG P, 1977, DIELECTRIC SPECTROSC, P245
   Huang JH, 1998, J MATER SCI LETT, V17, P2033
   Ilshner B., 1993, J PHYS IV, V3, P763
   Jang J, 1998, J MATER SCI, V33, P5445, DOI 10.1023/A:1004466804733
   Karabanova L, 1998, J APPL POLYM SCI, V68, P161, DOI 10.1002/(SICI)1097-4628(19980404)68:1<161::AID-APP18>3.0.CO;2-3
   KARABANOVA L, 2000, P 9 INT C POL MED SU, P13
   Karabanova LV, 2004, POLYM ENG SCI, V44, P940, DOI 10.1002/pen.20085
   Karabanova LV, 2002, RUSS J APPL CHEM+, V75, P800, DOI 10.1023/A:1020322931890
   Kryszewski M, 1998, POLYM ADVAN TECHNOL, V9, P244, DOI 10.1002/(SICI)1099-1581(199804)9:4<244::AID-PAT748>3.0.CO;2-J
   LIPATOV YS, 1992, POLYM INT, V28, P99, DOI 10.1002/pi.4990280202
   LIPATOV YS, 1994, ADV INTERPENETRATING, P456
   MARTIN GC, 1981, J APPL POLYM SCI, V26, P1465, DOI 10.1002/app.1981.070260503
   Tager A. A., 1978, PHYSICAL CHEM POLYM, P544
   Tager A. A., 1977, VYSOKOMOL SOEDIN, V19, P1654
   WANG JS, 1995, MACROMOLECULES, V28, P7527
   YU S, 1990, J MACROMOL SCI REV M, V30, P209
NR 20
TC 18
Z9 24
U1 0
U2 13
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PD JAN 28
PY 2005
VL 15
IS 4
BP 499
EP 507
DI 10.1039/b410178b
PG 9
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 890ZK
UT WOS:000226550300009
DA 2018-10-19
ER

PT J
AU Liao, CS
   Lee, GB
   Wu, JJ
   Chang, CC
   Hsieh, TM
   Huang, FC
   Luo, CH
AF Liao, CS
   Lee, GB
   Wu, JJ
   Chang, CC
   Hsieh, TM
   Huang, FC
   Luo, CH
TI Micromachined polymerase chain reaction system for multiple DNA
   amplification of upper respiratory tract infectious diseases
SO BIOSENSORS & BIOELECTRONICS
LA English
DT Article
DE polymerase chain reaction; DNA diagnosis; multiplex PCR; MEMS
ID STREPTOCOCCUS-PNEUMONIAE; CAPILLARY-ELECTROPHORESIS;
   HAEMOPHILUS-INFLUENZAE; RAPID IDENTIFICATION; BLOOD CULTURES; PCR; GENES
AB This paper presents a micro polymerase chain reaction (PCR) chip for the DNA-based diagnosis of microorganism genes and the detection of their corresponding antibiotic-resistant genes. The micro PCR chip comprises cheap biocompatible soda-lime glass substrates with integrated thin-film platinum resistors as heating/sensing elements, and is fabricated using micro-electro-mechanical-system (MEMS) techniques in a reliable batch-fabrication process. The heating and temperature sensing elements are made of the same material and are located inside the reaction chamber in order to ensure a uniform temperature distribution. This study performs the detection of several genes associated with upper respiratory tract infection microorganisms, i.e. Streptococcus pneumoniae, Haemopilus influenze, Staphylococcu aureus, Streptococcus pyogenes, and Neisseria meningitides, together with their corresponding antibiotic-resistant genes. The lower thermal inertia of the proposed micro PCR chip relative to conventional bench-top PCR systems enables a more rapid detection operation with reduced sample and reagent consumption. The experimental data reveal that the high heating and cooling rates of the system (20 and 10 degreesC/s, respectively) pen-nit successful DNA amplification within 15 min. The micro PCR chip is also capable of performing multiple DNA amplification, i.e. the simultaneous duplication of multiple genes under different conditions in separate reaction wells. Compared with the large-scale PCR system, it is greatly advantageous for fast diagnosis of multiple infectious diseases. Multiplex PCR amplification of two DNA segments in the same well is also feasible using the proposed micro device. The developed micro PCR chip provides a crucial tool for genetic analysis, molecular biology, infectious disease detection, and many other biomedical applications. (C) 2004 Elsevier B.V. All rights reserved.
C1 Natl Cheng Kung Univ, Dept Engn Sci, Tainan 701, Taiwan.
   Natl Cheng Kung Univ, Inst Microelect Mech Syst Engn, Tainan 701, Taiwan.
   Natl Cheng Kung Univ, Dept Med Technol, Tainan 701, Taiwan.
   Kaohsiung Med Univ, Grad Inst Publ Hlth, Kaohsiung 807, Taiwan.
   Natl Cheng Kung Univ, Dept Elect Engn, Tainan 701, Taiwan.
RP Lee, GB (reprint author), Natl Cheng Kung Univ, Dept Engn Sci, Tainan 701, Taiwan.
EM gwobin@mail.ncku.edu.tw
RI Lee, Gwo-Bin/D-3032-2012
OI Lee, Gwo-Bin/0000-0001-6910-9133
CR Baron EJ, 2001, CLIN INFECT DIS, V33, P220, DOI 10.1086/321816
   Chang CC, 2000, INFECT IMMUN, V68, P2630, DOI 10.1128/IAI.68.5.2630-2637.2000
   Chang HC, 2001, J CLIN MICROBIOL, V39, P3466, DOI 10.1128/JCM.39.10.3466-3471.2001
   DAVID H, 1993, DIAGNOSTIC MOL MICRO, P539
   Fauci AS, 2001, CLIN INFECT DIS, V32, P675, DOI 10.1086/319235
   Fuh DT, 2001, J MED ENG TECHNOL, V25, P118, DOI 10.1080/03091900110052441
   GILLESPIE SH, 1994, J CLIN MICROBIOL, V32, P1308
   Hakenbeck R, 1999, MICROB DRUG RESIST, V5, P91, DOI 10.1089/mdr.1999.5.91
   HASSANKING M, 1994, J CLIN MICROBIOL, V32, P1721
   Hendolin PH, 2000, J CLIN MICROBIOL, V38, P125
   Hsueh PR, 1998, CLIN INFECT DIS, V26, P584, DOI 10.1086/514567
   Huang AH, 2000, J HOSP INFECT, V44, P309, DOI 10.1053/jhin.1999.0692
   Kataja J, 1999, ANTIMICROB AGENTS CH, V43, P48, DOI 10.1128/AAC.43.1.48
   Kopp MU, 1998, SCIENCE, V280, P1046, DOI 10.1126/science.280.5366.1046
   Lagally ET, 2000, SENSOR ACTUAT B-CHEM, V63, P138, DOI 10.1016/S0925-4005(00)00350-6
   LAGALLY ET, 2001, MICRO TOTAL ANAL SYS, P117
   LEAVES N, 2000, J ANTIMICROB CHEMOTH, V445, P599
   Monstein HJ, 2001, FEMS MICROBIOL LETT, V199, P103, DOI 10.1016/S0378-1097(01)00171-9
   Northrup M. A., 1993, P 7 INT C SOL STAT S, V93, P924
   NORTHRUP MA, 1995, MEMS MINIATURE DNA A, V9, P764
   PERSING DH, 1994, DIAGNOSTIC MOL MICRO
   RADSTROM P, 1994, J CLIN MICROBIOL, V32, P2738
   Tay F.E.H, 2002, MICROFLUIDICS BIOMEM
   Woolley AT, 1996, ANAL CHEM, V68, P4081, DOI 10.1021/ac960718q
   Zhang QT, 2002, SENSOR ACTUAT B-CHEM, V82, P75, DOI 10.1016/S0925-4005(01)00993-5
NR 25
TC 69
Z9 69
U1 1
U2 9
PU ELSEVIER ADVANCED TECHNOLOGY
PI OXFORD
PA OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON,
   OXFORD OX5 1GB, OXON, ENGLAND
SN 0956-5663
J9 BIOSENS BIOELECTRON
JI Biosens. Bioelectron.
PD JAN 15
PY 2005
VL 20
IS 7
BP 1341
EP 1348
DI 10.1016/j.bios.2004.05.006
PG 8
WC Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical;
   Electrochemistry; Nanoscience & Nanotechnology
SC Biophysics; Biotechnology & Applied Microbiology; Chemistry;
   Electrochemistry; Science & Technology - Other Topics
GA 887ZN
UT WOS:000226344100012
PM 15590288
DA 2018-10-19
ER

PT J
AU Case, ED
   Smith, IO
   Baumann, MJ
AF Case, ED
   Smith, IO
   Baumann, MJ
TI Microcracking and porosity in calcium phosphates and the implications
   for bone tissue engineering
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE hydroxyapatite; bone tissue engineering; microcracking; thermal
   expansion anisotropy; bone remodeling
ID THERMAL-EXPANSION ANISOTROPY; GRAIN-SIZE; MECHANICAL-PROPERTIES;
   RESIDUAL-STRESS; THOROUGHBRED RACEHORSES; BRITTLE MATERIALS; 3RD
   METACARPAL; CERAMICS; FRACTURE; ALUMINA
AB Calcium phosphates including hydroxyapatite (HA) have been widely studied as bone scaffold materials. However their mechanical properties are highly variable and may be a function of thermal expansion anisotropy (TEA) induced stresses and microcracking. There is confusion concerning the mechanisms and microscopic identification of microcracks in HA. This study presents clear evidence of microcracking from micrographs of as-sintered HA surfaces which avoids the complications of identifying TEA-induced microcracks on fracture surfaces. Additionally, the existing literature of TEA-induced microcracking is briefly reviewed and pertinent papers involving likely microcracking in HA are analyzed. The recent realization in the biomedical literature notes that microcracks are of critical importance in remodeling and repair of damaged bone tissue. Hence, the similarities between microcracking in HA used for scaffolds in bone tissue engineering and that in the normal bone repair process is of importance in designing HA scaffolds with improved mechanical properties and biocompatibility. (C) 2004 Elsevier B.V. All rights reserved.
C1 Michigan State Univ, Dept Chem Engn & Mat Sci, E Lansing, MI 48824 USA.
RP Baumann, MJ (reprint author), Michigan State Univ, Dept Chem Engn & Mat Sci, 2527 Engn Bldg, E Lansing, MI 48824 USA.
EM casee@egr.msu.edu; smithian@egr.msu.edu; mbaumann@egr.msu.edu
CR Bae IJ, 1997, J AM CERAM SOC, V80, P1149
   BARSOUM M, 1997, FUNDAMENTAL CERAMICS, P411
   Bentolila V, 1998, BONE, V23, P275, DOI 10.1016/S8756-3282(98)00104-5
   BERRY KA, 1986, J AM CERAM SOC, V69, P143, DOI 10.1111/j.1151-2916.1986.tb04719.x
   Burr DB, 1997, J BONE MINER RES, V12, P6, DOI 10.1359/jbmr.1997.12.1.6
   Burr DB, 2002, BONE, V30, P2, DOI 10.1016/S8756-3282(01)00619-6
   Case E.D., 2002, SATURATION THEMOMECH, P137
   CASE ED, 1981, J NUCL MATER, V102, P135, DOI 10.1016/0022-3115(81)90553-5
   CASE ED, 1981, MATER SCI ENG, V51, P175, DOI 10.1016/0025-5416(81)90193-2
   CASE ED, 1980, J MATER SCI, V15, P149, DOI 10.1007/BF00552439
   CASE ED, 1983, MICROCRACK HEALING D, P507
   CLEVELAND JJ, 1978, J AM CERAM SOC, V61, P478, DOI 10.1111/j.1151-2916.1978.tb16121.x
   CORBRIDGE DEC, 1995, PHOSPHORUS OUTLINE C, P455
   Davidge RW, 1968, J MATER SCI, V3, P629, DOI 10.1007/BF00757910
   ELLIOTT JC, 1994, STRUCTURE CHEM APATI, P29
   EVANS AG, 1984, J AM CERAM SOC, V67, P255
   FU Y, 1984, J AM CERAM SOC, V67, P626, DOI 10.1111/j.1151-2916.1984.tb19607.x
   GERMAN RM, 1994, POWDER METALLURGY SC, P244
   GERMAN RM, 1996, SINTERING THEORY PRA, P99
   GUPTA TK, 1972, J AM CERAM SOC, V55, P276, DOI 10.1111/j.1151-2916.1972.tb11281.x
   HALQUANI R, 1994, J MATER SCI-MATER M, V5, P563
   HASSELMAN DPH, 1993, J AM CERAM SOC, V76, P2180, DOI 10.1111/j.1151-2916.1993.tb07752.x
   HIRAI M, 1990, J NUCL MATER, V173, P247, DOI 10.1016/0022-3115(90)90392-Z
   Hoepfner TP, 2004, MATER LETT, V58, P489, DOI 10.1016/S0167-577X(03)00531-7
   Johnson KA, 2001, AM J VET RES, V62, P787, DOI 10.2460/ajvr.2001.62.787
   KINGREY WD, 1976, INTRO CERAMICS, P504
   Kon M, 2001, J DENT RES, V80, P1758, DOI 10.1177/00220345010800081501
   KUSZYK JA, 1973, J AM CERAM SOC, V56, P420, DOI 10.1111/j.1151-2916.1973.tb12714.x
   LEE WJ, 1989, MAT SCI ENG A-STRUCT, V119, P113, DOI 10.1016/0921-5093(89)90530-3
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   Luo J, 1997, J EUR CERAM SOC, V17, P1565, DOI 10.1016/S0955-2219(97)00014-9
   Mackert JR, 2001, J DENT RES, V80, P1574, DOI 10.1177/00220345010800061901
   MANNING WR, 1972, J AM CERAM SOC, V55, P342, DOI 10.1111/j.1151-2916.1972.tb11306.x
   MECHOLSKY JJ, 1981, TOUGHENING GLASS CER, P15
   Mooney DJ, 1999, SCI AM, V280, P60, DOI 10.1038/scientificamerican0499-60
   MORI S, 1993, BONE, V14, P103, DOI 10.1016/8756-3282(93)90235-3
   Muir P, 1999, BONE, V25, P571, DOI 10.1016/S8756-3282(99)00205-7
   Nye J. F., 1985, PHYS PROPERTIES CRYS, P22
   Paulik SW, 1996, J MATER RES, V11, P2795, DOI 10.1557/JMR.1996.0354
   QUARLES LD, 1992, J BONE MINER RES, V7, P683
   Radtke CL, 2003, AM J VET RES, V64, P1110, DOI 10.2460/ajvr.2003.64.1110
   RAHAMAN MN, 2003, CERAMIC PROCESSING S, P416
   Raynaud S, 2002, BIOMATERIALS, V23, P1081, DOI 10.1016/S0142-9612(01)00220-4
   Reilly GC, 1997, J ORTHOP RES, V15, P862, DOI 10.1002/jor.1100150611
   Rice RW, 1996, J MATER SCI, V31, P1969, DOI 10.1007/BF00356616
   RICHERSON DW, 1992, MODERN CERAMIC ENG, P549
   RUYS AJ, 1995, BIOMATERIALS, V16, P409, DOI 10.1016/0142-9612(95)98859-C
   SARNO RD, 1995, J MATER SCI, V30, P4380, DOI 10.1007/BF00361521
   Stepnik MW, 2004, VET SURG, V33, P2, DOI 10.1111/j.1532-950x.2004.04007.x
   SUETSUGU Y, 2001, KEY ENG MATER, V192, P287
   TOTH JM, 1991, J APPL BIOMATER, V2, P37, DOI 10.1002/jab.770020106
   Wheeler DL, 1997, J BIOMED MATER RES, V35, P249, DOI 10.1002/(SICI)1097-4636(199705)35:2<249::AID-JBM12>3.0.CO;2-C
   YAN MF, 1981, MATER SCI ENG, V48, P55
   Zimmermann A, 2000, MATER SCI FORUM, V347-3, P211, DOI 10.4028/www.scientific.net/MSF.347-349.211
NR 54
TC 31
Z9 32
U1 0
U2 7
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD JAN 15
PY 2005
VL 390
IS 1-2
BP 246
EP 254
DI 10.1016/j.msea.2004.08.021
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 888KI
UT WOS:000226372400030
DA 2018-10-19
ER

PT J
AU Kikuchi, A
   Okano, T
AF Kikuchi, A
   Okano, T
TI Nanostructured designs of biomedical materials: Applications of cell
   sheet engineering to functional regenerative tissues and organs
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article; Proceedings Paper
CT 8th European Symposium on Controlled Drug Delivery
CY APR 07-09, 2004
CL Noordwijk, NETHERLANDS
DE cell-adhesive surfaces; cell non-adhesive surfaces; cell detachment;
   hydrophilic surfaces; nanophase separated surfaces; thermoresponsive
   polymer; cell sheet engineering
ID RESPONSIVE CULTURE DISHES; MICRODOMAIN-STRUCTURED SURFACES; TOTAL
   ARTIFICIAL-HEART; PLATELET-ADHESION; 2-DIMENSIONAL MANIPULATION; BLOOD
   COMPATIBILITY; PROTEIN ADSORPTION; GRAFTED SURFACES;
   POLY(N-ISOPROPYLACRYLAMIDE)-GRAFTED SURFACES; CYTOSKELETAL
   REORGANIZATION
AB Biomaterials surface design is critical for control of cell-materials interactions. Materials surface characteristics important to cell-materials interactions are the following: (a) nonfouling surfaces where cells cannot interact; (b) surfaces that interact with cells but do not alter cell morphology or metabolism (passive adhesion processes); and (c) surfaces that strongly interact with cells and cell-surface receptors to alter cell shape after metabolic interactions (active adhesion). In this paper, we briefly discuss the relationship between materials surface characteristics and cells for biomaterials designs in these categories. We have extensively investigated the thermoresponsive polymer, poly(N-isopropylacrylamide) (PIPAAm), as grafted surfaces allowing recovery of confluent cell monolayers as contiguous living cell sheets for tissue engineering applications. Cellular interactions with PIPAAm-grafted surfaces can be regulated vertically using the thickness of the PIPAAm-grafted layers in nanometer-scale levels, as well as laterally (spatially) using nano-patterned PIPAAm chemistry on various other surface chemistries. PIPAAm-grafted surfaces with 15-20-nm thick layers exhibit temperature-dependent cell adhesion/detachment control, while surfaces with PIPAAm layer thicknesses of more than 30 nm do not support cell adhesion. These changes in cell adhesion are explained by the limited mobility of the surface grafted polymer chains as a function of grafting, hydration, and temperature. (c) 2004 Elsevier B.V. All rights reserved.
C1 Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, COE Program Century 21, Tokyo 1628666, Japan.
RP Kikuchi, A (reprint author), Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, COE Program Century 21, 8-1 Kawadacho, Tokyo 1628666, Japan.
EM kik-uchia@abmes.twm.ac.jp; tokano@abmes.twmu.ac.jp
RI Okano, Teruo/J-4028-2012
CR Akiyama Y, 2004, LANGMUIR, V20, P5506, DOI 10.1021/la036139f
   AMIJI M, 1993, J BIOMAT SCI-POLYM E, V4, P217, DOI 10.1163/156856293X00537
   AMIJI M, 1992, BIOMATERIALS, V13, P682, DOI 10.1016/0142-9612(92)90128-B
   Aoyagi T, 2000, J BIOMAT SCI-POLYM E, V11, P101, DOI 10.1163/156856200743526
   BAE YH, 1990, J POLYM SCI POL PHYS, V28, P923, DOI 10.1002/polb.1990.090280609
   Bamford CH, 1996, POLYMER, V37, P4885, DOI 10.1016/0032-3861(96)00538-1
   DEVRIES WC, 1984, NEW ENGL J MED, V310, P273, DOI 10.1056/NEJM198402023100501
   Ebara M, 2000, MACROMOLECULES, V33, P8312, DOI 10.1021/ma000121j
   Ebara M, 2004, BIOMACROMOLECULES, V5, P505, DOI 10.1021/bm0343601
   Ebara M, 2003, BIOMACROMOLECULES, V4, P344, DOI 10.1021/bm025692t
   EBARA M, 2004, IN PRESS TISSUE ENG
   GOODMAN SL, 1989, J BIOMED MATER RES, V23, P105, DOI 10.1002/jbm.820230109
   GRASEL TG, 1986, BIOMATERIALS, V7, P315, DOI 10.1016/0142-9612(86)90002-5
   Han DK, 1996, J BIOMED MATER RES, V30, P23, DOI 10.1002/(SICI)1097-4636(199601)30:1<23::AID-JBM4>3.0.CO;2-T
   Harimoto M, 2002, J BIOMED MATER RES, V62, P464, DOI 10.1002/jbm.10228
   Heskins M., 1968, J MACROMOL SCI CHEM, V2, P1441, DOI [10.1080/10601326808051910, DOI 10.1080/10601326808051910]
   Hirose M, 2000, BIOMACROMOLECULES, V1, P377, DOI 10.1021/bm0002961
   IKADA Y, 1981, J BIOMED MATER RES, V15, P697, DOI 10.1002/jbm.820150507
   Ito E, 1998, J BIOMED MATER RES, V42, P148
   IWANAGA S, 2004, UNPUB
   Joyce L D, 1986, J Heart Transplant, V5, P203
   JOYCE LD, 1983, T AM SOC ART INT ORG, V29, P81
   Kanazawa H, 1997, J PHARMACEUT BIOMED, V15, P1545, DOI 10.1016/S0731-7085(96)02004-3
   Kanazawa H, 1996, ANAL CHEM, V68, P100, DOI 10.1021/ac950359j
   Kanazawa H, 1997, ANAL CHEM, V69, P823, DOI 10.1021/ac961024k
   Kikuchi A, 2002, PROG POLYM SCI, V27, P1165, DOI 10.1016/S0079-6700(02)00013-8
   Kikuchi A, 1998, J BIOMAT SCI-POLYM E, V9, P1331, DOI 10.1163/156856298X00424
   KIKUCHI A, UNPUB
   KINUGASA E, 1989, J JPN ARTIF ORGANS, V18, P1346
   Kobayashi J, 2001, ANAL CHEM, V73, P2027, DOI 10.1021/ac0013507
   Kushida A, 2000, J BIOMED MATER RES, V51, P216, DOI 10.1002/(SICI)1097-4636(200008)51:2<216::AID-JBM10>3.0.CO;2-K
   Kushida A, 1999, J BIOMED MATER RES, V45, P355, DOI 10.1002/(SICI)1097-4636(19990615)45:4<355::AID-JBM10>3.0.CO;2-7
   Kushida A, 2001, J BIOMED MATER RES, V54, P37, DOI 10.1002/1097-4636(200101)54:1<37::AID-JBM5>3.0.CO;2-7
   MARUYAMA A, 1988, BIOMATERIALS, V9, P471, DOI 10.1016/0142-9612(88)90041-5
   MARUYAMA A, 1989, BIOMATERIALS, V10, P291, DOI 10.1016/0142-9612(89)90068-9
   MATSUDA T, 1995, J BIOMED MATER RES, V29, P749, DOI 10.1002/jbm.820290611
   Nakajima K, 2001, BIOMATERIALS, V22, P1213, DOI 10.1016/S0142-9612(00)00270-2
   Nandkumar MA, 2002, BIOMATERIALS, V23, P1121, DOI 10.1016/S0142-9612(01)00225-3
   Nishida K, 2004, TRANSPLANTATION, V77, P379, DOI 10.1097/01.TP.0000110320.45678.30
   NOJIRI C, 1990, J BIOMED MATER RES, V24, P1151, DOI 10.1002/jbm.820240903
   NOJIRI C, 1992, J BIOMAT SCI-POLYM E, V4, P75
   NOJIRI C, 1989, T ASAIO, V35, P357
   OKANO T, 1978, J APPL POLYM SCI, V22, P369, DOI 10.1002/app.1978.070220206
   OKANO T, 1981, J BIOMED MATER RES, V15, P393, DOI 10.1002/jbm.820150310
   OKANO T, 1995, BIOMATERIALS, V16, P297, DOI 10.1016/0142-9612(95)93257-E
   OKANO T, 1993, J BIOMED MATER RES, V27, P1243, DOI 10.1002/jbm.820271005
   OKANO T, 1979, JPN J ARTIF ORGANS, V8, P292
   OKANO T, 1979, J JPN ARTIF ORGANS, V8, P800
   OKANO T, 1979, SYNTHESES AMPHIPHILI
   OKUYAMA Y, 1993, J BIOMAT SCI-POLYM E, V4, P545, DOI 10.1163/156856293X00195
   Park KD, 1996, ASAIO J, V42, pM876, DOI 10.1097/00002480-199609000-00117
   PIAO AZ, 1992, ASAIO J, V38, P638
   Razatos A, 2000, LANGMUIR, V16, P9155, DOI 10.1021/la000818y
   Sakai H, 1996, ADVANCED BIOMATERIALS IN BIOMEDICAL ENGINEERING AND DRUG DELIVERY SYSTEMS, P229
   SAKAMAOTO C, 2004, J CHROMATOGR A, V103, P247
   Shimizu T, 2003, BIOMATERIALS, V24, P2309, DOI 10.1016/S0142-9612(03)00110-8
   Shimizu T, 2002, J BIOMED MATER RES, V60, P110, DOI 10.1002/jbm.1284
   Shimizu T, 2001, TISSUE ENG, V7, P141, DOI 10.1089/107632701300062732
   SHIMIZU T, 2002, CIRC RES, V90, P40
   TAKEI YG, 1994, MACROMOLECULES, V27, P6163, DOI 10.1021/ma00099a035
   TAKEI YG, 1993, BIOCONJUGATE CHEM, V4, P341, DOI 10.1021/bc00023a006
   Tsuda Y, 2004, J BIOMED MATER RES A, V69A, P70, DOI 10.1002/jbm.a.20114
   TSUDA Y, 2004, IN PRESS BIOMATERIAL
   Uchida K, 2000, BIOMATERIALS, V21, P923, DOI 10.1016/S0142-9612(99)00260-4
   Winblade ND, 2000, BIOMACROMOLECULES, V1, P523, DOI 10.1021/bm000040v
   Yakushiji T, 1998, LANGMUIR, V14, P4657, DOI 10.1021/la980090+
   YAMADA N, 1990, MAKROMOL CHEM-RAPID, V11, P571
   Yamanaka H, 2003, ANAL CHEM, V75, P1658, DOI 10.1021/ac0263768
   Yamato M, 2000, BIOMATERIALS, V21, P981, DOI 10.1016/S0142-9612(99)00239-2
   Yamato M, 1999, J BIOMED MATER RES, V44, P44, DOI 10.1002/(SICI)1097-4636(199901)44:1<44::AID-JBM5>3.0.CO;2-X
   Yamato M, 2002, BIOMATERIALS, V23, P561, DOI 10.1016/S0142-9612(01)00138-7
   Yamato M, 2001, J BIOMED MATER RES, V55, P137, DOI 10.1002/1097-4636(200104)55:1<137::AID-JBM180>3.0.CO;2-L
   Yamato M, 2001, TISSUE ENG, V7, P473, DOI 10.1089/10763270152436517
   YOSHIDA R, 1995, NATURE, V374, P240, DOI 10.1038/374240a0
   Yoshizako K, 2002, ANAL CHEM, V74, P4160, DOI 10.1021/ac025523z
   YUI N, 1984, MAKROMOL CHEM-RAPID, V5, P805
   YUI N, 1984, MAKROMOL CHEM, V185, P2259
   YUI N, 1986, J BIOMED MATER RES, V20, P929, DOI 10.1002/jbm.820200708
NR 78
TC 180
Z9 192
U1 2
U2 58
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
J9 J CONTROL RELEASE
JI J. Control. Release
PD JAN 3
PY 2005
VL 101
IS 1-3
SI SI
BP 69
EP 84
DI 10.1016/j.jconrel.2004.08.026
PG 16
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 884LP
UT WOS:000226086800008
PM 15588895
DA 2018-10-19
ER

PT B
AU Lee, CC
   Kim, J
AF Lee, CC
   Kim, J
GP IEEE
TI Fundamentals of fluxless soldering technology
SO 2005 10th International Symposium on Advanced Packaging Materials:
   Processes, Properties and Interfaces
LA English
DT Proceedings Paper
CT 10th International Symposium on Advanced Packaging Materials
CY MAR 16-18, 2005
CL Irvine, CA
SP IEEE
DE fluxless bonding; fluxless soldering; tin-gold alloys; tin-gold solders
ID TRANSMISSION ELECTRON-MICROSCOPY; TIN MULTILAYER COMPOSITE;
   ROOM-TEMPERATURE; GOLD; JOINTS; COUPLES; AG
AB Fluxless (flux-free) soldering technology deals with investigating and developing techniques and methods that can eliminate the use of fluxes in the soldering process. The fluxless feature in soldering processes has become increasing more important and received more attention from industries because there are more and more devices and products that cannot take fluxes in the soldering process. Examples are MEMS devices, sensor devices, biomedical devices, and photonic devices. In addition, in flip-chip soldering processes with very small gap between chips and substrates, flux residues are hard to clean out or are embedded in the underfills. The residues may reduce the reliability of the resulting flip-chip devices.
   There are two basic fluxless approaches that have been reported. The first is to use chemicals or RF plasma to convert or to remove the oxide layer that already exists. The existence of oxide layer is the reason why the flux is needed in nearly all soldering operations. The second approach is to remove the root cause, which is solder oxidation. This is accomplished by producing the solder materials in a non-oxidizing environment, followed immediately by capping the solder with a barrier layer that would prevent oxygen from penetrating into the solder layer.
   In this paper, we first present the root cause of needing fluxes in the soldering process. The fluxless processes dealing with oxides are summarized. The four fundamental steps of the oxidation prevention approach are reported. A fluxless process based on Sn-rich Sn-Au alloys is described as an example to illustrate the fluxless fundamentals. Results show that strong and nearly void-free joints can indeed be produced using this new technology.
C1 Univ Calif Irvine, Irvine, CA 92697 USA.
RP Lee, CC (reprint author), Univ Calif Irvine, Irvine, CA 92697 USA.
CR BERANEK, 1997, P IEEE EL COMP TECHN, P755
   BERNIER, 1998, NATURE WHITE RESIDUE
   BUENE L, 1980, THIN SOLID FILMS, V65, P247, DOI 10.1016/0040-6090(80)90258-8
   BUENE L, 1980, THIN SOLID FILMS, V67, P95, DOI 10.1016/0040-6090(80)90292-8
   Chen YC, 1997, IEEE T COMPON PACK A, V20, P46, DOI 10.1109/95.558543
   Chuang RW, 2004, IEEE T COMPON PACK T, V27, P177, DOI 10.1109/TCAPT.2004.825757
   Chuang RW, 2002, IEEE T COMPON PACK T, V25, P453, DOI 10.1109/TCAPT.2002.801113
   Hong SM, 2004, IEEE T ADV PACKAGING, V27, P90, DOI 10.1109/TADVP.2003.821079
   KALLMAYER C, 1996, P 1996 IEEE CPMT INT, P18
   KIM DW, 2004, P IEEE EL COMP TECHN, P1642
   KOOPMAN N, 1993, P ELECTR C, P595, DOI 10.1109/ECTC.1993.346788
   LEE CC, 1995, MATER RES SOC SYMP P, V390, P225, DOI 10.1557/PROC-390-225
   LEE CC, 1993, IEEE T COMPON HYBR, V16, P311, DOI 10.1109/33.232058
   Lee CC, 2003, IEEE T COMPON PACK T, V26, P416, DOI 10.1109/TCAPT.2003.815109
   LEE CC, 1991, IEEE T COMPON HYBR, V14, P407, DOI 10.1109/33.87322
   Lin W, 1999, IEEE TRANS ADV PACK, V22, P592, DOI 10.1109/6040.803451
   MARINKOVIC Z, 1988, THIN SOLID FILMS, V156, P105, DOI 10.1016/0040-6090(88)90286-6
   Matijasevic G., 1994, International Journal of Microcircuits and Electronic Packaging, V17, P108
   MATIJASEVIC GS, 1993, THIN SOLID FILMS, V223, P276, DOI 10.1016/0040-6090(93)90533-U
   Matsuki H, 2001, INTERNATIONAL SYMPOSIUM ON ADVANCED PACKAGING MATERIALS: PROCESSES, PROPERTIES AND INTERFACES, PROCEEDINGS, P135, DOI 10.1109/ISAOM.2001.916563
   NAKAHARA S, 1981, THIN SOLID FILMS, V84, P185, DOI 10.1016/0040-6090(81)90468-5
   Okamoto H., 1987, PHASE DIAGRAM BINARY, P278
   Park CB, 2001, MATER TRANS, V42, P820, DOI 10.2320/matertrans.42.820
   So WW, 2000, IEEE T COMPON PACK T, V23, P377, DOI 10.1109/6144.846777
   *US DEP DEF, 1977, MILSTD883 US DEP DEF
   ZAKEL E, 1994, P 1994 IEMT S, P177
NR 26
TC 2
Z9 2
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-9085-7
PY 2005
BP 33
EP 38
PG 6
WC Engineering, Manufacturing; Engineering, Electrical & Electronic;
   Materials Science, Multidisciplinary; Physics, Condensed Matter
SC Engineering; Materials Science; Physics
GA BCO74
UT WOS:000230430400008
DA 2018-10-19
ER

PT S
AU Tzavaras, A
   Kontodimopoulos, N
   Monoyiou, E
   Kalatzis, I
   Piliouras, N
   Trapezanidis, I
   Cavouras, D
   Ventouras, E
AF Tzavaras, A.
   Kontodimopoulos, N.
   Monoyiou, E.
   Kalatzis, I.
   Piliouras, N.
   Trapezanidis, I.
   Cavouras, D.
   Ventouras, E.
GP IEEE
TI Upgrading undergraduate biomedical engineering laboratory training
SO 2005 27th Annual International Conference of the IEEE Engineering in
   Medicine and Biology Society, Vols 1-7
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 27th Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY AUG 31-SEP 03, 2005
CL Shanghai, PEOPLES R CHINA
SP IEEE Engn Med & Biol Soc, Chinese Acad Engn Sci
DE biomedical engineering; laboratory training; student-centered learning
ID EDUCATION
AB This paper presents the upgrading of biomedical engineering laboratory training at the Department of Medical Instrumentation Technology of the Technological Educational Institution of Athens (TEI-A), taking place in the framework of the "Upgrading of Undergraduate Curricula of TEI-A" project. The educational material of selected specialized laboratory sectors is totally renewed, and new sectors are introduced, so that student-centered learning is promoted utilizing advanced computer-enhanced educational environments. The current implementation status is presented for the laboratories dealing with biosignal acquisition, medical data digital processing and, more extensively, computer networks applications in medicine, where a training application simulating a Radiology Department computer network was developed. Benefits of the use of a balanced training approach, combining hands-on experience with computer simulations, are discussed.
C1 Inst Educ Technol, Dept Med Instrumentat Technol, Athens 12210, Greece.
RP Tzavaras, A (reprint author), Inst Educ Technol, Dept Med Instrumentat Technol, Agiou Spyridonas Str, Athens 12210, Greece.
CR Cook JL, 1998, BRAIN RES PROTOC, V3, P1, DOI 10.1016/S1385-299X(98)00012-9
   DREYER KJ, 2001, PACS GUIDE DIGITAL R
   Gunderman RB, 2003, RADIOLOGY, V227, P15, DOI 10.1148/radiol.2271021124
   Harris TR, 2002, ANNU REV BIOMED ENG, V4, P29, DOI 10.1146/annurev.bioeng.4.091701.125502
   Kontodimopoulos N., 2004, WSEAS Transactions on Advances in Engineering Education, V1, P42
   Kontodimopoulos N, 2004, P ANN INT IEEE EMBS, V26, P5184
   *NAT EL MAN ASS AM, 2003, DIG IM COMM MED DI 1
   Spencer JA, 1999, BRIT MED J, V318, P1280
NR 8
TC 1
Z9 1
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-8740-6
J9 P ANN INT IEEE EMBS
PY 2005
BP 353
EP 356
DI 10.1109/IEMBS.2005.1616417
PG 4
WC Engineering, Biomedical
SC Engineering
GA BER00
UT WOS:000238998400091
PM 17282186
DA 2018-10-19
ER

PT S
AU Blagosklonov, O
   Cardot, JC
   Roux, C
   Gharbi, T
   Picart, P
AF Blagosklonov, O.
   Cardot, J. C.
   Roux, C.
   Gharbi, T.
   Picart, P.
GP IEEE
TI The first experience of a dedicated biomedical education unit at the
   University of Franche-Comte
SO 2005 27th Annual International Conference of the IEEE Engineering in
   Medicine and Biology Society, Vols 1-7
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 27th Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY AUG 31-SEP 03, 2005
CL Shanghai, PEOPLES R CHINA
SP IEEE Engn Med & Biol Soc, Chinese Acad Engn Sci
AB Biomedical activity is rapidly expanding. Actually, the demand for hi-tech technologies in health is in constant increase. At the Franche-Comte High Institute of Engineers (ISIFC) an engineer can acquire the knowledge and skills to carry out various tasks in biomedical engineering field including academic research, in-hospital devices maintenance or industrial development.
   The main advantage of the ISIFC is that it offers an exceptional multidisciplinary programme thank to close cooperation between Besancon University Hospital professionals and Engineering Sciences professors and researchers. As a result, the graduates obtain real experience in the both fields.
   The majority of the ISIFC engineers are employed by firms producing and/or commercializing health-oriented materials and equipments such as Alcis, Arthesis, Aventis Pasteur, Biomerieux, Imasonic, Medos, Statice Santk, Sophysa, Symbios, Praxim, Protheos, Tornier, Zimmer etc.
C1 Inst Super Ingn Franche Comte, Besancon, France.
RP Blagosklonov, O (reprint author), Inst Super Ingn Franche Comte, Besancon, France.
OI GHARBI, Tijani/0000-0002-3620-2806
NR 0
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-8740-6
J9 P ANN INT IEEE EMBS
PY 2005
BP 361
EP 362
DI 10.1109/IEMBS.2005.1616419
PG 2
WC Engineering, Biomedical
SC Engineering
GA BER00
UT WOS:000238998400093
PM 17282188
DA 2018-10-19
ER

PT S
AU Lu, XY
   He, J
   Qin, T
   Jiang, DX
   Chen, W
AF Lu Xiaoying
   He Jian
   Qin Tian
   Jiang Dongxu
   Chen Wei
GP IEEE
TI Construction of multimedia courseware and web-based e-learning courses
   of "Biomedical Materials"
SO 2005 27th Annual International Conference of the IEEE Engineering in
   Medicine and Biology Society, Vols 1-7
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 27th Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY AUG 31-SEP 03, 2005
CL Shanghai, PEOPLES R CHINA
SP IEEE Engn Med & Biol Soc, Chinese Acad Engn Sci
DE multimedia courseware; web courses; Biomedical Materials
AB In order to reform the traditional teaching methodology and to improve the teaching effect, we developed new teaching system for course "Biomedical Materials" in our university by the support of the computer technique and Internet. The new teaching system includes the construction of the multimedia courseware and web-based e-learning courses. More than 2000 PowerPoint slides have been designed and optimized and flash movies for several capitals are included. On the basis of this multimedia courseware, a web-based educational environment has been established further, which includes course contents, introduction of the teacher, courseware. download, study forum, sitemap of the web, and relative link. The multimedia courseware has been introduced in the class teaching for "Biomedical Materials" for 6 years and a good teaching effect has been obtained. The web-based e-learning courses have been constructed for two years and proved that they are helpful for the students by their preparing and reviewing the teaching contents before and after the class teaching.
C1 SE Univ, Biomed & Engn Dept, State Key Lab Bioelect, Nanjing 210096, Peoples R China.
RP Lu, XY (reprint author), SE Univ, Biomed & Engn Dept, State Key Lab Bioelect, Nanjing 210096, Peoples R China.
CR BUYENS J, 2002, MICROSOFT FRONTPAGE
   Gu H. Q., 1993, BIOMEDICAL MAT
   HU B, 2004, ASP NETWORK PROGRAMM
   LI BL, 2002, MASTER ELECT DEMO
   LIU K, 2002, 80 WONDERFUL EXAMPLE
   SONG TY, 2001, MULTIMEDIA DEMO METH
   WANG J, 2002, CONTACT PHOTOSHOP 6
   YU MS, 1993, TODAY TOMORROW BIOME
   YU YT, 2000, BIOMEDICAL MAT
   ZHU ZS, 2002, MASTER FLASH MX SHOR
NR 10
TC 1
Z9 1
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-8740-6
J9 P ANN INT IEEE EMBS
PY 2005
BP 2886
EP 2889
DI 10.1109/IEMBS.2005.1617077
PG 4
WC Engineering, Biomedical
SC Engineering
GA BER00
UT WOS:000238998402179
PM 17282846
DA 2018-10-19
ER

PT S
AU Lymberis, A
AF Lymberis, A.
GP IEEE
TI Wearable Health Systems and Applications: The contribution of
   Information & Communication Technologies
SO 2005 27th Annual International Conference of the IEEE Engineering in
   Medicine and Biology Society, Vols 1-7
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 27th Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY AUG 31-SEP 03, 2005
CL Shanghai, PEOPLES R CHINA
SP IEEE Engn Med & Biol Soc, Chinese Acad Engn Sci
DE smart wearable; health systems; biomedical sensors; Information &
   Communication Technologies
ID DISEASE MANAGEMENT; INTELLIGENT
AB The interest for wearable health systems originates mainly from the need to extend health services out of the hospital and monitor patients over extensive periods of time. Smart Wearable Health Systems (SWHS) are integrated systems in contact with or near to the body able to sense, (and/or act), process and communicate biomedical and physical parameters. Significant advances in biomedical technology, materials engineering, micro/nanotechnologies and Information and Communication Technologies (ICT) lead to new possibilities for increasing miniaturisation, communication capabilities and system "intelligence". The new possibilities for wearable monitoring are mainly provided at the level of microsensors, wrist and other body worn devices, and smart biomedical clothing. Research and development in these areas has been strongly supported through public funding and private investments worldwide. In Europe the major R&D activities were promoted and supported by the European Commission, Information Society Technologies (IST) programme, mainly through health telematics (telemedicine, e-Health) and micro-nano technologies activities. The aim of these projects was the development and testing of innovative integrated user-friendly systems, environments and scenarios of use that could lead to market exploitation in a short to mid term future (3-5 years). This paper presents the rationale and the results of research on wearable health systems in Europe and comments on the current challenges and futures perspectives in the field.
C1 Commiss European Communities, Informat Soc Directorate Gen, B-1049 Brussels, Belgium.
RP Lymberis, A (reprint author), Commiss European Communities, Informat Soc Directorate Gen, B-1049 Brussels, Belgium.
CR BONATO P, 2003, IEEE ENG MED BIO JUN, P18
   DITTMAR A, 2003, P 25 ANN INT C IEEE, V4, P3744
   Doughty K, 1996, J Telemed Telecare, V2, P71, DOI 10.1258/1357633961929826
   Hovorka Roman, 2004, Diabetes Technol Ther, V6, P307, DOI 10.1089/152091504774197990
   Lauter J., 2004, STUDIES HLTH TECHNOL, P34
   Lymberis A, 2003, TELEMED J E-HEALTH, V9, P379, DOI 10.1089/153056203772744716
   LYMBERIS A, 2004, STUDIES HLTH TECHNOL, V104, P155
   Marculescu D., 2003, P IEEE, V91, P1991
   PARADISO R, 2003, P 25 ANN INT C IEEE, V4, P3720
   Rubel P, 2001, COMPUT CARDIOL, V28, P193, DOI 10.1109/CIC.2001.977624
   van Halteren Aart, 2004, Stud Health Technol Inform, V108, P181
   WEBER L, 2004, STUDIES HLTH TECHNOL, V108, P260
   Weingarten SR, 2002, BRIT MED J, V325, P925, DOI 10.1136/bmj.325.7370.925
   Wilkinson J.M, 2002, INT NEWSLETTER M SEP, V4, P37
NR 14
TC 3
Z9 3
U1 1
U2 14
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 0-7803-8740-6
J9 P ANN INT IEEE EMBS
PY 2005
BP 4149
EP 4152
DI 10.1109/IEMBS.2005.1615377
PG 4
WC Engineering, Biomedical
SC Engineering
GA BER00
UT WOS:000238998403208
PM 17281147
DA 2018-10-19
ER

PT B
AU Lymberis, A
AF Lymberis, A
GP IEEE
TI Progress in R&D on wearable and implantable biomedical sensors for
   better healthcare and medicine
SO 2005 3rd IEEE/EMBS Special Topic Conference on Microtechnology in
   Medicine and Biology
SE IEEE Engineering in Medicine and Biology Society Annual Conference
   (EMBS)
LA English
DT Proceedings Paper
CT 3rd IEEE/EMBS Special Topic Conference on Microtechnology in Medicine
   and Biology
CY MAY 12-15, 2005
CL Oahu, HI
SP IEEE, EMBS
DE wearable biomedical sensors; implantable biomedical sensors;
   microtechnologies
AB The management and coordination of healthcare and medicine throughout the entire range of services. from primary to tertiary care. undergo fundamental changes such as, more emphasis on prevention and education or users. new ways or delivering care and empowerment or individuals to manage their own health. This is being possible mainly thanks to extraordinary progress in sciences and technologies e.g. micro and nano technologies, mobile communications, human computer interface and genomics. Integrated smart micro and nano systems provide large spectrum of solutions spanning from health monitoring and diagnosis at the point of care, to chronic diseases management. healthy lifestyle support and human performance monitoring and assessment.
   Communicative biomedical sensors/biosensors and wearable integrated systems are becoming major driving forces for cutting edge developments. Further research in the intersection or disciplines like micro-nano technologies, materials, physiology/biology/medicine and Information & Communication Technologies (ICT) is necessary in order to achieve highly performing. user-friendly, and cost-effective wearable and implantable medical/healthcare systems.
C1 European Commiss, Informat Soc Directorate Gen, Brussels, Belgium.
RP Lymberis, A (reprint author), European Commiss, Informat Soc Directorate Gen, Brussels, Belgium.
CR Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423
   DEROSSI D, 2000, 1 ANN INT IEEE EMBS
   DITTMAR A, 1997, BIOMEDICAL MICROSENS, P13
   KIMBERLEY TJ, 2002, NEUROMUSCULAR ELECT, V85
   Lymberis A, 2003, TELEMED J E-HEALTH, V9, P379, DOI 10.1089/153056203772744716
   Wilkinson J.M, 2002, INT NEWSLETTER M SEP, V4, P37
   1999, TEL 21 CENT OPP CIT
NR 7
TC 1
Z9 1
U1 1
U2 8
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-8711-2
J9 ENG MED BIOL SOC ANN
PY 2005
BP 296
EP 298
DI 10.1109/MMB.2005.1548453
PG 3
WC Engineering, Biomedical
SC Engineering
GA BDL92
UT WOS:000234204800090
DA 2018-10-19
ER

PT B
AU Perale, G
   Maccagnan, S
   Contro, R
AF Perale, G
   Maccagnan, S
   Contro, R
GP IEEE
TI Novel technological process to manufacture ceramic microelectrodes for
   biomedical applications implying microextrusion of preceramic precursors
SO 2005 3rd IEEE/EMBS Special Topic Conference on Microtechnology in
   Medicine and Biology
SE IEEE Engineering in Medicine and Biology Society Annual Conference
   (EMBS)
LA English
DT Proceedings Paper
CT 3rd IEEE/EMBS Special Topic Conference on Microtechnology in Medicine
   and Biology
CY MAY 12-15, 2005
CL Oahu, HI
SP IEEE, EMBS
DE ceramic-based microelectrodes; preceramic polymers; electrically
   conductive ceramics; extrusion
ID MULTISITE MICROELECTRODES
AB A novel technological process is under development to obtain ceramic microelectrodes from preceramic precursors, basically for biomedical applications. A microextrusion approach is applied. Commercially available silicone resins are used as preceramic polymers. Drugging with carbon black results in electrically conductive ceramics. A coextrusion approach is used to obtain the filament with inner conductive lines. Chemical reticulation and pyrolysis are applied to convert polymeric resins into ceramics. Some different geometries of profiles and cross sections can be considered and obtained. Circular microelectrodes can be provided with diameters in the range between 100 mu m and 5mm and wide coextrusion dimension ratios are obtainable. Preliminary results on filaments with diameter between 100 mu m and 500 mu m showed bending strength ranging from 30MPa to 1100MPa and average conductivity of 0.375 1/Omega cm for a 50% weight carbon black load. Selecting such characteristics and related materials mainly depends on specific applications. Biomedical electrodes can be devised as stimulators or sensors in neurosurgery, beep brain stimulation and cell biology. It's important to achieve strict control of the above characteristics demanded by desired performances and obtained by suitably adjusting the technological process. Such control is hard to attain for great sensitiveness of some features of microgeometry and micro-structure to process parameters.
C1 Politecn Milan, Dept Bioengn, I-20133 Milan, Italy.
RP Perale, G (reprint author), Politecn Milan, Dept Bioengn, Via Golgi 39, I-20133 Milan, Italy.
CR Burmeister JJ, 2001, ANAL CHEM, V73, P1037, DOI 10.1021/ac0010429
   Burmeister JJ, 2000, ANAL CHEM, V72, P187, DOI 10.1021/ac9907991
   Colombo P, 2003, J AM CERAM SOC, V86, P1025, DOI 10.1111/j.1151-2916.2003.tb03413.x
   Interrante L. V., 1998, CHEM ADV MAT
   MACCAGNAN G, Patent No. 03011791
   MOXON K, 2005, IN PRESS CERAMIC BAS
   Pantano CG, 1999, J SOL-GEL SCI TECHN, V14, P7, DOI 10.1023/A:1008765829012
NR 7
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-8711-2
J9 ENG MED BIOL SOC ANN
PY 2005
BP 323
EP 325
DI 10.1109/MMB.2005.1548461
PG 3
WC Engineering, Biomedical
SC Engineering
GA BDL92
UT WOS:000234204800098
DA 2018-10-19
ER

PT B
AU Zhu, XY
   Mills, KL
   Peters, PR
   Naruse, K
   Csete, ME
   Thouless, MD
   Takayama, S
AF Zhu, XY
   Mills, KL
   Peters, PR
   Naruse, K
   Csete, ME
   Thouless, MD
   Takayama, S
GP IEEE
TI Reconfigurable protein matrices for prolonged neuroblasts patterning and
   retraction
SO 2005 3rd IEEE/EMBS Special Topic Conference on Microtechnology in
   Medicine and Biology
SE IEEE Engineering in Medicine and Biology Society Annual Conference
   (EMBS)
LA English
DT Proceedings Paper
CT 3rd IEEE/EMBS Special Topic Conference on Microtechnology in Medicine
   and Biology
CY MAY 12-15, 2005
CL Oahu, HI
SP IEEE, EMBS
DE micro/nano fabrication; patterning; ECM
ID SURFACES; CELLS; MODEL
AB Here we present long-term patterning and response studies of neuroblasts on arrays of extracellular matrix (ECM) protein lines fabricated by cracking a polymer-supported thin film and selectively depositing proteins inside the cracks. Neuroblasts cultured for five days on the protein matrix switched between spreading and retraction upon changing the protein line width. This technique provides a novel tool to pursue further understanding of the basic mechanisms of neuroblast pathfinding on adhesion and morphology. Biomedical device design will also benefit from materials engineered with the reconfigurable protein patterns.
C1 Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
RP Zhu, XY (reprint author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
CR Clarkson ED, 1999, P SOC EXP BIOL MED, V222, P157, DOI 10.1046/j.1525-1373.1999.d01-126.x
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Elbert DL, 2001, BIOMACROMOLECULES, V2, P430, DOI 10.1021/bm0056299
   Hutchinson JW, 1992, ADV APPL MECH, V29, P64
   Jiang XY, 2003, J AM CHEM SOC, V125, P2366, DOI 10.1021/ja029485c
   Nelson CM, 2003, LANGMUIR, V19, P1493, DOI 10.1021/la026178b
   OKANO T, 1995, BIOMATERIALS, V16, P297, DOI 10.1016/0142-9612(95)93257-E
   SANES DH, 2000, DEV NERVOUS SYSTEM
   Schutt M, 2003, CHEM BIOL, V10, P487, DOI 10.1016/S1074-5521(03)00128-5
   THOULESS MD, 1990, J AM CERAM SOC, V73, P2144, DOI 10.1111/j.1151-2916.1990.tb05290.x
   Yeo WS, 2003, J AM CHEM SOC, V125, P14994, DOI 10.1021/ja038265b
   ZHU X, 2005, IN PRESS NATURE MAT
NR 12
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-8711-2
J9 ENG MED BIOL SOC ANN
PY 2005
BP 393
EP 395
DI 10.1109/MMB.2005.1548485
PG 3
WC Engineering, Biomedical
SC Engineering
GA BDL92
UT WOS:000234204800122
DA 2018-10-19
ER

PT B
AU Nishizawa, M
   Kaji, H
AF Nishizawa, M
   Kaji, H
GP IEEE
TI Electrochemical bio-lithography for in situ control of cellular adhesion
   and growth on a chip
SO 2005 3rd IEEE/EMBS Special Topic Conference on Microtechnology in
   Medicine and Biology
SE IEEE Engineering in Medicine and Biology Society Annual Conference
   (EMBS)
LA English
DT Proceedings Paper
CT 3rd IEEE/EMBS Special Topic Conference on Microtechnology in Medicine
   and Biology
CY MAY 12-15, 2005
CL Oahu, HI
SP IEEE, EMBS
DE patterning; cells; microelectrode
ID CELLS
AB Controlling the interfaces between cells and materials is important subject for a wide range of research fields such as cell biology, tissue engineering, and biomedical devices. Here we report a novel electrochemical method to direct the adhesion and growth of mammalian cells on a substrate during cultivation in situ, named "Electrochemical Bio-Lithography". We found that the cell-repellent nature of the albumin- or heparin-coated substrates can be locally switched to cell-adhesive, by treatment with hypobromous acid electrochemically generated at the tip of the scanning microelectrode. Since this technique can be conducted under typical physiological conditions, we were able to direct cellular proliferation and migration by drawing adhesive micropatterns over the preexisting cellular pattern. The integration of this electrochemical system into a microfluiclic device will provide a novel type of cell-chip which enables on-demand immobilization of cells just prior to the use of devices.
C1 Tohoku Univ, Grad Sch Engn, Dept Bioengn & Robot, Sendai, Miyagi 980, Japan.
RP Nishizawa, M (reprint author), Tohoku Univ, Grad Sch Engn, Dept Bioengn & Robot, Sendai, Miyagi 980, Japan.
CR Kaji H, 2004, LANGMUIR, V20, P16, DOI 10.1021/la035537f
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   Li Nianzhen, 2003, Crit Rev Biomed Eng, V31, P423, DOI 10.1615/CritRevBiomedEng.v31.i56.20
   NAJI H, 2004, J AM CHEM SOC, V126, P15026
   Nishizawa M, 2002, LANGMUIR, V18, P3645, DOI 10.1021/la011576k
NR 5
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-8711-2
J9 ENG MED BIOL SOC ANN
PY 2005
BP 396
EP 397
DI 10.1109/MMB.2005.1548486
PG 2
WC Engineering, Biomedical
SC Engineering
GA BDL92
UT WOS:000234204800123
DA 2018-10-19
ER

PT B
AU Chen, CJ
   Haik, Y
   Chatterjee, J
AF Chen, CJ
   Haik, Y
   Chatterjee, J
GP IEEE
TI Development of nanotechnology for biomedical applications
SO 2005 Emerging Information Technology Conference (EITC)
LA English
DT Proceedings Paper
CT Emerging Information Technology Conference (EITC)
CY AUG 15-16, 2005
CL Taipei, TAIWAN
AB This presentation discusses the technological advancement in nanotechnology and some aspects of applications in engineering devices and biotechnologies. The lecture outlines the logical development of technology and engineering following (1) initiation of idea and visualization, (2) ability to control and measurements and (3) intense effort in engineering developments. The talk includes a brief review of the historical development in biology, nano and potential applications of electro-magnetic phenomena. The talk also describes the activities in the Center for Nanomagnetics and Biotechnology for clinical applications using nanomagnetic particles. Several magnetic phenomena in life sciences are illustrated. Brief discussions of nano materials are introduced. The lecture then concludes with possible near term applications and long term developments of nanotechnology in biomedical and bioengineering.
C1 Florida State Univ, Ctr Nanomagnet & Biotechnol, Coll Engn, Florida A&M Univ, Tallahassee, FL 32310 USA.
RP Chen, CJ (reprint author), Florida State Univ, Ctr Nanomagnet & Biotechnol, Coll Engn, Florida A&M Univ, Tallahassee, FL 32310 USA.
CR CHEN CJ, 2003, RECENT RES DEV MAGNE
   CHEN CJ, 2004, HDB THEORETICAL COMP
NR 2
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-9328-7
PY 2005
BP 9
EP 12
PG 4
WC Computer Science, Information Systems; Computer Science,
   Interdisciplinary Applications; Engineering, Biomedical; Engineering,
   Electrical & Electronic
SC Computer Science; Engineering
GA BDZ91
UT WOS:000236376100003
DA 2018-10-19
ER

PT S
AU Lin, HY
   Lin, CP
   Lee, GB
   Chou, TC
AF Lin, HY
   Lin, CP
   Lee, GB
   Chou, TC
GP IEEE
TI The recognition of lysozyme by patterned molecularly imprinted polymers
SO 2005 IEEE 31ST ANNUAL NORTHEAST BIOENGINEERING CONFERENCE
SE Annual IEEE Northeast Bioengineering Conference
LA English
DT Proceedings Paper
CT IEEE 31st Annual Northeast Bioengineering Conference
CY APR 02-03, 2005
CL Stevens Inst Technol, Hoboken, NJ
SP IEEE, EMB
HO Stevens Inst Technol
AB Micro-Electro-Mechanical-System (MEMS) micro-sensing devices have recently been extensively researched for their application in biomedical diagnostics. Molecularly imprinted polymers with highly specific binding to targets and their low cost have potential for use in devices as sensing materials. Both techniques were combined to synthesize localized molecularly imprinted polymers (MIPS) by microcontact printing for integration in a micro-total analysis system (mu TAS).
C1 Natl Cheng Kung Univ, Dept Chem Engn, Tainan 70101, Taiwan.
RP Lin, HY (reprint author), Natl Cheng Kung Univ, Dept Chem Engn, Tainan 70101, Taiwan.
RI Lee, Gwo-Bin/D-3032-2012
OI Lee, Gwo-Bin/0000-0001-6910-9133
CR BERNARD A, 1998, LANGMUIR, V14, P2226
   Dickert FL, 1999, TRAC-TREND ANAL CHEM, V18, P192, DOI 10.1016/S0165-9936(98)00123-X
   Katz A, 2000, NATURE, V403, P286, DOI 10.1038/35002032
   Shi HQ, 1999, NATURE, V398, P593
   Xia YN, 1999, CHEM REV, V99, P1823, DOI 10.1021/cr980002q
NR 5
TC 1
Z9 1
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0277-1063
BN 0-7803-9105-5
J9 NORTHEAST BIOENGIN C
PY 2005
BP 40
EP 41
PG 2
WC Engineering, Biomedical
SC Engineering
GA BCO98
UT WOS:000230459300019
DA 2018-10-19
ER

PT S
AU Nishizawa, Y
   Takeda, S
   Obara, M
   Hongo, A
AF Nishizawa, Y
   Takeda, S
   Obara, M
   Hongo, A
GP IEEE
TI Biomedical material ablation by femtosecond laser double pulses through
   small-core hollow fibers
SO 2005 IEEE LEOS Annual Meeting Conference Proceedings (LEOS)
SE IEEE Lasers and Electro-Optics Society (LEOS) Annual Meeting
LA English
DT Proceedings Paper
CT 18th Annual Meeting of the IEEE-Lasers-and-Electro-Optical-Society
CY OCT 22-28, 2005
CL Sydney, AUSTRALIA
SP IEEE Lasers & Elect Opt Soc
C1 Keio Univ, Dept Elect & Elect Engn, Kohoku Ku, Yokohama, Kanagawa 2138522, Japan.
RP Nishizawa, Y (reprint author), Keio Univ, Dept Elect & Elect Engn, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2138522, Japan.
CR Matsuura Y, 2002, J APPL PHYS, V91, P887, DOI 10.1063/1.1425070
   Ozono K, 2003, APPL PHYS A-MATER, V77, P303, DOI 10.1007/s00339-003-2119-3
NR 2
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1092-8081
BN 0-7803-9217-5
J9 IEEE LEOS ANN MTG
PY 2005
BP 93
EP 94
DI 10.1109/LEOS.2005.1547894
PG 2
WC Engineering, Electrical & Electronic; Optics
SC Engineering; Optics
GA BDR62
UT WOS:000235109700049
DA 2018-10-19
ER

PT S
AU Herraiz, JL
   Espana, S
   Udias, JM
   Vaquero, JJ
   Desco, M
AF Herraiz, J. L.
   Espana, S.
   Udias, J. M.
   Vaquero, J. J.
   Desco, M.
BE Yu, B
TI Statistical reconstruction methods in PET: Resolution limit, noise, edge
   artifacts and considerations for the design of better scanners
SO 2005 IEEE Nuclear Science Symposium Conference Record, Vols 1-5
SE IEEE NUCLEAR SCIENCE SYMPOSIUM - CONFERENCE RECORD
LA English
DT Proceedings Paper
CT Nuclear Science Symposium/Medical Imaging Conference
CY OCT 23-29, 2005
CL Fajardo, PR
SP IEEE Nucl & Plasma Sci Soc, Brookhaven Natl Lab, CEA Saclay, DOE, CERN, Lawrence Berkeley Natl Lab, Lawrence Livermore Natl Lab, Stanford Linear Accelerator Ctr, Univ Calif Davis, Univ Washington
DE image reconstruction; positron emission tomography; resolution limit;
   noise; iterative methods; MLEM; OSEM
ID EMISSION-TOMOGRAPHY
AB Small animal positron emission tomography (PET) scanners are being increasingly used as a basic measurement tool in modern biomedical research. The new designs and technologies of these scanners and the modern reconstruction methods have allowed to reach high spatial resolution and sensitivity. Despite their successes, some important issues remain to be addressed in high resolution PET imaging. First, iterative reconstruction methods like maximum likelihood-expectation maximization (MLEM) are known to recover resolution, but also to create noisy images and edge artifacts if some kind of regularization is not imposed. Second, the limit of resolution achievable by iterative methods on high resolution scanners is not quantitatively understood. Third, the use of regularization methods like Sieves or maximum a posteriori (MAP) requires the determination of the optimal values of several adjustable parameter that may be object-dependent.
   In this work we review these problems in high resolution PET and establish that the origin of them is more related with the physical effects involved in the emission and detection of the radiation during the acquisition than with the kind of iterative reconstruction method chosen. These physical effects (positron range, non-collinearity, scatter inside the object and inside the detector materials) cause that the tube of response (TOR) that connects the voxels with a line of response (LOR) is rather thick. This implies that the higher frequencies of the patient organ structures are not recorded by the scanner and therefore cannot be recovered during the reconstruction. As iterations grow, MLEM algorithms try to recover higher frequencies in the image. Once that a certain critic frequency is reached, this only maximizes high frequency noise.
   Using frequency response analyses techniques, we determine the maximum achievable resolution, before edge artifacts spoil the quality of the image, for a particular scanner as a function of the thickness of the TOR, and independently of the reconstruction method employed. With the same techniques, we can deduce well defined stopping criteria for reconstructions methods. Also, criteria for the highest number of subsets which should be used and how the design of the scanners can be optimized when statistical reconstruction methods are employed, is established.
C1 Univ Complutense Madrid, Dpto Fis Atom Mol & Nucl, Madrid, Spain.
RP Herraiz, JL (reprint author), Univ Complutense Madrid, Dpto Fis Atom Mol & Nucl, Madrid, Spain.
RI Vaquero, Juan Jose/D-3033-2009; Desco, Manuel/D-2822-2009; Espana,
   Samuel/E-9240-2010; Udias, Jose/A-7523-2010; LOPEZ HERRAIZ,
   JOAQUIN/E-9234-2010
OI Vaquero, Juan Jose/0000-0001-9200-361X; Desco,
   Manuel/0000-0003-0989-3231; Espana, Samuel/0000-0001-9092-4597; Udias,
   Jose/0000-0003-3714-764X; LOPEZ HERRAIZ, JOAQUIN/0000-0001-7208-8863
CR Bettinardi V, 2002, EUR J NUCL MED, V29, P7, DOI 10.1007/s002590100651
   Boreman GD, 2001, MODULATION TRANSFER
   BROWNE J, 1996, IEEE T MED IMAG, V15
   HERRAIZ JL, 2004, IEEE NUC SCI S MED I, P106, DOI UNSP M05-106
   POLITTE DG, 1988, IEEE T NUCL SCI, V35, P608, DOI 10.1109/23.12796
   SABBA N, 2002, IEEE NUC SCI S MED I, DOI UNSP M11-170-
   Shepp L A, 1982, IEEE Trans Med Imaging, V1, P113, DOI 10.1109/TMI.1982.4307558
   Slijpen ETP, 1999, IEEE T NUCL SCI, V46, P2233, DOI 10.1109/23.819309
   SNYDER DL, 1987, IEEE T MED IMAGING, V6, P228, DOI 10.1109/TMI.1987.4307831
NR 9
TC 1
Z9 1
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1082-3654
BN 0-7803-9221-3
J9 IEEE NUCL SCI CONF R
PY 2005
BP 1846
EP 1850
PG 5
WC Instruments & Instrumentation; Nuclear Science & Technology; Radiology,
   Nuclear Medicine & Medical Imaging
SC Instruments & Instrumentation; Nuclear Science & Technology; Radiology,
   Nuclear Medicine & Medical Imaging
GA BFH22
UT WOS:000241851903003
DA 2018-10-19
ER

PT S
AU Sboros, V
   Glynos, E
   Butler, M
   Moran, CM
   Ross, J
   Pye, SD
   McDicken, WN
   Koutsos, V
AF Sboros, V
   Glynos, E
   Butler, M
   Moran, CM
   Ross, J
   Pye, SD
   McDicken, WN
   Koutsos, V
GP IEEE
TI Microbubble nano-interrogation using the Atomic Force Microscope
SO 2005 IEEE Ultrasonics Symposium, Vols 1-4
SE ULTRASONICS SYMPOSIUM
LA English
DT Proceedings Paper
CT IEEE International Ultrasonics Symposium
CY SEP 18-21, 2005
CL Rotterdam, NETHERLANDS
SP IEEE
ID CONTRAST AGENT MICROBUBBLES; BEHAVIOR; CAMERA
AB The Atomic Force Microscope (AFM) is a versatile tool that provides spatial and force resolution of the order of Angstroms and subnationewtons, respectively; therefore, it is ideally suited to study morphology and mechanical properties of materials at the nanometer scale. This paper introduces the use of the AFM to study the topography and the mechanical properties of individual biSphere (R) microbubbles (Point Biomedical Corp, San Carlos, CA, USA) microbubbles. The Bioscope AFM (Veeco, Santa Barbara, CA, USA) was used for the measurements: a) Tapping mode AFM was used for imaging, with cantilevers resonating at 5-8 kHz (NP-20, Veeco). b) Contact mode AFM was used for mechanical measurements using tipless cantilevers (NSC-20, MikroMash, Spain) with spring constants ranging from 0.03-15 N/m.
   The resolution of the topography of the microbubble was as small as 20 nm. Such figures are comparable with data from electron microscopy, but AFM provides superior flexibility as it can interrogate microbubbles in various chemical and physical environments (in liquid at a range of different temperatures, pressures and viscosities). Optimal measurements of the stiffness of microbubbles ranging in size from 1-10 mu m was provided by cantilevers between 0.3-0.6 N/m as cantilevers with lower spring constant were too soft for the measurements, and higher spring constant would destroy the microbubbles. The stiffness (effective spring constant) of the microbubbles ranged between 1 and 5 N/m. These measurements can be translated to shell properties by using an appropriate model for the shape and structure of the microbubbles.
C1 Univ Edinburgh, Sch Clin Sci & Community Hlth, Edinburgh EH8 9YL, Midlothian, Scotland.
RP Sboros, V (reprint author), Univ Edinburgh, Sch Clin Sci & Community Hlth, Edinburgh EH8 9YL, Midlothian, Scotland.
RI Glynos, Emmanouil/M-2571-2015
OI Sboros, Vassilis/0000-0002-9133-7252; Koutsos,
   Vasileios/0000-0002-2203-8179
CR BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   Chin CT, 2003, REV SCI INSTRUM, V74, P5026, DOI 10.1063/1.1626013
   de Jong N, 2000, ULTRASOUND MED BIOL, V26, P487, DOI 10.1016/S0301-5629(99)00159-3
   Hertz H., 1882, J REINE ANGEW MATH, V92, P156, DOI DOI 10.1515/CRLL.1882.92.156
   Morgan KE, 2000, IEEE T ULTRASON FERR, V47, P1494, DOI 10.1109/58.883539
   Postema M, 2004, ULTRASOUND MED BIOL, V30, P1337, DOI 10.1016/j.ultrasmedbio.2004.08.008
   Sboros V, 2003, ULTRASOUND MED BIOL, V29, P687, DOI 10.1016/S0301-5629(03)00027-9
   SBOROS V, 2002, IEEE ULTR S, P1897
   Vinogradova OI, 2004, J PHYS-CONDENS MAT, V16, pR1105, DOI 10.1088/0953-8984/16/32/R01
NR 9
TC 0
Z9 0
U1 0
U2 4
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1051-0117
BN 0-7803-9382-1
J9 ULTRASON
PY 2005
BP 985
EP 987
PG 3
WC Acoustics; Engineering, Biomedical; Physics, Applied
SC Acoustics; Engineering; Physics
GA BDY24
UT WOS:000236090701065
DA 2018-10-19
ER

PT B
AU Pau, JL
   Rivera, C
   Pereiro, J
   Navarro, A
   Munoz, E
AF Pau, JL
   Rivera, C
   Pereiro, J
   Navarro, A
   Munoz, E
GP IEEE
TI Ultraviolet and visible nitride photodetectors: Applications
SO 2005 SPANISH CONFERENCE ON ELECTRON DEVICES, PROCEEDINGS
LA English
DT Proceedings Paper
CT 5th Spanish Conference on Electron Devices
CY FEB 02-04, 2005
CL Tarragona, SPAIN
SP Minist Educ & Ciencia, gencat, Diputacio Tarragona, Red IberNAM, LEAR Corp, La Caixa, Univ Rovira Virgili, IEEE Electron Devices Soc
ID III NITRIDES; GAN; SKIN
AB One of the main interests of wide-bandgap materials such as diamond, Ill-nitrides or SiC is their intrinsic ability to perform selective ultraviolet detection. Over the rest, Ill-nitrides present the undoubted advantage of tuning the absorption edge in a wide spectral range by varying the At and In mole fractions in AlGaN and InGaN ternary alloys. This property makes them suited for many applications in the ultraviolet and visible ranges. This work presents a short view of fabrication and spectral responses of AlGaN- and InGaN-based photodetectors and their potential use in industrial, environment, military and biomedical research. For visible detection, as an alternative to InGaN bulk-based devices, InGaN/GaN multiple-quantum-well (MQW) photodiodes are also described.
C1 ETSI Telecomunicac, ISOM, E-28040 Madrid, Spain.
RP Pau, JL (reprint author), ETSI Telecomunicac, ISOM, Ciudad Univ, E-28040 Madrid, Spain.
EM jlpau@die.upm.es
RI Navarro-Tobar, Alvaro/K-7864-2014; Pau, Jose Luis/L-1193-2014
OI Navarro-Tobar, Alvaro/0000-0003-3606-1780; Pereiro Viterbo,
   Juan/0000-0002-2582-3498
CR Ambacher O, 1998, J PHYS D APPL PHYS, V31, P2653, DOI 10.1088/0022-3727/31/20/001
   Carrano JC, 1997, ELECTRON LETT, V33, P1980, DOI 10.1049/el:19971322
   Look DC, 2001, PHYS STATUS SOLIDI B, V228, P293, DOI 10.1002/1521-3951(200111)228:1<293::AID-PSSB293>3.0.CO;2-F
   MACLAUGHLIN JA, 1982, SCIENCE, V216, P1001, DOI 10.1126/science.6281884
   Munoz E, 2004, NATO SCI SER II MATH, V144, P161
   Munoz E, 2001, J PHYS-CONDENS MAT, V13, P7115, DOI 10.1088/0953-8984/13/32/316
   Pau JL, 2004, J APPL PHYS, V95, P8275, DOI 10.1063/1.1748855
   Pau JL, 2002, P SOC PHOTO-OPT INS, V4650, P104, DOI 10.1117/12.467653
   Pearton SJ, 2000, MAT SCI ENG R, V30, P55, DOI 10.1016/S0927-796X(00)00028-0
   Rivera C, 2004, SUPERLATTICE MICROST, V36, P849, DOI 10.1016/j.spmi.2004.09.040
   Rivera C, 2004, PHYS STATUS SOLIDI A, V201, P2658, DOI 10.1002/pssa.200405019
   SETLOW RB, 1974, P NATL ACAD SCI USA, V71, P3363, DOI 10.1073/pnas.71.9.3363
NR 12
TC 0
Z9 0
U1 1
U2 4
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-8810-0
PY 2005
BP 7
EP 10
PG 4
WC Engineering, Electrical & Electronic; Instruments & Instrumentation;
   Optics
SC Engineering; Instruments & Instrumentation; Optics
GA BCM87
UT WOS:000230064900002
DA 2018-10-19
ER

PT B
AU Blagosklonov, O
   Cardot, JC
   Roux, C
   Gharbi, T
   Picart, P
AF Blagosklonov, Oleg
   Cardot, Jean-Claude
   Roux, Cristophe
   Gharbi, Tijani
   Picart, Philippe
BE Malpica, F
   Welsch, F
   Tremante, A
   Lawler, J
TI Institut Superieur d'Ingenieurs de Franche-Comte: Dual skills for high
   level bio-medical engineers
SO 3rd International Conference on Education and Information Systems:
   Technologies and Applications, Vol 1, Proceedings
LA English
DT Proceedings Paper
CT 3rd International Conference on Education and Information Systems
CY JUL 14-17, 2005
CL Orlando, FL
SP Int Inst Informat & Syst, Int Federat Syst Res
DE biomedical education; multidisciplinary; cooperation academic education
AB Biomedical activity is rapidly expanding. Actually, the demand for hi-tech technologies in health is in constant increase. At the High Institute of Engineers of Franche Comte (ISIFC) an engineer can acquire the knowledge and skins to carry out various tasks in biomedical engineering field including academic research, in-hospital devices maintenance or industrial development.
   The main advantage of the ISICF is that it offers an exceptional multidisciplinary programme thank to close cooperation between Besancon University Hospital professionals and Engineering Sciences professors and researchers. As a result, the graduates obtain real experience in the both fields.
   The majority of the ISIFC engineers are employed by firms producing and/or commercializing health-oriented materials and equipments such as Alcis, Arthesis, Aventis Pasteur, Biomdrieux, Imasonic, Medos, Statice Sante, Sophysa, Symbios, Praxim, Protheos, Tornier, Zimmer etc.
C1 Inst Super Ingn Franche Comte, Besancon, France.
OI GHARBI, Tijani/0000-0002-3620-2806
NR 0
TC 0
Z9 0
U1 0
U2 0
PU INT INST INFORMATICS & SYSTEMICS
PI ORLANDO
PA 14269 LORD BARCLAY DR, ORLANDO, FL 32837 USA
BN 978-980-6560-33-8
PY 2005
BP 206
EP 207
PG 2
WC Computer Science, Information Systems; Computer Science,
   Interdisciplinary Applications; Education & Educational Research
SC Computer Science; Education & Educational Research
GA BFQ04
UT WOS:000243711100043
DA 2018-10-19
ER

PT S
AU Doraiswami, R
   Tummala, R
AF Doraiswami, R
   Tummala, R
GP IEEE
TI Nano-composite lead-free interconnect and reliability
SO 55th Electronic Components & Technology Conference, Vols 1 and 2, 2005
   Proceedings
SE ELECTRONIC COMPONENTS AND TECHNOLOGY CONFERENCE
LA English
DT Proceedings Paper
CT 55th Electronic Components and Technology Conference
CY MAY 31-JUN 04, 2005
CL Lake Buena Vista, FL
SP Elect Components, Assemblies & Mat Assoc, Elect Ind Alliance, IEEE, CPMT
AB Lead free solder bumping requirements have challenged researchers to develop new technologies to achieve fine pitch interconnects. ITRS has predicts that by 2017 the industry will require 70 micron pitch area array lead free interconnects for flip chips. This paper describes bumping, assembly and reliability evaluation of a new nano composite 20 micron pitch interconnect technology.
   Nanoparticles are the most common building blocks in several applications of Nanotechnology-Beside, the enormous increase of their surface area, the high surface to volume ratio of the nano particles results in extraordinary high reactivity, and unusual physical properties (optical, magnetic, etc.). Several types of nanostructures (nano particles, nano-wires and nano-rods) can be fabricated. Dispersed nano particles are used in several important applications, e.g., catalysis, biomedical applications, nano coatings and nanocomposites. Nanostructured materials, prepared by consolidating nanoparticles with a very high density of grain boundary, have been shown to lead to dramatically improved mechanical and physical properties. Lead free interconnect reliability has been a concern due tin pest (whiskers), intermetalics and high temperature reflow problems. This problem becomes even more pronounced when the pitch of the flip chip reduces to 100 microns or lesser. This paper proposes a novel nano metal composite for fine pitch lead free interconnect as an alternative to solder for fine pitch flip chip interconnect [1-2].
   This paper describes design, process, fabrication and reliability test for composite interconnects fabricated using Ni nano particles distributed in a tin core. A wafer level process is developed for flip chip having 20 micron pitch composite nano structured interconnect. The composition and intermetallics formed at the chip-to- interconnect-interface are evaluated when sent through 4 reflow cycles. Composition of the intemetalics is evaluated to study the distribution Ni3Sn4, Cu6Sn5 and Cu3Sn. Shear test on the interconnects provide bump adhesion strength and fatigue resistance information. The failure mode associated with shear test is also presented. The chip is thermally cycled in a oven from -55 degrees C to 125 degrees C and after every 100 cycles is evaluated for defects using X-Ray and Sonoscan techniques. A crossection is made and the composition at interface is also evaluated for intermetalic diffusion. The paper provides optimized data for next generation nano composite interconnect for fine pitch flip chip to achieve high reliability.
   This paper describes design, process, fabrication and reliability test for composite interconnects fabricated using Ni nano particles distributed in a tin core. A wafer level process is developed for flip chip having 20 micron pitch composite nano structured interconnect. The composition and intermetallics formed at the chip-to- interconnect-interface are evaluated when sent through 4 reflow cycles. Composition of the intermetalics is evaluated to study the distribution Ni3Sn4, Cu6Sn5 and Cu3Sn. Shear test on the interconnects provide bump adhesion strength and fatigue resistance information. The failure mode associated with shear test is also presented. The chip is thermally cycled in a oven from -55 degrees C to 125 degrees C and after every 100 cycles is evaluated for defects using X-Ray and Sonoscan techniques. A crossection is made and the composition at interface is also evaluated for intermetalic diffusion. The paper provides optimized data for next generation nano composite interconnect for fine pitch flip chip to achieve high reliability.
   Introduction: The European commission has required that all electronics be converted to lead free process by 2006. Fine pitch techniques for flip chip drives I/O density and chip size. Screen printing, solder jetting,ball placement and electroplating techniques are the leading techniques used for bumping wafers. Identifying new techniques to develop finepitch bumping becomes very important since the existing techniques have limitation to migrating towards nano interconnects.
   Several types of interconnects have been proposed by researcher to address mechanical issues of lead free flip chip assembly. Georgia Tech. has introduced sea of leads, helical interconnects and metal coated polymer posts as novel interconnects to solve compliant, reliability, electrical and high density fabrications issues for interconnects [3-6]. Nano interconnects have inherent problem of mechanical strength at the interface and very high interface resistance. It becomes very important to develop a new technique which has the best of properties of nano materials and high interfacial strength.
   Interconnect materials choice is based on the mechanical and electrical property of materials. Tin has emerged as the predominant material used in interconnects. NEMI has identified Sn3.5Ag and Sn3.5Ag0.7Cu as the lead free solders with the best of electrical and mechanical properties. Both these solders have tin as a predominant metal ranging up to 96% of the composition.
   Nickel is a high strength material used as barrier metallurgy in UBM on chips and surface finishes on substrates. Its inherent magnetic properties are detrimental to high speed signal transmission.. It has very good adhesion to metals and organics. The modulus and shear strength of nickel is several times greater than tin and tin based alloys (solder).
   In this paper nickel nano particles, having 50mn size as a statistical average, have been used develop a novel wafer level nickel-tin composite interconnect process using electroplating. The interconnects formed vary in dimensions depending on the particle distribution in the interconnect. A shear test is conducted to compare shear strengths of the nano composite interconnect with conventional lead free solder interconnects. By understanding the results from the shear test the reliability effects due to the presence of Sn3.5Ag or Sn3.5Ag0.7 is evaluated. Effects of L,C &R introduced my nano composite interconnect, which interterm affect high speed signal propagation, is also evaluated.
C1 Georgia Inst Technol, Packaging Res Ctr, Atlanta, GA 30332 USA.
RP Doraiswami, R (reprint author), Georgia Inst Technol, Packaging Res Ctr, Atlanta, GA 30332 USA.
CR Aggarwal AO, 2004, 9TH INTERNATIONAL SYMPOSIUM ON ADVANCED PACKAGING MATERIALS: PROCESSES, PROPERTIES AND INTERFACES, 2004 PROCEEDINGS, P69, DOI 10.1109/ISAPM.2004.1287991
   BAKIR MS, 2002, P 52 EL COMP TECHN C, P1087
   BROWN WD, 1999, ADV ELECT PACKAGING
   DORAISWAMI R, 2003, ADV FINE PITCH LEAD, P834
   MA L, 2002, P EL COMP TECHN C, P1359
   Tummala RR, 2001, FUNDAMENTALS MICROSY
   ZHU Q, 2002, P C THERM PHEN EL SY, P833
NR 7
TC 1
Z9 1
U1 0
U2 6
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0569-5503
BN 0-7803-8906-9
J9 ELEC COMP C
PY 2005
BP 871
EP 873
PG 3
WC Engineering, Electrical & Electronic
SC Engineering
GA BCP57
UT WOS:000230581600140
DA 2018-10-19
ER

PT S
AU Giffoni, YA
   Ramos, ECT
   Ramos, AS
   Sandim, HRZ
   Pacheco, MTT
AF Giffoni, YA
   Ramos, ECT
   Ramos, AS
   Sandim, HRZ
   Pacheco, MTT
BE Salgado, L
   Filho, FA
TI Preparation of Nb-40Ti powders by high-energy milling
SO ADVANCED POWDER TECHNOLOGY IV
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 4th International Latin-American Conference on Power Technology
CY NOV 19-21, 2003
CL Guaruja, BRAZIL
SP Abbott, Basf, Brassinter, Bruker, Dorst, Eckagranules, Engefor, GM, Hoganas, Magneti Marelli, Mahle Miba, Metaldyne, Metalpo, Mextra, Osterwalder, Qmp, Qualisinter, Shimadzu, Uniwidia, Zoz, CNPz, FINEP, CAPES, FAPESP
DE titanium alloys; biomaterials; mechanical alloying
ID TITANIUM-ALLOYS; CORROSION; IMPLANTS; BONE
AB Porous Ti-Nb alloys are promising candidates for biomedical applications. In the present study, alloy powders containing 60 wt-% Nb were prepared by high-energy milling of Nb, Ti, and/or TiH2 powders. The high-energy milling process was carried out in a planetary ball mill. The starting and as-milled materials were characterized by X-ray diffraction (XRD), and scanning electron microscopy (SEM). Elemental (Nb, and Ti) and TiH2 powder mixtures with composition Nb-40wt%Ti were mechanically alloyed for 2 to 30 h. The formation of a BCC Nb(Ti) solid solution by high-energy milling using elemental Ti powder to produce Nb-40Ti was observed after milling for 30 h. A HCP-Ti solid solution was formed after milling for 30 h due to the partial decomposition of titanium hydride powder mixture during high-energy milling.
C1 UNIVAP, Inst Pesquisa & Desenvolvimento, BR-12244000 Sao Jose Dos Campos, SP, Brazil.
   FAENQUIL, Dept Mat Engn, BR-12600000 Lorena, SP, Brazil.
RP Giffoni, YA (reprint author), UNIVAP, Inst Pesquisa & Desenvolvimento, BR-12244000 Sao Jose Dos Campos, SP, Brazil.
RI Pacheco, Marcos/B-7991-2012; Sandim, Hugo/F-2778-2013
OI Pacheco, Marcos/0000-0002-1725-4803; Sandim, Hugo/0000-0003-4522-6639
CR FROES FH, 1995, MAT SCI ENG A-STRUCT, V192, P612
   Grosgogeat B, 1999, BIOMATERIALS, V20, P933, DOI 10.1016/S0142-9612(98)00248-8
   Hwang Y, 2002, MATER LETT, V54, P1, DOI 10.1016/S0167-577X(01)00526-2
   Kaczmar JW, 2000, J MATER PROCESS TECH, V106, P58, DOI 10.1016/S0924-0136(00)00639-7
   Kanagaraja S, 2001, BIOMATERIALS, V22, P1809, DOI 10.1016/S0142-9612(00)00362-8
   Khan MA, 1999, BIOMATERIALS, V20, P631, DOI 10.1016/S0142-9612(98)00217-8
   KOCK CC, 1988, INT MATER REV, V33, P201
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Lee KM, 1996, J ALLOY COMPD, V241, P153, DOI 10.1016/0925-8388(96)02306-7
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Mante F, 1999, BIOMATERIALS, V20, P1051, DOI 10.1016/S0142-9612(98)00257-9
   Nishiguchi S, 2001, BIOMATERIALS, V22, P2525, DOI 10.1016/S0142-9612(00)00443-9
   Okazaki Y, 1996, MAT SCI ENG A-STRUCT, V213, P138, DOI 10.1016/0921-5093(96)10247-1
   Senkov ON, 2000, J ALLOY COMPD, V297, P246, DOI 10.1016/S0925-8388(99)00558-7
   Suryanarayana C, 2001, PROG MATER SCI, V46, P1, DOI 10.1016/S0079-6425(99)00010-9
   Yang JY, 2000, PHYSICA B, V279, P241, DOI 10.1016/S0921-4526(99)01228-4
   Ye LL, 1998, MAT SCI ENG A-STRUCT, V241, P290, DOI 10.1016/S0921-5093(97)00505-4
   ZHOVNIR YNT, 1998, MET SCI HEAT TREAT, V40, P210
NR 18
TC 1
Z9 1
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-984-9
J9 MATER SCI FORUM
PY 2005
VL 498-499
BP 146
EP 151
DI 10.4028/www.scientific.net/MSF.498-499.146
PG 6
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BDK21
UT WOS:000233984500024
DA 2018-10-19
ER

PT S
AU Georgiadis, A
   Sergeev, E
AF Georgiadis, Anthimos
   Sergeev, Elena
BE Mizuno, M
   Zhu, D
   Kriven, WM
TI DRY HIGH SPEED MILLING AS A NEW MACHINING TECHNOLOGY OF CERAMICS FOR
   BIOMEDICAL AND OTHER APPLICATIONS
SO ADVANCES IN BIOCERAMICS AND BIOCOMPOSITES
SE Ceramic Engineering and Science Proceedings
LA English
DT Proceedings Paper
CT 29th International Conference on Advanced Ceramics and Composites
CY JAN 23-28, 2005
CL Cocoa Beach, FL
SP Amer Ceram Soc
AB Ceramics are the first choice for orthopaedic, dental and other biomedical applications. Because of the processes used, the conventional production of ceramic parts is moreover limited to materials that are not optimal from a medical point of view. Further critical issues for biomedical applications are cooling lubricants and polishing materials used for machining the ceramics. Absorption into the surface of the machined ceramic parts makes them not neutral for the human body so they can cause allergic reactions or diseases. The developed thy, high speed milling of ceramics (Ceramill) presented in this work solves this problem. The method and a prototype machine tool for 3D treatment with the implementation of advanced controls, CAD-CAM coupling, high speed spindle, the dry process and the dedicated new tools have been developed and approved in field tests. Work pieces with dimensions till 200x400x400 mm has been constructed. Suitable geometries and coatings for new milling tools have been determined. The machining tests were performed with various parameters such as diamond coating thickness and composition. The trials have been performed with aluminium oxide, zirconium oxide and silicon nitride. Ceratnill leads to accurately finished products with tolerances of the order of magnitude of 1 micron and surface roughness of 0.2 microns. First measurements of the Weibull factor for silicon nitride show an encouraging value of 57 by a load of 628 MPa. A first model for the process based on the mechanistic approach has been established on the MatLab platform.
C1 [Georgiadis, Anthimos; Sergeev, Elena] Univ Luneburg, D-21339 Luneburg, Germany.
RP Georgiadis, A (reprint author), Univ Luneburg, Volgershall 1, D-21339 Luneburg, Germany.
CR ALTINTAS U, 2000, MANUFACTURING AUTOMA
   ALTINTAS U, 1991, ANN CIRP, P31
   Armarego E.A.J., 1969, MACHINING METALS
   BINNER JGP, 1990, ADV CERAMIC PROCESSI
   HUANG PT, 1999, J IND TECHNOLOGY, V15
   *IBAG GMBH, IBAG SPINDL HF 100 A
   Jayaram S, 2001, INT J MACH TOOL MANU, V41, P265, DOI 10.1016/S0890-6955(00)00076-6
   KLINE WA, 1982, INT J MACH TOOL MANU, P7
   Konig W, 1973, SPEZIFISCHE SCHNITTK
   Moufki A, 2000, INT J MECH SCI, V42, P1205, DOI 10.1016/S0020-7403(99)00036-3
   PAUCKSCH E, 1992, ZERSPANTECHNIK
NR 11
TC 2
Z9 2
U1 0
U2 3
PU AMER CERAMIC SOC
PI WESTERVILLE
PA 735 CERAMIC PLACE, WESTERVILLE, OH 43081-8720 USA
SN 0196-6219
BN 978-1-57498-236-7
J9 CERAM ENG SCI PROC
PY 2005
VL 26
IS 6
BP 41
EP 51
PG 11
WC Materials Science, Ceramics; Materials Science, Composites
SC Materials Science
GA BOE32
UT WOS:000276374000006
DA 2018-10-19
ER

PT S
AU Flack, WW
   Nguyen, HA
   Neisser, M
   Sison, E
   Lu, PH
   Plass, B
   Makii, T
   Murakami, Y
AF Flack, WW
   Nguyen, HA
   Neisser, M
   Sison, E
   Lu, PH
   Plass, B
   Makii, T
   Murakami, Y
BE Sturtevant, JL
TI A comparison of new thick photoresists for solder bumping
SO Advances in Resist Technology and Processing XXII, Pt 1 and 2
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Advances in Resist Technology and Processing XXII
CY FEB 28-MAR 02, 2005
CL San Jose, CA
SP SPIE, AZ Elect Mat, Rohm & Haas Elect Mat
DE advanced packaging; thick photoresist; solder bumping; plating; process
   optimization
ID SOLVENT
AB The performance requirements for ultra-thick photoresists are rapidly increasing with the dramatic growth in lithographic applications that require electroplating processes. Two of the main applications for ultra-thick photoresists are advanced packaging and nanotechnology (MEMS). Flipchip packaging has become widely adopted to address electrical device performance and chip form factor considerations. The growth in the nanotechnology market is driven by a wide range of products, which include accelerometers, inkjet print heads, biomedical sensors and optical switches.
   The requirements of thick photoresists for solder electroplating are significantly different from typical thin photoresists used in front end of line applications. As the photoresist becomes thicker, processing times increase for many process steps. Photospeed gets slower due to the requirements for more chemical reactions per area of coating. Coating uniformity and edge bead control also become more difficult as photoresist films get thicker and time delay issues between process steps can arise. This result has led to the requirement for special photoresist formulations for thick photoresist films. These are traditionally positive tone DNQ-Novolak materials such as AZ 50XT. Such materials can be designed to work for a particular range of thicknesses, but as the desired thicknesses increases the processing times can become very long for high volume manufacturing.
   Many new bumping schemes require photoresists in a 60 to 70 mu m thickness range. While DNQ-Novolak chemistry can work, there is a desire for faster alternatives to improve total cost of ownership (COO) of the lithography cell. In order to have fast photospeeds and reasonable processing times a chemistry that is very photo efficient is needed. Negative tone cross linking chemistries, which can give tens of thousands of chemical events for one photochemical event, provide excellent photospeed and process times. Positive tone chemically amplified photoresist provide hundreds or thousands of chemical events per photochemical event. They are somewhat slower in photospeed than free radical materials, but still provide reasonable photospeeds.
   This paper compares the lithography and processing performance of these two newer types of thick film chemistries with the performance of a state of the art DNQ-Novolak thick film photoresist. The lithographic performance of these three ultra-thick positive photoresists were optimized to control critical dimensions (CD), sidewall angles and aspect ratios. The experimental results includes process latitude studies, electroplating performance and stripping performance. The general result is that negative free radical chemistry has the edge in photo-speed and processing times, but positive photoresist is better for stripping and perhaps for process integration.
C1 Ultratech Inc, San Jose, CA 95134 USA.
RP Flack, WW (reprint author), Ultratech Inc, San Jose, CA 95134 USA.
CR BEAUCHEMIN BT, 1994, P SOC PHOTO-OPT INS, V2195, P610
   DERBYSHIRE K, 1995, SOLID STATE TECH SEP, P57
   Ficner S, 1996, P SOC PHOTO-OPT INS, V2724, P654, DOI 10.1117/12.241864
   FLACK W, 2001, SPIE, V4326
   Gardiner AB, 1997, P SOC PHOTO-OPT INS, V3049, P850, DOI 10.1117/12.275886
   MACK CA, 1996, DATA STORAGE     MAY, P55
   RANJAN M, 2002, ADV PACKAGING    AUG
   SCHURZ D, 1997, SPIE, V3236
   TODD B, 1999, SPIE, V3874
NR 9
TC 1
Z9 1
U1 1
U2 3
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5733-7
J9 P SOC PHOTO-OPT INS
PY 2005
VL 5753
BP 899
EP 911
DI 10.1117/12.598469
PN 1&2
PG 13
WC Materials Science, Multidisciplinary; Materials Science,
   Characterization & Testing; Optics
SC Materials Science; Optics
GA BCI43
UT WOS:000229580700096
DA 2018-10-19
ER

PT J
AU Alteheld, A
   Feng, YK
   Kelch, S
   Lendlein, A
AF Alteheld, A
   Feng, YK
   Kelch, S
   Lendlein, A
TI Biodegradable, amorphous copolyester-urethane networks having
   shape-memory properties
SO ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
LA English
DT Article
DE amorphous materials; materials science; polymers; shape-memory polymers
ID IN-VITRO DEGRADATION; BIOMEDICAL APPLICATIONS;
   OLIGO(EPSILON-CAPROLACTONE) SEGMENTS; BIOMATERIALS; POLYMERS; IMPLANTS;
   SURGERY; ACID)
C1 GKSS Forschungszentrum Geesthacht GmbH, Inst Chem, D-14513 Teltow, Germany.
RP Lendlein, A (reprint author), GKSS Forschungszentrum Geesthacht GmbH, Inst Chem, Kantstr 55, D-14513 Teltow, Germany.
EM andreas.lendlein@gkss.de
RI feng, yakai/F-3854-2015; Lendlein, Andreas/K-9553-2013
OI feng, yakai/0000-0002-4511-0874; Lendlein, Andreas/0000-0003-4126-4670
CR Bruining MJ, 2002, BIOMATERIALS, V23, P1213, DOI 10.1016/S0142-9612(01)00237-X
   Edelman ER, 2000, BIOMATERIALS, V21, P2279, DOI 10.1016/S0142-9612(00)00154-X
   El Feninat F, 2002, ADV ENG MATER, V4, P91, DOI 10.1002/1527-2648(200203)4:3<91::AID-ADEM91>3.0.CO;2-B
   FOX TG, 1950, J APPL PHYS, V21, P581, DOI 10.1063/1.1699711
   GILDING DK, 1979, POLYMER, V20, P1459, DOI 10.1016/0032-3861(79)90009-0
   Jabbal-Gill I, 2001, ADV DRUG DELIVER REV, V51, P97, DOI 10.1016/S0169-409X(01)00173-9
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lendlein A, 2002, ANGEW CHEM INT EDIT, V41, P2034, DOI 10.1002/1521-3773(20020617)41:12<2034::AID-ANIE2034>3.0.CO;2-M
   Lendlein A, 2001, P NATL ACAD SCI USA, V98, P842, DOI 10.1073/pnas.031571398
   Lendlein A, 1999, CHEM UNSERER ZEIT, V33, P279, DOI 10.1002/ciuz.19990330505
   Li SM, 1999, J BIOMED MATER RES, V48, P342, DOI 10.1002/(SICI)1097-4636(1999)48:3<342::AID-JBM20>3.0.CO;2-7
   Liu L, 2005, BIOMATERIALS, V26, P233, DOI 10.1016/j.biomaterials.2004.02.025
   Lloyd AW, 2001, BIOMATERIALS, V22, P769, DOI 10.1016/S0142-9612(00)00237-4
   Lu L, 1999, J BIOMED MATER RES, V46, P236, DOI 10.1002/(SICI)1097-4636(199908)46:2<236::AID-JBM13>3.0.CO;2-F
   OSADA Y, 1995, NATURE, V376, P219, DOI 10.1038/376219a0
   Ramchandani M, 1998, J CONTROL RELEASE, V54, P167, DOI 10.1016/S0168-3659(97)00113-2
   Rickert D, 2003, J BIOMED MATER RES B, V67B, P722, DOI 10.1002/jbm.b.10069
   STOY VA, 1990, Patent No. 0439892
   TAKEDA K, 1988, ANGEW MAKROMOL CHEM, V157, P123, DOI 10.1002/apmc.1988.051570110
   VERT M, 1984, MACROMOLECULAR BIOMA, P119
   WARD IM, 1975, STRUCTURE PROPERTIES, P256
   Williams DF, 2003, SADHANA-ACAD P ENG S, V28, P563, DOI 10.1007/BF02706447
   Witschi C, 1998, J CONTROL RELEASE, V51, P327, DOI 10.1016/S0168-3659(97)00188-0
   Wu LB, 2004, BIOMATERIALS, V25, P5821, DOI 10.1016/j.biomaterials.2004.01.038
   YAMAGUCHI K, 1993, J CONTROL RELEASE, V24, P81, DOI 10.1016/0168-3659(93)90169-6
NR 25
TC 166
Z9 171
U1 8
U2 75
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1433-7851
J9 ANGEW CHEM INT EDIT
JI Angew. Chem.-Int. Edit.
PY 2005
VL 44
IS 8
BP 1188
EP 1192
DI 10.1002/anie.200461360
PG 5
WC Chemistry, Multidisciplinary
SC Chemistry
GA 898WM
UT WOS:000227106900006
PM 15654685
OA Bronze
DA 2018-10-19
ER

PT J
AU Giri, S
   Trewyn, BG
   Stellmaker, MP
   Lin, VSY
AF Giri, S
   Trewyn, BG
   Stellmaker, MP
   Lin, VSY
TI Stimuli-responsive controlled-release delivery system based on
   mesoporous silica nanorods capped with magnetic nanoparticles
SO ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
LA English
DT Article
DE drug delivery; fluorescence; magnetic properties; mesoporous materials;
   nanostructures
ID DRUG-DELIVERY; IN-VITRO; SUPERPARAMAGNETIC NANOPARTICLES; ORGANIC
   FUNCTIONALIZATION; BIOMEDICAL APPLICATIONS; GENE DELIVERY; IRON-OXIDES;
   MCM-41; MOLECULES; CELLS
C1 Iowa State Univ, Dept Chem, Ames, IA 50011 USA.
   Iowa State Univ, US DOE Ames Lab, Ames, IA 50011 USA.
RP Lin, VSY (reprint author), Iowa State Univ, Dept Chem, Ames, IA 50011 USA.
EM vsylin@iastate.edu
OI Giri, Supratim/0000-0002-1658-1968
CR Biaglow JE, 2000, ANAL BIOCHEM, V281, P77, DOI 10.1006/abio.2000.4533
   Bulte JWM, 2001, NAT BIOTECHNOL, V19, P1141, DOI 10.1038/nbt1201-1141
   CARLSSON J, 1978, BIOCHEM J, V173, P723, DOI 10.1042/bj1730723
   CHAN DCF, 1993, J MAGN MAGN MATER, V122, P374
   Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016
   Chattopadhyay P, 2002, IND ENG CHEM RES, V41, P6049, DOI 10.1021/ie020205b
   Diaz JF, 1996, J MOL CATAL B-ENZYM, V2, P115, DOI 10.1016/S1381-1177(96)00017-3
   Doyle PS, 2002, SCIENCE, V295, P2237, DOI 10.1126/science.1068420
   Gellissen J, 1999, MAGN RESON IMAGING, V17, P557, DOI 10.1016/S0730-725X(98)00206-9
   GREUNHAGEN JA, 2005, APPL SPECTROSC, V59, P424
   Gu HW, 2003, J AM CHEM SOC, V125, P15702, DOI 10.1021/ja0359310
   Gupta AK, 2004, J MATER SCI-MATER M, V15, P493, DOI 10.1023/B:JMSM.0000021126.32934.20
   Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012
   Han YJ, 1999, J AM CHEM SOC, V121, P9897, DOI 10.1021/ja992138r
   Hernandez R, 2004, J AM CHEM SOC, V126, P3370, DOI 10.1021/ja039424u
   Hilger I, 2001, RADIOLOGY, V218, P570, DOI 10.1148/radiology.218.2.r01fe19570
   Hirsch LR, 2003, P NATL ACAD SCI USA, V100, P13549, DOI 10.1073/pnas.2232479100
   Huh S, 2003, CHEM MATER, V15, P4247, DOI 10.1021/cm0210041
   Huh S, 2003, CHEM COMMUN, P2364, DOI 10.1039/b306255d
   Jordan A, 1999, J MAGN MAGN MATER, V194, P185, DOI 10.1016/S0304-8853(98)00558-7
   Josephson L, 2002, BIOCONJUGATE CHEM, V13, P554, DOI 10.1021/bc015555d
   Lai CY, 2003, J AM CHEM SOC, V125, P4451, DOI 10.1021/ja028650l
   Lee J., 2005, ANGEW CHEM, V117, P1092
   Lin VSY, 2001, J AM CHEM SOC, V123, P11510, DOI 10.1021/ja016223m
   Lubbe AS, 1999, J MAGN MAGN MATER, V194, P149, DOI 10.1016/S0304-8853(98)00574-5
   Ma M, 2003, COLLOID SURFACE A, V212, P219, DOI 10.1016/S0927-7757(02)00305-9
   Mal NK, 2003, NATURE, V421, P350, DOI 10.1038/nature01362
   Marler B, 1996, MICROPOROUS MATER, V6, P375, DOI 10.1016/0927-6513(96)00016-8
   Munoz B, 2003, CHEM MATER, V15, P500, DOI 10.1021/cm021217q
   Neuberger T, 2005, J MAGN MAGN MATER, V293, P483, DOI 10.1016/j.jmmm.2005.01.064
   Perez JM, 2002, J AM CHEM SOC, V124, P2856, DOI 10.1021/ja017773n
   Perez JM, 2002, NAT BIOTECHNOL, V20, P816, DOI 10.1038/nbt720
   Radu DR, 2005, CHEM COMMUN, P1264, DOI 10.1039/b412618a
   Radu DR, 2004, J AM CHEM SOC, V126, P13216, DOI 10.1021/ja046275m
   Radu DR, 2004, J AM CHEM SOC, V126, P1640, DOI 10.1021/ja038222v
   Ramila A, 2003, J SOL-GEL SCI TECHN, V26, P1199, DOI 10.1023/A:1020764319963
   Scherer F, 2002, GENE THER, V9, P102, DOI 10.1038/sj/gt/3301624
   Schillinger U, 2005, J MAGN MAGN MATER, V293, P501, DOI 10.1016/j.jmmm.2005.01.032
   Takahashi H, 2001, MICROPOR MESOPOR MAT, V44, P755, DOI 10.1016/S1387-1811(01)00257-8
   Tourne-Peteilh C, 2003, NEW J CHEM, V27, P1415, DOI 10.1039/b307046h
   Trewyn BG, 2004, NANO LETT, V4, P2139, DOI 10.1021/nl048774r
   Vallet-Regi M, 2004, SOLID STATE IONICS, V172, P435, DOI 10.1016/j.ssi.2004.04.036
   Vallet-Regi M, 2001, CHEM MATER, V13, P308, DOI 10.1021/cm0011559
   Wang DS, 2004, NANO LETT, V4, P409, DOI 10.1021/nl035010n
   Winkler H, 1999, ADV MATER, V11, P1444, DOI 10.1002/(SICI)1521-4095(199912)11:17<1444::AID-ADMA1444>3.0.CO;2-H
   Xu CJ, 2004, J AM CHEM SOC, V126, P9938, DOI 10.1021/ja0464802
   Yoon TJ, 2005, ANGEW CHEM INT EDIT, V44, P1068, DOI 10.1002/anie.200461910
   Zhang WH, 2000, CHEM MATER, V12, P1408, DOI 10.1021/cm990740a
   Zhang WH, 2001, CHEM MATER, V13, P648, DOI 10.1021/cm000621r
NR 49
TC 723
Z9 735
U1 25
U2 402
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1433-7851
J9 ANGEW CHEM INT EDIT
JI Angew. Chem.-Int. Edit.
PY 2005
VL 44
IS 32
BP 5038
EP 5044
DI 10.1002/anie.200501819
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA 957JY
UT WOS:000231367300007
PM 16038000
DA 2018-10-19
ER

PT J
AU Knudson, AG
AF Knudson, AG
TI A personal sixty-year tour of genetics and medicine
SO ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS
SE Annual Review of Genomics and Human Genetics
LA English
DT Review; Book Chapter
DE cancer; two hits; genetic chaos
ID TAY-SACHS-DISEASE; DOMINANTLY INHERITED CANCER; DEPENDENT DNA
   POLYMERASE; EKER RAT MODEL; TSC2 GENE; RETINOBLASTOMA; MUTATION;
   CHROMOSOME; DELETION; SARCOMA
AB The past 60 years surely constitute a Golden Age for biomedical science, and for medical genetics in particular. A personal experience began with an encounter with inborn errors of metabolism, selection, and the incidences of hereditary diseases, and peaked with molecular biology, virology, and cytogenetics, finally focusing all three on the problem of cancer. If the past dominates my contribution to this volume it is probably because octogenarians have much more past than future. There is also a strong temptation to contemplate a past that spans a Golden Age in genetics from the discovery by Avery and his colleagues that the genetic material of our cells is DNA, to the revelations of the human genome. Here I wish to tell how I first came upon the subject of genetics, how I became diverted to medicine just as medicine was making its first enduring relationship with genetics, and how this merger has led to a preoccupation with medical genetics and the genetic Gotterdammerung that is cancer.
C1 Fox Chase Canc Ctr, Philadelphia, PA 19111 USA.
RP Knudson, AG (reprint author), Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA.
EM Alfred.Knudson@fccc.edu
CR BALTIMORE D, 1970, NATURE, V226, P1209, DOI 10.1038/2261209a0
   BENEDICT WF, 1983, SCIENCE, V219, P973, DOI 10.1126/science.6336308
   Borsook H, 1935, PROC R SOC SER B-BIO, V118, P488, DOI 10.1098/rspb.1935.0069
   BRENNER S, 1961, NATURE, V190, P576, DOI 10.1038/190576a0
   CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0
   Childs B., 1999, GENETIC MED LOGIC DI
   EKER R, 1961, NATURE, V189, P858, DOI 10.1038/189858b0
   ELLERMAN V, 1908, PARASITENKD ORIG ABT, V46, P595
   FRANCKE U, 1976, MED PEDIATR ONCOL, V2, P379, DOI 10.1002/mpo.2950020404
   FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0
   GAUCHER PCE, 1882, THESIS FACULTE MED P
   GODBOUT R, 1983, NATURE, V304, P451, DOI 10.1038/304451a0
   GROS F, 1961, NATURE, V190, P581, DOI 10.1038/190581a0
   HALLETT WY, 1965, AM REV RESPIR DIS, V92, P714
   HINO O, 1993, P NATL ACAD SCI USA, V90, P327, DOI 10.1073/pnas.90.1.327
   HUNT JA, 1958, NATURE, V181, P1062, DOI 10.1038/1811062a0
   JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7
   Kaback MM, 2001, ADV GENET, V44, P253
   KNUDSON A. G., 1967, J VIROL, V1, P1150
   KNUDSON AG, 1973, PROG MED GENET, V9, P113
   KNUDSON AG, 1972, AM J HUM GENET, V24, P514
   KNUDSON AG, 1951, J PEDIATR-US, V39, P408, DOI 10.1016/S0022-3476(51)80199-9
   KNUDSON AG, 1961, AM J CLIN NUTR, V9, P55, DOI 10.1093/ajcn/9.1.55
   KNUDSON AG, 1973, AM J HUM GENET, V25, P108
   KNUDSON AG, 1979, AM J HUM GENET, V31, P401
   KNUDSON AG, 1967, AM J HUM GENET, V19, P388
   KNUDSON AG, 1978, SEMIN ONCOL, V5, P57
   KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820
   KNUDSON AG, 1972, J NATL CANCER I, V48, P313
   KNUDSON AG, 1966, AM NAT, V100, P162, DOI 10.1086/282410
   KNUDSON AG, 1965, CANCER, V18, P815, DOI 10.1002/1097-0142(196507)18:7<815::AID-CNCR2820180707>3.0.CO;2-M
   KNUDSON AG, 1953, AMA AM J DIS CHILD, V85, P316, DOI 10.1001/archpedi.1953.02050070328007
   KNUDSON AG, 1976, NEW ENGL J MED, V295, P1120, DOI 10.1056/NEJM197611112952007
   KNUDSON AG, 1965, GENETICS DIS
   KNUDSON AG, 1968, STRUCTURAL CHEM MOL, P281
   KNUDSON AG, 1962, CEREBRAL SPHINGOLIPI, P395
   KOBAYASHI T, 1995, NAT GENET, V9, P70, DOI 10.1038/ng0195-70
   KRUH J, 1956, J BIOL CHEM, V220, P905
   LEJEUNE J, 1959, CR HEBD ACAD SCI, V248, P1721
   NOWELL PC, 1960, SCIENCE, V132, P1497
   OKADA S, 1969, SCIENCE, V165, P698, DOI 10.1126/science.165.3894.698
   OWEN RD, 1945, SCIENCE, V102, P400, DOI 10.1126/science.102.2651.400
   PAULING L, 1949, SCIENCE, V110, P543, DOI 10.1126/science.110.2865.543
   Rennebeck G, 1998, P NATL ACAD SCI USA, V95, P15629, DOI 10.1073/pnas.95.26.15629
   Rous P, 1911, J EXP MED, V13, P397, DOI 10.1084/jem.13.4.397
   Schoenheimer R, 1942, DYNAMIC STATE BODY C
   SCHWEET R, 1958, P NATL ACAD SCI USA, V44, P1029, DOI 10.1073/pnas.44.10.1029
   SPARKES RS, 1980, SCIENCE, V208, P1042, DOI 10.1126/science.7375916
   STEHELIN D, 1976, NATURE, V260, P170, DOI 10.1038/260170a0
   TEMIN HM, 1970, NATURE, V226, P1211, DOI 10.1038/2261211a0
   Tucker M, 2000, J NATL CANCER I, V92, P530, DOI 10.1093/jnci/92.7.530
   Vilenchik MM, 2003, P NATL ACAD SCI USA, V100, P12871, DOI 10.1073/pnas.2135498100
   YEUNG RS, 1994, P NATL ACAD SCI USA, V91, P11413, DOI 10.1073/pnas.91.24.11413
NR 53
TC 10
Z9 11
U1 0
U2 2
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0139 USA
SN 1527-8204
EI 1545-293X
J9 ANNU REV GENOM HUM G
JI Annu. Rev. Genomics Hum. Genet.
PY 2005
VL 6
BP 1
EP 14
DI 10.1146/annurev.genom.6.080604.162320
PG 14
WC Genetics & Heredity
SC Genetics & Heredity
GA 972GE
UT WOS:000232441500002
PM 16124851
OA Bronze
DA 2018-10-19
ER

PT S
AU Levin, IW
   Bhargava, R
AF Levin, IW
   Bhargava, R
TI Fourier transform infrared vibrational spectroscopic imaging:
   Integrating microscopy and molecular recognition
SO ANNUAL REVIEW OF PHYSICAL CHEMISTRY
SE Annual Review of Physical Chemistry
LA English
DT Review; Book Chapter
DE Fourier transform infrared spectroscopy; interferometry; histopathology;
   brain tissue; bone tissue; breast tissue; esophageal tissue; skin
   tissue; prostate tissue; pharmaceuticals; single cells; drug delivery
ID PLANE ARRAY DETECTION; RESOLVED FT-IR; GRAM-SCHMIDT ORTHOGONALIZATION;
   INDUCED REORIENTATION DYNAMICS; DISPERSED LIQUID-CRYSTAL;
   BARRETTS-ESOPHAGUS; POLYMERIC SYSTEMS; RAMAN-SPECTROSCOPY; DELIVERY
   SYSTEMS; SINGLE CELLS
AB The recent development of Fourier transform infrared (FTIR) spectroscopic imaging has enhanced our capability to examine, on a microscopic scale, the spatial distribution of vibrational spectroscopic signatures of materials spanning the physical and biomedical disciplines. Recent activity in this emerging area has concentrated on instrumentation development, theoretical analyses to provide guidelines for imaging practice, novel data processing algorithms, and the introduction of the technique to new fields. To illustrate the impact and promise of this spectroscopic imaging methodology, we present fundamental principles of the technique in the context of FTIR spectroscopy and review new applications in various venues ranging from the physical chemistry of macromolecular systems to the detection of human disease.
C1 NIDDK, Phys Chem Lab, NIH, Bethesda, MD 20892 USA.
RP Levin, IW (reprint author), NIDDK, Phys Chem Lab, NIH, Bethesda, MD 20892 USA.
EM iwl@helix.nih.gov; rb3l9b@nih.gov
RI Coe, James/D-2578-2013
OI Bhargava, Rohit/0000-0001-7360-994X
CR Arfken G. B., 2000, MATH METHODS PHYS
   Bhargava R, 2004, APPL SPECTROSC, V58, P995, DOI 10.1366/0003702041655412
   Bhargava R, 1999, APPL SPECTROSC, V53, P1313, DOI 10.1366/0003702991945812
   Bhargava R, 2000, APPL SPECTROSC, V54, P486, DOI 10.1366/0003702001949898
   Bhargava R, 2001, APPL SPECTROSC, V55, P1580, DOI 10.1366/0003702011954143
   Bhargava R, 2000, APPL SPECTROSC, V54, P1743, DOI 10.1366/0003702001949069
   Bhargava R, 2001, ANAL CHEM, V73, P5157, DOI 10.1021/ac010380m
   Bhargava R, 2003, ADV POLYM SCI, V163, P137, DOI 10.1007/b11052
   Bhargava R, 2003, APPL SPECTROSC, V57, P357, DOI 10.1366/00037020360625880
   Bhargava R, 2003, MACROMOLECULES, V36, P92, DOI 10.1021/ma021336r
   Bhargava R, 1998, APPL SPECTROSC, V52, P323, DOI 10.1366/0003702981943653
   Bhargava R, 2002, ANAL CHEM, V74, P1429, DOI 10.1021/ac011153n
   Bhargava R, 2001, APPL SPECTROSC, V55, P1079, DOI 10.1366/0003702011952983
   Bhargava R, 2000, APPL SPECTROSC, V54, P470, DOI 10.1366/0003702001949870
   Bhargava R, 2004, J PHYS CHEM A, V108, P3896, DOI 10.1021/jp037847c
   Bhargava R, 2000, APPL SPECTROSC, V54, P1690, DOI 10.1366/0003702001948745
   BHARGAVA R, 2000, E ANAL S
   BHARGAVA R, 2002, PITTCON 2002
   BRISSEY GM, 1984, ANAL CHEM, V56, P2002, DOI 10.1021/ac00276a005
   BUDEVSKA BO, 1993, APPL SPECTROSC, V47, P1843, DOI 10.1366/0003702934065920
   Budevska BO, 2003, APPL SPECTROSC, V57, P124, DOI 10.1366/000370203321535015
   Cadet F, 1996, SPECTROSC LETT, V29, P901, DOI 10.1080/00387019608001620
   Carr GL, 2001, REV SCI INSTRUM, V72, P1613, DOI 10.1063/1.1347965
   Chalmers J.M., 2002, HDB VIBRATIONAL SPEC, V5
   Chan KLA, 2003, ANAL CHEM, V75, P2140, DOI 10.1021/ac026456b
   Chan KLA, 2003, APPL SPECTROSC, V57, P381, DOI 10.1366/00037020360625907
   COHEN S, 1991, PHARMACEUT RES, V8, P713, DOI 10.1023/A:1015841715384
   Colarusso P, 1998, APPL SPECTROSC, V52, p106A, DOI 10.1366/0003702981943545
   Coutts-Lendon CA, 2003, J CONTROL RELEASE, V93, P223, DOI 10.1016/j.jconrel.2003.06.003
   CROCOMBE RA, 1991, P SPIE INT SOC OPT E, V1575, P189
   CROCOMBE RA, 1999, P 12 INT C FOUR TRAN, P277
   DEHASETH JA, 1977, ANAL CHEM, V49, P1977
   DIEM M, 1999, APPL SPECTROSC, V53, P148, DOI DOI 10.1366/0003702991946712
   DOANE JW, 1986, APPL PHYS LETT, V48, P269, DOI 10.1063/1.96577
   Drewitz DJ, 1997, AM J GASTROENTEROL, V92, P212
   Ekgasit S, 2001, APPL SPECTROSC, V55, P1352, DOI 10.1366/0003702011953478
   Fabian H, 2002, BIOPOLYMERS, V67, P354, DOI 10.1002/bip.10088
   FERNANDEZ DC, 2004, UNPUB NAT BIOTECH
   Garidel P, 2003, PHYS CHEM CHEM PHYS, V5, P2673, DOI 10.1039/b302749j
   Gazi E, 2003, J PATHOL, V201, P99, DOI 10.1002/path.1421
   GRAHAM JR, 1999, OSA FTS M SANT BARB
   GREGORIOU VG, 1991, CHEM PHYS LETT, V179, P491, DOI 10.1016/0009-2614(91)87092-P
   Gremlich H U, 2000, INFRARED RAMAN SPECT
   Griffiths PR, 1986, FOURIER TRANSFORM IN
   Haaland DM, 1997, APPL SPECTROSC, V51, P340, DOI 10.1366/0003702971940468
   Haka AS, 2000, APPL SPECTROSC, V54, P753, DOI 10.1366/0003702001950049
   HASEGAWA R, 1993, APPL SPECTROSC, V47, P1386, DOI 10.1366/0003702934067441
   HELM D, 1991, J GEN MICROBIOL, V137, P69, DOI 10.1099/00221287-137-1-69
   HIRSCHFELD T, 1979, APPL SPECTROSC, V33, P525, DOI 10.1366/0003702794925390
   Huang ZW, 2003, INT J ONCOL, V23, P649
   Huffman SW, 2004, CHEM PHYS LIPIDS, V130, P167, DOI 10.1016/j.chemphyslip.2004.03.004
   Huffman SW, 2002, APPL SPECTROSC, V56, P965, DOI 10.1366/000370202760249684
   Jamin N, 1998, P NATL ACAD SCI USA, V95, P4837, DOI 10.1073/pnas.95.9.4837
   Kazarian SG, 2003, MACROMOLECULES, V36, P9866, DOI 10.1021/ma035210l
   Kendall C, 2003, J PATHOL, V200, P602, DOI 10.1002/path.1376
   Kidder LH, 1997, OPT LETT, V22, P742, DOI 10.1364/OL.22.000742
   Kidder LH, 1997, NAT MED, V3, P235, DOI 10.1038/nm0297-235
   Kidder LH, 1999, J BIOMED OPT, V4, P7, DOI 10.1117/1.429915
   Knoll B, 1999, NATURE, V399, P134, DOI 10.1038/20154
   Koenig J, 2002, ADV MATER, V14, P457, DOI 10.1002/1521-4095(20020318)14:6<457::AID-ADMA457>3.0.CO;2-8
   Koenig J. L., 1999, SPECTROSCOPY POLYM
   Koenig JL, 1998, SPECTROSCOPY, V13, P22
   Koenig JL, 2001, ANAL CHEM, V73, p360A, DOI 10.1021/ac012471p
   KOENIG JL, 1998, MICROSPECTROSCOPIC I
   KOHRI S, 1993, APPL SPECTROSC, V47, P1367, DOI 10.1366/0003702934067342
   Lasch P, 2002, VIB SPECTROSC, V28, P147, DOI 10.1016/S0924-2031(01)00153-9
   Lasch P, 2002, BIOPOLYMERS, V67, P335, DOI 10.1002/bip.10095
   Lasch P, 1998, CELL MOL BIOL, V44, P189
   Laubereau A., 1985, TIME RESOLVED VIBRAT, V4
   Lester DS, 1998, CELL MOL BIOL, V44, P29
   Lewis EN, 1997, ANN NY ACAD SCI, V820, P234, DOI 10.1111/j.1749-6632.1997.tb46199.x
   Lewis EN, 1997, APPL SPECTROSC, V51, P563, DOI 10.1366/0003702971940602
   LEWIS EN, 1995, ANAL CHEM, V67, P3377, DOI 10.1021/ac00115a003
   Lewis EN, 1996, APPL SPECTROSC, V50, P263, DOI 10.1366/0003702963906618
   LEWIS EN, 1995, J MICROSC SOC AM, V1, P35
   Marcott C, 1998, CELL MOL BIOL, V44, P109
   MARCOTT C, 1994, ANAL CHEM, V66, pA1065, DOI 10.1021/ac00093a001
   MARCOTT C, 1999, PHOSPHORUS SULFUR, V146, P417
   Mariey L, 2001, VIB SPECTROSC, V26, P151, DOI 10.1016/S0924-2031(01)00113-8
   Massart D.L., 1990, CHEMOMETRICS TXB
   MASUTANI K, 1992, APPL SPECTROSC, V46, P560, DOI 10.1366/0003702924124871
   Mendelsohn R, 1999, J BIOMED OPT, V4, P14, DOI 10.1117/1.429916
   Mendelsohn R, 2000, APPL SPECTROSC, V54, P1183, DOI 10.1366/0003702001950751
   Mendelsohn R, 2003, J BIOMED OPT, V8, P185, DOI 10.1117/1.1560645
   MESSERSCHMIDT RG, 1995, PRACTICAL GUIDE INFR, P3
   MESSERSCHMIDT RG, 1988, PRACTICAL SPECTROSCO, V6
   Michaels CA, 2004, APPL SPECTROSC, V58, P257, DOI 10.1366/000370204322886582
   NAKANO T, 1993, APPL SPECTROSC, V47, P1354, DOI 10.1366/0003702934067702
   National Cancer Institute (NCI), 1973, SEER CANC STAT REV
   Oh SJ, 1998, ANAL CHEM, V70, P1768, DOI 10.1021/ac971290d
   PALMER RA, 1993, APPL SPECTROSC, V47, P1297, DOI 10.1366/0003702934067568
   PALMER RA, 1989, APPL SPECTROSC, V43, P193, DOI 10.1366/0003702894203101
   Paschalis EP, 1996, CALCIFIED TISSUE INT, V59, P480, DOI 10.1007/BF00369214
   PETERS JH, 1994, J THORAC CARDIOV SUR, V108, P813
   PIZZI N, 1995, ARTIF INTELL MED, V7, P67, DOI 10.1016/0933-3657(94)00027-P
   POLAVARAPU PL, 1995, APPL SPECTROSC, V49, P229, DOI 10.1366/0003702953963797
   Rafferty DW, 2002, APPL SPECTROSC, V56, P1549, DOI 10.1366/000370202321116002
   Reffner JA, 1998, CELL MOL BIOL, V44, P1
   REFFNER JA, 1997, MIKROCHIM ACTA S, V14, P333
   ROUSCH PB, 1985, ASTM SPEC TECH PUBL, V949
   SAKAI H, 1978, APPL OPTICS, V17, P1342, DOI 10.1364/AO.17.001342
   SASAKI H, 1993, APPL SPECTROSC, V47, P1390, DOI 10.1366/0003702934067522
   Shaheen NJ, 2000, GASTROENTEROLOGY, V119, P333, DOI 10.1053/gast.2000.9302
   SHILOV SV, 1995, VIB SPECTROSC, V9, P57, DOI 10.1016/0924-2031(94)00043-G
   Shim MG, 1996, PHOTOCHEM PHOTOBIOL, V63, P662, DOI 10.1111/j.1751-1097.1996.tb05671.x
   Shin EM, 2002, J ADHESION, V78, P877, DOI 10.1080/00218460290010485
   SLOAN JJ, 1989, ADV SPECTROSC, V18, P219
   Snively C, 1996, MOL CRYST LIQ CRYS A, V289, P11, DOI 10.1080/10587259608042309
   Snively CM, 1999, APPL SPECTROSC, V53, P170, DOI 10.1366/0003702991946497
   Snively CM, 1999, OPT LETT, V24, P1841, DOI 10.1364/OL.24.001841
   Snively CM, 1998, MACROMOLECULES, V31, P3753, DOI 10.1021/ma971511h
   SOLTANIANZADEH H, 1993, IEEE T NUCL SCI, V40, P1204, DOI 10.1109/23.256737
   Sommer A. J., 1991, APPL SPECTROSC, V45, P1663
   Sommer AJ, 2001, APPL SPECTROSC, V55, P252, DOI 10.1366/0003702011951803
   SPARKS DT, 1982, ANAL CHEM, V54, P1922, DOI 10.1021/ac00249a003
   SUGISAWA H, 1992, MOL CRYST LIQ CRYST, V214, P11, DOI 10.1080/10587259208037278
   SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615
   Takahata H, 1998, J CONTROL RELEASE, V50, P237, DOI 10.1016/S0168-3659(97)00145-4
   THOMAS EV, 1990, ANAL CHEM, V62, P1091, DOI 10.1021/ac00209a024
   Turrell G., 1996, RAMAN MICROSCOPY DEV
   UHMANN W, 1991, APPL SPECTROSC, V45, P390, DOI 10.1366/0003702914337128
   van de Weert M, 2000, PHARMACEUT RES, V17, P1159, DOI 10.1023/A:1026498209874
   van der Weert M, 2000, J CONTROL RELEASE, V68, P31, DOI 10.1016/S0168-3659(00)00227-3
   Webb AR, 2002, STAT PATTERN RECOGNI
   WEST JL, 1988, MOL CRYST LIQ CRYST, V157, P427, DOI 10.1080/00268948808080247
   Wetzel DL, 1999, SCIENCE, V285, P1224, DOI 10.1126/science.285.5431.1224
   WHITE RL, 1981, ANAL CHEM, V53, P1778, DOI 10.1021/ac00235a014
   Wong PTT, 2002, BIOPOLYMERS, V67, P376, DOI 10.1002/bip.10166
   Zhang L, 2003, APPL SPECTROSC, V57, P14, DOI 10.1366/000370203321165151
NR 129
TC 192
Z9 194
U1 2
U2 86
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0139 USA
SN 0066-426X
BN 978-0-8243-1056-1
J9 ANNU REV PHYS CHEM
JI Annu. Rev. Phys. Chem.
PY 2005
VL 56
BP 429
EP 474
DI 10.1146/annurev.physchem.56.092503.141205
PG 52
WC Chemistry, Physical
SC Chemistry
GA 954VX
UT WOS:000231184400016
PM 15796707
DA 2018-10-19
ER

PT B
AU Mao, S
   Misra, D
   Seamans, J
   Thoma, GR
AF Mao, S
   Misra, D
   Seamans, J
   Thoma, GR
GP SOC IMAGING SCI & TECHNOL
TI Design strategies for a prototype electronic preservation system for
   biomedical documents
SO Archiving 2005, Final Program and Proceedings
LA English
DT Proceedings Paper
CT 2nd IS&T Archiving Conference
CY APR 26-29, 2005
CL Washington, DC
SP IS&T, Amer Inst Conservat, Assoc Lib Collect & Tech Serv, Coalit Networked Informat, Digital Lib Federat, Digital Preservat Coalit, ECPA, Inter Soc Color Council, Museum Comp Network, Online Comp Lib Ctr, Res Lib Grp, SPIE
AB Among the digital material considered for preservation at the National Library of Medicine (NLM) are TIFF, PDF and HTML files of biomedical journals, laboratory notebooks, correspondence of major figures in biomedical research, and similar documents. Although most of these materials are already in digital form (either as born-digital information, or converted to digital form through scanning), preservation of these materials involve complex administrative and technical issues, such as obtaining and storing adequate levels of metadata for a preserved resource, assuring intellectual integrity of the contents, and avoiding technical obsolescence of encoded information. (1,2) An R&D project has been initiated at NLM to develop a prototype system that would help investigate the key technical functions required to effectively preserve NLM's digital resources over the long term. This system, named the System for Preservation of Electronic Resources (SPER) has had its initial design and implementation phase completed. Here we describe the main functions of SPER, and the strategies adopted in designing the system to meet these functionalities in a modular and cost-effective manner. In particular, an automated metadata extraction subsystem is designed to minimize manual entry, using string matching and machine learning techniques. Also given are preliminary performance assessments of the subsystems in this prototype. We discuss the overall system architecture, automated metadata extraction techniques, and file migration in the SPER system.
CR HASTIE T, 2000, ESTIMATING NUMBER DA
   HASUER SE, 2001, P SPIE DOCUMENT RECO, V7, P248
   KIM J, 2001, SPIE C DOC REC RETR, V8, P111
   KRISHNAMOORTHY M, 1993, IEEE T PATTERN ANAL, V15, P737, DOI 10.1109/34.221173
   LE DX, 2001, P 14 IEEE S COMP BAS
   Mao S, 2004, Proceedings of the Fourth IASTED International Conference on Visualization, Imaging, and Image Processing, P329
   Mao S, 2004, FIRST INTERNATIONAL WORKSHOP ON DOCUMENT IMAGE ANALYSIS FOR LIBRARIES, PROCEEDINGS, P225
   Mao S, 2003, IEEE IMAGE PROC, P533
   *NISO, Z39872002 DATA DICT
   *TASI, INTR DIG PRES TECHN
   The Consultative Committee for Space Data Systems, REF MOD OP ARCH INF
   WALKER FL, 2003, P INF 2003 MEDF NJ I, P313
NR 12
TC 0
Z9 0
U1 0
U2 0
PU SOC IMAGING SCIENCE & TECHNOLOGY
PI SPRINGFIELD
PA 7003 KILWORTH LANE, SPRINGFIELD, VA 22151 USA
BN 0-89208-255-0
PY 2005
BP 48
EP 53
PG 6
WC Computer Science, Information Systems; Information Science & Library
   Science
SC Computer Science; Information Science & Library Science
GA BCZ85
UT WOS:000232157800011
DA 2018-10-19
ER

PT S
AU Leng, YX
   Yang, P
   Chen, JY
   Xu, LX
   Zhao, AS
   Sun, H
   Wang, J
   Huang, N
AF Leng, YX
   Yang, P
   Chen, JY
   Xu, LX
   Zhao, AS
   Sun, H
   Wang, J
   Huang, N
BE Zhang, X
   Tanaka, J
   Yu, Y
   Tabata, Y
TI The role of surface physical properties on blood compatibility of
   titanium oxide films synthesized by unbalanced magnetron sputtering
SO ASBM6: ADVANCED BIOMATERIALS VI
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 6th Asian Symposium on Biomedical Materials (ASM6)
CY JUL 19-22, 2004
CL Emei, PEOPLES R CHINA
SP Minist Educ, Chinese Assoc Sci & Technol, Natl Nat Sci Fdn China, Chinese Comm Biomat, Sichuan Univ, Natl Inst Mat Sci, SW Jiaotong Univ, Natl Engn Res Ctr Biomat
DE titanium oxide; unbalanced magnetron sputtering; blood compatibility;
   semiconducting properties
ID IMMERSION ION-IMPLANTATION; THIN-FILMS; HEMOCOMPATIBILITY; DEPOSITION;
   OXIDATION; TI
AB Surface modification has shown great potential for improving the hemocompatibility of biomedical materials and devices. In this paper we describe our work on improving blood compatibility with Ti-O thin films prepared by unbalanced DC magnetron sputtering. The structure and surface chemical and physical properties of the films were characterized by X-ray diffraction, X-ray photoelectron spectroscopy (XPS), SEM, sheet resistance tests, and Hall effect measurements. The sheet resistance of the titanium oxide samples increased with oxygen pressure and shows a sharp increase when only TiO2 exists in the films. The band gap, carrier density and sheet resistance of the titanium oxide films synthesized at different oxygen pressure are different. These properties affect blood compatibility significantly. We suggest that the semiconducting nature of n-type Ti-O films with bandgap 3.0-3.2 eV, sheet resistance greater than 1 ohm.cm and carrier density of about 1.17 x 10(16) cm(-2) leads to their excellent blood compatibility.
C1 SW Jiaotong Univ, Minist Educ, Key Lab Adv Technol Mat, Lab Surface Engn Artificial Organs Sichuan, Chengdu 610031, Peoples R China.
RP Leng, YX (reprint author), SW Jiaotong Univ, Minist Educ, Key Lab Adv Technol Mat, Lab Surface Engn Artificial Organs Sichuan, Chengdu 610031, Peoples R China.
EM yxleng@26.net; nhyang@262.net
RI Leng, Yongxiang/G-5488-2010
OI Leng, Y.X./0000-0001-6823-1233
CR Chen JY, 2002, SURF COAT TECH, V156, P289, DOI 10.1016/S0257-8972(02)00089-0
   Chen JY, 2002, BIOMATERIALS, V23, P2545, DOI 10.1016/S0142-9612(01)00389-1
   Huang N, 2003, BIOMATERIALS, V24, P2177, DOI 10.1016/S0142-9612(03)00046-2
   Leng YX, 2002, THIN SOLID FILMS, V420, P408, DOI 10.1016/S0040-6090(02)00814-3
   Leng YX, 2003, SURF COAT TECH, V166, P176, DOI 10.1016/S0257-8972(02)00780-6
   Leng YX, 2001, SURF COAT TECH, V138, P296, DOI 10.1016/S0257-8972(00)01172-5
   Mardare D, 2000, APPL SURF SCI, V156, P200, DOI 10.1016/S0169-4332(99)00508-5
   Mardare D, 2002, MATER LETT, V56, P210, DOI 10.1016/S0167-577X(02)00441-X
   Paxton AT, 1998, PHYS REV B, V57, P1579, DOI 10.1103/PhysRevB.57.1579
   Sawase T, 2001, Clin Implant Dent Relat Res, V3, P221, DOI 10.1111/j.1708-8208.2001.tb00144.x
   Sunny M C, 1991, J Biomater Appl, V6, P89, DOI 10.1177/088532829100600107
   Velten D, 2002, J BIOMED MATER RES, V59, P18, DOI 10.1002/jbm.1212
NR 12
TC 5
Z9 5
U1 0
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-967-9
J9 KEY ENG MAT
PY 2005
VL 288-289
BP 311
EP 314
DI 10.4028/www.scientific.net/KEM.288-289.311
PG 4
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BCO63
UT WOS:000230426600076
DA 2018-10-19
ER

PT S
AU Mayer, G
   Blanchemain, N
   Dupas-Bruzek, C
   Traisnel, M
   Derozier, D
   Laude, LD
   Hildebrand, HF
AF Mayer, G
   Blanchemain, N
   Dupas-Bruzek, C
   Traisnel, M
   Derozier, D
   Laude, LD
   Hildebrand, HF
BE Zhang, X
   Tanaka, J
   Yu, Y
   Tabata, Y
TI Physico-chemical modifications and biological improvements of biomedical
   PET as a consequence of excimer LASER irradiation
SO ASBM6: ADVANCED BIOMATERIALS VI
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 6th Asian Symposium on Biomedical Materials (ASM6)
CY JUL 19-22, 2004
CL Emei, PEOPLES R CHINA
SP Minist Educ, Chinese Assoc Sci & Technol, Natl Nat Sci Fdn China, Chinese Comm Biomat, Sichuan Univ, Natl Inst Mat Sci, SW Jiaotong Univ, Natl Engn Res Ctr Biomat
DE polyethylene terephthalate; LASER excimer irradiation; surface profile;
   surface energy; cristallinity; scanning electron microscopy; cell
   viability; vitality; proliferation; adhesion
ID ROUGHNESS; BEHAVIOR; ADHESION
AB LASER Excimer irradiation can modify surface properties for biocompatibility improvement of a medical device. The PETs from 3 different origins were used in this study. The samples have been irradiated by excimer LASER with 10 different energies. The surface profile, the surface energy and the materials crystallinity have been assessed. Biological characterizations were made with human embryonic epithelial cells L132: proliferation, vitality, viability, adhesion with the p-NPP, and morphology. - The profile measurements allowed to establish the ablation threshold, which was 36 mJ/cm(2). The surface hydrophilic state increased reciprocally with the irradiation intensity. The gain is 13 %. The irradiated and non-irradiated product has identical cristallinity. PET was shown not to be toxic for L132 cells. Cell proliferation and cell vitality showed dose-dependant increases reciprocal to the irradiation energy (from 88 to 138% with respect to control). The correlation was highly significant (RI = 0,8). SEM micrographs show that the cells are better spread on the surface of irradiated PET than on untreated PET.
C1 Fac Med Lille, UPRES EA 1049, Grp Rech Biomat, F-59045 Lille, France.
   Univ Mons, LPES, B-7000 Mons, Belgium.
   ENSCL, F-59652 Villeneuve Dascq, France.
   CERLA, F-59655 Villeneuve Dascq, France.
RP Mayer, G (reprint author), Fac Med Lille, UPRES EA 1049, Grp Rech Biomat, F-59045 Lille, France.
EM nblanchemain@univ-lille2.fr; hildebrand@univ-lille2.fr
CR Buth J, 2000, J VASC SURG, V31, P134, DOI 10.1016/S0741-5214(00)70075-9
   De Bartolo L, 2002, BIOMATERIALS, V23, P2485, DOI 10.1016/S0142-9612(01)00383-0
   Hornez JC, 2002, BIOMOL ENG, V19, P103, DOI 10.1016/S1389-0344(02)00017-5
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   Laude LD, 2001, NUCL INSTRUM METH B, V185, P147, DOI 10.1016/S0168-583X(01)00750-9
   Linez-Bataillon P, 2002, BIOMOL ENG, V19, P133, DOI 10.1016/S1389-0344(02)00024-2
   Parodi J C, 1991, Ann Vasc Surg, V5, P491, DOI 10.1007/BF02015271
   Redey SA, 2000, J BIOMED MATER RES, V50, P353, DOI 10.1002/(SICI)1097-4636(20000605)50:3<353::AID-JBM9>3.0.CO;2-C
   WATANABE H, 1993, POLYM INT, V31, P247, DOI 10.1002/pi.4990310306
NR 9
TC 0
Z9 0
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-967-9
J9 KEY ENG MAT
PY 2005
VL 288-289
BP 347
EP 350
DI 10.4028/www.scientific.net/KEM.288-289.347
PG 4
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BCO63
UT WOS:000230426600085
DA 2018-10-19
ER

PT S
AU Jee, KS
   Bae, JW
   Park, KD
   Kim, YH
   Shin, JW
   Lee, JW
AF Jee, KS
   Bae, JW
   Park, KD
   Kim, YH
   Shin, JW
   Lee, JW
BE Zhang, X
   Tanaka, J
   Yu, Y
   Tabata, Y
TI Heparinized tissue matrices as novel biomaterials
SO ASBM6: ADVANCED BIOMATERIALS VI
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 6th Asian Symposium on Biomedical Materials (ASM6)
CY JUL 19-22, 2004
CL Emei, PEOPLES R CHINA
SP Minist Educ, Chinese Assoc Sci & Technol, Natl Nat Sci Fdn China, Chinese Comm Biomat, Sichuan Univ, Natl Inst Mat Sci, SW Jiaotong Univ, Natl Engn Res Ctr Biomat
DE heparin; biological tissue; chemical modification
AB Novel approaches using bioactive molecules in the purpose for overcoming the limitation of established materials have been studied. Their ultimate goal is focused on improved blood/cell compatible biomaterials for various biomedical applications. Heparin-bound bioactive materials using bovine pericardium have been developed. From results of heparinized cellular or acellular tissue matrices, the effect of heparin on the tissue in cell-related biological responses as well as improved blood compatibility was confirmed. These heparinized matrices can be useful for tissue regeneration through the control of growth factor in tissue engineering as well as cardiovascular application.
C1 Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea.
   KIST, Biomat Res Ctr, Seoul, South Korea.
   Inje Univ, Dept Biomed Engn, Kimhae, Kyongnam, South Korea.
   Yonsei Univ, Coll Med, Dept Orthopaed Surg, Seoul, South Korea.
RP Jee, KS (reprint author), Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea.
EM kdp@ajou.ac.kr
CR CHEUNG DT, 1985, CONNECT TISSUE RES, V13, P109, DOI 10.3109/03008208509152389
   COURTMAN DW, 1994, J BIOMED MATER RES, V28, P655, DOI 10.1002/jbm.820280602
   Jee KS, 2003, BIOMATERIALS, V24, P3409, DOI 10.1016/S0142-9612(03)00204-7
   Park KD, 1997, BIOMATERIALS, V18, P47, DOI 10.1016/S0142-9612(96)00096-8
   PARK KD, 1994, ASAIO J, V40, P377
NR 5
TC 0
Z9 0
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-967-9
J9 KEY ENG MAT
PY 2005
VL 288-289
BP 453
EP 456
DI 10.4028/www.scientific.net/KEM.288-289.453
PG 4
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BCO63
UT WOS:000230426600111
DA 2018-10-19
ER

PT S
AU Xu, YX
   Wang, WJ
   Zhang, Y
   Song, XH
   Li, L
   Wang, JJ
   Cui, FZ
   Feng, QL
AF Xu, YX
   Wang, WJ
   Zhang, Y
   Song, XH
   Li, L
   Wang, JJ
   Cui, FZ
   Feng, QL
BE Zhang, X
   Tanaka, J
   Yu, Y
   Tabata, Y
TI A novel method for evaluating compatibility of hepatocytes with some
   kinds of biomaterials
SO ASBM6: ADVANCED BIOMATERIALS VI
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 6th Asian Symposium on Biomedical Materials (ASM6)
CY JUL 19-22, 2004
CL Emei, PEOPLES R CHINA
SP Minist Educ, Chinese Assoc Sci & Technol, Natl Nat Sci Fdn China, Chinese Comm Biomat, Sichuan Univ, Natl Inst Mat Sci, SW Jiaotong Univ, Natl Engn Res Ctr Biomat
DE biomaterial; biocompatibility; hepatocyte; automatic biochemical
   analyzer
ID LIVER
AB To evaluate the biocompatibility of biomedical materials for hepatic tissue engineering, another new method was introduced to observe hepatocytes functions. In this experiment, hepatocytes were seeded onto four kinds of membranes of PLLA, PLGA (90:10), PLGA (75:25), and Chitosan cross-linked with collagen. The culture mediums were collected at 21 day after seeding, and then albumin (Alb), Urea (UN), glucose (Glu), total protein (TP), and triglyceride (TG) in the supernatant were detected by automatic biochemical analyzer. Results showed that hepatocytes on film of Chitosan cross-linked with collagen exhibited the highest level of TP and TG. These results were highly corresponding with the results of morphological observation. This data indicated that analyzing TP and TG in culture medium by automatic biochemical analyzer might be applied to evaluate hepatocytes biocompatibility on materials as a convenient and feasible method.
C1 Chinese Peoples Liberat Army Gen Hosp, Inst Gen Surg, Beijing 1000853, Peoples R China.
   Tsing Hua Univ, Dept Mat Sci & Engn, Beijing 100084, Peoples R China.
RP Xu, YX (reprint author), Chinese Peoples Liberat Army Gen Hosp, Inst Gen Surg, Beijing 1000853, Peoples R China.
EM xu_yingxin@hotmail.com; wwj01@mails.tsinghua.edu.cn
CR [Anonymous], 1992, 10993 ISO
   Catapano G, 1996, INT J ARTIF ORGANS, V19, P61
   Davis MW, 1996, BIOMATERIALS, V17, P365, DOI 10.1016/0142-9612(96)85575-X
   Elcin YM, 1998, ARTIF ORGANS, V22, P837
   FRIEND JR, 1999, TISSUE ENG METHODS P, P245
   Kang S, 2000, BBA-MOL CELL BIOL L, V1529, P223, DOI 10.1016/S1388-1981(00)00151-7
   Mooney DJ, 1997, J BIOMED MATER RES, V37, P413, DOI 10.1002/(SICI)1097-4636(19971205)37:3<413::AID-JBM12>3.0.CO;2-C
   STRAIN AJ, SCIENCE, V295, P5557
NR 8
TC 0
Z9 0
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-967-9
J9 KEY ENG MAT
PY 2005
VL 288-289
BP 511
EP 514
DI 10.4028/www.scientific.net/KEM.288-289.511
PG 4
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BCO63
UT WOS:000230426600125
DA 2018-10-19
ER

PT S
AU Yu, ZT
   Zhou, L
   Lu, LJ
   Fan, MH
   Fu, YY
AF Yu, ZT
   Zhou, L
   Lu, LJ
   Fan, MH
   Fu, YY
BE Zhang, X
   Tanaka, J
   Yu, Y
   Tabata, Y
TI Investigation on mechanical compatibility matching for biomedical
   titanium alloys
SO ASBM6: ADVANCED BIOMATERIALS VI
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 6th Asian Symposium on Biomedical Materials (ASM6)
CY JUL 19-22, 2004
CL Emei, PEOPLES R CHINA
SP Minist Educ, Chinese Assoc Sci & Technol, Natl Nat Sci Fdn China, Chinese Comm Biomat, Sichuan Univ, Natl Inst Mat Sci, SW Jiaotong Univ, Natl Engn Res Ctr Biomat
DE titanium; near-beta type titanium alloys; mechanical properties;
   matching of mechanical compatibility; surgical implants
AB The effects of alloying elements such as Mo, Sn, Zr, Nb, deforming-rate, solid solution and aging treatment on mechanical property and microstructure of near beta type biomedical Ti alloys based on Ti-Nb-Zr system were studied. The Influential factors and their solution were discussed to keep matching of strength, elastic modulus, plasticity and toughness. Ti-Zr-Mo-Nb and Ti-Zr-Sn-Mo-Nb alloy systems possess excellent biocompatibility, lower elastic modulus, higher strength, finer plasticity and fracture toughness matching by means of solid solution and ageing treatment which are much more suitable for surgical implant and orthopedic materials.
C1 NW Inst Nonferrous Met Res, Xian 710016, Shaanxi, Peoples R China.
   Iowa State Univ Sci & Technol, Ctr Sustainable Environm Technol, Ames, IA 50011 USA.
RP Yu, ZT (reprint author), NW Inst Nonferrous Met Res, Xian 710016, Shaanxi, Peoples R China.
EM yzt@c-nin.com; Zhoul@c-nin.com; fan@ameslab.gov
OI Fan, Maohong/0000-0003-1334-7292
CR FROS FH, 1985, J MET, V37, P28
   Geetha M, 2001, J ALLOY COMPD, V329, P264, DOI 10.1016/S0925-8388(01)01604-8
   Song Y, 1999, MAT SCI ENG A-STRUCT, V260, P269, DOI 10.1016/S0921-5093(98)00886-7
   STEINEMANN S, 1993, TIT 92 SCI TECHN TMS
   SUMNER DR, 1992, CLIN ORTHOP RELAT R, P202
   Wang XT, 1999, ISSUES STUD, V35, P167
   YU ZT, 2004, RARE METALS LETT, V23, P5
NR 7
TC 7
Z9 11
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-967-9
J9 KEY ENG MAT
PY 2005
VL 288-289
BP 595
EP 598
DI 10.4028/www.scientific.net/KEM.288-289.595
PG 4
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BCO63
UT WOS:000230426600145
DA 2018-10-19
ER

PT J
AU Eglin, D
   Coradin, T
   Giraud Guille, MM
   Helary, C
   Livage, J
AF Eglin, D
   Coradin, T
   Giraud Guille, MM
   Helary, C
   Livage, J
TI Collagen-silica hybrid materials: Sodium silicate and sodium chloride
   effects on type I collagen fibrillogenesis
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article; Proceedings Paper
CT 2nd International Conference on New Biomedical Materials
CY APR 05-08, 2003
CL Cardiff, WALES
DE sodium silicate; type I collagen; fibrils
ID FIBRIL FORMATION; WATER
AB Collagen-silica hybrid materials have been considered for potential biomedical applications. Understanding of the collagen-silica interactions is the key to control hybrids structure and properties. For this purpose, the effect of sodium silicate and sodium chloride addition at two concentrations, 0.83 and 10 mM, on the kinetic of the type I collagen fibrillogenesis at 20degreesC, and pH 7.4 were studied. Absorbance profiles of fibrillogenesis experiments were collected together with measures of silicic acid concentration and transmission electron microscopy analysis. The specific effect of silica addition on the collagen fibrils self-assembly mechanisms was demonstrated by comparison with the sodium chloride. Sodium silicate at 10 mM inhibited the collagen fibrillogenesis. At the same concentration, the sodium chloride decreased the rate of the collagen fibril assembly. Collagen fibrillogenesis kinetic was not significantly disturbed by the presence of 0.83 mM of sodium chloride. However, the same concentration of sodium silicate modified the collagen fibrillogenesis kinetic. Transmission electron microscopy indicated for experiment with 0.83 mM of sodium silicate, the formation of longer and wider fibrils than for the equivalent collagen fibrillogenesis experiment with sodium chloride. The effect of sodium chloride is explained in terms of osmotic exclusion and influence on electrostatic interactions between collagen fibrils. The specific involvement of silicic acid in collagen helices hydrogen-bond interactions is suggested. Finally, the results of this study are discussed regarding the preparation of composites by co-gelation of type I collagen and sodium silicate, for potential application as bone repair device.
C1 Univ Paris 06, CNRS, EPHE, Lab Chim Mat Condensee, F-75252 Paris 05, France.
RP Eglin, D (reprint author), Univ Paris 06, CNRS, EPHE, Lab Chim Mat Condensee, 4 Pl Jussieu, F-75252 Paris 05, France.
EM eglin@ccr.jussieu.fr
RI Coradin, Thibaud/L-8932-2013
OI Eglin, David/0000-0002-8500-6887
CR Besseau L, 2002, BIOMATERIALS, V23, P27, DOI 10.1016/S0142-9612(01)00075-8
   Brasack I, 2000, J SOL-GEL SCI TECHN, V19, P479, DOI 10.1023/A:1008763900729
   COLLINS KD, 1985, Q REV BIOPHYS, V18, P323, DOI 10.1017/S0033583500005369
   Coradin T, 2002, MATER RES SOC SYMP P, V726, P79
   Delorenzi NJ, 1996, INT J BIOL MACROMOL, V19, P15, DOI 10.1016/0141-8130(96)01094-X
   ESTEVEROMERO JS, 1994, ANAL LETT, V27, P1557, DOI 10.1080/00032719408006389
   GELMAN RA, 1979, J BIOL CHEM, V254, P180
   GIRAUDGUILLE MM, 1994, J STRUCT BIOL, V113, P99, DOI 10.1006/jsbi.1994.1035
   GROSS J, 1958, J BIOL CHEM, V233, P355
   Iler R.K., 1979, CHEM SILICA SOLUBILI
   Kuznetsova N, 1998, BIOCHEMISTRY-US, V37, P11888, DOI 10.1021/bi980089+
   WILLIAMS BR, 1978, J BIOL CHEM, V253, P6578
   WOOD GC, 1960, BIOCHEM J, V75, P588, DOI 10.1042/bj0750588
   WOODHEADGALLOWA.JW, 1968, COLLAGEN ANATOMY PRO, P32
NR 14
TC 23
Z9 23
U1 1
U2 14
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2005
VL 15
IS 1-2
BP 43
EP 50
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 883HY
UT WOS:000226003400005
PM 15623929
DA 2018-10-19
ER

PT J
AU Tan, KH
   Chua, CK
   Leong, KF
   Cheah, CM
   Gui, WS
   Tan, WS
   Wiria, FE
AF Tan, KH
   Chua, CK
   Leong, KF
   Cheah, CM
   Gui, WS
   Tan, WS
   Wiria, FE
TI Selective laser sintering of biocompatible polymers for applications in
   tissue engineering
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article; Proceedings Paper
CT 2nd International Conference on New Biomedical Materials
CY APR 05-08, 2003
CL Cardiff, WALES
DE biomaterials; tissue engineering; selective laser sintering
ID SCAFFOLDS; FABRICATION; DESIGN
AB The ability to use biological substitutes to repair or replace damaged tissues lead to the development of Tissue Engineering (TE), a field that is growing in scope and importance within biomedical engineering. Anchorage dependent cell types often rely on the use of temporary three-dimensional scaffolds to guide cell proliferation. Computer-controlled fabrication techniques such as Rapid Prototyping (RP) processes have been recognised to have an edge over conventional manual-based scaffold fabrication techniques due to their ability to create structures with complex macro- and micro-architectures. Despite the immense capabilities of RP fabrication for scaffold production, commercial available RP modelling materials are not biocompatible and are not suitable for direct use in the fabrication of scaffolds. Work is carried out with several biocompatible polymers such as Polyetheretherketone (PEEK), Poly(vinyl alcohol) (PVA), Polycaprolactone (PCL) and Poly(L-lactic acid) (PLLA) and a bioceramic namely, Hydroxyapatite (HA). The parameters of the selective laser sintering (SLS) process are optimised to cater to the processing of these materials. SLS-fabricated scaffold specimens are examined using a Scanning Electron Microscope (SEM). Results observed from the micrographs indicate the viability of them being used for building TE scaffolds and ascertain the capabilities of the SLS process for creating highly porous scaffolds for Tissue Engineering applications.
C1 Nanyang Technol Univ, Sch Mech & Prod Engn, Singapore 639798, Singapore.
RP Chua, CK (reprint author), Nanyang Technol Univ, Sch Mech & Prod Engn, 50 Nanyang Ave, Singapore 639798, Singapore.
EM mckchua@ntu.edu.sg
RI Leong, Kah-Fai/B-6183-2009; Chua, Chee Kai/B-6171-2009
CR Chen GP, 2001, MAT SCI ENG C-BIO S, V17, P63, DOI 10.1016/S0928-4931(01)00338-1
   Chu C.C., 2000, BIOMEDICAL ENG HDB
   CHUA CK, RAPID PROTOTYPING J
   DOMB AJ, 1997, HDB BIODEGRADABLE PO
   Gibson I, 1997, RAPID PROTOTYPING J, V3, P129, DOI 10.1108/13552549710191836
   KU JCW, 2002, THESIS U HONG KONG
   LEE G, 1996, P SOL FREEF FABR S A, P15
   Lee G., 1993, P SOL FREEF FABR S A, P376
   Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9
   Li S, 1995, DEGRADABLE POLYM PRI
   Low KH, 2001, RAPID PROTOTYPING J, V7, P262, DOI 10.1108/13552540110410468
   Lu HH, 2003, J BIOMED MATER RES A, V64A, P465, DOI 10.1002/jbm.a.10399
   Wang M, 2001, J MATER SCI-MATER M, V12, P855, DOI 10.1023/A:1012899318688
   Wang YC, 2003, BIOMATERIALS, V24, P1047, DOI 10.1016/S0142-9612(02)00434-9
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yang SF, 2002, TISSUE ENG, V8, P1, DOI 10.1089/107632702753503009
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
NR 17
TC 142
Z9 155
U1 4
U2 58
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2005
VL 15
IS 1-2
BP 113
EP 124
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 883HY
UT WOS:000226003400011
PM 15623935
DA 2018-10-19
ER

PT S
AU Garcia, C
   Paucar, C
   Gaviria, J
   Duran, A
AF Garcia, C
   Paucar, C
   Gaviria, J
   Duran, A
BE Li, P
   Zhang, K
   Colwell, CW
TI Effect of some physical-chemical variables in the synthesis of
   hydroxyapatite by the precipitation route
SO BIOCERAMICS 17
SE Key Engineering Materials
LA English
DT Article; Proceedings Paper
CT 17th International Symposium on Ceramics in Medicine
CY DEC 08-12, 2004
CL New Orleans, LA
SP DePuy Inc, Ktryker Orthopaed, Zimmer Inc, Smith & Nephew Orthopaed, CeramTec, Cam Implants BV
DE biomedical applications; chemical properties; hydroxyapatite;
   precipitation route; synthesis
ID PHOSPHATE
AB The synthetic hydroxyapatite is a very useful material for numerous applications in medicine as a biomaterial. One of the most economic manufacturing process is the precipitation route. In the present work, synthetic hydroxyapatite was prepared using the precipitation route, starting with aqueous solutions of calcium nitrate (Ca(NO3).4H(2)O) and ammonium phosphate (H-2(PO4)NH4). The effects of physical-chemical variables such as pH, temperature, time of agitation, ageing time and heat treatment of the mixture were evaluated. The characterization of the samples obtained in different conditions made possible to conclude about the optimal values of the studied variables for the synthesis of this material in laboratory conditions.
C1 Univ Nacl Colombia Medellin, Fac Ciencias, Escuelas Fis & Quim, Medellin 3840, Colombia.
   CSIC, Inst Ceram & Vidrio, E-28049 Madrid, Spain.
RP Garcia, C (reprint author), Univ Nacl Colombia Medellin, Fac Ciencias, Escuelas Fis & Quim, Medellin 3840, Colombia.
EM cpgarcia@unalmed.edu.co; cgpaucar@unalmed.edu.co;
   jgarango@unalmed.edu.co; aduran@icv.csic.es
RI Garcia, Claudia/P-7860-2017; Paucar, Carlos/P-4755-2017
OI Garcia, Claudia/0000-0002-8241-9969; Paucar, Carlos/0000-0003-1457-0445
CR Elliott J. C., 1994, STRUCTURE CHEM APATI, P111
   Hsieh MF, 2001, J AM CERAM SOC, V84, P2123
   Lin FH, 1998, BIOMATERIALS, V19, P1101, DOI 10.1016/S0142-9612(98)00040-4
   Lin FH, 2000, MAT SCI ENG C-BIO S, V13, P97, DOI 10.1016/S0928-4931(00)00182-X
   Liu CS, 2001, BIOMATERIALS, V22, P301, DOI 10.1016/S0142-9612(00)00166-6
   Liu DM, 2002, BIOMATERIALS, V23, P1679, DOI 10.1016/S0142-9612(01)00295-2
   Petrov OE, 2001, MATER LETT, V48, P162, DOI 10.1016/S0167-577X(00)00297-4
   SANTOS C, 1994, THESIS U SANTIAGO SA
   SECKLER MM, 1999, MAT RES, V2, P59
   Velayudhan S, 2000, MATER LETT, V46, P142, DOI 10.1016/S0167-577X(00)00157-9
   Weng W, 1997, J EUR CERAM SOC, V17, P1151, DOI 10.1016/S0955-2219(96)00215-4
NR 11
TC 9
Z9 9
U1 0
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1013-9826
BN 0-87849-961-X
J9 KEY ENG MATER
PY 2005
VL 284-286
BP 47
EP 50
DI 10.4028/www.scientific.net/KEM.284-286.47
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BBZ54
UT WOS:000228359500012
OA Green Published
DA 2018-10-19
ER

PT S
AU Navarro, M
   Sanzana, ES
   Planell, JA
   Ginebra, MP
   Torres, PA
AF Navarro, M
   Sanzana, ES
   Planell, JA
   Ginebra, MP
   Torres, PA
BE Li, P
   Zhang, K
   Colwell, CW
TI In vivo behavior of calcium phosphate glasses with controlled solubility
SO BIOCERAMICS 17
SE Key Engineering Materials
LA English
DT Article; Proceedings Paper
CT 17th International Symposium on Ceramics in Medicine
CY DEC 08-12, 2004
CL New Orleans, LA
SP DePuy Inc, Ktryker Orthopaed, Zimmer Inc, Smith & Nephew Orthopaed, CeramTec, Cam Implants BV
DE calcium phosphate glasses; in vivo
ID BONE
AB Resorbable calcium phosphate glasses offer interesting solutions in the biomedical field, as bone cavity fillers, drug delivery systems, biodegradable reinforcing phase in the case of composites for bone fixation devices and tissue engineering scaffolds. In this work, two different glass formulations in the systems 44.5CaO-44.5P(2)O(5)-(11-X)Na(2)O-XTiO(2) (X=0or 5) have been elaborated. It is known that the incorporation or TiO(2) into the vitreous system reduces considerably the solubility of the glasses. To study the material solubility effect on the in vivo response, glass particles of the two formulations were implanted in rabbits. Results showed that both glasses elicited a similar biological response and good biocompatibility. The percentage of new bone formation in the glasses was comparable to that obtained for the autologous bone (control) after 12 weeks of implantation. The materials showed to have an osteoconductive potential. Finally, this study showed that in spite of the solubility difference of the studied glasses, there were no significant differences in the in vivo response
C1 Tech Univ Catalonia, Ctr Reference Bioengn Catalonia, Dept Mat Sci & Met, Biomat & Biomech Div, ES-08028 Barcelona, Spain.
   Univ Concepcion, Fac Med, Dept Surg, Concepcion, Chile.
RP Navarro, M (reprint author), Tech Univ Catalonia, Ctr Reference Bioengn Catalonia, Dept Mat Sci & Met, Biomat & Biomech Div, Avda Diagonal 647, ES-08028 Barcelona, Spain.
EM melba.navarro@upc.es; esanzana@udec.cl; maria.pau.ginebra@upc.es
RI Ginebra, Maria-Pau/J-8149-2017
OI Ginebra, Maria-Pau/0000-0002-4700-5621
CR BURNIE J, 1981, BIOMATERIALS, V2, P244, DOI 10.1016/0142-9612(81)90065-X
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Navarro M, 2004, J MATER SCI-MATER M, V15, P419, DOI 10.1023/B:JMSM.0000021113.88702.9d
   Navarro M, 2003, J BIOMED MATER RES A, V67A, P1009, DOI 10.1002/jbm.a.20014
   Navarro M, 2003, J AM CERAM SOC, V86, P1345, DOI 10.1111/j.1151-2916.2003.tb03474.x
   Roether JA, 2002, BIOMATERIALS, V23, P3871, DOI 10.1016/S0142-9612(02)00131-X
NR 6
TC 3
Z9 4
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1013-9826
BN 0-87849-961-X
J9 KEY ENG MATER
PY 2005
VL 284-286
BP 893
EP 896
DI 10.4028/www.scientific.net/KEM.284-286.893
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BBZ54
UT WOS:000228359500218
DA 2018-10-19
ER

PT S
AU Mansur, HS
   Mansur, AAP
   Pereira, MM
AF Mansur, HS
   Mansur, AAP
   Pereira, MM
BE Li, P
   Zhang, K
   Colwell, CW
TI XRD, SEM/EDX and FTIR characterization of Brazilian natural coral
SO BIOCERAMICS, VOL 17
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 17th International Symposium on Ceramics in Medicine
CY DEC 08-12, 2004
CL New Orleans, LA
SP DePuy Inc, Ktryker Orthopaed, Zimmer Inc, Smith & Nephew Orthopaed, CeramTec, Cam Implants BV
DE bioceramics; biomaterial; characterization; coral; scaffolds
AB In the present work, natural coral from Brazilian reefs were studied according to their crystallography by X-ray diffraction and microstructure by Scanning Electron Microscopy (SEM/EDX). FTIR spectroscopy was also used to evaluate the chemical functionalities and major components present in the material. The SEM morphology results have shown a tri-dimensional coral structure with porous ranging from 50 to 200 mu m. Aragonite was identified as the major crystalline phase through XRD analysis and FTIR spectroscopy. Strontium calcium carbonate, (Sr,Ca)CO3, was also identified by XRD analysis. After sintering at 900 degrees/1h, the conversion from aragonite to CaO and calcite was observed. These results have endorsed the high potential application of natural coral materials as 3D scaffolds for biomedical application, because of calcium carbonate compounds can be converted to RA by hydrothermal and biomimetic coating processes.
C1 Univ Fed Minas Gerais, Dept Met & Mat Engn, Lab Biomat & Tissue Engn, Belo Horizonte, MG, Brazil.
RP Mansur, HS (reprint author), Univ Fed Minas Gerais, Dept Met & Mat Engn, Lab Biomat & Tissue Engn, Belo Horizonte, MG, Brazil.
EM ahmansur@demet.ufmg.br; aapiscitelli@uol.com.br; mpereira@demet.ufmg.br
OI Mansur, Herman/0000-0002-3032-495X; Mansur,
   Alexandra/0000-0003-1526-2508
CR Farmer V. C., 1974, INFRARED SPECTRA MIN
   FERNANDES GF, 2000, QUIM NOVA, V23, P441
   FERRARI K. R., 2000, CERAMICA IND, V5, P53
   VUOLA J, 2001, NATURAL CORAL HYDROX
   White WB, 1997, ENVIRON GEOL, V30, P46, DOI 10.1007/s002540050131
   Xu Y, 2001, MATER CHARACT, V47, P83, DOI 10.1016/S1044-5803(01)00154-1
NR 6
TC 2
Z9 2
U1 0
U2 9
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-961-X
J9 KEY ENG MAT
PY 2005
VL 284-286
BP 43
EP 46
DI 10.4028/www.scientific.net/KEM.284-286.43
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BBZ54
UT WOS:000228359500011
DA 2018-10-19
ER

PT S
AU Nowak, D
   Florek, M
   Nowak, J
   Kwiatek, W
   Lekki, J
   Zieba, E
   Romero, PG
   Ben-Nissan, B
   Kuczumow, A
AF Nowak, D
   Florek, M
   Nowak, J
   Kwiatek, W
   Lekki, J
   Zieba, E
   Romero, PG
   Ben-Nissan, B
   Kuczumow, A
BE Li, P
   Zhang, K
   Colwell, CW
TI Micro-spectrometric investigations of inorganic components of the black
   corals for biomedical applications
SO BIOCERAMICS, VOL 17
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 17th International Symposium on Ceramics in Medicine
CY DEC 08-12, 2004
CL New Orleans, LA
SP DePuy Inc, Ktryker Orthopaed, Zimmer Inc, Smith & Nephew Orthopaed, CeramTec, Cam Implants BV
ID SKELETON COELENTERATA; CHITIN; ANTIPATHARIA; CUTICLE
AB The distribution of about twenty inorganic elements was traced in the skeletons of black corals of the Antipathes salix species. Electron microprobe and PIXE mappings revealed the peculiar structure of this material, composed of the large cells (arranged in annual rings), surrounded by thin layers with an elevated level of iodine (up to 5%). Our current knowledge of the chemical composition of these corals' skeleton is not complete. Essentially the organic skeleton is saturated with inorganic elements and several of these could be commercially important. In fact, they have never been investigated for biomedical applications. In this preliminary current work, black corals from the Antipathes salix species were studied with the aim of detecting the inorganic components of their matrix and their suitability as biomedical materials.
C1 Catholic Univ Lublin, Dept Chem, Lublin, Poland.
   Inst Nucl Phys, Dept Nucl Spect, PL-31342 Krakow, Poland.
   ICMAB, ES-08193 Bellaterra, Spain.
   Univ Technol, Dept Chem Mat & Forens Sci, Broadway, NSW 2007, Australia.
RP Nowak, D (reprint author), Catholic Univ Lublin, Dept Chem, Lublin, Poland.
EM b.ben-nissan@uts.edu.au; kuczon@kul.lublin.pl
RI Lekki, Janusz/B-5720-2013; Gomez-Romero, Pedro/B-7855-2008
OI Gomez-Romero, Pedro/0000-0002-6208-5340; Lekki,
   Janusz/0000-0001-9848-6448; Kwiatek, Wojciech/0000-0002-2197-8572
CR Brown C. H., 1975, STRUCTURAL MAT ANIMA
   Chevallier P, 1996, J TRACE MICROPROBE T, V14, P517
   Dillmann P, 1997, J TRACE MICROPROBE T, V15, P251
   ELLIS LC, 1980, COMP BIOCHEM PHYS B, V66, P163, DOI 10.1016/0305-0491(80)90102-9
   Goldberg W.M., 1978, MAR BIOL, V49, P669
   GOLDBERG WM, 1994, COMP BIOCHEM PHYS B, V107, P633, DOI 10.1016/0305-0491(94)90197-X
   Grigg R. W., 1977, REEF SHORE FAUNA HAW, P242
   Hammersley AP, 1997, J SYNCHROTRON RADIAT, V4, P67, DOI 10.1107/S0909049596015087
   HOLL SM, 1992, ARCH BIOCHEM BIOPHYS, V292, P107, DOI 10.1016/0003-9861(92)90057-4
   KIM K, 1992, BIOL BULL-US, V182, P195, DOI 10.2307/1542113
   Lebed S, 1999, NUCL INSTRUM METH B, V158, P44, DOI 10.1016/S0168-583X(99)00387-0
   Manoli F, 1997, J CRYST GROWTH, V182, P116, DOI 10.1016/S0022-0248(97)00318-7
   Vago R, 2002, J BIOCHEM BIOPH METH, V50, P253, DOI 10.1016/S0165-022X(01)00235-4
   Zhang M, 2000, INT J BIOL MACROMOL, V27, P99, DOI 10.1016/S0141-8130(99)00123-3
NR 14
TC 7
Z9 7
U1 0
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-961-X
J9 KEY ENG MAT
PY 2005
VL 284-286
BP 297
EP 300
DI 10.4028/www.scientific.net/KEM.284-286.297
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BBZ54
UT WOS:000228359500073
DA 2018-10-19
ER

PT S
AU de Carlos, A
   Borrajo, JP
   Serra, J
   Gonzalez, P
   Liste, S
   Leon, B
AF de Carlos, A
   Borrajo, JP
   Serra, J
   Gonzalez, P
   Liste, S
   Leon, B
BE Li, P
   Zhang, K
   Colwell, CW
TI In vitro cytotoxicity testing of wood-based biomorphic SiC ceramics
SO BIOCERAMICS, VOL 17
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 17th International Symposium on Ceramics in Medicine
CY DEC 08-12, 2004
CL New Orleans, LA
SP DePuy Inc, Ktryker Orthopaed, Zimmer Inc, Smith & Nephew Orthopaed, CeramTec, Cam Implants BV
DE bioactive glass; bioceramic; MG-63 cells; MTT assay; silicon carbide;
   Ti6Al4V
AB The aim of this study was to test the in vitro cytotoxicity of wood-based biomorphic Silicon Carbide (SiC) ceramics, using MG-63 human osteoblast-like cells. This innovative material has been recently developed and it exhibits unique mechanical properties towards their application in biomedical technology. In the solvent extraction test the SiC ceramic extracts had almost no effect on cellular activity even at 100% concentration. A similar behaviour was found for Ti6Al4V and bioactive glass, used as reference materials. The results of the cell morphology and the cellular attachment response have also demonstrated that the in vitro performance of these biomorphic SiC ceramics is qualitatively comparable to that produced by titanium alloy and bioactive glass, which seems very promising.
C1 Fac Biol, Dpto Bioquim Genet & Immunol, E-36200 Vigo, Spain.
   ETSI Ind, Dept Fis Aplicada, Vigo, Spain.
RP de Carlos, A (reprint author), Fac Biol, Dpto Bioquim Genet & Immunol, E-36200 Vigo, Spain.
EM adcarlos@uvigo.es; jpb@uvigo.es; jserra@uvigo.es; pglez@uvigo.es;
   liste@uvigo.es; bleon@uvigo.es
RI de Carlos, Alejandro/L-5819-2014; New Materials Group, FA3/D-6799-2014
OI de Carlos, Alejandro/0000-0003-0138-4918; New Materials Group,
   FA3/0000-0003-4286-2015; Serra, Julia/0000-0001-6187-4025; GONZALEZ,
   PIO/0000-0002-7353-712X
CR Gonzalez P, 2003, BIOMATERIALS, V24, P4827, DOI 10.1016/S0142-9612(03)00405-8
   MARTINEZFERNANDEZ, 2000, SCRIPTA MATER, V43, P813
   Singh M., 2000, CERAM SCI ENG P, V21, P39
   Varela-Feria F. M., 2002, Ceramic Engineering and Science Proceedings, V23, P681
NR 4
TC 3
Z9 3
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-961-X
J9 KEY ENG MAT
PY 2005
VL 284-286
BP 581
EP 584
DI 10.4028/www.scientific.net/KEM.284-286.581
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BBZ54
UT WOS:000228359500142
DA 2018-10-19
ER

PT S
AU Pelaez, A
   Pareja, A
   Garcia, CP
   Marquez, ME
   Toro, A
   Castaneda, R
   Abad, P
AF Pelaez, A
   Pareja, A
   Garcia, CP
   Marquez, ME
   Toro, A
   Castaneda, R
   Abad, P
BE Li, P
   Zhang, K
   Colwell, CW
TI Genotoxicity effects of ceramic coatings applied on metallic substrates
   using single cell gel electrophoresis assay in vitro
SO BIOCERAMICS, VOL 17
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 17th International Symposium on Ceramics in Medicine
CY DEC 08-12, 2004
CL New Orleans, LA
SP DePuy Inc, Ktryker Orthopaed, Zimmer Inc, Smith & Nephew Orthopaed, CeramTec, Cam Implants BV
DE coatings; genotoxicity; PVD; SCGE; sol-gel
ID BIOMEDICAL APPLICATIONS; VITREOUS COATINGS; DEVICES
AB Sol-Gel coatings are a good choice for protection and bioactivation of metals used as dentistry and standard surgical implant materials. These films should both prevent degradation of the substrates by wear or corrosion, and bioactivate the material for inducing the formation of a hydroxyapatite (HA) rich layer onto the material surface, thereby permitting a natural bonding to living tissues.
   The aim of this work was to estimate the clastogenicity in vitro by Single Cell Gel Electrophoresis Assay (SCGE) or "comet" assay of coatings of TiN applied by magnetron sputtering and of hybrid layers obtained by Sol-Gel containing glass, glass-ceramic and HA particles on stainless steel AISI 304.
   Six test specimens were prepared: AISI 304 Stainless Steel coated with an hybrid silica single film (SF), applied by sol-gel process, AISI 304 SS coated with double film with bioactive glass (DFG), glass-ceramics (DFGC) and HA (DFHA) particles, AISI 304 SS coated with TiN multi films (MFTiN) applied by PVD and bare AISI 304 SS (304SS). Significantly lower DNA migration (p > 0.005) was observed in the cells of the cultures corresponding to the samples coated with SF, DFG, DFGC, DFHA and MFTiN respect to the bare 304 SS. ne comparison between negative control and the same coated samples did not reveal any statistically significant difference (p > 0.005) in clastogenicity in vitro evaluated by SCGE.
C1 Univ Nacl Colombia, Biosci Sch, Medellin, Colombia.
   Univ Nacl Colombia, Sch Phys, Medellin, Colombia.
   Univ Nacl Colombia, Sch Mat, Medellin, Colombia.
   Inst Ciencias Salud, Fac Dent, Medellin, Colombia.
RP Pelaez, A (reprint author), Univ Nacl Colombia, Biosci Sch, Medellin, Colombia.
EM continuo@unalmed.edu.co; apareja@unalmed.edu.co;
   cpgarcia@unalmed.edu.co; memarquez@unalmed.edu.co;
   aotoro@unalmed.edu.co; rcastane@unalmed.edu.co; pdjabad@unalmed.edu.co
RI Castaneda Sepulveda, Roman Eduardo/S-5361-2017; Garcia,
   Claudia/P-7860-2017
OI Castaneda Sepulveda, Roman Eduardo/0000-0002-1805-3958; Garcia,
   Claudia/0000-0002-8241-9969; Toro, Alejandro/0000-0002-5589-5820;
   Pelaez-Vargas, Alejandro/0000-0001-7582-2760
CR Ballarre J, 2002, J NON-CRYST SOLIDS, V304, P278, DOI 10.1016/S0022-3093(02)01035-9
   CHRISTOFFERSEN MR, 1987, CALCIFIED TISSUE INT, V41, P27, DOI 10.1007/BF02555127
   Duran A, 2004, J MATER CHEM, V14, P2282, DOI 10.1039/b401370k
   Gallardo J, 2000, J SOL-GEL SCI TECHN, V19, P107, DOI 10.1023/A:1008726608539
   Gallardo J, 2001, J SOL-GEL SCI TECHN, V21, P65, DOI 10.1023/A:1011257516468
   Galliano P, 1998, J SOL-GEL SCI TECHN, V13, P723, DOI 10.1023/A:1008653208083
   Garcia C, 2003, MATER LETT, V57, P1810, DOI 10.1016/S0167-577X(02)01073-X
   Gurappa I, 2002, SURF COAT TECH, V161, P70, DOI 10.1016/S0257-8972(02)00380-8
   Harris GK, 2003, MUTAT RES-FUND MOL M, V533, P183, DOI 10.1016/j.mrfmmm.2003.08.025
   Innocenzi P. C., 1992, Journal of the European Ceramic Society, V10, P431, DOI 10.1016/0955-2219(92)90018-9
   Kannan S, 2003, MATER LETT, V57, P2382, DOI 10.1016/S0167-577X(02)01239-9
   Konca K, 2003, MUTAT RES-GEN TOX EN, V534, P15, DOI 10.1016/S1383-5718(02)00251-6
   SANCTIS O, 1990, J NONCRYST SOLIDS, V121, P338
   Singh NP, 2000, MUTAT RES-FUND MOL M, V455, P111, DOI 10.1016/S0027-5107(00)00075-0
NR 14
TC 5
Z9 7
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-961-X
J9 KEY ENG MAT
PY 2005
VL 284-286
BP 593
EP 596
DI 10.4028/www.scientific.net/KEM.284-286.593
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BBZ54
UT WOS:000228359500145
DA 2018-10-19
ER

PT S
AU Osaka, A
   Yoshioka, T
   Yabuta, T
   Tsuru, K
   Hayakawa, S
AF Osaka, A
   Yoshioka, T
   Yabuta, T
   Tsuru, K
   Hayakawa, S
BE Li, P
   Zhang, K
   Colwell, CW
TI Blood compatibility of organic-inorganic biomedical materials
SO BIOCERAMICS, VOL 17
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 17th International Symposium on Ceramics in Medicine
CY DEC 08-12, 2004
CL New Orleans, LA
SP DePuy Inc, Ktryker Orthopaed, Zimmer Inc, Smith & Nephew Orthopaed, CeramTec, Cam Implants BV
DE blood compatibility; organic-inorganic hybrids; titanium oxide
AB Organic-inorganic hybrids involving Ti-O bonds were coated on stainless-steel (SUS316L) substrates. Tetraisopropoxide and titanium methacrylate triisopropoxide were employed as the major starting chemicals to provide TiO2-polydimethylsiloxane (PDMS) layers or organotitanium molecular thin layers, respectively. Fourier transform infrared spectra indicated that each layer contained Ti-O bonds in their structure. The obtained hybrid layers had little effects on the blood-clotting times such as active partial thromboplastin time and prothrombin time. In addition, the number of adhered platelet on the TiO2-PDMS layers depended on the composition, while the organotitanium molecular thin layers suppressed fibrinogen adsorption compared with coating-free SUS 316L substrate.
C1 Okayama Univ, Biomat Lab, Fac Engn, Okayama 7008530, Japan.
   Okayama Univ, Biomed Engn Res Ctr, Okayama 7008530, Japan.
RP Osaka, A (reprint author), Okayama Univ, Biomat Lab, Fac Engn, Okayama 7008530, Japan.
EM osaka@cc.okayama-u.ac.jp; kanji@cc.okayama-u.ac.jp;
   satoshi@cc.okayama-u.ac.jp
RI HAYAKAWA, Satoshi/B-2104-2011
OI HAYAKAWA, Satoshi/0000-0002-1097-8614
CR Asano T, 2003, J CERAM SOC JPN, V111, P645, DOI 10.2109/jcersj.111.645
   IWAMOTO T, 1995, J MATER SCI, V30, P2566, DOI 10.1007/BF00362135
   Kitazaki Y., 1972, J ADHES SOC JPN, V8, P131
   LIU ZF, 1994, J PHYS CHEM-US, V98, P1253, DOI 10.1021/j100055a035
   MACKENZIE JD, 1992, J NON-CRYST SOLIDS, V147, P271, DOI 10.1016/S0022-3093(05)80629-5
   Marth M. S., 1992, J NONCRYST SOLIDS, V143, P93
   TAKASHIMA S, 2001, KEY ENG MATER, V192, P889
   Takemoto S, 2004, BIOMATERIALS, V25, P3485, DOI 10.1016/j.biomaterials.2003.10.070
   Yamada N, 1997, J MATER CHEM, V7, P1491, DOI 10.1039/a700793k
   Yoshioka T, 2003, BIOMATERIALS, V24, P2889, DOI 10.1016/S0142-9612(03)00127-3
   YOSHIOKA T, UNPUB T MAT RES SOC
NR 11
TC 0
Z9 0
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-961-X
J9 KEY ENG MAT
PY 2005
VL 284-286
BP 713
EP 716
DI 10.4028/www.scientific.net/KEM.284-286.713
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BBZ54
UT WOS:000228359500174
DA 2018-10-19
ER

PT S
AU Mansur, HS
   Mansur, AAP
   Bicallho, SMCM
AF Mansur, HS
   Mansur, AAP
   Bicallho, SMCM
BE Li, P
   Zhang, K
   Colwell, CW
TI Lignin-hydroxyapatite/tricalcium phosphate biocomposites: SEM/EDX and
   FTIR characterization
SO BIOCERAMICS, VOL 17
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 17th International Symposium on Ceramics in Medicine
CY DEC 08-12, 2004
CL New Orleans, LA
SP DePuy Inc, Ktryker Orthopaed, Zimmer Inc, Smith & Nephew Orthopaed, CeramTec, Cam Implants BV
DE bioceramics; biomaterial; characterization; lignin; scaffolds
AB In the present work, a novel biocomposite has been developed based on lignin (Lig) and HA/beta-TCP bioceramic materials. The Lig/HA and Lig/beta-TCP systems were investigated by Scanning Electron Microscopy coupled to EDX microprobe (SEM/EDX). Lignin is a lignosulfonate natural polymer with complex random coupling and the exact chemical structure is yet unknown. FTIR spectroscopy is an important tool for lignin characterization based on several major vibration bands associated with generally found chemical groups. Consequently, FTIR spectroscopy was used to evaluate the chemical functionalities and major components present in the material. SEM photomicrographs of biocomposites Lig/HA and Lig/beta-TCP have shown uniform dispersion of the natural polymer binder in the bioceramic matrix. Also, chemical composition obtained by EDX spectra have indicated lignin evenly distributed in the HA and beta-TCP compounds. Novel biocomposites based on lignin/RA and lignin/beta-TCP were developed with porosity ranging from 50 to 100 mu m. These results have confirmed the high potential application of lignin as a non-toxic natural polymer binder to be used as 3D scaffold template for biomedical applications.
C1 Univ Fed Minas Gerais, Dept Met & Mat Engn, Lab Biomat & Tissue Engn, Belo Horizonte, MG, Brazil.
RP Mansur, HS (reprint author), Univ Fed Minas Gerais, Dept Met & Mat Engn, Lab Biomat & Tissue Engn, Belo Horizonte, MG, Brazil.
EM hmansur@demet.ufmg.br; aapiscitelli@uol.com.br; jhs@jhs.med.br
OI Mansur, Alexandra/0000-0003-1526-2508; Mansur,
   Herman/0000-0002-3032-495X
CR HUTMACHER DW, 2000, BIOMATERIALS, V21, P25
   Moore WR, 2001, AUST NZ J SURG, V71, P354, DOI 10.1046/j.1440-1622.2001.2128.x
   Nada AAMA, 1998, POLYM DEGRAD STABIL, V60, P247, DOI 10.1016/S0141-3910(97)00072-4
   Vats A, 2003, CLIN OTOLARYNGOL, V28, P165, DOI 10.1046/j.1365-2273.2003.00686.x
NR 4
TC 10
Z9 11
U1 3
U2 6
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-961-X
J9 KEY ENG MAT
PY 2005
VL 284-286
BP 745
EP 748
DI 10.4028/www.scientific.net/KEM.284-286.745
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BBZ54
UT WOS:000228359500182
DA 2018-10-19
ER

PT S
AU Piconi, C
   Maccauro, G
   Muratori, F
AF Piconi, C
   Maccauro, G
   Muratori, F
BE Li, P
   Zhang, K
   Colwell, CW
TI Alumina matrix composites in arthroplasty
SO BIOCERAMICS, VOL 17
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 17th International Symposium on Ceramics in Medicine
CY DEC 08-12, 2004
CL New Orleans, LA
SP DePuy Inc, Ktryker Orthopaed, Zimmer Inc, Smith & Nephew Orthopaed, CeramTec, Cam Implants BV
DE alumina; ceramic; composite; zirconia
ID ZIRCONIA-TOUGHENED ALUMINA; CERAMIC BALL HEADS; ZRO2 FRACTION; WEAR;
   PROSTHESES; JOINTS
AB It is well known that the introduction of zirconia into the alumina matrix has a positive effect on bending strength of the material, and especially on toughness which is the main limit of alumina ceramics. While the many attempts made in the past to develop alumina matrix composites suitable for biomedical applications containing zirconia as a toughening phase (Zirconia Toughened Alumina - ZTA) did not leave the developmental stage, recently ball heads and inlays for THR bearings made out a three phase alumina matrix composite were introduced into the market. In the alumina matrix of this material both zirconia and exagonal aluminate platelets are distributed, and then it belongs to the class of Zirconia and Platelets Toughened Alumina - ZPTA. Besides ball heads and inlays, also several other innovative orthopedic devices made out this new ceramic biomaterial are in different development stage. This paper reviews the present status of alumina matrix composites in orthopedic application, with special attention to ZPTA.
C1 Catholic Univ Rome, Rome, Italy.
   Catholic Univ Rome, Dip Orthoped & Traumatol, I-00167 Rome, Italy.
RP Piconi, C (reprint author), Catholic Univ Rome, Polo Didatt Format,Lgo O Respighi 1, Rome, Italy.
EM corpico@libero.it; giuliomac@tiscali.it; fmuratori@inwind.it
OI MACCAURO, Giulio/0000-0002-7359-268X
CR Affatato S, 1999, BIOMATERIALS, V20, P971, DOI 10.1016/S0142-9612(98)00253-1
   Affatato S, 1999, BIOMATERIALS, V20, P1925, DOI 10.1016/S0142-9612(99)00093-9
   Burger W, 1997, J MATER SCI-MATER M, V8, P113, DOI 10.1023/A:1018562917779
   Burger W., 2001, KEY ENG MATER, p[192, 545], DOI DOI 10.4028/WWW.SCIENTIFIC.NET/KEM.192-195.545
   BURGER W, Patent No. 5830816
   Burger W., 1997, KERAM Z, V49, P1067
   CIAPETTI G, 2000, P 9 SIMCER CENTR CER, P39
   CLAUSSEN N, 1984, SCI TECHNOLOGY ZIRCO, V2, P325
   Deville S, 2003, J EUR CERAM SOC, V23, P2975, DOI 10.1016/S0955-2219(03)00313-3
   GARINO J, 2002, BIOCERAMICS JOINT AR, P131
   Heimke G, 2002, BIOMATERIALS, V23, P1539, DOI 10.1016/S0142-9612(01)00262-9
   Insley GM, 2004, KEY ENG MAT, V254-2, P675, DOI 10.4028/www.scientific.net/KEM.254-256.675
   Kaddick C, 2002, BIOCERAMICS JOINT AR, P16
   KADDICK C, 2000, BIOCERAMICS HIP JOIN, P146
   Lazennec JY, 2004, BIOCERAMICS IN JOINT ARTHROPLASTY, P51
   Maccauro G, 2004, BIOCERAMICS IN JOINT ARTHROPLASTY, P47
   MANDRINO A, 1992, J MATER SCI-MATER M, V3, P457, DOI 10.1007/BF00701243
   Merkert P, 2004, BIOCERAMICS IN JOINT ARTHROPLASTY, P129
   Merkert P., 2003, BIOCERAMICS JOINT AR, P123
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Piconi C, 1998, BIOMATERIALS, V19, P1489, DOI 10.1016/S0142-9612(98)00064-7
   Rack R, 2000, BIOCERAMICS HIP JOIN, P141
   Rack R., 2001, BIOCERAMICS JOINT AR, P103
   Rieu J., 1993, Clinical Materials, V12, P211, DOI 10.1016/0267-6605(93)90075-I
   SALOMONI A, 1994, J MATER SCI-MATER M, V5, P651, DOI 10.1007/BF00120349
   Stewart TD, 2003, J BIOMED MATER RES B, V66B, P567, DOI 10.1002/jbm.b.10035
   WILLMANN G, 2001, KEY ENG MATER, V192, P545
   ZABRA L, 2004, BIOCERAMICS JOINT AR, P163
NR 28
TC 11
Z9 11
U1 0
U2 7
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-961-X
J9 KEY ENG MAT
PY 2005
VL 284-286
BP 979
EP 982
DI 10.4028/www.scientific.net/KEM.284-286.979
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BBZ54
UT WOS:000228359500239
DA 2018-10-19
ER

PT S
AU Lawson, TR
   Catledge, SA
   Vohra, YK
AF Lawson, TR
   Catledge, SA
   Vohra, YK
BE Li, P
   Zhang, K
   Colwell, CW
TI Nanostructured diamond coated CoCrMo alloys for use in biomedical
   implants
SO BIOCERAMICS, VOL 17
SE KEY ENGINEERING MATERIALS
LA English
DT Article; Proceedings Paper
CT 17th International Symposium on Ceramics in Medicine
CY DEC 08-12, 2004
CL New Orleans, LA
SP DePuy Inc, Ktryker Orthopaed, Zimmer Inc, Smith & Nephew Orthopaed, CeramTec, Cam Implants BV
DE chromium nitride (CrN, Cr2N); cobalt-chromium-molybdenum (CoCrMo);
   diamond; total hip replacement
ID CHROMIUM NITRIDE INTERLAYERS; STEEL; DEPOSITION
AB A wide variety of materials are currently under consideration for use in biomedical implants. Within the scope of certain implants is the need to withstand extensive wear created by repeated use and pressure on high stress joints. Substantial research is directed toward metal-on-metal technology and cobalt chrome molybdenum (CoCrMo) is a prime candidate given its longevity [I]. Wear-resistant surface coatings for the standard CoCrMo biomedical alloy may be a simple and effective way to extend implant lifetime. In this study, we show that an initial plasma nitriding step for CoCrMo alloy is beneficial for attaining adhesion of a nanostructured diamond coating subsequently grown by microwave plasma chemical vapor deposition (CVD). The initial plasma nitriding step is quickly and easily performed in the CVD reactor and results in the formation of chromium nitride phases (CrN, Cr2N) as well as a phase transformation of cobalt from hexagonal to face centered cubic. We suggest that the success in terms of achieving adhesion of the diamond coating to the CoCrMo alloy involves chromium nitride phases acting as a diffusion barrier to carbon, thus preventing direct reaction of carbon with cobalt and the extensive graphitization that would follow.
C1 Univ Alabama, Birmingham, AL 35294 USA.
RP Lawson, TR (reprint author), Univ Alabama, 310 Campbell Hall,1300 Univ Blvd, Birmingham, AL 35294 USA.
EM vithar@uab.edu; catledge@uab.edu; ykvohra@uab.edu
CR Buijnsters JG, 2002, DIAM RELAT MATER, V11, P536, DOI 10.1016/S0925-9635(01)00628-8
   Cawley J, 2003, WEAR, V255, P999, DOI 10.1016/S0043-1648(03)00046-2
   Chekour L, 2003, WEAR, V255, P1438, DOI 10.1016/S0043-1648(03)00229-1
   Glozman O, 1997, DIAM RELAT MATER, V6, P1847, DOI 10.1016/S0925-9635(97)00151-9
   Glozman O, 1997, DIAM RELAT MATER, V6, P796, DOI 10.1016/S0925-9635(96)00671-1
   *NAT CTR HLTH STAT, 1994 REP
NR 6
TC 4
Z9 4
U1 1
U2 11
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 1013-9826
BN 0-87849-961-X
J9 KEY ENG MAT
PY 2005
VL 284-286
BP 1015
EP 1018
DI 10.4028/www.scientific.net/KEM.284-286.1015
PG 4
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BBZ54
UT WOS:000228359500248
DA 2018-10-19
ER

PT S
AU Cole, M
   Voelcker, NH
   Thissen, H
AF Cole, M
   Voelcker, NH
   Thissen, H
BE Nicolau, DV
TI Switchable coatings for biomedical applications
SO Biomedical Applications of Micro- and Nanoengineering II
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Biomedical Applications of Micro- and Nanoengineering II
CY DEC 13-15, 2004
CL Sydney, AUSTRALIA
SP SPIE, Univ New S Wales, Australian Govt Dept Def, Def Sci & Technol Org, Cochlear, NSW Minist Sci & Med Res
DE surface modification; protein adsorption; plasma polymerisation
ID POLY(ETHYLENE GLYCOL); PLASMA POLYMERIZATION; SURFACES; PROTEINS;
   ALLYLAMINE; ADSORPTION; ADHESION; RELEASE; DENSITY; LAYERS
AB The control over protein adsorption is of major importance for a variety of biomedical applications from diagnostic assays to tissue engineered medical devices. Most research has focused on the prevention of non-specific protein adsorption on solid substrates. Examples for surface modifications that significantly reduce protein adsorption include the grafting of polyacrylamide, poly (ethylene oxide) and polysaccharides.
   Here, we describe a method for creating surfaces that prevent non-specific protein adsorption, which in addition can be transformed into surfaces showing high protein adsorption on demand.
   Doped silicon wafers were used as substrate materials. Coatings were constructed by deposition of allylamine plasma polymer. The subsequent grafting of poly (ethylene oxide) aldehyde resulted in a surface with low protein fouling character. When the conductive silicon wafer was used as an electrode, the resulting field induced the adsorption of selected proteins.
   Surface modifications were analysed by X-ray photoelectron spectroscopy and atomic force microscopy. The controlled adsorption of proteins was investigated using a colorimetric assay to test enzymatic activity. The method described here represents an effective tool for the control over protein adsorption and is expected to find use in a variety of biomedical applications particularly in the area of biochips.
C1 Flinders Univ S Australia, Sch Chem Phys & Earth Sci, Bedford Pk, SA 5042, Australia.
RP Cole, M (reprint author), Flinders Univ S Australia, Sch Chem Phys & Earth Sci, GPO Box 2100, Bedford Pk, SA 5042, Australia.
RI Cole, Martin/A-4927-2008; Voelcker, Nicolas/D-6199-2012; Thissen,
   Helmut/D-3835-2011
OI Cole, Martin/0000-0001-8539-1466; Voelcker, Nicolas/0000-0002-1536-7804;
   
CR BAGHDOYAN S, 2004, NUCLEIC ACIDS RES, V32, P1
   Beck AJ, 2001, J PHYS CHEM B, V105, P5730, DOI 10.1021/jp0043468
   Chen Q, 2004, CHEM MATER, V16, P614, DOI 10.1021/cm034529h
   DESAI T, 2002, BUSINESS BRIEFING ME, P80
   Fuentes M, 2004, BIOTECHNOL PROGR, V20, P1134, DOI 10.1021/bp0499449
   GRIESSER HJ, 1989, VACUUM, V39, P485, DOI 10.1016/0042-207X(89)90272-8
   Hyun J, 2004, J AM CHEM SOC, V126, P7330, DOI 10.1021/ja049721e
   Jon SY, 2003, LANGMUIR, V19, P9989, DOI 10.1021/la034839e
   Kingshott P, 2002, BIOMATERIALS, V23, P4775, DOI 10.1016/S0142-9612(02)00228-4
   Kingshott P, 2002, BIOMATERIALS, V23, P2043, DOI 10.1016/S0142-9612(01)00334-9
   Kingshott P, 1999, CURR OPIN SOLID ST M, V4, P403, DOI 10.1016/S1359-0286(99)00018-2
   Lee KB, 2002, SCIENCE, V295, P1702, DOI 10.1126/science.1067172
   MINGHONG W, 1999, RADIAT PHYS CHEM, V56, P341
   RodriguezLopez JN, 1997, J BIOL CHEM, V272, P5469, DOI 10.1074/jbc.272.9.5469
   SHARMA S, 2003, LANGMUIR, V20, P348
   Szili E, 2004, BIOSENS BIOELECTRON, V19, P1395, DOI 10.1016/j.bios.2003.12.019
   Thissen H, 2002, SMART MATER STRUCT, V11, P792, DOI 10.1088/0964-1726/11/5/326
   Tirrell M, 2002, SURF SCI, V500, P61, DOI 10.1016/S0039-6028(01)01548-5
   Wang J, 2000, BIOELECTROCHEMISTRY, V52, P111, DOI 10.1016/S0302-4598(00)00081-7
   WANG Y, 2003, P 12 INT C SOL STAT, P979
   Wei J, 2003, COLLOID SURFACE B, V32, P275, DOI 10.1016/S0927-7765(03)00180-2
   Zdyrko B, 2003, LANGMUIR, V19, P10179, DOI 10.1021/la034974r
   Zhang K, 2002, J CONTROL RELEASE, V80, P169, DOI 10.1016/S0168-3659(02)00024-X
NR 23
TC 5
Z9 5
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5611-X
J9 P SOC PHOTO-OPT INS
PY 2005
VL 5651
BP 19
EP 27
DI 10.1117/12.582306
PG 9
WC Engineering, Biomedical; Instruments & Instrumentation; Imaging Science
   & Photographic Technology
SC Engineering; Instruments & Instrumentation; Imaging Science &
   Photographic Technology
GA BCC90
UT WOS:000228665300006
OA Green Published
DA 2018-10-19
ER

PT S
AU Williams, CM
   Nash, MA
   Poole-Warren, LA
AF Williams, CM
   Nash, MA
   Poole-Warren, LA
BE Nicolau, DV
TI Electrically conductive polyurethanes for biomedical applications
SO Biomedical Applications of Micro- and Nanoengineering II
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Biomedical Applications of Micro- and Nanoengineering II
CY DEC 13-15, 2004
CL Sydney, AUSTRALIA
SP SPIE, Univ New S Wales, Australian Govt Dept Def, Def Sci & Technol Org, Cochlear, NSW Minist Sci & Med Res
DE carbon nanotubes; cytotoxicity; cell inhibition; polyurethane; polymer
   nanocomposite; electrical conductivity
ID CARBON NANOTUBES; NEURITE GROWTH; NERVE GROWTH; FIELD; STIMULATION;
   POLYSTYRENE; ORIENTATION; DIRECTION; NEURONS; POLYMER
AB Electrical interfacing with neural tissue poses significant problems due to host response to the material. This response Generally leads to fibrous encapsulation and increased impedance across the electrode. In neural electrodes such as cochlear implants, an elastomeric material like silicone is used as an insulator for the metal electrode. This project ultimately aims to produce a polymer electrode with elastomeric mechanical properties, metal like conductivity and capability. The approach taken was to produce a nanocomposite elastomeric material based on polyurethane (PU) and carbon nanotubes. Carbon nanotubes are ideal due to their high aspect ratio as well as being a ballistic conductor. The choice of PU is based on its elastomeric properties, processability and biocompatibility. Multi-walled nanotubes (MWNTs) were dispersed ultrasonically in various dispersive solutions before being added at up to 20wt% to a 5wt% PU (Pellethane80A) in Dimethylacetamide (DMAc). Films were then solvent cast in a vacuum oven overnight. The resulting films were tested for conductivity using a two-probe technique and mechanically tested using an Instron tensiometer. The percolation threshold (p) of the PU/MWNT films occurred at loadings of between 7 and 10 wt% in this polymer system. Conductivity of the films (above p) was comparable to those for similar systems reported in the literature at up to approximately 7 x 10(-2) Scm(-1). Although PU stiffness increased with increased %loading of nanotubes, all composites were highly flexible and maintained elastomeric properties. From these preliminary results we have demonstrated electrical conductivity. So far it is evident that a superior percolation threshold is dependent on the degree of dispersion of the nanotubes. This has prompted work into investigating other preparations of the films, including melt-processing and electrospinning.
C1 Univ New S Wales, Kensington, NSW 2033, Australia.
RP Williams, CM (reprint author), Univ New S Wales, Kensington, NSW 2033, Australia.
OI Poole-Warren, Laura/0000-0002-4414-022X; Nash,
   Michael/0000-0003-3842-1567
CR ERSKINE L, 1995, DEV BIOL, V171, P330, DOI 10.1006/dbio.1995.1285
   HINKLE L, 1981, J PHYSIOL-LONDON, V314, P121, DOI 10.1113/jphysiol.1981.sp013695
   Huczko A, 2001, FULLERENE SCI TECHN, V9, P247, DOI 10.1081/FST-100102972
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   Kotwal A, 2001, BIOMATERIALS, V22, P1055, DOI 10.1016/S0142-9612(00)00344-6
   Lam CW, 2004, TOXICOL SCI, V77, P126, DOI 10.1093/toxsci/kfg243
   MCCAIG CD, 1991, EXP PHYSIOL, V76, P473, DOI 10.1113/expphysiol.1991.sp003514
   McCaig CD, 2000, DEV DYNAM, V217, P299, DOI 10.1002/(SICI)1097-0177(200003)217:3<299::AID-DVDY8>3.0.CO;2-G
   Mitchell CA, 2002, MACROMOLECULES, V35, P8825, DOI 10.1021/ma020890y
   O'Connell MJ, 2001, CHEM PHYS LETT, V342, P265, DOI 10.1016/S0009-2614(01)00490-0
   PATEL N, 1982, J NEUROSCI, V2, P483
   Qian D, 2000, APPL PHYS LETT, V76, P2868, DOI 10.1063/1.126500
   Rajnicek AM, 1998, DEV BIOL, V203, P412, DOI 10.1006/dbio.1998.9039
   RAJNICEK AM, 1992, EXP PHYSIOL, V77, P229, DOI 10.1113/expphysiol.1992.sp003580
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Shvedova AA, 2003, J TOXICOL ENV HEAL A, V66, P1909, DOI 10.1080/15287390390231566
   WONG JY, 1994, P NATL ACAD SCI USA, V91, P3201, DOI 10.1073/pnas.91.8.3201
NR 17
TC 6
Z9 6
U1 1
U2 14
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5611-X
J9 P SOC PHOTO-OPT INS
PY 2005
VL 5651
BP 329
EP 335
DI 10.1117/12.282321
PG 7
WC Engineering, Biomedical; Instruments & Instrumentation; Imaging Science
   & Photographic Technology
SC Engineering; Instruments & Instrumentation; Imaging Science &
   Photographic Technology
GA BCC90
UT WOS:000228665300038
DA 2018-10-19
ER

PT J
AU Ryan, MT
   Mulholland, CW
AF Ryan, MT
   Mulholland, CW
TI Evaluation of a distance-learning immunology and pathology module in a
   postgraduate biomedical science course
SO BRITISH JOURNAL OF BIOMEDICAL SCIENCE
LA English
DT Article
DE computer-aided learning; biomedical science; distance learning
AB An electronic presentation of materials for a distance-learning immunology and pathology module from a postgraduate biomedical science course is evaluated. Two different electronic presentation formats for the delivery of the educational material to distance learners are assessed. Responses from users of this material highlighted a preference for a format that has a design tailored to distance learning. There was no significant difference in learning outcome between those taking the module on campus and by distance learning. This suggests that the prerequisites for entry, learning materials and direction given to the students studying by distance learning are adequate for these students to achieve the learning objectives outlined in the course. The evaluation also gave direction for areas within the (CAL) application that can be improved for future students.
C1 Univ Coll Dublin, Fac Med Vet, Dept Vet Physiol & Biochem, Dublin 4, Ireland.
   Univ Ulster, Inst Lifelong Learning, Newtownabbey BT37 0QB, Antrim, North Ireland.
RP Ryan, MT (reprint author), Univ Coll Dublin, Fac Med Vet, Dept Vet Physiol & Biochem, Dublin 4, Ireland.
EM marion.ryan@ucd.ie
OI Ryan, Marion/0000-0001-7359-6085
CR Bloom B, 1956, HDB, P201
   Coleman JN, 1998, IEEE T EDUC, V41, P177, DOI 10.1109/13.704542
   COX K, 1997, COMP EDUC, V30, P157
   Davis MJ, 1997, ADV PHYSIOL EDUC, V17, P1
   Dewhurst DG, 2000, COMPUT EDUC, V35, P223, DOI 10.1016/S0360-1315(00)00033-6
   Draper SW, 1996, COMPUT EDUC, V26, P17, DOI 10.1016/0360-1315(95)00068-2
   GLASTONBURY B, 1994, CTISS FILE, V17, P33
   Gunn C, 1996, J COMPUT ASSIST LEAR, V12, P205, DOI 10.1111/j.1365-2729.1996.tb00052.x
   Harrold MW, 1998, AM J PHARM EDUC, V62, P24
   KING T, 1994, CTISS FILE, V17, P30
   Matthew IR, 1998, MED EDUC, V32, P89, DOI 10.1046/j.1365-2923.1998.00156.x
   PARLETT M, 1997, INTRO ILLUMINATIVE E
   PREECE J, 1994, HUMAN COMPUTER INTER
   Reid WA, EVALUATION COMPUTER
   Ryan M, 2000, BRIT J BIOMED SCI, V57, P28
   Sweeters W., 1994, Educational Technology, V34, P47
   Ward M, 1998, COMPUT EDUC, V31, P171, DOI 10.1016/S0360-1315(98)00024-4
   LEARNING TECHNOLOGY
   GUIDE I BIOMEDICAL S
NR 19
TC 2
Z9 2
U1 0
U2 0
PU STEP PUBLISHING LTD
PI TUNBRIDGE WELLS
PA SUBSCRIPTION DEPT, NORTH FARM RD, TUNBRIDGE WELLS TN2 3DR, KENT, ENGLAND
SN 0967-4845
J9 BRIT J BIOMED SCI
JI Br. J. Biomed. Sci.
PY 2005
VL 62
IS 1
BP 9
EP 14
DI 10.1080/09674845.2005.11732680
PG 6
WC Medical Laboratory Technology
SC Medical Laboratory Technology
GA 910BH
UT WOS:000227903900003
PM 15816205
DA 2018-10-19
ER

PT B
AU Laroussi, M
AF Laroussi, Mounir
BE Leys, C
TI LOW TEMPERATURE PLASMA-BASED STERILIZATION/DECONTAMINATION OF BIOLOGICAL
   MATTER
SO CAPPSA 2005, PROCEEDINGS
LA English
DT Proceedings Paper
CT 2nd International Workshop on Cold Atmospheric Pressure Plasmas: Sources
   and Applications
CY AUG 30-SEP 02, 2005
CL Bruges, BELGIUM
SP Minist Flemish Commun, Ghent Univ, Dept Appl Phys, Czech Techn Univ, Inst Chem Technol, Inst Plasma Phys
DE cold plasma; sterilization; ultraviolet; reactive species; bacteria
ID ATMOSPHERIC-PRESSURE; STERILIZATION; INACTIVATION; DISCHARGES; ROLES
AB In the last two decades, non-equilibrium atmospheric pressure plasmas have been used in several applications such as UV sources, surface treatment, and the cleaning of flue gases. Amongst the more recent novel applications, the use of atmospheric pressure "cold" plasmas in the biomedical field is presently experiencing a heightened interest from the plasma science research community. This is due to promising applications of these plasmas in medical research such as wound healing, tissue engineering, surface modification of biocompatible materials, and the sterilization of reusable heat sensitive medical instruments.
   In this paper, the focus will be on the effects of low temperature plasmas on the cells of bacteria. First an overview of research efforts carried out at both low and high pressures will be presented. Then a detailed review and discussion on the effects of atmospheric pressure non-equilibrium plasmas on the cells of bacteria will be given. This includes the evaluation of the inactivation kinetics and the roles of the various plasma agents in the inactivation process. In particular, measurements of the plasma temperature, the UV emission, and concentrations of various reactive species (O(3), NO(2), OH ...) for the special case of an air plasma are presented.
C1 Old Dominion Univ, Dept Elect & Comp Engn, Norfolk, VA 23510 USA.
RP Laroussi, M (reprint author), Old Dominion Univ, Dept Elect & Comp Engn, Norfolk, VA 23510 USA.
EM mlarouss@odu.edu
CR Bettleheim F. A., 1995, INTRO GEN ORGANIC BI
   BIRMINGHAM J, 2003, P EL C VER ENG INC S, P16
   BLAKELY EA, 2002, P IEEE INT C PLASM S, P253
   BLOCK SS, 1992, ENCY MICROBIOLOGY, V4, P87
   Bol'shakov AA, 2004, AIAA J, V42, P823, DOI 10.2514/1.9562
   KANAZAWA S, 1988, J PHYS D APPL PHYS, V21, P838, DOI 10.1088/0022-3727/21/5/028
   Kogelschatz U, 2002, IEEE T PLASMA SCI, V30, P1400, DOI 10.1109/TPS.2002.804201
   KOINUMA H, 1992, APPL PHYS LETT, V60, P816, DOI 10.1063/1.106527
   Kunhardt EE, 2000, IEEE T PLASMA SCI, V28, P189, DOI 10.1109/27.842901
   Laroussi M, 2004, INT J MASS SPECTROM, V233, P81, DOI 10.1016/j.ijms.2003.11.016
   Laroussi M, 2002, IEEE T PLASMA SCI, V30, P158, DOI 10.1109/TPS.2002.1003972
   Laroussi M, 2002, IEEE T PLASMA SCI, V30, P1409, DOI 10.1109/TPS.2002.804220
   Laroussi M, 2004, P IEEE INT C PLASM S, P122
   LAROUSSI M, 2003, NEW J PHYS, V5
   Mendis DA, 2000, IEEE T PLASMA SCI, V28, P1304, DOI 10.1109/27.893321
   Moisan M, 2001, INT J PHARMACEUT, V226, P1, DOI 10.1016/S0378-5173(01)00752-9
   MOISAN M, 1991, J PHYS D APPL PHYS, V24, P1025, DOI 10.1088/0022-3727/24/7/001
   MOISAN M, 2003, 5 INT WORKSH MICR DI, P210
   Moreau S, 2000, J APPL PHYS, V88, P1166, DOI 10.1063/1.373792
   Philip N, 2002, IEEE T PLASMA SCI, V30, P1429, DOI 10.1109/TPS.2002.804203
   SANCHEZESTRADA FS, 2002, P IEEE INT C PLASM S, P254
   Schoenbach KH, 1996, APPL PHYS LETT, V68, P13, DOI 10.1063/1.116739
   Scutze A, 1998, IEEE T PLASMA SCI, V26, P1685
   Stoffels E, 2002, PLASMA SOURCES SCI T, V11, P383, DOI 10.1088/0963-0252/11/4/304
NR 24
TC 0
Z9 0
U1 0
U2 11
PU UNIVERSITEIT GENT
PI GHENT
PA COUPURE LINKS 653, B-9000 GHENT, BELGIUM
BN 978-90-808669-2-8
PY 2005
BP 18
EP 27
PG 10
WC Engineering, Electrical & Electronic; Physics, Applied; Physics, Fluids
   & Plasmas
SC Engineering; Physics
GA BST18
UT WOS:000285739300003
DA 2018-10-19
ER

PT J
AU Li, N
   Jie, Q
   Zhu, SM
   Wang, RD
AF Li, N
   Jie, Q
   Zhu, SM
   Wang, RD
TI Preparation and characterization of macroporous sol-gel bioglass
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE sol-gel processes; porosity; glass; biomedical applications
ID BIOMEDICAL MATERIALS; GLASSES; BIOACTIVITY; SYSTEM
AB Sol-gel bioglasses have many advantages comparing to melt-derived bioglasses. 3-D scaffold prepared by sol-gel method is a promising substrate material for bone tissue engineering. But, it is difficult to produce macroporous sol-gel bioglasses with pores larger than 100 mu m. In this work. a series of macroporous bioglasses was produced by adding PEG particles into the sol as pore former. The mesoporous texture features of the samples were assessed through a nitrogen sorption technique. The macropore structure was collected by intrusion mercury porosimetry. In vitro tests showed that the samples had good bioactivity. Combining the sol-gel routine with the pore former might be a useful approach for preparation scaffolds with applications to the repair and reconstruction of damaged tissue. (c) 2004 Elsevier Ltd and Techna Group S.r.l. All rights reserved.
C1 Chinese Acad Sci, Shanghai Inst Ceram, Shanghai 200050, Peoples R China.
RP Zhu, SM (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, 1295 Ding Xi Rd, Shanghai 200050, Peoples R China.
EM smzhu@mail.sic.ac.cn
RI Zhu, Sumin/D-3686-2009; Jie, Qing/N-8673-2013; Jie, Qing/H-3780-2011
CR Coleman NJ, 2000, CERAM INT, V26, P171, DOI 10.1016/S0272-8842(99)00037-1
   GREENSPAN DC, 1997, BIOCERAMICS, V10, P391
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Jones JR, 2001, MATER SCI TECH SER, V17, P891, DOI 10.1179/026708301101510762
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Lenza RFS, 2002, J MATER SCI-MATER M, V13, P837, DOI 10.1023/A:1016592127407
   LI PJ, 1994, J AM CERAM SOC, V77, P1307, DOI 10.1111/j.1151-2916.1994.tb05407.x
   Martinez A, 2000, CHEM MATER, V12, P3080, DOI 10.1021/cm001107o
   Olmo N, 2003, BIOMATERIALS, V24, P3383, DOI 10.1016/S0142-9612(03)00200-X
   Perez-Pariente J., 2002, J BIOMED MATER RES, V61, P524
   Saravanapavan P, 2001, J BIOMED MATER RES, V54, P608, DOI 10.1002/1097-4636(20010315)54:4<608::AID-JBM180>3.0.CO;2-U
   Sepulveda P, 2002, J BIOMED MATER RES, V59, P340, DOI 10.1002/jbm.1250
   Yan HW, 2001, CHEM MATER, V13, P1374, DOI 10.1021/cm000895e
   Zhong J., 1997, BIOCERAMICS, V10, P265
   Zhong JP, 2000, J BIOMED MATER RES, V53, P694, DOI 10.1002/1097-4636(2000)53:6<694::AID-JBM12>3.0.CO;2-6
NR 15
TC 51
Z9 52
U1 1
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
J9 CERAM INT
JI Ceram. Int.
PY 2005
VL 31
IS 5
BP 641
EP 646
DI 10.1016/j.ceramint.2004.05.011
PG 6
WC Materials Science, Ceramics
SC Materials Science
GA 929PR
UT WOS:000229358700002
DA 2018-10-19
ER

PT J
AU Ding, SJ
   Wang, CW
   Chen, DCH
   Chang, HC
AF Ding, SJ
   Wang, CW
   Chen, DCH
   Chang, HC
TI In vitro degradation behavior of porous calcium phosphates under
   diametral compression loading
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE mechanical properties; biomedical application; calcium phosphate;
   degradation
ID HYDROXYAPATITE CERAMICS; BONE SUBSTITUTE; IMPLANTS; POROSITY;
   FABRICATION; SCAFFOLDS; FATIGUE; STRESS
AB Four different types of porous calcium phosphates were made on addition of a pore-forming compound (PVA) by sinter processing. Mechanical properties, morphology, and weight change with immersion time in Hanks' physiological solution were evaluated. The in vitro fatigue test was also performed. Experimental results showed the pore microstructure of the as-sintered bodies to be made up of the macropores and micropores. The initial strength of the porous bodies was dependent on the contents of the PVA additive. Porous bodies subjected to Cycling fatigue in Hanks' solution remarkably decreased in the strength. With increasing immersion time in solution, the tensile strength and elastic modulus of various porous bodies decreased. The weight loss data confirmed the degradation behavior of the porous bodies in Hank's solution. The biomedical uses of the present porous materials are limited to non-load bearing applications such as bone defect repair. (c) 2004 Elsevier Ltd and Techna Group S.r.l. All rights reserved.
C1 Chung Shan Med Univ, Inst Dent Mat, Taichung 402, Taiwan.
   Chung Shan Med Univ, Inst Vet Microbiol, Taichung 402, Taiwan.
   Natl Cheng Kung Univ, Inst Biomed Engn, Tainan 701, Taiwan.
RP Ding, SJ (reprint author), Chung Shan Med Univ, Inst Dent Mat, 110 Sec 1,Chien Kuo N Rd, Taichung 402, Taiwan.
EM sjding@csmu.edu.tw
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO;2-J
   *ASTM, 1982, C37372 ASTM, P182
   Baksh D, 1998, J MATER SCI-MATER M, V9, P743, DOI 10.1023/A:1008959103864
   Catanese J, 1999, J BIOMED MATER RES, V45, P327, DOI 10.1002/(SICI)1097-4636(19990615)45:4<327::AID-JBM7>3.0.CO;2-L
   Chu TMG, 2001, J MATER SCI-MATER M, V12, P471, DOI 10.1023/A:1011203226053
   da Silva MHP, 2002, J NON-CRYST SOLIDS, V304, P286, DOI 10.1016/S0022-3093(02)01036-0
   DUCHEYNE P, 1993, J BIOMED MATER RES, V27, P25, DOI 10.1002/jbm.820270105
   Flautre B, 2001, J MATER SCI-MATER M, V12, P679, DOI 10.1023/A:1011256107282
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   Goldstein S. A., 2001, CURR OPIN ORTHOP, V12, P424
   KIKUCHI M, 2002, J BIOMED MATER RES, V62, P256
   KLEIN CPA, 1990, HDB BIOACTIVE CERAMI, V2, P53
   LEHUEC JC, 1995, BIOMATERIALS, V16, P113, DOI 10.1016/0142-9612(95)98272-G
   LIN CL, 2003, P ANN C CHIN SOC MAT
   Lin JHC, 2001, J MATER SCI-MATER M, V12, P731, DOI 10.1023/A:1011280828663
   Liu DM, 1997, CERAM INT, V23, P135, DOI 10.1016/S0272-8842(96)00009-0
   Liu DM, 1996, BIOMATERIALS, V17, P1955, DOI 10.1016/0142-9612(95)00301-0
   Lu L, 2000, CURR OPIN ORTHOP, V11, P383
   Ogiso M, 1998, J BIOMED MATER RES, V39, P23, DOI 10.1002/(SICI)1097-4636(199801)39:1<23::AID-JBM4>3.3.CO;2-X
   Pilliar RM, 2001, BIOMATERIALS, V22, P963, DOI 10.1016/S0142-9612(00)00261-1
   Porter NL, 2001, J BIOMED MATER RES, V56, P504, DOI 10.1002/1097-4636(20010915)56:4<504::AID-JBM1122>3.0.CO;2-J
   Qiao GJ, 2002, INT J FATIGUE, V24, P499, DOI 10.1016/S0142-1123(01)00175-X
   Raynaud S, 1998, J MATER SCI-MATER M, V9, P221, DOI 10.1023/A:1008840308094
   REED JS, 1989, INTRO PRINCIPLES CER, P152
   RICHERSON DW, 1992, MODERN CERAMIC ENG, P520
   SHIMA T, 1979, J NEUROSURG, V51, P533, DOI 10.3171/jns.1979.51.4.0533
   Tampieri A, 2001, BIOMATERIALS, V22, P1365, DOI 10.1016/S0142-9612(00)00290-8
   WANG CW, 2003, J MED BIOL ENG, V23, P159
NR 28
TC 17
Z9 17
U1 4
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
J9 CERAM INT
JI Ceram. Int.
PY 2005
VL 31
IS 5
BP 691
EP 696
DI 10.1016/j.ceramint.2004.08.007
PG 6
WC Materials Science, Ceramics
SC Materials Science
GA 929PR
UT WOS:000229358700010
DA 2018-10-19
ER

PT J
AU Bunzli, JCG
   Piguet, C
AF Bunzli, JCG
   Piguet, C
TI Taking advantage of luminescent lanthanide ions
SO CHEMICAL SOCIETY REVIEWS
LA English
DT Review
ID CIRCULARLY-POLARIZED LUMINESCENCE; NEAR-INFRARED PHOTOLUMINESCENCE;
   TRIPLE-HELICAL COMPLEXES; ELECTRONIC ENERGY LEVELS;
   TRANSITION-METAL-COMPLEXES; TIME-RESOLVED FLUOROIMMUNOASSAY; CONTAINING
   LIQUID-CRYSTALS; D-F COMPLEXES; AQUO IONS; EXCITED-STATES
AB Lanthanide ions possess fascinating optical properties and their discovery, first industrial uses and present high technological applications are largely governed by their interaction with light. Lighting devices (economical luminescent lamps, light emitting diodes), television and computer displays, optical fibres, optical amplifiers, lasers, as well as responsive luminescent stains for biomedical analysis, medical diagnosis, and cell imaging rely heavily on lanthanide ions. This critical review has been tailored for a broad audience of chemists, biochemists and materials scientists; the basics of lanthanide photophysics are highlighted together with the synthetic strategies used to insert these ions into mono- and polymetallic molecular edifices. Recent advances in NIR-emitting materials, including liquid crystals, and in the control of luminescent properties in polymetallic assemblies are also presented.
C1 Ecole Polytech Fed Lausanne, LCSL, CH-1015 Lausanne, Switzerland.
   Univ Geneva, Dept Inorgan Analyt & Appl Chem, CH-1211 Geneva, Switzerland.
RP Bunzli, JCG (reprint author), Ecole Polytech Fed Lausanne, LCSL, CH-1015 Lausanne, Switzerland.
EM jean-claude.bunzli@epfl.ch; claude.piguet@chiam.unige.ch
RI Bunzli, Jean-Claude/C-7303-2008
OI Bunzli, Jean-Claude/0000-0003-0140-3402
CR Aime S, 1998, J CHEM SOC DALTON, P881, DOI 10.1039/a708667i
   Ananias D, 2004, J AM CHEM SOC, V126, P10410, DOI 10.1021/ja047905n
   Andre N, 2004, INORG CHEM, V43, P515, DOI 10.1021/ic0351996
   Archer RD, 1998, INORG CHEM, V37, P2089, DOI 10.1021/ic960244d
   Arenz S, 2005, CHEM PHYS LETT, V402, P75, DOI 10.1016/j.cplett.2004.12.008
   Artizzu F, 2005, INORG CHEM, V44, P840, DOI 10.1021/ic0483895
   Asfari Z., 2001, CALIXARENES 2001
   Auzel F, 2004, CHEM REV, V104, P139, DOI 10.1021/cr020357g
   Bazzicalupi C, 2000, CHEM COMMUN, P561, DOI 10.1039/a909581k
   Beeby A, 2000, J PHOTOCH PHOTOBIO B, V57, P83, DOI 10.1016/S1011-1344(00)00070-1
   Beeby A, 2000, CHEM COMMUN, P1183, DOI 10.1039/b002452j
   Beeby A, 1999, J CHEM SOC PERK T 2, P493, DOI 10.1039/a808692c
   Beer PD, 2004, INORG CHEM, V43, P3965, DOI 10.1021/ic0499401
   Billard I, 2003, INORG CHEM, V42, P1726, DOI 10.1021/ic0260318
   Billard I, 2004, EUR J INORG CHEM, P1190, DOI 10.1002/ejic.200300588
   Binnemans K, 2002, CHEM REV, V102, P2303, DOI 10.1021/cr010287y
   Binnemans K, 2002, J MATER CHEM, V12, P3374, DOI 10.1039/b206810a
   Binnemans K, 1998, J MATER CHEM, V8, P1551, DOI 10.1039/a803227k
   Binnemans K, 2000, J AM CHEM SOC, V122, P4335, DOI 10.1021/ja993351q
   Binnemans K, 2001, CHEMPHYSCHEM, V2, P680, DOI 10.1002/1439-7641(20011119)2:11<680::AID-CPHC680>3.0.CO;2-#
   BINNEMANS K, 2005, HDB PHYS CHEM RARE E, V35, pS225
   BLASSE G, 1979, HDB PHYSICS CHEM RAR, V4, pCH34
   Bobba G, 2002, CHEM COMMUN, P890, DOI 10.1039/b201451n
   Bornhop DJ, 2003, APPL SPECTROSC, V57, P1216, DOI 10.1366/000370203769699063
   Bornhop DJ, 1999, ANAL CHEM, V71, P2607, DOI 10.1021/ac981208u
   Boyaval J, 2001, MOL CRYST LIQ CRYST, V359, P337
   Bunzli J.-C. G., 2005, SPECTROSCOPIC PROPER, V83
   Bunzli J.-C.G., 1998, RARE EARTHS, P223
   Bunzli JCG, 2004, MET IONS BIOL SYST, V42, P39
   Bunzli JCG, 2002, CHEM REV, V102, P1897, DOI 10.1021/cr010299j
   BUNZLI JCG, 2000, CALIXARENES SEPARATI, V757, P179
   BUNZLI JCG, 2001, ENCY MAT SCI TECHNOL, V10, P4465
   Burton-Pye BP, 2005, DALTON T, P146, DOI 10.1039/b413005g
   Cantuel M, 2004, INORG CHEM, V43, P1840, DOI 10.1021/ic035292u
   Cantuel M, 2002, J CHEM SOC DALTON, P1929, DOI 10.1039/b200011c
   Carnall W.T., 1979, HDB PHYSICS CHEM RAR, V3
   CARNALL WT, 1968, J CHEM PHYS, V49, P4424, DOI 10.1063/1.1669893
   CARNALL WT, 1968, J CHEM PHYS, V49, P4443, DOI 10.1063/1.1669894
   CARNALL WT, 1968, J CHEM PHYS, V49, P4450, DOI 10.1063/1.1669896
   CARNALL WT, 1968, J CHEM PHYS, V49, P4447, DOI 10.1063/1.1669895
   Casnati A, 2003, EUR J ORG CHEM, P1475, DOI 10.1002/ejoc.200390206
   Charbonniere LJ, 2002, J AM CHEM SOC, V124, P7779, DOI 10.1021/ja0200847
   Chaumont A, 2004, INORG CHEM, V43, P5891, DOI 10.1021/ic049386v
   Choppin G. R., 1989, LANTHANIDE PROBES LI, P1
   Chudinov AV, 2004, RUSS J BIOORG CHEM+, V30, P89, DOI 10.1023/B:RUBI.0000015779.37503.8d
   COMBY S, 2005, UNPUB
   Coppo P, 2005, ANGEW CHEM INT EDIT, V44, P1806, DOI 10.1002/anie.200461953
   Cotton S., 1991, MCMILLAN PHYS SCI SE
   Crookes W., 1885, PHILOS T R SOC LON A, V176, P691
   de Sa GF, 2000, COORDIN CHEM REV, V196, P165, DOI 10.1016/S0010-8545(99)00054-5
   de Silva AP, 2000, COORDIN CHEM REV, V205, P41, DOI 10.1016/S0010-8545(00)00238-1
   de Silva AP, 1997, CHEM COMMUN, P1891
   Deng H, 1998, J AM CHEM SOC, V120, P3522, DOI 10.1021/ja9743654
   Dickins RS, 1998, NEW J CHEM, V22, P891, DOI 10.1039/a801004h
   Dickins RS, 2002, J AM CHEM SOC, V124, P12697, DOI 10.1021/ja020836x
   Donnio B., 2003, COMPREHENSIVE COORDI, P357, DOI DOI 10.1016/B0-08-043748-6/06150-8
   Driesen K, 2004, CHEM PHYS LETT, V395, P306, DOI 10.1016/j.cplett.2004.08.001
   Driesen K, 2004, CHEM MATER, V16, P1531, DOI 10.1021/cm031166c
   Driesen K, 2004, LIQ CRYST, V31, P601, DOI 10.1080/02678290410001667399
   Edder C, 2001, CHEM-EUR J, V7, P3014, DOI 10.1002/1521-3765(20010716)7:14<3014::AID-CHEM3014>3.0.CO;2-D
   Faulkner S, 2005, APPL SPECTROSC REV, V40, P1, DOI 10.1081/ASR-200038308
   Faulkner S, 2004, DALTON T, P1405, DOI 10.1039/b401302f
   Faulkner S, 2003, J AM CHEM SOC, V125, P10526, DOI 10.1021/ja035634v
   Faulkner S., 2004, COMPREHENSIVE COORDI, V9, P913
   Floquet S, 2004, CHEM-EUR J, V10, P1091, DOI 10.1002/chem.200305498
   Frias JC, 2003, ORG BIOMOL CHEM, V1, P905, DOI 10.1039/b301385p
   Fu LM, 2005, ANGEW CHEM INT EDIT, V44, P747, DOI 10.1002/anie.200462382
   Galyametdinov YG, 2002, LIQ CRYST, V29, P1581, DOI 10.1080/0267829021000034826
   GALYAMETDINOV YG, 1994, RUSS CHEM B+, V43, P938, DOI 10.1007/BF01558051
   GALYAMETDINOV YG, 1991, B ACAD SCI USSR CH+, V40, P1109, DOI 10.1007/BF00961392
   Galyametdinov YG, 2001, CHEM-EUR J, V7, P99, DOI 10.1002/1521-3765(20010105)7:1<99::AID-CHEM99>3.3.CO;2-K
   Gamelin DR, 2000, ACCOUNTS CHEM RES, V33, P235, DOI 10.1021/ar990102y
   Gau WJ, 1996, J ELECTROCHEM SOC, V143, P914, DOI 10.1149/1.1836558
   Gerner P, 2001, INORG CHEM, V40, P4534, DOI 10.1021/ic010081f
   Glover PB, 2003, J AM CHEM SOC, V125, P9918, DOI 10.1021/ja029886s
   Gorller-Walrand C., 1998, HDB PHYS CHEM RARE E, V25
   Guillet E, 2004, CHEM MATER, V16, P4063, DOI 10.1021/cm049296o
   GUILLOU O, 2004, HDB PHYS CHEM RARE E, V34, pCH221
   Gunnlaugsson T, 2004, CHEM COMMUN, P782, DOI 10.1039/b316176e
   Gunnlaugsson T, 2003, J AM CHEM SOC, V125, P12062, DOI 10.1021/ja035425a
   Guo D, 2004, CHEM COMMUN, P1486, DOI 10.1039/b403519d
   Gutierrez F, 2004, DALTON T, P1334, DOI 10.1039/b316246j
   Hai XD, 2004, ANAL SCI, V20, P245, DOI 10.2116/analsci.20.245
   Hanaoka K, 2003, ANGEW CHEM INT EDIT, V42, P2996, DOI 10.1002/anie.200351122
   Harrison BS, 2004, CHEM MATER, V16, P2938, DOI 10.1021/cm049937f
   Harvey EN, 1957, HIST LUMINESCENCE EA
   Hasegawa Y, 2004, J PHOTOCH PHOTOBIO C, V5, P183, DOI 10.1016/j.jphotochemrev.2004.10.003
   Hasegawa Y, 2003, J LUMIN, V101, P235, DOI 10.1016/S0022-2313(02)00440-4
   He HS, 2004, EUR J INORG CHEM, P837, DOI 10.1002/ejic.200300511
   Hebbink GA, 2003, J PHYS CHEM A, V107, P2483, DOI 10.1021/jp0260090
   Heer S, 2003, J LUMIN, V102, P144, DOI 10.1016/S0022-2313(02)00490-8
   Hemmila I, 2001, CRIT REV CL LAB SCI, V38, P441, DOI 10.1080/20014091084254
   HEMMILA I, 1995, BIOANALYTICAL APPL
   Hufner S., 1978, OPTICAL SPECTRA TRAN
   HURSKAINEN P, 1995, J ALLOY COMPD, V225, P489, DOI 10.1016/0925-8388(94)07055-5
   Imbert D, 2005, CHEM COMMUN, P1432, DOI 10.1039/b416575f
   Imbert D, 2003, J AM CHEM SOC, V125, P15698, DOI 10.1021/ja0386501
   IZATT RM, 1985, CHEM REV, V85, P271, DOI 10.1021/cr00068a003
   IZATT RM, 1991, CHEM REV, V91, P1721, DOI 10.1021/cr00008a003
   Jensen MP, 2003, J AM CHEM SOC, V125, P15466, DOI 10.1021/ja037577b
   Justel T, 1998, ANGEW CHEM INT EDIT, V37, P3085, DOI 10.1002/(SICI)1521-3773(19981204)37:22<3084::AID-ANIE3084>3.0.CO;2-W
   Kaltsoyannis N., 1999, F ELEMENTS
   Kang TS, 2003, ADV FUNCT MATER, V13, P205, DOI 10.1002/adfm.200390031
   Kido J, 2002, CHEM REV, V102, P2357, DOI 10.1021/cr010448y
   Kim S, 2004, NAT BIOTECHNOL, V22, P93, DOI 10.1038/nbt920
   KLEINERMAN M, 1968, J CHEM PHYS, V49, P3901, DOI 10.1063/1.1670698
   Klink SI, 2000, ANGEW CHEM INT EDIT, V39, P4319, DOI 10.1002/1521-3773(20001201)39:23<4319::AID-ANIE4319>3.0.CO;2-X
   Klink SI, 2002, SYNTHETIC MET, V127, P213, DOI 10.1016/S0379-6779(01)00625-7
   Kojima T., 1999, PHOSPHOR HDB, P623
   Korovin Y, 2001, REV INORG CHEM, V21, P299
   Lakowicz JR, 2001, CHEMPHYSCHEM, V2, P247, DOI 10.1002/1439-7641(20010417)2:4<247::AID-CPHC247>3.0.CO;2-G
   Latva M, 1997, J LUMIN, V75, P149, DOI 10.1016/S0022-2313(97)00113-0
   Lehn J.-M., 1995, SUPRAMOLECULAR CHEM
   Li C, 2002, CHEM COMMUN, P2034, DOI 10.1039/b206561b
   Lincoln SF, 2005, HELV CHIM ACTA, V88, P523, DOI 10.1002/hlca.200590036
   Liu S, 2004, CHEM SOC REV, V33, P445, DOI 10.1039/b309961j
   Lowe MP, 2000, CHEM COMMUN, P707, DOI 10.1039/b001629m
   Lukes I, 2001, COORDIN CHEM REV, V216, P287, DOI 10.1016/S0010-8545(01)00336-8
   Manning HC, 2004, BIOCONJUGATE CHEM, V15, P1488, DOI 10.1021/bc049904q
   MATHIS G, 1995, CLIN CHEM, V41, P1391
   Matsumoto K., 2003, MET IONS BIOL SYST, V40
   Maupin CL, 1998, J AM CHEM SOC, V120, P10563, DOI 10.1021/ja982147k
   MELHUISH WH, 1984, PURE APPL CHEM, V56, P231, DOI 10.1351/pac198456020231
   MENZEL ER, 1989, ANAL CHEM, V61, pA557, DOI 10.1021/ac00183a003
   Merbach A, 2001, CHEM CONTRAST AGENT
   Meskers SCJ, 2001, J PHYS CHEM A, V105, P4589, DOI 10.1021/jp004428w
   Mortellaro MA, 1996, J AM CHEM SOC, V118, P7414, DOI 10.1021/ja961323r
   Motson GR, 2001, J CHEM SOC DALTON, P1389, DOI 10.1039/b102295b
   MOUTIERS G, 2004, 6712 AF
   Muller G, 2002, CHEM COMMUN, P1522, DOI 10.1039/b203691f
   Muller G, 2002, EUR J INORG CHEM, P3101
   Muller G, 2001, J CHEM SOC DALTON, P2655, DOI 10.1039/b102728j
   NG DKP, 2001, HDB PHYS CHEM RARE E, V32, pCH210
   Nozary H, 1998, J AM CHEM SOC, V120, P12274, DOI 10.1021/ja982545n
   Ozawa L, 2003, CHEM REV, V103, P3835, DOI 10.1021/cr0203490
   Parac-Vogt TN, 2002, J CHEM SOC DALTON, P1602, DOI 10.1039/b109334g
   Parker D, 2000, COORDIN CHEM REV, V205, P109, DOI 10.1016/S0010-8545(00)00241-1
   Parker D, 2004, CHEM SOC REV, V33, P156, DOI 10.1039/b311001j
   Parker David, 2003, Met Ions Biol Syst, V40, P233
   Petoud S, 1999, J LUMIN, V82, P69, DOI 10.1016/S0022-2313(99)00015-0
   Petoud S, 2003, J AM CHEM SOC, V125, P13324, DOI 10.1021/ja0379363
   PIECHOCKI C, 1985, CHEM PHYS LETT, V122, P124, DOI 10.1016/0009-2614(85)85490-7
   Piguet C, 2005, COORDIN CHEM REV, V249, P705, DOI 10.1016/j.ccr.2004.08.023
   Piguet C, 1999, CHEM SOC REV, V28, P347, DOI 10.1039/a804240c
   Piguet C, 1997, J CHEM SOC DALTON, P421, DOI 10.1039/a605986d
   Piguet C, 2000, J CHEM SOC DALTON, P3999, DOI 10.1039/b003521l
   Piszczek G, 2001, J FLUORESC, V11, P101, DOI 10.1023/A:1016673300913
   Poole RA, 2005, ORG BIOMOL CHEM, V3, P1013, DOI 10.1039/b418964g
   Pope SJA, 2004, J AM CHEM SOC, V126, P9490, DOI 10.1021/ja047523h
   Pope SJA, 2004, CHEM COMMUN, P1550, DOI 10.1039/b402270j
   Pope SJA, 2003, DALTON T, P3780, DOI 10.1039/b309115e
   Pope SJA, 2003, CHEM COMMUN, P1550, DOI 10.1039/b303012a
   Reany O, 2000, J CHEM SOC PERK T 2, P1819, DOI 10.1039/b003963m
   Renaud F, 1999, J AM CHEM SOC, V121, P9326, DOI 10.1021/ja990898w
   RICHARDSON FS, 1991, J PHYS CHEM-US, V95, P6249, DOI 10.1021/j100169a036
   RICHARDSON FS, 1982, CHEM REV, V82, P541, DOI 10.1021/cr00051a004
   Riehl JP, 2005, HANDB PHYSI, V34, P289
   RIEHL JP, 1986, CHEM REV, V86, P1, DOI 10.1021/cr00071a001
   RIEHL JP, 2000, ENCY SPECTROSCOPY SP, P243
   Rodriguez-Cortinas R, 2002, INORG CHEM, V41, P5336, DOI 10.1021/ic025587s
   ROUNDHILL DM, 1995, PROG INORG CHEM, V43, P533, DOI 10.1002/9780470166444.ch6
   Sakamoto M, 2001, COORDIN CHEM REV, V219, P379, DOI 10.1016/S0010-8545(01)00341-1
   Sanada T, 1998, INORG CHEM, V37, P4712, DOI 10.1021/ic971568k
   Sastri V. R, 2003, MODERN ASPECTS RARE
   SELTZER MD, 1995, J CHEM EDUC, V72, P886, DOI 10.1021/ed072p886
   Shavaleev NM, 2003, CHEM COMMUN, P1134, DOI 10.1039/b301878d
   Shavaleev NM, 2005, INORG CHEM, V44, P61, DOI 10.1021/ic048875s
   Shavaleev NM, 2003, CHEM-EUR J, V9, P5283, DOI 10.1002/chem.200305132
   Shavaleev NM, 2002, J CHEM SOC DALTON, P3925, DOI 10.1039/b207832e
   Shen YR, 2000, PHYS REV B, V61, P11460, DOI 10.1103/PhysRevB.61.11460
   Shionoya S., 1999, PHOSPHOR HDB
   Silva FRGE, 2002, J PHYS CHEM A, V106, P1670, DOI 10.1021/jp012884u
   Silva FRGE, 2000, PHYS CHEM CHEM PHYS, V2, P5400
   Stang PJ, 1997, ACCOUNTS CHEM RES, V30, P502, DOI 10.1021/ar9602011
   Stouwdam JW, 2003, CHEM MATER, V15, P4604, DOI 10.1021/cm034495d
   Strohhofer C, 2003, OPT MATER, V21, P705, DOI 10.1016/S0925-3467(02)00056-3
   Suarez S, 2005, NEW J CHEM, V29, P1323, DOI 10.1039/b503591k
   Suarez S, 2004, CHEM MATER, V16, P3257, DOI [10.1021/cm049754t, 10.1021/cm.049754t]
   Suarez S, 2003, CHEM COMMUN, P1226, DOI 10.1039/b302438e
   Subhan MA, 2003, J LUMIN, V101, P307, DOI 10.1016/S0022-2313(02)00573-2
   Subhan MA, 2002, J CHEM SOC DALTON, P1416, DOI 10.1039/b108770c
   Subhan MA, 2001, J CHEM SOC DALTON, P492, DOI 10.1039/b007369p
   Supkowski RM, 2002, INORG CHIM ACTA, V340, P44, DOI 10.1016/S0020-1693(02)01022-8
   Telfer SG, 2004, INORG CHEM, V43, P5302, DOI 10.1021/ic049540d
   Terazzi E, 2005, J AM CHEM SOC, V127, P888, DOI 10.1021/ja0446101
   TORELLI S, 2005, CHEM-EUR J, V11, P3238
   Tsukube H, 2002, CHEM REV, V102, P2389, DOI 10.1021/cr010450p
   Tsukube H, 2002, COORDIN CHEM REV, V226, P227, DOI 10.1016/S0010-8545(01)00450-7
   Urbain G, 1909, ANN CHIM PHYS, V18, P222
   Van Deun R, 2004, INORG CHEM, V43, P8461, DOI 10.1021/ic048736a
   Van Deun R, 2003, PHYS CHEM CHEM PHYS, V5, P2754, DOI 10.1039/b304491b
   Van Deun R, 2003, J MATER CHEM, V13, P1520, DOI 10.1039/b305158g
   Vereb G, 1998, BIOPHYS J, V74, P2210, DOI 10.1016/S0006-3495(98)77930-5
   Vigato PA, 2004, COORDIN CHEM REV, V248, P1717, DOI 10.1016/j.cct.2003.09.003
   Visser AE, 2003, J SOLID STATE CHEM, V171, P109, DOI 10.1016/S0022-4596(02)00193-7
   Voloshin AI, 2001, J LUMIN, V93, P199, DOI 10.1016/S0022-2313(01)00194-6
   Wang HS, 2004, J PHYS CHEM B, V108, P8084, DOI 10.1021/jp049886
   Wasserscheid P., 2005, IONIC LIQUIDS SYNTHE
   Wegh RT, 1999, SCIENCE, V283, P663, DOI 10.1126/science.283.5402.663
   Weibel N, 2004, J AM CHEM SOC, V126, P4888, DOI 10.1021/ja031886k
   Weissleder R, 2001, NAT BIOTECHNOL, V19, P316, DOI 10.1038/86684
   Welton T, 1999, CHEM REV, V99, P2071, DOI 10.1021/cr980032t
   Werts MHV, 2002, PHYS CHEM CHEM PHYS, V4, P1542, DOI 10.1039/b107770h
   Williams DB, 2005, CHEM COMMUN, P1438, DOI 10.1039/b416830e
   XU YY, 1992, TALANTA, V39, P759, DOI 10.1016/0039-9140(92)80091-Q
   Yam VWW, 1999, COORDIN CHEM REV, V184, P157, DOI 10.1016/S0010-8545(98)00262-8
   Yamada T, 2003, INORG CHEM, V42, P7932, DOI 10.1021/ic020726r
   YU LJ, 1977, APPL PHYS LETT, V31, P719, DOI 10.1063/1.89528
   Yuan JL, 1997, ANAL BIOCHEM, V254, P283, DOI 10.1006/abio.1997.2444
   Zijlmans HJMAA, 1999, ANAL BIOCHEM, V267, P30, DOI 10.1006/abio.1998.2965
NR 210
TC 2191
Z9 2211
U1 55
U2 847
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0306-0012
EI 1460-4744
J9 CHEM SOC REV
JI Chem. Soc. Rev.
PY 2005
VL 34
IS 12
BP 1048
EP 1077
DI 10.1039/b406082m
PG 30
WC Chemistry, Multidisciplinary
SC Chemistry
GA 983SP
UT WOS:000233252700006
PM 16284671
DA 2018-10-19
ER

PT J
AU Mitsuishi, M
   Warisawa, S
   Sugita, N
   Suzuki, M
   Moriya, H
   Hashizume, H
   Fujiwara, K
   Abe, N
   Inoue, H
   Kuramoto, K
   Inoue, T
   Nakashima, Y
   Tanimoto, K
AF Mitsuishi, M
   Warisawa, S
   Sugita, N
   Suzuki, M
   Moriya, H
   Hashizume, H
   Fujiwara, K
   Abe, N
   Inoue, H
   Kuramoto, K
   Inoue, T
   Nakashima, Y
   Tanimoto, K
TI A study of bone micro-cutting characteristics using a newly developed
   advanced bone cutting machine tool for total knee arthroplasty
SO CIRP ANNALS-MANUFACTURING TECHNOLOGY
LA English
DT Article
DE biomedical material cutting; machine tool; cutting force analysis
AB Bone cutting experiments were conducted on a cadaver using a newly developed machine tool. The effectiveness of the system was evaluated by comparing the planned shape for the mating surface between the femur and an artificial joint with the cutting result. It is desirable to know the machining phenomena and characteristics at the microscale because the material and the tissue structure are anisotropic in both cortical and cancellous bones. In the paper, the influence of the material characteristics on machining is discussed for cortical bone. Pig cortical bone was used in the experiment for visualizing 2-dimensional micro-cutting.
C1 Univ Tokyo, Sch Engn, Dept Engn Synthesis, Tokyo, Japan.
   Chiba Univ, Grad Sch Med, Chiba, Japan.
   Okayama Univ, Grad Sch Med & Dent, Okayama, Japan.
   Okayama Univ, Grad Sch Med & Dent, Okayama, Japan.
   Nakashima Propeller Co Ltd, Okayama, Japan.
   CORETEC Inc, Okayama, Japan.
RP Mitsuishi, M (reprint author), Univ Tokyo, Sch Engn, Dept Engn Synthesis, Tokyo, Japan.
CR BERNARD A, 2002, ANN CIRP, V51, P635
   BURGER T, 2001, ANN CIRP, V50, P295
   Cowin SC., 2000, BONE MECH HDB
   ITOH S, 1983, B JSME, V26, P2295
   Mak TW, 2004, CIRP ANN-MANUF TECHN, V53, P117, DOI 10.1016/S0007-8506(07)60658-1
   Mitsuishi M, 2004, CIRP ANN-MANUF TECHN, V53, P107, DOI 10.1016/S0007-8506(07)60656-8
   MITSUISHI M, 2003, ANN CIRP, V52, P323
   NAODA Y, 2004, CIRP ICME 04, P461
   SHU LH, 2003, ANN CIRP, V52, P101
   Ueda K, 2000, ANN CIRP, V49, P343
   Vashishth D, 1997, J BIOMECH, V30, P763, DOI 10.1016/S0021-9290(97)00029-8
NR 11
TC 18
Z9 18
U1 0
U2 6
PU TECHNISCHE RUNDSCHAU EDITION COLIBRI LTD
PI BERN
PA NORDRING 4, CH-3001 BERN, SWITZERLAND
J9 CIRP ANN-MANUF TECHN
JI CIRP Ann-Manuf. Technol.
PY 2005
VL 54
IS 1
BP 41
EP 46
DI 10.1016/S0007-8506(07)60045-6
PG 6
WC Engineering, Industrial; Engineering, Manufacturing
SC Engineering
GA 942ZS
UT WOS:000230322000010
DA 2018-10-19
ER

PT J
AU Lendlein, A
   Kelch, S
AF Lendlein, A
   Kelch, S
TI Shape-memory polymers as stimuli-sensitive implant materials
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article
DE biodegradable shape-memory polymers; polymer systems; stimuli-sensitive
   implant materials; smart suture
ID OLIGO(EPSILON-CAPROLACTONE) SEGMENTS; BIOMEDICAL APPLICATIONS; IN-VITRO;
   ANGIOGENESIS; NETWORKS; STERILIZATION
AB Shape-memory polymers are stimuli-responsive materials. Upon exposure to an external stimulus, e.g. an increase in temperature, they have the capability of changing their shape. The shape-memory effect results from the polymer's structure and morphology in combination with a certain processing and programming technology. Stimuli-sensitive implant materials have a high potential for applications in minimally invasive surgery. A group of biodegradable implant materials with shape-memory has been developed for applications in biomedicine. These implant materials are not a single polymer but polymer systems that allow the variation of different macroscopic properties over a wide range by only small changes in the chemical structure. In this way, it is possible to implement a variety of different applications with tailor-made polymers of the same family. Two different types of degradable shape-memory polymer systems, covalently cross-linked polymer networks and thermoplastic elastomers, are presented and examples are given for each case.
C1 GKSS Res Ctr Geesthacht GmbH, Inst Chem, D-14513 Teltow, Germany.
RP Lendlein, A (reprint author), GKSS Res Ctr Geesthacht GmbH, Inst Chem, Kantstr 55, D-14513 Teltow, Germany.
EM lendlein@gkss.de
RI Lendlein, Andreas/K-9553-2013
OI Lendlein, Andreas/0000-0003-4126-4670
CR Binzen E, 2003, CLIN HEMORHEOL MICRO, V28, P183
   BRONZINO J, 1995, BIOMEDICAL ENG HDB
   Hall H, 2001, MICROVASC RES, V62, P315, DOI 10.1006/mvre.2001.2348
   LAURENCIN CT, 1995, BIOMEDICAL APPL SYNT
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lendlein A, 2002, ANGEW CHEM INT EDIT, V41, P2034, DOI 10.1002/1521-3773(20020617)41:12<2034::AID-ANIE2034>3.0.CO;2-M
   Lendlein A, 2001, P NATL ACAD SCI USA, V98, P842, DOI 10.1073/pnas.031571398
   Lendlein A, 1999, CHEM UNSERER ZEIT, V33, P279, DOI 10.1002/ciuz.19990330505
   LENDLEIN A, 2002, ENCY POLYM SCI TECHN
   LIPSCOMB P, 1996, APPL SHAPE MEMORY AL
   MAK AFT, 1998, HDB BIOMATERIAL PROP
   Mikos A.G, 2000, ELECT J BIOTECHNOLOG, V3
   Rickert D, 2003, J BIOMED MATER RES B, V67B, P722, DOI 10.1002/jbm.b.10069
   Rickert D, 2003, CLIN HEMORHEOL MICRO, V28, P175
   Rickert D, 2002, BIOMED TECH, V47, P285, DOI 10.1515/bmte.2002.47.11.285
   SHALABY SW, 1994, BIOMEDICAL POLYM
   Shastri VP, 2000, P NATL ACAD SCI USA, V97, P1970, DOI 10.1073/pnas.97.5.1970
   Suzuki Y, 1998, SHAPE MEMORY MAT
   THOMSON RC, 1997, PRINCIPLES TISSUE EN
   Tobushi H, 1996, J PHYS IV, V6, P377, DOI 10.1051/jp4:1996136
NR 20
TC 106
Z9 108
U1 1
U2 40
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2005
VL 32
IS 2
BP 105
EP 116
PG 12
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 912UH
UT WOS:000228104900004
PM 15764819
DA 2018-10-19
ER

PT J
AU Groth, T
   Seifert, B
   Albrecht, W
   Malsch, G
   Gross, U
   Fey-Lamprecht, F
   Michanetzis, G
   Missirlis, Y
   Engbers, G
AF Groth, T
   Seifert, B
   Albrecht, W
   Malsch, G
   Gross, U
   Fey-Lamprecht, F
   Michanetzis, G
   Missirlis, Y
   Engbers, G
TI Development of polymer membranes with improved haemocompatibility for
   biohybrid organ technology
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article
DE bioartificial organs; haemocompatibility; kidney epithelial cells;
   polymer membranes
ID ARTIFICIAL LIVER SUPPORT; BIOARTIFICIAL LIVER; DIALYSIS; SYSTEM; KIDNEY;
   BLOOD; IMMOBILIZATION; BIOMATERIALS; POLYLACTIDE; ACTIVATION
AB Biomedical technology has opened up possibilities of treating the failure of internal organs like kidney and liver by artificial organ therapy. Most of these techniques are based on polymer membranes, which allow the removal of excess of water, salts and toxins from the circulation. However, haemodialysis for the replacement of kidney function results in an increased morbidity and mortality of patients after long-term application. Conventional therapy, such as haemofiltration for the treatment of acute liver failure does not improve significantly the survival rate of patients. Biohybrid organ support as a combination of the artificial organ therapy with the functional activity of immobilised cells seems to be a solution of the problem. Membranes applied in these devices have to face both tissue cells and blood. Organ cells in biohybrid organs have to make intimate contact with the surface of membrane but must also develop close cell-cell-connections as a prerequisite for their survival and high functional activity. Blood to be detoxified will contact the other side of membrane and may not become activated by the synthetic material. New polymer membranes based on acrylonitrile were developed to address these requirements by tailoring the composition of copolymers and to be applied in a specific hollow fibre bioreactor with an outer fibre for blood contact, and an inner fibre for tissue contact or vice versa.
C1 GKSS Forschungszentrum Geesthacht GmbH, Inst Chem, Teltow, Germany.
   Free Univ Berlin, Inst Pathol, D-1000 Berlin, Germany.
   Univ Patras, Biomed Engn Lab, GR-26110 Patras, Greece.
   Holland Biomat Grp BV, Enschede, Netherlands.
RP Groth, T (reprint author), GKSS Forschungszentrum Geesthacht GmbH, Inst Chem, Teltow, Germany.
RI Seifert, Barbara/K-7569-2012
OI Groth, Thomas/0000-0001-6647-9657
CR ARNAOUT WS, 1990, J SURG RES, V48, P379, DOI 10.1016/0022-4804(90)90079-H
   COLTON CK, 1995, CELL TRANSPLANT, V4, P415, DOI 10.1016/0963-6897(95)00025-S
   DESCAMPSLATSCHA B, 1993, KIDNEY INT, V43, pS135
   DIXIT V, 1994, ARTIF ORGANS, V18, P371, DOI 10.1111/j.1525-1594.1994.tb02219.x
   Fey-Lamprecht F, 2003, J BIOMED MATER RES A, V65A, P144, DOI 10.1002/jbm.a.10328
   FLENDRIG LM, 1997, ARTIF ORGANS, V16, P209
   Franke RP, 2001, CLIN HEMORHEOL MICRO, V24, P101
   FROMM M, 1997, PHYSL MENSCHEN, P719
   GEJYO F, 1993, KIDNEY INT S, V41, P78
   GERLACH J, 1994, INT J ARTIF ORGANS, V17, P549
   GROTH T, 1995, BIOMATERIALS, V16, P1009, DOI 10.1016/0142-9612(95)94909-5
   HUBBELL JA, 1995, CHEM ENG NEWS, V13, P42
   Humes HD, 1999, NAT BIOTECHNOL, V17, P451, DOI 10.1038/8626
   IMAI Y, 1983, J BIOMED MATER RES, V17, P905, DOI 10.1002/jbm.820170602
   IP TK, 1989, ARTIF ORGANS, V13, P58, DOI 10.1111/j.1525-1594.1989.tb02833.x
   Jauregui HO, 1996, CELL TRANSPLANT, V5, P353, DOI 10.1016/0963-6897(95)02020-9
   Jung F, 2003, CLIN HEMORHEOL MICRO, V28, P189
   KAZATCHKINE MD, 1982, PROG ALLERGY, V30, P193
   KHAN IH, 1993, KIDNEY INT, V43, pS143
   KLINKMANN H, 1995, NEPHROL DIAL TRANSPL, V10, P39, DOI 10.1093/ndt/10.supp3.39
   KOLFF WJ, 1943, NED TIJDSCHR GENEES, V87, P1684
   Legallais C, 2001, J MEMBRANE SCI, V181, P81, DOI 10.1016/S0376-7388(00)00539-1
   Lins RL, 2000, CLIN NEPHROL, V53, P10
   LODISH H, 1995, MOL CELL BIOL, P623
   Mege JL, 1996, AM J KIDNEY DIS, V28, P395, DOI 10.1016/S0272-6386(96)90497-7
   Nikolovski J, 1999, CELL TRANSPLANT, V8, P351, DOI 10.1177/096368979900800403
   Qiang S, 1997, INT J ARTIF ORGANS, V20, P119
   RHODES NP, 1994, BIOMATERIALS, V15, P35, DOI 10.1016/0142-9612(94)90194-5
   RHODES NP, 1997, CELLULAR ENG, V2, P1
   Sanaka T, 1989, ASAIO Trans, V35, P527, DOI 10.1097/00002480-198907000-00114
   SCHMIDT B, 1995, CONTRIB NEPHROL, V113, P32
   Seifert B, 1997, BIOMATERIALS, V18, P1495, DOI 10.1016/S0142-9612(97)00079-3
   SEIFERT B, 1995, J BIOMAT SCI-POLYM E, V7, P277, DOI 10.1163/156856295X00319
   STUART J, 1986, CLIN HEMORHEOL, V6, P439
   SUSSMAN NL, 1993, BLOOD PURIFICAT, V11, P170, DOI 10.1159/000170114
   USSING HH, 1951, ACTA PHYSIOL SCAND, V23, P110, DOI 10.1111/j.1748-1716.1951.tb00800.x
   VONSENGBUSCH G, 1993, ARTIF ORGANS, V17, P244
   Ward R. A., 1988, T AM SOC ART INT ORG, V34, P334
   Yasutomi M, 2001, LIVER TRANSPLANT, V7, P38, DOI 10.1053/jlts.2001.18482
NR 39
TC 8
Z9 8
U1 0
U2 3
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2005
VL 32
IS 2
BP 129
EP 143
PG 15
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 912UH
UT WOS:000228104900006
PM 15764821
DA 2018-10-19
ER

PT J
AU MacLeod, AM
   Campbell, M
   Cody, JD
   Daly, C
   Donaldson, C
   Grant, A
   Khan, I
   Rabindranath, KS
   Vale, L
   Wallace, S
AF MacLeod, AM
   Campbell, M
   Cody, JD
   Daly, C
   Donaldson, C
   Grant, A
   Khan, I
   Rabindranath, KS
   Vale, L
   Wallace, S
TI Cellulose, modified cellulose and synthetic membranes in the
   haemodialysis of patients with end-stage renal disease
SO COCHRANE DATABASE OF SYSTEMATIC REVIEWS
LA English
DT Review
ID HIGH-FLUX DIALYSIS; BLOOD MONONUCLEAR-CELLS; C-REACTIVE PROTEIN;
   OXIDATIVE STRESS; DIALYZER MEMBRANE; BICARBONATE HEMODIALYSIS;
   BIOCOMPATIBLE MEMBRANE; NUTRITIONAL PARAMETERS; COMPLEMENT ACTIVATION;
   PLATELET ACTIVATION
AB Background When the kidney fails the blood-borne metabolites of protein breakdown and water cannot be excreted. The principle of haemodialysis is that such substances can be removed when blood is passed over a semipermeable membrane. Natural membrane materials include cellulose or modified cellulose, more recently various synthetic membranes have been developed. Synthetic membranes are regarded as being more "biocompatible" in that they incite less of an immune response than cellulose-based membranes.
   Objectives To assess the effects of different haemodialysis membrane material in patients with end-stage renal disease (ESRD).
   Search strategy We searched MEDLINE, EMBASE, PreMEDLINE, HealthStar CINAHL, the Cochrane Central Register of Controlled Trials (CENTRAL), Biosis, SIGLE, CRIB, UK National Research Register and reference lists of relevant articles. We contacted biomedical companies, known investigators and handsearched selected journals and conference proceedings. Date of most recent search: June 2004.
   Selection criteria All randomised controlled trials (RCTs) or quasi-RCTs comparing different haemodialysis membrane material in patients with ESRD.
   Data collection and analysis Two reviewers independently assessed the methodological quality of studies. Data was abstracted onto a standard form by one reviewer and checked by another. Relative Risk (RR) and weighted mean difference (WMD) with 95% confidence intervals (CI))
   Main results Thirty two studies were identified. Pre-dialysis beta(2) microglobulin concentrations were not significantly lower in patients treated with synthetic membranes (WMD-14.67, 95% CI-33.10 to 4.05). When analysed for change in beta(2) microglobulin, a fall was only noted with high-flux membranes. The incidence of amyloid was less in patients who were dialysed for six years with high-flux synthetic membranes (one study, RR 0.03, 95% CI 0.00 to 0.54). There was a significant difference in favour of the synthetic (high-flux) membrane in comparison to cellulose membranes for triglycerides (WMD- 0.66;95% CI-1.18 to -0.14) but not for modified cellulose membranes. Dialysis adequacy measured by Kt/V was marginally higher when cellulose membranes were used (WMD- 0.10;95% CI-0.16 to 0.04), whereas synthetic membranes achieved significantly higher Kt/V values when compared with modified cellulose membranes (WMD 0.20, 95% 0.11 to 0.29). There were no data on quality of life measures.
   Authors' conclusions We found no evidence of benefit when synthetic membranes were compared with cellulose/modified cellulose membranes in terms of reduced mortality no reduction in dialysis-related adverse symptoms. Despite the relatively large number of RCTs undertaken in this area none of the included studies reported any measures of quality of life.
C1 Univ Aberdeen, Aberdeen AB25 2ZD, Scotland.
RP MacLeod, AM (reprint author), Univ Aberdeen, Polwarth Bldg, Aberdeen AB25 2ZD, Scotland.
EM mmd175@abdn.ac.uk
RI Wallace, Sheila/A-6921-2018
OI Wallace, Sheila/0000-0003-2853-3653
CR AAKHUS S, 1995, BLOOD PURIFICAT, V13, P229, DOI 10.1159/000170206
   AKIZAWA T, 1986, T AM SOC ART INT ORG, V32, P76
   ALMADANI HA, 2000, MED SCI RES, V28, P23
   BAURMEISTER U, 1989, ARTIF ORGANS, V13, P52, DOI 10.1111/j.1525-1594.1989.tb02832.x
   BERGAMO, 1991, KIDNEY INT, V40, P714
   Biasioli S, 2000, ASAIO J, V46, P625, DOI 10.1097/00002480-200009000-00023
   BLANKESTIJN PJ, 1995, J AM SOC NEPHROL, V5, P1703
   Bonomini M, 1996, INT J ARTIF ORGANS, V19, P232
   CARAMELO C, 1994, NEPHROL DIAL TRANSPL, V9, P675, DOI 10.1093/ndt/9.6.675
   CHEUNG AK, 1990, J AM SOC NEPHROL, V1, P150
   CHURCHILL DN, 1993, NEPHRON, V65, P573, DOI 10.1159/000187566
   CHURCHILL DN, 1995, NEPHROLOGY DIALYSI S, V9, P52
   Clermont G, 2001, FREE RADICAL BIO MED, V31, P233, DOI 10.1016/S0891-5849(01)00577-9
   COLLINS DM, 1993, J AM SOC NEPHROL, V4, P148
   COMBE C, 1994, AM J KIDNEY DIS, V24, P437, DOI 10.1016/S0272-6386(12)80900-0
   Coyne DW, 1998, AM J KIDNEY DIS, V32, P1031, DOI 10.1016/S0272-6386(98)70079-4
   DANIELSON B G, 1986, Blood Purification, V4, P147, DOI 10.1159/000169438
   DAUGIRDAS JT, 1994, NEPHROL DIAL TRANSPL, V9, P145
   DAUGIRDAS JT, 2001, HDB DIALYSIS, P46
   De Broe M E, 1986, Blood Purif, V4, P168, DOI 10.1159/000169441
   De Vriese AS, 2003, NEPHROL DIAL TRANSPL, V18, P2596, DOI 10.1093/ndt/gfg437
   Depner T, 1999, AM J KIDNEY DIS, V33, P142, DOI 10.1016/S0272-6386(99)70272-6
   Dungen HD, 2001, INT J ARTIF ORGANS, V24, P357
   Eiselt J, 2001, ARTIF ORGANS, V25, P430, DOI 10.1046/j.1525-1594.2001.025006430.x
   Ferreira A, 2001, NEPHROL DIAL TRANSPL, V16, P1230, DOI 10.1093/ndt/16.6.1230
   Fourtounas C, 2001, NEPHROL DIAL TRANSPL, V16, P1077, DOI 10.1093/ndt/16.5.1077
   GARDINALI M, 1994, INT J ARTIF ORGANS, V17, P337
   Girndt M, 2000, AM J KIDNEY DIS, V35, P95, DOI 10.1016/S0272-6386(00)70307-6
   Goldberg IJ, 1996, NEPHROL DIAL TRANSPL, V11, P104
   Grooteman M P, 1995, ASAIO J, V41, P215
   Gutzwiller JP, 2002, NEPHROL DIAL TRANSPL, V17, P1037, DOI 10.1093/ndt/17.6.1037
   Hakim RM, 1996, J AM SOC NEPHROL, V7, P472
   Hartmann J, 1997, AM J KIDNEY DIS, V30, P366, DOI 10.1016/S0272-6386(97)90281-X
   HAUFE CC, 2001, KIDNEY INT S, V78, P177
   Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   HIMMELFARB J, 1993, J AM SOC NEPHROL, V4, P178
   Hoenich NA, 1997, CLIN NEPHROL, V48, P253
   Hoenich NA, 2000, AM J KIDNEY DIS, V36, P345, DOI 10.1053/ajkd.2000.8985
   HOSOKAWA S, 1991, International Urology and Nephrology, V23, P281, DOI 10.1007/BF02550425
   IVANOVICH P, 1993, NEPHROL DIAL TRANSPL, V8, P15, DOI 10.1093/ndt/8.supp2.15
   Kato A, 2001, ARTIF ORGANS, V25, P441, DOI 10.1046/j.1525-1594.2001.025006441.x
   KISHIMOTO T, 1993, NEPHROL DIAL TRANSPL, V8, P25, DOI 10.1093/ndt/8.supp2.25
   Kobayashi S, 2003, KIDNEY INT, V63, P1881, DOI 10.1046/j.1523-1755.2003.00920.x
   KRAMER BK, 1992, INT J ARTIF ORGANS, V15, P408
   Kuragano T, 2003, BLOOD PURIFICAT, V21, P176, DOI 10.1159/000069157
   Lang SM, 2001, PERITON DIALYSIS INT, V21, P52
   Lesaffer G, 2000, NEPHROL DIAL TRANSPL, V15, P50, DOI 10.1093/ndt/15.1.50
   LEVIN N, 1993, NEPHROL DIAL TRANSPL, V8, P2, DOI 10.1093/ndt/8.supp2.2
   LEVIN NW, 1993, NEPHROL DIAL TRANSPL, V8, P30, DOI 10.1093/ndt/8.supp2.30
   LINENWEBER S, 2001, KIDNEY INT S, V78, P282
   Locatelli F, 1996, KIDNEY INT, V50, P1293, DOI 10.1038/ki.1996.441
   Locatelli F., 1996, Journal of the American Society of Nephrology, V7, P1454
   Locatelli F, 2000, NEPHROL DIAL TRANSPL, V15, P1399, DOI 10.1093/ndt/15.9.1399
   MacLeod A, 1998, Health Technol Assess, V2, P1
   Matos JPS, 2000, AM J KIDNEY DIS, V35, P839, DOI 10.1016/S0272-6386(00)70253-8
   Memoli B, 2002, AM J KIDNEY DIS, V39, P266, DOI 10.1053/ajkd.2002.30545
   Memoli B, 2000, KIDNEY INT, V58, P417, DOI 10.1046/j.1523-1755.2000.00181.x
   MOLL S, 1990, INT J ARTIF ORGANS, V13, P273
   Munger MA, 2000, AM J KIDNEY DIS, V36, P130, DOI 10.1053/ajkd.2000.8285
   Navarro J, 1992, ASAIO J, V38, P811, DOI 10.1097/00002480-199210000-00013
   Ohi H, 2001, AM J KIDNEY DIS, V38, P384, DOI 10.1053/ajkd.2001.26106
   OPATRNY K, 1993, ARTIF ORGANS, V17, P971, DOI 10.1111/j.1525-1594.1993.tb03178.x
   Opatrny K, 1998, ARTIF ORGANS, V22, P816, DOI 10.1046/j.1525-1594.1998.06107.x
   Ottosson P, 2001, ASAIO J, V47, P229, DOI 10.1097/00002480-200105000-00014
   Parker TF, 1996, KIDNEY INT, V49, P551, DOI 10.1038/ki.1996.78
   Pertosa G, 2002, KIDNEY INT, V62, P602, DOI 10.1046/j.1523-1755.2002.00458.x
   QUEREDA C, 1988, INT J ARTIF ORGANS, V11, P259
   RABINDRANATH KS, 2004, COCHRANE DATABASE SY, V4
   RAO JNK, 1992, BIOMETRICS, V48, P577, DOI 10.2307/2532311
   Rao M, 2004, KIDNEY INT, V65, P682, DOI 10.1111/j.1523-1755.2004.00429.x
   Richardson D, 2003, AM J KIDNEY DIS, V42, P551, DOI 10.1016/S0272-6386(03)00788-1
   SANAKA T, 1995, NEPHROL DIAL TRANSPL, V10, P34, DOI 10.1093/ndt/10.supp3.34
   SCHAEFER RM, 1993, AM J NEPHROL, V13, P473, DOI 10.1159/000168666
   SCHAEFER RM, 1994, CLIN NEPHROL S1, V42, P21
   SCHIFFL H, 1995, CONTRIB NEPHROL, V112, P156
   SCHMITT GW, 1987, AM J MED, V83, P411, DOI 10.1016/0002-9343(87)90749-2
   Schouten WEM, 2000, NEPHROL DIAL TRANSPL, V15, P379, DOI 10.1093/ndt/15.3.379
   Sklar AH, 1998, AM J KIDNEY DIS, V31, P1007, DOI 10.1053/ajkd.1998.v31.pm9631846
   SKROEDER NR, 1994, INT J ARTIF ORGANS, V17, P521
   SKROEDER NR, 1995, AM J KIDNEY DIS, V25, P896, DOI 10.1016/0272-6386(95)90572-3
   SKROEDER NR, 1993, AM J KIDNEY DIS, V21, P519, DOI 10.1016/S0272-6386(12)80398-2
   SKTOEDER NR, 1994, ARTIF ORGANS, V18, P880
   STRASSER T, 1991, KLIN WOCHENSCHR, V69, P808, DOI 10.1007/BF01744274
   STUARD S, 1995, KIDNEY INT, V48, P93, DOI 10.1038/ki.1995.272
   Tayeb JS, 2000, AM J KIDNEY DIS, V35, P606, DOI 10.1016/S0272-6386(00)70005-9
   THYLEN P, 1992, AM J NEPHROL, V12, P393, DOI 10.1159/000168488
   Todeschini M, 2002, AM J KIDNEY DIS, V40, P783, DOI 10.1053/ajkd.2002.35690
   TRIDON A, 1987, NEPHROLOGIE, V8, P217
   Tsuruoka S, 2002, AM J KIDNEY DIS, V39, P127, DOI 10.1053/ajkd.2002.29901
   Usberti M, 2002, AM J KIDNEY DIS, V40, P590, DOI 10.1053/ajkd.2002.34919
   van Tellingen A, 2002, KIDNEY INT, V62, P632, DOI 10.1046/j.1523-1755.2002.00470.x
   van Tellingen A, 2004, NEPHROL DIAL TRANSPL, V19, P1198, DOI 10.1093/ndt.gfh122
   VANHOLDER R, 1991, KIDNEY INT, V39, P320, DOI 10.1038/ki.1991.40
   VANHOLDER R, 1992, INT J ARTIF ORGANS, V15, P89
   Varela MP, 2001, BLOOD PURIFICAT, V19, P370, DOI 10.1159/000046967
   VERBEELEN D, 1991, NEPHRON, V59, P567, DOI 10.1159/000186645
   Ward RA, 1997, NEPHROL DIAL TRANSPL, V12, P965, DOI 10.1093/ndt/12.5.965
   WARD RA, 1993, NEPHROL DIAL TRANSPL, V8, P47, DOI 10.1093/oxfordjournals.ndt.a092271
   WEHLE B, 1993, NEPHROL DIAL TRANSPL, V8, P20, DOI 10.1093/ndt/8.supp2.20
NR 99
TC 2
Z9 2
U1 0
U2 8
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1469-493X
EI 1361-6137
J9 COCHRANE DB SYST REV
JI Cochrane Database Syst Rev.
PY 2005
IS 3
AR CD003234.pub2
DI 10.1002/14651858.CD003234.pub2
PG 65
WC Medicine, General & Internal
SC General & Internal Medicine
GA 968ZI
UT WOS:000232202500121
DA 2018-10-19
ER

PT S
AU Wiesauer, K
   Pircher, M
   Gotzinger, E
   Engelke, R
   Ahrens, G
   Grutzner, G
   Hitzenberger, CK
   Stifter, D
AF Wiesauer, K
   Pircher, M
   Gotzinger, E
   Engelke, R
   Ahrens, G
   Grutzner, G
   Hitzenberger, CK
   Stifter, D
BE Neev, J
   Schaffer, CB
   Ostendorf, A
   Nolte, S
TI Ultra-high resolution optical coherence tomography for material
   characterization and quality control
SO Commercial and Biomedical Applications of Ultrafast Lasers V
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Commercial and Biomedical Applications of Ultrafast Lasers
   V
CY JAN 24-27, 2005
CL San Jose, CA
SP SPIE, Spectra Psys, IMRA Amer Inc
DE transversal optical coherence tomography; non-destructive testing;
   material characterization; ultra-high resolution; acousto-optic
   modulators
ID HIGH-SPEED
AB Optical coherence tomography (OCT), so far mainly used in the biomedical field. has a high potential as non-destructive and contactless technique for material characterization and analysis. For these applications, OCT systems with ultrahigh resolution in the micrometer range and capable of high imaging speeds are required. In this work, we combine ultra-high resolution imaging using a femtosecond Ti:sapphire laser as light source with the concepts of transversal OCT. Based on acquisition by heterodyne detection via acousto-optic modulators (AOMs), and by using an xy-galvano scanner unit we are able to obtain en-face scans with sizes as large as 3 x 3 mm 2 within a few seconds. The ultra-high resolution of our OCT system of 2.95 mu m axially and 4 tm laterally, both in air, is shown to be essential for imaging of different compounds and fibre materials. We demonstrate the benefits of en-face scanning OCT for various applications in material investigation where in-plane information is of interest which can hardly be obtained by cross-sectional OCT.
C1 Upper Austrian Res GmbH, A-4020 Linz, Austria.
RP Wiesauer, K (reprint author), Upper Austrian Res GmbH, Hafenstr 47-51, A-4020 Linz, Austria.
RI Wiesauer, Karin/D-3751-2013; Stifter, David/B-5767-2016
OI Michael, Pircher/0000-0001-9285-7527
CR Bashkansky M, 1997, OPT LETT, V22, P61, DOI 10.1364/OL.22.000061
   Bouma BE, 2002, HDB OPTICAL COHERENC
   De Martino A, 2001, PROC SPIE, V4431, P38, DOI 10.1117/12.447398
   DREXLER W, 1999, OPT LETT, V24, P2112
   DUBOIS A, 2004, APPL OPTICS, V43, P2847
   Dunkers JP, 2001, OPT LASER ENG, V35, P135, DOI 10.1016/S0143-8166(01)00010-0
   FERCHER AF, 1993, AM J OPHTHALMOL, V116, P113, DOI 10.1016/S0002-9394(14)71762-3
   Hitzenberger CK, 2003, OPT EXPRESS, V11, P2753, DOI 10.1364/OE.11.002753
   HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169
   JIAN L, 2003, SPIE, V4797, P394
   Kowalevicz AM, 2002, OPT EXPRESS, V10, P349, DOI 10.1364/OE.10.000349
   PIRCHER M, 2004, J PHYS MED BIOL, V49, P1257
   Saxer CE, 2000, OPT LETT, V25, P1355, DOI 10.1364/OL.25.001355
   Stifter D, 2003, APPL PHYS A-MATER, V76, P947, DOI 10.1007/s00339-002-2065-5
   SWANSON EA, 1992, OPT LETT, V17, P152
   Tearney GJ, 1997, SCIENCE, V276, P2037, DOI 10.1126/science.276.5321.2037
   UNTERHUBER A, 2003, OPT LETT, V28, P995
   Wang HW, 1999, PROC SPIE, V3598, P204, DOI 10.1117/12.347491
   WOJTKOWSKI M, 2004, OPT EXPRESS, V11, P2404
   Xie TQ, 2003, OPT EXPRESS, V11, P3210, DOI 10.1364/OE.11.003210
   YUN SH, 2003, OPT EXPRESS, V11, P3589
NR 21
TC 2
Z9 2
U1 0
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5688-8
J9 P SOC PHOTO-OPT INS
PY 2005
VL 5714
BP 108
EP 115
DI 10.1117/12.593612
PG 8
WC Optics; Physics, Applied
SC Optics; Physics
GA BCH75
UT WOS:000229338100012
DA 2018-10-19
ER

PT S
AU Hagiwara, Y
   Hongo, A
   Obara, M
AF Hagiwara, Y
   Hongo, A
   Obara, M
BE Neev, J
   Schaffer, CB
   Ostendorf, A
   Nolte, S
TI Ablation processing of biomedical materials with femtosecond double
   pulse lasers through hollow fiber
SO Commercial and Biomedical Applications of Ultrafast Lasers V
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Commercial and Biomedical Applications of Ultrafast Lasers
   V
CY JAN 24-27, 2005
CL San Jose, CA
SP SPIE, Spectra Psys, IMRA Amer Inc
DE femtosecond; laser; ablation; collagen; hollow fiber; double pulses
ID TI-SAPPHIRE LASER; DELIVERY
AB We have demonstrated the ablation processing of dry-collagen with double pulsed femtosecond lasers through a bent hollow fiber. Using a 320 mu m core-diameter hollow fiber, we have delivered an ultrashort pulse with a pulse width of 200 fs (straight condition), 320 fs (bent condition), and a near Gaussian beam profile. Furthermore, a precise biomedical material processing is obtainable with a transmitted femtosecond laser beam through a bent hollow fiber. The material processing speed is increased using femtosecond double pulses and by optimizing the delay time. The optimal delay time between the double pulses is from 1 ps to 3 ps, because the ablation rate decreased due to a plasma shielding effect beyond a 5ps delay time. Our results will open up new medical endoscopic applications.
C1 Keio Univ, Fac Sci & Technol, Dept Elect & Elect Engn, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan.
RP Hagiwara, Y (reprint author), Keio Univ, Fac Sci & Technol, Dept Elect & Elect Engn, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.
CR Choi TY, 2002, APPL SURF SCI, V197, P720, DOI 10.1016/S0169-4332(02)00400-2
   Clark SW, 2001, OPT LETT, V26, P1320, DOI 10.1364/OL.26.001320
   Gobel W, 2004, OPT LETT, V29, P1285, DOI 10.1364/OL.29.001285
   Juhasz T, 1999, IEEE J SEL TOP QUANT, V5, P902, DOI 10.1109/2944.796309
   KAMINO L, 2003, LEOS 2003 ANN M
   KRUEGER J, 1999, APPL PHYS A, V69, pS403
   Matsuura Y, 2002, J APPL PHYS, V91, P887, DOI 10.1063/1.1425070
   Neev J, 1996, IEEE J SEL TOP QUANT, V2, P790, DOI 10.1109/2944.577301
   Ozono K, 2003, APPL PHYS A-MATER, V77, P303, DOI 10.1007/s00339-003-2119-3
   Perry MD, 1999, J APPL PHYS, V85, P6803, DOI 10.1063/1.370197
   PREUSS S, 1993, APPL PHYS LETT, V62, P3049, DOI 10.1063/1.109135
   Semerok A, 2004, THIN SOLID FILMS, V453, P501, DOI 10.1016/j.tsf.2003.11.115
NR 12
TC 2
Z9 2
U1 0
U2 4
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5688-8
J9 P SOC PHOTO-OPT INS
PY 2005
VL 5714
BP 283
EP 289
DI 10.1117/12.589972
PG 7
WC Optics; Physics, Applied
SC Optics; Physics
GA BCH75
UT WOS:000229338100031
DA 2018-10-19
ER

PT J
AU Charitidis, C
   Logothetidis, S
AF Charitidis, C
   Logothetidis, S
TI Nanoscale effects on the nanomechanical properties of multifunctional
   materials
SO COMPUTATIONAL MATERIALS SCIENCE
LA English
DT Article; Proceedings Paper
CT Spring Meeting of the European-Materials-Research-Society
CY MAY 24-28, 2004
CL Strasbourg, FRANCE
SP European Mat Res Soc
ID DIAMOND-LIKE CARBON; THIN-FILMS; INDENTATION EXPERIMENTS; COATINGS;
   ADHESION; BEHAVIOR; DEPOSITION; HARDNESS; LOAD
AB Nanoscale measurements of mechanical and tribological properties play an important role in many emerging fields, such as surface engineering, magnetic storage disks, biomedical coatings and microelectromechanical systems. The understanding of scale effects is of great importance, since surface to volume ratio increases with miniaturization and surface phenomena dominate. Nanoindentation and nanoscratching tests are now commonly used for the evaluation of the functionality of the film-substrate compound and it can be satisfactorily used for the multifunctional materials characterization.
   In the present study nanoscale effects on the nanomechanical properties of flexible polymeric components and multilayered amorphous carbon (a-C) films using the nanoindentation and nanoscratching techniques, are considered. In specific, (i) Creep effects in nanoscale and the dependence of the dominant friction mechanisms and surface damage mechanisms on the applied load for flexible polymeric components. Load dependent transitions in the load range 1-15 mN, in both the scratch and the friction responses are considered and discussed as well as resultant deformation in nanoscale. The friction mechanism in the low-load range was adhesion. In the intermediate and high load ranges, adhesion, elastic and plastic deformations and ploughing mechanisms contributed to the friction behavior. (ii) The hardness behavior of multilayered a-C films and the role of the intrinsic material length, namely the total (100 nm) and bilayers thickness (10-45 nm), where it was found that the reduction of the bilayer thickness results in film's strengthening. (c) 2004 Elsevier B.V. All rights reserved.
C1 Aristotle Univ Thessaloniki, Dept Phys, Solid State Phys Sect, Lab Thin Films Nanosyst & Nanometrol, Thessaloniki 54124, Greece.
RP Charitidis, C (reprint author), Aristotle Univ Thessaloniki, Dept Phys, Solid State Phys Sect, Lab Thin Films Nanosyst & Nanometrol, Thessaloniki 54124, Greece.
EM cchar@skiathos.physics.auth.gr
OI Charitidis, Costas/0000-0003-1367-7603
CR ANGUS JC, 1986, PLASMA DEPOSITION TH, V4, P89
   BHUSHAN B, 1999, HDB MICRO NANO TRIBO
   Bichler C, 1997, SURF COAT TECH, V97, P299, DOI 10.1016/S0257-8972(97)00206-5
   CASEY F, 1999, P 42 ANN TECHN C, P415
   Charitidis C, 2003, DIAM RELAT MATER, V12, P1088, DOI 10.1016/S0925-9635(02)00268-6
   Charitidis C, 2000, SURF COAT TECH, V125, P201, DOI 10.1016/S0257-8972(99)00546-0
   CHARITIDIS C, UNPUB
   Chudoba T, 2001, SURF COAT TECH, V148, P191, DOI 10.1016/S0257-8972(01)01340-8
   Deng H, 1997, J APPL PHYS, V81, P5396, DOI 10.1063/1.364551
   Gioti M, 1998, APPL PHYS LETT, V73, P184, DOI 10.1063/1.121749
   Grill A, 1997, SURF COAT TECH, V94-5, P507, DOI 10.1016/S0257-8972(97)00458-1
   Gupta BK, 1995, WEAR, V190, P110, DOI 10.1016/0043-1648(95)06746-9
   Johnson K. L., 1985, CONTACT MECH
   KOELER JS, 1970, PHYS REV B, V2, P547
   KOSKINEN J, 1993, SURF COAT TECH, V62, P356, DOI 10.1016/0257-8972(93)90267-R
   LEHOCZKY SL, 1978, PHYS REV LETT, V41, P1814, DOI 10.1103/PhysRevLett.41.1814
   Leterrier Y, 1997, J POLYM SCI POL PHYS, V35, P1449, DOI 10.1002/(SICI)1099-0488(19970715)35:9<1449::AID-POLB15>3.0.CO;2-6
   Lettington AH, 1998, CARBON, V36, P555, DOI 10.1016/S0008-6223(98)00062-1
   Lifshitz Y, 1999, DIAM RELAT MATER, V8, P1659, DOI 10.1016/S0925-9635(99)00087-4
   Logothetidis S, 1999, THIN SOLID FILMS, V353, P208, DOI 10.1016/S0040-6090(99)00425-3
   Logothetidis S, 2004, CARBON, V42, P1133, DOI 10.1016/j.carbon.2003.12.054
   Mathioudakis C, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.205203
   MCCOLL IR, 1993, DIAM RELAT MATER, V3, P83
   MIYOSHI K, 1988, SURF COAT TECH, V36, P487, DOI 10.1016/0257-8972(88)90177-6
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   OUYANG M, 2000, POLYM DEGRAD STABIL, V70, P217, DOI DOI 10.1016/S0141-3910(00)00116-6
   PATSALAS P, 2000, J APPL PHYS, V88, P6349
   Sobrinho ASD, 1998, J VAC SCI TECHNOL A, V16, P3190, DOI 10.1116/1.581519
   Tadanaga K, 1996, J SOL-GEL SCI TECHN, V6, P107, DOI 10.1007/BF00402593
   Thome J, 2003, SURF COAT TECH, V174, P584, DOI 10.1016/S0257-8972(03)00703-5
   Tonelli AE, 2002, POLYMER, V43, P637, DOI 10.1016/S1089-3156(00)00028-3
   Voevodin AA, 1998, DIAM RELAT MATER, V7, P463, DOI 10.1016/S0925-9635(97)00214-8
   YOKOYAMA S, 1999, P 42 ANN TECHN C, P420
NR 33
TC 9
Z9 10
U1 1
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-0256
J9 COMP MATER SCI
JI Comput. Mater. Sci.
PY 2005
VL 33
IS 1-3
BP 296
EP 302
DI 10.1016/j.commatsci.2004.12.014
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 911QV
UT WOS:000228020500046
DA 2018-10-19
ER

PT S
AU Kimura, Y
AF Kimura, Y
BE DeHosson, JTM
   Brebbia, CA
   Nishida, SI
TI Improvement of corrosion resistance and bio compatibility of Ni-Ti shape
   memory alloy by various surface modifications
SO Computer Methods and Experimental Measurements for Surface Effects and
   Contact Mechanics VII
SE WIT TRANSACTIONS ON ENGINEERING SCIENCES
LA English
DT Proceedings Paper
CT 7th International Conference on Computer Methods and Experimental
   Measurements for Surface Effects and Contact Mechanics
CY SEP, 2005
CL Bologna, ITALY
SP Wessex Inst Technol, Univ Groningen, WIT Transact Engn Sci
DE nickel-titanium shape memory alloy; cytocompatibility;
   bio-compatibility; biomaterial
AB Nickel-titanium shape memory alloy (Ni-Ti alloy) has unique mechanical properties such as shape memory effect and super elasticity along with good wear and corrosion resistances. For this reason Ni-Ti alloy is expected to be used as implant material in the biomedical field. However, the biocompatibility of the Ni-Ti alloy is not fully examined. The purpose of this research is to evaluate in vitro cytocompatibility and to try to improve corrosion resistance for Ni-Ti alloy by various surface modifications. Ni-Ti alloy showed good cytocompatibility compared with that of a Ti-6Al-4V alloy, judging from the small amount of hIL-1 beta and LDH generations. Biocompatibility of the Ni-Ti alloy is superior compared with pure nickel. Also, it was made clear that the biocompatibility of the Ni-Ti alloy showed almost the same level as that of stainless steel, which gave a lot of actual results as a biomaterial until now. Therefore, it was understood that there is no problem in the biocompatibility of the Ni-Ti alloy for application as a biomaterial. Moreover, corrosion resistance of in air oxidized Ni-Ti alloy was recognized to be greatly improved.
C1 Kogakuin Univ, Dept Mat Sci & Technol, Tokyo 160, Japan.
RP Kimura, Y (reprint author), Kogakuin Univ, Dept Mat Sci & Technol, Tokyo 160, Japan.
CR Eliades T, 2000, EUR J ORTHODONT, V22, P317, DOI 10.1093/ejo/22.3.317
   Gil FJ, 1998, P I MECH ENG H, V212, P473, DOI 10.1243/0954411981534231
   KAKIUCHI T, 1996, KNOWLEDGE IMMUNOLOGY, P41
   MIYAZAKI S, 1993, MECH PROPERTIES SHAP, pCH1
   Ryhanen J, 1999, J BIOMED MATER RES, V47, P472, DOI 10.1002/(SICI)1097-4636(19991215)47:4<472::AID-JBM3>3.0.CO;2-Z
   TANAKA K, 1999, J SOC MATER SCI JPN, V48, P1341
   Thierry B, 2000, J BIOMED MATER RES, V51, P685, DOI 10.1002/1097-4636(20000915)51:4<685::AID-JBM17>3.0.CO;2-S
   TORRISI L, 1998, BIOMED MAT ENG, V9, P39
   Wataha JC, 1999, J BIOMED MATER RES, V45, P251, DOI 10.1002/(SICI)1097-4636(19990605)45:3<251::AID-JBM13>3.0.CO;2-5
NR 9
TC 0
Z9 0
U1 0
U2 1
PU WIT PRESS
PI SOUTHAMPTON
PA ASHURST LODGE, SOUTHAMPTON SO40 7AA, ASHURST, ENGLAND
SN 1746-4471
BN 1-84564-022-5
J9 WIT TRANS ENG SCI
PY 2005
VL 49
BP 3
EP 11
PG 9
WC Engineering, Mechanical; Mechanics; Materials Science, Characterization
   & Testing
SC Engineering; Mechanics; Materials Science
GA BDU51
UT WOS:000235463100001
DA 2018-10-19
ER

PT J
AU Buszewski, B
   Kowalska, S
   Krupczynska, K
AF Buszewski, B
   Kowalska, S
   Krupczynska, K
TI New generation of chromatographic packings and columns for determination
   of biologically active compounds
SO CRITICAL REVIEWS IN ANALYTICAL CHEMISTRY
LA English
DT Review
DE vitamins; steroids; nucleosides; peptides and proteins; separation
   techniques; stationary phase; sample preparation
ID PERFORMANCE LIQUID-CHROMATOGRAPHY; SUPERCRITICAL-FLUID EXTRACTION;
   WATER-SOLUBLE VITAMINS; ELECTROSPRAY-MASS-SPECTROMETRY; REVERSED-PHASE
   HPLC; HYDROPHOBIC INTERACTION CHROMATOGRAPHY; UNDERIVATIZED SMALL
   PEPTIDES; CHEMICALLY BONDED PHASES; ION-PAIR CHROMATOGRAPHY; CHIRAL
   STATIONARY-PHASE
AB Analysis of biologically active substances is particularly important in the pharmaceutical and biomedical area. For separation of polar compounds or complex mixtures by normal (NP) or reversed phase liquid chromatography (RP-HPLC) and/or electromigration techniques, it is necessary to apply a new generation of packings and columns with strictly defined properties. It is connected to the definition of chromatographic behavior and determination of compounds that are described by its structure, as well as chemical and physical properties. One of the factors playing a predominant role in the separation process is the interaction between analyte and stationary phases. During recent years a large variety of stationary phases have become available and have been also applied in routine and research chromatographic separations. Bonded phases are in widespread use and popular because of the great number of available packing materials, allowing the solution of a scale of different separation problems. At the present time analytical methods cannot be restricted only to the so-called "black box:' To meet the requirements of modern analytical techniques, strong demands are put on further, deeper understanding of the essence of the separation process, among other things, on the basis of conclusions about interactions between solute and stationary phase surfaces. For surface characterization different physicochemical methods such as CP/MAS, NMR, FT IR, DCS, chromatography, etc., have been described. The resolution, as reflected by efficiency, selectivity, and retention patterns on these materials, has been demonstrated. The effect of structure of stationary phases on retention of a model series of test analytes has been proved and numerically expressed by means of the Quantitative Structure-Retention Relationship (QSSR). The main aim of this paper is to present possibilities of determining different biologically active compounds (e.g., vitamins, steroids, nucleosides, peptides) in complex chromatographic methods (sample preparation, final analysis, validation) using new generation of stationary phases, columns, and chips divides. Special attention is dedicated to the advantage of packing materials imitating natural membranes because of the possible examination of the interaction between drug double left right arrow membrane. They can permit to the design of new pharmaceuticals and observation of processes taking place on the border of phases without interfering in natural systems.
C1 Nicholas Copernicus Univ, Fac Chem, Dept Environm Chem & Ecoanalyt, PL-87100 Torun, Poland.
RP Buszewski, B (reprint author), Nicholas Copernicus Univ, Fac Chem, Dept Environm Chem & Ecoanalyt, 7 Gagarin Str, PL-87100 Torun, Poland.
EM bbusz@chem.uni.torun.pl
RI Buszewski, Boguslaw/A-3187-2009; Studzinska, Sylwia/E-6689-2011
OI Studzinska, Sylwia/0000-0002-4658-7092
CR ABRAHAM MH, 1987, CHROMATOGRAPHIA, V23, P243, DOI 10.1007/BF02311772
   ABUBAKER MA, 1995, J CHROMATOGR B, V674, P31, DOI 10.1016/0378-4347(95)00284-2
   Adoubel AA, 2000, J LIQ CHROMATOGR R T, V23, P2433, DOI 10.1081/JLC-100100499
   Ake M, 1998, J CHROMATOGR A, V826, P183, DOI 10.1016/S0021-9673(98)00747-X
   AKIYAMA S, 1990, B CHEM SOC JPN, V63, P2809, DOI 10.1246/bcsj.63.2809
   Al-Haj MA, 2001, J CHROMATOGR SCI, V39, P29, DOI 10.1093/chromsci/39.1.29
   Albert K, 2003, J SEP SCI, V26, P215, DOI 10.1002/jssc.200390028
   *AM BIOSC, 2002, GEL FILTR PRINC METH
   AMIN M, 1993, ANAL CHEM, V65, P2346, DOI 10.1021/ac00065a030
   ARMSTRONG DW, 1994, CHIRALITY, V6, P496, DOI 10.1002/chir.530060609
   ARMSTRONG DW, 1987, CHIRALITY, V59, pA87
   BACZYK S, 1983, MIKROCHIM ACTA, V1, P437
   Bean KA, 1997, J CHROMATOGR B, V690, P65, DOI 10.1016/S0378-4347(96)00403-3
   BENJAMIN E, 2003, J CHROMATOGR A, V984, P97
   Berek D, 2002, J CHROMATOGR A, V976, P27, DOI 10.1016/S0021-9673(02)01150-0
   BERENDSEN GE, 1978, J LIQ CHROMATOGR, V1, P561, DOI 10.1080/01483917808060019
   BERENDSEN GE, 1980, J CHROMATOGR, V196, P21, DOI 10.1016/S0021-9673(00)80356-8
   BERTELLONI S, 1993, CLIN CHEM, V39, P1086
   BERTHOD A, 1992, ANAL CHEM, V64, P395, DOI 10.1021/ac00028a014
   Berthod A, 1996, J CHROMATOGR A, V731, P123, DOI 10.1016/0021-9673(95)01198-6
   Blanco D, 2000, ANALYST, V125, P427, DOI 10.1039/a909027d
   BOGAR RG, 1984, ANAL CHEM, V56, P1080, DOI 10.1021/ac00271a008
   Boonkerd S, 1996, J CHROMATOGR A, V756, P279, DOI 10.1016/S0021-9673(96)00636-X
   Borek E, 1972, Adv Cancer Res, V15, P163, DOI 10.1016/S0065-230X(08)60374-7
   Bowers LD, 1996, J CHROMATOGR B, V687, P61, DOI 10.1016/S0378-4347(96)00232-0
   BRAMHALL J, 1976, CLIN CHIM ACTA, V68, P203, DOI 10.1016/0009-8981(76)90383-1
   BRETER HJ, 1977, J CHROMATOGR, V140, P251, DOI 10.1016/S0021-9673(00)93584-2
   BRISTOW PA, 1977, CHROMATOGRAPHIA, V10, P279, DOI 10.1007/BF02263001
   Burri BJ, 1997, J CHROMATOGR A, V762, P201, DOI 10.1016/S0021-9673(96)00705-4
   BUSZEWSKA T, 1998, GIT SPEZIAL, V4, P65
   Buszewski B, 1999, J CHROMATOGR A, V845, P433, DOI 10.1016/S0021-9673(99)00141-7
   Buszewski B, 1998, CHROMATOGRAPHIA, V48, P615, DOI 10.1007/BF02467590
   Buszewski B, 2004, COMB CHEM HIGH T SCR, V7, P383
   Buszewski B, 2003, CHEM ANAL-WARSAW, V48, P347
   Buszewski B, 2003, J CHROMATOGR B, V792, P279, DOI 10.1016/S1570-0232(03)00283-6
   Buszewski B, 2002, LC GC EUR, V15, P792
   Buszewski B, 1997, ANAL CHEM, V69, P3277, DOI 10.1021/ac9612032
   Buszewski B, 2002, J LIQ CHROMATOGR R T, V25, P1229, DOI 10.1081/JLC-120004021
   BUSZEWSKI B, 1990, J CHROMATOGR, V499, P305, DOI 10.1016/S0021-9673(00)96981-4
   Buszewski B, 2001, CHROMATOGRAPHIA, V53, pS204, DOI 10.1007/BF02490329
   Buszewski B, 2001, MATER CHEM PHYS, V72, P30, DOI 10.1016/S0254-0584(01)00320-0
   BUSZEWSKI B, 1996, 21 INT S CHROM STUTT
   BUSZEWSKI B, 1998, J HIGH RES CHROMATOG, V21, P267
   BUSZEWSKI B, 1992, THESIS BRAITSLAVA ST
   Careri A, 2003, J CHROMATOGR A, V1000, P609, DOI 10.1016/S0021-9673(03)00237-1
   Careri M, 2002, J CHROMATOGR A, V970, P3, DOI 10.1016/S0021-9673(02)00903-2
   CAREY FA, 2001, ORGANIC CHEM
   CARR D, 2002, HDB ANAL PURIFICATIO
   CARR JW, 1986, ANAL CHEM, V58, P626, DOI 10.1021/ac00294a031
   CARTAS ST, 1995, ANAL CHIM ACTA, V302, P163, DOI 10.1016/0003-2670(94)00460-4
   Cavina G, 1983, Boll Chim Farm, V122, P531
   Chaimbault P, 1999, J CHROMATOGR A, V855, P191, DOI 10.1016/S0021-9673(99)00685-8
   CHANG JP, 2000, J CHROMATOGR A, V891, P235
   Chase GW, 1999, J AOAC INT, V82, P663
   CHIBA R, 1991, CHROMATOGRAPHIA, V588, P344
   Choudhary G, 1997, J CHROMATOGR A, V781, P161, DOI 10.1016/S0021-9673(97)00626-2
   CHRISTIANSON T, 1994, ANAL BIOCHEM, V223, P119, DOI 10.1006/abio.1994.1556
   Chu KO, 1998, ANAL LETT, V31, P2707
   Claessens HA, 1998, J CHROMATOGR A, V826, P135, DOI 10.1016/S0021-9673(98)00749-3
   Claessens HA, 1996, J CHROMATOGR A, V728, P259, DOI 10.1016/0021-9673(95)00904-3
   CLAUDY P, 1985, J CHROMATOGR, V329, P331, DOI 10.1016/S0021-9673(01)81940-3
   COHEN MB, 1980, J CHROMATOGR, V198, P435, DOI 10.1016/S0021-9673(00)80512-9
   COLE RB, 1997, ELECTROSPRAY IONIZAT
   DALDRUP T, 1984, CHROMATOGRAPHIA, V18, P81, DOI 10.1007/BF02268461
   DAVIS GE, 1979, J CHROMATOGR, V173, P281, DOI 10.1016/S0021-9673(00)92297-0
   DEAN B, 1988, CLIN CHIM ACTA, V176, P169, DOI 10.1016/0009-8981(88)90204-5
   Delaurent C, 1997, CHROMATOGRAPHIA, V45, P355, DOI 10.1007/BF02505584
   DELGADOZAMARRENO MM, 1995, J CHROMATOGR A, V694, P399, DOI 10.1016/0021-9673(94)01142-2
   DePhillips P, 2001, J CHROMATOGR A, V933, P57, DOI 10.1016/S0021-9673(01)01275-4
   DESIDERIO DM, 1996, PROTEIN PEPTIDE ANAL, V61
   Desportes C, 2000, J CHROMATOGR A, V893, P281, DOI 10.1016/S0021-9673(00)00698-1
   Di Pietro MC, 2001, J CHROMATOGR B, V751, P87, DOI 10.1016/S0378-4347(00)00471-0
   DINELLI G, 1994, ELECTROPHORESIS, V15, P1147, DOI 10.1002/elps.11501501173
   EDELSON EH, 1979, J CHROMATOGR, V174, P409, DOI 10.1016/S0021-9673(00)86015-X
   EHRLICH M, 1979, J CHROMATOGR SCI, V17, P531, DOI 10.1093/chromsci/17.9.531
   EKSTEEN R, 1978, J CHROMATOGR, V148, P413
   ELICONE C, 1994, J CHROMATOGR A, V676, P121, DOI 10.1016/0021-9673(94)00089-1
   ENGELHARDT H, 1997, LC GC EUR, V10, P803
   FALICK AM, 1989, TECHNIQUES PROTEIN C
   Fotsing L, 1997, J PHARMACEUT BIOMED, V15, P1113, DOI 10.1016/S0731-7085(96)02010-9
   Gadzala-Kopciuch R, 2003, J LIQ CHROMATOGR R T, V26, P195, DOI 10.1081/JLC-120017163
   GALUSHKO SV, 1993, CHROMATOGRAPHIA, V36, P39, DOI 10.1007/BF02263833
   Gamiz-Gracia L, 2000, CHROMATOGRAPHIA, V51, P428, DOI 10.1007/BF02490479
   GARNICK RL, 1988, ANAL CHEM, V60, P2546, DOI 10.1021/ac00174a004
   Gatti R, 1998, J PHARMACEUT BIOMED, V17, P337, DOI 10.1016/S0731-7085(97)00207-0
   GAZIANO JM, 1995, AM J CLIN NUTR, V61, P1248
   GEHRKE CW, 1989, J CHROMATOGR, V471, P3, DOI 10.1016/S0021-9673(00)94152-9
   GEHRKE CW, 1980, J CHROMATOGR, V188, P129, DOI 10.1016/S0021-9673(00)88424-1
   GEHRKE CW, 1978, J CHROMATOGR, V150, P455, DOI 10.1016/S0021-9673(00)88205-9
   GEHRKE CW, 1976, J CHROMATOGR, V123, P335, DOI 10.1016/S0021-9673(00)82202-5
   GILPIN RK, 1993, J CHROMATOGR A, V656, P217, DOI 10.1016/0021-9673(93)80803-G
   GOLDBERG ME, 1981, PHARM BIOCH PROPERTI
   GORAMASLAK G, 1997, SUPELCO REP, V16, P5
   GUO D, 1987, J CHROMATOGR, V386, P205
   HAGAR AF, 1994, J AOAC INT, V77, P1047
   HANSCH C, 1979, SUBSTITUENT CONSTANT
   HANSEN P, 1992, J CHROMATOGR, V627, P125, DOI 10.1016/0021-9673(92)87192-B
   HANSEN SJ, 1983, J CHROMATOGR SCI, V21, P560, DOI 10.1093/chromsci/21.12.560
   HARTWICK RA, 1975, J CHROMATOGR, V112, P651, DOI 10.1016/S0021-9673(00)99994-1
   HARTWICK RA, 1979, J LIQ CHROMATOGR, V2, P725, DOI 10.1080/01483917908060099
   HARTWICK RA, 1979, J CHROMATOGR, V186, P647, DOI 10.1016/S0021-9673(00)95285-3
   HATCH RG, 1990, J CHROMATOGR SCI, V28, P210, DOI 10.1093/chromsci/28.4.210
   HELOBE T, 1999, J CHROMATOGR A, V836, P315
   HEMRESY TP, 2003, J CHROMATOGR A, V1009, P15
   Higashi T, 2004, ANAL BIOANAL CHEM, V378, P875, DOI 10.1007/s00216-003-2252-z
   HONDO T, 1986, BUNSEKI KAGAKU, V35, P316
   Hu WC, 1996, J AM OIL CHEM SOC, V73, P1653, DOI 10.1007/BF02517967
   Hua-Bin L., 2000, J CHROMATOGR A, V891, P243
   Huang XA, 2002, ANAL CHEM, V74, P2336, DOI 10.1021/ac011202w
   HUNNICUTT ML, 1986, ANAL CHEM, V58, P748, DOI 10.1021/ac00295a021
   Igarashi Y, 1982, Rinsho Byori, VSuppl 52, P143
   INDYK H, 1985, J DAIRY SCI TECHNOL, V20, P19
   ITOH K, 1993, CLIN CHIM ACTA, V217, P221
   Ivanovic D, 1999, J PHARMACEUT BIOMED, V18, P999, DOI 10.1016/S0731-7085(98)00109-5
   IVANOVIC D, 1995, CHROMATOGRAPHIA, V40, P652, DOI 10.1007/BF02315132
   Iwase H, 2000, J CHROMATOGR A, V881, P189, DOI 10.1016/S0021-9673(00)00198-9
   JARONIEC M, 1981, J CHROMATOGR, V210, P130, DOI 10.1016/S0021-9673(00)91188-9
   JINNO K, 1997, CHROMATOGRAPHIC SEPA
   Jiskra J, 2002, J SEP SCI, V25, P1337, DOI 10.1002/jssc.200290005
   Juricskay S, 2000, CLIN BIOCHEM, V33, P97, DOI 10.1016/S0009-9120(99)00091-0
   JUSTOVA V, 1984, J CHROMATOGR, V290, P107, DOI 10.1016/S0021-9673(01)93565-4
   Kaliszan R., 1987, QUANTITATIVE STRUCTU
   KALISZAN R, 1995, HDB ADV MAT TESTING
   Kalman A, 1996, J CHROMATOGR A, V729, P155, DOI 10.1016/0021-9673(95)01059-9
   KERR SJ, 1970, BIOCHEMISTRY-US, V9, P690, DOI 10.1021/bi00805a032
   KHACHIK F, 1995, J CELL BIOCHEM, P236
   KIMATA K, 1989, J CHROMATOGR SCI, V27, P721, DOI 10.1093/chromsci/27.12.721
   Kintz P, 1999, J ANAL TOXICOL, V23, P424, DOI 10.1093/jat/23.6.424
   KITO M, 1990, J CHROMATOGR-BIOMED, V528, P91, DOI 10.1016/S0378-4347(00)82365-8
   KOBAYASHI S, 1989, J CHROMATOGR, V480, P179, DOI 10.1016/S0021-9673(01)84287-4
   KOHLER J, 1987, J CHROMATOGR, V385, P125, DOI 10.1016/S0021-9673(01)94628-X
   Koutny LB, 1996, ANAL CHEM, V68, P18, DOI 10.1021/ac9508311
   KOWALSKA S, IN PRESS J SEPARATIO
   Krupczynska K, 2005, ANAL CHIM ACTA, V540, P127, DOI 10.1016/j.aca.2004.11.039
   Krupczynska K, 2004, ANAL CHEM, V76, p226A, DOI 10.1021/ac041583o
   KUNITANI M, 1986, J CHROMATOGR, V371, P313, DOI 10.1016/S0021-9673(01)94716-8
   Kvasnicka F, 2005, J SEP SCI, V28, P813, DOI 10.1002/jssc.200500054
   LAMBERT D, 1992, J CHROMATOGR, V608, P311, DOI 10.1016/0021-9673(92)87137-W
   Lee J, 1999, J FOOD SCI, V64, P968, DOI 10.1111/j.1365-2621.1999.tb12261.x
   LENEHAN A, 2003, ANABOLIC STEROIDS
   LEROY B, 1998, CHEM NUCL NUCL
   Liebich HM, 1997, J CHROMATOGR A, V763, P193, DOI 10.1016/S0021-9673(96)00757-1
   LINDON JC, 1995, MAGN RESON CHEM, V33, P857, DOI 10.1002/mrc.1260331103
   Link AJ, 2002, TRENDS BIOTECHNOL, V20, pS8, DOI 10.1016/S1471-1931(02)00202-1
   LOCHMULLER CH, 1980, ANAL CHIM ACTA, V19, P116
   Lord GA, 1997, J CHROMATOGR A, V768, P9, DOI 10.1016/S0021-9673(96)01081-3
   LUNDELL N, 1992, CHROMATOGRAPHIA, V34, P369, DOI 10.1007/BF02268370
   Luque-Garcia JL, 2001, J CHROMATOGR A, V935, P3, DOI 10.1016/S0021-9673(01)01118-9
   Ma YC, 1997, J AM SOC MASS SPECTR, V8, P1010, DOI 10.1016/S1044-0305(97)00122-0
   MACIEL GE, 1980, J AM CHEM SOC, V102, P7606, DOI 10.1021/ja00545a056
   MAKIN HLJ, 1995, STEROID ANALY
   MANT CT, 1991, HIGH PERFORMANCE LI
   Manzi P, 1996, CHROMATOGRAPHIA, V43, P89, DOI 10.1007/BF02272829
   MASON SR, 1992, J CHROMATOGR-BIOMED, V581, P267, DOI 10.1016/0378-4347(92)80280-4
   MASUDA M, 1993, ANAL SCI, V9, P29, DOI 10.2116/analsci.9.29
   MATSUURA K, 1990, RAPID COMMUN MASS SP, V4, P381, DOI 10.1002/rcm.1290041007
   Matyska MT, 2001, J CHROMATOGR A, V924, P211, DOI 10.1016/S0021-9673(01)00830-5
   McCalley DV, 2003, J SEP SCI, V26, P187, DOI 10.1002/jssc.200390026
   MCCROSKEY MC, 1987, ANAL BIOCHEM, V163, P427, DOI 10.1016/0003-2697(87)90244-2
   MCGRAW CA, 1990, MED LAB SCI, V47, P17
   MILLER V, 1976, J CHROMATOGR, V119, P355, DOI 10.1016/S0021-9673(00)86799-0
   MOREL D, 1981, J CHROMATOGR, V214, P202, DOI 10.1016/S0021-9673(00)98525-X
   Moreno P, 2000, J CHROMATOGR A, V870, P207, DOI 10.1016/S0021-9673(99)01021-3
   NARAYANAN SR, 1994, J CHROMATOGR A, V658, P237, DOI 10.1016/0021-9673(94)80018-9
   Neue UD, 2003, J SEP SCI, V26, P174, DOI 10.1002/jssc.200390025
   NIERENBERG DW, 1987, J CHROMATOGR-BIOMED, V413, P79, DOI 10.1016/0378-4347(87)80215-3
   NONDEK L, 1986, J CHROMATOGR, V360, P241, DOI 10.1016/S0021-9673(00)91669-8
   NOZAKI O, 1995, J BIOLUM CHEMILUM, V10, P339, DOI 10.1002/bio.1170100606
   Nozaki O, 2001, J CHROMATOGR A, V935, P267, DOI 10.1016/S0021-9673(01)01104-9
   Ogawa H, 1983, Nihon Naibunpi Gakkai Zasshi, V59, P801
   ONeil M. J., 2001, MERCK INDEX ENCY CHE
   Ortiz Boyer F., 1999, Chromatographia, V50, P399, DOI 10.1007/BF02490733
   ORTIZBOYER F, 1998, CHROMATOGRAPHIA, V47, P367
   PASSWATER RA, 1999, BEGINNERS INTRO VITA
   PATEL AB, 1977, J CHROMATOGR, V130, P115, DOI 10.1016/S0021-9673(00)89787-3
   PEARSON JD, 1982, ANAL BIOCHEM, V124, P217, DOI 10.1016/0003-2697(82)90240-8
   Perez-Ruiz T, 2003, CHROMATOGRAPHIA, V58, P757, DOI 10.1365/s10337-003-0088-5
   PESEK JJ, 1994, J CHROMATOGR A, V687, P33, DOI 10.1016/0021-9673(94)00815-9
   Peter A, 1996, J CHROMATOGR A, V728, P455, DOI 10.1016/0021-9673(95)01022-X
   Petritis K, 2002, J CHROMATOGR A, V957, P173, DOI 10.1016/S0021-9673(02)00372-2
   Petritis K, 2001, J CHROMATOGR A, V913, P331, DOI 10.1016/S0021-9673(00)01268-1
   PLUSCEC J, 1987, J ASSOC OFF ANA CHEM, V70, P599
   Podda M, 1996, J LIPID RES, V37, P893
   Pursch M, 1996, ANAL CHEM, V68, P386, DOI 10.1021/ac950761y
   Que AH, 2000, J CHROMATOGR A, V887, P379, DOI 10.1016/S0021-9673(00)00427-1
   RANDERATH K, 1973, J CHROMATOGR, V82, P59, DOI 10.1016/S0021-9673(01)80075-3
   Rentel C, 1998, ANAL CHEM, V70, P4394, DOI 10.1021/ac971329e
   Righetti PG, 2005, CLIN CHIM ACTA, V357, P123, DOI 10.1016/j.cccn.2005.03.018
   RIVIER J, 1984, J CHROMATOGR, V288, P303, DOI 10.1016/S0021-9673(01)93709-4
   Rohrschneider L, 2001, J SEP SCI, V24, P3, DOI 10.1002/1615-9314(20010101)24:1<3::AID-JSSC3>3.0.CO;2-O
   SADLEJSOSNOWSKA N, 1986, J CHROMATOGR, V357, P227, DOI 10.1016/S0021-9673(01)95825-X
   SANDER LC, 1995, ANAL CHEM, V67, P3284, DOI 10.1021/ac00114a027
   SANDER LC, 1987, CRIT REV ANAL CHEM, V18, P299, DOI 10.1080/10408348708545263
   SCALIA S, 1995, J PHARMACEUT BIOMED, V13, P273, DOI 10.1016/0731-7085(95)01275-P
   SCARBOROUGH RM, 1984, P NATL ACAD SCI-BIOL, V81, P5575, DOI 10.1073/pnas.81.17.5575
   SCHAUMANN C, 1993, J CHROMATOGR, V646, P227, DOI 10.1016/S0021-9673(99)87024-1
   SCHIEWE J, 1995, J CHROMATOGR A, V717, P255, DOI 10.1016/0021-9673(95)00510-3
   SCHLITTLER MR, 1989, 9 ISPPP
   Schneiderman MA, 1997, J CHROMATOGR A, V765, P215, DOI 10.1016/S0021-9673(96)00923-5
   SCHNEIDERMAN MA, 1988, J ASSOC OFF ANA CHEM, V71, P815
   SCHONESHOFER M, 1983, J STEROID BIOCHEM, V18, P65, DOI 10.1016/0022-4731(83)90332-1
   Seifar R. M., 1998, Biomedical Chromatography, V12, P140
   SERPINET J, 1972, J CHROMATOGR, V68, P9, DOI 10.1016/S0021-9673(00)88758-0
   SHACKLETON CHL, 1993, J STEROID BIOCHEM, V45, P127, DOI 10.1016/0960-0760(93)90132-G
   Shediac R, 2001, J CHROMATOGR A, V925, P251, DOI 10.1016/S0021-9673(01)01036-6
   Shibata N, 1998, J CHROMATOGR B, V706, P191, DOI 10.1016/S0378-4347(97)00557-4
   Shimada K, 2001, J CHROMATOGR A, V935, P141, DOI 10.1016/S0021-9673(01)00943-8
   SHIMIZU M, 1995, J CHROMATOGR B, V672, P63, DOI 10.1016/0378-4347(95)00187-N
   SMITH RM, 1993, J CHROMATOGR A, V656, P381, DOI 10.1016/0021-9673(93)80811-L
   SOBER HA, 1970, HDB BIOCH SELECTED D
   Soczewinski E, 2002, J CHROMATOGR A, V965, P109, DOI 10.1016/S0021-9673(01)01278-X
   Somenath M, 2003, SAMPLE PREPARATION T
   SRIEWOELAN S, 1984, ACTA PHARM INDONES, V9, P143
   STANEVA L, 1989, IZV DURZH I KONTROL, V22, P12
   STASZCZUK P, 1988, CHROMATOGRAPHIA, V25, P881, DOI 10.1007/BF02311422
   Stead DA, 1998, J CHROMATOGR A, V798, P259, DOI 10.1016/S0021-9673(97)00840-6
   STEIMER T, 1985, J STEROID BIOCHEM, V23, P955, DOI 10.1016/0022-4731(85)90053-6
   STONE K, 1988, 2 S PROT SOC
   Stryer L., 1999, BIOCHEMISTRY
   Stulik K, 1997, ANAL CHIM ACTA, V352, P1, DOI 10.1016/S0003-2670(97)00262-6
   SZEPESY L, 1994, J CHROMATOGR A, V668, P337, DOI 10.1016/0021-9673(94)80123-1
   Szumski M, 2002, CRIT REV ANAL CHEM, V32, P1, DOI 10.1080/10408340290765434
   TAKEDA M, 1990, BIOMED CHROMATOGR, V4, P119, DOI 10.1002/bmc.1130040309
   TEMPST P, 1986, J CHROMATOGR, V359, P403, DOI 10.1016/0021-9673(86)80094-2
   Thiam S, 2000, ANAL CHEM, V72, P2541, DOI 10.1021/ac991306v
   TOMLINSON E, 1976, J PHARM PHARMACOL, V28, pP43
   Turner C, 2000, J CHROMATOGR A, V874, P275, DOI 10.1016/S0021-9673(00)00096-0
   Turner C, 2001, J CHROMATOGR A, V936, P215, DOI 10.1016/S0021-9673(01)01082-2
   Turpeinen U, 1997, CLIN CHEM, V43, P1386
   Uesugi T, 1997, J CHROMATOGR B, V703, P63, DOI 10.1016/S0378-4347(97)00430-1
   Unger K.K., 1979, POROUS SILICA
   Unger K. K., 1990, PACKINGS STATIONARY
   VANDERGREEF J, 1986, LC GC, V4, P636
   VANHOOF HJC, 1993, J CHROMATOGR-BIOMED, V621, P33, DOI 10.1016/0378-4347(93)80073-D
   VANMILTENBURG JC, 1983, J CHROMATOGR, V268, P147, DOI 10.1016/S0021-9673(01)95401-9
   Vinas P, 2003, J CHROMATOGR A, V1007, P77, DOI 10.1016/S0021-9673(03)00977-4
   VOELTER W, 1980, J CHROMATOGR, V199, P345, DOI 10.1016/S0021-9673(01)91386-X
   WALTERS MJ, 1987, J ASSOC OFF ANA CHEM, V70, P465
   WALTERS MJ, 1990, J ASSOC OFF ANA CHEM, V73, P904
   WARD TJ, 1996, LC GC, V9, P429
   WEISSMANN B, 1957, J BIOL CHEM, V224, P407
   WELLS J, 2002, PHARM REFORMULATION
   WILLCOX DL, 1983, ANAL BIOCHEM, V135, P304, DOI 10.1016/0003-2697(83)90687-5
   Williams TM, 2000, J VET PHARMACOL THER, V23, P57
   Wolthers BG, 1999, J CHROMATOGR A, V843, P247, DOI 10.1016/S0021-9673(99)00153-3
   Wu JC, 2000, ANALYST, V125, P391, DOI 10.1039/b000287i
   Xiong L, 2004, J CHROMATOGR A, V1030, P187, DOI 10.1016/j.chroma.2003.11.009
   Ye ML, 2000, J CHROMATOGR A, V869, P385, DOI 10.1016/S0021-9673(99)01192-9
   ZAKARIA M, 1981, J CHROMATOGR, V226, P267, DOI 10.1016/S0378-4347(00)86062-4
   Zbanyszek W, 2002, J LIQ CHROMATOGR R T, V25, P1243, DOI 10.1081/JLC-120004022
   ZHOU NE, 1991, J CHROMATOGR, V548, P179, DOI 10.1016/S0021-9673(01)88600-3
   1998, PRINCIPLES APPL HIGH
NR 252
TC 17
Z9 17
U1 0
U2 24
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1040-8347
EI 1547-6510
J9 CRIT REV ANAL CHEM
JI Crit. Rev. Anal. Chem.
PY 2005
VL 35
IS 2
BP 89
EP 116
DI 10.1080/10408340500207367
PG 28
WC Chemistry, Analytical
SC Chemistry
GA 964VK
UT WOS:000231908900001
DA 2018-10-19
ER

PT J
AU Kashyap, N
   Kumar, N
   Kumar, MNVR
AF Kashyap, N
   Kumar, N
   Kumar, MNVR
TI Hydrogels for pharmaceutical and biomedical applications
SO CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS
LA English
DT Review
DE hydrogels; environment-sensitive hydrogels; bioadhesive gels; tissue
   engineering; molecular imprinting; wound dressings; immunoisolation;
   drug delivery
ID DRUG-DELIVERY SYSTEM; CATIONIC COPOLYMER HYDROGELS; LINKED CHITOSAN
   HYDROGELS; CONTROLLED-RELEASE; PHASE-TRANSITION; IN-VITRO; INSULIN
   DELIVERY; BIOARTIFICIAL PANCREAS; STATISTICAL-MECHANICS; BIOADHESIVE
   POLYMER
AB Hydrogels are crosslinked hydrophilic polymer structures that can imbibe large amounts of water or biological fluids. Hydrogels are one of the upcoming classes of polymer-based systems that embrace numerous biomedical and pharmaceutical applications. This review discusses various parameters of hydrogels such as surface properties, water content and swelling behavior, effect of nature of polymer, ionic content, and thermodynamics, all of which can influence the biomedical usage of hydrogels. Meanwhile, intelligent or environment-sensitive hydrogels and bioadhesive hydrogels continue to be important materials for medical applications; therefore, a part of this review is devoted to some of their important classes. Hydrogels are extensively used for various biomedical applications-tissue engineering, molecular imprinting, wound dressings materials, immunoisolation, drug delivery, etc. Thus, this review aims to throw light on the numerous applications that hydrogels have in the biomedical arena.
C1 Natl Inst Pharmaceut Educ & Res, Dept Pharmaceut, Punjab, Punjab, India.
RP Kumar, MNVR (reprint author), Natl Inst Pharmaceut Educ & Res, Dept Pharmaceut, Punjab, Punjab, India.
EM mnvrkumar@niper.ac.in
RI Xu, Qingguo/C-1962-2014; Kumar, M N V R/D-6286-2011
OI Xu, Qingguo/0000-0003-3191-0771; Kumar, M N V R/0000-0001-5606-401X
CR ABOBAKR AM, 1994, INT J ARTIF ORGANS, V17, P171
   Allender CJ, 2000, INT J PHARM, V195, P39, DOI 10.1016/S0378-5173(99)00355-5
   BABA Y, 1992, ANAL CHEM, V64, P1920, DOI 10.1021/ac00041a029
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P19, DOI 10.1016/s0939-6411(03)00161-9
   Bernkop-Schnurch A, 1998, J CONTROL RELEASE, V50, P215, DOI 10.1016/S0168-3659(97)00136-3
   BERNKOPSCHNURCH KA, 2004, IN PRESS EUR J PHARM
   BOS GW, 2002, BUSINESS BRIEF PHARM, P184
   Brauker J, 1996, TRANSPLANTATION, V61, P1671, DOI 10.1097/00007890-199606270-00002
   BRAUN K, 1988, Zeitschrift fuer Experimentelle Chirurgie Transplantation und Kuenstliche Organe, V21, P58
   BROWN AS, 1981, PLAST RECONSTR SURG, V67, P810
   Bulmus V, 2000, BIOCONJUGATE CHEM, V11, P78, DOI 10.1021/bc9901043
   Bures P, 2001, J CONTROL RELEASE, V72, P25, DOI 10.1016/S0168-3659(01)00259-0
   Byrne ME, 2002, ADV DRUG DELIVER REV, V54, P149, DOI 10.1016/S0169-409X(01)00246-0
   CALAFIORE R, 2002, POLYM BIOMATERIALS
   Cerchiara T, 2002, J PHARM PHARMACOL, V54, P1453, DOI 10.1211/00223570281
   CHANG TMS, 1964, SCIENCE, V146, P524, DOI 10.1126/science.146.3643.524
   Chen G X, 1991, ASAIO Trans, V37, pM439
   Chenite A, 2001, CARBOHYD POLYM, V46, P39, DOI 10.1016/S0144-8617(00)00281-2
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   CHICK WL, 1975, T AM SOC ART INT ORG, V21, P8
   CHO YW, 1999, BIOMATERIALS, V20
   CHUNG DJ, 1992, J CONTROL RELEASE, V18, P45
   DERJAGUIN BV, 1969, ADHESION FUNDAMENTAL
   DEURLOO MJM, 1991, CANCER CHEMOTH PHARM, V27, P347, DOI 10.1007/BF00688856
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   EDELMAN ER, 1985, J BIOMED MATER RES, V19, P67, DOI 10.1002/jbm.820190107
   Elisseeff J, 2000, J BIOMED MATER RES, V51, P164, DOI 10.1002/(SICI)1097-4636(200008)51:2<164::AID-JBM4>3.0.CO;2-W
   Eouani C, 2001, EUR J PHARM BIOPHARM, V52, P45, DOI 10.1016/S0939-6411(01)00146-1
   Flory P. J, 1953, PRINCIPLES POLYM CHE
   Flory PJ, 1943, J CHEM PHYS, V11, P521, DOI 10.1063/1.1723792
   Flory PJ, 1943, J CHEM PHYS, V11, P512, DOI 10.1063/1.1723791
   Gariepy E. R., 2000, INT J PHARMACEUT, V203, P89, DOI DOI 10.1016/S0378-5173(00)00428-2
   Ghandehari H, 1997, BIOMATERIALS, V18, P861, DOI 10.1016/S0142-9612(97)00007-0
   GUO K, 1987, BIOCHIM BIOPHYS ACTA, V897, P377
   Haas J, 2002, EXPERT OPIN BIOL TH, V2, P287, DOI 10.1517/14712598.2.3.287
   Haginaka J, 1999, J CHROMATOGR A, V849, P331, DOI 10.1016/S0021-9673(99)00570-1
   Hashimoto T, 2004, BIOMATERIALS, V25, P1407, DOI 10.1016/j.biomaterials.2003.07.004
   HASSE C, 1983, TRANSPLANTATION, V36, P599
   HEJAZI R, 1993, POLYM BIOMATERIALS
   HELFMAN T, 1994, CLIN DERMATOL, V12, P121, DOI 10.1016/0738-081X(94)90262-3
   Hennink WE, 2004, INT J PHARM, V277, P99, DOI 10.1016/j.ijpharm.2003.02.002
   Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/S0169-409X(01)00240-X
   Hilt JZ, 2004, ADV DRUG DELIVER REV, V56, P1599, DOI 10.1016/j.addr.2004.04.002
   Hoffman A. S., 2002, ADV DRUG DELIVERY RE, V43, P3, DOI DOI 10.1016/S0169-409X(01)00239-3
   Holmes TC, 2002, TRENDS BIOTECHNOL, V20, P16, DOI 10.1016/S0167-7799(01)01840-6
   Hornof M, 2003, J CONTROL RELEASE, V89, P419, DOI 10.1016/S0168-3659(03)00135-4
   Huang G, 2004, J CONTROL RELEASE, V94, P303, DOI 10.1016/j.jconrel.2003.10.007
   Huang YB, 2002, MACROMOLECULES, V35, P1373, DOI 10.1021/ma011294r
   HUI HW, 1985, INT J PHARM, V26, P203, DOI 10.1016/0378-5173(85)90230-3
   HUNTSBERGER JR, 1967, J PAINT TECHNOL, V39, P199
   Ishihara M, 2002, BIOMATERIALS, V23, P833, DOI 10.1016/S0142-9612(01)00189-2
   IWATA H, 1994, J BIOMED MATER RES, V28, P1003, DOI 10.1002/jbm.820280905
   JEYANTHI R, 1990, BIOMATERIALS, V11, P238, DOI 10.1016/0142-9612(90)90004-A
   JEYANTHI R, 1990, J CONTROL RELEASE, V13, P91, DOI 10.1016/0168-3659(90)90078-8
   JONG SJ, 2001, J CONTROL RELEASE, V72, P47
   Jong SJD, 2001, J CONTROL RELEASE, V1, P261
   JUNGINGER HE, 1990, ACTA PHARM TECHNOL, V36, P110
   Kang HW, 1999, BIOMATERIALS, V20, P1339, DOI 10.1016/S0142-9612(99)00036-8
   KASHYAP N, 2004, DRUG DELIV TECH, V4, P31
   Kast CE, 2003, INT J PHARM, V256, P183, DOI 10.1016/S0378-5173(03)00076-0
   KATONO H, 1991, J CONTROL RELEASE, V16, P215, DOI 10.1016/0168-3659(91)90045-F
   Kaufmann PM, 1997, CELL TRANSPLANT, V6, P463, DOI 10.1016/S0963-6897(97)00052-3
   KHARE AR, 1995, BIOMATERIALS, V16, P559, DOI 10.1016/0142-9612(95)91130-Q
   KHOR E, 2003, BIOMATERIALS, V23, P2339
   Kim B, 2003, POLYMER, V44, P3701, DOI 10.1016/S0032-3861(03)00307-0
   Kim B, 2003, J APPL POLYM SCI, V89, P1606, DOI 10.1002/app.12337
   Kim HJ, 2000, BIOMATERIALS, V21, P131, DOI 10.1016/S0142-9612(99)00140-4
   Kim JJ, 2001, J CONTROL RELEASE, V77, P39, DOI 10.1016/S0168-3659(01)00447-3
   KINLOCH AJ, 1980, J MATER SCI, V15, P2141, DOI 10.1007/BF00552302
   Kirker KR, 2004, J BURN CARE REHABIL, V25, P276, DOI 10.1097/01.BCR.0000124790.69026.3D
   Kirker KR, 2002, BIOMATERIALS, V23, P3661, DOI 10.1016/S0142-9612(02)00100-X
   KISHIDA A, 2002, POLYM BIOMATERIALS
   KITANO S, 1992, J CONTROL RELEASE, V19, P162
   KOKUFATA E, 1991, NATURE, V351, P302, DOI 10.1038/351302a0
   KOST J, 1987, J BIOMED MATER RES, V21, P1367, DOI 10.1002/jbm.820211202
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Kuo CK, 2001, BIOMATERIALS, V22, P511, DOI 10.1016/S0142-9612(00)00201-5
   Kwok CS, 2001, J BIOMED MATER RES, V57, P151, DOI 10.1002/1097-4636(200111)57:2<151::AID-JBM1154>3.0.CO;2-5
   KWON IC, 1991, J CONTROL RELEASE, V17, P149, DOI 10.1016/0168-3659(91)90054-H
   Lai HL, 2003, INT J PHARM, V251, P175, DOI 10.1016/S0378-5173(02)00590-2
   Langer R, 2003, AICHE J, V49, P2990, DOI 10.1002/aic.690491202
   LANZA RP, 1992, DIABETES, V41, P886, DOI 10.2337/diabetes.41.7.886
   LANZA RP, 1993, TRANSPLANTATION, V56, P1067, DOI 10.1097/00007890-199311000-00003
   Lanza RP, 1997, IMMUNOL TODAY, V18, P135, DOI 10.1016/S0167-5699(97)01008-6
   Lee CH, 1996, J CONTROL RELEASE, V39, P93, DOI 10.1016/0168-3659(95)00142-5
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lee MK, 2000, ADV DRUG DELIVER REV, V42, P103, DOI 10.1016/S0169-409X(00)00056-9
   LEHR CM, 1994, CRIT REV THER DRUG, V11, P119
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   Lorenzo C. A., 2004, J CHROMATOGR B, VB 804, P231
   Lu ZR, 1999, NAT BIOTECHNOL, V17, P1101
   Lugao AB, 2002, RADIAT PHYS CHEM, V63, P543, DOI 10.1016/S0969-806X(01)00551-5
   Lugao AB, 2001, NUCL INSTRUM METH B, V185, P37, DOI 10.1016/S0168-583X(01)00807-2
   MAMADA A, 1990, MACROMOLECULES, V23, P1517, DOI 10.1021/ma00207a046
   Mao JS, 2003, J BIOMED MATER RES A, V64A, P301, DOI 10.1002/jbm.a.10223
   Mao JS, 2003, BIOMATERIALS, V24, P1067, DOI 10.1016/S0142-9612(02)00442-8
   MATTEW HWT, 2002, POLYM BIOMATERIALS
   McBain JW, 1925, J PHYS CHEM-US, V29, P188, DOI 10.1021/j150248a008
   Mi FL, 1999, J POLYM SCI POL PHYS, V37, P1551, DOI 10.1002/(SICI)1099-0488(19990715)37:14<1551::AID-POLB1>3.3.CO;2-8
   Morishita M, 2004, J CONTROL RELEASE, V97, P115, DOI 10.1016/j.jconrel.2004.03.008
   MYERS JA, 1983, PHARM J, V230, P263
   NAGAI T, 1985, PHARM INT, V6, P196
   Nakamura K, 2004, J CONTROL RELEASE, V95, P589, DOI 10.1016/j.jconrel.2003.12.022
   Needleman IG, 1998, J CLIN PERIODONTOL, V25, P74, DOI 10.1111/j.1600-051X.1998.tb02366.x
   Neill MAA, 2003, INT J PHARMACEUT, V263, P61
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   Obaidat AA, 1996, PHARMACEUT RES, V13, P989, DOI 10.1023/A:1016090103979
   OKUYAMA Y, 1993, J BIOMAT SCI-POLYM E, V4, P545, DOI 10.1163/156856293X00195
   Orive G, 2002, TRENDS BIOTECHNOL, V20, P382, DOI 10.1016/S0167-7799(02)02037-1
   OSADA Y, 1992, NATURE, V355, P242, DOI 10.1038/355242a0
   PACKNAEUSER CB, 2004, IN PRESS EUR J PHARM
   Panitch A, 1999, MACROMOLECULES, V32, P1701, DOI 10.1021/ma980875m
   Patel VR, 1996, PHARMACEUT RES, V13, P588, DOI 10.1023/A:1016054306763
   PEPPAS NA, 1993, ADV DRUG DELIVER REV, V11, P1, DOI 10.1016/0169-409X(93)90025-Y
   Peppas NA, 2000, ANNU REV BIOMED ENG, V2, P9, DOI 10.1146/annurev.bioeng.2.1.9
   Peppas NA, 1999, J CONTROL RELEASE, V62, P81, DOI 10.1016/S0168-3659(99)00027-9
   PHILIPP B, 1989, PROG POLYM SCI, V14, P91, DOI 10.1016/0079-6700(89)90018-X
   Podual K, 2000, J CONTROL RELEASE, V67, P9, DOI 10.1016/S0168-3659(00)00195-4
   Podual K, 2000, POLYMER, V41, P3975, DOI 10.1016/S0032-3861(99)00620-5
   REACH G, 1981, DIABETES, V30, P296, DOI 10.2337/diab.30.4.296
   REINHART CT, 1984, J MEMBRANE SCI, V18, P227, DOI 10.1016/S0376-7388(00)85036-X
   RICHARDSON JL, 1992, ADV DRUG DELIVER REV, V8, P341, DOI 10.1016/0169-409X(92)90008-E
   Rihova B, 2000, ADV DRUG DELIVER REV, V42, P65
   ROBINSON JR, 1995, ADV DRUG DELIVER REV, V16, P45, DOI 10.1016/0169-409X(95)00013-W
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Sahoo SK, 1998, J COLLOID INTERF SCI, V206, P361, DOI 10.1006/jcis.1998.5692
   SAWAHATA K, 1990, J CONTROL RELEASE, V14, P253, DOI 10.1016/0168-3659(90)90165-P
   Seliktar D, 2000, ANN BIOMED ENG, V28, P351, DOI 10.1114/1.275
   Shapiro L, 1997, BIOMATERIALS, V18, P583, DOI 10.1016/S0142-9612(96)00181-0
   Shiino D, 1995, J CONTROL RELEASE, V37, P269, DOI 10.1016/0168-3659(95)00084-4
   Shu XZ, 2001, INT J PHARM, V212, P19, DOI 10.1016/S0378-5173(00)00582-2
   SIEGEL RA, 1988, J CONTROL RELEASE, V8, P179, DOI 10.1016/0168-3659(88)90044-2
   Singla AK, 2001, J PHARM PHARMACOL, V53, P1047, DOI 10.1211/0022357011776441
   Southern LJ, 2000, J HEART VALVE DIS, V9, P241
   SUDEE R, 2002, DRUG DELIV, V9, P19
   SUZUKI A, 1990, NATURE, V346, P345, DOI 10.1038/346345a0
   Tamburic S, 1995, PHARM SCI, V1, P107, DOI DOI 10.1111/J.2042-7158.1995.TB00403.X
   TANAKA T, 1982, SCIENCE, V218, P467, DOI 10.1126/science.218.4571.467
   TEDER H, 1993, ANTICANCER RES, V13, P2161
   ULUDAG H, 1995, J CONTROL RELEASE, V33, P273, DOI 10.1016/0168-3659(94)00094-B
   Valenta C, 2001, J CONTROL RELEASE, V77, P323, DOI 10.1016/S0168-3659(01)00520-X
   Vinogradov SV, 2002, ADV DRUG DELIVER REV, V54, P135, DOI 10.1016/S0169-409X(01)00245-9
   VOS PD, 1993, INT J ARTIF ORGANS, V16, P205
   Wang TG, 1998, ARTIF ORGANS, V22, P68
   Ward R.S., 1993, ASAIO J, V39, P261
   Weidener J, 2003, DRUG DISCOV TODAY, V8, P906
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   Woolfson A., 2002, POLYM BIOMATERIALS
   WOOLFSON AD, 1995, J CONTROL RELEASE, V35, P49, DOI 10.1016/0168-3659(95)00018-4
   Wozniewicz B, 1996, TRANSPLANT P, V28, P3542
   Yang J, 2001, BIOTECHNOL LETT, V23, P1385, DOI 10.1023/A:1011600414225
   YATES DW, 1984, INJURY, V16, P23, DOI 10.1016/0020-1383(84)90109-8
   Yusof NLBM, 2001, J BIOMED MATER RES, V54, P59, DOI 10.1002/1097-4636(200101)54:1<59::AID-JBM7>3.0.CO;2-U
   ZEMAN SPO, 2001, NAT BIOTECHNOL, V19, P201
   Zhong X, 1996, CHEM ENG SCI, V51, P3235, DOI 10.1016/0009-2509(95)00344-4
   ZHU H, 2002, J BIOMED MATER RES, V64, P532
   ZONG N, 2001, TETRAHEDRON LETT, V42, P1839
NR 157
TC 147
Z9 154
U1 6
U2 96
PU BEGELL HOUSE INC
PI NEW YORK
PA 145 MADISON AVE, NEW YORK, NY 10016 USA
SN 0743-4863
J9 CRIT REV THER DRUG
JI Crit. Rev. Ther. Drug Carr. Syst.
PY 2005
VL 22
IS 2
BP 107
EP 149
DI 10.1615/CritRevTherDrugCarrierSyst.v22.i2.10
PG 43
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 921AT
UT WOS:000228737300001
PM 15862110
DA 2018-10-19
ER

PT S
AU Suaste-Gomez, E
   Gonzalez-Ballesteros, R
   Castillo-Rivas, V
AF Suaste-Gomez, E
   Gonzalez-Ballesteros, R
   Castillo-Rivas, V
BE MendezVilas, A
TI Pyroelectric and photoacustic properties of
   Pb-0.88(Ln)(0.08)Ti0.98Mn0.02O3 (Ln = La, Sm, Eu) piezoceramics for
   biomedical use
SO CROSS-DISCIPLINARY APPLIED RESEARCH IN MATERIALS SCIENCE AND TECHNOLOGY
SE Materials Science Forum
LA English
DT Article; Proceedings Paper
CT 1st International Meeting on Applied Physics
CY OCT 13-18, 2003
CL Badajoz, SPAIN
SP Dept Phys Univ Extremadura, Junta Extremadura & Consejer Educ, Cienc Tecnol, INNOVA
DE ferroelectric ceramic; pyroelectricity; rare-earth elements;
   pyroelectric ceramic; photoacustic
ID TITANATE
AB In this work are studied the pyroelectric and photoacustic properties of Pb-0.88(Ln)(0.08)Ti0.98Mn0.02O3 (Ln = La, Sm, Eu) ferroelectric ceramic system. These type of ferroelectric ceramics presents high values in the following characteristics: dielectric constant, Curie temperature, electromechanical anisotropy, and frequencies of operation. These properties make them useful for applications such as: the detection of infrared radiation, ultrasonic transducers for biomedical applications. The relationship between dielectric constant and temperature measurements as well as pyroelectric measurements using the technique of Byer-Roundy were performed. Values of the pyroelectric coefficient and figure of merit for infrared detector materials were obtained. Also the photoacustic spectra of the samples was obtained.
C1 CINVESTAV IPN, Dept Ing Elect, Secc Bioelectron, Mexico City 07000, DF, Mexico.
RP Suaste-Gomez, E (reprint author), CINVESTAV IPN, Dept Ing Elect, Secc Bioelectron, Apdo Postal 14-740, Mexico City 07000, DF, Mexico.
EM esuaste@mail.cinvestav.mx; moyocoyani@hotmail.com; vcastil9@hotmail.com
CR BYER RL, 1972, IEEE T SON ULTRASON, VSU19, P333, DOI 10.1109/T-SU.1972.29679
   CHYNOWETH AG, 1956, J APPL PHYS, V27, P78, DOI 10.1063/1.1722201
   GLASS AM, 1968, PHYS REV, V172, P564, DOI 10.1103/PhysRev.172.564
   GLASS AM, 1969, J APPL PHYS, V40, P4699, DOI 10.1063/1.1657277
   JAFFE B, 1955, J RES NAT BUR STAND, V55, P239, DOI 10.6028/jres.055.028
   Perez Martinez O., 1995, Revista Mexicana de Fisica, V41, P85
   Ramirez-Rosales D, 2001, SOLID STATE COMMUN, V118, P371, DOI 10.1016/S0038-1098(01)00072-2
   ROSENCWAIG A, 1976, J APPL PHYS, V47, P64, DOI 10.1063/1.322296
   Suaste-Gomez E., 2002, Ferroelectrics, V273, P273, DOI 10.1080/00150190211757
NR 9
TC 2
Z9 2
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
BN 0-87849-962-8
J9 MATER SCI FORUM
PY 2005
VL 480
BP 645
EP 649
PG 5
WC Materials Science, Multidisciplinary; Physics, Condensed Matter
SC Materials Science; Physics
GA BBW59
UT WOS:000228157300105
DA 2018-10-19
ER

PT J
AU Muller, AJ
   Albuerne, J
   Marquez, L
   Raquez, JM
   Degee, P
   Dubois, P
   Hobbs, J
   Hamley, IW
AF Muller, AJ
   Albuerne, J
   Marquez, L
   Raquez, JM
   Degee, P
   Dubois, P
   Hobbs, J
   Hamley, IW
TI Self-nucleation and crystallization kinetics of double crystalline
   poly(p-dioxanone)-b-poly(epsilon-caprolactone) diblock copolymers
SO FARADAY DISCUSSIONS
LA English
DT Article; Proceedings Paper
CT Meeting on Self-Organising Polymers
CY JUL 19-21, 2004
CL Univ Leeds, Leeds, ENGLAND
HO Univ Leeds
ID DIFFERENTIAL SCANNING CALORIMETRY; HEXAGONALLY PERFORATED LAYERS;
   BLOCK-COPOLYMERS; POLYMER CRYSTALLIZATION; TRIBLOCK COPOLYMERS;
   ISOTHERMAL CRYSTALLIZATION; CONFINED CRYSTALLIZATION; POLY(ETHYLENE
   OXIDE); EPSILON-CAPROLACTONE; MOLECULAR-WEIGHT
AB The crystallization kinetics of each constituent of poly(p-dioxanone)-b-poly(epsilon-caprolactone) diblock copolymers (PPDX-b-PCL) has been determined in a wide composition range by differential scanning calorimetry and compared to that of the equivalent homopolymers. Spherulitic growth rates were also measured by polarized optical microscopy while atomic force microscopy was employed to reveal the morphology of one selected diblock copolymer. It was found that crystallization drives structure formation and both components form lamellae within mixed spherulitic superstructures. The overall isothermal crystallization kinetics of the PPDX block at high temperatures, where the PCL is molten, was determined by accelerating the kinetics through a previous self-nucleation procedure. The application of the Lauritzen and Ho. man theory to overall growth rate data yielded successful results for PPDX and the diblock copolymers. The theory was applied to isothermal overall crystallization of previously self-nucleated PPDX ( where growth should be the dominant factor if self-nucleation was effective) and the energetic parameters obtained were perfectly matched with those obtained from spherulitic growth rate data of neat PPDX. A quantitative estimate of the increase in the energy barrier for crystallization of the PPDX block, caused by the covalently bonded molten PCL as compared to homo-PPDX, was thus determined. This energy increase can dramatically reduce the crystallization rate of the PPDX block as compared to homo-PPDX. In the case of the PCL block, both the crystallization kinetics and the self-nucleation results indicate that the PPDX is able to nucleate the PCL within the copolymers and heterogeneous nucleation is always present regardless of composition. Finally, preliminary results on hydrolytic degradation showed that the presence of relatively small amounts of PCL within PPDX-bPCL copolymers substantially retards hydrolytic degradation of the material in comparison to homo-PPDX. This increased resistance to hydrolysis is a complex function of composition and its knowledge may allow future prediction of the lifetime of the material for biomedical applications.
C1 Univ Simon Bolivar, Dept Ciencia Mat, Grp Polimeros, Caracas 1080A, Venezuela.
   Univ Mons, Lab Polymer & Composite Mat, B-7000 Mons, Belgium.
   Univ Sheffield, Dept Chem, Sheffield S3 7HF, S Yorkshire, England.
   Univ Leeds, Dept Chem, Leeds LS2 9JT, W Yorkshire, England.
RP Muller, AJ (reprint author), Univ Simon Bolivar, Dept Ciencia Mat, Grp Polimeros, Apartado 89000, Caracas 1080A, Venezuela.
EM amuller@usb.ve
RI Muller, Alejandro/A-1415-2008; Hamley, Ian/D-1643-2009; DUBOIS,
   Philippe/B-9983-2008
OI Muller, Alejandro/0000-0001-7009-7715; Hamley, Ian/0000-0002-4549-0926;
   Dubois, Philippe/0000-0003-1534-1564
CR Albuerne J, 2003, MACROMOLECULES, V36, P1633, DOI 10.1021/ma025766t
   Andjelic S, 2001, J APPL POLYM SCI, V79, P742, DOI 10.1002/1097-4628(20010124)79:4<742::AID-APP190>3.3.CO;2-A
   Arnal ML, 2001, MACROMOLECULES, V34, P7973, DOI 10.1021/ma011058g
   Arnal ML, 2004, EUR POLYM J, V40, P1461, DOI 10.1016/j.eurpolymj.2004.02.023
   Avrami M, 1941, J CHEM PHYS, V9, P177, DOI 10.1063/1.1750872
   Avrami M., 1940, Journal of Chemical Physics, V8, P212, DOI 10.1063/1.1750631
   Avrami M, 1939, J CHEM PHYS, V7, P1103, DOI 10.1063/1.1750380
   Balsamo V, 2000, MACROMOL CHEM PHYSIC, V201, P2711, DOI 10.1002/1521-3935(20001201)201:18<2711::AID-MACP2711>3.3.CO;2-Y
   Bezwada RS, 1997, HDB BIODEGRADABLE PO, P29
   Bhattarai N, 2003, EUR POLYM J, V39, P1365, DOI 10.1016/S0014-3057(02)00389-0
   Bogdanov B, 1999, MACROMOLECULES, V32, P726, DOI 10.1021/ma980226a
   Brandrup J., 1999, POLYM HDB
   CASTILLO V, 2004, UNPUB
   Choi YR, 1998, MACROMOLECULES, V31, P8766, DOI 10.1021/ma981069i
   DOUZINAS KC, 1991, MACROMOLECULES, V24, P4457, DOI 10.1021/ma00015a033
   FILLON B, 1993, J POLYM SCI POL PHYS, V31, P1383, DOI 10.1002/polb.1993.090311013
   Floudas G, 1997, MACROMOLECULES, V30, P4381, DOI 10.1021/ma9616118
   GERVAIS M, 1981, POLYMER, V22, P1129, DOI 10.1016/0032-3861(81)90304-9
   Hamley IW, 1996, MACROMOLECULES, V29, P8835, DOI 10.1021/ma960343a
   Hillmyer MA, 1997, MACROMOL SYMP, V117, P121, DOI 10.1002/masy.19971170116
   Ho RM, 2003, MACROMOLECULES, V36, P9085, DOI 10.1021/ma0347868
   Hobbs JK, 2001, MACROMOLECULES, V34, P5508, DOI 10.1021/ma0104478
   LAMBERT WS, 1994, MACROMOLECULES, V27, P3537, DOI 10.1021/ma00091a014
   LAURITZEN JI, 1973, J APPL PHYS, V44, P4340, DOI 10.1063/1.1661962
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Loo YL, 2002, MACROMOLECULES, V35, P2365, DOI 10.1021/ma011824j
   Loo YL, 2001, MACROMOLECULES, V34, P8968, DOI 10.1021/ma011521p
   Lotz B., 1969, POLYMER, V10, P820
   MANDELKERN L, 1993, PHYS PROPERTIES POLY
   Mark JE, 1996, PHYS PROPERTIES POLY
   Muller AJ, 2002, MACROMOLECULES, V35, P3048, DOI 10.1021/ma012026w
   MULLER AJ, 2004, IN PRESS MACR S
   Nojima S, 2002, POLYMER, V43, P4087, DOI 10.1016/S0032-3861(02)00217-3
   NOJIMA S, 1992, MACROMOLECULES, V25, P2237, DOI 10.1021/ma00034a027
   OMALLEY JJ, 1977, J POLYM SCI PS, V60, P151
   Quiram DJ, 1998, MACROMOLECULES, V31, P4891, DOI 10.1021/ma971218h
   Quiram DJ, 1997, MACROMOLECULES, V30, P8338, DOI 10.1021/ma9708050
   Quiram DJ, 1997, MACROMOLECULES, V30, P4551, DOI 10.1021/ma961524f
   RANGARAJAN P, 1995, MACROMOLECULES, V28, P4932, DOI 10.1021/ma00118a022
   RANGARAJAN P, 1995, MACROMOLECULES, V28, P1422, DOI 10.1021/ma00109a013
   RANGARAJAN P, 1993, MACROMOLECULES, V26, P4640, DOI 10.1021/ma00069a034
   Raquez JM, 2000, MACROMOL RAPID COMM, V21, P1063, DOI 10.1002/1521-3927(20001001)21:15<1063::AID-MARC1063>3.0.CO;2-B
   Reiter G, 2003, J POLYM SCI POL PHYS, V41, P1869, DOI 10.1002/polp.10518
   Reiter G, 2001, PHYS REV LETT, V87, DOI [10.1103/PhysRevLett.87.226101, 10.1103/PhysRevLett.87.186101, 10.1103/PhysRevLett.87.166103]
   RICHARDSON PH, 1995, POLYMER, V36, P3059, DOI 10.1016/0032-3861(95)97866-E
   ROBITAILLE C, 1983, MACROMOLECULES, V16, P665, DOI 10.1021/ma00238a033
   Rohadi A, 2000, POLYM J, V32, P602, DOI 10.1295/polymj.32.602
   Rohadi A, 2000, POLYM J, V32, P859, DOI 10.1295/polymj.32.859
   Ryan AJ, 1997, MACROMOLECULES, V30, P1723, DOI 10.1021/ma960943+
   RYAN AJ, 1995, MACROMOLECULES, V28, P3860, DOI 10.1021/ma00115a016
   Sabino MA, 2004, BIOMACROMOLECULES, V5, P358, DOI 10.1021/bm034367i
   Sabino MA, 2000, MACROMOL CHEM PHYSIC, V201, P2687, DOI 10.1002/1521-3935(20001201)201:18<2687::AID-MACP2687>3.0.CO;2-#
   Schmalz H, 2003, MACROMOL CHEM PHYSIC, V204, P111, DOI 10.1002/macp.200290063
   Schultz JM., 2001, POLYM CRYSTALLIZATIO
   Shiomi T, 2002, MACROMOLECULES, V35, P8056, DOI 10.1021/ma0200118
   Sommer J-U, 2003, POLYM CRYSTALLIZATIO
   Ueda M, 2003, POLYMER, V44, P6995, DOI 10.1016/S0032-3861(03)00697-9
   Wang YB, 2001, J POLYM SCI POL CHEM, V39, P2755, DOI 10.1002/pola.1254
   Weimann PA, 1999, J POLYM SCI POL PHYS, V37, P2053, DOI 10.1002/(SICI)1099-0488(19990815)37:16<2053::AID-POLB9>3.3.CO;2-C
   WUNDERLICH B, 1976, MACROMOLECULAR PHYSI, V2, P52
   Xu JT, 2003, EUR POLYM J, V39, P2091, DOI 10.1016/S0014-3057(03)00155-1
   Zhu L, 2002, MACROMOLECULES, V35, P3553, DOI 10.1021/ma012184n
   Zhu L, 1999, PHYS REV B, V60, P10022, DOI 10.1103/PhysRevB.60.10022
   Zhu L, 2001, POLYMER, V42, P9121, DOI 10.1016/S0032-3861(01)00394-9
   Zhu L, 2002, ADV MATER, V14, P31, DOI 10.1002/1521-4095(20020104)14:1<31::AID-ADMA31>3.0.CO;2-3
   Zhu L, 2001, POLYMER, V42, P5829, DOI 10.1016/S0032-3861(00)00902-2
NR 66
TC 103
Z9 103
U1 2
U2 30
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1359-6640
EI 1364-5498
J9 FARADAY DISCUSS
JI Faraday Discuss.
PY 2005
VL 128
BP 231
EP 252
DI 10.1039/b403085k
PG 22
WC Chemistry, Physical
SC Chemistry
GA 872PX
UT WOS:000225220800016
PM 15658776
DA 2018-10-19
ER

PT S
AU Lendlein, A
   Kelch, S
AF Lendlein, A
   Kelch, S
BE VanderBiest, O
   Gasik, M
   Vleugels, J
TI Degradable, multifunctional polymeric biomaterials with shape-memory
SO FUNCTIONALLY GRADED MATERIALS VIII
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 8th International Symposium on Multifunctional and Functionally Graded
   Materials (FMG2004)
CY JUL 11-14, 2004
CL Leuven, BELGIUM
SP Royal Soc Flemish Engineers, Technol Inst, Katholieke Univ Leuven, Dept Met & Mat Engn
DE elastomers; polymer networks; shape-memory polymers; stimuli-sensitive
   polymers; functionalized material; multifunctionality
ID POLYETHER-BASED POLYURETHANES; HEAT SHRINKABLE PRODUCTS;
   HYBRID-COMPOSITES; OLIGO(EPSILON-CAPROLACTONE) SEGMENTS; BIOMEDICAL
   APPLICATIONS; SMART SYSTEMS; POLYNORBORNENE; BEHAVIOR
C1 GKSS Forschungszentrum Geesthacht GmbH, D-14513 Teltow, Germany.
RP Lendlein, A (reprint author), GKSS Forschungszentrum Geesthacht GmbH, Kantstr 55, D-14513 Teltow, Germany.
EM lendlein@gkss.de; kelch@gkss.de
RI Lendlein, Andreas/K-9553-2013
OI Lendlein, Andreas/0000-0003-4126-4670
CR Charlesby A, 1960, ATOMIC RAD POLYM, P198
   CHEN W, 1983, RADIAT PHYS CHEM, V22, P593, DOI 10.1016/0146-5724(83)90068-7
   El Feninat F, 2002, ADV ENG MATER, V4, P91, DOI 10.1002/1527-2648(200203)4:3<91::AID-ADEM91>3.0.CO;2-B
   Jeong HM, 2000, J MATER SCI, V35, P279, DOI 10.1023/A:1004728814128
   Jeong HM, 2000, POLYMER, V41, P1849, DOI 10.1016/S0032-3861(99)00334-1
   Kim BK, 1998, POLYMER, V39, P2803, DOI 10.1016/S0032-3861(97)00616-2
   Kim BK, 1996, POLYMER, V37, P5781, DOI 10.1016/S0032-3861(96)00442-9
   KLEINHEINS G, 1984, KUNSTST-GER PLAST+, V74, P445
   KLEINHEINS G, 1986, KUNSTST-GER PLAST+, V76, P1069
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lendlein A, 2002, ANGEW CHEM INT EDIT, V41, P2034, DOI 10.1002/1521-3773(20020617)41:12<2034::AID-ANIE2034>3.0.CO;2-M
   Lendlein A, 2001, P NATL ACAD SCI USA, V98, P842, DOI 10.1073/pnas.031571398
   Li FK, 1997, J APPL POLYM SCI, V64, P1511, DOI 10.1002/(SICI)1097-4628(19970523)64:8<1511::AID-APP8>3.0.CO;2-K
   Li FK, 1996, J APPL POLYM SCI, V62, P631, DOI 10.1002/(SICI)1097-4628(19961024)62:4<631::AID-APP6>3.0.CO;2-U
   Lin JR, 1998, J APPL POLYM SCI, V69, P1563, DOI 10.1002/(SICI)1097-4628(19980822)69:8<1563::AID-APP11>3.0.CO;2-W
   Lin JR, 1998, J APPL POLYM SCI, V69, P1575, DOI 10.1002/(SICI)1097-4628(19980822)69:8<1575::AID-APP12>3.0.CO;2-U
   LIPSCOMB P, 1996, APPL SHAPE MEMORY AL
   Machi S, 1996, RADIAT PHYS CHEM, V47, P333, DOI 10.1016/0969-806X(95)00125-H
   Maitland DJ, 2002, P SOC PHOTO-OPT INS, V4626, P394, DOI 10.1117/12.472105
   MANTOVANI D, 2000, JOM, V10, P36
   Metcalfe A, 2003, BIOMATERIALS, V24, P491, DOI 10.1016/S0142-9612(02)00362-9
   NAKASIMA A, 1991, EUR J ORTHODONT, V13, P179, DOI 10.1093/ejo/13.3.179
   OTA S, 1981, RADIAT PHYS CHEM, V18, P81, DOI 10.1016/0146-5724(81)90066-2
   Otsuka K, 1999, INTERMETALLICS, V7, P511, DOI 10.1016/S0966-9795(98)00070-3
   Otsuka K., 1998, SHAPE MEMORY MAT, P1
   Rickert D, 2003, J BIOMED MATER RES B, V67B, P722, DOI 10.1002/jbm.b.10069
   Rickert D, 2003, CLIN HEMORHEOL MICRO, V28, P175
   SAKURAI K, 1993, J APPL POLYM SCI, V47, P937, DOI 10.1002/app.1993.070470521
   SAKURAI K, 1989, J APPL POLYM SCI, V38, P1191, DOI 10.1002/app.1989.070380616
   Uchino K., 1998, SHAPE MEMORY MAT, P184
   Van Humbeeck J, 1999, MAT SCI ENG A-STRUCT, V273, P134, DOI 10.1016/S0921-5093(99)00293-2
   Wache HM, 2003, J MATER SCI-MATER M, V14, P109, DOI 10.1023/A:1022007510352
   Wei ZG, 1998, J MATER SCI, V33, P3743, DOI 10.1023/A:1004692329247
   Wei ZG, 1998, J MATER SCI, V33, P3763, DOI 10.1023/A:1004674630156
   WILKES KE, 2000, JOM, V10, P45
   Yang DZ, 2000, MATER DESIGN, V21, P503, DOI 10.1016/S0261-3069(00)00008-X
NR 36
TC 53
Z9 53
U1 0
U2 7
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-970-9
J9 MATER SCI FORUM
PY 2005
VL 492-493
BP 219
EP 223
DI 10.4028/www.scientific.net/MSF.492-493.219
PG 5
WC Materials Science, Multidisciplinary; Materials Science, Biomaterials;
   Materials Science, Characterization & Testing; Materials Science,
   Coatings & Films
SC Materials Science
GA BCR97
UT WOS:000230986100036
DA 2018-10-19
ER

PT S
AU Kaufman, JD
   Klapperich, CM
AF Kaufman, JD
   Klapperich, CM
BE Wahl, KJ
   Huber, N
   Mann, AB
   Bahr, DF
   Cheng, YT
TI Nanomechanical testing of hydrated biomaterials: Sample preparation,
   data validation and analysis
SO Fundamentals of Nanoindentation and Nanotribology III
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Fundamentals of Nanoindentation and Nanotribology III held
   at the 2004 MRS Fall Meeting
CY NOV 29-DEC 03, 2004
CL Boston, MA
SP MRS
AB Implants, tissue engineering scaffold materials, drug delivery and bio-micro electromechanical systems (BioMEMs) all use polymer or hydrogel materials. These applications require both mechanical performance and successful integration of the material into a biological environment. Mechanical strength, storage and loss moduli, wear resistance and surface adhesion proper-ties are all critical in biomedical device design and can be determined using nanoindentation. The difficulty of obtaining large samples of specialized materials, and the complexity of testing soft materials in traditional materials testing apparatus, make nanoindentation an attractive alternative. Our previous research using nanoindentation to measure the surface mechanical properties of non-hydrated polymers led to improvement in nanoindentation testing protocols. One of the major challenges in using this technique for hydrogels and tissues is maintaining and controlling hydration of the materials during the test. Here we describe the design of a microfluidic platform for nanoindentation that facilitates continuous hydration of hydrogel samples and high throughput nanomechanical testing. Data from creep experiments on synthetic, hydrated poly-2-hydroxyethyl methaerylate (poly-HEMA) are presented. In addition, we show data to validate the materials properties determined from nanomechanical testing by complementary testing. Finally, the data is fitted to a phenomenological model for viscoelastic materials, specifically the three-element standard linear solid model used by Cheng et al. [1].
C1 Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
RP Kaufman, JD (reprint author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
OI Klapperich, Catherine/0000-0001-6103-849X
CR Cheng L, 2000, J POLYM SCI POL PHYS, V38, P10, DOI 10.1002/(SICI)1099-0488(20000101)38:1<10::AID-POLB2>3.0.CO;2-6
   EBENSTEIN DM, 1996, THESIS U CALIFORNIA
   KLAPPERICH CM, 2004, WORLD BIOM C SYDN AU
   KLAPPERICH CM, 2004, MAT RES SOC P, V823
   OLIVER WC, 1992, J MATER RES, V7, P6
   Tsui TY, 1997, MATER RES SOC SYMP P, V473, P57
   XIA X, 2000, THESIS U MINNESOTA
NR 7
TC 1
Z9 1
U1 0
U2 2
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-789-X
J9 MATER RES SOC SYMP P
PY 2005
VL 841
BP 69
EP 74
PG 6
WC Materials Science, Multidisciplinary; Mechanics; Materials Science,
   Characterization & Testing
SC Materials Science; Mechanics
GA BCI82
UT WOS:000229609400010
DA 2018-10-19
ER

PT S
AU Salzer, R
   Steiner, G
   Tunc, S
AF Salzer, R
   Steiner, G
   Tunc, S
BE Kundu, T
TI In-vivo investigation of protein adsorption on implant surfaces
SO Health Monitoring and Smart Nondestructive Evaluation of Structural and
   Biological Systems IV
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Health Monitoring and Smart Nondestructive Evaluation of
   Structural and Biological Systems IV
CY MAR 07-09, 2005
CL San Diego, CA
SP SPIE
DE infrared; Raman; spectroscopic imaging; biomolecules; biomimetic
   material
ID ATOMIC-FORCE MICROSCOPY; DEPENDENT CONFORMATIONS; FIBRINOGEN
AB A decisive problem in biomedical or biomaterial research of the post-genomic era is the determination of protein structure and function. Common techniques that can give full structural information do not permit in-vivo measurements. Vibrational Proteomics - an innovative combination of biochemical techniques and infrared or Raman spectroscopy - can provide information which will hell) substantially to fill this gap. Infrared and Raman spectroscopy are well established as methods for qualitative and quantitative analysis of protein secondary structure, in solution and even when adsorbed to implant surfaces. Their singular advantage over other techniques is that spectra can be obtained for proteins in a wide range of environments, in solutions and on surfaces including polymers, metals and bioceramics. Here we report on structural changes in fibrinogen from the dissolved to the adsorbed state on implant material of different hydrophobicity. FTIR imaging permits the identification of coagulation spots on the implant.
C1 Dresden Univ Technol, Inst Analyt Chem, D-01062 Dresden, Germany.
RP Salzer, R (reprint author), Dresden Univ Technol, Inst Analyt Chem, D-01062 Dresden, Germany.
RI Tunc, Sibel/C-1651-2016
CR Bergkvist M, 2003, J BIOMED MATER RES A, V64A, P349, DOI 10.1002/jbm.a.10423
   Cacciafesta P, 2000, LANGMUIR, V16, P8167, DOI 10.1021/la000362k
   HALL CE, 1959, J BIOPHYS BIOCHEM CY, V5, P11, DOI 10.1083/jcb.5.1.11
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   Jones DB, 2004, PROTEOMICS, V4, P1007, DOI 10.1002/pmic.200300662
   JORGENSEN L, 2003, INT J PHARM, V18, P7
   JUN HW, 2005, BIOMACROMOLECULES
   Kawamoto N, 1998, J BIOMAT SCI-POLYM E, V9, P543, DOI 10.1163/156856298X00037
   Kopecky V, 2003, BIOCHEM BIOPH RES CO, V300, P41, DOI 10.1016/S0006-291X(02)02765-1
   LU DR, 1991, J COLLOID INTERF SCI, V144, P271, DOI 10.1016/0021-9797(91)90258-A
   Lu XY, 2003, J BIOMED MATER RES A, V66A, P722, DOI 10.1002/jbm.a.10014
   MATHEWS CK, 1999, BIOCHEMISTRY-US, P161
   Ortega-Vinuesa JL, 1998, J COLLOID INTERF SCI, V207, P228, DOI 10.1006/jcis.1998.5624
   Salzer R, 2003, P SOC PHOTO-OPT INS, V5047, P362, DOI 10.1117/12.484153
   SARVER RW, 1991, ANAL BIOCHEM, V199, P61, DOI 10.1016/0003-2697(91)90269-Y
   Sit PS, 1999, THROMB HAEMOSTASIS, V82, P1053
   Ta TC, 2000, ANAL CHEM, V72, P2627, DOI 10.1021/ac991137e
   TUNC S, UNPUB COLLOIDS SUR B
NR 18
TC 1
Z9 1
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5749-3
J9 P SOC PHOTO-OPT INS
PY 2005
VL 5768
BP 19
EP 26
DI 10.1117/12.598386
PG 8
WC Engineering, Civil; Instruments & Instrumentation; Materials Science,
   Characterization & Testing; Optics
SC Engineering; Instruments & Instrumentation; Materials Science; Optics
GA BCO19
UT WOS:000230386200003
DA 2018-10-19
ER

PT B
AU Zarkadas, DM
   Li, B
   Sirkar, KK
AF Zarkadas, Dimitrios M.
   Li, Baoan
   Sirkar, Kamalesh K.
GP ASME
TI Polymeric Hollow Fiber Heat Exchangers (PHFHEs): A new type of compact
   heat exchanger for lower temperature applications
SO HT2005: PROCEEDINGS OF THE ASME SUMMER HEAT TRANSFER CONFERENCE 2005,
   VOL 4
LA English
DT Proceedings Paper
CT ASME Heat Transfer Summer Conference
CY JUL 15-22, 2005
CL San Francisco, CA
SP ASME
ID FILM; CONDENSATION; PERFORMANCE; SYSTEMS
AB Plastic heat exchangers are characterized by an inferior thermal performance compared to their metal counterparts. Therefore, their usage is mainly limited to handling corrosive media or when ultra high purity is required, e.g., pharmaceutical industry. Polymeric Hollow Fiber Heat Exchangers (PHFHEs) have recently been proposed [1] as a new type of heat exchanger that can overcome these constraints and offer the same or better thermal performance than metallic shell and tube or plate heat exchangers while occupying a much smaller volume. In this paper we report our results for heat transfer in PHFHEs with both parallel and cross flow in the shell side of the device. Fibers made of polypropylene (PP) and polyetheretherketone (PEEK) were tested. In addition, steam condensation studies in PHFHEs are reported for the first time. The overall heat transfer coefficients achieved for water-water and water-brine systems are as high as 1400 Wm(-2) K-1. These values are higher than any value reported for plastic heat exchangers and comparable with commonly acceptable design values for metal shell and tube heat exchangers. Similar coefficients were obtained for steam condensation. Polymeric hollow fiber heat exchangers can also achieve high thermal effectiveness, large number of transfer units (NTU) and very small height of a transfer unit (HTU), if properly rated. If designed like commercial membrane contactors, they can achieve up to 12 transfer units in a single device, not longer than 60-70 cm! In addition, the conductance per unit volume PHFHEs achieved was up to one order of magnitude higher compared to metal heat transfer equipment. This superior thermal performance is also accompanied by considerably lower pressure drops. Therefore, the operation of PHFHEs will be characterized by a low operating cost. Combined with the much lower cost, lower weight and elimination of metal contamination polymer materials offer, it is obvious that PHFHEs constitute a potential substitute for metal heat exchangers on both thermal performance and economical grounds. Possible application fields include the food, pharmaceutical and biomedical industries as well as applications where corrosion resistant, light and very efficient devices are required, i.e., desalination, solar and offshore heat transfer applications.
C1 New Jersey Inst Technol, Ctr Membrane Technol, York Dept Chem Engn, Newark, NJ 07102 USA.
RP Zarkadas, DM (reprint author), New Jersey Inst Technol, Ctr Membrane Technol, York Dept Chem Engn, Newark, NJ 07102 USA.
CR BANDELIER P, 1992, MAT TECH PARIS, V9, P67
   BIGG DM, 1989, POLYM ENG SCI, V29, P1111, DOI 10.1002/pen.760291607
   Bourouni K, 1997, DESALINATION, V114, P111, DOI 10.1016/S0011-9164(98)00003-4
   Brouwers HJH, 1996, INT J HEAT MASS TRAN, V39, P391, DOI 10.1016/0017-9310(95)00113-N
   Burns JR, 2001, APPL THERM ENG, V21, P495, DOI 10.1016/S1359-4311(00)00063-6
   DAVIDSON J, 1999, P REN ADV EN SYST 21
   Deronzier JC, 1997, APPL THERM ENG, V17, P799, DOI 10.1016/S1359-4311(96)00086-5
   Drummond M, 2003, ARTIF ORGANS, V27, P465, DOI 10.1046/j.1525-1594.2003.07240.x
   DUERI JP, 2002, Patent No. 6428747
   El-Dessouky HT, 1999, DESALINATION, V122, P271, DOI 10.1016/S0011-9164(99)00048-X
   ELGAS RJ, 1997, Patent No. 9725080
   GITHENS RE, 1965, CHEM ENG PROG, V61, P55
   HETSRONI G, 1994, CHEM ENG PROCESS, V33, P91, DOI 10.1016/0255-2701(94)85007-0
   JACHUCK RJJ, 1994, CHEM ENG RES DES, V72, P255
   JOHANNSEN K, 1983, LOW REYNOLDS NUMBER, P229
   Kays W. M., 1984, COMPACT HEAT EXCHANG
   Kern DQ, 1965, PROCESS HEAT TRANSFE
   LAURO F, 1979, DESALINATION, V31, P221, DOI 10.1016/S0011-9164(00)88523-9
   LIU W, 2000, T ASME, V122, P84
   LONDON AL, 1983, LOW REYNOLDS NUMBER, P815
   MCFALL FB, 1999, Patent No. 6001306
   MORCOS VH, 1995, J ELASTOM PLAST, V27, P200, DOI 10.1177/009524439502700208
   Perry R. H, 1999, PERRYS CHEM ENG HDB
   Raju KS, 1983, LOW REYNOLDS NUMBER, P899
   Raman R, 2000, J SOL ENERG-T ASME, V122, P92, DOI 10.1115/1.1288214
   SCHLUNDLER EU, 1983, HEAT EXCHANGER DESIG
   SHAH RK, 1983, LOW REYNOLDS NUMBER, P21
   WANG KL, 1993, J MEMBRANE SCI, V85, P265, DOI 10.1016/0376-7388(93)85280-A
   WEAVER JM, 1960, CHEM ENG PROG, V56, P49
   WHARRY JR, 1995, MET FINISH, V93, P693
   Whitley D. M., 1957, CHEM ENG, V64, P308
   Zaheed L, 2005, J POWER SOURCES, V140, P304, DOI 10.1016/j.jpowsour.2004.08.024
   Zaheed L, 2004, APPL THERM ENG, V24, P2323, DOI 10.1016/j.applthermaleng.2004.03.018
   Zarkadas DM, 2004, IND ENG CHEM RES, V43, P8093, DOI 10.1021/ie040143k
NR 34
TC 3
Z9 3
U1 0
U2 11
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 0-7918-4734-9
PY 2005
BP 429
EP 438
DI 10.1115/HT2005-72590
PG 10
WC Thermodynamics
SC Thermodynamics
GA BFN98
UT WOS:000243380100051
DA 2018-10-19
ER

PT S
AU Ban, YH
   Choi, SJ
   Jiang, ZW
   Park, C
AF Ban, YH
   Choi, SJ
   Jiang, ZW
   Park, C
BE Wei, YL
   Chong, KT
   Takahashi, T
   Liu, SP
   Li, Z
   Jiang, ZW
   Choi, JY
TI Development of a belt-type wearable sensor system with multi-function
   for home health care - art. no. 60401Y
SO ICMIT 2005: Mechatronics, MEMS, and Smart Materials
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 3rd International Conference on Mechatronics and Information Technology
   (ICMIT 05)
CY SEP 20-23, 2005
CL Chongqing, PEOPLES R CHINA
SP Chongqing Inst Technol, Korea/Japan Joint Adv Mech Res Assoc, Mech Engn Soc, Chongqing Inst Technol, Mechatron Res Ctr, Biomed & Welfare Div, CRC, Inst B W E, Yamaguchi Univ, Fac Symbiot Syst Sci, Fukushima Univ, Natl Sci Fdn China, China Assoc Artificial Intelligence, China Assoc Automatizat, Special Comm Intelligent Automatizat, Inst Control Automat & Syst Engineers, Soc Instruments & Control Engn, Korea Soc Precis Engn, Japan Soc Mech Engineers, Robot Soc Japan, Korea Inst Informat & Telecommun Fac Engn, Chongqing Sci & Technol Comm, Mech Engn Soc Chongqing, Chongqing Educ Comm, Biomed Engn Soc Chongqing
DE belt-type wearable sensor; body impedance; ECG; primary health care;
   respiration; %BF
AB Some reports show that the physiological information measured in hospital is not enough without the one measured in home. The physiological information monitored in home, therefore, is strongly required recently. The goal of this research is to develop a wearable and tractable sensor system for detecting biomedical signals such as cardiac rhythm, respiration, body movement, and percentage of body fat (%BF) and for home health care. A belt type sensor for this purpose is developed, which consists of sensing materials of PVDF film and conductive fabrics. Also several data processing techniques, such as the discrete wavelet transform, cross correlation and adaptive filtering method, were introduced to eliminate noises and base wandering and to extract the specified components. The ECG and respiration signals obtained by the proposed belt type sensor system gave good agreements with commercial medical system. Furthermore, the body fat (%BF) measurement based on the four-electrode BIA was also built in the belt sensor. The body fat was calculated by measuring the body impedance from the belt type sensor and compared with the predicted %BF measured by the commercial adipometer (TBF-607). The results validated also the efficiency of the belt type sensor system.
C1 Yamaguchi Univ, Dept Mech Engn, Ube, Yamaguchi 7558611, Japan.
RP Ban, YH (reprint author), Yamaguchi Univ, Dept Mech Engn, Ube, Yamaguchi 7558611, Japan.
CR Edwards T., 1991, DISCRETE WAVELET TRA
   EISENBERG A, 1992, GUIDE TECHNICAL EDIT
   Kyle UG, 2005, NUTRITION, V21, P161, DOI 10.1016/j.nut.2004.04.023
   Liedtke R.J., 1998, FUNDAMENTALS BIOELEC
   LUKASHI HC, 1998, AVIAT SPACE ENV MED, V59, P1163
   Piccoli A, 2005, KIDNEY INT, V67, P301, DOI 10.1111/j.1523-1755.2005.00083.x
   Quiroga RQ, 2001, BRAIN RES PROTOC, V8, P16
NR 7
TC 0
Z9 0
U1 0
U2 4
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-6072-9
J9 P SOC PHOTO-OPT INS
PY 2005
VL 6040
BP Y401
EP Y401
AR 60401Y
DI 10.1117/12.664240
PG 6
WC Engineering, Electrical & Electronic; Engineering, Mechanical;
   Instruments & Instrumentation; Materials Science, Multidisciplinary
SC Engineering; Instruments & Instrumentation; Materials Science
GA BDU16
UT WOS:000235358400070
DA 2018-10-19
ER

PT J
AU Byoungjoong, K
   Park, JH
   Cho, J
   Kwon, K
   Lim, S
   Yoon, J
   Cheon, C
   Kim, YK
   Kwon, Y
AF Byoungjoong, K
   Park, JH
   Cho, J
   Kwon, K
   Lim, S
   Yoon, J
   Cheon, C
   Kim, YK
   Kwon, Y
TI Novel low-cost planar probes with broadside apertures for nondestructive
   dielectric measurement of biological materials at microwave frequencies
SO IEEE TRANSACTIONS ON MICROWAVE THEORY AND TECHNIQUES
LA English
DT Article
DE biomedical application; microelectromechanical systems (MEMS);
   nondestructive measurement; planar-type probe
ID ENDED COAXIAL LINE; LYMPH-NODE; SENSORS; PERMITTIVITY; CALIBRATION;
   RADIATION; LIQUIDS; TISSUES
AB Novel planar-type probes were developed to demonstrate the possibility of replacing the existing high-cost open-ended coaxial probes. The planar probes of this study define an aperture on the broadside of the probe body. In this way, the contact area can be maximized and/or customized according to specific medical needs. The probes with various aperture sizes and shapes can also be fabricated simultaneously in a single batch process. Three probes are developed in this paper: a probe combining two laminates, a microelectromechanical systems (MEMS)-based probe with a single benzocyclobutene (BCB) layer on a quartz substrate, and another MEMS probe with two BCB layers defined on a silicon substrate. The third probe was specifically designed for monolithic integration with driving circuits on a single substrate. Limitations in the high-frequency performance of the planar probes were carefully studied, and higher order modes and incomplete shielding were found to be the main causes. The measurement results of each probe showed excellent compatibility with those of the open-ended coaxial probe up to almost 40 GHz. The proposed planar-type probes have great potentials for practical medical applications in view of low cost, disposability, and monolithic integration capability with the driving circuits.
C1 Seoul Natl Univ, Ctr Three Dimens Millimeter Wave Integrated, Sch Elect Engn, Seoul 151742, South Korea.
   Seoul Natl Univ, Dept Elect Engn, Seoul 130743, South Korea.
RP Byoungjoong, K (reprint author), Samsung Elect Co, Syst Large Scale Integrat Div, RF Grp, Yongin 449711, South Korea.
EM ykwon@snu.ac.kr
CR BAKHTIARI S, 1994, IEEE T MICROW THEORY, V42, P1261, DOI 10.1109/22.299765
   Choi JW, 2004, BREAST CANCER RES TR, V86, P107, DOI 10.1023/B:BREA.0000032979.52773.fb
   Cole KS, 1941, J CHEM PHYS, V9, P341, DOI 10.1063/1.1750906
   ESSELLE KPAP, 1988, IEEE T INSTRUM MEAS, V37, P101, DOI 10.1109/19.2675
   FRATTICCIOLI E, 2002, IEEE MTT S INT MICR, V2, P647
   Hagl DA, 2003, IEEE T MICROW THEORY, V51, P1194, DOI 10.1109/TMTT.2003.809626
   Hagness SC, 1998, IEEE T BIO-MED ENG, V45, P1470, DOI 10.1109/10.730440
   Harrington R. F., 1961, TIME HARMONIC ELECTR
   JOINES WT, 1994, MED PHYS, V21, P547, DOI 10.1118/1.597312
   KANG B, 2004, IEEE MTT S INT MICR, P1441
   KRAG DN, 1993, SURG ONCOL, V2, P335, DOI 10.1016/0960-7404(93)90064-6
   LARSON LE, 1991, MICR MILL WAV MON CI, P27
   MISRA D, 1990, IEEE T MICROW THEORY, V38, P8, DOI 10.1109/22.44150
   NYSHADHAM A, 1992, IEEE T MICROW THEORY, V40, P305, DOI 10.1109/22.120103
   POURNAROPOULOS CL, 1994, IEEE T INSTRUM MEAS, V43, P111, DOI 10.1109/19.293405
   Raj A, 2001, IEEE T INSTRUM MEAS, V50, P905, DOI 10.1109/19.948297
   STUCHLY MA, 1980, IEEE T INSTRUM MEAS, V29, P176, DOI 10.1109/TIM.1980.4314902
   STUCHLY SS, 1998, 12 INT MICR RAD C, V3, P755
   SUROWIEC AJ, 1988, IEEE T BIO-MED ENG, V35, P257, DOI 10.1109/10.1374
   WEI YZ, 1991, IEEE T MICROW THEORY, V39, P526, DOI 10.1109/22.75296
   WELLER TM, 1995, IEEE T MICROW THEORY, V43, P534, DOI 10.1109/22.372098
NR 21
TC 3
Z9 3
U1 0
U2 1
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 0018-9480
J9 IEEE T MICROW THEORY
JI IEEE Trans. Microw. Theory Tech.
PD JAN
PY 2005
VL 53
IS 1
BP 134
EP 143
DI 10.1109/TMTT.2004.839904
PG 10
WC Engineering, Electrical & Electronic
SC Engineering
GA 887ZI
UT WOS:000226343600015
DA 2018-10-19
ER

PT J
AU Bloomsmith, MA
   Else, JG
AF Bloomsmith, MA
   Else, JG
TI Behavioral management of chimpanzees in biomedical research facilities:
   The state of the science
SO ILAR JOURNAL
LA English
DT Article
DE animal care; animal husbandry; animal training; behavioral management;
   breeding; chimpanzee; distress; environmental enrichment
ID CAPTIVE CHIMPANZEES; PAN-TROGLODYTES; ABNORMAL BEHAVIORS; YOUNG
   CHIMPANZEES; PEER GROUPS; FEEDING ENRICHMENT; FORAGE MATERIAL;
   LARGE-SAMPLE; AGGRESSION; ROCKING
AB The current status of the behavioral management of chimpanzees housed in US research facilities is examined, and recent advances are described. Behavioral management includes the application of environmental enrichment, animal training, and environmental design for improving animal welfare. Authors surveyed the six major chimpanzee holding facilities and found that the vast majority of chimpanzees are housed socially, with access to the outdoors. The institutions currently invest in behavioral scientists, enrichment specialists, and, most recently, chimpanzee trainers to implement and study chimpanzee behavioral management. This review is based on the substantial scientific literature related to managing social behavior, identifying the behavioral effects of restricted socialization, evaluating various forms of enrichment, and describing positive reinforcement animal training. Authors outline recent accomplishments in behavioral management, summarize behavioral issues that have been evaluated, and identify issues for future consideration. It is proposed that the enhanced application of behavioral management techniques, including training., could significantly reduce chimpanzee stress that is generally associated with experimental manipulations, and could improve animal welfare and the quality of biomedical research. The next challenge is to implement effectively and thoroughly the approaches that have been shown to be beneficial.
C1 Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA.
RP Bloomsmith, MA (reprint author), Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA.
FU NCRR NIH HHS [RR-00165]
CR ALFORD PL, 1995, ZOO BIOL, V14, P347, DOI 10.1002/zoo.1430140406
   Aureli F, 1997, AM J PRIMATOL, V41, P213, DOI 10.1002/(SICI)1098-2345(1997)41:3<213::AID-AJP4>3.0.CO;2-#
   Baker KC, 1997, ZOO BIOL, V16, P225, DOI 10.1002/(SICI)1098-2361(1997)16:3<225::AID-ZOO3>3.3.CO;2-H
   Baker KC, 2000, AM J PRIMATOL, V51, P161, DOI 10.1002/1098-2345(200007)51:3<161::AID-AJP1>3.0.CO;2-5
   Baker KC, 1996, AM J PRIMATOL, V40, P283, DOI 10.1002/(SICI)1098-2345(1996)40:3<283::AID-AJP5>3.0.CO;2-U
   Baker KC, 1996, APPL ANIM BEHAV SCI, V49, P403, DOI 10.1016/0168-1591(96)01061-1
   Baker KC, 2000, ETHOLOGY, V106, P527, DOI 10.1046/j.1439-0310.2000.00553.x
   BAKER KC, 1996, CONTEMP TOP LAB ANIM, V35, P71
   BAKER KC, 2004, ANIM WELFARE, V12, P239
   BARD KA, 1994, EARLY DEV PARENTING, V3, P19
   BETTINGER T, 1994, ZOO BIOL, V13, P167, DOI 10.1002/zoo.1430130208
   Bloomsmit MA, 1990, LAB ANIM, V19, P42
   BLOOMSMITH M, 1992, AM ASS ZOOL PARKS AQ, P403
   Bloomsmith M. A., 2000, American Journal of Primatology, V51, P44
   Bloomsmith M. A., 2000, American Journal of Primatology, V51, P45
   Bloomsmith M.A., 1989, P336
   BLOOMSMITH MA, 1990, LAB ANIM SCI, V40, P319
   Bloomsmith MA, 1998, ZOO BIOL, V17, P333, DOI 10.1002/(SICI)1098-2361(1998)17:4<333::AID-ZOO6>3.3.CO;2-3
   BLOOMSMITH MA, 1995, APPL ANIM BEHAV SCI, V44, P65, DOI 10.1016/0168-1591(95)00570-I
   BLOOMSMITH MA, 1988, AM J PRIMATOL, V16, P155, DOI 10.1002/ajp.1350160206
   BLOOMSMITH MA, 1994, ZOO BIOL, V13, P557, DOI 10.1002/zoo.1430130605
   BLOOMSMITH MA, 1992, ZOO BIOL, V11, P53, DOI 10.1002/zoo.1430110107
   Bloomsmith MA, 2003, APPL ANIM BEHAV SCI, V84, P235, DOI 10.1016/j.applanim.2003.08.005
   BLOOMSMITH MA, 1994, APPL ANIM BEHAV SCI, V39, P73, DOI 10.1016/0168-1591(94)90017-5
   Bloomsmith MA, 2000, ZOO BIOL, V19, P541, DOI 10.1002/1098-2361(2000)19:6<541::AID-ZOO6>3.0.CO;2-3
   BLOOMSMITH MA, 2001, APES CHALLENGES 21 C, P88
   BLOOMSMITH MA, 2005, IN PRESS NURSERY REA
   BLOOMSMITH MA, 1989, AM J PRIMATOL S, V1, P93
   Bloomsmith MA, 1991, INT J COMP PSYCHOL, V4, P171
   BLOOMSTRAND M, 1986, ZOO BIOL, V5, P293, DOI 10.1002/zoo.1430050307
   BRENT L, 1991, ZOO BIOL, V10, P353, DOI 10.1002/zoo.1430100409
   Brent L, 1997, ZOO BIOL, V16, P335
   BRENT L, 1995, PRIMATES, V36, P265, DOI 10.1007/BF02381352
   BRENT L, 1989, LAB ANIM SCI, V39, P345
   Brent L, 2004, LAB ANIMAL, V33, P37, DOI 10.1038/laban0104-37
   BRENT L, 1995, J MED PRIMATOL, V24, P12, DOI 10.1111/j.1600-0684.1995.tb00139.x
   BRENT L, 1991, J MED PRIMATOL, V20, P29
   Brent L, 1996, AM J PRIMATOL, V39, P139, DOI 10.1002/(SICI)1098-2345(1996)39:2<139::AID-AJP5>3.0.CO;2-#
   Brent L, 1998, J Appl Anim Welf Sci, V1, P5, DOI 10.1207/s15327604jaws0101_2
   Brent L, 1996, LAB ANIM SCI, V46, P405
   Brent L., 2001, CARE MANAGEMENT CAPT
   BRENT L, 1989, AM J PRIMATOL S, V1, P65
   Caws C, 2003, INT J PRIMATOL, V24, P1077, DOI 10.1023/A:1026280329544
   Davenport R. K., 1970, CHIMPANZEE, V3, P337
   DEWAAL FBM, 1986, ETHOL SOCIOBIOL, V7, P237, DOI 10.1016/0162-3095(86)90051-8
   DEWAAL FBM, 1989, ZOO BIOL S, V1, P89
   EDER G, 1994, ROLE CHIMPANZEE RES
   Erwin J., 1979, CAPTIVITY BEHAV PRIM
   Erwin J., 1992, CHIMPANZEE CONSERVAT, P65
   FITCH AL, 1989, AM J PRIMATOL S, V1, P71
   FRITZ J, 1992, AM J PRIMATOL, V27, P161, DOI 10.1002/ajp.1350270302
   FRITZ J, 1992, ZOO BIOL, V11, P313, DOI 10.1002/zoo.1430110503
   FRITZ J, 1989, AM J PRIMATOL S, V1, P79
   FULK R, 1992, CAPTIVE ENV HUSBANDR, pR12
   GOFF C, 1994, ZOO BIOL, V3, P61
   HANNAH AC, 1990, ZOO BIOL, V9, P233, DOI 10.1002/zoo.1430090306
   Howell S, 2003, LAB ANIMAL, V32, P31, DOI 10.1038/laban1103-31
   HOWELL SM, 1993, ANIM WELFARE, V2, P153
   Keeling ME, 1991, LOOKING GLASS, P57
   Kessel A, 1996, ANIMAL TECHNOLOGY, V47, P1
   KING NE, 1994, ZOO BIOL, V13, P51, DOI 10.1002/zoo.1430130107
   Lambeth SP, 2004, AM J PRIMATOL, V62, P37
   LAMBETH SP, 1994, ANIM WELFARE, V3, P13
   LAMBETH SP, 1992, LAB ANIM SCI, V42, P261
   Lambeth SP, 1997, ZOO BIOL, V16, P327, DOI 10.1002/(SICI)1098-2361(1997)16:4<327::AID-ZOO4>3.0.CO;2-C
   Laule GE, 1996, ZOO BIOL, V15, P587, DOI 10.1002/(SICI)1098-2361(1996)15:6<587::AID-ZOO4>3.0.CO;2-7
   MAKI K, 1989, NTT REVIEW, V1, P71
   MAKI S, 1989, ZOO BIOL, V8, P79, DOI 10.1002/zoo.1430080110
   MAKI S, 1993, INFANT BEHAV DEV, V16, P373, DOI 10.1016/0163-6383(93)80042-7
   Maple T., 1979, CAPTIVITY BEHAV PRIM, P239
   Morgan Kathleen N., 1998, P153
   Nash LT, 1999, AM J PRIMATOL, V48, P15, DOI 10.1002/(SICI)1098-2345(1999)48:1<15::AID-AJP2>3.0.CO;2-R
   NOVAK MA, 1988, AM J PRIMATOL, V14, P435
   *NRC, 1996, GUID CAR US LAB AN
   NRC (National Research Council), 1997, CHIMP RES STRAT THEI
   ORKIN JL, 1993, LAB ANIM SCI, V43, P260
   PAQUETTE D, 1988, ZOO BIOL, V7, P15, DOI 10.1002/zoo.1430070103
   Pazol KA, 1997, ANIM WELFARE, V6, P133
   PAZOL KA, 1993, ANIM WELFARE, V2, P113
   PRINCE AM, 1989, J MED PRIMATOL, V18, P27
   Pruetz JD, 1992, ANIM WELFARE, V1, P127
   Pruetz JD, 1995, FOLIA PRIMATOL, V65, P174, DOI 10.1159/000156886
   PRUETZ JDE, 2001, CARE MANAGEMENT CAPT, P17
   ROGERS CM, 1970, CHIMPANZEE, V3, P361
   Russell WMS, 1959, PRINCIPLES HUMANE EX
   Sanz Crickette, 1999, Journal of Applied Animal Welfare Science, V2, P1, DOI 10.1207/s15327604jaws0201_1
   Seres M, 2001, ZOO BIOL, V20, P501, DOI 10.1002/zoo.10003
   SHEFFERLY N, 1992, AM J PRIMATOL, V26, P119, DOI 10.1002/ajp.1350260206
   Shepherdson David J., 1998, P1
   Spijkerman RP, 1995, NETH J ZOOL, V45, P402
   Spijkerman RP, 1997, INT J PRIMATOL, V18, P439, DOI 10.1023/A:1026342602018
   SPIJKERMAN RP, 1990, FOLIA PRIMATOL, V55, P41, DOI 10.1159/000156496
   Spijkerman RP, 1996, BEHAVIOUR, V133, P717, DOI 10.1163/156853996X00440
   Visalberghi E, 2002, ZOO BIOL, V21, P539, DOI 10.1002/zoo.10057
   Whittaker Margaret, 2001, P131
   WRANGHAM RW, 1992, CHIMPANZEE CONSERVAT, P71
   Wrangham RW, 1994, CHIMPANZEE CULTURES
NR 97
TC 18
Z9 18
U1 0
U2 13
PU INST LABORATORY ANIMAL RESEARCH, NATL RES COUNCIL
PI WASHINGTON
PA 500 FIFTH ST, N W, WASHINGTON, DC 20001 USA
SN 1084-2020
J9 ILAR J
JI ILAR J.
PY 2005
VL 46
IS 2
BP 192
EP 201
DI 10.1093/ilar.46.2.192
PG 10
WC Veterinary Sciences
SC Veterinary Sciences
GA 901BW
UT WOS:000227259000012
PM 15775028
OA Bronze
DA 2018-10-19
ER

PT J
AU Singh, VR
AF Singh, VR
TI Smart sensors: Physics, technology and applications
SO INDIAN JOURNAL OF PURE & APPLIED PHYSICS
LA English
DT Review
DE smart sensors; biochips; biosensors; silicon strain sensor;
   physiological sensor
ID BIOCHIPS
AB The semiconductor technology has advanced a rapid progress in the sensors which are heart of instrumentation systems. These days, most of the sensors are 'smart' in nature. In such sensors, the sensing elements and associated electronics are integrated on the same chip. Generally, silicon is preferred as sensor material because it can give a suitable physical conversion effect and can give suitable signal processing circuit, with integration of the sensing element and electronic circuits on the chip, by using standard planar technology. The smart sensors have main advantages of fast signal conditioning, higher signal-to-noise ratio, self testing, auto calibration, small physical size, high reliability, failure prevention and detection. In the present paper, recent advances in smart sensors along with their design and fabrication aspects, are discussed. The smart sensors developed in this Laboratory, mainly smart pressure sensors and smart lithotripsy sensor, are presented, besides smart sensors used in industrial controls, automotive and biomedical fields. Biochips and biosensors are also cited for some of the specific applications.
C1 Natl Phys Lab, Instrumentat & Sensors Grp, New Delhi 110012, India.
RP Singh, VR (reprint author), Natl Phys Lab, Instrumentat & Sensors Grp, Dr Krishnan Rd, New Delhi 110012, India.
EM vrsingh@mail.nplindia.ernet.in
CR AGARWAL R, 2000, P NAT C BIOM ENG ROO, P224
   Bhatia KG, 2002, INDIAN J PURE AP PHY, V40, P515
   GIACHINO JM, 1986, SENSOR ACTUATOR, V10, P239, DOI 10.1016/0250-6874(86)80048-8
   Gomez R, 2001, BIOMED MICRODEVICES, V3, P201, DOI 10.1023/A:1011403112850
   Gomez R, 2002, SENSOR ACTUAT B-CHEM, V86, P198, DOI 10.1016/S0925-4005(02)00175-2
   HEINTZ F, 1989, SENSOR ACTUATOR, V13, P39
   HUIJSING JH, 1992, SENSOR ACTUAT A-PHYS, V30, P167, DOI 10.1016/0924-4247(92)80212-L
   Lee MY, 2003, BIOTECHNOL BIOENG, V83, P20, DOI 10.1002/bit.10642
   Lochab J, 2004, INDIAN J PURE AP PHY, V42, P595
   MCCONNELL HM, 1992, SCIENCE, V257, P1906, DOI 10.1126/science.1329199
   SINGH K, 2000, 24 NAT S INSTR GOA I
   SINGH K, 2000, P AS PAC IEEE C BIOM, P863
   Singh R., 1993, IETE Technical Review, V10, P557
   Singh VR, 2004, INDIAN J PURE AP PHY, V42, P189
   SINGH VR, 1974, BIOTELEMETRY, V2, P28
   SINGH VR, 1997, P C METR REL ENV NEW
   SINGH VR, 1997, PHYS SEMICONDUCTOR D, P195
   SINGH VR, 1996, P IND S MOD AUT IND, P10
   SINGH VR, 1996, MAIN GROUP ELEMENTS, P204
   SINGH VR, 1996, ADV METROLOGY ITS RO, P242
   SMITH G, 1995, SENSOR ACTUAT A-PHYS, V46, P521
   Vo-Dinh T, 1999, ANAL CHEM, V71, P358, DOI 10.1021/ac980043m
   Vo-Dinh T, 2001, SENSOR ACTUAT B-CHEM, V74, P2, DOI 10.1016/S0925-4005(00)00705-X
NR 23
TC 6
Z9 6
U1 2
U2 14
PU NATL INST SCIENCE COMMUNICATION
PI NEW DELHI
PA DR K S KRISHNAN MARG, NEW DELHI 110 012, INDIA
SN 0019-5596
J9 INDIAN J PURE AP PHY
JI Indian J. Pure Appl. Phys.
PD JAN
PY 2005
VL 43
IS 1
BP 7
EP 16
PG 10
WC Physics, Multidisciplinary
SC Physics
GA 893DE
UT WOS:000226698700001
DA 2018-10-19
ER

PT B
AU Nowak, MD
AF Nowak, Michael D.
GP ASME
TI Combined mechanical engineering materials lecture and mechanics of
   materials laboratory: Cross-disciplinary teaching
SO Innovations in Engineering Education - 2005: Mechanical Engineering
   Education; Mechanical Engineering Technology Department Heads
LA English
DT Proceedings Paper
CT ASME International Mechanical Engineering Congress and Exposition
CY NOV 05-11, 2005
CL Orlando, FL
SP ASME, Proc Ind Div, ASME, Rail Transportat Div, ASME, Noise Control & Acoust Div, ASME, Triol Div, ASME, Pressure Vessels & Piping Div, ASME, Bioengn Div, ASME, Mat Div, ASME, Appl Mech Div, ASME, Fluids Engn Div, ASME, Micro Elect Mech Syst Div, ASME, Heat Transfer Div, ASME, Nucl Engn Div, ASME, Power Div, ASME, Solar Energy Div, ASME, Safety Engn & Risk Anal Div, ASME, Technol & Soc Div, ASME, Adv Energy Syst Div, ASME, Aerosp Div, ASME, Comp & Informat Engn Div
AB We have developed a course combining a Mechanical Engineering Materials Laboratory with a Materials Science lecture for a small combined population of undergraduate Mechanical and Biomedical Engineering students. By judicious selection of topic order, we have been able to utilize one lecture and one laboratory for both Mechanical and Biomedical Engineering students (with limited splitting of groups).
   The primary reasons for combining the Mechanical and Biomedical students are to reduce faculty load and required resources in a small university. For schools with medium or small Mechanical and Biomedical Engineering programs, class sizes could be improved if they could include other populations. The heterogeneous populations also aid in teaching students that the same engineering techniques are useful in more than a single engineering realm.
   The laboratory sections begin with the issues common to designing and evaluating mechanical testing, followed by tensile, shear, and torsion evaluation of metals. To introduce composite materials, wood and cement are evaluated. While the Mechanical Engineering students are evaluating impact and strain gauges, the Biomedical Engineering students are performing tensile studies of soft tissues, and compression of long bones.
   The basic materials lectures (beginning at the atomic level) are in common with both Mechanical and Biomedical student populations, until specific topics such as human body materials are discussed. Three quarters of the term is thus taught on a joint basis, and three or four lectures are split. Basic metal, plastic and wood behavior is common to both groups.
C1 Univ Hartford, Coll Engn Technol & Architecture, Dept Civil Environ & Biomed Engn, Hartford, CT 06001 USA.
RP Nowak, MD (reprint author), Univ Hartford, Coll Engn Technol & Architecture, Dept Civil Environ & Biomed Engn, Hartford, CT 06001 USA.
NR 0
TC 0
Z9 0
U1 0
U2 3
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 0-7918-4232-0
PY 2005
BP 137
EP 142
PG 6
WC Education, Scientific Disciplines; Engineering, Multidisciplinary;
   Engineering, Mechanical
SC Education & Educational Research; Engineering
GA BFM36
UT WOS:000243055200018
DA 2018-10-19
ER

PT S
AU Postma, H
   Perego, RC
   Borella, A
   Siegler, P
   Wynants, R
   Schillebeeckx, P
AF Postma, H
   Perego, RC
   Borella, A
   Siegler, P
   Wynants, R
   Schillebeeckx, P
BE Haight, RC
   Chadwick, MB
   Kawano, T
   Talou, P
TI Some applications of neutron resonance capture analysis
SO International Conference on Nuclear Data for Science and Technology, Pts
   1 and 2
SE AIP CONFERENCE PROCEEDINGS
LA English
DT Proceedings Paper
CT International Conference on Nuclear Data for Science and Technology
CY SEP 26-OCT 01, 2004
CL Santa Fe, NM
SP OECD Nucl Energy Agcy, Int Atom Energy Agcy, US DOE, Los Alamos Natl Lab, Acqiris Corp, Amer Inst Phys, Canberra Ind Inc, Eljen Technologies, Goodfellow Corp, Inst Phys, St Gobain, Bicron, Scionix USA, Struck, Techsource, Thermoelectron, Wiener, Natl Nucl Data Ctr
ID ACTIVATION ANALYSIS
AB The probability for nuclei to capture neutrons reveals sharp peaks, so-called "resonances," which occur at neutron energies specific for each element. These resonances are very suitable for identifying and quantifying elements in objects and materials. They are the basis of an analytical method called "Neutron-Resonance-Capture-Analysis" (NRCA). This is a fully non-destructive method applicable to almost all stable isotopes, which determines the bulk elemental composition, and does not require any sample preparation and results in negligible residual activity. Up to now NRCA has been mostly applied for archaeological applications. In this paper we review the technique and discuss the applicability of the technique in the biomedical field and in material science.
C1 Tech Univ Delft, IRI, NL-2629 JB Delft, Netherlands.
RP Postma, H (reprint author), Tech Univ Delft, IRI, Mekelweg 15, NL-2629 JB Delft, Netherlands.
RI Borella, Alessandro/K-3054-2012
CR Blaauw M, 2003, NUCL INSTRUM METH A, V505, P508, DOI 10.1016/S0168-9002(03)01134-3
   BOCKHOFF KH, 1990, NUCL SCI ENG, V106, P192
   BORELLA A, AIP CONF PROC
   de Jonge S., GEDER2487 IRMM
   Gonzalez J., GERINF0697 IRMM
   GUNSING F, 1994, THESIS DELFT U
   PEREGO RC, 2004, P MOD TRENDS ACT AN
   POSTMA H, IN PRESS J RADIOANAL
   POSTMA H, 2003, CZECH J PHYS, V33, pA233
   POSTMA H, 2004, P MOD TRENDS ACT AN
   POSTMA H, IN PRESSA ARCHAEOMET
   Tzaphlidou M, 2002, APPL RADIAT ISOTOPES, V57, P779, DOI 10.1016/S0969-8043(02)00171-9
   VOGEL AI, 1961, QUANTITATIVE INORGAN
   Winkler EM, 1994, STONE ARCHITECTURE
NR 14
TC 0
Z9 0
U1 0
U2 1
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 0-7354-0254-X
J9 AIP CONF PROC
PY 2005
VL 769
BP 1393
EP 1396
PN 1-2
PG 4
WC Nuclear Science & Technology; Physics, Applied; Physics, Nuclear
SC Nuclear Science & Technology; Physics
GA BCP35
UT WOS:000230511801071
DA 2018-10-19
ER

PT J
AU Kawashita, M
AF Kawashita, M
TI Ceramic microspheres for biomedical applications
SO INTERNATIONAL JOURNAL OF APPLIED CERAMIC TECHNOLOGY
LA English
DT Article
ID Y-90 GLASS MICROSPHERES; PRIMARY LIVER-CANCER; HEPATIC
   RADIOEMBOLIZATION; SYSTEM FEO-FE2O3-CAO-SIO2; HEPATOCELLULAR-CARCINOMA;
   HYPERTHERMIC TREATMENT; MAMMARY-CARCINOMA; ARTERIAL Y-90; TUMOR-THERAPY;
   HEAT
AB Cera-mic microspheres are expected to be useful for cancer treatment and antibacterial treatment. In this article, several attempts to prepare ceramic microspheres for such biomedical applications are described. Ceramic microspheres containing large amounts of yttrium or phosphorus are useful for radiotherapy of cancers, since they can be activated to become P-emitters by neutron bombardment. Ferrimagnetic microspheres are useful as thermoseeds for hyperthermia of cancers because they can heat cancers locally by hysteresis loss of the ferrimagnetic materials under an alternating magnetic field. Silver-containing silica glass microspheres are useful as antibacterial materials when mixed with organic polymers, particularly fine-spun polymer fibers.
C1 Kyoto Univ, Grad Sch Engn, Ion Beam Engn Expt Lab, Kyoto 6158510, Japan.
RP Kawashita, M (reprint author), Kyoto Univ, Grad Sch Engn, Ion Beam Engn Expt Lab, Kyoto 6158510, Japan.
EM kawashita@kuee.kyoto-u.ac.jp
RI Kawashita, Masakazu/E-6632-2016
OI Kawashita, Masakazu/0000-0002-4329-9001
CR ANDERSON JH, 1992, RADIOTHER ONCOL, V25, P137, DOI 10.1016/0167-8140(92)90020-U
   ANDREWS JC, 1994, J NUCL MED, V35, P1637
   ARAKI N, 2004, T 7 WORLD BIOM C AUS, P1827
   BORRELLI NF, 1982, AM CERAM SOC BULL, V61, P819
   BORRELLI NF, 1984, PHYS MED BIOL, V29, P487, DOI 10.1088/0031-9155/29/5/001
   BURTON MA, 1989, NUCL MED BIOL, V16, P495
   Cao XC, 1999, CHINESE MED J-PEKING, V112, P430
   CAVALIER.R, 1967, CANCER, V20, P1351, DOI 10.1002/1097-0142(196709)20:9<1351::AID-CNCR2820200902>3.0.CO;2-#
   Chen SD, 2001, NUCL MED COMMUN, V22, P121, DOI 10.1097/00006231-200102000-00002
   Day DE, 1993, INTRO BIOCERAMICS, P305
   EBISAWA Y, 1991, NIPPON SERAM KYO GAK, V99, P7
   EBISAWA Y, 1993, J MATER SCI-MATER M, V4, P225, DOI 10.1007/BF00122273
   EBISAWA Y, 1990, J MATER SCI-MATER M, V1, P239, DOI 10.1007/BF00701083
   Ebisawa Y, 1997, BIOMATERIALS, V18, P1277, DOI 10.1016/S0142-9612(97)00067-7
   Ebisawa Y, 1997, J CERAM SOC JPN, V105, P947, DOI 10.2109/jcersj.105.947
   EHRHARDT GJ, 1987, NUCL MED BIOL, V14, P233
   ERBE EM, 1993, J BIOMED MATER RES, V27, P1301, DOI 10.1002/jbm.820271010
   HIRAOKA M, 1989, CANCER RES, V49, P3734
   HOULE S, 1989, RADIOLOGY, V172, P857, DOI 10.1148/radiology.172.3.2549567
   HYATT MJ, 1987, J AM CERAM SOC, V70, pC283, DOI 10.1111/j.1151-2916.1987.tb04901.x
   IKENAGA M, 1993, J ORTHOP RES, V11, P849, DOI 10.1002/jor.1100110611
   Kawashita M, 1999, J AM CERAM SOC, V82, P683
   Kawashita M, 2005, BIOMATERIALS, V26, P2231, DOI 10.1016/j.biomaterials.2004.07.014
   Kawashita M, 2004, J CERAM SOC JPN, V112, P373, DOI 10.2109/jcersj.112.373
   Kawashita M, 2003, J BIOMED MATER RES A, V66A, P266, DOI 10.1002/jbm.a.10547
   Kawashita M, 2003, BIOMATERIALS, V24, P2955, DOI 10.1016/S0142-9612(03)00094-2
   Kawashita M, 2001, J CERAM SOC JPN, V109, P39, DOI 10.2109/jcersj.109.39
   Kawashita M, 2000, BIOMATERIALS, V21, P393, DOI 10.1016/S0142-9612(99)00201-X
   KNOWLES JE, 1981, J MAGN MAGN MATER, V25, P105, DOI 10.1016/0304-8853(81)90153-0
   KOKUBO T, 1992, BIOCERAMICS, V3, P213
   Konaka H, 1997, J CERAM SOC JPN, V105, P833, DOI 10.2109/jcersj.105.833
   LUDERER AA, 1983, RADIAT RES, V94, P190, DOI 10.2307/3575874
   MANTRAVADI RVP, 1982, RADIOLOGY, V142, P783, DOI 10.1148/radiology.142.3.7063703
   OHURA K, 1991, J APPL BIOMATER, V2, P153, DOI 10.1002/jab.770020303
   OVERGAARD J, 1977, CANCER-AM CANCER SOC, V39, P2637, DOI 10.1002/1097-0142(197706)39:6<2637::AID-CNCR2820390650>3.0.CO;2-S
   OVERGAARD K, 1972, EUR J CANCER, V8, P573, DOI 10.1016/0014-2964(72)90111-9
   SHEPHERD FA, 1992, CANCER, V70, P2250, DOI 10.1002/1097-0142(19921101)70:9<2250::AID-CNCR2820700906>3.0.CO;2-4
   Tian JH, 1996, J NUCL MED, V37, P958
   WOLLNER I, 1988, CANCER, V61, P1336, DOI 10.1002/1097-0142(19880401)61:7<1336::AID-CNCR2820610711>3.0.CO;2-K
   YAN ZP, 1993, ACTA RADIOL, V34, P395
   YAN ZP, 1993, CANCER, V72, P3210, DOI 10.1002/1097-0142(19931201)72:11<3210::AID-CNCR2820721113>3.0.CO;2-6
NR 41
TC 24
Z9 24
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1546-542X
EI 1744-7402
J9 INT J APPL CERAM TEC
JI Int. J. Appl. Ceram. Technol.
PY 2005
VL 2
IS 3
BP 173
EP 183
DI 10.1111/j.1744-7402.2005.02023.x
PG 11
WC Materials Science, Ceramics
SC Materials Science
GA 934MU
UT WOS:000229713700001
DA 2018-10-19
ER

PT B
AU Tjandra, W
   Ravi, P
   Tam, KC
   Yao, J
AF Tjandra, Wiliana
   Ravi, Palaniswamy
   Tam, Kam Chiu
   Yao, Jia
BE Zhou, W
   Ngoi, B
   Lim, GC
TI Precipitation of calcium phosphate in the presence of double hydrophilic
   block copolymer PEO-b-PMAA
SO INTERNATIONAL JOURNAL OF NANOSCIENCE, VOL 4, NO 4
SE International Journal of Nanoscience Series
LA English
DT Proceedings Paper
CT 1st International Conference on Nanotechnology (Nanotech 2004)
CY JUL 13-17, 2004
CL Singapore, SINGAPORE
DE calcium phosphate; PEO-b-PMAA
ID CRYSTAL-GROWTH MODIFIERS; DESIGN
AB Polyethylene oxide-block-polymethacrytic acid (PEO-b-PMAA) copolymer was employed as template for the controlled precipitation of calcium phosphate from aqueous solution at different pH values. Two interesting superstructures of an organized inorganic/organic hybrid material were characterized by electron microscopy. At pH of 4, a nested structure was obtained, which consists of hybrid nancifilaments. The fibers originate from a core of similar size to the primary polymer aggregates, suggesting that cooperative interactions at a local level between dissolving calcium phosphate clusters and disassembling polymer units could be responsible for the highly anisotropic nature of the secondary growth process. At pH of 9, a fractal induced growth morphology was obtained through the mineralization process. Such calcium phosphate/polymer nanohybrids with complex morphologies are interesting and may find application as novel ceramics precursors, reinforcing fillers, or biomedical implants.
C1 Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore 639798, Singapore.
RP Tjandra, W (reprint author), Nanyang Technol Univ, Sch Mech & Aerosp Engn, 50 Nanyang Ave, Singapore 639798, Singapore.
RI Tam, Michael/G-4813-2010
OI Tam, Michael/0000-0002-7603-5635
CR Antonietti M, 1998, CHEM-EUR J, V4, P2493, DOI 10.1002/(SICI)1521-3765(19981204)4:12<2493::AID-CHEM2493>3.0.CO;2-V
   Colfen H, 2001, MACROMOL RAPID COMM, V22, P219, DOI 10.1002/1521-3927(20010201)22:4<219::AID-MARC219>3.0.CO;2-G
   Colfen H, 1998, LANGMUIR, V14, P582, DOI 10.1021/la970765t
   Mann S, 1995, BIOMIMETIC MAT CHEM
   Qi LM, 2000, ANGEW CHEM INT EDIT, V39, P604, DOI 10.1002/(SICI)1521-3773(20000204)39:3<604::AID-ANIE604>3.0.CO;2-B
   Qi LM, 2001, CHEM-EUR J, V7, P3526, DOI 10.1002/1521-3765(20010817)7:16<3526::AID-CHEM3526>3.0.CO;2-Z
   Ravi P, 2003, MACROMOLECULES, V36, P173, DOI 10.1021/ma021302j
   Sedlak M, 1998, MACROMOL CHEM PHYSIC, V199, P247, DOI 10.1002/(SICI)1521-3935(19980201)199:2<247::AID-MACP247>3.0.CO;2-9
   Yao J, 2003, J MATER CHEM, V13, P3053, DOI 10.1039/b308801d
   Yu SH, 2002, CHEM-EUR J, V8, P2937, DOI 10.1002/1521-3765(20020703)8:13<2937::AID-CHEM2937>3.0.CO;2-I
NR 10
TC 1
Z9 1
U1 0
U2 2
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA PO BOX 128 FARRER RD, SINGAPORE 9128, SINGAPORE
J9 INT J NANOSCI SER
PY 2005
VL 4
IS 4
BP 731
EP 736
DI 10.1142/S0219581X05003437
PG 6
WC Nanoscience & Nanotechnology
SC Science & Technology - Other Topics
GA BGE42
UT WOS:000246301500042
DA 2018-10-19
ER

PT J
AU De Teresa, JM
   Marquina, C
   Serrate, D
   Fernandez-Pacheco, R
   Morellon, L
   Algarabel, PA
   Ibarra, MR
AF De Teresa, J. M.
   Marquina, C.
   Serrate, D.
   Fernandez-Pacheco, R.
   Morellon, L.
   Algarabel, P. A.
   Ibarra, M. R.
TI From magnetoelectronic to biomedical applications based on the nanoscale
   properties of advanced magnetic materials
SO INTERNATIONAL JOURNAL OF NANOTECHNOLOGY
LA English
DT Article
DE magnetoelectronic applications; biomedical applications; half-metals;
   magnetic tunnel junctions; inter-grain tunnel magnetoresistance;
   encapsulated nanoparticles
ID HALF-METALLIC FERROMAGNETS; ELECTRON-SPIN POLARIZATION;
   TUNNEL-JUNCTIONS; LARGE MAGNETORESISTANCE; INTERGRAIN MAGNETORESISTANCE;
   DOUBLE PEROVSKITES; CURIE-TEMPERATURE; ROOM-TEMPERATURE; FIELD;
   PARTICLES
AB In this paper, we review some results obtained in our group in the framework of research projects concerning magnetoelectronic and biomedical applications with advanced magnetic materials. First, we focus on the type of materials used, and then we describe specific magnetoelectronic devices based on spin-dependent tunnelling and magnetic nanoparticles for biomedical applications. Special attention is drawn to the phenomena occurring at the nanometric scale, which in most cases completely determine the observed macroscopic properties.
C1 Univ Zaragoza, CSIC, Inst Ciencia Mat Aragon, Fac Ciencias, Zaragoza, Spain.
   Inst Nanociencia Aragon, Zaragoza, Spain.
RP De Teresa, JM (reprint author), Univ Zaragoza, CSIC, Inst Ciencia Mat Aragon, Fac Ciencias, Zaragoza, Spain.
EM deteresa@unizar.es; clara@unizar.es; serrate@unizar.es;
   pacheco@unizar.es; morellon@unizar.es; algarabe@unizar.es;
   ibarra@unizar.es
RI DE TERESA, JOSE/E-2430-2011; Serrate, David/B-1433-2016; Marquina,
   Clara/N-4123-2014; Algarabel, Pedro/K-8583-2014; Ibarra, Manuel
   Ricardo/K-1150-2014
OI DE TERESA, JOSE/0000-0001-9566-0738; Serrate, David/0000-0002-3260-9641;
   Marquina, Clara/0000-0003-0602-492X; Algarabel,
   Pedro/0000-0002-4698-3378; Ibarra, Manuel Ricardo/0000-0003-0681-8260;
   /0000-0003-3724-508X
CR Alexiou C, 2002, J MAGN MAGN MATER, V252, P363, DOI 10.1016/S0304-8853(02)00605-4
   ALVARADO SF, 1975, PHYS REV LETT, V34, P319, DOI 10.1103/PhysRevLett.34.319
   Bowen M, 2001, APPL PHYS LETT, V79, P1655, DOI 10.1063/1.1404125
   Brown PJ, 2000, J PHYS-CONDENS MAT, V12, P1827, DOI 10.1088/0953-8984/12/8/325
   Bulte JWM, 1999, J MAGN MAGN MATER, V194, P204, DOI 10.1016/S0304-8853(98)00556-3
   Butler WH, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.054416
   Cadek M, 2002, CARBON, V40, P923, DOI 10.1016/S0008-6223(01)00221-4
   Cullity B. D., 1974, INTRO MAGNETIC MAT
   Dagotto E, 2001, PHYS REP, V344, P1, DOI 10.1016/S0370-1573(00)00121-6
   De Teresa JM, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.144401
   De Teresa JM, 1999, SCIENCE, V286, P507, DOI 10.1126/science.286.5439.507
   De Teresa JM, 1999, PHYS REV LETT, V82, P4288, DOI 10.1103/PhysRevLett.82.4288
   DEGROOT RA, 1983, PHYS REV LETT, V50, P2024, DOI 10.1103/PhysRevLett.50.2024
   DeTeresa JM, 1997, NATURE, V386, P256
   Diouf B, 2003, J MAGN MAGN MATER, V265, P204, DOI 10.1016/S0304-8853(03)00267-1
   Faure-Vincent J, 2003, APPL PHYS LETT, V82, P4507, DOI 10.1063/1.1586785
   Fontcuberta J, 2002, J MAGN MAGN MATER, V242, P98, DOI 10.1016/S0304-8853(01)01208-2
   Gabillet L, 2004, J MAGN MAGN MATER, V272, pE1525, DOI 10.1016/j.jmmm.2003.12.1056
   Gruttner C, 2001, J MAGN MAGN MATER, V225, P1, DOI 10.1016/S0304-8853(00)01220-8
   Hehn M, 2004, EUR PHYS J B, V40, P19, DOI 10.1140/epjb/e2004-00234-6
   Inoue J, 1996, PHYS REV B, V53, P11927, DOI 10.1103/PhysRevB.53.R11927
   Jordan A, 2001, J MAGN MAGN MATER, V225, P118, DOI 10.1016/S0304-8853(00)01239-7
   JULLIERE M, 1975, PHYS LETT A, V54, P225, DOI 10.1016/0375-9601(75)90174-7
   Kato H, 2002, APPL PHYS LETT, V81, P328, DOI 10.1063/1.1493646
   Kobayashi KL, 1998, NATURE, V395, P677, DOI 10.1038/27167
   Kozlova N, 2003, J MAGN MAGN MATER, V261, P48, DOI 10.1016/S0304-8853(02)01411-7
   KRATSCHMER W, 1990, NATURE, V347, P354, DOI 10.1038/347354a0
   Kuznetsov AA, 2001, J MAGN MAGN MATER, V225, P95, DOI 10.1016/S0304-8853(00)01235-X
   LeClair P, 2002, APPL PHYS LETT, V80, P625, DOI 10.1063/1.1436284
   LeClair P, 2001, PHYS REV LETT, V86, P1066, DOI 10.1103/PhysRevLett.86,1066
   Lee S, 1999, PHYS REV LETT, V82, P4508, DOI 10.1103/PhysRevLett.82.4508
   Mariotto G, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.245426
   MARTINEZBOUBETA C, 2003, J APPL PHYS, V94, P4006
   MOODERA JS, 1988, PHYS REV LETT, V61, P637, DOI 10.1103/PhysRevLett.61.637
   MOODERA JS, 1993, PHYS REV LETT, V70, P853, DOI 10.1103/PhysRevLett.70.853
   MOODERA JS, 1995, PHYS REV LETT, V74, P3273, DOI 10.1103/PhysRevLett.74.3273
   Navarro J, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.092411
   Oleinik II, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.020401
   OTTO MJ, 1989, J PHYS-CONDENS MAT, V1, P2341, DOI 10.1088/0953-8984/1/13/007
   PALSTROM F, 2003, MRS BULL, V28, P725
   Pannetier M, 2004, SCIENCE, V304, P1648, DOI 10.1126/science.1096841
   Pardoe H, 2003, MAGN RESON IMAGING, V21, P483, DOI 10.1016/S0730-725X(03)00072-9
   Pardoe H, 2001, J MAGN MAGN MATER, V225, P41, DOI 10.1016/S0304-8853(00)01226-9
   Park JH, 1998, NATURE, V392, P794, DOI 10.1038/33883
   Rechenberg HR, 2001, J MAGN MAGN MATER, V226, P1930, DOI 10.1016/S0304-8853(00)00667-3
   Rittmannsberger H, 2000, EUR ADDICT RES, V6, P2, DOI 10.1159/000019003
   Seneor P, 1999, APPL PHYS LETT, V74, P4017, DOI 10.1063/1.123246
   Serrate D, 2004, EUR PHYS J B, V39, P35, DOI [10.1140/epjb/e2004-00167-0, 10.1140/epjb/e2004-001G7-0]
   Serrate D, 2002, APPL PHYS LETT, V80, P4573, DOI 10.1063/1.1485119
   Soulen RJ, 1998, SCIENCE, V282, P85, DOI 10.1126/science.282.5386.85
   Ziolo R. F., 2002, EUR CELLS MATER, V3, P92
NR 51
TC 16
Z9 16
U1 1
U2 8
PU INDERSCIENCE ENTERPRISES LTD
PI GENEVA
PA WORLD TRADE CENTER BLDG, 29 ROUTE DE PRE-BOIS, CASE POSTALE 856, CH-1215
   GENEVA, SWITZERLAND
SN 1475-7435
EI 1741-8151
J9 INT J NANOTECHNOL
JI Int. J. Nanotechnol.
PY 2005
VL 2
IS 1-2
BP 3
EP 22
PG 20
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 074FF
UT WOS:000239797400002
DA 2018-10-19
ER

PT J
AU Shikanov, A
   Kumar, N
   Domb, AJ
AF Shikanov, A
   Kumar, N
   Domb, AJ
TI Biodegradable polymers: An update
SO ISRAEL JOURNAL OF CHEMISTRY
LA English
DT Article
ID DRUG-DELIVERY SYSTEMS; PLASMID DNA; GAMMA-IRRADIATION; MOLECULAR-WEIGHT;
   IN-VITRO; POLY(4-HYDROXY-L-PROLINE ESTER); ALIPHATIC POLYESTERS;
   RICINOLEIC ACID; GENE DELIVERY; BONE FIXATION
AB The use of polymeric materials for the administration of pharmaceuticals, and as biomedical devices has increased dramatically. This review focuses on synthetic biodegradable polymers of current interest for medical use, based on ester and anhydride bonds. Special attention is given to factors affecting biodegradation, including: polymer structure, morphology, molecular weight, radiation, and chemical treatment, as well as the effects of drugs and plasticizers added to the polymer mass. The toxicity and biocompatibility of the polymers and their current and future applications in medicine are also briefly reviewed.
C1 Hebrew Univ Jerusalem, Dept Med Chem & Nat Prod, Sch Pharm, Fac Med, IL-91120 Jerusalem, Israel.
   NIPER, Dept Pharmaceut, Mohali 160062, India.
RP Domb, AJ (reprint author), Hebrew Univ Jerusalem, Dept Med Chem & Nat Prod, Sch Pharm, Fac Med, IL-91120 Jerusalem, Israel.
EM adomb@md.huji.ac.il
OI Shikanov, Ariella/0000-0003-0159-6419
CR Alexis F, 2005, POLYM INT, V54, P36, DOI 10.1002/pi.1697
   Amsden B, 2004, BIOMACROMOLECULES, V5, P637, DOI 10.1021/bm034457n
   Arvanitoyannis IS, 1999, J MACROMOL SCI R M C, VC39, P205
   ATALA A, 2005, REGENERATIVE MED LI, V994, P181
   BENEDICT CV, 1983, J APPL POLYM SCI, V28, P327, DOI 10.1002/app.1983.070280128
   BENEDICT CV, 1983, J APPL POLYM SCI, V28, P335, DOI 10.1002/app.1983.070280129
   Bezwada R. S., 1990, T SOC BIOMATER, VXIII, P194
   BOGDANSKY S, 1990, DRUGS PHARM SCI, V45, P231
   Bostman O, 2000, BIOMATERIALS, V21, P2615, DOI 10.1016/S0142-9612(00)00129-0
   CHU CC, 1985, POLYMER, V26, P591, DOI 10.1016/0032-3861(85)90160-0
   Dang WB, 1996, J CONTROL RELEASE, V42, P83, DOI 10.1016/0168-3659(96)01371-5
   Dang WB, 1996, PHARMACEUT RES, V13, P683, DOI 10.1023/A:1016035229961
   DOMB AJ, 1995, BIOMATERIALS, V16, P1069, DOI 10.1016/0142-9612(95)98902-Q
   Domb AJ, 1997, DRUG TARG D, V7, P135
   Durselen L, 2001, J BIOMED MATER RES, V58, P666, DOI 10.1002/jbm.1067
   Durucan C, 2001, ADV ENG MATER, V3, P227, DOI 10.1002/1527-2648(200104)3:4<227::AID-ADEM227>3.3.CO;2-T
   Eberhart RC, 2003, J BIOMAT SCI-POLYM E, V14, P299, DOI 10.1163/156856203321478838
   Edwards RC, 2001, J ORAL MAXIL SURG, V59, P19, DOI 10.1053/joms.2001.19267
   Erbacher P, 1998, PHARMACEUT RES, V15, P1332, DOI 10.1023/A:1011981000671
   Freudenberg S, 2004, EUR SURG RES, V36, P376, DOI 10.1159/000081648
   Gomes ME, 2004, INT MATER REV, V49, P261, DOI 10.1179/095066004225021918
   GREISLER HP, 1988, J VASC SURG, V7, P697, DOI 10.1067/mva.1988.avs0070697
   Hakkarainen M, 2002, ADV POLYM SCI, V157, P113
   HAYASHI T, 1994, PROG POLYM SCI, V19, P663, DOI 10.1016/0079-6700(94)90030-2
   Huang SJ, 1999, MACROMOL SYMP, V144, P7, DOI 10.1002/masy.19991440104
   Hyon SH, 2003, MACROMOL SYMP, V197, P355, DOI 10.1002/masy.200350731
   Jeong B, 2000, J CONTROL RELEASE, V63, P155, DOI 10.1016/S0168-3659(99)00194-7
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Joraku A, 2005, LARYNGOSCOPE, V115, P244, DOI 10.1097/01.mlg.0000154726.77915.cc
   KAWAGUCHI T, 1982, CHEM PHARM BULL, V30, P1517
   KEMNITZER J, 1997, HDB BIODEGRADABLE PO, V7, P251
   Koh JJ, 2000, GENE THER, V7, P2099, DOI 10.1038/sj.gt.3301334
   KOHN J, 1987, J AM CHEM SOC, V109, P817, DOI 10.1021/ja00237a030
   KOIDE M, 1993, J BIOMED MATER RES, V27, P79, DOI 10.1002/jbm.820270111
   Korhonen H, 2004, MACROMOL CHEM PHYSIC, V205, P937, DOI 10.1002/macp.200300208
   Krasko MY, 2003, J POLYM SCI POL CHEM, V41, P1059, DOI 10.1002/pola.10651
   Lee M, 2001, PHARMACEUT RES, V18, P427, DOI 10.1023/A:1011037807261
   Leong K W, 1995, Connect Tissue Res, V31, pS69, DOI 10.3109/03008209509116838
   LEONG KW, 1991, POLYM CONTROLLED DRU, V127
   LEONG KW, 1997, CONTROLLED DRUG DELI, V469
   LEWIS DH, 1984, LONG ACTING CONTRACE, V1, P77
   Lim YB, 1999, J AM CHEM SOC, V121, P5633, DOI 10.1021/ja984012k
   Mader K, 1996, APPL RADIAT ISOTOPES, V47, P1669, DOI 10.1016/S0969-8043(96)00236-9
   Maheshwari A, 2000, MOL THER, V2, P121, DOI 10.1006/mthe.2000.0105
   Mano JF, 2004, COMPOS SCI TECHNOL, V64, P789, DOI 10.1016/j.compscitech.2003.09.001
   MCCORMICK CL, 1985, ENCY POLYM SCI ENG, V1, P611
   MENDAK SH, 1984, ANN THORAC SURG, V38, P488, DOI 10.1016/S0003-4975(10)64190-2
   Montanari L, 1998, J CONTROL RELEASE, V56, P219, DOI 10.1016/S0168-3659(98)00082-0
   Mumper RJ, 1999, DRUG TARGETING DELIV, V10, P143
   Murphy WL, 1999, J PERIODONTAL RES, V34, P413, DOI 10.1111/j.1600-0765.1999.tb02275.x
   Nagarsekar A, 1999, J DRUG TARGET, V7, P11, DOI 10.3109/10611869909085489
   Nathan A., 1994, BIOMEDICAL POLYM DES, P117
   Orloff LA, 1997, ADV DRUG DELIVER REV, V24, P3, DOI 10.1016/S0169-409X(96)00478-4
   PARK TG, 1994, J CONTROL RELEASE, V30, P161, DOI 10.1016/0168-3659(94)90263-1
   Perrin D.E., 1997, HDB BIODEGRADABLE PO, V7, P63
   PITT CG, 1981, J APPL POLYM SCI, V26, P3779, DOI 10.1002/app.1981.070261124
   POTTS JE, 1984, KIRK OTHMER ENCY C S
   Pruitt LA, 2003, ADV POLYM SCI, V162, P63
   Putnam D, 1999, MACROMOLECULES, V32, P3658, DOI 10.1021/ma982004i
   Schindler A, 1977, CONT TOPICS POLYM SC, V2, P251
   Shikanov A, 2004, J BIOMED MATER RES A, V69A, P47, DOI 10.1002/jbm.a.20101
   Shikinami Y, 2005, BIOMATERIALS, V26, P5542, DOI 10.1016/j.biomaterials.2005.02.016
   SIEMANN U, 1985, P INT S CONTROLLED R, V12, P53
   Soppimath KS, 2001, J CONTROL RELEASE, V75, P331, DOI 10.1016/S0168-3659(01)00404-7
   Teomim D, 2001, BIOMACROMOLECULES, V2, P1015, DOI 10.1021/bm010078n
   Thomson RC, 1995, ADV POLYM SCI, V122, P245
   Tomihata K, 2001, J BIOMED MATER RES, V58, P511, DOI 10.1002/jbm.1048
   VACANTI JP, 1999, LANCET S1, V354, P132
   VERT M, 2005, BIOMACROMOLECULES, V6, P358
   Wake MC, 1996, CELL TRANSPLANT, V5, P465, DOI 10.1016/0963-6897(96)00025-5
   WALTER KA, 1995, NEUROSURGERY, V37, P1129, DOI 10.1227/00006123-199512000-00013
   WILLIAMS DF, 1984, J APPL POLYM SCI, V29, P1865, DOI 10.1002/app.1984.070290537
   Wu XS, 2001, J BIOMAT SCI-POLYM E, V12, P21, DOI 10.1163/156856201744425
   Zhang XC, 1996, INT J PHARM, V137, P199, DOI 10.1016/0378-5173(96)04521-8
NR 74
TC 19
Z9 19
U1 0
U2 8
PU LASER PAGES PUBL LTD
PI JERUSALEM
PA MERKAZ SAPIR 6/36, GIVAT SHAUL, PO BOX 35409, JERUSALEM 91352, ISRAEL
SN 0021-2148
J9 ISRAEL J CHEM
JI Isr. J. Chem.
PY 2005
VL 45
IS 4
BP 393
EP 399
DI 10.1560/ATQM-MQ02-GLDU-EF6L
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA 988CZ
UT WOS:000233570300002
DA 2018-10-19
ER

PT J
AU Kenawy, ER
   Abdel-Hay, FI
   Abou El-Magd, A
   Mahmoud, Y
AF Kenawy, ER
   Abdel-Hay, FI
   Abou El-Magd, A
   Mahmoud, Y
TI Biologically active polymers: Modification and anti-microbial activity
   of chitosan derivatives
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE anti-microbial polymers; chitosan; biomedical polymers; biocide;
   biological applications of polymers
ID QUATERNARY AMMONIUM; ANTIBACTERIAL ACTIVITY; PHOSPHONIUM GROUPS;
   ADSORPTION; SURFACE; BIOCIDES; RELEASE; FABRICS; CHITIN; FIBER
AB The principal derivative of chitin is chitosan, which is obtained by deacetylation of chitin. Chemical modification of synthetic and natural polymers is a convenient way to obtain materials with unique chemical and physical properties. Chitosan has an amino group at C-2 which is important because amino groups are nucleophilic and readily react with electrophilic reagents. Chitosan modified under mild conditions often results in regioselectivity for the C-2 amino group.
   In the present work, this reactivity was exploited to attach biologically active moieties into the amino groups of chitosan to yield anti-microbial chitosans. Specifically, vanillin, p-hydroxybenzaldehyde, p-chlorobenzaldehyde, anisaldehyde, methyl 4-hydroxybenzoate, methyl 2,4-dihydroxybenzoate, propyl 3,4,5-trihydroxybenzoate and 2-hydroxymethylbenzoate were attached. The anti-microbial activity of these modified chitosans was explored against fungi such as Candida albicans SC5314, Aspergillus flavus and Fusarium oxysporium. Also, they were tested against bacteria such as Bacillus subtilis, Escherichia coli and Staphylococcus aureus. These modified chitosans were found to be highly active toward fungi species more than bacterial species.
C1 Tanta Univ, Fac Sci, Dept Chem, Polymer Res Grp, Tanta, Egypt.
   Tanta Univ, Fac Sci, Dept Bot, Tanta, Egypt.
RP Kenawy, ER (reprint author), Tanta Univ, Fac Sci, Dept Chem, Polymer Res Grp, Tanta, Egypt.
EM ekenawy@yahoo.com
RI ABOUELMAGD, Ahmed/A-2952-2012
OI Mahmoud, Yehia/0000-0002-7009-0115; Kenawy,
   El-Refaie/0000-0002-0194-843X
CR Agullo E, 2003, MACROMOL BIOSCI, V3, P521, DOI 10.1002/mabi.200300010
   Benesch J, 2002, BIOMATERIALS, V23, P2561, DOI 10.1016/S0142-9612(01)00391-X
   Chen Y, 2004, J APPL POLYM SCI, V92, P368, DOI 10.1002/app.20038
   Cho YW, 1999, BIOMATERIALS, V20, P2139, DOI 10.1016/S0142-9612(99)00116-7
   Choi HM, 2004, J APPL POLYM SCI, V92, P3343, DOI 10.1002/app.20332
   Debbaudt A, 2001, MACROMOL BIOSCI, V1, P249, DOI 10.1002/1616-5195(20010801)1:6<249::AID-MABI249>3.0.CO;2-G
   Dodane V, 1998, PHARM SCI TECHNOL TO, V1, P246, DOI 10.1016/S1461-5347(98)00059-5
   Hu SG, 2002, J APPL POLYM SCI, V86, P2977, DOI 10.1002/app.11261
   Huh MW, 2001, J APPL POLYM SCI, V81, P2769, DOI 10.1002/app.1723
   Humeres E, 2002, J PHYS ORG CHEM, V15, P852, DOI 10.1002/poc.559
   Kenawy ER, 2002, J POLYM SCI POL CHEM, V40, P2384, DOI 10.1002/pola.10325
   Kenawy ER, 2002, J CONTROL RELEASE, V81, P57, DOI 10.1016/S0168-3659(02)00041-X
   Kenawy ER, 2003, MACROMOL BIOSCI, V3, P107, DOI 10.1002/mabi.200390016
   Kenawy ER, 2002, MACROMOL BIOSCI, V2, P261, DOI 10.1002/1616-5195(200208)2:6<261::AID-MABI261>3.0.CO;2-2
   Kenawy ER, 2001, J APPL POLYM SCI, V82, P1364, DOI 10.1002/app.1973
   Kenawy ER, 1998, J CONTROL RELEASE, V50, P145, DOI 10.1016/S0168-3659(97)00126-0
   Koseva N, 2001, J BIOACT COMPAT POL, V16, P3
   Lim SH, 2004, CARBOHYD RES, V339, P313, DOI 10.1016/j.carres.2003.10.024
   Mahmoud Y. A. G., 2001, ARAB J BIOTECH, V4, P15
   Morimoto M, 2001, BIOMACROMOLECULES, V2, P1133, DOI 10.1021/bm010063p
   PLASCENCIAJATOMEA, 2003, MACROMOL BIOSCI, V3, P582
   Shin Y, 2001, J APPL POLYM SCI, V80, P2495, DOI 10.1002/app.1357
   Sun YY, 2001, J APPL POLYM SCI, V80, P2460, DOI 10.1002/app.1353
   Sun YY, 2001, J POLYM SCI POL CHEM, V39, P3348, DOI 10.1002/pola.1317
   Tang XH, 2002, J APPL POLYM SCI, V83, P1886, DOI 10.1002/app.2316
   Tozaki H, 1997, J PHARM SCI, V86, P1016, DOI 10.1021/js970018g
   Tsubokawa N, 2000, REACT FUNCT POLYM, V43, P341, DOI 10.1016/S1381-5148(99)00065-6
   Wang LH, 2002, J BIOMED MATER RES, V63, P610, DOI 10.1002/jbm.10382
   Zhu P, 2004, J APPL POLYM SCI, V93, P1037, DOI 10.1002/app.20563
NR 29
TC 50
Z9 50
U1 2
U2 32
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD JAN
PY 2005
VL 20
IS 1
BP 95
EP 111
DI 10.1177/0883911505049655
PG 17
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA 886QA
UT WOS:000226242200006
DA 2018-10-19
ER

PT J
AU Ciardelli, G
   Silvestri, D
   Cristallini, C
   Barbani, N
   Giusti, P
AF Ciardelli, G
   Silvestri, D
   Cristallini, C
   Barbani, N
   Giusti, P
TI The relevance of the transfer of molecular information between natural
   and synthetic materials in the realisation of biomedical devices with
   enhanced properties
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE molecular information; molecular imprinting; biosensors; tissue
   engineering
ID BIOARTIFICIAL POLYMERIC MATERIALS; ACID COPOLYMER MEMBRANE; IMPRINTED
   POLYMERS; ACRYLIC-ACID; TEMPLATE POLYMERIZATION; PHARMACEUTICAL
   APPLICATIONS; RADICAL POLYMERIZATION; SELECTIVE RECOGNITION; ARTIFICIAL
   ANTIBODIES; REACTION-MECHANISM
AB Past and recent attempts to introduce in synthetic polymers molecular information from natural substances through simple blending, template polymerization and molecular imprinting are reviewed. The most promising approaches that can open the way to the realisation of new materials with improved biocompatibility, antibody- or enzyme-like performances are analysed more deeply. The realisation of bioartificial blends from natural and synthetic polymers, molecularly imprinted nanospheres or membranes that can act as recognition element in (bio)sensing devices, as synthetic enzymes or as key constituents of body fluids purification tools is presented in order to make the reader aware of the fascinating possibilities that these techniques make available to the biomedical science and engineering in the close future. The last part of the paper describes recent attempts to insert recognition elements for large molecules as proteins, DNA segments, viruses or whole cells in synthetic polymer systems, in order to develop new systems in the treatments of diseases and for tissue-engineering applications.
C1 Univ Pisa, Dept Chem Engn Ind Chem & Mat Sci, Pisa, Italy.
   CNR, Sect Pisa, Composite & Biomed Mat Inst, I-56100 Pisa, Italy.
RP Ciardelli, G (reprint author), Univ Pisa, Dept Chem Engn Ind Chem & Mat Sci, Pisa, Italy.
EM gianluca.ciardelli@ing.unipi.it
OI Ciardelli, Gianluca/0000-0003-0199-1427; Cristallini,
   Caterina/0000-0002-5924-8401
CR Aherne A, 1996, J AM CHEM SOC, V118, P8771, DOI 10.1021/ja960123c
   Allender CJ, 2000, INT J PHARM, V195, P39, DOI 10.1016/S0378-5173(99)00355-5
   ANDERSSON LI, 1995, P NATL ACAD SCI USA, V92, P4788, DOI 10.1073/pnas.92.11.4788
   ANDERSSON LI, 1996, ADV MOL CELL BIOL B, V15, P651
   BAMFORD CH, 1980, MAKROMOL CHEM, V1, P52
   BOLISAY LD, 2003, MRS FALL M 2003 BOST
   Bossi A, 2001, ANAL CHEM, V73, P5281, DOI 10.1021/ac0006526
   Bures P, 2001, J CONTROL RELEASE, V72, P25, DOI 10.1016/S0168-3659(01)00259-0
   Byrne ME, 2002, ADV DRUG DELIVER REV, V54, P149, DOI 10.1016/S0169-409X(01)00246-0
   CERRAI P, 1996, MACROMOL CHEM PHYS, V197, P1
   CHALLA G, 1981, PURE APPL CHEM, V53, P627, DOI 10.1351/pac198153030627
   Cheong SH, 1997, MACROMOLECULES, V30, P1317, DOI 10.1021/ma961014l
   Cheong SH, 1998, J POLYM SCI POL CHEM, V36, P1725, DOI 10.1002/(SICI)1099-0518(199808)36:11<1725::AID-POLA5>3.0.CO;2-Q
   Ciardelli G, 2002, MACROMOL CHEM PHYSIC, V203, P1666, DOI 10.1002/1521-3935(200207)203:10/11<1666::AID-MACP1666>3.0.CO;2-D
   Ciardelli G, 2001, POLYM INT, V50, P588, DOI 10.1002/pi.670
   CIARDELLI G, 2004, MAT RES SOC S P, V787
   Cormack PAG, 1999, REACT FUNCT POLYM, V41, P115, DOI 10.1016/S1381-5148(99)00024-3
   Cristallini C, 2004, MACROMOL BIOSCI, V4, P31, DOI 10.1002/mabi.200300026
   Cristallini C, 2001, MACROMOL CHEM PHYSIC, V202, P2104, DOI 10.1002/1521-3935(20010601)202:10<2104::AID-MACP2104>3.0.CO;2-H
   Cristallini C, 1999, POLYM INT, V48, P1251, DOI 10.1002/(SICI)1097-0126(199912)48:12<1251::AID-PI297>3.0.CO;2-H
   GIUSTI P, 1994, BIOMATERIALS, V15, P1229, DOI 10.1016/0142-9612(94)90274-7
   Giusti P., 1996, POLYM MAT ENCY, P538
   GLAD M, 1995, REACT POLYM, V25, P47, DOI 10.1016/0923-1137(95)00018-E
   Hilal N, 2003, J MEMBRANE SCI, V213, P97, DOI 10.1016/S0376-7388(02)00516-1
   Hirayama K, 1998, CHEM LETT, P731, DOI 10.1246/cl.1998.731
   Hjerten S, 1997, CHROMATOGRAPHIA, V44, P227, DOI 10.1007/BF02466386
   KABANOV VA, 1979, MAKROMOL CHEM S, V3, P41
   Kobayashi T, 2001, ANAL CHIM ACTA, V435, P141, DOI 10.1016/S0003-2670(00)01281-2
   Kobayashi T, 1998, ANAL CHIM ACTA, V365, P81, DOI 10.1016/S0003-2670(97)00667-3
   KOBAYASHI T, 1995, CHEM LETT, P927, DOI 10.1246/cl.1995.927
   KOST J, 1992, TRENDS BIOTECHNOL, V10, P127, DOI 10.1016/0167-7799(92)90194-Z
   Lai JP, 2001, ANAL CHIM ACTA, V442, P105, DOI 10.1016/S0003-2670(01)01115-1
   Lanza F, 1999, ANAL CHEM, V71, P2092, DOI 10.1021/ac981446p
   Levi R, 1997, ANAL CHEM, V69, P2017, DOI 10.1021/ac960983b
   Liao JL, 1996, CHROMATOGRAPHIA, V42, P259, DOI 10.1007/BF02290306
   MANESIOTIS P, 2003, SYNTHETIC RECEPTORS
   MathewKrotz J, 1996, J AM CHEM SOC, V118, P8154, DOI 10.1021/ja954066j
   MAYES AG, 1994, ANAL BIOCHEM, V222, P483, DOI 10.1006/abio.1994.1521
   Mosbach K, 2001, J AM CHEM SOC, V123, P12420, DOI 10.1021/ja017096x
   MOSBACH K, 1994, TRENDS BIOCHEM SCI, V19, P9, DOI 10.1016/0968-0004(94)90166-X
   Mosbach K, 1996, BIO-TECHNOL, V14, P163, DOI 10.1038/nbt0296-163
   Nicholls IA, 2001, ANAL CHIM ACTA, V435, P9, DOI 10.1016/S0003-2670(01)00932-1
   Ou SH, 2004, ANAL CHIM ACTA, V504, P163, DOI 10.1016/S0003-2670(03)00531-2
   PARMPI P, 2004, MAT RES SOC S, V787
   Perez-Moral N, 2004, ANAL CHIM ACTA, V504, P15, DOI 10.1016/S0003-2670(03)00533-6
   PILETSKII S A, 1990, Biopolimery i Kletka, V6, P55
   Piletsky SA, 1999, J MEMBRANE SCI, V157, P263, DOI 10.1016/S0376-7388(99)00007-1
   Rachkov A, 2004, ANAL CHIM ACTA, V504, P191, DOI 10.1016/S0003-2670(03)00764-5
   Rachkov A, 2001, BBA-PROTEIN STRUCT M, V1544, P255, DOI 10.1016/S0167-4838(00)00226-0
   Rachkov A, 2000, J CHROMATOGR A, V889, P111, DOI 10.1016/S0021-9673(00)00568-9
   Rainaldi I, 2000, MACROMOL CHEM PHYSIC, V201, P2424, DOI 10.1002/1521-3935(20001101)201:17<2424::AID-MACP2424>3.0.CO;2-8
   Ramstrom O, 1996, CHEM BIOL, V3, P471, DOI 10.1016/S1074-5521(96)90095-2
   Sellergren B, 2000, ANGEW CHEM INT EDIT, V39, P1031, DOI 10.1002/(SICI)1521-3773(20000317)39:6<1031::AID-ANIE1031>3.0.CO;2-F
   Sellergren B, 1998, CHEM MATER, V10, P4037, DOI 10.1021/cm980730u
   SHEA KJ, 1994, TRENDS POLYM SCI, V2, P166
   Silvestri D, 2004, J BIOMAT SCI-POLYM E, V15, P255, DOI 10.1163/156856204322977175
   SLINCHENKO O, SYNTHETIC RECEPTORS
   SRIVASTAVA AK, 1987, J MACROMOL SCI R M C, VC27, P171
   Steinke J, 1995, ADV POLYM SCI, V123, P81
   Subrahmanyam S, 2001, BIOSENS BIOELECTRON, V16, P631, DOI 10.1016/S0956-5663(01)00191-9
   Wang HY, 1997, J CHEM TECHNOL BIOT, V70, P355, DOI 10.1002/(SICI)1097-4660(199712)70:4<355::AID-JCTB793>3.0.CO;2-#
   Wang HY, 1996, LANGMUIR, V12, P4850, DOI 10.1021/la960243y
   Wizeman WJ, 2001, BIOMATERIALS, V22, P1485
   WULFF G, 1972, ANGEW CHEM INT EDIT, V11, P341
   WULFF G, 1995, ANGEW CHEM INT EDIT, V34, P1812, DOI 10.1002/anie.199518121
   Ye L, 2000, MACROMOLECULES, V33, P8239, DOI 10.1021/ma000825t
   Ye L, 2001, REACT FUNCT POLYM, V48, P149, DOI 10.1016/S1381-5148(01)00050-5
   YOSHIKAWA M, 1995, J MEMBRANE SCI, V108, P171, DOI 10.1016/0376-7388(95)00160-8
   Yoshikawa M, 1996, CHEM LETT, P611, DOI 10.1246/cl.1996.611
   Yoshikawa M, 1997, MACROMOL RAPID COMM, V18, P761, DOI 10.1002/marc.1997.030180902
   Yu YH, 2002, ANGEW CHEM INT EDIT, V41, P4459, DOI 10.1002/1521-3773(20021202)41:23<4459::AID-ANIE4459>3.0.CO;2-2
   Zi-Hui Meng, 2001, Analytica Chimica Acta, V435, P121, DOI 10.1016/S0003-2670(01)00858-3
NR 72
TC 8
Z9 8
U1 0
U2 9
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2005
VL 16
IS 2
BP 219
EP 236
DI 10.1163/1568562053115417
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 907QW
UT WOS:000227734000007
PM 15794487
DA 2018-10-19
ER

PT J
AU Ouchi, T
   Kontani, T
   Saito, T
   Ohya, Y
AF Ouchi, T
   Kontani, T
   Saito, T
   Ohya, Y
TI Suppression of cell attachment and protein adsorption onto amphiphilic
   polylactide-grafted dextran films
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE biodegradable polymer; dextran; polylactide cell attachment; protein
   adsorption
ID TRIMETHYLSILYL PROTECTION METHOD; L-LACTIDE; BLOCK-COPOLYMERS; IN-VITRO;
   ACID; POLYMERIZATION; DEGRADATION; PULLULAN; SURFACE
AB To develop novel biodegradable biomedical materials, potylactide-grafted dextrans (Dex-g-PLA)s having various lengths, numbers of graft chains and sugar units were synthesized using the trimethylsilyl (TMS) protection method. To explore the possibility of using Dex-g-PLA as a biomedical soft-material, the contact angle, cell attachment and protein adsorption properties of the films prepared from these biodegradable and amphiphilic graft co-polymers were investigated. The poly-L-lactide (PLLA) film did not absorb water at all because of its high hydrophobicity, while the graft co-polymer films started immediately to swell after immersion in PBS. The percentage of water absorption at equilibrium increased with increasing sugar unit content. The receding contact angle of the Dex-g-PLA films against water was smaller than that of the PLLA film. The receding contact angle of Dex-g-PLA films against water decreased with increasing the sugar unit content. The top surface of the Dex-g-PLA film was suggested to be covered with hydrophilic Dex segments by means of annealing in water and to afford the wettable surface. Such a wettable surface led to the suppression of cell attachment and protein adsorption onto the film.
C1 Kansai Univ, Fac Engn, Dept Appl Chem, Suita, Osaka 5648680, Japan.
   Kansai Univ, High Technol Res Ctr, Suita, Osaka 5648680, Japan.
RP Ouchi, T (reprint author), Kansai Univ, Fac Engn, Dept Appl Chem, Suita, Osaka 5648680, Japan.
EM touchi@ipcku.karisai-u.ac.jp; yohya@ipcku.kansai-u.ac.jp
CR CELLI A, 1992, POLYMER, V33, P2699, DOI 10.1016/0032-3861(92)90440-8
   Choi EJ, 1999, MACROMOLECULES, V32, P7402, DOI 10.1021/ma981453f
   de Jong SJ, 2000, MACROMOLECULES, V33, P3680, DOI 10.1021/ma992067g
   Donabedian DH, 1998, MACROMOLECULES, V31, P1032, DOI 10.1021/ma961741g
   FRAZZA E J, 1971, Journal of Biomedical Materials Research Biomedical Materials Symposium, V1, P43
   Harada A, 1998, MACROMOLECULES, V31, P288, DOI 10.1021/ma971277v
   Kissel T, 1996, J CONTROL RELEASE, V39, P315, DOI 10.1016/0168-3659(95)00163-8
   KRICHELDORF HR, 1993, MAKROMOL CHEM-M SYMP, V73, P47, DOI 10.1002/masy.19930730107
   Li YX, 1997, POLYMER, V38, P6197, DOI 10.1016/S0032-3861(97)00178-X
   OGAWA Y, 1988, CHEM PHARM BULL, V36, P1095
   Ohya Y, 1998, MACROMOL CHEM PHYSIC, V199, P2017, DOI 10.1002/(SICI)1521-3935(19980901)199:9<2017::AID-MACP2017>3.0.CO;2-9
   Ohya Y, 1998, MACROMOLECULES, V31, P4662, DOI 10.1021/ma980377d
   Otsuka H, 2000, BIOMACROMOLECULES, V1, P39, DOI 10.1021/bm990005s
   Ouchi T, 2003, J POLYM SCI POL CHEM, V41, P2462, DOI 10.1002/pola.10783
   Ouchi T, 2003, POLYMER, V44, P3927, DOI 10.1016/S0032-3861(03)000308-2
   Ouchi T, 2001, MACROMOL BIOSCI, V1, P371, DOI 10.1002/1616-5195(20011201)1:9<371::AID-MABI371>3.3.CO;2-N
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   TANADA Y, 1994, J BIOMED MATER RES, V28, P783
   Tasaka F, 1999, MACROMOLECULES, V32, P6386, DOI 10.1021/ma990766n
   Yamaoka T, 2001, J BIOMED MATER RES, V54, P470, DOI 10.1002/1097-4636(20010315)54:4<470::AID-JBM20>3.3.CO;2-O
   Ydens I, 2000, MACROMOLECULES, V33, P6713, DOI 10.1021/ma0002803
NR 21
TC 12
Z9 12
U1 2
U2 14
PU VSP BV
PI ZEIST
PA PO BOX 346, 3700 AH ZEIST, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2005
VL 16
IS 8
BP 1035
EP 1045
DI 10.1163/1568562054414649
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 955LF
UT WOS:000231226700008
PM 16128236
DA 2018-10-19
ER

PT J
AU Mequanint, K
   Sheardown, H
AF Mequanint, K
   Sheardown, H
TI 2-methacryloyloxyethyl N-butylcarbamate: a new co-monomer for synthesis
   of polyurethane hydrogels with improved mechanical properties for
   biomedical applications
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE hydrogel; 2-methacryloyloxyethyl N-butylcarbamate (MBC); 2-hydroxyethyl
   methacrylate (HEMA); mechanical properties; protein adsorption
ID CORNEAL EPITHELIAL-CELLS; WATER-ABSORPTION; ADSORPTION; COMPOSITES;
   COPOLYMERS; PROTEINS; SURFACES; ADHESION; STATES; HEMA
AB Hydrogels with tunable hydrophilic and mechanical properties were synthesized by the free radical polymerization of 2-hydroxyethyl methacrylate (HEMA) and 2-methacryloyloxyethyl N-butylcarbamate. The resulting hydrogels were investigated for their equilibrium water content, sessile drop water contact angles, gel fraction, mechanical properties and protein adsorption. Results indicated that co-polymer hydrogels have good hydrophilicity and that, with the incorporation of the 2-methacryloyloxyethyl N-butylcarbamate, mechanical properties could be improved significantly without affecting other important properties. Lysozyme and albumin adsorption experiments demonstrated that, similar to most hydrogel materials, the co-polymer hydrogels adsorb more lysozyme than albumin and that the adsorption was dependent on hydrophilicity. The control poly(HEMA) hydrogels were found to adsorb more protein than the co-polymer hydrogels; this is thought to be primarily a consequence of protein absorption rather than protein adsorption.
C1 McMaster Univ, Dept Chem Engn, Hamilton, ON L8S 4L7, Canada.
   McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8S 4L7, Canada.
RP Sheardown, H (reprint author), McMaster Univ, Dept Chem Engn, Hamilton, ON L8S 4L7, Canada.
EM sheardow@mcmaster.ca
OI Mequanint, Kibret/0000-0002-7888-418X
CR BAE YH, 1993, ADV DRUG DELIVER REV, V11, P109, DOI 10.1016/0169-409X(93)90029-4
   BARNES A, 1988, POLYMER, V29, P2191, DOI 10.1016/0032-3861(88)90111-5
   BERCHTOLD K, 2001, P RADT EUR C BAS, pCH4
   Brazel CS, 1999, POLYMER, V40, P3383, DOI 10.1016/S0032-3861(98)00546-1
   Bruining MJ, 2002, BIOMATERIALS, V23, P1213, DOI 10.1016/S0142-9612(01)00237-X
   CASTILLO EJ, 1985, BIOMATERIALS, V6, P338, DOI 10.1016/0142-9612(85)90089-4
   CHIRILA TV, 1995, J BIOMED MATER RES, V29, P1029, DOI 10.1002/jbm.820290815
   Crawford GJ, 2002, OPHTHALMOLOGY, V109, P883, DOI 10.1016/S0161-6420(02)00958-2
   DAVIS PA, 1991, HIGH PERFORMANCE BIO, P343
   DECKER C, 1991, EUR POLYM J, V27, P403, DOI 10.1016/0014-3057(91)90196-U
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   Franco M, 2000, J BIOMED MATER RES, V52, P261, DOI 10.1002/1097-4636(200011)52:2<261::AID-JBM4>3.0.CO;2-2
   Garrett Q, 1996, INVEST OPHTH VIS SCI, V37, P2594
   Garrett Q, 1998, BIOMATERIALS, V19, P2175, DOI 10.1016/S0142-9612(98)00125-2
   Garrett Q, 2000, INVEST OPHTH VIS SCI, V41, P1687
   Hodge RM, 1996, POLYMER, V37, P1371, DOI 10.1016/0032-3861(96)81134-7
   Jarvie AWP, 1998, BIOMATERIALS, V19, P1957, DOI 10.1016/S0142-9612(98)00100-8
   Karlsson JO, 1997, POLYMER, V38, P4727, DOI 10.1016/S0032-3861(96)01075-0
   Kliment K, 1968, J Biomed Mater Res, V2, P237, DOI 10.1002/jbm.820020207
   KOBAYASHI H, 1991, BIOMATERIALS, V12, P747, DOI 10.1016/0142-9612(91)90024-5
   Liu Q, 2000, BIOMATERIALS, V21, P2163, DOI 10.1016/S0142-9612(00)00137-X
   MACK EJ, 1988, HYDROGELS MED PHARM, V2, P65
   Merrett K, 2001, J BIOMAT SCI-POLYM E, V12, P647, DOI 10.1163/156856201316883467
   MONTHEARD JP, 1992, J MACROMOL SCI R M C, VC32, P1, DOI 10.1080/15321799208018377
   Moszner N, 2001, PROG POLYM SCI, V26, P535, DOI 10.1016/S0079-6700(01)00005-3
   MOUSSA K, 1993, J POLYM SCI POL CHEM, V31, P2197, DOI 10.1002/pola.1993.080310903
   Muh E, 2002, BIOMATERIALS, V23, P2849, DOI 10.1016/S0142-9612(01)00411-2
   Muller-Plathe F, 1998, MACROMOLECULES, V31, P6721, DOI 10.1021/ma980685b
   Nagura M, 1997, POLYM GELS NETW, V5, P455, DOI 10.1016/S0966-7822(97)00016-6
   NATHAN P, 1974, APPL MICROBIOL, V28, P465
   Okoroafor EU, 1999, J PHYS D APPL PHYS, V32, P2454, DOI 10.1088/0022-3727/32/18/319
   Peppas NA, 2000, ANNU REV BIOMED ENG, V2, P9, DOI 10.1146/annurev.bioeng.2.1.9
   REFOJO MF, 1965, J APPL POLYM SCI, V9, P3417, DOI 10.1002/app.1965.070091019
   REFOJO MF, 1979, J POLYM SCI POL SYM, P227
   ROORDA WE, 1988, BIOMATERIALS, V9, P494, DOI 10.1016/0142-9612(88)90044-0
   Sideridou I, 2002, BIOMATERIALS, V23, P1819, DOI 10.1016/S0142-9612(01)00308-8
   Stol M, 1993, J Biomater Appl, V7, P224, DOI 10.1177/088532829300700302
   Vermette P., 2001, BIOMEDICAL APPL POLY
   VOLDRICH Z, 1975, J BIOMED MATER RES, V9, P675, DOI 10.1002/jbm.820090612
   Young CD, 1998, J MEMBRANE SCI, V146, P83, DOI 10.1016/S0376-7388(98)00097-0
   Zhang JM, 2002, POLYM BULL, V48, P277, DOI 10.1007/s00289-002-0028-9
NR 41
TC 6
Z9 6
U1 0
U2 8
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2005
VL 16
IS 10
BP 1303
EP 1318
DI 10.1163/156856205774269548
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 977YB
UT WOS:000232838300008
PM 16268255
DA 2018-10-19
ER

PT J
AU Verma, S
   Padmawar, PA
   Hauck, T
   Canteenwala, T
   Chiang, LY
   Pritzker, KPH
AF Verma, S
   Padmawar, PA
   Hauck, T
   Canteenwala, T
   Chiang, LY
   Pritzker, KPH
TI Synthesis of water-soluble highly two-photon responsive
   [60]fullerene-diphenylaminofluorene chromophore dyads
SO JOURNAL OF MACROMOLECULAR SCIENCE-PURE AND APPLIED CHEMISTRY
LA English
DT Article
DE C60; diphenylaminofluorene; poly(ethylene-glycol); amphiphilic molecule;
   molecular self-assembly
ID POLY(ETHYLENE OXIDE); ELECTRON-TRANSFER; VESICLE
AB We have synthesized an amphiphilic donor-acceptor type [60] fullerene-diphenylaminofluorene (DPAF) containing oligo( ethylene glycol) moieties, denoted C-60-DPAF-EG(n). The hydrophobic C-60-DPAF moiety consisting of an electron-donating diphenylaminofluorene unit and an electron-accepting C-60 cage shows large cross-sections of two-photon absorptivity (2PA) in the nanosecond region. The attachment of two hydrophilic oligo( ethylene glycol) segments on DPAF mainly increases water-solubility of the corresponding chromophoric macromolecules that enhances their potential application in biomedical treatments. Here, we present the synthesis and self-assembly study of these amphiphilic materials in aqueous solution. New C-60-DPAF-EGn compounds were structurally characterized by various spectroscopic methods including, H-1-NMR, C-13-NMR, FT-IR, and UV spectroscopies. In the vesicle formation investigation, UV-visible absorption spectra, dynamic light scattering measurements, and transmission electron microscopy were used as primary methods for morphology characterization of molecular self-assembly behavior of these amphiphilic [60]fullerene-diphenylaminofluorene chromophore dyads.
C1 Univ Massachusetts, Dept Chem, Lowell, MA 01854 USA.
   Mt Sinai Hosp, Pathol & Lab Med, Toronto, ON, Canada.
   Univ Toronto, Toronto, ON, Canada.
RP Chiang, LY (reprint author), Univ Massachusetts, Dept Chem, Lowell, MA 01854 USA.
EM long_chiang@uml.edu
CR Burger C, 2004, J COLLOID INTERF SCI, V275, P632, DOI 10.1016/j.jcis.2004.02.048
   CHIANG LY, 2002, CHEM COMMUN, V17, P1854
   Effenberger F, 1998, SYNTHESIS-STUTTGART, P1372
   Georgakilas V, 2002, P NATL ACAD SCI USA, V99, P5075, DOI 10.1073/pnas.072006599
   Guldi DM, 2002, J ORG CHEM, V67, P1141, DOI 10.1021/jo0108313
   HAO J, 2004, CHEM COMMUN, V5, P602
   Huang XD, 2000, MACROMOL CHEM PHYSIC, V201, P2660
   Imahori H, 1997, ADV MATER, V9, P537, DOI 10.1002/adma.19970090704
   Jeng US, 1999, J PHYS CHEM B, V103, P1059, DOI 10.1021/jp9834659
   Kannan R, 2001, CHEM MATER, V13, P1896, DOI 10.1021/cm000747o
   Li Z, 2004, J APPL POLYM SCI, V92, P867, DOI 10.1002/app.13695
   Martin N, 1998, CHEM REV, V98, P2527, DOI 10.1021/cr9701039
   Padmawar PA, 2004, J MACROMOL SCI PURE, VA41, P1387, DOI 10.1081/MA-200035292
   Rispens MT, 2002, DEV FULL SC, V4, P387
   Tan CH, 2004, LANGMUIR, V20, P9882, DOI 10.1021/la049747j
   Zojer E, 2004, CHEM-EUR J, V10, P2668, DOI 10.1002/chem.200305650
NR 16
TC 5
Z9 5
U1 1
U2 7
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1060-1325
J9 J MACROMOL SCI PURE
JI J. Macromol. Sci.-Pure Appl. Chem.
PY 2005
VL A42
IS 11
BP 1497
EP 1505
DI 10.1080/10601320500229038
PG 9
WC Polymer Science
SC Polymer Science
GA 990BD
UT WOS:000233717300006
DA 2018-10-19
ER

PT J
AU Berry, CC
AF Berry, CC
TI Possible exploitation of magnetic nanoparticle-cell interaction for
   biomedical applications
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID GENE-THERAPY; CLINICAL-APPLICATIONS; PENETRATING PEPTIDES; RESONANCE;
   ADHESION; DELIVERY; ENDOCYTOSIS; DOXORUBICIN; DEFORMATION; TENSEGRITY
AB Magnetic nanoparticles have been advocated for use in magnetic resonance (MR) image enhancement and as bio-carriers in biological systems for many years. However it is only in recent years that the fields of nanotechnology, materials science and cell biology have combined to enable us to fully comprehend the potential uses of such nanoparticles in biomedical applications. This short review aims to detail some of the more recent advances using magnetic nanoparticles in biological research, highlighting possible biomedical applications and relating how the advancement of such research relies on parallel interdisciplinary research in materials chemistry.
C1 Univ Glasgow, Ctr Cell Engn, IBLS, Glasgow G12 8QQ, Lanark, Scotland.
RP Berry, CC (reprint author), Univ Glasgow, Ctr Cell Engn, IBLS, Joseph Black Bldg,Univ Ave, Glasgow G12 8QQ, Lanark, Scotland.
EM Catherine.berry@bio.gla.ac.uk
CR Alexiou C, 2000, CANCER RES, V60, P6641
   ALLEMANN E, 1993, PHARMACEUT RES, V10, P1732, DOI 10.1023/A:1018970030327
   Allport JR, 2001, EXP HEMATOL, V29, P1237, DOI 10.1016/S0301-472X(01)00739-1
   Araujo L, 1999, J DRUG TARGET, V6, P373, DOI 10.3109/10611869908996844
   ARIAS JL, 2000, J CONTROL RELEASE, V77, P309
   Babincova M, 2000, MED HYPOTHESES, V54, P177, DOI 10.1054/mehy.1999.0011
   BAUCH AR, 2001, BIOPHYS J, V80, P2649
   Bausch AR, 1999, BIOPHYS J, V76, P573, DOI 10.1016/S0006-3495(99)77225-5
   Bausch AR, 1998, BIOPHYS J, V75, P2038, DOI 10.1016/S0006-3495(98)77646-5
   Berry CC, 2004, INT J PHARM, V269, P211, DOI 10.1016/j.ijpharm.2003.09.042
   Berry CC, 2003, J PHYS D APPL PHYS, V36, pR198, DOI 10.1088/0022-3727/36/13/203
   BONADONNA G, 1993, ANN ONCOL, V4, P359, DOI 10.1093/oxfordjournals.annonc.a058514
   Bonnemain B, 1998, J DRUG TARGET, V6, P167, DOI 10.3109/10611869808997890
   Brigger I, 2002, ADV DRUG DELIVER REV, V54, P631, DOI 10.1016/S0169-409X(02)00044-3
   BRIGHTMAN MW, 1965, AM J ANAT, V117, P193, DOI 10.1002/aja.1001170204
   Caplen NJ, 2001, TRENDS MOL MED, V7, P488, DOI 10.1016/S1471-4914(01)02168-2
   CARTMELL SH, 2003, EUR CELLS MAT, V6, P7
   Chen CS, 1999, OSTEOARTHR CARTILAGE, V7, P81, DOI 10.1053/joca.1998.0164
   CHEN J, 2001, AM J PHYSIOL-CELL PH, V280, pC1478
   Cho CS, 2001, J CONTROL RELEASE, V77, P7, DOI 10.1016/S0168-3659(01)00390-X
   Connolly J, 2002, EUR CELLS MATER, V3, P106
   Davis SS, 1997, TRENDS BIOTECHNOL, V15, P217, DOI 10.1016/S0167-7799(97)01036-6
   Dobson J, 2001, FEBS LETT, V496, P1, DOI 10.1016/S0014-5793(01)02386-9
   Eastwood M, 1998, P I MECH ENG H, V212, P85, DOI 10.1243/0954411981533854
   Fujimoto LM, 2000, TRAFFIC, V1, P161, DOI 10.1034/j.1600-0854.2000.010208.x
   FUSSELL GW, 2004, BIOMATERIALS, V15, P2971
   Gaur U, 2000, INT J PHARM, V202, P1, DOI 10.1016/S0378-5173(99)00447-0
   Goodwin SC, 2001, TOXICOL SCI, V60, P177, DOI 10.1093/toxsci/60.1.177
   GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hogemann D, 2002, BIOCONJUGATE CHEM, V13, P116, DOI 10.1021/bc015549h
   Ingber DE, 1997, ANNU REV PHYSIOL, V59, P575, DOI 10.1146/annurev.physiol.59.1.575
   Josephson L, 1999, BIOCONJUGATE CHEM, V10, P186, DOI 10.1021/bc980125h
   Kawashima Y, 2001, ADV DRUG DELIVER REV, V47, P1, DOI 10.1016/S0169-409X(00)00117-4
   KREUTER J, 1994, EUR J DRUG METAB PH, V19, P253, DOI 10.1007/BF03188928
   Lacava LM, 2001, BIOPHYS J, V80, P2483, DOI 10.1016/S0006-3495(01)76217-0
   LANZA GM, 2003, ACAD RADIOL, V9, pS330
   Lebaron RG, 2000, TISSUE ENG, V6, P85, DOI 10.1089/107632700320720
   Lubbe AS, 1996, CANCER RES, V56, P4686
   Lubbe AS, 2001, J SURG RES, V95, P200, DOI 10.1006/jsre.2000.6030
   Lubbe AS, 1999, J MAGN MAGN MATER, V194, P149, DOI 10.1016/S0304-8853(98)00574-5
   Lundberg P, 2003, J MOL RECOGNIT, V16, P227, DOI 10.1002/jmr.630
   Luo D, 2000, NAT BIOTECHNOL, V18, P33
   Mijailovich SM, 2002, J APPL PHYSIOL, V93, P1429, DOI 10.1152/japplphysiol.00255.2002
   Moghimi SM, 2001, PHARMACOL REV, V53, P283
   Mornet S, 2004, J MATER CHEM, V14, P2161, DOI 10.1039/b402025a
   Nichol C, 2001, J NUCL MED, V42, P1368
   Niemeyer CM, 2001, ANGEW CHEM INT EDIT, V40, P4128, DOI 10.1002/1521-3773(20011119)40:22<4128::AID-ANIE4128>3.0.CO;2-S
   OGRADY K, 2003, J PHYS D, V36, pR165
   Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201
   Pap T, 2002, ARTHRITIS RES, V4, P10, DOI 10.1186/ar377
   Portet D, 2001, J COLLOID INTERF SCI, V238, P37, DOI 10.1006/jcis.2001.7500
   QUALMANN B, 2000, J CELL BIOL, V150, P111
   Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200
   Rudge SR, 2000, BIOMATERIALS, V21, P1411, DOI 10.1016/S0142-9612(00)00006-5
   Schafer DA, 2002, CURR OPIN CELL BIOL, V14, P76, DOI 10.1016/S0955-0674(01)00297-6
   Shen TT, 1996, BIOCONJUGATE CHEM, V7, P311, DOI 10.1021/bc960003u
   STPIERRE TG, 2000, EUR BIOPHYS J, V26, P455
   Svensson EC, 1996, MOL MED TODAY, V2, P166, DOI 10.1016/1357-4310(96)88792-2
   Tartaj P, 2003, J PHYS D APPL PHYS, V36, pR182, DOI 10.1088/0022-3727/36/13/202
   WIDDER KJ, 1983, EUR J CANCER CLIN ON, V19, P135, DOI 10.1016/0277-5379(83)90408-X
   WILHELM C, 2002, BIOMATERIALS, V24, P1001
   WUNDERBALDINGER P, 2001, BIOCONJUGATE CHEM, V131, P264
   Zhu C, 2000, ANNU REV BIOMED ENG, V2, P189, DOI 10.1146/annurev.bioeng.2.1.189
NR 64
TC 159
Z9 162
U1 0
U2 30
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2005
VL 15
IS 5
BP 543
EP 547
DI 10.1039/b409715g
PG 5
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 893EZ
UT WOS:000226703400001
DA 2018-10-19
ER

PT J
AU Singh, J
   Wolfe, DE
AF Singh, J
   Wolfe, DE
TI Nano and macro-structured component fabrication by electron
   beam-physical vapor deposition (EB-PVD)
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Review
ID TITANIUM NITRIDE FILMS; ACTIVATED REACTIVE EVAPORATION; THERMAL BARRIER
   COATINGS; ASSISTED DEPOSITION; THIN-FILMS; MULTILAYER COATINGS; HARD
   COATINGS; TIN FILMS; SUBSTRATE TEMPERATURE; GROWTH ORIENTATION
AB The objective of this paper is to demonstrate the versatility of electron beam-physical vapor deposition (EB-PVD) technology in engineering new materials with controlled microstructure and microchemistry in the form of coatings. EB-PVD technology is being explored in forming net-shaped components for many applications including space, turbine, optical, biomedical and auto industry. Coatings are often applied on components to extend their performance and life under severe environmental conditions including thermal, corrosion, wear, and oxidation. In addition, coatings have been used in designing and developing sensors. Performance and properties of the coatings depend upon its composition, microstructure and deposition condition. This paper presents recent results of various materials including ceramic, metallic, and functionally graded coatings produced by EB-PVD. Simultaneous co-evaporation of multiple ingots of different compositions in the high energy EB-PVD chamber has brought considerable interest in the architecture of functional graded coatings, nano-laminated coatings and designing of new structural materials that could not be produced economically by conventional methods. In addition, high evaporation and condensate rate allowed fabricating precision net-shaped components with nanograined microstructure for various applications. This paper will also present the results of various metallic and ceramic coatings including chromium, titanium carbide (TiC), hafnium carbide (HfC), tantalum carbide (TaC), hafnium nitride (HfN), titanium-boron-carbonitride (TiBCN), and partially yttria stabilized zirconia (YSZ), and HfO2-based TBC coatings deposited by EB-PVD for various applications. (C) 2005 Springer Science + Business Media, Inc.
C1 Penn State Univ, Appl Res Lab, State Coll, PA 16804 USA.
RP Singh, J (reprint author), Penn State Univ, Appl Res Lab, 115 MRI Bldg, State Coll, PA 16804 USA.
EM jxs46@psu.edu
CR AMATEAU MF, 2000, 2 I MAN SUST TECHN
   ANDOH Y, 1989, NUCL INSTRUM METH B, V39, P158, DOI 10.1016/0168-583X(89)90761-1
   ARAI T, 1988, THIN SOLID FILMS, V165, P139, DOI 10.1016/0040-6090(88)90685-2
   ARNAULT JC, 1993, NUCL INSTRUM METH B, V80-1, P1384, DOI 10.1016/0168-583X(93)90804-F
   AUCIELLO O, 1991, SURFACE MODIFICATION, P109
   Barna P. B., 1995, GROWTH MECH POLYCRYS, P1
   BARNA PB, 1993, SURF COAT TECH, V57, P7, DOI 10.1016/0257-8972(93)90330-Q
   Barna PB., 1991, DIAGNOSTICS APPL THI, P295
   BATTY SV, 1995, THIN SOLID FILMS, V266, P96, DOI 10.1016/0040-6090(95)06693-4
   Beele W, 1999, SURF COAT TECH, V120, P61, DOI 10.1016/S0257-8972(99)00342-4
   Brogren M, 2000, THIN SOLID FILMS, V370, P268, DOI 10.1016/S0040-6090(00)00914-7
   Bunshah RF, 1994, HDB DEPOSITION TECHN
   Chin KC, 2004, CHEM PHYS LETT, V383, P72, DOI 10.1016/j.cplett.2003.11.007
   Choy KL, 2003, PROG MATER SCI, V48, P57, DOI 10.1016/S0079-6425(01)00009-3
   CHU X, 1992, J VAC SCI TECHNOL A, V10, P1604, DOI 10.1116/1.578030
   CHU Z, 1995, J APPL PHYS, V77, P4403
   Dini JW, 1997, MATER MANUF PROCESS, V12, P437, DOI 10.1080/10426919708935157
   DIXIT GA, 1993, APPL PHYS LETT, V62, P357, DOI 10.1063/1.109644
   ENSINGER W, 1993, NUCL INSTRUM METH B, V80-1, P1409, DOI 10.1016/0168-583X(93)90810-S
   ENSINGER W, 1993, SURFACE MODIFICATION TECHNOLOGIES VI, P859
   ENSINGER W, 1993, NUCL INSTRUM METH B, V80-1, P445, DOI 10.1016/0168-583X(93)96158-9
   Ensinger W, 1995, NUCL INSTRUM METH B, V106, P142, DOI 10.1016/0168-583X(95)00693-1
   Eskildsen SS, 1999, SURF COAT TECH, V116, P18, DOI 10.1016/S0257-8972(99)00142-5
   Fauchais P, 2000, INT J THERM SCI, V39, P852, DOI 10.1016/S1290-0729(00)01195-9
   Gerlach JW, 1996, APPL PHYS LETT, V68, P2360, DOI 10.1063/1.115858
   Gilmore DL, 1999, J THERM SPRAY TECHN, V8, P576, DOI 10.1361/105996399770350278
   GILMORE DL, 1999, MRS FALL M BOST M A
   GLASS DE, 2001, EFFECTIVENESS DIFFUS, P1264
   GOI, 2003, COMMUNICATION
   Haberland H., 1995, 2 INT C BEAM PROC MA, P69
   HAYWOOD B, 1990, ADV MATER PROCESS, V12, P35
   HILL RJ, 1986, PHYSL VAPOR DEPOSITI
   HIRVONEN JK, 1989, ANNU REV MATER SCI, V19, P401
   HIRVONEN JK, 1991, MATER SCI REP, V6, P215, DOI 10.1016/0920-2307(91)90008-B
   Hocking M. G., 1989, METALLIC CERAMIC COA
   HOLLECK H, 1988, SURF COAT TECH, V36, P707, DOI 10.1016/0257-8972(88)90011-4
   Holleck H, 1999, SURFACE ENGINEERING: SCIENCE AND TECHNOLOGY I, P207
   HOLLECK H, 1991, MAT SCI ENG A-STRUCT, V140, P609, DOI 10.1016/0921-5093(91)90485-6
   HOLLECK H, 1990, SURF COAT TECH, V41, P179, DOI 10.1016/0257-8972(90)90166-A
   HOLLECK H, 1999, TMS PUBLICATION, P207
   HULL R, 1992, MATER RES SOC SYMP P, V239, P379
   JACOBSON BE, 1984, THIN SOLID FILMS, V118, P285, DOI 10.1016/0040-6090(84)90199-8
   Je JH, 1997, J APPL PHYS, V81, P6126, DOI 10.1063/1.364394
   JIANG H, 1995, THIN SOLID FILMS, V258, P51, DOI 10.1016/0040-6090(94)06367-2
   KAUFMAN H, 1987, CHARACTERISTICS CAPA, P1
   KIUCHI M, 1988, NUCL INSTRUM METH B, V33, P649
   KNUYT G, 1995, THIN SOLID FILMS, V258, P159, DOI 10.1016/0040-6090(94)06353-2
   KOLITSCH A, 1993, THIN FILM PROCESSES, V80, P258
   Kutner G., 1991, ADV MATER PROCESS, V4, P68
   KUWAHARA K, 1981, THIN SOLID FILMS, V78, P41, DOI 10.1016/0040-6090(81)90416-8
   LEONHARDT T, 2000, C P 36 AM I AER AER, P1
   LEVIT M, 1996, MAT SCI ENG A-STRUCT, V206, P3038
   Ma KJ, 1995, SURF COAT TECH, V76, P297
   MATTOX DM, 1988, ION IMPLANTATION PLA, P9
   MCINTYRE R, 1996, MAT P, V8, P455
   MESSIER R, 1984, J VAC SCI TECHNOL A, V2, P500, DOI 10.1116/1.572604
   Milewski JO, 1998, MATER MANUF PROCESS, V13, P719, DOI 10.1080/10426919808935294
   Miller R. A, 1995, THERM BARR COAT WORK, P17
   MILLER RA, 1987, SURF COAT TECH, V30, P1, DOI 10.1016/0257-8972(87)90003-X
   MILLER RA, 1987, SURF COAT TECH, V309, P1
   Movchan B. A., 1969, Fizika Metallov i Metallovedenie, V28, P653
   MOVCHAN M, 1996, P EB PVD WORKSH PENN
   Nakamura Y, 1995, SURF COAT TECH, V76, P337
   NICHOLLS JR, 1997, AGARD SMP M THERM BA
   NIMMAGADDA R, 1977, THIN SOLID FILMS, V45, P477
   NOYAN IC, 1995, CRIT REV SOLID STATE, V20, P125, DOI 10.1080/10408439508243733
   OBERLANDER BC, 1992, MATER SCI TECH SER, V8, P657, DOI 10.1179/mst.1992.8.8.657
   Oettel H, 1995, SURF COAT TECH, V76, P265
   PEITER A, 1987, STRAIN           AUG, P103
   PIERCE JR, 1954, THEORY DESIGN ELECTR
   Pochet LF, 1997, SURF COAT TECH, V94-5, P70, DOI 10.1016/S0257-8972(97)00478-7
   QUAEYHAEGENS C, 1995, THIN SOLID FILMS, V258, P1710
   QULI FA, 1999, THESIS PENN STATE U
   QULI FA, 1999, J MAT SCI ENG B, P139
   RAGHURAM AC, 1972, J VAC SCI TECHNOL, V9, P1389, DOI 10.1116/1.1317046
   RAUSCHENBACH B, 1989, NUCL INSTRUM METH B, V42, P216, DOI 10.1016/0168-583X(89)90709-X
   Ravichandran KS, 1999, J AM CERAM SOC, V82, P673
   REED BD, 1997, 107453 NASA, P1
   RICKERBY DS, 1988, THIN SOLID FILMS, V157, P195, DOI 10.1016/0040-6090(88)90004-1
   Rigney DV, 1997, J THERM SPRAY TECHN, V6, P167, DOI 10.1007/s11666-997-0008-6
   ROHDE SL, 1993, J ELECTRON MATER, V22, P1327, DOI 10.1007/BF02817695
   ROTH T, 1987, THIN SOLID FILMS, V153, P123, DOI 10.1016/0040-6090(87)90176-3
   SANDHU G, 1993, APPL PHYS LETT, V63, P240
   SCHROEDER M, 1997, ADV MATER PROCESS, V8, P19
   *SCI COAT INC, TECHN APPL GUID, P1
   SEQUEDA F, 1986, J MET, P55
   SHAH PL, 1979, IEEE T ELECTRON DEV, V26, P631, DOI 10.1109/T-ED.1979.19470
   SHCULTZ U, 1997, P AGARD WORKSH THERM
   SHERMAN AJ, 1991, J METALS         JUL, P20
   SINGH J, 1994, J MATER SCI, V29, P5232, DOI 10.1007/BF01171533
   Singh J, 2002, J MATER SCI, V37, P3261, DOI 10.1023/A:1016187101616
   SINGH J, 1993, 108419 NASA, P1
   SINGH J, 2003, FUNCTIONALLY GRADED
   SINGH J, 2003, TAILORED MICROSTRUCT
   SINGH J, 1997, J MATER SCI, P3891
   SINGH J, 2004, IN PRESS J ADV MAT M
   SINGH J, 2002, J ADV MAT PROCESS, V160, P39
   SINGH J, 1996, SURF ENG B, V7, P8
   SINGH J, 1996, ADV MATER PROCESS, V11, P32
   SMITH D, 1995, THIN FILM DEPOSITION, P431
   Sobota J, 2001, SURF COAT TECH, V142, P590, DOI 10.1016/S0257-8972(01)01173-2
   SOHN YH, 1993, THESIS WORCESTER POL
   SPROUL W, 1994, CUTTING TOOL ENG, V2, P52
   STELMACK LA, 1989, NUCL INSTRUM METH B, V37-8, P787, DOI 10.1016/0168-583X(89)90299-1
   STIMMELL J, 1986, J VAC SCI TECHNOL B, V4, P1377, DOI 10.1116/1.583461
   SUNDGREN JE, 1983, THIN SOLID FILMS, V105, P367, DOI 10.1016/0040-6090(83)90319-X
   SUNDGREN JE, 1985, THIN SOLID FILMS, V128, P21, DOI 10.1016/0040-6090(85)90333-5
   SUNDGREN JE, 1995, MAT PROCESSES SURFAC, P453
   Tan YJ, 2003, SURF COAT TECH, V167, P255, DOI 10.1016/S0257-8972(02)00916-7
   THORNTON JA, 1975, J VAC SCI TECHNOL, V12, P830, DOI 10.1116/1.568682
   THORNTON JA, 1974, J VAC SCI TECHNOL, V11, P666, DOI 10.1116/1.1312732
   UNAL O, 1994, J AM CERAM SOC, V77, P984, DOI 10.1111/j.1151-2916.1994.tb07256.x
   VANDERDRIFT A, 1967, PHILIPS RES REP, V22, P267
   VAUER VE, 1962, T 9 NAT VAC S, P35
   VOSSEN JL, 1978, THIN FILM PROCESSES, P11
   WOLF G, 1991, NUCL INSR METH PHY B, V29, P173
   WOLF GK, 1992, J VAC SCI TECHNOL A, V10, P1757, DOI 10.1116/1.577743
   Wolfe D, 1998, J MATER SCI, V33, P3677, DOI 10.1023/A:1004675900887
   Wolfe DE, 2000, SURF COAT TECH, V124, P142, DOI 10.1016/S0257-8972(99)00644-1
   Wolfe DE, 2003, SURF COAT TECH, V165, P8, DOI 10.1016/S0257-8972(02)00666-7
   Wolfe DE, 2002, J MATER SCI, V37, P3777, DOI 10.1023/A:1016533913894
   Wolfe DE, 2002, SURF COAT TECH, V160, P206, DOI 10.1016/S0257-8972(02)00404-8
   Wolfe DE, 1999, J MATER SCI, V34, P2997, DOI 10.1023/A:1004668325924
   WOLFE DE, 1997, TMS ANN M ORL, P93
   WOLFE DE, 2001, THESIS PENN STATE U
   WOLFE DE, 1996, EFFECT SUBSTRATE ROT
   WOLFE DE, 1997, P ADV COATING TECHNO, P93
   WOLFE DE, IN PRESS J SURF COAT
   WOLFE DE, 1997, 98109 EB PVD PENNS S
   WOLFE DE, 1996, NATO ADV STUDY I SER, V21, P441
   WOLFE JSD, 2003, 2 INT MAT S U NOV LI
   Xiang Q, 2000, THIN SOLID FILMS, V370, P243, DOI 10.1016/S0040-6090(00)00915-9
   ZONG D, 2001, THIN SOLID FILMS, V398, P320
NR 133
TC 83
Z9 89
U1 9
U2 135
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0022-2461
J9 J MATER SCI
JI J. Mater. Sci.
PD JAN 1
PY 2005
VL 40
IS 1
BP 1
EP 26
DI 10.1007/s10853-005-5682-5
PG 26
WC Materials Science, Multidisciplinary
SC Materials Science
GA 897BB
UT WOS:000226977900001
DA 2018-10-19
ER

PT J
AU Tuusa, SMR
   Puska, MA
   Lassila, LVJ
   Vallittu, PK
AF Tuusa, SMR
   Puska, MA
   Lassila, LVJ
   Vallittu, PK
TI Residual monomers released from glass-fibre-reinforced composite
   photopolymerised in contact with bone and blood
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID IN-VITRO; FLEXURAL PROPERTIES; RESIN COMPOSITES; BIOMEDICAL
   APPLICATIONS; OXYGEN INHIBITION; FISSURE SEALANTS; DENTAL RESINS; HPLC
   ANALYSIS; BIS-GMA; CARBON
AB Purpose: The aim of this study was to determine the quantity of residual monomers of glass fibre-reinforced composite released into water from the composite that had been photopolymerized in contact with bone and blood. Materials and methods: E-glass fibre reinforced composite (FRC) made of E-glass fibre veil and the bis-GMA-TEGDMA-PMMA resin system was used in the study. In the first group, pieces of non-polymerised FRC were photopolymerised (40 s) in air which influenced the oxygen inhibited resin layer (positive control). In the second group, the FRC was polymerized between two glass plates allowing both surfaces to be well polymerized (negative control). In the test groups, the FRC was polymerized in contact with bone or in contact with blood. FRC specimens from all four groups were incubated in three milliliters of deionised water at 37 degreesC for three days. At the end of the incubation period, the residual monomers were extracted from the water with dichloromethane, and the residual monomers of TEGDMA and bis-GMA quantitatively analysed by HPLC. The degree of monomer conversion was measured by FTIR from the surface of the test specimen. Differences between the groups were analysed using one-way ANOVA (p < 0.05). Results: The total quantity of residual monomers released from FRC polymerized in contact with bone was lower (0.55 wt%) than in the positive control group (0.97 wt%) (p = 0.021), and only slightly exceeded that of the negative control group (0.42 wt%) (p = 0.717). The total quantity of monomers released from FRC polymerized in contact with blood was at the level of the negative control group. The main residual monomer released was TEGDMA. The surfaces of the positive and negative controls showed a clear difference between the degree of monomer conversion, 34.0 and 62.8%, respectively, when analysed with FTIR (p < 0.001). Conclusion: The surface of the bone or contact with blood did not significantly inhibit the photoinitiated free radical polymerisation of the dimethacrylate monomer system of the FRC. (C) 2005 Springer Science + Business Media, Inc.
C1 Univ Turku, Inst Dent, Dept Prosthet Dent & Biomat Res, Turku, Finland.
RP Tuusa, SMR (reprint author), Univ Turku, Inst Dent, Dept Prosthet Dent & Biomat Res, Turku, Finland.
EM sari.tuusa@utu.fi
CR BRADLEY JS, 1980, BIOMATERIALS, V1, P38, DOI 10.1016/0142-9612(80)90057-5
   Ciapetti G, 2000, J BIOMED MATER RES, V52, P338, DOI 10.1002/1097-4636(200011)52:2<338::AID-JBM13>3.3.CO;2-C
   Drummond JL, 2003, DENT MATER, V19, P226, DOI 10.1016/S0109-5641(02)00034-9
   FEITH R, 1975, ACTA ORTHOP SCAND S, V161, P1
   GOLDBERG AJ, 1992, DENT MATER, V8, P197, DOI 10.1016/0109-5641(92)90083-O
   Hamid A, 1997, DENT MATER, V13, P98, DOI 10.1016/S0109-5641(97)80018-8
   HASTINGS GW, 1985, POLYMER, V26, P1331, DOI 10.1016/0032-3861(85)90308-8
   INOUE K, 1982, J ORAL REHABIL, V9, P493, DOI 10.1111/j.1365-2842.1982.tb01039.x
   JANG BZ, 1992, COMPOS SCI TECHNOL, V44, P333, DOI 10.1016/0266-3538(92)90070-J
   Lassila LVJ, 2002, BIOMATERIALS, V23, P2221, DOI 10.1016/S0142-9612(01)00355-6
   Lastumaki TM, 2003, J MATER SCI-MATER M, V14, P803, DOI 10.1023/A:1025044623421
   Lewis G, 1997, J BIOMED MATER RES, V38, P155, DOI 10.1002/(SICI)1097-4636(199722)38:2<155::AID-JBM10>3.0.CO;2-C
   LIN ST, 1994, BIOMATERIALS, V15, P1057, DOI 10.1016/0142-9612(94)90091-4
   Lovell LG, 1999, J DENT RES, V78, P1469, DOI 10.1177/00220345990780081301
   Mariotti A, 1998, EUR J ORAL SCI, V106, P1022, DOI 10.1046/j.0909-8836.1998.eos106607.x
   MAROM G, 1993, BIOMATERIALS, V14, P127, DOI 10.1016/0142-9612(93)90224-P
   MAYER J, 1994, COMPOSITES, V25, P763, DOI 10.1016/0010-4361(94)90213-5
   Miettinen VM, 1996, J PROSTHET DENT, V76, P531
   Nathanson D, 1997, J AM DENT ASSOC, V128, P1517, DOI 10.14219/jada.archive.1997.0091
   Noda M, 1999, J BIOMED MATER RES, V47, P374, DOI 10.1002/(SICI)1097-4636(19991205)47:3<374::AID-JBM12>3.0.CO;2-7
   Olea N, 1996, ENVIRON HEALTH PERSP, V104, P298, DOI 10.2307/3432888
   Ortengren U, 2001, J ORAL REHABIL, V28, P1106, DOI 10.1046/j.1365-2842.2001.00802.x
   Pelka M, 1999, Clin Oral Investig, V3, P194, DOI 10.1007/s007840050101
   Peutzfeldt A, 1997, EUR J ORAL SCI, V105, P97, DOI 10.1111/j.1600-0722.1997.tb00188.x
   Pulgar R, 2000, ENVIRON HEALTH PERSP, V108, P21, DOI 10.2307/3454291
   Puska MA, 2003, BIOMATERIALS, V24, P417, DOI 10.1016/S0142-9612(02)00354-X
   RUEGGEBERG FA, 1990, J DENT RES, V69, P1652, DOI 10.1177/00220345900690100501
   RUYTER IE, 1981, ACTA ODONTOL SCAND, V39, P27, DOI 10.3109/00016358109162255
   RUYTER IE, 1980, J PROSTHET DENT, V43, P95, DOI 10.1016/0022-3913(80)90362-5
   Scotchford CA, 2003, BIOMATERIALS, V24, P4871, DOI 10.1016/S0142-9612(03)00403-4
   Shajii L, 1999, BIOMATERIALS, V20, P1897, DOI 10.1016/S0142-9612(99)00087-3
   SHINTANI H, 1995, J LIQ CHROMATOGR, V18, P613, DOI 10.1080/10826079508009261
   Shinzato S, 2000, J BIOMED MATER RES, V53, P51
   Sideridou I, 2002, BIOMATERIALS, V23, P1819, DOI 10.1016/S0142-9612(01)00308-8
   Tarumi H, 2000, J DENT RES, V79, P1838, DOI 10.1177/00220345000790110401
   Vallittu PK, 1999, J PROSTHET DENT, V81, P318, DOI 10.1016/S0022-3913(99)70276-3
   Vallittu PK, 1997, J MATER SCI-MATER M, V8, P489, DOI 10.1023/A:1018578210453
   Wada H, 2004, J DENT RES, V83, P222, DOI 10.1177/154405910408300307
NR 38
TC 15
Z9 16
U1 0
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 2005
VL 16
IS 1
BP 15
EP 20
DI 10.1007/s10856-005-6441-5
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 901KV
UT WOS:000227282300003
PM 15754139
DA 2018-10-19
ER

PT J
AU Yamashita, K
   Nakamura, S
AF Yamashita, K
   Nakamura, S
TI Concept and development of vector ceramics for bio-interface engineering
SO JOURNAL OF THE CERAMIC SOCIETY OF JAPAN
LA English
DT Review
DE vector ceramics; electrovector ceramics; hydroxyapatite; electrical
   polarization; biointerface engineering; biomaterials; bioceramics
ID ELECTRICALLY POLARIZED HYDROXYAPATITE; CALCIUM-PHOSPHATE CERAMICS;
   BIOACTIVE GLASS-CERAMICS; TRANSMISSION ELECTRON-MICROSCOPY;
   DEXTRAN-MAGNETITE COMPLEX; SIMULATED BODY-FLUID; IN-VITRO;
   MAMMARY-CARCINOMA; APATITE FORMATION; SURFACE-CHARGES
AB A vector material is defined as the one to manipulate surrounding inorganic and organic compounds, microorganisms, and tissues using a force irradiated locally and continuously from the material itself. The effect given by a vector material is ca materials are of unparalleled importance under the circumstance of the limited use of external forces such as in vivo. We have recently experimentally demonstrated the effectiveness of electrically polarized hydroxyapatite (HA) electrets as vector ceramics, which can independently irradiate an electrostatic force to the surrounding constituents; crystal growth from a simulated body fluid was accelerated or decelerated and proliferation of a microorganism was controlled on the surfaces of polarized HA, depending upon the electric signs of surface charges. Prior to our study, certain types of vector effects have already been employed in biomedical applications; the so-called 45S5-type bioactive glass (Bioglass(R)), developed by Hench et al., has long been recognized to be bioactive because of its solubility in a aqueous medium. Radioactive ceramics irradiate, beta-ray to and work on surrounding cancer cells. These are also vector materials. In addition to these examples, various kinds of vector effects and ceramics are now under development. This advanced report presents the concept of vector effects and reviews the examples of vector ceramics.
C1 Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo 1010062, Japan.
RP Yamashita, K (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, 2-3-10 Kanda Surugadai, Tokyo 1010062, Japan.
CR ABE Y, 1984, J AM CERAM SOC, V67, P142
   BREEDIS C, 1954, AM J PATHOL, V30, P969
   Bromer H., 1973, German patent, Patent No. [2,326,100, 2326100]
   Conzone SD, 1998, J BIOMED MATER RES, V42, P617
   Day DE, 1993, INTRO BIOCERAMICS, P305
   Driskell T D, 1972, J Biomed Mater Res, V6, P345, DOI 10.1002/jbm.820060107
   EBISAWA Y, 1991, J CERAM SOC JPN, V99, P7
   EHRHARDT GJ, 1987, NUCL MED BIOL, V14, P233
   ERBE EM, 1993, J BIOMED MATER RES, V27, P1301, DOI 10.1002/jbm.820271010
   FUJITA Y, 1991, J BIOMED MATER RES, V25, P991, DOI 10.1002/jbm.820250806
   Hafeli UO, 1999, INT J RADIAT ONCOL, V44, P189, DOI 10.1016/S0360-3016(98)00554-9
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   HOLAND W, 1991, J NON-CRYST SOLIDS, V129, P152, DOI 10.1016/0022-3093(91)90091-J
   HOLAND W, 1985, J BIOMED MATER RES, V19, P303, DOI 10.1002/jbm.820190311
   Hyatt MJ, 1987, J AM CERAM SOC, V70C, P283
   Ikeuchi M, 2003, J BIOMED MATER RES A, V67A, P1115, DOI 10.1002/jbm.a.10041
   Imayoshi N., 1997, MEM FAC ENG OKAYAMA, V31, P39
   INUZUKA M, IN PRESS SOLID STATE
   Ito A, 2000, J BIOMED MATER RES, V50, P178, DOI 10.1002/(SICI)1097-4636(200005)50:2<178::AID-JBM12>3.0.CO;2-5
   Ito A, 2002, J BIOMED MATER RES, V60, P224, DOI 10.1002/jbm.10068
   Ito A, 2002, MAT SCI ENG C-BIO S, V22, P21, DOI 10.1016/S0928-4931(02)00108-X
   Jordan A, 1999, J MAGN MAGN MATER, V194, P185, DOI 10.1016/S0304-8853(98)00558-7
   Jordan A, 1997, INT J HYPERTHER, V13, P587, DOI 10.3109/02656739709023559
   Kasuga T, 2003, J CERAM SOC JPN, V111, P633, DOI 10.2109/jcersj.111.633
   KASUGA T, 2004, J CERAM SOC JAPAN S, V112, pS800
   Kawamura H, 2003, J BIOMED MATER RES A, V65A, P468, DOI 10.1002/jbm.a.10524
   Kawamura H, 2000, J BIOMED MATER RES, V50, P184, DOI 10.1002/(SICI)1097-4636(200005)50:2<184::AID-JBM13>3.0.CO;2-3
   Kawashita M, 1999, J AM CERAM SOC, V82, P683
   Kawashita M, 2003, BIOMATERIALS, V24, P2955, DOI 10.1016/S0142-9612(03)00094-2
   Kawashita M., 2002, BIOCERAMICS, P645
   KIM HM, 1995, J AM CERAM SOC, V78, P2405, DOI 10.1111/j.1151-2916.1995.tb08677.x
   KITSUGI T, 1987, J BIOMED MATER RES, V21, P467, DOI 10.1002/jbm.820210407
   KLEIN CPAT, 1987, BIOMATERIALS, V8, P234, DOI 10.1016/0142-9612(87)90071-8
   KLEIN CPAT, 1984, BIOMATERIALS, V5, P362, DOI 10.1016/0142-9612(84)90036-X
   Kobayashi T, 2001, J BIOMED MATER RES, V57, P477, DOI 10.1002/1097-4636(20011215)57:4<477::AID-JBM1193>3.0.CO;2-5
   KOKUBO T, 1991, BIOMATERIALS, V12, P155, DOI 10.1016/0142-9612(91)90194-F
   Kokubo T., 1982, Bulletin of the Institute for Chemical Research, Kyoto University, V60, P260
   KOKUBO T, 1986, J MATER SCI, V21, P536, DOI 10.1007/BF01145520
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   Konaka H, 1997, J CERAM SOC JPN, V105, P833, DOI 10.2109/jcersj.105.833
   KOTANI S, 1991, J BIOMED MATER RES, V25, P1303, DOI 10.1002/jbm.820251010
   LUDERER AA, 1983, RADIAT RES, V94, P190, DOI 10.2307/3575874
   Maeda H, 2004, J EUR CERAM SOC, V24, P2125, DOI 10.1016/S0955-2219(03)00327-3
   MITSUMORI M, 1994, INT J HYPERTHER, V10, P785, DOI 10.3109/02656739409012371
   Mitsumori M, 1996, HEPATO-GASTROENTEROL, V43, P1431
   MOONGA BS, 1995, J BONE MINER RES, V10, P453
   Moroz P, 2002, INT J HYPERTHER, V18, P267, DOI 10.1080/02656730110108785
   NAKAHIRA A, 2004, J CERAM SOC JPN S, V112, pS845
   Nakamura S, 2004, J BIOMED MATER RES A, V68A, P90, DOI 10.1002/jbm.a.10124
   Nakamura S, 2002, J BIOMED MATER RES, V61, P593, DOI 10.1002/jbm.10224
   Nakamura S, 2001, J APPL PHYS, V89, P5386, DOI 10.1063/1.1357783
   NEO M, 1992, J BIOMED MATER RES, V26, P1419, DOI 10.1002/jbm.820261103
   NEO M, 1993, J BIOMED MATER RES, V27, P999, DOI 10.1002/jbm.820270805
   NEO M, 1992, J BIOMED MATER RES, V26, P255, DOI 10.1002/jbm.820260210
   Obata A, 2004, BIOMATERIALS, V25, P5163, DOI 10.1016/j.biomaterials.2003.12.028
   Obata A, 2003, J BIOMED MATER RES A, V67A, P413, DOI 10.1002/jbm.a.10069
   OBATA A, 2004, J CERAM SOC JAPAN S, V112, pS822
   Ohgaki M, 2001, J BIOMED MATER RES, V57, P366, DOI 10.1002/1097-4636(20011205)57:3<366::AID-JBM1179>3.0.CO;2-X
   OHTSUKI C, 1992, J NON-CRYST SOLIDS, V143, P84, DOI 10.1016/S0022-3093(05)80556-3
   OHTSUKI C, 1992, J MATER SCI-MATER M, V3, P119, DOI 10.1007/BF00705279
   Ohtsuki C, 1991, PHOSPHORUS RES B, V1, P191
   Ohtsuki C., 1991, J CERAM SOC JPN, V99, P1
   ONO K, 1990, BIOMATERIALS, V11, P265
   Otsuki C., 1994, BIOCERAMICS, V7, P73
   OVERGAARD J, 1995, LANCET, V345, P540, DOI 10.1016/S0140-6736(95)90463-8
   OWADA H, 1989, SOLID STATE IONICS, V35, P401, DOI 10.1016/0167-2738(89)90327-5
   Owada H., 1986, J CERAM SOC JPN, V94, P837
   Oyane A, 2003, J BIOMED MATER RES A, V65A, P188, DOI 10.1002/jbm.a.10482
   Ozawa M., 1995, SEITAIZAIRYOU, V13, P167
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   RECK R, 1984, LARYNGOSCOPE, V94, P1, DOI 10.1288/00005537-198402001-00001
   Ruoslahti E, 1996, EXP CELL RES, V227, P1, DOI 10.1006/excr.1996.0243
   SCHWARTZ Z, 1994, J CELL BIOCHEM, V56, P340, DOI 10.1002/jcb.240560310
   Takeda H, 2002, J MATER CHEM, V12, P2490, DOI 10.1039/b202262c
   Toyama Y, 2002, SOLID STATE IONICS, V151, P159, DOI 10.1016/S0167-2738(02)00704-X
   Tsuru K, 1995, P 17 INT C GLASS, V5, P85
   Ueshima M, 2002, SOLID STATE IONICS, V151, P29, DOI 10.1016/S0167-2738(02)00600-8
   Ueshima M, 2002, ADV MATER, V14, P591, DOI 10.1002/1521-4095(20020418)14:8<591::AID-ADMA591>3.0.CO;2-7
   Ueshima M, 2002, J BIOMED MATER RES, V60, P578, DOI 10.1002/jbm.10113
   Wang P., 1990, SILICATES IND, V7-8, P231
   YAMAGUCHI M, 1987, BIOCHEM PHARMACOL, V36, P4007, DOI 10.1016/0006-2952(87)90471-0
   YAMASHITA K, 1995, J AM CERAM SOC, V78, P1191, DOI 10.1111/j.1151-2916.1995.tb08468.x
   YAMASHITA K, 1988, SOLID STATE IONICS, V28, P660, DOI 10.1016/S0167-2738(88)80121-8
   Yamashita K, 1996, CHEM MATER, V8, P2697, DOI 10.1021/cm9602858
   Yamashita K, 2002, PHOSPHORUS SULFUR, V177, P1889, DOI 10.1080/10426500290093829
   YAMASHITA K, 1990, SOLID STATE IONICS, V40-1, P918, DOI 10.1016/0167-2738(90)90153-I
   YAMASHITA K, 1986, J AM CERAM SOC, V69, P590, DOI 10.1111/j.1151-2916.1986.tb04813.x
NR 90
TC 50
Z9 50
U1 0
U2 15
PU CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI
PI TOKYO
PA 22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN
SN 1882-0743
EI 1348-6535
J9 J CERAM SOC JPN
JI J. Ceram. Soc. Jpn.
PD JAN
PY 2005
VL 113
IS 1313
BP 1
EP 9
DI 10.2109/jcersj.113.1
PG 9
WC Materials Science, Ceramics
SC Materials Science
GA 897YC
UT WOS:000227041800001
OA Bronze
DA 2018-10-19
ER

PT J
AU Van Loo, PLR
   Blom, HJM
   Meijer, MK
   Baumans, V
AF Van Loo, PLR
   Blom, HJM
   Meijer, MK
   Baumans, V
TI Assessment of the use of two commercially available environmental
   enrichments by laboratory mice by preference testing
SO LABORATORY ANIMALS
LA English
DT Article
DE mice; preference; welfare; environmental enrichment; nest box; nesting
   material
ID NESTING MATERIAL; ANIMAL-WELFARE; STRESS
AB In the field of biomedical research, the demand for standardization of environmental enrichment for laboratory animals is growing. For laboratory mice, a wide variety of environmental enrichment items are commercially available. Most of these comply with the demands for standardization, hygiene and ergonomics. Whether these items also comply with their actual purpose, to enhance the well-being of the mice, is often not assessed scientifically. In this study, we tested the preference of mice for two commercially available nest boxes differing in shape and material: the Shepherd Shack/DesRes (SS/DR) and the Tecniplast Mouse House (TMH), in a simple preference test. To indicate strength of preference, both nest boxes were also tested against a highly preferred nesting material. Preference for the most preferred nest box was investigated further. Our results indicated a strong preference by mice for the SS/DR, but not for the TMH. Furthermore, nesting material was almost always combined with the SS/DR, but not with the TMH. More elaborate testing of the SS/DR in an automated preference test system confirmed that mice spent significantly more time in a cage in which an SS/DR is provided. Differences between both nest boxes are discussed with regard to their attractiveness to mice. It is also argued that enrichment should primarily be developed in concordance with the animals' needs prior to the marketing of enrichment tools.
C1 Univ Utrecht, Dept Lab Anim Sci, NL-3508 TD Utrecht, Netherlands.
   Karolinska Inst, S-17177 Stockholm, Sweden.
RP Van Loo, PLR (reprint author), Univ Utrecht, Dept Lab Anim Sci, POB 80166, NL-3508 TD Utrecht, Netherlands.
EM P.L.P.vanloo@vet.uu.nl
CR Baumans V, 2002, CONTEMP TOP LAB ANIM, V41, P13
   BLOM HJM, 1992, APPL ANIM BEHAV SCI, V35, P67, DOI 10.1016/0168-1591(92)90017-6
   *COUNC EUR, 1997, RES ACC CAR LAB AN
   Dean SW, 1999, LAB ANIM, V33, P309, DOI 10.1258/002367799780487823
   Eskola S, 1999, SCAND J LAB ANIM SCI, V26, P134
   HUGHES BO, 1989, ANIM BEHAV, V37, P210, DOI 10.1016/0003-3472(89)90111-5
   JENSEN P, 1993, APPL ANIM BEHAV SCI, V37, P161, DOI 10.1016/0168-1591(93)90108-2
   KORNERUPHANSEN A, 1999, ICLAS FELASA C PALM
   Mortell N., 2001, Animal Technology, V52, P1
   Olsson I. Anna S., 2002, Laboratory Animals (London), V36, P243, DOI 10.1258/002367702320162379
   POOLE TB, 1998, ANIMAL TECHNOLOGY, V49, P7
   Sambrook TD, 1997, ANIM WELFARE, V6, P207
   TRUSZKOWSKI J, 1974, Acta Theriologica, V19, P441
   TSAI PP, 1999, ICLAS FELASA JOINT C, P112
   Van de Weerd H, 1995, ENV ENRICHMENT INFOR, V2, P145
   Van de Weerd HA, 1998, ANIM WELFARE, V7, P11
   Van de Weerd HA, 1998, APPL ANIM BEHAV SCI, V55, P369, DOI 10.1016/S0168-1591(97)00043-9
   Van de Weerd Heleen A., 2002, Journal of Applied Animal Welfare Science, V5, P87, DOI 10.1207/S15327604JAWS0502_01
   Van Loo PLP, 2002, APPL ANIM BEHAV SCI, V76, P65, DOI 10.1016/S0168-1591(01)00200-3
   VandeWeerd HA, 1997, LAB ANIM, V31, P133, DOI 10.1258/002367797780600152
   Ward G. E., 1991, ANIMAL TECHNOLOGY, V42, P149
   WEISS JM, 1972, SCI AM, V226, P104, DOI 10.1038/scientificamerican0672-104
   Wemelsfelder F, 1997, APPL ANIM BEHAV SCI, V53, P75, DOI 10.1016/S0168-1591(96)01152-5
   WIEPKEMA PR, 1993, ANIM WELFARE, V2, P195
NR 24
TC 19
Z9 19
U1 1
U2 9
PU ROYAL SOC MEDICINE PRESS LTD
PI LONDON
PA 1 WIMPOLE STREET, LONDON W1G 0AE, ENGLAND
SN 0023-6772
J9 LAB ANIM-UK
JI Lab. Anim.
PD JAN
PY 2005
VL 39
IS 1
BP 58
EP 67
DI 10.1258/0023677052886501
PG 10
WC Veterinary Sciences; Zoology
SC Veterinary Sciences; Zoology
GA 890CO
UT WOS:000226489500004
PM 15703125
OA Bronze
DA 2018-10-19
ER

PT S
AU Della Valle, G
   Galzerano, G
   Toncelli, A
   Tonelli, M
   Laporta, P
AF Della Valle, G.
   Galzerano, G.
   Toncelli, A.
   Tonelli, M.
   Laporta, P.
BE Abramski, KM
   Lapucci, A
   Plinski, EF
TI Novel solid-state lasers for Lidar applications at 2 mu m
SO LASERS AND APPLICATIONS
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Lasers and Applications
CY AUG 30, 2005
CL Warsaw, POLAND
DE Solid state laser; diode-pumped laser; tunable laser; laser material
ID HO
AB A review on the results achieved by our group in the development of novel solid-state lasers for Lidar applications at 2 mu m is presented. These lasers, based on fluoride crystals (YLF(4), BaY(2)F(8), and KYF(4)) doped with Tm and Ho ions, are characterized by high-efficiency and wide wavelength tunability around 2 mu m. Single crystals of LiYF(4), BaY(2)F(8), and KYF(4) codoped with the same Tm(3+) and Ho(3+) concentrations were successfully grown by the Czochralski method. The full spectroscopic characterization of the different laser crystals and the comparison between the laser performance are presented. Continuous wave operation was efficiently demonstrated by means of a CW diode-pumping. These oscillators find interesting applications in the field of remote sensing (Lidar and Dial systems) as well as in high-resolution molecular spectroscopy, frequency metrology, and biomedical applications.
C1 [Della Valle, G.; Galzerano, G.; Laporta, P.] Ist Foton & Nanotecnol CNR, Dipartimento Fis, I-20133 Milan, Italy.
RP Della Valle, G (reprint author), Ist Foton & Nanotecnol CNR, Dipartimento Fis, Piazza L Da Vinci 32, I-20133 Milan, Italy.
EM gianluca.galzerano@fisi.polimi.it
OI GALZERANO, GIANLUCA/0000-0002-4388-1421; Della Valle,
   Giuseppe/0000-0003-0117-2683
CR Cornacchia F, 2002, APPL PHYS B-LASERS O, V75, P817, DOI 10.1007/s00340-002-1055-9
   HEMMATI H, 1987, APPL PHYS LETT, V51, P564, DOI 10.1063/1.98348
   Marano M, 2003, OPT MATER, V24, P327, DOI 10.1016/S0925-3467(03)00145-9
   McAleavey FJ, 1997, IEEE J SEL TOP QUANT, V3, P1103, DOI 10.1109/2944.649549
   Mobert PEA, 1998, LASER PHYS, V8, P210
   REMSKI RL, 1969, IEEE J QUANTUM ELECT, VQE 5, P214, DOI 10.1109/JQE.1969.1075760
   STORM ME, 1989, APPL OPTICS, V28, P408, DOI 10.1364/AO.28.000408
NR 7
TC 1
Z9 1
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-0-8194-5965-7
J9 PROC SPIE
PY 2005
VL 5958
AR 59581H
DI 10.1117/12.619930
PG 8
WC Optics; Physics, Applied
SC Optics; Physics
GA BRU42
UT WOS:000283716700042
DA 2018-10-19
ER

PT S
AU Yang, Y
   Li, K
   Nam, SH
   Yin, SZ
   Wang, Q
AF Yang, Y
   Li, K
   Nam, SH
   Yin, SZ
   Wang, Q
BE Stockman, SA
   Yao, HW
   Schubert, EF
TI A unique point OLED source
SO Light-Emitting Diodes: Research, Manufacturing, and Applications IX
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 9th Conference on Light-Emitting Diodes
CY JAN 25-27, 2005
CL San Jose, CA
SP SPIE, Aixtron Inc, Lumileds Lighting, LLC, USA Res Off
DE organic light-emitting diodes (OLED's); polymer light-emitting diodes
   (PLED's); point source; fiber-based devices; poly(phenylene vinylene);
   PPV; conjugated polymers
ID ORGANIC ELECTROLUMINESCENT DEVICES; ELECTRO-LUMINESCENCE; POLYMERS;
   DIODES; FILMS
AB Highly luminous polymers have been successfully prepared by copolymerization of various arylene vinylene units. Among the copolymers synthesized, poly(phenylene vinylene) (PPV) and its derivatives have been studied most intensively because they show fairly strong fluorescence and have a wide structural variety. In this paper, light-emitting polymers and traditional organic LED technology are briefly reviewed at first. A novel and unique point source based on the organic LED fabricated on an optical fiber is then proposed. As proof of concept, some preliminary experimental results are shown. Two light-emitting materials needed for our experiments are synthesized. It is illustrated that the unique point OLED source is feasible, which can lead to many practical applications, such as biomedical imaging.
C1 Penn State Univ, Dept Elect Engn, University Pk, PA 16802 USA.
RP Yang, Y (reprint author), Penn State Univ, Dept Elect Engn, University Pk, PA 16802 USA.
CR ADACHI C, 1988, JPN J APPL PHYS, V27, P269
   Bernius M, 2000, THIN SOLID FILMS, V363, P55, DOI 10.1016/S0040-6090(99)00982-7
   BURROUGHES JH, 1990, NATURE, V347, P539, DOI 10.1038/347539a0
   DOI S, 1993, SYNTHETIC MET, V57, P4174, DOI 10.1016/0379-6779(93)90577-J
   HAMADA Y, 1995, JPN J APPL PHYS, V34, P824
   HELFRICH W, 1965, PHYS REV LETT, V14, P229, DOI 10.1103/PhysRevLett.14.229
   Nakada H., 1996, Inorganic and Organic Electroluminescence, P385
   Ohnishi T, 1997, IEEE T ELECTRON DEV, V44, P1253, DOI 10.1109/16.605464
   OHNISHI T, 2000, Patent No. 5247460
   OHNISHI T, 1996, MAT MEASUREMENT MOL, V81, P545
   PARTRIDGE RH, 1983, POLYMER, V24, P733, DOI 10.1016/0032-3861(83)90012-5
   TANG CW, 1989, J APPL PHYS, V65, P3610, DOI 10.1063/1.343409
   TANG CW, 1987, APPL PHYS LETT, V51, P913, DOI 10.1063/1.98799
   TANG CW, 1996, IEEE1996 SID INT S D, V17, P181
   VanSlyke SA, 1996, APPL PHYS LETT, V69, P2160, DOI 10.1063/1.117151
   VINCETT PS, 1982, THIN SOLID FILMS, V94, P171, DOI 10.1016/0040-6090(82)90509-0
NR 16
TC 0
Z9 0
U1 0
U2 3
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5713-2
J9 P SOC PHOTO-OPT INS
PY 2005
VL 5739
BP 42
EP 50
DI 10.1117/12.587220
PG 9
WC Engineering, Electrical & Electronic; Optics
SC Engineering; Optics
GA BCE20
UT WOS:000228826900006
DA 2018-10-19
ER

PT J
AU Yang, R
   Xu, S
   Wang, Z
   Yang, W
AF Yang, R
   Xu, S
   Wang, Z
   Yang, W
TI Aqueous extraction of corncob xylan and production of
   xylooligosaccharides
SO LWT-FOOD SCIENCE AND TECHNOLOGY
LA English
DT Article
DE corncob; xylooligosaccharides; steaming; crystalline structure of
   cellulose; xylan-lignin complex
ID ENZYMATIC HYDROLYSIS EXTRACTION; CONTAINING NATURAL MATERIALS; LIGNIN;
   STREPTOMYCES; PRETREATMENT; SYSTEM
AB Xylooligosaccharide, which is usually produced from xylan by enzymatic hydrolysis, is a newly developed functional oligosaccharide having many beneficial biomedical and health effects. In this study, a process for producing xylooligosaccharides from corncob was developed. The procedure consisted of soaking the corncob in 1.0 g/l H2SO4 at 60 &DEG; C for 12h, followed by filtrating and washing with tap water to pH 6 and steaming at 135-140 &DEG; C for 0.5 h. The steamed corncob was mashed and hydrolysed by xylanase. The cumulative yield of xylooligosaccharides after enzymatic hydrolysis was close to 67.7 g/100 g by steaming (based on xylan in raw material), and the purity of xylooligosaccharides was over 70 g/100 g (based on the total sugars in the hydrolysate). This study demonstrated that the xylan-lignin complex present in the corncob was affected during steaming at 135 &DEG; C for 30 min. Almost all of the xylan was removed from the lignin after steam application and subsequent enzymatic hydrolysis. &COPY; 2004 Swiss Society of Food Science and Technology. Published by Elsevier Ltd. All rights reserved.
C1 SoYangtze Univ, Sch Food Sci & Technol, Wuxi 214036, Jiangsu, Peoples R China.
   Alabama A&M Univ, Dept Food & Anim Sci, Normal, AL 35762 USA.
RP Yang, R (reprint author), SoYangtze Univ, Sch Food Sci & Technol, Wuxi 214036, Jiangsu, Peoples R China.
EM yrj@sytu.edu.cn; wyang@aamu.edu
CR DAS NN, 1984, CARBOHYD RES, V129, P197
   Dekker R.F.H., 1985, BIOSYNTHESIS BIODEGR, P505
   ERIKSSON O, 1980, WOOD SCI TECHNOL, V14, P267, DOI 10.1007/BF00383454
   FENGEL D, 1976, SVEN PAPPERSTIDN, V79, P24
   FENGEL D, 1976, HOLZFORSCHUNG, V30, P1, DOI 10.1515/hfsg.1976.30.1.1
   KARR WE, 1991, J WOOD CHEM TECHNOL, V11, P447
   KARR WE, 1991, J WOOD CHEM TECHNOL, V11, P465
   KOGA K, 1985, OLIGOSACCARIDES, V3, P130
   KOSIKOVA B, 1978, HOLZFORSCHUNG, V32, P15, DOI 10.1515/hfsg.1978.32.1.15
   KUSAKABE I, 1976, J AGR CHEM SOC JPN, V50, P209, DOI 10.1271/nogeikagaku1924.50.5_209
   KUSAKABE I, 1976, J AGR CHEM SOC JPN, V50, P199, DOI 10.1271/nogeikagaku1924.50.5_199
   MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030
   Olsson L, 1996, ENZYME MICROB TECH, V18, P312, DOI 10.1016/0141-0229(95)00157-3
   PELLERIN P, 1991, ENZYME MICROB TECH, V13, P617, DOI 10.1016/0141-0229(91)90074-K
   Sasaka M., 1995, BIOTECHNOL BIOENG, V45, P517
   Selvendran R R, 1985, J Cell Sci Suppl, V2, P51
   WILLIAM S, 1984, AOAC OFFICIAL METHOD
NR 17
TC 71
Z9 80
U1 4
U2 27
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0023-6438
J9 LWT-FOOD SCI TECHNOL
JI LWT-Food Sci. Technol.
PY 2005
VL 38
IS 6
BP 677
EP 682
DI 10.1016/j.lwt.2004.07.023
PG 6
WC Food Science & Technology
SC Food Science & Technology
GA 924AE
UT WOS:000228950000014
DA 2018-10-19
ER

PT J
AU Hedia, HSM
   Shabara, MAN
   Fattah, AA
   Helal, MMK
AF Hedia, HSM
   Shabara, MAN
   Fattah, AA
   Helal, MMK
TI Effect of crack configuration and pre-crack length on stress intensity
   factors - Study of the tearing mode using a three-dimensional finite
   element model
SO MATERIALPRUFUNG
LA English
DT Article
ID NOTCH TIP SHARPNESS
AB In this paper, the results for the stress intensity factor of a mode III (tearing mode) have been investigated using the method of finite element analysis. A compact tension specimen containing a pre-crack and subjected to out-of-plane tearing loads has been used. A three-dimensional finite element analysis (FEA) model using the ANSYS program has been built for specimens made of different biomedical materials such as stainless steel, titanium, alumina, high density polyethylene (HDPE) and polymethyl methacrylate(PMMA). Such materials are used for hip and knee replacement and for dental implants. The effects of notch angle, notch tip radius and pre-crack length on the stress intensity factor for the mode III have been studied. The model was extended to study the effect of crack and bonding line separation distance on stress intensity factors for specimens made of different homogeneous materials such as stainless steel bonding with epoxy as a filler material. The number of elements along the crack front and crack tip has been varied to determine its effects on the stress intensity factors. It is concluded that the pre-crack must be greater than or equal to 33% of the total crack length and the notch must be a blunt notch in order to obtain the stress intensity factor, K-III, independently, of the crack notch angle. However, the stress intensity factor is independent of the crack and bonding line separation distance when it is less than or equal to 15% of the specimen width. The results for the stress intensity factors, K-III,, are obtained using a linear elastic fracture mechanics (LEFM) approach.
C1 Mansoura Univ, Prod Engn & Mech Design Dept, Fac Engn, Mansoura, Egypt.
RP Hedia, HSM (reprint author), Mansoura Univ, Prod Engn & Mech Design Dept, Fac Engn, Mansoura, Egypt.
RI Hedia, Hassan/I-8289-2012
CR *ANSYS, 1992, ANSYS US MAN VERS 50
   *ASTM, 1983, 399 ASTM E
   *ASTM E, 1995, 647 ASTM E
   CHUNG YL, 1992, ENG FRACT MECH, V4, P321
   DOLAN TJ, 1970, PRECLUDE FAILURE PHI
   Farshad M, 1998, ENG FRACT MECH, V60, P597, DOI 10.1016/S0013-7944(98)00020-4
   Fett T., 1998, STRESS INTENSITY FAC
   FINLAYSON FE, 1998, THESIS
   HE MY, 2001, ENG FRACT MECH, V65, P1
   Hedia HSM, 2002, MATERIALPRUFUNG, V44, P122
   Hedia HSM, 2002, MATERIALPRUFUNG, V44, P117
   Hertzberg W. R., 1996, DEFORMATION FRACTURE
   Stephens R.L., 2001, METAL FATIGUE ENG
   Wearing JL, 1999, ENG ANAL BOUND ELEM, V23, P3, DOI 10.1016/S0955-7997(98)00057-5
   Wong JSS, 2003, ACTA MATER, V51, P4929, DOI 10.1016/S1359-6454(03)00335-5
   Yamauchi T, 2002, J WOOD SCI, V48, P532, DOI 10.1007/BF00766652
   YOUNG MJ, 1993, INT J FRACTURE, V60, P1, DOI 10.1007/BF00034508
NR 17
TC 0
Z9 0
U1 2
U2 7
PU CARL HANSER VERLAG
PI MUNICH
PA KOLBERGERSTRASSE 22, POSTFACH 86 04 20, D-81679 MUNICH, GERMANY
SN 0025-5300
J9 MATERIALPRUFUNG
JI Materialprufung
PY 2005
VL 47
IS 10
BP 568
EP 573
DI 10.3139/120.100691
PG 6
WC Materials Science, Characterization & Testing
SC Materials Science
GA 987XO
UT WOS:000233551200003
DA 2018-10-19
ER

PT J
AU Ramanujan, RV
   Yeow, YY
AF Ramanujan, RV
   Yeow, YY
TI Synthesis and characterisation of polymer-coated metallic magnetic
   materials
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article
DE magnetic material; polymer; microsphere; ball milling; coating;
   biomedical applications
AB Polymer-coated magnetic microspheres can be used for bioengineering applications: hence. the synthesis and characterization of such materials was studied. Cobalt and iron powders were ball milled and subsequently characterized by scanning electron microscopy (SEM) and XRD methods. The average size of the ball milled Co powders was 7.4 mum after 1 h of milling; for Fe, the smallest average size was 808 nm after 10 h of milling. These milled powders were then coated, using the solvent evaporation technique with the polymer poly-L-lactic acid (PLLA) to form microspheres. The process parameters to form microspheres with the smallest diameter. spherical morphology and a narrow size distribution was determined. The stirring speed and polymer viscosity were found to control the size and shape of microspheres. The Co and Fe microspheres had an average size of 105 and 125 mum, respectively. The VSM results showed that saturation magnetization decreased with polymer coating thickness. (C) 2004 Elsevier B.V. All rights reserved.
C1 Nanyang Technol Univ, Sch Mat Engn, Singapore 639798, Singapore.
RP Ramanujan, RV (reprint author), Nanyang Technol Univ, Sch Mat Engn, Singapore 639798, Singapore.
EM ramanujan@ntu.edu.sg
RI Ramanujan, Raju/A-2245-2011
CR Carpenter EE, 2001, J MAGN MAGN MATER, V225, P17, DOI 10.1016/S0304-8853(00)01222-1
   Chen C.W., 1977, MAGNETISM METALLURGY
   CHEN JP, 1994, J APPL PHYS, V75, P5876, DOI 10.1063/1.355546
   Craik D., 1995, MAGNETISM PRINCIPLES
   EDELMAN ER, 1985, J BIOMED MATER RES, V19, P67, DOI 10.1002/jbm.820190107
   Hertzog B, 1997, SCIENTIFIC AND CLINICAL APPLICATIONS OF MAGNETIC CARRIERS, P77
   Jiles D., 1990, INTRO MAGNETISM MAGN
   KOCH CC, 1991, MATERIALS SCI TECHNO, V15, P194
   KRAKHMALEV P, 2001, P 22 RIS INT S MAT S, P301
   Kuznetsov AA, 1997, SCIENTIFIC AND CLINICAL APPLICATIONS OF MAGNETIC CARRIERS, P379
   Lubbe AS, 2001, J SURG RES, V95, P200, DOI 10.1006/jsre.2000.6030
   McHenry ME, 2000, ACTA MATER, V48, P223, DOI 10.1016/S1359-6454(99)00296-7
   Murty BS, 1998, INT MATER REV, V43, P101, DOI 10.1179/imr.1998.43.3.101
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   SENYEI A, 1978, J APPL PHYS, V49, P3578, DOI 10.1063/1.325219
   SURYANARAYANA C, 1995, INT MATER REV, V40, P41, DOI 10.1179/imr.1995.40.2.41
NR 16
TC 16
Z9 16
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD JAN
PY 2005
VL 25
IS 1
BP 39
EP 41
DI 10.1016/j.msec.2004.04.001
PG 3
WC Materials Science, Multidisciplinary
SC Materials Science
GA 888KH
UT WOS:000226372300006
DA 2018-10-19
ER

PT J
AU Mattioli-Belmonte, M
   Gabbanelli, F
   Marcaccio, M
   Giantomassi, F
   Tarsi, R
   Natali, D
   Callegari, A
   Paolucci, F
   Biagini, G
AF Mattioli-Belmonte, M
   Gabbanelli, F
   Marcaccio, M
   Giantomassi, F
   Tarsi, R
   Natali, D
   Callegari, A
   Paolucci, F
   Biagini, G
TI Bio-characterisation of tosylate-doped polypyrrole films for biomedical
   applications
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article
DE tosylate-doped polypyrrole; over-oxidation; biomaterial
ID CONDUCTING POLYMER; MECHANICAL-PROPERTIES; GLUCOSE-OXIDASE; ADHESION;
   OVEROXIDATION; BIOMATERIALS; MORPHOLOGY
AB Electroactive polymers such as polypyrrole (PPy) are receiving particular interest because they can combine inherent biological properties that can specifically trigger desired cellular responses for many biological applications. The aim of the present work was to evaluate more efficient solutions, achieved by different oxidisations of tosylate-doped PPy films in different chemico-physical conditions. in view of their long-term biomedical applications. The conductivity and the release of the tosylate ion were assessed. Morpho-functional studies were also performed. A gradual increase in impedance of the oxidised tosylate-doped PPy films soaked in MEM and a reduced conductivity after over-oxidation was found. Scanning electron microscopy (SEM) analysis showed the presence of a hierarchical organisation of the PPy films and a partially different morphology between oxidised and over-oxidised films. Cell behaviour was also randomly affected in relation to the oxidative state of the studied Ppy films. On the basis of the results, growth of these tosylate-doped Ppy films directly in the sol-gel matrix or on the surface of metal alloys could be hypothesised in order to improve bioactive material of potential use in modern regenerative medicine. However, in view of their in vivo application, over-oxidation must be considered as it may represent the degraded material that is likely to form under a biological oxidising environment. (C) 2004 Elsevier B.V. All rights reserved.
C1 Univ Politecn Marche, Ist Morfol Umana Normale, Fac Med & Chirurg, I-60020 Ancona, Italy.
   Univ Bologna, Dipartimento Chim Ciamician, Bologna, Italy.
   Univ Politecn Marche, Ist Microbiol & Sci Biomed, Ancona, Italy.
RP Mattioli-Belmonte, M (reprint author), Univ Politecn Marche, Ist Morfol Umana Normale, Fac Med & Chirurg, Via Tronto 10-A, I-60020 Ancona, Italy.
EM belmonte@univpm.it
RI Mattioli-Belmonte, Monica/J-5861-2012; Paolucci, Francesco/A-8708-2008
OI Paolucci, Francesco/0000-0003-4614-8740
CR Aoki T, 1996, BIOMATERIALS, V17, P1971, DOI 10.1016/0142-9612(96)00015-4
   BECK F, 1987, BER BUNSEN PHYS CHEM, V91, P967, DOI 10.1002/bbpc.19870910927
   Cen L, 2003, BIOSENS BIOELECTRON, V18, P363, DOI 10.1016/S0956-5663(02)00149-5
   CHEN Y, 2000, ANALYST, V225, P2249
   Collier JH, 2000, J BIOMED MATER RES, V50, P574, DOI 10.1002/(SICI)1097-4636(20000615)50:4<574::AID-JBM13>3.0.CO;2-I
   Cui XY, 2003, BIOMATERIALS, V24, P777, DOI 10.1016/S0142-9612(02)00415-5
   De Giglio E, 2001, BIOMATERIALS, V22, P2609, DOI 10.1016/S0142-9612(00)00449-X
   De Giglio E, 2000, J BIOMAT SCI-POLYM E, V11, P1073, DOI 10.1163/156856200743580
   DIAZ AF, 1983, IBM J RES DEV, V27, P342, DOI 10.1147/rd.274.0342
   DIAZ AF, 1986, HDB CONDUCTING POLYM, V1, P81
   DUFFITT GL, 1992, J CHEM SOC FARADAY T, V88, P1417, DOI 10.1039/ft9928801417
   Garner B, 1999, J BIOMED MATER RES, V44, P121, DOI 10.1002/(SICI)1097-4636(199902)44:2<121::AID-JBM1>3.0.CO;2-A
   Hallab NJ, 2001, TISSUE ENG, V7, P55, DOI 10.1089/107632700300003297
   HEINZE J, 2001, ORGANIC ELECTROCHEMI, P1309
   KANATZIDIS MG, 1990, CHEM ENG NEWS, V68, P36, DOI 10.1021/cen-v068n049.p036
   KO JM, 1994, SYNTHETIC MET, V64, P9, DOI 10.1016/0379-6779(94)90267-4
   Lombello CB, 2002, J MATER SCI-MATER M, V13, P867, DOI 10.1023/A:1016552413295
   Long LH, 2001, BIOCHEM BIOPH RES CO, V286, P991, DOI 10.1006/bbrc.2001.5514
   LYONS MEG, 1993, ANALYST, V118, P361, DOI 10.1039/an9931800361
   MATTJOLIBELMONT.M, 2002, 65 NANOMED, V65
   NOFTLE RE, 1987, J ELECTROANAL CHEM, V227, P229, DOI 10.1016/0022-0728(87)80078-5
   PANDE R, 1993, MATER RES SOC SYMP P, V292, P135
   PICKUP PG, 1999, MOD ASPECT ELECTROC, P33
   PREZYNA LA, 1991, MACROMOLECULES, V24, P5283, DOI 10.1021/ma00019a010
   Rodriguez I, 2000, J ELECTROANAL CHEM, V491, P117, DOI 10.1016/S0022-0728(00)00194-7
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Van der Pauw L.J., 1958, Philips Research Reports, V13, P1
   WARREN LF, 1989, J ELECTROCHEM SOC, V136, P2286, DOI 10.1149/1.2097303
   Warriner K, 1997, MAT SCI ENG C-BIOMIM, V5, P81, DOI 10.1016/S0928-4931(97)00026-X
   WYNNE KJ, 1985, MACROMOLECULES, V18, P2361, DOI 10.1021/ma00154a005
   YANG R, 1990, J PHYS CHEM-US, V94, P6117, DOI 10.1021/j100378a087
NR 31
TC 16
Z9 18
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD JAN
PY 2005
VL 25
IS 1
BP 43
EP 49
DI 10.1016/j.msec.2004.04.002
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 888KH
UT WOS:000226372300007
DA 2018-10-19
ER

PT S
AU Kaufman, JD
   Klapperich, CM
AF Kaufman, JD
   Klapperich, CM
BE Viney, C
   Katti, K
   Ulm, FJ
   Hellmich, C
TI Nanomechanical testing of hydrated biornaterials: Sample preparation,
   data validation and analysis
SO Mechanical Properties of Bioinspired and Biological Materials
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Mechanical Properties of Bioinspired and Biological
   Materials held at the 2004 MRS Fall Meeting
CY NOV 29-DEC 02, 2004
CL Boston, MA
SP Mat Res Soc, Hysitron Co
AB Implants, tissue engineering scaffold materials, drug delivery and bio-micro electromechanical systems (BioMEMs) all use polymer or hydrogel materials. These applications require both mechanical performance and successful integration of the material into a biological environment. Mechanical strength, storage and loss moduli, wear resistance and surface adhesion properties are all critical in biomedical device design and can be determined using nanoindentation. The difficulty of obtaining large samples of specialized materials, and the complexity of testing soft materials in traditional materials testing apparatus, make nanoindentation an attractive alternative. Our previous research using nanoindentation to measure the surface mechanical properties of non-hydrated polymers led to improvement in nanoindentation testing protocols. One of the major challenges in using this technique for hydrogels and tissues is maintaining and controlling hydration of the materials during the test. Here we describe the design of a microfluidic platform for nanoindentation that facilitates continuous hydration of hydrogel samples and high throughput nanomechanical testing. Data from creep experiments on synthetic, hydrated poly-2-hydroxyethyl methacrylate (poly-HEMA) are presented. In addition, we show data to validate the materials properties determined from nanomechanical testing by complementary testing. Finally, the data is fitted to a phenomenological model for viscoelastic materials, specifically the three-element standard linear solid model used by Cheng et al. [I].
C1 Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
RP Kaufman, JD (reprint author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
OI Klapperich, Catherine/0000-0001-6103-849X
CR Cheng L, 2000, J POLYM SCI POL PHYS, V38, P10, DOI 10.1002/(SICI)1099-0488(20000101)38:1<10::AID-POLB2>3.0.CO;2-6
   EBENSTEIN DM, 1996, THESIS U CALIFORNIA
   KLAPPERICH CM, 2004, WORLD BIOM C SYDN AU
   KLAPPERICH CM, 2004, MAT RES SOC P, V823
   OLIVER WC, 1992, J MATER RES, V7, P6
   Tsui TY, 1997, MATER RES SOC SYMP P, V473, P57
   XIA X, 2000, THESIS U MINNESOTA
NR 7
TC 0
Z9 0
U1 0
U2 1
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-792-X
J9 MATER RES SOC SYMP P
PY 2005
VL 844
BP 287
EP 292
PG 6
WC Materials Science, Biomaterials; Materials Science, Characterization &
   Testing
SC Materials Science
GA BCF71
UT WOS:000229087800040
DA 2018-10-19
ER

PT J
AU Laborde-Lahoz, P
   Maser, W
   Martinez, T
   Benito, A
   Seeger, T
   Cano, P
   de Villoria, RG
   Miravete, A
AF Laborde-Lahoz, P
   Maser, W
   Martinez, T
   Benito, A
   Seeger, T
   Cano, P
   de Villoria, RG
   Miravete, A
TI Mechanical characterization of carbon nanotube composite materials
SO MECHANICS OF ADVANCED MATERIALS AND STRUCTURES
LA English
DT Article
ID ORGANIC POLYMER; SINGLE; LOAD
AB The unique mechanical, electrical, and electrochemical properties of single-wall carbon nanotubes (SWNTs) and their versatility render these structures potentially promising for a number of structural biomedical applications. Among a series of critical parameters, such as the diameter and structure of the SWNT, its length is considered crucial in attaining the outstanding mechanical properties that this system exhibits at a molecular level. Therefore, long nanotubes are desirable for achieving high stiffness and strength. In this article, SWNTs and SWNT/organic matrix composites have been fabricated and characterized. Their microstructure has been studied via electron microscopy and a series of mechanical tests on these materials have been performed. Additionally, mathematical formulations are used to obtain the stiffness and strength of SWNTs embedded in organic matrices and a theory-experiment correlation study has been carried out. It is shown that the mechanical properties of nanotubes in composite matrix justify their proposed use as electromechanical actuators.
C1 Univ Texas, Hlth Sci Ctr, Houston, TX USA.
   Inst Carboquim, Zaragoza, Spain.
   Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA.
   Univ Zaragoza, Zaragoza, Spain.
   Univ Houston, Houston, TX USA.
RP Miravete, A (reprint author), Composites Engn & Applicat Ctr, 5000 Gulf Freeway,Bldg 3,Rm 152-B, Houston, TX 77024 USA.
EM amiravete@uh.edu
RI Maser, Wolfgang/L-7342-2014; BENITO, ANA/B-2065-2012
OI Maser, Wolfgang/0000-0003-4253-0758; BENITO, ANA/0000-0002-8654-7386;
   Guzman de Villoria, Roberto/0000-0001-6369-5266
CR Aizawa M, 2003, CHEM PHYS LETT, V368, P121, DOI 10.1016/S0009-2614(02)01767-0
   Allaoui A, 2002, COMPOS SCI TECHNOL, V62, P1993, DOI 10.1016/S0266-3538(02)00129-X
   Ando Y, 2002, J CRYST GROWTH, V237, P1926, DOI 10.1016/S0022-0248(01)02248-5
   [Anonymous], 2001, ASM HDB, V21
   Bandyopadhyaya R, 2002, NANO LETT, V2, P25, DOI 10.1021/nl010065f
   CHOI Y, 2000, APPL PHYS LETT, V76, P17
   Coleman JN, 2000, ADV MATER, V12, P213, DOI 10.1002/(SICI)1521-4095(200002)12:3<213::AID-ADMA213>3.0.CO;2-D
   Dalton AB, 2000, J PHYS CHEM B, V104, P10012, DOI 10.1021/jp002857o
   Duclaux L, 2002, CARBON, V40, P1751, DOI 10.1016/S0008-6223(02)00043-X
   Gojny FH, 2003, CHEM PHYS LETT, V370, P820, DOI 10.1016/S0009-2614(03)00187-8
   Gong XY, 2000, CHEM MATER, V12, P1049, DOI 10.1021/cm9906396
   IIJIMA S, 1993, NATURE, V363, P603, DOI 10.1038/363603a0
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   Lau KT, 2002, CARBON, V40, P2965, DOI 10.1016/S0008-6223(02)00245-2
   LI X, 2002, CARBON, V41, P579
   Mehan ML, 2000, COMPOS SCI TECHNOL, V60, P1013, DOI 10.1016/S0266-3538(99)00194-3
   MIRAVETE A, 2001, ANAL COMPOSITE STRUC
   Piggott M. R., 1980, LOAD BEARING FIBRE C
   Pipes RB, 2003, COMPOS SCI TECHNOL, V63, P1349, DOI 10.1016/S0266-3538(03)00020-4
   QUIAN D, 2000, APPL PHYS LETT, V76, P2828
   Schadler LS, 1998, APPL PHYS LETT, V73, P3842, DOI 10.1063/1.122911
   Shaffer MSP, 1998, CARBON, V36, P1603, DOI 10.1016/S0008-6223(98)00130-4
   SHIMODA H, 2002, PHYS REV LETT, V88, DOI DOI 10.1103/PhysRevLett.88.015502
   Yakobson BI, 1997, AM SCI, V85, P324
   Yu MF, 2000, PHYS REV LETT, V84, P5552, DOI 10.1103/PhysRevLett.84.5552
   Yu MF, 2000, SCIENCE, V287, P637, DOI 10.1126/science.287.5453.637
   Zhu HW, 2002, SCIENCE, V296, P884, DOI 10.1126/science.1066996
NR 27
TC 30
Z9 30
U1 0
U2 7
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 1537-6494
J9 MECH ADV MATER STRUC
JI Mech. Adv. Mater. Struct.
PD JAN-FEB
PY 2005
VL 12
IS 1
BP 13
EP 19
DI 10.1080/15376490590491792
PG 7
WC Materials Science, Multidisciplinary; Mechanics; Materials Science,
   Characterization & Testing; Materials Science, Composites
SC Materials Science; Mechanics
GA 886NJ
UT WOS:000226235300002
DA 2018-10-19
ER

PT B
AU Tyber, J
   Gall, K
   Frick, C
   Ortega, A
   Toelle, J
   Steinke, D
   Hardy, E
   Pacaccio, D
AF Tyber, J.
   Gall, K.
   Frick, C.
   Ortega, A.
   Toelle, J.
   Steinke, D.
   Hardy, E.
   Pacaccio, D.
BE Helmus, M
   Medlin, D
TI Improved fracture healing with use of shape memory alloys
SO Medical Device Materials II: Proceedings from the Materials & Processes
   for Medical Devices Conference 2004
LA English
DT Proceedings Paper
CT Materials and Processes for Medical Devices (MPMD)
CY AUG 25-27, 2004
CL St Paul, MN
SP ASM Int
AB The introduction of shape memory alloys (SMA) as an active implant material has greatly advanced the medical industry. The most heavily utilized SMA in biomedical applications is nickel titanium (NiTiNOL) due to its ability to instantaneously recover large amounts of deformation at a constant stress level. This paper describes the design of a new form of bone plate, utilizing the mechanical properties of NiTiNOL. Also investigated is the biocompatibility of NiTiNOL, demonstrating the potential of NiTiNOL as a biomedical material. The results will be compared to the standard bone plate material, stainless steel (SS).
C1 Univ Colorado, Boulder, CO 80309 USA.
RP Tyber, J (reprint author), Univ Colorado, Boulder, CO 80309 USA.
OI Frick, Carl/0000-0002-8202-924X
CR ALLGOWER M, 1995, MANUAL INTERNAL FIXA, P58
   Duerig T, 1999, MAT SCI ENG A-STRUCT, V273, P149, DOI 10.1016/S0921-5093(99)00294-4
   Gall K, 1999, INT J PLASTICITY, V15, P69, DOI 10.1016/S0749-6419(98)00060-6
   KLIENNULEND J, 1987, BONE MINER, V293, P8
   PILLIAR R, 2003, ASM MAT PROCESSES ME
NR 5
TC 0
Z9 0
U1 1
U2 3
PU ASM INTERNATIONAL
PI MATERIALS PARK
PA 9503 KINSMAN RD, MATERIALS PARK, OH 44073 USA
BN 978-0-87170-824-3
PY 2005
BP 124
EP 127
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA BFY36
UT WOS:000245431900022
DA 2018-10-19
ER

PT B
AU Bradley, D
   Chaney, S
   Fischer, S
AF Bradley, D.
   Chaney, S.
   Fischer, S.
BE Helmus, M
   Medlin, D
TI Characterization of biomedical wire for optimum performance in suture
   needle manufacture and use
SO Medical Device Materials II: Proceedings from the Materials & Processes
   for Medical Devices Conference 2004
LA English
DT Proceedings Paper
CT Materials and Processes for Medical Devices (MPMD)
CY AUG 25-27, 2004
CL St Paul, MN
SP ASM Int
AB Stabilizing thermomechanical treatments were introduced during suture needle Custom 455 (R) wire stock manufacture to resolve residual stresses. Elongation properties of the material were increased by as much as 133% in final wire form and 8% after precipitation hardening without significant impact to the bend moment and stiffness of the wire. It is hoped that low residual stress wire stock material will improve the attachability of final needle wire forms to suture material. Similar post-draw increases in elongation have been observed in initial evaluation of other needle stock alloys such as Custom 465 (R) and Custom 470 (R).
C1 Ft Wayne Met Res Prod Corp, Ft Wayne, IN USA.
RP Bradley, D (reprint author), Ft Wayne Met Res Prod Corp, Ft Wayne, IN USA.
CR Atienza JM, 2003, MATER STRUCT, V36, P548, DOI 10.1007/BF02480832
   Petzow Gunter, METALLOGRAPHIC ETCHI
NR 2
TC 0
Z9 0
U1 0
U2 1
PU ASM INTERNATIONAL
PI MATERIALS PARK
PA 9503 KINSMAN RD, MATERIALS PARK, OH 44073 USA
BN 978-0-87170-824-3
PY 2005
BP 184
EP 188
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA BFY36
UT WOS:000245431900032
DA 2018-10-19
ER

PT B
AU Kurisky, GA
   D'Ambrisi, RP
AF Kurisky, George A.
   D'Ambrisi, Richard P.
BE Helmus, M
   Medlin, D
TI Desirable biocompatible and physical characteristics of selected
   stainless steel alloys and specialty wire materials for use in the
   design and manufacture of implants and medical devices
SO Medical Device Materials II: Proceedings from the Materials & Processes
   for Medical Devices Conference 2004
LA English
DT Proceedings Paper
CT Materials and Processes for Medical Devices (MPMD)
CY AUG 25-27, 2004
CL St Paul, MN
SP ASM Int
AB The research described in this paper is a technical literature search with additional comments and insight from a wire drawing industry perspective. This paper has two goals. The first goal is to locate relevant citations in literature for alloys 304V, 316LVM, Nitronic (R) 50, Nitronic 60, 25-6M0, 27-7 MO and MP35N (R). This search utilized key words that related to desirable biocompatible and physical characteristics of these alloys. The second goal is to offer future investigators easy access to this information in a concise format that would facilitate their research, product development and subsequent selection of these alloys for medical wire device applications. Our research included several prominent technical metallurgy reference holdings. We focused specific attention to extensive database literature sources offered by our ASM membership. The results of our work confirmed the premise that these alloys have been extensively studied for biomedical applications by previous investigators. Our research uncovered considerable knowledge on the topic. In some cases, selected alloys are used as the standard to validate new materials and technologies. We were able to conclude that these alloys have a very successful and well-documented use in medical devices. It is evident that design and manufacturing professionals can continue to confidently choose these stainless steel wire alloys for medical device applications.
C1 Maryland Specialty Wire, Cockeysville, MD USA.
RP Kurisky, GA (reprint author), Maryland Specialty Wire, Cockeysville, MD USA.
CR Bendel LP, 1997, JMRI-J MAGN RESON IM, V7, P1170, DOI 10.1002/jmri.1880070635
   BHAT SV, 2002, BIOMATERIALS, P26
   *CAN COMM, 2003, ADV MET EXP CAP
   Chen XM, 2004, AM J ROENTGENOL, V182, P1075, DOI 10.2214/ajr.182.4.1821075
   DAVIS JR, 2003, HDB MAT MED DEVICES, P14
   Disegi J A, 2000, Injury, V31 Suppl 4, P2
   FREIHEIT JM, 1953, YALE J BIOL MED, V25, P509
   HELSEN JA, 1999, METALS BIOMATERIALS, pR9
   KAPILA S, 1989, AM J ORTHOD DENTOFAC, V96, P100, DOI 10.1016/0889-5406(89)90251-5
   Park J.B., 2003, BIOMATERIALS PRINCIP, P1
   VONRECUM AF, 1987, HDB BIOMATERIALS EVA, P15
   Wise D.L., 2000, BIOMATERIALS BIOENGI, P63
NR 12
TC 0
Z9 0
U1 0
U2 2
PU ASM INTERNATIONAL
PI MATERIALS PARK
PA 9503 KINSMAN RD, MATERIALS PARK, OH 44073 USA
BN 978-0-87170-824-3
PY 2005
BP 221
EP 224
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA BFY36
UT WOS:000245431900039
DA 2018-10-19
ER

PT B
AU Goodman, SL
   Mengelt, TJ
   Ali, M
   Kostrna, SLP
   Ulfig, RM
   Kelly, TF
AF Goodman, Steven L.
   Mengelt, Terri J.
   Ali, Muhammad
   Kostrna, Stephanie L. P.
   Ulfig, Robert M.
   Kelly, Thomas F.
BE Helmus, M
   Medlin, D
TI Three-dimensional atomic structure and compositional analysis of medical
   devices with the local electrode atom probe
SO Medical Device Materials II: Proceedings from the Materials & Processes
   for Medical Devices Conference 2004
LA English
DT Proceedings Paper
CT Materials and Processes for Medical Devices (MPMD)
CY AUG 25-27, 2004
CL St Paul, MN
SP ASM Int
ID ALLOY
AB The development of improved implantable biomaterials and the development of ever smaller medical devices for minimally invasive procedures places ever increasing demands on material performance. This ongoing development, in turn, requires greater understanding of material nanostructure. However, existing methods to determine material structure have substantial limitations in that currently used analytical instrumentation is not able to determine structure and composition at sub-manometer levels in three dimensions. The recently introduced Local Electrode Atom Probe microscope (LEAPS) can meet this critical need by providing 3-D atomic structure and composition of medical device materials. LEAP microscopy can readily determine the 3-D bulk and (near) surface nanostructure of biomedical metals and devices with sub-manometer resolution and identify all elements. This is demonstrated herein with three alloys that are widely used in stents, guide wires, orthopedic prosthetics and other device applications. Materials examined include 316L stainless steel, cobalt-chrome-molybdenum, and nitinol. LEAP imaging of these materials, and devices produced from these materials, can provide unique information regarding nanoscale composition, implanted ion distribution, precipitate and grain boundary structure, and elemental distribution across buried interfaces. In development are methods to determine the nanostructure and composition of surface oxides that will utilize the LEAP's intrinsic single atomic layer depth resolution. Such nanostructural information can assist in research, process development, failure analysis, and quality control.
C1 Imago Sci Instruments Corp, Madison, WI USA.
RP Goodman, SL (reprint author), Imago Sci Instruments Corp, Madison, WI USA.
CR GOODMAN SL, 2004, T 7 WORLD BIOM C, P371
   GOODMAN SL, 2004, P MICR MICR S2, V10
   Kelly T. F., 2003, MICROSCOPY TODAY, V11, P8
   Kelly TE, 2004, MICROSC MICROANAL, V10, P373, DOI 10.1017/S1431927604040565
   Kelly TF, 2000, MATER CHARACT, V44, P59, DOI 10.1016/S1044-5803(99)00055-8
   KOSTRNA SLP, 2004, P MICR MICR S2, V10, P206
   RAJAN K, 1984, METALL TRANS A, V15, P1335, DOI 10.1007/BF02648562
   RAJAN K, 1982, METALL TRANS A, V13, P1161, DOI 10.1007/BF02645497
NR 8
TC 0
Z9 0
U1 0
U2 2
PU ASM INTERNATIONAL
PI MATERIALS PARK
PA 9503 KINSMAN RD, MATERIALS PARK, OH 44073 USA
BN 978-0-87170-824-3
PY 2005
BP 263
EP 266
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA BFY36
UT WOS:000245431900047
DA 2018-10-19
ER

PT J
AU Repsilber, D
   Ziegler, A
AF Repsilber, D
   Ziegler, A
TI Two-color microarray experiments - Technology and sources of variance
SO METHODS OF INFORMATION IN MEDICINE
LA English
DT Article
DE agilent; chip; comparative hybridization; gene expression; microarray;
   technical variance
ID GENE-EXPRESSION; HYBRIDIZATION; CDNA; ARRAYS
AB Objectives: Microarray gene expression experiments have a complex technical background. Knowledge about certain technical details is inevitable to judge alternatives for both experimental design and analysis. Here, we introduce the necessary details for the so-called two-color microarray experiments and review major sources of technical variance.
   Methods: We follow the sequence of experimental steps during a typical two-color microarray gene expression experiment, stressing decisive points in the choice of technique, experimental handling and biophysical basics. We point out where technical variation is to be expected.
   Results: Tissue storage, RNA extraction techniques, as well as the microarray hybridization represent major components of technical variance to be considered. Depending on the possibilities for access to the biomedical material under investigation, choice of amplification and labeling techniques can also be decisive to avoid additional technical variance. The two-color microarray experimental approach seeks to avoid a group of probe-level technical biases making use of the advantages of an incomplete block-design.
   Conclusions: It is worth to know the major sources of technical variance during the typical experimental sequence, both for choice of experimental design and techniques of molecular biology, as well as for the understanding of quality control and normalization approaches. Here, early investments pay at the level of reduced technical variance, allowing for enhanced detection levels for the effects under investigation.
C1 Univ Lubeck, Inst Med Biometrie & Stat, Lubeck, Germany.
RP Repsilber, D (reprint author), Univ Klinikum Schleswig Holstein, Inst Med Biometrie & Stat, Campus Lubeck,Ratzeburger Allee 160,Haus 4, D-23538 Lubeck, Germany.
EM dirk.repsilber@imbs.uni-luebeck.de
OI Ziegler, Andreas/0000-0002-8386-5397
CR *AG TECHN, 2003, AG SUR PRINT TECHN C
   ALWINE JC, 1977, P NATL ACAD SCI USA, V74, P5350, DOI 10.1073/pnas.74.12.5350
   Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365
   Breit S, 2004, BRIT J HAEMATOL, V126, P231, DOI 10.1111/j.1365-2141.2004.05017.x
   Bretz F, 2005, METHOD INFORM MED, V44, P423
   DeRisi J, 1996, NAT GENET, V14, P457
   Duggan DJ, 1999, NAT GENET, V21, P10, DOI 10.1038/4434
   Eisen MB, 1999, METHOD ENZYMOL, V303, P179
   Ittrich C, 2005, METHOD INFORM MED, V44, P418
   Kane MD, 2000, NUCLEIC ACIDS RES, V28, P4552, DOI 10.1093/nar/28.22.4552
   Katzer M, 2003, IEEE T NANOBIOSCI, V2, P202, DOI 10.1109/TNB.2003.817023
   Khomyakova EB, 2004, CELL MOL BIOL, V50, P217
   King HC, 2001, JAMA-J AM MED ASSOC, V286, P2280, DOI 10.1001/jama.286.18.2280
   Klur S, 2004, GENOMICS, V83, P508, DOI 10.1016/j.ygeno.2003.09.005
   LANDGREBE J, 2004, SILICO BIOL, V4, P38
   Lipsitt DR, 1999, GEN HOSP PSYCHIAT, V21, P1
   Parmigiani G., 2003, ANAL GENE EXPRESSION
   Rahnenfuhrer J, 2005, METHOD INFORM MED, V44, P405
   Repsilber D, 2005, METHOD INFORM MED, V44, P461
   RISHI AS, 2002, REV PLANT BIOCH BIOT, V1, P81
   Schena M., 2003, MICROARRAY ANAL
   Simon R, 2003, DESIGN ANAL DNA MICR
   SOUTHERN EM, 1992, GENOMICS, V13, P1008, DOI 10.1016/0888-7543(92)90014-J
   SULTMANN H, 2001, CDNA MICROARRAYS GEN
   Tefferi A, 2002, MAYO CLIN PROC, V77, P927
   VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663
   Watson SJ, 2000, BIOL PSYCHIAT, V48, P1147, DOI 10.1016/S0006-3223(00)01080-5
NR 27
TC 9
Z9 9
U1 0
U2 1
PU SCHATTAUER GMBH-VERLAG MEDIZIN NATURWISSENSCHAFTEN
PI STUTTGART
PA HOLDERLINSTRASSE 3, D-70174 STUTTGART, GERMANY
SN 0026-1270
J9 METHOD INFORM MED
JI Methods Inf. Med.
PY 2005
VL 44
IS 3
BP 400
EP 404
PG 5
WC Computer Science, Information Systems; Health Care Sciences & Services;
   Medical Informatics
SC Computer Science; Health Care Sciences & Services; Medical Informatics
GA 948RY
UT WOS:000230734600008
PM 16113763
DA 2018-10-19
ER

PT J
AU Lindberg, DAB
AF Lindberg, DAB
TI Research opportunities and challenges in 2005
SO METHODS OF INFORMATION IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 49th Annual Conference of the
   German-Society-for-Medical-Informatics-Biometry-and-Epidemiology
CY SEP 26-30, 2004
CL Innsbruck, AUSTRIA
SP German Soc Med Informat Biometry & Epidemiol
DE literature review; medical informatics; computerized patient record;
   population surveillance; cohort studies
ID US; STANDARD; JAPAN; NIH
AB Objectives. Biomedical informatics practice and research have become so brood that I will comment on only three areas. These are the electronic health record; prospective population studies, and interactive publications.
   Methods. Review of the literature, Internet resources and material and reports generated by internal and external research projects.
   Results: Development of an electronic health record continues to be problematic in the U.S. A number of large-scale prospective cohort studies of normal populations are now actively occurring or in planning stages in a number of countries; these present special research opportunities in biomedical informatics. Although there are engineering challenges to the implementation of interactive publications, they have the potential to enhance understanding, learning, and memory of scientific and health concepts.
   Conclusions: Three areas of bio-medical informatics challenge us and offer interesting and worthy research opportunities. These include the electronic health record, prospective cohort studies, and interactive publications.
C1 Natl Lib Med, Bethesda, MD 20894 USA.
RP Lindberg, DAB (reprint author), Natl Lib Med, 8600 Rockville Pike, Bethesda, MD 20894 USA.
EM lindberg@nlm.nih.gov
CR BECKER J, 1998, MANAGING MULTIDIMENS
   Brown PJB, 1998, METHOD INFORM MED, V37, P415
   BULTERMAN D, 2003, WORLD C EL CORP GOV, P2083
   Collins FS, 2004, NATURE, V429, P475, DOI 10.1038/nature02628
   Fincke EM, 2005, RADIOLOGY, V234, P319, DOI 10.1148/radiol.2342041680
   FINCKE EM, 2004, RADIOLOGY
   GRAY J, 2000, RULES THUMB DATA ENG
   Hammond WE, 2003, ST HEAL T, V96, P266
   HUMPHREYS BL, 1998, J AM MED INFORM ASSN, V1, P1
   Kaiser J, 2004, SCIENCE, V305, P458
   Kaiser J, 2004, SCIENCE, V305, P764
   Kaiser J, 2002, SCIENCE, V298, P1158, DOI 10.1126/science.298.5596.1158
   LAVEN P, 2003, EBU TECH REV
   LINDBERG DAB, 1993, METHOD INFORM MED, V32, P281
   MARTI V, 1993, ODA BASED CODER DECO, P849
   McDonald CJ, 2003, CLIN CHEM, V49, P624, DOI 10.1373/49.4.624
   Sweeney L, 1997, J LAW MED ETHICS, V25, P98, DOI 10.1111/j.1748-720X.1997.tb01885.x
   Triendl R, 2003, NAT MED, V9, P982, DOI 10.1038/nm0803-982b
   Wang Amy Y, 2002, Proc AMIA Symp, P845
   WATANABE S, 1993, EUR J CANCER, V29A, P2305, DOI 10.1016/0959-8049(93)90226-6
NR 20
TC 8
Z9 8
U1 0
U2 1
PU SCHATTAUER GMBH-VERLAG MEDIZIN NATURWISSENSCHAFTEN
PI STUTTGART
PA HOLDERLINSTRASSE 3, D-70174 STUTTGART, GERMANY
SN 0026-1270
J9 METHOD INFORM MED
JI Methods Inf. Med.
PY 2005
VL 44
IS 4
BP 483
EP 486
PG 4
WC Computer Science, Information Systems; Health Care Sciences & Services;
   Medical Informatics
SC Computer Science; Health Care Sciences & Services; Medical Informatics
GA 972YQ
UT WOS:000232490100002
PM 16342914
DA 2018-10-19
ER

PT J
AU Ceusters, W
   Smith, B
   Goldberg, L
AF Ceusters, W
   Smith, B
   Goldberg, L
TI A terminological and ontological analysis of the NCI thesaurus
SO METHODS OF INFORMATION IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 49th Annual Conference of the
   German-Society-for-Medical-Informatics-Biometry-and-Epidemiology
CY SEP 26-30, 2004
CL Innsbruck, AUSTRIA
SP German Soc Med Informat Biometry & Epidemiol
DE ontology; medical terminology; standardization; quality control
ID MEDICAL LANGUAGE SYSTEM
AB Objective: The National Cancer Institute Thesaurus is described by its authors as "a biomedical vocabulary that provides consistent, unambiguous codes and definitions for concepts used in cancer research" and which,exhibits ontology-like properties in its construction and use". We performed a qualitative analysis of the Thesaurus in order to assess its conformity with principles of good practice in terminology and ontology design.
   Materials and Methods. We used both the on-line browsable version of the Thesaurus and its OWL-representation (version 04.08b, released on August 2, 2004), measuring each in light of the requirements put forward in relevant ISO terminology standards and in light of ontological principles advanced in the recent literature.
   Results: We found many mistakes and inconsistencies with respect to the term-formation principles used, the underlying knowledge representation system, and missing or inappropriately assigned verbal and formal definitions.
   Conclusion: Version 04.08b of the NCI Thesaurus suffers from the same broad range of problems that have been observed in other biomedical terminologies. For its further development, we recommend the use of a more principled approach that allows the Thesaurus to be tested not just for internal consistency but also for its degree of correspondence to that part of reality which it is designed to represent.
C1 Univ Saarland, European Ctr Ontol Res, D-66041 Saarbrucken, Germany.
   Univ Buffalo, Dept Philosophy, Buffalo, NY USA.
   Univ Saarland, Inst Formal Ontol & Med Informat Sci, D-6600 Saarbrucken, Germany.
   Univ Buffalo, Sch Dent Med, Buffalo, NY USA.
RP Ceusters, W (reprint author), Univ Saarland, European Ctr Ontol Res, Postfach 151150, D-66041 Saarbrucken, Germany.
EM werner.ceusters@ecor.uni-saarland.de
RI Ceusters, Werner/H-2269-2013; Smith, Barry/A-9525-2011
OI Ceusters, Werner/0000-0002-2676-8689; Smith, Barry/0000-0003-1384-116X
CR BODENREIDER O, 2004, P 3 INT C FORM ONT I, P185
   CANTOR MN, 2003, P AMIA S, P125
   Ceusters W, 2004, ST HEAL T, V102, P145
   CEUSTERS W, 2003, P C EL PAT REC TEPR
   CEUSTERS W, 2004, P 11 WORLD C MED INF, P482
   Cimino JJ, 1998, J AM MED INFORM ASSN, V5, P41, DOI 10.1136/jamia.1998.0050041
   *COLL AM PATH, SNOMED CLIN TERMS CO
   de Coronado S, 2004, ST HEAL T, V107, P33
   DECORONADO S, 2004, PROT WORKSH JUL 6 9
   FISCHER DH, CONVERTING THESAURUS
   GAMPER J, P 5 INT C TERM KNOWL
   GOLBECK J, 2003, J WEB SEMANT, V1, P75, DOI DOI 10.1016/J.WEB-SEM.2003.07.007
   Grenon P, 2004, ST HEAL T, V102, P20
   Hahn U, 2003, Pac Symp Biocomput, P577
   HARTEL F, 2004, W3C WORKSH SEM WEB L
   Kumar A, 2003, LECT NOTES ARTIF INT, V2821, P135
   KUMAR A, 2004, MEDINFO 2004 P 11 WO, P1700
   *LAB APPL ONT DOLC, 2005, DESCR ONT LING COGN
   OGDEN CK, 1923, MEANING MEANING
   Rosse C, 2003, J BIOMED INFORM, V36, P478, DOI 10.1016/j.jbi.2003.11.007
   SCHNEIDER L, 16114019 ISSN
   SMITH B, 2004, INT C FORM ONT INF S, P73
   SMITH B, 2003, P AMIA S, P609
   Smith B., 2004, P 11 WORLD C MED INF, P444
   Smith Barry, 2003, AMIA Annu Symp Proc, P609
   SPYNS P, STAR200420
   SWARTZ N, USE MENTION
   *W3C, 2004, RES DESC FRAM RDF CO
   W3C, 2004, OWL WEB ONT LANG REF
   WIELEMAKER J, TRIPLE20 RDF TRIPLE
   WIELEMAKER J, 2003, PRACTICAL ASPECTS DE, P31
NR 31
TC 59
Z9 60
U1 0
U2 1
PU SCHATTAUER GMBH-VERLAG MEDIZIN NATURWISSENSCHAFTEN
PI STUTTGART
PA HOLDERLINSTRASSE 3, D-70174 STUTTGART, GERMANY
SN 0026-1270
J9 METHOD INFORM MED
JI Methods Inf. Med.
PY 2005
VL 44
IS 4
BP 498
EP 507
PG 10
WC Computer Science, Information Systems; Health Care Sciences & Services;
   Medical Informatics
SC Computer Science; Health Care Sciences & Services; Medical Informatics
GA 972YQ
UT WOS:000232490100004
PM 16342916
DA 2018-10-19
ER

PT S
AU Lee, DS
   Chung, KH
   Yang, HS
   Park, SH
   Kim, SJ
   Pyo, HB
AF Lee, DS
   Chung, KH
   Yang, HS
   Park, SH
   Kim, SJ
   Pyo, HB
BE Chiao, JC
   Jamieson, DN
   Faraone, L
   Dzurak, AS
TI Plastic thermally-controllable platform with integrated thin film
   micro-components
SO Micro- and Nanotechnology: Materials, Processes, Packaging, and Systems
   II
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Micro- and Nanotechnology - Materials , Processes,
   Packaging, and Systems II
CY DEC 13-15, 2004
CL Sydney, AUSTRALIA
SP SPIE, Univ New S Wales, Australian Govt Dept Def, Def Sci &Technol Org, Cochlear, Minist Sci & Med Res, Univ Adelaide, Ctr Biomed Engn
DE micro-patterning on polymer; thermal isolation; COC; injection molding
ID MICROFLUIDIC DEVICE; CHIP; ELECTROPHORESIS; DIAGNOSTICS; FABRICATION;
   PCR
AB We present a novel technology for a cyclo-olefin-copolymer (COC) plastic microfluidic platform for heat control With fully semiconductor process-compatible photolithographic 5 mu m-wide metal patterns, for heaters, electrodes., and temperature sensors and a thin membrane structure.
   Through tests of compatibility of some thermoplastic materials with chemical Solutions and temperature tolerance to the semiconductor processes (thin film depositions, photolithography, and etchings), we selected COC as a semiconductor process-compatible plastic material for biomedical applications. For photolithography processes, we manufactured the 5 COC wafer with flat Surface with c.a. 3 nm Surface roughness, employing a novel flame-torched injection-molding method. Furthermore, the part of heating blocks on COC wafers is controlled thickness to the 100 pm. to enhance the heat-ramping speeds through reduction of the thermal mass.
   In order to fabricate the Au thin film micro-patterns for temperature sensors, heaters, and electrodes, Au film (100 nm) was deposited by e-beam evaporator and patterned by using standard photolithography, and wet-etched. The micropatterned Au temperature sensors, heaters, and electrodes was demonstrated For insulating layers, Al2O3 film was deposited by an ALD system, patterned by using the standard photo lithography, and wet-etched.
   Using the COC microfluidic platform, we tested thermal cycling with simple heating and natural cooling on chip with water and. heating rates (5 degrees C/s when heating, 3 degrees C/s when cooling) are obtained. Therefore. the COC microfluidic platform can be applied to,I DNA lab-on-a-chip.
C1 ETRI, BioMEMS Team, Taejon 305350, South Korea.
RP Lee, DS (reprint author), ETRI, BioMEMS Team, Taejon 305350, South Korea.
CR Ahn CH, 2004, P IEEE, V92, P154, DOI 10.1109/JPROC.2003.820548
   Boone T, 2002, ANAL CHEM, V74, p78A, DOI 10.1021/ac021943c
   Buch JS, 2004, ANAL CHEM, V76, P874, DOI 10.1021/ac034913y
   Buchholz BA, 2001, ANAL CHEM, V73, P157, DOI 10.1021/ac001023z
   Huber DL, 2003, SCIENCE, V301, P352, DOI 10.1126/science.1080759
   Kim K, 2004, CHEM COMMUN, P1466, DOI 10.1039/b402914c
   Ko JS, 2003, LAB CHIP, V3, P106, DOI 10.1039/b301794j
   Koh CG, 2003, ANAL CHEM, V75, P4591, DOI 10.1021/ac0343836
   Kopp MU, 1998, SCIENCE, V280, P1046, DOI 10.1126/science.280.5366.1046
   Lagally ET, 2004, ANAL CHEM, V76, P3162, DOI 10.1021/ac035310p
   Lee DS, 2004, LAB CHIP, V4, P401, DOI 10.1039/b313547k
   Lim JW, 2004, ELECTROCHEM SOLID ST, V7, pF45, DOI 10.1149/1.1756541
   Madou M, 2000, CHEM REV, V100, P2679, DOI 10.1021/cr980098o
   Mastrangelo CH, 1998, P IEEE, V86, P1769, DOI 10.1109/5.704282
   Ritala M, 1999, NANOTECHNOLOGY, V10, P19, DOI 10.1088/0957-4484/10/1/005
   Rossier J, 2002, ELECTROPHORESIS, V23, P858, DOI 10.1002/1522-2683(200203)23:6<858::AID-ELPS858>3.0.CO;2-3
   Vilkner T, 2004, ANAL CHEM, V76, P3373, DOI 10.1021/ac040063q
   Wang Z, 2003, J AM CHEM SOC, V125, P15278, DOI 10.1021/ja036581k
   Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153
   Xiang JH, 2004, LANGMUIR, V20, P3278, DOI 10.1021/la036088m
   Yang H, 2004, ANAL CHEM, V76, P1537, DOI 10.1021/ac035270p
NR 21
TC 0
Z9 0
U1 0
U2 5
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5610-1
J9 P SOC PHOTO-OPT INS
PY 2005
VL 5650
BP 429
EP 437
DI 10.1117/12.582342
PG 9
WC Materials Science, Multidisciplinary; Materials Science,
   Characterization & Testing; Optics
SC Materials Science; Optics
GA BCD14
UT WOS:000228693800054
DA 2018-10-19
ER

PT S
AU Liu, CG
   Qiu, YF
   Lian, K
AF Liu, CG
   Qiu, YF
   Lian, K
BE Papautsky, I
TI Polymer-based valves with tunable opening pressures for biomedical
   applications
SO Microfluidics, BioMEMS, and Medical Microsystems III
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Microfludics, BioMEMS, and Medical Microsystems III
CY JAN 24-26, 2005
CL San Jose, CA
SP SPIE, Semiconduct Equipment and Mat Int, Soild State Technol, Sandia Natl Lab
DE microfluidics; polymer-based valve; PDMS material; injection molding;
   hyper-elastic; simulation
AB A series of polymer-based Polydimethylsiloxanes (PDMS) ball valves with different opening pressures have been developed for biomedical applications. By tuning different weight ratios of the two components (the base and the curing agent) of PDMS, the valves will have different opening pressures because of different stiffness of the PDMS materials. The curing conditions and mechanical properties of the PDMS material with different ratios have been thoroughly studied. The compressive Young's modulus of the material can be tuned from 310 KPa to 2.0 MPa. Such kind valves can be fabricated by injection molding, one of the cheapest fabrication techniques. Also such kind valve has no dead volume and easily to be integrated into micro-total analysis systems (mu TAS).
C1 Louisiana State Univ, Ctr Adv Microstruct & Devices, Baton Rouge, LA 70806 USA.
RP Liu, CG (reprint author), Louisiana State Univ, Ctr Adv Microstruct & Devices, 6980 Jefferson Highway, Baton Rouge, LA 70806 USA.
CR ARMANI D, MEMS 99, P222
   Cooney CG, 2004, SENSOR ACTUAT A-PHYS, V116, P519, DOI 10.1016/j.sna.2004.05.015
   Go JS, 2004, SENSOR ACTUAT A-PHYS, V114, P438, DOI 10.1016/j.sna.2003.12.028
   Lotters JC, 1997, J MICROMECH MICROENG, V7, P145, DOI 10.1088/0960-1317/7/3/017
   Schotter J, 2002, IEEE T MAGN, V38, P3365, DOI 10.1109/TMAG.2002.802290
   Tamanaha CR, 2002, J MICROMECH MICROENG, V12, pN7, DOI 10.1088/0960-1317/12/2/401
   Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113
   YAO TJ, P MEMS 2000 MIY JAP, P624
NR 8
TC 1
Z9 1
U1 0
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5692-6
J9 P SOC PHOTO-OPT INS
PY 2005
VL 5718
BP 179
EP 185
DI 10.1117/12.590859
PG 7
WC Engineering, Biomedical; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA BCE50
UT WOS:000228863400024
DA 2018-10-19
ER

PT B
AU Dewidar, MM
   Khalil, KA
   Hassan, MK
   Tag, G
   Seo, DW
   Lim, JK
AF Dewidar, MM
   Khalil, KA
   Hassan, MK
   Tag, G
   Seo, DW
   Lim, JK
BE Sih, GC
   Tu, ST
   Wang, Z
TI Processing and mechanical properties of porous 316L stainless steel for
   artificial hip joints
SO MULTISCALE DAMAGE RELATED TO ENVIRONMENT ASSISTED CRACKING
SE Fracture Mechanics Symposium
LA English
DT Proceedings Paper
CT 3rd Annual Meeting of the Fracture-Mechanics-Group
CY NOV 02-05, 2005
CL Zhengzhou Univ, Zhengzhou, PEOPLES R CHINA
SP E China Univ Sci Technol, Natl Tech Res Ctr Safety Engn Pressure Vessel & Pipelines, Nanjing Univ Technol, Zhengzhou Univ Technol, China Pressure Vessel Inst, Natl Sci Fdn, China, Natl Sci Fdn, US, Boiler & Pressure Vessel Safety Super Bureau China, Henan Dept Sci & Technol, Fracture Mech Grp
HO Zhengzhou Univ
DE 316L stainless steel; porous; artificial hip joints; selective laser
   sintering; processing; mechanical properties
ID TITANIUM; IMPLANTS; BEHAVIOR; MODEL
AB 316L stainless steel is considered as one of the attractive metallic materials for biomedical applications due to its mechanical properties, biocompatibility, and corrosion resistance. It has been demonstrated that 316L stainless steel is well accepted by human tissues. In the present investigation, highly porous 316L stainless steel parts were produced by using a novel powder metallurgy process, which includes the selective laser sintering process and traditional sintering. Porous 316L stainless steel used for medical applications was successfully fabricated in the porosity range from 40 to 50 vol.% by controlling the selective laser sintering parameters and sintering behaviour. Elastic modulus and strength of the 316L stainless steel material was investigated as a function of the selective laser sintering process and the furnace cycle, or in the other words as a function of porosity.
C1 High Inst Energy, Dept Mech Design & Mat, Aswan, Egypt.
RP Dewidar, MM (reprint author), High Inst Energy, Dept Mech Design & Mat, Aswan, Egypt.
EM dewidar5@hotmail.com
CR ANA YB, 2005, MATER LETT, V59, P2178
   Becker BS, 1997, J MATER SCI-MATER M, V8, P793, DOI 10.1023/A:1018525015421
   DENG X, 2005, INT J FATIGUE, P1
   Dewidar M, 2001, ADVANCES IN MANUFACTURING TECHNOLOGY - XV, P181
   German R. M., 1994, POWDER METALLURGY SC
   German R. M., 1998, POWDER METALLURGY IR
   German RM, 1985, LIQUID PHASE SINTERI
   Gibson L. G., 1997, CELLULAR SOLIDS STRU
   Laptev A, 2004, POWDER METALL, V47, P85, DOI 10.1179/003258904225015536
   LEE WH, 2005, APPL SURF SCI
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   MANIATOPOULOS C, 1988, J PROSTHET DENT, V59, P438, DOI 10.1016/0022-3913(88)90039-X
   MANIATOPOULOS C, 1988, J PROSTHET DENT, V59, P662, DOI 10.1016/0022-3913(88)90378-2
   MANIATOPOULOS C, 1986, J BIOMED MATER RES, V20, P1309, DOI 10.1002/jbm.820200907
   MURRAY GAW, 1981, J BONE JOINT SURG BR, V63, P138
   Simmons CA, 1999, J BIOMED MATER RES, V47, P127, DOI 10.1002/(SICI)1097-4636(199911)47:2<127::AID-JBM3>3.0.CO;2-C
   SUN ZM, 2005, ACTA MAT
   Thieme M, 2001, J MATER SCI-MATER M, V12, P225, DOI 10.1023/A:1008958914818
   Wegner LD, 2001, INT J MECH SCI, V43, P1061, DOI 10.1016/S0020-7403(00)00035-7
   Xina R, 2005, BIOMATERIALS, V26, P6477
NR 20
TC 0
Z9 0
U1 2
U2 4
PU EAST CHINA UNIV SCIENCE AND TECHNOLOGY PRESS
PI SHANGHAI
PA MEILONG RD, SHANGHAI 200237, PEOPLES R CHINA
BN 7-5628-1804-5
J9 FRACTURE MECH SYMP
PY 2005
BP 43
EP 49
PG 7
WC Engineering, Mechanical; Mechanics
SC Engineering; Mechanics
GA BDQ87
UT WOS:000234971500006
DA 2018-10-19
ER

PT B
AU Dewidar, MM
   Seo, DW
   Lim, JK
AF Dewidar, MM
   Seo, DW
   Lim, JK
BE Sih, GC
   Tu, ST
   Wang, Z
TI Processing of high porosity Ti-6Al-4V by powder sintering process for
   biomedical applications
SO MULTISCALE DAMAGE RELATED TO ENVIRONMENT ASSISTED CRACKING
SE Fracture Mechanics Symposium
LA English
DT Proceedings Paper
CT 3rd Annual Meeting of the Fracture-Mechanics-Group
CY NOV 02-05, 2005
CL Zhengzhou Univ, Zhengzhou, PEOPLES R CHINA
SP E China Univ Sci Technol, Natl Tech Res Ctr Safety Engn Pressure Vessel & Pipelines, Nanjing Univ Technol, Zhengzhou Univ Technol, China Pressure Vessel Inst, Natl Sci Fdn, China, Natl Sci Fdn, US, Boiler & Pressure Vessel Safety Super Bureau China, Henan Dept Sci & Technol, Fracture Mech Grp
HO Zhengzhou Univ
DE Ti-6Al-4V; porous materials; space-holder; decomposition; sintering
   process; biomedical application
ID BONE CEMENTS; TI
AB Due to their excellent mechanical properties, superior biocompatibility, corrosion resistance titanium and its alloys are currently considered as the most important metallic materials for biomedical applications. In the present study, an effective method of fabricating porous metal was developed. Porous Ti-6Al-4Vusing a space-holder method and powder sintering process for biomedical applications are successfully fabricated in the porosities between 30% and 70%. The results showed that spherical-shaped pores were obtained depending on the shape and size distribution of the space-holder. The porous Ti-6Al-4V parts are characterized by using scanning electron microscopy. The results show that this process is promise to fabricate biomaterials for bone implants.
C1 High Inst Energy, Dept Mech Design & Mat, Aswan, Egypt.
RP Dewidar, MM (reprint author), High Inst Energy, Dept Mech Design & Mat, Aswan, Egypt.
EM dewidar5@hotmail.com
CR Amigo V, 2003, J MATER PROCESS TECH, V141, P117, DOI 10.1016/S0924-0136(03)00243-7
   *ASTM, 1995, 158995 ASTM F
   DAVID CD, 2004, ADV ENG MATER, V6, P369
   De Aza AH, 2002, BIOMATERIALS, V23, P937, DOI 10.1016/S0142-9612(01)00206-X
   Deb S, 2005, BIOMATERIALS, V26, P3713, DOI 10.1016/j.biomaterials.2004.09.065
   Deb S, 2002, BIOMATERIALS, V23, P3387, DOI 10.1016/S0142-9612(02)00039-X
   Deb S, 1997, J MATER SCI-MATER M, V8, P829, DOI 10.1023/A:1018589302217
   HEEMAN C, 2005, MAT SCI ENG A-STRUCT, V396, P99
   Laptev A, 2004, POWDER METALL, V47, P85, DOI 10.1179/003258904225015536
   Li JP, 2004, J MATER SCI-MATER M, V15, P951, DOI 10.1023/B:JMSM.0000042680.10087.15
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Martin B, 2000, ADV ENG MATER, V2, P196
   MASAYUKI K, 2003, WILEY PERIODICALS, P88
   Oh IH, 2003, SCRIPTA MATER, V49, P1197, DOI 10.1016/j.scriptamat.2003.08.018
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   Wen CE, 2001, SCRIPTA MATER, V45, P1147, DOI 10.1016/S1359-6462(01)01132-0
NR 16
TC 0
Z9 0
U1 0
U2 1
PU EAST CHINA UNIV SCIENCE AND TECHNOLOGY PRESS
PI SHANGHAI
PA MEILONG RD, SHANGHAI 200237, PEOPLES R CHINA
BN 7-5628-1804-5
J9 FRACTURE MECH SYMP
PY 2005
BP 177
EP 183
PG 7
WC Engineering, Mechanical; Mechanics
SC Engineering; Mechanics
GA BDQ87
UT WOS:000234971500028
DA 2018-10-19
ER

PT S
AU Rabiei, A
   Thomas, B
AF Rabiei, A
   Thomas, B
BE Laurencin, CT
   Botchwey, EA
TI Processing and development of nano-scale HA coatings for biomedical
   application
SO Nanoscale Materials Science in Biology and Medicine
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Nanoscale Materials Science in Biology and Medicine held at
   the 2004 MRS Fall Meeting
CY NOV 28-DEC 02, 2004
CL Boston, MA
SP Mat Res Soc
AB Functionally graded Hydroxyapatite coating with graded Crystallinity across the thickness of the film has been processed and tested as a more effective orthopedic/ dental implant coating. The present study aims to increase the service-life of an orthopedic/ dental implant by creating materials that form a strong, long lasting, bond with the Ti substrate as well as juxtaposed bone. The health relatedness of the new material is to increase bonding between an implant and juxtaposed bone so that a patient who has received joint or dental replacement surgery may quickly return to a normal active lifestyle. Cross-sectional transmission electron microscopy analysis displayed that the films have a graded crystal structure with the crystalline layer near the substrate and the amorphous layer at the top surface. Compositional analysis was performed using SEM-EDX at the top surface as well as STEM-EDX at the cross section of the film. The average calcium to phosphorous ratio at the surface is 1.46, obtained by SEM-EDX. The Ca/P ratios in the crystalline and amorphous layers of the film are 1.6 to 1.7, close to the ratio of 1.67 for HA.
C1 N Carolina State Univ, Dept Mech & Aerosp Engn, Raleigh, NC 27695 USA.
RP Rabiei, A (reprint author), N Carolina State Univ, Dept Mech & Aerosp Engn, Raleigh, NC 27695 USA.
CR FEDDES B, 2000, SURF COAT TECH, V185, P346
   vanDijk K, 1996, BIOMATERIALS, V17, P405, DOI 10.1016/0142-9612(96)89656-6
NR 2
TC 2
Z9 2
U1 0
U2 3
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-793-8
J9 MATER RES SOC SYMP P
PY 2005
VL 845
BP 193
EP 199
PG 7
WC Materials Science, Multidisciplinary; Materials Science, Biomaterials
SC Materials Science
GA BCE01
UT WOS:000228804900028
DA 2018-10-19
ER

PT S
AU Newaz, G
   Georgiev, DG
   Mian, A
   Auner, G
   Herfurth, H
   Witte, R
AF Newaz, G
   Georgiev, DG
   Mian, A
   Auner, G
   Herfurth, H
   Witte, R
BE Laurencin, CT
   Botchwey, EA
TI Laser fabrication and characterization of adhesive-free joints for
   encapsulation of biomedical implant devices
SO Nanoscale Materials Science in Biology and Medicine
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Nanoscale Materials Science in Biology and Medicine held at
   the 2004 MRS Fall Meeting
CY NOV 28-DEC 02, 2004
CL Boston, MA
SP Mat Res Soc
ID DIFFUSION; INTERFACE
AB Laser-fabricated joints of sub-millimeter widths between biocompatible, dissimilar materials have the potential for applications as encapsulation of miniature implant biomedical devices. In this work, we briefly describe the laser joining method of a very promising system, polyimide/titanium-coated borosilicate glass, and present and discuss results from characterization of such laser joints by means of mechanical failure (tensile) tests, optical microscopy, X-ray photoelectron spectroscopy (XPS) and Raman spectroscopy. Our results suggest the formation of strong chemical bonds between Ti-containing species and certain polymeric functional groups. Mechanical tensile strength failure test showed that such joint experience only limited, disappearing with time degradation as a result of soaking in physiological solutions.
C1 Wayne State Univ, Coll Engn, Ctr Smart Sensors & Integrated Microsyst, Detroit, MI 48202 USA.
RP Newaz, G (reprint author), Wayne State Univ, Coll Engn, Ctr Smart Sensors & Integrated Microsyst, Detroit, MI 48202 USA.
OI Mian, Ahsan/0000-0002-2033-6738
CR Bauer I, 2004, P SOC PHOTO-OPT INS, V5339, P454, DOI 10.1117/12.530239
   Faupel F, 1997, DEFECT DIFFUS FORUM, V143, P887, DOI 10.4028/www.scientific.net/DDF.143-147.887
   Georgiev DG, 2004, APPL SURF SCI, V236, P71, DOI 10.1016/j.apsusc.2004.03.261
   Girardeaux C, 1996, J ELECTRON SPECTROSC, V77, P209, DOI 10.1016/0368-2048(95)02521-9
   GIRARDEAUX C, 1994, J ELECT SPECTROSC RE, V7, P11
   Marin N, 1997, NUCL INSTRUM METH B, V131, P109, DOI 10.1016/S0168-583X(97)00197-3
   MIAN A, IN PRESS J MAT SCI M
   OHUCHI FS, 1986, J VAC SCI TECHNOL A, V4, P1039, DOI 10.1116/1.573450
NR 8
TC 2
Z9 2
U1 0
U2 0
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-793-8
J9 MATER RES SOC SYMP P
PY 2005
VL 845
BP 267
EP 272
PG 6
WC Materials Science, Multidisciplinary; Materials Science, Biomaterials
SC Materials Science
GA BCE01
UT WOS:000228804900039
DA 2018-10-19
ER

PT S
AU Hai, NH
   Lemoine, R
   Remboldt, S
   Strand, MA
   Wignall, S
   Shield, JE
   Leslie-Pelecky, D
AF Hai, NH
   Lemoine, R
   Remboldt, S
   Strand, MA
   Wignall, S
   Shield, JE
   Leslie-Pelecky, D
BE Laurencin, CT
   Botchwey, EA
TI The stability and oxidation resistance of iron- and cobalt-based
   magnetic nanoparticle fluids fabricated by inert-gas condensation
SO Nanoscale Materials Science in Biology and Medicine
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Nanoscale Materials Science in Biology and Medicine held at
   the 2004 MRS Fall Meeting
CY NOV 28-DEC 02, 2004
CL Boston, MA
SP Mat Res Soc
ID CLUSTER GUN; ANISOTROPY
AB Magnetic nanoparticle fluids have numerous biomedical applications, including magnetic imaging, drug delivery, and hyperthermia treatment for cancer. Ideal magnetic nanoparticle fluids have well-separated, biocompatible nanoparticles with a small size distribution that form a stable colloid. We have combined inert-gas condensation, which produces nanoparticles with low polydispersity, with deposition directly into a surfactant-laden fluid to prevent agglomeration. Iron, cobalt, and iron-nitride nanoparticle fluids fabricated using inert-gas condensation have with mean particle sizes from 5-50 nm and remain stable over long periods of time. Iron and cobalt nanoparticles oxidize on exposure to air, with oxidation rates dependent on surfactant type and concentration. Iron-nitride fluids are more oxidation and corrosion resistant, while retaining the same high degree of colloidal stability. Magnetic properties vary depending on the nanoparticle size and material, but can be varied from superparamagnetic to ferromagnetic with coercivities on the order of 1000 Oe. In addition to future biomedical applications, inert-gas condensation into fluids offers the opportunity to study interparticle interactions over a broad range of intrinsic materials parameters and interparticle separations.
C1 Univ Nebraska, Dept Phys & Astron, Lincoln, NE 68588 USA.
RP Hai, NH (reprint author), Univ Nebraska, Dept Phys & Astron, Lincoln, NE 68588 USA.
CR Granqvust C., 1976, J APPL PHYS, V47, P220
   GRIMES CA, 2000, J APPL PHYS, V87, P564
   Hafeli U., 1997, SCI CLIN APPL MAGNET
   HAHN H, 1990, J APPL PHYS, V67, P1113, DOI 10.1063/1.345798
   Jack KH, 2000, MATER SCI FORUM, V325-3, P91, DOI 10.4028/www.scientific.net/MSF.325-326.91
   Li D, 2004, J MAGN MAGN MATER, V277, P64, DOI 10.1016/j.jmmm.2003.10.011
   MEIKLEJOHN WH, 1956, PHYS REV, V102, P1413, DOI 10.1103/PhysRev.102.1413
   NAKATANI I, 1990, J MAGN MAGN MATER, V85, P11, DOI 10.1016/0304-8853(90)90006-C
   NGUYEN H, 2005, IN PRESS MAGN MAGN M
   Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201
   ROSENZWEIG RE, 1985, FERRHYDRODYNAMICS
   Stoyanov S, 2003, J APPL PHYS, V93, P7592, DOI 10.1063/1.1544503
   Stoyanov S, 2003, J APPL PHYS, V93, P7190, DOI 10.1063/1.1555898
   Wagener M, 1999, J MAGN MAGN MATER, V201, P41, DOI 10.1016/S0304-8853(99)00055-4
NR 14
TC 1
Z9 1
U1 0
U2 4
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-793-8
J9 MATER RES SOC SYMP P
PY 2005
VL 845
BP 351
EP 356
PG 6
WC Materials Science, Multidisciplinary; Materials Science, Biomaterials
SC Materials Science
GA BCE01
UT WOS:000228804900053
DA 2018-10-19
ER

PT S
AU Nakajima, H
AF Nakajima, H
BE Naka, M
   Yamane, T
TI Fabrication of lotus-type porous metals, intermetallic compounds and
   semiconductors
SO NEW FRONTIERS OF PROCESSING AND ENGINEERING IN ADVANCED MATERIALS
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT International Conference on New Frontiers of Process Science and
   Engineering in Advanced Materials/ 14th Iketani Conference
CY NOV 24-26, 2004
CL Kyoto, JAPAN
SP High Temp Soc Japan, Osaka Univ, Joining & Welding Res Inst, Iketani Sci & Technol Fdn, Murata Sci Fdn
DE porous materials; metals; intermetallic compounds; semiconductors;
   solidification; hydrogen; nitrogen
ID UNIDIRECTIONAL SOLIDIFICATION; SILICON
AB Lotus-type porous materials, whose long cylindrical pores were aligned along the same direction, were fabricated by unidirectional solidification in a pressurized gas atmosphere. The pores were formed in the solidified materials as a result of precipitation due to supersaturated gas during solidification of the liquid material dissolved with gas atoms. The lotus-type porous materials with homogeneous size and porosity of the evolved pores can be obtained by the mould casting method with constant solidification rate for the materials with high thermal conductivity. On the other hand, the novel continuous floating zone melting method was invented to fabricate the porous materials with low thermal conductivity. Recently we succeeded in fabricating lotus-type porous materials such as various metals and alloys, intermetallic compound Ni3Al and NiTi, and semiconductor silicon. The fabrication conditions comprise a pressure up to 3.0 MPa and the use of a mixture gas of hydrogen (or nitrogen) and argon (or helium). Such lotus-type porous materials are expected to be employed in various applications such as machine parts, biomedical materials, etc.
C1 Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan.
RP Nakajima, H (reprint author), Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan.
EM nakajima@sanken.osaka-u.ac.jp
CR Banhart J, 2001, PROG MATER SCI, V46, P559, DOI 10.1016/S0079-6425(00)00002-5
   CULLIS AG, 1991, NATURE, V353, P335, DOI 10.1038/353335a0
   Hyun SK, 2004, J JPN I MET, V68, P39, DOI 10.2320/jinstmet.68.39
   Hyun SK, 2003, MATER LETT, V57, P3149, DOI 10.1016/S0167-577X(03)00012-0
   Nakahata T, 2004, MAT SCI ENG A-STRUCT, V384, P373, DOI 10.1016/j.msea.2004.07.004
   Nakajima H., 2003, CELLULAR METALS MANU, P191
   Nakanishi N, 2000, J OCCUP HEALTH, V42, P1, DOI 10.1539/joh.42.1
NR 7
TC 3
Z9 3
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-980-6
J9 MATER SCI FORUM
PY 2005
VL 502
BP 367
EP 372
DI 10.4028/www.scientific.net/MSF.502.367
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Materials Science, Characterization & Testing
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BDL89
UT WOS:000234200300060
DA 2018-10-19
ER

PT S
AU Porjazoska, A
   Yilmaz, OK
   Kayaman-Apohan, N
   Baysal, K
   Cvetkovska, M
   Baysal, BM
AF Porjazoska, A
   Yilmaz, OK
   Kayaman-Apohan, N
   Baysal, K
   Cvetkovska, M
   Baysal, BM
BE KorugicKarasz, LS
   MacKnight, WJ
   Martuscelli, E
TI Synthesis of an ABA triblock copolymer of poly(DL-lactide) and
   poly(ethylene glycol) and blends with poly(epsilon-caprolactone) as a
   promising material for biomedical application
SO NEW POLYMERIC MATERIALS
SE ACS SYMPOSIUM SERIES
LA English
DT Article; Proceedings Paper
CT Symposium on New Poymeric Materias
CY OCT 22-25, 2003
CL Capri, ITALY
SP Polymer Chem In, ACS Div
ID DRUG-RELEASE; DEGRADATION; BEHAVIOR; ACID
AB The aim of this work was preparation of blends based on ABA triblock copolymers [A=poly(DL-lactide); B=poly(ethylene glycol)] and poly(epsilon-caprolactone) (PCL), their characterization, hydrolytic degradation study, and evaluation of the possibility to use these materials in tissue engineering. GPC, FTIR, H-1 NMR and DSC analyses were used for block copolymers characterization, and the corresponding blends with PCL, were characterized by FTIP, TGA, DSC and contact angle measurements. Porous films were prepared from triblock copolymers, and corresponding blends using solvent casting particulate-leaching technique. Hydrolytic in vitro degradation was performed in phosphate buffer solution. Preliminary cell growth experiments, using L929 mouse fibroblasts, were performed to observe the attachment and growth of cells on polymer matrices.
C1 Sv Kiril & Metodij Univ, Fac Technol & Met, Skopje 1000, Macedonia.
   TUBITAK, Res Inst Genet Engn & Biotechnol, TR-41470 Gebze, Turkey.
   Marmara Univ, Dept Chem, TR-81040 Istanbul, Turkey.
   Bogazici Univ, Dept Chem Engn, TR-34342 Istanbul, Turkey.
RP Porjazoska, A (reprint author), Sv Kiril & Metodij Univ, Fac Technol & Met, Skopje 1000, Macedonia.
CR BARRERA DA, 1995, MACROMOLECULES, V28, P425, DOI 10.1021/ma00106a004
   Berkland C, 2002, J CONTROL RELEASE, V82, P137, DOI 10.1016/S0168-3659(02)00136-0
   Cai Q, 2000, J BIOMAT SCI-POLYM E, V11, P273, DOI 10.1163/156856200743698
   Chen CC, 2003, BIOMATERIALS, V24, P1167, DOI 10.1016/S0142-9612(02)00466-0
   Davis MW, 1996, BIOMATERIALS, V17, P365, DOI 10.1016/0142-9612(96)85575-X
   Dogan M, 1999, J APPL POLYM SCI, V74, P2848, DOI 10.1002/(SICI)1097-4628(19991213)74:12<2848::AID-APP8>3.3.CO;2-W
   Guo YL, 1998, J BIOL CHEM, V273, P4027, DOI 10.1074/jbc.273.7.4027
   Hurrell S, 2001, J MATER SCI-MATER M, V12, P811, DOI 10.1023/A:1017925019985
   Jeong JH, 2000, COLLOID SURFACE B, V18, P371, DOI 10.1016/S0927-7765(99)00162-9
   John G, 1997, J POLYM SCI POL CHEM, V35, P1901, DOI 10.1002/(SICI)1099-0518(19970730)35:10<1901::AID-POLA4>3.0.CO;2-Q
   Kim CH, 2000, J APPL POLYM SCI, V77, P226, DOI 10.1002/(SICI)1097-4628(20000705)77:1<226::AID-APP29>3.0.CO;2-8
   Lee SH, 2002, J POLYM SCI POL CHEM, V40, P2545, DOI 10.1002/pola.10339
   MOONEY DJ, 1995, J BIOMED MATER RES, V29, P959, DOI 10.1002/jbm.820290807
   Penco M, 2000, J APPL POLYM SCI, V78, P1721, DOI 10.1002/1097-4628(20001205)78:10<1721::AID-APP20>3.0.CO;2-6
   Sarazin P, 2004, BIOMATERIALS, V25, P5965, DOI 10.1016/j.biomaterials.2004.01.065
   Sheth M, 1997, J APPL POLYM SCI, V66, P1495, DOI 10.1002/(SICI)1097-4628(19971121)66:8<1495::AID-APP10>3.0.CO;2-3
   Tziampazis E, 2000, BIOMATERIALS, V21, P511, DOI 10.1016/S0142-9612(99)00212-4
   Wang J, 2002, J CONTROL RELEASE, V82, P289, DOI 10.1016/S0168-3659(02)00137-2
   Xiong XY, 2003, MACROMOLECULES, V36, P9979, DOI 10.1021/ma035292d
NR 19
TC 1
Z9 1
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 SIXTEENTH ST NW, WASHINGTON, DC 20036 USA
SN 0097-6156
BN 0-8412-3928-2
J9 ACS SYM SER
PY 2005
VL 916
BP 119
EP 135
PG 17
WC Chemistry, Multidisciplinary; Materials Science, Multidisciplinary;
   Polymer Science
SC Chemistry; Materials Science; Polymer Science
GA BDO71
UT WOS:000234566100010
DA 2018-10-19
ER

PT J
AU Konefal, A
   Dybek, M
   Lobodziec, W
   Szczucka, K
AF Konefal, A
   Dybek, M
   Lobodziec, W
   Szczucka, K
TI Thermal and epithermal neutrons in the vicinity of the Primus Siemens
   biomedical accelerator
SO NUKLEONIKA
LA English
DT Article
DE biomedical accelerators; thermal neutrons; epithermal neutrons
ID MEDICAL ACCELERATOR; SPECTRA
AB In this paper, the thermal and epithermal neutron fluence distributions in the vicinity of the Primus Siemens accelerator are presented. The measurements were carried out by the use of the neutron activation method for 15 MV X-rays and electron beams of 18 MeV and 21 MeV. From the radiation safety point of view for the hospital personnel, it is important to know the thermal and epithermal neutron fluence distribution in the vicinity of the accelerator because the neutrons interacting with atoms of a medium by various processes induce the activity of objects (accelerator, other apparatus etc.) and walls in the treatment room. The thermal and epithermal neutron capture, particularly, in high atomic number materials of the accelerator head can be a significant source of gamma radiation and it has to be taken into account for estimation of the work safety of the personnel. Values of the neutron fluence were normalized to the maximum photon (or electron) dose D-max,D-gamma(e) measured at the central axis of therapeutic X-ray (or electron) beam in a water phantom. The thermal neutron fluences measured during the 15 MV X-ray emission varied between 1.1 x 10(5) n (.) cm(-1 .) Gy(-1) and 4.4 x 10(5) n (.) cm(-2) (.) Gy(-1) whereas the epithermal neutron fluences ranged from 0.2 x 10(5) n (.) cm(-2) (.) Gy(-1) to 1.8 x 10(5) n (.) cm(-2) (.) Gy(-1). In the case of electron beams, the neutron fluence measurements were performed only at the isocentre. The obtained thermal and epithermal neutron fluences were 1.2 x 10(4) n (.) cm(-2) (.) Gy(-1) and 0.6 x 10(4) n (.) cm(-2) (.) Gy(-1), respectively, for the 18 MeV electrons. In the the case of the 21 MeV electron beams the thermal neutron fluence was 2.0 x 10(4) n (.) cm(-2) (.) Gy(-1) whereas the epithermal neutron fluence was 0.8 x 10(4) n (.) cm(-2 .) Gy(-1).
C1 Silesian Univ, Inst Phys, PL-40007 Katowice, Poland.
   Hosp Mem St Leszcynski, Dept Radiotherapy, PL-40074 Katowice, Poland.
RP Konefal, A (reprint author), Silesian Univ, Inst Phys, 4 Uniwersytecka Str, PL-40007 Katowice, Poland.
EM akonefal@uranos.cto.us.edu.pl
CR [Anonymous], 1995, ICRP PUBL, V74
   BECKURC K, 1968, NIJTRONNAYA FIZIKA
   Berman BL, 1998, ATOM DATA NUCL DATA, V38, P199
   Carrier JF, 2004, MED PHYS, V31, P484, DOI 10.1118/1.1644532
   Cymerman U, 1984, Nowotwory, V34, P31
   Firestone RB, 1996, TABLE ISOTOPES
   FIRK FWK, 1970, ANN REV NUCL SCI, V20, P39
   Followill David S, 2003, J Appl Clin Med Phys, V4, P189, DOI 10.1120/1.1571671
   Gudowska I., 1996, Nukleonika, V41, P105
   Kase KR, 1998, HEALTH PHYS, V74, P38, DOI 10.1097/00004032-199801000-00005
   KONEFAL A, 2003, PHYS MED, V20, pS147
   KONEFAL A, 2001, POL J MED PHYS ENG, V2, P291
   LEVNGER JS, 1960, NUCL PHOTO DISINTEGR
   MACDONALD N, 1965, NUCL STRUCTURE ELECT
   Macklin RL, 1956, P 1 INT C PEAC US AT, V5, P96
   Mao XS, 1997, HEALTH PHYS, V72, P524, DOI 10.1097/00004032-199704000-00003
   *NBS, 1982, 822543 NBSIR
   *NBS, 1973, NBS SPEC PUBL, V380
   Ongaro C, 2000, PHYS MED BIOL, V45, pL55, DOI 10.1088/0031-9155/45/12/101
   Price WJ, 1964, NUCL RAD DETECTION
   Scott M.B., 1955, PHYS REV, V100, P205
   Wu Raymond K, 2003, J Appl Clin Med Phys, V4, P162, DOI 10.1120/1.1561954
NR 22
TC 15
Z9 15
U1 0
U2 1
PU INST NUCLEAR CHEMISTRY TECHNOLOGY
PI WARSAW
PA DORODNA 16 STR, 03-195 WARSAW, POLAND
SN 0029-5922
J9 NUKLEONIKA
JI Nukleonika
PY 2005
VL 50
IS 2
BP 73
EP 81
PG 9
WC Chemistry, Inorganic & Nuclear; Physics, Nuclear
SC Chemistry; Physics
GA 937VA
UT WOS:000229952800005
DA 2018-10-19
ER

PT J
AU Allan, PS
   Tarverdi, K
AF Allan, PS
   Tarverdi, K
TI Novel articulated support structure for orthopaedic and general
   engineering applications
SO PLASTICS RUBBER AND COMPOSITES
LA English
DT Article; Proceedings Paper
CT Biennial Polymer Process Engineering International Meeting
CY JUL 05-06, 2005
CL Univ Bradford, Bradford, ENGLAND
HO Univ Bradford
DE biomedical; splint; twin-screw extrusion; seating; composite
AB The present paper discusses investigations into the manufacture, testing and application of a highly flexible structure incorporating innovative joints linked together to form a sheet that can be conformed around complex three-dimensional shapes which can be easily 'switched' from a flexible state to a highly stable/rigid one and a process which can be reversed. In the present study, consideration will be given to preparation, characterisation and properties of the manufactured modules. A range of techniques used to characterise these materials will be discussed, including compressive strength, impact and recovery measurements.
C1 Brunel Univ, Wolfson Ctr Mat Proc, Uxbridge UB8 3PH, Middx, England.
RP Tarverdi, K (reprint author), Brunel Univ, Wolfson Ctr Mat Proc, Uxbridge UB8 3PH, Middx, England.
EM Karnik.Tarverdi@brunel.ac.uk
CR BEVIS MJ, 1996, P 20 INT BPF COMP C
   CONEN V, 2001, P 8 ANN INT C COMP E, P143
   Metaxas R, 2000, POWER ENG J, V14, P51, DOI 10.1049/pe:20000206
   Olofinjana A, 2001, INT J MACH TOOL MANU, V41, P209, DOI 10.1016/S0890-6955(00)00060-2
   Pozar D.M., 1998, MICROWAVE ENG
   Thostenson ET, 1999, COMPOS PART A-APPL S, V30, P1055, DOI 10.1016/S1359-835X(99)00020-2
   Tressler JF, 1999, COMPOS PART A-APPL S, V30, P477, DOI 10.1016/S1359-835X(98)00137-7
NR 7
TC 0
Z9 0
U1 0
U2 1
PU MANEY PUBLISHING
PI LEEDS
PA HUDSON RD, LEEDS LS9 7DL, ENGLAND
SN 1465-8011
J9 PLAST RUBBER COMPOS
JI Plast. Rubber Compos.
PY 2005
VL 34
IS 5-6
BP 283
EP 286
DI 10.1179/174328905X64795
PG 4
WC Materials Science, Composites; Polymer Science
SC Materials Science; Polymer Science
GA 992GD
UT WOS:000233871500013
DA 2018-10-19
ER

PT J
AU Prowans, P
   El Fray, M
   Jursa, J
AF Prowans, P
   El Fray, M
   Jursa, J
TI Study on degradation and systemic toxicity of multiblock
   poly(aliphatic/aromatic-ester) copolymers
SO POLIMERY
LA English
DT Article
DE multiblock copolyesters; dimer fatty acid; degradation; toxicity test;
   hemolysis; mechanical properties
ID MECHANICAL-BEHAVIOR; PHYSICAL-PROPERTIES; FATTY-ACID; VITAMIN-E;
   POLYANHYDRIDES; ANTIOXIDANT; TEREPHTHALATE); POLYETHYLENE; POLYESTER;
   POLYMERS
AB The series of PED multiblock copolymers were synthesized. They are composed of poly(butylene terephthalate) (PBT) aromatic units (hard segments) and aliphatic sequences of dimer fatty acids (DFA) (soft segments). The composition of hard segments vary in the range from 26 to 70 wt. %. These polymers can be "tailor-made", and therefore, their properties can change along with the composition, from very soft and flexible materials to semi-rigid polymers. Their susceptibility to degradation is a function of hard/soft segment composition. Degradation test (buffer saline solution, pH = 7.4, temp. 37 degreesC, time 5 weeks) as well as in vivo implantation test for 6 months confirm this statement. Polymers containing higher concentrations of soft segments are more susceptible to degradation than the materials with higher concentrations of hard, aromatic segments as demonstrated by GPC and ATR FT-IR. The chloroformic extracts from PED copolymers were analyzed by GC/MS to evaluate the chemical composition of potential extractables, especially from the polymers demonstrating higher susceptibility to degradation. Prepared saline extracts were subjected to the pyrogenicity tests on rabbits. The influence of the polymer composition on skin irritation was also evaluated by the intracutaneous injections of polymer extracts. Additionally, hemolysis test in contact with bulk polymers was performed. Evaluating the nature of local tissue response to PED extracts and the results of hemolysis test, we did not detect any indication of systemic toxicity over the compositional range of PED copolymers. These novel copolymers were shown to be biocompatible and are very promising materials for biomedical applications.
C1 Clin Gen & Hand Surg, Pomeranian Med Acad Szczecin, PL-71344 Szczecin, Poland.
   Tech Univ Szczecin, Polymer Inst, PL-70322 Szczecin, Poland.
   Pomeranian Med Acad Szczecin, Dept Microbiol & Med Immunol, PL-70111 Szczecin, Poland.
   Pomeranian Med Acad Szczecin, Sect Microbiol & Med Immunol, PL-70111 Szczecin, Poland.
RP El Fray, M (reprint author), Clin Gen & Hand Surg, Pomeranian Med Acad Szczecin, Ul Unii Lubelskiej 1, PL-71344 Szczecin, Poland.
EM mirfray@ps.pl
RI Prowans, Piotr/B-5495-2015; El Fray, Miroslawa/J-4128-2016
OI Prowans, Piotr/0000-0002-6102-364X; 
CR Al-Malaika S, 2000, POLYM POLYM COMPOS, V8, P537
   ALMALAIKA S, 1994, J POLYM SCI POL CHEM, V32, P3099, DOI 10.1002/pola.1994.080321610
   Dawids S. G., 1993, TEST PROCEDURES BLOO
   Deschamps AA, 2001, POLYMER, V42, P9335, DOI 10.1016/S0032-3861(01)00453-0
   DOMB AJ, 1993, J POLYM SCI POL CHEM, V31, P1275, DOI 10.1002/pola.1993.080310523
   Domb AJ, 1994, BIOMEDICAL POLYM, P69
   *DSM PROD FOLD, 2002, ARN GEN INF APPL PRO
   El Fray M, 2000, J MATER SCI-MATER M, V11, P757
   El Fray M, 1996, ANGEW MAKROMOL CHEM, V234, P103
   El Fray M, 2000, TAILORED POLYMERS & APPLICATIONS, P133
   ELFRAY M, 2003, MATER ENG, V17, P1
   ELFRAY M, 1998, Patent No. 329794
   FENG Y, 2001, EPOLYMERS
   FOLDES E, 1992, J APPL POLYM SCI, V46, P507, DOI 10.1002/app.1992.070460317
   Hoeschele G K, 1976, Patent No. [US 3954689, 3954689]
   Krasko MY, 2002, POLYM ADVAN TECHNOL, V13, P960, DOI 10.1002/pat.267
   Prowans P, 2002, BIOMATERIALS, V23, P2973, DOI 10.1016/S0142-9612(02)00026-1
   Sakkers RJB, 1998, J MATER SCI-MATER M, V9, P375, DOI 10.1023/A:1013227428530
   Schnabel W., 1981, POLYM DEGRADATION PR
   Schubert MA, 1996, J BIOMED MATER RES, V32, P493, DOI 10.1002/(SICI)1097-4636(199612)32:4<493::AID-JBM1>3.3.CO;2-H
   SHIEH L, 1994, J BIOMED MATER RES, V28, P1465, DOI 10.1002/jbm.820281212
   SITTING M, 1991, HDB TOXIC HAZARDOUS, P659
   Stareczek T, 1999, POLIMERY-W, V44, P218
   SUTHERLAND K, 1993, J CLIN INVEST, V92, P2360, DOI 10.1172/JCI116841
   SWANSON JW, 1974, J BIOMED MATER RES, V8, P357, DOI 10.1002/jbm.820080603
   Teomim D, 1999, J POLYM SCI POL CHEM, V37, P3337, DOI 10.1002/(SICI)1099-0518(19990815)37:16<3337::AID-POLA32>3.0.CO;2-S
   WILLIAMS DF, 1982, J MATER SCI, V17, P1233, DOI 10.1007/BF00752233
   WINTERMANTEL E, 2002, MED BIOKOMPATIBLEN W
NR 28
TC 7
Z9 7
U1 0
U2 6
PU INDUSTRIAL CHEMISTRY RESEARCH INST
PI WARSAW
PA 8 RYDYGIERA STR, 01-793 WARSAW, POLAND
SN 0032-2725
J9 POLIMERY-W
JI Polimery
PY 2005
VL 50
IS 2
BP 131
EP 138
PG 8
WC Polymer Science
SC Polymer Science
GA 894IZ
UT WOS:000226786000006
DA 2018-10-19
ER

PT S
AU Chiba, A
   Kumagai, K
   Takeda, H
   Nomura, N
AF Chiba, A
   Kumagai, K
   Takeda, H
   Nomura, N
BE Zhong, ZY
   Saka, H
   Kim, TH
   Holm, EA
   Han, YF
   Xie, XS
TI Mechanical properties of forged low Ni and C-containing Co-Cr-Mo
   biomedical implant alloy
SO PRICM 5: THE FIFTH PACIFIC RIM INTERNATIONAL CONFERENCE ON ADVANCED
   MATERIALS AND PROCESSING, PTS 1-5
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 5th Pacific Rim International Conference on Advanced Materials and
   Processing
CY NOV 02-05, 2004
CL Beijing, PEOPLES R CHINA
SP Chinese Soc Met, Japan Inst Met, Korea Inst Met & Mat, Minerals, Met & Mat Soc
DE joint prostheses; biomaterial; Co-Cr-Mo alloy; hot-forging; mechanical
   properties; wear
AB In order to examine the influence of variation in grain size and microstructure on mechanical properties of a low Ni and C-containing Co-29Cr-6Mo alloy for biomedical implant materials, the tensile properties and the dry friction wear characteristics of the wrought Co-29Cr-6Mo alloy without addition of Ni and C were investigated. The microstructure of as-forged alloys, consisting of fcc phase mixed with athermal hcp martensite, is found to become finer as the reduction during forging increases. The hot-forging processes for fabricating the fine microstructure with different grain sizes of 43, 11 and 3 pm has been successfully established under the condition that forging temperature of higher than 1273 K is strictly kept during forging. The tensile properties, such as the yield stress, the tensile stress and the elongation, are improved with decreasing the gram size and thereby increasing the volume fraction of the fcc phase in the microstructure. The dry wear resistance against the alumina ball is enhanced by decreasing the grain size.
C1 Iwate Univ, Dept Welfare Engn, Morioka, Iwate 0200801, Japan.
   Iwate Univ, Morioka, Iwate 0200801, Japan.
RP Chiba, A (reprint author), Iwate Univ, Dept Welfare Engn, Morioka, Iwate 0200801, Japan.
EM a.chiba@iwate-u.ac.jp; t5103002@iwate-u.ac.jp; N.Nomura@iwate-u.ac.jp
RI Chiba, Akihiko/D-1326-2011; NOMURA, Naoyuki/L-7149-2017
CR BASKETTER DA, 1993, CONTACT DERMATITIS, V28, P15, DOI 10.1111/j.1600-0536.1993.tb03318.x
   CLEMOW AJT, 1980, WEAR, V61, P219, DOI 10.1016/0043-1648(80)90287-2
   HOLLANDER R, 1975, J BIOMED MATER RES, V9, P367, DOI 10.1002/jbm.820090311
   Montero-Ocampo C, 1999, METALL MATER TRANS A, V30, P611, DOI 10.1007/s11661-999-0052-6
   Sage M., 1950, REV MET, V47, P139
NR 5
TC 48
Z9 48
U1 0
U2 6
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-960-1
J9 MATER SCI FORUM
PY 2005
VL 475-479
BP 2317
EP 2321
DI 10.4028/www.scientific.net/MSF.475-479.2317
PN 1-5
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BBR99
UT WOS:000227494702156
DA 2018-10-19
ER

PT S
AU Inamura, T
   Fukui, Y
   Hosoda, H
   Wakashima, K
   Miyazaki, S
AF Inamura, T
   Fukui, Y
   Hosoda, H
   Wakashima, K
   Miyazaki, S
BE Zhong, ZY
   Saka, H
   Kim, TH
   Holm, EA
   Han, YF
   Xie, XS
TI Pseudoelastic properties of cold-rolled TiNbAl alloy
SO PRICM 5: THE FIFTH PACIFIC RIM INTERNATIONAL CONFERENCE ON ADVANCED
   MATERIALS AND PROCESSING, PTS 1-5
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 5th Pacific Rim International Conference on Advanced Materials and
   Processing
CY NOV 02-05, 2004
CL Beijing, PEOPLES R CHINA
SP Chinese Soc Met, Japan Inst Met, Korea Inst Met & Mat, Minerals, Met & Mat Soc
DE beta-titanium; biomedical shape memory alloy; superelasticity; texture
ID MECHANICAL-PROPERTIES
AB Microstructures and pseudo-elasticity of as-rolled Ti-24mol%Nb-3mol%Al, a newly developed functional biomedical beta-Ti alloy (bcc), at room temperature were characterized. The material was homogenized at 1273K after arc-melting and quenched into water to obtain single phase of P. Cold-rolling of 99% reduction in thickness was carried out and then, microstructures and pseudo-elastic properties were examined. theta-2 theta XRD measurement revealed that the as-rolled material was consisted with the parent P phase and martensite phase (alpha", C-center orthorhombic). X-ray pole figure measurements revealed that the rolling texture was a mixture of < 110 >(beta){001}(beta)-type and < 112 >(beta){111}(beta)-type textures. Shape recovery strain of 4% appeared along TD without any intermediate annealing after the cold-rolling.
C1 Tokyo Inst Technol, Precis & Intelligence Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan.
   Univ Tsukuba, Inst Mat Sci, Tsukuba, Ibaraki 3058573, Japan.
RP Inamura, T (reprint author), Tokyo Inst Technol, Precis & Intelligence Lab, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268503, Japan.
EM inamura@pi.titech.ac.jp; hosoda@pi.titech.ac.jp;
   wakashim@pi.titech.ac.jp; miyazaki@ims.tsukuba.ac.jp
RI Inamura, Tomonari/E-5712-2014; Miyazaki, Shuichi/A-3113-2012
OI Miyazaki, Shuichi/0000-0003-3849-4176
CR Brooks C. R., 1982, HEAT TREATMENT STRUC, P329
   BROWN ARG, 1964, NATURE, V201, P914, DOI 10.1038/201914a0
   Fukui Y, 2004, MATER TRANS, V45, P1077, DOI 10.2320/matertrans.45.1077
   FUKUI Y, 2003, T MRS J, V28, P623
   Hosoda H, 2003, MATER SCI FORUM, V426-4, P3121, DOI 10.4028/www.scientific.net/MSF.426-432.3121
   HOSODA H, 2000, INT WORKSH BIOINT MA, P26
   Hosoda H, 2001, T MRS J, V26, P243
   Hosoda H, 2001, T MRS J, V26, P235
   HOSODA N, 2001, 4 PAC RIM INT C ADV, V2, P1623
   Inamura T, 2004, MATER TRANS, V45, P1083, DOI 10.2320/matertrans.45.1083
   KURODA D, 1996, IRON STEEL I JPN, V9, P421
   Kuroda K., 2003, T MRS J, V28, P631
   MOFFAT DL, 1988, METALL TRANS A, V19, P1677, DOI 10.1007/BF02645135
   OKAZAKI Y, 1993, MATER T JIM, V34, P1217, DOI 10.2320/matertrans1989.34.1217
   TADA H, 1998, 3 PAC RIM INT C ADV, V2, P3086
NR 15
TC 18
Z9 18
U1 0
U2 7
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-960-1
J9 MATER SCI FORUM
PY 2005
VL 475-479
BP 2323
EP 2327
DI 10.4028/www.scientific.net/MSF.475-479.2323
PN 1-5
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BBR99
UT WOS:000227494702157
DA 2018-10-19
ER

PT S
AU Zhentao, Y
   Lian, Z
   Maohong, F
   Sibo, Y
AF Zhentao, Y
   Lian, Z
   Maohong, F
   Sibo, Y
BE Zhong, ZY
   Saka, H
   Kim, TH
   Holm, EA
   Han, YF
   Xie, XS
TI Investigation on near-beta titanium alloy Ti-5Zr-3Sn-5Mo-15Nb for
   surgical implant materials
SO PRICM 5: THE FIFTH PACIFIC RIM INTERNATIONAL CONFERENCE ON ADVANCED
   MATERIALS AND PROCESSING, PTS 1-5
SE MATERIALS SCIENCE FORUM
LA English
DT Article; Proceedings Paper
CT 5th Pacific Rim International Conference on Advanced Materials and
   Processing
CY NOV 02-05, 2004
CL Beijing, PEOPLES R CHINA
SP Chinese Soc Met, Japan Inst Met, Korea Inst Met & Mat, Minerals, Met & Mat Soc
DE titanium; near-beta type titanium alloys; surgical implant materials
AB A newly designed near-beta type biomedical Ti alloy Ti-5Zr-3Sn-5Mo-15Nb (TLM) were introduced which are much more suitable for surgical implant and orthopedic materials. The typical mechanical properties and microstructure were studied by means of the alloying elements, process and heat treatment. The alloy possesses excellent biocompatibility, lower elastic modulus, higher strength, finer plasticity and fracture toughness matching by means of solid solution and aging treatment. The better workability of TLM alloy results from the stress-induced martensite transform.
C1 NW Inst Nonferrous Met Res, Xian 710016, Shaanxi, Peoples R China.
   Iowa State Univ, Ctr Sustainable Environm Technol, Ames, IA 50011 USA.
RP Zhentao, Y (reprint author), NW Inst Nonferrous Met Res, Xian 710016, Shaanxi, Peoples R China.
EM ayzt@c-nin.com; Zhoul@c-nin.com; fan@ameslab.gov
CR FROS FH, 1985, J MET, V37, P28
   Geetha M, 2001, J ALLOY COMPD, V329, P264, DOI 10.1016/S0925-8388(01)01604-8
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Song Y, 1999, MAT SCI ENG A-STRUCT, V260, P269, DOI 10.1016/S0921-5093(98)00886-7
   STEINEMANN SG, 1993, SEMLITSCH TITANIUM, V92, P2689
   SUMNER DR, 1992, CLIN ORTHOP RELAT R, P202
   WARRENDALE MS, 1993, PENNSYLVANIA, P2689
   YU ZT, 2004, RARE METALS LETT, V23, P5
NR 9
TC 1
Z9 1
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI ZURICH-UETIKON
PA BRANDRAIN 6, CH-8707 ZURICH-UETIKON, SWITZERLAND
SN 0255-5476
BN 0-87849-960-1
J9 MATER SCI FORUM
PY 2005
VL 475-479
BP 2353
EP 2357
PN 1-5
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BBR99
UT WOS:000227494702163
DA 2018-10-19
ER

PT B
AU He, CL
   Huang, ZM
   Liu, L
   Han, XJ
AF He, CL
   Huang, ZM
   Liu, L
   Han, XJ
GP Donghua Univ, State Key Lab Modificat Chem Fibes & Polymer Mat
TI Electrospun core-shell PLLA nanofiber and its potential for drug release
SO Proceedings of 2005 International Conference on Advanced Fibers and
   Polymer Materials (ICAFPM 2005), Vol 1 and 2: NEW CENTURY , NEW
   MATERIALS AND NEW LIFE
LA English
DT Proceedings Paper
CT International Conference on Advanced Fibers and Polymer Materials
   (ICAFPM 2005)
CY OCT 19-21, 2005
CL Shanghai, PEOPLES R CHINA
SP State Key Lab Modificat Chem Fibers & Polymer Mat
AB Electrospinning has been developed to fabricate composite nanofibers for biomedical applications such as drug delivery systems and tissue engineering scaffolds. The objective of this study was to evaluate the physical-chemical properties and drug release properties of electrospun core-shell poly (L-lactic acid) (PLLA) fibrous membranes used as a controlled release carriers for tetracycline hydrochloride (TCH). The fibrous membranes were fabricated by coaxial electrospinning in which PLLA (2:1 mixture of chloroform and acetone by weight as a solvent) and TCH/PLLA (2:1 mixture of methanol and chloroform by weight as a solvent) were used as the shell and the core materials, respectively. The electrospun fibers and their membranes were characterized by scanning electron microscope (SEM), transmission electron microscopy (TEM), and differential scanning calorimetry (DSC), whereas the mechanical performances of fibrous membranes were tested through tensile test. The drug release behavior was investigated by UV-VIS spectroscopy. Results indicated that the morphology of fibers and distribution of fiber diameter relied on the processing parameters, and the uniform composite fibers with eminent mechanical properties could be obtained when the core and shell solution concentrations were kept at 5 wt% (0.3 ml.h-1 flow rate) and 8-10 wt% (5.0 ml.h-I flow rate), respectively. TCH could be encapsulated in the PLLA ultrafine fibers and maintain a sustaining release from the fibrous membranes, suggesting that the thus obtained core-shell composite fibrous membranes can be a promising candidate for drug release carrier.
C1 Tongji Univ, Sch Aeronaut Astronaut & Mech, Shanghai 200092, Peoples R China.
RP Huang, ZM (reprint author), Tongji Univ, Sch Aeronaut Astronaut & Mech, Shanghai 200092, Peoples R China.
RI He, Chuanglong/C-2976-2011
OI He, Chuanglong/0000-0001-8330-8542
CR Nair LS, 2004, EXPERT OPIN BIOL TH, V4, P659, DOI 10.1517/14712598.4.5.659
   Verreck G, 2003, J CONTROL RELEASE, V92, P349, DOI 10.1016/S0168-3659(03)00342-0
NR 2
TC 0
Z9 0
U1 0
U2 11
PU CHEMICAL INDUSTRY PRESS
PI BEIJING
PA NO. 3 HUIXINLI CHAOYANGQU, BEIJING 100029, PEOPLES R CHINA
BN 7-5025-7717-3
PY 2005
BP 708
EP 712
PG 5
WC Nanoscience & Nanotechnology; Materials Science, Composites; Materials
   Science, Textiles; Polymer Science
SC Science & Technology - Other Topics; Materials Science; Polymer Science
GA BDR60
UT WOS:000235106600184
DA 2018-10-19
ER

PT B
AU Sell, SA
   Barnes, CP
   Knapp, DC
   Walpoth, BH
   Bowlin, GL
AF Sell, SA
   Barnes, CP
   Knapp, DC
   Walpoth, BH
   Bowlin, GL
GP Donghua Univ, State Key Lab Modificat Chem Fibes & Polymer Mat
TI The new 'spin' on vascular tissue engineering
SO Proceedings of 2005 International Conference on Advanced Fibers and
   Polymer Materials (ICAFPM 2005), Vol 1 and 2: NEW CENTURY , NEW
   MATERIALS AND NEW LIFE
LA English
DT Proceedings Paper
CT International Conference on Advanced Fibers and Polymer Materials
   (ICAFPM 2005)
CY OCT 19-21, 2005
CL Shanghai, PEOPLES R CHINA
SP State Key Lab Modificat Chem Fibers & Polymer Mat
AB Over the years there has been considerable effort to develop biomedical textiles for applications ranging from tissue engineering scaffolds to vascular grafts to wound dressings and hemostatic bandages. Biomedical textiles used for such applications must meet many criteria, among which are the following: the material must be biocompatible and function without interrupting other physiological processes and the textile production method must be reproducible and allow for a wide range of shapes and sizes such that the morphological and mechanical properties of the textile are sufficient for the intended use. The method of electrospinning is a simple fabrication process that achieves the goals of many biomedical textiles. Our lab has successfully electrospun the biodegradable polymers poly(glycolic acid) (PGA), poly(lactic acid) (PLA), polycaprolactone (PCL), and polydioxanone (PDS) as well as natural polymers including collagen (types I, II, III and IV), elastin, fibrinogen, hemoglobin, and myoglobin. In addition, blends and copolymers of these synthetic and/or natural polymers have also been electrospun to develop novel biomedical textiles, including tissue engineering scaffolds. vascular grafts, wound dressings, and hemostatic bandages (U.S. and International Patents Pending). The majority of these structures are comprised of fibers ranging in diameter from 80 nm to 1.5 microns. The fiber diameters are controllable via electrospinning solution concentration, and the mechanical properties of the scaffolds are controllable via fiber diameter and fiber orientation. With various compositions, fiber dimensions, and fiber orientations, the mechanical properties and degradation rates of the electrospun textiles can be tailored. Cellular/tissue interactions have been shown to be dependent on the characteristics of the electrospun scaffolds with composition and fiber diameter as the dominant variables. The results from all this preliminary work are very promising in that the ideal biomedical textile may be customized for a specific application using this technology leading to the ultimate goal of biomimicking extracellular matrix, in particular for vascular tissue engineering. Data to date regarding our work fabricating and testing electrospun scaffolds for completely tissue engineered blood vessels (in vitro tissue engineering) and bioresorbable vascular grafts (in vivo tissue engineering) will be presented.
C1 Virginia Commonwealth Univ, Richmond, VA 23298 USA.
RP Sell, SA (reprint author), Virginia Commonwealth Univ, Med Coll Virginia Campus, Richmond, VA 23298 USA.
RI Bowlin, Gary/E-8617-2010
OI Sell, Scott/0000-0002-6785-3193
NR 0
TC 0
Z9 0
U1 2
U2 10
PU CHEMICAL INDUSTRY PRESS
PI BEIJING
PA NO. 3 HUIXINLI CHAOYANGQU, BEIJING 100029, PEOPLES R CHINA
BN 7-5025-7717-3
PY 2005
BP 912
EP 915
PG 4
WC Nanoscience & Nanotechnology; Materials Science, Composites; Materials
   Science, Textiles; Polymer Science
SC Science & Technology - Other Topics; Materials Science; Polymer Science
GA BDR60
UT WOS:000235106600228
DA 2018-10-19
ER

PT B
AU Li, Z
   Xu, XF
AF Li, Z
   Xu, XF
GP Donghua Univ, State Key Lab Modificat Chem Fibes & Polymer Mat
TI Synthesis, characterization and performance of the biomedical breathable
   polyurethane material
SO Proceedings of 2005 International Conference on Advanced Fibers and
   Polymer Materials (ICAFPM 2005), Vol 1 and 2: NEW CENTURY , NEW
   MATERIALS AND NEW LIFE
LA English
DT Proceedings Paper
CT International Conference on Advanced Fibers and Polymer Materials
   (ICAFPM 2005)
CY OCT 19-21, 2005
CL Shanghai, PEOPLES R CHINA
SP State Key Lab Modificat Chem Fibers & Polymer Mat
DE hydrophilic polyurethane; mechanical property; contact angle; blood
   compatibility
AB A series of thermoplastic polyurethane materials were synthesized based on 4, 4'-diphenylmethane-diisocyanate(MIDI), chain-extender (BDO), polyethylene glycol (PEG) and polytetramethylene-ether glycol (PTMG), stannous octoate by changing proportion of PEG in soft segment. The experiment used Fourier transform infrared spectrum (FTIR) to signify internal structure of material, tested mechanical properties, water contact angles, moisture permeability and blood compatibility of synthetic material. The result indicated that choosing appropriate proportion of PEG in soft segment is advantageous to balance mechanical properties and affinity of new-type synthetic material.
C1 Jiaxing Coll, Sch Garments & Arts Design, Jiaxing 314001, Zhejiang, Peoples R China.
RP Li, Z (reprint author), Jiaxing Coll, Sch Garments & Arts Design, Jiaxing 314001, Zhejiang, Peoples R China.
CR Fu M., 1999, POLYURETHANE ELASTOM
   JOHNSON L, 2000, BREATHABLE TPE FILMS, P30
   Yan R.X., 1998, WATER SOLUBLE POLYM
NR 3
TC 0
Z9 0
U1 0
U2 2
PU CHEMICAL INDUSTRY PRESS
PI BEIJING
PA NO. 3 HUIXINLI CHAOYANGQU, BEIJING 100029, PEOPLES R CHINA
BN 7-5025-7717-3
PY 2005
BP 963
EP 966
PG 4
WC Nanoscience & Nanotechnology; Materials Science, Composites; Materials
   Science, Textiles; Polymer Science
SC Science & Technology - Other Topics; Materials Science; Polymer Science
GA BDR60
UT WOS:000235106600240
DA 2018-10-19
ER

PT B
AU Liu, M
   Yu, WD
AF Liu, M
   Yu, WD
GP Donghua Univ, State Key Lab Modificat Chem Fibes & Polymer Mat
TI Investigation on the biocompatibility of keratin membranes
SO Proceedings of 2005 International Conference on Advanced Fibers and
   Polymer Materials (ICAFPM 2005), Vol 1 and 2: NEW CENTURY , NEW
   MATERIALS AND NEW LIFE
LA English
DT Proceedings Paper
CT International Conference on Advanced Fibers and Polymer Materials
   (ICAFPM 2005)
CY OCT 19-21, 2005
CL Shanghai, PEOPLES R CHINA
SP State Key Lab Modificat Chem Fibers & Polymer Mat
DE keratin; membrane; biocompatibility; wool; fiber
ID SPONGE SCAFFOLDS; WOOL KERATIN; FILMS; CULTIVATION
AB Artificial keratin membranes are made frorn the keratin materials Such as wool or other animal hairs through the dissolution with various chemicals at first and then the preparation into the membranes in Filtration and dry, that means there are many extra chemicals which influence the biocompatibility of the compound though keratin is ecological and biocompatible. Therefore, the membranes formed in milder solvents and low damaged treatment frorn wool fibers has been investigated by means of biocompatibility tests, which were conducted through the general methods according to ISO 10993 in order to evaluate the capacity of skin irritation, hemolysis and cell Cultivation. The animal tests show that the keratin membranes prepared by authors are good compatibility and have no significant anaphylaxis because the primary irritation index (PII) is below 0.4. Consequently, the wool keratin membrane is one kind of friendly and most prospective biomaterials for biomedical and histological utilization.
C1 Donghua Univ, Text Mat & Technol Lab, Shanghai 200051, Peoples R China.
RP Yu, WD (reprint author), Donghua Univ, Text Mat & Technol Lab, Shanghai 200051, Peoples R China.
CR EARLAND C, 1959, BIOCHIM BIOPHYS ACTA, V36, P273, DOI 10.1016/0006-3002(59)90104-0
   FEUGHELMAN M, 1985, ENCY POLYM SCI ENG, V8, P566
   Katoh K, 2004, BIOMATERIALS, V25, P4255, DOI 10.1016/j.biomaterials.2003.11.018
   Katoh K, 2004, J APPL POLYM SCI, V91, P756, DOI 10.1002/app.13236
   KOGA J, 1989, J APPL POLYM SCI, V37, P2131, DOI 10.1002/app.1989.070370805
   ODONNELL IJ, 1964, AUST J BIOL SCI, V17, P973, DOI 10.1071/BI9640973
   SCHALLER H, 1980, J APPL POLYM SCI, V25, P783
   Tachibana A, 2002, J BIOTECHNOL, V93, P165, DOI 10.1016/S0168-1656(01)00395-9
   Tanabe T, 2002, BIOMATERIALS, V23, P817, DOI 10.1016/S0142-9612(01)00187-9
   WU ZY, 1996, J SU ZHOU I SILK TEX, V16, P71
   Yamauchi K, 1997, COLLOID SURFACE B, V9, P117, DOI 10.1016/S0927-7765(96)01322-7
   Yamauchi K, 1998, J BIOMAT SCI-POLYM E, V9, P259, DOI 10.1163/156856298X00640
   Yamauchi K, 1996, J BIOMED MATER RES, V31, P439, DOI 10.1002/(SICI)1097-4636(199608)31:4<439::AID-JBM1>3.0.CO;2-M
   YOSHIMIZU H, 1991, MACROMOLECULES, V24, P862, DOI 10.1021/ma00004a008
   74898 ASTM F
   GBT16886102000
   345630
   1099312003 ISO
NR 18
TC 0
Z9 0
U1 0
U2 3
PU CHEMICAL INDUSTRY PRESS
PI BEIJING
PA NO. 3 HUIXINLI CHAOYANGQU, BEIJING 100029, PEOPLES R CHINA
BN 7-5025-7717-3
PY 2005
BP 1011
EP 1014
PG 4
WC Nanoscience & Nanotechnology; Materials Science, Composites; Materials
   Science, Textiles; Polymer Science
SC Science & Technology - Other Topics; Materials Science; Polymer Science
GA BDR60
UT WOS:000235106600252
DA 2018-10-19
ER

PT B
AU Oates, WS
   Smith, RC
AF Oates, William S.
   Smith, Ralph C.
GP ASME
TI Nonlinear open loop optimal tracking using magnetostrictive transducers
SO Proceedings of the ASME Dynamic Systems and Control Division 2005, Pts A
   and B
LA English
DT Proceedings Paper
CT ASME International Mechanical Engineering Congress and Exposition
CY NOV 05-11, 2005
CL Orlando, FL
SP ASME, Proc Ind Div, ASME, Rail Transportat Div, ASME, Noise Control & Acoust Div, ASME, Triol Div, ASME, Pressure Vessels & Piping Div, ASME, Bioengn Div, ASME, Mat Div, ASME, Appl Mech Div, ASME, Fluids Engn Div, ASME, Micro Elect Mech Syst Div, ASME, Heat Transfer Div, ASME, Nucl Engn Div, ASME, Power Div, ASME, Solar Energy Div, ASME, Safety Engn & Risk Anal Div, ASME, Technol & Soc Div, ASME, Adv Energy Syst Div, ASME, Aerosp Div, ASME, Comp & Informat Engn Div
ID INVERSE COMPENSATION; HYSTERESIS; SMART
AB The design of high performance smart material devices requires control laws that can achieve stringent performance criteria required in many industrial, automotive, aerospace and biomedical applications. Moderate to high field inputs are often required which introduces nonlinear hysteretic constitutive behavior This often cannot be effectively compensated using linear control theory. In the present work, a nonlinear optimal control methodology is developed for tracking a reference trajectory when nonlinear hysteretic constitutive behavior is significant. For brevity, we focus on open loop control for regimes when disturbances are minimal. The nonlinear control design is investigated on magnetostrictive rod-type actuators by implementing a homogenized energy model. Significant emphasis is place on material behavior at multiple length scales to produce an accurate and efficient model to compensate for nonlinear hysteretic magnetostrictive constitutive behavior.
C1 N Carolina State Univ, Dept Math, Ctr Res Sci Computat, Raleigh, NC 27695 USA.
RP Oates, WS (reprint author), N Carolina State Univ, Dept Math, Ctr Res Sci Computat, Box 8205, Raleigh, NC 27695 USA.
CR Ascher U M, 1995, NUMERICAL SOLUTION B
   BITTANTI S, 1972, PERIODIC OPTIMIZATIO, V2, P183
   Bryson A. E., 1969, APPL OPTIMAL CONTROL
   Dapino MJ, 2000, IEEE T MAGN, V36, P545, DOI 10.1109/20.846217
   DAPRATO G, 1987, SIAM J CONTROL OPTIM, V25, P706, DOI 10.1137/0325039
   Duerig TW, 2002, MRS BULL, V27, P101, DOI 10.1557/mrs2002.44
   Ge P, 1996, IEEE T CONTR SYST T, V4, P209, DOI 10.1109/87.491195
   Grant D, 1997, IEEE CONTR SYST MAG, V17, P80, DOI 10.1109/37.588180
   JILES DC, 1984, J PHYS D APPL PHYS, V17, P1265, DOI 10.1088/0022-3727/17/6/023
   Lewis F. L., 1995, OPTIMAL CONTROL
   NEALIS JM, UNPUB IEEE T CONTROL
   OATES W, UNPUB J INTELL MAT S
   Smith R, 2005, SMART MAT SYSTEMS MO
   SMITH R, 1995, J INTEL MAT SYST STR, V9, P468
   Smith R. C., 1999, Proceedings of the 38th IEEE Conference on Decision and Control (Cat. No.99CH36304), P2875, DOI 10.1109/CDC.1999.831370
   Smith RC, 2001, MATH COMPUT MODEL, V33, P285, DOI 10.1016/S0895-7177(00)00245-4
   Smith RC, 2000, P AMER CONTR CONF, P2750, DOI 10.1109/ACC.2000.878710
   Straub FK, 2004, J INTEL MAT SYST STR, V15, P249, DOI 10.1177/1045389X04042795
   Tao G., 1996, ADAPTIVE CONTROL SYS
NR 19
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-4216-4
PY 2005
BP 17
EP 24
PG 8
WC Automation & Control Systems
SC Automation & Control Systems
GA BFY96
UT WOS:000245508100003
DA 2018-10-19
ER

PT B
AU Xu, AP
   Qu, YX
   Wang, JW
   Shaw, LL
AF Xu, AP
   Qu, YX
   Wang, JW
   Shaw, LL
BE Batra, RC
   Qian, LF
   Zhang, YL
   Li, XN
   Tso, SK
TI Design for solid freeform fabrication of dental restoration
SO Proceedings of the International Conference on Mechanical Engineering
   and Mechanics 2005, Vols 1 and 2
LA English
DT Proceedings Paper
CT International Conference on Mechanical Engineering and Mechanics
CY OCT 26-28, 2005
CL Nanjing Univ Sci & Technol, Nanjing, PEOPLES R CHINA
HO Nanjing Univ Sci & Technol
DE bio-CAD; dental restoration; multiple materials; solid freeform
   fabrication
AB Solid freeform fabrication (SFF) has been increasingly used in biomedical applications such as dental restoration, orthopedic implants, scaffolds and drug delivery where complex-shaped objects made of multiple materials or functionally graded materials are typically desired. This paper shows the design process for SFF of the hollow multi-material complex-shaped object such as dental crown during dental restoration, which is covered with a layer of dental porcelain outside, and a layer of noble metal inside; besides, a removable material needs to be used in the hollow cave as the supporting structure. First of all, the design process begins with a 3D surface model in STL format. With the aid of Magics RP (Materialise, Belgium), the surface model will be converted into a solid model, and then the solid model needs to be further processed and divided into three parts to which different materials will be respectively specified in order to meet the requirements of multi-material object. After that, a special process planning needs to be conducted. Finally, the multi-material dental crown can be fabricated via selective slurry extrusion (SSE) based technique of SFF. The case study demonstrates the feasibility of SFF technique for biomedical applications.
C1 Hebei Univ Technol, Sch Mech Engn, Tianjin 300130, Peoples R China.
RP Xu, AP (reprint author), Hebei Univ Technol, Sch Mech Engn, Tianjin 300130, Peoples R China.
CR ANPING XU, COMPUTER AIDED DESIG, V37, P1308
   WANG J, 2004, P 15 SFF S, P816
   COLGATE CORPORATION
NR 3
TC 8
Z9 8
U1 0
U2 1
PU SCIENCE PRESS BEIJING
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100707, PEOPLES R CHINA
BN 1-933100-14-1
PY 2005
BP 1216
EP 1219
PG 4
WC Engineering, Multidisciplinary; Mechanics
SC Engineering; Mechanics
GA BDC76
UT WOS:000232717800250
DA 2018-10-19
ER

PT B
AU Bahar, E
AF Bahar, Ezekiel
BE Hamza, MH
TI Mueller Matrix applied to detection and identification of bio-medical
   materials possessing chirality
SO Proceedings of the Second IASTED International Conference on Antennas,
   Radar, and Wave Propagation
LA English
DT Proceedings Paper
CT 2nd IASTED International Conference on Antennas, Radar, and Wave
   Propagation
CY JUL 19-21, 2005
CL Banff, CANADA
SP Int Assoc Sci & Technol Dev, IASTED Tech Comm Telecommun, IEEE Antennas & Propagat Soc
DE bio-electromagnetics; wave propagation
AB All sixteen Mueller Matrix elements of Bio-Medical Materials measured by an optical polarimetric scatterometer are examined to develop discrimination algorithms. Special attention was given to the eight quasi off diagonal scattering elements of the Mueller Matrix in order to examine the feasibility of bio-medical identification. Since bio-medical materials possess some degree of chirality, the specific impact of chirality on the Mueller Matrix elements is analyzed extensively. It is shown that (to within first order in chirality) only the eight quasi off diagonal elements of the Mueller Matrix are effected by the chiral property of the bio-medical materials. This reinforces the experimental observations from previous scattering experiments that the quasi off diagonal Mueller Matrix elements could provide a basis for bio-medical detection and identification. The analysis provides the specific relationship between the quasi off diagonal elements and the degree of chirality of the biomedical materials, in order to determine whether the chiral effects are sufficiently large to provide the accuracy necessary to conduct species-level discrimination in the presence of spurious (noise) contributions due to surface roughness, etc. The specific dependence of scattering due to chirality upon frequency and angle of incidence is also determined.
C1 Univ Nebraska, Dept Elect Engn, Lincoln, NE 68588 USA.
RP Bahar, E (reprint author), Univ Nebraska, Dept Elect Engn, Lincoln, NE 68588 USA.
CR BAHAR E, 1972, RADIO SCI, V50
   CRITTENDEN PE, 2002, THESIS U NEBRASKA LI
NR 2
TC 0
Z9 0
U1 0
U2 1
PU ACTA PRESS ANAHEIM
PI ANAHEIM
PA PO BOX 5124, ANAHEIM, CA 92814-5124 USA
BN 0-88986-503-5
PY 2005
BP 207
EP 210
PG 4
WC Engineering, Electrical & Electronic; Telecommunications
SC Engineering; Telecommunications
GA BEW24
UT WOS:000239789900039
DA 2018-10-19
ER

PT S
AU Noureddine, B
   Mohamed, M
   Lies, D
AF Noureddine, Batel
   Mohamed, Mehenni
   Lies, Dekar
BE Ardil, C
TI Attenuation in Transferred RF Power to a Biomedical Implant due to the
   Misalignment Coils
SO PROCEEDINGS OF WORLD ACADEMY OF SCIENCE, ENGINEERING AND TECHNOLOGY, VOL
   10
SE Proceedings of World Academy of Science Engineering and Technology
LA English
DT Proceedings Paper
CT Conference of the World-Academy-of-Science-Engineering-and-Technology
CY DEC 16-18, 2005
CL Cracow, POLAND
DE Biomedical implant field; misalignment coils; power attenuation;
   transmitter and receiver coils
AB In biomedical implant field, a new formula is given for the study of Radio Frequency power attenuation by simultaneous effects of side and angular misalignment of the supply/data transfer coils. A confrontation with the practical measurements done into a Faraday cage, allowed a checking of the obtained theoretical results. The DC supply systems without material connection and the data transmitters used in the case of biomedical implants, can be well dimensioned by taking into account the possibility of power attenuation by misalignment of transfer coils.
C1 [Noureddine, Batel; Lies, Dekar] Yahia Fares Univ Ctr, Engn Sci Inst, Medea 26001, Algeria.
RP Noureddine, B (reprint author), Yahia Fares Univ Ctr, Engn Sci Inst, Medea 26001, Algeria.
CR CHOSSAT M, 1977, MEMORANDUM MATH
   FLACK FC, 1971, MED BIOL ENG, V9
   JEUTTEUR DC, 1994, MED LIFE SCI ENG, V13, P131
   KO WEN, 1977, MED BIOL ENG COMPUTI
   MEHENNI M, 1992, THESIS NATL SCH POLY
   Mehenni M., 1992, FEEDING EXTERNAL ELE, V14
   Nasar S.A., 1997, INTRO ELECTROMAGNETI
   Soma M., 1987, IEEE T BIOMEDICAL EN, V34
   TAFLOVE A, 1975, IEEE T MICROW THEORY, V23, P623, DOI 10.1109/TMTT.1975.1128640
   Terman F. E., 1943, RADIO ENG HDB
   YAVORSKI B, 1986, MEMORANDUM PHYS
NR 11
TC 3
Z9 3
U1 0
U2 0
PU WORLD ACAD SCI, ENG & TECH-WASET
PI CANAKKALE
PA PO BOX 125, CANAKKALE, 17100, TURKEY
SN 1307-6884
J9 PROC WRLD ACAD SCI E
PY 2005
VL 10
BP 160
EP 164
PG 5
WC Computer Science, Interdisciplinary Applications; Computer Science,
   Theory & Methods
SC Computer Science
GA BIK61
UT WOS:000260416300031
DA 2018-10-19
ER

PT J
AU Stojilovic, N
   Bender, ET
   Ramsier, RD
AF Stojilovic, N
   Bender, ET
   Ramsier, RD
TI Surface chemistry of zirconium
SO PROGRESS IN SURFACE SCIENCE
LA English
DT Review
DE zirconium; oxidation; surface chemistry; subsurface species; diffusion;
   water; oxygen; hydrogen; nuclear materials; alloys; zircaloy
AB This article presents an overview of the surface chemistry of zirconium, focusing on the relationship of what is known from model studies and how this connects to current and future applications of Zr-based materials. The discussion includes the synergistic nature of adsorbate interactions in this system, the role of impurities and alloying elements, and temperature-dependent surface-subsurface transport. Finally, some potential uses of zirconium and its alloys for biomedical and nanolithographic applications are presented. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Akron, Dept Phys, Akron, OH 44325 USA.
   Univ Akron, Dept Chem, Akron, OH 44325 USA.
RP Ramsier, RD (reprint author), Univ Akron, Dept Phys, 250 Buchtel Commons,Ayer Hall 111, Akron, OH 44325 USA.
EM rex@uakron.edu
CR Ankrah S, 2003, J PHYS-CONDENS MAT, V15, P1899, DOI 10.1088/0953-8984/15/12/307
   Ardlin BI, 2002, DENT MATER, V18, P590, DOI 10.1016/S0109-5641(01)00095-1
   Arima T, 2001, J NUCL MATER, V294, P148, DOI 10.1016/S0022-3115(01)00453-6
   Arima T, 1998, J NUCL MATER, V257, P67, DOI 10.1016/S0022-3115(98)00069-5
   ASBURY DA, 1987, SURF SCI, V185, P213, DOI 10.1016/S0039-6028(87)80623-4
   AXELSSON KO, 1985, SURF SCI, V164, P109, DOI 10.1016/0039-6028(85)90702-2
   Baek JH, 2002, J NUCL MATER, V304, P107
   Bai XD, 1998, J NUCL MATER, V254, P266, DOI 10.1016/S0022-3115(97)00346-2
   Barberis P, 1997, J NUCL MATER, V246, P232, DOI 10.1016/S0022-3115(97)00038-X
   Barberis P, 2001, J NUCL MATER, V288, P241, DOI 10.1016/S0022-3115(00)00727-3
   Bastl Z, 2002, SURF INTERFACE ANAL, V34, P477, DOI 10.1002/sia.1342
   BEHM RJ, 1983, J CHEM PHYS, V78, P7486, DOI 10.1063/1.444739
   Bellanger G, 2000, J MATER SCI, V35, P1759, DOI 10.1023/A:1004732703500
   Benezra V, 1999, MATER RES SOC SYMP P, V550, P337
   Bodansky D., 1996, NUCL ENERGY PRINCIPL
   Bottcher A, 1999, PHYS STATUS SOLIDI A, V173, P101, DOI 10.1002/(SICI)1521-396X(199905)173:1<101::AID-PSSA101>3.0.CO;2-R
   Bouvier P, 2002, J NUCL MATER, V300, P118, DOI 10.1016/S0022-3115(01)00756-5
   BRODKIN JS, 1993, THIN SOLID FILMS, V234, P512, DOI 10.1016/0040-6090(93)90320-O
   Buczynski BW, 2003, COLLOID SURFACE B, V30, P167, DOI 10.1016/S0927-7765(03)00068-7
   Cho JH, 1997, PHYS REV B, V56, P9282, DOI 10.1103/PhysRevB.56.9282
   CHOU MY, 1989, PHYS REV B, V39, P5623, DOI 10.1103/PhysRevB.39.5623
   Clarke AH, 1997, SURF INTERFACE ANAL, V25, P948, DOI 10.1002/(SICI)1096-9918(199711)25:12<948::AID-SIA338>3.0.CO;2-K
   Cohen P, 1980, WATER COOLANT TECHNO
   Cox B, 1997, J ALLOY COMPD, V256, pL4, DOI 10.1016/S0925-8388(96)02956-8
   COX B, 1993, J NUCL MATER, V199, P258, DOI 10.1016/0022-3115(93)90147-Q
   COX B, 1995, J NUCL MATER, V218, P261, DOI 10.1016/0022-3115(94)00654-7
   Cox B, 1999, J NUCL MATER, V270, P134, DOI 10.1016/S0022-3115(98)00898-8
   Cox B, 1999, J NUCL MATER, V264, P283, DOI 10.1016/S0022-3115(98)00492-9
   Cox B, 1997, J NUCL MATER, V249, P17, DOI 10.1016/S0022-3115(97)00191-8
   COX B, 1995, J NUCL MATER, V218, P113, DOI 10.1016/0022-3115(94)00651-2
   Cox B., 1976, ADV CORROSION SCI TE, V5
   D'Souza DH, 2002, LETT APPL MICROBIOL, V35, P414, DOI 10.1046/j.1472-765X.2002.01206.x
   DAVIES JA, 1965, J ELECTROCHEM SOC, V112, P675, DOI 10.1149/1.2423662
   DEGONZALEZ CO, 1988, SURF SCI, V193, P305, DOI 10.1016/0039-6028(88)90438-4
   ElMahdy GA, 1996, THIN SOLID FILMS, V286, P289, DOI 10.1016/S0040-6090(95)08503-3
   Elmoselhi MB, 1995, J ALLOY COMPD, V231, P716, DOI 10.1016/0925-8388(95)01759-3
   Farkas N, 2005, J VAC SCI TECHNOL A, V23, P846, DOI 10.1116/1.1864052
   Farkas N, 2005, NANOTECHNOLOGY, V16, P262, DOI 10.1088/0957-4484/16/2/014
   Farkas N, 2004, APPL PHYS LETT, V85, P5691, DOI 10.1063/1.1833569
   Farkas N, 2004, THIN SOLID FILMS, V447, P468, DOI 10.1016/S0040-6090(03)01252-5
   Farkas N, 2004, J VAC SCI TECHNOL A, V22, P1879, DOI 10.1116/1.1723269
   Farkas N, 2003, J VAC SCI TECHNOL A, V21, P1188, DOI 10.1116/1.1560712
   Fehlner F. P., 1970, OXID MET, V2, P59
   Feibelman PJ, 1996, SURF SCI, V360, P297, DOI 10.1016/0039-6028(96)00599-7
   Feibelman PJ, 1996, PHYS REV B, V53, P13740, DOI 10.1103/PhysRevB.53.13740
   Fernandez GE, 2002, J ALLOY COMPD, V330, P483, DOI 10.1016/S0925-8388(01)01622-X
   Fischer H, 2002, DENT MATER, V18, P570, DOI 10.1016/S0109-5641(01)00091-4
   FLINN BJ, 1993, PHYS REV B, V47, P16499, DOI 10.1103/PhysRevB.47.16499
   FOORD JS, 1980, SURF SCI, V94, P339, DOI 10.1016/0039-6028(80)90011-4
   Frank H, 2002, J NUCL MATER, V306, P85, DOI 10.1016/S0022-3115(02)00879-6
   Garcia EA, 1999, J NUCL MATER, V273, P221, DOI 10.1016/S0022-3115(98)00691-6
   GARCIA EA, 1994, J NUCL MATER, V210, P78, DOI 10.1016/0022-3115(94)90225-9
   Grandjean A, 1999, J NUCL MATER, V273, P111, DOI 10.1016/S0022-3115(99)00036-7
   GRIFFITHS K, 1988, J VAC SCI TECHNOL A, V6, P210, DOI 10.1116/1.574982
   HARUO N, 1997, KOGAKU SHUHO KYUSHU, V70, P569
   HOFLUND GB, 1983, J VAC SCI TECHNOL A, V1, P1837, DOI 10.1116/1.572224
   HOFLUND GB, 1987, J VAC SCI TECHNOL A, V5, P112
   HOOD GM, 1994, J NUCL MATER, V210, P1, DOI 10.1016/0022-3115(94)90215-1
   Howlader MMR, 1998, J NUCL MATER, V253, P149, DOI 10.1016/S0022-3115(97)00309-7
   HUANG JH, 1993, MAT SCI ENG A-STRUCT, V161, P247, DOI 10.1016/0921-5093(93)90519-K
   HUI KC, 1985, SOLID STATE COMMUN, V56, P83, DOI 10.1016/0038-1098(85)90539-3
   ILTIS X, 1994, J NUCL MATER, V209, P180, DOI 10.1016/0022-3115(94)90294-1
   Jomard G, 2000, MOL SIMULAT, V24, P111, DOI 10.1080/08927020008024191
   JOMARD G, 2000, APPL SURF SCI, V177, P230
   Jones AC, 2004, J MATER CHEM, V14, P3101, DOI 10.1039/b405525j
   Kang YC, 2002, APPL SURF SCI, V195, P196, DOI 10.1016/S0169-4332(02)00541-X
   Kang YC, 2002, SURF SCI, V519, P229, DOI 10.1016/S0039-6028(02)02210-0
   Kang YC, 2002, J NUCL MATER, V303, P125, DOI 10.1016/S0022-3115(02)00845-0
   Kang YC, 2001, J VAC SCI TECHNOL A, V19, P1996, DOI 10.1116/1.1339020
   Kang YC, 2000, J NUCL MATER, V281, P57, DOI 10.1016/S0022-3115(00)00131-8
   KANG YC, 2002, VACUUM, V64, P113
   Kim HG, 2002, J NUCL MATER, V306, P44, DOI 10.1016/S0022-3115(02)01226-6
   Kim JM, 2004, APPL PHYS LETT, V85, P6368, DOI 10.1063/1.1841470
   Kim W, 1995, SURF COAT TECH, V76-77, P595, DOI 10.1016/0257-8972(95)02576-6
   Kim YS, 1999, J NUCL MATER, V270, P165, DOI 10.1016/S0022-3115(98)00904-0
   Kohal RJ, 2004, J PERIODONTOL, V75, P1262, DOI 10.1902/jop.2004.75.9.1262
   Kovar M, 1997, J CHEM PHYS, V106, P4797, DOI 10.1063/1.473478
   KUBO T, 1991, J NUCL SCI TECHNOL, V28, P122, DOI 10.1080/18811248.1991.9731331
   Kurahashi M, 1999, SURF SCI, V420, P259, DOI 10.1016/S0039-6028(98)00838-3
   Kurahashi M, 1997, J VAC SCI TECHNOL A, V15, P2548, DOI 10.1116/1.580768
   LI AJ, 1995, J CHEM PHYS, V103, P7187, DOI 10.1063/1.470347
   Li B, 1997, SURF SCI, V370, P97, DOI 10.1016/S0039-6028(96)00955-7
   Li B, 1997, SURF SCI, V384, P70, DOI 10.1016/S0039-6028(97)00159-3
   LI B, 1995, SURF SCI, V330, P276, DOI 10.1016/0039-6028(95)00052-6
   LI B, 1995, SURF SCI, V322, P373, DOI 10.1016/0039-6028(95)90045-4
   LI YS, 1995, APPL SURF SCI, V89, P263, DOI 10.1016/0169-4332(95)00032-1
   Li YS, 1996, APPL SURF SCI, V103, P389, DOI 10.1016/S0169-4332(96)00535-1
   Li YS, 1995, SURF REV LETT, V2, P759, DOI 10.1142/S0218625X95000686
   LIN JM, 1984, APPL SURF SCI, V18, P315, DOI 10.1016/0378-5963(84)90318-0
   Lin YP, 2000, J NUCL MATER, V277, P11, DOI 10.1016/S0022-3115(99)00153-1
   LOU JR, 1988, CAN J CHEM, V66, P3157, DOI 10.1139/v88-487
   Lyapin A, 2004, SURF SCI, V552, P160, DOI 10.1016/j.susc.2004.01.016
   Maslar JE, 2001, J NUCL MATER, V298, P239, DOI 10.1016/S0022-3115(01)00657-2
   MCINTYRE NS, 1991, SURF INTERFACE ANAL, V17, P757, DOI 10.1002/sia.740171102
   MCINTYRE NS, 1991, J NUCL MATER, V178, P80, DOI 10.1016/0022-3115(91)90458-J
   McNatt JS, 2002, J PHYS D APPL PHYS, V35, P1855, DOI 10.1088/0022-3727/35/15/306
   Meyer G, 1996, J NUCL MATER, V229, P48, DOI 10.1016/0022-3115(95)00228-6
   Michaelis A, 1998, THIN SOLID FILMS, V313, P756, DOI 10.1016/S0040-6090(97)00992-9
   MITCHELL DJ, 1984, J VAC SCI TECHNOL A, V2, P780, DOI 10.1116/1.572571
   Miyagawa Y., 1998, Surface and Coatings Technology, V103-104, P323, DOI 10.1016/S0257-8972(98)00408-3
   Miyake M, 1999, J NUCL MATER, V270, P233, DOI 10.1016/S0022-3115(98)00779-X
   MOORE WT, 1979, J PHYS C SOLID STATE, V12, pL887, DOI 10.1088/0022-3719/12/23/003
   MORANT C, 1989, SURF SCI, V218, P331, DOI 10.1016/0039-6028(89)90156-8
   Morgan JM, 2002, J APPL PHYS, V91, P9375, DOI 10.1063/1.1476079
   Moya JS, 2000, ACTA MATER, V48, P4749, DOI 10.1016/S1359-6454(00)00267-6
   Nagano H, 1996, CORROS SCI, V38, P781, DOI 10.1016/0010-938X(95)00166-H
   NEERGAARDWALTENBURG H, 1994, J PHYS CHEM-US, V98, P12075, DOI 10.1021/j100097a037
   NICHTLPECHER W, 1991, PHYS REV B, V43, P6946, DOI 10.1103/PhysRevB.43.6946
   Nishino Y, 1997, J NUCL MATER, V248, P292, DOI 10.1016/S0022-3115(97)00126-8
   Nishino Y, 1996, J NUCL MATER, V228, P346, DOI 10.1016/0022-3115(95)00194-8
   Ojima K, 2000, APPL SURF SCI, V165, P141, DOI 10.1016/S0169-4332(00)00370-6
   Ojima K, 2000, APPL SURF SCI, V165, P149, DOI 10.1016/S0169-4332(00)00371-8
   Okuyama H, 1998, SURF SCI, V401, P344, DOI 10.1016/S0039-6028(98)00020-X
   Olmedo D, 2002, J MATER SCI-MATER M, V13, P793, DOI 10.1023/A:1016131310025
   Oskarsson M, 2001, J NUCL MATER, V297, P77, DOI 10.1016/S0022-3115(01)00580-3
   Oskarsson M, 2001, J NUCL MATER, V295, P97, DOI 10.1016/S0022-3115(01)00480-9
   PALACIO C, 1987, SURF SCI, V191, P385, DOI 10.1016/S0039-6028(87)81185-8
   Parise M, 1998, J NUCL MATER, V256, P35, DOI 10.1016/S0022-3115(98)00045-2
   Park K, 1999, J NUCL MATER, V270, P154, DOI 10.1016/S0022-3115(98)00903-9
   Patel AM, 1997, BIOMATERIALS, V18, P441, DOI 10.1016/S0142-9612(96)00152-4
   Pecheur D, 2000, J NUCL MATER, V278, P195, DOI 10.1016/S0022-3115(99)00253-6
   PETERSON WJ, 1985, APPL SURF SCI, V24, P121, DOI 10.1016/0169-4332(85)90216-8
   Phadnis SV, 1999, T I MET FINISH, V77, P200, DOI 10.1080/00202967.1999.11871283
   Pichugin AT, 2000, MATER SCI+, V36, P683, DOI 10.1023/A:1011355723821
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Qin Z, 1999, J NUCL MATER, V264, P228, DOI 10.1016/S0022-3115(98)00465-6
   RAMASUBRAMANIAN N, 1990, J NUCL MATER, V175, P237, DOI 10.1016/0022-3115(90)90212-6
   Raspopov SA, 1997, J CHEM SOC FARADAY T, V93, P2113, DOI 10.1039/a608475c
   Ries MD, 2002, J BONE JOINT SURG AM, V84A, P129, DOI 10.2106/00004623-200200002-00018
   Sawicki JA, 1999, J NUCL MATER, V264, P169, DOI 10.1016/S0022-3115(98)00463-2
   Schweinsberg M, 1997, ELECTROCHIM ACTA, V42, P3303, DOI 10.1016/S0013-4686(97)00181-3
   Sergeev VS, 2003, ATOM ENERGY+, V95, P613, DOI 10.1023/B:ATEN.0000007884.41282.34
   Shi LQ, 2002, J VAC SCI TECHNOL A, V20, P1840, DOI 10.1116/1.1506174
   SHIH HD, 1976, SURF SCI, V60, P445, DOI 10.1016/0039-6028(76)90328-9
   Shimizu K, 1998, CAN J CHEM, V76, P1796, DOI 10.1139/cjc-76-12-1796
   Song Z, 2004, J VAC SCI TECHNOL A, V22, P711, DOI 10.1116/1.1690252
   Spector M, 2001, J BONE JOINT SURG AM, V83A, P80, DOI 10.2106/00004623-200100022-00004
   Stojilovic N, 2005, J VAC SCI TECHNOL A, V23, P1013, DOI 10.1116/1.1864054
   Stojilovic N, 2004, J VAC SCI TECHNOL A, V22, P1631, DOI 10.1116/1.1723308
   Stojilovic N, 2004, CHEM PHYS LETT, V399, P53, DOI 10.1016/j.cplett.2004.10.003
   Stojilovic N, 2004, SURF SCI, V565, P243, DOI 10.1016/j.susc.2004.07.015
   Stojilovic N, 2004, SOLID STATE COMMUN, V130, P623, DOI 10.1016/j.ssc.2004.03.023
   Stojilovic N, 2004, SURF SCI, V553, P23, DOI 10.1016/j.susc.2004.02.002
   Stojilovic N, 2003, APPL SURF SCI, V218, P188, DOI 10.1016/S0169-4332(03)00584-1
   Stojilovic N, 2002, SURF INTERFACE ANAL, V33, P945, DOI 10.1002/sia.1475
   STOJILOVIC N, IN PRESS APPL SURF S
   TAKEUCHI H, 1988, J CHEM SOC FARAD T 1, V84, P4235, DOI 10.1039/f19888404235
   TAKEUCHI K, 1995, SURF SCI, V323, P30, DOI 10.1016/0039-6028(94)00621-0
   TANABE T, 1989, SURF SCI, V222, P84, DOI 10.1016/0039-6028(89)90336-1
   TAPPING RL, 1995, INT J MASS SPECTROM, V146, P75, DOI 10.1016/0168-1176(95)04205-Y
   Taylor DF, 2000, J NUCL MATER, V277, P295, DOI 10.1016/S0022-3115(99)00159-2
   Tokash JC, 2005, SURF INTERFACE ANAL, V37, P379, DOI 10.1002/sia.1993
   Uchida M, 2002, BIOMATERIALS, V23, P313, DOI 10.1016/S0142-9612(01)00110-7
   Vaillancourt M, 1995, J NUCL MATER, V227, P58, DOI 10.1016/0022-3115(95)00144-1
   Vermoyal JJ, 2001, J NUCL MATER, V298, P297, DOI 10.1016/S0022-3115(01)00648-1
   Vermoyal JJ, 1999, ELECTROCHIM ACTA, V45, P1039, DOI 10.1016/S0013-4686(99)00307-2
   Veshchunov MS, 1998, J NUCL MATER, V255, P250, DOI 10.1016/S0022-3115(98)00018-X
   Vittoz C, 1999, J ADHES SCI TECHNOL, V13, P1045, DOI 10.1163/156856199X00505
   Wang YM, 1997, SURF SCI, V380, P540, DOI 10.1016/S0039-6028(97)00039-3
   WANG YM, 1995, SURF SCI, V343, pL1167, DOI 10.1016/0039-6028(95)00897-7
   WANG YM, 1993, APPL SURF SCI, V72, P237, DOI 10.1016/0169-4332(93)90192-E
   WANG YM, 1995, SURF SCI, V342, P272, DOI 10.1016/0039-6028(95)00807-1
   Watanabe K, 1998, FUSION ENG DES, V39-40, P1055, DOI 10.1016/S0920-3796(98)00161-6
   WEST PE, 1987, J VAC SCI TECHNOL A, V5, P1124, DOI 10.1116/1.574814
   WONG PC, 1995, SURF REV LETT, V2, P165, DOI 10.1142/S0218625X95000170
   WONG PC, 1987, SOLID STATE COMMUN, V62, P293, DOI 10.1016/0038-1098(87)90815-5
   WONG PC, 1987, CAN J PHYS, V65, P464, DOI 10.1139/p87-062
   WONG PC, 1995, APPL SURF SCI, V89, P255, DOI 10.1016/0169-4332(95)00031-3
   WONG PC, 1987, SURF SCI, V187, pL599, DOI 10.1016/0167-2584(87)90854-1
   Yamamoto M, 1997, SURF SCI, V387, P300, DOI 10.1016/S0039-6028(97)00365-8
   Yamamoto M, 1996, PHYS REV B, V54, P14111, DOI 10.1103/PhysRevB.54.14111
   YAMAMOTO M, 1990, J CHEM SOC FARADAY T, V86, P157, DOI 10.1039/ft9908600157
   YAMAMOTO M, 1991, J CHEM SOC FARADAY T, V87, P1591, DOI 10.1039/ft9918701591
   Yamamoto M, 1996, PHYS REV B, V53, P13772, DOI 10.1103/PhysRevB.53.13772
   Yamanaka S, 1997, J NUCL MATER, V247, P315, DOI 10.1016/S0022-3115(97)00101-3
   Yamanaka S, 1995, J ALLOY COMPD, V231, P503, DOI 10.1016/0925-8388(95)01864-6
   YAMOKOSKI EA, 2005, J ASTM INT, V2
   YAU TE, 1983, SCC ZIRCONIUM ITSL A, V39
   YAU TL, 1992, STRESS CORROSION CRA, pCH11
   ZEHRINGER R, 1989, SURF SCI, V215, P501, DOI 10.1016/0039-6028(89)90272-0
   Zhang CS, 1996, SURF SCI, V346, P206, DOI 10.1016/0039-6028(95)00904-3
   ZHANG CS, 1995, J NUCL MATER, V223, P238, DOI 10.1016/0022-3115(95)00030-5
   Zhang CS, 1998, J NUCL MATER, V257, P1, DOI 10.1016/S0022-3115(98)00432-2
   ZHANG CS, 1994, SURF SCI, V313, P308, DOI 10.1016/0039-6028(94)90051-5
   ZHANG CS, 1995, SURF SCI, V338, P157, DOI 10.1016/0039-6028(95)00600-1
   Zhang CS, 2002, J NUCL MATER, V300, P7, DOI 10.1016/S0022-3115(01)00714-0
   ZHANG CS, 1991, SURF SCI, V245, P373, DOI 10.1016/0039-6028(91)90039-U
   ZHANG CS, 1992, J VAC SCI TECHNOL A, V10, P2560, DOI 10.1116/1.578099
   ZHANG CS, 1993, J NUCL MATER, V199, P231
   Zhang CS, 1995, J ALLOY COMPD, V231, P354, DOI 10.1016/0925-8388(95)01847-6
   ZHANG CS, 1991, SURF SCI, V264, P1
   Zhdanov VP, 1996, APPL SURF SCI, V99, P205, DOI 10.1016/0169-4332(96)00098-0
   ZOU H, 1995, APPL SURF SCI, V90, P59, DOI 10.1016/0169-4332(95)00056-9
NR 193
TC 63
Z9 64
U1 2
U2 37
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0079-6816
J9 PROG SURF SCI
JI Prog. Surf. Sci.
PY 2005
VL 78
IS 3-4
BP 101
EP 184
DI 10.1016/j.progsurf.2005.07.001
PG 84
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA 980XN
UT WOS:000233051600002
DA 2018-10-19
ER

PT S
AU Allen, MG
   Cook, DJ
   Decker, BK
   Hensley, JM
   Rosen, DI
   Silva, ML
   Sonnenfroh, DM
   Wainner, RT
AF Allen, MG
   Cook, DJ
   Decker, BK
   Hensley, JM
   Rosen, DI
   Silva, ML
   Sonnenfroh, DM
   Wainner, RT
BE Razeghi, M
   Brown, GJ
TI In-situ and stand-off sensing using QC/IC laser technology from 3-100
   microns
SO Quantum Sensing and Nanophotonic Devices II
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Quantum Sensing and Nanophotonic Devices II
CY JAN 23-27, 2005
CL San Jose, CA
SP SPIE
DE quantum cascade laser; LIDAR; cavity enhance spectroscopy; gas
   detection; absorption
ID QUANTUM-CASCADE LASERS; ABSORPTION-MEASUREMENTS; SPECTROSCOPY;
   TEMPERATURE; OPERATION; GAS
AB Recent advances in current-pumped, bandgap-engineered semiconductor lasers have dramatically impacted laser-based sensor concepts for in-situ trace species measurement and standoff sensing applications. These devices allow a common technology platform to access strong fundamental vibrational absorption transitions of many gases., liquids, and solids in the mid-wave and long-wave Ilk, as well as far-Ilk, or THz. The THz wavelength region is particularly interesting for applications related to structure penetrating detection of hidden materials and biomolecular spectroscopy. This presentation will briefly review the important properties of these lasers as they apply to sensor design and present highlights of recent sensor development activity for trace gas analysis in environmental and biomedical applications, remote sensing LIDAR systems, and detection of hidden explosives.
C1 Phys Sci Inc, Andover, MA 01810 USA.
RP Allen, MG (reprint author), Phys Sci Inc, 20 New England Business Ctr, Andover, MA 01810 USA.
CR ALLEN MG, 1995, APPL OPTICS, V34, P3240, DOI 10.1364/AO.34.003240
   Bakhirkin YA, 2004, APPL OPTICS, V43, P2257, DOI 10.1364/AO.43.002257
   Barkan A, 2004, OPT LETT, V29, P575, DOI 10.1364/OL.29.000575
   Capasso F, 2000, IEEE J SEL TOP QUANT, V6, P931, DOI 10.1109/2944.902142
   COOK D, 2004, 535408 SPIE
   COOK D, 2003, S OPT TECHN IND ENV
   Gittins CM, 2000, OPT LETT, V25, P1162, DOI 10.1364/OL.25.001162
   HCNSLCY JM, 2005, OSA OPT TER SCI TECH
   Kohler R, 2002, NATURE, V417, P156, DOI 10.1038/417156a
   KOSTEREV A, APP OPT, V39, P4425
   Kumar S, 2004, APPL PHYS LETT, V84, P2494, DOI 10.1063/1.1695099
   Mahler L, 2004, APPL PHYS LETT, V84, P5446, DOI 10.1063/1.1767957
   Sonnenfroh DM, 2001, APPL OPTICS, V40, P812, DOI 10.1364/AO.40.000812
   Wainner RT, 2002, APPL PHYS B-LASERS O, V75, P249, DOI 10.1007/s00340-002-0984-7
   Yang RQ, 2001, IEEE J QUANTUM ELECT, V37, P282, DOI 10.1109/3.903079
NR 15
TC 3
Z9 3
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5706-X
J9 P SOC PHOTO-OPT INS
PY 2005
VL 5732
BP 134
EP 143
DI 10.1117/12.598279
PG 10
WC Instruments & Instrumentation; Optics; Spectroscopy
SC Instruments & Instrumentation; Optics; Spectroscopy
GA BCF41
UT WOS:000229036500014
DA 2018-10-19
ER

PT S
AU Elliott, TB
   Knudson, GB
   Shoemaker, MO
   Ledney, GD
AF Elliott, TB
   Knudson, GB
   Shoemaker, MO
   Ledney, GD
BE Gazso, LG
   Ponta, CC
TI Inactivation of biological warfare agent simulants by ionizing radiation
SO Radiation Inactivation of Bioterrorism Agents
SE NATO SCIENCE SERIES, SUB-SERIES I: LIFE AND BEHAVIOURAL SCIENCES
LA English
DT Proceedings Paper
CT NATO Advanced Research Workshop on Radiation Inactivation of
   Bioterrorism Agents
CY MAR 07-09, 2004
CL Frederic Joliot-Curie Natl Res Inst Radiobiol & Radiohygiene, Budapest,
   HUNGARY
SP NATO
HO Frederic Joliot-Curie Natl Res Inst Radiobiol & Radiohygiene
ID BACILLUS-ATROPHAEUS; STRAINS
AB The Armed Forces Radiobiology Research Institute (AFRRI) in the U. S. Department of Defense conducts biomedical research on the effects of ionizing radiation. It has the largest radiobiology program in the United States and is a national resource in the response to nuclear and radiation accidents. Bacterial spores are potential biological weapons because they can be prepared and distributed by aerosol, they endure harsh environmental conditions, and they are infectious. Decontamination procedures for large concentrations of spores must be effective and practical. We determined the dose response of bacterial spores to three qualities, or types, of ionizing radiation.
   Inactivation of dry and hydrated bacterial spores with gamma radiation has been more thoroughly studied than spore inactivation with neutron radiation. Decimalreduction curves were produced at AFRRI for Bacillus atrophaeus (B. subtilis var. niger, B. globigii, '' BG ''), B. pumilus, B. thuringiensis, and B. anthracis Sterne spores, both wet and dry, using doses of 0.3 to 7.2 kGy neutrons delivered at a dose rate of 44 to 49 Gy/min (D-n/D-T = 0.95) in the AFRRI training, research, isotope-producing General Atomic (TRIGA) Mark-F nuclear reactor, and doses of 0.6 to 24.0 kGy gamma rays delivered at dose rates of 112 to 120 Gy/min in the AFRRI cobalt-60 ((CO)-C-60) gamma-photon irradiation facility. Decimal-reduction curves were constructed by plotting the spore survival fraction in terms of colony-forming units vs. radiation dose. All four species showed greater sensitivity to neutron radiation than to gamma radiation, regardless of the state of hydration. Dry spores of all four species were more sensitive to gamma radiation than were hydrated spores. In contrast, the state of hydration, whether dry or hydrated, of spores of B. subtilis and B. pumilus, which were embedded in filter paper strips, did not affect their sensitivity to neutron radiation. Wet B. thuringiensis spores were only slightly more sensitive to neutrons than were B. thuringiensis spores in dry powdered form. Furthermore, the species most resistant to neutron and gamma radiations was a concentrated B. anthracis Sterne spore suspension. When the starting spore concentration, the Bacillus species used, the radiation quality (neutron or gamma), and the state of hydration are known, the radiation decimal-reduction curves generated in these studies can be used to predict bacterial spore survival.
   Electron-beam radiation (e-beam) has been used to inactivate microorganisms in spices, fresh food, medical components, and hazardous waste. AFRRI assessed the efficacy of using an e-beam for decontamination of bulk biological agents and of byproducts of the decontamination procedures such as wipes and aqueous runoff. Biological agent surrogates were tested under controlled conditions to determine the effectiveness of e-beam for decontamination. Using the AFRRI linear accelerator (LINAC) to deliver doses of 2 to 20 kGy at a dose rate of 1 kGy/min, radiation Decimal-reduction curves were constructed for Bacillus atrophaeus spores in a dry powder and B. anthracis Sterne spores in a slurry. Doses of 0.25 to 1.0 kGy were delivered to vegetative Gram-negative bacterial cells of Serratia marcescens. The LINAC produced 13-MeV electrons at 30 pulses/sec with a 4-mu sec pulse width generated through a water scatterer. Spore samples were irradiated in an array of three screw-capped polystyrene tubes. Dosimetry was performed at the beginning of each experimental run with LiF:Ti,Mg thermoluminescent dosimeters (TLDs), product type TLD-100 (Bicrong (R)). TLDs were processed with the Bicron (R)/Harshaw Model 5500 Automatic TLD Reader. The inactivation data for dry B. atraphaeus spores, B. anthracis Sterne spores, and S. marcescens were fitted to a mathematical ton-rula. The e-beam decimal-reduction curves for the bacterial spores were similar to our previously generated gamma-photon radiation curves. The vegetative bacterial cells of S. marcescens were more susceptible to high-speed electrons than were the bacterial spores. These experimental findings support the concept of using a truck-mounted transportable LINAC in the field for decontaminating bulk materials that are contaminated with pathogenic bacteria.
C1 Armed Forces Radiobiol Res Inst, Bethesda, MD 20889 USA.
RP Elliott, TB (reprint author), Armed Forces Radiobiol Res Inst, 8901 Wisconsin Ave, Bethesda, MD 20889 USA.
CR *AM ASS PHYS MED, 1983, MED PHYS, V10, P741
   Carter RE, 1973, 733 ARM FORC RAD RES
   COLE LA, 1988, CLOUBS SECRECY ARMYS
   ELLIOT TB, 1995, INT J RADIAT BIOL, V68, P311, DOI 10.1080/09553009514551241
   Fritze D, 2001, INT J SYST EVOL MICR, V51, P35, DOI 10.1099/00207713-51-1-35
   LEDNEY GD, 1996, 961 ARMED FORCES RAD
   NAKAMURA LK, 1989, INT J SYST BACTERIOL, V39, P295, DOI 10.1099/00207713-39-3-295
NR 7
TC 1
Z9 1
U1 0
U2 5
PU I O S PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1566-7693
BN 1-58603-488-X
J9 NATO SCI SER I LIFE
PY 2005
VL 365
BP 153
EP 160
PG 8
WC Biology; Microbiology; Nuclear Science & Technology; Physics, Applied
SC Life Sciences & Biomedicine - Other Topics; Microbiology; Nuclear
   Science & Technology; Physics
GA BCE05
UT WOS:000228807300017
DA 2018-10-19
ER

PT S
AU Zhang, J
   Chou, C
   Jensen, T
   Gray, J
AF Zhang, J
   Chou, C
   Jensen, T
   Gray, J
BE Thompson, DO
   Chimenti, DE
TI Development of a high-resolution CT system and 3D data visualization
   tools
SO Review of Progress in Quantitative Nondestructive Evaluation, Vols 24A
   and 24B
SE AIP CONFERENCE PROCEEDINGS
LA English
DT Proceedings Paper
CT 31st Annual Review of Progress in Quantitative Nondestructive Evaluation
CY JUL 25-30, 2004
CL Colorado Sch Mines, Golden, CO
HO Colorado Sch Mines
AB The need for material characterization covers broad areas including new materials development, failure analysis, biomedical applications and process development and characterization. Length scales of 0.1 mu through 500 mu are of key importance to if processes are to be understood and a measure of control on those processes achieved. Computed tomography (CT) imaging of objects is increasingly important in that it can provide 3D information nondestructively about the internal features of interest. We present results from a recently developed mu CT system based cm a 130 kVp microfocus tube, an amorphous Si array detector and a micro-stepped positioner. At present the highest resolutions available are voxel sizes of 2.5 microns with a field of view of 4 mm. The data volumes are several gigabytes and have 1400x1400x500voxels. Larger fields of view can be obtained at lower resolution. In generating these 31) data sets a number of issues need to be addressed including detector noise and artifacts, transfer of data from systems, efficient reconstruction of the large data sets, visualization of the data and finally, extraction of information from the data. Parallel processing for the CT reconstruction is implemented on a 64 node Linux cluster and provides reconstruction of a 3D volume in 12 minutes. A custom 3D visualization tool implements volume rendering on a PC and provides 3D viewing of the objects. Users have various functions such as histogram lookup table, mapping, region of interest clipping, normalization, and transparency to explore and interrogate the data. Examples from the CT scanning system will be presented.
C1 Iowa State Univ, Ctr NDE, Ames, IA 50011 USA.
RP Zhang, J (reprint author), Iowa State Univ, Ctr NDE, 1915 Scholl Rd, Ames, IA 50011 USA.
CR Fan P., 2001, THESIS IOWA STATE U
   FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612
   JASIUNIENE E, 2000, P 15 WORLD C NOND TE
   XU JD, 1994, REV PROG Q, V13, P557
   Zhang J., 2003, THESIS IOWA STATE U
NR 5
TC 0
Z9 0
U1 0
U2 0
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 0-7354-0245-0
J9 AIP CONF PROC
PY 2005
VL 760
BP 686
EP 693
PG 8
WC Acoustics; Engineering, Electrical & Electronic; Materials Science,
   Multidisciplinary; Materials Science, Characterization & Testing; Optics
SC Acoustics; Engineering; Materials Science; Optics
GA BCE68
UT WOS:000228893300088
DA 2018-10-19
ER

PT S
AU Oliveira, L
   Lage, A
AF Oliveira, L
   Lage, A
BE Tuchin, VV
TI Monte Carlo simulation for the optical transmittance in biological
   tissues during the action of osmotic agents
SO Saratov Fall Meeting 2004: Optical Technologies in Biophysics and
   Medicine VI
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 2004 Saratov Fall Meeting
CY SEP 21-24, 2004
CL Saratov, RUSSIA
SP Russian Fdn Basic Res, US Civilian Res & Dev Fdn Independent States Former Soviet Union, SPIE Russian Chapter, IEEE MTT, ED, AP, CPMT Saratov Penza Chapter, TECHNOSERV S, Ltd, Almus, Ltd, Saratov State Univ, Res Educ Inst Opt & Biophoton SSU, Russian Acad Sci, Inst Precis Mech & Control, Res Educ Ctr Nonlinear Dynam & Biophys CRDF & Minist Educ & Sci RF, Volga Reg Ctr New Informat Technologies, Russian Acad Nat Sci, Saratov Reg Div, Russian Soc Photobiol, Saratov State Tech Univ, Inst Business & Business Adm
DE Monte Carlo; optical transmittance; biological optical properties
AB Computational methods have been used with great application to biomedical optics. The events created by the interaction of radiation with biological materials can easily be translated to computer languages with the objective of producing simulation techniques to be used prior to physical intervention. The addition of biocompatible and hyper osmotic agents to several types of biological tissues has proven the enhancement of transparency to radiation flux by reduction of material's optical properties. The evolutionary behavior of the agent's action in the tissue samples before saturation has been observed by numerous researchers but has never been described mathematically. In the present work we will describe the application of Monte Carlo simulation to estimate the evolutionary states of optical transparency of biological tissues when immersed in an osmotic solution. We begin our study with typical values for the optical properties of rabbit muscle and proceed by reducing the absorption and scattering coefficients independently and simultaneously. The results show the number of transmitted, absorbed, scattered and reflected photons in different stages of the action of a generic osmotic agent over a small and well defined tissue sample.
C1 Ctr Ciencias & Tecnol Opt, P-4150 Oporto, Portugal.
RP Oliveira, L (reprint author), Ctr Ciencias & Tecnol Opt, Rua Caldas Xavier 38, P-4150 Oporto, Portugal.
RI Oliveira, Luis/B-7198-2017
OI Oliveira, Luis/0000-0003-0667-3428
CR CHEONG WF, 1990, IEEE J QUANTUM ELECT, V26, P2166, DOI 10.1109/3.64354
   Galanzha EI, 2003, J PHYS D APPL PHYS, V36, P1739, DOI 10.1088/0022-3727/36/14/313
   KIN F, 2001, LASER SURG MED, V29, P213
   MEGLINSKI IV, 2001, 4 PAC RIM C, V1, P1
   Prahl S., 1988, THESIS U TEXAS AUSTI
   WANG L., 1995, COMPUTER METHODS PRO, V47
   2002, BIOMEDICAL PHOTONICS, pCH3
   1987, OPTICS EUGENE HECHT
NR 8
TC 0
Z9 0
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5752-3
J9 P SOC PHOTO-OPT INS
PY 2005
VL 5771
BP 225
EP 236
DI 10.1117/12.634821
PG 12
WC Biophysics; Engineering, Biomedical; Optics
SC Biophysics; Engineering; Optics
GA BCW59
UT WOS:000231561200028
DA 2018-10-19
ER

PT J
AU Bollen, PJA
   Remie, R
   Kloots, W
   Barfred, L
   Salomon, S
   Ritskes-Hoitinga, M
AF Bollen, PJA
   Remie, R
   Kloots, W
   Barfred, L
   Salomon, S
   Ritskes-Hoitinga, M
TI Post-graduate teaching in microsurgery using a combination of
   alternative non-animal and in vivo methods
SO SCANDINAVIAN JOURNAL OF LABORATORY ANIMAL SCIENCE
LA English
DT Article
ID RAT
AB Over recent years alternative, non-animal methods have been developed for use in microsurgical training courses, for the training of suture techniques, dexterity and hand-eye coordination. Nevertheless, it is still hard to imagine that alternative methods will be able to replace in vivo teaching completely, because properties of biological tissue are different from those of latex or other artificial materials. Also the dynamics of biological processes, such as a pulsating bloodstream, are difficult to simulate in alternative models. However, the number of animals used in microsurgical training courses can be limited by combining non-animal methods with in vivo training. Moreover, individual techniques can be improved greatly by using non-animal methods. In a five-day introductory course in microsurgical and experimental techniques at the Biomedical Laboratory, University of Southern Denmark, we have limited the average number of animals to one rat per day per participant, by using alternative non-animal methods extensively on the first course day. Nearly all participants were able to produce a successful end-to-end anastomosis of the femoral artery during the second or third day of the course. The alternative methods used included a training device for microsurgical anastomosis and the MD PVC-Rat, an artificial rat with life-size latex abdominal vessels.
C1 Univ So Denmark, Biomed Labs, Fac Hlth Sci, DK-5000 Odense, Denmark.
   Vejle Hosp, Velje, Denmark.
   Hosp Fyn Svendborg, Svendborg, Denmark.
RP Bollen, PJA (reprint author), Univ So Denmark, Biomed Labs, Fac Hlth Sci, Winsloewparken 23, DK-5000 Odense, Denmark.
EM pbollen@health.sdu.dk
RI Ritskes-Hoitinga, J./H-8083-2014
CR ACLAND RD, 1977, MICROSURGERY PRACTIC
   Crosby NL, 1995, MICROSURG, V16, P655, DOI 10.1002/micr.1920160913
   Dongen J. J. van, 1996, Animal Technology, V47, P19
   Erel E, 2003, MICROSURG, V23, P147, DOI 10.1002/micr.10106
   Fanua SP, 2001, MICROSURG, V21, P379, DOI 10.1002/micr.21812
   Flecknell P., 1996, LAB ANIMAL ANAESTHES
   KAUFMAN T, 1984, Microsurgery, V5, P57, DOI 10.1002/micr.1920050113
   KLOOTS WJ, 1995, LAB ANIM SCI, V45, P588
   KOHN D, 1997, ANESTHESIA ANALGESIA
   Miko I, 2001, MICROSURG, V21, P121, DOI 10.1002/micr.1021
   Pless J, 1978, Ugeskr Laeger, V140, P850
   POPP MB, 1981, AM J PHYSIOL, V241, P606
   Remie R, 2001, LAB ANIMAL, V30, P48
   Salomon S, 1996, SCAND J LAB ANIM SCI, V23, P73
   VANDONGEN JJ, 1990, MNAUAL MICROSURGERY
NR 15
TC 1
Z9 1
U1 0
U2 7
PU SCANDINAVIAN FEDERATION LABORATORY ANIMAL SCIENCE
PI SOBORG
PA C/O MARGARETA BERTRAM, NATIONAL FOOD AGENCY, MORKHOJ BYGHADE 19, DK-2860
   SOBORG, DENMARK
SN 0901-3393
J9 SCAND J LAB ANIM SCI
JI Scand. J. Lab. Anim. Sci.
PY 2005
VL 32
IS 3
BP 183
EP 187
PG 5
WC Veterinary Sciences
SC Veterinary Sciences
GA 978WK
UT WOS:000232903500005
DA 2018-10-19
ER

PT S
AU Lin, CM
   Yen, SK
AF Lin, CM
   Yen, SK
BE Gupta, M
   Lim, CYH
TI In vitro corrosion behavior and apatite-formation of electrolytic
   nanocrystalline TiO2 coating for biomedical applications
SO Science and Technology of Nanomaterials - ICMAT 2003
SE JOURNAL OF METASTABLE AND NANOCRYSTALLINE MATERIALS SERIES
LA English
DT Proceedings Paper
CT ICMAT Symposium on Science and Technologies of Nanomaterials
CY DEC 07-12, 2003
CL Singapore, SINGAPORE
SP NUS, Mat Engn Initiat, Fac Engn, NUS Nanosci & Nanotechnol Initiat
DE apatite; corrosion; electrolytic; nanocrystalline; TiO2
AB Titanium and titanium alloys are among the most widely used materials in biomedical devices because of their high corrosion resistance and excellent biocompatibility. The excellent tissue response to titanium is believed to relate to the chemical and biochemical properties of surface native titanium oxide. In effect, the surface native titanium oxide consists of nonstoichiometric titanium oxide and display amorphous of low crystallinity. After implantation for a long time, titanium implants cannot bond directly to living bone. A fibrous capsule is normally formed between the titanium implant and natural bone. In the other hand, titanium ions release into the bioliquid is expected. In the metal-tissue interaction studies, it indicated that a high concentration of titanium have been detected both in osseous tissue and surrounding organs after 3 years. Titanium ions release will inhibit apatite formation and may combine with biomolecules induce toxicity and allergy. Cathodic electrolytic deposition is an important method in ceramic processing. In this paper, the nanocrystalline TiO2 coating were prepared by electrolytic deposition process, the TiO2 coated specimens were characterization by XRD, SEM, AFM and dynamic cyclic polarization. According to the XRD results, we can clearly identified that electrolytic deposition titanium hydrate gel annealed at 300 degrees C for 1 hr will form to anatase TiO2, and its grain size about 2.77 nm. From cross-section and dynamic cyclic polarization tests, we can found that dense TiO2 coated exhibited thickness about 1.2 mu m, and effective improved corrosion resistance of Ti substrate than thermally grown oxide. From immersion tests, we can found that anatase TiO2 exhibited excellent bioactive.
C1 Natl Chung Hsing Univ, Dept Mat Engn, Taichung 402, Taiwan.
RP Lin, CM (reprint author), Natl Chung Hsing Univ, Dept Mat Engn, 250,Kuo Kuang Rd, Taichung 402, Taiwan.
CR Hanawa T, 1999, MAT SCI ENG A-STRUCT, V267, P260, DOI 10.1016/S0921-5093(99)00101-X
   JACOBLABARRE JT, 1994, J BIOMED MATER RES, V28, P699, DOI 10.1002/jbm.820280607
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Wang JY, 1996, J BIOMED MATER RES, V32, P655, DOI 10.1002/(SICI)1097-4636(199612)32:4<655::AID-JBM19>3.0.CO;2-C
NR 4
TC 1
Z9 1
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1422-6375
BN 0-87849-953-9
J9 J METASTAB NANOCRYST
PY 2005
VL 23
BP 121
EP 124
DI 10.4028/www.scientific.net/JMNM.23.121
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA BBZ72
UT WOS:000228398300030
DA 2018-10-19
ER

PT J
AU Al-Qasas, NS
   Rohani, S
AF Al-Qasas, NS
   Rohani, S
TI Synthesis of pure hydroxyapatite and the effect of synthesis conditions
   on its yield, crystallinity, morphology and mean particle size
SO SEPARATION SCIENCE AND TECHNOLOGY
LA English
DT Article
DE hydroxyapatite; purity; mean particle size; precipitation;
   crystallinity; Rietveld refinement
ID AMORPHOUS CALCIUM-PHOSPHATE; PRECIPITATION; CONVERSION; POWDERS
AB Hydroxyapatite (HAP) is a calcium phosphate compound with the chemical formula Ca-5 (PO4 )(3)OH. This compound is especially significant in biomedical applications since it resembles the mineral constituents of the hard tissue in the human body. Its biocompatibility, castability, and sinterability make it a very attractive material for simulating bones and therefore for implantations. The objective of this study was to produce HAP with a high purity and to determine quantitatively the exact percentage of HAP in the synthesized powder. Hydrothermal methods have been used to produce HAP. In the present work, Hydroxyapatite powder was produced using the chemical precipitation method in a batch and semi-batch modes of operation. The effect of temperature, pH, and reactant addition rates on the mean particle size was studied. Results showed a maximum in the mean particle size at pH 9, while a minimum was observed at around 45 degrees C. As the reactant addition rate increased the mean particle size increased as well. The purity of the obtained powder was characterized using both quantitative and qualitative techniques. The quantitative results were performed using the powerful Rietveld refinement method. The quantitative results were obtained for three samples. Results showed that pure HAP was produced at a temperature of 85 degrees C, pH 9 and reactant addition rate of 1.3 mL/min.
C1 Univ Western Ontario, Dept Chem & Biochem Engn, London, ON N6A 5B9, Canada.
RP Rohani, S (reprint author), Univ Western Ontario, Dept Chem & Biochem Engn, London, ON N6A 5B9, Canada.
EM rohani@eng.uwo.ca
CR ALQASAS NS, 2004, THESIS
   Amjad Z., 1998, CALCIUM PHOSPHATES B
   Arifuzzaman SM, 2004, J CRYST GROWTH, V267, P624, DOI 10.1016/j.jcrysgro.2004.04.024
   BOSKEY AL, 1973, J PHYS CHEM-US, V77, P2313, DOI 10.1021/j100638a011
   EANES ED, 1965, NATURE, V208, P365, DOI 10.1038/208365a0
   Elliott J.C., 1994, STUDIES INORGANIC CH
   GENCK WJ, 1972, AICHE S SER 121, V68, P57
   Gomez-Morales J, 2001, CRYST RES TECHNOL, V36, P15, DOI 10.1002/1521-4079(200101)36:1<15::AID-CRAT15>3.3.CO;2-5
   HARRIES JE, 1987, J CRYST GROWTH, V84, P563, DOI 10.1016/0022-0248(87)90046-7
   JENKINS R, 1996, SERIES MONOGRAPHS AN, P138
   KIM WS, 2002, CHEM ENG T, V1, P611
   KING PL, 2004, SHORT COURSE SERIES, V33, P57
   Kivrak N, 1998, J AM CERAM SOC, V81, P2245
   Koumoulidis GC, 2003, NATO SCI SER II MATH, V102, P83
   Liu CS, 2001, BIOMATERIALS, V22, P301, DOI 10.1016/S0142-9612(00)00166-6
   MATHEW M, 1988, J CRYST SPECTROSC, V18, P235, DOI 10.1007/BF01194315
   MEYER JL, 1978, CALC TISS RES, V25, P209, DOI 10.1007/BF02010771
   Petrov OE, 2001, MATER LETT, V48, P162, DOI 10.1016/S0167-577X(00)00297-4
   Raynaud S, 2002, BIOMATERIALS, V23, P1073, DOI 10.1016/S0142-9612(01)00219-8
   Riman RE, 2002, SOLID STATE IONICS, V151, P393, DOI 10.1016/S0167-2738(02)00545-3
   Rodriguez-Lorenzo LM, 2000, CHEM MATER, V12, P2460, DOI 10.1021/cm001033g
   Saeri MR, 2003, MATER LETT, V57, P4064, DOI 10.1016/S0167-577X(03)00266-0
   Salahi E, 2001, CFI-CERAM FORUM INT, V78, pE43
   Sarig S, 2002, J CRYST GROWTH, V237, P55, DOI 10.1016/S0022-0248(01)01850-4
   SECKLER MM, 1999, MAT RES, V2, P59
   Shuk P, 2001, J MATER RES, V16, P1231, DOI 10.1557/JMR.2001.0170
   SUDARSANAN K, 1969, ACTA CRYSTALL B-STRU, VB 25, P1534, DOI 10.1107/S0567740869004298
   Torrent-Burgues J, 2001, CRYST RES TECHNOL, V36, P1075, DOI 10.1002/1521-4079(200110)36:8/10<1075::AID-CRAT1075>3.0.CO;2-E
   YOUNG RA, 1982, J APPL CRYSTALLOGR, V15, P430, DOI 10.1107/S002188988201231X
NR 29
TC 18
Z9 19
U1 1
U2 12
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0149-6395
EI 1520-5754
J9 SEP SCI TECHNOL
JI Sep. Sci. Technol.
PY 2005
VL 40
IS 15
BP 3187
EP 3224
DI 10.1080/01496390500385400
PG 38
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA 997JV
UT WOS:000234242400010
DA 2018-10-19
ER

PT S
AU Godignon, P
AF Godignon, P
BE Nipoti, R
   Poggi, A
   Scorzoni, A
TI SiC materials and technologies for sensors development
SO SILICON CARBIDE AND RELATED MATERIALS 2004
SE Materials Science Forum
LA English
DT Article; Proceedings Paper
CT 5th European Conference on Silicon Carbide and Related Materials
CY AUG 31-SEP 04, 2004
CL Bologna, ITALY
SP Comune Bologna, Giunta Reg Emilia Romagna, Prov Biologna, Univ Bologna, President Italian Consiglio Nazl Ric
DE SiC sensors; Hall sensors; SiC micromachining; biomedical sensors
ID SILICON-CARBIDE
AB Silicon Carbide has proven its strong interest for power and high frequency devices but it also has superior characteristics for application in the sensors and MEMS fields. The characteristic requirements of the starting material are different from that of power devices since the level of defects is not so critical while the layer stress is important especially in 3C-SiC on Si. The key process for MEMS fabrication is the etching, which is progressing thanks to ICP process improvements. A perfect control of the etching step could allow the obtention of nano-resonators in SiC with fairly superior characteristics to the Si ones. Other electrical sensors for high temperature application such as gas sensors or Hall sensors have been also successfully developed taking profit of the deep etching process improvement and high temperature contact developments.
C1 Ctr Nacl Microelect, Bellaterra 08193, Barcelona, Spain.
RP Godignon, P (reprint author), Ctr Nacl Microelect, Campus UAB, Bellaterra 08193, Barcelona, Spain.
EM philippe.godignon@cnm.es
CR Catellani A, 2000, PHYS REV B, V62, pR4794, DOI 10.1103/PhysRevB.62.R4794
   Galli G, 1999, PHYS REV LETT, V83, P2006, DOI 10.1103/PhysRevLett.83.2006
   GODIGNON P, 2004, P MRS SPRING M SAN F
   Gonzalez P, 2003, BIOMATERIALS, V24, P4827, DOI 10.1016/S0142-9612(03)00405-8
   KROTZ G, 1995, P INT C SIC REL MAT, P829
   Okojie RS, 1997, P TRANSD 97 IEEE, P1407
   ROBERT JL, Patent No. 0011087
   Santavirta S, 1998, ARCH ORTHOP TRAUM SU, V118, P89, DOI 10.1007/s004020050319
   SHOR JS, 1994, IEEE T ELECTRON DEV, V41, P661, DOI 10.1109/16.285013
NR 9
TC 30
Z9 30
U1 1
U2 13
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 0255-5476
BN 0-87849-963-6
J9 MATER SCI FORUM
PY 2005
VL 483
BP 1009
EP 1014
DI 10.4028/www.scientific.net/MSF.483-485.1009
PG 6
WC Materials Science, Multidisciplinary; Materials Science,
   Characterization & Testing
SC Materials Science
GA BCB85
UT WOS:000228549600241
DA 2018-10-19
ER

PT S
AU Fargas, M
   von Busse, A
   Bunte, J
AF Fargas, M
   von Busse, A
   Bunte, J
BE Cane, C
   Chiao, JC
   Verdu, FV
TI Laser material micro-processing of shape memory alloys
SO SMART SENSORS, ACTUATORS, AND MEMS II
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference Sensors, Actuators, and MEMS II
CY MAY 09-11, 2005
CL Seville, SPAIN
SP Amer Soc Regional Anesthesia
AB Due to their precise focusing properties and the possibility of an excellent non-tactile energy coupling, lasers represent a suitable machining process for miniaturised components of shape memory alloys (SMAs) in micro-system and biomedical technology. SMAs find increasing application in these fields because of their special properties such as super-elasticity and shape memory effect.
   Current research is concentrated on the development of suitable and economic process strategies for machining microcomponents and -actuators using ultra-short-pulse lasers. The application of this laser type enables the realisation of miniaturised components made of SMAs without damaging the grain structure and therefore maintaining the shape memory effect. The processed miniaturised components are characterised with respect to the achieved geometrical resolution, the surface quality of the processed areas and their mechanical functionality.
   For real production, a reduction of the processing time is necessary. Therefore, different process strategies consisting in different numbers of process cycles (simultaneous material removal and smoothing, material removal and subsequent smoothing) are investigated machining NiTi-components. In this paper, results of the laser based method regarding processing time and surface quality will be presented. In addition, the application of these strategies for the realisation of exemplary actuator or component geometries (e.g. for minimal invasive surgery) will be demonstrated.
C1 Laser Zentrum Hannover eV, D-30419 Hannover, Germany.
RP Fargas, M (reprint author), Laser Zentrum Hannover eV, Hollerithallee 8, D-30419 Hannover, Germany.
EM fa@lzh.de
CR Duerig T., 2002, P SOC PHOTO-OPT INS, V4763, P7
   Haferkamp H, 1999, P SOC PHOTO-OPT INS, V3675, P267, DOI 10.1117/12.352800
   HAKERKAMP H, 2004, P LASE SAN JOS
   Otsuka K, 2002, MRS BULL, V27, P91, DOI 10.1557/mrs2002.43
   Pelton AR, 2000, MATER SCI FORUM, V327-3, P63, DOI 10.4028/www.scientific.net/MSF.327-328.63
   Stockel D., 1995, P SHAP MEM ALL POW S, P1
   Van Humbeeck J, 2001, ADV ENG MATER, V3, P837, DOI 10.1002/1527-2648(200111)3:11<837::AID-ADEM837>3.0.CO;2-0
NR 7
TC 1
Z9 1
U1 0
U2 4
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5831-7
J9 PROC SPIE
PY 2005
VL 5836
BP 162
EP 170
DI 10.1117/12.608695
PG 9
WC Instruments & Instrumentation; Optics
SC Instruments & Instrumentation; Optics
GA BCX90
UT WOS:000231822100016
DA 2018-10-19
ER

PT S
AU Ocana, JL
   Molpeceres, C
   Lauzurica, S
   Morales, M
AF Ocana, JL
   Molpeceres, C
   Lauzurica, S
   Morales, M
BE Cane, C
   Chiao, JC
   Verdu, FV
TI Advanced 3D micromachining techniques using V-UV laser sources in the
   nanosecond regime
SO Smart Sensors, Actuators, and MEMS II
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference Sensors, Actuators, and MEMS II
CY MAY 09-11, 2005
CL Seville, SPAIN
SP Amer Soc Regional Anesthesia
DE laser micromachining; laser ablation; laser processing of advanced
   materials
AB Laser micromachining techniques are among the most promising fabrication processes in strategic industrial fields. Although lasers systems have been widely applied last twenty years in semiconductor industry for microfabrication process development, the current availability of new excimer and Diode Pumped Solid State Lasers (DPSS) sources are extending the applications fields of laser microprocessing. Nowadays MEMs, fluidic devices, advanced sensors and biomedical devices and instruments are among the more promising developments of this technology. Nevertheless the fast progress of this technology has brought as a consequence the building up of specific laser based machines for each process of interest (most of them until now strictly 2D), and an important gap has been generated, from the fabrication point of view, in fully 3D potential applications.
   In this work, the conception, design and first results of a fully automatized 3D laser micromachining workstation, based on the main concept of flexibility, is presented. This system integrates two UV laser sources, excimer and DPSS in ns pulse regime, and an advanced positioning system (with six degrees of freedom) for complex parts machining.
   Several examples of first results obtained with this system, including processing of semiconductors for sensoring and photovoltaic applications, organic materials for biomedical devices and metallic materials for different strategic industrial sectors are presented.
C1 Univ Politecn Madrid, Ctr Laser, Madrid 28031, Spain.
RP Ocana, JL (reprint author), Univ Politecn Madrid, Ctr Laser, Crta Valencia Km 7-3, Madrid 28031, Spain.
RI Morales Furio, Miguel/D-5318-2011; LAUZURICA SANTIAGO, SARA/R-8219-2018;
   Molpeceres, Carlos/F-1268-2016; OCANA, JOSE LUIS/I-7475-2012
OI Morales Furio, Miguel/0000-0001-7425-9742; LAUZURICA SANTIAGO,
   SARA/0000-0003-4398-6474; Molpeceres, Carlos/0000-0002-6236-8359; OCANA,
   JOSE LUIS/0000-0001-9263-8404
CR Gower M.C., 2000, OPT EXPRESS, V7, P57
   HOLMES AS, 2001, 2 INT S LAS PREC MIC
   KEIPER B, 1999, P ICLAEO 1999, P1
   METEV SM, 1998, SERIES MAT SCI, V19
   MILLER JC, 1994, PRINCIPLES APPL
   Molpeceres C, 2005, J MICROMECH MICROENG, V15, P1271, DOI 10.1088/0960-1317/15/6/019
   MOMMA C, 1996, APPL PHYS A, V63, P109
   NIE M, 2000, MICROSYST TECHNOL, V6, P184
   Pfleging W, 2000, APPL SURF SCI, V154, P633, DOI 10.1016/S0169-4332(99)00468-7
   STASSENBOHLEN I, 2003, SPIE, V4977, P198
   WOLFF B, 1992, APPL PHYS A, V54, P363
NR 11
TC 0
Z9 0
U1 0
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5831-7
J9 P SOC PHOTO-OPT INS
PY 2005
VL 5836
BP 307
EP 317
DI 10.1117/12.608818
PG 11
WC Instruments & Instrumentation; Optics
SC Instruments & Instrumentation; Optics
GA BCX90
UT WOS:000231822100031
DA 2018-10-19
ER

PT S
AU Ochoteco, E
   Pomposo, JA
   Grande, H
   Rodriguez, J
AF Ochoteco, E
   Pomposo, JA
   Grande, H
   Rodriguez, J
BE Cane, C
   Chiao, JC
   Verdu, FV
TI A self-supported polypyrrole artificial muscle: design optimization
SO SMART SENSORS, ACTUATORS, AND MEMS II
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference Sensors, Actuators, and MEMS II
CY MAY 09-11, 2005
CL Seville, SPAIN
SP Amer Soc Regional Anesthesia
DE conducting polymer; actuator; artificial muscle; simplified device; low
   power consumption device
ID CONDUCTING POLYMERS; ACTUATORS
AB Conducting polymers, due to their property of oxidize and reduce in a reversible way, have largely been studied as adequate materials for constructing actuators. The volume change produced in these processes is used for the stuck of a conducting polymer film on a not-volume-changing layer for the development of artificial muscles. One of the main drawbacks that these multilayer artificial muscles show lies on the fact that they delaminate after several working cycles. In one of our previous works, a simplified, single film, self-supported artificial muscle was developed assembling different polypyrrole structures in the same synthesis process. This produces not only "all-polymeric" but rather "all-conducting-polymer" artificial muscles that are able to move in electrolytic media without showing delamination problems after long cycling times. This new generation of simplified artificial muscles seems to be suitable for biomedical related applications. In the present work, actuator's basement is explained and design configurations analyzed.
C1 CIDETEC Ctr Electrochem Technol, E-20009 Donostia San Sebastian, Spain.
RP Ochoteco, E (reprint author), CIDETEC Ctr Electrochem Technol, Parque Tecnol Miramon,Pa Miramon 196, E-20009 Donostia San Sebastian, Spain.
EM eochoteco@cidetec.es
OI pomposo, jose a./0000-0003-4620-807X; Pomposo, Jose
   A./0000-0001-9458-4200
CR BAUGHMAN RH, 1990, SCI APPL CONDUCTING
   DellaSanta A, 1997, SYNTHETIC MET, V90, P93, DOI 10.1016/S0379-6779(97)81256-8
   HILLMAN AR, 1988, J ELECTROANAL CHEM, V244, P353, DOI 10.1016/0022-0728(88)80120-7
   Lu W, 2004, CHEM MATER, V16, P1615, DOI 10.1021/cm0301591
   Madden JD, 2000, SYNTHETIC MET, V113, P185, DOI 10.1016/S0379-6779(00)00195-8
   MARQUE P, 1990, J PHYS CHEM-US, V94, P8614, DOI 10.1021/j100386a024
   OCHOTECO E, IN PRESS CHEM COMMUN
   OTERO TF, 1992, J ELECTROANAL CHEM, V341, P369, DOI 10.1016/0022-0728(92)80495-P
   OTERO TF, 1993, NATO ADV SCI INST SE, V246, P179
   OTERO TF, 1995, BIOELECTROCH BIOENER, V38, P411, DOI 10.1016/0302-4598(95)01802-L
   Otero TF, 1998, ADV MATER, V10, P491, DOI 10.1002/(SICI)1521-4095(199804)10:6<491::AID-ADMA491>3.0.CO;2-Q
   OTERO TF, 1997, HDB ORGANIC CONDUCTI, V4, P517
   OTERO TF, 1992, Patent No. 9200095
   PEI QB, 1993, SYNTHETIC MET, V57, P3718, DOI 10.1016/0379-6779(93)90503-O
   Qibing Pei, 1993, Smart Materials and Structures, V2, P1, DOI 10.1088/0964-1726/2/1/001
   Sansinena JM, 1997, CHEM COMMUN, P2217, DOI 10.1039/a705341j
   SMELA E, 1995, SCIENCE, V268, P1735, DOI 10.1126/science.268.5218.1735
   SMELA E, 2000, ELECTROCHIM ACTA, V45, P2121
   TAKASHIMA W, 1995, SYNTHETIC MET, V71, P2265, DOI 10.1016/0379-6779(94)03252-2
NR 19
TC 0
Z9 0
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5831-7
J9 PROC SPIE
PY 2005
VL 5836
BP 649
EP 656
DI 10.1117/12.607922
PG 8
WC Instruments & Instrumentation; Optics
SC Instruments & Instrumentation; Optics
GA BCX90
UT WOS:000231822100068
DA 2018-10-19
ER

PT S
AU Fernandez, D
   Moreno, L
   Baselga, J
AF Fernandez, D
   Moreno, L
   Baselga, J
BE Cohen, YB
TI Towards standardization of EAP actuators test procedures
SO Smart Structures and Materials 2005: Electroactive Polymer Actuators and
   Devices( EAPAD)
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Smart Structures and Materials 2005 Conference
CY MAR 07-10, 2005
CL San Diego, CA
SP SPIE, Amer Soc Mech Engineers, Boeing Co, Journal Intelligent Mat Syst & Struct, Sage Publicat, Rhombus Consultants Grp, CSA Engn Inc, ISIS Canada, KAIST, Smart Infra Struct Technol Ctr
DE EAP characterization; smart materials characterization; artificial
   muscles; digital force generator
AB Since the field of Electroactive Polymers (EAP) actuators is fairly new there are no standard testing processes for such intelligent materials. This drawback can seriously limit the scope of application of EAP actuators, since the targeted industrial sectors (aerospace, biomedical...) demand high reliability and product assurance. As a first iteration two elements are required to define a test standard for an EAP actuator: a Unit Tester, and a Component Specification. In this paper a EAP Unit Tester architecture is presented along with the required classification of measurements to be included in the EAP actuator Component Specification. The proposed EAP Unit Tester allows on-line monitoring and recording of the following properties of the specimen under test: large deformation, small tip displacement, temperature at the electrodes, weight of the specimen, voltage and current driven into the EAP, load being applied to the actuator, output voltage of the EAP in sensing operation and mode of operation (structure / sensor / actuator / smart). The measurements are taken simultaneously, in real-time. The EAP Unit Tester includes a friendly Graphical User Interface. It uses embedded Excel tools to visualize data. In addition, real-time connectivity with MATLAB allows an easy testing of control algorithms.
   A novel methodology to measure the properties of EAP specimens versus a variable load is also presented. To this purpose a force signals generator in the range of mN was developed. The device is based on a DC mini-motor. It generates an opposing force to the movement of the EAP actuator. Since the device constantly opposes the EAP actuator movement it has been named Digital Force Generator (DFG). The DFG design allows simultaneous length and velocity measuring versus different load signals. By including such a device in the EAP Unit Tester the most suitable application for the specimen under test can be easily identified (vibration damper, large deformation actuator, large force actuator, fast actuator...).
C1 EADS Astrium CRISA, Madrid 28760, Spain.
RP Fernandez, D (reprint author), EADS Astrium CRISA, C Torres Quevedo 9,PTM, Madrid 28760, Spain.
OI Moreno, Luis/0000-0002-4450-680X
CR BARCOHEN, 2001, ELECTROACTIVE POLYM
   BARCOHEN J, 2002, P SPIE SMART STRUCT
   BHAT ND, 2003, THESIS TEXAS A M U
   FINNI T, 2001, MUSCLE MECH HUMAN MO
   MEIJER K, 1999, UTILIZATION ELECTROA
   Newbury K.M., 2002, THESIS VIRGINIA POLY
   SHANIPOOR M, 2004, IONIC POLYM CONDUCTO
   WALLACE GG, 2003, CONDUCTING ELECTROAC
NR 8
TC 0
Z9 0
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5740-X
J9 P SOC PHOTO-OPT INS
PY 2005
VL 5759
BP 274
EP 282
DI 10.1117/12.599106
PG 9
WC Instruments & Instrumentation; Materials Science, Composites; Polymer
   Science
SC Instruments & Instrumentation; Materials Science; Polymer Science
GA BCN04
UT WOS:000230111000031
DA 2018-10-19
ER

PT S
AU Lalli, JH
   Claus, RO
   Hill, AB
   Mecham, JB
   Davis, BA
   Subrahmanyan, S
   Goff, RM
AF Lalli, JH
   Claus, RO
   Hill, AB
   Mecham, JB
   Davis, BA
   Subrahmanyan, S
   Goff, RM
BE White, EV
TI Commercial applications of Metal Rubber (TM)
SO SMART STRUCTURES AND MATERIALS 2005: INDUSTRIAL AND COMMERCIAL
   APPLICATIONS OF SMART STRUCTURES TECHNOLOGIES
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Smart Structures and Materials 2005 Conference
CY MAR 07-10, 2005
CL San Diego, CA
SP SPIE, Amer Soc Mech Engineers, Boeing Co, Journal Intelligent Mat Syst & Struct, Sage Publicat, Rhombus Consultants Grp, CSA Engn Inc, ISIS Canada, KAIST, Smart Infra Struct Technol Ctr
DE electrostatic self-assembly; nanocomposite; Metal Rubber (TM); sensors;
   electrodes; interconnects; flexible; lightweight; electrically
   conductive; elastomer
AB This paper describes the commercial applications of Metal Rubber (TM), the first material of its kind, a self-assembled free-standing electrically conductive elastomer in biomedical, aerospace and microelectronic areas. Metal Rubber (TM) is a novel nanocomposite formed via the self-assembly processing of metal nanoparticles and elastomeric polyectrolytes. This type of processing allows for control over bulk mechanical and electrical properties and requires only ppm quantities of metal to achieve percolation. The use of nanostructured precursors also results in transparent, electrically conductive nanocomposites. Metal Rubber (TM) elastomers are being developed as electrodes, for biomedical applications; flexible interconnects for microelectronics, and sensors to detect fatigue, impact and large strain for aerospace applications. This novel material may be formed as a conformal coating on nearly any substrate or as free standing films.
C1 NanoSon Inc, Blacksburg, VA 24060 USA.
RP Lalli, JH (reprint author), NanoSon Inc, 1485 S Main St, Blacksburg, VA 24060 USA.
EM jlalli@nanosonic.com; roclaus@vt.edu
CR Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   LALLI JH, 2003, P SPIE, V4991
   Liu YJ, 1999, SMART MATER STRUCT, V8, P100, DOI 10.1088/0964-1726/8/1/011
NR 3
TC 3
Z9 3
U1 0
U2 6
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5743-4
J9 PROC SPIE
PY 2005
VL 5762
BP 1
EP 7
DI 10.1117/12.606788
PG 7
WC Instruments & Instrumentation; Materials Science, Multidisciplinary
SC Instruments & Instrumentation; Materials Science
GA BCN14
UT WOS:000230112600001
DA 2018-10-19
ER

PT S
AU Arzberger, SC
   Tupper, ML
   Lake, MS
   Barrett, R
   Mallick, K
   Hazelton, C
   Francis, W
   Keller, PN
   Campbell, D
   Feucht, S
   Codell, D
   Wintergerst, J
   Adams, L
   Mallioux, J
   Denis, R
   White, K
   Long, M
   Munshi, NA
   Gall, K
AF Arzberger, SC
   Tupper, ML
   Lake, MS
   Barrett, R
   Mallick, K
   Hazelton, C
   Francis, W
   Keller, PN
   Campbell, D
   Feucht, S
   Codell, D
   Wintergerst, J
   Adams, L
   Mallioux, J
   Denis, R
   White, K
   Long, M
   Munshi, NA
   Gall, K
BE White, EV
TI Elastic Memory Composites (EMC) for deployable industrial and commercial
   applications
SO Smart Structures and Materials 2005: Industrial and Commercial
   Applications of Smart Structures Technologies
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Smart Structures and Materials 2005 Conference
CY MAR 07-10, 2005
CL San Diego, CA
SP SPIE, Amer Soc Mech Engineers, Boeing Co, Journal Intelligent Mat Syst & Struct, Sage Publicat, Rhombus Consultants Grp, CSA Engn Inc, ISIS Canada, KAIST, Smart Infra Struct Technol Ctr
DE Elastic Memory Composite (EMC); shape memory polymer; composite;
   thermoset; epoxy; cyanate ester; deployable; smart materials;
   multifunctional components; commercial uses
ID THERMOMECHANICAL PROPERTIES; BIOMEDICAL APPLICATIONS;
   PERCOLATION-THRESHOLD; CARBON NANOTUBES; STRAIN RECOVERY; POLYMER FOAM;
   NANOCOMPOSITES; BEHAVIOR; STRESS; THIN
AB The use of smart materials and multifunctional components has the potential to provide enhanced performance, improved economics, and reduced safety concerns for applications ranging from outer space to subterranean. Elastic Memory Composite (EMC) materials, based on shape memory polymers and used to produce multifunctional components and structures, are being developed and qualified for commercial use as deployable components and structures. EMC materials are sin-filar to traditional fiber-reinforced composites except for the use of a thermoset shape memory resin that enables much higher packaging strains than traditional composites without damage to the fibers or the resin. This unique capability is being exploited in the development of very efficient EMC structural components for deployable spacecraft systems as well as capability enhancing components for use in other industries. The present paper is intended primarily to describe the transition of EMC materials as smart structure technologies into viable industrial and commercial products. Specifically, the paper discusses: 1) TEMBO (R) EMC materials for deployable space/aerospace systems, 2) TEMBO (R) EMC resins for terrestrial applications, 3) future generation EMC materials.
C1 CTD Inc, Lafayette, CO 80026 USA.
RP Arzberger, SC (reprint author), CTD Inc, 2600 Campus Dr,Suite D, Lafayette, CO 80026 USA.
CR Abrahamson ER, 2003, J INTEL MAT SYST STR, V14, P623, DOI 10.1177/104538903036213
   Arzberger SC, 2003, P SOC PHOTO-OPT INS, V5179, P143, DOI 10.1117/12.507157
   *ASTM E, 59584 ASTM E
   BARRAU S, 2002, MACROMOLECULES, V36, P5187
   BEAVERS FL, 2002, 43 AIAA ASME ASCH AH
   CAMBELL D, 2004, ASCE EARTH SPAC 2004
   Chen PC, 1995, ASTR SOC P, V79, P252
   Conley Peter L., 1998, SPACE VEHICLE MECH E
   El Feninat F, 2002, ADV ENG MATER, V4, P91, DOI 10.1002/1527-2648(200203)4:3<91::AID-ADEM91>3.0.CO;2-B
   Francis W, 2004, 45 AIAA ASME ASCE AH
   Francis W, 2003, 44 AIAA ASME ASCE AH
   GALL K, 2003, 44 AIAA ASME ASCE AH
   Hamerton I., 1994, CHEM TECHNOLOGY CYAN, P195
   Hazelton C.S, 2003, 44 AIAA ASME ASCE AH
   Irie M., 1998, SHAPE MEMORY POLYM
   Jeong HM, 2001, EUR POLYM J, V37, P2245, DOI 10.1016/S0014-3057(01)00123-9
   Keller P, 2004, 45 AIAA ASME ASCE AH
   Koerner H, 2004, NAT MATER, V3, P115, DOI 10.1038/nmat1059
   LAKE MS, 2004, 2004 IEEE AER C BIG
   LAKE MS, 2000, TM2000210089 NASA
   LAKE MS, 1998, SPAC TECHN APPL INT
   LANGER RS, 2000, Patent No. 6160084
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lendlein A, 2002, ANGEW CHEM INT EDIT, V41, P2034, DOI 10.1002/1521-3773(20020617)41:12<2034::AID-ANIE2034>3.0.CO;2-M
   Li FK, 2000, J APPL POLYM SCI, V75, P68, DOI 10.1002/(SICI)1097-4628(20000103)75:1<68::AID-APP8>3.0.CO;2-I
   Liang C, 1997, J INTEL MAT SYST STR, V8, P380, DOI 10.1177/1045389X9700800411
   Liu CD, 2002, MACROMOLECULES, V35, P9868, DOI 10.1021/ma021141j
   Metcalfe A, 2003, BIOMATERIALS, V24, P491, DOI 10.1016/S0142-9612(02)00362-9
   Monkman GJ, 2000, MECHATRONICS, V10, P489, DOI 10.1016/S0957-4158(99)00068-9
   Murphey T. W., 2004, 45 AIAA ASME ASCE AH
   *NASA, 6001 NASA
   Nogales A, 2004, MACROMOLECULES, V37, P7669, DOI 10.1021/ma049440r
   Sandler J, 1999, POLYMER, V40, P5967, DOI 10.1016/S0032-3861(99)00166-4
   Sandler JKW, 2003, POLYMER, V44, P5893, DOI 10.1016/S0032-3861(03)00539-1
   SHRIER LL, 1995, CORROSION METAL ENV
   Tey SJ, 2001, SMART MATER STRUCT, V10, P321, DOI 10.1088/0964-1726/10/2/318
   Tobushi H, 1996, SMART MATER STRUCT, V5, P483, DOI 10.1088/0964-1726/5/4/012
   Tobushi H, 2001, J INTEL MAT SYST STR, V12, P283, DOI 10.1106/FNSX-AP9V-QP1R-NMWV
   WANG Z, 2000, POLYM CLAY NANOCOMPO
   WHITE CV, 2000, SPIE PHOT E OPT MECH
NR 40
TC 15
Z9 17
U1 4
U2 25
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5743-4
J9 P SOC PHOTO-OPT INS
PY 2005
VL 5762
BP 35
EP 47
DI 10.1117/12.600583
PG 13
WC Instruments & Instrumentation; Materials Science, Multidisciplinary
SC Instruments & Instrumentation; Materials Science
GA BCN14
UT WOS:000230112600005
DA 2018-10-19
ER

PT S
AU McKnight, G
   Momoda, L
   Croft, D
   Lee, DG
   Shin, D
   Carman, G
AF McKnight, G
   Momoda, L
   Croft, D
   Lee, DG
   Shin, D
   Carman, G
BE White, EV
TI Miniature thin film NiTi hydraulic actuator with MEMS microvalves
SO Smart Structures and Materials 2005: Industrial and Commercial
   Applications of Smart Structures Technologies
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Smart Structures and Materials 2005 Conference
CY MAR 07-10, 2005
CL San Diego, CA
SP SPIE, Amer Soc Mech Engineers, Boeing Co, Journal Intelligent Mat Syst & Struct, Sage Publicat, Rhombus Consultants Grp, CSA Engn Inc, ISIS Canada, KAIST, Smart Infra Struct Technol Ctr
DE shape memory alloy; thin film; microvalve; actuation
AB The implementation of smaller, lighter, and more agile military systems requires new actuation technologies that offer high power density in compact form factors. The Compact Hybrid Actuator Program (CHAP) is pursuing active material based, rectifying actuators to create new actuation solutions for these demanding applications. Our actuator approach is based on thin film NiTi membranes operating in parallel (high intrinsic power density, > 125 kW/kg) combined with liquid rectification, MEMS passive check valves, and commercially available power electronics. Previous results demonstrated 8 micron thick membrane actuation with 150 Hz forced convection response and force output of 100N. This paper focuses on two developments critical in scaling up previous single membrane results to power levels sufficient for military applications. This first is the development of SOI MEMS fabricated microvalve arrays which exhibit high flow rate at high frequencies. The second focus area is the design, fabrication, and assembly of a form factor compact actuator. The initial prototype demonstration of this concept shows great promise for thin film NiTi based actuation both in military technologies and in other areas which demand extremely compact actuation such as embedded fluid delivery for biomedical applications.
C1 Hughes Res Labs, Malibu, CA 90265 USA.
RP McKnight, G (reprint author), Hughes Res Labs, 3011 Malibu Canyon Rd, Malibu, CA 90265 USA.
CR ALSHEHRI Y, 2004, 22 ANN MICR ENG C, P52
   Ho KK, 2000, THIN SOLID FILMS, V370, P18, DOI 10.1016/S0040-6090(00)00947-0
   LAVINE AS, 2000, THERMAL SCI ENG, V8, P13
   Li B, 2005, SENSOR ACTUAT A-PHYS, V117, P325, DOI 10.1016/j.sna.2004.06.029
   Momoda LA, 2003, P SOC PHOTO-OPT INS, V5054, P85, DOI 10.1117/12.483889
NR 5
TC 2
Z9 2
U1 0
U2 4
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5743-4
J9 P SOC PHOTO-OPT INS
PY 2005
VL 5762
BP 187
EP 195
DI 10.1117/12.607307
PG 9
WC Instruments & Instrumentation; Materials Science, Multidisciplinary
SC Instruments & Instrumentation; Materials Science
GA BCN14
UT WOS:000230112600021
DA 2018-10-19
ER

PT S
AU Choi, SH
   Kim, JW
   Chu, SH
   Park, Y
   King, GC
   Lillehei, PT
   Kim, SJ
   Elliott, JR
AF Choi, SH
   Kim, JW
   Chu, SH
   Park, Y
   King, GC
   Lillehei, PT
   Kim, SJ
   Elliott, JR
BE Varadan, VK
TI Ferritin-templated quantum-dots for quantum logic gates
SO SMART STRUCTURES AND MATERIALS 2005: SMART ELECTRONICS, MEMS, BIOMEMS,
   AND NANOTECHNOLOGY
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Smart Structures and Materials 2005 Conference
CY MAR 07-10, 2005
CL San Diego, CA
SP SPIE, Amer Soc Mech Engineers, Boeing Co, Journal Intelligent Mat Syst & Struct, Sage Publicat, Rhombus Consultants Grp, CSA Engn Inc, ISIS Canada, KAIST, Smart Infra Struct Technol Ctr
ID 2-IMINOTHIOLANE METHYL 4-MERCAPTOBUTYRIMIDATE; BIOMIMETIC SYNTHESIS;
   MAGNETIC PROTEINS; HORSE SPLEEN; MAGNETOFERRITIN; COMPUTATION;
   COMPUTERS; HARDWARE; OXIDE; CAGE
AB Quantum logic gates (QLGs) or other logic systems are based on quantum-dots (QD) with a stringent requirement of size uniformity. The QD are widely known building units for QLGs. The size control of QD is a critical issue in quantum-dot fabrication. The work presented here offers a new method to develop quantum-dots using a bio-template, called ferritin, that ensures QD production in uniform size of nano-scale proportion. This technology is essential for NASA, Dol), and industrial nanotechnology applications such as: ultra-high density data storage, quantum electronic devices, biomedical nanorobots, molecular tagging, terahertz radiation sources, nanoelectromechanical systems (NEMS), etc. The bio-template for uniform yield of QD is based on a ferritin protein that allows reconstitution of core material through the reduction and chelation processes. By either the magnetic or electrical property of reconstituted core materials, the QD can be used for logic gates which are fundamental building blocks for quantum computing. However, QLGs are in an incubation stage and still have many potential obstacles that need to be addressed, such as an error collection, a decoherence, and a hardware architecture. One of the biggest challenges for developing QLG is the requirement of ordered and uniform size of QD for arrays on a substrate with nanometer precision. The other methods known so far, such as self-assembled QD grown in the Stranski-Krastanov mode, are usually randomly organized. The QD development by bio-template includes the electrochentical/chemical reconsitution of ferridris with different core materials, such as iron, cobalt, manganese, platinum, and nickel. The other bio-template method used in our laboratory is dendrimers, precisely defined chemical structures. With ferritin-templated QD, we fabricated the heptagon-shaped patterned array via direct nano manipulation of the ferritin molecules with a tip of atomic force microscope (AFM). We also designed various nanofabrication methods of QD arrays using a wide range manipulation techniques. The precise control of the ferritin-templated QD for a patterned arrangement are offered by various methods, such as a site-specific immobilization of thiolated ferritins through local oxidation using the AFM tip, ferritin arrays induced by gold nanoparticle manipulation, thiolated ferritin positioning by shaving method, etc. In the signal measurements, the current-voltage curve is obtained by measuring the current through the ferritin, between the tip and the substrate for potential sweeping or at constant potential. The measured resistance near zero bias was 1.8 teraohm for single holoferritin and 5.7 teraohm for single apoferritin, respectively.
C1 NASA, Langley Res Ctr, Hampton, VA 23681 USA.
RP Choi, SH (reprint author), NASA, Langley Res Ctr, Hampton, VA 23681 USA.
RI Lillehei, Peter/C-9196-2009; Kim, Jae-Woo/A-8314-2008
OI Lillehei, Peter/0000-0001-8183-9980; 
CR AWSCHALOM DD, 1992, PHYS REV LETT, V68, P3092, DOI 10.1103/PhysRevLett.68.3092
   BARENCO A, 1995, PHYS REV A, V52, P3457, DOI 10.1103/PhysRevA.52.3457
   Borgstrom M, 2001, APPL PHYS LETT, V78, P1367, DOI 10.1063/1.1351528
   Darder M, 1999, ANAL CHEM, V71, P5530, DOI 10.1021/ac990759x
   del Barco E, 1999, PHYS REV B, V60, P11898, DOI 10.1103/PhysRevB.60.11898
   Douglas T, 2000, INORG CHEM, V39, P1828, DOI 10.1021/ic991269q
   GIDER S, 1995, SCIENCE, V268, P77, DOI 10.1126/science.7701343
   HARRISON PM, 1996, BIOCHIM BIOPHYS ACTA, V161, P1275
   Hu M, 2002, J VAC SCI TECHNOL A, V20, P589, DOI 10.1116/1.1458941
   JELINSKI L, 1999, BIOL RELATED ASPECTS
   JUE R, 1978, BIOCHEMISTRY-US, V17, P5399, DOI 10.1021/bi00618a013
   Kohmoto S, 1999, APPL PHYS LETT, V75, P3488, DOI 10.1063/1.125364
   LAMBERT JM, 1978, BIOCHEMISTRY-US, V17, P5406, DOI 10.1021/bi00618a014
   Lee H, 2000, J VAC SCI TECHNOL B, V18, P2193, DOI 10.1116/1.1306281
   Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120
   MACKLE P, 1993, J AM CHEM SOC, V115, P8471, DOI 10.1021/ja00071a076
   MELDRUM FC, 1991, NATURE, V349, P684, DOI 10.1038/349684a0
   MELDRUM FC, 1992, SCIENCE, V257, P522, DOI 10.1126/science.1636086
   MELDRUM FC, 1995, J INORG BIOCHEM, V58, P59, DOI 10.1016/0162-0134(94)00037-B
   Nielsen MA, 2000, QUANTUM COMPUTATION
   Ohshima T, 2003, 2ND INTERNATIONAL CONFERENCE ON SEMICONDUCTOR QUANTUM DOTS, P1364, DOI 10.1002/pssc.200303096
   Okuda M, 2003, BIOTECHNOL BIOENG, V84, P187, DOI 10.1002/bit.10748
   Pavlovic E, 2002, J COLLOID INTERF SCI, V254, P200, DOI 10.1006/jcis.2002.8565
   Song HZ, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.085303
   Tejada J, 1997, PHYS REV LETT, V79, P1754, DOI 10.1103/PhysRevLett.79.1754
   Tejada J, 2001, POLYHEDRON, V20, P1751, DOI 10.1016/S0277-5387(01)00684-2
   Tejada J, 2001, NANOTECHNOLOGY, V12, P181, DOI 10.1088/0957-4484/12/2/323
   Torres F, 2000, APPL PHYS LETT, V77, P3248, DOI 10.1063/1.1325393
   TREFFRY A, 1978, BIOCHEM J, V171, P313, DOI 10.1042/bj1710313
   Wong KKW, 1998, CHEM MATER, V10, P279, DOI 10.1021/cm970421o
   Wong KKW, 1996, ADV MATER, V8, P928, DOI 10.1002/adma.19960081114
   YAMADA H, 1993, FISH PHYSIOL BIOCHEM, V12, P1, DOI 10.1007/BF00004317
   Zborowski M, 1996, CYTOMETRY, V24, P251, DOI 10.1002/(SICI)1097-0320(19960701)24:3<251::AID-CYTO8>3.0.CO;2-K
   ZHANG B, 2004, INORG CHEM
   Zhao GH, 2001, BIOCHEMISTRY-US, V40, P10832, DOI 10.1021/bi011052j
NR 35
TC 1
Z9 1
U1 1
U2 12
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5744-2
J9 PROC SPIE
PY 2005
VL 5763
BP 213
EP 232
DI 10.1117/12.625319
PG 20
WC Engineering, Electrical & Electronic; Instruments & Instrumentation;
   Materials Science, Multidisciplinary
SC Engineering; Instruments & Instrumentation; Materials Science
GA BCN83
UT WOS:000230338300025
DA 2018-10-19
ER

PT S
AU Berman, M
   Phatak, A
   Lagerstrom, R
AF Berman, M
   Phatak, A
   Lagerstrom, R
BE Bearman, GH
   MahadevanJansen, A
   Leveson, RM
TI ICE: A statistical approach to identifying constituents of biomedical
   hyperspectral images
SO Spectral Imaging: Instrumentation, Applications, and Analysis III
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT Conference on Spectral Imaging - Instrumentation. Applications and
   Analysis III
CY JAN   23, 2005
CL San Jose, CA
SP SPIE, Cambridge Res & Instrumentat Inc, Carl Zeiss Jena
DE convex geometry; endmember; hyperspectral; mixture; simplex
AB A problem of considerable interest in the hyperspectral and chemical imaging communities in recent years has been the automated identification and mapping of the constituent materials ("endmembers") present in a hyperspectral image. Several of the more important endmember-finding algorithms are discussed and some of their shortcomings highlighted. A relatively new algorithm, ICE, which attempts to address these shortcomings, is introduced. Although ICE was originally developed for exploration applications of airborne hyperspectral data, its performance on two biomedical data sets is investigated. Possible future research directions are outlined.
C1 CSIRO, N Ryde, NSW 2113, Australia.
RP Berman, M (reprint author), CSIRO, Macquarie Univ Campus, N Ryde, NSW 2113, Australia.
RI Whitford, Linda/C-2470-2009; Lagerstrom, Ryan/A-3642-2009; Berman,
   Mark/D-3411-2009
CR Berman M, 2004, IEEE T GEOSCI REMOTE, V42, P2085, DOI 10.1109/TGRS.2004.835299
   Berman M., 1999, P 13 INT C APPL GEOL, V1, P222
   BOARDMAN E, 1995, JPL PUBL, V951, P23
   BOARDMAN JW, 1993, JPL PUBLICATION, V9326, P11
   BOX GEP, 1979, ROBUSTNESS STAT, P201, DOI DOI 10.1016/B978-0-12-438150-6.50018-2
   CRAIG MD, 1994, IEEE T GEOSCI REMOTE, V32, P542, DOI 10.1109/36.297973
   de Juan A, 2004, TRAC-TREND ANAL CHEM, V23, P70, DOI 10.1016/S0165-9936(04)00101-3
   *ENVI, 2000, ENV VIS IM US GUID V
   GREEN AA, 1988, IEEE T GEOSCI REMOTE, V26, P65, DOI 10.1109/36.3001
   Hastie T, 2001, ELEMENTS STAT LEARNI
   HAZEWINKEL M, 1995, ENCY MATH, V5
   LEE JB, 1990, IEEE T GEOSCI REMOTE, V28, P295, DOI 10.1109/36.54356
   Nocedal J., 1999, NUMERICAL OPTIMIZATI
   Press WH, 1992, NUMERICAL RECIPES C
   Weibel E. R, 1980, STEREOLOGICAL METHOD, V2
   Winter M. E., 1999, P 13 INT C APPL GEOL, V2, P337
NR 16
TC 2
Z9 2
U1 0
U2 1
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5668-3
J9 P SOC PHOTO-OPT INS
PY 2005
VL 5694
BP 62
EP 73
DI 10.1117/12.600291
PG 12
WC Spectroscopy
SC Spectroscopy
GA BCH87
UT WOS:000229357000008
DA 2018-10-19
ER

PT S
AU Xu, ZQ
   Kumar, A
   Kumar, A
   Sikder, A
AF Xu, ZQ
   Kumar, A
   Kumar, A
   Sikder, A
BE Basu, SN
   Krzanowski, JE
   Patscheider, J
   Gogotsi, Y
TI Synthesis and characterization of nanocrystalline diamond and its
   biomedical application
SO Surface Engineering 2004 - Fundamentals and Applications
SE MATERIALS RESEARCH SOCIETY SYMPOSIUM PROCEEDINGS
LA English
DT Proceedings Paper
CT Symposium on Ultrafast Lasers for Materials Science held at the 2004 MRS
   Fall Meeting
CY NOV 30-DEC 01, 2004
CL Boston, MA
SP MRS
ID FILMS
AB Diamond is known as the material that has excellent mechanical, electrical and chemical properties. Diamond is also an ideal interface that is compatible with microelectronics process and biological environments to work as a biosensor platform with excellent selectivity and stability. In our study, nanocrystalline diamond (NCD) films were grown on Si substrates by the microwave plasma enhanced chemical vapor deposition (MPECVD) method. Parameters such as gas composition, temperature and pressure are investigated to get the best film quality. Scanning electron microscopy (SEM) and Raman spectroscopy were used to characterize the NCD films. Then the NCD films were treated by hydrogen plasma in the CVD chamber to obtain the hydrogen terminated surface. This hydrogenated NCD film is ready for bio-modification and can work as the platform of the biosensors. Fourier Transform Infrared Spectroscopy (FTIR) and Xray Photoelectron Spectroscopy (XPS) were employed to confirm the surface hydrogenation.
C1 Univ S Florida, Dept Mech Engn, Tampa, FL 33620 USA.
RP Xu, ZQ (reprint author), Univ S Florida, Dept Mech Engn, Tampa, FL 33620 USA.
CR Aleksov A, 2004, DIAM RELAT MATER, V13, P233, DOI 10.1016/j.diamond.2003.11.090
   Bhattacharyya S, 2001, APPL PHYS LETT, V79, P1441, DOI 10.1063/1.1400761
   BIRRELL J, 2004, DIAM RELAT MATER, V14, P1588
   Bower C, 2000, APPL PHYS LETT, V77, P830, DOI 10.1063/1.1306658
   Davidson JL, 2003, DIAM RELAT MATER, V12, P429, DOI 10.1016/S0925-9635(03)00041-4
   Deuerler F., 2002, INT J REFRACT MET H, V20, P115
   Gruen DM, 1999, ANNU REV MATER SCI, V29, P211, DOI 10.1146/annurev.matsci.29.1.211
   Krainsky IL, 1998, APPL PHYS LETT, V72, P2574, DOI 10.1063/1.121422
   Maier F, 1999, SURF SCI, V443, P177, DOI 10.1016/S0039-6028(99)01010-9
   Qiu DJ, 2004, DIAM RELAT MATER, V13, P419, DOI 10.1016/j.diamond.2003.11.086
   Sharda T, 2001, DIAM RELAT MATER, V10, P1592, DOI 10.1016/S0925-9635(01)00415-0
   THOMS BD, 1994, APPL PHYS LETT, V65, P2957, DOI 10.1063/1.112503
   Wang T, 2004, DIAM RELAT MATER, V13, P6, DOI 10.1016/j.diamond.2003.08.014
   Weide J., 1994, PHYS REV B, V50, P5803
   Yoshikawa H, 2001, DIAM RELAT MATER, V10, P1588, DOI 10.1016/S0925-9635(01)00414-9
   Zhang Q, 1998, J APPL PHYS, V83, P1349, DOI 10.1063/1.367311
NR 16
TC 1
Z9 1
U1 0
U2 2
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DRIVE, WARRENDALE, PA 15088-7563 USA
SN 0272-9172
BN 1-55899-791-1
J9 MATER RES SOC SYMP P
PY 2005
VL 843
BP 55
EP 60
PG 6
WC Materials Science, Coatings & Films; Physics, Condensed Matter
SC Materials Science; Physics
GA BCH96
UT WOS:000229372000008
DA 2018-10-19
ER

PT S
AU Hladky-Hennion, AC
   Cochran, JK
   Meyer, R
   Markley, DC
   Newnham, RE
AF Hladky-Hennion, AC
   Cochran, JK
   Meyer, R
   Markley, DC
   Newnham, RE
BE WongNg, W
   Goyal, A
   Guo, R
   Bhalla, AS
TI The wagon wheel transducer as a vector sensor and a directional
   projector
SO SYNTHESIS, PROPERTIES, AND CRYSTAL CHEMISTRY OF PEROVSKITE-BASED
   MATERIALS
SE CERAMIC TRANSACTIONS
LA English
DT Proceedings Paper
CT 106th Annual Meeting of the American-Ceramic-Society
CY APR 18-21, 2004
CL Indianapolis, IN
SP Amer Ceram Soc
AB Traditional flextensional transducers have been used extensively for fish-finding, oil exploration, sonar systems, and low frequency biomedical applications in the 1-100 kHz range. Our goal is to develop a family of small, low-cost, underwater and biomedical transducers based on extrusion technology. Some of these designs resemble traditional Class IV and Class VII flextensional transducers and will expand their useful operating range. Others incorporate features of tonpilz and vector sensor transducers. Miniature versions of these high-power, low frequency transducers are being optimized to produce broadband transmit and receive response, engineered vibration modes,. and optimized acoustic beam patterns. Transducer topologies with various shapes, cross-sections, and symmetries can be fabricated through high volume, low-cost ceramic and metal extrusion processes. Dimensions of the pieces can be as small as one millimeter and as large as 10 cm, which provide resonance frequencies from above 1 MHz to below 10 kHz. The acoustic vibration modes, resonance frequencies and radiation patterns of these transducers are controlled through the symmetry and external shape of the transducer material, poling pattern, the driving and receiving electrode geometries and driving conditions. This is the first in a series of papers devoted to small, multimode flextensional transducers with active shells. The specific aim of this paper is to present a flextensional transducer shaped like a wagon wheel with active shells, which combines the advantages of small size and low-cost manufacturing with control of the shape of the acoustic radiation/receive pattern. The performance of the transducer as a vector sensor and as a directional projector is emphasized.
C1 CNRS, IEMN, UMR 8520, F-59046 Lille, France.
RP Hladky-Hennion, AC (reprint author), CNRS, IEMN, UMR 8520, 41,Blvd Vauban, F-59046 Lille, France.
RI HLADKY-HENNION, Anne-Christine/I-3237-2017
OI HLADKY-HENNION, Anne-Christine/0000-0001-6339-8448
CR Butler S.C., 2000, P MTS IEEE OC 2000 C, V3, P1469
   Ehrlich S. L., 1973, U. S. Patent No, Patent No. [3732535, 3, 732, 535]
   Ehrlich S. L., 1966, U.S. patent, Patent No. [3290646, 3,290,646]
   HLADKYHENNION AC, 1993, J ACOUST SOC AM, V94, P621, DOI 10.1121/1.406878
   HOWARTH TR, 1997, P MTS IEEE OC 1997 C, V2, P1195
   Hurysz KM, 2002, PROCESSSING AND PROPERTIES OF LIGHTWEIGHT CELLULAR METALS AND STRUCTURES, P167
   Hurysz KM, 2003, J EUR CERAM SOC, V23, P2047, DOI 10.1016/S0955-2219(03)00027-X
   HURYSZ KM, 2003, IN PRESS INNOVATIVE, V7
   KO SH, 1974, J ACOUST SOC AM, V56, P1890, DOI 10.1121/1.1903528
   LAN J, 1996, P MTS IEEE OC 1996 C, V2, P763
   OH R, 2003, INNOVATIVE PROCESSES, V7
   RYNNE EF, 1993, INNOVATIVE APPROACHE, P38
   Zhang J, 2001, ULTRASONICS, V39, P91, DOI 10.1016/S0041-624X(00)00055-X
NR 13
TC 0
Z9 0
U1 0
U2 0
PU AMER CERAMIC SOC
PI WESTERVILLE
PA 735 CERAMIC PLACE, WESTERVILLE, OH 43081-8720 USA
SN 1042-1122
BN 1-57498-190-0
J9 CERAM TRANS
PY 2005
VL 169
BP 17
EP 37
PG 21
WC Materials Science, Ceramics
SC Materials Science
GA BBR78
UT WOS:000227471800002
DA 2018-10-19
ER

PT S
AU Bellucci, S
   Balasubramanian, C
   Mancia, F
   Marchetti, M
   Regi, M
   Tombolini, F
AF Bellucci, S
   Balasubramanian, C
   Mancia, F
   Marchetti, M
   Regi, M
   Tombolini, F
BE Quan, C
   Chau, FS
   Asundi, A
   Wong, BS
   Lim, CT
TI Composite materials based on Carbon Nanotubes for aerospace applications
SO Third International Conference on Experimental Mechanics and Third
   Conference of the Asian-Committee-on-Experimental-Mechanics, Pts 1and 2
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 3rd International Conference on Experimental Mechanics/3rd Conference of
   the Asian-Committee-on-Experimental-Mechanics
CY NOV 29-DEC 01, 2004
CL Singapore, SINGAPORE
SP Asian Comm Expt Mech, Natl Univ Singapore, Dept Mech Engn, Nanyang Technol Univ, Sch Mech & Product Engn, Lee Fdn, USAF Off Sci Res, Asian Off Aerosp Res & Dev, SPIE
DE carbon nanotubes; composite materials; mechanical properties; aerospace
   structuress; anisogrid lattices
ID ARC-DISCHARGE
AB Electrical and mechanical proper-ties of composite materials based on Carbon Nanotubes are considered for aerospace applications. Nanostructured materials gained great importance in the past decade, owing to their wide ranging potential applications in many areas, e.g. mechanical, structural, sensor, biomedical, electronics. Of particular interest are carbon nanotubes, which can be used as a main constituent of composite materials with exceptional mechanical and electrical properties, very suitable for aerospace applications, also due to their light weight, mechanical strength and flexibility. We present results obtained recently in our laboratories concerning the electrical and mechanical properties (including resilience measurement, stress analysis, conductivity) of carbon nanotubes we synthesized by arc discharge and other techniques, embedded in a polymer matrix.
C1 Ist Nazl Fis Nucl, Lab Nazl Frascati, I-00044 Frascati, Italy.
RP Bellucci, S (reprint author), Ist Nazl Fis Nucl, Lab Nazl Frascati, Via E Fermi 40, I-00044 Frascati, Italy.
RI Bellucci, Stefano/C-9235-2011; Chidambara Thanupillai,
   Balasubramanian/H-2138-2013
OI Bellucci, Stefano/0000-0003-0326-6368
CR BELLUCCI S, IN PRESS RELATIVISTI
   BELLUCCI S, 2004, IN PRESS PHYS ST JUL
   Lange H, 2003, CARBON, V41, P1617, DOI 10.1016/S0008-6223(03)00111-8
   Lau KT, 2002, COMPOS PART B-ENG, V33, P263
   REGI M, 2004, S SULL TECHN AV SVIL
   REGI M, AEROTECNICA MISSILI, V83
   REGI M, AEROTECNICA MISSILI, V82
   Takikawa H, 1999, J PHYS D APPL PHYS, V32, P2433, DOI 10.1088/0022-3727/32/18/315
   Vasiliev VV, 2001, COMPOS STRUCT, V54, P361, DOI 10.1016/S0263-8223(01)00111-8
   Zeng H, 1998, CARBON, V36, P259, DOI 10.1016/S0008-6223(97)00167-X
   Zhang HY, 2003, PHYSICA B, V325, P224, DOI 10.1016/S0921-4526(02)01528-4
NR 11
TC 3
Z9 3
U1 0
U2 6
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 0-8194-5852-X
J9 P SOC PHOTO-OPT INS
PY 2005
VL 5852
BP 121
EP 126
DI 10.1117/12.621441
PN 1&2
PG 6
WC Instruments & Instrumentation; Materials Science, Biomaterials;
   Materials Science, Characterization & Testing; Optics; Imaging Science &
   Photographic Technology
SC Instruments & Instrumentation; Materials Science; Optics; Imaging
   Science & Photographic Technology
GA BCL69
UT WOS:000229932000019
DA 2018-10-19
ER

PT B
AU Dittmar, A
   Lymberis, A
AF Dittmar, A
   Lymberis, A
GP IEEE
TI Smart clothes and associated wearable devices for biomedical ambulatory
   monitoring
SO TRANSDUCERS '05, DIGEST OF TECHNICAL PAPERS, VOLS 1 AND 2
LA English
DT Proceedings Paper
CT 13th International Conference on Solid-State Sensors, Actuators and
   Microsystems
CY JUN 05-09, 2005
CL Seoul, SOUTH KOREA
SP Korean Sensors Soc, IEEE Electron Devices Soc, IEEE Robot & Automat Soc, IEE Japan, Sensors & Micromach Soc, Int Federat Automat Control, Inst Control, Automat & Syst Engineers, Inst Elect Engineers Korea, Korean Inst Elect Engineers, Korean Soc Mech Engineers, Korean Soc Precis Engn, Korean Robot Soc
DE smart clothes; WBS (Wearable Biomedical Sensors); non-invasive sensors;
   flexible technology; ambulatory measurement; monitoring; textile-made
   sensors; textile-made electrodes
ID EMOTIONS
AB The world is becoming more and more "health conscious". Society, health policy and patients' needs are all changing dramatically.
   The challenges society is currently facing are related to: The increase in the aging population, changing lifestyles, the need for healthcare cost-containment, the improvement and monitoring of healthcare quality, the prevention approaches rather than treatment.
   In addition, patients and health consumers are waiting for : non invasive, mini invasive... painless methods for diagnosis and treatment, home care, ambulatory methods, short stays in hospital, use of telemedicine, enhancement of rehabilitation, information and involvement in their own treatment.
   Health smart clothes which are in contact with almost all the surface of the skin offer large possibilities for the location of sensors for non invasive measurements. Head band, collar, tee-shirt, socks, shoes, belts for chest, arm, wrist, legs... provide localization with specific purpose taking into account their proximity of an organ or a source of biosignal, and also its ergonomic possibility (user friendly) to fix a sensor, and the associated instrumentations (batteries, amplifiers, signal processing, telecom, alarm, display...).
   Progress in science and technology offers, for the first time, intelligence, speed, miniaturization, sophistication and new materials at low cost. In this new landscape, microtechnologies, information technologies and telecommunications are a key factor. Microsensors : Microtechnologies offer the possibility of small size, but also intelligent, active device, working with low energy, wireless and non invasive or mini invasive. These sensors have to be thin, flexible and compatible with textile, or made using textile technologies, new fibers with specific properties: mechanical, electrical, optical...
   The field of applications is very large, e.g. continuous monitoring on elderly population, professional and military activities, athletes performance and condition, and people with disabilities.
   The research are oriented toward two complementary directions : Improving the relevancy of each sensor and increasing the number of sensors for having a more global synthetic and robust information(1).
C1 Inst Natl Sci Appl, CNRS, LPM, F-69621 Villeurbanne, France.
RP Dittmar, A (reprint author), Inst Natl Sci Appl, CNRS, LPM, Bat L De Vinci,20 Ave Albert Einstein, F-69621 Villeurbanne, France.
EM dittmar@univ-lyon1.fr; andreas.lymberis@cec.eu.int
CR AXISA F, 2005, THESIS INSA LYON
   AXISA F, 2005, UNPUB IEEE T INFORM
   BONFIGLIO A, 2003, NEW GENERATION WEARA, P258
   Collet C, 1997, J AUTONOM NERV SYST, V62, P45, DOI 10.1016/S0165-1838(96)00108-7
   De Rossi D, 2000, 1ST ANNUAL INTERNATIONAL IEEE-EMBS SPECIAL TOPIC CONFERENCE ON MICROTECHNOLOGIES IN MEDICINE & BIOLOGY, PROCEEDINGS, P587, DOI 10.1109/MMB.2000.893853
   DITTMAR A, Patent No. 0402037
   DITTMAR A, 2003, 25 ANN INT C IEEE EM
   Dittmar A., 2004, STUD HLTH TECHNOL IN, V108, P9
   EKMAN P, 1983, SCIENCE, V221, P1208, DOI 10.1126/science.6612338
   GROSSMAN P, 2003, NEW GENERATION WEARA, P73
   GUILLEMAUD R, 2003, NEW GENERATION WEARA, P209
   HEALEY J, 2003, NEW GENERATION WEARA, P194
   HERZOG RK, 2003, 25 ANN INT C IEEE EM
   JONES M, 2003, NEW GENERATION WEARA, P216
   Khalil S., 2004, P SOC PHOTO-OPT INS, V5270, P38
   KIRSTEIN T, 2003, NEW GENERATION WEARA, P201
   LAUTER J, 2003, 25 ANN INT C IEEE EM
   LEITCH P, 2003, NEW GENERATION WEARA, P54
   LORUSSI F, 2003, NEW GENERATION WEARA, P175
   LUPRANO J, 2003, NEW GENERATION WEARA, P100
   Lymberis A, 2003, TELEMEDICINE J E HLT, V9
   LYMBERIS A, 2003, 25 ANN INT C IEEE EM
   MCADAMS E, 2003, NEW GENERATION WEARA, P115
   MOHAN A, 2004, THESIS MIT
   MOHAN A, 2003, NEW GENERATION WEARA, P291
   MUNRO B, 2003, NEW GENERATION WEARA, P187
   NOURY N, 2004, P 26 ANN INT C IEEE, P3266
   PARADISO R, 2003, 25 ANN INT C IEEE EM
   Park S, 2002, DES AUT CON, P170, DOI 10.1109/DAC.2002.1012614
   Saranummi N, 2002, IEEE T BIO-MED ENG, V49, P1385, DOI 10.1109/TBME.2002.806021
   WALLACE GG, 2003, NEW GENERATION WEARA, P241
   WEBER L, 2003, NEW GENERATION WEARA, P169
NR 32
TC 1
Z9 1
U1 0
U2 12
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-8994-8
PY 2005
BP 221
EP 227
PG 7
WC Engineering, Biomedical; Engineering, Electrical & Electronic;
   Engineering, Mechanical
SC Engineering
GA BCZ93
UT WOS:000232189100055
DA 2018-10-19
ER

PT B
AU Lei, KF
   Li, WJ
AF Lei, KF
   Li, WJ
GP IEEE
TI Microfluidic mixing by fluidic discretization
SO TRANSDUCERS '05, DIGEST OF TECHNICAL PAPERS, VOLS 1 AND 2
LA English
DT Proceedings Paper
CT 13th International Conference on Solid-State Sensors, Actuators and
   Microsystems
CY JUN 05-09, 2005
CL Seoul, SOUTH KOREA
SP Korean Sensors Soc, IEEE Electron Devices Soc, IEEE Robot & Automat Soc, IEE Japan, Sensors & Micromach Soc, Int Federat Automat Control, Inst Control, Automat & Syst Engineers, Inst Elect Engineers Korea, Korean Inst Elect Engineers, Korean Soc Mech Engineers, Korean Soc Precis Engn, Korean Robot Soc
DE microfluidic mixing; micropump; micromixer
AB A new concept of microfluidic mixing based on fluid "discretization" is proposed in this paper. Polymer based micropumps, micromixer and microchannels have been designed and integrated in a single PMMA chip microfluidic system. The optically transparent and biocompatible material used to fabricate the microfluidic system will enable many biomedical and chemical analysis applications. The idea of "discretized" microfluidic mixing is to manipulate fluids as "discretize" volumes by pumping fluids by two micropumps into a microchamber alternatively in order to increasing the interfacial surface area. Hence, the diffusion between fluids can be completed in a shorter time and fluids can be mixed instantly without external energy in the chamber. The design, implementation and experimental results are presented in this paper.
C1 Chinese Univ Hong Kong, Ctr Micro & Nano Syst, Shatin, Hong Kong, Peoples R China.
RP Li, WJ (reprint author), Chinese Univ Hong Kong, Ctr Micro & Nano Syst, Shatin, Hong Kong, Peoples R China.
EM wen@acae.cuhk.edu.hk
RI Li, Wen Jung/A-6153-2010; Li, Wen Jung/M-9995-2013
OI Li, Wen Jung/0000-0001-9616-6213; Li, Wen Jung/0000-0001-9616-6213
CR BRANEBJERG P, 1996, PROC IEEE MICR ELECT, P441
   CHOW WWY, 2004, IN PRESS NANOTECHNOL
   LEI KF, 2005, J MICROMECHANICS MIC
   LEI KF, 2004, J MICROSYSTEM TECHNO
   LEI KF, 2004, 2004 IEEE RSJ INT C
   Lu LH, 2002, J MICROELECTROMECH S, V11, P462, DOI 10.1109/JMEMS.2002.802899
   MIYAKE R, 1993, MICRO ELECTRO MECHANICAL SYSTEMS, PROCEEDINGS, P248
   YAN Z, 2000, IEEE MEMS 2000, P80
NR 8
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-8994-8
PY 2005
BP 1537
EP 1540
PG 4
WC Engineering, Biomedical; Engineering, Electrical & Electronic;
   Engineering, Mechanical
SC Engineering
GA BCZ93
UT WOS:000232189100379
DA 2018-10-19
ER

PT J
AU Patil, GV
   Pokhrel, K
AF Patil, GV
   Pokhrel, K
TI Biomedical solid waste management in an Indian hospital: a case study
SO WASTE MANAGEMENT
LA English
DT Article
AB The objectives of this study were: (i) to assess the waste handling and treatment system of hospital bio-medical solid waste and its mandatory compliance with Regulatory Notifications for Bio-medical Waste (Management and Handling) Rules, 1998, under the Environment (Protection Act 1986), Ministry of Environment and Forestry, Govt. of India, at the chosen KLE Society's J. N. Hospital and Medical Research Center, Belgaum, India and (ii) to quantitatively estimate the amount of non-infectious and infectious waste generated in different wards/sections. During the study, it was observed that: (i) the personnel working under the occupier (who has control over the institution to take all steps to ensure biomedical waste is handled without any adverse effects to human health and the environment) were trained to take adequate precautionary measures in handling these bio-hazardous waste materials, (ii) the process of segregation, collection, transport, storage and final disposal of infectious waste was done in compliance with the Standard Procedures, (iii) the final disposal was by incineration in accordance to EPA Rules 1998, (iv) the non-infectious waste was collected separately in different containers and treated as general waste, and (v) on an average about 520 kg of non-infectious and 101 kg of infectious waste is generated per day (about 2.31 kg per day per bed, gross weight comprising both infectious and noninfectious waste). This hospital also extends its facility to the neighboring clinics and hospitals by treating their produced waste for incineration. (c) 2004 Elsevier Ltd. All rights reserved.
C1 Bundelkhand Univ, Inst Pharm, Jhansi 284128, Uttar Pradesh, India.
   KLE Soc JN Med Coll, Hosp Adm, Belgaum 590010, India.
RP Patil, GV (reprint author), Bundelkhand Univ, Inst Pharm, Jhansi 284128, Uttar Pradesh, India.
EM patilgayathripatil@rediffmail.com
OI Patil, Gayathri/0000-0001-5618-2788
CR Baveja G., 2000, HOSP TODAY, V5, P485
   *CENS IND, 2001, BELG DISTR
   GUPTA SP, 1998, STAT METHODS
   JASWAL PS, 2000, ENV LAW
   Manohar D, 1998, IND J ENV HLTH, V40, P319
   SANDHU TS, 2003, TRIBUNE         0630
   Shah S., 2001, OCCUPATIONAL HLTH HA
NR 7
TC 56
Z9 56
U1 1
U2 16
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0956-053X
J9 WASTE MANAGE
JI Waste Manage.
PY 2005
VL 25
IS 6
BP 592
EP 599
DI 10.1016/j.wasman.2004.07.011
PG 8
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 948VB
UT WOS:000230742700007
PM 15993343
DA 2018-10-19
ER

PT J
AU Liu, XY
   Chu, PK
   Ding, CX
AF Liu, XY
   Chu, PK
   Ding, CX
TI Surface modification of titanium, titanium alloys, and related materials
   for biomedical applications
SO MATERIALS SCIENCE & ENGINEERING R-REPORTS
LA English
DT Review
DE titanium; titanium alloys; surface modification; biomedical engineering
ID SPRAYED HYDROXYAPATITE COATINGS; SELF-ASSEMBLED MONOLAYERS; DIAMOND-LIKE
   CARBON; IMMERSION ION-IMPLANTATION; SIMULATED BODY-FLUID;
   CALCIUM-PHOSPHATE PRECIPITATION; CHEMICALLY TREATED TITANIUM; CONTAINING
   THIN COATINGS; METAL-OXIDE SURFACES; BONE-BONDING ABILITY
AB Titanium and titanium alloys are widely used in biomedical devices and components, especially as hard tissue replacements as well as in cardiac and cardiovascular applications, because of their desirable properties, such as relatively low modulus, good fatigue strength, formability, machinability, corrosion resistance, and biocompatibility. However, titanium and its alloys cannot meet all of the clinical requirements. Therefore, in order to improve the biological, chemical, and mechanical properties, surface modification is often performed. This article reviews the various surface modification technologies pertaining to titanium and titanium alloys including mechanical treatment, thermal spraying, sol-gel, chemical and electrochemical treatment, and ion implantation from the perspective of biomedical engineering. Recent work has shown that the wear resistance, corrosion resistance, and biological properties of titanium and titanium alloys can be improved selectively using the appropriate surface treatment techniques while the desirable bulk attributes of the materials are retained. The proper surface treatment expands the use of titanium and titanium alloys in the biomedical fields. Some of the recent applications are also discussed in this paper. (C) 2004 Elsevier B.V. All rights reserved.
C1 City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China.
   Chinese Acad Sci, Shanghai Inst Ceram, Shanghai 200050, Peoples R China.
RP Chu, PK (reprint author), City Univ Hong Kong, Dept Phys & Mat Sci, Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.
EM xyliu@mail.sic.ac.cn; paul.chu@cityu.edu.hk
RI Chu, Paul/B-5923-2013; Liu, Xuanyong/J-2609-2018
OI Chu, Paul/0000-0002-5581-4883; 
CR Allen M, 2001, J BIOMED MATER RES, V58, P319, DOI 10.1002/1097-4636(2001)58:3<319::AID-JBM1024>3.0.CO;2-F
   Alonso F, 1996, SURF COAT TECH, V83, P301, DOI 10.1016/0257-8972(96)02767-3
   Anderson James M., 1996, P165
   Andreazza P, 1998, THIN SOLID FILMS, V319, P62, DOI 10.1016/S0040-6090(97)01086-9
   [Anonymous], 1989, ILLUSTRATED ENCY DIC, P1800
   Aronoff YG, 1997, J AM CHEM SOC, V119, P259, DOI 10.1021/ja953848+
   Aronsson BO, 1997, J BIOMED MATER RES, V35, P49
   *ASTM, 1997, B600 ASTM, P6
   Aziz-Kerrzo M, 2001, BIOMATERIALS, V22, P1531, DOI 10.1016/S0142-9612(00)00309-4
   Baek SH, 2002, CHEM VAPOR DEPOS, V8, P29, DOI 10.1002/1521-3862(20020116)8:1<29::AID-CVDE29>3.0.CO;2-Q
   BAIER RE, 1983, PHYSICOCHEMICAL ASPE, V2, P895
   Baleani M, 2000, ARTIF ORGANS, V24, P296, DOI 10.1046/j.1525-1594.2000.06486.x
   Bania P. J., 1993, TITANIUM ALLOYS 1990, P3
   BAUER TW, 1991, J BONE JOINT SURG AM, V73A, P1439, DOI 10.2106/00004623-199173100-00001
   Baumann H, 2002, NUCL INSTRUM METH B, V196, P286, DOI 10.1016/S0168-583X(02)01298-3
   BEHRNDT H, 1991, MAT SCI ENG A-STRUCT, V139, P58, DOI 10.1016/0921-5093(91)90596-F
   Berberich F, 2001, APPL SURF SCI, V179, P13, DOI 10.1016/S0169-4332(01)00256-2
   BJORLING M, 1992, MACROMOLECULES, V25, P3956
   BLAHA P, 1985, PHYS REV B, V31, P2316, DOI 10.1103/PhysRevB.31.2316
   BOBYN JD, 1980, CLIN ORTHOP RELAT R, P263
   Boehm HP, 1971, DISCUSS FARADAY SOC, V52, P264
   Bouos M.I., 1993, PLASMA SPRAYING THEO, P3
   BRENDEL T, 1992, J MATER SCI-MATER M, V3, P175, DOI 10.1007/BF00713445
   Brinker C. J., 1990, SOL GEL SCI PHYS CHE
   Brovelli D, 1999, LANGMUIR, V15, P4324, DOI 10.1021/la981758n
   Browne M, 2000, BIOMATERIALS, V21, P385, DOI 10.1016/S0142-9612(99)00200-8
   BUCHANAN RA, 1987, J BIOMED MATER RES, V21, P367, DOI 10.1002/jbm.820210309
   Buser D, 1999, J BIOMED MATER RES, V45, P75, DOI 10.1002/(SICI)1097-4636(199905)45:2<75::AID-JBM1>3.0.CO;2-P
   BUTTER R, 1995, DIAM RELAT MATER, V4, P857, DOI 10.1016/0925-9635(94)05280-8
   Cao Y, 1996, BIOMATERIALS, V17, P419, DOI 10.1016/0142-9612(96)89658-X
   Chai CS, 1998, BIOMATERIALS, V19, P2291, DOI 10.1016/S0142-9612(98)90138-7
   Chandra L, 1996, DIAM RELAT MATER, V5, P674, DOI 10.1016/0925-9635(95)00431-9
   Chang E, 1997, J MATER SCI-MATER M, V8, P193, DOI 10.1023/A:1018583522322
   Cheang P, 1996, BIOMATERIALS, V17, P1901, DOI 10.1016/0142-9612(95)00146-8
   CHEN J, 1993, J MATER ENG PERFORM, V2, P839, DOI 10.1007/BF02645683
   Chen JY, 2002, SURF COAT TECH, V156, P289, DOI 10.1016/S0257-8972(02)00089-0
   Chen YM, 2001, SURF COAT TECH, V141, P156, DOI 10.1016/S0257-8972(01)01201-4
   CHO SB, 1995, J AM CERAM SOC, V78, P1769, DOI 10.1111/j.1151-2916.1995.tb08887.x
   CLEMENCE JF, 1995, BIOCONJUGATE CHEM, V6, P411, DOI 10.1021/bc00034a011
   Collier J P, 1993, J Arthroplasty, V8, P389, DOI 10.1016/S0883-5403(06)80037-9
   COLLINGS EW, 1984, ASM SERIES METAL PRO
   COLLIOUD A, 1993, BIOCONJUGATE CHEM, V4, P528, DOI 10.1021/bc00024a016
   COLLIS JJ, 1992, BIOMATERIALS, V13, P548, DOI 10.1016/0142-9612(92)90107-Y
   COOLEY DR, 1992, J PROSTHET DENT, V67, P93, DOI 10.1016/0022-3913(92)90057-H
   CORNELL RM, 1975, J COLLOID INTERF SCI, V53, P6, DOI 10.1016/0021-9797(75)90028-4
   de Andrade MC, 1999, J BIOMED MATER RES, V46, P441, DOI 10.1002/(SICI)1097-4636(19990915)46:4<441::AID-JBM1>3.0.CO;2-9
   De Aza PN, 2000, BIOMATERIALS, V21, P1735, DOI 10.1016/S0142-9612(00)00058-2
   DeAza PN, 1997, BIOMATERIALS, V18, P1285, DOI 10.1016/S0142-9612(97)00063-X
   DEAZA PN, 1994, SCRIPTA METALL MATER, V31, P1001, DOI 10.1016/0956-716X(94)90517-7
   DeAza PN, 1996, J MICROSC-OXFORD, V182, P24, DOI 10.1111/j.1365-2818.1996.tb04794.x
   Degasne I, 1999, CALCIFIED TISSUE INT, V64, P499, DOI 10.1007/s002239900640
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   DEGROOT K, 1987, HIGH TECH CERAMICS, P381
   Diebold U, 2003, SURF SCI REP, V48, P53, DOI 10.1016/S0167-5729(02)00100-0
   Dieudonne SC, 2002, BIOMATERIALS, V23, P3041, DOI 10.1016/S0142-9612(02)00068-6
   Ding SJ, 2003, BIOMATERIALS, V24, P4233, DOI 10.1016/S0142-9612(03)00315-6
   Ding SJ, 1999, J BIOMED MATER RES, V47, P551, DOI 10.1002/(SICI)1097-4636(19991215)47:4<551::AID-JBM12>3.0.CO;2-C
   Ding SJ, 1999, J BIOMED MATER RES, V44, P266, DOI 10.1002/(SICI)1097-4636(19990305)44:3<266::AID-JBM5>3.0.CO;2-4
   DISCHLER B, 1983, SOLID STATE COMMUN, V48, P105, DOI 10.1016/0038-1098(83)90936-5
   Dowson D, 1981, INTRO BIOMECHANICS J
   DRISKELL TD, 1994, EARLY HIST CALCIUM O, P3
   EBERT R, 1982, P WORLD C MED PHYS B, P307
   ELWING H, 1987, J BIOMED MATER RES, V21, P263, DOI 10.1002/jbm.820210209
   ERDTMANN M, 1994, BIOMATERIALS, V15, P1043, DOI 10.1016/0142-9612(94)90089-2
   Fazan F, 2000, J MATER SCI-MATER M, V11, P787, DOI 10.1023/A:1008901512273
   FINKLEA HO, 1979, J PHYS CHEM-US, V83, P353, DOI 10.1021/j100466a011
   FOLKERS JP, 1995, LANGMUIR, V11, P813, DOI 10.1021/la00003a024
   Fraker A. C., 1983, ASTM STP, V786, P206
   FREEMAN MAR, 1994, J BONE JOINT SURG BR, V76B, P432
   Freese H. L., 2001, TITANIUM MED, P25
   Fujibayashi S, 2001, J BIOMED MATER RES, V56, P562, DOI 10.1002/1097-4636(20010915)56:4<562::AID-JBM1128>3.3.CO;2-D
   Fukumoto S, 1999, MAT SCI ENG A-STRUCT, V263, P205, DOI 10.1016/S0921-5093(98)01166-6
   FURLONG RJ, 1991, J BONE JOINT SURG BR, V73, P741
   GABBI C, 1995, BIOMATERIALS, V16, P515, DOI 10.1016/0142-9612(95)91123-G
   GEESINK RGT, 1987, CLIN ORTHOP RELAT R, P147
   GEESINK RGT, 1989, ORTHOPEDICS, V12, P1239
   Gledhill HC, 1999, BIOMATERIALS, V20, P315, DOI 10.1016/S0142-9612(98)00166-5
   Gnedenkov S.V., 1999, PROT METAL, V35, P480
   GOMBOTZ WR, 1987, CRIT REV BIOCOMPAT, V4, P1
   Gonzalez JEG, 1999, J ELECTROANAL CHEM, V471, P109, DOI 10.1016/S0022-0728(99)00260-0
   GRANT DM, 1992, DIAM RELAT MATER, V1, P727, DOI 10.1016/0925-9635(92)90198-W
   Grill A., 1994, SYNTHETIC DIAMOND EM, P91
   Gross KA, 1998, J BIOMED MATER RES, V39, P407, DOI 10.1002/(SICI)1097-4636(19980305)39:3<407::AID-JBM9>3.0.CO;2-N
   Gross KA, 1998, J MATER SCI-MATER M, V9, P839, DOI 10.1023/A:1008948228880
   GROSS KA, 1998, P 15 INT THERM SPRAY, P1133
   GRUNER H, 1985, Patent No. 0222853
   Haman JD, 1999, J BIOMED MATER RES, V48, P856, DOI 10.1002/(SICI)1097-4636(1999)48:6<856::AID-JBM14>3.0.CO;2-I
   HAMAN JD, 1995, J THERM SPRAY TECHN, V4, P179, DOI 10.1007/BF02646110
   Hammerl C, 1999, NUCL INSTRUM METH B, V148, P851, DOI 10.1016/S0168-583X(98)00660-0
   Han Y, 2003, SURF COAT TECH, V168, P249, DOI 10.1016/S0257-8972(03)00016-1
   Hanawa T, 1997, J BIOMED MATER RES, V36, P131, DOI 10.1002/(SICI)1097-4636(199707)36:1<131::AID-JBM16>3.0.CO;2-L
   Hanawa T, 1999, MAT SCI ENG A-STRUCT, V267, P260, DOI 10.1016/S0921-5093(99)00101-X
   HANAWA T, 1995, MATER T JIM, V36, P438, DOI 10.2320/matertrans1989.36.438
   HANAWA T, 1994, AM SOC TEST MATER, V1196, P170, DOI 10.1520/STP25192S
   Hanawa T, 1996, CORROS SCI, V38, P1579, DOI 10.1016/0010-938X(96)00053-4
   Hanawa T, 1996, CORROS SCI, V38, P2061, DOI 10.1016/S0010-938X(96)89124-4
   HANAWA T, 1993, J ELECTRON SPECTROSC, V63, P347, DOI 10.1016/0368-2048(93)80032-H
   Hanawa T, 1998, J MATER SCI-MATER M, V9, P89, DOI 10.1023/A:1008847014938
   HANAWA T, 1994, P S COMP BIOM IMPL S, P126
   HANAWA T, 1997, J JPN SOC BIOMATER, V15, P249
   Harris J. M., 1992, POLYETHYLENE GLYCOL
   HEGDE RI, 1993, J VAC SCI TECHNOL B, V11, P1287, DOI 10.1116/1.586931
   Heiman R. B., 1996, PLASMA SPRAY COATING
   Heinrich G, 1997, SURF COAT TECH, V94-5, P514, DOI 10.1016/S0257-8972(97)00459-3
   HENCH LL, 1993, INTRO BIOCERAMICS, P41
   HENCH LL, 1975, ADV BIOMED ENG, V5, P35
   HENDRICH VE, 1985, REP PROG PHYS, V48, P1481
   Henry P J, 1987, Int J Oral Maxillofac Implants, V2, P23
   Herbert CB, 1997, CHEM BIOL, V4, P731, DOI 10.1016/S1074-5521(97)90311-2
   Hignett B., 1987, METALS HDB, V5, P107
   HIMENO T, 2001, BIOCERAMICS, V14, P641
   Hohl F, 1995, SURF COAT TECH, V74-75, P765, DOI 10.1016/0257-8972(95)08274-3
   Hofer R, 2001, LANGMUIR, V17, P4014, DOI 10.1021/la001756e
   Holmlin RE, 2001, LANGMUIR, V17, P2841, DOI 10.1021/la0015258
   HOWIE DW, 1990, IMPLANT BONE INTERFA
   Huang N, 1998, BIOMATERIALS, V19, P771, DOI 10.1016/S0142-9612(98)00212-9
   Huang N, 1994, J Biomater Appl, V8, P404, DOI 10.1177/088532829400800406
   Huang NP, 2001, LANGMUIR, V17, P489, DOI 10.1021/la000736+
   Hypolite CL, 1997, BIOCONJUGATE CHEM, V8, P658, DOI 10.1021/bc9701252
   Ianno NJ, 1995, THIN SOLID FILMS, V270, P275, DOI 10.1016/0040-6090(95)06710-8
   ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P65, DOI 10.1002/jbm.820290110
   ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P1071, DOI 10.1002/jbm.820290907
   Itoh Y, 1999, SURF COAT TECH, V111, P172, DOI 10.1016/S0257-8972(98)00728-2
   Iwasaki Y, 2003, COLLOID SURFACE B, V32, P77, DOI 10.1016/S0927-7765(03)00147-4
   JASTY M, 1993, J APPL BIOMATER, V4, P273, DOI 10.1002/jab.770040310
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Jonasova L, 2004, BIOMATERIALS, V25, P1187, DOI 10.1016/j.biomaterials.2003.08.009
   Jonasova L, 2002, BIOMATERIALS, V23, P3095, DOI 10.1016/S0142-9612(02)00043-1
   JONES LC, 1987, CLIN ORTHOP RELAT R, P192
   Jones MI, 1999, DIAM RELAT MATER, V8, P457, DOI 10.1016/S0925-9635(98)00426-9
   Jones MI, 2000, J BIOMED MATER RES, V52, P413, DOI 10.1002/1097-4636(200011)52:2<413::AID-JBM23>3.0.CO;2-U
   Jung MJ, 2003, THIN SOLID FILMS, V435, P145, DOI 10.1016/S0040-6090(03)00344-4
   KANE KR, 1994, J APPL BIOMATER, V5, P353, DOI 10.1002/jab.770050411
   Kang GH, 1996, SURF COAT TECH, V86, P421, DOI 10.1016/S0257-8972(96)02980-5
   KARLSSON KH, 1989, J NON-CRYST SOLIDS, V112, P69, DOI 10.1016/0022-3093(89)90495-X
   KARRHOLM J, 1994, J BONE JOINT SURG BR, V76B, P912
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   KELLER J C, 1990, International Journal of Oral and Maxillofacial Implants, V5, P360
   Kenausis GL, 2000, J PHYS CHEM B, V104, P3298, DOI 10.1021/jp993359m
   KERN M, 1994, J DENT, V22, P300, DOI 10.1016/0300-5712(94)90067-1
   Khor KA, 1997, J THERM SPRAY TECHN, V6, P109, DOI 10.1007/BF02646320
   Khor KA, 2004, BIOMATERIALS, V25, P1177, DOI 10.1016/j.biomaterials.2003.08.008
   Khor KA, 2003, BIOMATERIALS, V24, P2233, DOI 10.1016/S0142-9612(03)00027-9
   Khor KA, 2003, BIOMATERIALS, V24, P723, DOI 10.1016/S0142-9612(02)00404-0
   Khor KA, 2003, BIOMATERIALS, V24, P769, DOI 10.1016/S0142-9612(02)00413-1
   Khor KA, 1998, J THERM SPRAY TECHN, V7, P254, DOI 10.1361/105996398770351007
   Kim HM, 1996, J BIOMED MATER RES, V32, P409, DOI 10.1002/(SICI)1097-4636(199611)32:3<409::AID-JBM14>3.0.CO;2-B
   Kim HW, 2004, BIOMATERIALS, V25, P3351, DOI 10.1016/j.biomaterials.2003.09.104
   Kim HW, 2004, BIOMATERIALS, V25, P2533, DOI 10.1016/j.biomaterials.2003.09.041
   Klinger A, 1997, J BIOMED MATER RES, V36, P387, DOI 10.1002/(SICI)1097-4636(19970905)36:3<387::AID-JBM13>3.0.CO;2-B
   Knob LJ, 1987, METALS HDB CORROSION, V13, P669
   KNOTEK O, 1992, SURF COAT TECH, V54, P536
   KOKUBO T, 1990, J NON-CRYST SOLIDS, V120, P138, DOI 10.1016/0022-3093(90)90199-V
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   KOKUBO T, 1987, J MATER SCI, V22, P4067, DOI 10.1007/BF01133359
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   Kokubo T., 1993, INTRO BIOCERAMICS, P75
   KOZHUKHAROV V, 1993, J MATER SCI, V28, P1283, DOI 10.1007/BF01191965
   Krupa D, 2002, BIOMATERIALS, V23, P3329, DOI 10.1016/S0142-9612(02)00020-0
   Krupa D, 1999, SURF COAT TECH, V111, P86, DOI 10.1016/S0257-8972(98)00714-2
   Krupa D, 2001, VACUUM, V63, P715, DOI 10.1016/S0042-207X(01)00263-9
   Krupa D, 1999, SURF COAT TECH, V114, P250, DOI 10.1016/S0257-8972(99)00052-3
   Krupa D, 2001, BIOMATERIALS, V22, P2139, DOI 10.1016/S0142-9612(00)00405-1
   Krupa D, 1996, SURF COAT TECH, V79, P240, DOI 10.1016/0257-8972(95)02457-3
   Kurrat R, 1998, COLLOID SURFACE B, V11, P187, DOI 10.1016/S0927-7765(98)00039-3
   Kweh SWK, 2002, BIOMATERIALS, V23, P775, DOI 10.1016/S0142-9612(01)00183-1
   Lacefield WR, 1993, INTRO BIOCERAMICS, P223
   LAUSMAA J, 1990, APPL SURF SCI, V44, P133, DOI 10.1016/0169-4332(90)90100-E
   Lausmaa J., 2001, TITANIUM MED, P231
   LeClair P, 2000, THIN SOLID FILMS, V376, P9, DOI 10.1016/S0040-6090(00)01192-5
   Lee BH, 2004, J BIOMED MATER RES A, V69A, P279, DOI 10.1002/jbm.a.20126
   Lee BH, 2002, J BIOMED MATER RES, V61, P466, DOI 10.1002/jbm.10190
   Lee DH, 1998, APPL PHYS LETT, V73, P2423, DOI 10.1063/1.122469
   LEGEROS RZ, 1993, INTRO BIOCERAMICS, P139
   Leng YX, 2003, SURF SCI, V531, P177, DOI 10.1016/S0039-6028(03)00487-4
   Leng YX, 2000, THIN SOLID FILMS, V377, P573, DOI 10.1016/S0040-6090(00)01306-7
   Leng YX, 2001, SURF COAT TECH, V138, P296, DOI 10.1016/S0257-8972(00)01172-5
   Li H, 2004, SURF COAT TECH, V182, P227, DOI 10.1016/j.surfcoat.2003.08.081
   Li H, 2002, BIOMATERIALS, V23, P2105, DOI 10.1016/S0142-9612(01)00326-X
   Li H, 2000, MAT SCI ENG A-STRUCT, V293, P71, DOI 10.1016/S0921-5093(00)01245-4
   Li H, 2002, BIOMATERIALS, V23, P85, DOI 10.1016/S0142-9612(01)00082-5
   LI PJ, 1994, J BIOMED MATER RES, V28, P7, DOI 10.1002/jbm.820280103
   LI PJ, 1992, J AM CERAM SOC, V75, P2094, DOI 10.1111/j.1151-2916.1992.tb04470.x
   LI PJ, 1993, J BIOMED MATER RES, V27, P1495, DOI 10.1002/jbm.820271205
   LI PJ, 1994, J AM CERAM SOC, V77, P1307, DOI 10.1111/j.1151-2916.1994.tb05407.x
   Liang FH, 2003, J MATER SCI LETT, V22, P1665, DOI 10.1023/B:JMSL.0000004643.03120.ca
   Liu JX, 2003, THIN SOLID FILMS, V429, P225, DOI 10.1016/S0040-6090(03)00146-9
   Liu XH, 1996, J BIOMATER APPL, V10, P330
   Liu Xuanyong, 2002, Journal of the Chinese Ceramic Society, V30, P20
   Liu XY, 2004, BIOMATERIALS, V25, P1755, DOI 10.1016/j.biomaterials.2003.08.024
   Liu XY, 2003, SURF COAT TECH, V172, P270, DOI 10.1016/S0257-8972(03)00344-X
   Liu XY, 2002, BIOMATERIALS, V23, P4065, DOI 10.1016/S0142-9612(02)00143-6
   Liu XY, 2002, BIOMATERIALS, V23, P963, DOI 10.1016/S0142-9612(01)00210-1
   Liu XY, 2001, BIOMATERIALS, V22, P2007, DOI 10.1016/S0142-9612(00)00386-0
   LOMG M, 1998, BIOMATERIALS, V19, P1621
   Lu X, 2004, BIOMATERIALS, V25, P1779, DOI 10.1016/j.biomaterials.2003.08.028
   Lucchini JP, 1996, CLIN ORAL IMPLAN RES, V7, P397, DOI 10.1034/j.1600-0501.1996.070414.x
   Lynn AK, 2002, BIOMATERIALS, V23, P1947, DOI 10.1016/S0142-9612(01)00320-9
   Maege I, 1998, MACROMOL SY, V126, P7, DOI 10.1002/masy.19981260104
   Maitz MF, 2002, SURF COAT TECH, V158, P151, DOI 10.1016/S0257-8972(02)00189-5
   Maitz MF, 2002, BIOMOL ENG, V19, P269, DOI 10.1016/S1389-0344(02)00039-4
   Makino Y, 1998, SURF COAT TECH, V98, P934, DOI 10.1016/S0257-8972(97)00309-5
   Mandl S, 2002, SURF COAT TECH, V156, P276, DOI 10.1016/S0257-8972(02)00085-3
   Mantese JV, 1996, MRS BULL, V21, P52
   Mardare CC, 2003, J EUR CERAM SOC, V23, P1027, DOI 10.1016/S0955-2219(02)00278-9
   Marra KG, 1997, MACROMOLECULES, V30, P6483, DOI 10.1021/ma970481f
   MASUDA Y, 1990, NIPPON SERAM KYO GAK, V98, P1255
   MATEJKA D, 1989, PLASMA SPRAYING META, P25
   Matsue T, 2002, VACUUM, V66, P435, DOI 10.1016/S0042-207X(02)00167-7
   Mattox D. M., 1994, HDB DEPOSITION TECHN
   MCCOLL IR, 1994, DIAM RELAT MATER, V3, P83, DOI 10.1016/0925-9635(94)90035-3
   MCKELLOP HA, 1990, J BIOMED MATER RES, V24, P1413, DOI 10.1002/jbm.820241102
   MERRITT K, 1988, J BIOMED MATER RES, V22, P111, DOI 10.1002/jbm.820220204
   MEZGER PR, 1992, J DENT, V20, P342, DOI 10.1016/0300-5712(92)90021-4
   Michel R, 2002, LANGMUIR, V18, P3281, DOI 10.1021/la011715y
   Milella E, 2001, BIOMATERIALS, V22, P1425, DOI 10.1016/S0142-9612(00)00300-8
   MITAMURA Y, 1986, T AM SOC ART INT ORG, V32, P444
   Mittal K. L., 1979, SURFACE CONTAMINATIO, V1, P3
   Miyayama N, 1999, JPN J DENT MAT, V18, P109
   Morra M, 2001, WATER BIOMATERIALS S
   Morscher E., 1995, ENDOPROSTHETICS
   MORSCHER EW, 1991, J BONE JOINT SURG BR, V73, P705
   Mrksich M, 1996, ANNU REV BIOPH BIOM, V25, P55, DOI 10.1146/annurev.bb.25.060196.000415
   MU Y, 2000, J BIOMED MATER RES, V49, P283
   Mueller H J, 1970, J Biomed Mater Res, V4, P29, DOI 10.1002/jbm.820040105
   MULLERMAI C, 1994, BIOCERAMICS, V7, P159
   Nagano M, 1996, BIOMATERIALS, V17, P1771, DOI 10.1016/0142-9612(95)00357-6
   Nanci A, 1998, J BIOMED MATER RES, V40, P324
   Nie X, 2002, SURF COAT TECH, V149, P245, DOI 10.1016/S0257-8972(01)01453-0
   Nie X, 2001, J BIOMED MATER RES, V57, P612, DOI 10.1002/1097-4636(20011215)57:4<612::AID-JBM1208>3.0.CO;2-H
   Nie X, 2000, SURF COAT TECH, V125, P407, DOI 10.1016/S0257-8972(99)00612-X
   Nishiguchi S, 2001, J BIOMED MATER RES, V54, P198, DOI 10.1002/1097-4636(200102)54:2<198::AID-JBM6>3.0.CO;2-7
   Nishiguchi S, 1999, BIOMATERIALS, V20, P491, DOI 10.1016/S0142-9612(98)90203-4
   Nishio K, 2000, J BIOMED MATER RES, V52, P652, DOI 10.1002/1097-4636(20001215)52:4<652::AID-JBM9>3.3.CO;2-N
   Nonami T, 1999, J MATER SCI-MATER M, V10, P475, DOI 10.1023/A:1008996908797
   Ogden HR, 1961, RARE METALS HDB, P559
   OHRING M, MAT SCI THIN FILM DE, P277
   OHTSUKI C, 1992, J NON-CRYST SOLIDS, V143, P84, DOI 10.1016/S0022-3093(05)80556-3
   Ohtsuki C, 1997, J BIOMED MATER RES, V35, P39, DOI 10.1002/(SICI)1097-4636(199704)35:1<39::AID-JBM5>3.0.CO;2-N
   OKABE Y, 1991, NUCL INSTRUM METH B, V61, P44, DOI 10.1016/0168-583X(91)95558-U
   OKABE Y, 1989, NUCL INSTRUM METH B, V39, P619, DOI 10.1016/0168-583X(89)90861-6
   OKABE Y, 1994, SURF COAT TECH, V66, P384, DOI 10.1016/0257-8972(94)90035-3
   Orban JM, 2000, MACROMOLECULES, V33, P4205, DOI 10.1021/ma9915780
   Pan J, 1996, J BIOMED MATER RES, V30, P393
   PAN J, 1998, J BIOMED MAT RES, V40
   Parfitt G., 1976, PROGR SURFACE MEMBRA, V11, P181
   Park CH, 1998, THIN SOLID FILMS, V312, P182, DOI 10.1016/S0040-6090(97)00719-0
   PARK K, 1986, J COLLOID INTERF SCI, V111, P197, DOI 10.1016/0021-9797(86)90019-6
   PARK SS, 1991, J APPL PHYS, V69, P2618, DOI 10.1063/1.348653
   PARKER TE, 1975, J PHYS CHEM SOLIDS, V36, P377, DOI 10.1016/0022-3697(75)90062-1
   PARKER TL, 1994, DIAM RELAT MATER, V3, P1120, DOI 10.1016/0925-9635(94)90104-X
   PARKS GA, 1965, CHEM REV, V65, P177, DOI 10.1021/cr60234a002
   PARTENFELDER U, 1993, J MATER SCI-MATER M, V4, P292, DOI 10.1007/BF00122283
   Patsi ME, 1998, J SOL-GEL SCI TECHN, V11, P55, DOI 10.1023/A:1008684815735
   Peltola T, 1999, J BIOMED MATER RES, V44, P12, DOI 10.1002/(SICI)1097-4636(199901)44:1<12::AID-JBM2>3.0.CO;2-E
   Peltola T, 1998, J BIOMED MATER RES, V41, P504, DOI 10.1002/(SICI)1097-4636(19980905)41:3<504::AID-JBM22>3.0.CO;2-G
   Peng XL, 1998, THIN SOLID FILMS, V312, P207, DOI 10.1016/S0040-6090(97)00588-9
   PETERSON CD, 1988, J BIOMED MATER RES, V22, P887, DOI 10.1002/jbm.820221005
   Pham MT, 2000, THIN SOLID FILMS, V379, P50, DOI 10.1016/S0040-6090(00)01553-4
   PIVETEAU LD, 2001, TITANIUM MED, P267
   POLMEAR JJ, 1981, LIGHT ALLOYS, pCH6
   Prevey PS, 2000, J THERM SPRAY TECHN, V9, P369, DOI 10.1361/105996300770349827
   PRICE JB, 1993, THIN SOLID FILMS, V236, P311, DOI 10.1016/0040-6090(93)90688-L
   Puleo DA, 2002, BIOMATERIALS, V23, P2079, DOI 10.1016/S0142-9612(01)00339-8
   Ramires PA, 2001, BIOMATERIALS, V22, P1467, DOI 10.1016/S0142-9612(00)00269-6
   Ratner B. D., 2001, TITANIUM MED, P1
   Rats D, 1995, THIN SOLID FILMS, V270, P177, DOI 10.1016/0040-6090(95)06913-5
   RIEU J, 1991, BIOMATERIALS, V12, P139, DOI 10.1016/0142-9612(91)90192-D
   RINTOUL TC, 1993, AM SOC ARTIF INTERN, V39, P168
   ROSTOKER W, 1981, BIOMATERIALS, V2, P221, DOI 10.1016/0142-9612(81)90061-2
   SALSBURY RL, 1991, NATL THERMAL SPRAY C, P471
   SAMUNEVA B, 1993, J MATER SCI, V28, P2353, DOI 10.1007/BF01151665
   SCHINDLER PW, 1990, REV MINERAL, V23, P281
   SCHUTZ RW, 1993, BETA TITANIUM ALLOYS IN THE 1990S, P75
   Schwartz Z, 1996, J BIOMED MATER RES, V30, P145
   SCHWARZ K, 1987, CRC CR REV SOL STATE, V13, P211, DOI 10.1080/10408438708242178
   Scotchford CA, 1998, J BIOMED MATER RES, V41, P431, DOI 10.1002/(SICI)1097-4636(19980905)41:3<431::AID-JBM13>3.0.CO;2-L
   Serro AP, 1997, BIOMATERIALS, V18, P963, DOI 10.1016/S0142-9612(97)00031-8
   Shigematsu I, 2000, J MATER SCI LETT, V19, P967, DOI 10.1023/A:1006720306017
   Sigal GB, 1998, J AM CHEM SOC, V120, P3464, DOI 10.1021/ja970819l
   Silva PL, 1998, SURF COAT TECH, V102, P191, DOI 10.1016/S0257-8972(97)00576-8
   Sittig C, 1999, J MATER SCI-MATER M, V10, P35, DOI 10.1023/A:1008840026907
   SKARTVEIT L, 1990, ACTA ODONTOL SCAND, V48, P169, DOI 10.3109/00016359009005872
   SMITH DC, 1991, J BIOMED MATER RES, V25, P1069, DOI 10.1002/jbm.820250903
   Sobiecki J.R., 2002, VACUUM, V64, P41
   SOOD DK, 1992, SURF COAT TECH, V51, P307, DOI 10.1016/0257-8972(92)90255-9
   SPITSYN BV, 1981, J CRYST GROWTH, V52, P219, DOI 10.1016/0022-0248(81)90197-4
   SUGIMOTO T, 1995, INTERNAL MED VER 6, P2004
   Sul YT, 2001, MED ENG PHYS, V23, P329, DOI 10.1016/S1350-4533(01)00050-9
   Sumitomo Chemical Co, 1975, Patent Application, Patent No. 158745
   Sun LM, 2001, J BIOMED MATER RES, V58, P570, DOI 10.1002/jbm.1056.abs
   SUNDGREN JE, 1986, J COLLOID INTERF SCI, V113, P530, DOI 10.1016/S0021-9797(86)90446-7
   SUTHERLAND DS, 1993, BIOMATERIALS, V14, P893, DOI 10.1016/0142-9612(93)90130-T
   Swart K M, 1992, J Oral Implantol, V18, P130
   Taborelli M, 1997, CLIN ORAL IMPLAN RES, V8, P208, DOI 10.1034/j.1600-0501.1997.080307.x
   Takebe J, 2000, J BIOMED MATER RES, V51, P398, DOI 10.1002/1097-4636(20000905)51:3<398::AID-JBM14>3.0.CO;2-#
   Takeuchi M, 2003, BIOMATERIALS, V24, P1821, DOI 10.1016/S0142-9612(02)00576-8
   Tamura RN, 1997, J PERIODONTAL RES, V32, P287, DOI 10.1111/j.1600-0765.1997.tb00536.x
   Tanahashi M, 1997, J BIOMED MATER RES, V34, P305
   TANG L, 1995, BIOMATERIALS, V16, P483, DOI 10.1016/0142-9612(95)98822-V
   Tang ZY, 2000, LANGMUIR, V16, P1696, DOI 10.1021/la981491s
   TAO S, 1999, Patent No. 991240340
   Tao SY, 2000, J BIOMED MATER RES, V52, P572
   Tegoulia VA, 2001, LANGMUIR, V17, P4396, DOI 10.1021/la001790t
   Tegoulia VA, 2000, J BIOMED MATER RES, V50, P291, DOI 10.1002/(SICI)1097-4636(20000605)50:3<291::AID-JBM2>3.0.CO;2-1
   TENGVALL P, 1992, Clinical Materials, V9, P115, DOI 10.1016/0267-6605(92)90056-Y
   TENGVALL P, 1989, BIOMATERIALS, V10, P118, DOI 10.1016/0142-9612(89)90043-4
   TENGVALL P, 1989, BIOMATERIALS, V10, P166, DOI 10.1016/0142-9612(89)90019-7
   Textor M, 2000, LANGMUIR, V16, P3257, DOI 10.1021/la990941t
   Textor M., 2001, TITANIUM MED, P171
   Thomsen P, 1997, J MATER SCI-MATER M, V8, P653, DOI 10.1023/A:1018579605426
   Thorwarth G, 2001, SURF COAT TECH, V136, P236, DOI 10.1016/S0257-8972(00)01021-5
   TORREGROSA F, 1995, THIN SOLID FILMS, V266, P245, DOI 10.1016/0040-6090(96)80028-9
   Tosatti S, 2003, BIOMATERIALS, V24, P4949, DOI 10.1016/S0142-9612(03)00420-4
   Tosatti S, 2002, LANGMUIR, V18, P3537, DOI 10.1021/la011459p
   TRAPALIS C, 1993, J MATER SCI, V28, P1276, DOI 10.1007/BF01191964
   Tsui YC, 1998, BIOMATERIALS, V19, P2015, DOI 10.1016/S0142-9612(98)00103-3
   Tsyganov I, 2002, SURF COAT TECH, V158, P318, DOI 10.1016/S0257-8972(02)00190-1
   Tung M. S., 1998, CALCIUM PHOSPHATE BI
   Uchida M, 2004, SURF COAT TECH, V177, P627, DOI 10.1016/S0257-8972(03)00937-X
   ULMAN A, 1990, ADV MATER, V2, P573, DOI 10.1002/adma.19900021203
   VAUDAUX P, 1990, CLIN IMPLANT MATERIA, V9, P31
   Vercaigne S, 1998, J BIOMED MATER RES, V41, P41, DOI 10.1002/(SICI)1097-4636(199807)41:1<41::AID-JBM5>3.0.CO;2-Q
   Viviente JL, 1999, VACUUM, V52, P141, DOI 10.1016/S0042-207X(98)00213-9
   Voevodin AA, 1996, SURF COAT TECH, V86-7, P516, DOI 10.1016/S0257-8972(96)03069-1
   WALIVAARA B, 1994, BIOMATERIALS, V15, P827, DOI 10.1016/0142-9612(94)90038-8
   Walivaara Bengt, 1993, Clinical Materials, V12, P141, DOI 10.1016/0267-6605(93)90065-F
   WANG BC, 1993, J BIOMED MATER RES, V27, P1315, DOI 10.1002/jbm.820271012
   Wang CX, 2003, BIOMATERIALS, V24, P3069, DOI 10.1016/S0142-9612(03)00154-6
   Wang CX, 2002, MATER LETT, V54, P30, DOI 10.1016/S0167-577X(01)00532-8
   Wang XX, 2002, BIOMATERIALS, V23, P1353, DOI 10.1016/S0142-9612(01)00254-X
   Wang XX, 2000, J BIOMED MATER RES, V52, P171, DOI 10.1002/1097-4636(200010)52:1<171::AID-JBM22>3.0.CO;2-O
   Wang Y, 1998, J THERM SPRAY TECHN, V7, P50, DOI 10.1007/s11666-006-5003-9
   Wang YL, 2000, CHEM COMMUN, P587, DOI 10.1039/b000419g
   Watanabe H, 2003, SURF COAT TECH, V169, P452, DOI 10.1016/S0257-8972(03)00190-7
   Weber M, 1998, HELV CHIM ACTA, V81, P1359, DOI 10.1002/hlca.19980810546
   Wen F, 2002, SURF COAT TECH, V156, P208, DOI 10.1016/S0257-8972(02)00088-9
   Wen HB, 1997, BIOMATERIALS, V18, P1471, DOI 10.1016/S0142-9612(97)82297-1
   Wen HB, 1998, J MATER SCI-MATER M, V9, P121, DOI 10.1023/A:1008859417664
   Weng W, 1997, J EUR CERAM SOC, V17, P1151, DOI 10.1016/S0955-2219(96)00215-4
   Weng WJ, 1999, J AM CERAM SOC, V82, P27
   Weng WJ, 1998, BIOMATERIALS, V19, P125, DOI 10.1016/S0142-9612(97)00177-4
   Wennerberg A, 1996, BIOMATERIALS, V17, P15, DOI 10.1016/0142-9612(96)80750-2
   Wennerberg A, 1996, J BIOMED MATER RES, V30, P251, DOI 10.1002/(SICI)1097-4636(199602)30:2<251::AID-JBM16>3.0.CO;2-P
   Wieser E, 1999, SURF COAT TECH, V111, P103, DOI 10.1016/S0257-8972(98)00717-8
   Williams D. F., 1987, DEFINITIONS BIOMATER
   WILLIAMS DF, 2001, TITANIUM MED, P13
   WILLIAMS JM, 1985, P ASM C APPL ION PLA, P141
   WILLIAMS RL, 1988, BIOMATERIALS, V9, P181, DOI 10.1016/0142-9612(88)90119-6
   WISBEY A, 1987, BIOMATERIALS, V8, P477, DOI 10.1016/0142-9612(87)90085-8
   Wolke JGC, 1998, J BIOMED MATER RES, V39, P524
   Woodward JT, 1996, LANGMUIR, V12, P3626, DOI 10.1021/la9510689
   Xiao SJ, 1998, LANGMUIR, V14, P5507, DOI 10.1021/la980257z
   Xiao SJ, 1997, J MATER SCI-MATER M, V8, P867, DOI 10.1023/A:1018501804943
   XIAO SJ, 2001, TITANIUM MED, P417
   Xu GC, 2003, SURF COAT TECH, V169, P299, DOI 10.1016/S0257-8972(03)00113-0
   Xue WB, 1998, J AM CERAM SOC, V81, P1365
   Xue WC, 2004, SURF COAT TECH, V185, P340, DOI 10.1016/j.surfcoat.2003.12.018
   Xue WC, 2004, BIOMATERIALS, V25, P415, DOI 10.1016/S0142-9612(03)00545-3
   Yang BC, 2004, BIOMATERIALS, V25, P1003, DOI 10.1016/S0142-9612(03)00626-4
   Yang BC, 1999, J BIOMED MATER RES, V47, P213, DOI 10.1002/(SICI)1097-4636(199911)47:2<213::AID-JBM11>3.0.CO;2-C
   Yang CY, 1997, J BIOMED MATER RES, V36, P39
   YANG P, 2002, SURF COAT TECH, V156, P2840
   Yang ZH, 1999, LANGMUIR, V15, P1731, DOI 10.1021/la980839g
   Yatsuzuka M, 2000, VACUUM, V59, P330, DOI 10.1016/S0042-207X(00)00286-4
   Yerokhin AL, 1999, SURF COAT TECH, V122, P73, DOI 10.1016/S0257-8972(99)00441-7
   Yerokhin AL, 2000, SURF COAT TECH, V130, P195, DOI 10.1016/S0257-8972(00)00719-2
   Yoshida K, 1999, J BIOMED MATER RES, V48, P778, DOI 10.1002/(SICI)1097-4636(1999)48:6<778::AID-JBM3>3.0.CO;2-C
   Yoshinari M, 2000, J BIOMED MATER RES, V52, P388, DOI 10.1002/1097-4636(200011)52:2<388::AID-JBM20>3.0.CO;2-E
   Yoshinari M, 2001, BIOMATERIALS, V22, P2043, DOI 10.1016/S0142-9612(00)00392-6
   Yoshinari M, 2001, BIOMATERIALS, V22, P709, DOI 10.1016/S0142-9612(00)00234-9
   Zeiler E, 1999, SURF COAT TECH, V116, P599, DOI 10.1016/S0257-8972(99)00136-X
   ZHANG D, 1991, CORR CONTR 7 APCCC C, P793
   Zheng XB, 2000, BIOMATERIALS, V21, P841, DOI 10.1016/S0142-9612(99)00255-0
   Zhu XL, 2002, J BIOMED MATER RES, V60, P333, DOI 10.1002/jbm.10105
   Zhu XL, 2001, BIOMATERIALS, V22, P2199, DOI 10.1016/S0142-9612(00)00394-X
   Zwilling V, 1999, ELECTROCHIM ACTA, V45, P921, DOI 10.1016/S0013-4686(99)00283-2
NR 377
TC 1630
Z9 1699
U1 86
U2 898
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0927-796X
EI 1879-212X
J9 MAT SCI ENG R
JI Mater. Sci. Eng. R-Rep.
PD DEC 24
PY 2004
VL 47
IS 3-4
BP 49
EP 121
DI 10.1016/j.mser.2004.11.001
PG 73
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 899JZ
UT WOS:000227142000001
OA Green Published
DA 2018-10-19
ER

PT J
AU Pernegger, H
   Frais-Kolbl, H
   Griesmayer, E
   Kagan, H
AF Pernegger, H
   Frais-Kolbl, H
   Griesmayer, E
   Kagan, H
TI Design and test of a high-speed single-particle beam monitor
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS
   SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT
LA English
DT Article; Proceedings Paper
CT 10th International Vienna Conference on Instrumentation
CY FEB 16-21, 2004
CL Vienna, AUSTRIA
SP Fed Minist Educ, Sci & Culture, Fed Minist Transport, Innovat & Technol, Austrian Acad Sci, Univ Technol, Vienna, Vienna Convent Bur, European Phys Soc
DE CVD diamond; semiconductor radiation detectors; proton detectors; proton
   accelerators; high-speed electronics; biomedical nuclear imaging
AB The paper presents the first test results of a charged-particle solid-state detector with very fast signal response. We used polycrystalline Chemical-Vapor-Deposition (pCVD) diamond as active sensor material and high-bandwidth RF amplifiers to develop a charged-particle detector suitable for high counting rates. The pCVD diamond is segmented with large and small pads for position sensitivity. The detector is intended as a high-speed beam monitor and diagnostics system for proton accelerators in the field of medical ion therapy and high-energy physics experiments. (C) 2004 Elsevier B.V. All rights reserved.
C1 CERN, Dept Phys, Geneva, Switzerland.
   Fachhsch Wirschaft & Tech, Wiener Neustadt, Austria.
   Ohio State Univ, Dept Phys, Columbus, OH 43210 USA.
RP Pernegger, H (reprint author), CERN, Dept Phys, Geneva, Switzerland.
EM heinz.pernegger@cern.ch
CR ADAM W, 1997, ELECTROCHEMICAL SOC, V97, P491
   FERNANDEZHERNAN.L, 2004, P 2004 IEEE INSTR ME
   FRAISKOLBI H, UNPUB IEEE T NUCL SC
   HUHTINEN M, 2003, COMMUNICATION
   MOTTER R, 1998, MEDAUSTRON MACHBARKE
NR 5
TC 7
Z9 7
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-9002
J9 NUCL INSTRUM METH A
JI Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc.
   Equip.
PD DEC 11
PY 2004
VL 535
IS 1-2
BP 108
EP 114
DI 10.1016/j.nima.2004.07.213
PG 7
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Nuclear; Physics, Particles & Fields
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA 877OS
UT WOS:000225580500014
DA 2018-10-19
ER

PT J
AU Katti, KS
AF Katti, KS
TI Biomaterials in total joint replacement
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Review
DE THR; biomedical; review; bone; mechanical properties
ID HYDROXYAPATITE HA PARTICLES; L-LACTIDE PLLA; COMPOSITE BIOMATERIALS;
   MECHANICAL-PROPERTIES; POLYETHYLENE COMPOSITES; BIODEGRADABLE POLYMERS;
   BIORESORBABLE DEVICES; POTENTIAL APPLICATION; FORGED COMPOSITES; BONE
AB The current state of materials systems used in total hip replacement is presented in this paper. An overview of the various material systems used in total hip replacement reported in literature is presented in this paper. Metals, polymers, ceramics and composites are used in the design of the different components of hip replacement implants. The merits and demerits of these material systems are evaluated in the context of mechanical properties most suitable for total joint replacement such as a hip implant. Current research on advanced polymeric nanocomposites and biomimetic composites as novel materials systems for bone replacement is also discussed. This paper examines the current research in the materials science and the critical issues and challenges in these materials systems that require further research before application in biomedical industry. (C) 2003 Elsevier B.V. All rights reserved.
C1 N Dakota State Univ, Dept Civil Engn, Fargo, ND 58105 USA.
RP Katti, KS (reprint author), N Dakota State Univ, Dept Civil Engn, CIE 201B, Fargo, ND 58105 USA.
EM Kalpana.katti@ndsu.nodak.edu
CR Abusafieh A, 1997, J APPL POLYM SCI, V63, P75, DOI 10.1002/(SICI)1097-4628(19970103)63:1<75::AID-APP8>3.0.CO;2-P
   Abusafieh A, 1997, J BIOMED MATER RES, V38, P314
   BAGAMBISA FB, 1993, J BIOMED MATER RES, V27, P1047, DOI 10.1002/jbm.820270810
   Bakos D, 1999, BIOMATERIALS, V20, P191, DOI 10.1016/S0142-9612(98)00163-X
   Barrows TH, 1986, CLIN MATER, V1, P233
   Black J., 1992, BIOL PERFORMANCE MAT
   Bleach NC, 2002, BIOMATERIALS, V23, P1579, DOI 10.1016/S0142-9612(01)00283-6
   BONFIELD W, 1993, INTRO BIOCERAMICS, V1, P290
   BRUNSKI JB, 1996, BIOMATERIALS SCI INT
   CHANG FK, 1990, J BIOMED MATER RES, V24, P873, DOI 10.1002/jbm.820240707
   Chang MC, 2003, BIOMATERIALS, V24, P2853, DOI 10.1016/S0142-9612(03)00115-7
   Chang MC, 2002, J MATER SCI-MATER M, V13, P993, DOI 10.1023/A:1019825132610
   Chang MC, 2002, J MATER SCI LETT, V20, P1129
   CHARNLEY J, 1970, CLIN ORTHOP RELAT R, P7
   CHARNLEY J, 1961, LANCET, V1, P1129
   CHEVALIER J, 1977, BIOCERAMICS, V10
   CHO S, 1997, KEY ENG MATER, P132
   Christel P, 1988, Ann N Y Acad Sci, V523, P234, DOI 10.1111/j.1749-6632.1988.tb38516.x
   Christel P., 1997, BIOL BIOMECHANICAL P, P81
   CHRISTEL PS, 1980, MECHANICAL PROPERTIE, P367
   Claes L., 1997, BIOL BIOMECHANICAL P, P81
   Corvelli AA, 1999, J MATER SCI, V34, P2421, DOI 10.1023/A:1004562732460
   Currey JD, 1984, MECH ADAPTATIONS BON
   DAVIDSON JA, P SOC MAN ENG IT IL
   EHSANI N, 1995, KEY ENG MATER, V104, P373
   FRATZ P., 1997, J STRUCT BIOL, V122, P119
   Fujihara K, 2003, BIOMATERIALS, V24, P2661, DOI 10.1016/S0142-9612(03)00065-6
   Galego N, 2000, POLYM TEST, V19, P485, DOI 10.1016/S0142-9418(99)00011-2
   GILDING DK, 1979, POLYMER, V20, P1459, DOI 10.1016/0032-3861(79)90009-0
   GILLETT A, 1986, BIOMATERIALS, V6, P113
   Greish YE, 2001, BIOMATERIALS, V22, P807, DOI 10.1016/S0142-9612(00)00243-X
   GROSS V, 1998, CRC CRITIC REV BIOCO, V4, P2
   Guo HB, 2003, BIOMATERIALS, V24, P667, DOI 10.1016/S0142-9612(02)00381-2
   HELLMICH C, 2002, ULM J ENG MECH, V123, P898
   HELMER JD, 1969, P S US CER SURG IMP
   Hench L. L., 1993, INTRO BIOCERAMICS, V1
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   HEYWOOD BR, 1990, CONNECT TISSUE RES, V25, P103, DOI 10.3109/03008209009006985
   HIGASHI S, 1986, BIOMATERIALS, V7, P183, DOI 10.1016/0142-9612(86)90099-2
   HUANG J, 1997, J MATER SCI-MATER M, V8, P779
   HUISKES R, 1983, J BIOMECH, V16, P385, DOI 10.1016/0021-9290(83)90072-6
   Hulbert SF, 1987, HIGH TECH CERAMICS, P3
   Ignjatovic N, 1999, BIOMATERIALS, V20, P809, DOI 10.1016/S0142-9612(98)00234-8
   Ignjatovic N, 1999, J MICROSC-OXFORD, V196, P23
   Iooss P, 2001, BIOMATERIALS, V22, P2785, DOI 10.1016/S0142-9612(01)00022-9
   JOCKISCH KA, 1992, J BIOMED RES, V26, P113
   Kasuga T, 2003, BIOMATERIALS, V24, P3247, DOI 10.1016/S0142-9612(03)00190-X
   KASUGA T, 2001, BIOMATERIALS, V22, P1923
   Kato K, 1997, J MATER SCI, V32, P5533, DOI 10.1023/A:1018616306104
   Katti K., 2002, P 15 ASCE ENG MECH C
   KATTI KS, 2001, P 2001 MRS FALL M S
   Kikuchi M, 1997, J MATER SCI-MATER M, V8, P361, DOI 10.1023/A:1018580816388
   KIKUCHI M, 1999, BIOCERAMICS, V12, P393
   Legeros Racquel Z., 1993, Clinical Materials, V14, P65, DOI 10.1016/0267-6605(93)90049-D
   LEWANDOWSKASZUMIEL, 1999, J BIOMED MATER RES, V48, P289
   LI J, 1995, BIOMATERIALS, V16, P417, DOI 10.1016/0142-9612(95)98860-G
   Liou SC, 2003, BIOMATERIALS, V24, P3981, DOI 10.1016/S0142-9612(03)00303-X
   Liu Q, 1997, BIOMATERIALS, V18, P1263, DOI 10.1016/S0142-9612(97)00069-0
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Lopes MA, 1999, BIOMATERIALS, V20, P2085, DOI 10.1016/S0142-9612(99)00112-X
   MAGEE FP, 1988, CLIN ORTHOP RELAT R, V1, P235
   McKee G K, 1966, J Bone Joint Surg Br, V48, P245
   Moursi AM, 2002, BIOMATERIALS, V23, P133, DOI 10.1016/S0142-9612(01)00088-6
   MOURTIER A, 1989, J SOLID STATE CHEM, V78, P215
   Ota Y, 1998, J AM CERAM SOC, V81, P1665
   Pazo A, 1998, ACTA MATER, V46, P2551, DOI 10.1016/S1359-6454(98)80039-6
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   Ravaglioli A., 1992, BIOCERAMICS MAT PROP, P422
   Reed CS, 1996, CHEM MATER, V8, P440, DOI 10.1021/cm9503644
   Reis RL, 1995, J MATER SCI-MATER M, V6, P786, DOI 10.1007/BF00134318
   Rodriguez-Lorenzo LM, 2001, BIOMATERIALS, V22, P583, DOI 10.1016/S0142-9612(00)00218-0
   ROSATO DV, 1983, BIOCOMPATIBLE POLYM, P1022
   RUSTON N, 1984, BIOMATERIALS, V5, P352
   RUYS AJ, 1991, BIOCERAMICS, V4, P281
   SCHMITT FO, 1985, ANNU REV BIOPHYS BIO, V4, P1
   Shikinami Y, 1999, BIOMATERIALS, V20, P859, DOI 10.1016/S0142-9612(98)00241-5
   Shikinami Y, 2001, BIOMATERIALS, V22, P3197, DOI 10.1016/S0142-9612(01)00072-2
   SIMOES JA, 1999, COMPOS SCI TECHNOL, V60, P559
   Sousa RA, 2002, POLYM ENG SCI, V42, P1032, DOI 10.1002/pen.11010
   STENZEL KH, 1974, ANNU REV BIOPHYS BIO, V3, P231, DOI 10.1146/annurev.bb.03.060174.001311
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Tancred DC, 1998, BIOMATERIALS, V19, P1735, DOI 10.1016/S0142-9612(98)00082-9
   Toshihiro K., 2001, BIOMATERIALS, V22, P19
   VACANTI CA, 1994, OTOLARYNG CLIN N AM, V27, P263
   VALLO CI, 1999, J BIOMED RES, V48, P158
   Van Blitterswijk C A, 1986, BIOMATERIALS, V7, P553
   Vaz CM, 2002, BIOMATERIALS, V23, P629, DOI 10.1016/S0142-9612(01)00150-8
   VERHEYEN CCPM, 1993, J MATER SCI-MATER M, V4, P58, DOI 10.1007/BF00122979
   VERT M, 1986, POLYM MED, V2, P263
   VONRECUM, 1999, HDB BIOMATERIALS EVA, P915
   WALKER PS, 1971, WEAR, V17, P285, DOI 10.1016/0043-1648(71)90032-9
   Wang M, 2001, BIOMATERIALS, V22, P1311, DOI 10.1016/S0142-9612(00)00283-0
   WANG M, 1994, BRIT CERAM T, V93, P91
   Wang M., 1996, P 7 EUR C COMP MAT L, P455
   Wang XJ, 2002, BIOMATERIALS, V23, P4787, DOI 10.1016/S0142-9612(02)00229-6
   Watari F, 1997, COMPOS PART B-ENG, V28, P5, DOI 10.1016/S1359-8368(96)00021-2
   Williams D. F., 1987, DEFINITIONS BIOMATER
   WILSON J, 1981, J BIOMED MATER RES, V15, P805, DOI 10.1002/jbm.820150605
   WONG H, 2002, MAT SCI ENG C-BIO S, V20, P111
   WOO SLY, 1974, J BIOMED MATER RES, V8, P321, DOI 10.1002/jbm.820080513
   Yasuda HY, 2000, BIOMATERIALS, V21, P2045, DOI 10.1016/S0142-9612(00)00090-9
   YOSHIMURA M, 1994, J MATER SCI, V29, P3399, DOI 10.1007/BF00352039
   Zhang RY, 1999, J BIOMED MATER RES, V45, P285
NR 103
TC 251
Z9 255
U1 5
U2 105
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD DEC 10
PY 2004
VL 39
IS 3
BP 133
EP 142
DI 10.1016/j.colsurfb.2003.12.002
PG 10
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 878HE
UT WOS:000225636600006
PM 15556342
DA 2018-10-19
ER

PT J
AU Kuo, SM
   Niu, GCC
   Chang, SJ
   Kuo, CH
   Bair, MS
AF Kuo, SM
   Niu, GCC
   Chang, SJ
   Kuo, CH
   Bair, MS
TI A one-step method for fabricating chitosan microspheres
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE polysaccharides; extrusion; microgels; microspheres; crosslinking
ID DRUG-RELEASE; ISLETS; BIOCOMPATIBILITY; POLYSACCHARIDES; GLUTARALDEHYDE;
   MICROCAPSULES; MEMBRANES; DELIVERY; KINETICS; DESIGN
AB A simple and in situ method, by using a high-voltage electrostatic system, for the fabrication of chitosan microspheres (in a form of isolatable microgels) by an extrusion process, exhibiting variable sizes and different membrane structures, was presented. The chitosan microspheres exhibited good sphericity and were in the range of 185.8 +/- 13.8 to 380.9 +/- 11.5 mum in diameter. There were two significant factors, the pump flow rate and electrostatic field strength, that affected the chitosan microsphere size. The microsphere size decreased when the flow rate was increased from 0.1 to 0.4 mL/h. Also, the microsphere size decreased when the electrostatic field strength was increased from 5.5 to 6.5 kV/cm. However, when the electrostatic field strength was raised to 7 kV/cm and higher, the microsphere size increased. For the latter case, with other parameters fixed, chitosan microsphere size can be controlled by adjusting the electrostatic field strength and predetermined by a simple linear regression equation: Microsphere Diameter (D, in mum) = -(75.48) + 45.67 x (Electrostatic Field Strength, E, in kV/cm), at [7 less than or equal to (Electrostatic Field Strength) less than or equal to 10] (R-2 = 0.956, P < 0.001). Following treatment with various ratios of crosslinking/gelating (Na5P3O10/NaOH) agents, the prepared chitosan microspheres exhibited distinct membrane structures that yielded various mechanical strengths. In the Na5P3O10/NaOH ratio of 19, the chitosan microspheres had a distinct two-layer structure. The selection of crosslinking/gelating ratio provided an additional degree of freedom, permitting the simultaneous regulation of mechanical properties and permeability of the microspheres, without extra manipulation, and thus, improved applicability in the biomedical field. When the chitosan microsphere extrusion process was used to encapsulate (beta-tricalcium phosphate powder for application as bony material, we found that the ultra fine (beta-tricalcium phosphate powder was trapped inside of the membrane very well. After appropriate collecting procedures, stored microspheres also retained good spherical shape. (C) 2004 Wiley Periodicals.
C1 I SHOU Univ, Dept Biomed Engn, Kaohsiung, Taiwan.
RP Niu, GCC (reprint author), I SHOU Univ, Dept Biomed Engn, Kaohsiung, Taiwan.
EM gniu@isu.edu.tw
CR Acikgoz M, 1996, J MICROENCAPSUL, V13, P141, DOI 10.3109/02652049609052903
   Amiji MM, 1996, J BIOMAT SCI-POLYM E, V8, P281, DOI 10.1163/156856296X00309
   ETUK BR, 1995, J MICROENCAPSUL, V12, P173, DOI 10.3109/02652049509015288
   FAN MY, 1990, DIABETES, V39, P519, DOI 10.2337/diabetes.39.4.519
   Genta I, 1998, CARBOHYD POLYM, V36, P81, DOI 10.1016/S0144-8617(98)00022-8
   Genta I, 1997, INT J PHARM, V152, P237, DOI 10.1016/S0378-5173(97)00096-3
   Gutowska A, 2001, ANAT RECORD, V263, P342, DOI 10.1002/ar.1115
   HALLE JP, 1994, CELL TRANSPLANT, V3, P365, DOI 10.1177/096368979400300503
   HALLE JP, 1993, TRANSPLANTATION, V55, P350, DOI 10.1097/00007890-199302000-00023
   He P, 1999, INT J PHARM, V187, P53, DOI 10.1016/S0378-5173(99)00125-8
   Hsu Brend Ray-Sea, 1994, Journal of the Formosan Medical Association, V93, P240
   ILLUM L, 1994, PHARMACEUT RES, V11, P1186, DOI 10.1023/A:1018901302450
   Kuo SM, 2003, J APPL POLYM SCI, V89, P3897, DOI 10.1002/app.12590
   Lorenzo-Lamosa ML, 1998, J CONTROL RELEASE, V52, P109, DOI 10.1016/S0168-3659(97)00203-4
   LUM ZP, 1992, TRANSPLANTATION, V53, P1180, DOI 10.1097/00007890-199206000-00002
   Mi FL, 1999, BIOMATERIALS, V20, P1603, DOI 10.1016/S0142-9612(99)00064-2
   Mi FL, 2001, BIOMATERIALS, V22, P165, DOI 10.1016/S0142-9612(00)00167-8
   Mi FL, 2000, CARBOHYD POLYM, V41, P389, DOI 10.1016/S0144-8617(99)00104-6
   Mi FL, 2002, BIOMATERIALS, V23, P181, DOI 10.1016/S0142-9612(01)00094-1
   OHYA Y, 1993, J MICROENCAPSUL, V10, P1, DOI 10.3109/02652049309015307
   SU CH, 2003, 8 BIOCH ENG C TAIW
   Suzuki T, 1999, J BIOSCI BIOENG, V88, P194, DOI 10.1016/S1389-1723(99)80201-1
   THANOO BC, 1992, J PHARM PHARMACOL, V44, P283, DOI 10.1111/j.2042-7158.1992.tb03607.x
   Wang YC, 2003, BIOMATERIALS, V24, P1047, DOI 10.1016/S0142-9612(02)00434-9
NR 24
TC 40
Z9 41
U1 3
U2 20
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD DEC 5
PY 2004
VL 94
IS 5
BP 2150
EP 2157
DI 10.1002/app.21131
PG 8
WC Polymer Science
SC Polymer Science
GA 866FR
UT WOS:000224759700038
DA 2018-10-19
ER

PT J
AU Cerri, G
   de' Gennaro, M
   Bonferoni, MC
   Caramella, C
AF Cerri, G
   de' Gennaro, M
   Bonferoni, MC
   Caramella, C
TI Zeolites in biomedical application: Zn-exchanged clinoptilolite-rich
   rock as active carrier for antibiotics in anti-acne topical therapy
SO APPLIED CLAY SCIENCE
LA English
DT Article; Proceedings Paper
CT Euroclay Conference
CY 2003
CL Modena, ITALY
DE zeolite; clinoptilolite; cation exchange capacity; acne; drug carrier;
   pharmaceutical application
ID SILVER-ZEOLITE; NATURAL CLINOPTILOLITE; ERYTHROMYCIN-RESISTANT; NORTHERN
   SARDINIA; ZINC; MINERALS; WATER
AB A clinoptilolite-rich rock was evaluated as inorganic Zn2+ releasing carrier for antibiotic erythromycin. The perspective is its use in the topical treatment of acne, a diffused skin pathology, given the efficacy of zinc-erythromycin combination against resistant Propionibacterium strains. The tested rock is an ash-rich epiclastite collected in Northern-Central part of Sardinia island (Italy). ICP chemical analyses of the bulk rock evidenced a composition compatible with topical applications. A 66 wt.% of clinoptilolite content was determined by means of XRD analysis (reference intensity ratio [RIR] technique). EDS chemical analyses of zeolite crystals were performed on polished thin section. The CEC of the rock is 1.45+/-0.08 meq/g. Using a specific exchange method, the material was previously Na-conditioned then Zn-conditioned. A substantially complete Zn-form was obtained, as demonstrated by AAS analyses. A back-exchange reaction toward Na-form was performed in the same conditions (65degreesC in 1 M NaCl solution): zinc release was fast and almost complete (94%). Zn-conditioned powder was then micronized to achieve a volume/surface ratio suitable for a topical therapy. After micronization, the specific surface area, determined by BET gas adsorption, was 30.2 m(2)/g, and 92% of the powdered rock was lower than 30 mum in size (measured by a Coulter Counter apparatus); the so-called "volume-surface diameter" was 6.48 mum, compatible with the intended topical application. Zn2+ release was measured on micronized rock at 37 degreesC both in physiologic solution as in 0.05 M KH2PO4/Na2HPO4 buffer. Also in these conditions, a prompt and significant zinc release was recorded: after 30 min, 68% and 60%, respectively. Erythromycin was charged onto the micronized material using a solvent evaporation method. HPLC determinations showed that 85% of the drug contacted with the carrier was loaded. The simultaneous release of zinc and erythromycin were evaluated in phosphate buffer. Eighty-two percent of the loaded antibiotic was released after 30 min. Zinc exchange is substantially unaffected by the contemporary drug release. The request to file an international patent for this pharmaceutical application has been accepted by the European International Preliminary Examination Office. (C) 2004 Elsevier B.V. All rights reserved.
C1 Univ Sassari, Ist Sci Geol Mineral, I-07100 Sassari, Italy.
   Univ Naples Federico II, Dipartimento Sci Terra, I-80134 Naples, Italy.
   Univ Pavia, Dipartimento Chim Farmaceut, I-27100 Pavia, Italy.
RP Cerri, G (reprint author), Univ Sassari, Ist Sci Geol Mineral, Corso Angioj 10, I-07100 Sassari, Italy.
EM gcerri@uniss.it
RI de Gennaro, Maurizio/H-4404-2011; Bonferoni, Maria Cristina/G-2760-2017
OI Bonferoni, Maria Cristina/0000-0002-1194-9372; Cerri,
   Guido/0000-0002-6685-3351
CR *AAVV, 1995, US PHARM, P2391
   Abe Y, 2003, INT J PROSTHODONT, V16, P141
   Armbruster T, 2001, REV MINERAL GEOCHEM, V45, P1, DOI 10.2138/rmg.2001.45.1
   ARMBRUSTER T, 2001, STUDIES SURFACE CHEM, V135
   BOJAR RA, 1994, BRIT J DERMATOL, V130, P329, DOI 10.1111/j.1365-2133.1994.tb02929.x
   Carretero MI, 2002, APPL CLAY SCI, V21, P155, DOI 10.1016/S0169-1317(01)00085-0
   CERJANSTEFANOVI.S, 1997, NATURAL ZEOLITES SOF, P121
   Cerri G, 2002, CLAY CLAY MINER, V50, P127, DOI 10.1346/000986002761002739
   Cerri G, 2001, CONTRIB MINERAL PETR, V140, P404, DOI 10.1007/s004100000196
   CERRI G, 2000, THESIS U SASSARI ITA
   Cerri G., 2002, B SOC GEOL ITAL, V121, P3
   Chipera Steve J., 1995, POWDER DIFFR, V10, P47
   Cik G, 2001, CHEMOSPHERE, V44, P313, DOI 10.1016/S0045-6535(00)00306-4
   Coombs DS, 1998, EUR J MINERAL, V10, P1037
   Cowan MM, 2003, J IND MICROBIOL BIOT, V30, P102, DOI 10.1007/s10295-002-0022-0
   deGennaro M, 1996, MINER DEPOSITA, V31, P452, DOI 10.1007/BF00196127
   Edmundson I C, 1967, Adv Pharm Sci, V2, P95
   FOYE WO, 1991, PRINCIPI CHIM FARMAC, P772
   FUJIMOTO T, 1998, FUEL ENERGY ABSTR, V39, P214
   HABBEMA L, 1989, BRIT J DERMATOL, V121, P497, DOI 10.1111/j.1365-2133.1989.tb15518.x
   HARUNA J, 1993, MICROPOROUS MATER, V1, P235
   HEBBORN P, 1976, Patent No. 4000263
   HOLLAND KT, 1992, BRIT J DERMATOL, V126, P505, DOI 10.1111/j.1365-2133.1992.tb15124.x
   Hotta M, 1998, J ORAL REHABIL, V25, P485, DOI 10.1046/j.1365-2842.1998.00265.x
   IZMIROVA N, 2001, STUDIES SURFACE SCI, V135
   Kallo D, 2001, REV MINERAL GEOCHEM, V45, P519, DOI 10.2138/rmg.2001.45.15
   Kirov G.N., 1997, NATURAL ZEOLITES SOF, P133
   KLEINER DM, 2003, OFF J SOC ACAD EMERG, V10, P570
   Langella A, 2000, MICROPOR MESOPOR MAT, V37, P337, DOI 10.1016/S1387-1811(99)00276-0
   LANGELLA A, 1999, CLINOPTILOLITE BEARI, P237
   LEOPHAIRATANA A, 2002, CORPORATE ENV REPORT
   Morishita M, 1998, J CLIN DENT, V9, P94
   Mumpton F.A., 2000, NATURAL ZEOLITES 3 M, P19
   Ozawa T., 1997, FUEL ENERGY ABSTR, V38, P29
   Papaioannou DS, 2002, RES VET SCI, V72, P61, DOI 10.1053/rvsc.2001.0524
   Pavelic K, 2002, J CANCER RES CLIN, V128, P37, DOI 10.1007/s00432-001-0301-6
   Pavelic K, 2001, J MOL MED-JMM, V78, P708, DOI 10.1007/s001090000176
   PAVELIC K, 2001, STUDIES SURFACE SCI, V135
   Pories WJ, 1966, ZINC METABOLISM, P378
   Quintavalla S, 2002, MEAT SCI, V62, P373, DOI 10.1016/S0309-1740(02)00121-3
   Rivera-Garza M, 2000, MICROPOR MESOPOR MAT, V39, P431, DOI 10.1016/S1387-1811(00)00217-1
   RodriguezFuentes G, 1997, ZEOLITES, V19, P441, DOI 10.1016/S0144-2449(97)00087-0
   Semmens M., 1978, NATURAL ZEOLITES OCC, P517
   SEMMENS MJ, 1988, WATER RES, V22, P537, DOI 10.1016/0043-1354(88)90052-8
   SHAKER SK, 1992, J HELMINTHOL, V66, P288, DOI 10.1017/S0022149X00014735
   Takai K, 2002, MICROBIOL IMMUNOL, V46, P75, DOI 10.1111/j.1348-0421.2002.tb02661.x
   Tanimoto T., 1996, ZEOLITES, V16, P82
   Thom DC, 2003, ORAL SURG ORAL MED O, V95, P101, DOI 10.1067/moe.2003.90
   TOTOKI S, 1995, ZEOLITES, V15, P666
   Toyoda M, 1998, DERMATOLOGY, V196, P130, DOI 10.1159/000017846
   VANDENBOSSCHE GMR, 1991, INT J PHARM, V67, P195, DOI 10.1016/0378-5173(91)90432-N
   YAMAMOTO T, 1997, ZEOLITES, V18, P235
   ZAMZOW MJ, 1990, SEPAR SCI TECHNOL, V25, P1555, DOI 10.1080/01496399008050409
NR 53
TC 55
Z9 57
U1 1
U2 24
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-1317
J9 APPL CLAY SCI
JI Appl. Clay Sci.
PD DEC
PY 2004
VL 27
IS 3-4
BP 141
EP 150
DI 10.1016/j.clay.2004.04.004
PG 10
WC Chemistry, Physical; Materials Science, Multidisciplinary; Mineralogy
SC Chemistry; Materials Science; Mineralogy
GA 878EJ
UT WOS:000225629100002
DA 2018-10-19
ER

PT J
AU Keselowsky, BG
   Collard, DM
   Garcia, AJ
AF Keselowsky, BG
   Collard, DM
   Garcia, AJ
TI Surface chemistry modulates focal adhesion composition and signaling
   through changes in integrin binding
SO BIOMATERIALS
LA English
DT Article
DE surface chemistry; focal adhesion; integrin; cell adhesion; signaling
ID CALVARIAL OSTEOBLAST DIFFERENTIATION; SELF-ASSEMBLED MONOLAYERS;
   EMBRYONIC STEM-CELLS; FIBRONECTIN CONFORMATION; FIBROBLAST ADHESION;
   PROTEIN ADSORPTION; LIVING CELLS; IN-VITRO; KINASE; GOLD
AB Biomaterial surface properties influence protein adsorption and elicit diverse cellular responses in biomedical and biotechnological applications. However, the molecular mechanisms directing cellular activities remain poorly understood. Using a model system with well-defined chemistries (CH3, OIL COOH, NH2) and a fixed density of the single adhesive ligand fibronectin, we investigated the effects of surface chemistry on focal adhesion assembly and signaling. Surface chemistry strongly modulated integrin binding and specificity-alpha(5)beta(1) integrin binding affinity followed the pattern OH > NH2 = COOH > CH3, while integrin alpha(5)beta(1) displayed the relationship COOH > NH2 much greater than OH = CH3. Immunostaining and biochemical analyses revealed that surface chemistry modulates the structure and molecular composition of cell-matrix adhesions as well as focal adhesion kinase (FAK) signaling. The neutral hydrophilic OH functionality supported the highest levels of recruitment of talin, alpha-actinin, paxillin, and tyrosine-phosphorylated proteins to adhesive structures. The positively charged NH2 and negatively charged COOH surfaces exhibited intermediate levels of recruitment of focal adhesion components, while the hydrophobic CH3 substrate displayed the lowest levels. These patterns in focal adhesion assembly correlated well with integrin alpha(5)beta(1) binding. Phosphorylation of specific tyrosine residues in FAK also showed differential sensitivity to surface chemistry. Finally, surface chemistry-dependent differences in adhesive interactions modulated osteoblastic differentiation. These differences in focal adhesion assembly and signaling provide a potential mechanism for the diverse cellular responses elicited by different material properties. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Georgia Inst Technol, Coulter Sch Biomed Engn, Atlanta, GA 30332 USA.
   Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.
   Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
RP Garcia, AJ (reprint author), Georgia Inst Technol, Coulter Sch Biomed Engn, Atlanta, GA 30332 USA.
EM andres.garcia@me.gatech.edu
RI Keselowsky, Benjamin/A-8000-2009
CR Allen LT, 2003, P NATL ACAD SCI USA, V100, P6331, DOI 10.1073/pnas.1031426100
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   BAIN CD, 1989, J AM CHEM SOC, V111, P321, DOI 10.1021/ja00183a049
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P837, DOI 10.1002/jbm.820260702
   BRANDS R, 1988, EXP CELL RES, V176, P309, DOI 10.1016/0014-4827(88)90333-3
   Brash JL, 2000, J BIOMAT SCI-POLYM E, V11, P1135, DOI 10.1163/156856200744237
   BRASH JL, 1987, PROTEINS INTERFACES, P490
   BRODBECK WG, 2003, P NATL ACAD SCI USA, V99, P10287
   Byers BA, 2002, J BONE MINER RES, V17, P1931, DOI 10.1359/jbmr.2002.17.11.1931
   Cary LA, 1996, J CELL SCI, V109, P1787
   Cheng SL, 2001, J BONE MINER RES, V16, P277, DOI 10.1359/jbmr.2001.16.2.277
   COLL JL, 1995, P NATL ACAD SCI USA, V92, P9161, DOI 10.1073/pnas.92.20.9161
   Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793
   Gallant ND, 2002, LANGMUIR, V18, P5579, DOI 10.1021/la025554p
   Garcia AJ, 2002, CRIT REV EUKAR GENE, V12, P151, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i2.50
   Garcia AJ, 1999, BIOMATERIALS, V20, P2427, DOI 10.1016/S0142-9612(99)00170-2
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Garcia AJ, 1998, J BIOL CHEM, V273, P10988, DOI 10.1074/jbc.273.18.10988
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Gorbet MB, 2001, J LAB CLIN MED, V137, P345, DOI 10.1067/mlc.2001.114677
   GRINNELL F, 1980, CELL, V19, P517, DOI 10.1016/0092-8674(80)90526-7
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Ilic Dusko, 1995, Nature (London), V377, P539
   Jung DR, 2001, CRIT REV BIOTECHNOL, V21, P111, DOI 10.1080/20013891081700
   Katz BZ, 2000, MOL BIOL CELL, V11, P1047, DOI 10.1091/mbc.11.3.1047
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   KESELOWSKY BG, IN PRESS BIOMATERIAL
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LOTZ MM, 1989, J CELL BIOL, V109, P1795, DOI 10.1083/jcb.109.4.1795
   McClary KB, 2000, J BIOMED MATER RES, V50, P428, DOI 10.1002/(SICI)1097-4636(20000605)50:3<428::AID-JBM18>3.0.CO;2-H
   McClary KB, 1999, BIOMATERIALS, V20, P2435, DOI 10.1016/S0142-9612(99)00171-4
   MERWIN JR, 1990, J CELL PHYSIOL, V142, P117, DOI 10.1002/jcp.1041420115
   Michael KE, 2003, LANGMUIR, V19, P8033, DOI 10.1021/la034810a
   Mostafavi-Pour Z, 2003, J CELL BIOL, V161, P155, DOI 10.1083/jcb.200210176
   Moursi AM, 1997, J CELL SCI, V110, P2187
   Moursi AM, 1996, J CELL SCI, V109, P1369
   Mrksich M, 1996, ANNU REV BIOPH BIOM, V25, P55, DOI 10.1146/annurev.bb.25.060196.000415
   Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373
   PORTER MD, 1987, J AM CHEM SOC, V109, P3559, DOI 10.1021/ja00246a011
   Priddle H, 1998, J CELL BIOL, V142, P1121, DOI 10.1083/jcb.142.4.1121
   Reiske HR, 1999, J BIOL CHEM, V274, P12361, DOI 10.1074/jbc.274.18.12361
   Reyes CD, 2003, J BIOMED MATER RES A, V67A, P328, DOI 10.1002/jbm.a.10122
   Sastry SK, 1999, J CELL BIOL, V144, P1295, DOI 10.1083/jcb.144.6.1295
   Sastry SK, 2000, EXP CELL RES, V261, P25, DOI 10.1006/excr.2000.5043
   SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680
   Scotchford CA, 2002, J BIOMED MATER RES, V59, P84, DOI 10.1002/jbm.1220
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   Stephansson SN, 2002, BIOMATERIALS, V23, P2527, DOI 10.1016/S0142-9612(01)00387-8
   SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191
   Tamura Y, 2001, J BONE MINER RES, V16, P1772, DOI 10.1359/jbmr.2001.16.10.1772
   Tengvall P, 1998, BIOMATERIALS, V19, P407, DOI 10.1016/S0142-9612(97)00110-5
   Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200
   Tziampazis E, 2000, BIOMATERIALS, V21, P511, DOI 10.1016/S0142-9612(99)00212-4
   ULMAN A, 1989, LANGMUIR, V5, P1147, DOI 10.1021/la00089a003
   Zamir E, 2001, J CELL SCI, V114, P3583
   Zhao JH, 1998, J CELL BIOL, V143, P1997, DOI 10.1083/jcb.143.7.1997
NR 59
TC 385
Z9 392
U1 9
U2 111
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2004
VL 25
IS 28
BP 5947
EP 5954
DI 10.1016/j.biomaterials.2004.01.062
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 845AQ
UT WOS:000223208400005
PM 15183609
DA 2018-10-19
ER

PT J
AU Rosenbloom, AJ
   Sipe, DM
   Shishkin, Y
   Ke, Y
   Devaty, RP
   Choyke, WJ
AF Rosenbloom, AJ
   Sipe, DM
   Shishkin, Y
   Ke, Y
   Devaty, RP
   Choyke, WJ
TI Nanoporous SiC: A candidate semi-permeable material for biomedical
   applications
SO BIOMEDICAL MICRODEVICES
LA English
DT Article
DE silicon carbide; ultrafiltration; membrane; microdialysis; biosensor
ID SILICON-CARBIDE; POLY(ETHYLENE GLYCOL); PROTEIN ADSORPTION;
   PLATELET-ADHESION; IN-VITRO; STENTS; HEMOCOMPATIBILITY;
   BIOCOMPATIBILITY; CONSTRUCTION; CULTURES
AB We have fabricated free-standing SiC nanoporous membranes in both p-type and n-type material. We showed that these membranes will permit the diffusion of proteins up to 29000 Daltons, while excluding larger proteins. By using radioactively labeled albumin, we also show that porous SiC has very low protein adsorption, comparable to the best commercially available polymer nanoporous membrane.
C1 Carnegie Mellon Univ, Mol Biosensors & Imaging Ctr, Pittsburgh, PA 15213 USA.
   Carnegie Mellon Univ, Inst Complex Engineered Syst, Pittsburgh, PA 15213 USA.
   Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15213 USA.
   Univ Pittsburgh, Dept Phys & Astron, Pittsburgh, PA 15260 USA.
RP Rosenbloom, AJ (reprint author), Carnegie Mellon Univ, Mol Biosensors & Imaging Ctr, Pittsburgh, PA 15213 USA.
EM alan2@andrew.cmu.edu
CR Auditore A, 2002, BIOMOL ENG, V19, P85, DOI 10.1016/S1389-0344(02)00042-4
   Bai S, 2003, MATER RES SOC SYMP P, V742, P151
   BOLZ A, 1990, ARTIF ORGANS, V14, P260, DOI 10.1111/j.1525-1594.1990.tb02967.x
   Bolz A, 1996, TEX HEART I J, V23, P162
   Carrie D, 2001, J Interv Cardiol, V14, P1, DOI 10.1111/j.1540-8183.2001.tb00702.x
   Chu WH, 1999, J MICROELECTROMECH S, V8, P34, DOI 10.1109/84.749400
   Desai TA, 1998, BIOTECHNOL BIOENG, V57, P118, DOI 10.1002/(SICI)1097-0290(19980105)57:1<118::AID-BIT14>3.0.CO;2-G
   Elbaz M, 2002, CATHETER CARDIO INTE, V56, P305, DOI 10.1002/ccd.10240
   FISSELL WH, 4 ANN BIOMEMS NAN WO
   Hamm CW, 2003, CATHETER CARDIO INTE, V60, P375, DOI 10.1002/ccd.10656
   Jahnsen H, 1999, METHODS, V18, P160, DOI 10.1006/meth.1999.0769
   Kalnins U, 2002, MED SCI MONITOR, V8, pPI16
   Kim S, 2000, JPN J APPL PHYS 1, V39, P5875, DOI 10.1143/JJAP.39.5875
   Kotzar G, 2002, BIOMATERIALS, V23, P2737, DOI 10.1016/S0142-9612(02)00007-8
   Leoni L, 2002, SENSORS, V2, P111, DOI 10.3390/s20300111
   Monnink SHJ, 1999, J INVEST MED, V47, P304
   NAJI A, 1991, BIOMATERIALS, V12, P690, DOI 10.1016/0142-9612(91)90118-T
   Nurdin N., 2003, European Cells & Materials, V5, P17
   Santavirta S, 1998, ARCH ORTHOP TRAUM SU, V118, P89, DOI 10.1007/s004020050319
   SCHMIDT S, 1993, J BIOMED MATER RES, V27, P1393, DOI 10.1002/jbm.820271106
   Sharma S, 2002, LANGMUIR, V18, P8728, DOI 10.1021/la026097f
   SHOR JS, 1994, J ELECTROCHEM SOC, V141, P778, DOI 10.1149/1.2054810
   Takami Y, 1998, J BIOMED MATER RES, V40, P24, DOI 10.1002/(SICI)1097-4636(199804)40:1<24::AID-JBM3>3.3.CO;2-U
   Tao SL, 2003, ADV DRUG DELIVER REV, V55, P315, DOI 10.1016/S0169-409X(02)00227-2
   Unverdorben Martin, 2003, J Interv Cardiol, V16, P325, DOI 10.1034/j.1600-6143.2003.08058.x
   Weisenberg BA, 2002, J BIOMED MATER RES, V60, P283, DOI 10.1002/jbm.10076
   Zhang F, 2001, J BIOMED MATER RES, V56, P324, DOI 10.1002/1097-4636(20010905)56:3<324::AID-JBM1100>3.0.CO;2-P
   Zhang S, 2000, BIOSENS BIOELECTRON, V15, P273, DOI 10.1016/S0956-5663(00)00076-2
NR 28
TC 79
Z9 82
U1 1
U2 19
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1387-2176
J9 BIOMED MICRODEVICES
JI Biomed. Microdevices
PD DEC
PY 2004
VL 6
IS 4
BP 261
EP 267
DI 10.1023/B:BMMD.0000048558.91401.1d
PG 7
WC Engineering, Biomedical; Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA 872AR
UT WOS:000225178600001
PM 15548873
DA 2018-10-19
ER

PT J
AU Iemma, F
   Spizzirri, U
   Muzzalupo, R
   Puoci, F
   Trombino, S
   Picci, N
AF Iemma, F
   Spizzirri, U
   Muzzalupo, R
   Puoci, F
   Trombino, S
   Picci, N
TI Spherical hydrophilic microparticles obtained by the radical
   copolymerisation of functionalised bovine serum albumin
SO COLLOID AND POLYMER SCIENCE
LA English
DT Article
DE acryloylated bovine serum albumin; reverse-phase suspension
   polymerisation; spherical microparticles; hydrogels
ID IN-VITRO EVALUATION; DRUG-DELIVERY; 2,4,6-TRINITROBENZENESULFONIC ACID;
   MICROSPHERES; RELEASE; NANOPARTICLES; HYDROGELS
AB Unsaturated groups were introduced onto proteins in order to produce macromers that are able to undergo radical polymerisation. The initial protein used was bovine serum albumin (BSA) because it is biodegradable, biocompatible and easily available. Methacrylic groups were introduced onto BSA by reaction with methacrylic anhydride at controlled pH and temperature. The experimental conditions allowed the protein to be kept water-soluble. This water-solubility of the derivatised protein was essential when realising spherical polymeric microparticles via reverse phase suspension copolymerisation with N,N-dimethyacrylamide (DMAA). During the derivatisation, the insertion of the polymerisable groups affects only the sterically-available chemical functions of the native protein. Therefore, chain growth during the copolymerisation process involves only these groups, achieving a polymeric network around a structurally unmodified protein. The polymeric systems show high water affinity, ascribable to the hydrophilic properties of BSA. We have demonstrated that the achievement of the spherical form during the polymerisation depends on two factors: the degree of derivatisation of BSA, and the weight/weight (w/w) ratio of the protein to the comonomer. The beads obtained were characterised by Fourier transform IR spectrophotometry, particle size distribution analysis, and scanning electron microscopy (SEM). The samples investigated showed a remarkable affinity for water and a high swelling capacity. These properties depend upon the degree of derivatisation of BSA and on the percentage of DMAA in the copolymerisation mixture. In this paper we describe the starting materials and the experimental conditions used to prepare protein hydrogels by radical copolymerisation, which are intended for use in pharmaceutical and biomedical applications.
C1 Univ Calabria, Dipartimento Sci Farmaceut, I-87036 Arcavacata Di Rende, CS, Italy.
RP Iemma, F (reprint author), Univ Calabria, Dipartimento Sci Farmaceut, I-87036 Arcavacata Di Rende, CS, Italy.
EM francesca.iemma@unical.it
OI Puoci, Francesco/0000-0002-5963-6762; Picci, Nevio/0000-0003-1985-2724;
   Trombino, Sonia/0000-0001-9939-4457; Iemma,
   Francesca/0000-0001-9548-0446; MUZZALUPO, RITA/0000-0003-3486-6120
CR Arnedo A, 2002, INT J PHARM, V244, P59, DOI 10.1016/S0378-5173(02)00300-9
   Chuo WH, 1996, INT J PHARM, V144, P241, DOI 10.1016/S0378-5173(96)04742-4
   Fundueanu G, 2001, INT J PHARM, V218, P13, DOI 10.1016/S0378-5173(01)00570-1
   GALLO JM, 1989, J PHARM SCI, V78, P190, DOI 10.1002/jps.2600780303
   Ghassabian S, 1996, INT J PHARM, V130, P49, DOI 10.1016/0378-5173(95)04255-5
   Kao WJ, 2003, MATER SCI FORUM, V426-4, P3145, DOI 10.4028/www.scientific.net/MSF.426-432.3145
   Katti D, 1999, J MICROENCAPSUL, V16, P231, DOI 10.1080/026520499289202
   Kriwet B, 1998, J CONTROL RELEASE, V56, P149, DOI 10.1016/S0168-3659(98)00078-9
   Kumar ABM, 1998, BIOMATERIALS, V19, P725, DOI 10.1016/S0142-9612(97)00188-9
   Langer K, 2003, INT J PHARM, V257, P169, DOI 10.1016/S0378-5173(03)00134-0
   LONGO WE, 1982, J PHARM SCI, V71, P1323, DOI 10.1002/jps.2600711205
   MacAdam AB, 1997, INT J PHARM, V151, P47, DOI 10.1016/S0378-5173(97)04886-2
   Merodio M, 2001, EUR J PHARM SCI, V12, P251, DOI 10.1016/S0928-0987(00)00169-X
   Miyata T, 2002, ADV DRUG DELIVER REV, V54, P79, DOI 10.1016/S0169-409X(01)00241-1
   Muzzalupo R, 2001, COLLOID POLYM SCI, V279, P688, DOI 10.1007/s003960000472
   Park HY, 1998, INT J PHARM, V175, P231, DOI 10.1016/S0378-5173(98)00289-0
   PARK K, 1988, BIOMATERIALS, V9, P435, DOI 10.1016/0142-9612(88)90009-9
   Pitarresi G, 2004, BIOMATERIALS, V25, P4333, DOI 10.1016/j.biomaterials.2003.11.015
   Sahin S, 2002, J CONTROL RELEASE, V82, P345, DOI 10.1016/S0168-3659(02)00141-4
   SNYDER SL, 1975, ANAL BIOCHEM, V64, P284, DOI 10.1016/0003-2697(75)90431-5
   Truter EJ, 2001, CELL BIOL INT, V25, P51, DOI 10.1006/cbir.2000.0677
   van Staden JF, 1998, ANAL CHIM ACTA, V369, P163, DOI 10.1016/S0003-2670(98)00228-1
   WIDDER KJ, 1983, PHARMACOL THERAPEUT, V20, P377, DOI 10.1016/0163-7258(83)90033-5
   Wunder A, 2003, J IMMUNOL, V170, P4793, DOI 10.4049/jimmunol.170.9.4793
   ZENG XM, 1995, EUR J PHARM SCI, V3, P87, DOI 10.1016/0928-0987(94)00078-E
NR 25
TC 21
Z9 21
U1 0
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0303-402X
EI 1435-1536
J9 COLLOID POLYM SCI
JI Colloid Polym. Sci.
PD DEC
PY 2004
VL 283
IS 3
BP 250
EP 256
DI 10.1007/s00396-004-1071-x
PG 7
WC Chemistry, Physical; Polymer Science
SC Chemistry; Polymer Science
GA 881UD
UT WOS:000225894000003
DA 2018-10-19
ER

PT J
AU Frais-Kolbl, H
   Griesmayer, E
   Kagan, H
   Pernegger, H
AF Frais-Kolbl, H
   Griesmayer, E
   Kagan, H
   Pernegger, H
TI A fast low-noise charged-particle CVD diamond detector
SO IEEE TRANSACTIONS ON NUCLEAR SCIENCE
LA English
DT Article
DE biomedical nuclear imaging; diamond; high-speed electronics; proton
   accelerators; proton detectors; semiconductor radiation detectors
ID RADIATION DETECTORS
AB This paper presents the design and test results of a charged-particle solid-state detector with ultrafast signal response based on polycrystalline chemical-vapor-deposition (pCVD) diamond as active detector material and a high-bandwidth RF amplifier. We tested the detector at the Indiana University Cyclotron Facility Bloomington, IN, in a proton beam with a kinetic energy ranging from 55 to 200 MeV. The detector signals showed an average pulsewidth of 1.38 ns, which enables single-particle counting at instantaneous rates approaching the gigahertz range. The detector operated with a signal-to-noise ratio of 7 : 1 for 200-MeV protons and a single-particle detection efficiency up to 99%.
C1 Fachhsch Wirtschaft & Tech, A-2700 Wiener Neustadt, Austria.
   European Org Nucl Res, Dept Phys, CH-1211 Geneva, Switzerland.
   Ohio State Univ, Dept Phys, Columbus, OH 43210 USA.
RP Frais-Kolbl, H (reprint author), Fachhsch Wirtschaft & Tech, A-2700 Wiener Neustadt, Austria.
CR ADAM W, 1997, P ELECTROCHEM SOC, P491
   Berdermann E, 2001, DIAM RELAT MATER, V10, P1770, DOI 10.1016/S0925-9635(01)00443-5
   BERGER MJ, 2004, ESTAR PSTAR ASTAR CO
   Bergonzo P, 2001, PHYS STATUS SOLIDI A, V185, P167, DOI 10.1002/1521-396X(200105)185:1<167::AID-PSSA167>3.0.CO;2-F
   FRANKLIN M, 1992, NUCL INSTRUM METH A, V315, P39, DOI 10.1016/0168-9002(92)90677-V
   HAN S, 1993, DIAM RELAT MATER, V2, P835, DOI 10.1016/0925-9635(93)90234-S
   Han S, 1995, REV SCI INSTRUM, V66, P5516, DOI 10.1063/1.1146077
   Moritz P, 2001, DIAM RELAT MATER, V10, P1765, DOI 10.1016/S0925-9635(01)00434-4
   NAIL M, 1993, P MAT RES SOC S 5, V302, P263
   POTTER R, 1998, MEDAUSTRON MACHBARKE
   Ramo S., 1939, P IRE, V27, P584, DOI DOI 10.1109/JRPROC.1939.228757
   *RD42 COLL, 1994, DRDCP56 RD42 COLL
   Shockley W, 1938, J APPL PHYS, V9, P635, DOI 10.1063/1.1710367
   ZHAO S, 1994, THESIS OHIO STATE U
NR 14
TC 25
Z9 25
U1 0
U2 6
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 0018-9499
J9 IEEE T NUCL SCI
JI IEEE Trans. Nucl. Sci.
PD DEC
PY 2004
VL 51
IS 6
BP 3833
EP 3837
DI 10.1109/TNS.2004.839366
PN 3
PG 5
WC Engineering, Electrical & Electronic; Nuclear Science & Technology
SC Engineering; Nuclear Science & Technology
GA 879LE
UT WOS:000225718500001
OA Green Published
DA 2018-10-19
ER

PT J
AU Kiem, S
   Oh, WS
   Peck, KR
   Lee, NY
   Lee, JY
   Song, JH
   Hwang, ES
   Kim, EC
   Cha, CY
   Choe, KW
AF Kiem, S
   Oh, WS
   Peck, KR
   Lee, NY
   Lee, JY
   Song, JH
   Hwang, ES
   Kim, EC
   Cha, CY
   Choe, KW
TI Phase variation of biofilm formation in Staphylocloccus aureus by IS256
   insertion and its impact on the capacity adhering to polyurethane
   surface
SO JOURNAL OF KOREAN MEDICAL SCIENCE
LA English
DT Article
DE bacterial adhesion; biofilms; cell adhesion molecules; Staphylococcus
   aureus
ID POLYSACCHARIDE INTERCELLULAR ADHESIN; STAPHYLOCOCCUS-EPIDERMIDIS; SLIME
   PRODUCTION; VIRULENCE; MUTANTS
AB While ica gene of Staphylococcus epidermidis is known to undergo phase variation by insertion of IS256, the phenomenon in Staphylococcus aureus has not been evaluated. Six biofilm-positive strains were tested for the presence of biofilm-negative phase-variant strains by Congo red agar test. For potential phase-valiant strains, pulsed-field gel electrophoresis was done to exclude the possibility of contamination. To investigate the mechanism of the biofilm-negative phase variation, PCR for each ica genes were done. Changes of ica genes detected by PCR were confirmed by southern hybridization, and their nucleotides were analyzed by DNA sequencing. Influence of ica genes and biofilm formation on capacity for adherence to biomedical material was evaluated by comparing the ability of adhering to polyurethane surface among a biofilm-negative phase-variant strain and its parent strain. A biofilm-negative phase-variant S. aureus strain was detected from 6 strains tested. icaC gene of the phase-variant strain was found to be inactivated by insertion of additional gene segment, IS256. The biofilm-negative phase-variant strain showed lower adhering capacity to polyurethane than its parent strain. This study shows that phase variation of ica gene occurs in S. aureus by insertion of IS256 also, and this biofilm-negative phase variation reduces adhering capacity of the bacteria.
C1 Sungkyunkwan Univ, Sch Med, Div Infect Dis, Samsung Med Ctr, Seoul 135710, South Korea.
   Sungkyunkwan Univ, Sch Med, Dept Lab Med, Samsung Med Ctr, Seoul 135710, South Korea.
   ARFID, Seoul, South Korea.
   Seoul Natl Univ, Coll Med, Dept Microbiol, Seoul, South Korea.
   Seoul Natl Univ, Coll Med, Dept Lab Med, Seoul, South Korea.
   Seoul Natl Univ, Coll Med, Dept Med, Seoul, South Korea.
RP Kiem, S (reprint author), Sungkyunkwan Univ, Sch Med, Div Infect Dis, Samsung Med Ctr, 50 Ilwon Dong, Seoul 135710, South Korea.
EM smkimkor@smc.samsung.co.kr
RI Song, Jae Hoon/C-9602-2011; Hwang, Eung-Soo/J-5731-2012
CR BASELGA R, 1993, INFECT IMMUN, V61, P4857
   CHRISTENSEN GD, 1987, INFECT IMMUN, V55, P2870
   Cramton SE, 1999, INFECT IMMUN, V67, P5427
   FREEMAN DJ, 1989, J CLIN PATHOL, V42, P872, DOI 10.1136/jcp.42.8.872
   Gerke C, 1998, J BIOL CHEM, V273, P18586, DOI 10.1074/jbc.273.29.18586
   GOERING RV, 1992, J CLIN MICROBIOL, V30, P577
   Heilmann C, 1996, INFECT IMMUN, V64, P277
   Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x
   Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x
   MACK D, 1994, INFECT IMMUN, V62, P3244
   Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996
   Ziebuhr W, 1999, MOL MICROBIOL, V32, P345, DOI 10.1046/j.1365-2958.1999.01353.x
NR 12
TC 26
Z9 29
U1 0
U2 4
PU KOREAN ACAD MEDICAL SCIENCES
PI SEOUL
PA 302 75 DONG DU ICHON, DONG YONGSAN KU, SEOUL 140 031, SOUTH KOREA
SN 1011-8934
J9 J KOREAN MED SCI
JI J. Korean Med. Sci.
PD DEC
PY 2004
VL 19
IS 6
BP 779
EP 782
DI 10.3346/jkms.2004.19.6.779
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA 895LH
UT WOS:000226863400001
PM 15608385
OA Other Gold, Green Published
DA 2018-10-19
ER

PT J
AU Pereira, D
   Cachinho, S
   Ferro, MC
   Fernandes, MHV
AF Pereira, D
   Cachinho, S
   Ferro, MC
   Fernandes, MHV
TI Surface behaviour of high MgO-containing glasses of the Si-Ca-P-Mg
   system in a synthetic physiological fluid
SO JOURNAL OF THE EUROPEAN CERAMIC SOCIETY
LA English
DT Article
DE surfaces; apatite; MgO; biomedical applications
ID SIMULATED BODY-FLUID; IN-VITRO BIOACTIVITY; DOT 2SIO(2) SYSTEM;
   COMPOSITIONAL DEPENDENCE; INVITRO EVALUATION; APATITE FORMATION;
   CAO.SIO2 GLASSES; CERAMICS; LAYER; BONE
AB Two glasses of the Si-Ca-P-Mg system with low SiO2 content (25 and 29 mol%) and high MgO contents (31 and 36 mol%, respectively) have been immersed in a Kokubo's synthetic physiological solution for different times up to 30 days. The surface modifications of the glasses were observed by SEM and the changes in the surface composition followed by EDS. ICP was used to assess the evolution of ionic concentrations in the solution, namely Ca and P.
   It was observed that both glasses induced the precipitation of Ca-P rich layers on their surfaces, although these were poorly attached to the glass substrate. Ca and P ions required for the apatite formation were mainly provided by the composition of the glass, which was severely dissolved in the solution.
   The observed apatite-forming ability of these glasses, notwithstanding their high MgO content, suggests that further improvements at the surface and in the glasses can lead to attractive potentially bioactive materials. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Aveiro, CICECO, Dept Ceram & Glass Engn, P-3810193 Aveiro, Portugal.
RP Fernandes, MHV (reprint author), Univ Aveiro, CICECO, Dept Ceram & Glass Engn, P-3810193 Aveiro, Portugal.
EM helena@cv.ua.pt
RI Fernandes, Maria Helena/K-6917-2014
OI Ferro, Marta/0000-0003-3716-8643; V Fernandes, Maria
   Helena/0000-0002-1240-2512
CR Agathopoulos S, 2003, KEY ENG MAT, V240-2, P217, DOI 10.4028/www.scientific.net/KEM.240-242.217
   ANDERSSON OH, 1990, J NON-CRYST SOLIDS, V119, P290, DOI 10.1016/0022-3093(90)90301-2
   ANDERSSON OH, 1990, J MATER SCI-MATER M, V1, P219, DOI 10.1007/BF00701080
   ANDERSSON OH, 1991, J NON-CRYST SOLIDS, V129, P145, DOI 10.1016/0022-3093(91)90090-S
   BIGI A, 1993, J INORG BIOCHEM, V49, P69, DOI 10.1016/0162-0134(93)80049-F
   Brink M, 1997, J BIOMED MATER RES, V36, P109, DOI 10.1002/(SICI)1097-4636(199707)36:1<109::AID-JBM13>3.3.CO;2-Q
   BROMER H, 1977, SCI CERAM, V9, P219
   EBISAWA Y, 1990, J MATER SCI-MATER M, V1, P239, DOI 10.1007/BF00701083
   Ebisawa Y., 1992, J MATER SCI-MATER M, V4, P225
   GROSS UM, 1990, HDB BIOACTIVE CERAMI, V1, P25
   Hench L.L., 1993, ADV SERIES CERAMICS, V1
   Hench L. L., 1990, HDB BIOACTIVE CERAMI, VI, P7
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hill R, 1996, J MATER SCI LETT, V15, P1122, DOI 10.1007/BF00539955
   HOLAND W, 1991, J NON-CRYST SOLIDS, V129, P152, DOI 10.1016/0022-3093(91)90091-J
   HOLAND W, 1983, GLASS TECHNOL, V24, P318
   Karlsson KH, 1998, GLASS PHYS CHEM+, V24, P280
   KASUGA T, 1987, J MATER SCI, V22, P3721, DOI 10.1007/BF01161484
   KIM CY, 1989, J NON-CRYST SOLIDS, V113, P195, DOI 10.1016/0022-3093(89)90011-2
   KITSUGI T, 1992, BIOMATERIALS, V13, P393, DOI 10.1016/0142-9612(92)90045-P
   KOKUBO T, 1990, J NON-CRYST SOLIDS, V120, P138, DOI 10.1016/0022-3093(90)90199-V
   KOKUBO T, 1991, BIOMATERIALS, V12, P155, DOI 10.1016/0142-9612(91)90194-F
   KOKUBO T, 1992, J MATER SCI-MATER M, V3, P79, DOI 10.1007/BF00705272
   Kokubo T., 1982, Bulletin of the Institute for Chemical Research, Kyoto University, V60, P260
   Kokubo T., 1990, HDB BIOACTIVE CERAMI, P41
   LI P, 1993, J MATER SCI-MATER M, V4, P127, DOI 10.1007/BF00120381
   LI P, 1993, THESIS LEIDEN
   LI PJ, 1994, J NON-CRYST SOLIDS, V168, P281, DOI 10.1016/0022-3093(94)90340-9
   LI PJ, 1990, J NON-CRYST SOLIDS, V119, P112, DOI 10.1016/0022-3093(90)90247-J
   MOYA JS, 1994, J MATER SCI-MATER M, V5, P529, DOI 10.1007/BF00124885
   Navarro JMF, 1991, VIDRIO CONSEJO SUPER
   OGINO M, 1980, J NON-CRYST SOLIDS, V38-9, P673, DOI 10.1016/0022-3093(80)90514-1
   OHTSUKI C, 1992, J NON-CRYST SOLIDS, V143, P84, DOI 10.1016/S0022-3093(05)80556-3
   OHTSUKI C, 1992, J MATER SCI-MATER M, V3, P119, DOI 10.1007/BF00705279
   OHTSUKI C, 1991, J BIOMED MATER RES, V25, P1363, DOI 10.1002/jbm.820251105
   OHURA K, 1991, J BIOMED MATER RES, V25, P357, DOI 10.1002/jbm.820250307
   OHURA K, 1992, J MATER SCI-MATER M, V3, P95, DOI 10.1007/BF00705275
   OKASAKI M, 1991, BIOMATERIALS, V12, P831
   OKASAKI M, 1995, BIOMATERIALS, V16, P703
   OLIVEIRA JM, 1995, BIOMATERIALS, V16, P849, DOI 10.1016/0142-9612(95)94146-C
   Oliveira JM, 2002, BIOMATERIALS, V23, P371, DOI 10.1016/S0142-9612(01)00115-6
   Pereira M.M., 1995, J AM CERAM SOC, V78, P463
   REHMAN I, 1994, BIOMATERIALS, V15, P865, DOI 10.1016/0142-9612(94)90044-2
   REIS RL, 1998, BIOCERAMICS, V11, P169
   Roman J, 2001, BIOMATERIALS, V22, P2013, DOI 10.1016/S0142-9612(00)00387-2
   Salinas AJ, 2000, BIOMATERIALS, V21, P251, DOI 10.1016/S0142-9612(99)00150-7
   VOGEL W, 1990, J NON-CRYST SOLIDS, V123, P349, DOI 10.1016/0022-3093(90)90807-X
   VOGEL W, 1986, J NON-CRYST SOLIDS, V80, P34, DOI 10.1016/0022-3093(86)90377-7
NR 49
TC 25
Z9 26
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0955-2219
J9 J EUR CERAM SOC
JI J. European Ceram. Soc.
PD DEC
PY 2004
VL 24
IS 15-16
BP 3693
EP 3701
DI 10.1016/j.jeurceramsoc.2004.02.006
PG 9
WC Materials Science, Ceramics
SC Materials Science
GA 859JN
UT WOS:000224259400001
DA 2018-10-19
ER

PT J
AU Zhao, H
   Li, LC
   Okino, ST
   Kane, CJ
   Carroll, PR
   Dahiya, R
AF Zhao, H
   Li, LC
   Okino, ST
   Kane, CJ
   Carroll, PR
   Dahiya, R
TI Kidney gene database: A curated and integrated database of genes
   involved in kidney disease
SO JOURNAL OF UROLOGY
LA English
DT Article
DE kidney; database; databases; genetic; gene expression; kidney diseases
AB Purpose: We have created a curated and integrated database, the Kidney Gene Database (KGDB) (http: / /www.urogene.org/kgdb) that contains current information about genes or genomic loci involved in human kidney disease.
   Materials and Methods: Genes that undergo molecular, genetic or epigenetic events that affect kidney function are identified through a biomedical literature search and catalogued in the database.
   Results: Events that are currently screened for are gene amplification, mutation, deletion, polymorphism, loss of heterozygosity, DNA methylation and DNA hypomethylation. In addition, genes that are uniquely expressed in the kidney, as determined by analyzing the expressed sequence tags database and the Serial Analysis of Gene Expression database, are also included in KGDB. For each gene KGDB provides basic information about the gene product, a tissue type gene expression profile, links to protein, mRNA and genomic DNA sequence information, relevant literature citations and cross-references to other databases.
   Conclusions: We present KGDB, which is to our knowledge the first curated and integrated database of genes involved in human kidney disease. KGDB is free, widely accessible and easy to use, and it provides a wealth of relevant information. In addition, KGDB will be continuously updated every 6 months to include new information published in the biomedical literature or in gene expression databases. We envision that KGDB will serve as a valuable resource for scientists and clinicians.
C1 Univ Calif San Francisco, Urol Res Ctr 112F, San Francisco, CA 94121 USA.
   Vet Affairs Med Ctr, Dept Urol, San Francisco, CA USA.
RP Dahiya, R (reprint author), Univ Calif San Francisco, Urol Res Ctr 112F, 4150 Clement St, San Francisco, CA 94121 USA.
EM rdahiya@urol.ucsf.edu
CR Hirschman L, 2002, BIOINFORMATICS, V18, P1553, DOI 10.1093/bioinformatics/18.12.1553
   Lash AE, 2000, GENOME RES, V10, P1051, DOI 10.1101/gr.10.7.1051
   Levine AE, 2001, NUCLEIC ACIDS RES, V29, P300, DOI 10.1093/nar/29.1.300
   Li LC, 2003, NUCLEIC ACIDS RES, V31, P291, DOI 10.1093/nar/gkg008
   Mack R, 2002, DRUG DISCOV TODAY, V7, pS89, DOI 10.1016/S1359-6446(02)02286-9
   Schuler GD, 1997, J MOL MED, V75, P694, DOI 10.1007/s001090050155
   Tate R, 2003, EUR J CANCER, V39, P961, DOI 10.1016/S0959-8049(03)00070-4
   ZHENG F, 2003, SCI AGING KNOWLEDGE, pPE20
NR 8
TC 1
Z9 1
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD DEC
PY 2004
VL 172
IS 6
BP 2344
EP 2346
DI 10.1097/01.ju.0000144106.91876.7a
PN 1
PG 3
WC Urology & Nephrology
SC Urology & Nephrology
GA 872GE
UT WOS:000225194900050
PM 15538263
DA 2018-10-19
ER

PT J
AU Kim, GH
AF Kim, GH
TI Electroactive polymer composites as a tactile sensor for biomedical
   applications
SO MACROMOLECULAR RESEARCH
LA English
DT Article
DE self-sensing; health monitoring; smart material; polymer composite;
   microstructure; electrostriction
ID ELECTRIC-FIELD; ELECTROSTRICTION; ELASTOMERS; ELECTRORHEOLOGY
AB Modern applications could benefit from multifunctional materials having anisotropic optical, electrical, thermal, or mechanical properties, especially when coupled with locally controlled distribution of the directional response. Such materials are difficult to engineer by conventional methods, but the electric field-aided technology presented herein is able to locally tailor electroactive composites. Applying an electric field to a polymer in its liquid state allows the orientation of chain- or fiber-like inclusions or phases from what was originally an isotropic material. Such composites can be formed from liquid solutions, melts, or mixtures of pre-polymers and cross-linking agents. Upon curing, a "created composite" results; it consists of these "pseudofibers" embedded in a matrix. One can also create oriented composites from embedded spheres, flakes, or fiber-like shapes in a liquid plastic. Orientation of the externally applied electric field defines the orientation of the field-aided self-assembled composites. The strength and duration of exposure of the electric field control the degree of anisotropy created. Results of electromechanical testing of these modified materials, which are relevant to sensing and actuation applications, are presented. The materials' micro/nanostructures were analyzed using microscopy and X-ray diffraction techniques.
C1 Samsung Elect Co LTD, Gyeonggi 449900, South Korea.
RP Kim, GH (reprint author), Samsung Elect Co LTD, San 24 Nongseo, Gyeonggi 449900, South Korea.
EM xrdghk@yahoo.com
CR Bowen CP, 1998, J MATER RES, V13, P205, DOI 10.1557/JMR.1998.0027
   BOWEN CP, 1995, J INTEL MAT SYST STR, V6, P159, DOI 10.1177/1045389X9500600203
   FILANCBOWEN TR, 2003, PRECEEDING SPIE, V5051, P218
   FILANCBOWEN TR, 2002, IEEE SENS 2002 ORL F, V2, P1648
   Guillot FM, 2001, J ACOUST SOC AM, V110, P2980, DOI 10.1121/1.1416905
   Happel J., 1965, LOW REYNOLDS NUMBER
   Hase M, 1999, J INTEL MAT SYST STR, V10, P508, DOI 10.1106/B6EX-9DXD-WP5D-KDJY
   Horvath AT, 2002, INT J MOD PHYS B, V16, P2690, DOI 10.1142/S0217979202012852
   Kim G, 2004, J MATER RES, V19, P1164, DOI 10.1557/JMR.2004.0151
   Kim GH, 2002, J INTEL MAT SYST STR, V13, P479, DOI 10.1106/104538902030335
   Landau L D, 1984, ELECTRODYNAMICS CONT
   Lehmann W, 2001, NATURE, V410, P447, DOI 10.1038/35068522
   Liu B, 2001, J RHEOL, V45, P641, DOI 10.1122/1.1366716
   Martin JE, 1999, J CHEM PHYS, V111, P4273, DOI 10.1063/1.479725
   Pelrine R, 2000, SCIENCE, V287, P836, DOI 10.1126/science.287.5454.836
   Peterson R. E., 1974, STRESS CONCENTRATION
   RAUCH BJ, 1993, THERMOELASTIC STRESS, P581
   Shkel YM, 1996, J APPL PHYS, V80, P4566, DOI 10.1063/1.363439
   Shkel YM, 1999, J RHEOL, V43, P1307, DOI 10.1122/1.551023
   SHKEL YM, 2001, J RHEOL, V45, P447
   Stratton J. A., 1941, ELECTROMAGNETIC THEO
NR 21
TC 10
Z9 11
U1 0
U2 13
PU POLYMER SOC KOREA
PI SEOUL
PA ROOM 601, HATCHON BUILDING, 831 YEOKSAM-DONG, KANGNAM-KU, SEOUL 135-792,
   SOUTH KOREA
SN 1598-5032
J9 MACROMOL RES
JI Macromol. Res.
PD DEC
PY 2004
VL 12
IS 6
BP 564
EP 572
DI 10.1007/BF03218445
PG 9
WC Polymer Science
SC Polymer Science
GA 884UB
UT WOS:000226111000004
DA 2018-10-19
ER

PT J
AU Tvrdeic, A
   Durkovic, M
   Birus, I
AF Tvrdeic, A
   Durkovic, M
   Birus, I
TI Tail pressure pain in Wistar rats: influence of gender and time of day
SO PERIODICUM BIOLOGORUM
LA English
DT Article
DE gender; time of day; tail pressure; rat
ID SEX-DIFFERENCES; THERMAL NOCICEPTION; INDUCED ANALGESIA; DIURNAL RHYTHM;
   SENSITIVITY; MORPHINE; MICE; ANTINOCICEPTION; BEHAVIOR; AGE
AB Background and Purpose: The gender should be considered as a basic variable at all levels of biomedical and health related research. Thus, we tested the hypothesis whether gender and time of day affect tail pressure thresholds in Wistar rats.
   Materials and Methods: Eleven female and 11 male Wistar rats at the age of 6 months were used. After two days of habituation period, tail pressure thresholds were determined twice a day (9.00-10.00 h and 15.00-16.00 h) on 3 consecutive days. Expressed in grains (g), the pain thresholds were measured by applying increasing force on the tail, until the tail was withdrawn as the result of pain. Data were analyzed using analysis of variance (ANOVA) and expressed as the mean +/- S.E.M.
   Results: The pain thresholds were significantly higher in finale, as compared to female rats, when testing took place in the morning (days 1-3; F (5, 52) = 4.93; P < 0.01). When testing took place in the afternoon, there was no difference in the pain threshold values between female and finale rats (days 1-3; F (5, 52) = 2.19, not significant at P < 0.05). Significant decrease in afternoon pain threshold values, as compared to morning values, was detected within male (days 1-3; F (5, 56) = 3.5; P < 0.05), but not within female rats (days 1-3; F (5, 48) = 1.1 not significant at P < 0.05).
   Conclusion: The results presented here indicate that both gender and tune of day during the light phase of the day cycle affected tail pressure thresholds in Wistar rats.
C1 Univ JJ Strossmayer Osijek, Sch Med, Dept Pharmacol, Osijek 31000, Croatia.
   Univ JJ Strossmayer Osijek, Sch Med, Dept Chem & Biochem, Osijek 31000, Croatia.
RP Tvrdeic, A (reprint author), Univ JJ Strossmayer Osijek, Sch Med, Dept Pharmacol, Huttlerova 4, Osijek 31000, Croatia.
EM tvrdeic@mefos.hr
OI Tvrdeic, Ante/0000-0002-8881-2278
CR AKUNNE HC, 1994, PHARMACOL BIOCHEM BE, V48, P411, DOI 10.1016/0091-3057(94)90545-2
   Barrett AC, 2002, EUR J PHARMACOL, V452, P163, DOI 10.1016/S0014-2999(02)02274-4
   BEATTY WW, 1976, PHYSIOL BEHAV, V16, P413, DOI 10.1016/0031-9384(76)90319-X
   Chesler EJ, 2002, NEUROSCI BIOBEHAV R, V26, P907, DOI 10.1016/S0149-7634(02)00103-3
   COVINO BG, 1980, PAIN, V9, P141, DOI DOI 10.1016/0304-3959(80)90002-0
   Craft RM, 2003, LIFE SCI, V72, P2675, DOI 10.1016/S0024-3205(03)00178-4
   Endoh T, 1999, LIFE SCI, V65, P1685, DOI 10.1016/S0024-3205(99)00417-8
   FREDERICKSON RCA, 1977, SCIENCE, V198, P756, DOI 10.1126/science.561998
   GOLOMBEK DA, 1991, EUR J PHARMACOL, V194, P25, DOI 10.1016/0014-2999(91)90119-B
   GOMES MM, 1993, PHYSIOL BEHAV, V55, P651
   Jourdan D, 2000, EUR J PAIN-LONDON, V4, P291, DOI 10.1053/eujp.2000.0188
   KAVALIERS M, 1983, BRAIN RES, V279, P387, DOI 10.1016/0006-8993(83)90216-0
   KAYSER V, 1996, BRAIN RES, V742, P777
   Keogh E, 2000, PAIN, V85, P225, DOI 10.1016/S0304-3959(99)00270-5
   KERDELHUE B, 1983, BRAIN RES, V261, P243, DOI 10.1016/0006-8993(83)90627-3
   Mogil JS, 2000, NEUROSCI BIOBEHAV R, V24, P375, DOI 10.1016/S0149-7634(00)00015-4
   ONEILL MF, 1989, NEUROPHARMACOLOGY, V28, P243, DOI 10.1016/0028-3908(89)90099-3
   Perissin L, 2000, LIFE SCI, V67, P1477, DOI 10.1016/S0024-3205(00)00733-5
   RANDALL LO, 1957, ARCH INT PHARMACOD T, V111, P409
   Rollman GB, 1995, PAIN FORUM, V4, P231, DOI 10.1016/S1082-3174(11)80026-7
   SCHLOSBERG AJ, 1978, PHYSIOL BEHAV, V20, P117, DOI 10.1016/0031-9384(78)90061-6
   STEIN C, 1988, PHARMACOL BIOCHEM BE, V31, P445, DOI 10.1016/0091-3057(88)90372-3
   WRIGHT DM, 1981, EUR J PHARMACOL, V69, P385
NR 23
TC 1
Z9 1
U1 0
U2 4
PU PERIODICUM BIOLOGORUM
PI ZAGREB
PA HRVATSKO PRIRODOSLOVNO DRUSTVO ILICA 16/111, 41000 ZAGREB, CROATIA
SN 0031-5362
J9 PERIOD BIOL
JI Period. Biol.
PD DEC
PY 2004
VL 106
IS 4
BP 427
EP 431
PG 5
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 884QT
UT WOS:000226101600018
DA 2018-10-19
ER

PT J
AU Mirtaheri, P
   Omtveit, T
   Klotzbuecher, T
   Grimnes, S
   Martinsen, OG
   Tonnessen, TI
AF Mirtaheri, P
   Omtveit, T
   Klotzbuecher, T
   Grimnes, S
   Martinsen, OG
   Tonnessen, TI
TI Miniaturization of a biomedical gas sensor
SO PHYSIOLOGICAL MEASUREMENT
LA English
DT Article
DE conductivity; ischemia; miniaturization; PCO2 sensor
ID BIOLOGICAL-MATERIALS; PCO2; ISCHEMIA; ELECTRODES; SURFACE
AB In a previous study, we concluded that a conductivity based PCO2 sensor is an attractive solution for early detection of ischemia and presented two design geometries. For organ surface measurements, the planar design was suitable but it was difficult to insert the sensor into the tissue. A cylindrical design solution was favored for insertion due to the large membrane contact area and easy placement in a medical catheter. Since the previous cylindrical prototype was large and could damage the tissue, a more miniaturized sensor was needed. In the current paper, we present a miniaturized sensor with an outer diameter of 1 mm. The applied technology for manufacturing the sensor was a combination of mechanical turning, excimer laser drilling and conventional molding technique. The materials applied were PEEK (polyetherether ketone), PI (polyimide) with gold layers and polysiloxane. The membrane had to be gas permeable while acting as a barrier for ion transport, and was made of polysiloxane and had a thickness of 100-150 mum. The miniaturized sensor was tested for calibration, response time, drifting and pressure sensitivity. The results show that the miniaturized PCO2 sensor is capable of rapid and stable measurements both in vitro and ex vivo. The result from this study will be applied for the industrial manufacturing of such a biomedical sensor as a clinical product.
C1 Rikshosp Univ Hosp, Intervent Ctr, N-0027 Oslo, Norway.
   Univ Oslo, Dept Phys, N-1048 Blindern, Norway.
   Rikshosp Univ Hosp, Dept Clin Engn, Oslo, Norway.
   Alertis Med AS, Oslo, Norway.
   Inst Mikrotech Mainz GMBH, Dept Opt, Mainz, Germany.
   Rikshosp Univ Hosp, Dept Anesthesiol, Oslo, Norway.
RP Mirtaheri, P (reprint author), Rikshosp Univ Hosp, Intervent Ctr, N-0027 Oslo, Norway.
RI Martinsen, Orjan/M-4459-2014
OI Martinsen, Orjan/0000-0003-1632-4352; Klotzbucher,
   Thomas/0000-0002-4630-2966
CR ARQUINT P, 1994, THESIS U NEUCHATEL
   FOSTER KR, 1989, CRIT REV BIOMED ENG, V17, P25
   Grimnes S, 2000, BIOIMPEDANCE BIOELEC
   Kvarstein G, 2004, CRIT CARE MED, V32, P232, DOI 10.1097/01.CCM.0000104948.41544.FC
   Kvarstein G, 2003, ACTA ANAESTH SCAND, V47, P675, DOI 10.1034/j.1399-6576.2003.00134.x
   Lide D. R., 2004, CRC HDB CHEM PHYS
   LIS K, 1979, PFLUG ARCH EUR J PHY, V381, P289, DOI 10.1007/BF00583262
   Mirtaheri P, 2004, PHYSIOL MEAS, V25, P421, DOI 10.1088/0967-3334/25/2/002
   NUNN JF, 1993, NUNNS APPL RESP PHYS
   ONARAL B, 1982, MED BIOL ENG COMPUT, V20, P299, DOI 10.1007/BF02442796
   SCHWAN HP, 1968, ANN NY ACAD SCI, V148, P191, DOI 10.1111/j.1749-6632.1968.tb20349.x
   SCHWAN HP, 1963, REV SCI INSTRUM, V36, P481
   SEVERINGHAUS JW, 1958, J APPL PHYSIOL, V13, P515
   STOW RW, 1957, ARCH PHYS MED REHAB, V7, P646
   Tonnessen TI, 1996, ACTA ANAESTH SCAND, V40, P510, DOI 10.1111/j.1399-6576.1996.tb04481.x
   Tonnessen TI, 1997, ACTA ANAESTH SCAND, V41, P659
NR 16
TC 10
Z9 10
U1 3
U2 17
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0967-3334
EI 1361-6579
J9 PHYSIOL MEAS
JI Physiol. Meas.
PD DEC
PY 2004
VL 25
IS 6
BP 1511
EP 1522
AR PII S0967-3334(04)81668-X
DI 10.1088/0967-3334/25/6/015
PG 12
WC Biophysics; Engineering, Biomedical; Physiology
SC Biophysics; Engineering; Physiology
GA 891OW
UT WOS:000226591400015
PM 15712728
DA 2018-10-19
ER

PT J
AU Wang, LC
   Chen, JW
   Liu, HI
   Chen, ZQ
   Zhang, Y
   Wang, CY
   Feng, ZG
AF Wang, LC
   Chen, JW
   Liu, HI
   Chen, ZQ
   Zhang, Y
   Wang, CY
   Feng, ZG
TI Synthesis and evaluation of biodegradable segmented multiblock
   poly(ether ester) copolymers for biomaterial applications
SO POLYMER INTERNATIONAL
LA English
DT Article
DE poly(ether ester); degradation; cytotoxicity; cell adhesion;
   biocompatibility
ID HUMAN ENDOTHELIAL-CELLS; IN-VITRO DEGRADATION; BLOCK-COPOLYMERS;
   CONTROLLED-RELEASE; TEREPHTHALATE); POLYESTERS; POLYMERS; BONE;
   PROTEINS; ADHESION
AB Based on 1,4-succinic acid, 1,4-butanediol, poly(ethylene glycol)s and dimethyl terephthalate, biodegradable segmented multiblock copolymers of poly[(butylene terephthalate)-co-poly(butylene succinate)-block-poly(ethylene glycol)] (PTSG) were synthesized with different poly(butylene succinate) (PBS) molar fractions and varying the poly(ethylene glycol) (PEG) segment length, and were evaluated as biomedical materials. The copolymer extracts showed no in vitro cytotoxicity. However, sterilization of the copolymers by gamma irradiation had some limited effect on the cytotoxicity and mechanical properties. A copolymer consisting of PEG-1000 and 20 mol% PBS, assigned as 1000PBS20 after SO2 gas plasma treatment, sustained the adhesion and growth of dog vascular smooth muscle cells. The in vivo biocompatibility of this sample was also measured subcutaneously in rats for 4 weeks. The assessments indicated that these poly(ether ester) copolymers are good candidates for anti-adhesion barrier and drug controlled-release applications. (C) 2004 Society of Chemical Industry.
C1 Beijing Inst Technol, Sch Mat Sci & Engn, Beijing 100081, Peoples R China.
   Acad Mil Med Sci, Lab Tissue Engn, Beijing 100850, Peoples R China.
RP Feng, ZG (reprint author), Beijing Inst Technol, Sch Mat Sci & Engn, Beijing 100081, Peoples R China.
EM sainfeng@bit.edu.cn
CR Amass W, 1998, POLYM INT, V47, P89, DOI 10.1002/(SICI)1097-0126(1998100)47:2<89::AID-PI86>3.0.CO;2-F
   Bezemer JM, 1999, J CONTROL RELEASE, V62, P393, DOI 10.1016/S0168-3659(99)00170-4
   Bezemer JM, 2000, J BIOMED MATER RES, V52, P8, DOI 10.1002/1097-4636(200010)52:1<8::AID-JBM2>3.0.CO;2-3
   BOUNEKHEL M, 1995, POLYM DEGRAD STABIL, V49, P347, DOI 10.1016/0141-3910(95)00097-6
   Claase MB, 2003, J BIOMED MATER RES A, V64A, P291, DOI 10.1002/jbm.a.10418
   Deschamps AA, 2004, BIOMATERIALS, V25, P247, DOI 10.1016/S0142-9612(03)00495-2
   Deschamps AA, 2001, POLYMER, V42, P9335, DOI 10.1016/S0032-3861(01)00453-0
   Deschamps AA, 2003, BIOMATERIALS, V24, P2643, DOI 10.1016/S0142-9612(03)00054-1
   Deschamps AA, 2002, J CONTROL RELEASE, V78, P175, DOI 10.1016/S0168-3659(01)00497-7
   Du C, 2002, BIOMATERIALS, V23, P4649, DOI 10.1016/S0142-9612(02)00214-4
   Gumpenberger T, 2003, BIOMATERIALS, V24, P5139, DOI 10.1016/S0142-9612(03)00460-5
   Kellomaki M, 2002, BIOMATERIALS, V23, P283, DOI 10.1016/S0142-9612(01)00107-7
   KIM HC, 2001, POLYMER, V42, P1849
   Kint DPR, 2003, POLYMER, V44, P1321, DOI 10.1016/S0032-3861(02)00938-2
   Muller RJ, 2001, J BIOTECHNOL, V86, P87, DOI 10.1016/S0168-1656(00)00407-7
   Okada M, 2002, PROG POLYM SCI, V27, P87, DOI 10.1016/S0079-6700(01)00039-9
   Pu FR, 2002, BIOMATERIALS, V23, P2411, DOI 10.1016/S0142-9612(01)00377-5
   REED AM, 1981, POLYMER, V22, P499, DOI 10.1016/0032-3861(81)90169-5
   Signori F, 2003, MACROMOL SYMP, V197, P289, DOI 10.1002/masy.200350726
   van Dorp AGM, 1999, J BIOMED MATER RES, V47, P292, DOI 10.1002/(SICI)1097-4636(19991205)47:3<292::AID-JBM2>3.0.CO;2-B
   VANDIJKHUIZENRADER, 2002, BIOMATERIALS, V23, P4719
   Witt U, 2001, CHEMOSPHERE, V44, P289, DOI 10.1016/S0045-6535(00)00162-4
   Witt U, 1999, ANGEW CHEM INT EDIT, V38, P1438, DOI 10.1002/(SICI)1521-3773(19990517)38:10<1438::AID-ANIE1438>3.0.CO;2-U
   Zhang Y, 2003, POLYM INT, V52, P1351, DOI 10.1002/pi.1222
   Zhang Y, 2002, ACTA CHIM SINICA, V60, P2225
NR 25
TC 20
Z9 20
U1 1
U2 15
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 0959-8103
J9 POLYM INT
JI Polym. Int.
PD DEC
PY 2004
VL 53
IS 12
BP 2145
EP 2154
DI 10.1002/pi.1645
PG 10
WC Polymer Science
SC Polymer Science
GA 874JW
UT WOS:000225347700034
DA 2018-10-19
ER

PT J
AU Satoh, T
   Nishiyama, K
   Nagahata, M
   Teramoto, A
   Abe, K
AF Satoh, T
   Nishiyama, K
   Nagahata, M
   Teramoto, A
   Abe, K
TI The research on physiological property of functionalized hyaluronan:
   interaction between sulfated hyaluronan and plasma proteins
SO POLYMERS FOR ADVANCED TECHNOLOGIES
LA English
DT Article
DE hyaluronan (hyaluronic acid); polysaccharides; plasma proteins;
   biomaterials; chromatography
ID POLYELECTROLYTE COMPLEX PEC; FIBROBLAST HPLF FUNCTION; HEPARIN
AB Hyaluronan (HA) is a natural polysaccharides which has no sulfated group but high molecular weight in comparison with other glycosaminoglycans (GAGs). Previously it has been cleared up that the cell function of human keratinocytes is affected by S-HA (HA substituted with sulfated groups). Most biomedical materials contact with blood components, proteins, cells, etc. In this study, the interaction between S-HA and blood components is discussed, that is, plasma proteins. And the application of S-HA for new analytical and separation method of some proteins is pointed out. None of the proteins were adsorbed to HA. Fibronectin and fibinogen were adsorbed to S-HA, but immunoglobulin-G and insulin were not adsorbed to it as well as heparin. However, albumin could interact only with heparin, and it did not interact with S-HA. Furthermore S-HA adsorbed the plasma proteins that did not adsorb to heparin. It is clear that S-HA showed different interaction with the plasma proteins in comparison with natural sulfated polysaccharides. Copyright (C) 2004 John Wiley Sons, Ltd.
C1 Shinshu Univ, Dept Funct Polymer Sci, Fac Text Sci & Technol, Nagano 3868567, Japan.
RP Abe, K (reprint author), Shinshu Univ, Dept Funct Polymer Sci, Fac Text Sci & Technol, Tokida 3-15-1, Nagano 3868567, Japan.
EM kojiabe@giptc.shinshu-u.ac.jp
CR ANDEREGG G, 1954, HELV CHIM ACTA, V37, P113, DOI 10.1002/hlca.19540370114
   Bedsted T, 2003, BIOCHEMISTRY-US, V42, P8143, DOI 10.1021/bi034363y
   FERANDEZ JA, 1999, THROMB HAEMOSTASIS, V82, P1462
   Hamano T, 1998, J BIOMED MATER RES, V41, P257, DOI 10.1002/(SICI)1097-4636(199808)41:2<257::AID-JBM11>3.0.CO;2-I
   Hamano T, 1998, J BIOMAT SCI-POLYM E, V9, P985, DOI 10.1163/156856298X00299
   Hamano T, 1998, J BIOMED MATER RES, V41, P270, DOI 10.1002/(SICI)1097-4636(199808)41:2<270::AID-JBM12>3.3.CO;2-B
   JALKANEN M, 1991, RECEPTORS EXTRACELLU, P1
   Kopp R, 2002, ASAIO J, V48, P598, DOI 10.1097/01.MAT.0000033639.23941.7E
   SATOH T, 2004, SENI GAKKAISHI, V74
   SCULLY MF, 1988, BIOCHEM J, V254, P547, DOI 10.1042/bj2540547
   Sears P, 1996, P NATL ACAD SCI USA, V93, P12086, DOI 10.1073/pnas.93.22.12086
   SEKIGUCHI K, 1983, J BIOL CHEM, V258, P4359
   Teramoto A, 1999, POLYM ADVAN TECHNOL, V10, P681, DOI 10.1002/(SICI)1099-1581(199912)10:12<681::AID-PAT920>3.3.CO;2-J
NR 13
TC 8
Z9 9
U1 0
U2 5
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 1042-7147
J9 POLYM ADVAN TECHNOL
JI Polym. Adv. Technol.
PD DEC
PY 2004
VL 15
IS 12
BP 720
EP 725
DI 10.1002/pat.486
PG 6
WC Polymer Science
SC Polymer Science
GA 881UV
UT WOS:000225895800005
DA 2018-10-19
ER

PT J
AU Dias, AMA
   Caco, AI
   Coutinho, JAP
   Santos, LMNBF
   Pineiro, MM
   Vega, LF
   Gomes, MFC
   Marrucho, IM
AF Dias, AMA
   Caco, AI
   Coutinho, JAP
   Santos, LMNBF
   Pineiro, MM
   Vega, LF
   Gomes, MFC
   Marrucho, IM
TI Thermodynamic properties of perfluoro-n-octane
SO FLUID PHASE EQUILIBRIA
LA English
DT Article
DE oxygen; perfluoro-n-octane; solubility; density; vapor pressure;
   thermodynamic functions; regular solution theory; soft-SAFT EoS
ID AQUEOUS-SOLUTIONS; SOLUBILITY; GASES; ALKANES; PRESSURE; ETHANE; OXYGEN;
   ACID
AB Fluorocarbons are attracting much attention nowadays because of their unique properties, which may provide interesting applications in areas as wide as environmental, biomedical and material science. However, the behavior of these compounds is not well understood and only scattered data can be found in the open literature and company technical reports.
   In this work, three important properties of perfluoro-n-octane were experimentally determined: the liquid density, the vapor pressure and the oxygen solubility. Liquid density was measured, in the temperature range between 288 and 313 K with a vibrating tube densimeter and vapor pressure was measured with an apparatus based on the static method up to 333 K.
   The solubility of oxygen in perfluoro-n-octane, in the temperature range between 288 and 313 K and at pressures close to atmospheric, was determined experimentally with a precision apparatus based on the saturation method at constant pressure. Experimental solubility data, density and vapor pressure were correlated with the soft-SAFT EoS. (c) 2004 Elsevier B.V. All rights reserved.
C1 Univ Aveiro, Dept Chem, CICECO, P-3810193 Aveiro, Portugal.
   Univ Porto, Fac Ciencias, Dept Quim, CIQ, P-4169007 Oporto, Portugal.
   Univ Vigo, Fac Sci, Dept Appl Phys, E-36200 Vigo, Spain.
   CSIC, Inst Ciencia Mat Barcelona, ICMAB, E-08193 Barcelona, Spain.
   Univ Clermont Ferrand, Lab Thermodynam Solut & Polymeres, F-63177 Clermont Ferrand, France.
RP Marrucho, IM (reprint author), Univ Aveiro, Dept Chem, CICECO, P-3810193 Aveiro, Portugal.
EM imarrucho@dq.ua.pt
RI Dias, Ana/F-1858-2010
OI Dias, Ana/0000-0002-0865-0257; Santos, Luis/0000-0003-3040-0358;
   Marrucho, Isabel/0000-0002-8733-1958; Coutinho,
   Joao/0000-0002-3841-743X; Vega, Lourdes/0000-0002-7609-4184; Pineiro,
   Manuel M/0000-0002-3955-3564
CR BATTINO R, 1984, FLUID PHASE EQUILIBR, V15, P231, DOI 10.1016/0378-3812(84)87009-0
   BENNAIM A, 1985, J SOLUTION CHEM, V14, P245
   BENNAIM A, 1980, HYDROPHOBIC INTERACT
   BENSON BB, 1976, J CHEM PHYS, V64, P689, DOI 10.1063/1.432215
   CACO AI, 2004, J PHYS CHEM B, V108, P1450
   CACO AI, UNPUB
   CARNICER J, 1979, REV ACAD CIENCIAS ZA, V34, P115
   CHICKOS JS, 1992, J ORG CHEM, V57, P1897, DOI 10.1021/jo00032a052
   *DIPPR, 1998, THERM PROP DAT
   Dymond J. H., 1980, VIRIAL COEFFICIENTS
   GJALDBAEK JC, 1952, ACTA CHEM SCAND, V6, P623, DOI 10.3891/acta.chem.scand.06-0623
   HASZELDINE RN, 1951, J CHEM SOC, P603, DOI 10.1039/jr9510000603
   Hesse PJ, 1996, J CHEM ENG DATA, V41, P195, DOI 10.1021/je9502455
   HILDEBRAND JH, 1970, REGULAR RELATED SOLU
   KREGLEWSKI A, 1962, B ACAD POL SCI-CHIM, V10, P629
   MACK HG, 1987, J CHEM PHYS, P87
   Makranczy J., 1976, HUNG J IND CHEM, V4, P269
   Poling BE, 2001, PROPERTIES GASES LIQ
   Prausnitz J.M., 1999, MOL THERMODYNAMICS F
   PRAUSNITZ JM, 1961, AICHE J, V7, P682, DOI 10.1002/aic.690070430
   Riess J. C., 1998, BLOOD SUBSTITUTES PR, VII
   Riess JG, 2001, CHEM REV, V101, P2797, DOI 10.1021/cr970143c
   Steele WV, 1997, J CHEM ENG DATA, V42, P1021, DOI 10.1021/je9701036
   THOMSEN ES, 1963, ACTA CHEM SCAND, V17, P127, DOI 10.3891/acta.chem.scand.17-0127
   VANDANA V, 1994, FLUID PHASE EQUILIBR, V99, P209, DOI 10.1016/0378-3812(94)80032-4
   WILHELM E, 1977, CHEM REV, V77, P219, DOI 10.1021/cr60306a003
NR 26
TC 45
Z9 45
U1 1
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-3812
J9 FLUID PHASE EQUILIBR
JI Fluid Phase Equilib.
PD NOV 9
PY 2004
VL 225
IS 1-2
BP 39
EP 47
DI 10.1016/j.fluid.2004.07.004
PG 9
WC Thermodynamics; Chemistry, Physical; Engineering, Chemical
SC Thermodynamics; Chemistry; Engineering
GA 906JH
UT WOS:000227636500005
DA 2018-10-19
ER

PT J
AU Berkland, C
   Pack, DW
   Kim, K
AF Berkland, C
   Pack, DW
   Kim, K
TI Controlling surface nano-structure using flow-limited field-injection
   electrostatic spraying (FFESS) Of poly(D,L-lactide-co-glycolide)
SO BIOMATERIALS
LA English
DT Article
DE electrohydrodynamics; electrospraying; electrospinning; surface
   patterning; coating; poly(D,L-lactide-co-glycolide)
ID LIQUID CLUSTER BEAM; IONIZATION MASS-SPECTROMETRY; THIN-FILMS; IN-VITRO;
   BIODEGRADABLE NANOSPHERES; L-LACTIDE; RELEASE; SCAFFOLDS; FABRICATION;
   MEMBRANES
AB Improved control of surface micro- and nano-structure may lead to enhanced performance of degradable biomedical devices Such as surgical dressings, vascular grafts, tissue engineering scaffolds, sutures, and structures for guided tissue regeneration. An electrohydrodynamic method called flow-limited field-injection electrostatic spraying (FFESS) has been developed as an improved technique for the controlled deposition of polymeric material. Injecting charge using a nano-sharpened tungsten needle in a process called field ionization can efficiently induce an ionic state in a Solution Of poly(D,L-lactide-co-glycolide) increasing its capacity to carry charge. As a result, sprays have been produced that are finer and more precisely controlled than sprays produced by conventional electrospraying techniques, which employ hypodermic needles as the spray nozzle. Here, the effect of FFESS variables including applied voltage, polymer solution flow rate, and solvent properties (surface tension, viscosity, vapor pressure) on spray performance have been qualitatively evaluated. Under certain conditions, increasing the applied voltage produced an increasingly rough surface morphology. Similarly, by reducing solvent surface tension and increasing solvent vapor pressure, more distinct Surface structures could be formed including uniform nanoparticles. Working ranges of the important parameters for the production of Specific Structure types such as smooth Or Porous Surfaces, non-woven or melded fibers, and distinct or melded nanoparticles have been defined. FFESS technology provides a simple yet powerful technique for fabricating biomedical devices with a precisely defined nano-structure potentially capable Of utilizing a broad range of biocompatible polymeric materials. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Illinois, Dept Elect & Comp Engn, Urbana, IL 61801 USA.
   Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA.
RP Kim, K (reprint author), Univ Illinois, Dept Elect & Comp Engn, 45 EL,MC 702 1406 W Green St, Urbana, IL 61801 USA.
EM kevinkim@uiuc.edu
CR Beck JL, 2001, MASS SPECTROM REV, V20, P61, DOI 10.1002/mas.1003
   Berkland C, 2002, J CONTROL RELEASE, V82, P137, DOI 10.1016/S0168-3659(02)00136-0
   Boland ED, 2001, J MACROMOL SCI PURE, V38, P1231, DOI 10.1081/MA-100108380
   Buchko CJ, 1999, POLYMER, V40, P7397, DOI 10.1016/S0032-3861(98)00866-0
   Carino GP, 2000, J CONTROL RELEASE, V65, P261, DOI 10.1016/S0168-3659(99)00247-3
   Choi H, 2002, J MATER RES, V17, P1888, DOI 10.1557/JMR.2002.0279
   Cich M, 1998, APPL PHYS LETT, V73, P2116, DOI 10.1063/1.122396
   Cohen S, 1994, Int J Technol Assess Health Care, V10, P121
   Deitzel JM, 2001, POLYMER, V42, P261, DOI 10.1016/S0032-3861(00)00250-0
   Feng SS, 2001, J CONTROL RELEASE, V71, P53, DOI 10.1016/S0168-3659(00)00364-3
   Gaspar MM, 1998, J CONTROL RELEASE, V52, P53
   Gibson P, 2001, COLLOID SURFACE A, V187, P469, DOI 10.1016/S0927-7757(01)00616-1
   Han DK, 1997, MACROMOLECULES, V30, P6077, DOI 10.1021/ma970302u
   Hirosue S, 2001, J CONTROL RELEASE, V70, P231, DOI 10.1016/S0168-3659(00)00353-9
   Jain RA, 2000, BIOMATERIALS, V21, P2475, DOI 10.1016/S0142-9612(00)00115-0
   JALIL R, 1990, J MICROENCAPSUL, V7, P297, DOI 10.3109/02652049009021842
   Jung T, 2000, J CONTROL RELEASE, V67, P157, DOI 10.1016/S0168-3659(00)00201-7
   Kapur A, 2002, PROTEIN SCI, V11, P147, DOI 10.1101/ps.27702
   Kawashima Y, 1999, J CONTROL RELEASE, V62, P279, DOI 10.1016/S0168-3659(99)00048-6
   KIM K, 1994, NANOSTRUCT MATER, V4, P597, DOI 10.1016/0965-9773(94)90069-8
   KIM K, 1976, J APPL PHYS, V47, P1964, DOI 10.1063/1.322920
   KITCHELL JP, 1985, METHOD ENZYMOL, V112, P436
   Kreitz MR, 1997, BIOMATERIALS, V18, P1645, DOI 10.1016/S0142-9612(97)00106-3
   Laurencin CT, 2001, BIOMATERIALS, V22, P1271, DOI 10.1016/S0142-9612(00)00279-9
   LEWIS D H, 1990, P1
   Ma PX, 2001, TISSUE ENG, V7, P23, DOI 10.1089/107632701300003269
   Makela P, 2002, BIOMATERIALS, V23, P2587, DOI 10.1016/S0142-9612(01)00396-9
   Morozov VN, 1998, INT J MASS SPECTROM, V178, P143, DOI 10.1016/S1387-3806(98)14083-6
   Murphy WL, 2000, BIOMATERIALS, V21, P2521, DOI 10.1016/S0142-9612(00)00120-4
   Rayleigh J.W.S., 1882, PHILOS MAG, V4, P184
   Rhee SH, 2001, THIN SOLID FILMS, V396, P23, DOI 10.1016/S0040-6090(01)01183-X
   RYU CK, 1995, APPL PHYS LETT, V67, P3337, DOI 10.1063/1.115239
   RYU CK, 1995, APPL PHYS LETT, V66, P2496, DOI 10.1063/1.113145
   Shea LD, 2000, TISSUE ENG, V6, P605, DOI 10.1089/10763270050199550
   Shin YM, 2001, POLYMER, V42, P9955, DOI 10.1016/S0032-3861(01)00540-7
   STOLNIK S, 1995, COLLOID SURFACE A, V97, P235, DOI 10.1016/0927-7757(95)03081-N
   Tice T. R., 1991, PARENTERAL DRUG DELI, P315
   TICE TR, 1984, PHARM TECHNOL, V11, P26
   Wang DM, 2000, J MEMBRANE SCI, V169, P39, DOI 10.1016/S0376-7388(99)00330-0
   Wong DL, 2000, BIOCHEMISTRY-US, V39, P15410, DOI 10.1021/bi001164v
   WOOSLEY JP, 1988, J APPL PHYS, V64, P4278, DOI 10.1063/1.341301
   WU XS, 1995, SYNTHESIS PROPERTIES, P1015
   WU XS, 1995, PREPARATION CHARACTE
   Yang Y, 2001, THIN SOLID FILMS, V396, P97, DOI 10.1016/S0040-6090(01)01236-6
   Yarin AL, 2001, J APPL PHYS, V90, P4836, DOI 10.1063/1.1408260
   ZELLIN G, 1995, BIOMATERIALS, V16, P601, DOI 10.1016/0142-9612(95)93857-A
NR 46
TC 74
Z9 81
U1 3
U2 43
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2004
VL 25
IS 25
BP 5649
EP 5658
DI 10.1016/j.biomaterials.2004.01.018
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 829ID
UT WOS:000222040300010
PM 15159081
DA 2018-10-19
ER

PT J
AU Eisenbarth, E
   Velten, D
   Muller, M
   Thull, R
   Breme, J
AF Eisenbarth, E
   Velten, D
   Muller, M
   Thull, R
   Breme, J
TI Biocompatibility of beta-stabilizing elements of titanium alloys
SO BIOMATERIALS
LA English
DT Review
DE beta-titanium alloy; biocompatibility; cell morphology; osteoblast
ID CORROSION BEHAVIOR; PURE TITANIUM; IMPLANTS; NIOBIUM; BONE; FIBROBLASTS;
   CYTOTOXICITY; TI-6AL-7NB; PASSIVITY; TANTALUM
AB In comparison to the presently used alpha + beta titanium alloys for biomedical applications, beta-titanium alloys have many advantageous mechanical properties, such as an improved wear resistance, a high elasticity and an excellent cold and hot formability. This will promote their future increased application as materials for orthopaedic joint replacements. Not all elements with beta-stabilizing properties in titanium alloys are suitable for biomaterial applications-corrosion and wear processes cause a release of these alloying elements to the surrounding tissue. In this investigation, the biocompability of alloying elements for beta- and near beta-titanium alloys was tested in order to estimate their suitability for biomaterial components. Titanium (grade 2) and the implant steel X2CrNiMo18153 (AISI 316 L) were tested as reference materials. The investigation included the corrosion properties of the elements, proliferation, mitochondrial activity, cell morphology and the size of MC3T3-E1 cells and GM7373 cells after 7 days incubation in direct contact with polished slices of the metals. The statistical significance was considered by Weir-test and Lord-test (alpha = 0.05). The biocompatibility range of the investigated metals is (decreasing biocompatibility): niobium-tantalum, titanium, zirconium-aluminium-316 L-molybdenum. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Saarland, Lehrstuhl Met Werkstoffe, D-66041 Saarbrucken, Germany.
   Univ Wurzburg, Lehrstuhl Funkt Swerkstoffe Med & Zahnmed, D-97070 Wurzburg, Germany.
RP Eisenbarth, E (reprint author), Univ Saarland, Lehrstuhl Met Werkstoffe, D-66041 Saarbrucken, Germany.
EM e.eisenbarth@mx.uni-saarland.de
CR BLACK J, 1988, J BONE JOINT SURG BR, V70, P517
   BRUNETTE DM, 2001, TITANIUM MED MAT SCI, P174
   COLLINGS EW, 1994, TITANIUM ALLOYS MAT, P3
   EISENBARTH E, 2001, BIOMATERIALIEN, V2
   Helsen J. A., 1998, METALS BIOMATERIALS, P30
   JOHANSSON CB, 1990, BIOMATERIALS, V11, P277, DOI 10.1016/0142-9612(90)90010-N
   Jonsson AK, 2002, THIN SOLID FILMS, V402, P242, DOI 10.1016/S0040-6090(01)01715-1
   Kato H, 2000, J BIOMED MATER RES, V53, P28, DOI 10.1002/(SICI)1097-4636(2000)53:1<28::AID-JBM4>3.3.CO;2-6
   Khan MA, 1999, BIOMATERIALS, V20, P631, DOI 10.1016/S0142-9612(98)00217-8
   Kobayashi E, 1998, J MATER SCI-MATER M, V9, P625, DOI 10.1023/A:1008927407556
   Messer RLW, 1999, DENT MATER, V15, P1, DOI 10.1016/S0109-5641(99)90023-4
   Messer RLW, 1999, BIOMATERIALS, V20, P1647, DOI 10.1016/S0142-9612(99)00044-7
   Metikos-Hukovic M, 2003, BIOMATERIALS, V24, P3765, DOI 10.1016/S0142-9612(03)00252-7
   Niinomi M, 1999, MAT SCI ENG A-STRUCT, V263, P193, DOI 10.1016/S0921-5093(98)01167-8
   Nishiguchi S, 1999, J BIOMED MATER RES, V48, P689, DOI 10.1002/(SICI)1097-4636(1999)48:5<689::AID-JBM13>3.3.CO;2-3
   Okazaki Y, 1998, MATER T JIM, V39, P1063, DOI 10.2320/matertrans1989.39.1063
   OKAZAKI Y, 2000, ADV ENG MATER, V2, pS278
   Peuster M, 2003, BIOMATERIALS, V24, P4057, DOI 10.1016/S0142-9612(03)00274-6
   Pypen CMJM, 1998, J MATER SCI-MATER M, V9, P761, DOI 10.1023/A:1008919422520
   Rogers SD, 1997, J BONE JOINT SURG BR, V79B, P311, DOI 10.1302/0301-620X.79B2.7192
   ROSENBERG HW, 1970, P 1 INT C TIT, P851
   SACHS L, 1984, ANGEWANDTE STAT
   Scharnweber D, 2002, J MATER SCI-MATER M, V13, P1215, DOI 10.1023/A:1021118811893
   SEMLITSCH M, 1985, BIOMED TECH, V30, P334, DOI 10.1515/bmte.1985.30.12.334
   SEMLITSCH MF, 1992, BIOMATERIALS, V13, P781, DOI 10.1016/0142-9612(92)90018-J
   Steinemann S. G., 1980, EVALUATION BIOMATERI, P1
   TANGVALL P, 2001, J BIOMED MATER RES, V57, P285
   Thomsen P, 1997, J MATER SCI-MATER M, V8, P653, DOI 10.1023/A:1018579605426
   Trentani L, 2002, BIOMATERIALS, V23, P2863, DOI 10.1016/S0142-9612(01)00413-6
   Trillo EA, 2001, J MATER SCI-MATER M, V12, P283, DOI 10.1023/A:1011210101895
   UNGERSBOCK A, 1994, J MATER SCI-MATER M, V5, P788, DOI 10.1007/BF00213136
   VELTEN D, 2003, Z METALLKD, V94, P6
   Wack T, 1999, MATER SCI FORUM, V299-3, P348, DOI 10.4028/www.scientific.net/MSF.299-300.348
   WAPNER KL, 1991, CLIN ORTHOP RELAT R, P12
   Yu SY, 1997, CORROSION, V53, P965, DOI 10.5006/1.3290281
   ZITTER H, 1988, WERKST KORROS, V39, P574, DOI 10.1002/maco.19880391204
   Zwicker R, 1980, P 4 INT C TIT KYOT J, P505
NR 37
TC 369
Z9 382
U1 7
U2 133
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2004
VL 25
IS 26
BP 5705
EP 5713
DI 10.1016/j.biomaterials.2004.01.021
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 829QL
UT WOS:000222064600002
PM 15147816
DA 2018-10-19
ER

PT J
AU Errachid, A
   Zine, N
   Samitier, J
   Bausells, J
AF Errachid, A
   Zine, N
   Samitier, J
   Bausells, J
TI FET-based chemical sensor systems fabricated with standard technologies
SO ELECTROANALYSIS
LA English
DT Article
DE ISFET; MEMFET; multi-sensor needle; integrated sensor; FET biosensor
ID FIELD-EFFECT TRANSISTORS; ION-IMPLANTATION; SILICON; ISFET; MEMBRANE;
   PH; HYDROGEN; FILMS; MICROELECTRODES; ELECTRODES
AB Miniaturized solid-state ion sensors based on field-effect transistors on silicon can take advantage of the capabilities of microelectronics and microsystems technology for the integration of combined functionalities. Optimized solid-state chemical sensors usually require specific materials and fabrication processes. However, if standard fabrication processes can be used, integrated chemical sensor systems can be developed in a shorter time and in a cost effective way. We show that, for applications in which a long operating time is not required, such as in disposable biomedical sensors, good integrated sensor systems can be fabricated with standard materials and processes. Specific examples are presented, such as multisensor systems, sensors with integrated signal-processing circuits and sensors with particle manipulation electrodes.
C1 CSIC, IMB, Ctr Nacl Microelect, Bellaterra 08193, Spain.
   Parc Cient Barcelona, Ctr Bioelect & Nanobiociencia, Barcelona 08028, Spain.
RP Bausells, J (reprint author), CSIC, IMB, Ctr Nacl Microelect, Campus UAB, Bellaterra 08193, Spain.
EM Joan.Bausells@cnm.es
RI Bausells, Joan/K-1808-2014
OI Bausells, Joan/0000-0003-3706-4975
CR ABE H, 1979, IEEE T ELECTRON DEV, V26, P1939, DOI 10.1109/T-ED.1979.19799
   Andersson H, 2003, SENSOR ACTUAT B-CHEM, V92, P315, DOI 10.1016/S0925-4005(03)00266-1
   Baccar ZM, 1996, SENSOR ACTUAT B-CHEM, V32, P101, DOI 10.1016/0925-4005(96)80117-1
   Bausells J, 1999, SENSOR ACTUAT B-CHEM, V57, P56, DOI 10.1016/S0925-4005(99)00135-5
   BAUSELLS J, 1996, SPIE, V2882, P307
   Bergveld P, 2003, SENSOR ACTUAT B-CHEM, V88, P1, DOI 10.1016/S0925-4005(02)00301-5
   BERGVELD P, 1970, IEEE T BIO-MED ENG, VBM17, P70, DOI 10.1109/TBME.1970.4502688
   BERGVELD P, 1989, SENSOR ACTUATOR, V18, P309, DOI 10.1016/0250-6874(89)87038-6
   BERGVELD P, 1981, SENSOR ACTUATOR, V1, P17, DOI 10.1016/0250-6874(81)80004-2
   Bousse L, 1996, SENSOR ACTUAT B-CHEM, V34, P270, DOI 10.1016/S0925-4005(96)01906-5
   BOUSSE L, 1982, J CHEM PHYS, V76, P5128, DOI 10.1063/1.442812
   BOUSSE L, 1988, IEEE ELECTR DEVICE L, V9, P44, DOI 10.1109/55.20408
   BOUSSE L, 1994, SENSOR ACTUAT B-CHEM, V17, P157, DOI 10.1016/0925-4005(94)87044-6
   BOUSSE L, 1990, SENSOR ACTUAT B-CHEM, V1, P361, DOI 10.1016/0925-4005(90)80231-N
   Cane C, 1996, SENSOR ACTUAT B-CHEM, V35, P136, DOI 10.1016/S0925-4005(97)80043-3
   CARAS S, 1980, ANAL CHEM, V52, P1935, DOI 10.1021/ac50062a035
   Casanella R, 2003, IEE Proc Nanobiotechnol, V150, P70, DOI 10.1049/ip-nbt:20031100
   COSOFRET VV, 1995, ANAL CHEM, V67, P1647, DOI 10.1021/ac00106a001
   COSOFRET VV, 1994, ANAL LETT, V27, P3039, DOI 10.1080/00032719408000310
   COSOFRET VV, 1994, TALANTA, V41, P931, DOI 10.1016/0039-9140(94)E0106-2
   Errachid A, 2002, MAT SCI ENG C-BIO S, V21, P9, DOI 10.1016/S0928-4931(02)00054-1
   Errachid A, 2001, SENSOR ACTUAT B-CHEM, V78, P279, DOI 10.1016/S0925-4005(01)00826-7
   Errachid A, 1999, SENSOR ACTUAT B-CHEM, V60, P43, DOI 10.1016/S0925-4005(99)00242-7
   ESASHI M, 1978, IEEE T BIO-MED ENG, V25, P184, DOI 10.1109/TBME.1978.326245
   FERNANDEZBUSQUETS, 2003, CELL MOL LIFE SCI, V60, P88
   FERNANDEZMORALE.FH, 2000, THESIS U BARCELONA S
   GOTOH M, 1989, J MEMBRANE SCI, V41, P291, DOI 10.1016/S0376-7388(00)82409-6
   HAAK JR, 1992, SENSOR ACTUAT B-CHEM, V8, P211, DOI 10.1016/0925-4005(92)85020-W
   HAMMOND PA, 2002, P EUR PRAG CZECH REP, V16, P840
   HARSANYI G, 2000, SENSORS BIOMEDICAL A
   ITO T, 1988, IEEE T ELECTRON DEV, V35, P56, DOI 10.1109/16.2415
   Ivorra A, 2003, BIOSENS BIOELECTRON, V19, P391, DOI 10.1016/S0956-5663(03)00204-5
   JOHANSSON G, 1975, TALANTA, V22, P953, DOI 10.1016/0039-9140(75)80109-3
   Kovacs GTA, 1998, P IEEE, V86, P1536, DOI 10.1109/5.704259
   LANTER F, 1982, ANAL CHIM ACTA, V135, P51, DOI 10.1016/S0003-2670(01)85264-8
   MADOU MJ, 1989, CHEM SENSING SOLID S
   MATSUO T, 1981, SENSOR ACTUATOR, V1, P77, DOI 10.1016/0250-6874(81)80006-6
   MOSS SD, 1978, IEEE T BIO-MED ENG, V25, P49, DOI 10.1109/TBME.1978.326377
   NAJAFI K, 1985, IEEE T ELECTRON DEV, V32, P1206, DOI 10.1109/T-ED.1985.22102
   Pethig R, 1997, TRENDS BIOTECHNOL, V15, P426, DOI 10.1016/S0167-7799(97)01096-2
   PHAM MT, 1984, SENSOR ACTUATOR, V5, P217, DOI 10.1016/0250-6874(84)80012-8
   PHAM MT, 1992, SENSOR ACTUAT B-CHEM, V7, P576, DOI 10.1016/0925-4005(92)80367-7
   POHL HA, 1978, DIELECTROPHORESIS
   SANADA Y, 1982, FRESEN Z ANAL CHEM, V312, P526, DOI 10.1007/BF00636072
   Sibbald A., 1986, Journal of Molecular Electronics, V2, P51
   SIBBALD A, 1983, IEE PROC-I, V130, P233, DOI 10.1049/ip-i-1.1983.0042
   SIU WM, 1979, IEEE T ELECTRON DEV, V26, P1805, DOI 10.1109/T-ED.1979.19690
   Sola A, 2003, TRANSPLANTATION, V75, P744, DOI 10.1097/01.TP.0000054683.72223.2D
   Sze SM, 1969, PHYS SEMICONDUCTOR D
   VANDERSPIEGEL J, 1983, SENSOR ACTUATOR, V4, P291, DOI 10.1016/0250-6874(83)85035-5
   WIKBY A, 1975, TALANTA, V22, P663, DOI 10.1016/0039-9140(75)80007-5
   WISE KD, 1970, IEEE T BIO-MED ENG, VBM17, P238, DOI 10.1109/TBME.1970.4502738
   WONG HS, 1989, IEEE T ELECTRON DEV, V36, P479, DOI 10.1109/16.19957
   YATES DE, 1974, J CHEM SOC FARAD T 1, V70, P1807, DOI 10.1039/f19747001807
   YOON E, 1990, IEEE SOL STAT SENS A, P161
   ZINE N, 2003, P EUR GUIM PORT, V17, P526
NR 56
TC 25
Z9 25
U1 1
U2 17
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1040-0397
J9 ELECTROANAL
JI Electroanalysis
PD NOV
PY 2004
VL 16
IS 22
BP 1843
EP 1851
DI 10.1002/elan.200403072
PG 9
WC Chemistry, Analytical; Electrochemistry
SC Chemistry; Electrochemistry
GA 876SX
UT WOS:000225518900004
DA 2018-10-19
ER

PT J
AU Kan, CW
   Fredlake, CP
   Doherty, EAS
   Barron, AE
AF Kan, CW
   Fredlake, CP
   Doherty, EAS
   Barron, AE
TI DNA sequencing and genotyping in miniaturized electrophoresis systems
SO ELECTROPHORESIS
LA English
DT Review
DE DNA sequencing and genotyping; microchannel electrophoresis;
   miniaturization; review
ID CAPILLARY-ARRAY ELECTROPHORESIS; DOUBLE-STRANDED DNA;
   POLYMERASE-CHAIN-REACTION; HUMAN-GENOME-PROJECT; LINEAR POLYACRYLAMIDE
   SOLUTIONS; INDUCED FLUORESCENCE DETECTION; IMPROVED HYDROLYTIC
   STABILITY; CONFORMATION POLYMORPHISM ANALYSIS; ASSEMBLED MAGNETIC
   MATRICES; THROUGHPUT GENETIC-ANALYSIS
AB Advances in microchannel electrophoretic separation systems for DNA analyses have had important impacts on biological and biomedical sciences, as exemplified by the successes of the Human Genome Project (HGP). As we enter a new era in genomic science, further technological innovations promise to provide other far-reaching benefits, many of which will require continual increases in sequencing and genotyping efficiency and throughput, as well as major decreases in the cost per analysis. Since the high-resolution size- and/or conformation-based electrophoretic separation of DNA is the most critical step in many genetic analyses, continual advances in the development of materials and methods for microchannel electrophoretic separations will be needed to meet the massive demand for high-quality, low-cost genomic data. In particular, the development (and commercialization) of miniaturized genotyping platforms is needed to support and enable the future breakthroughs of biomedical science. In this review, we briefly discuss the major sequencing and genotyping techniques in which high-throughput and high-resolution electrophoretic separations of DNA play a significant role. We review recent advances in the development of technology for capillary electrophoresis (CE), including capillary array electrophoresis (CAE) systems. Most of these CE/CAE innovations are equally applicable to implementation on microfabricated electrophoresis chips. Major effort is devoted to discussing various key elements needed for the development of integrated and practical microfluidic sequencing and genotyping platforms, including chip substrate selection, microchannel design and fabrication, microchannel surface modification, sample preparation, analyte detection, DNA sieving matrices, and device integration. Finally, we identify some of the remaining challenges, and some of the possible routes to further advances in high-throughput DNA sequencing and genotyping technologies.
C1 Northwestern Univ, Dept Biol & Chem Engn, Evanston, IL 60208 USA.
RP Barron, AE (reprint author), Northwestern Univ, Dept Biol & Chem Engn, 2145 Sheridan Rd,Rm136, Evanston, IL 60208 USA.
EM a-barron@northwestern.edu
RI Barron, Annelise/B-7639-2009
FU NHGRI NIH HHS [1 R01 HG019770-01]
CR Albargheuthi MN, 2000, ELECTROPHORESIS, V21, P4096, DOI 10.1002/1522-2683(200012)21:18<4096::AID-ELPS4096>3.0.CO;2-W
   Albarghouthi M, 2001, ELECTROPHORESIS, V22, P737, DOI 10.1002/1522-2683(200102)22:4<737::AID-ELPS737>3.0.CO;2-S
   Albarghouthi MN, 2002, ELECTROPHORESIS, V23, P1429, DOI 10.1002/1522-2683(200205)23:10<1429::AID-ELPS1429>3.0.CO;2-A
   ANSORGE W, 1992, ELECTROPHORESIS, V13, P616, DOI 10.1002/elps.11501301125
   Auroux PA, 2002, ANAL CHEM, V74, P2637, DOI 10.1021/ac020239t
   Barbier V, 2003, CURR OPIN BIOTECH, V14, P51, DOI 10.1016/S0958-1669(02)00007-1
   Barbier V, 2002, ELECTROPHORESIS, V23, P1441, DOI 10.1002/1522-2683(200205)23:10<1441::AID-ELPS1441>3.0.CO;2-H
   Barron AE, 1996, ELECTROPHORESIS, V17, P744, DOI 10.1002/elps.1150170421
   BARRON AE, 1993, J CHROMATOGR A, V652, P3, DOI 10.1016/0021-9673(93)80639-P
   Bashkin J, 1996, APPL THEOR ELECTROPH, V6, P23
   Becker H, 2000, ELECTROPHORESIS, V21, P12, DOI 10.1002/(SICI)1522-2683(20000101)21:1<12::AID-ELPS12>3.3.CO;2-Z
   BECKER H, 2000, SENSOR ACTUAT A-PHYS, V83, P120
   Beebe DJ, 2000, NATURE, V404, P588, DOI 10.1038/35007047
   Belder D, 2002, ELECTROPHORESIS, V23, P3567, DOI 10.1002/1522-2683(200210)23:20<3567::AID-ELPS3567>3.0.CO;2-3
   Belder D, 2001, ELECTROPHORESIS, V22, P3813, DOI 10.1002/1522-2683(200109)22:17<3813::AID-ELPS3813>3.0.CO;2-D
   Berti L, 2001, BIOCONJUGATE CHEM, V12, P493, DOI 10.1021/bc000155w
   Berti L, 2001, ANAL BIOCHEM, V292, P188, DOI 10.1006/abio.2001.5069
   Blazej RG, 2003, GENOME RES, V13, P287, DOI 10.1101/gr.396203
   Brazill SA, 2001, ANAL CHEM, V73, P4882, DOI 10.1021/ac010521k
   Breadmore MC, 2003, ANAL CHEM, V75, P1880, DOI 10.1021/ac0204855
   Broyles BS, 2003, ANAL CHEM, V75, P2761, DOI 10.1021/ac025503x
   Buchholz BA, 2001, ELECTROPHORESIS, V22, P4118, DOI 10.1002/1522-2683(200111)22:19<4118::AID-ELPS4118>3.0.CO;2-Q
   Buchholz BA, 2002, ELECTROPHORESIS, V23, P1398, DOI 10.1002/1522-2683(200205)23:10<1398::AID-ELPS1398>3.0.CO;2-8
   Buchholz BA, 2001, ANAL CHEM, V73, P157, DOI 10.1021/ac001023z
   Bums M A, 1998, SCIENCE, V282, P484
   Butler JM, 1998, TRENDS BIOTECHNOL, V16, P158, DOI 10.1016/S0167-7799(98)01173-1
   Butler JM, 2004, ELECTROPHORESIS, V25, P1397, DOI 10.1002/elps.200305822
   Butler JM, 2001, FORENSIC DNA TYPING
   Carey L, 2002, ELECTROPHORESIS, V23, P1386, DOI 10.1002/1522-2683(200205)23:10<1386::AID-ELPS1386>3.0.CO;2-M
   Carrilho E, 2000, ELECTROPHORESIS, V21, P55
   Carrilho E, 1996, ANAL CHEM, V68, P3305, DOI 10.1021/ac960411r
   Chen XX, 2002, ANAL CHEM, V74, P1772, DOI 10.1021/ac0109422
   Chiari M, 2000, ELECTROPHORESIS, V21, P1521, DOI 10.1002/(SICI)1522-2683(20000501)21:8<1521::AID-ELPS1521>3.0.CO;2-Y
   CHIESL TN, 2004, IN PRESS ANAL CHEM
   Chou HP, 1999, P NATL ACAD SCI USA, V96, P11, DOI 10.1073/pnas.96.1.11
   Chu BJ, 2002, J CHROMATOGR A, V966, P1, DOI 10.1016/S0021-9673(02)00702-1
   Chung DT, 2004, J FORENSIC SCI, V49, P733
   COHEN AS, 1988, P NATL ACAD SCI USA, V85, P9660, DOI 10.1073/pnas.85.24.9660
   Collins FS, 2001, JAMA-J AM MED ASSOC, V285, P540, DOI 10.1001/jama.285.5.540
   Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626
   Collins FS, 2003, SCIENCE, V300, P286, DOI 10.1126/science.1084564
   Crabtree HJ, 2000, ELECTROPHORESIS, V21, P1329, DOI 10.1002/(SICI)1522-2683(20000401)21:7<1329::AID-ELPS1329>3.0.CO;2-2
   Cretich M, 2003, ELECTROPHORESIS, V24, P2322, DOI 10.1002/elps.200305479
   Culbertson CT, 2000, ANAL CHEM, V72, P5814, DOI 10.1021/ac0006268
   Culbertson CT, 1998, ANAL CHEM, V70, P3781, DOI 10.1021/ac9804487
   Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201
   Doherty EAS, 2004, ANAL CHEM, V76, P5249, DOI 10.1021/ac049721x
   Doherty EAS, 2003, ELECTROPHORESIS, V24, P4170, DOI 10.1002/elps.200305702
   Doherty EAS, 2002, ELECTROPHORESIS, V23, P2766, DOI 10.1002/1522-2683(200208)23:16<2766::AID-ELPS2766>3.0.CO;2-S
   Dolnik V, 1999, J BIOCHEM BIOPH METH, V41, P103, DOI 10.1016/S0165-022X(99)00041-X
   Dovichi N. J., 1997, ANAL NUCL ACIDS CAPI, P236
   Dovichi NJ, 2000, ANGEW CHEM INT EDIT, V39, P4463, DOI 10.1002/1521-3773(20001215)39:24<4463::AID-ANIE4463>3.0.CO;2-8
   Dovichi NJ, 1997, ELECTROPHORESIS, V18, P2393, DOI 10.1002/elps.1150181229
   Doyle PS, 2002, SCIENCE, V295, P2237, DOI 10.1126/science.1068420
   Du M, 2003, ELECTROPHORESIS, V24, P3147, DOI 10.1002/elps.200305572
   DUNN WC, 2000, ANAL CHEM, V77, P157
   Edman CF, 1997, NUCLEIC ACIDS RES, V25, P4907, DOI 10.1093/nar/25.24.4907
   EDWARDS A, 1991, AM J HUM GENET, V49, P746
   Emrich CA, 2002, ANAL CHEM, V74, P5076, DOI 10.1021/ac020236g
   Flanagan JH, 1998, ANAL CHEM, V70, P2676, DOI 10.1021/ac980018g
   Ford SM, 1999, J BIOMECH ENG-T ASME, V121, P13, DOI 10.1115/1.2798035
   Fu AY, 1999, NAT BIOTECHNOL, V17, P1109
   Fu AY, 2002, ANAL CHEM, V74, P2451, DOI 10.1021/ac0255330
   Gelfi C, 2000, ELECTROPHORESIS, V21, P785, DOI 10.1002/(SICI)1522-2683(20000301)21:4<785::AID-ELPS785>3.0.CO;2-E
   Gelfi C, 1996, ELECTROPHORESIS, V17, P738, DOI 10.1002/elps.1150170420
   Giordano BC, 2001, ELECTROPHORESIS, V22, P334, DOI 10.1002/1522-2683(200101)22:2<334::AID-ELPS334>3.0.CO;2-O
   Glazer AN, 1997, CURR OPIN BIOTECH, V8, P94, DOI 10.1016/S0958-1669(97)80163-2
   Goedecke N, 2004, ELECTROPHORESIS, V25, P1678, DOI 10.1002/elps.200305897
   Goetzinger W, 1998, ELECTROPHORESIS, V19, P242, DOI 10.1002/elps.1150190217
   Grover WH, 2003, SENSOR ACTUAT B-CHEM, V89, P315, DOI 10.1016/S0925-4005(02)00468-9
   Gurtner C, 2002, ELECTROPHORESIS, V23, P1543, DOI 10.1002/1522-2683(200205)23:10<1543::AID-ELPS1543>3.0.CO;2-#
   Hadd AG, 2000, J CHROMATOGR A, V894, P191, DOI 10.1016/S0021-9673(00)00459-3
   Hammer RP, 2002, BIOCONJUGATE CHEM, V13, P1244, DOI 10.1021/bc0155869
   HAMMOND HA, 1994, AM J HUM GENET, V55, P15
   Han J, 1999, J VAC SCI TECHNOL A, V17, P2142, DOI 10.1116/1.581740
   Han JY, 2002, ANAL CHEM, V74, P394, DOI 10.1021/ac0107002
   HASHIMOTO M, 2003, NUCLEIC ACIDS RES, V24, pE41
   He Y, 2000, J CHROMATOGR A, V894, P179, DOI 10.1016/S0021-9673(00)00676-2
   Heller C, 2000, ELECTROPHORESIS, V21, P593, DOI 10.1002/(SICI)1522-2683(20000201)21:3<593::AID-ELPS593>3.0.CO;2-U
   Heller C, 2001, ELECTROPHORESIS, V22, P629, DOI 10.1002/1522-2683(200102)22:4<629::AID-ELPS629>3.0.CO;2-S
   Heller MJ, 2002, ANNU REV BIOMED ENG, V4, P129, DOI 10.1146/annurev.bioeng.4.020702.153438
   Heller MJ, 2000, ELECTROPHORESIS, V21, P157, DOI 10.1002/(SICI)1522-2683(20000101)21:1<157::AID-ELPS157>3.0.CO;2-E
   Henry AC, 2000, ANAL CHEM, V72, P5331, DOI 10.1021/ac000685l
   Henry C, 2003, CHEM ENG NEWS, V81, P12, DOI 10.1021/cen-v081n016.p012
   Hofmann O, 2001, LAB CHIP, V1, P108, DOI 10.1039/b105110p
   HUANG XHC, 1992, ANAL CHEM, V64, P2149, DOI 10.1021/ac00042a021
   HUANG XHC, 1992, ANAL CHEM, V64, P967, DOI 10.1021/ac00032a025
   Hung SC, 1998, ANAL BIOCHEM, V255, P32, DOI 10.1006/abio.1997.2451
   Hung SC, 1997, ANAL BIOCHEM, V252, P78, DOI 10.1006/abio.1997.2287
   Jackman RJ, 1998, ANAL CHEM, V70, P2280, DOI 10.1021/ac971295a
   Ju JY, 1996, NUCLEIC ACIDS RES, V24, P1144, DOI 10.1093/nar/24.6.1144
   JU JY, 1995, ANAL BIOCHEM, V231, P131, DOI 10.1006/abio.1995.1512
   KAMBARA H, 1993, NATURE, V361, P565, DOI 10.1038/361565a0
   Kan CW, 2004, ELECTROPHORESIS, V25, P1007, DOI 10.1002/elps.200305785
   Kan CW, 2003, ELECTROPHORESIS, V24, P4161, DOI 10.1002/elps.200305670
   Kan CW, 2003, ELECTROPHORESIS, V24, P55, DOI 10.1002/elps.200390031
   KARNEI T, 2003, ANAL CHEM, V75, P5300
   Kartalov EP, 2004, NUCLEIC ACIDS RES, V32, P2873, DOI 10.1093/nar/gkh613
   Khandurina J, 2000, ANAL CHEM, V72, P2995, DOI 10.1021/ac991471a
   Kheterpal I, 1996, ELECTROPHORESIS, V17, P1852, DOI 10.1002/elps.1150171209
   Kim Y, 1997, J CHROMATOGR A, V781, P315, DOI 10.1016/S0021-9673(97)00472-X
   Koonin SE, 1998, SCIENCE, V279, P36, DOI 10.1126/science.279.5347.36
   Kourkine IV, 2002, BIOTECHNIQUES, V33, P318, DOI 10.2144/02332st04
   Kourkine IV, 2002, ELECTROPHORESIS, V23, P1375, DOI 10.1002/1522-2683(200205)23:10<1375::AID-ELPS1375>3.0.CO;2-U
   Kourkine IV, 2002, ANAL CHEM, V74, P2565, DOI 10.1021/ac020025b
   Koutny L, 2000, ANAL CHEM, V72, P3388, DOI 10.1021/ac9913614
   Lagally ET, 2000, SENSOR ACTUAT B-CHEM, V63, P138, DOI 10.1016/S0925-4005(00)00350-6
   Lagally ET, 2001, LAB CHIP, V1, P102, DOI 10.1039/b109031n
   Lagally ET, 2001, ANAL CHEM, V73, P565, DOI 10.1021/ac001026b
   Lagally ET, 2004, ANAL CHEM, V76, P3162, DOI 10.1021/ac035310p
   Lai SY, 2004, ANAL CHEM, V76, P1175, DOI 10.1021/ac034990t
   Lammertink RGH, 2003, MACROMOLECULES, V36, P9154, DOI 10.1021/ma0258253
   Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536
   Lassiter SJ, 2000, ANAL CHEM, V72, P5373, DOI 10.1021/ac000744v
   Lee JN, 2003, ANAL CHEM, V75, P6544, DOI 10.1021/ac0346712
   LERMAN LS, 1982, BIOPOLYMERS, V21, P995, DOI 10.1002/bip.360210511
   Li LL, 2004, ELECTROANAL, V16, P81, DOI 10.1002/elan.200302921
   Liang DH, 1999, ELECTROPHORESIS, V20, P2856, DOI 10.1002/(SICI)1522-2683(19991001)20:14<2856::AID-ELPS2856>3.0.CO;2-#
   Liang DH, 1999, MACROMOLECULES, V32, P6326, DOI 10.1021/ma9901792
   Lieberwirth U, 1998, ANAL CHEM, V70, P4771, DOI 10.1021/ac980230k
   Lin YW, 2003, J CHROMATOGR A, V1014, P47, DOI 10.1016/S0021-9673(03)01408-0
   Linder V, 2001, ANAL CHEM, V73, P4181, DOI 10.1021/ac010421e
   Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447
   Liu J, 2002, ELECTROPHORESIS, V23, P1531, DOI 10.1002/1522-2683(200205)23:10<1531::AID-ELPS1531>3.0.CO;2-D
   Liu RH, 2002, J MICROELECTROMECH S, V11, P45, DOI 10.1109/84.982862
   Liu SR, 2003, ELECTROPHORESIS, V24, P3755, DOI 10.1002/elps.200305617
   Liu SR, 1999, ANAL CHEM, V71, P566, DOI 10.1021/ac980783v
   Liu TB, 2001, ELECTROPHORESIS, V22, P449, DOI 10.1002/1522-2683(200102)22:3<449::AID-ELPS449>3.3.CO;2-K
   LUCKEY JA, 1990, NUCLEIC ACIDS RES, V18, P4417, DOI 10.1093/nar/18.15.4417
   Madabhushi RS, 1998, ELECTROPHORESIS, V19, P224
   Manz A, 2001, PURE APPL CHEM, V73, P1555, DOI 10.1351/pac200173101555
   Manz A, 2001, LAB CHIP, V1, p1N, DOI 10.1039/b106826c
   MANZ A, 1991, TRAC-TREND ANAL CHEM, V10, P144, DOI 10.1016/0165-9936(91)85116-9
   McCormick RM, 1997, ANAL CHEM, V69, P2626, DOI 10.1021/ac9701997
   McDonald JC, 2002, ACCOUNTS CHEM RES, V35, P491, DOI 10.1021/ar010110q
   McWhorter S, 2000, ELECTROPHORESIS, V21, P1267, DOI 10.1002/(SICI)1522-2683(20000401)21:7<1267::AID-ELPS1267>3.0.CO;2-C
   Melton L, 2003, NATURE, V422, P917, DOI 10.1038/422917b
   Merikangas KR, 2003, SCIENCE, V302, P599, DOI 10.1126/science.1091468
   Minc N, 2004, ANAL CHEM, V76, P3770, DOI 10.1021/ac035246b
   Mitchell P, 2001, NAT BIOTECHNOL, V19, P717, DOI 10.1038/90754
   Moritani T, 2003, ELECTROPHORESIS, V24, P2772, DOI 10.1002/elps.200305547
   Moritani T, 2003, ELECTROPHORESIS, V24, P2764, DOI 10.1002/elps.200305546
   MUNRO NJ, 2001, ANAL CHEM, V73, P1748
   Nataraj AJ, 1999, ELECTROPHORESIS, V20, P1177, DOI 10.1002/(SICI)1522-2683(19990101)20:6<1177::AID-ELPS1177>3.0.CO;2-2
   Ng JMK, 2002, ELECTROPHORESIS, V23, P3461, DOI 10.1002/1522-2683(200210)23:20<3461::AID-ELPS3461>3.0.CO;2-8
   Nishimura A, 2000, CHEM PHARM BULL, V48, P774
   Oda RP, 1998, ANAL CHEM, V70, P4361, DOI 10.1021/ac980452i
   Olsen KG, 2002, ANAL CHEM, V74, P1436, DOI 10.1021/ac0156969
   ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8
   Paegel BM, 2002, ANAL CHEM, V74, P5092, DOI 10.1021/ac0203645
   Paegel BM, 2000, ANAL CHEM, V72, P3030, DOI 10.1021/ac000054r
   Paegel BM, 2003, CURR OPIN BIOTECH, V14, P42, DOI 10.1016/S0958-1669(02)00004-6
   Paegel BM, 2002, P NATL ACAD SCI USA, V99, P574, DOI 10.1073/pnas.012608699
   Pang HM, 1999, J BIOCHEM BIOPH METH, V41, P121, DOI 10.1016/S0165-022X(99)00042-1
   Park SJ, 2002, SCIENCE, V295, P1503, DOI 10.1126/science.1067003
   Pethig R, 1998, J MICROMECH MICROENG, V8, P57, DOI 10.1088/0960-1317/8/2/004
   Piggee CA, 1997, J CHROMATOGR A, V781, P367, DOI 10.1016/S0021-9673(97)00637-7
   Pugmire DL, 2002, ANAL CHEM, V74, P871, DOI 10.1021/ac011026r
   Qi SZ, 2002, LAB CHIP, V2, P88, DOI [10.1039/b200370h, 10.1039/b20037h]
   Ramsey JM, 1999, NAT BIOTECHNOL, V17, P1061, DOI 10.1038/15044
   Ren H, 1999, ELECTROPHORESIS, V20, P2501, DOI 10.1002/(SICI)1522-2683(19990801)20:12<2501::AID-ELPS2501>3.0.CO;2-H
   Reyes DR, 2002, ANAL CHEM, V74, P2623, DOI 10.1021/ac0202435
   Righetti PG, 2002, ELECTROPHORESIS, V23, P1361, DOI 10.1002/1522-2683(200205)23:10<1361::AID-ELPS1361>3.0.CO;2-J
   Roberts MA, 1997, ANAL CHEM, V69, P2035, DOI 10.1021/ac961038q
   Ross D, 2002, ANAL CHEM, V74, P2556, DOI 10.1021/ac025528w
   Ruiz-Martinez MC, 1998, ANAL CHEM, V70, P1516, DOI 10.1021/ac971143f
   Salas-Solano O, 2000, ANAL CHEM, V72, P3129, DOI 10.1021/ac000055j
   Salas-Solano O, 1998, ANAL CHEM, V70, P3996, DOI 10.1021/ac980457f
   Salas-Solano O, 1998, ANAL CHEM, V70, P1528, DOI 10.1021/ac9711448
   Sanders JC, 2003, ANAL CHEM, V75, P986, DOI 10.1021/ac020425z
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   Sassi AP, 1996, ELECTROPHORESIS, V17, P1460, DOI 10.1002/elps.1150170910
   SASSI AP, 1999, Patent No. 5883211
   Scherer JR, 1999, ELECTROPHORESIS, V20, P1508, DOI 10.1002/(SICI)1522-2683(19990601)20:7<1508::AID-ELPS1508>3.0.CO;2-7
   Scherer JR, 2001, BIOTECHNIQUES, V31, P1150, DOI 10.2144/01315rr04
   Schmalzing D, 1999, ANAL BIOCHEM, V270, P148, DOI 10.1006/abio.1999.4067
   Schmalzing D, 1997, P NATL ACAD SCI USA, V94, P10273, DOI 10.1073/pnas.94.19.10273
   Schmalzing D, 1998, ANAL CHEM, V70, P2303, DOI 10.1021/ac971381a
   Shi YN, 2003, ELECTROPHORESIS, V24, P3371, DOI 10.1002/elps.200305553
   Sia SK, 2003, ELECTROPHORESIS, V24, P3563, DOI 10.1002/elps.200305584
   SimoAlfonso E, 1996, ELECTROPHORESIS, V17, P732, DOI 10.1002/elps.1150170419
   SimoAlfonso E, 1996, ELECTROPHORESIS, V17, P723, DOI 10.1002/elps.1150170418
   Simpson PC, 1998, P NATL ACAD SCI USA, V95, P2256, DOI 10.1073/pnas.95.5.2256
   SLATER GW, 1992, ELECTROPHORESIS, V13, P574, DOI 10.1002/elps.11501301116
   Slater GW, 2002, ELECTROPHORESIS, V23, P3791, DOI 10.1002/elps.200290002
   Slater GW, 2003, CURR OPIN BIOTECH, V14, P58, DOI 10.1016/S0958-1669(02)00012-5
   Slater GW, 2000, ELECTROPHORESIS, V21, P3873, DOI 10.1002/1522-2683(200012)21:18<3873::AID-ELPS3873>3.0.CO;2-8
   SLATER GW, 1989, BIOPOLYMERS, V28, P1781, DOI 10.1002/bip.360281011
   Slyadnev MN, 2001, ANAL CHEM, V73, P4037, DOI 10.1021/ac010318p
   SMITH LM, 1986, NATURE, V321, P674, DOI 10.1038/321674a0
   Song LG, 2001, J CHROMATOGR A, V915, P231, DOI 10.1016/S0021-9673(01)00593-3
   Song LG, 2001, ELECTROPHORESIS, V22, P1987, DOI 10.1002/1522-2683(200106)22:10<1987::AID-ELPS1987>3.0.CO;2-K
   Song LG, 2001, ELECTROPHORESIS, V22, P729, DOI 10.1002/1522-2683(200102)22:4<729::AID-ELPS729>3.0.CO;2-O
   Song LG, 2001, ELECTROPHORESIS, V22, P3688, DOI 10.1002/1522-2683(200109)22:17<3688::AID-ELPS3688>3.0.CO;2-I
   Soper SA, 2002, ANAL CHIM ACTA, V470, P87, DOI 10.1016/S0003-2670(02)00356-2
   Soper SA, 1998, ANAL CHEM, V70, P4036, DOI 10.1021/ac980288z
   Soper SA, 1999, J CHROMATOGR A, V853, P107, DOI 10.1016/S0021-9673(99)00651-2
   Sudor J, 2001, ELECTROPHORESIS, V22, P720, DOI 10.1002/1522-2683(200102)22:4<720::AID-ELPS720>3.0.CO;2-N
   Tabuchi M, 2004, NAT BIOTECHNOL, V22, P337, DOI 10.1038/nbt939
   TAKAHASHI S, 1994, ANAL CHEM, V66, P1021, DOI 10.1021/ac00079a016
   TERRY SC, 1979, IEEE T ELECTRON DEV, V26, P1880, DOI 10.1109/T-ED.1979.19791
   Thomas G, 2004, ELECTROPHORESIS, V25, P1668, DOI 10.1002/elps.200405886
   Thorsen T, 2002, SCIENCE, V298, P580, DOI 10.1126/science.1076996
   Tian HJ, 2002, ANAL BIOCHEM, V309, P212, DOI 10.1016/S0003-2697(02)00297-X
   Tian HJ, 2000, ANAL BIOCHEM, V283, P175, DOI 10.1006/abio.2000.4577
   UENO K, 1994, ANAL CHEM, V66, P1424, DOI 10.1021/ac00081a010
   Vaidya B, 2002, ANALYST, V127, P1289, DOI 10.1039/b205801b
   VANDERSCHOOT B, 1985, SENSOR ACTUATOR, V8, P11, DOI 10.1016/0250-6874(85)80020-2
   Verpoorte E, 2002, ELECTROPHORESIS, V23, P677, DOI 10.1002/1522-2683(200203)23:5<677::AID-ELPS677>3.0.CO;2-8
   Vreeland WN, 2003, ANAL CHEM, V75, P3059, DOI 10.1021/ac0259921
   Vreeland WN, 2002, ANAL CHEM, V74, P4328, DOI 10.1021/ac0258094
   Wabuyele MB, 2001, ELECTROPHORESIS, V22, P3939, DOI 10.1002/1522-2683(200110)22:18<3939::AID-ELPS3939>3.0.CO;2-9
   Wang Y, 2003, ANAL CHEM, V75, P1130, DOI 10.1021/ac020683w
   Wang YM, 2002, ELECTROPHORESIS, V23, P1460, DOI 10.1002/1522-2683(200205)23:10<1460::AID-ELPS1460>3.0.CO;2-J
   Wei W, 2001, ANAL CHEM, V73, P1776, DOI 10.1021/ac0012997
   WILLIAMS DC, 1995, ANAL CHEM, V67, P3427, DOI 10.1021/ac00115a010
   Wolfe KA, 2002, ELECTROPHORESIS, V23, P727, DOI 10.1002/1522-2683(200203)23:5<727::AID-ELPS727>3.0.CO;2-O
   Wolfsberg TG, 2002, NAT GENET, V32, P4, DOI 10.1038/ng964
   Woolley AT, 1996, ANAL CHEM, V68, P4081, DOI 10.1021/ac960718q
   Woolley AT, 1998, ANAL CHEM, V70, P684, DOI 10.1021/ac971135z
   Woolley AT, 1997, ANAL CHEM, V69, P2181, DOI 10.1021/ac961237+
   WOOLLEY AT, 1995, ANAL CHEM, V67, P3676, DOI 10.1021/ac00116a010
   WOOLLEY AT, 1994, P NATL ACAD SCI USA, V91, P11348, DOI 10.1073/pnas.91.24.11348
   Wu CH, 1997, MACROMOLECULES, V30, P4574, DOI 10.1021/ma9701088
   Wu CH, 1998, ELECTROPHORESIS, V19, P231, DOI 10.1002/elps.1150190216
   Xiao DQ, 2004, ANAL CHEM, V76, P2055, DOI 10.1021/ac035254s
   Xu F, 2002, ELECTROPHORESIS, V23, P3608, DOI 10.1002/1522-2683(200210)23:20<3608::AID-ELPS3608>3.0.CO;2-3
   Xu JD, 2000, ANAL CHEM, V72, P1930, DOI 10.1021/ac991216q
   Xu YC, 2003, ANAL CHEM, V75, P2975, DOI 10.1021/ac030031n
   Xue G, 2001, J CHROMATOGR A, V914, P245, DOI 10.1016/S0021-9673(00)01167-5
   Zhou HH, 2000, ANAL CHEM, V72, P1045, DOI 10.1021/ac991117c
NR 231
TC 95
Z9 98
U1 3
U2 26
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0173-0835
J9 ELECTROPHORESIS
JI Electrophoresis
PD NOV
PY 2004
VL 25
IS 21-22
BP 3564
EP 3588
DI 10.1002/elps.200406161
PG 25
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 878WV
UT WOS:000225679000008
PM 15565709
DA 2018-10-19
ER

PT J
AU Yiannaki, EE
   Zintzaras, E
   Analatos, A
   Theodoridou, C
   Dalekos, GN
   Germenis, AE
AF Yiannaki, EE
   Zintzaras, E
   Analatos, A
   Theodoridou, C
   Dalekos, GN
   Germenis, AE
TI Evaluation of a microsphere-based flow cytometric assay for diagnosis of
   Celiac disease
SO JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY
LA English
DT Article
DE flow cytometry; Celiac disease; ELISA; microspheres
ID ANTITISSUE TRANSGLUTAMINASE ANTIBODIES; TISSUE TRANSGLUTAMINASE;
   GUINEA-PIG; FOLLOW-UP; TESTS; ANTIGLIADIN; SPRUE; KITS
AB The multiplexed particle-based flow cytometric technology proposes a new approach for the diagnosis of autoimmune diseases combining the advantages of conventional methods with the ability to quantitatively determine multiple autoantibodies in the same sample, simultaneously and rapidly. Recently, a commercial kit (FIDIS Celiac, Biomedical Diagnostics, Marne la Valle, France) was introduced for the simultaneous detection of IgA anti-tissue transglutaminase (anti-tTG), IgG, and IgA anti-gliadin antibodies (AGA). This study was undertaken to evaluate and compare the FIDIS Celiac kit with standardized commercial ELISAs (QUANTA Lite, INOVA Diagnostics Inc., San Diego, CA). A disease group consisted of 21 samples from untreated patients with biopsy confirmed celiac disease (CD), and two control groups of historical sera (207 from regular blood donors and 181 from chronically infected hepatitis patients) were studied. All control sera were negative for IgA anti-endomysial antibodies (EmA) and had an IgA concentration above the lower normal limit. Concerning the reproducibility, intra- and inter-assay coefficients of variation (CVs) ranging between 2% and 12%, and between 3% and 21%, respectively, were observed. Regarding the diagnostic quality, each assay was compared to the disease diagnosis using the McNemar test and the kappa (K) parameter, while ROC analysis was applied. Generally, the performance of FIDIS assay was proved almost equally adequate to that of ELISA in the detection of IgA anti-tTG antibodies, IgA and IgG AGA. However, the performance of FIDIS assay was found surmounting that of ELISA among hepatitis patients, possibly due to the avoidance of debris and unbound cross contaminants and, hence, the "noise" of such materials in samples under analysis. Taking our results together with the simplicity and the high throughput of FIDIS assay, its overall performance in the diagnosis of CD seems better than that of ELISA.
C1 Univ Thessaly, Univ Hosp Larissa, Sch Med, Dept Immunol & Histocompatibil, GR-41110 Larisa, Greece.
   Univ Thessaly, Sch Med, Dept Biometr, GR-41110 Larisa, Greece.
   Univ Thessaly, Sch Med, Dept Internal Med, Acad Liver Unit, GR-41110 Larisa, Greece.
RP Germenis, AE (reprint author), Univ Thessaly, Univ Hosp Larissa, Sch Med, Dept Immunol & Histocompatibil, GR-41110 Larisa, Greece.
EM agermen@med.uth.gr
OI Germenis, Anastasios/0000-0002-3315-6947
CR Altman DG, 1994, PRACTICAL STAT MED R, P403
   Bardella MT, 2001, DIGEST LIVER DIS, V33, P426, DOI 10.1016/S1590-8658(01)80015-3
   Basso D, 2001, J CLIN LAB ANAL, V15, P112, DOI 10.1002/jcla.1012
   Carroccio A, 2002, CLIN CHEM, V48, P1546
   Carroccio A, 2001, GUT, V49, P506, DOI 10.1136/gut.49.4.506
   Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797
   Fabiani E, 2001, EUR J GASTROEN HEPAT, V13, P659, DOI 10.1097/00042737-200106000-00008
   Farrell RJ, 2002, NEW ENGL J MED, V346, P180, DOI 10.1056/NEJMra010852
   Fine KD, 2001, AM J GASTROENTEROL, V96, P138, DOI 10.1016/S0002-9270(00)02257-7
   Foldes-Papp Z, 2002, J IMMUNOASS IMMUNOCH, V23, P211, DOI 10.1081/IAS-120003662
   Horvath K, 2002, AM J GASTROENTEROL, V97, P2702
   Kellar KL, 2002, EXP HEMATOL, V30, P1227, DOI 10.1016/S0301-472X(02)00922-0
   Kumar V, 2001, CLIN DIAGN LAB IMMUN, V8, P678, DOI 10.1128/CDLI.8.4.678-685.2001
   Martini S, 2002, CLIN CHEM, V48, P960
   Martini S, 2001, CLIN CHEM, V47, P1722
   MILLER J, 1996, IN CONTACT WITH GODS, P65
   Rouquette AM, 2003, AM J CLIN PATHOL, V120, P676, DOI 10.1309/GJHKOD24YDDXWONF
   Sugai E, 2000, AM J GASTROENTEROL, V95, P2318
   Tesei N, 2003, ALIMENT PHARM THERAP, V17, P1415, DOI 10.1046/j.1365-2036.2003.01595.x
   Vecchi M, 2003, SCAND J GASTROENTERO, V38, P50, DOI 10.1080/00365520310000438
   Vignali DAA, 2000, J IMMUNOL METHODS, V243, P243, DOI 10.1016/S0022-1759(00)00238-6
   Vivas S, 2003, EUR J GASTROEN HEPAT, V15, P479, DOI [10.1097/00042737-200305000-00004, 10.1097/01.meg.0000059104.41030.1c]
   Wong RCW, 2002, J CLIN PATHOL, V55, P488, DOI 10.1136/jcp.55.7.488
   Woodward M, 1999, EPIDEMIOLOGY STUDY D, P94
   ZWEIG MH, 1993, CLIN CHEM, V39, P561
NR 25
TC 15
Z9 15
U1 0
U2 3
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016 USA
SN 1532-1819
J9 J IMMUNOASS IMMUNOCH
JI J. Immunoass. Immunoch.
PD NOV
PY 2004
VL 25
IS 4
BP 345
EP 357
DI 10.1081/IAS.200033832
PG 13
WC Biochemical Research Methods; Immunology; Medical Laboratory Technology
SC Biochemistry & Molecular Biology; Immunology; Medical Laboratory
   Technology
GA 869FM
UT WOS:000224968800004
PM 15552589
DA 2018-10-19
ER

PT J
AU Marin-Franch, P
   Cochran, S
   Kirk, K
AF Marin-Franch, P
   Cochran, S
   Kirk, K
TI Progress towards ultrasound applications of new single crystal materials
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN ELECTRONICS
LA English
DT Article; Proceedings Paper
CT Annual Conference of the British-Association-for-Crystal-Growth
CY 2003
CL Oxford Univ, Oxford, ENGLAND
SP British Assoc Crystal Growth
HO Oxford Univ
ID 1-3 COMPOSITE PIEZOELECTRICS; TRANSDUCER APPLICATIONS
AB In recent years, single crystal materials with better piezoelectric properties than the existing ceramics have become available. These new materials will potentially provide improved performance in ultrasonic applications such as NDT, sonar and biomedical diagnosis. In order to select the best material and optimize transducer design, comparison must be carried out. However, due to material and transducer fabrication costs, initial comparisons can be based on simulation. In this paper, a comparison is reported between transducers based on the single crystal lead magnesium niobate-lead titanate (PMN-32% PT) and the ceramic lead zirconate titanate (PZT-5H). Material performance is assessed both for single materials and piezoelectric-polymer composite configurations by defining the relevant piezoelectric parameters. Furthermore, the effect of such parameters on the performance of different ultrasonic transducers is illustrated. Practical limitations are also discussed. We conclude that the new single crystal material will be capable of outperforming the present widely used ceramic for almost all practical applications. (C) 2004 Kluwer Academic Publishers.
C1 Univ Paisley, Sch ICT J123, Paisley PA1 2BE, Renfrew, Scotland.
RP Marin-Franch, P (reprint author), Univ Paisley, Sch ICT J123, Paisley PA1 2BE, Renfrew, Scotland.
EM mari-ph0@wpmail.paisley.ac.uk
RI Cochran, Sandy/M-4087-2017
OI Cochran, Sandy/0000-0001-7324-7790
CR Berlincourt D. A., 1964, PHYS ACOUSTICS, V1
   Caidahl K, 1998, LANCET, V352, P1264, DOI 10.1016/S0140-6736(98)02361-7
   Cheng KC, 2003, IEEE T ULTRASON FERR, V50, P1177, DOI 10.1109/TUFFC.2003.1235328
   HAYWARD G, 1989, J ACOUST SOC AM, V86, P1643, DOI 10.1121/1.398594
   HEDRICK WR, 1994, ULTRASOUND PHYS INST, P96
   Jaffe B, 1971, PIEZOELECTRIC CERAMI
   KRAUTKRAMER J, 1990, ULTRASONIC TESTING M, P187
   LEWIS G. K., 1980, ACOUST IMAGING, V8, P395
   Moulson A.J., 1990, ELECTROCERAMICS
   NEWNHAM RE, 1978, MATER RES BULL, V13, P525, DOI 10.1016/0025-5408(78)90161-7
   OAKLEY CG, 2000, IEEE ULTRASONICS S P, V2
   OAKLEY CG, 2000, IEEE ULTRASONICS S P, V1, P1157
   Park SE, 1997, IEEE T ULTRASON FERR, V44, P1140, DOI 10.1109/58.655639
   Ritter T, 2000, IEEE T ULTRASON FERR, V47, P792, DOI 10.1109/58.852060
   SHAULOV A, 1986, IEEE T ULTRASON FERR, V33, P812
   SMITH WA, 1991, IEEE T ULTRASON FERR, V38, P40, DOI 10.1109/58.67833
   SMITH WA, 1993, IEEE T ULTRASON FERR, V40, P41, DOI 10.1109/58.184997
   STANSFIELD D, 1991, UNDERWATER ELECTROAC, P18
NR 18
TC 17
Z9 17
U1 3
U2 11
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4522
J9 J MATER SCI-MATER EL
JI J. Mater. Sci.-Mater. Electron.
PD NOV
PY 2004
VL 15
IS 11
BP 715
EP 720
DI 10.1023/B:JMSE.0000043418.10953.38
PG 6
WC Engineering, Electrical & Electronic; Materials Science,
   Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Engineering; Materials Science; Physics
GA 857ZD
UT WOS:000224158700004
DA 2018-10-19
ER

PT J
AU Qiang, L
   Cao, CB
   Zhang, Y
   Man, XL
   Zhu, HS
AF Qiang, L
   Cao, CB
   Zhang, Y
   Man, XL
   Zhu, HS
TI The preparation of insoluble fibroin films induced by degummed fibroin
   or fibroin microspheres
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID MORI SILK FIBROIN; PHYSICAL-PROPERTIES; TEMPERATURE; MEMBRANE
AB Blending degummed fibroin (DF) or insoluble fibroin microspheres with concentrated fibroin solution, the insoluble films were obtained through drying the solution at 40-45degreesC. The conformation of silk fibroin films was analyzed by infrared spectrum and X-ray diffractometry. The results demonstrated that beta-sheet conformation increased rapidly when the degummed silk or insoluble microspheres blended with fibroin, while the pure SF membrane was mainly composed of alpha/random coil conformation when the other conditions kept same. This suggested that fibroin microspheres and degummed fibroin could induce the formation of beta-sheet crystal and the insoluble films, without methanol after-treatment, could be obtained at approximately room temperature. Although the fibroin films blending with DF had many protuberances, the films containing fibroin microspheres had the smooth surface and could be used effectively in biotechnological materials and biomedical application. (C) 2004 Kluwer Academic Publishers.
C1 Beijing Inst Technol, Res Ctr Mat Sci, Beijing 100081, Peoples R China.
RP Cao, CB (reprint author), Beijing Inst Technol, Res Ctr Mat Sci, Beijing 100081, Peoples R China.
EM cbcao@bit.edu.cn
RI Cao, Chuanbao/J-5396-2013
OI Cao, Chuanbao/0000-0003-2830-4383
CR Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Cai KY, 2002, BIOMATERIALS, V23, P1153, DOI 10.1016/S0142-9612(01)00230-7
   CHIARINI A, BIOMATERIALS, V24, P789
   DEMURA M, 1991, J MEMBRANE SCI, V59, P39, DOI 10.1016/S0376-7388(00)81220-X
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Kweon H, 2001, J APPL POLYM SCI, V80, P928, DOI 10.1002/app.1172
   Kweon HY, 2001, J APPL POLYM SCI, V80, P1848, DOI 10.1002/app.1281
   MASUHIRO T, 1994, J POLYM SCI POL LETT, V32, P961
   Mathur AB, 1997, BIOPOLYMERS, V42, P61, DOI 10.1002/(SICI)1097-0282(199707)42:1<61::AID-BIP6>3.0.CO;2-#
   Nam J, 2001, J APPL POLYM SCI, V81, P3008, DOI 10.1002/app.1751
   Noishiki Y, 2002, J APPL POLYM SCI, V86, P3425, DOI 10.1002/app.11370
   NORIHIKO M, 1990, POLYMER, V31, P265
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Sun YY, 1997, J APPL POLYM SCI, V65, P959, DOI 10.1002/(SICI)1097-4628(19970801)65:5<959::AID-APP14>3.0.CO;2-N
   Tretinnikov ON, 2001, LANGMUIR, V17, P7406, DOI 10.1021/la010791y
   Tsuboi Y, 2001, APPL PHYS A-MATER, V73, P637, DOI 10.1007/s003390100984
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   YOSHIMIZU H, 1990, J APPL POLYM SCI, V40, P1745, DOI 10.1002/app.1990.070400928
NR 18
TC 31
Z9 35
U1 0
U2 7
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD NOV
PY 2004
VL 15
IS 11
BP 1193
EP 1197
DI 10.1007/s10856-004-5918-y
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 894SM
UT WOS:000226811900004
PM 15880927
DA 2018-10-19
ER

PT J
AU Wei, J
   Li, YB
   Zuo, Y
   Peng, XL
   Zhang, L
AF Wei, J
   Li, YB
   Zuo, Y
   Peng, XL
   Zhang, L
TI Development of biomimetic needle-like apatite nanocrystals by a simple
   new method
SO JOURNAL OF MATERIALS SCIENCE & TECHNOLOGY
LA English
DT Article
DE biomimetic; apatite; nanocrystals; biomedical applications
ID HYDROXYAPATITE
AB A new method of calcium nitrate and sodium phosphate as reactants was employed to prepare biomimetic apatite nanocrystals by a simple heating treatment in water. The structure and properties of the apatite crystals were investigated by TEM, XRD, IR, ICP and TG. It is found that the apatite nanocrystals contain OH-, CO32-, Na+ and HPO42- ions in their crystal structure. The crystal water is removed during heating from 200degreesC to 400degreesC. CO32- and HPO42- are decomposed at 600degreesC to 800degreesC, also there is lattice water lost at this temperature stage. The morphology of the apatite nanocrystals is needle-like with a length less than 80 nm. The size and crystallinity of the apatite nanocrystals increase with water treatment temperature and time. Compared to the apatite crystals sintered at 800degreesC, water treated apatite nanocrystals are poorly crystallized apatite. The results indicate that the apatite nanocrystals have similarity in composition, structure, morphology and crystallinity to that of bone apatite crystals. It can be used to make apatite crystals/polymer biomimetic bone repair materials or for other biomedical applications.
C1 Sichuan Univ, Res Ctr Nanobiomat, Chengdu 610064, Peoples R China.
RP Li, YB (reprint author), Sichuan Univ, Res Ctr Nanobiomat, Chengdu 610064, Peoples R China.
EM nic7504@scu.edu.cn
CR LI YB, 1994, J MATER SCI-MATER M, V5, P326
   LI YB, 1994, BIOMATERIALS, V15, P835
   LI YB, 1999, 4 AS S BIOM MAT SING, P89
   Liu CS, 2001, BIOMATERIALS, V22, P301, DOI 10.1016/S0142-9612(00)00166-6
   Liu DM, 2001, BIOMATERIALS, V22, P1721, DOI 10.1016/S0142-9612(00)00332-X
   MONMA H, 1987, J MATER SCI, V22, P4247, DOI 10.1007/BF01132015
   PARK JB, 1992, BIOMATERIALS INTRO, P123
   SADA E, 1991, CHEM ENG COMMUN, V103, P57, DOI 10.1080/00986449108910862
   SENYA I, 1987, J CERAM SOC JPN, V95, P759
   TAKEO H, 1989, J MATER SCI LETT, V8, P305
   TAKEO H, 1987, J CERAM SOC JPN, V95, P825
   WANG X, 2001, CHIN J BIOMED ENG, V10, P199
   Wang XJ, 2002, BIOMATERIALS, V23, P4787, DOI 10.1016/S0142-9612(02)00229-6
   WANG XJ, 2001, T 27 ANN M SFB US, P305
   Yan YG, 2003, EUR POLYM J, V39, P411
   YI Z, 2003, HIGH TECHNOL LETT, V4, P58
   YOSHIO M, 1990, J CERAM SOC JPN, V98, P1255
   Yuan HP, 1999, BIOMATERIALS, V20, P1799, DOI 10.1016/S0142-9612(99)00075-7
NR 18
TC 5
Z9 6
U1 0
U2 4
PU JOURNAL MATER SCI TECHNOL
PI SHENYANG
PA 72 WENHUA RD, SHENYANG 110015, PEOPLES R CHINA
SN 1005-0302
J9 J MATER SCI TECHNOL
JI J. Mater. Sci. Technol.
PD NOV
PY 2004
VL 20
IS 6
BP 665
EP 667
PG 3
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 878CE
UT WOS:000225623300006
DA 2018-10-19
ER

PT J
AU Fu, Q
   Zhou, N
   Huang, WH
   Wang, DP
   Zhang, LY
AF Fu, Q
   Zhou, N
   Huang, WH
   Wang, DP
   Zhang, LY
TI Formation and characterization of bone-like nanoscale hydroxyapatite in
   glass bone cement
SO JOURNAL OF MATERIALS SCIENCE & TECHNOLOGY
LA English
DT Article
DE bioactivity; bone cement; hydroxyapatite; microstructure
ID BIOCERAMICS
AB Glass based bone cement (GBC) was synthesized by mixing CaO-SiO2-P2O5 based glass powder with ammonium phosphate liquid medium. Bone-like hydroxyapatite (HAP, Ca-10(PO4)(6)(OH)(2)) was found to form after GBC was immersed in simulated body fluid (SBF). HAP crystal grew with an increasing time along c axle and reached about 200 nm in length after 30 days, however, the end plane granularity remained 30similar to50 rim. The chemical composition, crystal structure and morphology of HAP formed from GBC were proved to have great resemblance with living HAP. It is believed that GBC was a desirable biomedical material with high bioactivity. Furthermore, the high compressive strength guaranteed the possibility of GBC in clinical application.
C1 Tongji Univ, Sch Mat Sci & Engn, Shanghai 200092, Peoples R China.
RP Huang, WH (reprint author), Tongji Univ, Sch Mat Sci & Engn, Shanghai 200092, Peoples R China.
EM whhuang@mail.tongji.edu.cn
RI Fu, Qiang/B-1972-2013
CR CHO SB, 1998, J MATER SCI-MATER M, V9, P278
   DeAza PN, 1996, J MATER SCI-MATER M, V7, P399, DOI 10.1007/BF00122007
   Filho OP, 1996, J BIOMED MATER RES, V30, P509
   GAN FX, 1990, MODERN GLASS SCI TEC, P282
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   KOKUBO T, 1991, BIOMATERIALS, V12, P155, DOI 10.1016/0142-9612(91)90194-F
   MALONEY WJ, 1990, J BONE JOINT SURG BR, V72, P966
   Ohtsuki C., 1991, J CERAM SOC JPN, V99, P1
   Park JB, 1992, BIOMATERIALS INTRO, P192
   Shinzato S, 2001, J BIOMED MATER RES, V56, P571, DOI 10.1002/1097-4636(20010915)56:4<571::AID-JBM1129>3.0.CO;2-H
   Tamura J, 1996, J BIOMED MATER RES, V30, P85, DOI 10.1002/(SICI)1097-4636(199601)30:1<85::AID-JBM11>3.0.CO;2-P
   VOGGEL W, 1984, FRONTIER GLASS SCI T, P44
NR 12
TC 2
Z9 2
U1 0
U2 0
PU JOURNAL MATER SCI TECHNOL
PI SHENYANG
PA 72 WENHUA RD, SHENYANG 110015, PEOPLES R CHINA
SN 1005-0302
J9 J MATER SCI TECHNOL
JI J. Mater. Sci. Technol.
PD NOV
PY 2004
VL 20
IS 6
BP 772
EP 774
PG 3
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 878CE
UT WOS:000225623300037
DA 2018-10-19
ER

PT J
AU Popat, KC
   Mor, G
   Grimes, C
   Desai, TA
AF Popat, KC
   Mor, G
   Grimes, C
   Desai, TA
TI Poly (ethylene glycol) grafted nanoporous alumina membranes
SO JOURNAL OF MEMBRANE SCIENCE
LA English
DT Article
DE poly (ethylene glycol); nanoporous alumina membranes; anodization
ID PROTEIN SURFACE INTERACTIONS; INDUCED PLATELET ACTIVATION; POLY(ETHYLENE
   GLYCOL); TRIBLOCK COPOLYMERS; POLYETHYLENE OXIDE; SENSOR NETWORK; FILMS;
   ADSORPTION; PREVENTION; TEMPERATURE
AB Membranes currently used for separation of sub-micron particles in biomedical applications are of asymmetric or anisotropic variety and are made from polymers such as polysulfone or polyacrylonitrile. Several bioincompatibilities are associated with these polymeric membranes limiting their applications. Aluminum oxide substrates have been chosen for several reasons, including compatibility with our processing protocols, chemical and thermal stability, and ease in post-processing surface modification. Several studies have shown this material to be bioinert. However, the biocompatibility of the membrane material must be further investigated and improved. With proper surface modification, the protein adsorption can be lowered and the non-fouling characteristics can be improved. In this study we graft alumina membranes with a biocompatible polymer like poly (ethylene glycol) to investigate protein adsorption. Albumin and fibrinogen were selected as model proteins since they are important components in immunogenic and thrombogenic reactions. X-ray photoelectron spectroscopy (XPS) and atomic force microscopy (AFM) were used to characterize PEG films on alumina membranes. (C) 2004 Elsevier B.V. All rights reserved.
C1 Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
   Penn State Univ, Dept Elect Engn, State Coll, PA USA.
RP Desai, TA (reprint author), Boston Univ, Dept Biomed Engn, 44 Cummington St, Boston, MA 02215 USA.
EM tdesai@bu.edu
OI Popat, Ketul C./0000-0002-2417-7789
CR AMIJI M, 1992, J BIOMAT SCI-POLYM E, V3, P375, DOI 10.1163/156856292X00196
   AMIJI M, 1993, J COLLOID INTERF SCI, V155, P251, DOI 10.1006/jcis.1993.1031
   AMIJI M, 1992, BIOMATERIALS, V13, P682, DOI 10.1016/0142-9612(92)90128-B
   Andrade J.D., 1985, SURFACE INTERFACIAL, V1, P1985
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   Band I. M., 1979, Atomic Data and Nuclear Data Tables, V23, P443, DOI 10.1016/0092-640X(79)90027-5
   CAI QY, 2002, SENSOR ACTUAT B-CHEM, V79, P144
   CUYPERS PA, 1983, J BIOL CHEM, V258, P2426
   DEGENNES PG, 1980, MACROMOLECULES, V13, P1069, DOI 10.1021/ma60077a009
   Dickey EC, 2002, SENSORS-BASEL, V2, P91, DOI 10.3390/s20300091
   DUNLEAVY M, 1996, MED DEVICE TECHNOL, V7, P18
   Emoto K, 1996, ANAL CHEM, V68, P3751, DOI 10.1021/ac960114m
   GRAINGER DW, 1989, J BIOMED MATER RES, V23, P979, DOI 10.1002/jbm.820230903
   Grimes CA, 2003, SENSORS, V3, P69, DOI 10.3390/s30300069
   GRINGELL D, 1994, J BIOMED MATER RES, V28, P505
   HARMS J, 1979, J BIOMED MATER RES, V13, P67, DOI 10.1002/jbm.820130109
   Harris J. M., 1992, POLYETHYLENE GLYCOL
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P159, DOI 10.1016/0021-9797(91)90044-9
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Kamath KR, 1996, J BIOMAT SCI-POLYM E, V7, P977, DOI 10.1163/156856296X00381
   *NAT I STAND TECHN, 2001, NIST EL EFF ATT LENG
   *NAT I STAND TECHN, 2001, NIST XRAY PHOT SPECT
   Patai S., 1989, CHEM ORGANIC SILICON
   Popat KC, 2003, J VAC SCI TECHNOL B, V21, P645, DOI 10.1116/1.1545733
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   SCHWEPPE J, 1994, J ELECTRON SPECTROSC, V67, P463, DOI 10.1016/0368-2048(93)02059-U
   Sharma S, 2002, LANGMUIR, V18, P8728, DOI 10.1021/la026097f
   Sharma S, 2003, APPL SURF SCI, V206, P218, DOI 10.1016/S0169-4332(02)01220-5
   STARK MB, 1989, BIOTECHNOL BIOENG, V34, P942, DOI 10.1002/bit.260340709
   STRASSER CM, 1989, J BIOMED MATER RES, V23, P1385
   Szleifer I, 1997, BIOPHYS J, V72, P595, DOI 10.1016/S0006-3495(97)78698-3
   TSENG YC, 1992, J BIOMED MATER RES, V26, P373, DOI 10.1002/jbm.820260308
   Ulman A., 1991, INTRO ULTRATHIN ORGA
   Varghese OK, 2002, J MATER RES, V17, P1162
   Vasant EF, 1995, CHARACTERIZATION CHE
   WASSERMAN SR, 1989, LANGMUIR, V5, P1074, DOI 10.1021/la00088a035
   Yang XP, 2002, SENSORS-BASEL, V2, P455, DOI 10.3390/s21100455
   YINCHAO T, 1995, BIOMATERIALS, V16, P963
   Zhang R, 2002, SENSORS, V2, P331, DOI 10.3390/s20800331
NR 39
TC 22
Z9 23
U1 1
U2 20
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0376-7388
J9 J MEMBRANE SCI
JI J. Membr. Sci.
PD NOV 1
PY 2004
VL 243
IS 1-2
BP 97
EP 106
DI 10.1016/j.memsci.2004.05.030
PG 10
WC Engineering, Chemical; Polymer Science
SC Engineering; Polymer Science
GA 860TL
UT WOS:000224366100011
DA 2018-10-19
ER

PT J
AU Covolan, VL
   Di Ponzio, R
   Chiellini, F
   Fernandes, EG
   Solaro, R
   Chiellini, E
AF Covolan, VL
   Di Ponzio, R
   Chiellini, F
   Fernandes, EG
   Solaro, R
   Chiellini, E
TI Polyurethane based materials for the production of biomedical materials
SO MACROMOLECULAR SYMPOSIA
LA English
DT Article; Proceedings Paper
CT 16th Italian Meeting on Science and Technology of Macromolecules
CY SEP 22-23, 2003
CL Pisa, ITALY
SP Macromol Italian Assoc
DE block copolymer; hexamethylene diisocyanate; poly(epsilon-caprolactone)
   diol; poly(ethylene glycol); polyurethane
ID RELEASE
AB Polyurethanes (PUs) composed by hard and soft segments have been extensively used in the manufacturing of biocompatible prosthesis and medical devices. A broad variety of PUs can be obtained by modifying the balance between both segments. In the present work, different basically-flexible PUs have been prepared by employing different combinations of aliphatic hexamethylene diisocyanate, poly(ethylene glycol) (Mw 400 Da), poly(epsilon-caprolacione) diol (Mw 530 Da), and 1,4-butanediol. Thermal analysis of the synthesized PUs demonstrated high thermal stability and the assumption of glassy state well Mow room temperature, in agreement with their marked flexibility. Morphological characterization of PUs films indicated that films prepared by spin coating were smoother and more homogeneous than those obtained by casting. Biological assays performed by using 3T3/BALB-C mouse embryo fibroblast cell line confirmed the absence of toxicity and hence the biocompatibility of PU-films.
C1 Univ Pisa, INSTM, Dept Chem & Ind Chem, Operat Unit, I-56126 Pisa, Italy.
RP Chiellini, E (reprint author), Univ Pisa, INSTM, Dept Chem & Ind Chem, Operat Unit, Via Risorgimento 35, I-56126 Pisa, Italy.
EM emochie@dcci.unipi.it
RI Chiellini, Federica/F-3233-2010; Fernandes, Elizabeth/I-6736-2013;
   Grillo Fernandes, Elizabeth/B-6084-2016
OI Chiellini, Federica/0000-0003-4680-9975; Grillo Fernandes,
   Elizabeth/0000-0003-4830-1286
CR Bizzarri R, 2002, MACROMOL CHEM PHYSIC, V203, P1684, DOI 10.1002/1521-3935(200207)203:10/11<1684::AID-MACP1684>3.0.CO;2-L
   Chiellini E, 2001, J BIOACT COMPAT POL, V16, P441, DOI 10.1106/6CFL-4E8A-L7XR-MUF7
   Chiellini F, 2003, MACROMOL SYMP, V197, P369, DOI 10.1002/masy.200350732
   Chiellini F, 2002, J APPL POLYM SCI, V85, P2729, DOI 10.1002/app.10799
   CHIELLINI F, 2001, MACROMOL RAPID COMM, V22, P1285
   IKADA Y, 1992, Patent No. 0482467A2
   KOBAYASHI H, 1991, J BIOMED MATER RES, V25, P1481, DOI 10.1002/jbm.820251206
   SHANTHA KL, 1993, J APPL POLYM SCI, V50, P1863, DOI 10.1002/app.1993.070501102
   Sheikh N, 2000, INT J ADHES ADHES, V20, P299, DOI 10.1016/S0143-7496(99)00060-3
   Solaro R, 2003, J MATER SCI-MATER M, V14, P705, DOI 10.1023/A:1024963700223
   SUBHAGA CS, 1995, J MICROENCAPSUL, V12, P617, DOI 10.3109/02652049509006792
   Ulrich H., 1983, ENCY CHEM TECHNOLOGY, P576
   YU T, 2000, ACS POLYM PREPR, V41, P1699
NR 13
TC 9
Z9 9
U1 0
U2 7
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1022-1360
J9 MACROMOL SYMP
JI Macromol. Symp.
PD NOV
PY 2004
VL 218
BP 273
EP 282
DI 10.1002/masy.200451428
PG 10
WC Polymer Science
SC Polymer Science
GA 890QV
UT WOS:000226526800030
DA 2018-10-19
ER

PT J
AU Lin, XY
   Li, XD
   Fan, HS
   Wen, XT
   Lu, J
   Zhang, XD
AF Lin, XY
   Li, XD
   Fan, HS
   Wen, XT
   Lu, J
   Zhang, XD
TI In situ synthesis of bone-like apatite/collagen nano-composite at low
   temperature
SO MATERIALS LETTERS
LA English
DT Article
DE nanocomposite; bone-like apatite; collagen; low temperature; in situ
   synthesis
ID NANOCOMPOSITE
AB A nano-composite of bone-like apatite/collagen was prepared by a new method-low-temperature in situ synthesis using calcium nitrate, diammoniun hydrogen phosphate and cow hide collagen as starting materials. The composite was investigated via X-ray diffraction (XRD), Fourier transform infrared (FTIR), scanning electron microscopy (SEM) and transmission electron microscopy (TEM). It was found that bone-like nanoapatite particles were distributed uniformly in collagen fibrils in the composite. The composite with homogeneous microstructure was similar to natural bone in crystallite phase composition and crystal size. The biomimetic composite is expected to exhibit desirable properties in biomedical applications. (C) 2004 Elsevier B.V. All rights reserved.
C1 Sichuan Univ, Biomed Engn Res Ctr, Chengdu 610064, Peoples R China.
   SW Univ Sci & Technol, Sichuan 621002, Mianyang, Peoples R China.
RP Li, XD (reprint author), Sichuan Univ, Biomed Engn Res Ctr, Chengdu 610064, Peoples R China.
EM xli20004@yahoo.com
RI Li, Xudong/D-4444-2011
OI Li, Xudong/0000-0002-7939-5150
CR AARON W, 2003, BIOMATERIALS, V24, P4881
   AOKI H, 1991, SCIENCE MED APPL HYD
   ARIF A, 1996, J COLLOID INTERF SCI, V179, P608
   Bilezikian J. P., 1996, PRINCIPLES BONE BIOL
   Chapman MW, 1997, J BONE JOINT SURG AM, V79A, P495, DOI 10.2106/00004623-199704000-00004
   FAN SJ, 1992, T 19 ANN M SOC BIOM, P104
   JOON BP, 1992, BIOMATERIALS INTRO
   KENNETH D, 1996, J ORTHOP RES, V14, P351
   Kevor S, 1995, J BIOMED MATER RES, V29, P803
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Li HY, 2003, MATER LETT, V57, P2848, DOI 10.1016/S0167-577X(02)01386-1
   LI Y, 2004, J MATER SCI-MATER M, V5, P326
   LIU YH, 1993, BIOMED MAT RES FAR E, P161
   MCPHERSON JM, 1985, COLLAGEN REL RES, V5, P119
   Tadic D, 2002, BIOMATERIALS, V23, P2553, DOI 10.1016/S0142-9612(01)00390-8
   WANG RZ, 1995, J MATER SCI LETT, V14, P490, DOI 10.1007/BF00665911
NR 16
TC 43
Z9 47
U1 0
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD NOV
PY 2004
VL 58
IS 27-28
BP 3569
EP 3572
DI 10.1016/j.matlet.2004.06.044
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 861WO
UT WOS:000224449500042
DA 2018-10-19
ER

PT J
AU Silva, HM
   Schneider, SG
   Neto, CM
AF Silva, HM
   Schneider, SG
   Neto, CM
TI Study of nontoxic aluminum and vanadium-free titanium alloys for
   biomedical applications
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT 2nd Meeting of the Brazilian-Society-for-Materials-Research (Brazil-MRS)
CY OCT 26-29, 2003
CL Rio de Janeiro, BRAZIL
SP Brazilian Soc Mat Res
DE beta-type Ti alloys; biomedical applications; microstructure; mechanical
   properties
AB Pure titanium and its alloys are the most attractive materials for biomedical applications. Studies have shown that P-type titanium alloys, containing the elements Mo, Zr, Nb, Ta and Fe, can exhibit an elastic modulus lower than Ti-6AI-4V alloy. This work describes the microstructures and mechanical properties of two beta-type titanium alloys, Ti-8Nb-13Zr and Ti-18Nb-13Zr (wt.%), which were produced by furnace arc-melting in argon atmosphere, heat treatment and rotary swaging. Microstructural analyses of the materials in as-cast and heat-treated conditions are performed using light microscopy and scanning electron microscopy (SEM). Mechanical characterization of these alloys is based on tensile and hardness tests. Results indicate that the route of thermomechanical processing is available to obtain a homogeneous martensitic alpha' microstructure and good mechanical properties for the alloys, which can be used for biomedical applications. (C) 2004 Elsevier B.V. All rights reserved.
C1 ITA, BR-12228904 Sao Jose Dos Campos, SP, Brazil.
   Fac Engn Quim, FAENQUIL, DEMAR, BR-12600970 Lorena, SP, Brazil.
RP Silva, HM (reprint author), ITA, Pca Marechal Ar Eduardo Gomes,50 Vila Acacias, BR-12228904 Sao Jose Dos Campos, SP, Brazil.
EM helenam@ita.br
RI Schneider, Sandra/E-6087-2015
CR DAVIDSON JA, 1994, BIO-MED MATER ENG, V4, P231
   Geetha M, 2001, J ALLOY COMPD, V329, P264, DOI 10.1016/S0925-8388(01)01604-8
   Helmus M.N., 1995, ENCY HDB BIOMATERIAL, V1, P27
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Ratner BD, 1996, INTRO MAT MED
   ROBARE EW, 1997, ADV SCI TECHNOLOGY T, P283
   ZAVAGLIA CAC, 1993, THESIS UNICAMP
NR 7
TC 42
Z9 45
U1 2
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD NOV 1
PY 2004
VL 24
IS 5
BP 679
EP 682
DI 10.1016/j.msec.2004.08.051
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA 879PY
UT WOS:000225730900017
DA 2018-10-19
ER

PT J
AU Kohn, J
AF Kohn, J
TI New approaches to biomaterials design
SO NATURE MATERIALS
LA English
DT Editorial Material
ID POLYMER SURFACES; CHEMISTRY; LIBRARY
AB The adoption of combinatorial and computational methods in biomaterials design is a highway towards the discovery and realization of tailored polymeric materials to satisfy the specific requirements of many diverse biomedical or prosthetic applications.
C1 Rutgers State Univ, New Jersey Ctr Biomat, Piscataway, NJ 08854 USA.
RP Kohn, J (reprint author), Rutgers State Univ, New Jersey Ctr Biomat, 610 Taylor Rd, Piscataway, NJ 08854 USA.
EM Joachim@rutchem.rutgers.edu
CR ANDERSON DG, 2004, NAT BIOTECHNOL, V22, P828
   Brocchini S, 1998, J BIOMED MATER RES, V42, P66, DOI 10.1002/(SICI)1097-4636(199810)42:1<66::AID-JBM9>3.0.CO;2-M
   Brocchini S, 1997, J AM CHEM SOC, V119, P4553, DOI 10.1021/ja970389z
   Eberhart ME, 2004, NAT MATER, V3, P659, DOI 10.1038/nmat1229
   Eksterowicz JE, 2002, J MOL GRAPH MODEL, V20, P469, DOI 10.1016/S1093-3263(01)00148-6
   Garcia JG, 2003, METHOD ENZYMOL, V369, P391
   Lemmen C, 2000, J COMPUT AID MOL DES, V14, P215, DOI 10.1023/A:1008194019144
   LOWE G, 1995, JCS REV, P309
   MENGER FM, 1995, J ORG CHEM, V60, P6666, DOI 10.1021/jo00126a008
   Meredith JC, 2003, J BIOMED MATER RES A, V66A, P483, DOI 10.1002/jbm.a.10004
   Meredith JC, 2000, MACROMOLECULES, V33, P9747, DOI 10.1021/ma001298g
   Smith AP, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.015503
   Weber N, 2004, J BIOMED MATER RES A, V68A, P496, DOI 10.1002/jbm.a.20086
   Zeltinger J, 2004, BIOMATER FORUM, V26, P8
NR 14
TC 72
Z9 72
U1 0
U2 36
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1476-1122
J9 NAT MATER
JI Nat. Mater.
PD NOV
PY 2004
VL 3
IS 11
BP 745
EP 747
DI 10.1038/nmat1249
PG 3
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 866QA
UT WOS:000224786800002
PM 15516948
DA 2018-10-19
ER

PT J
AU Regidor, E
AF Regidor, E
TI The use of personal data from medical records and biological materials:
   ethical perspectives and the basis for legal restrictions in health
   research
SO SOCIAL SCIENCE & MEDICINE
LA English
DT Article
DE biological materials; medical records; personal data; health; ethics
ID GENETIC DISCRIMINATION; DEVELOPING-COUNTRIES; INFORMED CONSENT; PRIVACY;
   INSURANCE; EPIDEMIOLOGY; PROTECTION; WILL; INFORMATION; GUIDELINES
AB This paper discusses the moral justification for using personal data without informed consent, from both medical records and biological materials, in research where subjects are not physically present in the study and will never have any contact with the study investigators. Although the idea of waiving the requirement for informed consent in certain investigations has been mentioned in several ethical guidelines formulated by epidemiologists and physicians since the late 1980s, these guidelines are now of limited use due to legal restrictions on the use of personal data in most western countries. Several misconceptions that form the basis for legal restriction of health research are discussed: lack of knowledge of the need to link personal information from health services with personal information produced outside the health system in many biomedical investigations; the assumption of a deterministic model of disease causation in which the prediction of disease occurrence is based on a genetic association despite the fact that most genotypes for common diseases are incompletely penetrant; the lack of a logical rationale for the recommendation in the Declaration of Helsinki that only research that offers some benefit to study subjects is justified; the great lack of knowledge about research methodology revealed in some alternatives proposed to avoid using personal data; and the lack of a debate about the ethical double standard of institutions and investigators in countries that prohibit the use of personal data but finance and carry out studies in other countries where it is permitted. (C) 2004 Elsevier Ltd. All rights reserved,
C1 Univ Complutense Madrid, Fac Med, Dept Prevent Med Publ Hlth & Hish Sci, E-28040 Madrid, Spain.
RP Regidor, E (reprint author), Univ Complutense Madrid, Fac Med, Dept Prevent Med Publ Hlth & Hish Sci, Ciudad Univ, E-28040 Madrid, Spain.
EM enriqueregidor@hotmail.com
RI Sandall, Jane/D-4146-2009
OI Sandall, Jane/0000-0003-2000-743X; Regidor, Enrique/0000-0002-2374-9861
CR Abbott A, 2000, NATURE, V406, P340, DOI 10.1038/35019167
   Angell M, 1997, NEW ENGL J MED, V337, P847, DOI 10.1056/NEJM199709183371209
   ANNAS GJ, 1993, JAMA-J AM MED ASSOC, V270, P2346, DOI 10.1001/jama.270.19.2346
   Annas GJ, 2001, NEW ENGL J MED, V345, P385, DOI 10.1056/NEJM200108023450523
   Beauchamp T, 1994, PRINCIPLES BIOMEDICA
   Beauchamp T. L., 1996, ETHICS EPIDEMIOLOGY, P24
   BEAUCHAMP TL, 1991, J CLIN EPIDEMIOL, V44, pS151
   Berkman L. F., 2000, SOCIAL EPIDEMIOLOGY
   BIROS MH, 1995, JAMA-J AM MED ASSOC, V273, P1283, DOI 10.1001/jama.273.16.1283
   CAPRON AM, 1991, J CLIN EPIDEMIOL, V44, pS81
   CHAMBERLAYNE R, 1998, CANADIAN J PUBLIC HL, V89, P279
   COUGHLIN SS, 1992, EPIDEMIOLOGY, V3, P343, DOI 10.1097/00001648-199207000-00009
   Coughlin SS, 1997, CASE STUDIES PUBLIC
   Coughlin SS, 1996, ETHICS EPIDEMIOLOGY, P145
   Council for International Organizations of Medical Sciences, 1991, INT GUID ETH REV EP
   DAVISON C, 1994, SOCIOL HEALTH ILL, V16, P340, DOI 10.1111/1467-9566.ep11348762
   Diez-Roux AV, 1998, AM J EPIDEMIOL, V148, P1027
   Doll R, 2001, BRIT MED J, V323, P1421
   Doyal L, 1997, BRIT MED J, V314, P1107, DOI 10.1136/bmj.314.7087.1107
   Evers K, 2002, NEW ENGL J MED, V346, P1579, DOI 10.1056/NEJMsb020527
   Gostin LO, 1998, ANN INTERN MED, V129, P833, DOI 10.7326/0003-4819-129-10-199811150-00017
   Gostin LO, 2001, JAMA-J AM MED ASSOC, V285, P3015, DOI 10.1001/jama.285.23.3015
   HARPER PS, 1993, LANCET, V341, P224, DOI 10.1016/0140-6736(93)90080-Z
   Holtzman NA, 2000, NEW ENGL J MED, V343, P141, DOI 10.1056/NEJM200007133430213
   Horner JS, 1998, PUBLIC HEALTH, V112, P217
   HUDSON KL, 1995, SCIENCE, V270, P391, DOI 10.1126/science.270.5235.391
   KORN D, 2000, NATL BIOETHICS ADVIS, V2
   LAKO CJ, 1986, SOC SCI MED, V23, P293, DOI 10.1016/0277-9536(86)90350-3
   Lapham EV, 1996, SCIENCE, V274, P621, DOI 10.1126/science.274.5287.621
   LAST JM, 1990, INT J EPIDEMIOL, V19, P226, DOI 10.1093/ije/19.1.226
   Lurie P, 1997, NEW ENGL J MED, V337, P853, DOI 10.1056/NEJM199709183371212
   Melton LJ, 1997, NEW ENGL J MED, V337, P1466, DOI 10.1056/NEJM199711133372012
   NBAC, 2001, ETH POL ISS RES INV, V1
   NBAC, 1999, RES INV HUM BIOL MAT, V1
   Redelmeier DA, 1997, NEW ENGL J MED, V336, P453, DOI 10.1056/NEJM199702133360701
   Riis P, 2000, JAMA-J AM MED ASSOC, V284, P3045, DOI 10.1001/jama.284.23.3045
   ROTHMAN KJ, 1981, NEW ENGL J MED, V304, P600, DOI 10.1056/NEJM198103053041010
   SMITH R, 1997, BRIT MED J, V313, P16
   Strobl J, 2000, BRIT MED J, V321, P890, DOI 10.1136/bmj.321.7265.890
   The National Commission for the Protection of Human Subjects of Biomedical & Behavioral Research, 1979, BELM REP ETH GUID PR
   Vandenbroucke JP, 1998, BRIT MED J, V316, P1331, DOI 10.1136/bmj.316.7141.1331
   Varmus H, 1997, NEW ENGL J MED, V337, P1003, DOI 10.1056/NEJM199710023371411
   WALD N, 1994, BRIT MED J, V309, P1422, DOI 10.1136/bmj.309.6966.1422
   Walker AM, 1997, EPIDEMIOLOGY, V8, P671, DOI 10.1097/00001648-199710000-00010
   Watts G, 1999, BRIT MED J, V319, P273, DOI 10.1136/bmj.319.7205.273a
   WELCH CA, 2001, NEW ENGL J MED, V345, P271
   WOODWARD B, 1995, NEW ENGL J MED, V333, P1419, DOI 10.1056/NEJM199511233332112
   Woodward B, 1999, JAMA-J AM MED ASSOC, V282, P1947, DOI 10.1001/jama.282.20.1947
   *WORK GROUP ROYAL, 1994, J R COLL PHYSICIANS, V28, P439
   *WORLD MED ASS, 2000, JAMA-J AM MED ASSOC, V284, P3043, DOI DOI 10.1001/JAMA.284.23.3043
   WRIGHT CE, 1995, JAMA-J AM MED ASSOC, V274, P1786
   WUKADINOVICH DM, 1999, EPIDEMIOLOGY, V10, P91
   1995, OFFICIAL J EUROPEA L, V38, P31
   1964, NEW ENGLAND J MED, V271, P473
NR 54
TC 17
Z9 17
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0277-9536
J9 SOC SCI MED
JI Soc. Sci. Med.
PD NOV
PY 2004
VL 59
IS 9
BP 1975
EP 1984
DI 10.1016/j.socscimed.2004.02.032
PG 10
WC Public, Environmental & Occupational Health; Social Sciences, Biomedical
SC Public, Environmental & Occupational Health; Biomedical Social Sciences
GA 852CZ
UT WOS:000223734100018
PM 15312931
DA 2018-10-19
ER

PT J
AU Andersen, HM
AF Andersen, HM
TI "Villagers": Differential treatment in a Ghanaian hospital
SO SOCIAL SCIENCE & MEDICINE
LA English
DT Article
DE health workers; hospitals; differential treatment; patient categories;
   bureaucracy; Ghana
ID PATIENT SATISFACTION; SERVICES; QUALITY; CARE
AB Differential treatment of patients by health workers in African medical institutions is acknowledged by patients, health workers and policy-makers alike to be an obstacle in the realization of government objectives of equity in health care. This qualitative study understands the production and legitimization of differential treatment from the perspective of health workers. On the basis of qualitative field material from a hospital in Northern Ghana the relation between socio-cultural, biomedical and bureaucratic aspects of hospital practice is explored through a focus on categorizations of patients. It is concluded that to blame the "bad attitudes" of health workers for differential treatment is not an adequate explanation. It is important to acknowledge that differential treatment can be understood as a form of agency, and is related to the conditions of hospital work and to the professional and social identities of health workers. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Copenhagen, Inst Anthropol, DK-1220 Copenhagen K, Denmark.
RP Andersen, HM (reprint author), Univ Copenhagen, Inst Anthropol, Frederiksholms Kanal 4, DK-1220 Copenhagen K, Denmark.
EM Helle.max.Andersen@anthro.ku.dk
CR Andaleeb SS, 2001, SOC SCI MED, V52, P1359, DOI 10.1016/S0277-9536(00)00235-5
   BRITAN GM, 1980, HIERARCHY SOC ANTHR, P1
   Cohen Ronald, 1980, HIERARCHY SOC ANTHR, P73
   Foster P. J., 1965, ED SOCIAL CHANGE GHA
   Franco LM, 2002, SOC SCI MED, V54, P1255, DOI 10.1016/S0277-9536(01)00094-6
   Freidson E., 1970, PROFESSIONAL DOMINAN
   Gellner D., 2001, INSIDE ORG ANTHR WOR
   GILSON L, 1994, SOC SCI MED, V39, P767, DOI 10.1016/0277-9536(94)90038-8
   HERZFELD M, 1992, SOCIAL PRODUCTION IN
   Jackson JL, 2001, SOC SCI MED, V52, P609, DOI 10.1016/S0277-9536(00)00164-7
   JESPERSEN J, 1998, GHANA POLITISK OKONO
   Jewkes R, 1998, SOC SCI MED, V47, P1781, DOI 10.1016/S0277-9536(98)00240-8
   Keyes C. F., 1991, RESHAPING LOCAL WORL, P1
   Kleinman A, 1980, PATIENTS HEALERS CON
   Lentz Carola, 1994, SOCIAL ANTHR, V2, P149
   Lipsky M., 1978, STREET LEVEL BUREAUC
   Lupton D, 1994, MED CULTURE ILLNESS
   MacCormack C.P., 1992, SOCIAL BASIS HLTH HE
   Mann Kristin, 1985, MARRYING WELL MARRIA
   MASEMANN V, 1974, CAN J AFR STUD, V8, P479, DOI 10.2307/483708
   McPake B, 1999, SOC SCI MED, V49, P849, DOI 10.1016/S0277-9536(99)00144-6
   *MIN HLTH GHAN, 1995, MED TERM HLTH STRAT
   *MIN HLTH GHAN, 1996, HLTH SECT 5 YEAR PRO
   Oppong C., 1974, MARRIAGE MATRILINEAL
   Price R., 1975, SOC BUREAUCRACY CONT
   Senah KA, 1997, MONEY BE MAN POPULAR
   Turner B, 1987, MED POWER SOCIAL KNO
   *WORLD BANK, 2003, GHAN HLTH SECT PROGR
   Wright Susan, 1994, ANTHR ORG
   1996, BOLGATANGA REGIONAL
NR 30
TC 41
Z9 41
U1 0
U2 7
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0277-9536
J9 SOC SCI MED
JI Soc. Sci. Med.
PD NOV
PY 2004
VL 59
IS 10
BP 2003
EP 2012
DI 10.1016/j.socscimed.2004.03.005
PG 10
WC Public, Environmental & Occupational Health; Social Sciences, Biomedical
SC Public, Environmental & Occupational Health; Biomedical Social Sciences
GA 856BB
UT WOS:000224017500002
PM 15351468
DA 2018-10-19
ER

PT J
AU Loir, AS
   Garrelie, F
   Donnet, C
   Rogemond, F
   Subtil, JL
   Forest, B
   Belin, M
   Laporte, P
AF Loir, AS
   Garrelie, F
   Donnet, C
   Rogemond, F
   Subtil, JL
   Forest, B
   Belin, M
   Laporte, P
TI Towards the deposition of tetrahedral diamond-like carbon films on hip
   joints by femtosecond pulsed laser ablation
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 31st International Conference on Metallurgical Coatings and Thin Films
CY APR 19-23, 2004
CL San Diego, CA
SP AVS Sci & Technol Soc, Adv Surface Engn Div
DE DLC; femtosecond pulsed laser deposition; adhesion; hip joint
ID AMORPHOUS-CARBON; THIN-FILMS; NANOCRYSTALLINE DIAMOND; BIOLOGICAL
   APPLICATIONS; DLC COATINGS; ADHESION
AB Compared to conventional nanosecond laser ablation, femtosecond pulsed laser deposition (PLD) allows the production of higher energy ions (up to a few keV) in the plasma plume, which strongly affect the structure and properties of the deposited films. In this work, tetrahedral diamond-like carbon (ta-C) films have been deposited by femtosecond PLD on various substrates, including 316L stainless steel, in order to extend the wear resistance of materials used for hip joint replacement. The deposition process has been optimized to obtain smooth and wear-resistant carbon films by ablating a graphite target in ultra-high vacuum conditions at room temperature, with a laser fluence (energy density) ranging from 1 to 6 J cm(-2). In situ sputter cleaning of the substrates in an argon atmosphere prior to carbon deposition has been widely investigated: tensile tests show that the adhesion of the films on stainless steel substrates is remarkably enhanced by removing the contamination and oxidized top-coats. The films exhibit high wear resistance (in the 10(-8) to 10(-9) mm(3) N-1 m(-1) range) with moderate hardness (in the 20-30 GPa range), which may be favorable for the accommodation motion between contacting surfaces in a hip joint. The ability of these films to satisfy the biomedical requirements is discussed and the possibility to deposit homogeneous ta-C films on a 22.2-mm diameter hemispherical surface is examined. Finally, homogeneous films have been deposited on a 316L stainless steel femoral head, whose wear behavior will be quantified using a walking simulator during several millions of cycles (corresponding to the human activity during several years). (C) 2004 Elsevier B.V. All rights reserved.
C1 Univ St Etienne, Lab Traitement Signal & Instrumentat, UMR 5516, F-42000 St Etienne, France.
   Ecole Cent Lyon, Lab Tribol & Dyanm Syst, UMR 5513, F-69134 Ecully, France.
   Ecole Natl Super Mines, Ctr Sci Mat & Struct, F-42023 St Etienne, France.
RP Donnet, C (reprint author), Univ St Etienne, Lab Traitement Signal & Instrumentat, UMR 5516, Batiment F 10 Rue Barrouin, F-42000 St Etienne, France.
EM Christophe.Donnet@univ-st-etienne.fr
RI LOIR, Anne-Sophie/J-4041-2012
OI LOIR, Anne-Sophie/0000-0001-9169-1545
CR Bulir J, 1997, THIN SOLID FILMS, V292, P318, DOI 10.1016/S0040-6090(96)08951-1
   Chrisey D., 1994, PULSED LASER DEPOSIT
   ERDEMIR A, 2000, MODERN TRIBOLOGY HDB, V2, P871
   Garrelie F, 2003, SURF COAT TECH, V163, P306, DOI 10.1016/S0257-8972(02)00481-4
   Garrelie F, 2002, PROC SPIE, V4760, P301, DOI 10.1117/12.482098
   Grill A, 2003, DIAM RELAT MATER, V12, P166, DOI 10.1016/S0925-9635(03)00018-9
   Hauert R, 2003, DIAM RELAT MATER, V12, P583, DOI 10.1016/S0925-9635(03)00081-5
   Hou QR, 1999, APPL PHYS A-MATER, V68, P343, DOI 10.1007/s003390050900
   Loir AS, 2004, THIN SOLID FILMS, V453, P531, DOI 10.1016/j.tsf.2003.11.135
   Loir AS, 2003, APPL SURF SCI, V208, P553, DOI 10.1016/S0169-4332(02)01380-6
   Matsuyama N, 2001, J APPL PHYS, V89, P1938, DOI 10.1063/1.1334640
   Morshed MM, 2003, SURF COAT TECH, V174, P579, DOI 10.1016/S0257-8972(03)00701-1
   Morshed MM, 2003, SURF COAT TECH, V163, P541, DOI 10.1016/S0257-8972(02)00619-9
   PAPPAS DL, 1992, J APPL PHYS, V71, P5675, DOI 10.1063/1.350501
   Perriere J, 2002, J APPL PHYS, V91, P690, DOI 10.1063/1.1426250
   Podgornik B, 2001, DIAM RELAT MATER, V10, P2232, DOI 10.1016/S0925-9635(01)00514-3
   Qian F, 1999, J APPL PHYS, V86, P2281, DOI 10.1063/1.371043
   Robertson J, 2002, MAT SCI ENG R, V37, P129, DOI 10.1016/S0927-796X(02)00005-0
   Schwan J, 1996, J APPL PHYS, V79, P1416, DOI 10.1063/1.360979
   Sharda T, 2001, DIAM RELAT MATER, V10, P1592, DOI 10.1016/S0925-9635(01)00415-0
   SHI X, 1997, PHILOS MAG B, V76, P351
   Tiainen VM, 2001, DIAM RELAT MATER, V10, P153, DOI 10.1016/S0925-9635(00)00462-3
   Tsui YY, 2000, SURF COAT TECH, V126, P96, DOI 10.1016/S0257-8972(99)00642-8
   Voevodin AA, 1996, SURF COAT TECH, V82, P199, DOI 10.1016/0257-8972(95)02734-3
   Wei Q, 2001, SURF COAT TECH, V146, P250, DOI 10.1016/S0257-8972(01)01394-9
NR 25
TC 12
Z9 17
U1 0
U2 6
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD NOV-DEC
PY 2004
VL 188
BP 728
EP 734
DI 10.1016/j.surfcoat.2004.07.046
PG 7
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 872YQ
UT WOS:000225245800116
DA 2018-10-19
ER

PT J
AU Ahmed, W
   Sein, H
   Jackson, M
   Polini, R
AF Ahmed, W
   Sein, H
   Jackson, M
   Polini, R
TI Chemical vapour deposition of diamond films onto tungsten carbide dental
   burs
SO TRIBOLOGY INTERNATIONAL
LA English
DT Article
DE wear; diamond; HFCVD; cutting tools
ID CVD DIAMOND; CEMENTED CARBIDE; COATINGS; WEAR; TOOLS
AB Considerable literature is now available on the deposition of CVD diamond onto flat substrates the most common being silicon. However, very little work has been reported on the deposition of diamond onto complex three-dimensional substrates such as dental burs, micro drills and biomedical implants. Diamond is hard, wear resistant, biocompatible and corrosion resistant and therefore is an attractive candidate for uses in dental tools and for medical devices. This study focuses on the deposition of diamond, using a hot filament CVD system, on cobalt-cemented tungsten carbide (WC-Co) rotary cutting dental burs. Conventional dental burs are generally made of sintered polycrystalline diamond (PCD). These have a number of problems associated with heterogeneity of the crystallite, decreased cutting efficiency and a short life. A preferential (1 1 1) faceted diamond has been obtained after 12 h deposition at a growth rate of 1.2 mum/h. Diamond coated WC-Co dental burs and conventional sintered burs are used in turning, milling and drilling operations for machining materials made from metal alloys and borosilicate glass. After machining with excessive cutting performance, calculations can be made on flank and crater wear areas. Diamond coated WC-Co dental bur offer significantly lower erosion and higher wear resistance compared to uncoated WC-Co tools and sintered burs. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Manchester Metropolitan Univ, Dept Chem & Mat, Manchester M1 5GD, Lancs, England.
   Tennessee Technol Univ, Dept Mech Engn, Cookeville, TN 38505 USA.
   Univ Roma Tor Vergata, Dipartimento Sci & Tecnol Chim, I-00133 Rome, Italy.
RP Ahmed, W (reprint author), Manchester Metropolitan Univ, Dept Chem & Mat, Chester St, Manchester M1 5GD, Lancs, England.
EM w.ahmed@mmu.ac.uk
RI Polini, Riccardo/D-2289-2017
OI Polini, Riccardo/0000-0002-6551-0883; Ahmed, Waqar/0000-0003-4152-5172
CR Ahmed W, 2000, VACUUM, V56, P153, DOI 10.1016/S0042-207X(99)00147-5
   Amirhaghi S, 2001, SURF COAT TECH, V135, P126, DOI 10.1016/S0257-8972(00)01083-5
   Amirhaghi S, 1999, DIAM RELAT MATER, V8, P845, DOI 10.1016/S0925-9635(98)00319-7
   BORGES CM, 1999, J PROSTHET DENT, P73
   Endler I, 1999, DIAM RELAT MATER, V8, P834, DOI 10.1016/S0925-9635(98)00359-8
   Gabler J, 2000, DIAM RELAT MATER, V9, P921, DOI 10.1016/S0925-9635(99)00278-2
   Guseva MB, 1997, DIAM RELAT MATER, V6, P89, DOI 10.1016/S0925-9635(96)00729-7
   Inspektor A, 1997, INT J REFRACT MET H, V15, P49, DOI 10.1016/S0263-4368(96)00045-5
   Kamiya S, 2000, DIAM RELAT MATER, V9, P191, DOI 10.1016/S0925-9635(00)00229-6
   MAY PW, 1994, DIAM RELAT MATER, V3, P810, DOI 10.1016/0925-9635(94)90274-7
   PINES MS, 1979, J AM DENT ASSOC, V99, P831, DOI 10.14219/jada.archive.1979.0403
   Sein H, 2002, DIAM RELAT MATER, V11, P731, DOI 10.1016/S0925-9635(01)00579-9
   SEIN H, 2003, J SURFACE COATINGS T, V163, P196
   Tang W, 2001, DIAM RELAT MATER, V10, P1700, DOI 10.1016/S0925-9635(01)00398-3
   Wang WL, 1999, DIAM RELAT MATER, V8, P123, DOI 10.1016/S0925-9635(98)00317-3
NR 15
TC 9
Z9 9
U1 0
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0301-679X
J9 TRIBOL INT
JI Tribol. Int.
PD NOV-DEC
PY 2004
VL 37
IS 11-12
BP 957
EP 964
DI 10.1016/j.triboint.2004.07.013
PG 8
WC Engineering, Mechanical
SC Engineering
GA 869SE
UT WOS:000225003600013
OA Green Published
DA 2018-10-19
ER

PT J
AU Nsungwa-Sabiiti, J
   Kallander, K
   Nsabagasani, X
   Namusisi, K
   Pariyo, G
   Johansson, A
   Tomson, G
   Peterson, S
AF Nsungwa-Sabiiti, J
   Kallander, K
   Nsabagasani, X
   Namusisi, K
   Pariyo, G
   Johansson, A
   Tomson, G
   Peterson, S
TI Local fever illness classifications: implications for home management of
   malaria strategies
SO TROPICAL MEDICINE & INTERNATIONAL HEALTH
LA English
DT Article
DE paediatric fever; illness classification; malaria; home treatment;
   Uganda
ID CHILDHOOD FEVERS; CONTROL PROGRAM; UGANDA; PERSPECTIVE; CARE;
   PHARMACEUTICALS; PERCEPTIONS; DIAGNOSIS; DISTRICT; SERVICES
AB BACKGROUND The Ugandan Ministry of Health has adopted the WHO Home Based Fever Management strategy (HBM) to improve access to antimalarial drugs for prompt (<24 h) presumptive treatment of all fevers in children under 5 years. Village volunteers will distribute pre-packed antimalarials free of charge to caretakers of febrile children 2 months to 5 years ('Homapaks').
   OBJECTIVE To explore the local understanding and treatment practices for childhood fever illnesses and discuss implications for the HBM strategy.
   METHODS Focus Group Discussions were held with child caretakers in three rural communities in Kasese district, West Uganda, and analysed for content in respect to local illness classifications and associated treatments for childhood fevers.
   RESULTS Local understanding of fever illnesses and associated treatments was complex. Some fever illness classifications were more commonly mentioned, including 'Fever of Mosquito', 'Chest Problem', 'the Disease', 'Stomach Wounds' and 'Jerks', all of which could be biomedical malaria. Although caretakers refer to all these classifications as 'fever' treatment differed; some were seen as requiring urgent professional western treatment and others were considered severe but 'non-western' and would preferentially be treated with traditional remedies.
   CONCLUSIONS The HBM strategy does not address local community understanding of 'fever' and its influence on treatment. While HBM improves drug access, Homapaks are likely to be used for only those fevers where 'western' treatment is perceived appropriate, implying continued delayed and under-treatment of potential malaria. Hence, HBM strategies also need to address local perceptions of febrile illness and adapt information and training material accordingly.
C1 Makerere Univ, Inst Publ Hlth, Kampala, Uganda.
   Karolinska Inst, IHCAR, Div Int Hlth, S-17176 Stockholm, Sweden.
   Makerere Univ, Makerere Inst Social Res, Kampala, Uganda.
   Makerere Univ, Dept Pharmacol & Therapeut, Kampala, Uganda.
   Karolinska Inst, Med Management Ctr, S-10401 Stockholm, Sweden.
   Minist Hlth, Child Hlth Div, Kampala, Uganda.
RP Nsungwa-Sabiiti, J (reprint author), Makerere Univ, Inst Publ Hlth, Box 7072, Kampala, Uganda.
EM jsabiiti@infocom.co.ug; karin.kallander@phs.ki.se;
   xnsabagasani@upholduganda.org; nyamurungi@yahoo.co.in;
   gpariyo@iph.ac.ug; annika.johansson@phs.ki.se; goran.tomson@phs.ki.se;
   stefan.peterson@phs.ki.se
RI Pariyo, George/K-2335-2017
OI Pariyo, George/0000-0002-4411-2309; Peterson, Stefan/0000-0001-7203-3096
CR Adome RO, 1996, POPULAR PILLS COMMUN
   Amin AA, 2003, TROP MED INT HEALTH, V8, P1143, DOI 10.1046/j.1360-2276.2003.01140.x
   Attaran A, 2004, LANCET, V363, P237, DOI 10.1016/S0140-6736(03)15330-5
   Bender D E, 1994, Health Transit Rev, V4, P63
   BIRUNGI H, 1994, ESSENT DRUGS MONIT, V18, P11
   Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8
   Chandramohan D, 2002, TROP MED INT HEALTH, V7, P45, DOI 10.1046/j.1365-3156.2002.00827.x
   Comoro C, 2003, ACTA TROP, V87, P305, DOI 10.1016/S0001-706X(03)00113-X
   *DISH UG, 2002, KAS DISTR PROF
   Dunyo SK, 2000, T ROY SOC TROP MED H, V94, P285, DOI 10.1016/S0035-9203(00)90324-9
   HARDON A, 2001, APPL HLTH RES ANTHR
   Hill Z, 2003, TROP MED INT HEALTH, V8, P668, DOI 10.1046/j.1365-3156.2003.01058.x
   Iyun BF, 1996, SOC SCI MED, V42, P437, DOI 10.1016/0277-9536(95)00103-4
   JITTA J, 1996, KAMPALA WOMEN GETTIN
   Kallander K, 2004, ACTA TROP, V90, P211, DOI 10.1016/j.actatropica.2003.11.013
   KENGEYAKAYONDO JF, 1994, ACTA TROP, V58, P267, DOI 10.1016/0001-706X(94)90020-5
   Kidane G, 2000, LANCET, V356, P550, DOI 10.1016/S0140-6736(00)02580-0
   Kilian AHD, 2003, TROP MED INT HEALTH, V8, P431, DOI 10.1046/j.1365-3156.2003.01044.x
   Lambrechts T, 1999, B WORLD HEALTH ORGAN, V77, P582
   Lubanga RGN, 1997, ACTA TROP, V68, P53, DOI 10.1016/S0001-706X(97)00071-5
   Marsh VM, 1999, TROP MED INT HEALTH, V4, P383, DOI 10.1046/j.1365-3156.1999.00403.x
   *MIN HLTH TANZ, 2004, AD MORB MORT PROJ
   *MIN HLTH UG, 2002, IMPL GUID HOM BAS MA
   MUELA SH, 2000, THESIS U BASEL
   Nuwaha F, 2002, TROP MED INT HEALTH, V7, P462, DOI 10.1046/j.1365-3156.2002.00877.x
   OGDEN J, 1996, KAMPALA WOMEN GETTIN
   Reynolds-Whyte S., 1991, CONTEXT MED DEV COUN, P299
   ROOTH I, 1991, J TROP MED HYG, V94, P195
   SACHS L, 1992, SOC SCI MED, V34, P307, DOI 10.1016/0277-9536(92)90272-R
   Sirima SB, 2003, TROP MED INT HEALTH, V8, P133, DOI 10.1046/j.1365-3156.2003.00997.x
   vanderGeest S, 1997, TROP MED INT HEALTH, V2, P903, DOI 10.1046/j.1365-3156.1997.d01-410.x
   VANDERGEEST S, 1987, SOC SCI MED, V25, P273, DOI 10.1016/0277-9536(87)90230-9
   *WHO, 2002, IMCI AD GUID 1A
   *WHO, 2004, WHOHTMMAL20041096 ID
   WHYTE SR, 1992, CULT MED PSYCHIAT, V16, P163, DOI 10.1007/BF00117017
   Williams HA, 2004, SOC SCI MED, V59, P501, DOI 10.1016/j.socscimed.2003.11.010
   Winch PJ, 1996, SOC SCI MED, V42, P1057, DOI 10.1016/0277-9536(95)00293-6
NR 37
TC 52
Z9 52
U1 0
U2 3
PU BLACKWELL PUBLISHING LTD
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND
SN 1360-2276
J9 TROP MED INT HEALTH
JI Trop. Med. Int. Health
PD NOV
PY 2004
VL 9
IS 11
BP 1191
EP 1199
DI 10.1111/j.1365-3156.2004.01319.x
PG 9
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 872DR
UT WOS:000225188100008
PM 15548315
OA Bronze
DA 2018-10-19
ER

PT J
AU Li, SJ
   Yang, R
   Li, S
   Hao, YL
   Cui, YY
   Niinomi, M
   Guo, ZX
AF Li, SJ
   Yang, R
   Li, S
   Hao, YL
   Cui, YY
   Niinomi, M
   Guo, ZX
TI Wear characteristics of Ti-Nb-Ta-Zr and Ti-6Al-4V alloys for biomedical
   applications
SO WEAR
LA English
DT Article
DE titanium-niobium-tantalum-zirconium alloy; biomaterial; wear
ID MOLECULAR-WEIGHT POLYETHYLENE; TITANIUM-ALLOYS; STAINLESS-STEEL;
   CORROSIVE WEAR
AB The influences of heat treatment, variation in Nb content, surface modification and counterface materials on the wear characteristics of new beta type Ti-Nb-Ta-Zr alloys and conventional metallic implant alloy Ti-6Al-4V were investigated, using a reciprocal pin-on-disc wear device in a 0.9% NaCl solution. For the wear test of sliding on stainless steel disc, experimental results show that the wear resistance of Ti-29Nb-13Ta-4.6Zr and Ti-6Al-4V is insensitive to their mechanical properties, such as hardness and ultimate tensile strength. Increase in Nb content results in an improvement of the wear resistance of the beta type alloy to some degree. The wear resistance of Ti-29Nb-13Ta-4.6Zr improved significantly after oxidation treatment, due to the presence of Nb2O5 oxide particles on the diffusion hardened surface of the alloy. For wear test of sliding on ultra-high molecular weight polyethylene (UHMWPE) and bone of pig, the wear losses of both Ti-Nb-Ta-Zr and Ti-6Al-4V are much less compared with that sliding on stainless steel and there is almost no wear on the surface of oxided Ti-29Nb-13Ta-4.6Zr. (C) 2004 Elsevier B.V. All rights reserved.
C1 Chinese Acad Sci, Inst Met Res, Shenyang Natl Lab Mat Sci, Shenyang 110016, Peoples R China.
   Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418580, Japan.
   Univ London Queen Mary & Westfield Coll, Dept Mat, London E1 4NS, England.
RP Yang, R (reprint author), Chinese Acad Sci, Inst Met Res, Shenyang Natl Lab Mat Sci, 72 Wenhua Rd, Shenyang 110016, Peoples R China.
EM ryang@imr.ac.cn
RI Guo, Zheng Xiao/C-1706-2009; Niinomi, Mitsuo/B-5965-2011
OI Guo, Zheng Xiao/0000-0001-5404-3215; 
CR ALLEN C, 1981, WEAR, V74, P287, DOI 10.1016/0043-1648(81)90169-1
   Black J., 1992, BIOL PERFORMANCE MAT
   BLANCHET TA, 1989, TRIBOL T, V32, P371, DOI 10.1080/10402008908981902
   GROBLER PE, 1990, WEAR, V135, P339, DOI 10.1016/0043-1648(90)90035-9
   IJZERMANS AB, 1969, WEAR, V14, P397, DOI 10.1016/0043-1648(69)90002-7
   JASTY M, 1993, J APPL BIOMATER, V4, P273, DOI 10.1002/jab.770040310
   Li HD, 1990, SURFACE INTERFACE MA, P106
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   MARCUS K, 1991, WEAR, V151, P323, DOI 10.1016/0043-1648(91)90259-W
   MARCUS K, 1993, SOV J FRICT WEAR, V14, P27
   Mishra A. K., 1996, ASTM STP, V1272, P96
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   PARR GR, 1985, J PROSTHET DENT, V54, P410, DOI 10.1016/0022-3913(85)90562-1
   PETERSON MB, 1989, INT8617231 NSF CHIN
   PETERSON MB, 1989, P 16 LEEDS LYON S VI
   PETERSON MB, 1992, 124248 NTIS ADA US D
   Poggie RA, 1996, MATER MANUF PROCESS, V11, P185, DOI 10.1080/10426919608947472
   RODENBECK GM, 1992, WEAR, V154, P305
   SILVER FH, 1994, BIOMATERIALS MED DEV, P5
   Song Y, 1999, MAT SCI ENG A-STRUCT, V260, P269, DOI 10.1016/S0921-5093(98)00886-7
   Song Y, 2001, STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY, P273
   Tang X, 2000, J MATER SCI, V35, P1805, DOI 10.1023/A:1004792922155
   TUMMLER HP, 1985, TITANIUM 84 SCI TECH, V2, P1335
   Wagner C. D., 1979, HDB XRAY PHOTOELECTR
   Wang KK, 1996, ASTM STP, V1272, P76
   ZWICKER J, 1985, TITANIUM 84 SCI TECH, V2, P1343
NR 26
TC 67
Z9 74
U1 2
U2 41
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0043-1648
J9 WEAR
JI Wear
PD NOV
PY 2004
VL 257
IS 9-10
BP 869
EP 876
DI 10.1016/j.wear.2004.04.001
PG 8
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA 866BH
UT WOS:000224747400002
DA 2018-10-19
ER

PT J
AU Zhou, YL
   Niinomi, M
   Akahori, T
AF Zhou, YL
   Niinomi, M
   Akahori, T
TI Decomposition of martensite alpha '' during aging treatments and
   resulting mechanical properties of Ti-Ta alloys
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE Young's modulus; Ti-Ta alloy; aging treatment; mechanical property;
   biomedical implant material
ID TITANIUM-TANTALUM ALLOYS; YOUNGS MODULUS; BIOMEDICAL APPLICATIONS;
   TENSILE PROPERTIES; HEAT-TREATMENT; CAST-IRON; BIOCOMPATIBILITY;
   CORROSION; IMPLANTS; TI-29NB-13TA-4.6ZR
AB Effects of Ta content and aging temperature on the decomposition of martensite alpha" in the Ti-Ta alloys with Ta contents from 30 mass% to 50 mass% and the resulting mechanical properties, including the dynamic Young's modulus, were investigated for biomedical applications. The microstructures were examined using a scanning electron microscopy (SEM), a transmission electron microscopy (TEM) and an X-ray diffraction (XRD) analysis. The decomposition of martensite alpha" phase in the Ti-Ta alloys depends on both Ta content and aging temperature. Various microstructures such as alpha, (beta + omega) and (alpha + beta) phases precipitate in the Ti-Ta alloys after the aging treatments are performed between 723 K and 873 K for 259.2 ks. The dynamic Young's modulus and mechanical properties of the Ti-Ta alloys are found to be sensitive to the microstructures caused by Ta content and aging temperature. The Ti-30% Ta alloy with alpha phase values much lower modulus and higher strength-to-modulus ratio than the currently used implant biomaterials, and thus has a great potential to become a new candidate alloy for biomedical applications. (C) 2004 Elsevier B.V. All rights reserved.
C1 Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418580, Japan.
RP Zhou, YL (reprint author), Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418580, Japan.
EM shuu@sp-mac4.tutpse.tut.ac.jp
RI Niinomi, Mitsuo/B-5965-2011
CR Bagariatskii IA, 1958, SOV PHYS DOKL, V3, P1014
   Bania P. J., 1984, BETA TITANIUM ALLOYS, P209
   Boccaccini AR, 1997, Z METALLKD, V88, P23
   Bothe R., 1940, SURG GYNECOL OBSTET, V71, P598
   Boyer R., 1994, MAT PROPERTIES HDB T
   BOYER RR, 1997, MINERAL METALS MAT, P349
   Burke GL, 1940, CAN MED ASSOC J, V43, P125
   BYWATER KA, 1972, PHILOS MAG, V25, P1275, DOI 10.1080/14786437208223853
   BYWATER KA, 1972, PHILOS MAG, V25, P1249, DOI 10.1080/14786437208223852
   COLLINGS EW, 1984, PHYSICAL METALLURGY
   Cui Z., 2000, METALLOGRAPHY HEAT T
   DAVIS R, 1979, ACTA METALL MATER, V27, P1041, DOI 10.1016/0001-6160(79)90192-5
   FAN ZY, 1993, SCRIPTA METALL MATER, V29, P1427, DOI 10.1016/0956-716X(93)90331-L
   Fedotov S G, 1986, PHYS MET METALLOGR, V62, P109
   GANESAN P, 1974, J LESS-COMMON MET, V34, P209, DOI 10.1016/0022-5088(74)90161-1
   Hao YL, 2003, METALL MATER TRANS A, V34A, P1007, DOI 10.1007/s11661-003-0230-x
   Hao YL, 2002, METALL MATER TRANS A, V33, P3137, DOI 10.1007/s11661-002-0299-7
   Hon YH, 2003, MATER TRANS, V44, P2384, DOI 10.2320/matertrans.44.2384
   HUNT M, 1991, MATER ENG, V113, P27
   LEDBETTER H, 1992, Z METALLKD, V83, P195
   Lee CM, 2002, J ORAL REHABIL, V29, P314, DOI 10.1046/j.1365-2842.2002.00825.x
   LEE YT, 1991, METALL TRANS A, V22, P709, DOI 10.1007/BF02670293
   LEE YT, 1990, MAT SCI ENG A-STRUCT, V128, P77, DOI 10.1016/0921-5093(90)90097-M
   LEVENTHAL GS, 1951, J BONE JOINT SURG AM, V33-A, P473, DOI 10.2106/00004623-195133020-00021
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   LOPATA SL, 1965, T METALL SOC AIME, V233, P288
   Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1
   MATTHEW J, 1982, TITANIUM TITANIUM AL
   MENDIRATTA MG, 1975, METALL TRANS, VA  6, P940, DOI 10.1007/BF02672324
   MURAKAMI Y, 1980, TITANIUM 80 SCI TECH, P153
   Murry J. L., 1987, PHASE DIAGRAM BINARY
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   PERL DP, 1980, SCIENCE, V208, P297, DOI 10.1126/science.7367858
   PILLIAR RM, 1991, MRS BULL, V16, P55
   PLENK H, 1990, CONCISE ENCY MED DEN, P355
   Prigent H, 1998, J BIOMED MATER RES, V39, P200, DOI 10.1002/(SICI)1097-4636(199802)39:2<200::AID-JBM5>3.0.CO;2-T
   SOLAR RJ, 1979, J BIOMED MATER RES, V13, P217, DOI 10.1002/jbm.820130206
   Song Y, 1999, MAT SCI ENG A-STRUCT, V260, P269, DOI 10.1016/S0921-5093(98)00886-7
   Steinemann S. G., 1980, EVALUATION BIOMATERI, P1
   SUMNER DR, 1992, CLIN ORTHOP RELAT R, V274, P202
   Trillo EA, 2001, J MATER SCI-MATER M, V12, P283, DOI 10.1023/A:1011210101895
   WILLIAMS JC, 1970, METALL TRANS, V1, P2648
   WOOD JR, 1997, MINERALS METALS MAT, P421
   Zhou YL, 2004, MAT SCI ENG A-STRUCT, V371, P283, DOI 10.1016/j.msea.2003.12.011
NR 45
TC 82
Z9 89
U1 2
U2 26
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
EI 1873-4936
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD OCT 25
PY 2004
VL 384
IS 1-2
BP 92
EP 101
DI 10.1016/j.msea.2004.05.084
PG 10
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 862KK
UT WOS:000224489300012
DA 2018-10-19
ER

PT J
AU Baranoski, GVG
   Krishnaswamy, A
   Kimmel, B
AF Baranoski, GVG
   Krishnaswamy, A
   Kimmel, B
TI An investigation on the use of data-driven scattering profiles in Monte
   Carlo simulations of ultraviolet light propagation in skin tissues
SO PHYSICS IN MEDICINE AND BIOLOGY
LA English
DT Article
ID OPTICAL-PROPERTIES; MODEL; RADIATION; CELLS
AB Ultraviolet light can affect the appearance and medical condition of the human skin by triggering biophysical processes such as erythema, melanogenesis, photoaging and carcinogenesis. The evolution of these processes is related to the amount of ultraviolet light absorbed by skin pigments. This amount may vary with the wavelength and path length of the radiation that is propagated within the skin tissues. For many years, biomedical researchers have been investigating the propagation of ultraviolet light in skin tissues through Monte Carlo simulations. The scattering of the incident radiation by tissue internal structures, a key component in this process, is usually approximated by functions without a plausible connection with the underlying physical phenomena. In this paper, we examine the origins of such an approach, and question its generalized use with respect to wavelengths and biological materials for which there is no supporting data available. Furthermore, we perform comparisons to demonstrate that the accuracy and predictability of Monte Carlo simulations of ultraviolet propagation in skin tissues can be improved by using a data-driven approach to represent the scattering profile of these tissues.
C1 Univ Waterloo, Nat Phenomena Simulat Grp, Sch Comp Sci, Waterloo, ON N2L 3G1, Canada.
RP Baranoski, GVG (reprint author), Univ Waterloo, Nat Phenomena Simulat Grp, Sch Comp Sci, 200 Univ Ave W, Waterloo, ON N2L 3G1, Canada.
EM gvgbaran@curumin.math.uwaterloo.ca
RI Baranoski, Gladimir/A-1944-2008
CR ANDERSON RR, 1981, J INVEST DERMATOL, V77, P13, DOI 10.1111/1523-1747.ep12479191
   BARANOSKI, 2003, CS200345 U WAT SCH C
   BARTH J, 1999, CIE 134 COLLECTION P
   BRULS WAG, 1984, PHOTOCHEM PHOTOBIOL, V40, P485, DOI 10.1111/j.1751-1097.1984.tb04622.x
   BRULS WAG, 1984, PHOTOCHEM PHOTOBIOL, V40, P231, DOI 10.1111/j.1751-1097.1984.tb04581.x
   Burden R., 1993, NUMERICAL ANAL
   Churmakov DY, 2003, J PHYS D APPL PHYS, V36, P1722, DOI 10.1088/0022-3727/36/14/311
   Cotton SD, 1996, P SOC PHOTO-OPT INS, V2708, P814, DOI 10.1117/12.237846
   CULLEN JJ, 1994, PHOTOSYNTH RES, V39, P303, DOI 10.1007/BF00014589
   DIFFEY BL, 1983, PHYS MED BIOL, V28, P647, DOI 10.1088/0031-9155/28/6/005
   Dunn A, 1996, IEEE J SEL TOP QUANT, V2, P898, DOI 10.1109/2944.577313
   Everett M A, 1966, Photochem Photobiol, V5, P533
   FITZPATRICK T, 1995, ITS ROLE HUMAN PHOTO, P177
   FLOCK ST, 1989, IEEE T BIO-MED ENG, V36, P1162, DOI 10.1109/TBME.1989.1173624
   Henyey LG, 1941, ASTROPHYS J, V93, P70, DOI 10.1086/144246
   Jacques S. L., 1987, Lasers in the Life Sciences, V1, P309
   KELFKENS G, 1989, PHYS MED BIOL, V34, P599, DOI 10.1088/0031-9155/34/5/004
   KOLLIAS N, 1995, ITS ROLE HUMAN PHOTO, P31
   Krishnaswamy A., 2004, J GRAPHICS TOOLS, V9, P31
   KRISHNASWAMY A, 2002, CS200221 U WAT SCH C
   Lagarias JC, 1998, SIAM J OPTIMIZ, V9, P112, DOI 10.1137/S1052623496303470
   Meglinski IV, 2003, COMPUT METH PROG BIO, V70, P179, DOI 10.1016/S0169-2607(02)00099-8
   METROPOLIS N, 1949, J AM STAT ASSOC, V44, P335, DOI 10.2307/2280232
   Mourant JR, 1998, APPL OPTICS, V37, P3586, DOI 10.1364/AO.37.003586
   Nicodemus F.E., 1992, PHYS BASED VISION PR, P94
   Pathak M. A., 1974, SUNLIGHT MAN, P725
   PATHAKM, 1995, ITS ROLE HUMAN PHOTO, P125
   Prahl S., 1988, THESIS U TEXAS AUSTI
   Prahl SA, 1989, P SPIE IS, V5, P102
   REYNOLDS LO, 1980, J OPT SOC AM, V70, P1206, DOI 10.1364/JOSA.70.001206
   Shimada M, 2001, PHYS MED BIOL, V46, P2397, DOI 10.1088/0031-9155/46/9/309
   Simpson CR, 1998, PHYS MED BIOL, V43, P2465, DOI 10.1088/0031-9155/43/9/003
   STANZL K, 1995, ITS ROLE HUMAN PHOTO, P59
   Talreja P.S., 2001, AAPS PHARMSCI, V3, P1
   TAYLOR HR, 1998, NEW ENGL J MED, V319, P1429
   Tessendorf J., 1994, SPIE CHARACTERIZATIO, P75
   Tuchin V, 2000, TISSUE OPTICS LIGHT
   van der Leun J., 1966, THESIS U UTRECHT NET
   Van Der Leun Jan C., 1993, P95
   VANGEMERT MJC, 1989, IEEE T BIO-MED ENG, V36, P1146, DOI 10.1109/10.42108
   WAN S, 1981, PHOTOCHEM PHOTOBIOL, V34, P493, DOI 10.1111/j.1751-1097.1981.tb09030.x
   WANG LH, 1995, COMPUT METH PROG BIO, V47, P131, DOI 10.1016/0169-2607(95)01640-F
   WILSON BC, 1983, MED PHYS, V10, P824, DOI 10.1118/1.595361
   WITT A, 1977, ASTROPHYS J SUPPL SE, V15, P1
   YOON G, 1987, IEEE J QUANTUM ELECT, V23, P1721, DOI 10.1109/JQE.1987.1073224
   Zimnyakov D. A., 2002, HDB OPTICAL MED DIAG, P987
NR 46
TC 3
Z9 3
U1 0
U2 1
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 0031-9155
J9 PHYS MED BIOL
JI Phys. Med. Biol.
PD OCT 21
PY 2004
VL 49
IS 20
BP 4799
EP 4809
AR PII S0031-9155(04)81824-4
DI 10.1088/0031-9155/49/4799
PG 11
WC Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging
SC Engineering; Radiology, Nuclear Medicine & Medical Imaging
GA 869EE
UT WOS:000224965400011
PM 15566176
DA 2018-10-19
ER

PT J
AU Rapacz-Kmita, A
   Slosarczyk, A
   Paszkiewicz, Z
   Paluszkiewicz, C
AF Rapacz-Kmita, A
   Slosarczyk, A
   Paszkiewicz, Z
   Paluszkiewicz, C
TI Phase stability of hydroxyapatite-zirconia (HAp-ZrO2) composites for
   bone replacement
SO JOURNAL OF MOLECULAR STRUCTURE
LA English
DT Article; Proceedings Paper
CT 7th International Conference on Molecular Spectroscopy
CY SEP 11-14, 2003
CL Wroclaw, POLAND
SP Matl State Comm Sci Res, Univ Wroclaw, Polish Acad Sci, Inst Low Temperature & Structure Res
DE hydroxyapatite; hydroxyapatite composite; zirconia; X-ray diffraction;
   fourier transform infrared spectroscopy
ID THERMAL-DECOMPOSITION; COATED HYDROXYAPATITE; MECHANICAL-PROPERTIES
AB During the production of biomedical hydroxyapatite-zirconia (HAp-ZrO2) composites new phases which determine the biocompatibility of implant materials may occur in the system. These phenomena may be associated both with the phase decomposition of hydroxyapatite itself and the interactions between the matrix material and particles of reinforcing zirconia phase. The work deals with the investigations of phase stability of HAp-ZrO2 composites at high temperature. The composites studied have been in the form of dense sinters obtained by the hot pressing process. (C) 2004 Elsevier B.V. All rights reserved.
C1 Jagiellonian Univ, Reg Lab Physicochem, PL-30060 Krakow, Poland.
   AGH Univ Sci & Technol, Fac Mat Sci & Ceram, PL-30059 Krakow, Poland.
RP Paluszkiewicz, C (reprint author), Jagiellonian Univ, Reg Lab Physicochem, Ul Ingardena 3, PL-30060 Krakow, Poland.
EM kmita@uci.agh.edu.pl; aslosar@uci.agh.edu.pl; ucpalusz@cyf-kr.edu.pl
CR ANDRONESCU E, 2002, KEY ENG MAT, V206
   Bucko MM, 1995, J AM CERAM SOC, V78, P3397, DOI 10.1111/j.1151-2916.1995.tb07985.x
   FOWLER BO, 1974, INORG CHEM, V13, P194, DOI 10.1021/ic50131a039
   Heimann RB, 1997, J MATER SCI LETT, V16, P437, DOI 10.1023/A:1018591605388
   LI J, 1993, J MATER SCI-MATER M, V4, P50, DOI 10.1007/BF00122977
   Liao CJ, 1999, BIOMATERIALS, V20, P1807, DOI 10.1016/S0142-9612(99)00076-9
   Matsuno T, 2000, J MATER SCI LETT, V19, P573, DOI 10.1023/A:1006722110462
   Pampuch R., 1992, NAUKA PROCESACH CERA
   Park E, 1998, MATER LETT, V36, P38, DOI 10.1016/S0167-577X(97)00287-5
   PYDA W, 2001, COMPOSITES, V1, P2
   Silva VV, 2001, COMPOS SCI TECHNOL, V61, P301, DOI 10.1016/S0266-3538(00)00222-0
   STUBICAN VS, 1981, ADV CERAM, V3
NR 12
TC 38
Z9 42
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-2860
J9 J MOL STRUCT
JI J. Mol. Struct.
PD OCT 18
PY 2004
VL 704
IS 1-3
SI SI
BP 333
EP 340
DI 10.1016/j.molstruc.2004.02.047
PG 8
WC Chemistry, Physical
SC Chemistry
GA 847BW
UT WOS:000223364800052
DA 2018-10-19
ER

PT J
AU Zhu, HG
   Ji, J
   Barbosa, MA
   Shen, JC
AF Zhu, HG
   Ji, J
   Barbosa, MA
   Shen, JC
TI Protein electrostatic self-assembly on poly(DL-Lactide) scaffold to
   promote osteoblast growth
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE cell adhesion; cell-material interactions; surface modification; tissue
   engineering
ID ALTERNATE LAYERS; ULTRATHIN FILMS; POLYELECTROLYTES; ADSORPTION; CELLS;
   PROLIFERATION; REFLECTIVITY; BIOMATERIALS; SURFACES; NEUTRON
AB The development of protein coating on 3D biodegradable scaffold based on electrostatic self-assembly (ESA) to promote osteoblast growth is reported. Poly (ethylenimine) (PEI) was employed to obtain a stable positively charged surface on poly(DL-lactide) (PDL-LA) substrate. An extracellular-matrix (ECM)-like biomacromolecule, gelatin, was chosen as the polyelectrolyte to deposit on the activated PDL-LA substrate via ESA technique. Osteoblast (MC3T3) was then cultured on unmodified and gelatin-modified PDL-LA scaffolds. Osteoblast testing regarding total intracellular protein content, total DNA content, cell activity, and cell morphology on the ECM-like multilayer-modified PDL-LA scaffold showed that osteoblast growth was promoted. It will be easy to replace the gelatin with osteoinductive proteins or other pollyelectrolytes to promote specific osteoblast functions. In comparison with conventional coating methods, polyelectrolyte multilayers are easy and stable to prepare. They may be a good choice for the surface modification of complex biomedical devices, especially for the 3D tissue-engineering scaffold. These very flexible systems allow broad medical applications for drug delivery and tissue engineering. (C) 2004 Wiley Periodicals, Inc.
C1 Zhejiang Univ, Dept Polymer Sci & Engn, Hangzhou 310027, Peoples R China.
   INEB, Lab Biomat, Oporto, Portugal.
RP Ji, J (reprint author), Zhejiang Univ, Dept Polymer Sci & Engn, Hangzhou 310027, Peoples R China.
EM jianji@mail.hz.zj.cn
RI Zhu, Huiguang/A-8591-2010
OI Barbosa, Mario/0000-0003-3568-7482; Ji, Jian/0000-0001-9870-4038
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Bertrand P, 2000, MACROMOL RAPID COMM, V21, P319, DOI 10.1002/(SICI)1521-3927(20000401)21:7<319::AID-MARC319>3.0.CO;2-7
   Chluba J, 2001, BIOMACROMOLECULES, V2, P800, DOI 10.1021/bm015529i
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   DECHER G, 1991, BER BUNSEN PHYS CHEM, V95, P1430, DOI 10.1002/bbpc.19910951122
   Goldstein AS, 2001, BIOMATERIALS, V22, P1279, DOI 10.1016/S0142-9612(00)00280-5
   HONG JD, 1993, PROG COLL POL SCI S, V93, P98
   HUNTER A, 1995, BIOMATERIALS, V16, P287, DOI 10.1016/0142-9612(95)93256-D
   ILER RK, 1966, J COLLOID INTERF SCI, V21, P569, DOI 10.1016/0095-8522(66)90018-3
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   KLEINFELD ER, 1994, SCIENCE, V265, P370, DOI 10.1126/science.265.5170.370
   KORNEEV D, 1995, PHYSICA B, V213, P954, DOI 10.1016/0921-4526(95)00333-5
   LASCHEWSKY A, 1997, EUR CHEM CHRON, V2, P13
   Liao HH, 2003, BIOMATERIALS, V24, P649, DOI 10.1016/S0142-9612(02)00379-4
   LVOV Y, 1993, LANGMUIR, V9, P481, DOI 10.1021/la00026a020
   LVOV Y, 1994, LANGMUIR, V10, P4232, DOI 10.1021/la00023a052
   Mikos A. G., 1996, U.S. patent, Patent No. [5,514,378, 5514378]
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Park SY, 2001, MACROMOLECULES, V34, P3384, DOI 10.1021/ma001601d
   Sano M, 1996, ANNU REV MATER SCI, V26, P153
   SCHMITT J, 1993, MACROMOLECULES, V26, P7058, DOI 10.1021/ma00077a052
   *SIGMA, 1998, PROD INF DNA QUANT K
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Sullivan DM, 2001, J AM CHEM SOC, V123, P11805, DOI 10.1021/ja016536h
   Ulman A, 1996, CHEM REV, V96, P1533, DOI 10.1021/cr9502357
   WEST DC, 1985, ANAL BIOCHEM, V147, P289, DOI 10.1016/0003-2697(85)90274-X
   Zhu HG, 2003, BIOMACROMOLECULES, V4, P378, DOI 10.1021/bm025773p
   Zhu YB, 2003, BIOMACROMOLECULES, V4, P446, DOI 10.1021/bm025723k
   Zund G, 1999, EUR J CARDIO-THORAC, V15, P519, DOI 10.1016/S1010-7940(99)00068-8
NR 29
TC 24
Z9 25
U1 0
U2 7
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD OCT 15
PY 2004
VL 71B
IS 1
BP 159
EP 165
DI 10.1002/jbm.b.30080
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 858KK
UT WOS:000224190500020
PM 15368240
DA 2018-10-19
ER

PT J
AU Bureau, B
   Zhang, XH
   Smektala, F
   Adam, JL
   Troles, J
   Ma, HL
   Boussard-Pledel, C
   Lucas, J
   Lucas, P
   Le Coq, D
   Riley, MR
   Simmons, JH
AF Bureau, B
   Zhang, XH
   Smektala, F
   Adam, JL
   Troles, J
   Ma, HL
   Boussard-Pledel, C
   Lucas, J
   Lucas, P
   Le Coq, D
   Riley, MR
   Simmons, JH
TI Recent advances in chalcogenide glasses
SO JOURNAL OF NON-CRYSTALLINE SOLIDS
LA English
DT Article; Proceedings Paper
CT 10th International Conference on the Physics of Non-Crystalline Solids
   (PNCS)
CY JUL 13-17, 2003
CL Univ Parma, Parma, ITALY
HO Univ Parma
AB Compared to oxide-based glasses, vitreous materials involving chalcogens form a rather new family of glasses which have received attention, mainly because of their transmission in the mid-infrared. Indeed as low phonon compounds, these heavy-anion glasses allow the fabrication of molded optics for infrared cameras as well as infrared fibers operating in a large spectral range. These waveguides, when correctly tapered, allows the development of a new generation of sensitive evanescent-wave optical sensors which have been used for biomedical applications. Here we will focus on the spectral analysis of biomolecules present in human lung cells by measuring their infrared signatures. Because they contain heavy polarizable anions as well as lone-pair electrons, these glasses exhibit very large non-linear properties compared to silica and are candidates for fast optical switching and signal regeneration in telecom. Due to the technological interest in chalcogenide glasses, more information is needed on their structural organization and Se-77 MR spectroscopy appears to be a useful tool for checking the local environment of the Se atoms. (C) 2004 Elsevier B.V. All rights reserved.
C1 Univ Rennes 1, CNRS, Lab Verres & Ceram, UMR 6512, F-35042 Rennes, France.
   Univ Arizona, Arizona Mat Lab, Tucson, AZ 85712 USA.
RP Bureau, B (reprint author), Univ Rennes 1, CNRS, Lab Verres & Ceram, UMR 6512, Campus Beaulieu, F-35042 Rennes, France.
EM bruno.bureau@univ-rennes1.fr
RI SMEKTALA, Frederic/T-2155-2017
OI SMEKTALA, Frederic/0000-0002-6787-9289; Le Coq,
   David/0000-0001-7898-3463; ZHANG, Xiang-Hua/0000-0002-2180-6543
CR Bureau B, 2003, SOLID STATE SCI, V5, P219, DOI 10.1016/S1293-2558(02)00102-4
   Harbold JM, 2002, IEEE PHOTONIC TECH L, V14, P822, DOI 10.1109/LPT.2002.1003105
   Hocde S, 2001, SOLID STATE SCI, V3, P279, DOI 10.1016/S1293-2558(00)01135-3
   Keirsse J, 2003, VIB SPECTROSC, V32, P23, DOI 10.1016/S0924-2031(03)00044-4
   KEIRSSE J, 2003, NONCRYST SOLIDS, V327, P430
   KOKORINA VF, 1996, LASER OPTICAL SCI TE
   Le Coq D, 2001, INT J INORG MATER, V3, P233, DOI 10.1016/S1466-6049(01)00007-1
   Naumann D, 2000, INFRARED SPECTROSCOP, P102
   Quemard C, 2001, J PHYS CHEM SOLIDS, V62, P1435, DOI 10.1016/S0022-3697(01)00059-2
   RIGAS B, 1990, P NATL ACAD SCI USA, V87, P8140, DOI 10.1073/pnas.87.20.8140
   Schardt CR, 2000, J NON-CRYST SOLIDS, V274, P23, DOI 10.1016/S0022-3093(00)00200-3
   Tanaka K, 2002, CR CHIM, V5, P805, DOI 10.1016/S1631-0748(02)01441-8
NR 12
TC 212
Z9 220
U1 10
U2 70
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-3093
J9 J NON-CRYST SOLIDS
JI J. Non-Cryst. Solids
PD OCT 15
PY 2004
VL 345
BP 276
EP 283
DI 10.1016/j.jnoncrysol.2004.08.096
PG 8
WC Materials Science, Ceramics; Materials Science, Multidisciplinary
SC Materials Science
GA 877PT
UT WOS:000225583200054
DA 2018-10-19
ER

PT J
AU Xiao, H
   Nayak, BR
   Lowe, TL
AF Xiao, H
   Nayak, BR
   Lowe, TL
TI Synthesis and characterization of novel
   thermoresponsive-co-biodegradable hydrogels composed of
   N-isopropylacrylamide, poly(L-lactic acid), and dextran
SO JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
LA English
DT Article
DE hydrogels; thermoresponsive; biodegradable; LCST; N-isopropylacrylamide;
   poly(L-lactic acid); dextran; dynamic swelling; drug delivery; tissue
   engineering
ID DRUG-DELIVERY; MOLECULAR-WEIGHT; COPOLYMER GELS; IN-VITRO; SENSITIVE
   HYDROGELS; SWELLING PROPERTIES; CONTROLLED-RELEASE; POLYMER NETWORKS;
   RESPONSIVE GELS; LACTIC-ACID
AB A series of novel multifunctional hydrogels that combined the merits of both thermoresponsive and biodegradable polymeric materials were designed, synthesized, and characterized. The hydrogels were copolymeric networks composed of Nisopropylacrylamide (NIPAAM) as a thermoresponsive component, poly(L-lactic acid) (PLLA) as a hydrolytically degradable and hydrophobic component, and dextran as an enzymatically degradable and hydrophilic component. The chemical structures of the hydrogels were characterized by an attenuated total reflection-Fourier transform infrared spectroscopy (ATR-FTIR) technique. The hydrogels were thermoresponsive, showing a lower critical solution temperature (LCST) at approximately 32 degreesC, and their swelling properties strongly depended on temperature changes, the balance of the hydrophilic/hydrophobic components, and the degradation of the PLLA component. The degradation of the hydrogels caused by hydrolytic cleavage of ester bonds in the PLLA component was faster at 25 degreesC below the LCST than at 37 degreesC above the LCST, determined by the ATR-FTIR technique. Due to their multifunctional properties, the designed hydrogels show great potential for biomedical applications, including drug delivery and tissue engineering. (C) 2004 Wiley Periodicals, Inc.
C1 Penn State Univ, Dept Surg, Hershey, PA 17033 USA.
   Penn State Univ, Dept Bioengn, Hershey, PA 17033 USA.
   Penn State Univ, Dept Mat Sci & Engn, Hershey, PA 17033 USA.
RP Lowe, TL (reprint author), Penn State Univ, Dept Surg, Hershey, PA 17033 USA.
EM tlowe@psu.edu
CR Berkland C, 2001, J CONTROL RELEASE, V73, P59, DOI 10.1016/S0168-3659(01)00289-9
   BRAZEL CS, 1995, MACROMOLECULES, V28, P8016, DOI 10.1021/ma00128a007
   Bromberg LE, 1998, ADV DRUG DELIVER REV, V31, P197, DOI 10.1016/S0169-409X(97)00121-X
   Bryant SJ, 2003, J BIOMED MATER RES A, V64A, P70, DOI 10.1002/jbm.a.10319
   Cadee JA, 2000, J BIOMED MATER RES, V50, P397
   CIMA LG, 1991, J BIOMECH ENG-T ASME, V113, P143, DOI 10.1115/1.2891228
   Crotts G, 1998, J MICROENCAPSUL, V15, P699, DOI 10.3109/02652049809008253
   Dunne M, 2000, BIOMATERIALS, V21, P1659, DOI 10.1016/S0142-9612(00)00040-5
   Finne A, 2003, J POLYM SCI POL CHEM, V41, P1296, DOI 10.1002/pola.10682
   Galaev IY, 1999, TRENDS BIOTECHNOL, V17, P335, DOI 10.1016/S0167-7799(99)01345-1
   Guilherme MR, 2003, POLYMER, V44, P4213, DOI 10.1016/S0032-3861(03)00370-7
   HOFFMAN AS, 1995, ARTIF ORGANS, V19, P458, DOI 10.1111/j.1525-1594.1995.tb02359.x
   Huang L, 1999, J APPL POLYM SCI, V74, P937, DOI 10.1002/(SICI)1097-4628(19991024)74:4<937::AID-APP20>3.0.CO;2-K
   Iwasaki Y, 2003, J POLYM SCI POL CHEM, V41, P68, DOI 10.1002/pola.10554
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Jiang CF, 2001, J POLYM SCI POL CHEM, V39, P3780, DOI 10.1002/pola.10023
   KAMATH KR, 1993, ADV DRUG DELIVER REV, V11, P59, DOI 10.1016/0169-409X(93)90027-2
   KANEKO Y, 1995, J MEMBRANE SCI, V101, P13, DOI 10.1016/0376-7388(94)00268-4
   Kanellakopoulou K, 2000, DRUGS, V59, P1223, DOI 10.2165/00003495-200059060-00003
   Katime I, 2001, POLYM INT, V50, P869, DOI 10.1002/pi.707
   KENLEY RA, 1987, MACROMOLECULES, V20, P2398, DOI 10.1021/ma00176a012
   Kurian P, 2002, J POLYM SCI POL CHEM, V40, P3093, DOI 10.1002/pola.10391
   Kurian P, 2002, J POLYM SCI POL CHEM, V40, P1209, DOI 10.1002/pola/10209
   Kurisawa M, 1998, MACROMOL CHEM PHYSIC, V199, P705, DOI 10.1002/(SICI)1521-3935(19980401)199:4<705::AID-MACP705>3.3.CO;2-0
   Langer R, 2000, ACCOUNTS CHEM RES, V33, P94, DOI 10.1021/ar9800993
   Lee WF, 2001, J APPL POLYM SCI, V81, P2888, DOI 10.1002/app.1739
   Lowe TL, 1999, MACROMOL CHEM PHYSIC, V200, P51, DOI 10.1002/(SICI)1521-3935(19990101)200:1<51::AID-MACP51>3.0.CO;2-H
   Lowe TL, 1999, LANGMUIR, V15, P4259, DOI 10.1021/la981194n
   Meyer T, 2002, J POLYM SCI POL CHEM, V40, P3144, DOI 10.1002/pola.10400
   Neradovic D, 1999, MACROMOL RAPID COMM, V20, P577, DOI 10.1002/(SICI)1521-3927(19991101)20:11<577::AID-MARC577>3.0.CO;2-D
   Nuttelman CR, 2002, BIOMATERIALS, V23, P3617, DOI 10.1016/S0142-9612(02)00093-5
   PARK TG, 1994, J CONTROL RELEASE, V30, P161, DOI 10.1016/0168-3659(94)90263-1
   PARK TG, 1995, J CONTROL RELEASE, V33, P211, DOI 10.1016/0168-3659(94)00084-8
   Qiu Y, 2001, ADV DRUG DELIVER REV, V53, P321, DOI 10.1016/S0169-409X(01)00203-4
   Ramkissoon-Ganorkar C, 1999, J CONTROL RELEASE, V59, P287, DOI 10.1016/S0168-3659(99)00006-1
   Schmidmaier G, 2001, J BIOMED MATER RES, V58, P449
   Shibayama M, 1996, MACROMOLECULES, V29, P2019, DOI 10.1021/ma951390q
   Stile RA, 1999, MACROMOLECULES, V32, P7370, DOI 10.1021/ma990130w
   Tsuji F, 2002, POLYMER, V43, P1789
   van de Weert M, 2000, PHARMACEUT RES, V17, P1159, DOI 10.1023/A:1026498209874
   vanDijkWolthuis WNE, 1997, POLYMER, V38, P6235, DOI 10.1016/S0032-3861(97)00189-4
   Vernon B, 1996, MACROMOL SYMP, V109, P155, DOI 10.1002/masy.19961090115
   Vernon B, 2000, J BIOMED MATER RES, V51, P69
   Vishalakshi B, 2003, J POLYM SCI POL CHEM, V41, P2288, DOI 10.1002/pola.10771
   Wang CH, 2002, J POLYM SCI POL CHEM, V40, P1112, DOI 10.1002/pola.10201
   Watanabe J, 2002, BIOMACROMOLECULES, V3, P1375, DOI 10.1021/bm025652p
   WU XS, 1992, J POLYM SCI POL CHEM, V30, P2121, DOI 10.1002/pola.1992.080301005
   Zhang JT, 2004, J POLYM SCI POL CHEM, V42, P1249, DOI 10.1002/pola.11092
   Zhang YL, 2002, J MATER SCI-MATER M, V13, P773, DOI 10.1023/A:1016123125046
   Zhang YL, 2002, J BIOMATER APPL, V16, P305, DOI 10.1106/088532802024248
   Zhang YL, 2002, J BIOMED MATER RES, V59, P318, DOI 10.1002/jbm.1248
   Zhang YL, 2000, J POLYM SCI POL CHEM, V38, P2392, DOI 10.1002/1099-0518(20000701)38:13<2392::AID-POLA120>3.0.CO;2-P
   Zhang YL, 1999, J POLYM SCI POL CHEM, V37, P4554, DOI 10.1002/(SICI)1099-0518(19991215)37:24<4554::AID-POLA13>3.0.CO;2-T
NR 53
TC 6
Z9 6
U1 1
U2 13
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0887-624X
J9 J POLYM SCI POL CHEM
JI J. Polym. Sci. Pol. Chem.
PD OCT 15
PY 2004
VL 42
IS 20
BP 5054
EP 5066
DI 10.1002/pola.20327
PG 13
WC Polymer Science
SC Polymer Science
GA 858YS
UT WOS:000224229400003
DA 2018-10-19
ER

PT J
AU Kholodovych, V
   Smith, JR
   Knight, D
   Abramson, S
   Kohn, J
   Welsh, WJ
AF Kholodovych, V
   Smith, JR
   Knight, D
   Abramson, S
   Kohn, J
   Welsh, WJ
TI Accurate predictions of cellular response using QSPR: a feasibility test
   of rational design of polymeric biomaterials
SO POLYMER
LA English
DT Article
DE biomaterials; tyrosine degradable polyarylates; QSPR model
ID TYROSINE-DERIVED POLYCARBONATES; HIV-1 PROTEASE INHIBITORS; DEGRADABLE
   BIOMATERIALS; POLY(ETHER CARBONATE)S; STATISTICAL QUALITY;
   ESTROGEN-RECEPTOR; MODELS; CHEMISTRY; BINDING; FIBRINOGEN
AB We present a Surrogate (semi-empirical) model for prediction of cellular response to the surfaces of biodegradable polymers that have been designed for tissue engineering applications. The predictions of our model, when tested against experimental results, show a high degree of accuracy that is sufficient for rational design of polymeric materials for biomedical applications. The model was determined by fitting experimental data for a series of 62 polyarylates to a small number of polymer structure-based 'molecular descriptors' using the technique of partial least squares (PLS) regression. While PLS is commonly applied in quantitative structure activity relationship (QSAR) analysis employed in the pharmaceutical industry, this study marks the first time the technique has been extended to the problem of biomaterials discovery/design. Quantitative predictions of cellular response to six polymers (untested prior to model building) concurred with experiment within 15.8% on average. This performance compares quite favorably with the overall variation in experimental values for the library of polyarylates. Examination of the PLS 'loadings' reveals those structure-based features most associated with variations in the polymer performance properties, thereby providing direct guidance to the synthetic chemist in biomaterials design. (C) 2004 Published by Elsevier Ltd.
C1 Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA.
   Univ Med & Dent New Jersey, Inst Informat, Piscataway, NJ 08854 USA.
   Univ Med & Dent New Jersey, Dept Chem & Biol Chem, Piscataway, NJ 08854 USA.
   Univ Med & Dent New Jersey, New Jersey Ctr Biomat, Piscataway, NJ 08854 USA.
   Rutgers State Univ, Dept Mech & Aerosp Engn, New Brunswick, NJ 08903 USA.
RP Kholodovych, V (reprint author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, 675 Hoes Lane, Piscataway, NJ 08854 USA.
EM welshwj@umdnj.edu
CR Anderson T. W., 2003, INTRO MULTIVARIATE S
   Brocchini S, 1998, J BIOMED MATER RES, V42, P66, DOI 10.1002/(SICI)1097-4636(199810)42:1<66::AID-JBM9>3.0.CO;2-M
   Brocchini S, 1997, J AM CHEM SOC, V119, P4553, DOI 10.1021/ja970389z
   BROCCHINI S, 1997, PRELIMINARY STUDIES
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   CHILKOTI A, 1995, ANAL CHEM, V67, P2883, DOI 10.1021/ac00113a024
   Draper N. R., 1981, APPL REGRESSION ANAL
   ERTEL SI, 1994, J BIOMED MATER RES, V28, P919, DOI 10.1002/jbm.820280811
   HARNETT D, 1980, INTRO STAT ANAL
   James K, 1999, BIOMATERIALS, V20, P2203, DOI 10.1016/S0142-9612(99)00151-9
   Jayatilleke PRN, 2000, J MED CHEM, V43, P4446, DOI 10.1021/jm9905357
   Joliffe IT, 1986, PRINCIPLES COMPONENT
   KNIGHT D, 2003, DATA DRIVEN DESIGN O, P329
   Knight D., 2002, 20025636 AIAA
   LEFANTZI S, 2001, 20013294 AIAA
   LOWE G, 1995, JCS REV, P309
   Malinowski E.R., 1980, FACTOR ANAL CHEM
   MENGER FM, 1995, J ORG CHEM, V60, P6666, DOI 10.1021/jo00126a008
   Meredith JC, 2003, J BIOMED MATER RES A, V66A, P483, DOI 10.1002/jbm.a.10004
   Nair AC, 2002, J MED CHEM, V45, P973, DOI 10.1021/jm010417v
   PEREZLUNA VH, 1994, J BIOMED MATER RES, V28, P1111, DOI 10.1002/jbm.820281002
   Puri S, 2002, J CHEM INF COMP SCI, V42, P109, DOI 10.1021/ci010081y
   PURI S, 2002, J CHEM INF COMP SCI, V42, P209
   Reynolds CH, 1999, J COMB CHEM, V1, P297, DOI 10.1021/cc9900044
   Ryan PL, 2001, P NATL ACAD SCI USA, V98, P4323, DOI 10.1073/pnas.071615398
   Smith JR, 2004, MACROMOL RAPID COMM, V25, P127, DOI 10.1002/marc.200300193
   TODESCHINI R, 2003, DRAGON WEB VERSION
   Tong W, 1998, J CHEM INF COMP SCI, V38, P669, DOI 10.1021/ci980008g
   Tong WD, 1997, ENDOCRINOLOGY, V138, P4022, DOI 10.1210/en.138.9.4022
   Weber N, 2004, J BIOMED MATER RES A, V68A, P496, DOI 10.1002/jbm.a.20086
   WOLD S, 1983, ACTA PHARMACOL TOX, V52, P158
   Wold S, 1984, CHEMOMETRICS MATH ST, P17
   Wold S, 1995, METHODS PRINCIPLES M
   Yu C, 1999, BIOMATERIALS, V20, P265, DOI 10.1016/S0142-9612(98)00170-7
   Yu C, 1999, BIOMATERIALS, V20, P253, DOI 10.1016/S0142-9612(98)00169-0
   Yu SJ, 2002, CHEM RES TOXICOL, V15, P1229, DOI 10.1021/tx0255875
NR 36
TC 38
Z9 40
U1 0
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
J9 POLYMER
JI Polymer
PD OCT 13
PY 2004
VL 45
IS 22
BP 7367
EP 7379
DI 10.1016/j.polymer.2004.09.002
PG 13
WC Polymer Science
SC Polymer Science
GA 862NO
UT WOS:000224497900001
OA Other Gold
DA 2018-10-19
ER

PT J
AU Murata, H
   Chang, BJ
   Prucker, O
   Dahm, M
   Ruhe, J
AF Murata, H
   Chang, BJ
   Prucker, O
   Dahm, M
   Ruhe, J
TI Polymeric coatings for biomedical devices
SO SURFACE SCIENCE
LA English
DT Article; Proceedings Paper
CT INternational Conference on BIOSURF V - Functional Polymeric Surfaces in
   Biotechnology
CY SEP 25-26, 2003
CL Univ Zurich, Zurich, SWITZERLAND
HO Univ Zurich
DE coatings; biological compounds; glass surfaces; self-assembly;
   photochemistry
ID CELL-ADHESION; CARBON-BLACK; MONOLAYERS; SURFACES; BRUSHES
AB To improve the properties of materials in biomedical applications and to allow a better interaction of the medical device with the biological system surrounding it, frequently polymeric coatings are applied. However, the adhesion of the coating to the substrate usually poses a problem as the materials involved have either rather inert surfaces or strongly varying surface chemistries. We describe a new approach which allows to attach a wide variety of polymer films to organic substrates either of polymeric or biological origin. The technique is based on photochemical processes occurring in benzophenone group containing polymers, which lead to simultaneous crosslinking of the polymer in the coating and surface-attachment of the forming polymer network. The synthesis and characterization of monolayers and surface-attached polymer networks through this route are described and possible applications of this approach in the biomedical area are discussed. (C) 2004 Published by Elsevier B.V.
C1 Univ Freiburg, IMTEK, D-79110 Freiburg, Germany.
   Univ Hosp Mainz, Dept Cardiothorac & Vasc Surg, Mainz, Germany.
RP Ruhe, J (reprint author), Univ Freiburg, IMTEK, Kohler Alee 103, D-79110 Freiburg, Germany.
EM ruehe@imtek.de
RI Prucker, Oswald/E-3578-2010; Ruehe, Juergen/G-6157-2012
OI Prucker, Oswald/0000-0001-8683-7730; 
CR BRIDGER K, 1980, EUR POLYM J, V16, P1017, DOI 10.1016/0014-3057(80)90185-8
   Chang BJ, 2002, COLLOID SURFACE A, V198, P519, DOI 10.1016/S0927-7757(01)00952-9
   Dahm M, 2001, ANN THORAC SURG, V71, pS437, DOI 10.1016/S0003-4975(01)02513-9
   KRENKLER KP, 1978, ANGEW MAKROMOL CHEM, V53, P101
   LAIBLE R, 1980, ADV COLLOID INTERFAC, V13, P65, DOI 10.1016/0001-8686(80)87002-3
   Ouada H. Ben, 1988, J COLLOID INTERF SCI, V122, P441
   Prucker O, 1999, J AM CHEM SOC, V121, P8766, DOI 10.1021/ja990962+
   PRUCKER O, 2003, EUR COAT J, P40
   Ratner BD, 1996, INTRO MAT MED
   Ruhe J, 2002, J MACROMOL SCI-POL R, VC42, P91
   Toomey R, 2004, MACROMOLECULES, V37, P882, DOI 10.1021/ma034737v
   TSUBOKAWA N, 1989, J POLYM SCI POL CHEM, V27, P1701, DOI 10.1002/pola.1989.080270521
   TSUBOKAWA N, 1990, J MACROMOL SCI CHEM, VA27, P445
   Ulman A., 1991, INTRO ULTRATHIN ORGA
   Zhao B, 2000, PROG POLYM SCI, V25, P677, DOI 10.1016/S0079-6700(00)00012-5
NR 15
TC 43
Z9 43
U1 0
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0039-6028
J9 SURF SCI
JI Surf. Sci.
PD OCT 10
PY 2004
VL 570
IS 1-2
BP 111
EP 118
DI 10.1016/j.susc.2004.06.185
PG 8
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA 863DH
UT WOS:000224540300010
DA 2018-10-19
ER

PT J
AU Lin, YS
   Hung, Y
   Su, JK
   Lee, R
   Chang, C
   Lin, ML
   Mou, CY
AF Lin, YS
   Hung, Y
   Su, JK
   Lee, R
   Chang, C
   Lin, ML
   Mou, CY
TI Gadolinium(III)-incorporated nanosized mesoporous silica as potential
   magnetic resonance imaging contrast agents
SO JOURNAL OF PHYSICAL CHEMISTRY B
LA English
DT Article
ID MOLECULAR-SIEVES; RELAXATION; RELEASE; SYSTEM
AB A new class of potential magnetic resonance imaging contrast agents with nanosized mesoporous silica as the metal carrier is reported. Gadolinium-incorporated mesoporous silicas were synthesized by using longchain surfactant as a template. The products were characterized with X-ray powder diffraction, nitrogen adsorption-desorption isotherms, high-resolution transmission electron microscopy, X-ray photoelectron spectroscopy, Si-29-MAS NMR, and proton relaxivity. The materials showed much higher relaxivities, r(1) and r(2), than Gd-DTPA. The particles are nanosized and can enter cells easily. This is a completely novel biomedical application of mesoporous silica materials.
C1 Natl Taiwan Univ, Dept Chem, Taipei 106, Taiwan.
   Natl Taiwan Univ, Ctr Condensed Matter Sci, Taipei 106, Taiwan.
   Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan.
RP Mou, CY (reprint author), Natl Taiwan Univ, Dept Chem, Taipei 106, Taiwan.
EM cymou@ntu.edu.tw
RI Chang, Chen/B-5079-2009
OI MOU, CHUNG-YUAN/0000-0001-7060-9899
CR BECK JS, 1992, J AM CHEM SOC, V114, P10834, DOI 10.1021/ja00053a020
   BRESINSKA I, 1994, J PHYS CHEM-US, V98, P12989, DOI 10.1021/j100100a029
   Caravan P, 1999, CHEM REV, V99, P2293, DOI 10.1021/cr980440x
   Ciobanu L, 2003, PROG NUCL MAG RES SP, V42, P69, DOI 10.1016/S0079-6565(03)00004-9
   Gries H, 2002, TOP CURR CHEM, V221, P1
   GUERON M, 1975, J MAGN RESON, V19, P58, DOI 10.1016/0022-2364(75)90029-3
   JUNG CW, 1995, MAGN RESON IMAGING, V13, P661, DOI 10.1016/0730-725X(95)00024-B
   Lai CY, 2003, J AM CHEM SOC, V125, P4451, DOI 10.1021/ja028650l
   Lin HP, 2003, CHEM LETT, V32, P1092, DOI 10.1246/cl.2003.1092
   Mal NK, 2003, NATURE, V421, P350, DOI 10.1038/nature01362
   Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403
   Matos JR, 2001, J MATER CHEM, V11, P2580, DOI 10.1039/b102056k
   MERBACH AE, 2001, CHEM CONTRAST AGENTS
   Platas-Iglesias C, 2002, CHEM-EUR J, V8, P5121, DOI 10.1002/1521-3765(20021115)8:22<5121::AID-CHEM5121>3.0.CO;2-W
   Rodriguez-Castellon E, 2003, J SOLID STATE CHEM, V175, P159, DOI 10.1016/S0022-4596(03)00218-4
   RUMMENY E, 1991, INVEST RADIOL, V26, pS142, DOI 10.1097/00004424-199111001-00048
   STAKHEEV AY, 1993, J PHYS CHEM-US, V97, P5668, DOI 10.1021/j100123a034
   SUR SK, 1993, J MAGN RESON SER A, V103, P27, DOI 10.1006/jmra.1993.1127
   Weinmann HJ, 2003, EUR J RADIOL, V46, P33, DOI 10.1016/S0720-048X(02)00332-7
   WEISSLEDER R, 2002, NAT REV CANCER, V2, P1
   Yin W, 2003, J ALLOY COMPD, V360, P231, DOI 10.1016/S0925-8388(03)00304-9
NR 21
TC 105
Z9 106
U1 3
U2 35
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1520-6106
J9 J PHYS CHEM B
JI J. Phys. Chem. B
PD OCT 7
PY 2004
VL 108
IS 40
BP 15608
EP 15611
DI 10.1021/jp047829a
PG 4
WC Chemistry, Physical
SC Chemistry
GA 858TA
UT WOS:000224213500026
DA 2018-10-19
ER

PT J
AU Pavlov, KM
   Gureyev, TE
   Paganin, D
   Nesterets, YI
   Morgan, MJ
   Lewis, RA
AF Pavlov, KM
   Gureyev, TE
   Paganin, D
   Nesterets, YI
   Morgan, MJ
   Lewis, RA
TI Linear systems with slowly varying transfer functions and their
   application to X-ray phase-contrast imaging
SO JOURNAL OF PHYSICS D-APPLIED PHYSICS
LA English
DT Article
ID SYNCHROTRON-RADIATION; APPROXIMATION; RETRIEVAL; OBJECTS
AB A novel theoretical treatment of linear shift-invariant imaging systems is developed, which allows explicit solution of forward and inverse problems in the case of large values of the generalized Fresnel number. The method will be useful in a variety of domains including optical instrumentation, biomedical imaging and materials science. Our approach is used to integrate two particularly topical x-ray imaging methods, namely propagation-based and analyser-crystal-based x-ray phase-contrast imaging.
C1 Monash Univ, Sch Phys & Mat Engn, Clayton, Vic 3800, Australia.
   Monash Univ, Ctr Synchrotron Sci, Clayton, Vic 3800, Australia.
   CSIRO Mfg & Infrastruct Technol, Clayton, Vic 3169, Australia.
RP Pavlov, KM (reprint author), Monash Univ, Sch Phys & Mat Engn, Clayton, Vic 3800, Australia.
RI Nesterets, Yakov/A-7981-2010; Pavlov, Konstantin/A-3802-2008; Gureyev,
   Timur/A-9209-2011; paganin, david/B-9717-2009
OI Pavlov, Konstantin/0000-0002-1756-4406; Gureyev,
   Timur/0000-0002-1103-0649; Paganin, David/0000-0002-7758-7140
CR Bushuev VA, 1999, TECH PHYS LETT+, V25, P83, DOI 10.1134/1.1262407
   Bushuev VA, 1998, CRYSTALLOGR REP+, V43, P538
   Chapman D, 1997, PHYS MED BIOL, V42, P2015, DOI 10.1088/0031-9155/42/11/001
   Cloetens P, 1996, J PHYS D APPL PHYS, V29, P133, DOI 10.1088/0022-3727/29/1/023
   DAVIS TJ, 1995, NATURE, V373, P595, DOI 10.1038/373595a0
   DAVIS TJ, 1994, ACTA CRYSTALLOGR A, V50, P686, DOI 10.1107/S0108767394003478
   FORSTER E, 1980, KRIST TECH, V15, P937, DOI 10.1002/crat.19800150812
   Gureyev TE, 1998, J OPT SOC AM A, V15, P579, DOI 10.1364/JOSAA.15.000579
   Gureyev TE, 1997, NUOVO CIMENTO D, V19, P545, DOI 10.1007/BF03041015
   INGAL VN, 1995, J PHYS D APPL PHYS, V28, P2314, DOI 10.1088/0022-3727/28/11/012
   Mayo SC, 2002, J MICROSC-OXFORD, V207, P79, DOI 10.1046/j.1365-2818.2002.01046.x
   Nesterets YI, 2004, J PHYS D APPL PHYS, V37, P1262, DOI 10.1088/0022-3727/37/8/016
   Nugent KA, 1996, PHYS REV LETT, V77, P2961, DOI 10.1103/PhysRevLett.77.2961
   Paganin D, 2004, OPT COMMUN, V234, P87, DOI 10.1016/j.optcom.2004.02.015
   Paganin D, 2002, J MICROSC-OXFORD, V206, P33, DOI 10.1046/j.1365-2818.2002.01010.x
   Paganin D, 2001, ADV IMAG ELECT PHYS, V118, P85, DOI 10.1016/S1076-5670(01)80104-X
   Pagot E, 2003, APPL PHYS LETT, V82, P3421, DOI 10.1063/1.1575508
   PAPOULIS A, 1968, SYSTEMS TRANSFORMS A
   Pavlov KM, 2001, J PHYS D APPL PHYS, V34, pA168, DOI 10.1088/0022-3727/34/10A/335
   Rigon L, 2003, J PHYS D APPL PHYS, V36, pA107, DOI 10.1088/0022-3727/36/10A/322
   Snigirev A, 1995, REV SCI INSTRUM, V66, P5486, DOI 10.1063/1.1146073
   Somenkov V. A., 1991, Soviet Physics - Technical Physics, V36, P1309
   TEAGUE MR, 1983, J OPT SOC AM, V73, P1434, DOI 10.1364/JOSA.73.001434
   Treves F, 1980, INTRO PSEUDODIFFEREN, V2
   Wilkins SW, 1996, NATURE, V384, P335, DOI 10.1038/384335a0
NR 25
TC 50
Z9 50
U1 0
U2 3
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 0022-3727
J9 J PHYS D APPL PHYS
JI J. Phys. D-Appl. Phys.
PD OCT 7
PY 2004
VL 37
IS 19
BP 2746
EP 2750
AR PII S0022-3727(04)80720-4
DI 10.1088/0022-3727/37/19/021
PG 5
WC Physics, Applied
SC Physics
GA 864YO
UT WOS:000224669500023
DA 2018-10-19
ER

PT J
AU Wang, ZL
   Kong, XY
   Ding, Y
   Gao, PX
   Hughes, WL
   Yang, RS
   Zhang, Y
AF Wang, ZL
   Kong, XY
   Ding, Y
   Gao, PX
   Hughes, WL
   Yang, RS
   Zhang, Y
TI Semiconducting and piezoelectric oxide nanostructures induced by polar
   surfaces
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
ID SINGLE-CRYSTAL NANORINGS; NANOWIRE BUILDING-BLOCKS; ZINC-OXIDE;
   SPONTANEOUS POLARIZATION; INDUCED NANOHELIXES; ZNO NANOBELTS;
   NANOSPRINGS; MECHANISM; CONSTANTS; STABILITY
AB Zinc oxide, an important semiconducting and piezosecond material, has three key characteristics. First, it is a semiconductor, with a direct bandgap of 3.37 eV and a large exicitation binding energy (60 meV), and exhibits near-UV emission and transport conductivity. Secondly, due to its non-centrosymmetric symmetry, it is piezoelectric, which is a key phenomenon in building electro-mechanical coupled sensors and transductors. Finally, ZnO is bio-safe and bio-compatible, and can be used for biomedical applications without coating. With these unique advantages ZnO is one of the most important nanomaterials for integration with microsystems and biotechnology. Structurally, due to the three types of fastest growth directions - <0001>, <0 (11) over bar0>, and <2 (11) over bar0> - as well as the +/-(0001) polar surfaces, a diverse group of ZnO nanostructures have been grown in our laboratory. These included nanocombs, nanosprings, nanorings, nanobows, and nanopropellors. This article reviews our recent progress in the synthesis and characterisation of polar-surface-induced ZnO nanostructures, their growth mechanisms, and possible applications as sensors, transducters, and resonators. It is suggested that ZnO could be the next most important nanomaterial after carbon nanotubes.
C1 Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.
   Beijing Univ Sci & Technol, Dept Mat Phys, Beijing 100083, Peoples R China.
   Beijing Univ Sci & Technol, State Key Lab Adv Met & Mat, Beijing 100083, Peoples R China.
RP Wang, ZL (reprint author), Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.
EM zhong.wang@mse.gatech.edu
RI Gao, Puxian/E-1461-2011; Wang, Zhong Lin/E-2176-2011; Yang,
   Rusen/D-5536-2009; Kong, Xiang Yang/E-1593-2012; Kong,
   Xiangyang/F-2999-2013; Ding, Yong/F-3705-2017
OI Wang, Zhong Lin/0000-0002-5530-0380; Yang, Rusen/0000-0002-4019-4642;
   Kong, Xiang Yang/0000-0003-0659-4084; Ding, Yong/0000-0001-5805-347X
CR ARNOLD M, 2002, J PHYS CHEM B, V107, P659
   Bai XD, 2003, APPL PHYS LETT, V82, P4806, DOI 10.1063/1.1587878
   Bernardini F, 1998, PHYS REV B, V58, P15292, DOI 10.1103/PhysRevB.58.15292
   Bernardini F, 1997, PHYS REV B, V56, P10024, DOI 10.1103/PhysRevB.56.R10024
   CAHN JW, 1964, SURF SCI, V1, P387, DOI 10.1016/0039-6028(64)90006-8
   Comini E, 2002, APPL PHYS LETT, V81, P1869, DOI 10.1063/1.1504867
   COWLEY JM, 1957, ACTA CRYSTALLOGR, V10, P609, DOI 10.1107/S0365110X57002194
   Cui Y, 2001, SCIENCE, V291, P851, DOI 10.1126/science.291.5505.851
   Dai R.Z., 2003, ADV FUNCT MATER, V13, P9
   Dai Y, 2003, SOLID STATE COMMUN, V126, P629, DOI 10.1016/S0038-1098(03)00277-1
   Dai Y, 2002, CHEM PHYS LETT, V358, P83, DOI 10.1016/S0009-2614(02)00582-1
   Ding Y, 2004, J AM CHEM SOC, V126, P2066, DOI 10.1021/ja039354r
   DING Y, 2004, UNPUB PHYS REV B
   Duan XF, 2001, NATURE, V409, P66, DOI 10.1038/35051047
   Dulub O, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.016102
   Dulub O, 2002, SURF SCI, V519, P201, DOI 10.1016/S0039-6028(02)02211-2
   Gao PX, 2002, J PHYS CHEM B, V106, P12653, DOI 10.1021/jp0265485
   Gao PX, 2004, APPL PHYS LETT, V84, P2883, DOI 10.1063/1.1702137
   Gao PX, 2003, NANO LETT, V3, P1315, DOI 10.1021/nl034548q
   GAO PX, 2004, IN PRESS J PHYS CH B
   Hashimoto S, 1996, J AM CERAM SOC, V79, P1121, DOI 10.1111/j.1151-2916.1996.tb08559.x
   Huang Y, 2001, SCIENCE, V294, P1313, DOI 10.1126/science.1066192
   Hughes WL, 2004, J AM CHEM SOC, V126, P6703, DOI 10.1021/ja049266m
   Hughes WL, 2003, APPL PHYS LETT, V82, P2886, DOI 10.1063/1.1570497
   Kong XY, 2004, SCIENCE, V303, P1348, DOI 10.1126/science.1092356
   Kong XY, 2004, APPL PHYS LETT, V84, P975, DOI 10.1063/1.1646453
   Kong XY, 2003, NANO LETT, V3, P1625, DOI 10.1021/nl034463p
   Li C, 2000, MICRON, V31, P543, DOI 10.1016/S0968-4328(99)00136-5
   Lieber C.M., 1998, SOLID STATE COMMUN, V107, P106
   Ma C, 2004, J AM CHEM SOC, V126, P708, DOI 10.1021/ja0395644
   MAO S, 2002, APPL PHYS LETT, V83, P993
   Meyer B, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.035403
   MOORE D, 2004, PHYS LETT, V385, P8
   Nishio K, 1997, PHILOS MAG A, V76, P889, DOI 10.1080/01418619708214216
   Pan ZW, 2001, SCIENCE, V291, P1947, DOI 10.1126/science.1058120
   Parish R. V., 1977, METALLIC ELEMENTS
   SHI L, 2004, IN PRESS APPL PHYS L
   Staemmler V, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.106102
   TAKEUCHI S, 1994, PHILOS MAG A, V69, P1125, DOI 10.1080/01418619408242243
   TASKER PW, 1979, J PHYS C SOLID STATE, V12, P4977, DOI 10.1088/0022-3719/12/22/036
   Vigue F, 2001, APPL PHYS LETT, V79, P194, DOI 10.1063/1.1384907
   Wander A, 2001, PHYS REV LETT, V86, P3811, DOI 10.1103/PhysRevLett.86.3811
   Wang Z. L., 1998, FUNCTIONAL SMART MAT
   Wang Z.L., 2003, NANOWIRES NANOBELTS, V1
   Wang ZL, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.185502
   Wang ZL, 2003, NANOWIRES NANOBELTS, V2
   Xia YN, 2003, ADV MATER, V15, P353, DOI 10.1002/adma.200390087
   Yan Y, 1998, APPL PHYS LETT, V73, P2585, DOI 10.1063/1.122513
   Yang RS, 2004, NANO LETT, V4, P1309, DOI 10.1021/nl049317d
   Zhao MH, 2004, NANO LETT, V4, P587, DOI 10.1021/nl035198a
NR 50
TC 465
Z9 473
U1 11
U2 205
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-301X
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD OCT
PY 2004
VL 14
IS 10
BP 943
EP 956
DI 10.1002/adfm.200400180
PG 14
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 866ZD
UT WOS:000224811000001
DA 2018-10-19
ER

PT J
AU Etienne, O
   Picart, C
   Taddei, C
   Haikel, Y
   Dimarcq, JL
   Schaaf, P
   Voegel, JC
   Ogier, JA
   Egles, C
AF Etienne, O
   Picart, C
   Taddei, C
   Haikel, Y
   Dimarcq, JL
   Schaaf, P
   Voegel, JC
   Ogier, JA
   Egles, C
TI Multilayer polyelectrolyte films functionalized by insertion of
   defensin: A new approach to protection of implants from bacterial
   colonization
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
ID POLY(L-LYSINE)-G-POLY(ETHYLENE GLYCOL) LAYERS; METAL-OXIDE SURFACES;
   STAPHYLOCOCCUS-EPIDERMIDIS; ANTIMICROBIAL ACTIVITIES; BIOMEDICAL
   POLYMERS; PROTEIN ADSORPTION; RESISTANCE; ADHESION; NISIN; BIOMATERIALS
AB Infection of implanted materials by bacteria constitutes one of the most serious complications following prosthetic surgery. In the present study, we developed a new strategy based on the insertion of an antimicrobial peptide (defensin from Anopheles gambiae mosquitoes) into polyelectrolyte multilayer films built by the alternate deposition of polyanions and polycations. Quartz crystal microbalance and streaming potential measurements were used to follow step by step the construction of the multilayer films and embedding of the defensin within the films. Antimicrobial assays were performed with two strains: Micrococcus luteus (a gram-positive bacterium) and Escherichia coli D22 (a gram-negative bacterium). The inhibition of E. coli D22 growth at the surface of defensin-functionalized films was found to be 98% when 10 antimicrobial peptide layers were inserted in the film architecture. Noticeably, the biofunctionalization could be achieved only when positively charged poly(L-lysine) was the outermost layer of the film. On the basis of the results of bacterial adhesion experiments observed by confocal or electron microscopy, these observations could result from the close interaction of the bacteria with the positively charged ends of the films, which allows defensin to interact with the bacterial membrane structure. These results open new possibilities for the use of such easily built and functionalized architectures onto any type of implantable biomaterial. The modified surfaces are active against microbial infection and represent a novel means of local host protection.
C1 Univ Strasbourg 1, INSERM U595, Fac Chirurg Dent, F-67085 Strasbourg, France.
   Inst Charles Sadron, UPR 22 CNRS, F-67083 Strasbourg, France.
   Entomed SA, Illkirch Graffenstaden, France.
RP Egles, C (reprint author), Univ Strasbourg 1, INSERM U595, Fac Chirurg Dent, 11 Rue Humann, F-67085 Strasbourg, France.
EM christophe.egles@odonto-ulp.u-strasbg.fr
RI SCHAAF, Pierre/J-2751-2016; ETIENNE, olivier/D-1601-2013; etienne,
   olivier/D-9542-2011
OI SCHAAF, Pierre/0000-0001-7423-5492; ETIENNE,
   olivier/0000-0001-8870-4659; PICART, Catherine/0000-0003-0130-1000;
   PICART, Catherine/0000-0002-4854-6366
CR BARTH E, 1989, BIOMATERIALS, V10, P325, DOI 10.1016/0142-9612(89)90073-2
   Boulmedais F, 2004, BIOMATERIALS, V25, P2003, DOI 10.1016/j.biomaterials.2003.08.039
   Bower CK, 2002, COLLOID SURFACE B, V25, P81, DOI 10.1016/S0927-7765(01)00318-6
   Bulet P, 1999, DEV COMP IMMUNOL, V23, P329, DOI 10.1016/S0145-305X(99)00015-4
   Burns J L, 1993, Adv Pediatr Infect Dis, V8, P53
   Caruso F, 1997, LANGMUIR, V13, P3427, DOI 10.1021/la9608223
   Chluba J, 2001, BIOMACROMOLECULES, V2, P800, DOI 10.1021/bm015529i
   COCIANCICH S, 1993, J BIOL CHEM, V268, P19239
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   DARVEAU RP, 1991, ANTIMICROB AGENTS CH, V35, P1153, DOI 10.1128/AAC.35.6.1153
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   DEFEIJTER JA, 1978, BIOPOLYMERS, V17, P1759, DOI 10.1002/bip.1978.360170711
   Dielbandhoesing SK, 1998, APPL ENVIRON MICROB, V64, P4047
   Dimarcq JL, 2003, DRUG DISCOV TODAY, V8, P107, DOI 10.1016/S1359-6446(02)02582-5
   Ganzle MG, 1999, INT J FOOD MICROBIOL, V48, P37, DOI 10.1016/S0168-1605(99)00026-4
   Gottenbos B, 2003, BIOMATERIALS, V24, P2707, DOI 10.1016/S0142-9612(03)00083-8
   HAYNIE SL, 1995, ANTIMICROB AGENTS CH, V39, P301, DOI 10.1128/AAC.39.2.301
   Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313
   Hook F, 1998, J COLLOID INTERF SCI, V208, P63, DOI 10.1006/jcis.1998.5774
   Huang NP, 2001, LANGMUIR, V17, P489, DOI 10.1021/la000736+
   Jessel N, 2003, ADV MATER, V15, P692, DOI 10.1002/adma.200304634
   Kenausis GL, 2000, J PHYS CHEM B, V104, P3298, DOI 10.1021/jp993359m
   Ladam G, 2002, BIOMOL ENG, V19, P273, DOI 10.1016/S1389-0344(02)00031-X
   Martin I, 1996, EUR J BIOCHEM, V239, P156, DOI 10.1111/j.1432-1033.1996.0156u.x
   OFEK I, 1994, BACTERIAL ADHESION C
   Picart C, 2001, J CHEM PHYS, V115, P1086, DOI 10.1063/1.1375156
   Picart C, 2001, LANGMUIR, V17, P7414, DOI 10.1021/la010848g
   Picart C, 2002, P NATL ACAD SCI USA, V99, P12531, DOI 10.1073/pnas.202486099
   Rodahl M, 1996, SENSOR ACTUAT B-CHEM, V37, P111, DOI 10.1016/S0925-4005(97)80077-9
   RUPP ME, 1994, CLIN INFECT DIS, V19, P231, DOI 10.1093/clinids/19.2.231
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1
   STICKLER DJ, 1995, CELL MATER, V5, P167
   TIEFENTHALER K, 1989, J OPT SOC AM B, V6, P209, DOI 10.1364/JOSAB.6.000209
   Tryoen-Toth P, 2002, J BIOMED MATER RES, V60, P657, DOI 10.1002/jbm.10110
   Vautier D, 2003, CELL MOTIL CYTOSKEL, V56, P147, DOI 10.1002/cm.10140
   Vizioli J, 2001, INSECT BIOCHEM MOLEC, V31, P241, DOI 10.1016/S0965-1748(00)00143-0
   Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219
   WANG IW, 1995, J BIOMED MATER RES, V29, P485, DOI 10.1002/jbm.820290408
NR 39
TC 142
Z9 143
U1 0
U2 40
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD OCT
PY 2004
VL 48
IS 10
BP 3662
EP 3669
DI 10.1128/AAC.48.10.3662-3669.2004
PG 8
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA 858UH
UT WOS:000224217000003
PM 15388417
OA Bronze, Green Published
DA 2018-10-19
ER

PT J
AU El-Amin, SF
   Kofron, MD
   Attawia, MA
   Lu, HH
   Tuan, RS
   Laurencin, CT
AF El-Amin, SF
   Kofron, MD
   Attawia, MA
   Lu, HH
   Tuan, RS
   Laurencin, CT
TI Molecular regulation of osteoblasts for tissue engineered bone repair
SO CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
LA English
DT Article
ID INTEGRIN EXPRESSION; BIOERODIBLE POLYMERS; DYNAMIC REGULATION; IMPLANT
   MATERIALS; RECOGNITION SITE; CELL-ADHESION; MATRICES; BINDING; CULTURE;
   GROWTH
AB The use of biodegradable polymers in medicine and biomedical research is increasing. A key growth area has been the use of these materials in tissue engineering, especially for guided regeneration of bone and cartilage. Our interest has been in determining the mechanisms by which cellular attachment and growth occurs on these materials. In the current study, we examined human osteoblast cell adhesion, growth, and morphologic changes on polymeric scaffolds composed of polylactic-co-glycolic acid and polylactic acid materials. We examined these characteristics in association with measurements of levels of key adhesion integrin receptors in the presence and absence of antibodies against alpha(2), alpha(3), alpha(4), alpha(5), alpha(6), and beta(1) subunits, and the adhesion ligand peptides RGD (Arg-Gly-Asp) and RGE (Arg-Gly-Ser). At 2 hours, results showed initial cell adhesion was considerably decreased on polylactic-co-glycolic acid and polylactic acid in the presence of the alpha(2) and beta(1) antibodies with a 70% adhesion rate difference observed among the groups evaluated. Higher levels of inhibition were observed on polylactic-co-glycolic acid relative to polylactic acid, which may be correlated to a higher number of cells being able to interact with the surface initially. The presence of known competitive peptide (RGD) at 2 hours, revealed its ability to block cellular adhesion to these matrices relative to the control and noncompetitive peptide RGE on polylactic-co-glycolic acid matrices. Overall adhesion rate was affected by the presence of the integrin antibodies to the alpha(2), alpha(3), alpha(4), alpha(5), alpha(6), and beta(1) subunits with highest differences among polylactic-co-glycolic acid relative to its control, therefore suggesting that initial osteoblastic cell adhesion to commonly used biomaterials is regulated through integrin binding.
C1 Univ Virginia, Dept Orthopaed Surg, Charlottesville, VA 22903 USA.
   Univ Virginia, Dept Chem Engn, Charlottesville, VA 22903 USA.
   Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22903 USA.
   Depuy Johnson & Johnson, Raymond, MA USA.
   Natl Inst Musculoskeletal Res, NIH, Bethesda, MD USA.
   Columbia Univ, Dept Chem Engn, New York, NY 10027 USA.
RP Laurencin, CT (reprint author), Univ Virginia, Dept Orthopaed Surg, 400 Ray C Hunt Dr,Suite 330, Charlottesville, VA 22903 USA.
EM ctlf3f@virginia.edu
FU NIDCR NIH HHS [DE12864]; NIAMS NIH HHS [AR44051, AR39740, AR08562-01]
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   ATTAWIA MA, 1995, J BIOMED MATER RES, V29, P843, DOI 10.1002/jbm.820290709
   Attawia MA, 1996, J ORTHOPAED RES, V14, P445, DOI 10.1002/jor.1100140315
   ATTAWIA MA, 1995, BIOCHEM BIOPH RES CO, V213, P639, DOI 10.1006/bbrc.1995.2179
   Brekke JH, 1998, J BIOMED MATER RES, V43, P380, DOI 10.1002/(SICI)1097-4636(199824)43:4<380::AID-JBM6>3.0.CO;2-D
   Devin JE, 1996, J BIOMAT SCI-POLYM E, V7, P661, DOI 10.1163/156856296X00435
   DIAMOND MS, 1994, CURR BIOL, V4, P506, DOI 10.1016/S0960-9822(00)00111-1
   DSOUZA SE, 1988, SCIENCE, V242, P91, DOI 10.1126/science.3262922
   El-Amin SF, 2002, J ORTHOPAED RES, V20, P20, DOI 10.1016/S0736-0266(01)00062-6
   ELGENDY HM, 1993, BIOMATERIALS, V14, P263, DOI 10.1016/0142-9612(93)90116-J
   FAULL RJ, 1995, STEM CELLS, V13, P38, DOI 10.1002/stem.5530130106
   Goldstein AS, 1999, TISSUE ENG, V5, P421, DOI 10.1089/ten.1999.5.421
   Gronowicz G, 1996, J ORTHOPAED RES, V14, P878, DOI 10.1002/jor.1100140606
   HUGHES DE, 1993, J BONE MINER RES, V8, P527
   Ibim SEM, 1997, BIOMATERIALS, V18, P1565, DOI 10.1016/S0142-9612(97)00099-9
   Jackson D W, 1999, Clin Orthop Relat Res, pS31, DOI 10.1097/00003086-199910001-00005
   KAMATA T, 1994, J BIOL CHEM, V269, P26006
   Lanza R. P., 1997, PRINCIPLES TISSUE EN
   Laurencin CT, 1996, J BIOMED MATER RES, V30, P133, DOI 10.1002/(SICI)1097-4636(199602)30:2<133::AID-JBM1>3.0.CO;2-S
   Laurencin CT, 1998, CELLS MAT, V8, P175
   LAURENCIN CT, 1992, POLYM ADVAN TECHNOL, V3, P359
   Mould AP, 1996, J CELL SCI, V109, P2613
   Norman Maria E., 1994, Clinical Materials, V17, P85, DOI 10.1016/0267-6605(94)90016-7
   Peter SJ, 1998, J BIOMED MATER RES, V43, P422, DOI 10.1002/(SICI)1097-4636(199824)43:4<422::AID-JBM9>3.3.CO;2-T
   PIERSCHBACHER MD, 1987, J BIOL CHEM, V262, P17294
   PIERSCHBACHER MD, 1984, P NATL ACAD SCI-BIOL, V81, P5985, DOI 10.1073/pnas.81.19.5985
   PUELO DA, 1991, BONE, V12, P271
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Shah AK, 1999, BIOL CELL, V91, P131, DOI 10.1016/S0248-4900(99)80037-9
   Sinha RK, 1996, BONE, V18, P451, DOI 10.1016/8756-3282(96)00044-0
   Zhang RY, 1999, J BIOMED MATER RES, V45, P285
NR 31
TC 15
Z9 15
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-921X
J9 CLIN ORTHOP RELAT R
JI Clin. Orthop. Rel. Res.
PD OCT
PY 2004
IS 427
BP 220
EP 225
DI 10.1097/01.blo.0000137556.51604.0c
PG 6
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 861NC
UT WOS:000224422500035
PM 15552161
DA 2018-10-19
ER

PT J
AU Mucalo, MR
   Foster, DL
AF Mucalo, MR
   Foster, DL
TI A method for avoiding the xanthoproteic-associated discolouration in
   reprecipitated (nitric-acid-digested) hydroxyapatite prepared from
   mammalian bone tissue
SO CROATICA CHEMICA ACTA
LA English
DT Article
DE hydroxyapatite; mammalian bone; pyrolysis; reprecipitation;
   xanthoproteic discolouration; biomedical
ID ANIMAL-DERIVED BONE; BIOMEDICAL APPLICATIONS; YIELD MATERIALS
AB A procedure for producing kilogram quantities of a biornedically suitable reprecipitated hydroxyapatite (HAp) powder, which is free of the xanthoproteic-associated discolouration caused by nitric acid interaction with the protein content in bones during digestion, has been developed. Essentially bones were defatted by boiling and then pyrolysed at 1000 degreesC to burn off the collagenous proteins and produce flakey bleached bones. This bone was then crushed and ground and digested in nitric acid solution to produce digest solutions free of the highly staining orange colouration normally associated with nitric acid digestions of bone material.. Finely divided, white solids could then be reprecipitated as usual from the digests by addition of NaOH solution under a nitrogen atmosphere with heating and stirring at 70 degreesC of the precipitate to enable its maturation into an HAp phase. The products derived from this procedure were characterised using spectroscopic, microscopic and particle sizing techniques. These analyses showed the resultant powders to be low crystallinity hydroxyapatite of consistent morphology and which possessed either acceptably low or below detection limit levels of heavy metals so rendering it as a potentially valuable source of powder for biomedical applications such as plasma spraying or for implant or prosthesis manufacture.
C1 Univ Waikato, Dept Chem, Hamilton, New Zealand.
RP Mucalo, MR (reprint author), Univ Waikato, Dept Chem, Private Bag 3105, Hamilton, New Zealand.
EM m.mucalo@waikato.ac.nz
RI Mucalo, Michael/E-5263-2013
OI Mucalo, Michael/0000-0002-7655-9885
CR ABDELFATTAH WI, 1993, THERMOCHIM ACTA, V218, P465, DOI 10.1016/0040-6031(93)80445-G
   Aoki H, 1994, MED APPL HYDROXYAPAT
   DOWKER SEP, 1979, CALCIFIED TISSUE INT, V29, P177, DOI 10.1007/BF02408075
   EGIAZAROV GM, 1961, VOEN MED ZH, P34
   JOBLING A, 1983, P 36 UPGR WAST FEEDS, P183
   Johnson GS, 2000, J MATER SCI-MATER M, V11, P427, DOI 10.1023/A:1008987908917
   Johnson GS, 2000, J MATER SCI-MATER M, V11, P725, DOI 10.1023/A:1008979929632
   LINDHOLM TS, 2002, ADV SKELETAL RECONST
   Mucalo MR, 2003, KEY ENG MAT, V240-2, P427, DOI 10.4028/www.scientific.net/KEM.240-242.427
   TAYLOR DM, 1991, DEV BIOLOGICALS, V75, P97
   TILLMANS J, 1928, BIOCHEM Z, P198
NR 11
TC 1
Z9 1
U1 0
U2 2
PU CROATIAN CHEMICAL SOC
PI ZAGREB
PA MARULICEV TRG 19/II, 41001 ZAGREB, CROATIA
SN 0011-1643
J9 CROAT CHEM ACTA
JI Croat. Chem. Acta
PD OCT
PY 2004
VL 77
IS 3
BP 509
EP 517
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA 870KM
UT WOS:000225056000014
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Reynolds, MM
   Frost, MC
   Meyerhoff, ME
AF Reynolds, MM
   Frost, MC
   Meyerhoff, ME
TI Nitric oxide-releasing hydrophobic polymers: Preparation,
   characterization, and potential biomedical applications
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Review
DE nitric oxide; polymers; biocompatibility; thromboresistant; controlled
   release; diazeniumdiolates; nitrosothiols; free radicals
ID CONTROLLED BIOLOGICAL RELEASE; IN-VIVO EVALUATION; NITROGEN(II) OXIDE;
   CHEMICAL SENSORS; AQUEOUS-SOLUTION; RELAXING FACTOR; DIETHYLAMINE;
   ENDOTHELIUM; THROMBORESISTANT; IDENTIFICATION
AB The synthetic methods used recently in this laboratory to prepare a variety of novel nitric oxide (NO)-releasing hydrophobic polymers are reviewed. Nitric oxide is a well known inhibitor of platelet adhesion and activation. Thus, such NO release polymers have potential applications as thromboresistant coatings for a large number of blood-contacting biomedical devices (e.g., in vivo sensors, arteriovenous grafts, stents, catheters, extracorporeal circuits). The approaches taken to prepare NO releasing poly(vinyl chloride) (PVC), silicone rubber (SR), polymethacrylate (PM), and polyurethane (PU) materials are grouped into three categories: (1) dispersion/doping of discrete diazenium-diolated molecules within the polymeric films; (2) chemical derivatization of polymeric filler microparticles (e.g., silicon dioxide, titanium dioxide) to possess NO release chemistry and then their dispersion within the hydrophobic polymers; and (3) covalent attachment of NO release moieties to polymer backbones. Specific chemical examples of each of these approaches are summarized and the advantages and disadvantages of each are discussed. Other related work in the field of NO release polymers is also cited. It is further shown that several of the NO-releasing polymeric materials already prepared exhibit the expected improved thromboresistivity when tested in vivo using appropriate animal models. (C) 2004 Elsevier Inc. All rights reserved.
C1 Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.
RP Meyerhoff, ME (reprint author), Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.
EM mmeyerho@umich.edu
CR Annich GM, 2000, CRIT CARE MED, V28, P915, DOI 10.1097/00003246-200004000-00001
   Batchelor MM, 2003, J MED CHEM, V46, P5153, DOI 10.1021/jm030286t
   COLEMAN RW, 1993, CARDIOVASC PATHOL, V2, pS23
   Davies KM, 2001, J AM CHEM SOC, V123, P5473, DOI 10.1021/ja002899q
   DIODATI JG, 1993, THROMB HAEMOSTASIS, V70, P654
   DRAGO RS, 1960, J AM CHEM SOC, V82, P96, DOI 10.1021/ja01486a021
   DRAGO RS, 1961, J AM CHEM SOC, V83, P1819, DOI 10.1021/ja01469a012
   DRAGO RS, 1961, J AM CHEM SOC, V83, P4337, DOI 10.1021/ja01482a008
   DRAGO RS, 1962, ADV CHEM SER, V36, P143
   Fleming I, 1995, Adv Pharmacol, V34, P187
   FLESER PS, UNPUB NITRIC OXIDE R
   Frost MC, 2004, J AM CHEM SOC, V126, P1348, DOI 10.1021/ja039466i
   Frost MC, 2003, MICROCHEM J, V74, P277, DOI 10.1016/S0026-265X(03)00033-X
   Frost MC, 2002, ANAL CHEM, V74, P5942, DOI 10.1021/ac025944g
   Frost MC, 2002, CURR OPIN CHEM BIOL, V6, P633, DOI 10.1016/S1367-5931(02)00371-X
   Furchgott RF, 1999, BIOSCIENCE REP, V19, P235, DOI 10.1023/A:1020537506008
   Gagliardi S, 2001, PHYSICA B, V301, P110, DOI 10.1016/S0921-4526(01)00520-8
   GOLDSTEIN S, 1995, J AM CHEM SOC, V117, P12078, DOI 10.1021/ja00154a007
   Gries A, 1998, CIRCULATION, V97, P1481
   Hampl V, 1996, METHODS NITRIC OXIDE, P309
   HRABIE JA, 1993, J ORG CHEM, V58, P1472, DOI 10.1021/jo00058a030
   Karim A, 2000, POLYMER, V41, P8455, DOI 10.1016/S0032-3861(00)00245-7
   LIJINSKY W, 1994, NITROSOAMINES RELATE, P250
   Majerus PW, 1990, PHARMACOL BASIS THER, P1311
   MARAGOS CM, 1991, J MED CHEM, V34, P3242, DOI 10.1021/jm00115a013
   MARLETTA M A, 1990, Biofactors, V2, P219
   MONCADA S, 1988, BIOCHEM PHARMACOL, V37, P2495, DOI 10.1016/0006-2952(88)90236-5
   MONCADA S, 1991, CARDIOVASC PHARM, V17, pS1
   Mowery KA, 2000, BIOMATERIALS, V21, P9, DOI 10.1016/S0142-9612(99)00127-1
   OH BK, 2003, J AM CHEM SOC, V125, P552
   Parzuchowski PG, 2002, J AM CHEM SOC, V124, P12182, DOI 10.1021/ja020268l
   RADOMSKI MW, 1987, BIOCHEM BIOPH RES CO, V148, P1482, DOI 10.1016/S0006-291X(87)80299-1
   RAGSDALE RO, 1965, INORG CHEM, V4, P420, DOI 10.1021/ic50025a038
   Saavedra JE, 1999, J ORG CHEM, V64, P5124, DOI 10.1021/jo9901539
   Schoenfisch MH, 2000, ANAL CHEM, V72, P1119, DOI 10.1021/ac991370c
   Smith DJ, 1996, J MED CHEM, V39, P1148, DOI 10.1021/jm950652b
   TELTINGDIAZ M, 1994, ANAL CHEM, V66, P576, DOI 10.1021/ac00076a025
   Vaughn MW, 1998, AM J PHYSIOL-HEART C, V274, pH1705, DOI 10.1152/ajpheart.1998.274.5.H1705
   Vaughn MW, 1998, AM J PHYSIOL-HEART C, V274, pH2163, DOI 10.1152/ajpheart.1998.274.6.H2163
   WEN J, 1999, ADHESIVES SEALAN AUG
   Williams DLH, 1999, ACCOUNTS CHEM RES, V32, P869, DOI 10.1021/ar9800439
   Zhang HP, 2003, J AM CHEM SOC, V125, P5015, DOI 10.1021/ja0291538
   Zhang HP, 2002, BIOMATERIALS, V23, P1485, DOI 10.1016/S0142-9612(01)00274-5
NR 43
TC 71
Z9 74
U1 6
U2 60
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0891-5849
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD OCT 1
PY 2004
VL 37
IS 7
BP 926
EP 936
DI 10.1016/j.freeradbiomed.2004.06.019
PG 11
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 855YX
UT WOS:000224011900003
PM 15336308
DA 2018-10-19
ER

PT J
AU Tanaka, T
   Montanari, GC
   Mulhaupt, R
AF Tanaka, T
   Montanari, GC
   Mulhaupt, R
TI Polymer nanocomposites as dielectrics and electrical
   insulation-perspectives for processing technologies, material
   characterization and future applications
SO IEEE TRANSACTIONS ON DIELECTRICS AND ELECTRICAL INSULATION
LA English
DT Article
DE nanocomposite; polymer nanocomposite; nanofillers; advanced materials;
   dielectrics; electrical insulation
ID MECHANICAL-PROPERTIES; LAYERED SILICATES; EPOXY-RESINS; MORPHOLOGY;
   FUNCTIONALITY; BEHAVIOR; ETHENE; RUBBER
AB Polymer nanocomposites are defined as polymers in which small amounts of nanometer size fillers are homogeneously dispersed by only several weight percentages. Addition of just a few weight percent of the nano-fillers has profound impact on the physical, chemical, mechanical and electrical properties of polymers. Such change is often favorable for engineering purpose. This nanocomposite technology has emerged from the field of engineering plastics, and potentially expanded its application to structural materials, coatings, and packaging to medical/biomedical products, and electronic and photonic devices. Recently these 'hi-tech' materials with excellent properties have begun to attract research people in the field of dielectrics and electrical insulation. Since new properties are brought about from the interactions of nanofillers with polymer matrices, mesoscopic properties are expected to come out, which would be interesting to both scientists and engineers. Improved characteristics are expected as dielectrics and electrical insulation. Several interesting results to indicate foreseeable future have been revealed, some of which are described on materials and processing in the paper together with basic concepts and future direction.
C1 Waseda Univ, Grad Sch Informat Prod & Syst LSI, Kitakyushu, Fukuoka 8080135, Japan.
   Univ Bologna, Dept Elect Engn, High Voltage & Mat Engn Lab, I-40136 Bologna, Italy.
   Univ Freiburg, Inst Macromol Chem, D-7904 Freiburg, Germany.
RP Tanaka, T (reprint author), Waseda Univ, Grad Sch Informat Prod & Syst LSI, 2-7 Hibikino, Kitakyushu, Fukuoka 8080135, Japan.
CR Becker O, 2003, MACROMOLECULES, V36, P1616, DOI 10.1021/ma0213448
   Berndt H, 1996, MICROPOROUS MATER, V6, P1, DOI 10.1016/0927-6513(95)00092-5
   Brinker C. J., 1990, SOL GEL SCI
   Cao Y., 2003, IEEE C EL INS DIEL P, P116
   Chang S, 2000, CERAM ENG SCI P, V21, P653
   CHUJO K, 2002, TECHNOLOGICAL TRENDS, P1
   CHUJO K, 2001, ADV TECHNOLOGY APPL, P1
   Dietsche F, 2000, J APPL POLYM SCI, V75, P396, DOI 10.1002/(SICI)1097-4628(20000118)75:3<396::AID-APP9>3.0.CO;2-E
   Frechette M., 2001, IEEE C EL INS DIEL P, P92
   Ganter M, 2001, RUBBER CHEM TECHNOL, V74, P221, DOI 10.5254/1.3544946
   GILMAN JW, 1999, P NEW ADV FLAM RET T
   Heinemann J, 1999, MACROMOL RAPID COMM, V20, P423, DOI 10.1002/(SICI)1521-3927(19990801)20:8<423::AID-MARC423>3.0.CO;2-N
   HUBER D, 1998, INTERFACIAL ASPECTS
   IMAI T, 2002, IEEE INT S EL INS IS, P379
   Irwin P. C., 2003, IEEE C EL INS DIEL P, P120
   Kozak M., 2003, IEEE C EL INS DIEL P, P75
   Ladouce-Stelandre L, 2003, RUBBER CHEM TECHNOL, V76, P145, DOI 10.5254/1.3547730
   LAN L, 2003, P 8 ISH DELFT, P4
   LEWIS TJ, 1994, IEEE T DIELECT EL IN, V1, P812, DOI 10.1109/94.326653
   Muh E, 2001, ADV FUNCT MATER, V11, P425, DOI 10.1002/1616-3028(200112)11:6<425::AID-ADFM425>3.0.CO;2-0
   Mulhaupt R, 2001, KUNSTST-PLAST EUR, V91, P178
   MULHAUPT R, 2001, PLAST EUROPE, V91, P63
   Nelson J. K., 2003, IEEE C EL INS DIEL P, P719
   Nelson J. K., 2002, IEEE C EL INS DIEL P, P295
   Pernot H, 2002, NAT MATER, V1, P54, DOI 10.1038/nmat711
   Ray SS, 2003, PROG POLYM SCI, V28, P1539, DOI 10.1016/j.progpolymsci.2003.08.002
   Reichert P, 2000, MACROMOL MATER ENG, V275, P8, DOI 10.1002/(SICI)1439-2054(20000201)275:1<8::AID-MAME8>3.0.CO;2-6
   Sternstein SS, 2002, MACROMOLECULES, V35, P7262, DOI 10.1021/ma020482u
   SUN LM, 1994, POLYM J, V26, P939, DOI 10.1295/polymj.26.939
   TAKEZAWA Y, 2004, NAT CONV IEE JAP, P1
   TAKEZAWA Y, 2003, IEEE 7 ICPADM, P1146
   Tsuchida A, 1997, MACROMOLECULES, V30, P2818, DOI 10.1021/ma960846g
   Yin Y., 2003, IEEE 7 INT C PROP AP, P913
   YIN Y, 2003, IEEE 7 ICPADM NAG, P575
   Zanetti M, 2001, POLYMER, V42, P4501, DOI 10.1016/S0032-3861(00)00775-8
   ZHANG MY, 2003, IEEE 7 ICPADM NAG, P753
   ZHANG P, 2003, IEEE 7 ICPADM NAG, P1138
   Zilg C, 1999, MACROMOL CHEM PHYSIC, V200, P661, DOI 10.1002/(SICI)1521-3935(19990301)200:3<661::AID-MACP661>3.3.CO;2-W
   Zilg C, 2000, MACROMOL MATER ENG, V280, P41, DOI 10.1002/1439-2054(20000801)280:1<41::AID-MAME41>3.0.CO;2-Z
   Zilg C., 2003, IEEE C EL INS DIEL P, P546
NR 40
TC 509
Z9 543
U1 4
U2 143
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 1070-9878
J9 IEEE T DIELECT EL IN
JI IEEE Trns. Dielectr. Electr. Insul.
PD OCT
PY 2004
VL 11
IS 5
SI SI
BP 763
EP 784
DI 10.1109/TDEI.2004.1349782
PG 22
WC Engineering, Electrical & Electronic; Physics, Applied
SC Engineering; Physics
GA 862KQ
UT WOS:000224490000004
DA 2018-10-19
ER

PT J
AU Ellis, G
   Marco, C
   Gomez, M
AF Ellis, G
   Marco, C
   Gomez, M
TI Highly resolved transmission infrared microscopy in polymer science
SO INFRARED PHYSICS & TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT Interantional Workshop on the Infrared Microscopy and Spectroscopy with
   Accelerator-Bases Sources
CY JUL 08-11, 2003
CL Lake Tahoe, CA
DE synchrotron infrared microscopy; polymer; morphology; composite
ID SYNCHROTRON LIGHT-SOURCE; ISOTACTIC POLYPROPYLENE MELTS; BIOMEDICAL
   APPLICATIONS; IR SPECTROSCOPY; FT-IR; MICROSPECTROSCOPY; RADIATION;
   RESOLUTION; MORPHOLOGY; SPECTROMICROSCOPY
AB Over the last few years, the use of synchrotron-based IR sources for high-resolution microspectroscopy has been a subject of great interest. The special characteristics of synchrotron radiation allow one to obtain high quality IR spectra at high spatial resolution using commercial grade IR microscopes situated at IR beamlines. The application of this technique to the study of polymeric materials is discussed, with examples from a series of heterogeneous polymeric materials, which include polymer blends and fibre-reinforced polymer composites, from studies undertaken at the MIRAGE Beamline, LURE, Paris, France. (C) 2004 Elsevier B.V. All rights reserved.
C1 CSIC, Dept Fis & Ingn, Inst Ciencia & Tecnol Polimeros, E-28006 Madrid, Spain.
RP Ellis, G (reprint author), CSIC, Dept Fis & Ingn, Inst Ciencia & Tecnol Polimeros, C-Juan Cierva 3, E-28006 Madrid, Spain.
EM gary@ictp.csic.es
RI GOMEZ-FATOU RODRIGUEZ, MARIAN/C-9900-2012; Ellis, Gary/C-1617-2010
OI GOMEZ-FATOU RODRIGUEZ, MARIAN/0000-0002-0212-0634; Ellis,
   Gary/0000-0003-4851-6092
CR Abbe E., 1873, ARCH MIKROSK ANAT, V9, P413, DOI DOI 10.1007/BF02956173
   ADE H, 1993, SCIENCE, V262, P1427, DOI 10.1126/science.262.5138.1427
   ADE H, 1992, SCIENCE, V258, P972, DOI 10.1126/science.1439809
   ADE H, 2002, CHEM APPL SYNCHROTRO
   Anderson MS, 2002, REV SCI INSTRUM, V73, P1198, DOI 10.1063/1.1445864
   BADGER RM, 1951, REV SCI INSTRUM, V22, P935, DOI 10.1063/1.1745832
   Bailey JA, 2000, APPL SPECTROSC, V54, P159, DOI 10.1366/0003702001949122
   Bantignies J.-L., 1998, International Journal of Cosmetic Science, V20, P381, DOI 10.1046/j.1467-2494.1998.177055.x
   Bantignies JL, 2000, J COSMET SCI, V51, P73
   Bantignies JL, 1997, P SOC PHOTO-OPT INS, V3153, P125
   BERGIN FJ, 1989, APPL SPECTROSC, V43, P511, DOI 10.1366/0003702894202797
   BLOUNT ER, 1951, J OPT SOC AM, V51, P547
   Bouchon P, 2001, J FOOD SCI, V66, P918, DOI 10.1111/j.1365-2621.2001.tb08212.x
   BOWER DI, 1989, VIB SPECTROSC, P165
   Bozec L, 2001, J APPL PHYS, V90, P5159, DOI 10.1063/1.1403671
   CARR GL, 1995, REV SCI INSTRUM, V66, P1643, DOI 10.1063/1.1145870
   CARR GL, 1995, REV SCI INSTRUM, V66, P1490, DOI 10.1063/1.1145951
   Carr GL, 1998, NUOVO CIMENTO D, V20, P375, DOI 10.1007/BF03185537
   Carr GL, 2001, REV SCI INSTRUM, V72, P1613, DOI 10.1063/1.1347965
   Carr GL, 1999, VIB SPECTROSC, V19, P53, DOI 10.1016/S0924-2031(98)00048-4
   CARR GL, 1998, SYNCHR RAD NEWS, V11, P31
   CHALMERS JM, 1995, MACROMOL SYMP, V94, P33, DOI 10.1002/masy.19950940105
   Chalmers JM, 1998, ANALYST, V123, P579, DOI 10.1039/a707070e
   Cossy-Favre A, 1998, MACROMOLECULES, V31, P4957, DOI 10.1021/ma980029b
   Cricenti A, 2000, APPL SURF SCI, V162, P275, DOI 10.1016/S0169-4332(00)00204-X
   DINSMORE HL, 1959, SPECTROCHIM ACTA, V12, P1025
   Dumas P, 2000, ANALUSIS, V28, P68, DOI 10.1051/analusis:2000280068
   Dumas P, 2003, J BIOL PHYS, V29, P201, DOI 10.1023/A:1024448910761
   Dumas P., 2002, ADV SER PHYS CHEM A, V12A, P356
   DUNCAN WD, 1983, APPL OPTICS, V22, P2914, DOI 10.1364/AO.22.002914
   EGERTON RF, 1996, ELECT ENERGY LOSS SP
   Ellis G, 2004, J MACROMOL SCI PHYS, VB43, P253, DOI [10.1081/MB-120027762, 10.1018/MB-120027762]
   Ellis G, 2004, J MACROMOL SCI PHYS, VB43, P191, DOI [10.1018/MB-120027758, 10.1081/MB-120027758]
   Ellis G, 2002, MACROMOL SYMP, V184, P37, DOI 10.1002/1521-3900(200208)184:1<37::AID-MASY37>3.0.CO;2-4
   ELLIS G, 2001, INT J VIBR SPECTROSC, V5, P7
   ELLIS GFR, UNPUB
   Geller JT, 2000, J CONTAM HYDROL, V43, P63, DOI 10.1016/S0169-7722(99)00095-9
   Glerup M, 2002, SPECTROCHIM ACTA A, V58, P129, DOI 10.1016/S1386-1425(01)00516-9
   Guilhaumou N, 1998, APPL SPECTROSC, V52, P1029, DOI 10.1366/0003702981944797
   HALADA GP, 2001, P ELECTROCHEM SOC, V5, P149
   Hammiche A, 1999, APPL SPECTROSC, V53, P810, DOI 10.1366/0003702991947379
   HARTHCOCK MA, 1986, APPL SPECTROSC, V40, P210, DOI 10.1366/0003702864509529
   Hemley RJ, 1998, NUOVO CIMENTO D, V20, P539, DOI 10.1007/BF03185547
   Hitchcock AP, 2001, J SYNCHROTRON RADIAT, V8, P66, DOI 10.1107/S0909049500016447
   Holman HN, 2000, BIOPOLYMERS, V57, P329
   Holman HYN, 1999, GEOMICROBIOL J, V16, P307, DOI 10.1080/014904599270569
   Horiuchi S, 2003, J ELECTRON MICROSC, V52, P255, DOI 10.1093/jmicro/52.3.255
   HOULT R, 2002, INT J VIBR SPECTROSC, V6, P4
   HUMECKI HJ, 1996, PRACTICAL SPECTROSCO, V19
   Jackson M, 1997, J MOL STRUCT, V408, P105, DOI 10.1016/S0022-2860(96)09461-6
   Jamin N, 1998, P NATL ACAD SCI USA, V95, P4837, DOI 10.1073/pnas.95.9.4837
   KATON JE, 1994, VIB SPECTROSC, V7, P201, DOI 10.1016/0924-2031(94)85012-7
   KIELMANN F, 2002, VIB SPECTROSC, V29, P109
   KILCOYNE ALD, 2001, ALS NEWS         FAL
   Knoll B, 1999, NATURE, V399, P134, DOI 10.1038/20154
   Kreplak L, 2001, Int J Cosmet Sci, V23, P369, DOI 10.1046/j.0412-5463.2001.00118.x
   KRISHNAN K, 1990, FTIR MICROSAMPLING T, pCH3
   Lahrech A, 1996, OPT LETT, V21, P1315, DOI 10.1364/OL.21.001315
   Liu Z, 2002, J PHYS-CONDENS MAT, V14, P10641, DOI 10.1088/0953-8984/14/44/349
   Lotz B, 1996, POLYMER, V37, P4979, DOI 10.1016/0032-3861(96)00370-9
   Lustiger A, 1995, J ADHESION, V53, P1, DOI 10.1080/00218469508014368
   Marco C, 1997, J APPL POLYM SCI, V65, P2665, DOI 10.1002/(SICI)1097-4628(19970926)65:13<2665::AID-APP8>3.0.CO;2-9
   Marco C, 2002, J APPL POLYM SCI, V84, P1669, DOI 10.1002/app.10546
   Marco C, 2002, RECENT RES DEV APPL, V1, P587
   MESSERSCHMIDT RG, 1988, PRACTICAL SPECTROSCO, V6
   Michaels CA, 2000, J APPL PHYS, V88, P4832, DOI 10.1063/1.1309034
   Miller LM, 2002, REV SCI INSTRUM, V73, P1357, DOI 10.1063/1.1435824
   Miller LM, 2003, J BIOL PHYS, V29, P219, DOI 10.1023/A:1024401027599
   Miller LM, 2002, VIB SPECTROSC, V28, P159, DOI 10.1016/S0924-2031(01)00154-0
   Miyazawa T., 1964, J POLYM SCI C, V7, P59
   NEDKOV E, 2002, E-POLYMERS, V42, P1
   NORTON DR, 1985, POLYMER, V26, P704, DOI 10.1016/0032-3861(85)90108-9
   PARK C, 2004, NANOTECHNOLOGY, V14, pL11
   Piot O, 2001, J CEREAL SCI, V34, P191, DOI 10.1006/jcrs.2001.0391
   Polack F, 1999, P SOC PHOTO-OPT INS, V3775, P13, DOI 10.1117/12.366647
   Ratner B. D., 1998, ACS S SERIES, V694
   Raynal PI, 2000, PLANET SPACE SCI, V48, P1329, DOI 10.1016/S0032-0633(00)00113-6
   REFFNER JA, 1995, REV SCI INSTRUM, V66, P1298, DOI 10.1063/1.1145958
   REFFNER JA, 1997, MIKROCHIM ACTA S, V14, P339
   SCHMIDT PG, 1963, J POLYM SCI PART A, V1, P2317, DOI 10.1002/pol.1963.100010709
   Smith AP, 1996, APPL PHYS LETT, V69, P3833, DOI 10.1063/1.117120
   Smith DA, 1995, ULTRAMICROSCOPY, V61, P247
   Snively CM, 1999, J POLYM SCI POL PHYS, V37, P2353, DOI 10.1002/(SICI)1099-0488(19990901)37:17<2353::AID-POLB6>3.0.CO;2-Y
   Stohr J., 1996, NEXAFS SPECTROSCOPY, V25
   THEODORE K, 2001, PLANTA, V213, P881
   Tisinger LG, 2002, APPL SPECTROSC, V56, P1397, DOI 10.1366/00037020260377689
   Tordjeman P, 2001, EUR PHYS J E, V4, P459, DOI 10.1007/s101890170101
   Turrell G., 1996, RAMAN MICROSCOPY DEV
   Varga J, 1996, J POLYM SCI POL PHYS, V34, P657, DOI 10.1002/(SICI)1099-0488(199603)34:4<657::AID-POLB6>3.0.CO;2-N
   Varga J., 1995, POLYPROPYLENE STRUCT, VI, P56
   Varlot K, 1999, POLYMER, V40, P5691, DOI 10.1016/S0032-3861(98)00782-4
   Varlot K, 1997, ULTRAMICROSCOPY, V68, P123, DOI 10.1016/S0304-3991(97)00019-3
   WEIR CE, 1959, J RES NBS A PHYS CH, V63, P55, DOI 10.6028/jres.063A.003
   Wetzel DL, 1999, SCIENCE, V285, P1224, DOI 10.1126/science.285.5431.1224
   Wetzel DL, 2003, VIB SPECTROSC, V31, P109, DOI 10.1016/S0924-2031(02)00100-5
   Wilkinson TJ, 2002, APPL SPECTROSC, V56, P800, DOI 10.1366/000370202760076875
   WILKINSON TJ, 2001, ABSTR PAP AM CHEM S, V222, P36
   WILKINSON TJ, 2001, ABSTR PAP AM CHEM S, V223, P78
   WILLIAMS GP, 1982, NUCL INSTRUM METHODS, V195, P383, DOI 10.1016/0029-554X(82)90805-9
   Wu CM, 1999, POLYMER, V40, P4195, DOI 10.1016/S0032-3861(98)00682-X
   Wu CM, 1998, POLYM BULL, V41, P493, DOI 10.1007/s002890050392
   Zhang X, 2001, J ELECTROCHEM SOC, V148, pA463, DOI 10.1149/1.1362541
NR 102
TC 23
Z9 23
U1 0
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1350-4495
J9 INFRARED PHYS TECHN
JI Infrared Phys. Technol.
PD OCT
PY 2004
VL 45
IS 5-6
BP 349
EP 364
DI 10.1016/j.infrared.2004.01.015
PG 16
WC Instruments & Instrumentation; Optics; Physics, Applied
SC Instruments & Instrumentation; Optics; Physics
GA 848WT
UT WOS:000223499500005
DA 2018-10-19
ER

PT J
AU Morrison, ML
   Buchanan, RA
   Peker, A
   Peter, WH
   Horton, JA
   Liaw, PK
AF Morrison, ML
   Buchanan, RA
   Peker, A
   Peter, WH
   Horton, JA
   Liaw, PK
TI Cyclic- anodic-polarization studies of a Zr41.2Ti13.8Ni10Cu12.5Be22.5
   bulk metallic glass
SO INTERMETALLICS
LA English
DT Article; Proceedings Paper
CT 3rd International Conference on Bulk Metallic Glasses
CY OCT 12-16, 2003
CL Beijing, PEOPLES R CHINA
DE corrosion; glasses, metallic; biomedical applications
ID CORROSION BEHAVIOR; MECHANICAL-PROPERTIES; SUPERCOOLED LIQUID;
   FRACTURE-TOUGHNESS; FATIGUE BEHAVIOR; AMORPHOUS-ALLOYS; DEFORMATION;
   SUPERPLASTICITY; ZR55AL10CU30NI5; MICROSTRUCTURE
AB Cyclic-anodic-polarization tests were conducted on a Zr-based bulk metallic glass (BMG) with a chemical composition of Zr41.2Ti13.8Ni10Cu12.5Be22.5 [Liquidmetal-001, LM-001 (at.%)]. Samples were compared in two different electrolytes at two different temperatures.. Tests were conducted at 22 and 37 degreesC in both, an aerated 0.6 M NaCl electrolyte and a phosphate-buffered saline (PBS) electrolyte with a physiologically relevant dissolved oxygen content. For all tested conditions, the alloy demonstrated passive behavior at the open-circuit potential with low corrosion rates. However, a susceptibility to localized pitting corrosion was observed in all of the tested conditions. At both temperatures, statistical analyses revealed that the LM-001 BMG exhibited comparable or improved values for every corrosion parameter in the PBS electrolyte, as compared to the NaCl electrolyte. The mean differences between the protection potentials and the open-circuit corrosion potentials were determined to be positive values with greater magnitudes for the PBS electrolyte. Thus, the material may undergo pitting corrosion at surface flaws or after incubation-time periods, depending on the local and bulk environments, with lower probabilities for the PBS electrolyte. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA.
   Liquidmet Technol, Lake Forest, CA 92630 USA.
   Oak Ridge Natl Lab, Div Met & Ceram, Oak Ridge, TN 37831 USA.
RP Morrison, ML (reprint author), Univ Tennessee, Dept Mat Sci & Engn, 434 Dougherty Engn Bldg, Knoxville, TN 37996 USA.
EM mmorrison@utk.edu
RI BAI, JIE/D-7448-2016
OI Morrison, Mark/0000-0003-1956-0932
CR Bian Z, 2000, SCRIPTA MATER, V43, P1003, DOI 10.1016/S1359-6462(00)00524-8
   Chieh TC, 2003, MATER LETT, V57, P3022, DOI 10.1016/S0167-577X(02)01424-6
   Flores KM, 1999, SCRIPTA MATER, V41, P937, DOI 10.1016/S1359-6462(99)00243-2
   Gilbert CJ, 1997, APPL PHYS LETT, V71, P476, DOI 10.1063/1.119610
   Hays CC, 2000, PHYS REV LETT, V84, P2901, DOI 10.1103/PhysRevLett.84.2901
   He G, 2001, MATER TRANS, V42, P1109, DOI 10.2320/matertrans.42.1109
   HENCH LL, 1975, ADV BIOMED ENG, V5, P35
   Hiromoto S, 2002, J ELECTROCHEM SOC, V149, pB117, DOI 10.1149/1.1456921
   Hiromoto S, 2001, MATER TRANS, V42, P656, DOI 10.2320/matertrans.42.656
   Inoue A, 1999, MAT SCI ENG A-STRUCT, V267, P171, DOI 10.1016/S0921-5093(99)00089-1
   Inoue A, 1999, MATER T JIM, V40, P1382, DOI 10.2320/matertrans1989.40.1382
   INOUE A, 1994, MATER T JIM, V35, P85, DOI 10.2320/matertrans1989.35.85
   Inoue A, 1997, MATER SCI FORUM, V243-2, P197
   INOUE A, 1995, MATER T JIM, V36, P689, DOI 10.2320/matertrans1989.36.689
   Inoue A, 1996, MATER T JIM, V37, P1726, DOI 10.2320/matertrans1989.37.1726
   Kawamura Y, 1996, APPL PHYS LETT, V69, P1208, DOI 10.1063/1.117413
   Kawamura Y, 1997, SCRIPTA MATER, V37, P431, DOI 10.1016/S1359-6462(97)00105-X
   Kawamura Y, 1998, ACTA MATER, V46, P253, DOI 10.1016/S1359-6454(97)00235-8
   Koster U, 2001, SCRIPTA MATER, V44, P1649, DOI 10.1016/S1359-6462(01)00875-2
   Pang SJ, 2003, J MATER RES, V18, P1652, DOI 10.1557/JMR.2003.0227
   PECKER A, 1993, APPL PHYS LETT, V63, P2342
   Peter WH, 2003, J NON-CRYST SOLIDS, V317, P187, DOI 10.1016/S0022-3093(02)02009-4
   Peter WH, 2002, INTERMETALLICS, V10, P1157, DOI 10.1016/S0966-9795(02)00130-9
   Peter WH, 2002, INTERMETALLICS, V10, P1125, DOI 10.1016/S0966-9795(02)00152-8
   Schneibel JH, 2001, METALL MATER TRANS A, V32, P2819, DOI 10.1007/s11661-001-1032-7
   Schroeder V, 1998, SCRIPTA MATER, V38, P1481, DOI 10.1016/S1359-6462(98)00089-X
   Stansbury E. E., 2000, FUNDAMENTALS ELECTRO
   Vaidyanathan R, 2001, ACTA MATER, V49, P3781, DOI 10.1016/S1359-6454(01)00263-4
   Wang C, 2002, ACTA METALL SIN, V38, P765
NR 29
TC 61
Z9 66
U1 1
U2 25
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0966-9795
J9 INTERMETALLICS
JI Intermetallics
PD OCT-NOV
PY 2004
VL 12
IS 10-11
BP 1177
EP 1181
DI 10.1016/j.intermet.2004.04.005
PG 5
WC Chemistry, Physical; Materials Science, Multidisciplinary; Metallurgy &
   Metallurgical Engineering
SC Chemistry; Materials Science; Metallurgy & Metallurgical Engineering
GA 863MT
UT WOS:000224566700024
DA 2018-10-19
ER

PT J
AU Gomes, ME
   Reis, RL
AF Gomes, ME
   Reis, RL
TI Biodegradable polymers and composites in biomedical applications: from
   catgut to tissue engineering - Part 1 - Available systems and their
   properties
SO INTERNATIONAL MATERIALS REVIEWS
LA English
DT Review
DE biodegradable polymers; natural polymers; synthetic polymers; biomedical
   applications; biocompatibility; degradation
ID STARCH-BASED POLYMERS; IN-VITRO DEGRADATION; CALCIUM-PHOSPHATE
   FORMATION; BIOACTIVE GLASS-CERAMICS; CRUCIATE LIGAMENT RECONSTRUCTION;
   SYNTHETIC ABSORBABLE SUTURE; DRUG-DELIVERY SYSTEMS; SIMULATED
   BODY-FLUID; GEL-PREPARED SILICA; ULTRA-HIGH-STRENGTH
AB Biodegradable polymers form a unique class of materials that created an entirely new concept when originally proposed as biomaterials. That is, for the first time, a material performing a structural application was designed to be completely resorbed and to become weaker over time. This concept was first applied successfully with catgut sutures and later, with more arguable results, on bone fixation plates and pins. Current research on new and improved biodegradable polymers is focused on more sophisticated biomedical applications to solve patients' problems with higher efficacy and the least possible pain. One example is tissue engineering, in which a biodegradable scaffold seeded with an appropriate cell type provides a substitute for damaged human tissue while the natural process of regeneration is completed. An overview is given of the degradation properties and mechanisms of biodegradable polymers, their processability and biocompatibility, focusing on the aspects most relevant to biomedical applications. The main families of biodegradable polymeric systems are described and the systems that are commercially available or that are currently being studied and proposed for specific medical applications are reviewed.
C1 Univ Minho, 3Bs Res Grp, P-4710057 Braga, Portugal.
   Univ Minho, Dept Polymer Engn, P-4810058 Guimaraes, Portugal.
RP Reis, RL (reprint author), Univ Minho, 3Bs Res Grp, Campus Gualtar, P-4710057 Braga, Portugal.
EM rgreis@dep.uminho.pt
RI Group, 3Bs/E-4374-2012; Reis, Rui L./A-8938-2008; Gomes,
   Manuela/B-6282-2009
OI Group, 3Bs/0000-0002-5195-3456; Reis, Rui L./0000-0002-4295-6129; Gomes,
   Manuela/0000-0002-2036-6291
CR ABE Y, 1990, J MATER SCI-MATER M, V1, P233, DOI 10.1007/BF00701082
   Aggarwal N, 1999, CAN J VET RES, V63, P148
   Agrawal C M, 1995, Tissue Eng, V1, P241, DOI 10.1089/ten.1995.1.241
   Agrawal CM, 1997, MATER SCI FORUM, V250, P115, DOI 10.4028/www.scientific.net/MSF.250.115
   AIZAWA M, 1995, J CERAM SOC JPN, V103, P992, DOI 10.2109/jcersj.103.992
   ALLOCK HR, 1990, BIODEGRADABLE POLYM, P163
   An YHH, 1997, J MATER SCI-MATER M, V8, P493, DOI 10.1023/A:1018530327291
   ANDRIANO KP, 1993, J APPL BIOMATER, V4, P1, DOI 10.1002/jab.770040102
   Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   ANTIKAINEN T, 1994, PEDIATR NEUROSURG, V21, P77, DOI 10.1159/000120819
   BANNON BP, 1983, 796 STP, P7
   Barbucci R, 2000, J INORG BIOCHEM, V81, P229, DOI 10.1016/S0162-0134(00)00127-6
   BARTHOLOMEW RS, 1981, OPHTHALMOLOGICA, V183, P81, DOI 10.1159/000309144
   Benahmed M, 1996, BIOMATERIALS, V17, P2173, DOI 10.1016/0142-9612(96)00046-4
   Blanco MD, 2000, INT J PHARM, V202, P29, DOI 10.1016/S0378-5173(00)00408-7
   BOEREE NR, 1993, BIOMATERIALS, V14, P793, DOI 10.1016/0142-9612(93)90046-5
   BONFIELD W, 1987, J BIOMECH, V20, P1071, DOI 10.1016/0021-9290(87)90025-X
   BOS RRM, 1987, J ORAL MAXIL SURG, V45, P751, DOI 10.1016/0278-2391(87)90194-7
   BOS RRM, 1988, IMPL MAT BIOFUNCT, V8, P245
   BROWN SA, 1990, CLIN IMPL MAT, V9, P123
   BUCHOLZ RW, 1994, J BONE JOINT SURG AM, V76A, P319, DOI 10.2106/00004623-199403000-00001
   BURKERSRODA F, 2002, BIOMATERIALS, V23, P4221, DOI DOI 10.1016/S0142-9612(02)00170-9
   Calandrelli L, 2000, POLYMER, V41, P8027, DOI 10.1016/S0032-3861(00)00165-8
   Campoccia D, 1998, BIOMATERIALS, V19, P2101, DOI 10.1016/S0142-9612(98)00042-8
   CASCONE MG, 1993, CYTOTECHNOLOGY, V11, P137, DOI 10.1007/BF00746079
   Chen GP, 2000, ADV MATER, V12, P455, DOI 10.1002/(SICI)1521-4095(200003)12:6<455::AID-ADMA455>3.0.CO;2-C
   Chen GP, 2000, J BIOMED MATER RES, V51, P273, DOI 10.1002/(SICI)1097-4636(200008)51:2<273::AID-JBM16>3.0.CO;2-O
   CHESMEL K, 1999, BIOMATERIALS, V20, P342
   Cho SB, 1996, J BIOMED MATER RES, V33, P145, DOI 10.1002/(SICI)1097-4636(199623)33:3<145::AID-JBM4>3.0.CO;2-Q
   Choueka J, 1996, J BIOMED MATER RES, V31, P35, DOI 10.1002/(SICI)1097-4636(199605)31:1<35::AID-JBM5>3.0.CO;2-R
   Ciapetti G, 1998, J BIOMED MATER RES, V39, P286, DOI 10.1002/(SICI)1097-4636(199802)39:2<286::AID-JBM16>3.0.CO;2-B
   CLAES L, 1990, ADV BIOMAT, V9, P161
   CLEMENS JAM, 1995, THESIS U LEIDEN
   DAMINK LHHO, 1995, J BIOMED MATER RES, V29, P149, DOI 10.1002/jbm.820290203
   de Mestral F., 1989, Journal of the European Ceramic Society, V5, P47, DOI 10.1016/0955-2219(89)90008-3
   DEKKER A, 1994, CELL MATER, V4, P101
   DELECRIN J, 1994, CELL MATER, V4, P51
   DelGuerra RS, 1996, J MATER SCI-MATER M, V7, P8, DOI 10.1007/BF00121182
   DelGuerra RS, 1995, J MATER SCI-MATER M, V6, P824
   Dewez JL, 1999, BIOMATERIALS, V20, P547, DOI 10.1016/S0142-9612(98)00207-5
   Dobkowski J, 1999, J BIOMED MATER RES, V47, P234, DOI 10.1002/(SICI)1097-4636(199911)47:2<234::AID-JBM14>3.0.CO;2-X
   Doddi N., 1977, United States Patent, DOI 4,052,988, Patent No. 4052988
   Du C, 2002, BIOMATERIALS, V23, P4649, DOI 10.1016/S0142-9612(02)00214-4
   Dubois JC, 1999, BIOMATERIALS, V20, P1841, DOI 10.1016/S0142-9612(99)00082-4
   DUNN MG, 1992, AM J SPORT MED, V20, P507, DOI 10.1177/036354659202000504
   DUNN MG, 1993, J BIOMED MATER RES, V27, P1545, DOI 10.1002/jbm.820271211
   Dvir-Ginzberg M, 2003, TISSUE ENG, V9, P757, DOI 10.1089/107632703768247430
   El-Hadi A, 2002, POLYM TEST, V21, P665, DOI 10.1016/S0142-9418(01)00142-8
   Elvira C, 2002, BIOMATERIALS, V23, P1955, DOI 10.1016/S0142-9612(01)00322-2
   Espigares I, 2002, BIOMATERIALS, V23, P1883, DOI 10.1016/S0142-9612(01)00315-5
   Filho OP, 1996, J BIOMED MATER RES, V30, P509
   FIORDELISO J, 1994, J BIOMAT SCI-POLYM E, V5, P497
   Fu BX, 2002, POLYMER, V43, P5527, DOI 10.1016/S0032-3861(02)00389-0
   FUZUZAKI H, 1991, J BIOMED MATER RES, V25, P315
   Gomes ME, 2001, BIOMATERIALS, V22, P1911, DOI 10.1016/S0142-9612(00)00377-X
   Gomes ME, 2004, INT MATER REV, V49, P274, DOI 10.1179/095066004225021927
   Gomes ME, 2003, J BIOMED MATER RES A, V67A, P87, DOI 10.1002/jbm.a.10075
   Gomes ME, 2001, BIOMATERIALS, V22, P883, DOI 10.1016/S0142-9612(00)00211-8
   Gomes ME, 2002, MAT SCI ENG C-BIO S, V20, P19, DOI 10.1016/S0928-4931(02)00008-5
   Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3
   HANEIN D, 1995, CELL MATER, V5, P197
   Hanks CT, 1996, DENT MATER, V12, P186, DOI 10.1016/S0109-5641(96)80020-0
   Hanson Stephen, 1996, P215
   HATA K, 1995, J AM CERAM SOC, V78, P1049, DOI 10.1111/j.1151-2916.1995.tb08435.x
   HAYASHI T, 1994, PROG POLYM SCI, V19, P663, DOI 10.1016/0079-6700(94)90030-2
   He S, 2001, POLYMER, V42, P1251, DOI 10.1016/S0032-3861(00)00479-1
   HE S, 2000, BIOMATERIALS, V20, P2389
   HENCH LL, 1991, MRS BULL, V16, P62
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HIGASHI S, 1986, BIOMATERIALS, V7, P183, DOI 10.1016/0142-9612(86)90099-2
   HOLLAND SJ, 1990, BIOMATERIALS, V11, P206, DOI 10.1016/0142-9612(90)90157-L
   HOSSAINY SFA, 1994, BIOMATERIALS, V15, P921, DOI 10.1016/0142-9612(94)90118-X
   Huang J, 1997, J MATER SCI-MATER M, V8, P775, DOI 10.1023/A:1018516813604
   Huang J., 1997, J MATER SCI-MATER M, V8, P808
   IBNABDDJALIL M, 1994, J BIOMED MATER RES, V28, P289, DOI 10.1002/jbm.820280303
   IRTEL SI, 1994, J BIOMED MATER RES, V28, P919
   Karlsson JO, 1997, POLYMER, V38, P4727, DOI 10.1016/S0032-3861(96)01075-0
   Kas HS, 1997, J MICROENCAPSUL, V14, P689, DOI 10.3109/02652049709006820
   KELLER TS, 1990, J ORTHOPAED RES, V8, P592, DOI 10.1002/jor.1100080416
   Khor HL, 2002, MAT SCI ENG C-BIO S, V20, P71, DOI 10.1016/S0928-4931(02)00015-2
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Kirkpatrick CJ, 1998, P I MECH ENG H, V212, P75, DOI 10.1243/0954411981533845
   KIRKPATRICK CJ, 1990, J MATER SCI-MATER M, V1, P9, DOI 10.1007/BF00705347
   KIRKPATRICK CJ, 1992, ADV BIOMATER, V10, P53
   KIRKPATRICK J, 1998, MED DEVICE TECHNOL, V9, P22
   KNOWLES JC, 1992, BIOMATERIALS, V13, P491, DOI 10.1016/0142-9612(92)90099-A
   KOBAYASHI H, 1992, J BIOMED MATER RES, V26, P1463, DOI 10.1002/jbm.820261106
   KOBAYASHI H, 1992, J BIOMED MATER RES, V26, P1583, DOI 10.1002/jbm.820261205
   KOBAYASHI H, 1991, BIOMATERIALS, V12, P747, DOI 10.1016/0142-9612(91)90024-5
   KOHN J, 1987, J AM CHEM SOC, V109, P817, DOI 10.1021/ja00237a030
   KOHN J, 1996, BIOMATERIALS SCI, V64
   KOKUBO T, 1990, J NON-CRYST SOLIDS, V120, P138, DOI 10.1016/0022-3093(90)90199-V
   KOKUBO T, 1986, J MATER SCI, V21, P536, DOI 10.1007/BF01145520
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   KOKUBO T, 1995, EUR J SOL STATE INOR, V32, P819
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   Kokubo T, 1991, BIOCERAMICS, V4, P113
   KOOTEN TG, 1997, J MATER SCI-MATER M, V8, P835
   Koskikare K, 1996, J BIOMED MATER RES, V30, P417, DOI 10.1002/jbm.820300402
   Kunze C, 2003, BIOMATERIALS, V24, P967, DOI 10.1016/S0142-9612(02)00433-7
   Kuo CK, 2001, BIOMATERIALS, V22, P511, DOI 10.1016/S0142-9612(00)00201-5
   Kurisawa M, 1997, J BIOMAT SCI-POLYM E, V8, P691, DOI 10.1163/156856297X00506
   Kweon H, 2003, BIOMATERIALS, V24, P801, DOI 10.1016/S0142-9612(02)00370-8
   LAITINEN O, 1993, ARCH ORTHOP TRAUM SU, V112, P270, DOI 10.1007/BF00452963
   Langer R, 1999, J CONTROL RELEASE, V62, P7, DOI 10.1016/S0168-3659(99)00057-7
   LANGER R, 1999, SCI AM, V280, P62
   Lee JY, 2002, J CONTROL RELEASE, V78, P187, DOI 10.1016/S0168-3659(01)00498-9
   LEONOR IB, 2002, J MATER SCI-MATER M, V13, P1
   LEONOR IB, 2002, J MATER SCI-MATER M, V13, P935
   Li P, 1997, J BIOMED MATER RES, V34, P79, DOI 10.1002/(SICI)1097-4636(199701)34:1<79::AID-JBM11>3.0.CO;2-K
   LI P, 1992, J MATER SCI-MATER M, V3, P452, DOI 10.1007/BF00701242
   LI PJ, 1995, J BIOMED MATER RES, V29, P325, DOI 10.1002/jbm.820290307
   LI PJ, 1994, J NON-CRYST SOLIDS, V168, P281, DOI 10.1016/0022-3093(94)90340-9
   LI PJ, 1993, J BIOMED MATER RES, V27, P1495, DOI 10.1002/jbm.820271205
   Li SH, 1997, BIOMATERIALS, V18, P389, DOI 10.1016/S0142-9612(96)00122-6
   Li SH, 1996, J MATER SCI LETT, V15, P1882, DOI 10.1007/BF00264085
   LIN H, 1992, J BIOMED MATER RES, V26, P7
   Lin HR, 2003, MATER SCI FORUM, V426-4, P3043, DOI 10.4028/www.scientific.net/MSF.426-432.3043
   LITSKY AS, 1993, J APPL BIOMATER, V4, P109, DOI 10.1002/jab.770040116
   Liu Q, 1998, J MATER SCI-MATER M, V9, P23, DOI 10.1023/A:1008826410395
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Makela P, 2002, BIOMATERIALS, V23, P2587, DOI 10.1016/S0142-9612(01)00396-9
   Malafaya PB, 2001, J BIOMAT SCI-POLYM E, V12, P1227, DOI 10.1163/156856201753395761
   MALAFAYA PB, 2003, BIOCERAMICS, V240, P39
   MANNINEN MJ, 1993, J MATER SCI-MATER M, V4, P179, DOI 10.1007/BF00120389
   Maquet V, 1997, MATER SCI FORUM, V250, P15, DOI 10.4028/www.scientific.net/MSF.250.15
   Marijnissen WJCM, 2002, BIOMATERIALS, V23, P1511, DOI 10.1016/S0142-9612(01)00281-2
   Mark C., 1990, BIODEGRADABLE POLYM, P71
   Marois Y, 2000, J BIOMED MATER RES, V49, P216, DOI 10.1002/(SICI)1097-4636(200002)49:2<216::AID-JBM9>3.0.CO;2-X
   Marques AP, 2003, J MATER SCI-MATER M, V14, P167, DOI 10.1023/A:1022028114896
   Marques AP, 2002, BIOMATERIALS, V23, P1471, DOI 10.1016/S0142-9612(01)00272-1
   MARTIN RB, 1989, STRUCTURE FUNCTION A
   Mendes SC, 2001, BIOMATERIALS, V22, P2057, DOI 10.1016/S0142-9612(00)00395-1
   Mendes SC, 2003, TISSUE ENG, V9, pS91, DOI 10.1089/10763270360697003
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   MIDDLETON JC, 1998, MED PLAST BIOMAT MAR, P30
   MOLIU D, 1994, J MATER SCI-MATER M, V5, P7
   NAGAI M, 1991, PHOSPHORUS RES B, V1, P167
   Nguyen NC, 1997, J MATER SCI-MATER M, V8, P473, DOI 10.1023/A:1018574109544
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   Ogawa Y, 1997, J BIOMAT SCI-POLYM E, V8, P391, DOI 10.1163/156856297X00173
   Oliva A, 1998, BIOMATERIALS, V19, P1019, DOI 10.1016/S0142-9612(97)00249-4
   Oliveira AL, 1999, J MATER SCI-MATER M, V10, P827, DOI 10.1023/A:1008900428325
   OLIVEIRA JM, 1995, BIOMATERIALS, V16, P849, DOI 10.1016/0142-9612(95)94146-C
   OONISHI H, 1991, BIOMATERIALS, V12, P171, DOI 10.1016/0142-9612(91)90196-H
   Pachence JM, 1997, PRINCIPLES TISSUE EN, P273
   Park DJ, 2000, ANN OTO RHINOL LARYN, V109, P1157, DOI 10.1177/000348940010901214
   PENICHECOVAS C, 1995, POLYM INT, V38, P45, DOI 10.1002/pi.1995.210380105
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   PEREGO G, 1994, BIOMATERIALS, V15, P189, DOI 10.1016/0142-9612(94)90066-3
   Pereira CS, 1998, J MATER SCI-MATER M, V9, P825, DOI 10.1023/A:1008944127971
   PILLIAR RM, 1984, NATO ASI SER, P97
   PIZZOFERRATO A, 1992, ADV BIOMAT, V10, P63
   Pizzoferrato Arturo, 1994, Clinical Materials, V15, P173, DOI 10.1016/0267-6605(94)90081-7
   Poustis J., 1994, Clinical Materials, V16, P119, DOI 10.1016/0267-6605(94)90106-6
   Prestwich GD, 1998, J CONTROL RELEASE, V53, P93, DOI 10.1016/S0168-3659(97)00242-3
   Radder AM, 1996, J BIOMED MATER RES, V30, P341
   RADDER AM, 1994, J BIOMED MATER RES, V28, P141, DOI 10.1002/jbm.820280202
   RAO JK, 1994, BIOMATERIALS, V15, P5
   Ratner BD, 1997, NATO ADV SCI I E-APP, V346, P453
   RATNER BD, 1989, COMPREHENSIVE POLYM, V7, P201
   Rawlings Rees D., 1993, Clinical Materials, V14, P155, DOI 10.1016/0267-6605(93)90038-9
   RAY JA, 1981, SURG GYNECOL OBSTET, V153, P497
   Reis R.L., 2000, J APPL MED POLYM, V4, P1
   Reis RL, 1995, J MATER SCI-MATER M, V6, P786, DOI 10.1007/BF00134318
   Reis RL, 1997, ADV POLYM TECH, V16, P263, DOI 10.1002/(SICI)1098-2329(199711)16:4<263::AID-ADV2>3.0.CO;2-T
   Reis RL, 1996, POLYM ADVAN TECHNOL, V7, P784, DOI 10.1002/(SICI)1099-1581(199610)7:10<784::AID-PAT585>3.0.CO;2-1
   Reis RL, 1997, POLYM INT, V43, P347
   Reis RL, 1997, J MATER SCI-MATER M, V8, P897, DOI 10.1023/A:1018514107669
   REIS RL, 1998, J APPL MED POLYM, V2, P49
   REY C, 1990, Biomaterials, V11, P13
   Richards RG, 1995, CELL BIOL INT, V19, P1015, DOI 10.1006/cbir.1995.1044
   Rizvi Azam H., 1994, Clinical Materials, V16, P73, DOI 10.1016/0267-6605(94)90100-7
   Roessler M, 2000, J BIOMED MATER RES, V53, P167, DOI 10.1002/(SICI)1097-4636(2000)53:2<167::AID-JBM6>3.3.CO;2-A
   ROKKANEN PU, 1991, ANN MED, V23, P109, DOI 10.3109/07853899109148033
   ROVIRA A, 1993, J MATER SCI-MATER M, V4, P372, DOI 10.1007/BF00122195
   RUIJGROK JM, 1993, THESIS U LEIDEN NETH
   Sahlin JJ, 1997, J BIOMAT SCI-POLYM E, V8, P421, DOI 10.1163/156856297X00362
   Salgado AJ, 2002, MAT SCI ENG C-BIO S, V20, P27, DOI 10.1016/S0928-4931(02)00009-7
   SANTOS JD, 1994, BIOMATERIALS, V15, P5, DOI 10.1016/0142-9612(94)90188-0
   SANTOS JD, 1994, BIOCERAMICS, V7, P243
   SANTOS JD, 1995, J MATER SCI-MATER M, V6, P448
   SARTI B, 1995, BIOMATERIALS, V16, P785, DOI 10.1016/0142-9612(95)99641-X
   SAWADA Y, 1994, BRIT J PLAST SURG, V47, P158, DOI 10.1016/0007-1226(94)90046-9
   Schwarte LM, 1998, POLYMER, V39, P6057, DOI 10.1016/S0032-3861(98)00087-1
   SGOURAS D, 1990, J MATER SCI-MATER M, V1, P61, DOI 10.1007/BF00839070
   SHALABY SW, 1995, J APPL BIOMATER, V6, P219, DOI 10.1002/jab.770060313
   SILVA RM, 2003, BIOCERAMICS, V240
   SLIEDREGT A, 1993, THESIS U LEIDEN NETH
   Solchaga LA, 1999, J ORTHOPAED RES, V17, P205, DOI 10.1002/jor.1100170209
   Solchaga LA, 2000, INT CONGR SER, V1196, P233
   SOUEIDAN A, 1995, CELL MATER, V5, P31
   Sousa RA, 2002, POLYM ENG SCI, V42, P1032, DOI 10.1002/pen.11010
   Sousa RA, 2000, J APPL POLYM SCI, V77, P1303, DOI 10.1002/1097-4628(20000808)77:6<1303::AID-APP15>3.0.CO;2-1
   STOHELIN A, 1995, MED PLASTICS, V9, P8
   STRNAD Z, 1992, BIOMATERIALS, V13, P317, DOI 10.1016/0142-9612(92)90056-T
   TANAHASHI M, 1994, J AM CERAM SOC, V77, P2805, DOI 10.1111/j.1151-2916.1994.tb04508.x
   TANAHASHI M, 1995, J MATER SCI-MATER M, V6, P319, DOI 10.1007/BF00120299
   TATEISHI T, 1992, ADV BIOMAT, V10, P89
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Thomson R. C., 1995, ADV POLYM SCI, V122, P247
   TORMALA P, 1991, J BIOMED MATER RES, V25, P1, DOI 10.1002/jbm.820250102
   TORMALA P, 1993, CLIN MATER, V13, P35, DOI 10.1016/0267-6605(93)90087-N
   TORMALA P, 1992, Clinical Materials, V10, P29, DOI 10.1016/0267-6605(92)90081-4
   TORMALA P, 1990, Patent No. 4968317
   TORMALA P, 1988, Patent No. 4743257
   UNYI T, 1995, KEY ENG MATER, V103, P221, DOI 10.4028/www.scientific.net/KEM.103.221
   VAINIONPAA S, 1989, PROG POLYM SCI, V14, P679, DOI 10.1016/0079-6700(89)90013-0
   VAINIONPAA S, 1992, CLIN MAT, V9, P77
   VANBLITTERSWIJK CA, 1993, CELL MATER, V3, P11
   VASENIUS J, 1993, J BIOMED MATER RES, V26, P14
   Vasudev SC, 1997, BIOMATERIALS, V18, P375, DOI 10.1016/S0142-9612(96)00131-7
   Vaz CM, 2002, BIOMATERIALS, V23, P629, DOI 10.1016/S0142-9612(01)00150-8
   VERHEYEN CCPM, 1993, J BIOMED MATER RES, V27, P433, DOI 10.1002/jbm.820270404
   Wake MC, 1998, BIOMATERIALS, V19, P1255
   WALLIN R, 1995, MED DEVICE TECHNOL, P34
   WANG RZ, 1995, J MATER SCI LETT, V14, P490, DOI 10.1007/BF00665911
   WILLIAMS D F, 1992, Clinical Materials, V10, P9, DOI 10.1016/0267-6605(92)90078-8
   Williams D.F., 1992, ADV BIOMATER, V10, P525
   Xiao YL, 1999, J MATER SCI-MATER M, V10, P773, DOI 10.1023/A:1008946832443
   Yamada S, 1997, BIOMATERIALS, V18, P1037, DOI 10.1016/S0142-9612(97)00036-7
   Yamamoto A, 1998, BIOMATERIALS, V19, P871, DOI 10.1016/S0142-9612(97)00248-2
   Yamamoto A, 2000, J BIOMED MATER RES, V50, P114, DOI 10.1002/(SICI)1097-4636(200005)50:2<114::AID-JBM4>3.3.CO;2-Y
   YAO KD, 1995, POLYM INT, V38, P77, DOI 10.1002/pi.1995.210380110
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P2127, DOI 10.1016/0142-9612(96)00008-7
   Yoon JS, 1999, POLYMER, V40, P2303, DOI 10.1016/S0032-3861(98)00463-7
   YUEHUEI A, 1997, J MATER SCI-MATER M, V8, P493
   Zein I, 2002, BIOMATERIALS, V23, P1169, DOI 10.1016/S0142-9612(01)00232-0
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
   Zmora S, 2002, BIOMATERIALS, V23, P4087, DOI 10.1016/S0142-9612(02)00146-1
NR 231
TC 60
Z9 61
U1 0
U2 47
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 0950-6608
J9 INT MATER REV
JI Int. Mater. Rev.
PD OCT
PY 2004
VL 49
IS 5
BP 261
EP 273
DI 10.1179/095066004225021918
PG 13
WC Materials Science, Multidisciplinary
SC Materials Science
GA 866RJ
UT WOS:000224790300001
DA 2018-10-19
ER

PT J
AU Gomes, ME
   Reis, RL
AF Gomes, ME
   Reis, RL
TI Biodegradable polymers and composites in biomedical applications: from
   catgut to tissue engineering - Part 2 - Systems for temporary
   replacement and advanced tissue regeneration
SO INTERNATIONAL MATERIALS REVIEWS
LA English
DT Review
DE tissue engineering; biomaterials; biodegradable polymers; scaffolds;
   temporary applications
ID DRUG-DELIVERY SYSTEMS; POROUS POLYESTERURETHANE FOAM; IN-VITRO RELEASE;
   CELL-ADHESION; MECHANICAL-PROPERTIES; DEGRADATION-PRODUCTS; ORTHOPEDIC
   DEVICES; FIBER STRUCTURES; SEEDING DENSITY; BONE-CEMENT
AB During the past century, and particularly in the past three decades, the application of conventional materials technology has resulted in clear advances in substitution medicine. For example, the development of artificial hips and knees have brought enormous benefits to patients. However, there are still no materials available that can adequately replace or aid the regeneration of functional tissues such as bones or large bone segments. In an increasingly aging population, malfunction or loss of tissue from injury or disease has led to reduced quality of life for many patients at significant socio-economic cost. There is thus demand for the development of new therapies through a multidisciplinary, biology driven approach in which biological tissues are engineered using both materials and bio-technologies. Tissue engineering has created a new field of application for biodegradable polymers, paving the way for the development of new classes of biomaterials from synthetic or natural origin and for the design of new materials formats for hybrid tissues. A general overview is provided of the main applications of biodegradable polymers in medicine, with particular emphasis on tissue engineering. The approaches available to tissue engineers and the requirements scaffold materials must fulfil to promote adequate interaction with cells and tissues are described; predictable trends and future developments are discussed. Processing routes for biodegradable polymeric scaffolds are also considered, presenting examples of three-dimensional materials fabricated by different methodologies.
C1 Univ Minho, 3Bs Res Grp, P-4710057 Braga, Portugal.
   Univ Minho, Dept Polymer Engn, P-4810058 Guimaraes, Portugal.
RP Reis, RL (reprint author), Univ Minho, 3Bs Res Grp, Campus Gualtar, P-4710057 Braga, Portugal.
EM rgreis@dep.uminho.pt
RI Gomes, Manuela/B-6282-2009; Reis, Rui L./A-8938-2008; Group,
   3Bs/E-4374-2012
OI Gomes, Manuela/0000-0002-2036-6291; Reis, Rui L./0000-0002-4295-6129;
   Group, 3Bs/0000-0002-5195-3456
CR Agrawal CM, 2000, BIOMATERIALS, V21, P2443, DOI 10.1016/S0142-9612(00)00112-5
   Agrawal CM, 1997, MATER SCI FORUM, V250, P115, DOI 10.4028/www.scientific.net/MSF.250.115
   Aigner J, 1998, J BIOMED MATER RES, V42, P172, DOI 10.1002/(SICI)1097-4636(199811)42:2<172::AID-JBM2>3.0.CO;2-M
   AMINABHAVI TM, 1990, POLYM-PLAST TECHNOL, V29, P235, DOI 10.1080/03602559008049843
   Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   BERSCHT PC, 1995, J MATER SCI-MATER M, V6, P201, DOI 10.1007/BF00146856
   BRAYBROOK JH, 1990, PROG POLYM SCI, V15, P715, DOI 10.1016/0079-6700(90)90009-P
   BREM H, 1994, J NEUROSURG, V80, P283, DOI 10.3171/jns.1994.80.2.0283
   BRONDSTED H, 1991, BIOMATERIALS, V12, P584, DOI 10.1016/0142-9612(91)90056-G
   BRUDER SP, 2000, PRINCIPLES TISSUE EN, V683
   BUCHOLZ RW, 1994, J BONE JOINT SURG AM, V76A, P319, DOI 10.2106/00004623-199403000-00001
   Bures P, 2001, J CONTROL RELEASE, V72, P25, DOI 10.1016/S0168-3659(01)00259-0
   Byrne ME, 2002, ADV DRUG DELIVER REV, V54, P149, DOI 10.1016/S0169-409X(01)00246-0
   Chapekar MS, 2000, J BIOMED MATER RES, V53, P617, DOI 10.1002/1097-4636(2000)53:6<617::AID-JBM1>3.3.CO;2-3
   Chen GP, 2000, ADV MATER, V12, P455, DOI 10.1002/(SICI)1521-4095(200003)12:6<455::AID-ADMA455>3.0.CO;2-C
   Chen GP, 2000, J BIOMED MATER RES, V51, P273, DOI 10.1002/(SICI)1097-4636(200008)51:2<273::AID-JBM16>3.0.CO;2-O
   CHESMEL K, 1999, BIOMATERIALS, V20, P342
   CHU CR, 1995, J BIOMED MATER RES, V29, P1147, DOI 10.1002/jbm.820290915
   Coombes AGA, 1997, BIOMATERIALS, V18, P1153, DOI 10.1016/S0142-9612(97)00051-3
   Dee KC, 1996, BIOTECHNOL BIOENG, V50, P438, DOI 10.1002/(SICI)1097-0290(19960520)50:4<438::AID-BIT11>3.0.CO;2-F
   Di Silvio L., 1994, Clinical Materials, V16, P91, DOI 10.1016/0267-6605(94)90102-3
   Dobkowski J, 1999, J BIOMED MATER RES, V47, P234, DOI 10.1002/(SICI)1097-4636(199911)47:2<234::AID-JBM14>3.0.CO;2-X
   Dubois JC, 1999, BIOMATERIALS, V20, P1841, DOI 10.1016/S0142-9612(99)00082-4
   Freed LE, 1998, ADV DRUG DELIVER REV, V33, P15, DOI 10.1016/S0169-409X(98)00017-9
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Freed LE, 1998, EXP CELL RES, V240, P58, DOI 10.1006/excr.1998.4010
   Gao JM, 1998, J BIOMED MATER RES, V42, P417, DOI 10.1002/(SICI)1097-4636(19981205)42:3<417::AID-JBM11>3.3.CO;2-N
   Gomes M., 2002, J APPL MED POLYM, V6, P75
   Gomes ME, 2001, BIOMATERIALS, V22, P1911, DOI 10.1016/S0142-9612(00)00377-X
   Gomes ME, 2003, J BIOMED MATER RES A, V67A, P87, DOI 10.1002/jbm.a.10075
   Gomes ME, 2001, BIOMATERIALS, V22, P883, DOI 10.1016/S0142-9612(00)00211-8
   Gomes ME, 2002, MAT SCI ENG C-BIO S, V20, P19, DOI 10.1016/S0928-4931(02)00008-5
   Guidoin MF, 2000, BIOMATERIALS, V21, P2461, DOI 10.1016/S0142-9612(00)00114-9
   Gutsche AT, 1996, BIOMATERIALS, V17, P387, DOI 10.1016/0142-9612(96)85577-3
   HAYASHI T, 1994, PROG POLYM SCI, V19, P663, DOI 10.1016/0079-6700(94)90030-2
   He SL, 2000, BIOMATERIALS, V21, P2389, DOI 10.1016/S0142-9612(00)00106-X
   HELLER J, 1990, BIOMATERIALS, V11, P345, DOI 10.1016/0142-9612(90)90112-4
   HENCH LL, 1991, MRS BULL, V16, P62
   Holder WD, 1998, J BIOMED MATER RES, V41, P412, DOI 10.1002/(SICI)1097-4636(19980905)41:3<412::AID-JBM11>3.0.CO;2-K
   Holy CE, 2000, J BIOMED MATER RES, V51, P376, DOI 10.1002/1097-4636(20000905)51:3<376::AID-JBM11>3.0.CO;2-G
   HUNT JA, 1992, J MATER SCI-MATER M, V3, P160, DOI 10.1007/BF00713443
   Hutmacher D W, 2000, Med Device Technol, V11, P33
   Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.3.CO;2-Z
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   HUTMACHER DW, 2002, NATO ASI, V333
   HUTMACHER DW, 2002, 313 NATO ASI
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Ito Y, 1997, BIOMATERIALS, V18, P197, DOI 10.1016/S0142-9612(96)00119-6
   IWAMOTO M, 1993, EXP CELL RES, V207, P413, DOI 10.1006/excr.1993.1209
   Jiang GW, 1998, J BIOMED MATER RES, V43, P77, DOI 10.1002/(SICI)1097-4636(199821)43:1<77::AID-JBM9>3.0.CO;2-J
   Jones DA, 1996, BIOMATERIALS, V17, P337, DOI 10.1016/0142-9612(96)85572-4
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Kim HD, 1998, TISSUE ENG, V4, P35, DOI 10.1089/ten.1998.4.35
   King TW, 2000, J BIOMED MATER RES, V51, P383, DOI 10.1002/1097-4636(20000905)51:3<383::AID-JBM12>3.0.CO;2-D
   KOSE GT, 2002, TISSUE ENG BIODEGRAD, V301
   Kumar MNVR, 2000, J PHARM PHARM SCI, V3, P234
   Langer K, 1997, INT J PHARM, V158, P211, DOI 10.1016/S0378-5173(97)00256-1
   Langer R, 1999, J CONTROL RELEASE, V62, P7, DOI 10.1016/S0168-3659(99)00057-7
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Langer RS, 1999, SCI AM, V280, P86, DOI 10.1038/scientificamerican0499-86
   LANGER RS, 1981, BIOMATERIALS, V2, P201, DOI 10.1016/0142-9612(81)90059-4
   Laurencin CT, 1996, J BIOMED MATER RES, V30, P133, DOI 10.1002/(SICI)1097-4636(199602)30:2<133::AID-JBM1>3.0.CO;2-S
   Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19
   Li Y, 2001, BIOMATERIALS, V22, P609, DOI 10.1016/S0142-9612(00)00224-6
   Lin HR, 2002, J BIOMED MATER RES, V63, P271, DOI 10.1002/jbm.10183
   LITSKY AS, 1993, J APPL BIOMATER, V4, P109, DOI 10.1002/jab.770040116
   Lu L, 2000, BIOMATERIALS, V21, P1837, DOI 10.1016/S0142-9612(00)00047-8
   Malafaya PB, 2001, J BIOMAT SCI-POLYM E, V12, P1227, DOI 10.1163/156856201753395761
   MANNINEN MJ, 1993, J MATER SCI-MATER M, V4, P179, DOI 10.1007/BF00120389
   Maquet V, 1997, MATER SCI FORUM, V250, P15, DOI 10.4028/www.scientific.net/MSF.250.15
   Martin I, 2001, J BIOMED MATER RES, V55, P229, DOI 10.1002/1097-4636(200105)55:2<229::AID-JBM1009>3.3.CO;2-H
   Mendes SC, 2003, TISSUE ENG, V9, pS91, DOI 10.1089/10763270360697003
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   MIKOS AG, 1993, BIOMATERIALS, V14, P323, DOI 10.1016/0142-9612(93)90049-8
   MIKOS AG, 1993, J BIOMED MATER RES, V27, P183, DOI 10.1002/jbm.820270207
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   Minuth WW, 1998, CELL TISSUE RES, V291, P1
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Mooney DJ, 1999, SCI AM, V280, P60, DOI 10.1038/scientificamerican0499-60
   MOONEY DJ, 1995, J BIOMED MATER RES, V29, P959, DOI 10.1002/jbm.820290807
   Murphy WL, 2000, J BIOMED MATER RES, V50, P50, DOI 10.1002/(SICI)1097-4636(200004)50:1<50::AID-JBM8>3.0.CO;2-F
   Narasimhan B, 1997, J PHARM SCI, V86, P297, DOI 10.1021/js960372z
   Nguyen NC, 1997, J MATER SCI-MATER M, V8, P473, DOI 10.1023/A:1018574109544
   Nitsch M J, 1994, J Biomater Appl, V8, P247, DOI 10.1177/088532829400800305
   Ogawa Y, 1997, J BIOMAT SCI-POLYM E, V8, P391, DOI 10.1163/156856297X00173
   Ooya T, 1997, J BIOMAT SCI-POLYM E, V8, P437, DOI 10.1163/156856297X00371
   Patrick CW, 1999, TISSUE ENG, V5, P139, DOI 10.1089/ten.1999.5.139
   PEPPAS NA, 1987, J PHARM SCI, V76, P267, DOI 10.1002/jps.2600760319
   PEREGO G, 1994, BIOMATERIALS, V15, P189, DOI 10.1016/0142-9612(94)90066-3
   Poustis J., 1994, Clinical Materials, V16, P119, DOI 10.1016/0267-6605(94)90106-6
   RIVARD CH, 1995, J APPL BIOMATER, V6, P65, DOI 10.1002/jab.770060109
   Rotter N, 1998, J BIOMED MATER RES, V42, P347, DOI 10.1002/(SICI)1097-4636(19981205)42:3<347::AID-JBM2>3.0.CO;2-J
   Saad B, 1998, J BIOMED MATER RES, V39, P594, DOI 10.1002/(SICI)1097-4636(19980315)39:4<594::AID-JBM14>3.0.CO;2-7
   Saad B, 1996, J BIOMED MATER RES, V32, P355
   SAWADA Y, 1994, BRIT J PLAST SURG, V47, P158, DOI 10.1016/0007-1226(94)90046-9
   Schachter DM, 2002, J CONTROL RELEASE, V78, P143, DOI 10.1016/S0168-3659(01)00487-4
   SCHWARTE LM, 1997, POLYM PREPR, V38, P596
   Shapiro L, 1997, BIOMATERIALS, V18, P583, DOI 10.1016/S0142-9612(96)00181-0
   Sheridan MH, 2000, J CONTROL RELEASE, V64, P91, DOI 10.1016/S0168-3659(99)00138-8
   Simske SJ, 1997, MATER SCI FORUM, V250, P151, DOI 10.4028/www.scientific.net/MSF.250.151
   Sittinger M, 1996, J BIOMED MATER RES, V33, P57, DOI 10.1002/(SICI)1097-4636(199622)33:2<57::AID-JBM1>3.0.CO;2-K
   SITTINGER M, 1994, BIOMATERIALS, V15, P451, DOI 10.1016/0142-9612(94)90224-0
   Tabata Y, 2001, DRUG DISCOV TODAY, V6, P483, DOI 10.1016/S1359-6446(01)01753-6
   Teijon JM, 1997, BIOMATERIALS, V18, P383, DOI 10.1016/S0142-9612(96)00139-1
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Thomson R. C., 1995, ADV POLYM SCI, V122, P247
   Thomson RC, 1999, BIOMATERIALS, V20, P2007, DOI 10.1016/S0142-9612(99)00103-9
   THOMSON RC, 1995, J BIOMAT SCI-POLYM E, V7, P23, DOI 10.1163/156856295X00805
   Thomson RC, 1997, PRINCIPLES TISSUE EN, P263
   TORMALA P, 1991, J BIOMED MATER RES, V25, P1, DOI 10.1002/jbm.820250102
   Tziampazis E, 2000, BIOMATERIALS, V21, P511, DOI 10.1016/S0142-9612(99)00212-4
   UFF CR, 1995, BIOMATERIALS, V16, P355, DOI 10.1016/0142-9612(95)93852-5
   VACANTI CA, 1999, CLIN ORTHOP S, V367, P375
   VAINIONPAA S, 1989, PROG POLYM SCI, V14, P679, DOI 10.1016/0079-6700(89)90013-0
   VERDONSCHOT N, 1995, J BIOMED MATER RES, V29, P575, DOI 10.1002/jbm.820290504
   Vunjak-Novakovic G, 1998, BIOTECHNOL PROGR, V14, P193, DOI 10.1021/bp970120j
   Whang K, 1999, TISSUE ENG, V5, P35, DOI 10.1089/ten.1999.5.35
   Whang K, 2000, BIOMATERIALS, V21, P2545, DOI 10.1016/S0142-9612(00)00122-8
   Yang SF, 2002, TISSUE ENG, V8, P1, DOI 10.1089/107632702753503009
   Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
   Zignani M, 2000, EUR J PHARM BIOPHARM, V50, P251, DOI 10.1016/S0939-6411(00)00107-7
NR 123
TC 41
Z9 41
U1 1
U2 15
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0950-6608
EI 1743-2804
J9 INT MATER REV
JI Int. Mater. Rev.
PD OCT
PY 2004
VL 49
IS 5
BP 274
EP 285
DI 10.1179/095066004225021927
PG 12
WC Materials Science, Multidisciplinary
SC Materials Science
GA 866RJ
UT WOS:000224790300002
DA 2018-10-19
ER

PT J
AU Hong, YS
   Lau, LS
   Legge, RL
   Chen, P
AF Hong, YS
   Lau, LS
   Legge, RL
   Chen, P
TI Critical self-assembly concentration of an ionic-complementary peptide
   EAK16-I
SO JOURNAL OF ADHESION
LA English
DT Article
DE self-assembly; peptides; critical self-assembly concentration; surface
   tension; nanostructural transition; atomic force microscopy;
   axisymmetric drop shape analysis-profile
ID BIOLOGICAL-MATERIALS; OLIGOPEPTIDE; SALT; MICELLIZATION; ADSORPTION;
   SCAFFOLDS; PROTEINS; MICELLES; KINETICS; TENSION
AB Understanding the process of self-assembly of peptides has been important in various biomedical engineering applications. This work focuses on the effect of peptide concentration on the molecular self-assembly of an ionic-complementary peptide, EAK16-I(AEAKAEAKAEAKAEAK), in aqueous solution. The surface tension and self-assembled nanostructures were determined for a wide range of peptide concentrations using axisymmetric drop shape analysis-profile(ADSA-P)and atomic force microscopy(AFM), respectively. Surface tension measurements revealed a critical self-assembly concentration of 0.3 mg peptide/ml water, below which the surface tension decreased rapidly with increasing peptide concentration, and above which the surface tension remained at a constant, plateau value. There were two structural transitions observed with increasing peptide concentration: the first was from globular nanostructures to fibrils, and the second from the fibrils to relatively thick fibers. The second structural transition occurred at the critical self-assembly concentration as determined by the surface tension measurements. The nanostructural behavior of EAK16-I was compared with that of EAK16-II, which has the same amino acid composition but a different charge distribution. Salt effects were also examined by adding NaCl to the peptide solution. The salt addition facilitated the formation of peptide fibrils at low peptide concentrations but increased the critical self-assembly concentration, which occurred at 0.8 mg peptide/ml water in the presence of 20mM NaCl. The structural transitionsinvolved in the self-assembly of EAK16-I resemble those from protofibrils to fibrils observed with numerous naturally occurring peptides. An understanding of this structural transition may have relevance in the analysis and treatment of peptide/protein conformational diseases and have application in the production of self-assembled protein nanostructures.
C1 Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada.
RP Chen, P (reprint author), Univ Waterloo, Dept Chem Engn, 200 Univ Ave W, Waterloo, ON N2L 3G1, Canada.
EM p4chen@cape.uwaterloo.ca
RI Legge, Raymond/B-6460-2009
OI Legge, Raymond/0000-0001-9308-8870
CR Borisov OV, 2002, MACROMOLECULES, V35, P4472, DOI 10.1021/ma010934n
   BRACK A, 1975, NATURE, V256, P383, DOI 10.1038/256383a0
   Caplan MR, 2000, BIOMACROMOLECULES, V1, P627, DOI 10.1021/bm005586w
   Chen P, 1996, COLLOID SURFACE B, V6, P279, DOI 10.1016/0927-7765(96)01265-9
   Clint J. H., 1992, SURFACTANT AGGREGATI
   de la Paz ML, 2002, P NATL ACAD SCI USA, V99, P16052, DOI 10.1073/pnas.252340199
   Dutkiewicz E, 2002, COLLOID POLYM SCI, V280, P1009, DOI 10.1007/s00396-002-0723-y
   Fung SY, 2003, BIOPHYS J, V85, P537, DOI 10.1016/S0006-3495(03)74498-1
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   HIEMENZ PC, 1997, PRINCIPLES COLLOID S, P355
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Hong YS, 2003, BIOMACROMOLECULES, V4, P1433, DOI 10.1021/bm0341374
   Jun S, 2004, BIOPHYS J, V87, P1249, DOI 10.1529/biophysj.103.038166
   Khan MO, 1999, MACROMOLECULES, V32, P8836, DOI 10.1021/ma9905627
   KNICHEL M, 1995, SENSOR ACTUAT B-CHEM, V28, P85, DOI 10.1016/0925-4005(94)01543-Q
   Korolev N, 2000, BIOMACROMOLECULES, V1, P648, DOI 10.1021/bm000042f
   Lowe CR, 2000, CURR OPIN STRUC BIOL, V10, P428, DOI 10.1016/S0959-440X(00)00110-X
   Miller R, 2001, COLLOID SURFACE A, V183, P381, DOI 10.1016/S0927-7757(01)00523-4
   MIYAHISHI S, 2001, J COLLOID INTERF SCI, V179, P57
   NANDI PK, 1972, J AM CHEM SOC, V94, P1299, DOI 10.1021/ja00759a042
   Nowak AP, 2002, NATURE, V417, P424, DOI 10.1038/417424a
   PICULELL L, 1990, PROG COLL POL SCI S, V82, P198
   Ropers MH, 2003, J PHYS CHEM B, V107, P5281, DOI 10.1021/jp0264329
   Strong AE, 1999, J MATER CHEM, V9, P1097, DOI 10.1039/a806860g
   STRONG AE, 1998, CHEM COMMUN, V4, P473
   Tu EB, 1997, LANGMUIR, V13, P4234, DOI 10.1021/la9620770
   vanderVegt W, 1996, J COLLOID INTERF SCI, V179, P57, DOI 10.1006/jcis.1996.0188
   Vauthey S, 2002, P NATL ACAD SCI USA, V99, P5355, DOI 10.1073/pnas.072089599
   Whaley SR, 2000, NATURE, V405, P665
   Zhang L, 1996, LANGMUIR, V12, P2371, DOI 10.1021/la950670w
   ZHANG S, 2002, BIOTECHNOL ADV, V20, P339
   ZHANG SG, 1994, BIOPOLYMERS, V34, P663, DOI 10.1002/bip.360340508
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   Zhang SG, 2002, CURR OPIN CHEM BIOL, V6, P865, DOI 10.1016/S1367-5931(02)00391-5
   Zhang SG, 2002, BIOTECHNOL ADV, V20, P321, DOI 10.1016/S0734-9750(02)00026-5
NR 35
TC 30
Z9 33
U1 1
U2 13
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0021-8464
J9 J ADHESION
JI J. Adhes.
PD OCT-NOV
PY 2004
VL 80
IS 10-11
BP 913
EP 931
DI 10.1080/00218460490508616
PG 19
WC Engineering, Chemical; Materials Science, Multidisciplinary; Mechanics
SC Engineering; Materials Science; Mechanics
GA 865LN
UT WOS:000224704700003
DA 2018-10-19
ER

PT J
AU Silva, RM
   Silva, GA
   Coutinho, OP
   Mano, JF
   Reis, RL
AF Silva, RM
   Silva, GA
   Coutinho, OP
   Mano, JF
   Reis, RL
TI Preparation and characterisation in simulated body conditions of
   glutaraldehyde crosslinked chitosan membranes
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID N-ACETYLATED CHITOSANS; STARCH-BASED POLYMERS; IN-VITRO DEGRADATION;
   HYDROGEL MEMBRANES; BIOCOMPATIBILITY; LINKING; CHITIN; FILMS; ACID;
   PROLIFERATION
AB Chitosan membranes, aimed at biomedical applications, were prepared by a solvent casting methodology. Crosslinking was previously performed in acetic acid solution with glutaraldehyde, in order to obtain different degrees of crosslinking. Some membranes were neutralised in a NaOH solution. Mechanical tensile tests comprised quasi-static experiments at constant stress rate and temperature sweep dynamic mechanical analysis tests. This included measurements with the samples immersed in isotonic saline solution at 37degreesC, in order to simulate physiological conditions, that were performed using a specific liquid container. It was observed that for higher crosslinking levels the membranes become stiffer but their strength decreases; these results are in agreement with swelling tests, also performed at body temperature. All the membranes exhibited similar and significant damping properties in wet conditions, which were stable in a broad temperature range. Weight loss measurements showed that the developed membranes degrade slowly up to 60 days. Cytotoxicity screening, using cell culture tests, showed that eventually such materials could be adequate for use in biomedical applications. (C) 2004 Kluwer Academic Publishers.
C1 Univ Minho, Dept Polymer Engn, P-4800058 Guimaraes, Portugal.
   3Bs Res Grp, P-4710053 Braga, Portugal.
   Univ Minho, Dept Biol, P-4710053 Braga, Portugal.
RP Silva, RM (reprint author), Univ Minho, Dept Polymer Engn, Campus Azurem, P-4800058 Guimaraes, Portugal.
EM ricardosilva@dep.uminho.pt
RI Coutinho, Olga/K-7155-2013; Reis, Rui L./A-8938-2008; silva,
   gabriela/F-4409-2012; Mano, Joao/A-4418-2009; Group, 3Bs/E-4374-2012; da
   Silva, Ricardo/C-1143-2011
OI Reis, Rui L./0000-0002-4295-6129; silva, gabriela/0000-0001-5946-1918;
   Mano, Joao/0000-0002-2342-3765; Group, 3Bs/0000-0002-5195-3456; da
   Silva, Ricardo/0000-0003-1456-8724; Coutinho, Olga/0000-0002-0647-080X
CR AIBA S, 1994, CARBOHYD RES, V261, P297, DOI 10.1016/0008-6215(94)84025-3
   Begin A, 1999, INT J BIOL MACROMOL, V26, P63, DOI 10.1016/S0141-8130(99)00064-1
   Ge JJ, 2000, J MEMBRANE SCI, V165, P75, DOI 10.1016/S0376-7388(99)00228-8
   Gomes ME, 2001, BIOMATERIALS, V22, P1911, DOI 10.1016/S0142-9612(00)00377-X
   Hwang KT, 2003, J APPL POLYM SCI, V89, P3476, DOI 10.1002/app.12561
   Krajewska B, 2001, J CHEM TECHNOL BIOT, V76, P636, DOI 10.1002/jctb.429.abs
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Kurita K, 2000, CARBOHYD POLYM, V42, P19, DOI 10.1016/S0144-8617(99)00127-7
   Kurita K, 2001, PROG POLYM SCI, V26, P1921, DOI 10.1016/S0079-6700(01)00007-7
   Li F, 2002, BIOMATERIALS, V23, P343, DOI 10.1016/S0142-9612(01)00111-9
   Marques AP, 2002, BIOMATERIALS, V23, P1471, DOI 10.1016/S0142-9612(01)00272-1
   Mendes SC, 2001, BIOMATERIALS, V22, P2057, DOI 10.1016/S0142-9612(00)00395-1
   Mi FL, 2000, J POLYM SCI POL CHEM, V38, P2804, DOI 10.1002/1099-0518(20000801)38:15<2804::AID-POLA210>3.0.CO;2-Y
   Mi FL, 2001, J BIOMAT SCI-POLYM E, V12, P835, DOI 10.1163/156856201753113051
   Monteiro OAC, 1999, INT J BIOL MACROMOL, V26, P119, DOI 10.1016/S0141-8130(99)00068-9
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Musale DA, 2000, SEP PURIF TECHNOL, V21, P27, DOI 10.1016/S1383-5866(00)00188-X
   MUZZARELLI RAA, 1993, CARBOHYD POLYM, V20, P7, DOI 10.1016/0144-8617(93)90027-2
   Nordtveit RJ, 1996, CARBOHYD POLYM, V29, P163, DOI 10.1016/0144-8617(96)00003-3
   Reis RL, 1997, POLYM INT, V43, P347
   Rinaudo M, 1999, POLYMER, V40, P7029, DOI 10.1016/S0032-3861(99)00056-7
   Risbud MV, 2001, J MATER SCI-MATER M, V12, P75, DOI 10.1023/A:1026769422026
   Salgado AJ, 2002, MAT SCI ENG C-BIO S, V20, P27, DOI 10.1016/S0928-4931(02)00009-7
   Scotchford CA, 1998, BIOMATERIALS, V19, P1, DOI 10.1016/S0142-9612(97)00236-6
   SLATER TF, 1963, BIOCHIM BIOPHYS ACTA, V77, P383, DOI 10.1016/0006-3002(63)90513-4
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Sridhar S, 2001, POLYM INT, V50, P1156, DOI 10.1002/pi.761
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   TUZLAKOGLU K, IN PRESS MACROMOL BI
   Varum KM, 1997, CARBOHYD RES, V299, P99, DOI 10.1016/S0008-6215(96)00332-1
   Varum KM, 1996, BBA-GEN SUBJECTS, V1291, P5, DOI 10.1016/0304-4165(96)00038-4
   Wang XP, 2000, J APPL POLYM SCI, V75, P740, DOI 10.1002/(SICI)1097-4628(20000207)75:6<740::AID-APP2>3.0.CO;2-3
   Winblade ND, 2002, J BIOMED MATER RES, V59, P618, DOI 10.1002/jbm.1273
NR 33
TC 64
Z9 65
U1 3
U2 31
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD OCT
PY 2004
VL 15
IS 10
BP 1105
EP 1112
DI 10.1023/B:JMSM.0000046392.44911.46
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 866VR
UT WOS:000224802000007
PM 15516871
DA 2018-10-19
ER

PT J
AU Neumann, A
   Reske, T
   Held, M
   Jahnke, K
   Ragoss, C
   Maier, HR
AF Neumann, A
   Reske, T
   Held, M
   Jahnke, K
   Ragoss, C
   Maier, HR
TI Comparative investigation of the biocompatibility of various silicon
   nitride ceramic qualities in vitro
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID IMPLANT MATERIALS; CELLS; INVITRO; TOXICITY; CULTURE; TISSUE; INVIVO;
   SYSTEM
AB There is a controversy about the biocompatibility of silicon nitride ceramics contained in the literature, which appears to be related to a factor of the individual chemical composition of different qualities of silicon nitride ceramics and of the different surface properties. This study attempts to investigate the cytotoxicity of different qualities of industrial silicon nitride ceramics applying an L929-cell culture model in a direct contact assay combined with a cell viability assessment. Five different qualities of industrial standard silicon nitride ceramics were chosen for in vitro testing. The chemical composition was determined by EDS analysis. Different biomedically approved aluminium oxide qualities, a titanium alloy, glass and polyvinylchloride (PVC) served as control materials. L929 mice fibroblasts were incubated directly on the materials for 24 h, stained with bisbenzimide and propidium iodine for double fluorochromasia viability testing, and evaluated by inversion-fluorescence microscopy to control cell morphology, viability and cell counts compared to empty well values. Scanning electron microscopy was applied to additionally investigate cell morphology. There was no observation of cytotoxic effects on the silicon nitride ceramic samples; moreover cell morphology remained the same as on aluminium oxide and titanium. Viability testing revealed the presence of avital cells exclusively on PVC, which served as a negative control. Cell counts on all polished surfaces showed significantly higher numbers, whereas some rough surface samples showed significantly lower numbers. We conclude that silicon nitride ceramics show no cytotoxic effects and should be considered for biomedical application owing to its favourable physiochemical properties, especially its superior resistance to mechanical stress, which would be useful for compression loaded conditions. Polished surfaces would appear to promote advanced biocompatibility. (C) 2004 Kluwer Academic Publishers.
C1 Univ Essen Gesamthsch, Dept Otorhinolaryngol, D-45122 Essen, Germany.
   Inst Ceram Components Engn, D-52072 Aachen, Germany.
RP Neumann, A (reprint author), Univ Essen Gesamthsch, Dept Otorhinolaryngol, Hufelandstr 55, D-45122 Essen, Germany.
EM andreas.neumann@uni-essen.de
CR Amaral M, 2002, BIOMATERIALS, V23, P857, DOI 10.1016/S0142-9612(01)00194-6
   AMMAR A, 1984, ACTA NEUROCHIR, V72, P45, DOI 10.1007/BF01406813
   CHAWLA AS, 1982, J BIOMED MATER RES, V16, P501, DOI 10.1002/jbm.820160415
   CRISSMAN HA, 1987, EXP CELL RES, V173, P256, DOI 10.1016/0014-4827(87)90350-8
   DION I, 1994, J MATER SCI-MATER M, V5, P18, DOI 10.1007/BF00121148
   Doran A, 1998, BIOMATERIALS, V19, P751, DOI 10.1016/S0142-9612(97)00209-3
   GRISS P, 1980, MECH PROPERTIES BIOM, P217
   GROSS U, 1987, ADV BIOMATER, V7, P547
   HEIMKE G, 1980, MED BIOL ENG COMPUT, V18, P503, DOI 10.1007/BF02443328
   HOWLETT CR, 1989, CLIN ORTHOP RELAT R, P293
   JAHNKE K, 1983, BIOMATERIALS, V4, P137, DOI 10.1016/0142-9612(83)90056-X
   JOHNSON HJ, 1983, J BIOMED MATER RES, V17, P571, DOI 10.1002/jbm.820170403
   Johnsson R I, 1968, Ann N Y Acad Sci, V146, P66, DOI 10.1111/j.1749-6632.1968.tb20271.x
   KAWAHARA H, 1983, INT DENT J, V33, P350
   Kue R, 1999, BIOMATERIALS, V20, P1195, DOI 10.1016/S0142-9612(99)00007-1
   LATT SA, 1976, J HISTOCHEM CYTOCHEM, V24, P24, DOI 10.1177/24.1.943439
   MENGUCCI P, 1998, BIOMATERIALS, V17, P1339
   Neumann A, 2003, MATERIALWISS WERKST, V34, P1052, DOI 10.1002/mawe.200300704
   NORTHUP SJ, 1988, HDB BIOMATERIALS EVA, P209
   PLESTER D, 1981, AM J OTOL, V3, P104
   Polonchuk L, 2000, BIOMATERIALS, V21, P539, DOI 10.1016/S0142-9612(99)00189-1
   RICE RM, 1978, J BIOMED MATER RES, V12, P43, DOI 10.1002/jbm.820120105
   RICHERSON DW, 1989, MATER SCI FORUM, V47, P282
   ROSENBLUTH SA, 1965, J PHARM SCI-US, V54, P156, DOI 10.1002/jps.2600540139
   SOHRABI A, 1998, BIOCERAMICS, V11, P309
   Svensson I, 1997, AM J IND MED, V31, P335, DOI 10.1002/(SICI)1097-0274(199703)31:3<335::AID-AJIM10>3.0.CO;2-1
   TAS J, 1981, J HISTOCHEM CYTOCHEM, V29, P929, DOI 10.1177/29.8.6168679
   Wilsnack R E, 1973, Biomater Med Devices Artif Organs, V1, P543
NR 28
TC 58
Z9 67
U1 0
U2 8
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD OCT
PY 2004
VL 15
IS 10
BP 1135
EP 1140
DI 10.1023/B:JMSM.0000046396.14073.92
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 866VR
UT WOS:000224802000011
PM 15516875
DA 2018-10-19
ER

PT J
AU Kricheldorf, HR
AF Kricheldorf, HR
TI Biodegradable polymers with variable architectures via ring-expansion
   polymerization
SO JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
LA English
DT Article
DE A-B-A triblock copolymers; biodegradable; lactide; lactones; networks;
   ring-opening polymerization
ID CYCLIC TIN-ALKOXIDE; MACROCYCLIC POLYMERIZATION; EPSILON-CAPROLACTONE;
   L-LACTIDE; OPENING POLYCONDENSATION; TELECHELIC POLYLACTONES; MULTIBLOCK
   COPOLYESTERS; TRIMETHYLENE CARBONATE; TRIBLOCK COPOLYMERS; INITIATORS
AB Kinetically controlled ring-expansion polymerizations (REPs) are defined syntheses generating cyclic oligomers and polymers without linear intermediates and without equilibration reactions. This review reports syntheses of cyclic metal alkoxides and their use as initiators for REPs of lactones, cyclic diesters, and cyclocarbonates. In addition to homopolyesters. telechelic oligoesters or polyesters. random copolyesters, and A-B-A triblock copolymers can be prepared by these REPs. The in situ combination of REPs with condensation (mostly acylation) reactions allows a broad variation of end groups. The in situ combination of REPs with polycondensation enables various chain-extension reactions, including the syntheses of multiblock copolymers. With spirocyclic initiators, four-armed stars with functional end groups may be prepared. The in situ combination of REPs with condensation reactions of trifunctional or multifunctional reagents makes a broad variety of networks accessible. The average segment lengths may be controlled via the monomer/initiator ratios of the REP. All materials produced via the aforementioned REP processes are biodegradable and nontoxic, and this allows for biomedical and pharmaceutical applications. (C) 2004 Wiley Periodicals, Inc.
C1 Inst Tech & Makromol Chem, D-20146 Hamburg, Germany.
RP Kricheldorf, HR (reprint author), Inst Tech & Makromol Chem, Bundesstr 45, D-20146 Hamburg, Germany.
EM kricheld@chemie.uni-hamburg.de
CR BORNSTEIN J, 1959, J ORG CHEM, V24, P886, DOI 10.1021/jo01088a627
   CONSIDIN.WJ, 1966, J ORGANOMET CHEM, V5, P263, DOI 10.1016/S0022-328X(00)80364-2
   Kowalski A, 2000, MACROMOLECULES, V33, P1964, DOI 10.1021/ma991751s
   Kricheldorf H., 1994, POLYM PREPR, V35, P502
   Kricheldorf HR, 2003, MACROMOL RAPID COMM, V24, P359, DOI 10.1002/marc.200390063
   Kricheldorf HR, 2004, MACROMOL CHEM PHYSIC, V205, P1031, DOI 10.1002/macp.200400027
   Kricheldorf HR, 2004, POLYMER, V45, P3205, DOI 10.1016/j.polymer.2004.02.059
   KRICHELDORF HR, 1991, MACROMOLECULES, V24, P1944, DOI 10.1021/ma00008a035
   Kricheldorf HR, 2000, J MACROMOL SCI PURE, V37, P379, DOI 10.1081/MA-100101099
   Kricheldorf HR, 2003, BIOMACROMOLECULES, V4, P950, DOI 10.1021/bm0300148
   Kricheldorf HR, 2003, MACROMOLECULES, V36, P2302, DOI 10.1021/ma020812a
   Kricheldorf HR, 2002, POLYMER, V43, P1973, DOI 10.1016/S0032-3861(01)00745-5
   Kricheldorf HR, 1999, MACROMOL CHEM PHYSIC, V200, P587, DOI 10.1002/(SICI)1521-3935(19990301)200:3<587::AID-MACP587>3.0.CO;2-D
   Kricheldorf HR, 2002, MACROMOL CHEM PHYSIC, V203, P405, DOI 10.1002/1521-3935(20020101)203:2<405::AID-MACP405>3.0.CO;2-N
   Kricheldorf HR, 2001, BIOMACROMOLECULES, V2, P1110, DOI 10.1021/bm0100561
   Kricheldorf HR, 2002, J POLYM SCI POL CHEM, V40, P1047, DOI 10.1002/pola.10177
   Kricheldorf HR, 2001, MACROMOLECULES, V34, P3517, DOI 10.1021/ma001999d
   KRICHELDORF HR, 1988, MACROMOLECULES, V21, P286, DOI 10.1021/ma00180a002
   Kricheldorf HR, 2001, MACROMOL CHEM PHYSIC, V202, P1219, DOI 10.1002/1521-3935(20010401)202:7<1219::AID-MACP1219>3.0.CO;2-U
   Kricheldorf HR, 2000, MACROMOLECULES, V33, P696, DOI 10.1021/ma9909915
   Kricheldorf HR, 1999, MACROMOL CHEM PHYSIC, V200, P1726, DOI 10.1002/(SICI)1521-3935(19990701)200:7<1726::AID-MACP1726>3.0.CO;2-B
   Kricheldorf HR, 1999, MACROMOL CHEM PHYSIC, V200, P1183, DOI 10.1002/(SICI)1521-3935(19990501)200:5<1183::AID-MACP1183>3.0.CO;2-K
   Kricheldorf HR, 1999, J MACROMOL SCI PURE, VA36, P795, DOI 10.1081/MA-100101564
   Kricheldorf HR, 1999, MACROMOL RAPID COMM, V20, P319, DOI 10.1002/(SICI)1521-3927(19990601)20:6<319::AID-MARC319>3.3.CO;2-6
   Kricheldorf HR, 1998, MACROMOL CHEM PHYSIC, V199, P273, DOI 10.1002/(SICI)1521-3935(19980201)199:2<273::AID-MACP273>3.3.CO;2-4
   Kricheldorf HR, 1999, J POLYM SCI POL CHEM, V37, P2179, DOI 10.1002/(SICI)1099-0518(19990701)37:13<2179::AID-POLA33>3.0.CO;2-X
   Kricheldorf HR, 1998, MACROMOLECULES, V31, P614, DOI 10.1021/ma971055x
   Kricheldorf HR, 1999, MACROMOL CHEM PHYSIC, V200, P1174, DOI 10.1002/(SICI)1521-3935(19990501)200:5<1174::AID-MACP1174>3.0.CO;2-G
   Kricheldorf HR, 1998, J POLYM SCI POL CHEM, V36, P1373, DOI 10.1002/(SICI)1099-0518(19980715)36:9<1373::AID-POLA4>3.0.CO;2-U
   Kricheldorf HR, 1998, MACROMOLECULES, V31, P6403, DOI 10.1021/ma980246c
   Kricheldorf HR, 1998, MACROMOL CHEM PHYSIC, V199, P283, DOI 10.1002/(SICI)1521-3935(19980201)199:2<283::AID-MACP283>3.3.CO;2-0
   Kricheldorf HR, 1996, MACROMOLECULES, V29, P8689, DOI 10.1021/ma960927c
   KRICHELDORF HR, 1995, MACROMOLECULES, V28, P6718, DOI 10.1021/ma00124a004
   Kricheldorf HR, 1999, MACROMOLECULES, V32, P3559, DOI 10.1021/ma981134o
   Kricheldorf HR, 2001, MACROMOL CHEM PHYSIC, V202, P2525, DOI 10.1002/1521-3935(20010801)202:12<2525::AID-MACP2525>3.0.CO;2-C
   Kricheldorf HR, 2001, MACROMOL BIOSCI, V1, P364, DOI 10.1002/1616-5195(20011101)1:8<364::AID-MABI364>3.0.CO;2-Q
   Kricheldorf HR, 1996, MACROMOLECULES, V29, P1375, DOI 10.1021/ma9509826
   KRICHELDORF HR, 2002, BIOMACROMOLECULES, V3, P699
   KRICHELDORF HR, 2004, UNPUB
   KRICHELDORF HR, 2003, MACROMOLECULES
   KRICHELDORF HR, UNPUB MACROMOLECULES
   KRICHELDORF HR, IN PRESS BIOMACROMOL
   MCLAINE SJ, 1992, POLYM PREPR, V33, P179
   MEKROTRA RG, 1965, J ORGANOMET CHEM, V4, P145
   PASCH H, 1995, J CHROMATOGR A, V699, P24
   POMMIER JC, 1968, J ORGANOMET CHEM, V12, P433, DOI 10.1016/S0022-328X(00)88696-9
   RAMESDEN HE, 1957, Patent No. 2789994
   Ryner M, 2001, MACROMOLECULES, V34, P7281, DOI 10.1021/ma0106898
   SMITH PJ, 1972, J ORGANOMET CHEM, V40, P341, DOI 10.1016/S0022-328X(00)93372-2
   SOSNOWSKI S, 2002, COLLOID POLYM SCI, P280
   Stridsberg K, 1999, J POLYM SCI POL CHEM, V37, P3407, DOI 10.1002/(SICI)1099-0518(19990815)37:16<3407::AID-POLA40>3.3.CO;2-O
   Stridsberg K, 2000, MACROMOLECULES, V33, P2862, DOI 10.1021/ma991811u
NR 52
TC 81
Z9 87
U1 1
U2 26
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0887-624X
J9 J POLYM SCI POL CHEM
JI J. Polym. Sci. Pol. Chem.
PD OCT 1
PY 2004
VL 42
IS 19
BP 4723
EP 4742
DI 10.1002/pola.20261
PG 20
WC Polymer Science
SC Polymer Science
GA 854SD
UT WOS:000223922700001
OA Bronze
DA 2018-10-19
ER

PT J
AU Schultz-Darken, NJ
   Pape, RM
   Tannenbaum, PL
   Saltzman, W
   Abbott, DH
AF Schultz-Darken, NJ
   Pape, RM
   Tannenbaum, PL
   Saltzman, W
   Abbott, DH
TI Novel restraint system for neuroendocrine studies of socially living
   common marmoset monkeys
SO LABORATORY ANIMALS
LA English
DT Article
DE marmoset; restraint; long-term sampling; reproductive
   neuroendocrinology; behavioural adaptation; methods; cortisol
ID CALLITHRIX-JACCHUS; LUTEINIZING-HORMONE; NONHUMAN-PRIMATES;
   BIOMEDICAL-RESEARCH; RHESUS-MONKEY; LH-SECRETION; SEX STEROIDS; STRESS;
   SUPPRESSION; CORTISOL
AB We describe a novel soft jacket and sling-harness restraint that permits species-typical postures for small-bodied primates, such as the common marmoset (Callithrix jacchus), during long-term (> 6 h), continuous restraint. The restraint system is straightforward to use and manipulate, it is easily repaired, and the materials used are readily available. The soft jacket allows for increased versatility and longevity, and the sling-harness provides for greater movement and much longer duration of continuous restraint (up to 3 days) compared to a previously described, more conventional chair restraint for small-bodied primates. The new restraint system prevents the normal diurnal decrease in plasma cortisol levels across the daylight hours; however, it does not disrupt ovulatory cycles. Unlike the previously available techniques, therefore, this new restraint system is applicable to many neurobiological and neuroendocrine studies involving small-bodied, non-human primates and is especially suited to investigations requiring the maintenance of relationships within social groups.
C1 Univ Wisconsin, Natl Primate Res Ctr, Madison, WI 53715 USA.
   Univ Wisconsin, Dept Obstet & Gynecol, Madison, WI 53706 USA.
   Pharmaceut Res & Dev, Raritan, NJ 08869 USA.
   Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.
RP Schultz-Darken, NJ (reprint author), Univ Wisconsin, Natl Primate Res Ctr, 1220 Capitol Court, Madison, WI 53715 USA.
EM darken@primate.wisc.edu
FU NIMH NIH HHS [MH11417, MH53709]; NICHD NIH HHS [HD07678]; NCRR NIH HHS
   [RR000167]
CR Abbott D.H., 1991, P295
   Abbott D. H., 1993, P152
   Abbott D.H., 1992, P245
   Abbott D. H., 1993, PRIMATE SOCIAL CONFL, P331
   Abbott DH, 1997, ANN NY ACAD SCI, V807, P219, DOI 10.1111/j.1749-6632.1997.tb51923.x
   Abbott DH, 1998, COMP BIOCHEM PHYS C, V119, P261, DOI 10.1016/S0742-8413(98)00015-2
   ABBOTT DH, 1988, J ENDOCRINOL, V117, P329, DOI 10.1677/joe.0.1170329
   ABBOTT DH, 1987, J ZOOL, V213, P455, DOI 10.1111/j.1469-7998.1987.tb03720.x
   Abbott DH, 2003, COMPARATIVE MED, V53, P339
   ABBOTT DH, 1984, AM J PRIMATOL, V6, P169, DOI 10.1002/ajp.1350060305
   *APN NONH PRIM NUT, 1978, NUTR REQ NONH PRIM
   Baker JV, 1999, ANIM BEHAV, V58, P501, DOI 10.1006/anbe.1999.1200
   BARRETT J, 1990, J REPROD FERTIL, V90, P411
   BARRETT J, 1993, J REPROD FERTIL, V97, P301
   BLUM B, 1983, BRAIN RES BULL, V11, P399, DOI 10.1016/0361-9230(83)90174-0
   Bogert L.J., 1973, NUTR PHYS FITNESS
   Cameron JL, 1997, SEMIN REPROD ENDOCR, V15, P37, DOI 10.1055/s-2008-1067966
   CHEN MD, 1992, NEUROENDOCRINOLOGY, V56, P666, DOI 10.1159/000126291
   COE CL, 1992, AM J PRIMATOL, V28, P81, DOI 10.1002/ajp.1350280202
   COELHO AM, 1990, LAB ANIM SCI, V40, P388
   Collins P, 1998, J COGNITIVE NEUROSCI, V10, P332, DOI 10.1162/089892998562771
   DEELVIRA MCR, 1986, LAB ANIM, V20, P329, DOI 10.1258/002367786780808811
   Ferris CF, 2001, NEUROREPORT, V12, P2231, DOI 10.1097/00001756-200107200-00037
   French Jeffrey A., 1997, P34
   FRIDAY KE, 1990, AM J CLIN NUTR, V51, P470
   GEARING M, 1988, BRAIN RES BULL, V21, P117, DOI 10.1016/0361-9230(88)90126-8
   HARLOW CR, 1983, J ZOOL, V201, P273
   Hearn J.P., 1983, P181
   HEARN JP, 1977, LAB ANIM, V11, P261, DOI 10.1258/002367777780936459
   Kam K, 2000, ENDOCRINE, V12, P279, DOI 10.1385/ENDO:12:3:279
   KERR GR, 1972, PHYSIOL REV, V52, P415
   Mansfield K, 2003, COMPARATIVE MED, V53, P383
   NORMAN RL, 1994, BIOL REPROD, V50, P16, DOI 10.1095/biolreprod50.1.16
   OBYRNE KT, 1988, LAB ANIM, V22, P148, DOI 10.1258/002367788780864501
   OBYRNE KT, 1988, LAB ANIM, V22, P151, DOI 10.1258/002367788780864475
   OBYRNE KT, 1989, PHYSIOL BEHAV, V45, P1077, DOI 10.1016/0031-9384(89)90241-2
   Owen S, 1997, LAB ANIM, V31, P289, DOI 10.1258/002367797780596149
   PRYCE CR, 1993, BEHAV PROCESS, V30, P201, DOI 10.1016/0376-6357(93)90133-C
   PRYCE CR, 1993, J COMP PSYCHOL, V107, P99, DOI 10.1037//0735-7036.107.1.99
   Saltzman W, 1996, ANIM BEHAV, V51, P657, DOI 10.1006/anbe.1996.0070
   Saltzman W, 1998, HORM BEHAV, V33, P58, DOI 10.1006/hbeh.1998.1436
   SALTZMAN W, 1994, PHYSIOL BEHAV, V56, P801, DOI 10.1016/0031-9384(94)90246-1
   Scott L, 1994, MARMOSET ROLE PHARM, P1
   Smith TE, 1997, PHYSIOL BEHAV, V62, P225, DOI 10.1016/S0031-9384(97)00103-0
   Sokal R.R., 1995, BIOMETRY
   Stevenson M. F., 1988, ECOLOGY BEHAVIOUR NE, V2, P131
   SUMMERS PM, 1985, J REPROD FERTIL, V73, P133
   Tan Zhengguo, 2002, Journal of UOEH, V24, P361
   Tardif Suzette D., 1997, P11
   Tilbrook AJ, 2002, STRESS, V5, P83, DOI 10.1080/10253890290027912
   Tilbrook AJ, 1999, J ENDOCRINOL, V160, P469, DOI 10.1677/joe.0.1600469
   Turner AI, 2002, J ENDOCRINOL, V173, P113, DOI 10.1677/joe.0.1730113
   Wade CE, 1997, CONTEMP TOP LAB ANIM, V36, P55
NR 53
TC 17
Z9 17
U1 1
U2 3
PU ROYAL SOC MEDICINE PRESS LTD
PI LONDON
PA 1 WIMPOLE STREET, LONDON W1G 0AE, ENGLAND
SN 0023-6772
J9 LAB ANIM-UK
JI Lab. Anim.
PD OCT
PY 2004
VL 38
IS 4
BP 393
EP 405
DI 10.1258/0023677041958918
PG 13
WC Veterinary Sciences; Zoology
SC Veterinary Sciences; Zoology
GA 860LV
UT WOS:000224346000006
PM 15479554
OA Bronze
DA 2018-10-19
ER

PT J
AU Han, HD
   Nam, DE
   Seo, DH
   Kim, TW
   Shin, BC
   Choi, HS
AF Han, HD
   Nam, DE
   Seo, DH
   Kim, TW
   Shin, BC
   Choi, HS
TI Preparation and biodegradation of thermosensitive chitosan hydrogel as a
   function of pH and temperature
SO MACROMOLECULAR RESEARCH
LA English
DT Article
DE sol-gel transition; chitosan hydrogel; biodegradation
ID BIOMEDICAL APPLICATIONS; N-ISOPROPYLACRYLAMIDE; CONTROLLED-RELEASE;
   IN-VITRO; DELIVERY; TISSUE; DRUG; BIOCOMPATIBILITY; COPOLYMERS;
   LIPOSOMES
AB We have developed an injectable thermosensitive hydrogel for local drug delivery to treat cancers clinically. We selected chitosan as a polymer matrix because of its biocompatibility and biodegradability. Glycerol 2-phosphate disodium salt hydrate (beta-GP) was used to neutralize the chitosan solution to physiological pH. The chitosan solution displayed a sol-gel phase transition in a pH- and temperature-dependent manner and formed an endothermic hydrogel after subcutaneous injection into mouse in the presence of beta-GP Additionally, we evaluated the biodegradation of chitosan hydrogel in mice by measuring the volume of injected chitosan hydrogel after subcutaneous injection. The injected chitosan hydrogel in mice was sected and stained with hematoxylin-eosin reagent for histological observation to confirm biodegradation of the hydrogel by the infiltrated cells. Chitosan hydrogel systems that possess biocompatibility and biodegradability could be promising thermosensitive injectable materials useful as depot systems for local anti-cancer drug delivery.
C1 Korea Res Inst Chem Technol, Adv Mat Div, Taejon 305606, South Korea.
   Chungnam Natl Univ, Dept Chem Engn, Taejon 305764, South Korea.
RP Shin, BC (reprint author), Korea Res Inst Chem Technol, Adv Mat Div, POB 107, Taejon 305606, South Korea.
EM bcshin@pado.krict.re.kr
CR Berger J, 2004, EUR J PHARM BIOPHARM, V57, P19, DOI 10.1016/s0939-6411(03)00161-9
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P35, DOI 10.1016/s0939-6411(03)00160-7
   Chenite A, 2001, CARBOHYD POLYM, V46, P39, DOI 10.1016/S0144-8617(00)00281-2
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   Fujita M, 2004, BIOMATERIALS, V25, P699, DOI 10.1016/S0142-9612(03)00557-X
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Kofuji K, 2004, INT J PHARM, V272, P65, DOI 10.1016/j.ijpharm.2003.11.036
   Lee JW, 2003, MACROMOL RES, V11, P189, DOI 10.1007/BF03218351
   Lee SB, 2004, MACROMOL RES, V12, P269, DOI 10.1007/BF03218399
   Liu HF, 2004, J BIOMAT SCI-POLYM E, V15, P25, DOI 10.1163/156856204322752219
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Matthew H. W. T., 2000, BIOMATERIALS, V21, P2589
   Mi FL, 2002, BIOMATERIALS, V23, P181, DOI 10.1016/S0142-9612(01)00094-1
   Molinaro G, 2002, BIOMATERIALS, V23, P2717, DOI 10.1016/S0142-9612(02)00004-2
   Paavola A, 2000, INT J PHARM, V199, P85, DOI 10.1016/S0378-5173(00)00376-8
   Park YS, 2004, POLYM-KOREA, V28, P59
   Ruel-Gariepy E, 2002, J CONTROL RELEASE, V82, P373, DOI 10.1016/S0168-3659(02)00146-3
   Ruel-Gariepy E, 2004, EUR J PHARM BIOPHARM, V57, P53, DOI 10.1016/S0939-6411(03)00095-X
   Ruel-Gariepy E, 2000, INT J PHARM, V203, P89, DOI 10.1016/S0378-5173(00)00428-2
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   Unezaki S, 1996, INT J PHARM, V144, P11, DOI 10.1016/S0378-5173(96)04674-1
   Zhao HR, 2002, BIOMATERIALS, V23, P4459, DOI 10.1016/S0142-9612(02)00162-X
NR 22
TC 33
Z9 34
U1 5
U2 39
PU POLYMER SOC KOREA
PI SEOUL
PA ROOM 601, HATCHON BUILDING, 831 YEOKSAM-DONG, KANGNAM-KU, SEOUL 135-792,
   SOUTH KOREA
SN 1598-5032
J9 MACROMOL RES
JI Macromol. Res.
PD OCT
PY 2004
VL 12
IS 5
BP 507
EP 511
DI 10.1007/BF03218435
PG 5
WC Polymer Science
SC Polymer Science
GA 868XX
UT WOS:000224947500013
DA 2018-10-19
ER

PT J
AU Loong, CK
   Thiyagarajan, P
   Kolesnikov, AI
AF Loong, CK
   Thiyagarajan, P
   Kolesnikov, AI
TI Neutron-scattering characterization of nanostructured materials relevant
   to biotechnology
SO NANOTECHNOLOGY
LA English
DT Article; Proceedings Paper
CT Nanoscale Devices and System Integration Conference (NDSI-2004)
CY FEB 15-19, 2004
CL Miami, FL
ID MECHANICAL FORCE-FIELDS; NUCLEIC-ACID BASES; VIBRATIONAL DYNAMICS;
   OPTICAL SPECTROSCOPIES; INELASTIC-SCATTERING; PROTEIN DYNAMICS;
   AMORPHOUS ICE; REFLECTIVITY; FIBRIL; BONE
AB Biomedical nanotechnology is a rapidly emerging field that encompasses many disciplines including medicine, molecular biology, materials physics and chemistry, engineering, etc. The complexity of the targeted systems demands cross-disciplinary research and international collaboration. In the materials front, understanding the fundamental properties at molecular level is important to the realization of the full potential of substances and the fruition of eventual technological applications. Neutron-scattering characterization of biomolecular systems can in principle provide unique information pertinent to nanotechnological applications. But the method is not widely utilized because neutron facilities are not normally located at industrial laboratories and university campuses. We introduce the techniques of neutron scattering for studying the organization of nanoscale structural units and their dynamic response to physical-chemical conditions. Examples are given to illustrate neutron characterization of nanostructured biomaterials and the implications for biotechnology.
C1 Argonne Natl Lab, Intense Pulsed Neutron Source Div, Argonne, IL 60439 USA.
RP Loong, CK (reprint author), Argonne Natl Lab, Intense Pulsed Neutron Source Div, 9700 S Cass Ave, Argonne, IL 60439 USA.
EM ckloong@anl.gov
RI Kolesnikov, Alexander/I-9015-2012
OI Kolesnikov, Alexander/0000-0003-1940-4649
CR Aamouche A, 1996, J PHYS CHEM-US, V100, P5224, DOI 10.1021/jp952485x
   Aamouche A, 1997, J PHYS CHEM A, V101, P1808, DOI 10.1021/jp962318c
   Aamouche A, 1997, J PHYS CHEM A, V101, P10063, DOI 10.1021/jp972037k
   Burkoth TS, 2000, J AM CHEM SOC, V122, P7883, DOI 10.1021/ja000645z
   Charitat T, 1999, EUR PHYS J B, V8, P583, DOI 10.1007/s100510050725
   CHEN SH, 1986, ANNU REV PHYS CHEM, V37, P351, DOI 10.1146/annurev.pc.37.100186.002031
   Daniel RM, 2003, ANNU REV BIOPH BIOM, V32, P69, DOI 10.1146/annurev.biophys.32.110601.142445
   DOSTER W, 1989, NATURE, V337, P754, DOI 10.1038/337754a0
   Dresselhaus M. S., 1996, SCI FULLERENES CARBO
   Gilbert RJC, 1999, J MOL BIOL, V293, P1145, DOI 10.1006/jmbi.1999.3210
   GLIMCHER MJ, 1998, NATURE MINERAL PHASE, P23
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   JACROT B, 1976, REP PROG PHYS, V39, P911, DOI 10.1088/0034-4885/39/10/001
   Kolesnikov AI, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.035503
   Kolesnikov AI, 1999, PHYSICA B, V263, P650, DOI 10.1016/S0921-4526(98)01438-0
   Kolesnikov AI, 1999, PHYS REV B, V59, P3569, DOI 10.1103/PhysRevB.59.3569
   Levicky R, 1998, J AM CHEM SOC, V120, P9787, DOI 10.1021/ja981897r
   Loong CK, 2000, BONE, V26, P599, DOI 10.1016/S8756-3282(00)00273-8
   Lu K, 2003, J AM CHEM SOC, V125, P6391, DOI 10.1021/ja0341642
   Parak FG, 2003, REP PROG PHYS, V66, P103, DOI 10.1088/0034-4885/66/2/201
   Pawlukojc A, 2002, SPECTROCHIM ACTA A, V58, P2897, DOI 10.1016/S1386-1425(02)00086-0
   Pawlukojc A, 1997, SPECTROCHIM ACTA A, V53, P927, DOI 10.1016/S1386-1425(96)01875-6
   Pomes R, 2002, BIOPHYS J, V82, P2304, DOI 10.1016/S0006-3495(02)75576-8
   Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1
   RICHTER D, 2000, POLYM DYNAMICS NEUTR, P535
   Russell TP, 1996, PHYSICA B, V221, P267, DOI 10.1016/0921-4526(95)00937-X
   SKOLD K, 1986, NEUTRON SCATTERING, VA
   STUHRMANN HB, 2000, STRUCTURE DYNAMICS B, P391
   Tatke SS, 2004, NANOTECHNOLOGY, V15, pS684, DOI 10.1088/0957-4484/15/10/030
   Thiyagarajan P, 1996, STRUCTURE, V4, P79, DOI 10.1016/S0969-2126(96)00011-1
   Thiyagarajan P, 2000, J APPL CRYSTALLOGR, V33, P535, DOI 10.1107/S0021889899014387
   Zaccai G, 2000, SCIENCE, V288, P1604, DOI 10.1126/science.288.5471.1604
   Zaccai G, 2003, J PHYS-CONDENS MAT, V15, pS1673, DOI 10.1088/0953-8984/15/18/301
NR 33
TC 4
Z9 4
U1 0
U2 2
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0957-4484
EI 1361-6528
J9 NANOTECHNOLOGY
JI Nanotechnology
PD OCT
PY 2004
VL 15
IS 10
SI SI
BP S664
EP S671
AR PII S0957-4484(04)76289-3
DI 10.1088/0957-4484/15/10/027
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA 866ZP
UT WOS:000224812200028
DA 2018-10-19
ER

PT J
AU Zhu, YT
   Lowe, TC
   Langdon, TG
AF Zhu, YT
   Lowe, TC
   Langdon, TG
TI Performance and applications of nanostructured materials produced by
   severe plastic deformation
SO SCRIPTA MATERIALIA
LA English
DT Article
DE applications; manufacturing; nanostructured materials; severe plastic
   deformation
ID STRAIN RATE SUPERPLASTICITY; ULTRAFINE-GRAINED TITANIUM; COMMERCIAL
   ALUMINUM-ALLOYS; BONDING ARB PROCESS; MICROSTRUCTURAL EVOLUTION;
   NANOCRYSTALLINE MATERIALS; AL-ALLOY; THERMAL-STABILITY; METALS;
   REFINEMENT
AB Nanostructured materials produced by severe plastic deformation can be tailored to have both superior performance and superior properties. These materials are attractive for use in a range of applications from biomedical to aerospace industries. (C) 2004 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 Los Alamos Natl Lab, Div Technol, Los Alamos, NM 87545 USA.
   Univ So Calif, Dept Aerosp & Mech Engn, Los Angeles, CA 90089 USA.
   Univ So Calif, Dept Mat Sci, Los Angeles, CA 90089 USA.
RP Zhu, YT (reprint author), Los Alamos Natl Lab, Div Technol, MS G755, Los Alamos, NM 87545 USA.
EM yzhu@lanl.gov
RI Langdon, Terence/B-1487-2008; Zhu, Yuntian/B-3021-2008
OI Zhu, Yuntian/0000-0002-5961-7422
CR Agnew SR, 2000, MAT SCI ENG A-STRUCT, V285, P391, DOI 10.1016/S0921-5093(00)00669-9
   Ball A., 1969, MET SCI J, V3, P1, DOI DOI 10.1179/MSC.1969.3.1.1
   BALYANOV A, 2004, ASTIPTA MAT, V51, P225
   Barnes AJ, 2001, MATER SCI FORUM, V357-3, P3, DOI 10.4028/www.scientific.net/MSF.357-359.3
   GLEITER H, 1989, PROG MATER SCI, V33, P223, DOI 10.1016/0079-6425(89)90001-7
   Horita Z, 2000, METALL MATER TRANS A, V31, P691, DOI 10.1007/s11661-000-0011-8
   Horita Z, 2001, MAT SCI ENG A-STRUCT, V318, P34, DOI 10.1016/S0921-5093(01)01339-9
   Huang JY, 2001, ACTA MATER, V49, P1497, DOI 10.1016/S1359-6454(01)00069-6
   Jia D, 2001, APPL PHYS LETT, V79, P611, DOI 10.1063/1.1384000
   Jiang HG, 2000, MAT SCI ENG A-STRUCT, V290, P128, DOI 10.1016/S0921-5093(00)00919-9
   Kamachi M, 2003, MAT SCI ENG A-STRUCT, V361, P258, DOI 10.1016/S0921-5093(03)00522-7
   LANGDON TG, 1994, ACTA METALL MATER, V42, P2437, DOI 10.1016/0956-7151(94)90322-0
   Lee JC, 2002, ACTA MATER, V50, P4005, DOI 10.1016/S1359-6454(02)00200-8
   Lee SM, 2001, MATER SCI FORUM, V357-3, P321, DOI 10.4028/www.scientific.net/MSF.357-359.321
   Liao XZ, 2004, APPL PHYS LETT, V84, P592, DOI 10.1063/1.1644051
   Liao XZ, 2003, APPL PHYS LETT, V83, P5062, DOI 10.1063/1.1633975
   Liao XZ, 2003, APPL PHYS LETT, V83, P632, DOI 10.1063/1.1594836
   LIAO XZ, IN PRESS J APPL PHYS
   McFadden SX, 1999, NATURE, V398, P684
   Mishra RS, 1999, SCRIPTA MATER, V42, P163, DOI 10.1016/S1359-6462(99)00329-2
   RAABE GJ, IN PRESS MAT SCI E A
   Saito Y, 2000, SCRIPTA MATER, V42, P1139, DOI 10.1016/S1359-6462(00)00349-3
   Saito Y, 1998, SCRIPTA MATER, V39, P1221, DOI 10.1016/S1359-6462(98)00302-9
   Sato YS, 2004, SCRIPTA MATER, V50, P57, DOI 10.1016/j.scriptamat.2003.09.037
   Schiotz J, 1998, NATURE, V391, P561, DOI 10.1038/35328
   Segal VM, 2002, MAT SCI ENG A-STRUCT, V338, P331, DOI 10.1016/S0921-5093(02)00066-7
   Siegel R.W., 1993, FUNDAMENTAL PROPERTI, P3
   Stolyarov VV, 1999, NANOSTRUCT MATER, V11, P947, DOI 10.1016/S0965-9773(99)00384-0
   Stolyarov VV, 2003, MAT SCI ENG A-STRUCT, V343, P43, DOI 10.1016/S0921-5093(02)00366-0
   STOLYAROV VV, IN PRESS MAT SCI E A
   Su JQ, 2003, J MATER RES, V18, P1757, DOI 10.1557/JMR.2003.0243
   SURYANARAYANA C, 1995, INT MATER REV, V40, P41, DOI 10.1179/imr.1995.40.2.41
   Suryanarayana C, 1999, NONEQUILIBRIUM PROCE
   Tsuji N, 1999, SCRIPTA MATER, V40, P795, DOI 10.1016/S1359-6462(99)00015-9
   Valiev R., UNPUB
   Valiev RZ, 2002, J MATER RES, V17, P5, DOI 10.1557/JMR.2002.0002
   Valiev RZ, 1997, SCRIPTA MATER, V37, P1945, DOI 10.1016/S1359-6462(97)00387-4
   Valiev RZ, 2000, PROG MATER SCI, V45, P103, DOI 10.1016/S0079-6425(99)00007-9
   Vinogradov A, 2003, ADV ENG MATER, V5, P351, DOI 10.1002/adem.200310078
   Wang YM, 2002, NATURE, V419, P912, DOI 10.1038/nature01133
   Wang ZB, 2003, MAT SCI ENG A-STRUCT, V352, P144, DOI 10.1016/S0921-5093(02)00870-5
   YANG NYC, SCRIPTA MAT
   Zhilyaev AP, 2003, ACTA MATER, V51, P753, DOI 10.1016/S1359-6454(02)00466-4
   Zhilyaev AP, 2003, PHYS STATUS SOLIDI A, V198, P263, DOI 10.1002/pssa.200306608
   Zhou F, 2003, ACTA MATER, V51, P2777, DOI 10.1016/S1359-6454(03)00083-1
   Zhu YT, 2001, METALL MATER TRANS A, V32, P1559, DOI 10.1007/s11661-001-0245-0
NR 46
TC 203
Z9 211
U1 3
U2 44
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1359-6462
J9 SCRIPTA MATER
JI Scr. Mater.
PD OCT
PY 2004
VL 51
IS 8
BP 825
EP 830
DI 10.1016/j.scriptamat.2004.05.006
PG 6
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 847JW
UT WOS:000223389500014
DA 2018-10-19
ER

PT J
AU Arshak, K
   Morris, D
   Korostynska, O
   Jafer, E
   Arshak, A
   Harris, J
   Clifford, S
   Lyons, G
AF Arshak, K
   Morris, D
   Korostynska, O
   Jafer, E
   Arshak, A
   Harris, J
   Clifford, S
   Lyons, G
TI Novel silicone-based capacitive pressure sensors with high sensitivity
   for biomedical applications
SO E-POLYMERS
LA English
DT Article
ID POLYMER; COMPOSITES; RUBBERS
AB In this work, an investigation of the pressure-sensing properties of a silicone rubber was conducted. Small amounts of carbon black were added to the silicone during fabrication and the effect on the sensitivity was explored. A full investigation of the mechanical and electrical properties of each composition shows that adding carbon black to the material greatly increases its sensitivity to pressure. This increase in sensitivity appears to be related to improvements in the material's permittivity, which increases with carbon loading.
C1 Univ Limerick, Dept Elect & Comp Engn, Limerick, Ireland.
   Univ Limerick, Dept Phys, Limerick, Ireland.
RP Arshak, K (reprint author), Univ Limerick, Dept Elect & Comp Engn, Plassey Technol Pk, Limerick, Ireland.
EM arousian.arshak@ul.ie; arousian.arshak@ul.ie
RI OLaighin, Gearoid/A-5239-2009
OI OLaighin, Gearoid/0000-0002-1885-814X; Korostynska,
   Olga/0000-0003-0387-6609
CR Arshak KI, 2000, SENSOR ACTUAT A-PHYS, V79, P102, DOI 10.1016/S0924-4247(99)00275-7
   Chang CL, 2004, POLYM DEGRAD STABIL, V85, P769, DOI 10.1016/j.polymdegradstab.2003.12.001
   CRISTALLI C, 1995, IEEE EMBC CMBEC, P1541
   DARGAHI J, 1998, INT C INT ROB SYST, P1503
   Flick BB, 2000, IEEE T BIO-MED ENG, V47, P12, DOI 10.1109/10.817613
   Foulger SH, 1999, J APPL POLYM SCI, V72, P1573, DOI 10.1002/(SICI)1097-4628(19990620)72:12<1573::AID-APP10>3.3.CO;2-Y
   Hussain M, 2001, SCRIPTA MATER, V44, P1203, DOI 10.1016/S1359-6462(01)00685-6
   Hussain M, 2001, COMPOS PART A-APPL S, V32, P1689, DOI 10.1016/S1359-835X(01)00035-5
   JACKSON HW, 1989, INTRO ELECT CIRCUITS
   Leisen J, 1999, RUBBER CHEM TECHNOL, V72, P1, DOI 10.5254/1.3538790
   Liu KK, 2004, REV SCI INSTRUM, V75, P524, DOI 10.1063/1.1638894
   NEUMAN MR, 1994, IEEE ENG MED BIOL, V13, P409, DOI 10.1109/51.294013
   O'Sullivan S, 2003, J PHYS D APPL PHYS, V36, P1910, DOI 10.1088/0022-3727/36/15/324
   OSSWALD TA, 2003, MAT SCI POLYM ENGN
   PUERS R, 1993, SENSOR ACTUAT A-PHYS, V37-8, P93, DOI 10.1016/0924-4247(93)80019-D
   RADHAKRISHNAN S, 1994, MATER LETT, V18, P358, DOI 10.1016/0167-577X(94)90023-X
   Sichel E. K., 1982, CARBON BLACK POLYM C
   Tiwari A, 2004, THERMOCHIM ACTA, V417, P133, DOI 10.1016/j.tca.2003.10.003
   Wycisk R, 2002, J ELECTROSTAT, V56, P55, DOI 10.1016/S0304-3886(01)00204-2
NR 19
TC 0
Z9 0
U1 0
U2 4
PU EUROPEAN POLYMER FEDERATION
PI STRASBOURG
PA 1, QUAI LEZAY-MARNESIA, F067000 STRASBOURG, FRANCE
SN 1618-7229
J9 E-POLYMERS
JI e-Polymers
PD SEP 29
PY 2004
AR 061
PG 11
WC Polymer Science
SC Polymer Science
GA 858HL
UT WOS:000224182800001
DA 2018-10-19
ER

PT J
AU Gongora-Rubio, MR
   Fontes, MBA
   da Rocha, ZM
   Richter, EM
   Angnes, L
AF Gongora-Rubio, MR
   Fontes, MBA
   da Rocha, ZM
   Richter, EM
   Angnes, L
TI LTCC manifold for heavy metal detection system in biomedical and
   environmental fluids
SO SENSORS AND ACTUATORS B-CHEMICAL
LA English
DT Article; Proceedings Paper
CT 17th European Conference on Solid-State Transducers (Eurosensors XVII)
CY SEP 21-24, 2003
CL Univ Minho, Guimaraes, PORTUGAL
HO Univ Minho
DE low temperature cofired ceramics (LTCC); chemical sensors; FlA; heavy
   metals detection
ID TECHNOLOGY
AB This work gives a description of how low temperature cofired ceramics (LTCC) technology is a suitable material for the fabrication of a flow injection analysis (FIA) meso-analytical system applicable for detection of heavy metals (in trace levels) in biological and environmental fluids. This paper presents the design processing, fabrication and materials characterization issues of a LTCC manifold integrated with sensor electrodes. The requirement of on-line measurement tests with high sensitivity for heavy metals has motivated the development of sensors for electrochemical stripping techniques in flow. Experiments involving short time pre-concentration scheme (60 s), for mercury and cooper, indicate a lower detection limit of 0.9 and 0.45 mug L-1, respectively, which is much lower than the maximum tolerable concentration for urinary fluids. Lower limits can be attained utilizing longer deposition times in order to achieve requirements for fresh waters. (C) 2004 Elsevier B.V. All rights reserved.
C1 IPT, DITT, Lab Instrumentacao, Sao Paulo, Brazil.
   Univ Sao Paulo, LSI, EPUSP, Sao Paulo, Brazil.
   Univ Sao Paulo, Inst Quim, Sao Paulo, Brazil.
RP Gongora-Rubio, MR (reprint author), IPT, DITT, Lab Instrumentacao, Sao Paulo, Brazil.
EM gongoram@ipt.br
RI Richter, Eduardo/G-5711-2011; Gongora-Rubio, Mario/P-2211-2018;
   Institute of Chemistry - USP, Dept. of Chemistry/B-8988-2012
OI Richter, Eduardo/0000-0002-3840-8277; Gongora-Rubio,
   Mario/0000-0002-1267-055X; 
CR Bauer R., 1997, INTS MICR, P659
   DAROCHA ZM, 2004, IMAPS C EXH CER INT, V5
   ESPINOZAVALLEJO.P, 1998, MRS C P, V518
   FONBTES MBA, 2001, 16 INT C MICR EL PAC
   Fontes M. B. A., 1999, Journal of Solid-State Devices and Circuits, V7, P12
   Gongora-Rubio M, 1999, SENSOR ACTUAT A-PHYS, V73, P215, DOI 10.1016/S0924-4247(98)00238-6
   Gongora-Rubio MR, 2001, SENSOR ACTUAT A-PHYS, V89, P222, DOI 10.1016/S0924-4247(00)00554-9
   GONGORUBIO MR, 2002, P IBERSENSOR 2002, P72
   Hellio C, 2001, BIOFOULING, V17, P189, DOI 10.1080/08927010109378478
   Reay RJ, 1996, SENSOR ACTUAT B-CHEM, V34, P450, DOI 10.1016/S0925-4005(97)80018-4
   Richter EM, 2000, FRESEN J ANAL CHEM, V366, P444, DOI 10.1007/s002160050090
   Roosen A, 2001, J EUR CERAM SOC, V21, P1993, DOI 10.1016/S0955-2219(01)00158-3
   ROOSEN A, 2002, INT S MICR
   WAGNER M, 2002, INT S MICR
   WEGENG RS, 1996, 1996 SPRING NATK M A
NR 15
TC 33
Z9 33
U1 1
U2 10
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-4005
J9 SENSOR ACTUAT B-CHEM
JI Sens. Actuator B-Chem.
PD SEP 29
PY 2004
VL 103
IS 1-2
BP 468
EP 473
DI 10.1016/j.snb.2004.05.007
PG 6
WC Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation
SC Chemistry; Electrochemistry; Instruments & Instrumentation
GA 856SC
UT WOS:000224064100072
DA 2018-10-19
ER

PT J
AU Peppas, NA
   Ward, JH
AF Peppas, NA
   Ward, JH
TI Biomimetic materials and micropatterned structures using iniferters
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE biomimetic materials; synthesis; polymerization; fractional groups
ID LIVING RADICAL POLYMERIZATIONS; SURFACE-CHEMISTRY; POLYMER SURFACES;
   STAR POLYMERS; CELLS; DITHIOCARBAMATE; RECOGNITION; ATTACHMENT;
   COPOLYMERS; MONOLAYERS
AB In the preparation of biomimetic materials it is often required that efficient methods of polymerization be used, often methods that can lead to biomimetic polymers with relatively narrow molecular weight distribution. Living radical polymerization techniques have successfully been used to create low polydispersity linear polymers by free-radical polymerizations. Although this technique slows down the polymerization of multifunctional monomers, there is little effect on the network structure due to the high concentration of pendent double bonds. There are applications of the living radical polymerization in the synthesis of block copolymers. Essentially, the technique involves polymerizing a single type of monomer first to create a macromonomer that is capable of acting as an initiator because of the reversible bond between the polymer end group and the terminating group. This terminating group may be a thiol or a halogen and, under the right conditions, will dissociate to form radicals. A second monomer is then added to the system and the polymerization proceeds with the second monomer chemically attached to the polymer of the first monomer. We review methods of creating biomimetic block copolymers using the iniferter radical polymerization technique. The block copolymers would be used in the synthesis of micropatterned polymer films for use in biomaterials and other biomedical applications. (C) 2004 Elsevier B.V. All rights reserved.
C1 Univ Texas, Dept Chem Engn, Austin, TX 78712 USA.
   Univ Texas, Dept Biomed Engn, Austin, TX 78712 USA.
   Univ Texas, Div Pharmaceut, Austin, TX 78712 USA.
RP Peppas, NA (reprint author), Univ Texas, Dept Chem Engn, CPE 3-466,C-0400,1 Univ Stn, Austin, TX 78712 USA.
EM peppas@che.utexas.edu
CR Blawas AS, 1998, BIOMATERIALS, V19, P595, DOI 10.1016/S0142-9612(97)00218-4
   BUCK RP, 1995, BIOMEDICAL ENG HDB, P779
   BYME ME, 2002, POLYM ADVAN TECHNOL, V13, P798
   CHINN JA, 1995, BIOMEDICAL ENG HDB
   de Boer B, 2000, MACROMOLECULES, V33, P349, DOI 10.1021/ma9910944
   DeFife KM, 1999, J BIOMED MATER RES, V45, P148, DOI 10.1002/(SICI)1097-4636(199905)45:2<148::AID-JBM10>3.0.CO;2-U
   Deutsch J, 2000, J BIOMED MATER RES, V53, P267, DOI 10.1002/(SICI)1097-4636(2000)53:3<267::AID-JBM12>3.0.CO;2-J
   Higashi J, 1999, LANGMUIR, V15, P2080, DOI 10.1021/la9810511
   Hilt JZ, 2002, MATER RES SOC SYMP P, V729, P173
   Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3
   KANE RS, 1999, BIOMATERIALS, V20, P2362
   Kannurpatti AR, 1996, MACROMOLECULES, V29, P7310, DOI 10.1021/ma951914m
   Kannurpatti AR, 1997, J POLYM SCI POL PHYS, V35, P2297, DOI 10.1002/(SICI)1099-0488(199710)35:14<2297::AID-POLB10>3.0.CO;2-7
   LOWMAN AM, 1999, ENCY CONTROLLED DRUG
   Macilwain C, 1999, NATURE, V400, P95, DOI 10.1038/21937
   Madou MJ, 1997, FUNDAMENTALS MICROFA
   MATSUDA T, 1995, J BIOMED MATER RES, V29, P749, DOI 10.1002/jbm.820290611
   Matyjaszewski K, 1999, MACROMOLECULES, V32, P6526, DOI 10.1021/ma9904823
   Mayer J, 2000, J CONTROL RELEASE, V64, P81, DOI 10.1016/S0168-3659(99)00136-4
   MOORE JE, 1977, CHEM PROPERTIES CROS, P535
   Nakayama Y, 1996, MACROMOLECULES, V29, P8622, DOI 10.1021/ma9606014
   NEUMAN MR, 1995, BIOMEDICAL ENG HDB, P725
   OTSU T, 1982, MAKROMOL CHEM-RAPID, V3, P133
   OTSU T, 1982, MAKROMOL CHEM-RAPID, V3, P127
   Patel N, 1998, FASEB J, V12, P1447
   Patel N, 1999, LANGMUIR, V15, P7252, DOI 10.1021/la981268v
   Peppas NA, 1997, CURR OPIN COLLOID IN, V2, P531, DOI 10.1016/S1359-0294(97)80103-3
   PEPPAS NA, 2000, P EUR S CONTROL DRUG, V6, P21
   Scotchford CA, 1998, J BIOMED MATER RES, V41, P431, DOI 10.1002/(SICI)1097-4636(19980905)41:3<431::AID-JBM13>3.0.CO;2-L
   SCOTT R, 2000, HDB PHARM CONTROLLED, P47
   Sebenik A, 1998, PROG POLYM SCI, V23, P875, DOI 10.1016/S0079-6700(98)00001-X
   Shi HQ, 2000, J BIOMED MATER RES, V49, P1
   Shi HQ, 1999, NATURE, V398, P593
   SHINGHVI R, 1994, SCIENCE, V264, P296
   Shipp DA, 1998, MACROMOLECULES, V31, P8005, DOI 10.1021/ma981033q
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Tharanikkarasu K, 1997, J APPL POLYM SCI, V66, P1551
   Thomas CH, 1997, J BIOMED MATER RES, V37, P81, DOI 10.1002/(SICI)1097-4636(199710)37:1<81::AID-JBM10>3.0.CO;2-T
   TURNER SR, 1990, MACROMOLECULES, V23, P1856, DOI 10.1021/ma00208a050
   Ward JH, 2000, MACROMOLECULES, V33, P5137, DOI 10.1021/ma000001b
   Ward JH, 2002, POLYMER, V43, P1745, DOI 10.1016/S0032-3861(01)00779-0
   Ward JH, 2000, PROC SPIE, V4097, P221, DOI 10.1117/12.390582
   Ward JH, 2001, J BIOMED MATER RES, V56, P351, DOI 10.1002/1097-4636(20010905)56:3<351::AID-JBM1103>3.0.CO;2-A
   Zhang SG, 1999, BIOMATERIALS, V20, P1213, DOI 10.1016/S0142-9612(99)00014-9
   Zhang X, 2000, MACROMOLECULES, V33, P2340, DOI 10.1021/ma991076m
NR 45
TC 15
Z9 15
U1 0
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD SEP 22
PY 2004
VL 56
IS 11
BP 1587
EP 1597
DI 10.1016/j.addr.2003.10.046
PG 11
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 857QK
UT WOS:000224133200006
PM 15350290
DA 2018-10-19
ER

PT J
AU Li, HX
   Rothberg, LJ
AF Li, HX
   Rothberg, LJ
TI DNA sequence detection using selective fluorescence quenching of tagged
   oligonucleotide probes by gold nanoparticles
SO ANALYTICAL CHEMISTRY
LA English
DT Article
AB Simple, fast, economical, and sensitive detection of specific DNA sequences is crucial to pathogen detection and biomedical research. We have designed a novel fluorescent assay for DNA hybridization based on the electrostatic properties of DNA. We exploit the ability to create conditions where single-stranded DNA adsorbs on negatively charged gold nanoparticles while double-stranded DNA does not. Dye-tagged probe sequences have their fluorescence efficiently quenched when they are mixed with gold nanoparticles unless they hybridize with components of the analyte. Subfemtomole amounts of untagged target are detected in minutes using commercially available materials. Target sequences in complex mixtures of DNA and single-base mismatches in DNA sequences are easily detected.
C1 Univ Rochester, Dept Chem, Rochester, NY 14627 USA.
RP Rothberg, LJ (reprint author), Univ Rochester, Dept Chem, Rochester, NY 14627 USA.
EM rothberg@chem.rochester.edu
FU NIA NIH HHS [AG18231]
CR Alivisatos AP, 2004, NAT BIOTECHNOL, V22, P47, DOI DOI 10.1038/NBT927
   Brockman JM, 2000, ANNU REV PHYS CHEM, V51, P41, DOI 10.1146/annurev.physchem.51.1.41
   Cao YWC, 2002, SCIENCE, V297, P1536, DOI 10.1126/science.297.5586.1536
   Chan S, 2001, MAT SCI ENG C-BIO S, V15, P277, DOI 10.1016/S0928-4931(01)00219-3
   Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610
   Du H, 2003, J AM CHEM SOC, V125, P4012, DOI 10.1021/ja0290781
   Dubertret B, 2001, NAT BIOTECHNOL, V19, P365, DOI 10.1038/86762
   Elghanian R, 1997, SCIENCE, V277, P1078, DOI 10.1126/science.277.5329.1078
   Epstein JR, 2002, ANAL CHIM ACTA, V469, P3, DOI 10.1016/S0003-2670(02)00030-2
   Gaylord BS, 2003, J AM CHEM SOC, V125, P896, DOI 10.1021/ja027152+
   Gradar K. C., 1995, ANAL CHEM, V67, P735
   LI HX, IN PRESS J AM CHEM S
   LI HX, IN PRESS P NAT AC SC
   Lin VSY, 1997, SCIENCE, V278, P840, DOI 10.1126/science.278.5339.840
   LU J, IN PRESS ANAL CHEM
   Maxwell DJ, 2002, J AM CHEM SOC, V124, P9606, DOI 10.1021/ja025814p
   Pan SL, 2003, NANO LETT, V3, P811, DOI 10.1021/nl034055l
   Park SJ, 2002, SCIENCE, V295, P1503, DOI 10.1126/science.1067003
   ROLFS A, 1992, PCR CLIN DIAGNOSTICS
   SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0
   Taton TA, 2000, SCIENCE, V289, P1757, DOI 10.1126/science.289.5485.1757
NR 21
TC 227
Z9 231
U1 2
U2 80
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0003-2700
J9 ANAL CHEM
JI Anal. Chem.
PD SEP 15
PY 2004
VL 76
IS 18
BP 5414
EP 5417
DI 10.1021/ac049173n
PG 4
WC Chemistry, Analytical
SC Chemistry
GA 854UL
UT WOS:000223928800022
PM 15362900
DA 2018-10-19
ER

PT J
AU Lee, JY
   Buxton, GA
   Balazs, AC
AF Lee, JY
   Buxton, GA
   Balazs, AC
TI Using nanoparticles to create self-healing composites
SO JOURNAL OF CHEMICAL PHYSICS
LA English
DT Article
ID LATTICE SPRING MODEL; MIXTURES; NANOCOMPOSITES; SIMULATIONS; DEPLETION;
   POLYMERS; FRACTURE; BLENDS
AB The need for viable materials for optical communications, display technologies, and biomedical engineering is driving the creation of multilayer composites that combine brittle materials, such as glass, with moldable polymers. However, crack formation is a critical problem in composites where thin brittle films lie in contact with deformable polymer layers. Using computer simulations, we show that adding nanoparticles to the polymers yields materials in which the particles become localized at nanoscale cracks and effectively form "patches" to repair the damaged regions. Through micromechanics simulations, we evaluate the properties of these systems in the undamaged, damaged, and healed states and determine optimal conditions for harnessing nanoparticles to act as responsive, self-assembled "band aids" for composite materials. The results reveal situations where the mechanical properties of the repaired composites can potentially be restored to 75%-100% of the undamaged material. (C) 2004 American Institute of Physics.
C1 Univ Pittsburgh, Dept Chem Engn, Pittsburgh, PA 15261 USA.
RP Balazs, AC (reprint author), Univ Pittsburgh, Dept Chem Engn, Pittsburgh, PA 15261 USA.
EM balazsl@engr.pitt.edu
OI Balazs, Anna/0000-0002-5555-2692
CR ASAKURA S, 1958, J POLYM SCI, V33, P183, DOI 10.1002/pol.1958.1203312618
   BANASZAK M, 1992, MACROMOLECULES, V25, P3406, DOI 10.1021/ma00039a015
   Bockstaller MR, 2003, J AM CHEM SOC, V125, P5276, DOI 10.1021/ja034523t
   Buxton GA, 2004, MOL SIMULAT, V30, P249, DOI 10.1080/08927020310001659142
   Buxton GA, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.031802
   Buxton GA, 2002, J CHEM PHYS, V117, P7649, DOI 10.1063/1.1509447
   Buxton GA, 2001, MODEL SIMUL MATER SC, V9, P485, DOI 10.1088/0965-0393/9/6/302
   Calvert P, 2002, PHILOS T ROY SOC A, V360, P199, DOI 10.1098/rsta.2001.0925
   Cuesta JA, 1997, J CHEM PHYS, V107, P6379, DOI 10.1063/1.474298
   Dinsmore AD, 1999, LANGMUIR, V15, P314, DOI 10.1021/la981243w
   Dinsmore AD, 1996, NATURE, V383, P239, DOI 10.1038/383239a0
   Doxastakis M, 2004, J CHEM PHYS, V120, P9335, DOI 10.1063/1.1704634
   Drolet F, 1999, PHYS REV LETT, V83, P4317, DOI 10.1103/PhysRevLett.83.4317
   Gersappe D, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.058301
   Huh J, 2000, MACROMOLECULES, V33, P8085, DOI 10.1021/ma000708y
   Kickelbick G, 2003, PROG POLYM SCI, V28, P83, DOI 10.1016/S0079-6700(02)00019-9
   Kim JU, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.238301
   Lee J, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.136103
   Lee JY, 2003, MACROMOLECULES, V36, P7730, DOI 10.1021/ma034765d
   Lee JY, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.155503
   Lin KH, 2000, PHYS REV LETT, V85, P1770, DOI 10.1103/PhysRevLett.85.1770
   Matsen MW, 2002, J PHYS-CONDENS MAT, V14, pR21, DOI 10.1088/0953-8984/14/2/201
   McGuigan AP, 2003, THIN SOLID FILMS, V424, P219, DOI 10.1016/S0040-6090(02)01124-0
   MONETTE L, 1994, J APPL PHYS, V75, P1442, DOI 10.1063/1.356378
   MONETTE L, 1994, MODEL SIMUL MATER SC, V2, P53, DOI 10.1088/0965-0393/2/1/004
   Picu RC, 2003, J CHEM PHYS, V118, P11239, DOI 10.1063/1.1576216
   Rountree CL, 2002, ANNU REV MATER RES, V32, P377, DOI 10.1146/annurev.matsci.32.111201.142017
   Shou ZY, 2003, COMPOS INTERFACE, V10, P343, DOI 10.1163/156855403771953632
   Sinani VA, 2003, NANO LETT, V3, P1177, DOI 10.1021/nl0255045
   Spoerke ED, 2003, J BIOMED MATER RES A, V67A, P960, DOI 10.1002/jbm.a.10102
   Suo Z, 2003, J MECH PHYS SOLIDS, V51, P2169, DOI 10.1016/j.jmps.2003.09.022
   Thompson RB, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.031801
   Thompson RB, 2001, SCIENCE, V292, P2469, DOI 10.1126/science.1060585
   Trau M, 1997, LANGMUIR, V13, P6375, DOI 10.1021/la970568u
   Tuinier R, 2003, ADV COLLOID INTERFAC, V103, P1, DOI 10.1016/S0001-8686(02)00081-7
   *U KONST, 1995, PHYSICA A, V18
   White SR, 2001, NATURE, V409, P794, DOI 10.1038/35057232
NR 37
TC 114
Z9 117
U1 7
U2 100
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 0021-9606
EI 1089-7690
J9 J CHEM PHYS
JI J. Chem. Phys.
PD SEP 15
PY 2004
VL 121
IS 11
BP 5531
EP 5540
DI 10.1063/1.1784432
PG 10
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA 851XU
UT WOS:000223720600058
PM 15352848
DA 2018-10-19
ER

PT J
AU Zhang, JT
   Chua, LS
   Lynn, DM
AF Zhang, JT
   Chua, LS
   Lynn, DM
TI Multilayered thin films that sustain the release of functional DNA under
   physiological conditions
SO LANGMUIR
LA English
DT Article
ID BY-LAYER DEPOSITION; QUARTZ-CRYSTAL MICROBALANCE; ULTRATHIN
   POLYMER-FILMS; IN-VIVO REPAIR; POLYELECTROLYTE MULTILAYERS; GENE
   DELIVERY; PLASMID DNA; CORONARY-ARTERIES; BLOOD-VESSELS; MICROCAPSULES
AB The development of thin films and coatings that control the release of DNA from the surfaces of materials could have a significant impact on localized approaches to gene therapy. Here, we report multilayered polyelectrolyte assemblies that sustain the release of functional plasmid DNA from the surfaces of model substrates under physiological conditions. Multilayered assemblies consisting of alternating layers of plasmid DNA encoding for enhanced green fluorescent protein (EGFP) and a synthetic degradable polyamine were deposited on planar silicon and quartz substrates using a layer-by-layer fabrication process. Film growth was monitored by ellipsometry and UV spectrophotometry and correlated linearly with the number of polymer and plasmid layers deposited. In general, the thickness of deposited layers was found to be a function of both the pH and the ionic strength of the polyelectrolyte solutions used. Films up to 100 nm thick were investigated in this study. These assemblies erode gradually upon incubation in phosphate-buffered saline at 37 degreesC, as determined by ellipsometry and UV spectrophotometry, and sustain the release of incorporated plasmid into the incubation medium for a period of up to 30 h. Characterization of the released plasmid by agarose gel electrophoresis revealed that the DNA was released in a relaxed, open circular, rather than supercoiled, topology; subsequent cell transfection experiments demonstrated that the released plasmid is transcriptionally viable and promotes the expression of EGFP in the COS-7 cell line. These layered materials could represent an approach to the controlled administration of one or more functional DNA constructs from the surfaces of biomedical materials and devices.
C1 Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA.
RP Lynn, DM (reprint author), Univ Wisconsin, Dept Chem & Biol Engn, 1415 Engn Dr, Madison, WI 53706 USA.
RI Zhang, Jingtao/D-2590-2011
FU NIBIB NIH HHS [EB02746]
CR Ando S, 1999, J PHARM SCI, V88, P126, DOI 10.1021/js9801687
   Antipov AA, 2002, COLLOID SURFACE A, V198, P535, DOI 10.1016/S0927-7757(01)00956-6
   Antipov AA, 2001, J PHYS CHEM B, V105, P2281, DOI 10.1021/jp002184+
   Bertrand P, 2000, MACROMOL RAPID COMM, V21, P319, DOI 10.1002/(SICI)1521-3927(20000401)21:7<319::AID-MARC319>3.0.CO;2-7
   Caruso F, 1998, COLLOID SURFACE B, V10, P199, DOI 10.1016/S0927-7765(97)00067-2
   Caruso F, 1997, ANAL CHEM, V69, P2043, DOI 10.1021/ac961220r
   Chluba J, 2001, BIOMACROMOLECULES, V2, P800, DOI 10.1021/bm015529i
   Cho J, 2003, MACROMOLECULES, V36, P2845, DOI 10.1021/ma021049n
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Dubas ST, 2001, J AM CHEM SOC, V123, P5368, DOI 10.1021/ja015774+
   Dubas ST, 2001, MACROMOLECULES, V34, P3736, DOI 10.1021/ma001720t
   Elbert DL, 1999, LANGMUIR, V15, P5355, DOI 10.1021/la9815749
   Groth T, 2004, ANGEW CHEM INT EDIT, V43, P926, DOI 10.1002/anie.200301708
   Jin W, 2001, J AM CHEM SOC, V123, P8121, DOI 10.1021/ja015807l
   Klugherz BD, 2000, NAT BIOTECHNOL, V18, P1181
   Klugherz BD, 2002, HUM GENE THER, V13, P443, DOI 10.1089/10430340252792576
   Lang J, 1999, J PHYS CHEM B, V103, P11393, DOI 10.1021/jp9915073
   Luo D, 2000, NAT BIOTECHNOL, V18, P33
   LVOV Y, 1993, MACROMOLECULES, V26, P5396, DOI 10.1021/ma00072a016
   Lvov Y, 2001, NANO LETT, V1, P125, DOI 10.1021/nl0100015
   Lynn DM, 2000, J AM CHEM SOC, V122, P10761, DOI 10.1021/ja0015388
   Mendelsohn JD, 2003, BIOMACROMOLECULES, V4, P96, DOI 10.1021/bm0256101
   NELSON DL, 2000, LEHNINGER PRINCIPLES, P916
   Pei RJ, 2001, BIOMACROMOLECULES, V2, P463, DOI 10.1021/bm0001289
   Qiu XP, 2001, LANGMUIR, V17, P5375, DOI 10.1021/la010201w
   Richert L, 2002, BIOMACROMOLECULES, V3, P1170, DOI 10.1021/bm.0255490
   Saltzman WM, 1999, NAT BIOTECHNOL, V17, P534, DOI 10.1038/9835
   Saltzman WM, 2002, NAT REV DRUG DISCOV, V1, P177, DOI 10.1038/nrd744
   Sambrook JF, 2001, MOL CLONING LAB MANU, V1, p[17, 1]
   Schuler C, 2001, BIOMACROMOLECULES, V2, P921, DOI 10.1021/bm010052w
   Schwinte P, 2002, BIOMACROMOLECULES, V3, P1135, DOI 10.1021/bm025547f
   Schwinte P, 2001, J PHYS CHEM B, V105, P11906, DOI 10.1021/jp0123031
   Segura T, 2002, BIOCONJUGATE CHEM, V13, P621, DOI 10.1021/bc015575f
   Serizawa T, 2003, ANGEW CHEM INT EDIT, V42, P1115, DOI 10.1002/anie.200390293
   Serizawa T, 2002, MACROMOLECULES, V35, P8656, DOI 10.1021/ma012153s
   Serizawa T, 2002, BIOMACROMOLECULES, V3, P724, DOI 10.1021/bm0200027
   Shchukin DG, 2004, J AM CHEM SOC, V126, P3374, DOI 10.1021/ja036952x
   Shea LD, 1999, NAT BIOTECHNOL, V17, P551
   Shi XY, 2002, J PHYS CHEM B, V106, P1173, DOI 10.1021/jp0132634
   Shi XY, 2001, LANGMUIR, V17, P2036, DOI 10.1021/la001550d
   Singh M, 2000, P NATL ACAD SCI USA, V97, P811, DOI 10.1073/pnas.97.2.811
   Sukhishvili SA, 2000, J AM CHEM SOC, V122, P9550, DOI 10.1021/ja002410t
   Sukhishvili SA, 2002, MACROMOLECULES, V35, P301, DOI 10.1021/ma011346c
   Sukhorukov GB, 2001, MACROMOL RAPID COMM, V22, P44, DOI 10.1002/1521-3927(20010101)22:1<44::AID-MARC44>3.0.CO;2-U
   Thierry B, 2003, BIOMACROMOLECULES, V4, P1564, DOI 10.1021/bm0341834
   Thierry B, 2003, J AM CHEM SOC, V125, P7494, DOI 10.1021/ja034321x
   Tiourina OP, 2001, MACROMOL BIOSCI, V1, P209, DOI 10.1002/1616-5195(20010701)1:5<209::AID-MABI209>3.0.CO;2-Y
   Trimaille T, 2003, COLLOID SURFACE A, V221, P39, DOI 10.1016/S0927-7757(03)00105-5
   Trubetskoy VS, 1999, NUCLEIC ACIDS RES, V27, P3090, DOI 10.1093/nar/27.15.3090
   Tryoen-Toth P, 2002, J BIOMED MATER RES, V60, P657, DOI 10.1002/jbm.10110
   Vazquez E, 2002, J AM CHEM SOC, V124, P13992, DOI 10.1021/ja026405w
   Wang C, 2004, NAT MATER, V3, P190, DOI 10.1038/nmat1075
NR 52
TC 216
Z9 219
U1 1
U2 51
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD SEP 14
PY 2004
VL 20
IS 19
BP 8015
EP 8021
DI 10.1021/la048888i
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 853SF
UT WOS:000223847300020
PM 15350066
DA 2018-10-19
ER

PT J
AU Kumar, S
   Kumar, R
   Kumar, S
   Chakarvarti, SK
AF Kumar, Sanjeev
   Kumar, Rajesh
   Kumar, Shyam
   Chakarvarti, S. K.
TI Electrochemical synthesis of metallic microstructures using etched ion
   tracks in nuclear track filters
SO CURRENT SCIENCE
LA English
DT Article
AB Interest in nano/microstructures results from their numerous potential applications in various areas such as materials and biomedical sciences, electronics, optics, magnetism, energy storage and electrochemistry. Materials with micro/nanoscopic dimensions not only have potential technological applications in areas such as device technology and drug delivery, but also are of fundamental interest in that the properties of a material can change in this regime of transition between the bulk and molecular scales. Electrodeposition is a versatile technique combining low processing cost with ambient conditions that can be used to prepare metallic, polymeric and semiconducting microstructures. In the present work ion track membranes of Makrofol ( KG) have been used as templates for synthesis of metallic microstructures using the technique of electrodeposition.
C1 [Kumar, Sanjeev; Kumar, Shyam] Kurukshetra Univ, Dept Phys, Kurukshetra 136119, Haryana, India.
   [Kumar, Rajesh; Chakarvarti, S. K.] Deemed Univ, Nat Inst Technol, Dept Appl Phys, Kurukshetra 136119, Haryana, India.
RP Kumar, S (reprint author), Kurukshetra Univ, Dept Phys, Kurukshetra 136119, Haryana, India.
EM bhogrask@yahoo.co.in
CR Bate R. T., 1990, Nanotechnology, V1, P1, DOI 10.1088/0957-4484/1/1/001
   Bean C.P, 1969, U.S. Patent, Patent No. [34 483095, 3483095]
   CAI ZH, 1989, J AM CHEM SOC, V111, P4138, DOI 10.1021/ja00193a077
   CHAKARVARTI SK, 1991, NUCL INSTRUM METH B, V62, P109, DOI 10.1016/0168-583X(91)95936-8
   Dai HJ, 1996, NATURE, V384, P147, DOI 10.1038/384147a0
   Dobrev D, 1999, APPL PHYS A-MATER, V69, P233, DOI 10.1007/s003390050995
   Dobrev D., ELECTROCHEMICAL CELL
   FISCHER BE, 1983, REV MOD PHYS, V55, P907, DOI 10.1103/RevModPhys.55.907
   FOSS CA, 1994, J PHYS CHEM-US, V98, P2963, DOI 10.1021/j100062a037
   Frazier A. B., 1993, Journal of Microelectromechanical Systems, V2, P87, DOI 10.1109/84.232605
   GRANSTROM M, 1995, SCIENCE, V267, P1479, DOI 10.1126/science.267.5203.1479
   KLEIN JD, 1993, CHEM MATER, V5, P902, DOI 10.1021/cm00031a002
   MARTIN CR, 1994, SCIENCE, V266, P1961, DOI 10.1126/science.266.5193.1961
   MOLARES MET, 2001, NUCL INSTRUM METH B, V185, P192
   Pra LDD, 2002, NUCL INSTRUM METH B, V196, P81
   Schuchert IU, 2003, J ELECTROCHEM SOC, V150, pC189, DOI 10.1149/1.1554722
   Tian ML, 2003, NANO LETT, V3, P919, DOI 10.1021/nl034217d
   Toimil-Molares ME, 2003, APPL PHYS LETT, V82, P2139, DOI 10.1063/1.1563741
NR 18
TC 7
Z9 7
U1 0
U2 4
PU INDIAN ACAD SCIENCES
PI BANGALORE
PA C V RAMAN AVENUE, SADASHIVANAGAR, P B #8005, BANGALORE 560 080, INDIA
SN 0011-3891
J9 CURR SCI INDIA
JI Curr. Sci.
PD SEP 10
PY 2004
VL 87
IS 5
BP 642
EP 645
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA V43RP
UT WOS:000202952500021
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Lee, KG
   Kweon, HY
   Yeo, JH
   Woo, SO
   Lee, JH
   Park, YH
AF Lee, KG
   Kweon, HY
   Yeo, JH
   Woo, SO
   Lee, JH
   Park, YH
TI Structural and physical properties of silk fibroin/alginate blend
   sponges
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE silk fibroin; alginate; conformational analysis; mechanical properties;
   blends
ID FIBROIN MEMBRANES; ALGINATE; FILMS; IMMOBILIZATION; GROWTH; CELLS; FORM;
   GEL
AB Silk fibroin/alginate blend sponges were examined through IR spectroscopy, X-ray diffractometry, and differential scanning calorimetry to determine the structural changes of silk fibroin. The effects of fibroin/alginate blend ratios on the physical and mechanical properties were investigated to discover the feasibility of using these blend sponges as biomedical materials such as wound dressings. The compressive modulus of silk fibroin was increased up to 30 kPa, from 7.1 kPa, by blending with alginate. Thermal crystallization behavior of fibroin induced by heat treatment was restricted by blending with alginate. In spite of that, the structural characteristics of fibroin were not changed by incorporation with alginate. (C) 2004 Wiley Periodicals, Inc.
C1 Natl Inst Agr Sci & Technol, Dept Sericulture & Entomol, Suwon 441100, South Korea.
   Seoul Natl Univ, Coll Vet Med, Suwon 441744, South Korea.
   Seoul Natl Univ, Sch Biol Resources & Mat Engn, Suwon 441744, South Korea.
RP Kweon, HY (reprint author), Natl Inst Agr Sci & Technol, Dept Sericulture & Entomol, Suwon 441100, South Korea.
EM hykweon@rda.go.kr
CR ASAKURA T, 1984, MACROMOLECULES, V17, P1075, DOI 10.1021/ma00135a017
   Chiarini A, 2003, BIOMATERIALS, V24, P789, DOI 10.1016/S0142-9612(02)00417-9
   FREDDI G, 1995, J APPL POLYM SCI, V56, P1537, DOI 10.1002/app.1995.070561203
   HANAWA T, 1995, CHEM PHARM BULL, V43, P284
   Hauselmann HJ, 1996, AM J PHYSIOL-CELL PH, V271, pC742
   Kikuchi A, 1999, J CONTROL RELEASE, V58, P21, DOI 10.1016/S0168-3659(98)00141-2
   Kweon H, 2001, J APPL POLYM SCI, V80, P928, DOI 10.1002/app.1172
   KWEON HY, 1994, KOR J SER SCI, V36, P138
   Lai HL, 2003, INT J PHARM, V251, P175, DOI 10.1016/S0378-5173(02)00590-2
   LIANG CX, 1992, J APPL POLYM SCI, V45, P1937, DOI 10.1002/app.1992.070451108
   LIANG CX, 1990, SEN-I GAKKAISHI, V46, P535
   MAGOSHI J, 1975, J APPL POLYM SCI, V19, P1013, DOI 10.1002/app.1975.070190410
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   MIYAIRI S, 1978, AGR BIOL CHEM TOKYO, V42, P1661, DOI 10.1080/00021369.1978.10863228
   Nam J, 2001, J APPL POLYM SCI, V81, P3008, DOI 10.1002/app.1751
   Thomas A, 2000, BIOMATERIALS, V21, P1797, DOI 10.1016/S0142-9612(00)00072-7
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P961, DOI 10.1002/polb.1994.090320519
   Xiao CB, 2002, J APPL POLYM SCI, V84, P2554, DOI 10.1002/app.10582
   YAMAURA K, 1990, J APPL POLYM SCI, V41, P2409, DOI 10.1002/app.1990.070410941
   Zhang YQ, 1998, BIOTECHNOL ADV, V16, P961, DOI 10.1016/S0734-9750(98)00012-3
NR 20
TC 27
Z9 28
U1 2
U2 30
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD SEP 5
PY 2004
VL 93
IS 5
BP 2174
EP 2179
DI 10.1002/app.20714
PG 6
WC Polymer Science
SC Polymer Science
GA 842QX
UT WOS:000223020200023
DA 2018-10-19
ER

PT J
AU Lou, X
   Munro, S
   Wang, S
AF Lou, X
   Munro, S
   Wang, S
TI Drug release characteristics of phase separation pHEMA sponge materials
SO BIOMATERIALS
LA English
DT Article
DE pHEMA; porous hydrogel; drug delivery/release; porosity; optimisation
ID CROSS-LINKING AGENT; 2-HYDROXYETHYL METHACRYLATE; POLY(2-HYDROXYETHYL
   METHACRYLATE); BIOMEDICAL APPLICATIONS; POLYMER MEMBRANES; HYDROGELS;
   REACTIVITY; SOLUTES; MATRIX; CORNEA
AB A number of phase separation pHEMA sponge hydrogels have been prepared based on variations in monomer contents, concentration of cross-linking agent, solvent mixture and temperature of polymerization. The loading levels and release profiles of the anti-inflammatory drug prednisolone were examined for each of the pHEMA sponge materials. An effective diffusion coefficient determined by an optimization approach based on the experimental data was used to measure their release characteristics. The effect of morphological variations, revealed by the environmental scanning electron microscopy, and polymer/solvent volume fractions on these properties were discussed. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Western Australia, Ctr Ophthalmol & Visual Sci, Nedlands, WA 6009, Australia.
   Univ Western Australia, Lions Eye Inst, Nedlands, WA 6009, Australia.
   Univ Western Australia, Sch Math & Stat, Crawley, WA 6009, Australia.
RP Lou, X (reprint author), Univ Western Australia, Ctr Ophthalmol & Visual Sci, 2 Verdun St, Nedlands, WA 6009, Australia.
EM xlou@cyllene.uwa.edu.au
RI Wang, Song/B-9809-2008; Lou, Xia/A-7333-2010
OI Wang, Song/0000-0002-5198-8173; Lou, Xia/0000-0002-4052-8200
CR Ainaoui A, 2001, EUR J PHARM BIOPHARM, V51, P17, DOI 10.1016/S0939-6411(00)00139-9
   ATKINS TW, 1995, J BIOMED MATER RES, V29, P291, DOI 10.1002/jbm.820290303
   CHIRILA TV, 1993, POLYM INT, V32, P221, DOI 10.1002/pi.4990320303
   Chirila TV, 1998, PROG POLYM SCI, V23, P447, DOI 10.1016/S0079-6700(97)00036-1
   Chirila TV, 1998, CELL POLYM, V17, P141
   Clayton AB, 1997, POLYM INT, V44, P201, DOI 10.1002/(SICI)1097-0126(199710)44:2<201::AID-PI846>3.0.CO;2-B
   Clayton AB, 1997, POLYM INT, V42, P45, DOI 10.1002/(SICI)1097-0126(199701)42:1<45::AID-PI658>3.0.CO;2-W
   Crank J, 1975, MATH DIFFUSION
   FLYNN GL, 1974, J PHARM SCI-US, V63, P479, DOI 10.1002/jps.2600630403
   GOUDA JH, 1970, J POLYM SCI POL LETT, V8, P225, DOI 10.1002/pol.1970.110080402
   Haldon R.A., 1972, BR POLYM J, V4, P491
   HASA J, 1967, J POLYM SCI C, V16, P317
   Hicks CR, 2003, EYE, V17, P385, DOI 10.1038/sj.eye.6700333
   KORSMEYER RW, 1991, POLYM CONTROLLED DRU, P5
   KRAUCH CH, 1968, NATURWISSENSCHAFTEN, V55, P539, DOI 10.1007/BF00660126
   LEE P I, 1985, Journal of Controlled Release, V2, P277, DOI 10.1016/0168-3659(85)90051-3
   Lou X, 1999, J BIOMED MATER RES, V47, P404, DOI 10.1002/(SICI)1097-4636(19991205)47:3<404::AID-JBM16>3.0.CO;2-F
   Lou X, 2000, J MATER SCI-MATER M, V11, P319, DOI 10.1023/A:1008977818135
   Lou X, 1997, INT J POLYM MATER, V37, P1
   MURPHY SM, 1992, J MATER CHEM, V2, P1007, DOI 10.1039/jm9920201007
   OXLEY HR, 1993, BIOMATERIALS, V14, P1064, DOI 10.1016/0142-9612(93)90207-I
   PAPPAS NA, 1996, HYDROGELS MED PHARM, P65
   Pedley DG, 1980, BRIT POLYM J, V12, P99
   PEPPAS NA, 1985, ANN NY ACAD SCI, V446, P26, DOI 10.1111/j.1749-6632.1985.tb18388.x
   ROHSENOW WM, 1961, HEAT MASS MOMENTUM T, P39
   ROSENBERG M, 1960, J ULTRA MOL STRUCT R, V4, P298, DOI 10.1016/S0022-5320(60)80024-X
   RUDIN A, 1999, ELEMENTS POLYM SCI E, P232
   SINGH H, 1980, J SCI IND RES INDIA, V39, P162
   Vijayasekaran S, 1997, CORNEA, V16, P352
   WARREN TC, 1972, MACROMOLECULES, V5, P506, DOI 10.1021/ma60028a029
   YASUDA H, 1971, J MACROMOL SCI PHYS, VB  5, P111, DOI 10.1080/00222347108212523
   YASUDA H, 1966, J POLYM SCI A1, V4, P2913, DOI 10.1002/pol.1966.150041201
   YASUDA H, 1969, MAKROMOLEKUL CHEM, V126, P177
NR 33
TC 49
Z9 49
U1 6
U2 24
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2004
VL 25
IS 20
BP 5071
EP 5080
DI 10.1016/j.biomaterials.2004.01.058
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 820DF
UT WOS:000221366300025
PM 15109870
DA 2018-10-19
ER

PT J
AU Greene, JA
AF Greene, JA
TI An ethnography of nonadherence: Culture, poverty, and tuberculosis in
   urban Bolivia
SO CULTURE MEDICINE AND PSYCHIATRY
LA English
DT Article
DE anthropology; Aymara; Bolivia; ethnography; patient nonadherence;
   tuberculosis
ID NONCOMPLIANCE
AB The author conducted a focused descriptive ethnographic study of nonadherence with tuberculosis (TB) therapy among Aymara-speaking residents of the city of La Paz, Bolivia. A cohort of patient-inform ants was identified from the District III TB Control Registry of La Paz as having been nonadherent with their TB medication protocol. From June to August 1998, ethnographic material was collected through participant-observation and repeated interviews and visits in homes, workplaces, clinics, and the community. Ethnographic analysis revealed structural barriers to be more important than cultural differences in the production of nonadherence. Though informants maintained a variety of beliefs and practices related to Aymara medicine, the majority of patients were comfortable with a biomedical model of tuberculosis and maintained belief in the efficacy of antituberculosis chemotherapy and desire to finish treatment. Patients overwhelmingly cited hidden costs of treatments, poor access to care, ethnic discrimination, and prior maltreatment by the health system as reasons for abandoning treatment. These data suggest that overemphasis of cultural difference without exploration of other social dimensions of health care delivery can obscure a more practical understanding of nonadherence in marginalized populations.
C1 Harvard Univ, Sch Med, Dept Social Med, Boston, MA 02115 USA.
RP Greene, JA (reprint author), Harvard Univ, Sch Med, Dept Social Med, 641 Huntington Ave, Boston, MA 02115 USA.
EM greene@fas.harvard.edu
CR Abos-Hernandez R, 2002, INT J TUBERC LUNG D, V6, P470
   ALBO X, 1991, AM INDIGENA, V51, P107
   BARNHOORN F, 1992, SOC SCI MED, V34, P291, DOI 10.1016/0277-9536(92)90271-Q
   BARRAGAN LB, 1998, FDN S GABRIEL ORIGEN
   Bastien J, 1992, DRUM STETHOSCOPE INT
   BASTIEN JW, 1995, SOC SCI MED, V41, P77, DOI 10.1016/0277-9536(94)00297-7
   BELL J, 1988, S AFR MED J, V73, P31
   Buechler H. C., 1971, BOLIVIAN AYMARA
   Buechler Hans, 1996, WORLD S VELASQUEZ AU
   Classen C., 1991, S AFRICAN J ETHNOLOG, V14, P69
   CRANDON L, 1983, ETHNOLOGY, V22, P153, DOI 10.2307/3773577
   CRANDONMALAMUD L, 1991, FAT OUR SOULS SOCIAL
   CUELLAR JM, 1986, BOLIVIA SALUD CONCIE
   DUBANOSKI JP, 1988, DISS ABSTR INT B, V48, P3152
   Farmer P, 1991, Semin Respir Infect, V6, P254
   Farmer P, 1997, SOC SCI MED, V44, P347, DOI 10.1016/S0277-9536(96)00143-8
   Farmer P., 2001, INFECT INEQUALITIES
   HENDERSON MA, 1984, J ROY ARMY MED CORPS, V130, P22
   Hudelson P, 1995, SOC SCI MED, V41, P1677, DOI 10.1016/0277-9536(95)00128-T
   Kleinman A., 1988, ILLNESS NARRATIVES S
   LANGLEY GM, 1917, GEOGR REV, V4, P193
   Lerner BH, 1997, SOC SCI MED, V45, P1423, DOI 10.1016/S0277-9536(97)00067-1
   Mata J I, 1985, Med Anthropol, V9, P57
   *MDHSNS, 1996, PUBL TECHN MDHSNS, V11
   MOLLINEDO J, 1998, SEM ACT PROGR TUB
   *PAHO, 2001, COUNTR HLTH PROF BOL
   *PAHO, 1996, COUNTR HLTH PROF BOL
   *PNVCT, 1997, INF 1996 TUB
   SUMARTOJO E, 1993, AM REV RESPIR DIS, V147, P1311, DOI 10.1164/ajrccm/147.5.1311
   TROTTER RT, 1991, TRAINING MANUAL APPL, P180
   WEISE HJC, 1974, SOC SCI MED, V8, P359
   *WHO, 1998, REP TUB EP 1997
   [WHO World Health Organization], 2003, WHO REP 2003 GLOB TU
   WOOD B, 1994, INDIGENOUS PEOPLE PO, P55
NR 34
TC 40
Z9 42
U1 0
U2 8
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0165-005X
J9 CULT MED PSYCHIAT
JI Cult. Med. Psychiatr.
PD SEP
PY 2004
VL 28
IS 3
BP 401
EP 425
DI 10.1023/B:MEDI.0000046429.55801.c8
PG 25
WC Anthropology; Psychiatry; Social Sciences, Biomedical
SC Anthropology; Psychiatry; Biomedical Social Sciences
GA 877LS
UT WOS:000225572700008
PM 15600119
DA 2018-10-19
ER

PT J
AU Drotleff, S
   Lungwitz, U
   Breunig, M
   Dennis, A
   Blunk, T
   Tessmar, J
   Gopferich, A
AF Drotleff, S
   Lungwitz, U
   Breunig, M
   Dennis, A
   Blunk, T
   Tessmar, J
   Gopferich, A
TI Biomimetic polymers in pharmaceutical and biomedical sciences
SO EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
LA English
DT Review
DE biomaterial; biomimetic; tissue engineering; cell signaling; surface
   attachment; gene therapy; drug targeting
ID RECEPTOR-MEDIATED ENDOCYTOSIS; EPIDERMAL-GROWTH-FACTOR; POLYLYSINE DNA
   COMPLEXES; CELL-ADHESION PEPTIDES; MATRIX PROTEIN EXPRESSION;
   GENE-DELIVERY; EXTRACELLULAR-MATRIX; IN-VITRO; DRUG-DELIVERY;
   POLY(ETHYLENE GLYCOL)
AB This review describes recent developments in the emerging field of biomimetic polymeric biomaterials, which signal to cells via biologically active entities. The described biological effects are, in contrast to many other known interactions, receptor mediated and therefore very specific for certain cell types. As an introduction into this field, first some biological principles are illustrated such as cell attachment, cytokine signaling and endocytosis, which are some of the mechanisms used to control cells with biomimetic polymers. The next topics are then the basic design rules for the creation of biomimetic materials. Here, the major emphasis is on polymers that are assembled in separate building blocks, meaning that the biologically active entity is attached to the polymer in a separate chemical reaction. In that respect, first individual chemical standard reactions that may be used for this step are briefly reviewed. In the following chapter, the emphasis is on polymer types that have been used for the development of several biomimetic materials. There is, thereby, a delineation made between materials that are processed to devices exceeding cellular dimensions and materials predominantly used for the assembly of nanostructures. Finally, we give a few current examples for applications in which biomimetic polymers have been applied to achieve a better biomaterial performance. (C) 2004 Elsevier B.V. All rights reserved.
C1 Univ Regensburg, Dept Pharmaceut Technol, D-93053 Regensburg, Germany.
   Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA.
   Rice Univ, Dept Bioengn, Houston, TX 77251 USA.
RP Gopferich, A (reprint author), Univ Regensburg, Dept Pharmaceut Technol, Univ Str 31, D-93053 Regensburg, Germany.
EM achim.goepferich@chemie.uni-regensburg.de
RI Goepferich, Achim/G-1151-2016; Breunig, Miriam/K-2978-2016; Tessmar,
   Joerg/H-3606-2012
OI Goepferich, Achim/0000-0002-7646-0252; Breunig,
   Miriam/0000-0002-1320-6820; Tessmar, Joerg/0000-0001-7057-5369
CR ALBERTS B, 1994, MOL BIOL CELL, P502
   ALBERTS B, 1994, MOL BIOL CELL, P769
   ALBERTS B, 1994, MOL BIOL CELL, P618
   ALLEMANN E, 1993, EUR J PHARM BIOPHARM, V39, P173
   BARANY G, 1980, PEPTIDES, P1
   BAZILE D, 1995, J PHARM SCI, V84, P493, DOI 10.1002/jps.2600840420
   BAZILE DV, 1992, BIOMATERIALS, V13, P1093, DOI 10.1016/0142-9612(92)90142-B
   Bettinger T, 1999, BIOCONJUGATE CHEM, V10, P558, DOI 10.1021/bc990006h
   Bhadriraju K, 2000, BIOMATERIALS, V21, P267, DOI 10.1016/S0142-9612(99)00175-1
   Bieber T, 2002, J CONTROL RELEASE, V82, P441, DOI 10.1016/S0168-3659(02)00129-3
   BLUMENTHAL R, 1986, BIOCHEMISTRY-US, V25, P2231, DOI 10.1021/bi00356a057
   Blunk T, 2003, BIOMATERIALS, V24, P4335, DOI 10.1016/S0142-9612(03)00336-3
   Blunk T, 2002, TISSUE ENG, V8, P73, DOI 10.1089/107632702753503072
   BOBBITT JM, 1956, ADV CARBOHYD CHEM, V11, P1
   Bonassar LJ, 1998, J CELL BIOCHEM, P297, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<297::AID-JCB36>3.0.CO;2-6
   Boudreau Nancy J., 1999, Biochemical Journal, V339, P481, DOI 10.1042/0264-6021:3390481
   BREWER CF, 1967, ANAL BIOCHEM, V18, P248, DOI 10.1016/0003-2697(67)90007-3
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21
   CARLSSON J, 1978, BIOCHEM J, V173, P723, DOI 10.1042/bj1730723
   CHEN JB, 1994, FEBS LETT, V338, P167, DOI 10.1016/0014-5793(94)80357-9
   CHEN P, 1994, J CELL BIOL, V124, P547, DOI 10.1083/jcb.124.4.547
   Cho CW, 2000, BIOTECHNOL APPL BIOC, V32, P21, DOI 10.1042/BA20000022
   CIMA LG, 1994, J CELL BIOCHEM, V56, P155, DOI 10.1002/jcb.240560206
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   COTTEN M, 1990, P NATL ACAD SCI USA, V87, P4033, DOI 10.1073/pnas.87.11.4033
   CRISTIANO RJ, 1993, P NATL ACAD SCI USA, V90, P11548, DOI 10.1073/pnas.90.24.11548
   Cruise GM, 1998, BIOMATERIALS, V19, P1287, DOI 10.1016/S0142-9612(98)00025-8
   CURIEL DT, 1991, P NATL ACAD SCI USA, V88, P8850, DOI 10.1073/pnas.88.19.8850
   DONAHUE RE, 1992, J EXP MED, V176, P1125, DOI 10.1084/jem.176.4.1125
   DRUMHELLER PD, 1994, ANAL BIOCHEM, V222, P380, DOI 10.1006/abio.1994.1506
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Eiselt P, 1999, MACROMOLECULES, V32, P5561, DOI 10.1021/ma990514m
   Erbacher P, 1999, J GENE MED, V1, P210
   ERBACHER P, 1995, BIOCONJUGATE CHEM, V6, P401, DOI 10.1021/bc00034a010
   Erbacher P, 1999, GENE THER, V6, P138, DOI 10.1038/sj.gt.3300783
   Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4
   Ferris DM, 1999, BIOMATERIALS, V20, P2323, DOI 10.1016/S0142-9612(99)00161-1
   Fischbach C, 2001, SURF SCI, V491, P333, DOI 10.1016/S0039-6028(01)01297-3
   FOLKMAN J, 1992, J BIOL CHEM, V267, P10931
   GILLES MA, 1990, ANAL BIOCHEM, V184, P244, DOI 10.1016/0003-2697(90)90675-Y
   Godbey WT, 1999, J BIOMED MATER RES, V45, P268, DOI 10.1002/(SICI)1097-4636(19990605)45:3<268::AID-JBM15>3.0.CO;2-Q
   Godbey WT, 1999, P NATL ACAD SCI USA, V96, P5177, DOI 10.1073/pnas.96.9.5177
   GREEN NM, 1971, BIOCHEM J, V125, P781, DOI 10.1042/bj1250781
   Gref R, 2003, BIOMATERIALS, V24, P4529, DOI 10.1016/S0142-9612(03)00348-X
   Hacker M, 2003, BIOMATERIALS, V24, P4459, DOI 10.1016/S0142-9612(03)00346-6
   Harma H, 2000, LUMINESCENCE, V15, P351, DOI 10.1002/1522-7243(200011/12)15:6<351::AID-BIO624>3.0.CO;2-3
   Hasenbein ME, 2002, BIOMATERIALS, V23, P3937, DOI 10.1016/S0142-9612(02)00129-1
   HEITZ JR, 1968, ARCH BIOCHEM BIOPHYS, V127, P627, DOI 10.1016/0003-9861(68)90271-3
   Hermanson T. H., 1996, BIOCONJUGATE TECHNIQ, P139
   HERMANSON TH, 2004, BIOCONJUGATE TECHNIQ, P114
   HERMANSON TH, 1996, BIOCONJUGATE TECHNIQ, P169
   HERMANSON TH, 1996, BIOCONJUGATE TECHNIQ, P138
   HERMANSON TH, 1996, BIOCONJUGATE TECHNIQ, P177
   HERMANSON TH, 2004, BIOCONJUGATE TECHNIQ, P185
   HERMANSON TH, 2004, BIOCONJUGATE TECHNIQ, P64
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   HOECKER H, 1998, MACROMOL S, V130, P161
   Hu YH, 2003, J BIOMED MATER RES A, V64A, P583, DOI 10.1002/jbm.a.10438
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Hutmacher DW, 2001, ANN ACAD MED SINGAP, V30, P183
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337
   Ito Y, 1996, P NATL ACAD SCI USA, V93, P3598, DOI 10.1073/pnas.93.8.3598
   Ito Y, 1998, MAT SCI ENG C-BIO S, V6, P267, DOI 10.1016/S0928-4931(98)00061-7
   James K, 1996, MRS BULL, V21, P22, DOI 10.1557/S0883769400031808
   Jo S, 2001, BIOMACROMOLECULES, V2, P255, DOI 10.1021/bm000107e
   Jo S, 2000, POLYMER, V41, P7595, DOI 10.1016/S0032-3861(00)00117-8
   KABANOV AV, 1995, BIOCONJUGATE CHEM, V6, P7, DOI 10.1021/bc00031a002
   Kantlehner M, 2000, CHEMBIOCHEM, V1, P107, DOI 10.1002/1439-7633(20000818)1:2<107::AID-CBIC107>3.3.CO;2-W
   Kataoka K, 2001, ADV DRUG DELIVER REV, V47, P113, DOI 10.1016/S0169-409X(00)00124-1
   Kircheis R, 2001, J CONTROL RELEASE, V72, P165, DOI 10.1016/S0168-3659(01)00272-3
   Kircheis R, 2001, GENE THER, V8, P28, DOI 10.1038/sj.gt.3301351
   Klee D, 1999, ADV POLYM SCI, V149, P1
   Kuhl PR, 1996, NAT MED, V2, P1022, DOI 10.1038/nm0996-1022
   Langer R, 1995, CHEM ENG SCI, V50, P4109, DOI 10.1016/0009-2509(95)00226-X
   Langer R, 2003, AICHE J, V49, P2990, DOI 10.1002/aic.690491202
   LANGER R, 1990, BIOMATERIALS, V11, P738, DOI 10.1016/0142-9612(90)90038-R
   Leamon CP, 1999, BIOCONJUGATE CHEM, V10, P947, DOI 10.1021/bc990066n
   Lebaron RG, 2000, TISSUE ENG, V6, P85, DOI 10.1089/107632700320720
   Lecanda F, 1997, J CELL BIOCHEM, V67, P386, DOI 10.1002/(SICI)1097-4644(19971201)67:3<386::AID-JCB10>3.0.CO;2-B
   Lee ES, 2003, J CONTROL RELEASE, V91, P103, DOI 10.1016/S0168-3659(03)00239-6
   Lee H, 2002, J CONTROL RELEASE, V83, P109, DOI 10.1016/S0168-3659(02)00166-9
   Lee KY, 2000, MACROMOLECULES, V33, P4291, DOI 10.1021/ma9921347
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Li YP, 2003, INT J PHARM, V259, P93, DOI 10.1016/S0378-5173(03)00211-4
   Lilli C, 2002, J BIOMED MATER RES, V63, P577, DOI 10.1002/jbm.10301
   LIN HB, 1992, BIOMATERIALS, V13, P905, DOI 10.1016/0142-9612(92)90113-3
   Lin YS, 2001, ARTIF ORGANS, V25, P617, DOI 10.1046/j.1525-1594.2001.025008617.x
   Loebsack A, 2001, J BIOMED MATER RES, V57, P575, DOI 10.1002/1097-4636(20011215)57:4<575::AID-JBM1204>3.0.CO;2-9
   Lucke A, 2000, BIOMATERIALS, V21, P2361, DOI 10.1016/S0142-9612(00)00103-4
   Mann BK, 2001, BIOMATERIALS, V22, P439, DOI 10.1016/S0142-9612(00)00196-4
   Mann BK, 1999, BIOMATERIALS, V20, P2281, DOI 10.1016/S0142-9612(99)00158-1
   Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   Matthew H. W. T., 2000, BIOMATERIALS, V21, P2589
   Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575
   MERWIN JR, 1995, J IMMUNOL METHODS, V186, P257, DOI 10.1016/0022-1759(95)00150-9
   Miller C, 2001, BIOMATERIALS, V22, P1263, DOI 10.1016/S0142-9612(00)00278-7
   Mineo C, 2001, HISTOCHEM CELL BIOL, V116, P109
   MISLICK KA, 1995, BIOCONJUGATE CHEM, V6, P512, DOI 10.1021/bc00035a002
   Mitra S, 2001, J CONTROL RELEASE, V74, P317, DOI 10.1016/S0168-3659(01)00342-X
   Murphy WL, 2002, NAT BIOTECHNOL, V20, P30, DOI 10.1038/nbt0102-30
   Na K, 2003, EUR J PHARM SCI, V18, P165, DOI 10.1016/S0928-0987(02)00257-9
   Nishikawa M, 2001, HUM GENE THER, V12, P861, DOI 10.1089/104303401750195836
   Ogris M, 1999, GENE THER, V6, P595, DOI 10.1038/sj.gt.3300900
   Olivier JC, 2002, PHARMACEUT RES, V19, P1137, DOI 10.1023/A:1019842024814
   OMULLANE JE, 1990, INT J PHARM, V63, P177, DOI 10.1016/0378-5173(90)90169-5
   Pan D, 2003, CHEM COMMUN, P2400, DOI 10.1039/b307878g
   Park KH, 2002, BIOTECHNOL LETT, V24, P1401, DOI 10.1023/A:1019890229822
   PARTHASARATHI S, 1995, J VIROL, V69, P7991
   PARTIS MD, 1983, J PROTEIN CHEM, V2, P263, DOI 10.1007/BF01025358
   PATCHORNIK A, 1957, J AM CHEM SOC, V79, P5227, DOI 10.1021/ja01576a043
   PENG L, 1987, APPL BIOCHEM BIOTECH, V14, P91, DOI 10.1007/BF02798427
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   PLANK C, 1994, J BIOL CHEM, V269, P12918
   PLANK C, 1992, BIOCONJUGATE CHEM, V3, P533, DOI 10.1021/bc00018a012
   Plant GW, 1997, EXP NEUROL, V143, P287, DOI 10.1006/exnr.1997.6407
   Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165
   Purcell DFJ, 1996, J VIROL, V70, P887
   Putnam E A, 1992, Surg Oncol, V1, P49, DOI 10.1016/0960-7404(92)90056-Q
   Qian ZM, 2002, PHARMACOL REV, V54, P561, DOI 10.1124/pr.54.4.561
   Quirk RA, 2001, BIOMATERIALS, V22, P865, DOI 10.1016/S0142-9612(00)00250-7
   Ratner BD, 1996, J MOL RECOGNIT, V9, P617, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<617::AID-JMR310>3.0.CO;2-D
   Ratner BD, 1998, MACROMOL SYMP, V130, P327, DOI 10.1002/masy.19981300128
   RICKARD DJ, 1994, DEV BIOL, V161, P218, DOI 10.1006/dbio.1994.1022
   ROBEY PG, 1987, J CELL BIOL, V105, P457, DOI 10.1083/jcb.105.1.457
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Rowley JA, 2002, J BIOMED MATER RES, V60, P217, DOI 10.1002/jbm.1287
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Schaffner P, 1999, J MATER SCI-MATER M, V10, P837, DOI 10.1023/A:1008904513304
   Schense JC, 1999, BIOCONJUGATE CHEM, V10, P75, DOI 10.1021/bc9800769
   SCHULTZ G, 1991, J CELL BIOCHEM, V45, P346, DOI 10.1002/jcb.240450407
   Shakesheff KM, 1998, J BIOMAT SCI-POLYM E, V9, P507, DOI 10.1163/156856298X00596
   Shin H, 2004, BIOMATERIALS, V25, P895, DOI 10.1016/S0142-9612(03)00602-1
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Shin H, 2002, J BIOMED MATER RES, V61, P169, DOI 10.1002/jbm.10193
   Smith LC, 1998, ADV DRUG DELIVER REV, V30, P115, DOI 10.1016/S0169-409X(97)00111-7
   Stayton PS, 2000, J CONTROL RELEASE, V65, P203, DOI 10.1016/S0168-3659(99)00236-9
   Stella B, 2000, J PHARM SCI, V89, P1452, DOI 10.1002/1520-6017(200011)89:11<1452::AID-JPS8>3.0.CO;2-P
   Stewart J.M., 1984, SOLID PHASE PEPTIDE, P31
   Stile RA, 2001, BIOMACROMOLECULES, V2, P185, DOI 10.1021/bm0000945
   STOCKERT RJ, 1995, PHYSIOL REV, V75, P591
   STOLNIK S, 1995, ADV DRUG DELIVER REV, V16, P195, DOI 10.1016/0169-409X(95)00025-3
   STORM G, 1995, ADV DRUG DELIVER REV, V17, P31, DOI 10.1016/0169-409X(95)00039-A
   STUART CA, 1979, ENDOCRINOLOGY, V105, P1293, DOI 10.1210/endo-105-6-1293
   Suzuki Y, 2000, J BIOMED MATER RES, V50, P405, DOI 10.1002/(SICI)1097-4636(20000605)50:3<405::AID-JBM15>3.0.CO;2-Z
   Tessmar J, 2003, BIOMATERIALS, V24, P4475, DOI 10.1016/S0142-9612(03)00345-4
   Tessmar JK, 2002, BIOMACROMOLECULES, V3, P194, DOI 10.1021/bn015608u
   Tong YW, 1998, J BIOMED MATER RES, V42, P85, DOI 10.1002/(SICI)1097-4636(199810)42:1<85::AID-JBM11>3.3.CO;2-R
   Tong YW, 2001, BIOMATERIALS, V22, P1029, DOI 10.1016/S0142-9612(00)00338-0
   Trippel S B, 1995, J Rheumatol Suppl, V43, P129
   van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417
   von Harpe A, 2000, J CONTROL RELEASE, V69, P309, DOI 10.1016/S0168-3659(00)00317-5
   VONSTEENIS JH, 2003, J CONTROL RELEASE, V87, P167
   WAGNER E, 1994, ADV DRUG DELIVER REV, V14, P113, DOI 10.1016/0169-409X(94)90008-6
   WAGNER E, 1991, P NATL ACAD SCI USA, V88, P4255, DOI 10.1073/pnas.88.10.4255
   WAGNER E, 1991, BIOCONJUGATE CHEM, V2, P226, DOI 10.1021/bc00010a006
   WAGNER E, 1992, P NATL ACAD SCI USA, V89, P6099, DOI 10.1073/pnas.89.13.6099
   WAGNER E, 1990, P NATL ACAD SCI USA, V87, P3410, DOI 10.1073/pnas.87.9.3410
   WANG CY, 1984, BIOCHEMISTRY-US, V23, P4409, DOI 10.1021/bi00314a026
   Wang DQ, 1999, J CONTROL RELEASE, V57, P9, DOI 10.1016/S0168-3659(98)00099-6
   Wang YC, 2003, BIOMACROMOLECULES, V4, P224, DOI 10.1021/bm0256294
   Ward JH, 2001, J BIOMED MATER RES, V56, P351, DOI 10.1002/1097-4636(20010905)56:3<351::AID-JBM1103>3.0.CO;2-A
   Woods A, 1998, TRENDS CELL BIOL, V8, P189, DOI 10.1016/S0962-8924(98)01244-6
   Xu B, 1998, GENE THER, V5, P1235, DOI 10.1038/sj.gt.3300719
   Yoon JJ, 2002, BIOTECHNOL BIOENG, V78, P1, DOI 10.1002/bit.10239
   Zanta MA, 1997, BIOCONJUGATE CHEM, V8, P839, DOI 10.1021/bc970098f
   Zhou SB, 2003, J CONTROL RELEASE, V86, P195, DOI 10.1016/S0168-3659(02)00423-6
   Zisch AH, 2001, J CONTROL RELEASE, V72, P101, DOI 10.1016/S0168-3659(01)00266-8
NR 171
TC 107
Z9 111
U1 1
U2 42
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0935-1221
J9 EUR J PHARM BIOPHARM
JI Eur. J. Pharm. Biopharm.
PD SEP
PY 2004
VL 58
IS 2
BP 385
EP 407
DI 10.1016/j.ejpb.2004.03.018
PG 23
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 849GQ
UT WOS:000223527100016
PM 15296963
DA 2018-10-19
ER

PT J
AU Abele, MG
   Rusinek, H
AF Abele, MG
   Rusinek, H
TI Permanent conical magnet for interventional magnetic resonance imaging
SO IEEE TRANSACTIONS ON MAGNETICS
LA English
DT Article
DE biomedical imaging; boundary-element methods; ferrites; Laplace
   equations; magnetic fields; magnetic resonance imaging; neodymium
   alloys; permanent magnets; surgery
ID COMPACT; SYSTEM
AB We describe an open structure of permanently magnetized material for interventional magnetic resonance imaging of the brain. We transformed the ideal magnet, contained between two coaxial cones, into a practical device by a series of geometrical steps that minimize field perturbations. By taking advantage of the quasi-linear demagnetization characteristics of rare-earth materials, we could analyze the structure with an exact mathematical model. The magnet, built of material of remanence 1.38 T, generates a field of 0.45 T within its central gap 30 cm wide. Our numerical computations show a remarkable 0.25% field uniformity in the imaging region. The large opening makes the conical magnet suitable for interventional and surgical imaging.
C1 NYU, Sch Med, Dept Radiol, New York, NY 10016 USA.
RP Abele, MG (reprint author), NYU, Sch Med, Dept Radiol, 550 1St Ave, New York, NY 10016 USA.
EM hr18@nyu.edu
CR ABELE MG, 1992, IEEE T MAGN, V28, P931, DOI 10.1109/20.120031
   ABELE MG, 1993, STRUCTURES PERMANENT, P76
   Hadani M, 2001, NEUROSURGERY, V48, P799, DOI 10.1097/00006123-200104000-00021
   LUFKIN RB, 1999, INTERVENTIONAL MRI
   Masciocchi C, 1996, EUR J RADIOL, V22, P7, DOI 10.1016/0720-048X(95)00703-S
   Messineo D, 1998, MAGN RESON IMAGING, V16, P731, DOI 10.1016/S0730-725X(98)00080-0
   MIYAMOTO T, 1989, P 10 INT WORKSH RAR, P113
   MIYAMOTO T, 1989, J MAGN SOC JAPAN, V13, P465
   Schulder M, 2001, J NEUROSURG, V94, P936, DOI 10.3171/jns.2001.94.6.0936
   Steinmeier R, 1998, NEUROSURGERY, V43, P739, DOI 10.1097/00006123-199810000-00005
   STRNAT KJ, 1990, P IEEE, V78, P923, DOI 10.1109/5.56908
   Wutke R, 2001, Rontgenpraxis, V54, P43
NR 12
TC 2
Z9 2
U1 1
U2 4
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 0018-9464
J9 IEEE T MAGN
JI IEEE Trans. Magn.
PD SEP
PY 2004
VL 40
IS 5
BP 3382
EP 3386
DI 10.1109/TMAG.2004.834039
PG 5
WC Engineering, Electrical & Electronic; Physics, Applied
SC Engineering; Physics
GA 853TS
UT WOS:000223852400021
DA 2018-10-19
ER

PT J
AU Giavaresi, G
   Tschon, M
   Daly, JH
   Liggat, JJ
   Fini, M
   Torricelli, P
   Giardino, R
AF Giavaresi, G
   Tschon, M
   Daly, JH
   Liggat, JJ
   Fini, M
   Torricelli, P
   Giardino, R
TI Natural and synthetic polyesters for musculoskeletal tissue repair:
   Experimental in vitro and in vivo evaluations
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE polyesters; murine fibroblasts; animal model; biocompatibility; implant
ID HYDROXYBUTYRATE-HYDROXYVALERATE COPOLYMERS; CRUCIATE LIGAMENT
   RECONSTRUCTION; BIODEGRADABLE MEDICAL DEVICES; ANTIBIOTIC RELEASE;
   HYDROLYTIC DEGRADATION; BONE DEFECTS; FOLLOW-UP; DELIVERY; SYSTEMS;
   POLYMER
AB Two natural Biopol(TM) polyesters, containing 8% (D400G) and 12% (D600G) of hydroxyvalerate component, and a synthetic polyester based on 1,4 cyclohexanediol [Poly(cyclohexyl-sebacate) - PCS] were studied to investigate their in vitro and in vivo behavior for application in musculoskeletal tissue repair. The polyesters were placed in direct contact with L929 fibroblasts and cell proliferation (WST-1), cytotoxic effect (LDH), synthetic activity (total proteins) and cytokine production (IL-1beta, IL-6, TNFalpha) were assessed after an incubation period of 72 hours and 7 days. Then, 12 Sprague-Dawley rats underwent dorsal subcutaneous implants of tested polyesters under general anesthesia. After 1 and 4 weeks from surgery, the animals were pharmacologically euthanized and the implants retrieved with surrounding tissue for histologic and histomorphometric investigations. In vitro results showed that D600G behaved a little worse in comparison to other tested polyesters in terms of cell proliferation and TNFalpha at 7 days. PCS presented the lowest total protein value at 7 days. In vivo results indicated that PCS implants produced a higher (p < 0.01) extent of inflammatoty tissue in comparison to D600G at 1 week and to D40OG at 4 weeks, and the lowest vascular densities at both experimental times. D40OG seems to be the most suitable material for biomedical application when tested in fibroblast cultures and in the subcutaneous tissue of rats.
C1 Ist Ortopedici Rizzoli, Ist Ric Codivilla Putti, Serv Chirurg Sperimentale, Dept Expt Surg, I-40136 Bologna, Italy.
   Univ Strathclyde, Dept Pure & Appl Chem, Glasgow, Lanark, Scotland.
RP Giavaresi, G (reprint author), Ist Ortopedici Rizzoli, Ist Ric Codivilla Putti, Serv Chirurg Sperimentale, Dept Expt Surg, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM gianluca.giavaresi@ior.it
RI TORRICELLI, PAOLA/J-5298-2016; Fini, Milena/J-4808-2016
OI TORRICELLI, PAOLA/0000-0001-7494-9970; Fini, Milena/0000-0002-3732-3570;
   Giavaresi, Gianluca/0000-0001-7843-5969; Liggat,
   John/0000-0003-4460-5178
CR AMCDONALD P, 2003, ARTHROSCOPY, V19, pE22
   Athanasiou KA, 1998, ARTHROSCOPY, V14, P726, DOI 10.1016/S0749-8063(98)70099-4
   Baran ET, 2002, J MICROENCAPSUL, V19, P363, DOI 10.1080/02652040110105355
   Barber FA, 1999, ARTHROSCOPY, V15, P360, DOI 10.1016/S0749-8063(99)70052-6
   BRAUN D, 1993, ANGEW MAKROMOL CHEM, V210, P173, DOI 10.1002/apmc.1993.052100114
   Cao T, 2003, TISSUE ENG, V9, pS103, DOI 10.1089/10763270360697012
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chambers R, 2001, J MATER SCI, V36, P3785, DOI 10.1023/A:1017938203630
   Chen A, 1998, Zhonghua Wai Ke Za Zhi, V36, P96
   Chen J, 2002, J MICROENCAPSUL, V19, P191, DOI 10.1080/02652040110065431
   Chen LJ, 2002, BIOMATERIALS, V23, P2631, DOI 10.1016/S0142-9612(01)00394-5
   COX MK, 1990, BIODEGRADABLE POLYM
   DOYLE C, 1991, BIOMATERIALS, V12, P841, DOI 10.1016/0142-9612(91)90072-I
   Fini M, 1995, INT J ARTIF ORGANS, V18, P772
   Fini M, 2003, J Appl Biomater Biomech, V1, P155
   GALGUT P, 1991, J CLIN PERIODONTOL, V18, P581, DOI 10.1111/j.1600-051X.1991.tb00093.x
   Giardino R, 1998, INT J ARTIF ORGANS, V21, P473
   GOGOLEWSKI S, 1993, J BIOMED MATER RES, V27, P1135, DOI 10.1002/jbm.820270904
   GOWEN M, 1992, CYTOKINES BONE METAB, P71
   Gursel I, 2001, BIOMATERIALS, V22, P73, DOI 10.1016/S0142-9612(00)00170-8
   Gursel I, 2002, J MICROENCAPSUL, V19, P153, DOI 10.1080/02652040110065413
   GURSEL I, 1995, J MICROENCAPSUL, V12, P185, DOI 10.3109/02652049509015289
   HAMMOND T, 1995, DEGRADABLE POLYM PRI, P88
   HOLLAND SJ, 1987, BIOMATERIALS, V8, P289, DOI 10.1016/0142-9612(87)90117-7
   Hu SG, 2003, BIOMATERIALS, V24, P2685, DOI 10.1016/S0142-9612(03)00079-6
   Hurel C, 2000, KNEE SURG SPORT TR A, V8, P46, DOI 10.1007/s001670050010
   Hutcheon GA, 2001, BIOMATERIALS, V22, P667, DOI 10.1016/S0142-9612(00)00229-5
   Kazimoglu C, 2003, INT J ARTIF ORGANS, V26, P804
   Khang G, 2001, BIO-MED MATER ENG, V11, P89
   Kirkpatrick CJ, 1999, J MATER SCI-MATER M, V10, P589, DOI 10.1023/A:1008946615663
   KNOWLES JC, 1993, J MED ENG TECHNOL, V17, P129, DOI 10.3109/03091909309087593
   Kontio R, 2001, INT J ORAL MAX SURG, V30, P278, DOI 10.1054/ijom.2001.0067
   Kose GT, 2003, BIOMATERIALS, V24, P1949, DOI 10.1016/S0142-9612(02)00613-0
   Lajtai G, 2001, ARTHROSCOPY, V17, P597, DOI 10.1053/jars.2001.21535
   Lavasanifar A, 2002, ADV DRUG DELIVER REV, V54, P169, DOI 10.1016/S0169-409X(02)00015-7
   Luklinska ZB, 2003, J MICROSC-OXFORD, V211, P121, DOI 10.1046/j.1365-2818.2003.01204.x
   Moran JM, 2003, TISSUE ENG, V9, P63, DOI 10.1089/107632703762687546
   Nakayama Y, 1997, Nihon Ika Daigaku Zasshi, V64, P512
   Panyam J, 2003, ADV DRUG DELIVER REV, V55, P329, DOI 10.1016/S0169-409X(02)00228-4
   Ratner BD, 2002, J CONTROL RELEASE, V78, P211, DOI 10.1016/S0168-3659(01)00502-8
   Rokkanen PU, 2000, BIOMATERIALS, V21, P2607, DOI 10.1016/S0142-9612(00)00128-9
   SAITO T, 1991, BIOMATERIALS, V12, P309, DOI 10.1016/0142-9612(91)90039-D
   Schwendeman SP, 2002, CRIT REV THER DRUG, V19, P73, DOI 10.1615/CritRevTherDrugCarrierSyst.v19.i1.20
   Sendil D, 1999, J CONTROL RELEASE, V59, P207, DOI 10.1016/S0168-3659(98)00195-3
   Senkoylu A, 2002, INT J ARTIF ORGANS, V25, P1174
   Turesin F, 2001, J BIOMAT SCI-POLYM E, V12, P195, DOI 10.1163/156856201750180924
   van der Walle GAM, 2001, ADV BIOCHEM ENG BIOT, V71, P263
   Vesala AL, 2002, J CRANIOFAC SURG, V13, P607, DOI 10.1097/01.SCS.0000026452.58930.19
   Wang YD, 2003, J BIOMED MATER RES A, V66A, P192, DOI 10.1002/jbm.a.10534
   Yagmurlu MF, 1999, J BIOMED MATER RES, V46, P494
   YASIN M, 1990, BIOMATERIALS, V11, P451, DOI 10.1016/0142-9612(90)90057-W
   Yoon JJ, 2003, BIOMATERIALS, V24, P2323, DOI 10.1016/S0142-9612(03)00024-3
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Zinn M, 2001, ADV DRUG DELIVER REV, V53, P5, DOI 10.1016/S0169-409X(01)00218-6
NR 54
TC 7
Z9 7
U1 4
U2 16
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD SEP
PY 2004
VL 27
IS 9
BP 796
EP 805
PG 10
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 864MF
UT WOS:000224636900010
PM 15521220
DA 2018-10-19
ER

PT J
AU Bagno, A
   Di Bello, C
AF Bagno, A
   Di Bello, C
TI Surface treatments and roughness properties of Ti-based biomaterials
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID OSTEOBLAST-LIKE CELLS; MODIFIED TITANIUM IMPLANTS; SCREW-SHAPED
   IMPLANTS; BONE RESPONSE; IN-VITRO; COATED TITANIUM; REMOVAL TORQUE;
   BIOLOGICAL PROPERTIES; CHEMICAL-MODIFICATION; ADHESIVE PEPTIDES
AB Nowadays, the use of implanted devices is a well-acknowledged practice in the field of orthopaedic and dental surgery. Scientific research and clinical experience suggest that the successful exploitation of these devices mainly depends on osseointegration, considered as both anatomical congruency and load-bearing capacity. Indeed, the osseointegration process is influenced by a wide range of factors: anatomical location, implant size and design, surgical procedure, loading effects, biological fluids, age and sex, and, in particular, surface characteristics. For this reason, several attempts have been aimed at modifying implant surface composition and morphology to optimise implant-to-bone contact and improve integration.
   Preliminary interactions between implanted materials and biological environment are deemed to be governed by the surface properties; they control the amount and quality of cell adhesion on the surface and, consequently, cell/tissue growth. Thus, surface properties govern new bone tissue formation and implant osseointegration.
   This paper reviews the state of art in the field of physical, chemical and biochemical treatments commonly used on Ti-based biomaterials for the production of biomedical devices. In particular, roughness characteristics due to physical and chemical techniques are investigated; the development of biologically active surfaces by means of biochemical functionalisation is also considered. (C) 2004 Kluwer Academic Publishers.
C1 Univ Padua, Dept Chem Proc Engn, I-35131 Padua, Italy.
RP Bagno, A (reprint author), Univ Padua, Dept Chem Proc Engn, Via Marzolo 9, I-35131 Padua, Italy.
EM andrea.bagno@unipd.it
OI Bagno, Andrea/0000-0002-4296-3601
CR Abrahamsson I, 2002, J CLIN PERIODONTOL, V29, P448, DOI 10.1034/j.1600-051X.2002.290510.x
   ADELL R, 1990, International Journal of Oral and Maxillofacial Implants, V5, P347
   Agrawal CM, 1997, J BIOMED MATER RES, V36, P516, DOI 10.1002/(SICI)1097-4636(19970915)36:4<516::AID-JBM9>3.0.CO;2-H
   ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   ALBREKTSSON T, 1991, BONE-BIOMATERIAL INTERFACE, P357
   Amstutz H. C., 1996, CLIN ORTHOP S, V319S, P297
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Anselme K, 2000, BIOMATERIALS, V21, P1567, DOI 10.1016/S0142-9612(00)00042-9
   Aparicio C, 2003, BIOMATERIALS, V24, P263, DOI 10.1016/S0142-9612(02)00314-9
   Bessho K, 1999, CLIN ORAL IMPLAN RES, V10, P212, DOI 10.1034/j.1600-0501.1999.100304.x
   Bigerelle M, 2002, BIOMATERIALS, V23, P1563, DOI 10.1016/S0142-9612(01)00271-X
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   BROWNE M, 1994, BIOMATERIALS, V15, P894, DOI 10.1016/0142-9612(94)90113-9
   Browne M, 1996, J MATER SCI-MATER M, V7, P323, DOI 10.1007/BF00154543
   BRUNSKI B, 1998, INT J ORAL MAXILLOF, V3, P85
   Brunski J B, 1999, Adv Dent Res, V13, P99
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   Callen BW, 1995, PROG SURF SCI, V50, P269, DOI 10.1016/0079-6816(95)00061-5
   Carlsson L, 1988, Int J Oral Maxillofac Implants, V3, P21
   Castellani R, 1999, CLIN ORAL IMPLAN RES, V10, P369, DOI 10.1034/j.1600-0501.1999.100504.x
   CLAES L, 1976, ARCH ORTHOP TRAUM SU, V85, P155, DOI 10.1007/BF00415453
   Cochran DL, 1998, J BIOMED MATER RES, V40, P1, DOI 10.1002/(SICI)1097-4636(199804)40:1<1::AID-JBM1>3.0.CO;2-Q
   De Giglio E, 2000, J BIOMAT SCI-POLYM E, V11, P1073, DOI 10.1163/156856200743580
   Dee KC, 1996, BIOMATERIALS, V17, P209, DOI 10.1016/0142-9612(96)85765-6
   Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.0.CO;2-C
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   Dettin M, 2002, J BIOMED MATER RES, V60, P466, DOI 10.1002/jbm.10066
   Ferris DM, 1999, BIOMATERIALS, V20, P2323, DOI 10.1016/S0142-9612(99)00161-1
   Francois P, 1997, CLIN ORAL IMPLAN RES, V8, P217, DOI 10.1034/j.1600-0501.1997.080308.x
   Glass JR, 1996, BIOMATERIALS, V17, P1101, DOI 10.1016/0142-9612(96)85911-4
   Goransson A, 2003, BIOMATERIALS, V24, P197, DOI 10.1016/S0142-9612(02)00277-6
   GOTFREDSEN K, 1995, J BIOMED MATER RES, V29, P1223, DOI 10.1002/jbm.820291009
   Gotfredsen K, 1992, Clin Oral Implants Res, V3, P77, DOI 10.1034/j.1600-0501.1992.030205.x
   Hall J, 2000, APPL OSSEOINTEGRATIO, V1, P5
   Hansson S, 1999, CLIN ORAL IMPLAN RES, V10, P394, DOI 10.1034/j.1600-0501.1999.100506.x
   Healy KE, 1999, ANN NY ACAD SCI, V875, P24, DOI 10.1111/j.1749-6632.1999.tb08491.x
   Healy KE, 1996, BIOMATERIALS, V17, P195, DOI 10.1016/0142-9612(96)85764-4
   Heckman JD, 1999, J BONE JOINT SURG AM, V81A, P1717, DOI 10.2106/00004623-199912000-00009
   HULSHOFF JEG, 1995, J BIOMED MATER RES, V29, P967, DOI 10.1002/jbm.820290808
   HUNTER A, 1995, BIOMATERIALS, V16, P287, DOI 10.1016/0142-9612(95)93256-D
   JACOBS JJ, 1991, J BONE JOINT SURG AM, V73A, P1475, DOI 10.2106/00004623-199173100-00005
   JANSEN JA, 1991, CLIN ORAL IMPLAN RES, V74, P28
   Jansson E, 2002, BIOMATERIALS, V23, P2803, DOI 10.1016/S0142-9612(02)00021-2
   Jansson E, 2001, BIOMATERIALS, V22, P1803, DOI 10.1016/S0142-9612(00)00359-8
   Kapanen A, 2002, BIOMATERIALS, V23, P3733, DOI 10.1016/S0142-9612(02)00107-2
   Kasemo B, 1999, Adv Dent Res, V13, P8
   Klokkevold PR, 2001, CLIN ORAL IMPLAN RES, V12, P350, DOI 10.1034/j.1600-0501.2001.012004350.x
   Ku CH, 2002, BIOMATERIALS, V23, P1447, DOI 10.1016/S0142-9612(01)00266-6
   Larsson C, 1996, BIOMATERIALS, V17, P605, DOI 10.1016/0142-9612(96)88711-4
   Lee SJ, 2000, YONSEI MED J, V41, P704, DOI 10.3349/ymj.2000.41.6.704
   Li DH, 2002, J BIOMED MATER RES, V60, P325, DOI 10.1002/jbm.10063
   Liao HH, 1999, J BIOMED MATER RES, V47, P220, DOI 10.1002/(SICI)1097-4636(199911)47:2<220::AID-JBM12>3.0.CO;2-9
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   MacDonald DE, 1998, COLLOID SURFACE B, V11, P131, DOI 10.1016/S0927-7765(98)00030-7
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Mustafa K, 1998, CLIN ORAL IMPLAN RES, V9, P195, DOI 10.1034/j.1600-0501.1998.090307.x
   Mustafa K, 2001, CLIN ORAL IMPLAN RES, V12, P515, DOI 10.1034/j.1600-0501.2001.120513.x
   Nanci A, 1998, J BIOMED MATER RES, V40, P324
   Nishiguchi S, 2001, J BIOMED MATER RES, V54, P198, DOI 10.1002/1097-4636(200102)54:2<198::AID-JBM6>3.0.CO;2-7
   Perrin D, 2002, CLIN ORAL IMPLAN RES, V13, P465, DOI 10.1034/j.1600-0501.2002.130504.x
   Puleo DA, 2002, BIOMATERIALS, V23, P2079, DOI 10.1016/S0142-9612(01)00339-8
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Puleo DA, 1996, BIOMATERIALS, V17, P217, DOI 10.1016/0142-9612(96)85766-8
   Ramires PA, 2002, BIOMATERIALS, V23, P397, DOI 10.1016/S0142-9612(01)00118-1
   Rezania A, 2000, J BIOMED MATER RES, V52, P595, DOI 10.1002/1097-4636(20001215)52:4<595::AID-JBM3>3.0.CO;2-3
   Sakou T, 1998, BONE, V22, P591, DOI 10.1016/S8756-3282(98)00053-2
   Schmidmaier G, 2001, BONE, V28, P341, DOI 10.1016/S8756-3282(00)00456-7
   STOUT KJ, 1993, 15178EN EUR U BIRM C
   Sul YT, 2001, MED ENG PHYS, V23, P329, DOI 10.1016/S1350-4533(01)00050-9
   Suzuki K, 1997, BONE, V21, P507, DOI 10.1016/S8756-3282(97)00204-4
   Suzuki Y, 2000, J BIOMED MATER RES, V50, P405, DOI 10.1002/(SICI)1097-4636(20000605)50:3<405::AID-JBM15>3.0.CO;2-Z
   Taborelli M, 1997, CLIN ORAL IMPLAN RES, V8, P208, DOI 10.1034/j.1600-0501.1997.080307.x
   Takuma M, 1990, J Osaka Univ Dent Sch, V30, P86
   THOMAS KA, 1985, J BIOMED MATER RES, V19, P875, DOI 10.1002/jbm.820190802
   VANDIJK K, 1998, J BIOMED MATER RES, V41, P41
   Vercaigne S, 2000, CLIN ORAL IMPLAN RES, V11, P305, DOI 10.1034/j.1600-0501.2000.011004305.x
   Wennerberg A, 1996, Int J Oral Maxillofac Implants, V11, P38
   Wennerberg A, 1996, BIOMATERIALS, V17, P15, DOI 10.1016/0142-9612(96)80750-2
   Wennerberg A, 1998, CLIN ORAL IMPLAN RES, V9, P11, DOI 10.1034/j.1600-0501.1998.090102.x
   WENNERBERG A, 1995, CLIN ORAL IMPLAN RES, V6, P24, DOI 10.1034/j.1600-0501.1995.060103.x
   WENNERBERG A, 1992, J BIOMED ENG, V14, P412, DOI 10.1016/0141-5425(92)90087-2
   Wennerberg A, 2000, INT J ORAL MAX IMPL, V15, P331
   WOLKE JGC, 1994, J BIOMED MATER RES, V28, P1477, DOI 10.1002/jbm.820281213
   WONG M, 1995, J BIOMED MATER RES, V29, P1567, DOI 10.1002/jbm.820291213
NR 84
TC 153
Z9 158
U1 0
U2 64
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD SEP
PY 2004
VL 15
IS 9
BP 935
EP 949
DI 10.1023/B:JMSM.0000042679.28493.7f
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 856RE
UT WOS:000224061500001
PM 15448401
DA 2018-10-19
ER

PT J
AU Bae, IJ
   Standard, OC
   Roger, GJ
   Brazil, D
AF Bae, IJ
   Standard, OC
   Roger, GJ
   Brazil, D
TI Phase and microstructural development in alumina sol-gel coatings on
   CoCr alloy
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID ALPHA-ALUMINA; TRANSFORMATION; BOEHMITE; POLYETHYLENE; MECHANISM; METAL;
   WEAR; FABRICATION; AL2O3-CR2O3; GAMMA-AL2O3
AB Phase transformation of gamma-Al2O3 to alpha-Al2O3 in alumina sol gel coatings on biomedical CoCr alloy was studied as function of heat treatment temperature and time. Transformation in unseeded coatings was significant only above similar to 1200 degreesC. Addition of alpha-Al2O3 seed particles having an average size of approximately 40 nm lowered the phase transformation temperature to around 800 C. These particles were considered to act as heterogeneous nucleation sites for epitaxial growth of the alpha-Al2O3 phase. The kinetics and activation energy (420 kJ/mol) for the phase transformation in the seeded coatings were similar to those reported for seeded monolithic alumina gels indicating that the transformation mechanism is the same in the two material configurations. Avrami growth parameters indicated that the mechanism was diffusion controlled and invariant over the temperature range studied but that growth was possibly constrained by the finite size of the seed particles and/or coating thickness. The phase transformation occurred by the growth of alpha-Al2O3 grains at the expense of the precursor fine-grained gamma-Al2O3 matrix and near-complete transformation coincided with physical impingement of the growing grains. The grain size at impingement was similar to 100 nm which agreed well with that predicted from the theoretical linear spacing of seed particles in the initial sol. (C) 2004 Kluwer Academic Publishers.
C1 Univ New S Wales, Sch Mat Sci & Engn, Sydney, NSW 2052, Australia.
   Australian Surg Design & Mfg PL, St Leonards, NSW 2065, Australia.
RP Standard, OC (reprint author), Univ New S Wales, Sch Mat Sci & Engn, Sydney, NSW 2052, Australia.
EM o.standard@unsw.edu.au
CR Al-Saffar N, 1999, J LONG-TERM EFF MED, V9, P319
   AMSTUTZ HC, 1992, CLIN ORTHOP RELAT R, V276, P7
   ARMINI AJ, 1998, ASTM STP, V1346
   *ASTM, 1996, F7592 ASTM
   BADKAR PA, 1976, J MATER SCI, V11, P1794, DOI 10.1007/BF00708257
   BAE IJ, 2003, UNPUB U NEW S WALES
   Beltran AM., 1987, SUPERALLOYS, P135
   Brown M.E., 1980, REACTIONS SOLID STAT, V22
   Bunting EN, 1931, BUR STAND J RES, V6, P947
   BYE GC, 1974, J AM CERAM SOC, V57, P367, DOI 10.1111/j.1151-2916.1974.tb10925.x
   CHRISTIAN JW, 1975, TRANSFORMATION MET 1
   CORBETT S, 1998, NITRIC OXIDE BONE JO, P178
   Goodman S, 1996, ACTA ORTHOP SCAND, V67, P599, DOI 10.3109/17453679608997764
   HAM FS, 1958, J PHYS CHEM SOLIDS, V6, P335, DOI 10.1016/0022-3697(58)90053-2
   *INT CTR POWD DIFF, 2003, 421468 INT CTR POWD
   *INT CTR POWD DIFF, 2003, 231009 INT CTR POWD
   *INT CTR POWD DIFF, 2003, 211307 INT CTR POWD
   *INT CTR POWD DIFF, 2003, 160394 INT CTR POWD
   *INT CTR POWD DIFF, 2003, 100425 INT CTR POWD
   Kao HC, 2000, J AM CERAM SOC, V83, P362
   Kim SS, 2001, J AM CERAM SOC, V84, P1881
   KUMAGAI M, 1985, J AM CERAM SOC, V68, P500, DOI 10.1111/j.1151-2916.1985.tb15818.x
   Levin I, 1998, J AM CERAM SOC, V81, P1995
   Li YS, 1999, J RAMAN SPECTROSC, V30, P97, DOI 10.1002/(SICI)1097-4555(199902)30:2<97::AID-JRS352>3.0.CO;2-X
   LIVINGSTON BJ, 1997, T 4O ANN M ORTH RES, P141
   MCARDLE JL, 1986, J AM CERAM SOC, V69, pC98
   MCARDLE JL, 1993, J AM CERAM SOC, V76, P214, DOI 10.1111/j.1151-2916.1993.tb03710.x
   MCARDLE JL, 1989, J AM CERAM SOC, V72, P864, DOI 10.1111/j.1151-2916.1989.tb06235.x
   MOORE RL, 1993, J VAC SCI TECHNOL, V11, P168
   Oh CS, 1996, J MATER SCI, V31, P5321, DOI 10.1007/BF01159299
   OONISHI H, 2003, BIOCERAMICS, V15, P735
   PACH L, 1990, J MATER RES, V5, P278, DOI 10.1557/JMR.1990.0278
   RAJENDRAN S, 1994, J MATER SCI, V29, P5664, DOI 10.1007/BF00349962
   ROY DM, 1972, NATURE-PHYS SCI, V235, P118, DOI 10.1038/physci235118a0
   SCHMALZRIED TP, 1992, CLIN ORTHOP RELAT R, P60
   SCHULLER HM, 1990, ACTA ORTHOP SCAND, V61, P240, DOI 10.3109/17453679008993508
   Semlitsch M, 1997, P I MECH ENG H, V211, P73, DOI 10.1243/0954411971534700
   SHELLEMAN RA, 1986, J NON-CRYST SOLIDS, V82, P277, DOI 10.1016/0022-3093(86)90142-0
   Simpson TW, 1998, J AM CERAM SOC, V81, P61
   TSUCHIDA T, 1983, THERMOCHIM ACTA, V64, P337, DOI 10.1016/0040-6031(83)85009-6
   WILSON SJ, 1979, J SOLID STATE CHEM, V30, P247, DOI 10.1016/0022-4596(79)90106-3
   WILSON SJ, 1980, J SOLID STATE CHEM, V34, P315, DOI 10.1016/0022-4596(80)90429-6
   Yarbrough W. A., 1987, Journal of Materials Research, V2, P494, DOI 10.1557/JMR.1987.0494
   YOLDAS BE, 1982, J AM CERAM SOC, V65, P387, DOI 10.1111/j.1151-2916.1982.tb10490.x
   YOLDAS BE, 1973, J APPL CHEM BIOTECHN, V23, P803, DOI 10.1002/jctb.5020231103
   ZICHNER LP, 1992, CLIN ORTHOP RELAT R, P86
NR 46
TC 11
Z9 12
U1 0
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD SEP
PY 2004
VL 15
IS 9
BP 959
EP 966
DI 10.1023/B:JMSM.0000042681.25746.74
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 856RE
UT WOS:000224061500003
PM 15448403
DA 2018-10-19
ER

PT J
AU Forsythe, KM
   Robertson, DH
   Zheng, QH
AF Forsythe, KM
   Robertson, DH
   Zheng, QH
TI Ab initio MO calculation studies for several novel entries to tropane
   compounds
SO JOURNAL OF THEORETICAL & COMPUTATIONAL CHEMISTRY
LA English
DT Article
DE tropane compounds; conjugate addition reaction; isomerization;
   ring-opening reaction; ab initio MO calculation
ID ENANTIOSELECTIVE DEPROTONATION STRATEGY; DOPAMINE TRANSPORTERS;
   LIGAND-BINDING; ESTERS; SITES; SEROTONIN; ISOMERS; COCAINE; ANALOGS;
   DISEASE
AB Tropane alkaloids are generally known as anticholinergics. Radiolabeled tropane compounds could be brain imaging agents used in biomedical imaging technique positron emission tomography (PET). A novel entry to aryltropane analogs of cocaine was developed based on the conjugate addition reaction of Grignard reagents phenylmagnesium (10), (4'-isopropenylptienyl)magnesium (11), or 2-naphthylmagnesium bromide (12) to a,)3-unsaturated esters anhydroecgonine methyl ester (9) or t-butyl ester (13) which gave several aryltropanes (1-8) with high binding affinities for dopamine and serotonin transporters. Basic conditions are frequently employed in the radiolabeling chemistry of many aryltropane cocaine analogs (1-8b, 14-24b). However, isomerization at C-2 position can also occur under basic conditions, resulting in loss of the biologically potent 2beta-isomers (1-8b, 14-24b) by conversion to the much less active 2alpha-isomer (1-8a, 14-24a). Tropinone (25) could be envisaged as a convenient starting material for the synthesis of diverse tropane alkaloids. A novel entry into tropane alkaloid intermediates was developed based on the ring-opening reaction of tropinone. In this reaction, the enolate of tropinone, resulting from deprotonation with lithium diisopropylamide [LDA, LiN(CHMe2)(2)] or sodium bis(trimethylsilyl)amide [NaN(SiMe3)(2)] Was treated with alkyl chloroformate to give a novel, structurally unique class of tropane alkaloid intermediates 6-N-carboalkyoxy-N-methyl-2-cycloheptenone (26), 1-alkyoxycarboxy-6-N-carboalkoxy-N-methyl-2,7-cyclohept-dien (27) and 6-N-carboalkyoxy-N-methyl-7-carboalkoxy-2,7-cyclohept-dien-ol (28). In this paper we study the conjugate addition reaction of Grignard reagents to alpha, beta-unsaturated esters, the isomerization of aryltropane cocaine analogs, and the ring-opening reaction of tropinone by ab initio MO calculation at the Hartree-Fock (HF) level. The calculation results solely in terms of energetics indicate that the 2alpha-isomers (equatorial configurations) of aryltropane cocaine analogs are more stable than their 2beta-isomers (axial configurations), at the AMI, STO-3G and 3-21G(*) levels, and the Grignard 1,4- and then 1,2-addition (double addition) products (2, 4, 5 and 7) are likely more stable than the Grignard 1,4-addition (single addition) products (1, 3, 6 and 8), respectively, at the STO-3G and 3-21G(*) levels except at the AMI level. Therefore the tendency of Grignard addition toward double addition is competitive with single addition, and the isomerization tends to the formation of more stable 2a-isomers. Likewise, the calculation results solely in terms of energetics indicate that the stability of the reaction product forms is 28 > 27 > 26, at the AMI, STO-3G and 3-21G(*) levels, and the tendency of alkyl chloroformate addition toward double addition to the products 27 and 28 is competitive with single addition to the products 26. Ab initio MO calculations provide a theoretical rationalization for the chemoselectivity of the conjugate addition reaction and the ring-opening reaction, the most stable configurations of reaction products (1-8, 14-24, 26-28), and the isomerization between 1-8b, 14-24b and 1-8a, 14-24a, and between 27 and 28.
C1 Indiana Univ, Sch Med, Dept Radiol, Indianapolis, IN 46202 USA.
   Indiana Univ Purdue Univ, Dept Chem, Indianapolis, IN 46202 USA.
   Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA.
RP Zheng, QH (reprint author), Indiana Univ, Sch Med, Dept Radiol, 1345 W 16th St,L-3 Room 202, Indianapolis, IN 46202 USA.
EM qzheng@iupui.edu
CR Aggarwal VK, 1999, ANGEW CHEM INT EDIT, V38, P1985, DOI 10.1002/(SICI)1521-3773(19990712)38:13/14<1985::AID-ANIE1985>3.0.CO;2-7
   BOJA JW, 1991, EUR J PHARMACOL, V194, P133, DOI 10.1016/0014-2999(91)90137-F
   Brashear A, 1999, MOVEMENT DISORD, V14, P132, DOI 10.1002/1531-8257(199901)14:1<132::AID-MDS1022>3.3.CO;2-A
   CARROLL FI, 1991, J MED CHEM, V34, P883, DOI 10.1021/jm00107a003
   CARROLL FI, 1991, J MED CHEM, V34, P2719, DOI 10.1021/jm00113a008
   CLARKE RL, 1973, J MED CHEM, V16, P1260, DOI 10.1021/jm00269a600
   DAVIES HML, 1994, J MED CHEM, V37, P1262, DOI 10.1021/jm00035a005
   FROST JJ, 1993, ANN NEUROL, V34, P423, DOI 10.1002/ana.410340331
   Hicks FA, 2000, ORG LETT, V2, P219, DOI 10.1021/ol991310t
   INNIS RB, 1993, P NATL ACAD SCI USA, V90, P11965, DOI 10.1073/pnas.90.24.11965
   Lee JC, 1999, TETRAHEDRON LETT, V40, P7675, DOI 10.1016/S0040-4039(99)01589-0
   Majewski M, 1997, CAN J CHEM, V75, P754, DOI 10.1139/v97-091
   MAJEWSKI M, 1994, TETRAHEDRON LETT, V35, P3653, DOI 10.1016/S0040-4039(00)73063-2
   MAJEWSKI M, 1992, CAN J CHEM, V70, P2618, DOI 10.1139/v92-330
   MELTZER PC, 1996, J MED CHEM, V38, P855
   Mulholland GK, 1996, J NUCL MED, V37, P150
   MULHOLLAND GK, 1996, ABSTR PAP AM CHEM S, V212, DOI UNSP 76-NUCL
   MULHOLLAND GK, 1996, ABSTR PAP AM CHEM S, V212, DOI UNSP 162-MEDI
   SIMPKINS NS, 1990, CHEM SOC REV, V19, P335, DOI 10.1039/cs9901900335
   *WAV INC, SPART 5 1
   Zheng QH, 2000, SYNTHETIC COMMUN, V30, P333, DOI 10.1080/00397910008087326
   Zheng QH, 1996, NUCL MED BIOL, V23, P981, DOI 10.1016/S0969-8051(96)00133-3
   ZHENG QH, 2000, ABSTR PAP AM CHEM S, V230, DOI UNSP 231-MEDI
   ZHENG QH, 2000, ABSTR PAP AM CHEM S, V220, DOI UNSP 209-MEDI
   ZHENG QH, 2002, ABSTR PAP AM CHEM S, V223, DOI UNSP 112-MEDI
   ZHENG QH, 1995, J LABELLED COMPD RAD, V37, P139
   ZHENG QH, 1996, ABSTR PAP AM CHEM S, V212, DOI UNSP 371-ORGN
   Zheng Qi-Huang, 1997, Journal of Labelled Compounds and Radiopharmaceuticals, V40, P548
   Zheng Qi-Huang, 1997, Journal of Labelled Compounds and Radiopharmaceuticals, V40, P551
   ZIRKLE CL, 1962, J ORG CHEM, V27, P1269, DOI 10.1021/jo01051a037
NR 30
TC 1
Z9 1
U1 0
U2 4
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 0219-6336
J9 J THEOR COMPUT CHEM
JI J. Theor. Comput. Chem.
PD SEP
PY 2004
VL 3
IS 3
BP 305
EP 323
DI 10.1142/S0219633604001069
PG 19
WC Chemistry, Multidisciplinary
SC Chemistry
GA 868RH
UT WOS:000224930200004
DA 2018-10-19
ER

PT J
AU Amornchai, W
   Hoven, VP
   Tangpasuthadol, V
AF Amornchai, W
   Hoven, VP
   Tangpasuthadol, V
TI Surface modification of chitosan films-grafting ethylene glycol oligomer
   and its effect on protein adsorption
SO MACROMOLECULAR SYMPOSIA
LA English
DT Article; Proceedings Paper
CT 8th Pacific Polymer Conference
CY 2003
CL Bangkok, THAILAND
SP Pacific Polymer Federat
DE biomaterials; chitosan; poly(ethylene glycol); protein adsorption;
   surface modification
ID BLOOD-COMPATIBILITY; MEMBRANES
AB This work is a part of a series on surface modification of materials made of chitosan. This report focused on grafting monomethoxy ethylene glycol oligomers (mPEG) on the surface of chitosan films. The chemical reactions were performed by immersing the films in organic solvent containing aldehyde derivative of mPEG. The presence of ethylene glycol moieties was determined by attenuated total reflectance-infrared spectroscopy (ATR-IR) and nuclear magnetic resonance (NMR). The hydrophobicity of the modified surface, determined by air-water contact angle, decreased when the ethylene glycol derivatives were grafted on the film. The modified films were also subjected to protein adsorption study in order to assess their uses in biomedical applications. It was found that the presence of ethylene glycol units reduced the adsorption of proteins (albumin and lysozyme) on the films. We therefore have shown that manipulation of the interaction between chitosan and bio-macromolecules is possible by chemically modifying the surface of chitosan.
C1 Chulalongkorn Univ, Dept Chem, Fac Sci, Organ Synth Res Unit, Bangkok 10330, Thailand.
   Chulalongkorn Univ, Petrochem & Polymer Sci Program, Fac Sci, Bangkok 10330, Thailand.
RP Amornchai, W (reprint author), Chulalongkorn Univ, Dept Chem, Fac Sci, Organ Synth Res Unit, Bangkok 10330, Thailand.
EM varawut.t@chula.ac.th
RI Hoven, Voravee/F-9275-2010; Tangpasuthadol, Varawut/F-9260-2010
CR AIBA SI, 1998, 3 AS PAC CHIT CHIT S, V3, P424
   Amiji MM, 1997, CARBOHYD POLYM, V32, P193, DOI 10.1016/S0144-8617(97)00006-4
   Anderson D, 2001, J APPL POLYM SCI, V80, P1274, DOI 10.1002/app.1213
   Chapman RG, 2001, LANGMUIR, V17, P1225, DOI 10.1021/la001222d
   Haipeng G, 2000, J Biomed Mater Res, V52, P285, DOI 10.1002/1097-4636(200011)52:2<285::AID-JBM7>3.3.CO;2-7
   Higuchi A, 2002, BIOMATERIALS, V23, P2659, DOI 10.1016/S0142-9612(01)00406-9
   Hojo K, 2000, J PHARM PHARMACOL, V52, P67, DOI 10.1211/0022357001773526
   Khang G, 2002, J APPL POLYM SCI, V85, P1253, DOI 10.1002/app.10680
   Kiss E, 2002, J COLLOID INTERF SCI, V245, P91, DOI 10.1006/jcis.2001.7954
   KOYANO T, 1998, J BIOMED MATER RES, V39, P468
   Ladam G, 2001, LANGMUIR, V17, P878, DOI 10.1021/la0013087
   Qu X, 2001, POLYM BULL, V46, P223, DOI 10.1007/s002890170078
   Sashiwa H, 2000, BIOMACROMOLECULES, V1, P303, DOI 10.1021/bm005536r
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   TANGPASUTHADOL V, 2003, CARBOHYD RES, V338, P537
   Wang HT, 2001, J MATER CHEM, V11, P1374, DOI 10.1039/b009688l
NR 16
TC 15
Z9 15
U1 0
U2 8
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1022-1360
J9 MACROMOL SYMP
JI Macromol. Symp.
PD SEP
PY 2004
VL 216
BP 99
EP 107
DI 10.1002/masy.200451211
PG 9
WC Polymer Science
SC Polymer Science
GA 868JR
UT WOS:000224910400012
DA 2018-10-19
ER

PT J
AU Li, N
   Jie, Q
   Zhu, SM
   Wang, RD
AF Li, N
   Jie, Q
   Zhu, SM
   Wang, RD
TI A new route to prepare macroporous bioactive sol-gel glasses with high
   mechanical strength
SO MATERIALS LETTERS
LA English
DT Article
DE glasses; sol-gel; bioactive; strength
ID BIOMEDICAL MATERIALS; SCAFFOLDS
AB This paper reports a new method to obtain macroporous bioactive glasses by sol-gel and pore former technologies. The in vitro tests showed that the samples had good apatite-forming ability. Noticeably, these bioglasses exhibit high specific surface areas and excellent mechanical performances. The compressive strength is as high as 34.4 +/- 5.7 MPa. This method may be a useful approach for preparation of scaffolds for tissue engineering. (C) 2004 Elsevier B.V. All rights reserved.
C1 Chinese Acad Sci, Shanghai Inst Ceram, Shanghai 200050, Peoples R China.
RP Li, N (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, 1295 Ding Xi Rd, Shanghai 200050, Peoples R China.
EM lina@mail.sic.ac.cn
RI Jie, Qing/H-3780-2011; Jie, Qing/N-8673-2013; Zhu, Sumin/D-3686-2009
CR Agrawal CM, 1997, MATER SCI FORUM, V250, P115, DOI 10.4028/www.scientific.net/MSF.250.115
   Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO;2-J
   HAMADOUCHE M, 2000, BIOCERAMICS, V13, P593
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Jones JR, 2001, MATER SCI TECH SER, V17, P891, DOI 10.1179/026708301101510762
   Lenza RFS, 2002, J MATER SCI-MATER M, V13, P837, DOI 10.1023/A:1016592127407
   LI PJ, 1994, J AM CERAM SOC, V77, P1307, DOI 10.1111/j.1151-2916.1994.tb05407.x
   Pereira MM, 1996, J SOL-GEL SCI TECHN, V7, P59, DOI 10.1007/BF00401884
   Perez-Pariente J., 2002, J BIOMED MATER RES, V61, P524
   Sepulveda P, 2002, J BIOMED MATER RES, V59, P340, DOI 10.1002/jbm.1250
   Xu HHK, 2004, BIOMATERIALS, V25, P1029, DOI 10.1016/S0142-9612(03)00608-2
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Zhong J., 1997, BIOCERAMICS, V10, P265
   Zhong JP, 2000, J BIOMED MATER RES, V53, P694, DOI 10.1002/1097-4636(2000)53:6<694::AID-JBM12>3.0.CO;2-6
NR 14
TC 15
Z9 17
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD SEP
PY 2004
VL 58
IS 22-23
BP 2747
EP 2750
DI 10.1016/j.matlet.2004.03.049
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 844NC
UT WOS:000223164200009
DA 2018-10-19
ER

PT J
AU Bhat, N
   Kim, WJ
AF Bhat, N
   Kim, WJ
TI Precision force and position control of an ionic polymer metal composite
SO PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART I-JOURNAL OF
   SYSTEMS AND CONTROL ENGINEERING
LA English
DT Article
DE ionic polymer metal composite; microscale force control; microscale
   position control; smart material actuator; hybrid control
ID MUSCLES; DESIGN
AB In this paper, model-based precision force and position control of an ionic polymer metal composite (IPMC) is presented. A 23.8 mm x 3.4 mm x 0.16 mm IPMC strip was used as an actuator in a cantilever configuration. Open-loop force and position responses of an IPMC are not repeatable, and hence closed-loop precision control is of critical importance to ensure proper functioning, repeatability and reliability. After feedback controllers were designed and implemented with empirically obtained fourth-order plant transfer functions, the overshoot decreased from 460 to 2.8 per cent and the settling time was reduced from 37.5 to 3.22 s in force control. In position control the overshoot decreased from 333 to 20.3 per cent and the settling time was reduced from 21.5 to 2.56 s. Microscale precision force and position control capabilities of the IPMC actuator were also demonstrated experimentally. An 8 muN force resolution was achieved with a force noise of 0.5 muN r.m.s., and the position resolution was 6 pm with a position noise of 2.5 mum r.m.s. The maximum force and tip displacement achieved with the IPMC actuator under closed-loop control were 2 mN and 5 mm respectively. The IPMC actuator could follow various commanded force and position trajectories such as sinusoidal and trapezoidal position profiles, and a velocity profile with a 3 mm/s maximum velocity. A novel hybrid force and position control strategy demonstrated its utility in practical micromanipulation applications where the actuator force must be limited to prevent damaging micro-objects. High-precision control of the IPMC at low force level proved its potential for micromanufacturing and micromanipulation applications such as robotic and biomedical microgrippers.
C1 Texas A&M Univ, Dept Mech Engn, College Stn, TX 77843 USA.
RP Kim, WJ (reprint author), Texas A&M Univ, Dept Mech Engn, College Stn, TX 77843 USA.
EM wjkim@mengr.tamu.edu
CR BARCOHEN Y, 2000, P SPIE S SMART STRUC, V3987
   BARCOHEN Y, 1998, P ASCE SPEC C ROB CH, P15
   BARCOHEN Y, 2001, SPIE PUBLICATION, pCH1
   BHAT N, 2003, P ASME INT MECH ENG
   Hunter I. W., 1992, Technical Digest. IEEE Solid-State Sensor and Actuator Workshop (Cat. No.92TH0403-X), P178, DOI 10.1109/SOLSEN.1992.228297
   KANNO R, 1994, P JAP US S FLEX AUT, V2, P691
   KIM WJ, 2002, MICROGRIPPER DIS FEB
   Konyo M., 2000, Proceedings 2000 ICRA. Millennium Conference. IEEE International Conference on Robotics and Automation. Symposia Proceedings (Cat. No.00CH37065), P3416, DOI 10.1109/ROBOT.2000.845250
   Kothera CS, 2002, THESIS VIRGINIA POLY
   Lumia R, 1999, PROC SPIE, V3669, P322, DOI 10.1117/12.349689
   MALLAVARAPU K, 2001, THESIS VIRGINIA POLY
   *MATHW INC, 2002, OPT TOOLB
   OGURO K, 1992, J MICROMACHINE SOC, V5, P27
   Richardson RC, 2003, IEEE-ASME T MECH, V8, P245, DOI 10.1109/TMECH.2003.812835
   Sadeghipour K., 1992, Smart Materials and Structures, V1, P172, DOI 10.1088/0964-1726/1/2/012
   Shaheen HM, 2000, J CAMEL PRACT RES, V7, P15
   Shahinpoor M., 1994, Smart Materials and Structures, V3, P367, DOI 10.1088/0964-1726/3/3/012
   Shahinpoor M., 1992, Smart Materials and Structures, V1, P91, DOI 10.1088/0964-1726/1/1/014
NR 18
TC 45
Z9 45
U1 0
U2 10
PU PROFESSIONAL ENGINEERING PUBLISHING LTD
PI BURY ST EDMUNDS
PA NORTHGATE AVENUE, BURY ST EDMUNDS IP32 6BW, SUFFOLK, ENGLAND
SN 0959-6518
J9 P I MECH ENG I-J SYS
JI Proc. Inst. Mech. Eng. Part I-J Syst Control Eng.
PD SEP
PY 2004
VL 218
IS I6
BP 421
EP 432
DI 10.1243/0959651052010133
PG 12
WC Automation & Control Systems
SC Automation & Control Systems
GA 870GL
UT WOS:000225045500001
DA 2018-10-19
ER

PT J
AU Werner, A
   Isaksen, LW
   Malterud, K
AF Werner, A
   Isaksen, LW
   Malterud, K
TI 'I am not the kind of woman who complains of everything' - Illness
   stories on self and shame in women with chronic pain
SO SOCIAL SCIENCE & MEDICINE
LA English
DT Article
DE chronic pain; medically unexplained pain; somatisation; illness
   narratives; gender; Norway
ID CHRONIC-FATIGUE-SYNDROME; CHRONIC MUSCULAR PAIN; BACK-PAIN;
   FIBROMYALGIA; EXPERIENCE; NARRATIVES; PERSPECTIVES; SOMATIZATION;
   GUIDELINES; KNOWLEDGE
AB In this study, we explore issues of self and shame in illness accounts from women with chronic pain. We focused on how these issues within their stories were shaped according to cultural discourses of gender and disease. A qualitative study was conducted with in-depth interviews including a purposeful sampling of 10 women of varying ages and backgrounds with chronic muscular pain. The women described themselves in various ways as 'strong', and expressed their disgust regarding talk of illness of other women with similar pain. The material was interpreted within a feminist frame of reference, inspired by narrative theory and discourse analysis. We read the women's descriptions of their own (positive) strength and the (negative) illness talk of others as a moral plot and argumentation, appealing to a public audience of health personnel, the general public, and the interviewer: As a plot, their stories attempt to cope with psychological and alternative explanations of the causes of their pain. As performance, their stories attempt to cope with the scepticism and distrust they report having been met with. Finally, as arguments, their stories attempt to convince us about the credibility of their pain as real and somatic rather than imagined or psychological. In several ways, the women negotiated a picture of themselves that fits with normative, biomedical expectations of what illness is and how it should be performed or lived out in 'storied form' according to a gendered work of credibility as woman and as ill. Thus, their descriptions appear not merely in terms of individual behaviour, but also as organized by medical discourses of gender and diseases. Behind their stories, we hear whispered accounts relating to the medical narrative about hysteria; rejections of the stereotype medical discourse of the crazy, lazy, illness-fixed or weak woman. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Oslo, Ctr Womens Studies & Gender Res, N-0315 Oslo, Norway.
   Univ Bergen, Inst Sociol, N-5007 Bergen, Norway.
   Univ Bergen, Dept Publ & Primary Hlth Care, Sect Gen Practice, N-5009 Bergen, Norway.
   Univ Copenhagen, Inst Publ Hlth, Dept Gen Practice, DK-1168 Copenhagen, Denmark.
   Univ Copenhagen, Inst Publ Hlth, Res Unit, DK-1168 Copenhagen, Denmark.
RP Werner, A (reprint author), Univ Oslo, Ctr Womens Studies & Gender Res, POB 1040, N-0315 Oslo, Norway.
EM anne.werner@skk.uio.no
CR Album D., 1996, NAERE FREMMEDE PASIE
   Asbring P, 2002, QUAL HEALTH RES, V12, P148, DOI 10.1177/104973230201200202
   Asbring P, 2003, SOC SCI MED, V57, P711, DOI 10.1016/S0277-9536(02)00420-3
   Asbring P, 2001, J ADV NURS, V34, P312, DOI 10.1046/j.1365-2648.2001.01767.x
   Brodwin P, 1992, PAIN HUMAN EXPERIENC, P100
   Bury M, 1982, Sociol Health Illn, V4, P167, DOI 10.1111/1467-9566.ep11339939
   Charmaz K, 1983, Sociol Health Illn, V5, P168, DOI 10.1111/1467-9566.ep10491512
   Douglas M., 1999, IMPLICIT MEANINGS SE
   Eccleston C, 1997, SOC SCI MED, V45, P699, DOI 10.1016/S0277-9536(96)00404-2
   Epstein RM, 1999, ARCH INTERN MED, V159, P215, DOI 10.1001/archinte.159.3.215
   Ford CV, 1997, SCAND J WORK ENV HEA, V23, P7
   Frank Arthur W, 1995, WOUNDED STORYTELLER
   Frank AW, 2000, QUAL HEALTH RES, V10, P354, DOI 10.1177/104973200129118499
   FROBERG S, 1995, RES VIOLENCE THREATS, P38
   Giorgi A., 1985, PHENOMENOLOGY PSYCHO, P8
   Glenton C, 2003, SOC SCI MED, V57, P2243, DOI 10.1016/S0277-9536(03)00130-8
   GOOD B, 1994, MED RATIONALITY EXPE
   HAUG F, 1992, FEMALE MASOCHISM MEM, P31
   Honkasalo M L, 2001, Med Anthropol, V19, P319
   Hyden LC, 1997, SOCIOL HEALTH ILL, V19, P48, DOI 10.1111/1467-9566.00040
   Jackson J. E., 1992, PAIN HUMAN EXPERIENC, P138
   Johannisson K., 2001, GENDER INEQUALITIES, P99
   Johannsen FR, 1996, ISSUES SCI TECHNOL, V13, P6
   Kugelmann R, 1999, SOC SCI MED, V49, P1663, DOI 10.1016/S0277-9536(99)00240-3
   Kvale Steinar, 1996, INTERVIEWS INTRO QUA
   Leira H. K., 2002, GENDER VIOLENCE NORD, V545, P285
   LILLEAAS UB, 1995, 8 U OSL CTR WOM STUD
   Lillrank A, 2003, SOC SCI MED, V57, P1045, DOI 10.1016/S0277-9536(02)00479-3
   Malterud K, 2000, FAM MED, V32, P603
   MALTERUD K, 1993, FAM PRACT, V10, P201, DOI 10.1093/fampra/10.2.201
   MALTERUD K, 2002, NZ FAMILY PHYS, V29, P374
   MATTINGLY C, 1994, SOC SCI MED, V38, P811, DOI 10.1016/0277-9536(94)90153-8
   Miczo N, 2003, QUAL HEALTH RES, V13, P469, DOI 10.1177/1049732302250756
   OCHBERG RL, 1997, EXPLORING IDENTITY G, V2, P113
   Paulson M, 1999, J ADV NURS, V30, P1097, DOI 10.1046/j.1365-2648.1999.01162.x
   Pierret J, 2003, SOCIOL HEALTH ILL, V25, P4, DOI 10.1111/1467-9566.t01-1-00337
   PLUMMER K, 1995, TELLING SEXUAL STORI
   RIESSMAN CK, 1990, SOC SCI MED, V30, P1195, DOI 10.1016/0277-9536(90)90259-U
   Scheurich N, 2000, PERSPECT BIOL MED, V43, P461
   SHORTER E, 1992, PARALYSIS FATIGUE HI
   Showalter E., 1997, HYSTORIES HYSTERICAL
   Steihaug S, 2002, SCAND J PUBLIC HEALT, V30, P281, DOI 10.1080/14034940210133960
   Steihaug S, 2001, SCAND J PRIM HEALTH, V19, P249
   WARE NC, 1992, MED ANTHROPOL Q, V6, P347, DOI 10.1525/maq.1992.6.4.02a00030
   Werner A, 2003, SOC SCI MED, V57, P1409, DOI 10.1016/S0277-9536(02)00520-8
   Werner A, 2003, QUAL HEALTH RES, V13, P491, DOI 10.1177/1049732302250755
   WIDERBERG K, 2001, HIST KVALITATIVT FOR
   Wood B, 1999, J PSYCHOSOM RES, V47, P385, DOI 10.1016/S0022-3999(99)00025-2
   WOODGUSH G, 1995, J ROY SOC MED, V88, P6
NR 49
TC 140
Z9 142
U1 1
U2 22
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0277-9536
J9 SOC SCI MED
JI Soc. Sci. Med.
PD SEP
PY 2004
VL 59
IS 5
BP 1035
EP 1045
DI 10.1016/j.socscimed.2003.12.001
PG 11
WC Public, Environmental & Occupational Health; Social Sciences, Biomedical
SC Public, Environmental & Occupational Health; Biomedical Social Sciences
GA 834ST
UT WOS:000222431800012
PM 15186903
DA 2018-10-19
ER

PT J
AU Zhao, XJ
   Zhang, SG
AF Zhao, XJ
   Zhang, SG
TI Fabrication of molecular materials using peptide construction motifs
SO TRENDS IN BIOTECHNOLOGY
LA English
DT Review
ID SURFACTANT-LIKE PEPTIDES; SELF-COMPLEMENTARY OLIGOPEPTIDE; BETA-SHEET;
   AMPHIPHILE NANOFIBERS; REVERSIBLE HYDROGELS; BIOLOGICAL-MATERIALS;
   DESIGNED PEPTIDE; FORM NANOTUBES; PROTEINS; NANOWIRES
AB Biotechnology has generally been associated with gene cloning and expression, genomics, high throughput drug discovery, biomedical advancement and agricultural development. That is about to change. Biotechnology will expand to encompass discovery and fabrication of biological and molecular materials with diverse structures, functionalities and utilities. The advent of nanobiotechnology and nanotechnology have accelerated this trend. Analogous to the construction of an intricate architectural structure, diverse and numerous structural motifs are used to assemble a sophisticated complex. Nature has selected, produced and evolved numerous molecular architectural motifs over billions of years for particular functions. These molecular motifs can now be used to build materials from the bottom up. Biotechnology will continue to harness nature's enormous power to benefit other disciplines and society as a whole.
C1 MIT, Ctr Biomed Engn, Cambridge, MA 02139 USA.
   MIT, Ctr Bits & Atom, Cambridge, MA 02139 USA.
RP Zhang, SG (reprint author), MIT, Ctr Biomed Engn, 77 Massachusetts Ave,Technol Sq 500,NE47-379, Cambridge, MA 02139 USA.
EM Shuguang@mit.edu
CR Aggeli A, 2001, P NATL ACAD SCI USA, V98, P11857, DOI 10.1073/pnas.191250198
   Altman M, 2000, PROTEIN SCI, V9, P1095, DOI 10.1110/ps.9.6.1095
   Branden C., 1999, INTRO PROTEIN STRUCT
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Fields GB, 1999, BIOORGAN MED CHEM, V7, P75, DOI 10.1016/S0968-0896(98)00216-8
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Lee SW, 2002, SCIENCE, V296, P892, DOI 10.1126/science.1068054
   Loll PJ, 2003, J STRUCT BIOL, V142, P144, DOI 10.1016/S1047-8477(03)00045-5
   MADDOX J, 1998, REMAINS DISCOVERED
   Mao CB, 2003, P NATL ACAD SCI USA, V100, P6946, DOI 10.1073/pnas.0832310100
   Marini DM, 2002, NANO LETT, V2, P295, DOI 10.1021/nl015697g
   Mrksich M, 1996, ANNU REV BIOPH BIOM, V25, P55, DOI 10.1146/annurev.bb.25.060196.000415
   Nowak AP, 2002, NATURE, V417, P424, DOI 10.1038/417424a
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   PETSKO GA, 2003, PROTEIN STRUCTURE FU
   Pochan DJ, 2003, J AM CHEM SOC, V125, P11802, DOI 10.1021/ja0353154
   Reches M, 2003, SCIENCE, V300, P625, DOI 10.1126/science.1082387
   SANJANA N, IN PRESS J NEUROSCI
   Santoso S, 2002, NANO LETT, V2, P687, DOI [10.1021/nl025563i, 10.1021/n1025563i]
   Scheibel T, 2003, P NATL ACAD SCI USA, V100, P4527, DOI 10.1073/pnas.0431081100
   Schneider JP, 2002, J AM CHEM SOC, V124, P15030, DOI 10.1021/ja027993g
   SEMINO A, 2003, DIFFERENTIATION, V71, P262
   Takahashi Y, 2004, BIOORGAN MED CHEM, V12, P693, DOI 10.1016/j.bmc.2003.11.022
   Vauthey S, 2002, P NATL ACAD SCI USA, V99, P5355, DOI 10.1073/pnas.072089599
   von Maltzahn G, 2003, LANGMUIR, V19, P4332, DOI 10.1021/la026526+
   Wallin E, 1998, PROTEIN SCI, V7, P1029
   Whaley SR, 2000, NATURE, V405, P665
   Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821
   WHITESIDES GM, 1991, SCIENCE, V254, P1312, DOI 10.1126/science.1962191
   Yu YC, 1997, METHOD ENZYMOL, V289, P571
   ZHANG S, 2001, DIS CONFORMATION COM, P63
   ZHANG SG, 1992, EMBO J, V11, P3787, DOI 10.1002/j.1460-2075.1992.tb05464.x
   Zhang SG, 1997, P NATL ACAD SCI USA, V94, P23, DOI 10.1073/pnas.94.1.23
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   Zhang SG, 1999, BIOMATERIALS, V20, P1213, DOI 10.1016/S0142-9612(99)00014-9
   Zhang SG, 2004, NAT BIOTECHNOL, V22, P151, DOI 10.1038/nbt0204-151
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zhang SG, 2002, CURR OPIN CHEM BIOL, V6, P865, DOI 10.1016/S1367-5931(02)00391-5
   Zhang SG, 2002, BIOTECHNOL ADV, V20, P321, DOI 10.1016/S0734-9750(02)00026-5
NR 43
TC 101
Z9 108
U1 1
U2 19
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0167-7799
J9 TRENDS BIOTECHNOL
JI Trends Biotechnol.
PD SEP
PY 2004
VL 22
IS 9
BP 470
EP 476
DI 10.1016/j.tibech.2004.07.011
PG 7
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 856ZM
UT WOS:000224084800011
PM 15331228
DA 2018-10-19
ER

PT J
AU Latham, R
   Linford, R
   Schlindwein, W
AF Latham, R
   Linford, R
   Schlindwein, W
TI Biomedical applications of batteries
SO SOLID STATE IONICS
LA English
DT Article; Proceedings Paper
CT 15th International Symposium on the Reactivity of Solids
CY NOV 09-13, 2003
CL Kyoto, JAPAN
DE batteries; biological physics instrumentation; implants; fuel cells;
   medical applications
ID IMPLANTABLE CARDIAC DEFIBRILLATOR; LITHIUM-ION BATTERIES; DRUG-DELIVERY;
   TRANSDERMAL IONTOPHORESIS; MEDICAL APPLICATIONS; THALAMIC NUCLEUS; HUMAN
   SKIN; IN-VITRO; STIMULATION; ELECTROPORATION
AB An over-view is presented of the many ways in which batteries and battery materials are used in medicine and in biomedical studies. These include the use of batteries as power sources for motorised wheelchairs, surgical tools, cardiac pacemakers and defibrillators, dynamic prostheses, sensors and monitors for physiological parameters, neurostimulators, devices for pain relief, and iontophoretic, electroporative and related devices for drug administration. The various types of battery and fuel cell used for this wide range of applications will be considered, together with the potential harmful side effects, including accidental ingestion of batteries and the explosive nature of some of the early cardiac pacemaker battery systems. (C) 2004 Elsevier B.V. All rights reserved.
C1 De Montfort Univ, Res Off, Leicester LE1 9BH, Leics, England.
   De Montfort Univ, Sch Pharm, Leicester LE1 9BH, Leics, England.
   De Montfort Univ, Fac Hlth & Life Sci, Leicester LE1 9BH, Leics, England.
RP Linford, R (reprint author), De Montfort Univ, Res Off, Leicester LE1 9BH, Leics, England.
EM rgl@dmu.ac.uk
CR Adlhart OJ, 1997, ASAIO J, V43, P214
   ALESCH F, 1995, ACTA NEUROCHIR, V136, P75, DOI 10.1007/BF01411439
   Antonioli G, 1973, Minerva Med, V64, P2298
   AYLOR JH, 1992, IEEE T IND ELECTRON, V39, P398, DOI 10.1109/41.161471
   BALL GR, 1997, Patent No. 5624376
   BANGA AK, 1998, ELECTRICALLY ASSISTE, P11
   Bassen HI, 1998, PACE, V21, P1709, DOI 10.1111/j.1540-8159.1998.tb00268.x
   Ben-Zeev B, 2003, J CHILD NEUROL, V18, P254, DOI 10.1177/08830738030180041001
   BENABID AL, 1987, APPL NEUROPHYSIOL, V50, P344
   BRO P, 1979, POWER SOURCES, V7, P571
   Cleland MJ, 2000, J EMERG MED, V18, P305, DOI 10.1016/S0736-4679(99)00219-X
   CONNORS JD, 1992, Patent No. 5153495
   COOPER RA, 1995, J REHABIL RES DEV, V32, P255
   Crespi AM, 2001, J POWER SOURCES, V96, P33, DOI 10.1016/S0378-7753(01)00499-2
   Dawson TW, 2002, IEEE T BIO-MED ENG, V49, P254, DOI 10.1109/10.983460
   Delgado-Charro MB, 2001, STP PHARMA SCI, V11, P403
   Denet AR, 2003, J CONTROL RELEASE, V88, P253, DOI 10.1016/S0168-3659(03)00010-5
   Drews J, 2001, J POWER SOURCES, V97-8, P747, DOI 10.1016/S0378-7753(01)00649-8
   Droog EJ, 2003, MICROVASC RES, V65, P172, DOI 10.1016/S0026-2862(03)00002-5
   Gale CP, 2002, J ROY SOC MED, V95, P353, DOI 10.1258/jrsm.95.7.353
   Geier L, 1999, ANN OTO RHINOL LARYN, V108, P80
   GEORG G, 2001, HERTZ, V26, P64
   Gertner ME, 2003, ELECTROCHEM SOLID ST, V6, pJ4, DOI 10.1149/1.1558354
   GERTNER ME, 2003, INTERFACE, V12, P20
   Gong WS, 2000, ANN BIOMED ENG, V28, P572, DOI 10.1114/1.293
   Goto H, 1999, MED BIOL ENG COMPUT, V37, P377, DOI 10.1007/BF02513315
   Graupe D, 1998, SURG NEUROL, V50, P202, DOI 10.1016/S0090-3019(98)00074-3
   Greatbatch W, 1996, PACE, V19, P1836, DOI 10.1111/j.1540-8159.1996.tb03236.x
   GREATBATCH W, 1959, P NEW ENGL RES ENG M, V1, P8
   Halhal M, 2003, J FR OPHTALMOL, V26, P391
   Hashmi SA, 1997, IONICS, V3, P177, DOI 10.1007/BF02375614
   Helmstadter A, 2001, PHARMAZIE, V56, P583
   Holmes C.F., 2003, INTERFACE, V12, P26
   Holmes CF, 2001, J POWER SOURCES, V97-8, P739, DOI 10.1016/S0378-7753(01)00601-2
   HOLMES CF, 1999, ITE BATT LETT, V1, P132
   HORNING RJ, 1980, P 29 POW SOURC C CHE, P64
   Hu QH, 2003, PHARMAZIE, V58, P192
   Huggins RA, 2000, SOLID STATE IONICS, V134, P179, DOI 10.1016/S0167-2738(00)00725-6
   Ishikawa O, 2002, INT J PHARM, V249, P81, DOI 10.1016/S0378-5173(02)00476-3
   Kanikkannan N, 2002, BIODRUGS, V16, P339, DOI 10.2165/00063030-200216050-00003
   Latham RJ, 2002, SOLID STATE IONICS: TRENDS IN THE NEW MILLENNIUM, PROCEEDINGS, P283, DOI 10.1142/9789812776259_0030
   Latham RJ, 2003, IONICS, V9, P41, DOI 10.1007/BF02376535
   LIANG CC, 1982, Patent No. 4310609
   Lopez RF, 2003, J CONTROL RELEASE, V88, P65, DOI 10.1016/S0168-3659(02)00456-X
   Marro D, 2001, PHARMACEUT RES, V18, P1701, DOI 10.1023/A:1013318412527
   MEYER PF, 2003, J NEUROSCI METH, V25, P309
   MIROWSKI M, 1980, AM HEART J, V100, P1089, DOI 10.1016/0002-8703(80)90218-5
   Moser J. R, 1972, U.S. Patent, Patent No. [3,660,163, 3660163, 3,660,163, US]
   Newsom RL, 2002, IEEE T IND ELECTRON, V49, P1146, DOI 10.1109/TIE.2002.803240
   O'Suilleabhain PE, 2003, NEUROLOGY, V60, P786, DOI 10.1212/01.WNL.0000044156.56643.74
   OWNES BB, 1979, FAST ION TRANSPROT S, P61
   Passerini S, 2001, J POWER SOURCES, V97-8, P750, DOI 10.1016/S0378-7753(01)00602-4
   Perron M, 2003, PHYS THER, V83, P71
   Petley GW, 1998, MED ENG PHYS, V20, P33, DOI 10.1016/S1350-4533(97)00043-X
   PHIPPS JB, 1986, SOLID STATE IONICS, V18-9, P1073, DOI 10.1016/0167-2738(86)90311-5
   Rosenow JM, 2003, J NEUROSURG, V99, P167, DOI 10.3171/jns.2003.99.1.0167
   RUBEN SR, 1947, Patent No. 244045
   Rubino RS, 2001, J ELECTROCHEM SOC, V148, pA1029, DOI 10.1149/1.1390344
   Sasaki H, 1999, CRIT REV THER DRUG, V16, P85
   Saudek CD, 1996, JAMA-J AM MED ASSOC, V276, P1322, DOI 10.1001/jama.276.16.1322
   SCHLESINGER M, 2003, INTERFACE, V12, P19
   Schmidt CL, 2001, J POWER SOURCES, V97-8, P742, DOI 10.1016/S0378-7753(01)00648-6
   SCHOENFISCH MH, 1999, J BIOMED MATER RES, V51, P209
   Sekkat N, 2002, J CONTROL RELEASE, V81, P83, DOI 10.1016/S0168-3659(02)00046-9
   Sugibayashi K, 2000, J PHARM PHARMACOL, V52, P1179, DOI 10.1211/0022357001777306
   Takeuchi ES, 2002, MRS BULL, V27, P624, DOI 10.1557/mrs2002.199
   TAKEUCHI ES, 1995, J POWER SOURCES, V54, P115, DOI 10.1016/0378-7753(94)02050-D
   Tchin-Iou AVD, 1999, INT J ARTIF ORGANS, V22, P823
   TERRY R, 1990, EPILEPSIA S2, V31, P33
   Tezel A, 2003, J PHARM SCI, V92, P381, DOI 10.1002/jps.10299
   TILLER RG, 1991, Patent No. 4991069
   Uitto OD, 2003, PHARMACEUT RES, V20, P646, DOI 10.1023/A:1023259102279
   WEBB WA, 1995, GASTROINTEST ENDOSC, V41, P39, DOI 10.1016/S0016-5107(95)70274-1
   WHITE HS, 2003, INTERFACE, V12, P30
   Yokoyama K, 2000, J CLIN LASER MED SUR, V18, P9, DOI 10.1089/clm.2000.18.9
   Zempsky WT, 2003, DERMATOL SURG, V29, P627, DOI 10.1046/j.1524-4725.2003.29142.x
NR 76
TC 17
Z9 18
U1 0
U2 20
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-2738
J9 SOLID STATE IONICS
JI Solid State Ion.
PD AUG 31
PY 2004
VL 172
IS 1-4
SI SI
BP 7
EP 11
DI 10.1016/j.ssi.2004.04.024
PG 5
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA 871MZ
UT WOS:000225139100003
OA Green Published
DA 2018-10-19
ER

PT J
AU Vallet-Regi, M
   Pena, J
   Izquierdo-Barba, I
AF Vallet-Regi, M
   Pena, J
   Izquierdo-Barba, I
TI Synthesis of beta-tricalcium phosphate in layered or powdered fon-ns for
   biomedical applications
SO SOLID STATE IONICS
LA English
DT Article; Proceedings Paper
CT 15th International Symposium on the Reactivity of Solids
CY NOV 09-13, 2003
CL Kyoto, JAPAN
DE bioceramics; calcium phosphates (beta-TCP); coating; dip-coating;
   nanopowder
AB The objective of this work is to obtain p-tricalcium phosphate (beta-TCP) both in powdered form and as coatings onto polycrystalline alumina. The Liquid Mix Technique was utilized to prepare solutions with Ca/P ratio of 1.5 which were employed either to obtain powder or to dip-coat Al2O3 substrates 1, 5 or 10 times. All the coatings yielded a porous morphology that increased with their thickness. Two calcium phosphate polymorphs beta-TCP (stable up to 1100 degreesC) and alpha-TCP (obtained after a thermal treatment at 1450 degreesC) can be prepared in the powdered form. The prepared materials were characterised by X-ray diffraction (XRD), Fourier transform infrared (FTIR), scanning electron microscopy (SEM), EDAX and Elemental Analysis. The topography of the layers was studied by SFM. The theological properties of the precursor solutions were determined by viscosimetry. The bioactivity of these materials was tested by immersion in a simulated body fluid (SBF). (C) 2004 Elsevier B.V. All rights reserved.
C1 Univ Complutense Madrid, Fac Farm, Dept Quim Inorgan & Bioinorgan, E-28040 Madrid, Spain.
RP Vallet-Regi, M (reprint author), Univ Complutense Madrid, Fac Farm, Dept Quim Inorgan & Bioinorgan, E-28040 Madrid, Spain.
EM vallet@farm.ucm.es
RI Vallet-Regi, Maria/M-3378-2014; pena, juan/E-5913-2018; IZQUIERDO-BARBA,
   ISABEL/M-9921-2014
OI Vallet-Regi, Maria/0000-0002-6104-4889; pena, juan/0000-0002-5992-908X;
   IZQUIERDO-BARBA, ISABEL/0000-0002-4139-4646
CR Izquierdo-Barba I, 2003, EUR J INORG CHEM, P1608
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Pechini M. P., 1967, US Patent, Patent No. [3 330 697, 3330697]
   Pena J, 2003, J EUR CERAM SOC, V23, P1687, DOI 10.1016/S0955-2219(02)00369-2
   TAI LW, 1992, J MATER RES, V7, P502, DOI 10.1557/JMR.1992.0502
   Vallet-Regi M., 1995, PERSPECTIVES SOLID S, P37
NR 6
TC 9
Z9 11
U1 1
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-2738
J9 SOLID STATE IONICS
JI Solid State Ion.
PD AUG 31
PY 2004
VL 172
IS 1-4
SI SI
BP 445
EP 449
DI 10.1016/j.ssi.2004.04.038
PG 5
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA 871MZ
UT WOS:000225139100090
DA 2018-10-19
ER

PT J
AU Yang, P
   Chen, JY
   Leng, YX
   Sun, H
   Huang, N
   Chu, PK
AF Yang, P
   Chen, JY
   Leng, YX
   Sun, H
   Huang, N
   Chu, PK
TI Effect of annealing on structure and biomedical properties of amorphous
   hydrogenated carbon films
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 7th International Workshop on Plasma-Based Ion Implantation
CY SEP 17-19, 2003
CL San Antonio, TX
SP SW Res Inst
DE plasma immersion ion implantation-deposition; hydrogenated amorphous
   carbon (a-C : H) film; annealing; blood compatibility
ID DIAMOND-LIKE CARBON; IMMERSION ION-IMPLANTATION; BLOOD COMPATIBILITY;
   PROTEIN ADSORPTION; TITANIUM; PLASMA; DLC; COATINGS; HEMOCOMPATIBILITY;
   BIOCOMPATIBILITY
AB The usual failure of blood-contacting biomedical materials and devices arises from thrombogenesis. When a biomaterial comes in contact with a biological body, interface interaction will be concomitant between the biomaterial surface and biological substance, such as blood protein denaturation resulting from electrical charge transfer of proteins and platelet activation induced by interface thermodynamics. Diamond-like carbon (DLC) has been proposed for use in blood contacting devices. Further understanding of the intrinsic relationship between biomedical properties and structure of amorphous carbon films will promote improvement of their biocompatibility. In this study, hydrogenated amorphous carbon (a-C:H) films were fabricated at room temperature using plasma immersion ion implantation-deposition (PIII-D). A series of a-C:H films with different structures and chemical bonds were obtained by adjusting the DC bias voltage from - 75 to - 900 V, then their structure and physical properties were further modified by thermal anneal in vacuum at 600 degreesC. Raman, elastic recoil detection (ERD) and atomic force microscope (AFM) were used to characterize their structures and chemical bonds. The physical properties and surface characteristics of the films were also examined, including the carrier concentration and mobility, resistivity, and surface wettability. The anticoagulation of the films was evaluated employing in vitro platelet adhesion test. The adhesion, activation, and morphology of the platelets were investigated using scanning electron microscopy (SEM). The relationship between their structure and blood compatibility was elucidated. (C) 2004 Elsevier B.V. All rights reserved.
C1 SW Jiaotong Univ, Chinese Educ Minist, Sch Mat Sci & Engn, Key Lab Biomat Surface Modificat Sichuan, Chengdu 610031, Peoples R China.
   City Univ Hong Kong, Dept Phys & Mat Sci, Hong Kong, Hong Kong, Peoples R China.
RP Huang, N (reprint author), SW Jiaotong Univ, Chinese Educ Minist, Sch Mat Sci & Engn, Key Lab Biomat Surface Modificat Sichuan, Chengdu 610031, Peoples R China.
EM huangnan1956@163.com
RI Leng, Yongxiang/G-5488-2010; Chu, Paul/B-5923-2013
OI Chu, Paul/0000-0002-5581-4883; Leng, Y.X./0000-0001-6823-1233
CR Alanazi A, 2000, ASAIO J, V46, P440, DOI 10.1097/00002480-200007000-00014
   Alanazi A, 2000, ARTIF ORGANS, V24, P624, DOI 10.1046/j.1525-1594.2000.06576.x
   Chu PK, 1996, MAT SCI ENG R, V17, P207, DOI 10.1016/S0927-796X(96)00194-5
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Cui FZ, 2000, SURF COAT TECH, V131, P481, DOI 10.1016/S0257-8972(00)00809-4
   De Scheerder I, 2000, J INVASIVE CARDIOL, V12, P389
   Dion I., 1993, Bio-Medical Materials and Engineering, V3, P51
   FENG L, 1994, J COLLOID INTERF SCI, V166, P419, DOI 10.1006/jcis.1994.1313
   Goodman SL, 1996, J BIOMED MATER RES, V32, P249, DOI 10.1002/(SICI)1097-4636(199610)32:2<249::AID-JBM15>3.0.CO;2-E
   Huang N, 1998, BIOMATERIALS, V19, P771, DOI 10.1016/S0142-9612(98)00212-9
   Jones MI, 1999, DIAM RELAT MATER, V8, P457, DOI 10.1016/S0925-9635(98)00426-9
   Jones MI, 2000, J BIOMED MATER RES, V52, P413, DOI 10.1002/1097-4636(200011)52:2<413::AID-JBM23>3.0.CO;2-U
   Leng YX, 2000, THIN SOLID FILMS, V377, P573, DOI 10.1016/S0040-6090(00)01306-7
   LYMAN DJ, 1972, T AM SOC ART INT ORG, V18, P19
   McLaughlin JA, 1996, DIAM RELAT MATER, V5, P486, DOI 10.1016/0925-9635(96)80065-3
   Ogwu AA, 1999, PHYSICA B, V269, P335, DOI 10.1016/S0921-4526(99)00138-6
   PINZARI F, 2000, DIAM RELAT MATER, V10, P781
   Robertson J, 1997, DIAM RELAT MATER, V6, P212, DOI 10.1016/S0925-9635(96)00627-9
   ROBERTSON J, 1991, PROG SOLID STATE CH, V21, P199, DOI 10.1016/0079-6786(91)90002-H
   TANG Z, 2001, J APPL PHYS, V89, P1956
   THOMSON A, 1991, BIOMATERIALS, V2, P37
   Tran HS, 1999, J INVEST SURG, V12, P133
   VANOSS CJ, 1988, J CHEM REV, V88, P92
   Young T, 1805, PHILOS T R SOC LONDO, V95, P65, DOI DOI 10.1098/RSTL.1805.0005
NR 24
TC 22
Z9 22
U1 0
U2 5
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD AUG 2
PY 2004
VL 186
IS 1-2
BP 125
EP 130
DI 10.1016/j.surfcoat.2004.04.039
PG 6
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 840GB
UT WOS:000222844200024
DA 2018-10-19
ER

PT J
AU McKenzie, DR
   Newton-McGee, K
   Ruch, P
   Bilek, MM
   Gan, BK
AF McKenzie, DR
   Newton-McGee, K
   Ruch, P
   Bilek, MM
   Gan, BK
TI Modification of polymers by plasma-based ion implantation for biomedical
   applications
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 7th International Workshop on Plasma-Based Ion Implantation
CY SEP 17-19, 2003
CL San Antonio, TX
SP SW Res Inst
DE polymer; ion implantation; biomedical applications
ID SURFACE MODIFICATION; PEEK
AB |We describe the modification of the polymer poly(aryl ether ether ketone) (PEEK) carried out with the aim of improving its performance for biomedical applications. Polymer samples were exposed to plasmas of oxygen, argon, hydrogen and deuterium by placing them on a substrate holder to which 15 [is pulses of 10 and 15 kV were applied. We found that the treatment with oxygen decreased the contact angle with water drops to nearly zero while argon modification decreased the contact angle to half that of the untreated material. The deeper the treatment the longer the time required to recover the original hydrophobic character. We also found that the hydrogen treatment produced the deepest modification and that the electrical resistivity of the treated material was the same for hydrogen and argon but was higher for oxygen. The effects of the treatment on the infrared spectrum were observed using attenuated total reflection infrared spectroscopy and it was shown that oxygen produces a distinctly different modification to that produced by the other gases.
C1 Univ Sydney, Dept Appl Sci, Sch Phys, Sydney, NSW 2006, Australia.
RP McKenzie, DR (reprint author), Univ Sydney, Dept Appl Sci, Sch Phys, Sydney, NSW 2006, Australia.
EM mckenzie@physics.usyd.edu.au
RI Ruch, Patrick/K-3583-2012; Gan, Bee/B-3818-2009
OI McKenzie, David/0000-0002-2476-1301; Bilek, Marcela/0000-0003-3363-2664
CR Alterovitz S.A., 1991, HDB OPTICAL CONSTANT, VII, P837
   Dong H, 1999, SURF COAT TECH, V111, P29, DOI 10.1016/S0257-8972(98)00698-7
   Ha SW, 1997, SURF COAT TECH, V96, P293, DOI 10.1016/S0257-8972(97)00179-5
   Han S, 1997, SURF COAT TECH, V93, P261, DOI 10.1016/S0257-8972(97)00057-1
   Narushima K, 2002, JPN J APPL PHYS 1, V41, P6506, DOI 10.1143/JJAP.41.6506
   ZHANG RJ, 1995, WEAR, V181, P613, DOI 10.1016/0043-1648(95)90177-9
NR 6
TC 29
Z9 31
U1 0
U2 11
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD AUG 2
PY 2004
VL 186
IS 1-2
BP 239
EP 244
DI 10.1016/j.surfcoat.2004.04.093
PG 6
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 840GB
UT WOS:000222844200046
DA 2018-10-19
ER

PT J
AU Yang, P
   Huang, N
   Leng, YX
   Chen, JY
   Sun, H
   Wang, J
   Wan, GJ
AF Yang, P
   Huang, N
   Leng, YX
   Chen, JY
   Sun, H
   Wang, J
   Wan, GJ
TI Inhibition of adherent platelet activation produced by Ti-O thin film
   fabricated by PIII
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 7th International Workshop on Plasma-Based Ion Implantation
CY SEP 17-19, 2003
CL San Antonio, TX
SP SW Res Inst
DE blood compatibility; platelet activation; protein adsorption; Ti-O film
ID BLOOD COMPATIBILITY; BIOMATERIALS; MARKERS
AB Thrombogenesis is the principal problem associated with blood-contacting biomedical. devices. One of the important reasons is that most of the materials used in these devices cannot avoid inducing platelet adhesion and activation. Our recent investigation suggested that Ti-O thin film could be an alternative antithrombotic material. In this work, we focus our attention on behavior of platelets adhered on Ti-O film. Platelet adhesion experiments were conducted to examine the platelets/material interaction in vitro and the effect of protein adsorption on platelet adhesion and activation. The specific resultants of platelet release (GMP 140) were tested for evaluating the platelet activation. In vivo implantation was used to investigate formation of thrombus.
   The excellent anticoagulation performance of Ti-O films has been shown in in vivo long-term implantation. The release of specific resultants GMP140 from platelets contacting to Ti-O film was the lower than LTI-carbon. The morphology of adherent platelets maintains round and isolated. Apparently, the activation of platelets adhered on Ti-O film was suppressed. The results of in vitro test also suggest that the suppression of platelet activation is related to plasma protein adsorption. Preadsorbing fibrinogen doesn't cause the exacerbation of platelet activation. It seems reasonable to suggest that its excellent anticoagulation is caused by inhibition of adherent platelet activation produced by Ti-O film. (C) 2004 Elsevier B.V. All rights reserved.
C1 SW Jiaotong Univ, Inst Biomat & Surface Engn, Coll Mat Sci & Engn,Chinese Educ Minist, Key Lab Biomat Surface Modificat Sichuan,Lab Adv, Chengdu 610031, Peoples R China.
RP Huang, N (reprint author), SW Jiaotong Univ, Inst Biomat & Surface Engn, Coll Mat Sci & Engn,Chinese Educ Minist, Key Lab Biomat Surface Modificat Sichuan,Lab Adv, Chengdu 610031, Peoples R China.
EM huangnan1956@163.com
RI Leng, Yongxiang/G-5488-2010; Wan, Guojiang/A-6651-2013
OI Wan, Guojiang/0000-0002-1636-5405; Leng, Y.X./0000-0001-6823-1233
CR BOLZ A, 1990, ARTIF ORGANS, V14, P260, DOI 10.1111/j.1525-1594.1990.tb02967.x
   Cenni E, 1997, J BIOMED MATER RES, V36, P289, DOI 10.1002/(SICI)1097-4636(19970905)36:3<289::AID-JBM3>3.0.CO;2-A
   COURTNEY JM, 1994, BIOMATERIALS, V15, P737, DOI 10.1016/0142-9612(94)90026-4
   Goodman SL, 1996, J BIOMED MATER RES, V32, P249, DOI 10.1002/(SICI)1097-4636(199610)32:2<249::AID-JBM15>3.0.CO;2-E
   GROTH T, 1995, BIOMATERIALS, V16, P1009, DOI 10.1016/0142-9612(95)94909-5
   Heublein B, 1998, J ENDOVASC SURG, V5, P32, DOI 10.1583/1074-6218(1998)005<0032:SCCSCE>2.0.CO;2
   HORBETT T, 2000, ANN BIOMED ENG, V28, P16
   Huang N, 1998, BIOMATERIALS, V19, P771, DOI 10.1016/S0142-9612(98)00212-9
   Mollnes TE, 1999, THROMB HAEMOSTASIS, V82, P1132
   RHODES NP, 1994, J BIOMED MATER RES, V28, P435, DOI 10.1002/jbm.820280405
   SIXMA JJ, 1991, J BIOMAT SCI-POLYM E, V3, P17
NR 11
TC 11
Z9 14
U1 1
U2 4
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD AUG 2
PY 2004
VL 186
IS 1-2
BP 265
EP 269
DI 10.1016/j.surfcoat.2004.03.031
PG 5
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 840GB
UT WOS:000222844200051
DA 2018-10-19
ER

PT J
AU Wang, J
   Huang, N
   Pan, CJ
   Kwok, SCH
   Yang, P
   Leng, YX
   Chen, JY
   Sun, H
   Wan, GJ
   Liu, Z
   Chu, PK
AF Wang, J
   Huang, N
   Pan, CJ
   Kwok, SCH
   Yang, P
   Leng, YX
   Chen, JY
   Sun, H
   Wan, GJ
   Liu, Z
   Chu, PK
TI Bacterial repellence from polyethylene terephthalate surface modified by
   acetylene plasma immersion ion implantation-deposition
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 7th International Workshop on Plasma-Based Ion Implantation
CY SEP 17-19, 2003
CL San Antonio, TX
SP SW Res Inst
DE plasma immersion ion implantation; hydrogenated amorphous carbon (a-C :
   H); polyethylene terephthalate (PET); bacterial adhesion
ID PROSTHETIC VALVE ENDOCARDITIS; AMORPHOUS-CARBON; POLY(VINYL CHLORIDE);
   DEVICES; ADHESION; SPECTROSCOPY; INFECTIONS; EFFICACY; ENERGY; SILVER
AB There is an increasing interest in developing new methods to reduce bacterial adhesion onto polymeric materials used in biomedical implants. The antibacterial adsorption behavior on polyethylene terephthalate (PET) treated by plasma immersion ion implantation,re deposition (PIII-D) using acetylene (C2H2) at different working pressures is investigated. The surface structure of the treated PET is determined by Rutherford backscattering spectrometry (RBS), laser Raman spectroscopy, and X-ray photoelectron spectroscopy (XPS). The results show the formation of thin hydrogenated amorphous carbon (a-C:H) films with different structures and chemical bonds on the PET surface. The ability of Staphylococcus aureus (SA) and Staphylococcus epidermidis (SE) to adhere to PET is quantitatively determined by plate counting and Gamma-ray counting of the I-125-labeled bacteria in vitro. The adhesion efficiency of SA on the a-C:H film deposited at 0.5 Pa of working pressure is about 16% of that on the untreated PET surface, and the adhered bacterial concentration of SE on the carbon film deposited at 1.0 Pa is about 1/6 of that of the PET surface. Bacterial adhesion onto a-C:H films is influenced by the structures and chemical bonds of the materials. The reduction in bacterial adhesion can be explained by the free energy of adhesion (DeltaF(Adh)), which predicts whether microbial adhesion is energetically favorable (DeltaF(Adh) < 0) or not (DeltaF(Adh) > 0). Our results show that bacterial adhesion is energetically unfavorable on the a-C:H films deposited at 0.5 and 1.0 Pa, and this study suggests one possible method to repel bacteria from polymeric surfaces. (C) 2004 Elsevier B.V. All rights reserved.
C1 City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China.
   SW Jiaotong Univ, Sch Mat Sci & Engn, Chengdu 610031, Peoples R China.
   Southeast Univ, Affiliated Hosp, Coll Med, Nanjing 210009, Peoples R China.
RP Chu, PK (reprint author), City Univ Hong Kong, Dept Phys & Mat Sci, 88 Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.
EM paul.chu@cityu.edu.hk
RI Wan, Guojiang/A-6651-2013; Chu, Paul/B-5923-2013; Leng,
   Yongxiang/G-5488-2010
OI Wan, Guojiang/0000-0002-1636-5405; Chu, Paul/0000-0002-5581-4883; Leng,
   Y.X./0000-0001-6823-1233
CR ARNOW PM, 1993, CLIN INFECT DIS, V16, P778, DOI 10.1093/clind/16.6.778
   BUSSCHER HJ, 1984, APPL ENVIRON MICROB, V48, P980
   CALDERWOOD SB, 1985, CIRCULATION, V72, P31, DOI 10.1161/01.CIR.72.1.31
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Davenas J, 2002, BIOMOL ENG, V19, P263, DOI 10.1016/S1389-0344(02)00037-0
   Gray JE, 2003, BIOMATERIALS, V24, P2759, DOI 10.1016/S0142-9612(03)00057-7
   Ivanov-Omskii VI, 2000, CARBON, V38, P495, DOI 10.1016/S0008-6223(99)00121-9
   IVERT TSA, 1984, CIRCULATION, V69, P223, DOI 10.1161/01.CIR.69.2.223
   James NR, 2003, BIOMATERIALS, V24, P2205, DOI 10.1016/S0142-9612(03)00022-X
   KI DP, 1998, BIOMATERIALS, V19, P851
   Klueh U, 2000, J BIOMED MATER RES, V53, P621, DOI 10.1002/1097-4636(2000)53:6<621::AID-JBM2>3.0.CO;2-Q
   MATIN MA, 1989, ANN INTERN MED, V110, P9
   Pearson ML, 1996, INFECT CONT HOSP EP, V17, P438
   PITTET D, 1994, JAMA-J AM MED ASSOC, V271, P1598, DOI 10.1001/jama.271.20.1598
   Robertson J, 2002, MAT SCI ENG R, V37, P129, DOI 10.1016/S0927-796X(02)00005-0
   ROBERTSON J, 1991, PROG SOLID STATE CH, V21, P199, DOI 10.1016/0079-6786(91)90002-H
   ROBERTSON J, 1987, PHYS REV B, V35, P2946, DOI 10.1103/PhysRevB.35.2946
   Schneider RP, 1996, J COLLOID INTERF SCI, V182, P204, DOI 10.1006/jcis.1996.0452
   Schwan J, 1996, J APPL PHYS, V80, P440, DOI 10.1063/1.362745
   Sharma PK, 2002, ADV COLLOID INTERFAC, V98, P341, DOI 10.1016/S0001-8686(02)00004-0
   Sodhi RNS, 2001, J ELECTRON SPECTROSC, V121, P249, DOI 10.1016/S0368-2048(01)00338-3
   SUGARMAN B, 1986, AM J MED, V81, P78, DOI 10.1016/0002-9343(86)90517-6
   THRELKELD MG, 1995, PRINCIPLES PRACTICE, P783
   Triandafillu K, 2003, BIOMATERIALS, V24, P1507, DOI 10.1016/S0142-9612(02)00515-X
   Valentini L, 2001, DIAM RELAT MATER, V10, P1088, DOI 10.1016/S0925-9635(00)00391-5
   Van Oss CJ, 1997, J ADHESION, V63, P71, DOI 10.1080/00218469708015214
   Wantanabe S, 2002, THIN SOLID FILMS, V420, P253, DOI 10.1016/S0040-6090(02)00803-9
   Yoshida M, 2003, NUCL INSTRUM METH B, V206, P712, DOI 10.1016/S0168-583X(03)00869-3
NR 28
TC 62
Z9 65
U1 1
U2 16
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD AUG 2
PY 2004
VL 186
IS 1-2
BP 299
EP 304
DI 10.1016/j.surfcoat.2004.02.046
PG 6
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 840GB
UT WOS:000222844200058
DA 2018-10-19
ER

PT J
AU Smith, T
AF Smith, T
TI Biomedical testing
SO ADVANCED MATERIALS & PROCESSES
LA English
DT Article
AB Biomechanical testing of materials for medical devices provides information critical to design of implants that will give life-long service.
C1 Instron Corp, Canton, MA 02021 USA.
RP Smith, T (reprint author), Instron Corp, 100 Royall St, Canton, MA 02021 USA.
EM info_news@instron.com
NR 0
TC 77
Z9 77
U1 0
U2 3
PU ASM INTERNATIONAL
PI MATERIALS PARK
PA SUBSCRIPTIONS SPECIALIST CUSTOMER SERVICE, MATERIALS PARK, OH 44073-0002
   USA
SN 0882-7958
J9 ADV MATER PROCESS
JI Adv. Mater. Process.
PD AUG
PY 2004
VL 162
IS 8
BP 41
EP 43
PG 3
WC Materials Science, Multidisciplinary
SC Materials Science
GA 847JX
UT WOS:000223389600004
DA 2018-10-19
ER

PT J
AU Casas, J
   Persson, PV
   Iversen, T
   Cordova, A
AF Casas, J
   Persson, PV
   Iversen, T
   Cordova, A
TI Direct organocatalytic ring-opening polymerizations of lactones
SO ADVANCED SYNTHESIS & CATALYSIS
LA English
DT Article
DE lactones; organic acids; organic catalysis; polyesters; ring-opening
   polymerizations
ID EPSILON-CAPROLACTONE; ASYMMETRIC-SYNTHESIS; LIPASE CATALYSIS; AMINO;
   DERIVATIVES; KETONES
AB We have developed a novel organocatalytic, direct synthesis of aliphatic polyesters. The synthesis was based on a novel direct organic acid-catalyzed living ring-opening polymerization (ROP) of epsilon-caprolactone and delta-valerolactone with benzyl alcohol as the initiator. The organic acid-catalyzed ROPs were performed without solvent and the catalyst was recovered by precipitation of the polyester products. In addition, they were operationally simple, inexpensive and environmentally benign. Organic acid catalysis provides a new entry for the synthesis of valuable biodegradable materials as well as polyesters for biomedical applications.
C1 Stockholm Univ, Arrhenius Lab, Dept Organ Chem, S-10691 Stockholm, Sweden.
   Swedish Pulp & Paper Res Inst, STFI, S-11486 Stockholm, Sweden.
RP Cordova, A (reprint author), Stockholm Univ, Arrhenius Lab, Dept Organ Chem, S-10691 Stockholm, Sweden.
EM acordova@organ.su.se
RI Cordova, Armando/B-8885-2011
OI Cordova, Armando/0000-0001-9620-8698
CR Bogevig A, 2004, ANGEW CHEM INT EDIT, V43, P1109, DOI 10.1002/anie.200353018
   Chiellini E, 1996, ADV MATER, V8, P305, DOI 10.1002/adma.19960080406
   CONNOR EF, 2001, J AM CHEM SOC, V123, P914
   Cordova A, 1998, POLYMER, V39, P6519, DOI 10.1016/S0032-3861(98)00068-8
   Cordova A, 2003, SYNLETT, P1651, DOI 10.1055/s-2003-41423
   Cordova A, 2001, BIOMACROMOLECULES, V2, P1347, DOI 10.1021/bm0101015
   Cordova A, 2002, J ORG CHEM, V67, P301, DOI 10.1021/jo015881m
   Cordova A, 2002, J AM CHEM SOC, V124, P1866, DOI 10.1021/ja017833p
   Cordova A, 1998, J AM CHEM SOC, V120, P13521, DOI 10.1021/ja982252u
   Cordova A, 1998, MACROMOLECULES, V31, P1040, DOI 10.1021/ma971297x
   CORDOVA A, 2004, CHEM-EUR J, V10, P1957
   Dalko PI, 2001, ANGEW CHEM INT EDIT, V40, P3726, DOI 10.1002/1521-3773(20011015)40:20<3726::AID-ANIE3726>3.0.CO;2-D
   Dubois P, 1996, MACROMOLECULES, V29, P1965, DOI 10.1021/ma951738h
   Duthaler RO, 2003, ANGEW CHEM INT EDIT, V42, P975, DOI 10.1002/anie.200390283
   EISSEN M, 2001, ANGEW CHEM INT EDIT, V40, P414
   FERSHT A, 1985, ENZYME STRUCTURE MEC
   Fujisato T, 1996, MACROMOL SYMP, V103, P73
   Gross RA, 2001, CHEM REV, V101, P2097, DOI 10.1021/cr0002590
   Jarvo ER, 2002, TETRAHEDRON, V58, P2481, DOI 10.1016/S0040-4020(02)00122-9
   Jencks WP, 1969, CATALYSIS CHEM ENZYM
   Kobayashi S, 2001, CHEM REV, V101, P3793, DOI 10.1021/cr990121l
   List B, 2002, TETRAHEDRON, V58, P5573, DOI 10.1016/S0040-4020(02)00516-1
   Nederberg F, 2001, ANGEW CHEM INT EDIT, V40, P2712, DOI 10.1002/1521-3773(20010716)40:14<2712::AID-ANIE2712>3.0.CO;2-Z
   OKEEFE BJ, 2001, J CHEM SOC DA, V15, P2215
   Ovitt TM, 1999, J AM CHEM SOC, V121, P4072, DOI 10.1021/ja990088k
   Shibasaki Y, 2000, MACROMOLECULES, V33, P4316, DOI 10.1021/ma992138b
   Slomkowski S, 1996, MACROMOL SYMP, V103, P213
   VION JM, 1986, MACROMOLECULES, V19, P1828, DOI 10.1021/ma00161a009
   Wahlberg J, 2003, BIOMACROMOLECULES, V4, P1068, DOI 10.1021/bm0340725
NR 29
TC 61
Z9 62
U1 6
U2 46
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1615-4150
J9 ADV SYNTH CATAL
JI Adv. Synth. Catal.
PD AUG
PY 2004
VL 346
IS 9-10
BP 1087
EP 1089
DI 10.1002/adsc.200404082
PG 3
WC Chemistry, Applied; Chemistry, Organic
SC Chemistry
GA 858UO
UT WOS:000224217700009
DA 2018-10-19
ER

PT J
AU Carlsson, HE
   Schapiro, SJ
   Farah, I
   Hau, J
AF Carlsson, HE
   Schapiro, SJ
   Farah, I
   Hau, J
TI Use of primates in research: A global overview
SO AMERICAN JOURNAL OF PRIMATOLOGY
LA English
DT Article
DE nonhuman primates; research use; animal models
ID BIOMEDICAL-RESEARCH; LABORATORY-ANIMALS; NONHUMAN-PRIMATES; SCIENTIFIC
   PAPERS; RHESUS MACAQUES; RESPONSES; STATEMENT
AB We assessed the use of nonhuman primates and nonhuman primate biological material in research by reviewing studies published in 2001 in peer-reviewed journals. The number and species of primates used, the origin of the animals, the type of study, the area of research of the investigation, and the location at which the research was performed were tabulated. Additionally, factors related to the animals that may have affected the outcome of the experiments were recorded. A total of 2,937 articles involving 4,411 studies that employed nonhuman primates or nonhuman primate biological material were identified and analyzed. More than 41,000 animals were represented in the studies published in 2001. In the 14% of studies for which re-use could be determined, 69% involved animals that had been used in previous experiments. Published studies most commonly used nonhuman primates or nonhuman primate biological material from the species Chlorocebus aethaops (19%), Macaca mulatta (18%), M. fascicularis (9%), and Papio spp. (6%). Of these studies, 54% were classified as in vitro studies, 14% as noninvasive, 30% as chronic, and 1% were considered acute. Nonhuman primates were primarily used in research areas in which they appear to be the most appropriate models for humans. The most common areas of research were microbiology (including HIV/AIDS (26%)), neuroscience (19%), and biochemistry/chemistry (12%). Most (84%) of the primate research published in 2001 was conducted in North America, Europe, and Japan. The animals and conditions under which they were housed and used were rarely described. Although it is estimated that nonhuman primates account for an extremely small fraction of all animals used in research, their special status makes it important to report the many husbandry and environmental factors that influence the research results generated. This analysis has identified that editors rarely require authors to provide comprehensive information concerning the subjects (e.g., their origin), treatment conditions, and experimental procedures utilized in the studies they publish. The present analysis addresses the use of primates for research, including the effects of a shortage of suitable nonhuman primate subjects in many research areas. (C) 2004 Wiley-Liss, Inc.
C1 Univ Uppsala, Dept Neurosci, Div Comparat Med, SE-75123 Uppsala, Sweden.
   Univ Texas, MD Anderson Canc Ctr, Dept Vet Sci, Bastrop, TX USA.
RP Carlsson, HE (reprint author), Univ Uppsala, Dept Neurosci, Div Comparat Med, BMC Box 572, SE-75123 Uppsala, Sweden.
EM Hans-Erik.Carlsson@bmc.uu.se
RI Hau, Jann/C-8692-2012
OI Hau, Jann/0000-0001-8586-5705; Schapiro, Steven J./0000-0001-5406-1739
CR Balls M, 2000, DEV AN VET, V31, P1587
   BOCCIA ML, 1995, LAB ANIM, V29, P250, DOI 10.1258/002367795781088315
   BOISVERT DPJ, 1997, DEV ANIMAL VET SCI, V31, P399
   Bontrop RE, 2001, IMMUNOL REV, V183, P5, DOI 10.1034/j.1600-065x.2001.1830101.x
   Bowden D M, 1996, Contemp Top Lab Anim Sci, V35, P55
   Bowden D. M., 1992, I LAB ANIMAL RESOURC, V34, P53
   CLOUGH G, 1982, BIOL REV, V57, P487, DOI 10.1111/j.1469-185X.1982.tb00705.x
   Cohen J, 2000, SCIENCE, V287, P959, DOI 10.1126/science.287.5455.959
   CROOK G, 1991, AUSTR PRIMATOL, V6, P5
   ERWIN J, 1981, AM J PRIMATOL, V1, P261, DOI 10.1002/ajp.1350010302
   FRIDMAN EP, 1988, J MED PRIMATOL, V17, P309
   FRIDMAN EP, 1983, J MED PRIMATOL, V12, P287
   Goodman S, 2002, NATURE, V417, P684, DOI 10.1038/417684a
   Granados-Zuniga J, 1997, REV BIOL TROP, V45, P979
   *GREAT BRIT HOM OF, 2002, REP AN PROC COMM 200
   *GREAT BRIT HOM OF, 1998, REP AN PROC COMM 199
   Hagelin J, 1999, ACAD MED, V74, P1135, DOI 10.1097/00001888-199910000-00018
   HAMPSON J, 1990, ATLA-ALTERN LAB ANIM, V17, P335
   Hau J, 2000, DEV AN VET, V31, P1593
   Kaup F.-J., 2002, Primate Report, V62, P3
   KING FA, 1988, SCIENCE, V240, P1475, DOI 10.1126/science.3287624
   KINGSTON WR, 1994, PRIMATE EYE, V54, P23
   LANG CM, 1976, FED PROC, V35, P1123
   *NAT RES COUNC, 2003, INT PERSP FUT NONH P
   National Research Council, 1997, CHIMP RES STRAT THEI
   Obrink KJ, 2000, LAB ANIM, V34, P121, DOI 10.1258/002367700780457608
   PIFER L, 1994, SOC ANIM, V2, P95, DOI 10.1163/156853094X00126
   PRESCOTT MJ, 2002, COUNTING COST WELFAR
   RHIM JS, 1969, P SOC EXP BIOL MED, V132, P670
   Schapiro SJ, 2000, APPL ANIM BEHAV SCI, V68, P67, DOI 10.1016/S0168-1591(00)00090-3
   Schapiro SJ, 1996, AM J PRIMATOL, V40, P247
   SCHAPIRO SJ, 1994, LAB ANIM SCI, V44, P229
   *SCI STEER COMM, 2002, NEED NONH PRIM BIOM
   Sibal L R, 2001, ILAR J, V42, P74
   Smith JA, 1997, LAB ANIM, V31, P312, DOI 10.1258/002367797780596176
   Smith O.A., 1975, P127
   STEPHENS ML, 1995, ATLA-ALTERN LAB ANIM, V23, P579
   VANVLISSINGEN JMF, 1997, PRIMATE REP, V49, P81
   WEBER A, 1997, PRIMATE REP, V49, P11
   WILDE J, 1994, PRIMATE REP, V38, P1
   Yamamoto ME, 1999, INT J PRIMATOL, V20, P281, DOI 10.1023/A:1020578604925
   ZUCKER EL, 1996, LAB PRIMATOL NEWSL, V35, P8
   1976, LANCET, V308, P726
NR 43
TC 109
Z9 113
U1 3
U2 22
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0275-2565
J9 AM J PRIMATOL
JI Am. J. Primatol.
PD AUG
PY 2004
VL 63
IS 4
BP 225
EP 237
DI 10.1002/ajp.20054
PG 13
WC Zoology
SC Zoology
GA 848PB
UT WOS:000223478500003
PM 15300710
DA 2018-10-19
ER

PT J
AU Kobayashi, M
   Oka, M
AF Kobayashi, M
   Oka, M
TI Composite device for attachment of polyvinyl alcohol-hydrogel to
   underlying bone
SO ARTIFICIAL ORGANS
LA English
DT Article
DE attachment method; composite device; injection-molding; polyvinyl
   alcohol-hydrogel; titanium fiber mesh
ID ARTIFICIAL ARTICULAR-CARTILAGE; LOAD-BEARING CONDITIONS;
   BIOCOMPATIBILITY; PANCREAS
AB Polyvinyl alcohol-hydrogels (PVA-H) have been specifically proposed as promising prosthetic biomaterials because of their excellent mechanical properties and biocompatibility. However, it is very difficult to obtain stable long-term fixation of implanted PVA-H and this problem is the key point to be solved in the further development of PVA-H in biomedical applications more widely in various fields. Orthopedic implants using PVA-H have been developed and in the process this problem was solved using a composite device. This device consists of PVA-H and a titanium fiber mesh (TFM) as a porous tissue-ingrowth material. In the present study, the mechanical properties of this composite device produced using a new improved production method (injection molding) were investigated and animal experiments for in vivo evaluation were performed. In vitro tests showed that the shear strength at the interface of the PVA-H and TFM, and the mechanical properties of PVA-H itself were promising. Moreover, the histological appearance of the composite device implant in vivo showed abundant bone ingrowth into the deep pore spaces of TFM, which indicated that this device attached firmly to the adjacent bone. These results indicated this composite device prepared by this new method can supply firm attachment of PVA-H onto underlying bone, and that it will be available for various biomedical applications using PVA-H.
C1 Harvard Univ, Sch Med, Brigham & Womens Hosp, Orthoped Res Lab, Boston, MA USA.
   Kyoto Univ, Inst Frontier Med Sci, Tissue Regenerat Dept, Kyoto, Japan.
RP Kobayashi, M (reprint author), 75 Francis St, Boston, MA 02115 USA.
EM m-bear@rf7.so-net.ne.jp
CR Burczak K, 1996, BIOMATERIALS, V17, P2351, DOI 10.1016/S0142-9612(96)00076-2
   Castelli F, 2000, BIOMATERIALS, V21, P821, DOI 10.1016/S0142-9612(99)00252-5
   Chang YS, 1996, BIOMATERIALS, V17, P1141, DOI 10.1016/0142-9612(96)85917-5
   CHANG YS, 1994, CLIN MATER, V17, P181, DOI 10.1016/0267-6605(94)90034-5
   HYON SH, 1989, POLYM BULL, V22, P119, DOI 10.1007/BF00255200
   Kobayashi M, 2003, BIOMATERIALS, V24, P639, DOI 10.1016/S0142-9612(02)00378-2
   NOGUCHI T, 1991, J APPL BIOMATER, V2, P101, DOI 10.1002/jab.770020205
   Ohgawara H, 1998, ARTIF ORGANS, V22, P788, DOI 10.1046/j.1525-1594.1998.06185.x
   OKA M, 1990, Clinical Materials, V6, P361, DOI 10.1016/0267-6605(90)90053-X
   Oka M, 2000, P I MECH ENG H, V214, P59, DOI 10.1243/0954411001535246
   OKAMURA S, 1992, WORLD PVA
   PEPPAS NA, 1977, J BIOMED MATER RES, V11, P423, DOI 10.1002/jbm.820110309
   YOUNG TH, 2002, BIOMATERIALS, V23, P495
   Yura S, 1999, SIROT 99, P371
NR 14
TC 13
Z9 13
U1 2
U2 10
PU BLACKWELL PUBLISHING INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148 USA
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD AUG
PY 2004
VL 28
IS 8
BP 734
EP 738
DI 10.1111/j.1525-1594.2004.00079.x
PG 5
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 840ED
UT WOS:000222839000006
PM 15270955
OA Bronze
DA 2018-10-19
ER

PT J
AU Tan, J
   Saltzman, WM
AF Tan, J
   Saltzman, WM
TI Biomaterials with hierarchically defined micro- and nanoscale structure
SO BIOMATERIALS
LA English
DT Article
DE biomineralization; biomimetic materials; microstructure; nanostructure;
   bone tissue engineering; hydroxyapatite; osteoblast
ID SELF-ASSEMBLED MONOLAYERS; TOPOGRAPHICAL CONTROL; SURFACE;
   BIOMINERALIZATION; NUCLEATION; SUBSTRATA; CHEMISTRY; CERAMICS; PROTEINS;
   APATITE
AB Biomaterials and tissue engineering are becoming increasingly important in biomedical practice, particularly as the population ages. It is clear that cellular responses to materials depend on structural properties of the material at both the micrometer- and nanometer scale, but general methods for controlling material properties on both of these scales are lacking. Using a hierarchical approach that mimics natural material formation processes, we developed a method to produce materials with controlled physical structures at both the micrometer- and nanometer scale. Our method is based upon a pre-organized micropatterned template and conformal transformation of the architecture with nanostructured minerals, namely hydroxyapatite. The newly developed materials were biocompatible with bone cells, induced a range of desirable cellular responses, and may therefore have direct application in bone tissue engineering. In addition, the design principles employed in this study can be extrapolated to the other classes of biomedical materials, including polymers, metals, ceramics or hybrid combinations. (C) 2003 Published by Elsevier Ltd.
C1 Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA.
   Yale Univ, Dept Chem Engn, New Haven, CT 06511 USA.
RP Tan, J (reprint author), Cornell Univ, Sch Chem & Biomol Engn, 120 Olin Hall Cornell Univ, Ithaca, NY 14853 USA.
EM jt75@cornell.edu
FU NIDCR NIH HHS [DE-14097]
CR ADDADI L, 1985, P NATL ACAD SCI USA, V82, P4110, DOI 10.1073/pnas.82.12.4110
   Aizenberg J, 1999, NATURE, V398, P495, DOI 10.1038/19047
   Bancroft GN, 2002, P NATL ACAD SCI USA, V99, P12600, DOI 10.1073/pnas.202296599
   Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0
   Brunette DM, 1999, J BIOMECH ENG-T ASME, V121, P49, DOI 10.1115/1.2798042
   BUNKER BC, 1994, SCIENCE, V264, P48, DOI 10.1126/science.264.5155.48
   Cha JN, 2000, NATURE, V403, P289, DOI 10.1038/35002038
   Chance JJ, 1997, LANGMUIR, V13, P4487, DOI 10.1021/la970081l
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Dan N, 2000, TRENDS BIOTECHNOL, V18, P370, DOI 10.1016/S0167-7799(00)01482-7
   FISHMAN RB, 1993, J NEUROSCI, V13, P3485
   Griffith LG, 2002, ANN NY ACAD SCI, V961, P83, DOI 10.1111/j.1749-6632.2002.tb03056.x
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   HEUER AH, 1992, SCIENCE, V255, P1098, DOI 10.1126/science.1546311
   HOCH HC, 1996, NANOFABRICATION BIOS
   Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3
   Kale S, 2000, NAT BIOTECHNOL, V18, P954
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   LEGEROS RZ, 1991, CALCIUM PHOSPHATE OR
   Liu Q, 2002, BIOMATERIALS, V23, P3103, DOI 10.1016/S0142-9612(02)00050-9
   Lowenstam HA, 1989, BIOMINERALIZATION
   MADOU MJ, 1996, FUNDAMENTALS MICROFA
   MANN S, 1995, J MATER CHEM, V5, P935, DOI 10.1039/jm9950500935
   Mann S, 1996, NATURE, V382, P313, DOI 10.1038/382313a0
   MANN S, 1989, BIOMINERALIZATION CH
   Morse DE, 1999, TRENDS BIOTECHNOL, V17, P230, DOI 10.1016/S0167-7799(99)01309-8
   Murphy WL, 2002, J AM CHEM SOC, V124, P1910, DOI 10.1021/ja012433n
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   Rajnicek AM, 1997, J CELL SCI, V110, P2905
   Sellinger A, 1998, NATURE, V394, P256, DOI 10.1038/28354
   Simon A, 2002, J COLLOID INTERF SCI, V251, P278, DOI 10.1006/jcis.2002.8385
   Stupp SI, 1997, SCIENCE, V277, P1242, DOI 10.1126/science.277.5330.1242
   Tai HC, 1998, BIOTECHNOL PROGR, V14, P364, DOI 10.1021/bp980035r
   Tan J, 2002, BIOMATERIALS, V23, P3215, DOI 10.1016/S0142-9612(02)00074-1
   Tan J, 2001, BIOPHYS J, V81, P2569, DOI 10.1016/S0006-3495(01)75901-2
   Tanahashi M, 1997, J BIOMED MATER RES, V34, P305
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Wilkinson CDW, 2002, MAT SCI ENG C-BIO S, V19, P263, DOI 10.1016/S0928-4931(01)00396-4
   Wood MA, 2002, NANOTECHNOLOGY, V13, P605, DOI 10.1088/0957-4484/13/5/312
NR 40
TC 155
Z9 160
U1 2
U2 56
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2004
VL 25
IS 17
BP 3593
EP 3601
DI 10.1016/j.biomaterials.2003.10.034
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 808GS
UT WOS:000220558200027
PM 15020133
DA 2018-10-19
ER

PT J
AU Duan, YY
   Clark, GM
   Cowan, RSC
AF Duan, YY
   Clark, GM
   Cowan, RSC
TI A study of intra-cochlear electrodes and tissue interface by
   electrochemical impedance methods in vivo
SO BIOMATERIALS
LA English
DT Article
DE electrode-tissue interfaces; intra-cochlear electrodes; electrochemical
   impedance methods; implantable device; biomedical materials; neural
   prostheses
ID POROUS FILM ELECTRODES; CHRONIC ELECTRICAL-STIMULATION; GUINEA-PIG
   COCHLEA; AUDITORY-NERVE; SURFACE-AREA; DIFFUSION; MODEL; SPECTROSCOPY;
   PERILYMPH; BEHAVIOR
AB This paper presents methods, results and analysis for measurements of the electrochemical impedance of platinum electrodes (similar to0.43 mm(2)) over a 6-month implantation in the cat cochlea. The study aimed to improve our understanding of the effects of tissue response on impedance behaviour. An increase in impedance in the post-operative period was evident with a rise of the distorted arc at high frequencies in the complex plane, correlating to anomalous charge transport at the electrode-tissue interface. The impedance at low frequencies generally showed a capacitive dispersion modelled as a constant phase element, indicating a blocking characteristic of the electrodes. The study suggests that a reduction and changes in composition of perilymph or extracellular fluid adjacent to the electrodes, as a consequence of tissue response, causes the elevated "contact impedance". This affects the efficiency and quality of neural stimulating electrodes and neural recording electrodes. The finding of the crucial role of perilymph or extracellular fluid thin layer provides a new strategy for surface materials of neural electrodes, which is discussed in the paper. The interface characteristics must be considered during interpretation of studies undertaken in vitro or in acute experiments in vivo, where physiological fluid is abundant. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Cooperat Res Ctr Cochlear Implant & Hearing Aid I, Bion Ear Inst, Melbourne, Vic 3002, Australia.
RP Duan, YY (reprint author), Cooperat Res Ctr Cochlear Implant & Hearing Aid I, Bion Ear Inst, 2F-32 Gisborne St, Melbourne, Vic 3002, Australia.
EM yduan@bionicear.org
CR Barcia OE, 2002, ELECTROCHIM ACTA, V47, P2109, DOI 10.1016/S0013-4686(02)00081-6
   Bisquert J, 2002, J PHYS CHEM B, V106, P325, DOI [10.1021/jp011941g, 10.1021/jp01194lg]
   Bisquert J, 1998, J ELECTROANAL CHEM, V452, P229, DOI 10.1016/S0022-0728(98)00115-6
   Bisquert J, 1999, J ELECTROANAL CHEM, V475, P152, DOI 10.1016/S0022-0728(99)00346-0
   Bisquert J, 2002, ELECTROCHIM ACTA, V47, P3977, DOI 10.1016/S0013-4686(02)00372-9
   Bisquert J, 2001, J ELECTROANAL CHEM, V499, P112, DOI 10.1016/S0022-0728(00)00497-6
   Bisquert J, 2000, PHYS CHEM CHEM PHYS, V2, P4185, DOI 10.1039/b001708f
   Bisquert J, 1999, ELECTROCHEM COMMUN, V1, P429, DOI 10.1016/S1388-2481(99)00084-3
   Bisquert J, 2000, J PHYS CHEM B, V104, P2287, DOI 10.1021/jp993148h
   Bisquert J, 2000, ELECTROCHEM COMMUN, V2, P601, DOI 10.1016/S1388-2481(00)00089-8
   BOSHER SK, 1976, SCI FDN OTOLARYNGOLO, P290
   Brett CMA, 1999, ELECTROCHIM ACTA, V44, P4233, DOI 10.1016/S0013-4686(99)00138-3
   Clark G, 2000, IND PHYS, V6, P12
   Cotran RS, 1999, ROBBINS PATHOLOGIC B, P50
   Cotran RS, 1999, TISSUE REPAIR CELLUL, P89
   Diard JP, 1999, J ELECTROANAL CHEM, V471, P126, DOI 10.1016/S0022-0728(99)00262-4
   Elliott JM, 2000, PHYS CHEM CHEM PHYS, V2, P5653, DOI 10.1039/b006462i
   FLETCHER S, 1992, J ELECTROANAL CHEM, V337, P127, DOI 10.1016/0022-0728(92)80533-A
   Fogel R, 1996, PACE, V19, P188, DOI 10.1111/j.1540-8159.1996.tb03310.x
   FOSTER KR, 1995, BIOMEDICAL ENG HDB, P1385
   FOX WC, 1993, J BIOMED MATER RES, V27, P763
   HANNAN WJ, 1995, CLIN SCI, V89, P651, DOI 10.1042/cs0890651
   HARUTA A, 1995, ACTA OTO-LARYNGOL, V115, P504, DOI 10.3109/00016489509139356
   HATSUSHIKA S, 1990, ANN OTO RHINOL LARYN, V99, P871, DOI 10.1177/000348949009901104
   Hibbert DB, 2001, J ELECTROCHEM SOC, V148, pE1, DOI 10.1149/1.1344543
   Lang G, 1998, J ELECTROANAL CHEM, V457, P257, DOI 10.1016/S0022-0728(98)00301-5
   MACDONALD JR, 1992, ANN BIOMED ENG, V20, P289, DOI 10.1007/BF02368532
   OHYAMA K, 1988, HEARING RES, V35, P119, DOI 10.1016/0378-5955(88)90111-6
   Ovadia M, 1998, ELECTROANAL, V10, P262, DOI 10.1002/(SICI)1521-4109(199804)10:4<262::AID-ELAN262>3.0.CO;2-W
   PAASCH G, 1993, ELECTROCHIM ACTA, V38, P2653, DOI 10.1016/0013-4686(93)85083-B
   Pan J, 1996, ELECTROCHIM ACTA, V41, P1143, DOI 10.1016/0013-4686(95)00465-3
   Rossberg K, 1998, J ELECTROANAL CHEM, V443, P49, DOI 10.1016/S0022-0728(97)00494-4
   Roth B. J., 1995, BIOMEDICAL ENG HDB, P126
   SALT AN, 1991, ACTA OTO-LARYNGOL, V111, P899, DOI 10.3109/00016489109138428
   Tykocinski M, 2001, HEARING RES, V159, P53, DOI 10.1016/S0378-5955(01)00320-3
   Vassal N, 2000, ELECTROCHIM ACTA, V45, P1527, DOI 10.1016/S0013-4686(99)00369-2
   Weiland JD, 2000, IEEE T BIO-MED ENG, V47, P911, DOI 10.1109/10.846685
   Xu J, 1997, HEARING RES, V105, P1, DOI 10.1016/S0378-5955(96)00193-1
NR 38
TC 41
Z9 42
U1 0
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2004
VL 25
IS 17
BP 3813
EP 3828
DI 10.1016/j.biomaterials.2003.09.107
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 808GS
UT WOS:000220558200051
PM 15020157
DA 2018-10-19
ER

PT J
AU Markaki, AE
   Clyne, TW
AF Markaki, AE
   Clyne, TW
TI Magneto-mechanical stimulation of bone growth in a bonded array of
   ferromagnetic fibres
SO BIOMATERIALS
LA English
DT Article
DE porosity; magnetism; scaffold
ID IN-VIVO; CORROSION; ALLOYS; BEHAVIOR; IMPLANTS; SURFACE; FUSION; VITRO;
   SPINE
AB A brief experimental and theoretical study is presented into the elastic deformation of bonded arrays of ferromagnetic fibres. when subjected to an external magnetic field. Material made of such fibre arrays is of potential interest for certain biomedical applications, such as prosthetic implants. Externally imposed magnetic fields could be used to generate mechanical strains in surrounding tissue, with possible physiological benefits. It is shown that it should be possible to generate strains within embryonic bone cell networks. forming, within such a fibre array. which are sufficient to stimulate enhanced growth. The effects outlined here could thus form the basis of surgical or therapeutic advances. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Cambridge, Dept Mat Sci & Met, Cambridge CB2 3QZ, England.
RP Clyne, TW (reprint author), Univ Cambridge, Dept Mat Sci & Met, Pembroke St, Cambridge CB2 3QZ, England.
EM twe10@cam.ac.uk
RI Markaki, Athina/H-9676-2012
FU Engineering and Physical Sciences Research Council [GR/R95364/01]
CR Adair RK, 2000, REP PROG PHYS, V63, P415, DOI 10.1088/0034-4885/63/3/204
   Akhouayri O, 2000, J CELL BIOCHEM, V76, P217, DOI 10.1002/(SICI)1097-4644(20000201)76:2<217::AID-JCB6>3.3.CO;2-B
   ANGELINI E, 1991, J PROSTHET DENT, V65, P848, DOI 10.1016/S0022-3913(05)80026-5
   Ashby M.F., 2000, METAL FOAMS DESIGN G
   CRAVEN TG, 1994, SPINE, V19, P1664, DOI 10.1097/00007632-199408000-00003
   Delannay F., 1999, METFOAM 99, P293
   DUCHEYNE P, 1978, J MATER SCI, V13, P2650, DOI 10.1007/BF00552695
   GOEHLICH V, 1990, DENT MATER, V6, P103, DOI 10.1016/S0109-5641(05)80039-9
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Kang SB, 2002, MATER TRANS, V43, P1045, DOI 10.2320/matertrans.43.1045
   Kim HM, 2000, BIOMATERIALS, V21, P353, DOI 10.1016/S0142-9612(99)00190-8
   Kotani H, 2002, J BONE MINER RES, V17, P1814, DOI 10.1359/jbmr.2002.17.10.1814
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   Linovitz RJ, 2002, SPINE, V27, P1383, DOI 10.1097/00007632-200207010-00002
   Livingston T, 2002, J BIOMED MATER RES, V62, P1, DOI 10.1002/jbm.10157
   Mosley JR, 2000, J REHABIL RES DEV, V37, P189
   Oka M, 1997, J BONE JOINT SURG BR, V79B, P1003, DOI 10.1302/0301-620X.79B6.7606
   Paulus JA, 1997, BIOMATERIALS, V18, P1609, DOI 10.1016/S0142-9612(97)00102-6
   RUBIN CT, 1985, CALCIFIED TISSUE INT, V37, P411, DOI 10.1007/BF02553711
   RUBIN CT, 1984, J BONE JOINT SURG AM, V66A, P397, DOI 10.2106/00004623-198466030-00012
   RUBIN CT, 1984, J THEOR BIOL, V107, P321, DOI 10.1016/S0022-5193(84)80031-4
   Simske SJ, 1997, MATER SCI FORUM, V250, P151, DOI 10.4028/www.scientific.net/MSF.250.151
   SIVAKUMAR M, 1993, J MATER SCI, V28, P6081, DOI 10.1007/BF00365025
   SYVERUD M, 1987, DENT MATER, V3, P102, DOI 10.1016/S0109-5641(87)80039-8
   Thieme M, 2001, J MATER SCI-MATER M, V12, P225, DOI 10.1023/A:1008958914818
   UNDERWOOD EE, 1970, QUANTITATIVE STEREOL
   Vehof JWM, 2000, BIOMATERIALS, V21, P2003, DOI 10.1016/S0142-9612(00)00094-6
NR 27
TC 42
Z9 42
U1 2
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2004
VL 25
IS 19
BP 4805
EP 4815
DI 10.1016/j.biomaterials.2003.11.041
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 817XY
UT WOS:000221211400032
PM 15120527
DA 2018-10-19
ER

PT J
AU Sciacovelli, L
   Zardo, L
   Secchiero, S
   Plebani, M
AF Sciacovelli, L
   Zardo, L
   Secchiero, S
   Plebani, M
TI Quality specifications in EQA schemes: from theory to practice
SO CLINICA CHIMICA ACTA
LA English
DT Article; Proceedings Paper
CT International Conference on Laboratory Medicine
CY OCT   24, 2003
CL Padova, ITALY
DE external quality assessment; analytical performance laboratory;
   analytical total error; EQA control material; EQA statistical procedure
ID MEDICAL LABORATORIES; BIOLOGICAL VARIATION; PROGRAMS; APPROPRIATENESS;
   CHOLESTEROL; STANDARDS; GOALS; NEED
AB Background: External quality assessment (EQA) is a tool for quality management in clinical laboratories and its main objectives are assessment of participants and methods performance, training and advice. This paper describes the quality specifications used in EQA schemes of the Centre of Biomedical Research (CRB), in order to design schemes that can assess laboratory reliability performances, meet the changing needs and quality recommendations. Methods: Quality specifications for control materials, statistical procedures and goals to assess laboratory performance have been applied and introduced in EQA schemes managed by CRB. Results: The application of well-defined quality specifications has demonstrated effective. In particular, we report results on alkaline phosphatase and cholesterol obtained using commercial control materials and human serum controls, in two different EQA surveys; the inter-laboratory variability (CVinter%) for troponin I analysed with a diagnostic system and assigned values of CK-MB mass obtained using four different diagnostic systems; the percentage of acceptable performances obtained by means of the application of goals based on clinical criteria, biological variation, state-of-the-art and used for EQA schemes, and referring to some analytes with significant clinical values such as cholesterol, glucose, glycated hemoglobin and sodium. Conclusions: The design of reliable EQA schemes based on evidence-based quality specifications is a pre-requisite for supporting the quality improvement of clinical laboratories. (C) 2004 Elsevier B.V. All rights reserved.
C1 Ctr Ric Biomed, I-31033 Castelfranco Veneto, TV, Italy.
RP Sciacovelli, L (reprint author), Ctr Ric Biomed, Via Osped 18, I-31033 Castelfranco Veneto, TV, Italy.
EM laurasciacovelli@libero.it
OI Sciacovelli, Laura/0000-0003-3156-1399
CR *CLIN PATH ACCR, 2003, STAND EQA SCHEM LAB
   FRASER CG, 1993, CLIN CHEM, V39, P1447
   FRASER CG, 1993, SCAND J CLIN LAB INV, V53, P8, DOI 10.3109/00365519309085446
   Fraser CG, 1999, SCAND J CLIN LAB INV, V59, P487, DOI 10.1080/00365519950185210
   Fraser CG, 1997, ANN CLIN BIOCHEM, V34, P1
   Garde AH, 2000, CLIN CHEM, V46, P551
   International Federation of Clinical Chemistry (IFCC), 1997, FUND EXT QUAL ASS EQ
   *ISO, 1997, ISO GUID 43 PROF TES
   LEWIS LS, QUALITY CONTROL GOOD
   Libeer JC, 2001, CLIN CHIM ACTA, V309, P173, DOI 10.1016/S0009-8981(01)00518-6
   Libeer JC, 2001, ACCREDIT QUAL ASSUR, V6, P151, DOI 10.1007/PL00013513
   LIBEER JP, 1993, EXTERNAL QUALITY ASS
   *NCCLS, 1999, GP27A NCCLS, P19
   PETERSEN HP, 1994, ELEMENTS ANAL QUALIT, P187
   PETERSEN HP, 1993, UPPSALA J MED SCI, V98, P195
   PETERSEN PH, 1999, SCAND J CLIN LAB INV, V59, P475
   Plebani M, 2003, CLIN CHIM ACTA, V333, P131, DOI 10.1016/S0009-8981(03)00177-3
   Plebani M, 1999, CLIN CHIM ACTA, V280, P35, DOI 10.1016/S0009-8981(98)00196-X
   Ricos C, 1999, SCAND J CLIN LAB INV, V59, P491
   Sciacovelli L, 2001, CLIN CHIM ACTA, V309, P183, DOI 10.1016/S0009-8981(01)00521-6
   Sebastian-Gambaro MA, 1997, EUR J CLIN CHEM CLIN, V35, P845
   Secchiero S, 2003, CLIN CHIM ACTA, V333, P221, DOI 10.1016/S0009-8981(03)00189-X
   STOCKL D, 1995, EUR J CLIN CHEM CLIN, V33, P157
   Waise A, 1999, CLIN CHIM ACTA, V280, P47, DOI 10.1016/S0009-8981(98)00197-1
   Westgard JO, 1999, SCAND J CLIN LAB INV, V59, P483, DOI 10.1080/00365519950185201
   WONG ET, 1995, CLIN CHEM, V41, P1241
   2000, ILACG13
NR 27
TC 28
Z9 31
U1 1
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0009-8981
J9 CLIN CHIM ACTA
JI Clin. Chim. Acta
PD AUG
PY 2004
VL 346
IS 1
BP 87
EP 97
DI 10.1016/j.cccn.2004.02.037
PG 11
WC Medical Laboratory Technology
SC Medical Laboratory Technology
GA 838WQ
UT WOS:000222744400012
PM 15234640
DA 2018-10-19
ER

PT J
AU Cheng, RP
AF Cheng, RP
TI Beyond de novo protein design - de novo design of non-natural folded
   oligomers
SO CURRENT OPINION IN STRUCTURAL BIOLOGY
LA English
DT Review
ID CONTRACTION/EXTENSION MOLECULAR-MOTION; PHENYLENE ETHYNYLENE OLIGOMERS;
   HELICAL SECONDARY STRUCTURE; DYNAMIC CHEMICAL-DEVICES; BETA-PEPTIDE
   12-HELIX; SIDE-CHAIN CONTROL; AQUEOUS-SOLUTION; AMINO-ACIDS;
   ELECTROSTATIC INTERACTIONS; REVERSIBLE POLYMERIZATION
AB The mystery of how a protein sequence specifies a unique structure has intrigued chemists, leading to the design and study of foldamers, non-natural oligomeric molecules that adopt well-defined structures. Recently, the sequence specificity of the various regular repeating structures has been revealed for bioinspired foldamers and such foldamers have been created to adopt helical bundle tertiary structures. One major strategy for the generation of abiotic foldamers has involved molecular design of the monomer geometry. These advances in foldamer research may lead to future applications in biomedical and materials science.
C1 SUNY Buffalo, Dept Chem, Buffalo, NY 14260 USA.
RP Cheng, RP (reprint author), SUNY Buffalo, Dept Chem, Buffalo, NY 14260 USA.
EM chengr@buffalo.edu
CR Archer EA, 2002, J AM CHEM SOC, V124, P5074, DOI 10.1021/ja012696h
   Arvidsson PI, 2003, CHEMBIOCHEM, V4, P1345, DOI 10.1002/cbic.200300698
   Arvidsson PI, 2003, HELV CHIM ACTA, V86, P1522, DOI 10.1002/hlca.200390133
   ARVIDSSON PI, 2001, CHEM COMMUN, V7, P649
   Barboiu M, 2003, CHEM-EUR J, V9, P763, DOI 10.1002/chem.200390085
   Barboiu M, 2002, P NATL ACAD SCI USA, V99, P5201, DOI 10.1073/pnas.082099199
   Blatchly RA, 2003, J ORG CHEM, V68, P8780, DOI 10.1021/jo034827y
   Bruckner AM, 2003, ANGEW CHEM INT EDIT, V42, P4395, DOI 10.1002/anie.200351871
   Burkoth TS, 2002, CHEM BIOL, V9, P647, DOI 10.1016/S1074-5521(02)00140-0
   Cary JM, 2002, ORG LETT, V4, P4663, DOI 10.1021/ol0270982
   Cheng RP, 2002, J AM CHEM SOC, V124, P11564, DOI 10.1021/ja020728a
   Cheng RP, 2001, CHEM REV, V101, P3219, DOI 10.1021/cr000045i
   Cheng RP, 2001, J AM CHEM SOC, V123, P5162, DOI 10.1021/ja010438e
   Cubberley MS, 2001, CURR OPIN CHEM BIOL, V5, P650, DOI 10.1016/S1367-5931(01)00261-7
   De Pol S, 2004, ANGEW CHEM INT EDIT, V43, P511, DOI 10.1002/anie.200352267
   Doerksen RJ, 2003, CHEM COMMUN, P2534, DOI 10.1039/b309584c
   Dolain C, 2003, ANGEW CHEM INT EDIT, V42, P2738, DOI 10.1002/anie.200351080
   Etezady-Esfarjani T, 2002, HELV CHIM ACTA, V85, P1197, DOI 10.1002/1522-2675(200205)85:5<1197::AID-HLCA1197>3.0.CO;2-E
   Gabriel GJ, 2002, J AM CHEM SOC, V124, P15174, DOI 10.1021/ja0275358
   Gademann K, 2003, ANGEW CHEM INT EDIT, V42, P1534, DOI 10.1002/anie.200250290
   Gellman SH, 1998, ACCOUNTS CHEM RES, V31, P173, DOI 10.1021/ar960298r
   Gong B, 2001, CHEM-EUR J, V7, P4336, DOI 10.1002/1521-3765(20011015)7:20<4336::AID-CHEM4336>3.0.CO;2-1
   Gong B, 2002, P NATL ACAD SCI USA, V99, P11583, DOI 10.1073/pnas.162277099
   Gopi HN, 2002, HELV CHIM ACTA, V85, P3313, DOI 10.1002/1522-2675(200210)85:10<3313::AID-HLCA3313>3.0.CO;2-P
   Gruner Sibylle A W, 2002, Chemistry, V8, P4365, DOI 10.1002/1521-3765(20021004)8:19<4365::AID-CHEM4365>3.0.CO;2-U
   Hart SA, 2003, J AM CHEM SOC, V125, P4022, DOI 10.1021/ja029868a
   Hayen A, 2004, ANGEW CHEM INT EDIT, V43, P505, DOI 10.1002/anie.200352125
   Hill DJ, 2001, CHEM REV, V101, P3893, DOI 10.1021/cr990120t
   Hill DJ, 2002, P NATL ACAD SCI USA, V99, P5053, DOI 10.1073/pnas.072642799
   Huc I, 2004, EUR J ORG CHEM, P17, DOI 10.1002/ejoc.200300495
   Huc I, 2002, CHEM COMMUN, P578, DOI 10.1039/b111612f
   Huck BR, 2003, J AM CHEM SOC, V125, P9035, DOI 10.1021/ja034561c
   Jiang H, 2004, J AM CHEM SOC, V126, P1034, DOI 10.1021/ja039511m
   Jiang H, 2003, J AM CHEM SOC, V125, P3448, DOI 10.1021/ja029887k
   Jones TV, 2003, ORG LETT, V5, P3297, DOI 10.1021/ol0352254
   Kimmerlin T, 2003, HELV CHIM ACTA, V86, P2098, DOI 10.1002/hlca.200390166
   Kimmerlin T, 2002, HELV CHIM ACTA, V85, P1812, DOI 10.1002/1522-2675(200206)85:6<1812::AID-HLCA1812>3.0.CO;2-E
   Kolomiets E, 2003, CHEM COMMUN, P2868, DOI 10.1039/b311578j
   Langenhan JM, 2003, ANGEW CHEM INT EDIT, V42, P2402, DOI 10.1002/anie.200350932
   Lee HS, 2001, J AM CHEM SOC, V123, P7721, DOI 10.1021/ja010734r
   LePlae PR, 2002, J AM CHEM SOC, V124, P6820, DOI 10.1021/ja017869h
   Martinek TA, 2003, EUR J BIOCHEM, V270, P3657, DOI 10.1046/j.1432-1033.2003.03756.x
   Matsuda K, 2002, J AM CHEM SOC, V124, P11836, DOI 10.1021/ja027437m
   Nishinaga T, 2002, J AM CHEM SOC, V124, P5934, DOI 10.1021/ja025698q
   ODRIOZOLA L, 2004, CHEM COMMUN     0107, P62, DOI DOI 10.1039/b311045a
   Oh K, 2003, J ORG CHEM, V68, P8397, DOI 10.1021/jo035007o
   Oh K, 2001, NATURE, V414, P889, DOI 10.1038/414889a
   Park JS, 2003, J AM CHEM SOC, V125, P8539, DOI 10.1021/ja034180z
   Patch JA, 2002, CURR OPIN CHEM BIOL, V6, P872, DOI 10.1016/S1367-5931(02)00385-X
   Porter EA, 2002, ORG LETT, V4, P3317, DOI 10.1021/ol0266370
   Raguse TL, 2002, HELV CHIM ACTA, V85, P4154, DOI 10.1002/hlca.200290001
   Raguse TL, 2003, J AM CHEM SOC, V125, P5592, DOI 10.1021/ja0341485
   Raguse TL, 2001, ORG LETT, V3, P3963, DOI 10.1021/ol016868r
   Rueping M, 2004, CHEM-EUR J, V10, P1607, DOI 10.1002/chem.200305571
   Rueping M, 2002, HELV CHIM ACTA, V85, P2577, DOI 10.1002/1522-2675(200209)85:9<2577::AID-HLCA2577>3.0.CO;2-D
   Sanford AR, 2003, CURR ORG CHEM, V7, P1649, DOI 10.2174/1385272033486260
   Schmitt JL, 2003, HELV CHIM ACTA, V86, P1598, DOI 10.1002/hlca.200390137
   Seebach D, 2002, CHEM-EUR J, V8, P573, DOI 10.1002/1521-3765(20020201)8:3<573::AID-CHEM573>3.0.CO;2-H
   Seebach D, 1997, CHEM COMMUN, P2015, DOI 10.1039/a704933a
   Semetey V, 2002, ANGEW CHEM INT EDIT, V41, P1893, DOI 10.1002/1521-3773(20020603)41:11<1893::AID-ANIE1893>3.0.CO;2-F
   Sharma GVM, 2003, J AM CHEM SOC, V125, P13670, DOI 10.1021/ja035752i
   Stone MT, 2004, ORG LETT, V6, P469, DOI 10.1021/ol036238k
   van Gorp JJ, 2004, CHEM COMMUN, P60, DOI 10.1039/b312407j
   Woll MG, 2002, J AM CHEM SOC, V124, P12447, DOI 10.1021/ja0258778
   Woll MG, 2001, J AM CHEM SOC, V123, P11077, DOI 10.1021/ja011719p
   Wu CW, 2003, J AM CHEM SOC, V125, P13525, DOI 10.1021/ja037540r
   Wu YD, 1999, J AM CHEM SOC, V121, P9352, DOI 10.1021/ja990955l
   Yang XW, 2003, J AM CHEM SOC, V125, P9932, DOI 10.1021/ja0361897
   Yang XW, 2003, CHEM COMMUN, P56, DOI 10.1039/b209809a
   Zeng HQ, 2003, CHEM COMMUN, P1556, DOI 10.1039/b301791e
   Zeng HQ, 2002, J AM CHEM SOC, V124, P2903, DOI 10.1021/ja01701b
   Zhao DH, 2003, MACROMOLECULES, V36, P2712, DOI 10.1021/ma034159i
   Zhao DH, 2002, J AM CHEM SOC, V124, P9996, DOI 10.1021/ja026957e
   Zych AJ, 2002, HELV CHIM ACTA, V85, P3294, DOI 10.1002/1522-2675(200210)85:10<3294::AID-HLCA3294>3.0.CO;2-9
NR 74
TC 116
Z9 116
U1 2
U2 22
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0959-440X
J9 CURR OPIN STRUC BIOL
JI Curr. Opin. Struct. Biol.
PD AUG
PY 2004
VL 14
IS 4
BP 512
EP 520
DI 10.1016/j.sbi.2004.07.001
PG 9
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 852TT
UT WOS:000223780100018
PM 15313247
DA 2018-10-19
ER

PT J
AU Copty, A
   Golosovsky, M
   Davidov, D
   Frenkel, A
AF Copty, A
   Golosovsky, M
   Davidov, D
   Frenkel, A
TI Localized heating of biological media using a 1-W microwave near-field
   probe
SO IEEE TRANSACTIONS ON MICROWAVE THEORY AND TECHNIQUES
LA English
DT Article
DE microwave heating; microwave microscopy; near-field
ID CLINICAL-APPLICATIONS; CARDIAC ABLATION; ANTENNA; HYPERTHERMIA;
   MICROSCOPY; RADIATION; MAGNETITE; MECHANISM
AB A medium power microwave near-field probe operating at 9 GHz has been designed and tested. The probe radiates microwave energy through a very narrow slot microfabricated at the apex of the dielectric resonator. The radiation is very intensive at near-field distances from the slot and is capable of heating different materials. A temperature of similar to60degreesC - 100degreesC is achieved in an irradiated soot of a size as small as 270 x 500 mum(2). This probe may be used for selective irradiation of biological tissues and tissue welding. We demonstrate the probe ability to produce irreversible changes in biological media with a relatively low power source of similar to1 W. This feature makes it safe for usage in biomedical settings and opens the way to development of an inexpensive portable handheld device.
C1 Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel.
   Anafa Electromagnet Solut Ltd, IL-27000 Kiriat Bialik, Israel.
RP Copty, A (reprint author), Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel.
RI Golosovsky, Michael/L-8303-2013; Golosovsky, Michael/E-1401-2012
OI Golosovsky, Michael/0000-0003-3814-4539; 
CR ABE M, 1985, INT J RADIAT BIOL, V47, P347
   Abu-Teir M, 2001, REV SCI INSTRUM, V72, P2073, DOI 10.1063/1.1351837
   Alpert Y, 1999, IEEE T PLASMA SCI, V27, P555, DOI 10.1109/27.772285
   Bass LS, 1995, LASER SURG MED, V17, P315, DOI 10.1002/lsm.1900170402
   CERRI G, 1993, IEEE T MICROW THEORY, V41, P1135, DOI 10.1109/22.238538
   CHERRY PC, 1993, IEEE T BIO-MED ENG, V40, P771, DOI 10.1109/10.238461
   Dodd GD, 2000, RADIOGRAPHICS, V20, P9, DOI 10.1148/radiographics.20.1.g00ja019
   Fletcher DA, 2000, APPL PHYS LETT, V77, P2109, DOI 10.1063/1.1313368
   FRENKEL A, 2003, Patent No. 6538454
   Golosovsky M, 2002, IEEE T INSTRUM MEAS, V51, P1090, DOI 10.1109/TIM.2002.806006
   Golosovsky M, 2000, REV SCI INSTRUM, V71, P3927, DOI 10.1063/1.1289680
   Gu ZJ, 1999, IEEE T BIO-MED ENG, V46, P1480, DOI 10.1109/10.804576
   Gu ZJ, 2000, IEEE T MICROW THEORY, V48, P1892, DOI 10.1109/22.883868
   Hiraoka M, 2000, IEEE T MICROW THEORY, V48, P1789, DOI 10.1109/22.883855
   HURTER W, 1991, IEEE T MICROW THEORY, V39, P1048, DOI 10.1109/22.81680
   Jerby E, 2002, SCIENCE, V298, P587, DOI 10.1126/science.1077062
   Kaganovskii Y, 2001, J APPL PHYS, V89, P8273, DOI 10.1063/1.1373704
   Kirschvink JL, 1996, BIOELECTROMAGNETICS, V17, P187, DOI 10.1002/(SICI)1521-186X(1996)17:3<187::AID-BEM4>3.0.CO;2-#
   LAX M, 1977, J APPL PHYS, V48, P3919, DOI 10.1063/1.324265
   Lin JC, 1996, IEEE T BIO-MED ENG, V43, P657, DOI 10.1109/10.495286
   Lobel B, 2000, LASER SURG MED, V26, P4, DOI 10.1002/(SICI)1096-9101(2000)26:1<4::AID-LSM3>3.0.CO;2-J
   Phillips ABM, 1999, LASER SURG MED, V24, P264, DOI 10.1002/(SICI)1096-9101(1999)24:4<264::AID-LSM3>3.0.CO;2-#
   POLLEY SL, 1980, FOOD TECHNOL-CHICAGO, V34, P76
   Rappaport C, 2002, IEEE MICROW MAG, V3, P57, DOI 10.1109/6668.990686
   Rosner BT, 2002, REV SCI INSTRUM, V73, P2505, DOI 10.1063/1.1482150
   Sakran F, 2004, APPL PHYS LETT, V84, P4499, DOI 10.1063/1.1756682
   SHARP NC, 1995, LANCET, V346, P1003, DOI 10.1016/S0140-6736(95)91689-X
   Sterzer F, 2000, IEEE T MICROW THEORY, V48, P1885, DOI 10.1109/22.883867
   Wright AS, 2003, ANN SURG ONCOL, V10, P275, DOI 10.1245/ASO.2003.03.045
NR 29
TC 7
Z9 10
U1 1
U2 4
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 0018-9480
J9 IEEE T MICROW THEORY
JI IEEE Trans. Microw. Theory Tech.
PD AUG
PY 2004
VL 52
IS 8
BP 1957
EP 1963
DI 10.1109/TMTT.2004.831986
PN 2
PG 7
WC Engineering, Electrical & Electronic
SC Engineering
GA 843BW
UT WOS:000223051400013
DA 2018-10-19
ER

PT J
AU Nguon, B
   Jouaneh, M
AF Nguon, B
   Jouaneh, M
TI Design and characterization of a precision fluid dispensing valve
SO INTERNATIONAL JOURNAL OF ADVANCED MANUFACTURING TECHNOLOGY
LA English
DT Article
DE dispensing valve; fluid dispensing; time-pressure dispensing; adhesive
   jetting dispensing
AB Precision fluid dispensing is a complicated but yet relevant process where fluid is dispensed in a controlled manner. It is important and applicable in an array of applications ranging from dispensing of food products, biomedical applications to dispensing of adhesive and encapsulants in the semi-conductor industry. This paper discusses the design and characterization of a precision fluid dispensing hybrid valve based on the time-pressure, positive displacement pump, and adhesive jetting technologies. The main advantage of this dispensing method is that the amount of fluid dispensed is independent of the standoff height and does not rely on surface tension between the substrate and the fluid for clean dispensation. Specifically, the dispensed fluid is jetted from a fixed needle height, and hence, repeatability and accuracy is improved while eliminating vertical travel. A prototype valve was built and tested for precision and accuracy of milligrams over a range of pressures and time. The test results are promising, indicating high repeatability and accuracy for low to medium viscous materials and are comparable to existing commercially available precision dispensing systems.
C1 Univ Rhode Isl, Dept Mech Engn & Appl Mech, Kingston, RI 02881 USA.
RP Nguon, B (reprint author), Univ Rhode Isl, Dept Mech Engn & Appl Mech, Kingston, RI 02881 USA.
EM jouaneh@egr.uri.edu
OI Jouaneh, Musa/0000-0001-5754-0364
CR Bush R., 1997, Electronic Packaging and Production, V37, P56
   BUSH R, 1997, ELECT PACKAG PROD, V37, P62
   BUSH R, 1997, ELECT PACKAGING PROD, V37, P60
   Chen XB, 2000, IEEE T ELECTRON PA M, V23, P300, DOI 10.1109/6104.895075
   DIXON D, 1997, CIRCUITS ASSEMBLY, P36
   HOLDSWORTH SD, 1993, T I CHEM ENG C3, V71, P137
   LEE C, 2000, ADV PACKAG
   MURCH F, 2000, ISSUES PRACTICAL PRO
   NGUON B, 2002, THESIS U RHODE ISLAN
   Piracci AF, 2000, ADVANTAGES NONCONTAC
   SKELLAND AHP, 1967, NONNEWTONIAN FLOW H
NR 11
TC 21
Z9 30
U1 1
U2 8
PU SPRINGER LONDON LTD
PI GODALMING
PA SWEETAPPLE HOUSE CATTESHALL ROAD, GODALMING GU7 3DJ, SURREY, ENGLAND
SN 0268-3768
J9 INT J ADV MANUF TECH
JI Int. J. Adv. Manuf. Technol.
PD AUG
PY 2004
VL 24
IS 3-4
BP 251
EP 260
DI 10.1007/s00170-003-1738-3
PG 10
WC Automation & Control Systems; Engineering, Manufacturing
SC Automation & Control Systems; Engineering
GA 843ZE
UT WOS:000223125800011
DA 2018-10-19
ER

PT J
AU Jackson, MJ
   Hyde, LJ
   Ahmed, W
   Sein, H
   Flaxman, RP
AF Jackson, MJ
   Hyde, LJ
   Ahmed, W
   Sein, H
   Flaxman, RP
TI Diamond-coated cutting tools for biomedical applications
SO JOURNAL OF MATERIALS ENGINEERING AND PERFORMANCE
LA English
DT Article; Proceedings Paper
CT 2nd International Surface Engineering Congress
CY SEP 15-17, 2003
CL Indianapolis, IN
SP ASM Int
DE biomedical applications; CVD diamond; dental burs; microtools; wear
ID CHEMICAL-VAPOR-DEPOSITION; CEMENTED TUNGSTEN CARBIDE; CVD DIAMOND;
   FILMS; COATINGS; NUCLEATION; WEAR; GROWTH; STRESS; COBALT
AB Diamond coatings are attractive for cutting processes due to their high-hardness, low-friction coefficient; excellent wear resistance, and chemical inertness. The application of diamond coatings on cemented, tungsten carbide (WC-Co) burs has been the subject of much attention in recent years as a method to improve cutting performance and tool life. WC-Co burs containing 6% Co and 94% WC substrate, with an average grain size of 1-3 mum, were used in this study. To improve the adhesion between diamond and WC substrates, it is necessary to etch away the surface Co and prepare the surface for subsequent diamond growth. Hot filament chemical vapor deposition (HFCVD), with a modified vertical filament arrangement, has been used for the deposition of diamond films. Diamond film quality and purity has been characterized using scanning electron microscopy (SEM) and micro-Raman spectroscopy. The performance of diamond-coated WC-Co burs, uncoated WC-Co burs, and diamond-embedded (sintered) burs have been compared by drilling a series of holes into various materials such as human teeth, borosilicate glass, and acrylic teeth. Flank wear has been used to assess the wear rates of the burs when machining biomedical materials such as those just described.
C1 Tennessee Technol Univ, Ctr Mfg Res, Cookeville, TN 38505 USA.
   Manchester Metropolitan Univ, Dept Chem & Mat, Manchester M1 5GD, Lancs, England.
   Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England.
RP Jackson, MJ (reprint author), Tennessee Technol Univ, Ctr Mfg Res, POB 5014, Cookeville, TN 38505 USA.
EM mjackson@tntech.edu
OI Ahmed, Waqar/0000-0003-4152-5172
CR AGER JW, 1993, PHYS REV B, V48, P2601, DOI 10.1103/PhysRevB.48.2601
   Amirhaghi S, 2001, SURF COAT TECH, V135, P126, DOI 10.1016/S0257-8972(00)01083-5
   BORGES CM, 1999, J PROSTHET DENT, P73
   BRADEN M, 1976, FRONTIERS ORAL PHYSL
   Buck V, 1998, DIAM RELAT MATER, V7, P1544, DOI 10.1016/S0925-9635(98)00237-4
   CAPELLI E, 1996, DIAM RELAT MATER, V5, P292
   CHEN X, 1993, J APPL PHYS, V74, P1468
   Endler I, 1999, DIAM RELAT MATER, V8, P834, DOI 10.1016/S0925-9635(98)00359-8
   HAUBNER R, 1993, DIAM RELAT MATER, V2, P1505, DOI 10.1016/0925-9635(93)90021-S
   Inspektor A, 1997, INT J REFRACT MET H, V15, P49, DOI 10.1016/S0263-4368(96)00045-5
   INSPEKTOR A, 1994, SURF COAT TECH, V68, P359, DOI 10.1016/0257-8972(94)90186-4
   ITOH H, 1991, J MATER SCI, V26, P3763, DOI 10.1007/BF01184968
   Kamiya S, 2000, DIAM RELAT MATER, V9, P191, DOI 10.1016/S0925-9635(00)00229-6
   KLASS W, 1997, DIAM RELAT MATER, V6, P240
   LEYENDECKER T, 1991, SURF COAT TECH, V48, P253, DOI 10.1016/0257-8972(91)90013-M
   Lin JC, 1996, HYDROMETALLURGY, V43, P47, DOI 10.1016/0304-386X(96)00023-0
   Lopez JM, 1998, J MATER RES, V13, P2841, DOI 10.1557/JMR.1998.0388
   Lux B, 1996, CERAM INT, V22, P347, DOI 10.1016/0272-8842(95)00109-3
   LUX B, 1991, NATO ADV SCI I B-PHY, V266, P579
   MAY PW, 1994, DIAM RELAT MATER, V3, P810, DOI 10.1016/0925-9635(94)90274-7
   MURAKAWA M, 1991, SURF COAT TECH, V49, P359, DOI 10.1016/0257-8972(91)90083-9
   OAKES J, 1991, SURF COAT TECH, V47, P600, DOI 10.1016/0257-8972(91)90330-Y
   PINES MS, 1979, J AM DENT ASSOC, V99, P831, DOI 10.14219/jada.archive.1979.0403
   Polini R, 2003, SURF COAT TECH, V166, P127, DOI 10.1016/S0257-8972(02)00775-2
   Polo MC, 1997, DIAM RELAT MATER, V6, P579, DOI 10.1016/S0925-9635(96)00643-7
   REINECK I, 1993, SURF COAT TECH, V57, P47, DOI 10.1016/0257-8972(93)90335-L
   SAIJO K, 1990, SURF COAT TECH, V43-4, P30, DOI 10.1016/0257-8972(90)90057-J
   Sein H, 2003, SURF COAT TECH, V163, P196, DOI 10.1016/S0257-8972(02)00618-7
   Sein H, 2002, DIAM RELAT MATER, V11, P731, DOI 10.1016/S0925-9635(01)00579-9
   Trava-Airoldi VJ, 1998, SURF COAT TECH, V108, P437, DOI 10.1016/S0257-8972(98)00590-8
   WANG DY, 1993, DIAM RELAT MATER, V2, P304, DOI 10.1016/0925-9635(93)90072-A
   Weast R. C., 1989, HDB CHEM PHYS
   YASKIKI T, 1992, SURF COAT TECH, V52, P81
   ZHU W, 1995, J MATER RES, V10, P1455, DOI 10.1557/JMR.1995.1455
NR 34
TC 9
Z9 9
U1 0
U2 7
PU ASM INTERNATIONAL
PI MATERIALS PARK
PA SUBSCRIPTIONS SPECIALIST CUSTOMER SERVICE, MATERIALS PARK, OH 44073-0002
   USA
SN 1059-9495
J9 J MATER ENG PERFORM
JI J. Mater. Eng. Perform.
PD AUG
PY 2004
VL 13
IS 4
BP 421
EP 430
DI 10.1361/10599490419973
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA 846YE
UT WOS:000223354700007
DA 2018-10-19
ER

PT J
AU De Bartolo, L
   Gugliuzza, A
   Morelli, S
   Cirillo, B
   Gordano, A
   Drioli, E
AF De Bartolo, L
   Gugliuzza, A
   Morelli, S
   Cirillo, B
   Gordano, A
   Drioli, E
TI Novel PEEK-WC membranes with low plasma protein affinity related to
   surface free energy parameters
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID PLATELET-ADHESION; POLYMER SURFACES; HEPATOCYTES; ADSORPTION; ORGANS
AB There has been growing interest in innovative materials with specific physico-chemical properties that provide an improved blood/cell compatibility.
   In this paper we evaluated the performance of new membranes prepared from a modified polyetheretherketone (PEEK-WC) contacting human plasma proteins. These membranes were prepared by using the phase inversion technique. Membrane wettability and affinity to proteins were evaluated by means of contact angle experiments, roughness measurements, and quantitative UV analysis. The energy parameters of membrane surfaces were determined according to Good, van Oss and Chaudhury's theory.
   The extent of human albumin, fibrinogen and immunoglobulin G adsorption was related to quantitative expressions of the membrane surface hydrophilicity: the base parameter of surface free energy and the free energy of interfacial interaction. The performance of PEEK-WC membranes was compared to that of commercial membranes, which conventionally are used in biomedical applications. The experimental results showed a reduction of protein adsorption on PEEK-WC membranes with respect to other commercial membranes.
   The low protein affinity of PEEK-WC membranes is due to the intrinsic physico-chemical characteristics of the polymeric material which makes these membranes interesting for potential use in biomedical applications. (C) 2004 Kluwer Academic Publishers.
C1 Univ Calabria, CNR, ITM, I-87030 Arcavacata Di Rende, CS, Italy.
RP De Bartolo, L (reprint author), Univ Calabria, CNR, ITM, Via P Bucci Cubo 17-C, I-87030 Arcavacata Di Rende, CS, Italy.
EM l.debartolo@itm.cnr.it
RI De Bartolo, Loredana/E-5074-2015
OI De Bartolo, Loredana/0000-0003-3774-9114; Gugliuzza,
   Annarosa/0000-0002-2656-8695; MORELLI, SABRINA/0000-0001-7551-8427;
   Drioli, Enrico/0000-0003-1092-5368
CR *ASME, 1985, B461 ANSIASME
   Bismarck A, 1999, J COLLOID INTERF SCI, V217, P377, DOI 10.1006/jcis.1999.6345
   COURTNEY JM, 1994, BRIT MED BULL, V50, P966, DOI 10.1093/oxfordjournals.bmb.a072937
   De Bartolo L, 1999, J BIOMAT SCI-POLYM E, V10, P641, DOI 10.1163/156856299X00856
   De Bartolo L, 2000, BIOTECHNOL PROGR, V16, P102, DOI 10.1021/bp990128o
   De Bartolo L, 2002, BIOMATERIALS, V23, P2485, DOI 10.1016/S0142-9612(01)00383-0
   de Bartolo L, 1998, BIOM HLTH R, V16, P167
   De Bartolo L, 2001, J MATER SCI-MATER M, V12, P959, DOI 10.1023/A:1012857031409
   DEBARTOLO L, 2004, IN PRESS MAT SCI FOR
   DEBARTOLO L, 2003, MATER RES SOC S P, V752, DOI UNSP AA14.2.1
   Good R. J., 1992, MODERN APPROACHES WE
   GOOD RJ, 1992, J ADHES SCI TECHNOL, V6, P1269, DOI 10.1163/156856192X00629
   Gugliuzza A, 2002, EUR POLYM J, V38, P235, DOI 10.1016/S0014-3057(01)00186-0
   JANSEN B, 1984, J BIOMED MATER RES, V18, P655, DOI 10.1002/jbm.820180607
   KIMMERLE K, 1990, DESALINATION, V79, P283, DOI 10.1016/0011-9164(90)85012-Y
   Lee JH, 1998, J BIOMED MATER RES, V41, P304, DOI 10.1002/(SICI)1097-4636(199808)41:2<304::AID-JBM16>3.0.CO;2-K
   LU DR, 1991, J BIOMAT SCI-POLYM E, V3, P127, DOI 10.1163/156856291X00232
   MATSUDA T, 1994, BIOMATERIALS, V15, P417, DOI 10.1016/0142-9612(94)90219-4
   RATNER BD, 1993, J BIOMED MATER RES, V27, P283, DOI 10.1002/jbm.820270302
   Taniguchi M, 2001, LANGMUIR, V17, P4312, DOI 10.1021/la001791l
   VANOSS CJ, 1986, J PROTEIN CHEM, V5, P385, DOI 10.1007/BF01025572
   VANOSS CJ, 1994, INTERFACIAL FORCES A
NR 22
TC 18
Z9 19
U1 2
U2 14
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2004
VL 15
IS 8
BP 877
EP 883
DI 10.1023/B:JMSM.0000036275.60508.50
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 841YB
UT WOS:000222967400006
PM 15477739
DA 2018-10-19
ER

PT J
AU Gordin, DM
   Gloriant, T
   Texier, G
   Thibon, I
   Ansel, D
   Duval, JL
   Nagel, MD
AF Gordin, DM
   Gloriant, T
   Texier, G
   Thibon, I
   Ansel, D
   Duval, JL
   Nagel, MD
TI Development of a beta-type Ti-12Mo-5Ta alloy for biomedical
   applications: cytocompatibility and metallurgical aspects
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID TITANIUM-ALLOYS; SURFACE-ROUGHNESS; IMPLANT MATERIALS; MEDICAL IMPLANTS;
   CELL VIABILITY; TI; BEHAVIOR; MICROSTRUCTURE; TOPOGRAPHY; STRENGTH
AB Ti-based biocompatible alloys are especially used for replacing failed hard tissue. Some of the most actively investigated materials for medical implants are the beta-Ti alloys, as they have a low elastic modulus (to inhibit bone resorption). They are alloyed with elements such as Nb, Ta, Zr, Mo, and Fe. We have prepared a new beta-Ti alloy that combines Ti with the non-toxic elements Ta and Mo using a vacuum arc-melting furnace and then annealed at 950 degreesC for one hour. The alloy was finally quenched in water at room temperature. The Ti-12Mo-5Ta alloy was characterised by X-ray diffraction, optical microscopy, SEM and EDS and found to have a body-centred-cubic structure (beta-type). It had a lower Young's modulus (about 74 GPa) than the classical alpha/beta Ti-6Al-4V alloy (120 GPa), while its Vickers hardness remained very high (about 303 HV). This makes it a good compromise for a use as a bone substitute. The cytocompatibility of samples of Ti-12Mo-5Ta and Ti-6Al-4V titanium alloys with various surface roughnesses was assessed in vitro using organotypic cultures of bone tissue and quantitative analyses of cell migration, proliferation and adhesion. Mechanically polished surfaces were prepared to produce unorientated residual polished grooves and cells grew to a particularly high density on the smoother Ti-12Mo-5Ta surface tested. (C) 2004 Kluwer Academic Publishers.
C1 Inst Natl Sci Appl Rennes, Grp Rech Chim Met, GRCM EA 2620, CS 14315, F-35043 Rennes, France.
   Univ Technol Compiegne, UMR CNRS Genie Biomed 6600, F-60205 Compiegne, France.
RP Gloriant, T (reprint author), Inst Natl Sci Appl Rennes, Grp Rech Chim Met, GRCM EA 2620, CS 14315, F-35043 Rennes, France.
EM Thierry.Gloriant@insa-rennes.fr
OI Gordin, Doina Margareta/0000-0003-2200-9930
CR Ankem S, 1999, MAT SCI ENG A-STRUCT, V263, P127, DOI 10.1016/S0921-5093(98)01170-8
   Anselme K, 2000, BIOMATERIALS, V21, P1567, DOI 10.1016/S0142-9612(00)00042-9
   Bania P. J., 1993, TITANIUM ALLOYS 1990, P3
   Boyan B. D., 2001, TITANIUM MED, P561
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Brunette D M, 1988, Int J Oral Maxillofac Implants, V3, P231
   BUSHER D, 1991, J BIOMED MATER RES, V25, P889
   Cacciafesta P, 2001, SURF SCI, V491, P405, DOI 10.1016/S0039-6028(01)01303-6
   Chauvy PF, 1998, SURF COAT TECH, V110, P48, DOI 10.1016/S0257-8972(98)00608-2
   CHEHROUDI B, 1990, J BIOMED MATER RES, V24, P1203, DOI 10.1002/jbm.820240906
   Davidson J. A., 1986, P IMPL MAN MAT TECHN, P122
   Gonzalez JEG, 1999, J ELECTROANAL CHEM, V471, P109, DOI 10.1016/S0022-0728(99)00260-0
   Ho WF, 1999, BIOMATERIALS, V20, P2115, DOI 10.1016/S0142-9612(99)00114-3
   Ikeda M, 2002, METALL MATER TRANS A, V33, P487, DOI 10.1007/s11661-002-0110-9
   Jaeger N.A.F., 2001, TITANIUM MED, P343
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Lausmaa J., 2001, TITANIUM MED, P231
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   LUTTEROTTI L, 1992, J APPL CRYSTALLOGR, V25, P459, DOI 10.1107/S0021889892001122
   Michael J., 2000, ELECT BACKSCATTER DI, P75
   NIIOMI M, 1998, MAT SCI ENG A-STRUCT, V243, P231
   NIIOMI M, 2002, METALL MATER TRANS A, V33, P477
   OKASAKI Y, 2002, MAT T, V43, P3134
   Okazaki Y, 1998, MAT SCI ENG A-STRUCT, V243, P250, DOI 10.1016/S0921-5093(97)00809-5
   Okazaki Y, 1998, MATER T JIM, V39, P1053, DOI 10.2320/matertrans1989.39.1053
   Okazaki Y, 1998, MATER T JIM, V39, P1070, DOI 10.2320/matertrans1989.39.1070
   SCHUTZ RW, 1993, TITANIUM ALLOYS 1990, P75
   Schwartz Z, 1996, J BIOMED MATER RES, V30, P145
   SIGOT MF, 1992, SCI TECH TECHNOL, V20, P14
   SIGOTLUIZARD MF, 1986, IN VITRO CELL DEV B, V22, P234
   Sittig C, 1999, J MATER SCI-MATER M, V10, P35, DOI 10.1023/A:1008840026907
   Sittig C, 1999, J MATER SCI-MATER M, V10, P191, DOI 10.1023/A:1008997726370
   Song Y, 2002, MATER TRANS, V43, P3028, DOI 10.2320/matertrans.43.3028
   Song Y, 1999, MAT SCI ENG A-STRUCT, V260, P269, DOI 10.1016/S0921-5093(98)00886-7
   Steinemann S. G., 1980, EVALUATION BIOMATERI, P1
   Steinemann SG, 1986, BIOL BIOMECHANICAL P, P409
   WILKE HJ, 1990, ADV BIOMAT, V9, P309
NR 38
TC 49
Z9 51
U1 1
U2 9
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2004
VL 15
IS 8
BP 885
EP 891
DI 10.1023/B:JMSM.0000036276.32211.31
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 841YB
UT WOS:000222967400007
PM 15477740
DA 2018-10-19
ER

PT J
AU Choudhury, NR
AF Choudhury, NR
TI Template mediated hybrid from dendrimer
SO JOURNAL OF SOL-GEL SCIENCE AND TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 12th International Workshop on Sol-Gel-Science and Technology (Sol-Gel
   2003)
CY AUG 24-29, 2003
CL Sydney, AUSTRALIA
DE hybrid; template; nanocomposite; dendrimer
ID NANOCOMPOSITES
AB Novel dendrimer-titania hybrids were prepared in this work from hydroxy and amine terminated polyamidoamine dendrimer (PAMAM generation 4) and titanium alkoxide by an in-situ sol-gel process in presence of a ligand. Dendritic polymers are chosen because of their unique architectural features. Such dendrimer nanocomposite (DNC) can then be used for optical, catalytic, biomedical applications. The hybrid material formed in situ is found to be transparent, brittle and yellow in colour. The hybrids show higher thermal stability than their organic precursors. This is due to enhanced interaction of the inorganic material with the dendrimer through hydrogen bonding as evidenced by PA-FTIR. XPS studies show predominantly the existence of tetravalent titanium due to titania formation.
C1 Univ S Australia, Ian Wark Res Inst, ARC Special Res Ctr Particles & Mat Interfaces, Mawson Lakes, SA 5095, Australia.
RP Choudhury, NR (reprint author), Univ S Australia, Ian Wark Res Inst, ARC Special Res Ctr Particles & Mat Interfaces, Mawson Lakes, SA 5095, Australia.
EM namita.choudhury@unisa.edu.au
RI Roy Choudhury, Namita/F-8278-2011
CR Balogh L, 1998, J AM CHEM SOC, V120, P7355, DOI 10.1021/ja980861w
   Balogh L, 2001, NANO LETT, V1, P18, DOI 10.1021/nl005502p
   Balogh L, 1999, J NANOPART RES, V1, P353, DOI 10.1023/A:1010060404024
   CHUJO Y, 1996, ORGANIC INORGANIC PO, V6, P4793
   Gao Y, 2002, CHEM MATER, V14, P4522, DOI 10.1021/cm0211249
   Gao Y, 2001, CHEM MATER, V13, P3644, DOI 10.1021/cm010179s
   Gong AJ, 2000, J APPL POLYM SCI, V78, P2186, DOI 10.1002/1097-4628(20001213)78:12<2186::AID-APP150>3.0.CO;2-#
   Hu Q, 1999, POLYMER, V40, P4833, DOI 10.1016/S0032-3861(98)00264-X
   Ribot F, 1997, J SOL-GEL SCI TECHN, V8, P529, DOI 10.1023/A:1018374932557
   SANCHEZ C, 1990, INORGANIC ORGANOMETA, P267
   Tamaki R, 1998, APPL ORGANOMET CHEM, V12, P755, DOI 10.1002/(SICI)1099-0739(199810/11)12:10/11<755::AID-AOC783>3.0.CO;2-A
   Zhao MQ, 1999, CHEM MATER, V11, P3379, DOI 10.1021/cm990435p
NR 12
TC 8
Z9 8
U1 1
U2 3
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0928-0707
J9 J SOL-GEL SCI TECHN
JI J. Sol-Gel Sci. Technol.
PD AUG-SEP
PY 2004
VL 31
IS 1-3
BP 37
EP 45
DI 10.1023/B:JSST.0000047957.82633.a1
PG 9
WC Materials Science, Ceramics
SC Materials Science
GA 870FH
UT WOS:000225042500006
DA 2018-10-19
ER

PT J
AU Kim, JG
   Sim, SJ
   Kim, JH
   Kim, SH
   Kim, YH
AF Kim, JG
   Sim, SJ
   Kim, JH
   Kim, SH
   Kim, YH
TI Synthesis and polymerization of methacryloyl-PEG-Sulfonic acid as a
   functional macromer for biocompatible polymeric surfaces
SO MACROMOLECULAR RESEARCH
LA English
DT Article
DE biomaterials; blood-compatibiltity; surface modification; PEG macromer;
   methacryloyl group
ID POLYURETHANE; COPOLYMERS
AB Poly(ethylene glycol)s (PEGs) are unique in their material properties, such as biocompatibility, non-toxicity, and water-solublizing ability, which are extremely useful for a variety of biomedical applications. In addition, a variety of functional PEGs with specific functionality at one or both chain ends have been synthesized for many specialized applications. Surface modifications using PEG have been demonstrated to decrease protein adsorption and platelet or cell adhesion on biomaterials. Furthermore, PEGs having anionic sulfonate terminal units have been proven to enhance the blood compatibility of materials, which has been demonstrated by the negative cilia concept. The preparation of telechelic PEGs having a sulfonic acid group at one end and a polymerizable methacryloyl group at the other is an interesting undertaking for providing macromers that can be used in various vinyl copolymerization and gel systems. In this paper, preliminary results on the synthesis and polymerization behavior of a novel PEG macromer is described with the aim of identifying a biocompatible material for applications in various blood-contacting devices.
C1 Sungkyunkwan Univ, Dept Chem Engn, Suwon 440746, South Korea.
   Korea Adv Inst Sci & Technol, Biomat Res Ctr, Seoul 130650, South Korea.
RP Kim, JH (reprint author), Sungkyunkwan Univ, Dept Chem Engn, Suwon 440746, South Korea.
EM kimjh@skku.edu
RI Sim, Sang Jun/F-6697-2013
OI Sim, Sang Jun/0000-0003-1045-0286
CR Guo SR, 2001, POLYMER, V42, P1017, DOI 10.1016/S0032-3861(00)00472-9
   HAN DK, 1998, J BIOMAT SCI-POLYM E, V9, P164
   Han DK, 2003, J BIOMED MATER RES, V24, P2213
   Inoue H, 1997, J BIOMED MATER RES, V35, P255
   Ishihara K, 2000, J BIOMAT SCI-POLYM E, V11, P1183, DOI 10.1163/156856200744264
   Klement P, 2002, BIOMATERIALS, V23, P527, DOI 10.1016/S0142-9612(01)00135-1
   Lee SH, 2002, MACROMOL RES, V10, P85, DOI 10.1007/BF03218295
   Maiti S, 2001, J COLLOID INTERF SCI, V240, P630, DOI 10.1006/jcis.2001.7683
   SRINIVASAN S, 1971, BIOMEDICAL POLYM, P51
   WISE DL, 1995, ENCY HDB BIOMATERI B, V2, P1071
NR 10
TC 7
Z9 7
U1 2
U2 8
PU POLYMER SOC KOREA
PI SEOUL
PA ROOM 601, HATCHON BUILDING, 831 YEOKSAM-DONG, KANGNAM-KU, SEOUL 135-792,
   SOUTH KOREA
SN 1598-5032
J9 MACROMOL RES
JI Macromol. Res.
PD AUG
PY 2004
VL 12
IS 4
BP 379
EP 383
DI 10.1007/BF03218415
PG 5
WC Polymer Science
SC Polymer Science
GA 852FC
UT WOS:000223739600008
DA 2018-10-19
ER

PT J
AU Goller, G
   Oktar, FN
   Ozyegin, LS
   Kayali, ES
   Demirkesen, E
AF Goller, G
   Oktar, FN
   Ozyegin, LS
   Kayali, ES
   Demirkesen, E
TI Plasma-sprayed human bone-derived hydroxyapatite coatings: effective and
   reliable
SO MATERIALS LETTERS
LA English
DT Article
DE human-derived hydroxyapatite; calcination; plasma spraying; bond
   coating; bone grafts; transmitting infectious diseases; economic
ID MECHANICAL-PROPERTIES; RECONSTRUCTION; COMPOSITES; DENTIN
AB Human bone-derived hydroxyapatite (HHA) was used as plasma-spraying powder in this study. The starting powder was derived with the calcination method as described in recent literature. There have been very few researchers who were seriously interested in calcined HHA as a grafting material. Instead, demineralized HHA (from other humans) was usually preferred among surgeons. This brings some possible danger of transmission of infectious diseases like hepatitis B and C, human immunodeficiency virus (HIV), and almost incurable prion diseases like Creutzfeldt-Jakob disease (CJD) and bovine spongiform encephalopathy (BSE). Due to very high temperature application (850 degreesC), calcined HA seems to be safe and promising as an alternative product to other HA materials in the biomaterial market. As it is known, HA is very weak at load-bearing applications. To overcome this weakness, it is suggested to use it as a coating on metallic substrates. The HA plasma spraying process is a well-known process for such durable coatings. In addition, in order to gain higher strength, it is recommended to use a very thin bond-coating layer to prevent the mismatch of the thermal coefficients between metal and ceramic. Bond coatings are used very widely in industrial applications. Some biomedical bond-coating research has been conducted, but the reports are not yet commercialized. In this study, tensile strength, SEM and X-ray diffraction studies were performed. Bonding strength was found to be 6.91 MPa for nonbond-coated and 13.15 MPa for bond-coated HHA coatings. These results indicate that the application of bond coating with HHA had strengthened the structure of this material. The X-ray diffraction analysis showed a relatively high crystalline phase. SEM pictures indicate very good adhesion of the bond coating on the metal and on the main coating. The production of HHA with the calcination method is economic, and the resulting material (in combination with plasma spraying) can be used for bone grafting purposes. (C) 2004 Elsevier B.V. All rights reserved.
C1 Istanbul Tech Univ, Fac Chem & Met Engn, Dept Met & Mat Engn, TR-80626 Istanbul, Turkey.
   Marmara Univ, Fac Engn, Dept Ind Engn, Istanbul, Turkey.
   Marmara Univ, Sch Hlth Related Profess, Dept Dent Technol, Istanbul, Turkey.
RP Goller, G (reprint author), Istanbul Tech Univ, Fac Chem & Met Engn, Dept Met & Mat Engn, TR-80626 Istanbul, Turkey.
EM goller@itu.edu.tr; foktar@gmx.net; ozyeginsevgi@yahoo.com;
   kayali@itu.edu.tr; demirkesen@itu.edu.tr
OI Goller, Gultekin/0000-0003-4680-3936
CR BERNECKER F, 1993, HNO, V41, P250
   BLAKESLEE S, 2000, NY TIMES        0523
   CANN AJ, 2001, PRINCIPLES MOL VIROL, P258
   Celik E, 1997, SURF COAT TECH, V97, P361, DOI 10.1016/S0257-8972(97)00383-6
   Clemens JAM, 1997, J BIOMED MATER RES, V36, P55, DOI 10.1002/(SICI)1097-4636(199707)36:1<55::AID-JBM7>3.0.CO;2-K
   Entezarian M, 1996, JOM-J MIN MET MAT S, V48, P53, DOI 10.1007/BF03222969
   Goller G, 2003, CERAM INT, V29, P721, DOI 10.1016/S0272-8842(02)00223-7
   Goller G, 2002, MATER LETT, V56, P142
   GREEN E, 2000, LA TIMES        0521
   HEDGES SJ, 2000, CHICAGO TRIBUNE 0522
   Hing KA, 1999, J MATER SCI-MATER M, V10, P135, DOI 10.1023/A:1008929305897
   HUTTENBRINK KB, 1993, HNO, V41, P440
   JOSHI SV, 1993, J MATER SCI-MATER M, V4, P251, DOI 10.1007/BF00122276
   LIN JHC, 1995, MATER CHEM PHYS, V41, P282
   Oktar FN, 2003, KEY ENG MAT, V240-2, P315, DOI 10.4028/www.scientific.net/KEM.240-242.315
   Oktar FN, 2002, CERAM INT, V28, P617, DOI 10.1016/S0272-8842(02)00017-2
   Oktar FN, 1999, ARTIF CELL BLOOD SUB, V27, P367, DOI 10.3109/10731199909117706
   OKTAR FN, 1999, THESIS BOGAZICI U IS, P26
   STEELMAN VM, 1999, AORN J, P1
   UZE M, 1992, P INT ENG DAYS BOG U, P239
   Wenz B, 2001, BIOMATERIALS, V22, P1599, DOI 10.1016/S0142-9612(00)00312-4
NR 21
TC 48
Z9 49
U1 0
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD AUG
PY 2004
VL 58
IS 21
BP 2599
EP 2604
DI 10.1016/j.matlet.2004.03.032
PG 6
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 842PF
UT WOS:000223015700009
DA 2018-10-19
ER

PT J
AU Ozyegin, LS
   Oktar, FN
   Goller, G
   Kayali, ES
   Yazici, T
AF Ozyegin, LS
   Oktar, FN
   Goller, G
   Kayali, ES
   Yazici, T
TI Plasma-sprayed bovine hydroxyapatite coatings
SO MATERIALS LETTERS
LA English
DT Article
DE bovine derived hydroxyapatite; plasma spraying; bond-coating; economic
ID REINFORCED HYDROXYAPATITE; TITANIUM
AB With the increase in the life expectancy of humans, the maintenance of bone in our bodies has become crucial. Allografts extracted from different human and bovine sources bring the problem of potential disease transmittal, particularly the transmittal of disease that are difficult to detect. Autogen grafts bring another problem in surgery because the bone harvesting procedure creates cause for an additional surgery. In this study, the hydroxyapatite (HA) material was produced from bovine bones with the calcination method prohibits the transmission of various disease like mad cow disease (bovine spongiform encephalopathy (BSE)). In this study, the calcinated powder was used as plasma feeding powder for the plasma spraying process in biomedical applications. In industrial applications, the use of bond-coating prevents thermal coefficient mismatching and usually results in a stronger material. However, it was seen than bovine hydroxyapatite (BHA) was so strong that it does not need any bond-coating application. Nonetheless, bond-coating can be used to prevent the formation of micro-cracks. BHA material produced with the calcination method can be a very economic biomaterial for plasma spraying purposes when compared to other commercially available biomaterials. (C) 2004 Elsevier B.V. All rights reserved.
C1 Marmara Univ, Fac Engn, Dept Ind Engn, Istanbul, Turkey.
   Marmara Univ, Sch Hlth Related Profess, Dept Dent Technol, Istanbul, Turkey.
   Istanbul Tech Univ, Fac Chem & Met Engn, Dept Met & Mat Engn, TR-80626 Istanbul, Turkey.
RP Oktar, FN (reprint author), Marmara Univ, Fac Engn, Dept Ind Engn, Istanbul, Turkey.
EM ozyeginsevgi@yahoo.com; foktar@gmx.net; goller@itu.edu.tr;
   kayali@itu.edu.tr; tokayyazici@hotmail.com
OI Goller, Gultekin/0000-0003-4680-3936
CR Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Entezarian M, 1996, JOM-J MIN MET MAT S, V48, P53, DOI 10.1007/BF03222969
   Goldberg V M, 1993, Semin Arthroplasty, V4, P58
   Goller G, 2003, KEY ENG MAT, V240-2, P939
   Goller G, 2003, KEY ENG MAT, V240-2, P619
   Goller G, 2003, KEY ENG MAT, V240-2, P283
   HONG L, 1992, Journal of Biomedical Materials Research, V26, P7, DOI 10.1002/jbm.820260103
   Oktar FN, 2003, KEY ENG MAT, V240-2, P315, DOI 10.4028/www.scientific.net/KEM.240-242.315
   Oktar FN, 2003, KEY ENG MAT, V240-2, P327, DOI 10.4028/www.scientific.net/KEM.240-242.327
   Oktar FN, 1999, ARTIF CELL BLOOD SUB, V27, P367, DOI 10.3109/10731199909117706
   RITTER SK, CHEM ENG NEWS   0825
   TOMIN E, 2002, ARTHROPLAS ARTHROS S, V13, P114
   UZEL M, 1992, P INT ENG DAYS BOG U, P239
   Valerio P, 2004, KEY ENG MAT, V254-2, P837, DOI 10.4028/www.scientific.net/KEM.254-256.837
NR 14
TC 62
Z9 62
U1 0
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD AUG
PY 2004
VL 58
IS 21
BP 2605
EP 2609
DI 10.1016/j.matlet.2004.03.033
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 842PF
UT WOS:000223015700010
DA 2018-10-19
ER

PT J
AU Pothmann, D
   Ulusans, S
   Prols, F
   Klisch, J
AF Pothmann, D
   Ulusans, S
   Prols, F
   Klisch, J
TI Liquid 2-P-HEMA for endovascular tumor therapy: in vivo feasibility
   study
SO MEDICAL SCIENCE MONITOR
LA English
DT Article
DE hilar malignancy; liver tumors; mesenchymal hamartoma
ID POLY(2-HYDROXYETHYL METHACRYLATE) PARTICLES; RADIOPAQUE POLYMERIC
   BIOMATERIALS; ETHYLENE-VINYL ALCOHOL; ARTERIOVENOUS-MALFORMATIONS;
   POLYVINYL-ALCOHOL; BIOMEDICAL APPLICATIONS; ARTERIAL EMBOLIZATION;
   ETHANOL EMBOLIZATION; CELLULOSE-ACETATE; FUNCTIONAL-GROUPS
AB Background: To evaluate a new liquid polymer developed for selective arterial tumor embolization.
   Material/Methods: In six rabbits we embolized the renal artery with pure 2-P-HEMA. Three rabbits were killed immediately after embolization, one after 12 h, and two animals underwent follow-up angiography after two weeks. In a second part of the study we embolized the left renal artery in three mini-swine with pure 2-P-HEMA. The kidneys were examined post mortem by soft-tissue radiography and kidney-tissue section microscopy.
   Results: Complete occlusion of small distal arteries, most of the arterioles together with the precapillary vascular bed, was achieved in all animals. The speed of injection influenced the grade of distal occlusion; repeated injections through the same microcatheter were possible. The relatively fast injection speed of 0.3 ml/min led to an optimal distribution of the liquid embolic. There was no reperfusion in the two follow-up angiographies two weeks after embolization. Histopathologically, there was no angionecrosis and subintimal bleeding. No marked inflammatory reaction in the vessel wall or perivascular tissue was observed in the embolized arteries.
   Conclusions: This study suggests that liquid 2-P-HEMA may be feasible for the treatment of tumors.
C1 Univ Hosp Freiburg, Neuroctr,Res Grp Intervent Neuroradiol, Neuroradiol Sect, Dept Neuroradiol, D-79106 Freiburg, Germany.
   Univ Freiburg, Dept Cardiol & Angiol, Res Grp Expt & Clin Arteriogenesis, Freiburg, Germany.
   Univ Freiburg, Inst Anat 2, Freiburg, Germany.
RP Pothmann, D (reprint author), Univ Hosp Freiburg, Neuroctr,Res Grp Intervent Neuroradiol, Neuroradiol Sect, Dept Neuroradiol, Breisacher Str 64, D-79106 Freiburg, Germany.
EM pothmann@nz11.ukl.uni-freiburg.de
CR APSIMON HT, 1984, RADIOLOGY, V151, P59, DOI 10.1148/radiology.151.1.6701337
   BENZINA A, 1994, BIOMATERIALS, V15, P1122, DOI 10.1016/0142-9612(94)90232-1
   Benzina A, 1996, J BIOMED MATER RES, V32, P459, DOI 10.1002/(SICI)1097-4636(199611)32:3<459::AID-JBM20>3.0.CO;2-A
   BERTHOLD F, 1986, KLIN PADIATR, V198, P257, DOI 10.1055/s-2008-1026886
   Blanco MD, 2000, J PHARM PHARMACOL, V52, P1319, DOI 10.1211/0022357001777469
   Choe DH, 1997, INVEST RADIOL, V32, P260, DOI 10.1097/00004424-199705000-00002
   CIVERCHIAPEREZ L, 1980, P NATL ACAD SCI-BIOL, V77, P2064, DOI 10.1073/pnas.77.4.2064
   CRAWFORD GJ, 1993, CORNEA, V12, P348, DOI 10.1097/00003226-199307000-00012
   Davy KWM, 1997, POLYM INT, V43, P143, DOI 10.1002/(SICI)1097-0126(199706)43:2<143::AID-PI717>3.0.CO;2-M
   EDLING NPG, 1964, ACTA RADIOL DIAGN, V2, P316, DOI 10.1177/028418516400200406
   ELLMAN BA, 1980, INVEST RADIOL, V15, P318, DOI 10.1097/00004424-198007000-00008
   GERMANO IM, 1992, J NEUROSURG, V76, P607, DOI 10.3171/jns.1992.76.4.0607
   HALPERN BD, 1987, ENCY POLYM SCI ENG, V9, P486
   HOCHMUTH A, IN PRESS ACTA OTOLAR
   Horak D, 1997, BIOMATERIALS, V18, P1355, DOI 10.1016/S0142-9612(97)00059-8
   HORAK D, 1986, BIOMATERIALS, V7, P188, DOI 10.1016/0142-9612(86)90100-6
   Horak D, 2000, J BIOMED MATER RES, V51, P184, DOI 10.1002/(SICI)1097-4636(200008)51:2<184::AID-JBM6>3.0.CO;2-O
   Horak D, 1991, Polim Med, V21, P31
   HORAK D, 1992, BIOMATERIALS, V13, P521, DOI 10.1016/0142-9612(92)90103-U
   Horak D, 1997, J BIOMED MATER RES, V34, P183, DOI 10.1002/(SICI)1097-4636(199702)34:2<183::AID-JBM7>3.0.CO;2-M
   HORAK D, 1992, BIOMATERIALS, V6, P361
   HORAK D, 1996, J BIOMED MATER RES, V33, P1
   HORTON JA, 1983, AM J NEURORADIOL, V4, P143
   Janik V, 1990, Cesk Radiol, V44, P44
   JAYAKRISHNAN A, 1990, J BIOMED MATER RES, V24, P993, DOI 10.1002/jbm.820240803
   JAYAKRISHNAN A, 1992, J APPL POLYM SCI, V44, P743, DOI 10.1002/app.1992.070440421
   JEYANTHI R, 1990, BIOMATERIALS, V11, P238, DOI 10.1016/0142-9612(90)90004-A
   Kaminou T, 1996, EUR RADIOL, V6, P502
   Kazekawa K, 1997, J BIOMED MATER RES, V38, P79, DOI 10.1002/(SICI)1097-4636(199722)38:2<79::AID-JBM1>3.0.CO;2-D
   Kerber CW, 2000, NEUROSURG CLIN N AM, V11, P85, DOI 10.1016/S1042-3680(18)30148-7
   KERBER CW, 2000, J NEUROSURG, V96, P196
   Kiremitci M, 1993, J Biomater Appl, V7, P250, DOI 10.1177/088532829300700304
   Klisch J, 2002, NEURORADIOLOGY, V44, P503, DOI 10.1007/s00234-001-0761-z
   Klisch J, 2002, AM J NEURORADIOL, V23, P422
   Komemushi A, 2002, ACTA RADIOL, V43, P186, DOI 10.1034/j.1600-0455.2002.430217.x
   KOMEMUSHI A, 2002, ACTA RADIOL, V43, P188
   KONCHANIN RP, 1987, J UROLOGY, V137, P199, DOI 10.1016/S0022-5347(17)43949-8
   KOOLE LH, 1996, Patent No. 9605872
   Kruft MAB, 1997, BIOMATERIALS, V18, P31, DOI 10.1016/S0142-9612(96)00085-3
   Kruft MAB, 1996, BIOMATERIALS, V17, P1803, DOI 10.1016/0142-9612(95)00339-8
   KRUFT MAB, 1994, J BIOMED MATER RES, V28, P1259, DOI 10.1002/jbm.820281103
   KUHNE D, 1982, NEURORADIOLOGY, V23, P253
   LATSHAW RF, 1985, CARDIOVASC INTER RAD, V8, P24, DOI 10.1007/BF02552636
   Manke C, 2001, AM J NEURORADIOL, V22, P997
   Mason KP, 2000, RADIOLOGY, V217, P127, DOI 10.1148/radiology.217.1.r00se30127
   MONTAGUTI P, 1994, ARZNEIMITTEL-FORSCH, V44-1, P566
   MOSZNER N, 1995, ANGEW MAKROMOL CHEM, V224, P115, DOI 10.1002/apmc.1995.052240112
   Norbash AM, 2001, AM J NEURORADIOL, V22, P334
   Oowaki H, 2000, BIOMATERIALS, V21, P1039, DOI 10.1016/S0142-9612(99)00278-1
   PARK JH, 1986, INVEST RADIOL, V21, P577, DOI 10.1097/00004424-198607000-00011
   PAYNE MS, 1987, J BIOMED MATER RES, V21, P843, DOI 10.1002/jbm.820210703
   PEREGRIN JH, 1984, CARDIOVASC INTER RAD, V7, P97, DOI 10.1007/BF02552689
   Phatouros CC, 1999, AM J NEURORADIOL, V20, P1329
   PURDY PD, 1992, J NEUROSURG, V77, P217, DOI 10.3171/jns.1992.77.2.0217
   QUISLING RG, 1984, AM J NEURORADIOL, V5, P101
   RADHAKRISHNAN VV, 1992, ACTA NEUROCHIR, V117, P30, DOI 10.1007/BF01400631
   Rassweiler J, 1980, Rofo, V133, P644, DOI 10.1055/s-2008-1056808
   RICHTER G, 1981, FORTSCHR RONTG NEUEN, V135, P85, DOI 10.1055/s-2008-1056836
   RICHTER G, 1984, INVEST RADIOL, V19, P36, DOI 10.1097/00004424-198401000-00009
   SADATO A, 1994, NEURORADIOLOGY, V36, P634, DOI 10.1007/BF00600429
   Sampei K, 1996, NEURORADIOLOGY, V38, P291
   SCHUMACHER M, 2002, KLIN NEURORADIOLGIE, V4, P160
   SETTON A, 2001, P AM SOC NEUR 39 ANN, P288
   SHIGEMITSU T, 1991, JPN J OPHTHALMOL, V35, P354
   Siskin GP, 2000, AM J ROENTGENOL, V175, P767, DOI 10.2214/ajr.175.3.1750767
   SKUBA N D, 1989, Byulleten' Eksperimental'noi Biologii i Meditsiny, V107, P379
   SMETANA K, 1991, J BIOACT COMPAT POL, V6, P377
   SMETANA K, 1990, J BIOMED MATER RES, V24, P463, DOI 10.1002/jbm.820240405
   Suh DC, 2000, AM J NEURORADIOL, V21, P1277
   VETVICKA V, 1983, FOLIA BIOL-PRAGUE, V29, P424
   WHITE RI, 1977, RADIOLOGY, V125, P677, DOI 10.1148/125.3.677
   Wright KC, 1999, J VASC INTERV RADIOL, V10, P1207, DOI 10.1016/S1051-0443(99)70221-6
   YAMAMOTO M, 2001, J BIOMAT SCI-POLYM E, P77
NR 73
TC 0
Z9 5
U1 0
U2 2
PU INT SCIENTIFIC LITERATURE, INC
PI ALBERTSON
PA 1125 WILLIS AVE, ALBERTSON, NY 11507 USA
SN 1234-1010
J9 MED SCI MONITOR
JI Med. Sci. Monitor
PD AUG
PY 2004
VL 10
IS 8
BP BR286
EP BR293
PG 8
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 867HQ
UT WOS:000224833700008
PM 15277990
DA 2018-10-19
ER

PT J
AU Bermudez, PM
   Polini, NN
   Casanave, EB
AF Bermudez, PM
   Polini, NN
   Casanave, EB
TI A study of platelets in the armadillo Chaetophractus villosus
   (Xenarthra, Dasypodidae)
SO PLATELETS
LA English
DT Article
ID CONNECTED CANALICULAR SYSTEM; COMPARATIVE HEMATOLOGY; MEGAKARYOCYTE
   GROWTH; BLOOD-PLATELETS; AGGREGATION; THROMBOCYTES; COAGULATION;
   HEMOSTASIS; AGONISTS; ULTRASTRUCTURE
AB Nothing is known about haemostasis in Xenarthra, a widely distributed Order of American mammalians. Chaetophractus villosus, a member of the Dasypodidae family of this group, which is easily adapted to captivity, is of growing interest for biomedical research. In this work, we studied platelet number, MPV, ultrastructure of the platelets by SEM and TEM, and aggregation responses to ADP and ristocetin in this species. Blood samples were obtained by cardiac puncture in 20 anaesthetised animals. Platelet count and MPV were evaluated at the beginning and at the end of a 3-year experimental period, to detect possible variations related to time of captivity. SEM and TEM were done by routine methods adapted to the material, and aggregation response to ADP and ristocetin were evaluated by the Born method. The parameters studied did not show any sex-related differences, nor did the platelet count change during captivity. Nevertheless, MPV decreased during this period. Platelets were ultrastructurally similar to those of other mammals and human beings and responded to proven agonists. Data provided in this study will contribute to the understanding of the haemostatic process in this species.
C1 UNS, Dpt Biol Bioquim & Farm, Lab Fisiol Anim, Catedra Fisiol Anim, RA-8000 Bahia Blanca, Argentina.
   UNS, DBByF, Catedra Anal Clin 2, Bahia Blanca, Buenos Aires, Argentina.
   Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina.
RP Casanave, EB (reprint author), UNS, Dpt Biol Bioquim & Farm, Lab Fisiol Anim, Catedra Fisiol Anim, San Juan 670,B 8000 FWB, RA-8000 Bahia Blanca, Argentina.
EM casanave@criba.edu.ar
OI Casanave, Emma Beatriz/0000-0003-3482-8175
CR Bancroft AJ, 2000, PLATELETS, V11, P379
   BORN GVR, 1963, J PHYSIOL-LONDON, V168, P178, DOI 10.1113/jphysiol.1963.sp007185
   BOUDREAUX MK, 1988, LAB ANIM SCI, V38, P448
   CHEWYK LA, 1998, J ZOO WILDLIFE MED, V29, P177
   CHUVIROV GN, 1978, EXP PATHOL-JENA, V15, P319, DOI 10.1016/S0014-4908(78)80038-6
   DAIMON T, 1979, CELL TISSUE RES, V201, P431
   DAIMON T, 1985, J ANAT, V141, P193
   DAIMON T, 1987, J ANAT, V153, P185
   DAWSONSAUNDERS B, 1997, MANUAL MODERNO BIOES, P34
   DOTSON RL, 1987, COMP BIOCHEM PHYS A, V88, P553, DOI 10.1016/0300-9629(87)90080-6
   Du Plessis L, 1999, J MORPHOL, V239, P245
   du Plessis L, 2002, J COMP PATHOL, V127, P208, DOI 10.1053/jcpa.2002.0565
   duPlessis L, 1997, TISSUE CELL, V29, P217, DOI 10.1016/S0040-8166(97)80021-3
   DuPlessis L, 1996, J MORPHOL, V229, P309, DOI 10.1002/(SICI)1097-4687(199609)229:3<309::AID-JMOR5>3.0.CO;2-T
   EMERSON JD, 1983, UNDERSTANDING ROBUST, V3, P58
   Field CL, 2001, THROMB RES, V101, P267, DOI 10.1016/S0049-3848(00)00392-3
   George JN, 2000, LANCET, V355, P1531, DOI 10.1016/S0140-6736(00)02175-9
   GEWIRTZ H, 1985, P SOC EXP BIOL MED, V179, P324
   GLAUERT AM, 1975, FIXATION DEHYDRATION, P207
   HAOGLIN DC, 1983, UNDERSTANDING ROBUST, P447
   Harker LA, 1996, BLOOD, V88, P511
   Harker LA, 2000, BLOOD, V95, P2514
   Hart S, 1991, Tierarztl Prax, V19, P413
   HAYAT MA, 1986, TRANSMISSION ELECT M
   Jagadeeswaran P, 1999, BRIT J HAEMATOL, V107, P731, DOI 10.1046/j.1365-2141.1999.01763.x
   Johnson EH, 2002, ANAT HISTOL EMBRYOL, V31, P148, DOI 10.1046/j.1439-0264.2002.00379.x
   JOHNSTONE IB, 1980, CAN J PHYSIOL PHARM, V58, P1128, DOI 10.1139/y80-170
   Killingsworth C R, 1985, Vet Clin Pathol, V14, P19
   KRAFT W, 2000, DIAGNOSTICO LAB CLIN, P340
   LASSEN ED, 1995, VET CLIN N AM-EQUINE, V11, P351, DOI 10.1016/S0749-0739(17)30306-1
   LEWIS J, 1977, COMP BIOCH PHYSL
   LEWIS J C, 1986, Scanning Electron Microscopy, P199
   LEWIS JH, 1985, COMP BIOCHEM PHYS A, V82, P211, DOI 10.1016/0300-9629(85)90728-5
   LEWIS JH, 1976, AM J VET RES, V37, P601
   MATEO J, 2001, HEMATOLOGIA CLIN, P597
   MCCURMIN DM, 1993, DIAGNOSTICO FISICO P, P197
   MERCK NJ, 1991, MERCK VET MANUAL, P1832
   Meyer DJ, 2000, LAB MED VET INTERPRE
   MEYERS KM, 1979, AM J VET RES, V40, P260
   Norman EJ, 2001, VET CLIN PATH, V30, P137, DOI 10.1111/j.1939-165X.2001.tb00422.x
   PATTERSON WR, 1993, THROMB RES, V70, P225, DOI 10.1016/0049-3848(93)90129-C
   Pelagalli A, 2002, J COMP PATHOL, V127, P126, DOI 10.1053/jcpa.2002.0570
   PICA A, 1990, Archivio Italiano di Anatomia e di Embriologia, V95, P187
   Polini NN, 1999, COMP HAEMATOL INT, V9, P162
   POLINI NN, 2000, REV IBEROAMER THROMB, V13, P107
   QUINTANAGONZALE.S, 2002, GAC MED MEX, V138, P47
   Redford K. H., 1992, MAMMALS NEOTROPICS S, V2, P46
   Roussi J, 1996, THROMB RES, V81, P297, DOI 10.1016/0049-3848(96)00001-1
   RUIZ AOP, 1997, REV CUBANA INVEST BI, V16, P150
   Schmitt A, 2001, EXP HEMATOL, V29, P1295, DOI 10.1016/S0301-472X(01)00733-0
   Snedecor GW, 1980, STAT METHODS
   Soloviev MV, 1999, J SURG RES, V82, P180, DOI 10.1006/jsre.1998.5543
   SOSLAU G, 1993, THROMB RES, V72, P127, DOI 10.1016/0049-3848(93)90214-9
   SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1
   STAHL K, 1978, HAEMOSTASIS, V7, P242
   Takahashi O, 2000, FOOD CHEM TOXICOL, V38, P203, DOI 10.1016/S0278-6915(99)00155-6
   TVEDTEN H, 1993, DIAGNOSTICO CLINICOP
   VANDERVELDEN P, 1988, BRIT J HAEMATOL, V70, P345
   WEISER MG, 1984, AM J VET RES, V45, P518
   Wetzel P. M., 1982, SPECIAL PUBL SER U P, P345
   Wetzel R.M., 1985, P5
   Wetzel R.M., 1985, P23
   WINTROBE MM, 1999, CLIN HEMATOLOGY
   WITHE JG, 1987, BLOOD, V69, P878
   Zar JH, 1999, BIOSTAT ANAL, P663
   ZUCKERFRANKLIN D, 1985, BLOOD, V65, P241
NR 66
TC 0
Z9 1
U1 0
U2 3
PU CARFAX PUBLISHING
PI BASINGSTOKE
PA RANKINE RD, BASINGSTOKE RG24 8PR, HANTS, ENGLAND
SN 0953-7104
J9 PLATELETS
JI Platelets
PD AUG
PY 2004
VL 15
IS 5
BP 279
EP 285
DI 10.1080/09537100410001710272
PG 7
WC Cell Biology; Hematology
SC Cell Biology; Hematology
GA 843FM
UT WOS:000223063900001
PM 15370098
DA 2018-10-19
ER

PT J
AU Hinojosa, SZ
AF Hinojosa, SZ
TI Authorizing tradition: vectors of contention in Highland Maya midwifery
SO SOCIAL SCIENCE & MEDICINE
LA English
DT Article
DE Guatemala; Maya midwifery; biomedical change; maternal health; child
   care
ID EXTERNAL CEPHALIC VERSION; RURAL GUATEMALA; CARE; MIDWIVES; LABOR
AB In Guatemala, midwives deliver the majority of children and play an important health care role in rural areas. Maya midwives, using time-proven methods, are the chief providers of care for mothers and infants in these areas. In recent decades, however, the medical establishment has become interested in Maya midwives, and is currently engaged in training and certifying many of them. This study examines how Guatemalan health authorities have sought to change Maya midwifery, refashioning its vocational framework and retooling it in accordance with Western medical principles. I focus on the place of obligatory formal training and the use of biomedical materials in the experience of Kaqchikel Maya midwives, and consider how the health officials employ these means to undermine the midwives' knowledge base. Encounters between midwives and formal health personnel reveal an ongoing privileging of biomedical knowledge, one that preserves asymmetrical relationships between these practitioners. This creates an environment favorable to health personnel, and helps them to extend their influence through the midwives into the community. Given this, I contend that health personnel value local Maya midwives primarily for their role in furthering the goals of biomedicine. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Texas Pan Amer, Dept Psychol & Anthropol, Edinburg, TX 78541 USA.
RP Hinojosa, SZ (reprint author), Univ Texas Pan Amer, Dept Psychol & Anthropol, Edinburg, TX 78541 USA.
EM hinojosas@panam.edu
RI Sandall, Jane/D-4146-2009
OI Sandall, Jane/0000-0003-2000-743X
CR Acevedo D, 1997, DEMOGRAPHIC DIVERSITY AND CHANGE IN THE CENTRAL AMERICAN ISTHMUS, P271
   CALI EMR, 1995, THESIS U SAN CARLOS
   Camey XC, 1996, SOC SCI MED, V43, P199, DOI 10.1016/0277-9536(95)00362-2
   *CCAM, 1990, INCAP PUBL C, V275
   Cosminksy S, 2001, Med Anthropol, V20, P345
   COSMINSKY S, 1980, SOC SCI MED-MED ANTH, V14, P267, DOI 10.1016/0160-7987(80)90052-6
   COSMINSKY S, 2001, MESOAMERICAN HEALERS, P179
   COSMINSKY S, 1982, ANTHR HUMAN BIRTH, P233
   COSMINSKY S, 1977, MED ANTHROPOL, V1, P69
   DAY MM, IN PRESS MEXICAN MID
   DOUGLAS BG, 1969, THESIS STANFORD U
   FLYNN AM, 1978, BRIT MED J, V2, P591, DOI 10.1136/bmj.2.6137.591
   Glei DA, 2000, ETHNIC HEALTH, V5, P5, DOI 10.1080/13557850050007301
   Goldman N, 2003, SOC SCI MED, V56, P685, DOI 10.1016/S0277-9536(02)00065-5
   GREEN L B, 1989, Medical Anthropology Quarterly, V3, P246, DOI 10.1525/maq.1989.3.3.02a00030
   GREENBERG L, 1982, SOC SCI MED, V16, P1599, DOI 10.1016/0277-9536(82)90290-8
   Groark Kevin P., 1997, J LATIN AMER LORE, V20, P3
   HINOJOSA SZ, 1994, HUMAN MOSAIC, V28, P41
   HINOJOSA SZ, 1999, THESIS TULANE U
   HINOJOSA SZ, 1994, ANTHROPOLOGY-UCLA, V21, P1
   *HLTH CTR, 2000, MUNC HLTH REP
   *HLTH CTR, 1999, MUN HLTH REP
   *HLTH CTR, 1998, MUN HLTH REP
   *HLTH CTR, 2001, MUN HLTH REP
   *HLTH CTR, 1995, MUN HLTH REP
   Huber Brad R., 2001, MESOAMERICAN HEALERS, P139
   Hurtado E, 2001, MESOAMERICAN HEALERS, P211
   JORDAN B, 1989, SOC SCI MED, V28, P925, DOI 10.1016/0277-9536(89)90317-1
   JORDAN B, 1984, SOC SCI MED, V18, P637, DOI 10.1016/0277-9536(84)90292-2
   Jordan B., 1997, CHILDBIRTH AUTHORITA, P55
   Jordan B., 1993, BIRTH 4 CULTURES CRO
   KELLY I, 1956, J Trop Pediatr (Lond), V1, P200
   KLEIN S, 1995, BOOK MIDWIVES MANUAL
   Lang JB, 1997, J NURSE-MIDWIFERY, V42, P25, DOI 10.1016/S0091-2182(96)00069-9
   MELZACK R, 1991, J PAIN SYMPTOM MANAG, V6, P476, DOI 10.1016/0885-3924(91)90003-M
   Metz B, 2001, HUM ORGAN, V60, P259, DOI 10.17730/humo.60.3.2n9rx53ck001yn6w
   METZGER D, 1963, SOUTHWEST J ANTHROP, V19, P216, DOI 10.1086/soutjanth.19.2.3629170
   MOEDANO N., 1961, TLATOANI, V14, P40
   NEUBERG R, 1995, OBSTETRICS PRACTICAL
   *PAHO, 1994, SCI PUBL, V549
   *PAHO, 1986, SCI PUBL, V500
   PAINTER J, 1989, GUATEMALA FALSE HOPE
   Pan American Health Organization, 1998, HLTH AM, V1
   Paul L, 1975, Ethos, V3, P449, DOI 10.1525/eth.1975.3.3.02a00050
   Paul L., 1975, AM ETHNOL, V2, P707
   PINEDA MAG, 1988, B ESCUELA CIENCIAS A, V16, P3
   RANNEY B, 1973, AM J OBSTET GYNECOL, V116, P239, DOI 10.1016/0002-9378(73)91058-2
   Schwarz R A, 1981, Med Anthropol, V5, P51, DOI 10.1080/01459740.1981.9986975
   SHINZON C, 1987, OBSTET GYNECOL, V69, P67
   Tedlock Barbara, 1992, TIME HIGHLAND MAYA
   VARNEY H, 1980, NURSE MIDWIFERY
   VILLATORO EM, 1986, TRADICION POPULAR, V59, P1
   Ward V. M., 1992, International Family Planning Perspectives, V18, P59, DOI 10.2307/2133395
   WARD VM, 1990, COMPORTAMIENTO SEXUA
   *WHO UNICEF UNFPA, 2001, MAT MORT 1995 EST DE
   WOODS C, 1973, PROCESS MED CHANGE H
   World Health Organization Maternal and Newborn Health/Safe Motherhood Division of Reproductive Health, 1997, WHOFRHMSM9624
NR 57
TC 20
Z9 20
U1 0
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0277-9536
J9 SOC SCI MED
JI Soc. Sci. Med.
PD AUG
PY 2004
VL 59
IS 3
BP 637
EP 651
DI 10.1016/j.socscimed.2003.11.011
PG 15
WC Public, Environmental & Occupational Health; Social Sciences, Biomedical
SC Public, Environmental & Occupational Health; Biomedical Social Sciences
GA 826SB
UT WOS:000221847800015
PM 15144771
DA 2018-10-19
ER

PT J
AU Varma, AJ
   Kennedy, JF
   Galgali, P
AF Varma, AJ
   Kennedy, JF
   Galgali, P
TI Synthetic polymers functionalized by carbohydrates: a review
SO CARBOHYDRATE POLYMERS
LA English
DT Review
DE polymers; carbohydrates; monosaccharides
ID RING-OPENING POLYMERIZATION; LIPOPHILIC RADICAL INITIATOR;
   NUCLEAR-MAGNETIC-RESONANCE; ANHYDRO SUGAR-DERIVATIVES; CHEMICAL
   SYNTHESIS; CATIONIC POLYMERIZATION; MOLECULAR-WEIGHT; D-GLUCOSE;
   SUBSTITUTED 2,6-DIOXABICYCLO<3.1.1>HEPTANES; GLYCOPOLYMERIC INHIBITORS
AB Polymers based on carbohydrates have re-emerged as exciting topics of polymer research, due to a worldwide focus on sustainable materials. However, multi-step synthesis of these polymers have made their use as commodity plastics uneconomical, and currently their applications are restricted to biomedical fields. Functionalization of polymers has emerged as another important area of polymer science and technology. Chemically linking sugar moeities onto synthetic polymers is a unique method of functionalization of synthetic polymers, whereby not only is the polymer functionalized, but it can also get other desirable properties such as biodegradability-a property much debated and researched in modem times. This paper reviews several methods of anchoring carbohydrates onto polymers and the advantages and the disadvantages associated with each method, their current and potential applications, and their characterization methods. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Natl Chem Lab, Div Chem Engn, Polymer Sci & Engn Grp, Pune 411008, Maharashtra, India.
   Univ Birmingham, Sch Chem Sci, Birmingham Carbohydrate & Prot Technol Grp, Birmingham B15 2TT, W Midlands, England.
RP Varma, AJ (reprint author), Natl Chem Lab, Div Chem Engn, Polymer Sci & Engn Grp, Pune 411008, Maharashtra, India.
EM ajvarma@che.ncl.res.in; jfk@chembiotech.co.uk
RI Varma, Dr. A. J./B-8731-2009
CR AKIRA Y, 1999, LANGMUIR, V15, P462
   ALVAREZ C, 1988, POLYM BULL, V19, P521
   ALVAREZ C, 1991, POLYM COMMUN, V32, P504
   ANDRESZ H, 1978, MAKROMOL CHEM, V179, P301
   Aoi K, 1996, MACROMOLECULES, V29, P4456, DOI 10.1021/ma9601068
   Bahulekar R, 1998, BIOTECHNOL TECH, V12, P721, DOI 10.1023/A:1008856416274
   Bahulekar R, 1998, CARBOHYD POLYM, V37, P71, DOI 10.1016/S0144-8617(98)00027-7
   BAMFORD CH, 1990, B SOC CHIM BELG, V99, P919
   BEEREBOOM JJ, 1983, J AGR FOOD CHEM, V31, P664, DOI 10.1021/jf00117a049
   BIRD TP, 1960, CHEM IND-LONDON, P1331
   BLACK WAP, 1962, CHEM IND-LONDON, P1624
   BLACK WAP, 1963, J CHEM SOC, P4433, DOI 10.1039/jr9630004433
   BLUHM T, 1973, MACROMOLECULES, V6, P578, DOI 10.1021/ma60034a021
   BON AFS, 1999, POLYM PREPARATION AC, V40, P248
   BREDERECK H, 1963, J KLAR CHEM ZEITUNG, V87, P731
   Buchholz K., 1995, German Patent DE, Patent No. 4408391
   CALLSTROM MR, 1992, Patent No. 9208790
   CANEIRO MJ, 2001, CARBOHYD POLYM, V45, P135
   CARPINO LA, 1976, MAKROMOL CHEM, V177, P1631
   CARRAHER CE, 1981, ORG COAT PLAST CHEM, V45, P564
   CHEN XM, 1995, MACROMOLECULES, V28, P6014, DOI 10.1021/ma00122a005
   CHERNYAK AY, 1985, CARBOHYD RES, V141, P199, DOI 10.1016/S0008-6215(00)90452-X
   Chung T. C., 2002, FUNCTIONALIZATION PO
   COLSON P, 1974, J AM CHEM SOC, V96, P8081, DOI 10.1021/ja00833a038
   DORDICK JS, 1991, Patent No. 9117255
   DUNCAN R, 1989, J CONTROL RELEASE, V10, P51, DOI 10.1016/0168-3659(89)90017-5
   EBY R, 1982, CARBOHYD RES, V102, P131, DOI 10.1016/S0008-6215(00)88056-8
   EMMERLING WN, 1983, MAKROMOL CHEM, V184, P1441
   FAULKNER RN, 1977, ACS SYM SER, V41, P176
   FRASER C, 1995, MACROMOLECULES, V28, P7248, DOI 10.1021/ma00125a030
   FRECHET J, 1969, J AM CHEM SOC, V91, P1161, DOI 10.1021/ja01033a021
   FURUIKE T, 1995, MACROMOLECULES, V28, P7241, DOI 10.1021/ma00125a029
   GALGALI P, 2002, JCS CHEM COMMUNICATI, P2884
   GALGALI P, 2001, S POL SCI ENG IND SO
   GALGALI P, 2004, IN PRESS CARBOHYDRAT
   GERD J, 1991, MAKROMOLECULAR CHEM, V12, P625
   Goldstein I J, 1966, Adv Carbohydr Chem Biochem, V21, P431
   GOLDSTEIN IJ, 1968, ARCH BIOCHEM BIOPHYS, V127, P787, DOI 10.1016/0003-9861(68)90290-7
   GOOD C, 1985, MACROMOLECULES, V18, P595
   Goto M, 2001, MACROMOL CHEM PHYS, V202, P1161, DOI 10.1002/1521-3935(20010401)202:7<1161::AID-MACP1161>3.0.CO;2-0
   GRANDE D, 2000, POLYM PREPR AM CHEM, V41, P1000
   Gruber H, 2000, MACROMOL SYMP, V152, P95, DOI 10.1002/1521-3900(200003)152:1<95::AID-MASY95>3.0.CO;2-M
   GRUBER H, 1991, CARBOHYDRATES ORGANI, pCH4
   Hashimoto K, 1999, J POLYM SCI POL CHEM, V37, P303, DOI 10.1002/(SICI)1099-0518(19990201)37:3<303::AID-POLA7>3.0.CO;2-4
   Hashimoto K, 1999, J POLYM SCI POL CHEM, V37, P2773, DOI 10.1002/(SICI)1099-0518(19990801)37:15<2773::AID-POLA11>3.3.CO;2-T
   Havard JM, 1999, MACROMOLECULES, V32, P86, DOI 10.1021/ma981372j
   HAW S, 1956, NATURE, V178, P1222
   HAWORTH WN, 1946, J CHEM SOC, P488, DOI 10.1039/jr9460000488
   HELFERICH B, 1952, CHEM BER-RECL, V85, P175, DOI 10.1002/cber.19520850219
   HELFERICH B, 1958, HOPPESEYLERS Z PHYSL, V54, P311
   HOREJSI V, 1978, BIOCHIM BIOPHYS ACTA, V538, P293, DOI 10.1016/0304-4165(78)90357-4
   HUBBELL JA, 1994, TRENDS POLYM SCI, V2, P20
   IMOTO M, 1962, MAKROMOLECULAR CHEM, V53, P219
   ITO H, 1979, J AM CHEM SOC, V101, P5797, DOI 10.1021/ja00513a055
   JIRI C, 1978, Patent No. 2819522
   KABAT EA, 1954, J AM CHEM SOC, V76, P3709, DOI 10.1021/ja01643a034
   KABAT EA, 1957, J CELL COMPAR PHYSL, V50, P79, DOI 10.1002/jcp.1030500406
   KABAT EA, 1960, J IMMUNOL, V84, P82
   KALLIN E, 1989, J CARBOHYD CHEM, V8, P597, DOI 10.1080/07328308908048020
   KAREL F, 1980, Patent No. 3014632
   KEISUKE K, 1985, Patent No. 60192704
   KEISUKE K, 1985, Patent No. 60204795
   Khan R., 1976, Advances in Carbohydrate Chemistry and Biochemistry, V33, P235, DOI 10.1016/S0065-2318(08)60283-8
   KIMURA S, 1961, MAKROMOLEKUL CHEM, V50, P155
   KIMURA S, 1962, MAKROMOLEKUL CHEM, V58, P232
   KITANO H, 1994, LANGMUIR, V10, P4131, DOI 10.1021/la00023a036
   KITANO H, 1995, BIOCONJUGATE CHEM, V6, P131, DOI 10.1021/bc00031a016
   KITUGAWA M, 2001, MACROMOLECULAR CHEM, V202, P231
   KLEIN J, 1989, MAKROMOL CHEM-RAPID, V10, P629
   KLEIN J, 1987, MAKROMOL CHEM, V188, P1217
   KLEIN J, 1989, MAKROMOL CHEM, V190, P2527
   KLEIN J, 1990, MAKROMOL CHEM-RAPID, V11, P477
   KLEIN J, 1990, MAKROMOL CHEM, V191, P517
   KLEIN J, 1986, MAKROMOL CHEM-RAPID, V7, P621
   KLEIN J, 1988, MAKROMOL CHEM, V189, P805
   KLEIN J, 1985, MAKROMOL CHEM-RAPID, V6, P675
   KLEIN J, 1982, 1077A BMFT ET
   KOBAYASHI A, 1986, MAKROMOL CHEM-RAPID, V7, P645
   KOBAYASHI A, 1994, J BIOMAT SCI-POLYM E, V6, P325, DOI 10.1163/156856295X00030
   KOBAYASHI K, 1980, MACROMOLECULES, V13, P234, DOI 10.1021/ma60074a006
   KOBAYASHI K, 1988, J MACROMOL SCI CHEM, VA25, P655, DOI 10.1080/00222338808053391
   KOBAYASHI K, 1985, POLYM J, V17, P567, DOI 10.1295/polymj.17.567
   KOBAYASHI K, 1980, NIPPON KAGAKU KAISHI, P406, DOI 10.1246/nikkashi.1980.406
   KOBAYASHI K, 1977, BIOPOLYMERS, V16, P415, DOI 10.1002/bip.1977.360160214
   KOBAYASHI K, 1994, J CARBOHYD CHEM, V13, P753, DOI 10.1080/07328309408011678
   KOBAYASHI K, 1994, METHOD ENZYMOL, V247, P409
   Kobayashi K, 1996, MACROMOLECULES, V29, P8670, DOI 10.1021/ma9603443
   KOBAYASHI K, 1983, POLYM J, V15, P667, DOI 10.1295/polymj.15.667
   Kobayashi K., 2001, BAIOSAIENSU TO INDAS, V59, P679
   Kobayashi Kazukiyo, 1994, P261
   KONG F, 1984, MACROMOLECULES, V17, P983, DOI 10.1021/ma00135a001
   KOPS J, 1965, J POLYM SCI        C, V11, P119
   KORSHAK VV, 1961, VYSOKOMOL SOEDIN, V3, P477
   KOSMA P, 1987, CARBOHYD RES, V167, P39, DOI 10.1016/0008-6215(87)80266-5
   KOYAMA Y, 1986, SEIKEI DAIGAKU KOGAK, V41, P2749
   KRASKA B, 1978, TETEHEDRON LETT, V46, P4583
   KRAUSE F, 1984, Patent No. 9401476
   KUNZ M, 1993, CARBOHYDRATES ORGANI
   LEE J, 1999, BIOORGAN MED CHEM, V7, P1549
   LIN JWP, 1972, J POLYM SCI POL CHEM, P2045
   Liu XC, 1999, J POLYM SCI POL CHEM, V37, P1665, DOI 10.1002/(SICI)1099-0518(19990601)37:11<1665::AID-POLA12>3.3.CO;2-V
   MANDEVILLE WH, 1997, Patent No. 5700458
   MARK HF, 1988, ENCY POLYM SCI ENG, V13, P154
   MARTIN BD, 1992, MACROMOLECULES, V25, P7081, DOI 10.1021/ma00052a001
   MARUYAMA A, 1994, BIOMATERIALS, V15, P1035, DOI 10.1016/0142-9612(94)90088-4
   MASURA V, 1970, CARBOHYD RES, V15, P65, DOI 10.1016/S0008-6215(00)80295-5
   MATSUOKA K, 1995, MACROMOLECULES, V28, P2961, DOI 10.1021/ma00112a049
   MICHEEL F, 1974, LIEBIGS ANN CHEM, P702
   MICHEEL F, 1974, LIEBIGS ANN CHEM, P124
   MORIGUCHI K, 1994, Patent No. 06279631
   Mortell KH, 1996, J AM CHEM SOC, V118, P2297, DOI 10.1021/ja953574q
   MOSSL E, 1993, ANGEW MAKROMOL CHEM, V205, P185, DOI 10.1002/apmc.1993.052050116
   MUELLER HP, 1991, Patent No. 4006521
   NAKAGAWA T, 1993, Patent No. 05148314
   NAKAGAWA T, 1994, Patent No. 06145074
   Nichols PL, 1944, J AM CHEM SOC, V66, P1625, DOI 10.1021/ja01238a004
   NICHOLS PL, 1945, J AM CHEM SOC, V67, P1038
   NISHIMURA SI, 1994, MACROMOLECULES, V27, P157, DOI 10.1021/ma00079a023
   NISHIMURA SI, 1994, MACROMOLECULES, V27, P4876, DOI 10.1021/ma00096a004
   NISHIMURA SI, 1990, MACROMOLECULES, V23, P4182, DOI 10.1021/ma00220a024
   NISHIMURA SI, 1991, MACROMOLECULES, V24, P4236, DOI 10.1021/ma00015a002
   NISHIO K, 1978, MAKROMOL CHEM, V179, P1117
   NOLTE RJM, 1978, J ORG CHEM, V43, P1972, DOI 10.1021/jo00404a027
   Ohno K, 1998, J POLYM SCI POL CHEM, V36, P2473, DOI 10.1002/(SICI)1099-0518(199810)36:14<2473::AID-POLA5>3.0.CO;2-U
   Ohno K, 1999, MACROMOL CHEM PHYSIC, V200, P1619, DOI 10.1002/(SICI)1521-3935(19990701)200:7<1619::AID-MACP1619>3.0.CO;2-1
   OKUBO Y, 1980, J BACTERIOL, V144, P92
   OUCHI T, 1984, MAKROMOL CHEM, V185, P255
   PACITTI S, 2003, PLASTICS PACKAGING, P14
   PANZER HP, 1959, CHEM ENG NEWS, V37, P41
   PATIL DR, 1991, BIOTECHNOL BIOENG, V37, P639, DOI 10.1002/bit.260370706
   PATIL DR, 1991, MACROMOLECULES, V24, P2462
   Pictet A, 1918, HELV CHIM ACTA, V1, P226, DOI 10.1002/hlca.19180010124
   Pinilla IM, 2002, MACROMOLECULES, V35, P2977, DOI 10.1021/ma011301b
   REPPE W, 1930, Patent No. 714490
   REPPE W, 1936, Patent No. 2157347
   Reppe W., 1936, Ger. Pat., Patent No. [715 268, 715268]
   Rios P, 1997, J APPL POLYM SCI, V64, P1195
   ROBINSON R, 1970, CARBOHYD RES, V13, P425, DOI 10.1016/S0008-6215(00)80599-6
   ROY R, 1988, J CHEM SOC CHEM COMM, P1058, DOI 10.1039/c39880001058
   RUCKEL ER, 1966, J ORG CHEM, V31, P2233, DOI 10.1021/jo01345a035
   RUCKEL ER, 1967, BIOPOLYMERS, V5, P515, DOI 10.1002/bip.1967.360050606
   RUCKEL ER, 1966, J AM CHEM SOC, V88, P2605, DOI 10.1021/ja00963a052
   SAUTER NK, 1989, BIOCHEMISTRY-US, V28, P8388, DOI 10.1021/bi00447a018
   SCHUERCH C, 1981, ADV CARBOHYD CHEM BI, V39, P157
   SHARKEY PF, 1981, CARBOHYD RES, V96, P223, DOI 10.1016/S0008-6215(00)81872-8
   SHOWA, 1981, Patent No. 56047415
   SO LL, 1968, J BIOL CHEM, V243, P2003
   SPALTENSTEIN A, 1991, J AM CHEM SOC, V113, P686, DOI 10.1021/ja00002a053
   STIPANOVIC AJ, 1980, ABSTR PAP AM CHEM S, V179, P45
   Tirkistani FAA, 1997, CARBOHYD POLYM, V34, P329, DOI 10.1016/S0144-8617(97)00065-9
   TKACZ JS, 1972, CARBOHYD RES, V21, P465, DOI 10.1016/S0008-6215(00)84930-7
   Tokiwa Y, 2000, MACROMOLECULES, V33, P1636, DOI 10.1021/ma981451v
   TREADWAY RH, 1945, J AM CHEM SOC, V67, P1038, DOI 10.1021/ja01222a508
   TRUMBO DL, 1985, CARBOHYD RES, V135, P195, DOI 10.1016/S0008-6215(00)90771-7
   TWEEDDALE HJ, 1994, GLYCOCONJUGATE J, V11, P586, DOI 10.1007/BF00731310
   URYU T, 1971, MACROMOLECULES, V4, P342, DOI 10.1021/ma60021a018
   URYU T, 1981, J POLYM SCI POL CHEM, V19, P2313, DOI 10.1002/pol.1981.170190917
   URYU T, 1980, MAKROMOL CHEM, V181, P2137
   URYU T, 1979, J POLYM SCI POL LETT, V17, P673, DOI 10.1002/pol.1979.130171009
   URYU T, 1978, MAKROMOL CHEM, V179, P1773
   URYU T, 1970, MACROMOLECULES, V3, P345, DOI 10.1021/ma60015a014
   URYU T, 1984, MACROMOLECULES, V17, P1307, DOI 10.1021/ma00137a002
   URYU T, 1983, J AM CHEM SOC, V105, P6865, DOI 10.1021/ja00361a021
   URYU T, 1981, MACROMOLECULES, V14, P1, DOI 10.1021/ma50002a001
   URYU T, 1979, POLYM PREPARATION AM, V20, P813
   USMANI AM, 1983, POLYM SCI TECHNOL, V21, P247
   Vaidya U. R., 1993, Patent No. [9323456, WO9323456 A1]
   VARMA AJ, 1981, J ORG CHEM, V46, P799, DOI 10.1021/jo00317a030
   VARMA AJ, 2003, CHEM IND DIG MUMB IN
   VERUOVIC B, 1970, CARBOHYD RES, V14, P199, DOI 10.1016/S0008-6215(00)80487-5
   VETTER D, 1994, Patent No. 9412540
   VONVOLKER B, 1998, POLYMER, V39, P1617
   WANG P, 1992, J AM CHEM SOC, V114, P378, DOI 10.1021/ja00027a068
   WHISTLER RL, 1962, J ORG CHEM, V27, P2961, DOI 10.1021/jo01055a533
   WHISTLER RL, 1961, J ORG CHEM, V26, P1583, DOI 10.1021/jo01064a067
   WOLFROM ML, 1959, J AM CHEM SOC, V81, P4623, DOI 10.1021/ja01526a043
   WOLFROM ML, 1959, J AM CHEM SOC, V81, P5701, DOI 10.1021/ja01530a043
   Wulff G, 1996, MACROMOL CHEM PHYSIC, V197, P259, DOI 10.1002/macp.1996.021970120
   Wulff G, 1999, MACROMOL CHEM PHYSIC, V200, P774
   WULFF G, 1998, POLYM PREPR, V39, P124
   YAMAGUCHI H, 1980, BIOPOLYMERS, V19, P297, DOI 10.1002/bip.1980.360190208
   YAMAGUCHI S, 1994, Patent No. 06298866
   YOSHIDA T, 2000, CARBOHYD POLYM, V44, P141
   YURA H, 1997, Patent No. 09221524
   ZACHOVAL J, 1969, J AM CHEM SOC, V91, P1165, DOI 10.1021/ja01033a022
   Zhou WJ, 1997, MACROMOLECULES, V30, P7063, DOI 10.1021/ma970873m
   Zhou WJ, 1999, MACROMOLECULES, V32, P5507, DOI 10.1021/ma990397v
   1930, Patent No. 584840
NR 188
TC 90
Z9 94
U1 3
U2 46
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JUL 15
PY 2004
VL 56
IS 4
BP 429
EP 445
DI 10.1016/j.carbpol.2004.03.007
PG 17
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 838XQ
UT WOS:000222747100006
DA 2018-10-19
ER

PT J
AU Hsu, SH
   Chu, WP
   Lin, YS
   Chiang, YL
   Chen, DCH
   Tsai, CL
AF Hsu, SH
   Chu, WP
   Lin, YS
   Chiang, YL
   Chen, DCH
   Tsai, CL
TI The effect of an RGD-containing fusion protein CBD-RGD in promoting
   cellular adhesion
SO JOURNAL OF BIOTECHNOLOGY
LA English
DT Article
DE RGD-containing peptides; polyurethane; poly(L-lactide);
   poly(lactide-co-glycolide)
ID EXTRACELLULAR-MATRIX PROTEINS; ENDOTHELIAL-CELLS; PEPTIDES; FIBRONECTIN;
   ATTACHMENT; RECEPTOR; CULTURE; CHONDROCYTES; CARTILAGE; SURFACE
AB The effect of a recombinant RGD (arginine-glycine-aspartic acid)-containing fusion protein, cellulose-binding domain (CBD)RGD, on the cellular adhesion to a biomedical polyurethane (PU) was evaluated. A series of different cell lines, as well as freshly harvested animal cells, were grown on the PU surfaces with or without CBD-RGD, in serum or serum-free media. The results showed that the enhancement of cellular attachment by CBD-RGD varied with cell types. This is believed to be a result of the unique integrin receptors on each type of cell surface. The existence of certain divalent ions (Mg2+ and Mn2+) may increase the efficacy of the CBD-RGD, in a cell type-dependent manner. The fusion protein was also found to inhibit the platelet activation. The effect of CBD-RGD was further examined in two other substrate materials, poly(L-lactide) (PLLA) and poly(lactide-co-glycolide) (PLGA). The effect on cellular adhesion correlated with the amount of CBD-RGD physically adsorbed on the material surface. (C) 2004 Elsevier B.V. All rights reserved.
C1 Natl Chung Hsing Univ, Dept Chem Engn, Taichung 402, Taiwan.
   Natl Chung Hsing Univ, Grad Inst Vet Microbiol, Taichung 40227, Taiwan.
   Natl Taiwan Univ, Coll Med, Dept Orthopaed, Taipei 10764, Taiwan.
RP Hsu, SH (reprint author), Natl Chung Hsing Univ, Dept Chem Engn, 250 Kao Kung Rd, Taichung 402, Taiwan.
EM shhsu@nchu.edu.tw
OI Hsu, Shan-hui/0000-0003-3399-055X
CR Camper L, 1997, J CELL BIOL, V138, P1159, DOI 10.1083/jcb.138.5.1159
   CHEN DC, 2002, Patent No. 6407208B1
   CHEN DC, 2002, Patent No. 6407208
   Cheresh D., 1993, ADV MOL CELL BIOL, V6, P225
   Chiba M, 1996, J IMMUNOL METHODS, V191, P55, DOI 10.1016/0022-1759(96)00021-X
   FRESHNEY RI, 1994, CULTURE ANIMAL CELLS, P331
   GAILIT J, 1988, J BIOL CHEM, V263, P12927
   GARCIA AJ, 1998, BIOCHEMISTRY-US, V41, P9063
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Holland J, 1996, BIOMATERIALS, V17, P2147, DOI 10.1016/0142-9612(96)00028-2
   HSU JJ, 1999, P GLOB CHIN S BIOM C, P642
   HSU S, 2003, ARTIF ORGANS, V27, P1090
   HSU SH, 2003, Patent No. 6579322
   Ishaug-Riley SL, 1998, BIOMATERIALS, V19, P1405, DOI 10.1016/S0142-9612(98)00021-0
   Jeschke B, 2002, BIOMATERIALS, V23, P3455, DOI 10.1016/S0142-9612(02)00052-2
   KEMPCZINSKI RF, 1987, ENDOTHELIAL SEEDING, P57
   LARSSON CF, 2000, BIOMATERIALS, V21, P307
   LIN HB, 1992, BIOMATERIALS, V13, P905, DOI 10.1016/0142-9612(92)90113-3
   LOESER RF, 1994, EXP CELL RES, V211, P17, DOI 10.1006/excr.1994.1053
   MASSIA SP, 1991, J BIOMED MATER RES, V25, P223, DOI 10.1002/jbm.820250209
   Ohno S, 1999, BBA-MOL CELL RES, V1451, P196, DOI 10.1016/S0167-4889(99)00093-2
   PATTERSON RB, 1995, ASAIO J, V41, pM625, DOI 10.1097/00002480-199507000-00086
   PENKE B, 1984, J MED CHEM, V27, P845, DOI 10.1021/jm00373a006
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   SAMANEN J, 1991, J MED CHEM, V34, P3114, DOI 10.1021/jm00114a022
   TORD, 1994, J MOL CELL CARDIOL, V26, pR86
   TORDAY L, 1994, J MOL CELL CARDIOL, V26, pR86
   VARANI J, 1993, CYTOTECHNOLOGY, V13, P89, DOI 10.1007/BF00749935
   WILLIAMS RL, 1988, BIOMATERIALS, V9, P206, DOI 10.1016/0142-9612(88)90085-3
   Yasuda T, 1996, J BONE MINER RES, V11, P1430
NR 30
TC 23
Z9 24
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1656
J9 J BIOTECHNOL
JI J. Biotechnol.
PD JUL 15
PY 2004
VL 111
IS 2
BP 143
EP 154
DI 10.1016/j.jbiotec.2004.03.014
PG 12
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 837HY
UT WOS:000222620800004
PM 15219401
DA 2018-10-19
ER

PT J
AU Manso-Silvan, M
   Ceccone, G
   Rossi, F
AF Manso-Silvan, M
   Ceccone, G
   Rossi, F
TI Surface analysis of plasma-patterned biofunctional hybrid
   titanate-aminosilane xerogel films
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE amino groups; sol-gel; plasma etching; surface functionalization; X-ray
   photoelectron spectroscopy; confocal microscopy
ID THIN-FILM; MONOLAYERS; ADSORPTION; ACID
AB The functionalization and patterning of biomedical materials with enhanced surface activity is a main objective for the development of high-specificity biosensors. The surfaces of sol-gel condensed aminopropyltriethoxysilane-tetraisopropyl orthotitanate hybrid materials have been studied in order to describe the mechanisms that allow the fixation of amino groups. X-ray photoelectron spectra obtained from these surfaces are compared with those coming from the surfaces of plasma-etched coatings. The results show that aminopropyl radicals remain on the surface after room-temperature condensation and that they are drastically removed after partial etching of the coating in an Ar plasma. This confirms that the functionalization is effectively a surface feature and suggests that amino groups may remain at the surface covalently bonded to the original amorphous Si-O- structure. Further evidence of the surface functionalization efficiency is illustrated with contact angle and zeta-potential measurements. It is complementarily proved by confocal microscopy that masked regions conserve their molecular activity and are not affected by the etching process. These facts suggest that these materials could play an active role when incorporated into biosensor devices. (C) 2004 Elsevier Inc. All rights reserved.
C1 European Commiss, Inst Hlth & Consumer Protect, I-21020 Ispra, VA, Italy.
RP Manso-Silvan, M (reprint author), European Commiss, Inst Hlth & Consumer Protect, Via Enrico Fermi TP 203, I-21020 Ispra, VA, Italy.
EM miguel.manso@jrc.it
RI Manso Silvan, Miguel/B-4947-2010
OI Manso Silvan, Miguel/0000-0002-5063-1607; Rossi,
   Francois/0000-0003-3090-1398
CR Basyuk V.A., 1990, ZH PRIKL SPEKTROSK, V52, P935
   BIERSACK JP, 1980, NUCL INSTRUM METHODS, V174, P257, DOI 10.1016/0029-554X(80)90440-1
   Briggs D., 1994, PRACTICAL SURFACE AN, V1, P635
   Briggs D., 1998, SURFACE ANAL POLYM X
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Della Volpe C, 1997, J COLLOID INTERF SCI, V195, P121
   Kam L, 1999, BIOMATERIALS, V20, P2343, DOI 10.1016/S0142-9612(99)00163-5
   Kondo H, 1997, WEAR, V202, P149, DOI 10.1016/S0043-1648(96)07265-1
   Kowalczyk D, 1996, INT J ADHES ADHES, V16, P227, DOI 10.1016/0143-7496(95)00052-6
   Lahiri J, 1999, LANGMUIR, V15, P2055, DOI 10.1021/la9811970
   Liu XW, 2002, THIN SOLID FILMS, V409, P178, DOI 10.1016/S0040-6090(02)00146-3
   Manso M, 2002, BIOMATERIALS, V23, P349, DOI 10.1016/S0142-9612(01)00112-0
   Muller M, 1999, SURF COAT TECH, V116, P802, DOI 10.1016/S0257-8972(99)00268-6
   PUGGELLI M, 1994, THIN SOLID FILMS, V244, P1050, DOI 10.1016/0040-6090(94)90628-9
   SETHI RS, 1994, BIOSENS BIOELECTRON, V9, P243, DOI 10.1016/0956-5663(94)80127-4
   SOKOLL R, 1986, J CHEM SOC FARAD T 1, V82, P3391, DOI 10.1039/f19868203391
   Talroze RV, 1998, THIN SOLID FILMS, V325, P232, DOI 10.1016/S0040-6090(98)00505-7
   vanOss CJ, 1996, J DISPER SCI TECHNOL, V17, P433, DOI 10.1080/01932699608943513
   VASILJEVA LL, 1995, THIN SOLID FILMS, V261, P296, DOI 10.1016/S0040-6090(94)06458-X
   Wagner D., 1979, HDB XRAY PHOTOELECTR
   WANG D, 1993, J MATER SCI, V28, P2481, DOI 10.1007/BF01151683
   WHITESELL JK, 1994, MOL CRYST LIQ CRYS A, V240, P251, DOI 10.1080/10587259408029736
   Yu JG, 2001, J MATER SCI LETT, V20, P671, DOI 10.1023/A:1010994022745
   ZHANG L, 1998, THIN SOLID FILMS, V221, P327
NR 24
TC 6
Z9 6
U1 0
U2 3
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD JUL 15
PY 2004
VL 275
IS 2
BP 577
EP 583
DI 10.1016/j.jcis.2004.02.087
PG 7
WC Chemistry, Physical
SC Chemistry
GA 829QN
UT WOS:000222064800031
PM 15178289
DA 2018-10-19
ER

PT J
AU Raman, VI
   Palmese, GR
AF Raman, VI
   Palmese, GR
TI Design and characterization of nanoporous polymeric materials via
   reactive encapsulation of a chemically inert solvent
SO COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS
LA English
DT Article; Proceedings Paper
CT 3rd International TRI/Princeton Workshop on Characterization of Porous
   Materials - From Angstroms to Millimeters
CY JUN 23-25, 2003
CL Princeton, NJ
SP Quantachrome Corp
DE thermosetting; polymer; reactive encapsulation; porous; nanoporous
ID REVERSED-PHASE CHROMATOGRAPHY; HOLLOW-FIBER MEMBRANES; CARBON-DIOXIDE;
   TRANSPORT; ROD
AB Nanoporous polymeric materials are used as polyelectrolytes in fuel cells, separation membranes, sensors and actuators, templates for nanoparticle synthesis, and electroactive material in biomedical applications. Design of nanoporous polymeric materials for such applications entails controlling permeability by tailoring the pore size and pore chemistry. A novel method of synthesizing nanoporous polymeric materials is employed in this work. This technique involves the synthesis of nanoporous polymeric materials by reactive encapsulation of an inert solvent using a step-growth cross-linking polymerization reaction carried out until completion without micro/macroscopic phase separation. Key structural features of the porous materials synthesized in this way were investigated by scanning electron microscopy (SEM) after extraction and supercritical drying using carbon dioxide. Micrographs of the materials synthesized using the reactive encapsulation technique showed that materials with pore sizes less than 100 nm are obtained. Micrographs also showed that the reactive encapsulation technique can be employed to synthesize nanoporous polymeric materials of desired porosity and pore size by changing the solvent content. (C) 2004 Elsevier B.V. All rights reserved.
C1 Drexel Univ, Dept Chem Engn, Philadelphia, PA 19104 USA.
RP Palmese, GR (reprint author), Drexel Univ, Dept Chem Engn, Philadelphia, PA 19104 USA.
EM palmese@coe.drexel.edu
CR Chieng TH, 1996, LANGMUIR, V12, P319, DOI 10.1021/la950493z
   Chung YM, 2003, CATAL LETT, V85, P159, DOI 10.1023/A:1022181327349
   Drzal PL, 2000, POLYMER, V41, P4671, DOI 10.1016/S0032-3861(99)00652-7
   KIM JJ, 1994, J MEMBRANE SCI, V93, P209, DOI 10.1016/0376-7388(94)00070-0
   KIM JJ, 1995, J MEMBRANE SCI, V108, P25, DOI 10.1016/0376-7388(95)00148-7
   Krause B, 2002, DESALINATION, V144, P5, DOI 10.1016/S0011-9164(02)00280-1
   Liu Y, 2001, REACT FUNCT POLYM, V47, P201, DOI 10.1016/S1381-5148(01)00030-X
   Peled E, 2002, J POWER SOURCES, V106, P245, DOI 10.1016/S0378-7753(01)01028-X
   Piletsky SA, 1998, MACROMOLECULES, V31, P2137, DOI 10.1021/ma970818d
   QUAN H, 1999, J MEMBRANE SCI, V161, P287
   Raab M, 2001, J APPL POLYM SCI, V80, P214, DOI 10.1002/1097-4628(20010411)80:2<214::AID-APP1089>3.3.CO;2-H
   Saleh OA, 2003, NANO LETT, V3, P37, DOI 10.1021/nl0255202
   Su XC, 2002, SUPRAMOL CHEM, V14, P41, DOI 10.1080/10610270290006619
   Toimil-Molares ME, 2001, NUCL INSTRUM METH B, V185, P192, DOI 10.1016/S0168-583X(01)00755-8
   Unlusu B, 2001, J NON-CRYST SOLIDS, V279, P110, DOI 10.1016/S0022-3093(00)00398-7
   VANBOMMEL MJ, 1995, J NON-CRYST SOLIDS, V186, P78, DOI 10.1016/0022-3093(95)00072-0
   Wang HY, 1997, LANGMUIR, V13, P5396, DOI 10.1021/la970114x
   WANG QC, 1993, ANAL CHEM, V65, P2243, DOI 10.1021/ac00065a013
   WANG QC, 1994, J CHROMATOGR A, V669, P230, DOI 10.1016/0021-9673(94)80352-8
   Yoshikawa M, 1999, REACT FUNCT POLYM, V42, P93, DOI 10.1016/S1381-5148(98)00063-7
   Zhu XX, 1999, MACROMOLECULES, V32, P277, DOI 10.1021/ma980599b
NR 21
TC 15
Z9 15
U1 0
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7757
J9 COLLOID SURFACE A
JI Colloid Surf. A-Physicochem. Eng. Asp.
PD JUL 14
PY 2004
VL 241
IS 1-3
SI SI
BP 119
EP 125
DI 10.1016/j.colsurfa.2004.04.032
PG 7
WC Chemistry, Physical
SC Chemistry
GA 851VM
UT WOS:000223714100017
DA 2018-10-19
ER

PT J
AU Uchida, M
   Oyane, A
   Kim, HM
   Kokubo, T
   Ito, A
AF Uchida, M
   Oyane, A
   Kim, HM
   Kokubo, T
   Ito, A
TI Biomimetic coating of laminin-apatite composite on titanium metal and
   its excellent cell-adhesive properties
SO ADVANCED MATERIALS
LA English
DT Article
ID BODY ENVIRONMENT; FORMING ABILITY; PERI-IMPLANT; TI METAL; ATTACHMENT;
   EPITHELIUM
AB Titanium metal and its alloys are widely used as biomedical implant materials, since they exhibit good biocompatibility and superior mechanical properties.([1-3]) One important application of these metallic materials is in percutaneous implants, such as artificial tooth roots or skin terminals.([1]) Their bonding ability to epithelial tissue is not high enough, however, and the weak adhesion between an implant and its surrounding tissue leads to a deficient barrier against bacterial infection.([4-7]) For this reason, the development of titanium metal that has the ability to bond to epithelial tissue is strongly desired.
   Since teeth are natural skin-penetrating tissues, a tooth is believed to be a good model for an artificial percutaneous implant. Healthy natural teeth bond to their surrounding soft tissue through a strong adhesion to the epithelial cells that constitute the gingival epithelial tissue, and so prevent the invasion of bacteria.([4.5]) The biologically strong adhesion between a tooth and its surrounding epithelial tissue is attributed the cell-adhesive protein, laminin.([4]) Laminin is contained in the basement membranes and is believed to be a crucial molecule involved in the adhesion of epithelial cells to the surface of organ substrata, such as enamel.([8]) Therefore, it is expected that if laminin can be immobilized on the surface of titanium metal without any associated inactivation, then the surrounding epithelial tissue would strongly attach to the surface of the metal, analogous to natural teeth.
C1 Natl Inst Adv Ind Sci & Technol, Inst Human Sci & Biomed Engn, Tsukuba, Ibaraki 3050046, Japan.
   Natl Inst Adv Ind Sci & Technol, Res Ctr Macromol Technol, Koto Ku, Tokyo 1350064, Japan.
   Yonsei Univ, Sch Adv Mat Engn, Dept Ceram Engn, Seoul 120749, South Korea.
   Chubu Univ, Sci & Technol Res Inst, Kasugai, Aichi 4878501, Japan.
RP Uchida, M (reprint author), Natl Inst Adv Ind Sci & Technol, Inst Human Sci & Biomed Engn, 1-1-1 Higashi, Tsukuba, Ibaraki 3050046, Japan.
EM uchida-m@aist.go.jp
RI Ito, Atsuo/M-6785-2018; Uchida, Masaki/E-5416-2016
OI Ito, Atsuo/0000-0003-3318-040X; Uchida, Masaki/0000-0003-0710-8834
CR Brunette D. M., 2001, TITANIUM MED MAT SCI
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   El-Ghannam A, 1998, J BIOMED MATER RES, V41, P30, DOI 10.1002/(SICI)1097-4636(199807)41:1<30::AID-JBM4>3.0.CO;2-R
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Ikeda H, 2002, CLIN ORAL IMPLAN RES, V13, P243, DOI 10.1034/j.1600-0501.2002.130303.x
   Ikeda H, 2000, J PERIODONTOL, V71, P961, DOI 10.1902/jop.2000.71.6.961
   JANSEN JA, 1985, J DENT RES, V64, P891, DOI 10.1177/00220345850640060601
   Kim HM, 1997, J MATER SCI-MATER M, V8, P341, DOI 10.1023/A:1018524731409
   Kim HM, 1997, J CERAM SOC JPN, V105, P111, DOI 10.2109/jcersj.105.111
   Kim HM, 1996, J BIOMED MATER RES, V32, P409, DOI 10.1002/(SICI)1097-4636(199611)32:3<409::AID-JBM14>3.0.CO;2-B
   Kokubo T, 1998, ACTA MATER, V46, P2519, DOI 10.1016/S1359-6454(98)80036-0
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   MANN S, 1989, BIOMINERALIZATION CH
   MARTIN GR, 1987, ANNU REV CELL BIOL, V3, P57, DOI 10.1146/annurev.cb.03.110187.000421
   Shiraiwa M, 2002, J PERIODONTOL, V73, P852, DOI 10.1902/jop.2002.73.8.852
   Tamura RN, 1997, J PERIODONTAL RES, V32, P287, DOI 10.1111/j.1600-0765.1997.tb00536.x
   Uchida M, 2003, J BIOMED MATER RES A, V64A, P164, DOI 10.1002/jbm.a.10414
   WAKAMATU Y, 1991, NIHON U DENT J, V65, P1070
NR 18
TC 114
Z9 116
U1 4
U2 44
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 0935-9648
EI 1521-4095
J9 ADV MATER
JI Adv. Mater.
PD JUL 5
PY 2004
VL 16
IS 13
BP 1071
EP +
DI 10.1002/adma.200400152
PG 5
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 842KO
UT WOS:000223003200002
DA 2018-10-19
ER

PT J
AU Signori, F
   Solaro, R
   Lips, PAM
   Dijkstra, PJ
   Feijen, J
   Chiellini, E
AF Signori, F
   Solaro, R
   Lips, PAM
   Dijkstra, PJ
   Feijen, J
   Chiellini, E
TI Segmented multifunctional poly(ether ester) polymers containing
   H-bonding units. Preparation and characterization
SO MACROMOLECULAR CHEMISTRY AND PHYSICS
LA English
DT Article
DE biodegradable; multifunctional polymers; poly(ether-ester);
   polycondensation; structure-property relations
ID MULTIBLOCK COPOLYMERS; CONTROLLED-RELEASE; MATRICES; SYSTEMS
AB A series of poly(ether ester)s containing amide and carbarnate groups as H-bonding units and 13-50 mol-% of poly(ehtylene glycel) (PEG) segments were prepared by polycondensation in bulk using Ti(OBu)(4) as a catalyst. The copolymers were obtained starting from PEG/1,4-butanediol mixtures and a synthetic monomer carrying H-bonding groups. These polymers were designed for biomedical applications, where material biodegradability is required. The influence of the nature of the H-bonding units, the lenght of the polymethylene spacer between the H-bonding groups and the PEG content on the thermal and solubility properties of copolymers was investigated. Amide-containing copolymers were more thermally stable than those containing carbarnate groups. The PEG content also slightly affected the polymer thermal stability. The PEG content also slightly affected the presented multiple transitions, whose shape and peak temperature were strongly dependent on the PEG content. Polymer hydrophobicity, surface free energy and equilibrium swelling in phosphate buffer solution (PBS) at 37 degreesC were mainly influenced by the PEG content, whereas the nature of the H-bonding groups had little effect.
C1 Univ Pisa, Dept Chem & Ind Chem, INSTM, UdR, I-56126 Pisa, Italy.
   Univ Twente, Dept Chem Technol, NL-7500 AE Enschede, Netherlands.
RP Chiellini, E (reprint author), Univ Pisa, Dept Chem & Ind Chem, INSTM, UdR, Via Risorgimento 35, I-56126 Pisa, Italy.
EM emochie@dcci.unipi.it
RI Dijkstra, Pieter/N-9328-2013; Signori, Francesca/G-1937-2010
OI Signori, Francesca/0000-0002-9211-5352
CR Bezemer JM, 2000, J CONTROL RELEASE, V67, P249, DOI 10.1016/S0168-3659(00)00212-1
   Bezemer JM, 2000, J BIOMED MATER RES, V52, P8, DOI 10.1002/1097-4636(200010)52:1<8::AID-JBM2>3.0.CO;2-3
   Bizzarri R, 1999, J BIOACT COMPAT POL, V14, P504, DOI 10.1177/088391159901400605
   CHIELLINI E, 1995, J BIOMAT SCI-POLYM E, V7, P307
   Chiellini E, 2001, J BIOACT COMPAT POL, V16, P441, DOI 10.1106/6CFL-4E8A-L7XR-MUF7
   CHIELLINI E, 1992, J CONTROL RELEASE, V22, P273, DOI 10.1016/0168-3659(92)90102-W
   Deschamps AA, 2002, J BIOMAT SCI-POLYM E, V13, P1337, DOI 10.1163/15685620260449732
   Deschamps AA, 2002, J CONTROL RELEASE, V78, P175, DOI 10.1016/S0168-3659(01)00497-7
   FOWKES FM, 1964, IND ENG CHEM, V56, P40, DOI 10.1021/ie50660a008
   INTVELD PJA, 1992, MAKROMOL CHEM, V193, P1927
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   SEEBACH D, 1982, SYNTHESIS-STUTTGART, P138
   Signori F, 2003, MACROMOL CHEM PHYSIC, V204, P1971, DOI 10.1002/macp.200350057
   Solaro R, 2003, J MATER SCI-MATER M, V14, P705, DOI 10.1023/A:1024963700223
   Solaro R, 2003, MACROMOL CHEM PHYSIC, V204, P500, DOI 10.1002/macp.200390023
   Solaro R, 1997, J BIOACT COMPAT POL, V12, P27, DOI 10.1177/088391159701200103
   Stapert HR, 1999, MACROMOL CHEM PHYSIC, V200, P1921, DOI 10.1002/(SICI)1521-3935(19990801)200:8<1921::AID-MACP1921>3.0.CO;2-R
   STAPERT HR, 1998, Patent No. 1003459
   Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u
NR 19
TC 0
Z9 0
U1 1
U2 9
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1022-1352
J9 MACROMOL CHEM PHYSIC
JI Macromol. Chem. Phys.
PD JUL 5
PY 2004
VL 205
IS 10
BP 1299
EP 1308
DI 10.1002/macp.200400113
PG 10
WC Polymer Science
SC Polymer Science
GA 838RU
UT WOS:000222731600001
DA 2018-10-19
ER

PT J
AU Wang, HF
   Deng, XY
   Wang, J
   Gao, XF
   Xing, GM
   Shi, ZJ
   Gu, ZN
   Liu, YF
   Zhao, YL
AF Wang, HF
   Deng, XY
   Wang, J
   Gao, XF
   Xing, GM
   Shi, ZJ
   Gu, ZN
   Liu, YF
   Zhao, YL
TI XPS study of C-I covalent bond on single-walled carbon nanotubes (SWNTs)
SO ACTA PHYSICO-CHIMICA SINICA
LA English
DT Article
DE SWNTs; C-I covalent bond; X-ray photoelectron spectroscopy (XPS)
ID FLUORINATION
AB A simple method was used to synthesize the iodinated multi hydroxylated SWNTs (SWNTols) by the reaction of SWNTols with NaI in the presence of strong oxidant N-chloro-p-toluenesulfonamide. The formation of the C-I covalent bond was verified by comparing the electron binding energies of iodine of I-SWNTols and the reference materials, which were measured with the synchrotron radiation X-ray photoemission spectroscopy (SRXPS) as well as the conventional X-ray photoelectron spectroscopy (XPS). This result will be useful in applications of SWNTs in the biomedical and pharmaceutical sciences.
C1 Peking Univ, Coll Chem & Mol Engn, Beijing 100871, Peoples R China.
   Chinese Acad Sci, Inst High Energy Phys, Beijing 100039, Peoples R China.
RP Liu, YF (reprint author), Peking Univ, Coll Chem & Mol Engn, Beijing 100871, Peoples R China.
EM yliu@pku.edu.cn
RI Wang, Haifang/I-2776-2014; Deng, Xiaoyong/A-5682-2012; Gao,
   Xingfa/E-5691-2010; Wang, Jing/D-8136-2012
OI Wang, Haifang/0000-0002-7660-2089; Deng, Xiaoyong/0000-0001-6967-7050;
   Gao, Xingfa/0000-0002-1636-6336; 
CR Boltalina OV, 2000, J FLUORINE CHEM, V101, P273, DOI 10.1016/S0022-1139(99)00170-0
   GAARENSTROOM SW, 1977, J CHEM PHYS, V67, P3500, DOI 10.1063/1.435347
   HUSSAIN AA, 1995, ANAL BIOCHEM, V224, P221, DOI 10.1006/abio.1995.1033
   Khabashesku VN, 2002, ACCOUNTS CHEM RES, V35, P1087, DOI 10.1021/ar020146y
   MORGAN WE, 1973, J AM CHEM SOC, V95, P751, DOI 10.1021/ja00784a018
   Nakajima T, 1996, EUR J SOL STATE INOR, V33, P831
   Pan HL, 2003, NANO LETT, V3, P29, DOI 10.1021/nl025856b
   Sheng WW, 2003, NANOTECHNOLOGY, V14, P1203
   Shi ZJ, 1999, SOLID STATE COMMUN, V112, P35, DOI 10.1016/S0038-1098(99)00278-1
   Terrones M, 2003, ANNU REV MATER RES, V33, P419, DOI 10.1146/annurev.matsci.33.012802.100255
   VENKATESWARAN UD, 2002, PHYS REV B, V65
   Williams KA, 2002, NATURE, V420, P761, DOI 10.1038/420761a
   Zhou WY, 2002, APPL PHYS LETT, V80, P2553, DOI 10.1063/1.1468269
NR 13
TC 18
Z9 21
U1 2
U2 17
PU PEKING UNIV PRESS
PI BEIJING
PA PEKING UNIV, CHEMISTRY BUILDING, BEIJING 100871, PEOPLES R CHINA
SN 1000-6818
J9 ACTA PHYS-CHIM SIN
JI Acta Phys.-Chim. Sin.
PD JUL
PY 2004
VL 20
IS 7
BP 673
EP 675
DI 10.3866/PKU.WHXB20040701
PG 3
WC Chemistry, Physical
SC Chemistry
GA 839OM
UT WOS:000222794400001
DA 2018-10-19
ER

PT J
AU Preoteasa, EA
   Georgescu, R
   Ciortea, C
   Fluerasu, D
   Harangus, L
   Iordan, A
   Severcan, F
   Boyar, H
   Preoteasa, E
   Piticu, I
   Pantelica, D
   Gheordunescu, V
AF Preoteasa, EA
   Georgescu, R
   Ciortea, C
   Fluerasu, D
   Harangus, L
   Iordan, A
   Severcan, F
   Boyar, H
   Preoteasa, E
   Piticu, I
   Pantelica, D
   Gheordunescu, V
TI Standardless PIXE analysis of thick biomineral structures
SO ANALYTICAL AND BIOANALYTICAL CHEMISTRY
LA English
DT Article; Proceedings Paper
CT 3rd International Conference on Instrumental Methods of Analysis
CY SEP 23-27, 2003
CL Thessaloniki, GREECE
DE PIXE; trace elements; biomaterials; dental enamel; bone; multivariate
   statistics
ID X-RAY-EMISSION; TRACE-ELEMENTS; NUCLEAR MICROPROBE; ARTIFICIAL MOUTH;
   SECONDARY CARIES; TARGET PIXE; IN-VITRO; ENAMEL; BONE; TISSUES
AB The particle-induced X-ray emission (PIXE) of thick biomineral targets provides pertinent surface analysis, but if good reference materials are missing then complementary approaches are required to handle the matrix effects. This is illustrated by our results from qualitative and semiquantitative analysis of biornaterials and calcified tissues in which PIXE usually detected up to 20 elements with Z > 14 per sample, many at trace levels. Relative concentrations allow the classification of dental composites according to the mean Z and by multivariate statistics. In femur bones from streptozotocin-induced diabetic rats, trace element changes showed high individual variability but correlated to each other, and multivariate statistics improved discrimination of abnormal pathology. Changes on the in vitro demineralization of dental enamel suggested that a dissolution of Ca compounds in the outermost layer results in the uncovering of deeper layers containing higher trace element levels. Thus, in spite of significant limitations, standardless PIXE analysis of thick biomineral samples together with proper additional procedures can provide relevant information in biomedical research.
C1 Horia Hulubei Natl Inst Phys & Nucl Engn, Bucharest 76900, Romania.
   Middle E Tech Univ, Fac Sci, Dept Biol, TR-06531 Ankara, Turkey.
   Helident Dent Surg Ltd, Campina 2150, Romania.
   Inst Biochem, Bucharest 77700, Romania.
RP Preoteasa, EA (reprint author), Horia Hulubei Natl Inst Phys & Nucl Engn, POB MG-6, Bucharest 76900, Romania.
EM eugpre@ifin.nipne.ro
RI Neagu, Livia/E-8818-2011
OI Severcan, Feride/0000-0002-1717-2517
CR AHLBERG M, 1976, INT J APPL RADIAT IS, V27, P279, DOI 10.1016/0020-708X(76)90145-9
   Allolio B, 1996, Z Arztl Fortbild (Jena), V90, P19
   Andersen H. H, 1977, HYDROGEN STOPPING PO
   ANDERSON TW, 1984, INTRO MULTIVARIATE S
   Andrade E, 1998, NUCL INSTRUM METH B, V136, P908, DOI 10.1016/S0168-583X(97)00892-6
   ANTILLA A, 1986, ARCH ORAL BIOL, V31, P723
   Arai N, 1999, NUCL INSTRUM METH B, V150, P267, DOI 10.1016/S0168-583X(98)00952-5
   BADER A, 2003, INT J ARTIF ORGANS, V26, P840
   Barbotteau Y, 2004, NUCL INSTRUM METH B, V215, P214, DOI 10.1016/S0168-583X(03)01785-3
   Barbour J. C., 1995, HDB MODERN ION BEAM
   BAUMAN S, 1984, NUCL INSTRUM METH B, V3, P203, DOI 10.1016/0168-583X(84)90363-X
   BAVINGTON PR, 1969, DATA REDUCTION ERROR
   BISWAS SK, 1984, NUCL INSTRUM METH B, P337
   Boyar H, 2003, SPECTROSC-INT J, V17, P627, DOI 10.1155/2003/826545
   BRAZDES L, 2000, OSTEOPOROSIS S3, V11, pP102
   Brazdes L, 1999, ROM J PHYS, V44, P149
   BURTSCHER P, 2003, COMMUNICATION
   CALASTRINI F, 1998, NUCL INSTRUM METH B, V137, P975
   CAMPBELL JL, 1993, NUCL INSTRUM METH B, V77, P95, DOI 10.1016/0168-583X(93)95530-I
   CAMPBELL JL, 1984, NUCL INSTRUM METH B, V3, P185, DOI 10.1016/0168-583X(84)90361-6
   CAMUSSI A, 1986, METODISTAISTICI SPER
   CARUSO E, 1986, PHYS ENV BIOMEDICAL
   Carvalho ML, 1998, NUCL INSTRUM METH B, V136, P913, DOI 10.1016/S0168-583X(97)00760-X
   Chaudhri MA, 1995, NUTRITION, V11, P538
   CHOLEWA M, 1987, NUCL INSTRUM METH B, V22, P423, DOI 10.1016/0168-583X(87)90370-3
   CLAYTON E, 1985, ANAL CHEM, V57, P1075, DOI 10.1021/ac00283a025
   CLAYTON E, 1987, NUCL INSTRUM METH B, V22, P145, DOI 10.1016/0168-583X(87)90312-0
   COHEN DD, 1987, NUCL INSTRUM METH B, V22, P59, DOI 10.1016/0168-583X(87)90294-1
   Cohen DD, 2002, NUCL INSTRUM METH B, V189, P81, DOI 10.1016/S0168-583X(01)01011-4
   COHEN DD, 1985, ATOM DATA NUCL DATA, V33, P255, DOI 10.1016/0092-640X(85)90004-X
   Craig RG, 1997, RESTORATIVE DENT MAT
   Dahl JE, 1999, SCAND J WORK ENV HEA, V25, P285, DOI 10.5271/sjweh.436
   Ekmekcioglu C, 2001, NAHRUNG, V45, P309, DOI 10.1002/1521-3803(20011001)45:5<309::AID-FOOD309>3.0.CO;2-0
   Finet B, 2000, MATER LETT, V43, P159, DOI 10.1016/S0167-577X(99)00251-7
   Fontana M, 1999, AM J DENT, V12, pS8
   GARTEN RPH, 1984, TRAC-TREND ANAL CHEM, V3, P152, DOI 10.1016/0165-9936(84)88009-7
   Georgescu R., 1998, P S BALK PHYS LETT, V5, P1757
   Gomez S, 1999, BONE, V25, P33, DOI 10.1016/S8756-3282(99)00102-7
   Heintze SD, 1999, AM J DENT, V12, pS4
   HIRVONEN JP, 1995, HDB MODERN ION BEAM
   Jankuhn S, 2000, NUCL INSTRUM METH B, V161, P894, DOI 10.1016/S0168-583X(99)00954-4
   Johansson S A E, 1995, CHEM ANAL, V133
   Johansson S. A. E., 1988, PIXE NOVEL TECHNIQUE
   JOHANSSON SAE, 1976, NUCL INSTRUM METHODS, V137, P473, DOI 10.1016/0029-554X(76)90470-5
   Johnson R. A, 1988, APPL MULTIVARIATE ST
   KAJFOSZ J, 1984, NUCL INSTRUM METH B, V3, P147, DOI 10.1016/0168-583X(84)90352-5
   KAUFMANN HC, 1984, NUCL INSTRUM METH B, V3, P198, DOI 10.1016/0168-583X(84)90362-8
   Knott L, 1998, BONE, V22, P181, DOI 10.1016/S8756-3282(97)00279-2
   KRAUSE MO, 1979, J PHYS CHEM REF DATA, V8, P307, DOI 10.1063/1.555594
   Kruse-Jarres J D, 1987, J Trace Elem Electrolytes Health Dis, V1, P5
   Lane DW, 1996, NUCL INSTRUM METH B, V118, P392, DOI 10.1016/0168-583X(95)01181-1
   LAZZARI E, 1976, DENT BIOCH
   Leavitt J. A., 1995, HDB MODERN ION BEAM
   LINDH U, 1980, J RADIOANAL CHEM, V59, P167, DOI 10.1007/BF02516846
   MAXWELL JA, 1995, NUCL INSTRUM METH B, V95, P407, DOI 10.1016/0168-583X(94)00540-0
   MORENO EC, 1974, J DENT RES, V53, P226, DOI 10.1177/00220345740530020901
   MORO R, 1986, PHYS ENV BIOM RES
   Morohashi T, 2002, ARCH ORAL BIOL, V47, P499, DOI 10.1016/S0003-9969(02)00016-X
   NENITESCU CD, 1984, GEN CHEM
   Nie HL, 1999, BIOL TRACE ELEM RES, V71-2, P623, DOI 10.1007/BF02784252
   ORLIC I, 1990, NUCL INSTRUM METH B, V49, P166, DOI 10.1016/0168-583X(90)90236-N
   OSTROWSKI K, 1974, ANN NY ACAD SCI, V238, P186, DOI 10.1111/j.1749-6632.1974.tb26788.x
   PETRASCU M, 1984, NUCL INSTRUM METH B, V4, P396, DOI 10.1016/0168-583X(84)90585-8
   POPESCU A, 1981, SPECIAL BIOCH DENT
   POPESCU A, 1980, MED BIOCH
   Potocek V, 1996, NUCL INSTRUM METH B, V109, P197, DOI 10.1016/0168-583X(95)00905-1
   Prasad AS, 1988, ESSENTIAL TOXIC TRAC
   Preoteasa E. A., 2003, International Journal of Artificial Organs, V26, P840
   PREOTEASA EA, 1991, J RADIOAN NUCL CH AR, V151, P261, DOI 10.1007/BF02035484
   Preoteasa EA, 2002, NUCL INSTRUM METH B, V189, P426, DOI 10.1016/S0168-583X(01)01119-3
   PREOTEASA EA, 2003, IN PRESS ANN U BUCHA
   PREOTEASA EA, 2003, P 3 INT C INSTR METH, P417
   PREOTEASA EA, 2003, IN PRESS P INT C APP
   PREOTEASA EA, 2003, 33 C SPECTR 7 12 SEP, P718
   PREOTEASA EA, 2003, P 3 INT C INSTR METH, P413
   PREOTEASA EA, 2003, 33 C SPECTR 7 12 SEP, P566
   Prozesky VM, 2000, NUCL INSTRUM METH B, V161, P852, DOI 10.1016/S0168-583X(99)00895-2
   Randall LE, 2002, CONNECT TISSUE RES, V43, P205, DOI 10.1080/03008200290000538
   Reiche I, 1999, NUCL INSTRUM METH B, V150, P656, DOI 10.1016/S0168-583X(98)00949-5
   Reinert T, 1998, NUCL INSTRUM METH B, V136, P936, DOI 10.1016/S0168-583X(97)00784-2
   RESPALDIZA MA, 1987, NUCL INSTRUM METH B, V22, P446, DOI 10.1016/0168-583X(87)90376-4
   ROGERS PSZ, 1987, NUCL INSTRUM METH B, V22, P133, DOI 10.1016/0168-583X(87)90310-7
   ROKITA E, 1994, INT J PIXE, V4, P37
   Ryan CG, 2001, NUCL INSTRUM METH B, V181, P170, DOI 10.1016/S0168-583X(01)00374-3
   Salem S. I., 1974, Atomic Data and Nuclear Data Tables, V14, P91, DOI 10.1016/S0092-640X(74)80017-3
   Schiffner U, 1999, AM J DENT, V12, pS10
   SEIGEL RC, 1979, INT REV CONNECT TISS, V8, P73
   Siegel R C, 1979, Int Rev Connect Tissue Res, V8, P73
   Simmer JP, 2002, CONNECT TISSUE RES, V43, P441, DOI 10.1080/03008200290001159
   Sletten GBG, 1999, ACTA ODONTOL SCAND, V57, P316, DOI 10.1080/000163599428544
   SOMMER F, 1987, NUCL INSTRUM METH B, V22, P128, DOI 10.1016/0168-583X(87)90309-0
   SVALBE ID, 1984, NUCL INSTRUM METH B, V3, P651, DOI 10.1016/0168-583X(84)90456-7
   SVALBE ID, 1984, NUCL INSTRUM METH B, V3, P648, DOI 10.1016/0168-583X(84)90455-5
   TALREGA R, 1994, DAMAGE MECH COMPOSIT
   THELLIER M, 1993, METHOD ENZYMOL, V227, P535, DOI 10.1016/0076-6879(93)27023-A
   TORRISI L, 1986, PHYS ENV BIOMEDICAL
   VALKOVIC V, 1980, ANAL BIOL MAT TRACE
   Veigele Wm. J., 1973, Atomic Data, V5, P51, DOI 10.1016/S0092-640X(73)80015-4
   *VIV SCHAAN, 1999, TETR CER PROD INF
   VIZKELETHY G, 1995, HDB MODERN ION BEAM
   Warren MW, 2002, FORENSIC SCI INT, V125, P37, DOI 10.1016/S0379-0738(01)00614-4
   WOITTIEZ JRW, 1980, J RADIOANAL CHEM, V59, P213, DOI 10.1007/BF02516849
   Woltgens J H, 1991, J Biol Buccale, V19, P125
   WOOLSON RF, 1987, STAT METHODS ANAL BI
   YAMADA G, 1988, BIOL TRACE ELEM RES, V62, P75
   Ynsa MD, 2002, NUCL INSTRUM METH B, V189, P431, DOI 10.1016/S0168-583X(01)01120-X
   Ytrehus B, 1999, J WILDLIFE DIS, V35, P204, DOI 10.7589/0090-3558-35.2.204
   Zaichick V, 1999, APPL RADIAT ISOTOPES, V50, P283, DOI 10.1016/S0969-8043(97)10150-6
   Zhang YX, 2002, BIOL TRACE ELEM RES, V86, P65, DOI 10.1385/BTER:86:1:65
   Zipkin I., 1973, BIOL MINERALIZATION
NR 110
TC 14
Z9 14
U1 0
U2 7
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1618-2642
J9 ANAL BIOANAL CHEM
JI Anal. Bioanal. Chem.
PD JUL
PY 2004
VL 379
IS 5-6
BP 825
EP 841
DI 10.1007/s00216-004-2656-4
PG 17
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 848NK
UT WOS:000223474200015
PM 15179536
DA 2018-10-19
ER

PT J
AU Lavik, E
   Langer, R
AF Lavik, E
   Langer, R
TI Tissue engineering: current state and perspectives
SO APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
LA English
DT Review
ID NEURAL STEM-CELLS; GROWTH-FACTOR DELIVERY; RAT SPINAL-CORD; IN-VIVO;
   DRUG-DELIVERY; BIODEGRADABLE POLYMER; BIOMEDICAL APPLICATIONS;
   MECHANICAL-PROPERTIES; FUNCTIONAL-PROPERTIES; SURFACE MODIFICATION
AB Tissue engineering is an interdisciplinary field that involves cell biology, materials science, reactor engineering, and clinical research with the goal of creating new tissues and organs. Significant advances in tissue engineering have been made through improving singular aspects within the overall approach, e.g., materials design, reactor design, or cell source. Increasingly, however, advances are being made by combining several areas to create environments which promote the development of new tissues whose properties more closely match their native counterparts. This approach does not seek to reproduce all the complexities involved in development, but rather seeks to promote an environment which permits the native capacity of cells to integrate, differentiate, and develop new tissues. Progenitors and stem cells will play a critical role in understanding and developing new engineered tissues as part of this approach.
C1 Yale Univ, New Haven, CT 06520 USA.
   MIT, Cambridge, MA 02139 USA.
RP Lavik, E (reprint author), Yale Univ, POB 208284, New Haven, CT 06520 USA.
EM erin.lavik@yale.edu
CR Alison MR, 2002, J PATHOL, V197, P417, DOI 10.1002/path.1188
   Anseth KS, 2002, J CONTROL RELEASE, V78, P199, DOI 10.1016/S0168-3659(01)00500-4
   Arevalo-Silva CA, 2000, ARCH OTOLARYNGOL, V126, P1448, DOI 10.1001/archotol.126.12.1448
   Atala A, 2000, WORLD J UROL, V18, P364, DOI 10.1007/s003450000152
   Babensee JE, 2000, PHARMACEUT RES, V17, P497, DOI 10.1023/A:1007502828372
   Bancroft GN, 2002, P NATL ACAD SCI USA, V99, P12600, DOI 10.1073/pnas.202296599
   Banerjee P, 2000, J BIOMED MATER RES, V50, P331, DOI 10.1002/(SICI)1097-4636(20000605)50:3<331::AID-JBM6>3.3.CO;2-K
   BARRERA DA, 1995, MACROMOLECULES, V28, P425, DOI 10.1021/ma00106a004
   BELLAMKONDA R, 1995, J NEUROSCI RES, V41, P501, DOI 10.1002/jnr.490410409
   Benoit JP, 2000, J CONTROL RELEASE, V65, P285, DOI 10.1016/S0168-3659(99)00250-3
   Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534
   Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32
   Burdick JA, 2002, J CONTROL RELEASE, V83, P53, DOI 10.1016/S0168-3659(02)00181-5
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Carrier RL, 1999, BIOTECHNOL BIOENG, V64, P580, DOI 10.1002/(SICI)1097-0290(19990905)64:5<580::AID-BIT8>3.0.CO;2-X
   Chen GP, 2002, MACROMOL BIOSCI, V2, P67, DOI 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F
   Chen XY, 2003, POLYM J, V35, P148, DOI 10.1295/polymj.35.148
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   Dang WB, 1996, J CONTROL RELEASE, V42, P83, DOI 10.1016/0168-3659(96)01371-5
   Dang WB, 1996, PHARMACEUT RES, V13, P683, DOI 10.1023/A:1016035229961
   Dar A, 2002, BIOTECHNOL BIOENG, V80, P305, DOI 10.1002/bit.10372
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Elisseeff J, 1999, P NATL ACAD SCI USA, V96, P3104, DOI 10.1073/pnas.96.6.3104
   Elisseeff J, 2001, J ORTHOPAED RES, V19, P1098, DOI 10.1016/S0736-0266(01)00054-7
   Ellis DL, 1996, BIOMATERIALS, V17, P291, DOI 10.1016/0142-9612(96)85567-0
   Fournier E, 2003, BIOMATERIALS, V24, P3311, DOI 10.1016/S0142-9612(03)00161-3
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Freyman TM, 2001, BIOMATERIALS, V22, P2883, DOI 10.1016/S0142-9612(01)00034-5
   Fromstein JD, 2002, J BIOMAT SCI-POLYM E, V13, P391, DOI 10.1163/156856202320253929
   Fu K, 2003, J PHARM SCI, V92, P1582, DOI 10.1002/jps.10414
   Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433
   Gao JZ, 2001, TISSUE ENG, V7, P363, DOI 10.1089/10763270152436427
   Garellick G, 1999, J ARTHROPLASTY, V14, P407, DOI 10.1016/S0883-5403(99)90095-5
   Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797
   Guest JD, 1997, EXP NEUROL, V148, P502, DOI 10.1006/exnr.1997.6693
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hile DD, 2000, J CONTROL RELEASE, V66, P177, DOI 10.1016/S0168-3659(99)00268-0
   Hori Y, 2002, J SURG RES, V102, P156, DOI 10.1006/jsre.2001.6294
   HRKACH JS, 1995, MACROMOLECULES, V28, P4736, DOI 10.1021/ma00117a055
   Hrkach JS, 1996, ACS SYM SER, V627, P93
   Hunkeler D, 1997, TRENDS POLYM SCI, V5, P286
   HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9
   Ingber DE, 2002, CIRC RES, V91, P877, DOI 10.1161/01.RES.0000039537.73816.E5
   Jackson KA, 2002, J CELL BIOCHEM, P1, DOI 10.1002/jcb.10045
   Kaigler D, 2003, TISSUE ENG, V9, P95, DOI 10.1089/107632703762687573
   Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131
   Kipper MJ, 2002, BIOMATERIALS, V23, P4405, DOI 10.1016/S0142-9612(02)00181-3
   Kwon KW, 2002, POLYMER, V43, P3353, DOI 10.1016/S0032-3861(02)00155-6
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Langer R, 1998, NATURE, V392, P5
   Lavik EB, 2001, J BIOMED MATER RES, V58, P291, DOI 10.1002/1097-4636(2001)58:3<291::AID-JBM1019>3.0.CO;2-N
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Levenberg S, 2002, P NATL ACAD SCI USA, V99, P4391, DOI 10.1073/pnas.032074999
   LEWIS DD, 1990, BIODEGRADABLE POLYM
   Liu S, 1997, J NEUROSCI RES, V49, P425, DOI 10.1002/(SICI)1097-4547(19970815)49:4<425::AID-JNR4>3.0.CO;2-A
   Liu VA, 2002, BIOMED MICRODEVICES, V4, P257, DOI 10.1023/A:1020932105236
   Liu YC, 2002, TISSUE ENG, V8, P709, DOI 10.1089/107632702760240616
   Lu B, 2002, BRAIN RES, V943, P292, DOI 10.1016/S0006-8993(02)02906-2
   Mahoney MJ, 2001, NAT BIOTECHNOL, V19, P934, DOI 10.1038/nbt1001-934
   Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5
   Mann BK, 2002, J BIOMED MATER RES, V60, P86, DOI 10.1002/jbm.10042
   Marijnissen WJCM, 2002, BIOMATERIALS, V23, P1511, DOI 10.1016/S0142-9612(01)00281-2
   Martin DP, 2003, BIOCHEM ENG J, V16, P97, DOI 10.1016/S1369-703X(03)00040-8
   Matsumura G, 2003, BIOMATERIALS, V24, P2303, DOI 10.1016/S0142-9612(03)00043-7
   Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779
   MIKOS AG, 1993, BIOTECHNOL BIOENG, V42, P716, DOI 10.1002/bit.260420606
   MIKOS AG, 1993, BIOMATERIALS, V14, P323, DOI 10.1016/0142-9612(93)90049-8
   MIKOS AG, 1994, BIOMATERIALS, V15, P55, DOI 10.1016/0142-9612(94)90197-X
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   MOONEY DJ, 1994, CELL TRANSPLANT, V3, P203, DOI 10.1177/096368979400300209
   Morra M, 1999, LANGMUIR, V15, P4658, DOI 10.1021/la981345m
   Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8
   Murayama A, 2002, J NEUROSCI RES, V69, P837, DOI 10.1002/jnr.10339
   Murphy WL, 2000, BIOMATERIALS, V21, P2521, DOI 10.1016/S0142-9612(00)00120-4
   Nam YS, 1999, J MICROENCAPSUL, V16, P625
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   Nicolau DV, 1999, BIOSENS BIOELECTRON, V14, P317, DOI 10.1016/S0956-5663(98)00133-X
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Nof M, 2002, J BIOMED MATER RES, V59, P349, DOI 10.1002/jbm.1251
   O'Connell P, 2002, XENOTRANSPLANTATION, V9, P367, DOI 10.1034/j.1399-3089.2002.02056_1.x
   O'Connor SM, 2000, J NEUROSCI METH, V102, P187, DOI 10.1016/S0165-0270(00)00303-4
   Peppas NA, 1999, J CONTROL RELEASE, V62, P81, DOI 10.1016/S0168-3659(99)00027-9
   Plant GW, 1997, EXP NEUROL, V143, P287, DOI 10.1006/exnr.1997.6407
   Pomahac B, 1998, CRIT REV ORAL BIOL M, V9, P333, DOI 10.1177/10454411980090030601
   Ponticiello MS, 2000, J BIOMED MATER RES, V52, P246, DOI 10.1002/1097-4636(200011)52:2<246::AID-JBM2>3.0.CO;2-W
   PORT F, 2002, OPTN SRTS ANN REPORT
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Rodriguez A, 1999, PLAST RECONSTR SURG, V103, P1111, DOI 10.1097/00006534-199904040-00001
   Rosen VB, 2002, BIOMATERIALS, V23, P921
   Ruiz L, 1999, J BIOMAT SCI-POLYM E, V10, P931, DOI 10.1163/156856299X00540
   Saim AB, 2000, LARYNGOSCOPE, V110, P1694, DOI 10.1097/00005537-200010000-00023
   Sakiyama-Elbert SE, 2001, ANN REV MATER RES, V31, P183, DOI 10.1146/annurev.matsci.31.1.183
   Saltzman WM, 2002, NAT REV DRUG DISCOV, V1, P177, DOI 10.1038/nrd744
   Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389
   Sayers RD, 1998, BRIT J SURG, V85, P934
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Schugens C, 1996, POLYMER, V37, P1027, DOI 10.1016/0032-3861(96)87287-9
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726
   Shastri VP, 2000, P NATL ACAD SCI USA, V97, P1970, DOI 10.1073/pnas.97.5.1970
   Shaw D, 2003, J CRANIOFAC SURG, V14, P308, DOI 10.1097/00001665-200305000-00008
   Shum-Tim D, 1999, ANN THORAC SURG, V68, P2298, DOI 10.1016/S0003-4975(99)01055-3
   Sieminski AL, 2002, TISSUE ENG, V8, P1057, DOI 10.1089/107632702320934155
   Sikavitsas VI, 2002, J BIOMED MATER RES, V62, P136, DOI 10.1002/jbm.10150
   Simon P, 2003, EUR J CARDIO-THORAC, V23, P1002, DOI 10.1016/S1010-7940(03)00094-0
   Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435
   Sodian R, 2002, TISSUE ENG, V8, P863, DOI 10.1089/10763270260424222
   Sodian R, 2000, TISSUE ENG, V6, P183, DOI 10.1089/107632700320793
   Solter D, 1999, SCIENCE, V283, P1468, DOI 10.1126/science.283.5407.1468
   Stammen JA, 2001, BIOMATERIALS, V22, P799, DOI 10.1016/S0142-9612(00)00242-8
   STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   Thomas PA, 1997, J CONTROL RELEASE, V43, P273, DOI 10.1016/S0168-3659(96)01497-6
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Tong YW, 2001, BIOMATERIALS, V22, P1029, DOI 10.1016/S0142-9612(00)00338-0
   Vacanti JP, 1999, LANCET, V354, pSI32
   Vacanti MP, 2001, TRANSPLANT P, V33, P592, DOI 10.1016/S0041-1345(00)02158-8
   Vert M, 1998, J CONTROL RELEASE, V53, P85, DOI 10.1016/S0168-3659(97)00240-X
   Wang YD, 2003, J BIOMED MATER RES A, V66A, P192, DOI 10.1002/jbm.a.10534
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Watson MS, 2002, ADV MATER, V14, P1802, DOI 10.1002/adma.200290003
   Weber M, 2002, BIOMATERIALS, V23, P2003, DOI 10.1016/S0142-9612(01)00329-5
   WEISSMAN I, 1997, STEM CELLS LESSONS H
   Whitaker MJ, 2001, J PHARM PHARMACOL, V53, P1427, DOI 10.1211/0022357011777963
   Xu XM, 1999, EUR J NEUROSCI, V11, P1723, DOI 10.1046/j.1460-9568.1999.00591.x
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729
   Zhao K, 2003, BIOMATERIALS, V24, P1041, DOI 10.1016/S0142-9612(02)00426-X
NR 129
TC 205
Z9 232
U1 3
U2 40
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0175-7598
EI 1432-0614
J9 APPL MICROBIOL BIOT
JI Appl. Microbiol. Biotechnol.
PD JUL
PY 2004
VL 65
IS 1
BP 1
EP 8
DI 10.1007/s00253-004-1580-z
PG 8
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 831UM
UT WOS:000222221800001
PM 15221227
DA 2018-10-19
ER

PT J
AU Puskas, JE
   Chen, YH
AF Puskas, JE
   Chen, YH
TI Biomedical application of commercial polymers and novel
   polyisobutylene-based thermoplastic elastomers for soft tissue
   replacement
SO BIOMACROMOLECULES
LA English
DT Article; Proceedings Paper
CT 160th Meeting of the Rubber Division of the American-Chemical-Society
CY APR 28-30, 2003
CL San Francisco, CA
SP Amer Chem Soc
ID SILICONE BREAST IMPLANTS; POLYURETHANE-COATED PROSTHESES; BIOPROSTHETIC
   HEART-VALVES; VASCULAR GRAFTS; BLOCK-COPOLYMERS; CARBOCATIONIC
   POLYMERIZATION; MECHANICAL ANALYSIS; CORONARY-ARTERIES; MEME IMPLANT;
   VEIN GRAFTS
AB Novel polyisobutylene-based thermoplastic elastomers are introduced as prospective implant materials for soft tissue replacement and reconstruction. In comparison, poly(ethylene terephthalate) (PET), poly(tetrafluoroethylene) (PTFE), polypropylene (PP), polyurethanes (PU), and silicones are outlined from well-established implant history as being relatively inert and biocompatible biomaterials for soft tissue replacement, especially in vascular grafts and breast implants. Some general considerations for the design and development of polymers for soft tissue replacement are reviewed from the viewpoint of material science and engineenng, with special attention to synthetic materials used in vascular grafts and breast implants.
C1 Univ Western Ontario, Dept Chem & Biochem Engn, London, ON N6A 5B9, Canada.
RP Puskas, JE (reprint author), Univ Western Ontario, Dept Chem & Biochem Engn, London, ON N6A 5B9, Canada.
CR Allison AC, 1996, CURR TOP MICROBIOL, V210, P147
   AMIN P, 1993, J BIOMED MATER RES, V27, P655, DOI 10.1002/jbm.820270513
   [Anonymous], 2001, U.S. Patent, Patent No. [6,197,240, 6197240]
   ASAKURA T, 1990, CIRC RES, V66, P1045, DOI 10.1161/01.RES.66.4.1045
   AUTIAN J, 1961, Am J Hosp Pharm, V18, P329
   BAKKER D, 1990, J BIOMED MATER RES, V24, P489, DOI 10.1002/jbm.820240407
   Batich C, 1996, CURR TOP MICROBIOL, V210, P13
   BATICH C, 1992, J LONG-TERM EFF MED, V1, P255
   Black J., 1998, HDB BIOMATERIALS PRO
   BORETOS JW, 1973, CONCISE GUIDE BIOMED
   BOWLIN GL, 2000, BIOMATERIALS ENG DEV, V1, P85
   Brandon HJ, 2001, PLAST RECONSTR SURG, V108, P647, DOI 10.1097/00006534-200109010-00008
   Braybrook J.H., 1997, BIOCOMPATIBILITY ASS
   BRODY GS, 1984, PLAST RECONSTR SURG, V73, P420
   Bronzino J.D, 2000, BIOMEDICAL ENG HDB, V1
   Brown SL, 1997, LANCET, V350, P1531, DOI 10.1016/S0140-6736(97)03164-4
   BRUCK SD, 1985, INT J ARTIF ORGANS, V8, P65
   BURTON AC, 1965, PHYSL BIOPHYSICS CIR, P76
   Cadieux P., 2002, J COLL SURF B, V28, P95
   CAEUANA CM, 1999, CHEM ENG PROG
   CALRSON SJ, 1993, SILOXANE POLYM
   Chinn JA, 1998, J BIOMED MATER RES, V39, P130, DOI 10.1002/(SICI)1097-4636(19980101)39:1<130::AID-JBM15>3.0.CO;2-J
   CHRIST FR, 1992, J BIOMED MATER RES, V26, P607
   Cook RR, 1998, LANCET, V351, P520, DOI 10.1016/S0140-6736(05)78710-9
   Crawford DM, 2001, THERMOCHIM ACTA, V367, P125, DOI 10.1016/S0040-6031(00)00692-4
   Deacon J, 1985, P 11 ANN M SOC BIOM, P205
   Dumitriu S., 2002, POLYM BIOMATERIALS
   EDWARDS WS, 1978, ARCH SURG-CHICAGO, V113, P1225
   Elices M., 2000, STRUCTURAL BIOL MAT
   EYSSEN JE, 1984, PLAST RECONSTR SURG, V73, P415, DOI 10.1097/00006534-198403000-00013
   FELDMAN DS, 1995, ENCY HDB BIOMATERIAL, V1, P223
   FRANGOS JA, 1985, SCIENCE, V227, P1477, DOI 10.1126/science.3883488
   GLAGOV S, 1984, BLOOD VESSELS LYMPHA, pCH1
   Goldberg EP, 1997, PLAST RECONSTR SURG, V99, P258, DOI 10.1097/00006534-199701000-00050
   Goldberg EP, 1985, P 11 ANN M SOC BIOM, P208
   Greenwald DP, 1996, PLAST RECONSTR SURG, V98, P269, DOI 10.1097/00006534-199608000-00008
   Guidoin R, 1997, ASAIO J, V43, P69, DOI 10.1097/00002480-199701000-00013
   HAMLIN GW, 1978, BRIT J SURG, V65, P272, DOI 10.1002/bjs.1800650416
   Hardhammar PA, 1996, CIRCULATION, V93, P423, DOI 10.1161/01.CIR.93.3.423
   Harper CA, 2000, MODERN PLASTICS HDB
   HERGENROTHER RW, 1993, BIOMATERIALS, V14, P449, DOI 10.1016/0142-9612(93)90148-U
   HERGENROTHER RW, 1992, J APPL BIOMATER, V3, P17, DOI 10.1002/jab.770030104
   HERMAN S, 1984, PLAST RECONSTR SURG, V73, P411, DOI 10.1097/00006534-198403000-00012
   JO H, 1991, AM J PHYSIOL, V260, pH1992
   Jones D., 1988, ELASTOMERICS, V120, P12
   *KAN CORP, 2002, TECHN INF MSDS DAT S
   Kennedy J.P., 1990, U.S. Patent, Patent No. [4,946,899, 4946899]
   KENNEDY JP, 1993, MACROMOLECULES, V26, P567, DOI 10.1021/ma00056a002
   Kennedy JP, 2001, MACROMOL SYMP, V175, P127, DOI 10.1002/1521-3900(200110)175:1<127::AID-MASY127>3.0.CO;2-X
   KENNEDY JP, 2000, DESIGNED RUBBERY BIO, V2, P712
   KENNEDY JP, 1994, TAILORING POLYM BIOL, P24
   KIM HG, 1983, J COLLOID INTERF SCI, V157, P82
   KINLEY CE, 1980, J CARDIOVASC SURG, V21, P163
   KLIPADI DV, 2000, BIOMATERIALS ENG DEV, V1, P57
   KOSSOVSKY N, 1992, J APPL BIOMATER, V3, P239, DOI 10.1002/jab.770030313
   *KUR CO LTD TSUK R, 1997, TS POLYM DAT SHEET
   Kwon Y, 2002, POLYM PREPR, V43, P266
   Laemmel E, 1998, J BIOMED MATER RES, V39, P446, DOI 10.1002/(SICI)1097-4636(19980305)39:3<446::AID-JBM14>3.0.CO;2-8
   Lamba N. M. K., 1998, POLYURETHANES BIOMED
   Lane TH, 1996, CURR TOP MICROBIOL, V210, P3
   LEE H, 1971, HDB BIOMEDICAL PLAST, P6
   LEE JH, 1994, BIOMATERIALS, V15, P705, DOI 10.1016/0142-9612(94)90169-4
   LEE JH, 1994, J POLYM SCI POL CHEM, V32, P1569, DOI 10.1002/pola.1994.080320818
   LEVY RJ, 1985, SCIENCE, V228, P190, DOI 10.1126/science.3919445
   LIN HB, 1994, J BIOMED MATER RES, V28, P329, DOI 10.1002/jbm.820280307
   Lykissa ED, 1997, ANAL CHEM, V69, P4912, DOI 10.1021/ac970710w
   NOJIRI C, 1995, ARTIF ORGANS, V19, P32, DOI 10.1111/j.1525-1594.1995.tb02241.x
   NUTTELMAN CR, 2000, POLYM PREPR, V41, P1685
   OJHA M, 1994, CIRC RES, V74, P1227, DOI 10.1161/01.RES.74.6.1227
   OKADOME K, 1989, J CARDIOVASC SURG, V30, P932
   Pangman W.J., 1958, US Patent, Patent No. 2842775
   PANGMAN WJ, 1965, Patent No. 3189921
   Park JB, 1984, BIOMATERIALS SCI ENG
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   Peters W J, 1981, Ann Plast Surg, V6, P179, DOI 10.1097/00000637-198103000-00002
   Phillips JW, 1996, PLAST RECONSTR SURG, V97, P1215, DOI 10.1097/00006534-199605000-00017
   Pinchuk L, 1988, J Biomater Appl, V3, P260, DOI 10.1177/088532828800300206
   PINCHUK L, 1994, J BIOMAT SCI-POLYM E, V6, P225, DOI 10.1163/156856294X00347
   Pinchuk L., 1993, U. S. patent, Patent No. [5, 229 , 431 -A, 5229431]
   PINCHUK L, 1991, T 17 ANN M SOC BIOM, P98
   PINCHUK L, 1993, T 19 ANN M SOC BIOM, P22
   PINCHUK L, 1992, Patent No. 5144742
   PINCHUK L, 2001, POLYISOBUTYLENE BASE, P1452
   Pinchuk L, 1998, US Patent, Patent No. [5,741,331, 5741331, no 5,741331]
   Pinchuk L, 2000, US Patent, Patent No. [6,102,939, 6102939]
   Prowans P, 2002, BIOMATERIALS, V23, P2973, DOI 10.1016/S0142-9612(02)00026-1
   Puskas J.E., 2002, [No title captured], Patent No. [6,495,647, 6495647]
   Puskas J.E., 2001, U.S. Patent, Patent No. [2,268,446, 2268446]
   Puskas JE, 2003, POLYM ADVAN TECHNOL, V14, P763, DOI 10.1002/pat.392
   Puskas JE, 2001, MACROMOL MATER ENG, V286, P565, DOI 10.1002/1439-2054(20011001)286:10<565::AID-MAME565>3.0.CO;2-E
   Puskas JE, 2000, PROG POLYM SCI, V25, P403, DOI 10.1016/S0079-6700(00)00010-1
   PUSKAS JE, IN PRESS J POLYM SCI
   PUSKAS JE, 2002, NOVEL HIGHLY BRANCHE
   QIN Y, 1996, ASAIO J, pM702
   RATTNER BD, 1996, BIOMATERIALS SCI INT
   RHEE K, 1994, J BIOMECH, V27, P329, DOI 10.1016/0021-9290(94)90009-4
   RITTGERS SE, 1978, CIRC RES, V42, P792, DOI 10.1161/01.RES.42.6.792
   Rohrich RJ, 1996, PLAST RECONSTR SURG, V98, P553, DOI 10.1097/00006534-199609000-00032
   Salacinski HJ, 2001, J BIOMATER APPL, V15, P241, DOI 10.1106/NA5T-J57A-JTDD-FD04
   SCHOEN FJ, 1992, J THORAC CARDIOV SUR, V104, P1285
   Shadwick RE, 1998, AM SCI, V86, P535, DOI 10.1511/1998.43.798
   Song J, 2002, J POLYM SCI POL CHEM, V40, P1005, DOI 10.1002/pola.10193
   STOKES K, 1988, J BIOMATER APPL, V3, P284
   STOKES K, 1987, POLYURETHANES BIOMED, V2, P109
   STRANDNESS DE, 1975, HEMODUNAMICS SURG
   SZYCHER M, 1988, J BIOMATER APPL, V3, P383
   SZYCHER M, 1985, ASTM STP, V859, P308
   TAKAHARA A, 1991, J BIOMED MATER RES, V25, P342
   TOMALIA DA, 1990, ANGEW CHEM INT EDIT, V29, P138, DOI 10.1002/anie.199001381
   TOMIZAWA Y, 1995, ARTIF ORGANS, V19, P39, DOI 10.1111/j.1525-1594.1995.tb02242.x
   Toub MR, 1987, ELASTOMERICS, V119, P20
   Tse MF, 2000, POLYM ENG SCI, V40, P2182, DOI 10.1002/pen.11350
   Tseng DY, 1998, J BIOMED MATER RES, V42, P188, DOI 10.1002/(SICI)1097-4636(199811)42:2<188::AID-JBM4>3.0.CO;2-L
   vonRecum AF, 1999, HDB BIOMATERIALS EVA
   VOORHEES AB, 1952, ANN SURG, V135, P332, DOI 10.1097/00000658-195203000-00006
   WABERS HD, 1992, J BIOMAT SCI-POLYM E, V4, P107
   WALDEN R, 1980, ARCH SURG-CHICAGO, V115, P1166
   WHITE KA, 1985, P 11 ANN M SOC BIOMA, P57
   WILLIAMS DF, 1986, DEFINITIONS BIOMATER, P49
   WINTERMANTEL E, 2002, MEDIZINTESCHNIK BIOC, V3
   Wolf CJ, 2000, J BIOMAT SCI-POLYM E, V11, P1007, DOI 10.1163/156856200743544
   Wolf CJ, 1996, CURR TOP MICROBIOL, V210, P25
   YU J, 1994, INT J ARTIF ORGANS, V17, P499
   YU L, 1995, PLAST RECONSTR SURG, V97, P756
   Zdrahala RJ, 1996, J BIOMATER APPL, V11, P37, DOI 10.1177/088532829601100102
   Zhuang YJ, 1998, EUR J VASC ENDOVASC, V16, P301, DOI 10.1016/S1078-5884(98)80049-X
   2000, BREAST IMPLANTS INTR
   1995, PERMEABILITY FILM PR
   1965, USP PHARM USA, P902
NR 129
TC 153
Z9 159
U1 4
U2 68
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JUL-AUG
PY 2004
VL 5
IS 4
BP 1141
EP 1154
DI 10.1021/bm034513k
PG 14
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 837VG
UT WOS:000222668500001
PM 15244424
DA 2018-10-19
ER

PT J
AU Fussell, GW
   Cooper, SL
AF Fussell, GW
   Cooper, SL
TI Synthesis and characterization of acrylic terpolymers with RGD peptides
   for biomedical applications
SO BIOMATERIALS
LA English
DT Article
DE acrylic; RGD; vascular grafts; neutralization; chain transfer
ID ENDOTHELIAL-CELLS; VASCULAR GRAFTS; ATTACHMENT; ADHESION; BIOMATERIALS;
   FIBRONECTIN; RECEPTORS; POLYMERS; SURFACES
AB The goal of this research was to design a biomaterial, using acrylic terpolymers, which could support endothelial cells and function in small diameter vascular graft applications. Hexyl methacrylate (HMA) and octyl methacrylate (OMA) were used as comonomers to produce a material with a low glass transition temperature (T-g). Methacrylic acid (MAA) was used to provide ionic character. and methyl methacrylate (MMA) was selected because of its wide usage in biomedical applications. Cation neutralization was employed to modify the mechanical properties. RGD-based peptide sequences were attached to promote endothelial cell adhesion, because vascular grafts seeded with endothelial cells have fewer problems with thrombosis. The two methods used to incorporate peptide sequences were a chain transfer reaction during polymerization, and a coupling reaction attaching the peptides to carboxyl groups on the polymer after polymerization.
   The compositions that produced T(g)s of approximately 0degreesC were 75 mol% OMA and 92 mol% HMA. The Young's modulus of the HMA copolymer was approximately 0.37 MPa, well below the desired value of 0.9 MPa. Likewise, the Young's modulus of approximately 0.50 MPa for the OMA copolymer was also below the desired value. After partial neutralization with sodium cations, the Young's moduli increased to approximately 0.93 and 0.99 MPa, respectively. The chain transfer reaction lowered the molecular weights and mechanical properties of the copolymers, while the coupling reaction method had little effect on these properties. The chain transfer method appears to be a promising one-step method to produce polymers with a wide range of peptide concentrations. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Delaware, Dept Chem Engn, Newark, DE 19716 USA.
   N Carolina State Univ, Dept Chem Engn, Raleigh, NC 27695 USA.
RP Fussell, GW (reprint author), Drexel Univ, 2710 Jacqueline Dr,Apt L-12, Wilmington, DE 19810 USA.
EM gwf25@drexel.edu; scooper@unity.ncsu.edu
FU NHLBI NIH HHS [HL57917]
CR Bhat VD, 1998, J BIOMAT SCI-POLYM E, V9, P1117, DOI 10.1163/156856298X00686
   Bos GW, 1999, J BIOMED MATER RES, V44, P330, DOI 10.1002/(SICI)1097-4636(19990305)44:3<330::AID-JBM12>3.0.CO;2-O
   Bowlin GL, 2001, J BIOMATER APPL, V16, P157, DOI 10.1106/NCQT-JFV9-2EQ1-EBGU
   BOYD KL, 1988, J BIOMED MATER RES, V22, P163, DOI 10.1002/jbm.820220302
   Bruining MJ, 2002, BIOMATERIALS, V23, P1213, DOI 10.1016/S0142-9612(01)00237-X
   BURKEL WE, 1987, ANN NY ACAD SCI, V516, P131, DOI 10.1111/j.1749-6632.1987.tb33036.x
   CARRUTHERS JDA, 1986, CAN J OPHTHALMOL, V21, P84
   Casazza E, 2002, POLYMER, V43, P1207, DOI 10.1016/S0032-3861(01)00722-4
   CHARNLEY J, 1960, J BONE JOINT SURG BR, V42, P28
   CHERESH DA, 1987, P NATL ACAD SCI USA, V84, P6471, DOI 10.1073/pnas.84.18.6471
   COLEMAN MM, 1990, MACROMOLECULES, V23, P2339, DOI 10.1021/ma00210a033
   Coury Arthur J., 1996, P243
   DIDISHEIM P, 1996, BIOMATERIALS SCI INT, P283
   Fox T.G., 1956, B AM PHYS SOC, V1, P123
   FOXALL TL, 1986, J SURG RES, V41, P158, DOI 10.1016/0022-4804(86)90021-1
   HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9
   Iayadene F, 1998, EUR POLYM J, V34, P219, DOI 10.1016/S0014-3057(97)00099-2
   Irvine DJ, 2001, BIOMACROMOLECULES, V2, P85, DOI 10.1021/bm005584b
   Kerby RE, 2003, J ORAL REHABIL, V30, P780, DOI 10.1046/j.1365-2842.2003.01153.x
   KRALOVICH K, 2000, COMMUNICATION
   Krasia T, 2003, CHEM COMMUN, P538, DOI 10.1039/b212634f
   Lamba NMK, 1998, FRONTIERS TISSUE ENG, P121
   LAMBA NMK, 1999, TISSUE ENG VASCULAR, P553
   Ma YH, 2003, BIOMACROMOLECULES, V4, P864, DOI 10.1021/bm034118u
   MAZZUCOTELLI JP, 1994, INT J ARTIF ORGANS, V17, P112
   MILLERMJ, 1998, FRONTIERS TISSUE ENG, P213
   Murugesan G, 2000, J BIOMED MATER RES, V49, P396, DOI 10.1002/(SICI)1097-4636(20000305)49:3<396::AID-JBM13>3.0.CO;2-H
   NEMEC JW, 1985, ENCY POLYM SCI ENG, P201
   PAINTER PC, 1997, FUNDAMENTALS POLYM S, P478
   Parzuchowski PG, 2002, J AM CHEM SOC, V124, P12182, DOI 10.1021/ja020268l
   PIERSCHBACHER MD, 1984, P NATL ACAD SCI-BIOL, V81, P5985, DOI 10.1073/pnas.81.19.5985
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   RAVVE A, 1995, PRINCIPLES POLYM CHE, P496
   Risbud MV, 2002, J BIOMAT SCI-POLYM E, V13, P1067, DOI 10.1163/156856202320813792
   ROBINS D, 1992, BR J THEATRE NURS, V12, P9
   Roeder R, 1999, J BIOMED MATER RES, V47, P65, DOI 10.1002/(SICI)1097-4636(199910)47:1<65::AID-JBM9>3.0.CO;2-F
   RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111
   SAKARIASSEN KS, 1987, ANN NY ACAD SCI, V516, P52, DOI 10.1111/j.1749-6632.1987.tb33029.x
   Salacinski HJ, 2001, ARTIF ORGANS, V25, P974, DOI 10.1046/j.1525-1594.2001.06716.x
   SANK A, 1992, AM J SURG, V164, P199, DOI 10.1016/S0002-9610(05)81070-0
   SCHARF RE, 1987, BLUT, V55, P131, DOI 10.1007/BF00320567
   SZYMANSKI HA, 1968, NMR BAND HDB, P399
   Tiwari A, 2002, FASEB J, V16, DOI 10.1096/fj.01-0826com
   VANE JR, 1990, NEW ENGL J MED, V323, P27
   Williams DF, 1999, WILLIAMS DICT BIOMAT, P343
NR 45
TC 34
Z9 35
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2004
VL 25
IS 15
BP 2971
EP 2978
DI 10.1016/j.biomaterials.2003.09.062
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 778CM
UT WOS:000189221600008
PM 14967529
DA 2018-10-19
ER

PT J
AU Wang, J
   Huang, N
   Yang, P
   Leng, Y
   Sun, H
   Liu, ZY
   Chu, PK
AF Wang, J
   Huang, N
   Yang, P
   Leng, Y
   Sun, H
   Liu, ZY
   Chu, PK
TI The effects of amorphous carbon films deposited on polyethylene
   terephthalate on bacterial adhesion
SO BIOMATERIALS
LA English
DT Article
DE plasma immersion ion implantation-D (PIII-D); amorphous polymer-like
   carbon film (PLC); polyethylene terephthalate (PET); bacteria adhesion
ID PROSTHETIC VALVE ENDOCARDITIS; CONTACT-ANGLE GONIOMETRY; SOURCE
   ION-IMPLANTATION; MEDICAL DEVICES; SOLID-SURFACES; PLASMA; INFECTION;
   RELEASE; ENERGY
AB There is an increasing interest in developing new methods to reduce bacteria adhesion onto polymeric materials that are used in biomedical implants. The antibacterial behavior on polyethylene terephthalate (PET) treated by acetylene (C2H2) plasma immersion ion implantation-deposition (PIII-D) is investigated. The surface structure of the treated PET is determined by laser Raman spectroscopy, X-ray photoelectron spectroscopy (XPS) and attenuated total reflection Fourier transform infrared spectroscopy (ATR-FTIR). The results show that a thin amorphous polymer-like carbon (PLC) layer is formed on the PET surface. Atomic force micrographs (AFM) show that C2H2 PIII-D significantly changes the surface morphology of PET. The capacities of Staphylococcus aureus (SA) and Staphylococcus epidermidis (SE) to adhere onto PET are quantitatively determined by plate counting and Gamma-ray counting of I-125 radio labeled bacteria in vitro. The results indicate that the adhesion of the two kinds of bacteria to PET is suppressed by PLC. The adhesion efficiency of SE on the coated surface is only about 14% of that of the untreated PET surface, and that of SA is about 35% of that of the virgin surface. The electrokinetic potentials of the bacterial cells and substrates are determined by zeta potential measurement. All the substrates as well as the bacterial strain have negative zeta potentials, and it means that bacterial adhesion is not mediated by electrostatic interactions. The surface energy components of the various substrates and bacteria are calculated based on measurements in water, formamide and diiodomethane. The surface free energies obtained are used to calculate the interfacial free energies of adhesion (DeltaF(Adh)) of SA and SE onto various substrates, and it is found that bacterial adhesion is energetically unfavorable on the PLC deposited on PET by C2H2 PIII-D. (C) 2003 Elsevier Ltd. All rights reserved.
C1 SW Jiaotong Univ, Sch Mat Sci & Engn, Chengdu 610031, Peoples R China.
   City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China.
   Southeast Univ, Coll Med, Affiliated Hosp, Nanjing 210009, Peoples R China.
RP Chu, PK (reprint author), City Univ Hong Kong, Dept Phys & Mat Sci, Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.
EM paul.chu@cityu.edu.hk
RI Chu, Paul/B-5923-2013; Leng, Y.X./C-2278-2012
OI Chu, Paul/0000-0002-5581-4883; Leng, Y.X./0000-0001-6823-1233
CR BAKER AS, 1988, J BONE JOINT SURG AM, V70A, P1551, DOI 10.2106/00004623-198870100-00015
   BUSSCHER HJ, 1984, APPL ENVIRON MICROB, V48, P980
   CALDERWOOD SB, 1985, CIRCULATION, V72, P31, DOI 10.1161/01.CIR.72.1.31
   Davenas J, 2002, BIOMOL ENG, V19, P263, DOI 10.1016/S1389-0344(02)00037-0
   Desgranges P, 2001, J BIOMED MATER RES, V58, P1, DOI 10.1002/1097-4636(2001)58:1<1::AID-JBM10>3.0.CO;2-8
   Dewanjee MK, 1999, J HEART VALVE DIS, V8, P324
   HOLLANDER A, 1995, J COLLOID INTERF SCI, V169, P493, DOI 10.1006/jcis.1995.1060
   IVERT TSA, 1984, CIRCULATION, V69, P223, DOI 10.1161/01.CIR.69.2.223
   James NR, 2003, BIOMATERIALS, V24, P2205, DOI 10.1016/S0142-9612(03)00022-X
   KARCK M, 1993, CLIN MATER, V13, P149, DOI 10.1016/0267-6605(93)90102-D
   MCALLISTER EW, 1993, GASTROINTEST ENDOSC, V39, P422, DOI 10.1016/S0016-5107(93)70120-0
   Schneider RP, 1996, J COLLOID INTERF SCI, V182, P204, DOI 10.1006/jcis.1996.0452
   Sharma PK, 2002, ADV COLLOID INTERFAC, V98, P341, DOI 10.1016/S0001-8686(02)00004-0
   Smith TP, 2003, J NEUROSURG, V98, P421, DOI 10.3171/jns.2003.98.2.0421
   Sodhi RNS, 2001, J ELECTRON SPECTROSC, V121, P249, DOI 10.1016/S0368-2048(01)00338-3
   STAMM WE, 1978, ANN INTERN MED, V89, P764, DOI 10.7326/0003-4819-89-5-764
   Tanaka T, 2002, J VAC SCI TECHNOL A, V20, P625, DOI 10.1116/1.1458942
   THRELKELD MG, 1994, PRINCIPLES PRACTICE, P783
   Van Oss CJ, 1997, J ADHESION, V63, P71, DOI 10.1080/00218469708015214
   WAN CX, 2000, J BIOMED ENG, V17, P10
   Wantanabe S, 2002, THIN SOLID FILMS, V420, P253, DOI 10.1016/S0040-6090(02)00803-9
   Watanabe T, 2002, SURF COAT TECH, V156, P317, DOI 10.1016/S0257-8972(02)00096-8
   Weinstein RA, 2001, CLIN INFECT DIS, V33, P1386, DOI 10.1086/324190
   Yoshida M, 2003, NUCL INSTRUM METH B, V206, P712, DOI 10.1016/S0168-583X(03)00869-3
NR 24
TC 95
Z9 103
U1 1
U2 48
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2004
VL 25
IS 16
BP 3163
EP 3170
DI 10.1016/j.biomaterials.2003.10.010
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 800OV
UT WOS:000220038500005
PM 14980411
DA 2018-10-19
ER

PT J
AU Kemp, JD
   Bowser, R
AF Kemp, JD
   Bowser, R
TI PhD graduate training programs in pathology: 2003 report from the
   American Society for Investigative Pathology workshop on pathology
   graduate education
SO HUMAN PATHOLOGY
LA English
DT Article
DE graduate education; curriculum
ID BASIC SCIENCE; GAP
AB Graduate training is one of the most important activities in which we engage. Through PhD training programs in pathology, we continually renew the intellectual vigor of our discipline and assure its position as a vibrant force in the life sciences. To focus on this important issue, the Education Committee of the American Society for Investigative Pathology (ASIP) organized a workshop on April 11, 2003 for pathology graduate program directors from across the United States and Canada. The goals of this workshop were to better define the current models of pathology graduate training programs, to identify key issues pertaining to the curriculum of pathology training programs and strategies to better market pathology graduate training opportunities, and to identify challenges for the future. Twenty-three program directors and other faculty interested in pathology graduate education, as well as 2 invited PhD students, attended the workshop. Workshop participants concluded that the integration of more and better disease-related education into graduate training programs would attract more and better-qualified students into pathology career pathways that will ultimately fulfill important societal needs and train future leaders of the biomedical research community. The ASIP is facilitating this goal by taking a leadership role in publicizing educational efforts in pathology and by making systematic use of its Website for sharing information about curriculum ideas and materials, as well as course syllabi. (C) 2004 Elsevier Inc. All rights reserved.
C1 Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA.
   Univ Iowa Hlth Care, Dept Pathol, Iowa City, IA USA.
RP Bowser, R (reprint author), Univ Pittsburgh, Sch Med, Dept Pathol, BST S-420,200 Lothrop St, Pittsburgh, PA 15261 USA.
CR ARIAS IM, 1989, NEW ENGL J MED, V321, P972, DOI 10.1056/NEJM198910053211412
   BUNN HF, 1995, FASEB J, V9, P1392
   Gray ML, 2002, NAT MED, V8, P433, DOI 10.1038/nm0502-433
   Juliano RL, 2001, ACAD MED, V76, P1005, DOI 10.1097/00001888-200110000-00007
   Mallon WT, 2003, ACAD MED, V78, P302, DOI 10.1097/00001888-200303000-00014
NR 5
TC 2
Z9 2
U1 0
U2 2
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399 USA
SN 0046-8177
J9 HUM PATHOL
JI Hum. Pathol.
PD JUL
PY 2004
VL 35
IS 7
BP 785
EP 789
DI 10.1016/j.humpath.2004.03.014
PG 5
WC Pathology
SC Pathology
GA 843CK
UT WOS:000223052900003
PM 15257540
DA 2018-10-19
ER

PT J
AU Liu, BS
   Yao, CH
   Hsu, SH
   Yeh, TS
   Chen, YS
   Kao, ST
AF Liu, BS
   Yao, CH
   Hsu, SH
   Yeh, TS
   Chen, YS
   Kao, ST
TI A novel use of genipin-fixed gelatin as extracellular matrix for
   peripheral nerve regeneration
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE gelatin; genipin; peripheral nerve regeneration
ID CROSS-LINKING; SCIATIC-NERVE; SCHWANN-CELLS; IN-VITRO; SILICONE TUBES;
   COLLAGEN; LAMININ; FIBRONECTIN; CHAMBERS; BIOADHESIVES
AB Application of combining herbal medicine and biomedical material science to nerve regeneration is a new approach. In this study, we describe a novel use of purified genipin, which can be extracted from Gardenia jasminoides Ellis, fixing the gelatin to be an extracellular matrix for peripheral nerve regeneration. A 10-mm gap of rat sciatic nerve was created between the proximal and distal nerve stumps, which were sutured into silicone rubber tubes filled with either the genipin-fixed gelatin or collagen gel. Silicone rubber tubes filled with saline were used as controls. Six weeks after implantation, regeneration across the nerve gaps occurred in 80 and 90% of the animals from the groups of genipin-fixed gelatin and collagen, respectively, whereas only 30% in them control group. Large numbers of myelinated axons were also seen in the genipin-fixed gelatin (5104 +/- 3278) and the collagen groups (8063 +/- 1807). These findings indicated that the genipin-fixed gelatin could be an acceptable extracellular matrix for nerve regeneration.
C1 China Med Univ, Inst Chinese Med Sci, Taichung, Taiwan.
   Chungtai Inst Hlth Sci & Technol, Dept Radiol Technol, Taichang, Taiwan.
   Natl Chung Hsing Univ, Dept Chem Engn, Taichung 40227, Taiwan.
RP Chen, YS (reprint author), China Med Univ, Inst Chinese Med Sci, Taichung, Taiwan.
EM yuehsc@mail.cmu.edu.tw
OI Hsu, Shan-hui/0000-0003-3399-055X
CR BAILEY SB, 1993, J NEUROCYTOL, V22, P176, DOI 10.1007/BF01246356
   Bigi A, 2002, BIOMATERIALS, V23, P4827, DOI 10.1016/S0142-9612(02)00235-1
   Cenni E, 2000, J BIOMAT SCI-POLYM E, V11, P685, DOI 10.1163/156856200743959
   Chen YS, 2000, BIOMATERIALS, V21, P1541, DOI 10.1016/S0142-9612(00)00028-4
   Dahlin LB, 2001, SCAND J PLAST RECONS, V35, P29, DOI 10.1080/02844310151032510
   Danielsen N, 1988, Brain Res, V467, P39
   den Dunnen WFA, 2000, J BIOMED MATER RES, V51, P575, DOI 10.1002/1097-4636(20000915)51:4<575::AID-JBM5>3.3.CO;2-Q
   FIELDS RD, 1989, PROG NEUROBIOL, V33, P87, DOI 10.1016/0301-0082(89)90036-1
   Hadlock T, 2000, TISSUE ENG, V6, P119, DOI 10.1089/107632700320748
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   HOLLOWELL JP, 1990, EXP NEUROL, V110, P45, DOI 10.1016/0014-4886(90)90050-3
   KOSAKA M, 1990, EXP NEUROL, V107, P69, DOI 10.1016/0014-4886(90)90064-Y
   Mligiliche NL, 1999, E AFR MED J, V76, P400
   Mosahebi A, 2002, EXP NEUROL, V173, P213, DOI 10.1006/exnr.2001.7846
   Mosahebi A, 2001, TISSUE ENG, V7, P525, DOI 10.1089/107632701753213156
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V69, P149, DOI 10.1016/S0168-3659(00)00296-0
   SATOU T, 1986, ACTA PATHOL JAPON, V36, P199
   Strauch B, 2001, J RECONSTR MICROSURG, V17, P589, DOI 10.1055/s-2001-18812
   Sufan W, 2001, J NEUROTRAUM, V18, P329, DOI 10.1089/08977150151070991
   Sung HW, 1999, J BIOMED MATER RES, V46, P520
   Sung HW, 1998, J BIOMED MATER RES, V42, P560, DOI 10.1002/(SICI)1097-4636(19981215)42:4<560::AID-JBM12>3.0.CO;2-I
   Sung HW, 1999, J BIOMAT SCI-POLYM E, V10, P751, DOI 10.1163/156856299X00621
   Sung HW, 2001, J BIOMED MATER RES, V55, P538, DOI 10.1002/1097-4636(20010615)55:4<538::AID-JBM1047>3.3.CO;2-U
   TOMIHATA K, 1994, AM CHEM SOC S SERIES, V540
   VALENTINI RF, 1987, EXP NEUROL, V98, P350, DOI 10.1016/0014-4886(87)90247-0
   WANG GY, 1992, BRAIN RES, V583, P216, DOI 10.1016/S0006-8993(10)80027-7
   WOOLLEY AL, 1990, OTOLARYNG HEAD NECK, V103, P509, DOI 10.1177/019459989010300401
   Yamazaki M, 2001, J NEUROCHEM, V79, P45, DOI 10.1046/j.1471-4159.2001.00533.x
   Yoshii S, 2001, J HAND SURG-AM, V26A, P52, DOI 10.1053/jhsu.2001.20968
NR 29
TC 31
Z9 31
U1 0
U2 13
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD JUL
PY 2004
VL 19
IS 1
BP 21
EP 34
DI 10.1177/0885328204042544
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 840AJ
UT WOS:000222829100002
PM 15245641
DA 2018-10-19
ER

PT J
AU Kwok, SCH
   Yang, P
   Wang, J
   Liu, XY
   Chu, PK
AF Kwok, SCH
   Yang, P
   Wang, J
   Liu, XY
   Chu, PK
TI Hemocompatibility of nitrogen-doped, hydrogen-free diamond-like carbon
   prepared by nitrogen plasma immersion ion implantation-deposition
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE hydrogen-free diamond-like carbon; nitrogen implantation; plasma
   immersion ion implantation-deposition; (PIII-D); blood compatibility;
   carbon nitride films
ID THIN-FILMS; BLOOD COMPATIBILITY; NITRIDE FILMS; ARC METHOD; COATINGS;
   BIOCOMPATIBILITY; BIOMATERIALS
AB Amorphous hydrogenated carbon (a-C:H) has been shown to be a potential material in biomedical devices such as artificial heart valves, bone implants, and so on because of its chemical inertness, low coefficient of friction, high wear resistance, and good biocompatibility. However, the biomedical characteristics such as blood compatibility of doped hydrogen-free diamond-like carbon (DLC) have not been investigated in details. We recently began to investigate the potential use of nitrogen-doped, hydrogen-free DLC in artificial heart valves. In our experiments, a series of hydrogen-free DLC films doped with nitrogen were synthesized by plasma immersion ion implantation-deposition (PIII-D) utilizing a pulsed vacuum arc plasma source and different N to Ar (F-N/F-Ar) gas mixtures in the plasma chamber. The structures and properties of the film were evaluated by Raman spectroscopy, Rutherford backscattering spectrometry (RBS), and X-ray photoelectron spectroscopy (XPS). To assess the blood compatibility of the films and the impact on the blood compatibility by the presence of nitrogen, platelet adhesion tests were conducted. Our results indicate that the blood compatibility of both hydrogen-free carbon films (a-C) and amorphous carbon nitride films are better than that of low-temperature isotropic pyrolytic carbon (LTIC). The experimental results are consistent with the relative theory of interfacial energy and surface tension including both dispersion and polar components. Our results also indicate that an optimal fraction of sp(2) bonding is desirable, but an excessively high nitrogen concentration degrades the properties to an extent that the biocompatibility can be worse than that of LTIC. (C) 2004 Wiley Periodicals, Inc.
C1 City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China.
   SW Jiaotong Univ, Sch Mat Sci & Engn, Chengdu 610031, Peoples R China.
RP Chu, PK (reprint author), City Univ Hong Kong, Dept Phys & Mat Sci, Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.
EM paul.chu@cityu.edu
RI Liu, Xuanyong/J-2609-2018; Chu, Paul/B-5923-2013
OI Chu, Paul/0000-0002-5581-4883
CR Chang YY, 2003, DIAM RELAT MATER, V12, P2077, DOI 10.1016/S0925-9635(03)00290-5
   Chen JY, 2002, SURF COAT TECH, V156, P289, DOI 10.1016/S0257-8972(02)00089-0
   Chen JY, 2002, BIOMATERIALS, V23, P2545, DOI 10.1016/S0142-9612(01)00389-1
   CHENG YH, 2001, DIAMOND RELATIVE MAT, V10, P2107
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Chu PK, 2001, REV SCI INSTRUM, V72, P1660, DOI 10.1063/1.1340029
   Cui FZ, 2000, SURF COAT TECH, V131, P481, DOI 10.1016/S0257-8972(00)00809-4
   Dementjev AP, 2000, DIAM RELAT MATER, V9, P1904, DOI 10.1016/S0925-9635(00)00345-9
   Ferrari AC, 2003, DIAM RELAT MATER, V12, P905, DOI 10.1016/S0925-9635(02)00370-9
   Goodman SL, 1999, J BIOMED MATER RES, V45, P240, DOI 10.1002/(SICI)1097-4636(19990605)45:3<240::AID-JBM12>3.3.CO;2-3
   Grill A, 2003, DIAM RELAT MATER, V12, P166, DOI 10.1016/S0925-9635(03)00018-9
   Hauert R, 2003, DIAM RELAT MATER, V12, P583, DOI 10.1016/S0925-9635(03)00081-5
   Inaba H, 2002, JPN J APPL PHYS 1, V41, P5730, DOI 10.1143/JJAP.41.5730
   Leng YX, 2003, SURF SCI, V531, P177, DOI 10.1016/S0039-6028(03)00487-4
   Lifshitz Y, 1999, DIAM RELAT MATER, V8, P1659, DOI 10.1016/S0925-9635(99)00087-4
   Merel P, 1998, APPL SURF SCI, V136, P105, DOI 10.1016/S0169-4332(98)00319-5
   Petrov P, 2000, DIAM RELAT MATER, V9, P562, DOI 10.1016/S0925-9635(99)00348-9
   Rodil SE, 2003, DIAM RELAT MATER, V12, P931, DOI 10.1016/S0925-9635(02)00217-0
   Sheeja D, 2004, DIAM RELAT MATER, V13, P184, DOI 10.1016/j.diamond.2003.10.053
   Tessier PY, 2003, DIAM RELAT MATER, V12, P1066, DOI 10.1016/S0925-9635(02)00314-X
   Wang XH, 2000, SURF COAT TECH, V128, P36, DOI 10.1016/S0257-8972(00)00659-9
   Yang P, 2003, BIOMATERIALS, V24, P2821, DOI 10.1016/S0142-9612(03)00091-7
   YANG P, 2003, NUCL INSTRUM METHO B, V206
   [杨萍 Yang Ping], 2002, [中国生物医学工程学报, Chinese Journal of Biomedical Engineering], V21, P90
   Zhang XW, 2003, DIAM RELAT MATER, V12, P1, DOI 10.1016/S0925-9635(02)00246-7
   Zhou ZM, 2002, J PHYS D APPL PHYS, V35, P1991, DOI 10.1088/0022-3727/35/16/313
NR 26
TC 41
Z9 42
U1 2
U2 25
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL 1
PY 2004
VL 70A
IS 1
BP 107
EP 114
DI 10.1002/jbm.a.30070
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 833EA
UT WOS:000222318000012
PM 15174114
DA 2018-10-19
ER

PT J
AU Zhang, DS
   Arola, DD
AF Zhang, DS
   Arola, DD
TI Applications tissues of digital image correlation to biological
SO JOURNAL OF BIOMEDICAL OPTICS
LA English
DT Article
DE digital image correlation; biological tissue; interferometry
ID HOLOGRAPHIC-INTERFEROMETRY; ALUMINUM-ALLOY; POISSONS RATIO; AORTA
AB Optical methods are becoming commonplace in investigations of the physical and mechanical behavior of biological tissues. Digital image correlation (DIC) is a versatile optical method that shows tremendous promise for applications involving biological tissues and biomaterials. We present the fundamentals of DIC with an emphasis on the application to biological materials. An approach for surface preparation is described that facilitates its application to hydrated substrates. Three examples are presented that highlight the use of DIC for biomedical research. The first example describes the use of DIC to study the mechanical behavior of arterial tissues up to 40% elongation. The second example describes an evaluation of the mechanical properties of bovine hoof horn in the dehydrated and fully hydrated states. Uniaxial tension experiments are performed to determine the elastic modulus (E) and Poisson's ratio (v) of both the arterial and dermal tissues. Spatial variations in the mechanical properties are evident from the full-field characterization of both tissues. Finally, an application of DIC to study the evolution of loosening in cemented total hip replacements is described. The noncontact analysis enables measurement of the relative displacement between the bone/bone cement and bone cement/prosthesis interfaces. Based on the elementary optical arrangement, the simple surface preparation, and the ability to acquire displacement/strain measurements over a large range of deformation, DIC should serve as a valuable tool for biomedical research. Further developments will enable the use of DIC for in vivo applications. (C) 2004 Society of Photo-Optical Instrumentation Engineers.
C1 Univ Maryland Baltimore Cty, Dept Mech Engn, Baltimore, MD 21250 USA.
   Shanghai Univ, Dept Mech, Shanghai 200436, Peoples R China.
RP Zhang, DS (reprint author), Univ Maryland Baltimore Cty, Dept Mech Engn, 1000 Hilltop Circle, Baltimore, MD 21250 USA.
CR Arola D, 2002, EXP MECH, V42, P380
   AROLA D, 2002, P 21 SO BIOM ENG C B, P147
   Bastawros AF, 2000, J MECH PHYS SOLIDS, V48, P301, DOI 10.1016/S0022-5096(99)00035-6
   Braun S, 2000, AM J ORTHOD DENTOFAC, V118, P257, DOI 10.1067/mod.2000.108254
   BROUGHER JA, 2002, P SEM ANN C THEOR EX, P238
   BRUCK HA, 1989, EXP MECH, V29, P261, DOI 10.1007/BF02321405
   CHU TC, 1985, EXP MECH, V25, P232, DOI 10.1007/BF02325092
   Fung Y, 1993, BIOMECHANICS MECH PR, P321
   HUMPHREY JD, 1987, J BIOMECH, V20, P59, DOI 10.1016/0021-9290(87)90267-3
   Kishen A, 2001, J BIOMED MATER RES, V55, P121, DOI 10.1002/1097-4636(200104)55:1<121::AID-JBM160>3.3.CO;2-X
   Lu H, 1997, EXP MECH, V37, P433, DOI 10.1007/BF02317310
   McGowan DM, 2001, J AIRCRAFT, V38, P122, DOI 10.2514/2.2743
   Niu X, 2000, EXP TECHNIQUES, V24, P27, DOI 10.1111/j.1747-1567.2000.tb01332.x
   OVRYN B, 1987, ANN BIOMED ENG, V15, P67, DOI 10.1007/BF02364168
   OVRYN B, 1989, CRIT REV BIOMED ENG, V16, P269
   PETERS WH, 1982, OPT ENG, V21, P427, DOI 10.1117/12.7972925
   RAJKONDAWAR P, 2002, P SEM ANN C THEOR EX, P256
   SILVER FH, 1989, CRIT REV BIOMED ENG, V17, P323
   SMOLEK MK, 1994, J CATARACT REFR SURG, V20, P277, DOI 10.1016/S0886-3350(13)80578-0
   SUTTON MA, 1993, ASME AMD, V176, P20317
   Tong W, 1997, EXP MECH, V37, P452, DOI 10.1007/BF02317313
   Wang RZ, 1998, J BIOMECH, V31, P135
   Wattrisse B, 2001, EXP MECH, V41, P29, DOI 10.1007/BF02323101
   WOISETSCHLAGER J, 1994, APPL OPTICS, V33, P5011, DOI 10.1364/AO.33.005011
   YANG DT, 2002, P ANN M SOC BIOM, P546
   YANG DT, 2002, P SEM ANN C THEOR EX, P75
   Zentner A, 1996, ANGLE ORTHOD, V66, P463
   Zhang D, 1999, EXP MECH, V39, P62, DOI 10.1007/BF02329302
   Zhang D, 2002, P ANN INT IEEE EMBS, P1276, DOI 10.1109/IEMBS.2002.1106385
   ZHANG D, 2002, P SEM ANN C THEOR EX
   ZHANG D, 2002, EXP TECH, V25, P32
   Zhang D., 2002, P 10 ACM INT C MULT, P315, DOI DOI 10.1145/641007.641073
   Zhang DS, 2002, EXP MECH, V42, P409, DOI 10.1007/BF02412146
   Zhao WZ, 1996, J APPL POLYM SCI, V60, P1083, DOI 10.1002/(SICI)1097-4628(19960523)60:8<1083::AID-APP1>3.0.CO;2-H
   Zhou J, 1997, P NATL ACAD SCI USA, V94, P14255, DOI 10.1073/pnas.94.26.14255
NR 35
TC 100
Z9 110
U1 2
U2 2
PU SPIE-SOC PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98225 USA
SN 1083-3668
EI 1560-2281
J9 J BIOMED OPT
JI J. Biomed. Opt.
PD JUL-AUG
PY 2004
VL 9
IS 4
BP 691
EP 699
DI 10.1117/1.1753270
PG 9
WC Biochemical Research Methods; Optics; Radiology, Nuclear Medicine &
   Medical Imaging
SC Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine &
   Medical Imaging
GA 840NM
UT WOS:000222865800003
PM 15250755
DA 2018-10-19
ER

PT J
AU Qhobosheane, M
   Zhang, P
   Tan, WH
AF Qhobosheane, M
   Zhang, P
   Tan, WH
TI Assembly of silica nanoparticles for two-dimensional nanomaterials
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Article
DE silica nanoparticles; two-dimensional; nanomaterials; glutamate
ID ZEOLITE CRYSTALS; SELF-ORGANIZATION; COVALENT LINKER; GLASS;
   SUPERLATTICES; MONOLAYERS; FILMS; GEL
AB To realize the great potential of nanoparticles as new materials for biomedical applications, the nanoparticles will have to be assembled in such a way that the newly created assembly will have unique properties that conventional materials do not possess. This will enable nanomaterials to be used for many novel applications. We have attempted to assemble silica nanoparticles to create a two-dimensional nanomaterial, which might be useful for biosensor and biochip production. The silica nanoparticles are synthesized and assembled in a monolayer fashion through the use of halogenated silanes. Photolithography techniques are used to pattern the glass surface prior to nanoparticle attachment. The concentration of the silica nanoparticles in the solution controls the surface coverage of nanoparticles on the glass surface. Different patterned silica arrays can be made with controlled surface coverage. The nanoparticle-covered surface is successfully tested for surface-enhanced enzymatic reactivity for the detection of a neurotransmitter, glutamate. This report demonstrates the feasibility of assembling nanoparticles for biosensor development.
C1 Univ Florida, Dept Chem, Gainesville, FL 32611 USA.
   Univ Florida, Ctr Res Interface Bio Nano, Gainesville, FL 32611 USA.
RP Tan, WH (reprint author), Univ Florida, Dept Chem, Gainesville, FL 32611 USA.
RI Zhou, Feng/E-9510-2011; Tan, Weihong/A-5412-2008
OI Tan, Weihong/0000-0002-8066-1524
FU NINDS NIH HHS [R01-NS39891]
CR Andres RP, 1996, SCIENCE, V273, P1690, DOI 10.1126/science.273.5282.1690
   Caruso F, 2001, ADV MATER, V13, P1090, DOI 10.1002/1521-4095(200107)13:14<1090::AID-ADMA1090>3.0.CO;2-H
   Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016
   Choi SY, 2000, J AM CHEM SOC, V122, P5201, DOI 10.1021/ja000113i
   Cordek J, 1999, ANAL CHEM, V71, P1529, DOI 10.1021/ac980850l
   Fang XH, 1999, J AM CHEM SOC, V121, P2921, DOI 10.1021/ja9837809
   Ha K, 2001, ADV MATER, V13, P594, DOI 10.1002/1521-4095(200104)13:8<594::AID-ADMA594>3.0.CO;2-O
   Ingersoll CM, 1997, ANAL CHEM, V69, pA403, DOI 10.1021/ac9716901
   Jeng RJ, 2003, POLYMER, V44, P143, DOI 10.1016/S0032-3861(02)00730-9
   Kachan SM, 2002, SURF SCI, V507, P603, DOI 10.1016/S0039-6028(02)01322-5
   Kulak A, 2000, ANGEW CHEM INT EDIT, V39, P950, DOI 10.1002/(SICI)1521-3773(20000303)39:5<950::AID-ANIE950>3.0.CO;2-U
   Kulak A, 2000, J AM CHEM SOC, V122, P9308, DOI 10.1021/ja001321d
   Lee GS, 2000, TETRAHEDRON, V56, P6965, DOI 10.1016/S0040-4020(00)00517-2
   Lee GS, 2001, J AM CHEM SOC, V123, P9769, DOI 10.1021/ja010517q
   Li T, 1999, LANGMUIR, V15, P4328, DOI 10.1021/la970801o
   Liu XJ, 1999, ANAL CHEM, V71, P5054, DOI 10.1021/ac990561c
   Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0
   MURRAY CB, 1995, SCIENCE, V270, P1335, DOI 10.1126/science.270.5240.1335
   PANTANO P, 1995, ANAL CHEM, V67, pA481, DOI 10.1021/ac00111a002
   PARK JS, 2002, J CHEM SOC COMMUN
   PING DH, 2001, J APPL PHYS, V90, P9
   Qhobosheane M, 2001, ANALYST, V126, P1274, DOI 10.1039/b101489g
   RUTNAKORNPITUK M, 2002, POLYMER
   Santra S, 2001, ANAL CHEM, V73, P4988, DOI 10.1021/ac010406+
   Santra S, 2001, J BIOMED OPT, V6, P160, DOI 10.1117/1.1353590
   SBRANA F, 2002, CATAL TODAY
   Shenton W, 1997, NATURE, V389, P585
   STOBER W, 1968, J COLLOID INTERF SCI, V26, P62, DOI 10.1016/0021-9797(68)90272-5
   Taleb A, 1997, CHEM MATER, V9, P950, DOI 10.1021/cm960513y
   Tapec R, 2002, J NANOSCI NANOTECHNO, V2, P405, DOI 10.1166/jnn.2002.114
   Ulman A, 1996, CHEM REV, V96, P1533, DOI 10.1021/cr9502357
   Um SH, 2002, LANGMUIR, V18, P4455, DOI 10.1021/la020118o
   Whitesides GM, 1999, SCIENCE, V284, P89, DOI 10.1126/science.284.5411.89
   Yu YY, 2003, POLYMER, V44, P593, DOI 10.1016/S0032-3861(02)00824-8
NR 34
TC 17
Z9 17
U1 1
U2 15
PU AMER SCIENTIFIC PUBLISHERS
PI STEVENSON RANCH
PA 25650 NORTH LEWIS WAY, STEVENSON RANCH, CA 91381-1439 USA
SN 1533-4880
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD JUL
PY 2004
VL 4
IS 6
BP 635
EP 640
DI 10.1166/jnn.2004.014
PG 6
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 865JK
UT WOS:000224698300015
PM 15518399
DA 2018-10-19
ER

PT J
AU Zhu, SL
   Yang, XJ
   Hu, F
   Deng, SH
   Cui, ZD
AF Zhu, SL
   Yang, XJ
   Hu, F
   Deng, SH
   Cui, ZD
TI Processing of porous TiNi shape memory alloy from elemental powders by
   Ar-sintering
SO MATERIALS LETTERS
LA English
DT Article
DE porous TiNi alloy; powder metallurgy; Ar-sintering; shape memory alloy
ID MECHANICAL-PROPERTIES; NITI
AB Porous TiNi shape memory alloys attracted extensive interests for their potential use as biomedical materials because of their similar microstructure to human bone and the unique mechanical properties. In this paper, an equiatomic porous TiNi alloy was prepared from elemental powders by Ar-sintering. The pore features of the porous TiNi alloy were studied by optical microscopy and scanning electronic microscopy (SEM). The mechanism of pore-formation and pore-development were proposed. X-ray diffraction (XRD) and differential scanning calometry (DSC) were used to investigate the microstructure and the temperature of phase transformation of the alloy. Compression and flexural test were carried out to determine the mechanical properties of the porous TiNi alloy. The porous TiNi alloy sintered at 980 degreesC in argon for 8 It was found to be composed mainly of TiNi phase with promising properties, of which the ultimate compressive and flexural strength was 677 and 246 MPa, respectively. The porosity ratio of porous TiNi alloy was up to 45%. The DSC measurements revealed the A, and A(f) temperatures of the alloy was 32.5 and 45.6 degreesC, respectively. (C) 2004 Elsevier B.V. All rights reserved.
C1 Tianjin Univ, Sch Mat Sci & Engn, Tianjin 300072, Peoples R China.
RP Cui, ZD (reprint author), Tianjin Univ, Sch Mat Sci & Engn, Tianjin 300072, Peoples R China.
EM zdcui@tju.edu.cn
RI Zhu, Shengli/D-5281-2009
OI Zhu, Shengli/0000-0002-0190-2626
CR Chenglin C., 1997, T NONFERR METAL SOC, V7, P84
   Green SM, 1997, POWDER METALL, V40, P43, DOI 10.1179/pom.1997.40.1.43
   HEY JC, 1994, MAT SCI ENG A-STRUCT, V188, P291, DOI 10.1016/0921-5093(94)90384-0
   Hosoda H, 1998, INTERMETALLICS, V6, P291, DOI 10.1016/S0966-9795(97)00100-3
   IGHARO M, 1986, POWDER METALL, V29, P37, DOI 10.1179/pom.1986.29.1.37
   ITIN VI, 1994, MATER CHARACT, V32, P179, DOI 10.1016/1044-5803(94)90087-6
   LIPSCOMB IP, 1996, APPL SHAPE MEMORY AL, P5
   Massalski T B, 1996, BINARY ALLOY PHASE D, P2874
   McNeese MD, 2000, MAT SCI ENG A-STRUCT, V280, P334, DOI 10.1016/S0921-5093(99)00550-X
   Miller DA, 2001, MAT SCI ENG A-STRUCT, V308, P161, DOI 10.1016/S0921-5093(00)01982-1
   Munir Z. A., 1990, P 1 US JAP WORKSH CO, P123
   RHINES FN, 1950, J MET T AIME, V188, P378
   SAITO S, 1992, MAT SCI ENG A-STRUCT, V161, P91
   ZHANG N, 1992, MAT SCI ENG A-STRUCT, V150, P263, DOI 10.1016/0921-5093(92)90120-P
NR 14
TC 67
Z9 67
U1 0
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD JUL
PY 2004
VL 58
IS 19
BP 2369
EP 2373
DI 10.1016/j.matlet.2004.02.017
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 830ER
UT WOS:000222105000009
DA 2018-10-19
ER

PT J
AU Kim, HY
   Satoru, H
   Kim, JI
   Hosoda, H
   Miyazaki, S
AF Kim, HY
   Satoru, H
   Kim, JI
   Hosoda, H
   Miyazaki, S
TI Mechanical properties and shape memory behavior of ti-nb alloys
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE shape memory alloy; superelasticity; biomaterial; smart material;
   titanium based alloy
ID MARTENSITIC TRANSFORMATIONS; MO ALLOYS; SUPERELASTICITY
AB Mechanical properties and shape memory behavior of Ti-(20-29)at%Nb alloys were investigated in order to develop Ni-free biomedical shape memory alloys. The Ti-Nb alloys were fabricated by arc melting method. The ingots were cold-rolled with a reduction up to 95% in thickness and then solution treated at 1173 K for 1.8 ks. The martensitic transformation temperature decreased by 43 K per 1 at% increase of Nb content. The shape memory effect and superelastic behavior were observed at room temperature in the Ti-(22-25)at%Nb alloys and Ti-(25.5-27)at%Nb alloys, respectively. A small enthalpy of the martensitic transformation and a large difference between Ms and Mf were observed in the Ti-Nb alloys compared to Ti-Ni shape memory alloys. The maximum recovered strain of 3% was obtained at room temperature in solution treated Ti-(25-27)at%Nb alloys. The heat treatment at 573 K for 3.6 ks stabilized superelastic behavior of Ti-Nb alloys by increasing the critical stress for slip.
C1 Univ Tsukuba, Inst Sci Mat, Tsukuba, Ibaraki 3058573, Japan.
   Tokyo Inst Technol, Precis & Intelligent Lab, Yokohama, Kanagawa 2268503, Japan.
RP Miyazaki, S (reprint author), Univ Tsukuba, Inst Sci Mat, Tsukuba, Ibaraki 3058573, Japan.
EM miyazaki@ims.tsukuba.ac.jp
RI Miyazaki, Shuichi/A-3113-2012; Kim, Hee Young/F-6065-2011
OI Miyazaki, Shuichi/0000-0003-3849-4176; Kim, Hee
   Young/0000-0003-1981-6678
CR Ahmed T, 1996, J MATER SCI, V31, P4267, DOI 10.1007/BF00356449
   Baker C., 1971, Metal Science Journal, V5, P92
   DAVIS R, 1979, ACTA METALL MATER, V27, P1041, DOI 10.1016/0001-6160(79)90192-5
   DAVIS R, 1979, J MATER SCI, V14, P712
   DUERIG TW, 1982, ACTA METALL MATER, V30, P2161, DOI 10.1016/0001-6160(82)90137-7
   Grosdidier T, 2000, MAT SCI ENG A-STRUCT, V291, P218, DOI 10.1016/S0921-5093(00)00921-7
   Ho WF, 1999, BIOMATERIALS, V20, P2115, DOI 10.1016/S0142-9612(99)00114-3
   Hosoda H, 2003, MATER SCI FORUM, V426-4, P3121, DOI 10.4028/www.scientific.net/MSF.426-432.3121
   Hosoda H, 2001, T MRS J, V26, P243
   Kim HY, 2004, MATER TRANS, V45, P1090, DOI 10.2320/matertrans.45.1090
   Nitta K, 2001, STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY, P25
   OSHIDA Y, 1991, CORROSION ENG, V40, P1009
   SEMLITSCH M, 1985, BIOMED TECH, V30, P334, DOI 10.1515/bmte.1985.30.12.334
   Shabalovskaya S., 1994, P 1 INT C SHAP MEM S, P209
   Steinemann S. G., 1980, EVALUATION BIOMATERI, P1
   Takahashi E, 2002, MATER TRANS, V43, P2978, DOI 10.2320/matertrans.43.2978
   TAKEI F, 1983, SCRIPTA METALL MATER, V17, P987, DOI 10.1016/0036-9748(83)90436-2
NR 17
TC 195
Z9 205
U1 4
U2 61
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD JUL
PY 2004
VL 45
IS 7
BP 2443
EP 2448
DI 10.2320/matertrans.45.2443
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 845LX
UT WOS:000223245300082
OA Bronze
DA 2018-10-19
ER

PT J
AU Hu, YQ
   Zhu, KJ
AF Hu, YQ
   Zhu, KJ
TI Synthesis, characterization and degradation of poly(2,2-dimethyl
   trimethylene carbonate-co-epsilon-caprolactone-co-glycolide)
SO POLYMER DEGRADATION AND STABILITY
LA English
DT Article
DE biodegradable polymers; poly(epsilon-caprolactone); polyglycolide;
   random copolymers; poly(2,2-dimethyl trimethylene
   carbonate-co-epsilon-caprolactone-co-glycolide)
ID RING-OPENING POLYMERIZATION; EPSILON-CAPROLACTONE;
   2,2-DIMETHYLTRIMETHYLENE CARBONATE; HYDROLYTIC DEGRADATION;
   BIODEGRADABLE POLYMERS; L-LACTIDE; COPOLYMERS; GLYCOLIDE; ACID;
   DECOMPOSITION
AB Degradable tri-component copolymers were synthesized by the bulk copolymerisation of 2,2-dimethyl trimethylene carbonate (DTC), epsilon-caprolactone (CL) and glycolide (GA) using stannous octanoate as catalyst at 140 degreesC for 36 h. The mole fraction ratio in the feed of DTC and CL was fixed at 20/80 and the mole percent of GA was varied to obtain copolymers with different properties. The polymerisation products were characterized by H-1 NMR, C-13 NMR, FT-IR, GPC and DSC. It was found that the hydrophilicity of these materials increased with increasing GA content, according to measurements of static contact angles of distilled water on the surface of polymer films. Mechanical tests and hydrolytic degradation assays showed that copolymers of different degradability and mechanical properties could be tailored by adjusting the compositions. For the polymer P-3 (GA content about 10 mol%), the tensile strength and the elastic modulus could reach 4.3 MPa and 22 MPa, respectively. It took 4 weeks for the copolymer P-3 to degrade to about 82% (M-n,M-t/M-n,M-0) and 10 weeks to 40%. These low crystallinity copolymers could be processed into porous films with stable structures by means of combination of solvent volatilisation with salt leaching. These materials are expected to be useful for nerve reconstruction and other biomedical applications. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Zhejiang Univ, Dept Polymer Sci & Engn, Hangzhou 310027, Peoples R China.
RP Zhu, KJ (reprint author), Zhejiang Univ, Dept Polymer Sci & Engn, Hangzhou 310027, Peoples R China.
EM kjzhu@ipsm.zju.edu.cn
CR BARRERA DA, 1995, MACROMOLECULES, V28, P425, DOI 10.1021/ma00106a004
   Cai J, 1998, POLYMER, V39, P4409, DOI 10.1016/S0032-3861(97)10346-9
   Cai J., 1996, POLYM INT, V41, P369
   Cai Q, 2000, J BIOMAT SCI-POLYM E, V11, P273, DOI 10.1163/156856200743698
   CHU CC, 1981, J APPL POLYM SCI, V26, P1727, DOI 10.1002/app.1981.070260527
   COHN D, 1987, POLYMER, V28, P2018, DOI 10.1016/0032-3861(87)90035-8
   CRESCENZI V, 1972, EUR POLYM J, V8, P449, DOI 10.1016/0014-3057(72)90109-7
   ENDO M, 1987, MACROMOLECULES, V20, P2982, DOI 10.1021/ma00178a005
   ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B
   GILDING DK, 1979, POLYMER, V20, P1459, DOI 10.1016/0032-3861(79)90009-0
   HOVESTADT W, 1992, POLYMER, V33, P1941, DOI 10.1016/0032-3861(92)90497-K
   KENLEY RA, 1987, MACROMOLECULES, V20, P2398, DOI 10.1021/ma00176a012
   KEUL H, 1988, MAKROMOL CHEM, V189, P2303
   KOHN FE, 1983, EUR POLYM J, V19, P1081, DOI 10.1016/0014-3057(83)90001-0
   Kowalski A, 2000, MACROMOLECULES, V33, P1964, DOI 10.1021/ma991751s
   KRICHELDORF HR, 1992, POLYMER, V33, P2817, DOI 10.1016/0032-3861(92)90459-A
   KRICHELDORF HR, 1984, MACROMOLECULES, V17, P2173, DOI 10.1021/ma00140a051
   KRICHELDORF HR, 1988, MACROMOLECULES, V21, P286, DOI 10.1021/ma00180a002
   KRICHELDORF HR, 1991, MAKROMOL CHEM, V192, P2391
   Kricheldorf HR, 1998, MACROMOL CHEM PHYSIC, V199, P283, DOI 10.1002/(SICI)1521-3935(19980201)199:2<283::AID-MACP283>3.3.CO;2-0
   Li SM, 1996, MACROMOLECULES, V29, P57, DOI 10.1021/ma950531l
   LUNDBERG RD, 1969, J POLYM SCI A1, V7, P2915, DOI 10.1002/pol.1969.150071014
   Pack JW, 2002, J POLYM SCI POL CHEM, V40, P544, DOI 10.1002/pola.10123
   PASCH H, 1995, J CHROMATOGR A, V699, P21, DOI 10.1016/0021-9673(95)00061-Q
   Qian HT, 2000, POLYM DEGRAD STABIL, V68, P423, DOI 10.1016/S0141-3910(00)00031-8
   REED AM, 1981, POLYMER, V22, P494, DOI 10.1016/0032-3861(81)90168-3
   Schmidt P, 1996, MACROMOLECULES, V29, P3674, DOI 10.1021/ma951489x
   SEARLES S, 1960, J AM CHEM SOC, V82, P2928, DOI 10.1021/ja01496a062
   WILLIAMS DF, 1982, J MATER SCI, V17, P1233, DOI 10.1007/BF00752233
   WURM B, 1992, MAKROMOL CHEM-RAPID, V13, P9
NR 30
TC 13
Z9 17
U1 1
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0141-3910
J9 POLYM DEGRAD STABIL
JI Polym. Degrad. Stabil.
PD JUL
PY 2004
VL 85
IS 1
BP 705
EP 712
DI 10.1016/j.polymdegradstab.2003.12.010
PG 8
WC Polymer Science
SC Polymer Science
GA 836IM
UT WOS:000222549100020
DA 2018-10-19
ER

PT J
AU Wang, ZL
AF Wang, ZL
TI Zinc oxide nanostructures: growth, properties and applications
SO JOURNAL OF PHYSICS-CONDENSED MATTER
LA English
DT Review
ID INDIVIDUAL CARBON NANOTUBES; ZNO NANOBELTS; INDUCED NANOHELIXES; SILICON
   NANOWIRES; WORK FUNCTION; TIN DIOXIDE; SURFACES; OXYGEN;
   PHOTODESORPTION; CONDUCTIVITY
AB Zinc oxide is a unique material that exhibits semiconducting and piezoelectric dual properties. Using a solid-vapour phase thermal sublimation technique, nanocombs, nanorings, nanohelixes/nanosprings, nanobelts, nanowires and nanocages of ZnO have been synthesized under specific growth conditions. These unique nanostructures unambiguously demonstrate that ZnO probably has the richest family of nanostructures among all materials, both in structures and in properties. The nanostructures could have novel applications in optoelectronics, sensors, transducers and biomedical sciences. This article reviews the various nanostructures of ZnO grown by the solid-vapour phase technique and their corresponding growth mechanisms. The application of ZnO nanobelts as nanosensors, nanocantilevers, field effect transistors and nanoresonators is demonstrated.
C1 Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.
RP Wang, ZL (reprint author), Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.
EM zhong.wang@mse.gatech.edu
RI 李, 府中/H-4357-2011; Wang, Zhong Lin/E-2176-2011
OI Wang, Zhong Lin/0000-0002-5530-0380
CR ADVANI GN, 1980, J ELECT, V48, P403
   Arnold MS, 2003, J PHYS CHEM B, V107, P659, DOI 10.1021/jp0271054
   Avouris P, 2002, CHEM PHYS, V281, P429, DOI 10.1016/S0301-0104(02)00376-2
   Bai XD, 2003, NANO LETT, V3, P1147, DOI 10.1021/nl034342p
   Bai XD, 2003, APPL PHYS LETT, V82, P4806, DOI 10.1063/1.1587878
   BONASEWICZ P, 1986, J ELECTROCHEM SOC, V133, P2270, DOI 10.1149/1.2108393
   Collins PC, 2001, SCIENCE, V292, P706, DOI 10.1126/science.1058782
   Comini E, 2002, APPL PHYS LETT, V81, P1869, DOI 10.1063/1.1504867
   Cui Y, 2001, SCIENCE, V291, P851, DOI 10.1126/science.291.5505.851
   Dai HJ, 1996, NATURE, V384, P147, DOI 10.1038/384147a0
   Dai ZR, 2003, ADV FUNCT MATER, V13, P9, DOI 10.1002/adfm.200390013
   Dietl T, 2000, SCIENCE, V287, P1019, DOI 10.1126/science.287.5455.1019
   DING Y, 2003, J APPL PHYS, V95, P306
   DING Y, 2004, UNPUB PHYS REV B
   Dulub O, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.016102
   Dulub O, 2002, SURF SCI, V519, P201, DOI 10.1016/S0039-6028(02)02211-2
   Gallaso F. S, 1970, STRUCTURE PROPERTIES
   Gao PX, 2002, J PHYS CHEM B, V106, P12653, DOI 10.1021/jp0265485
   Gao PX, 2003, NANO LETT, V3, P1315, DOI 10.1021/nl034548q
   Gao PX, 2003, J AM CHEM SOC, V125, P11299, DOI 10.1021/ja035569p
   Gao RP, 2000, PHYS REV LETT, V85, P622, DOI 10.1103/PhysRevLett.85.622
   Gao RP, 2001, APPL PHYS LETT, V78, P1757, DOI 10.1063/1.1356442
   GOPEL W, 1989, SOLID STATE IONICS, V32-3, P440, DOI 10.1016/0167-2738(89)90253-1
   Hashimoto S, 1996, J AM CERAM SOC, V79, P1121, DOI 10.1111/j.1151-2916.1996.tb08559.x
   Huang MH, 2001, SCIENCE, V292, P1897, DOI 10.1126/science.1060367
   Huang MH, 2001, ADV MATER, V13, P113, DOI 10.1002/1521-4095(200101)13:2<113::AID-ADMA113>3.0.CO;2-H
   Hughes WL, 2003, APPL PHYS LETT, V82, P2886, DOI 10.1063/1.1570497
   Kamp B, 2001, SENSOR ACTUAT B-CHEM, V77, P534, DOI 10.1016/S0925-4005(01)00694-3
   Kim P, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.215502
   Kong J, 2000, SCIENCE, V287, P622, DOI 10.1126/science.287.5453.622
   Kong XY, 2004, SCIENCE, V303, P1348, DOI 10.1126/science.1092356
   Kong XY, 2004, APPL PHYS LETT, V84, P975, DOI 10.1063/1.1646453
   Kong XY, 2004, J PHYS CHEM B, V108, P570, DOI 10.1021/jp036993f
   Kong XY, 2003, NANO LETT, V3, P1625, DOI 10.1021/nl034463p
   Lao JY, 2003, NANO LETT, V3, P235, DOI 10.1021/nl025884u
   Ma C, 2004, J AM CHEM SOC, V126, P708, DOI 10.1021/ja0395644
   MA C, 2004, NATURE, V427, P497
   MEIROVICH L, 1986, ELEMENTS VIBRATION A
   Meyer B, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.035403
   MIZUSAKI J, 1990, J SOLID STATE CHEM, V88, P443, DOI 10.1016/0022-4596(90)90240-X
   Moore D, 2004, CHEM PHYS LETT, V385, P8, DOI 10.1016/j.cplett.2003.12.063
   Morales AM, 1998, SCIENCE, V279, P208, DOI 10.1126/science.279.5348.208
   Pan ZW, 2001, SCIENCE, V291, P1947, DOI 10.1126/science.1058120
   Poncharal P, 1999, SCIENCE, V283, P1513, DOI 10.1126/science.283.5407.1513
   Prinz GA, 1998, SCIENCE, V282, P1660, DOI 10.1126/science.282.5394.1660
   Ronning C, 2004, APPL PHYS LETT, V84, P783, DOI 10.1063/1.1645319
   SAMSON S, 1973, J APPL PHYS, V44, P4618, DOI 10.1063/1.1662011
   Schwab K, 2000, NATURE, V404, P974
   SHAPIRA Y, 1976, SURF SCI, V54, P43, DOI 10.1016/0039-6028(76)90086-8
   Shi L, 2004, APPL PHYS LETT, V84, P2638, DOI 10.1063/1.1697622
   Staemmler V, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.106102
   Sverdrup PG, 2001, J HEAT TRANS-T ASME, V123, P130, DOI 10.1115/1.1337651
   TASKER PW, 1979, J PHYS C SOLID STATE, V12, P4977, DOI 10.1088/0022-3719/12/22/036
   Vigue F, 2001, APPL PHYS LETT, V79, P194, DOI 10.1063/1.1384907
   Volz SG, 1999, APPL PHYS LETT, V75, P2056, DOI 10.1063/1.124914
   WAGNER RS, 1964, APPL PHYS LETT, V4, P89, DOI 10.1063/1.1753975
   Wander A, 2001, PHYS REV LETT, V86, P3811, DOI 10.1103/PhysRevLett.86.3811
   WANG XD, 2004, IN PRESS J PHYS CH B
   Wang ZL, 2000, APPL PHYS LETT, V77, P3349, DOI 10.1063/1.1327281
   Wang ZL, 2000, PURE APPL CHEM, V72, P209, DOI 10.1351/pac200072010209
   Wang ZL, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.185502
   Westwater J, 1997, J VAC SCI TECHNOL B, V15, P554, DOI 10.1116/1.589291
   Wolf SA, 2001, SCIENCE, V294, P1488, DOI 10.1126/science.1065389
   Zhang DH, 1996, MATER CHEM PHYS, V45, P248, DOI 10.1016/0254-0584(96)80115-5
   Zhao MH, 2004, NANO LETT, V4, P587, DOI 10.1021/nl035198a
   Zhong J, 2003, APPL PHYS LETT, V83, P3401, DOI 10.1063/1.1621729
NR 66
TC 2294
Z9 2338
U1 102
U2 1406
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 0953-8984
J9 J PHYS-CONDENS MAT
JI J. Phys.-Condes. Matter
PD JUN 30
PY 2004
VL 16
IS 25
BP R829
EP R858
AR PII S0953-8984(04)58969-5
DI 10.1088/0953-8984/16/25/R01
PG 30
WC Physics, Condensed Matter
SC Physics
GA 841SV
UT WOS:000222952800003
DA 2018-10-19
ER

PT J
AU Thornton, AJ
   Alsberg, E
   Albertelli, M
   Mooney, DJ
AF Thornton, AJ
   Alsberg, E
   Albertelli, M
   Mooney, DJ
TI Shape-defining scaffolds for minimally invasive tissue engineering
SO TRANSPLANTATION
LA English
DT Article
ID ALGINATE HYDROGELS; BIOMEDICAL APPLICATIONS; CHONDROCYTES; POLYMER;
   CULTURE; PHOTOPOLYMERIZATION; TRANSPLANTATION; CARTILAGE; DELIVERY;
   MEMORY
AB Background. Minimally invasive surgical procedures are increasingly important in medicine, but biomaterials consistent with this delivery approach that allow one to control the structure of the material after implantation are lacking. Biomaterials with shapememorizing properties could permit minimally invasive delivery of cell transplantation constructs and enable the formation of new tissues or structures in vivo in desired shapes and sizes.
   Methods. Macroporous alginate hydrogel scaffolds were prepared in a number of predefined geometries, compressed into significantly smaller, different "temporary" forms, and introduced into immunocompromised mice by means of minimally invasive surgical delivery through a small catheter. Scaffolds were rehydrated in situ with a suspension of cells (primary bovine articular chondrocytes) or cell-free medium and delivered through the same catheter. Specimens were harvested at 1 hr to evaluate the efficacy of cell delivery and the recovery of scaffold geometry, and at 8 and 24 weeks to evaluate neotissue formation.
   Results. A high percentage (88%) of scaffolds that were introduced with a catheter and rehydrated with cells had recovered their original shape and size within 1 hr. This delivery procedure resulted in cartilage structures with the geometry of the original scaffold by 2 months and histologically mature appearing tissue at 6 months.
   Conclusions. Shaped hydrogels, formed by covalently cross-linking, can be structurally collapsed into smaller, temporary shapes that permit their minimally invasive delivery in vivo. The rapid recovery of scaffold properties facilitates efficient cell seeding in vivo and permits neotissue formation in desired geometries.
C1 Univ Michigan, Dept Biol & Mat Sci, Sch Dent, Ann Arbor, MI 48109 USA.
   Univ Michigan, Unit Lab & Anim Med, Ann Arbor, MI 48109 USA.
   Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
RP Mooney, DJ (reprint author), Univ Michigan, Dept Biol & Mat Sci, Sch Dent, 1011 N Univ Ave,Room 5213, Ann Arbor, MI 48109 USA.
EM mooneyd@umich.edu
RI Albertelli, Megan/C-7650-2011
OI Albertelli, Megan/0000-0001-9433-229X; Alsberg, Eben/0000-0002-3487-4625
FU NIDCR NIH HHS [T32 DE 07057]; NCRR NIH HHS [T32 RR 07008]
CR Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   ALSBERG E, 2001, J DENT RES, V80, P1
   Arevalo-Silva CA, 2000, ARCH OTOLARYNGOL, V126, P1448, DOI 10.1001/archotol.126.12.1448
   ATALA A, 1994, J UROLOGY, V152, P641, DOI 10.1016/S0022-5347(17)32671-X
   Bent AE, 2001, NEUROUROL URODYNAM, V20, P157, DOI 10.1002/1520-6777(2001)20:2<157::AID-NAU18>3.0.CO;2-A
   Bratthall G, 2001, J CLIN PERIODONTOL, V28, P923, DOI 10.1034/j.1600-051x.2001.028010923.x
   Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217
   Chang SCN, 2001, J BIOMED MATER RES, V55, P503, DOI 10.1002/1097-4636(20010615)55:4<503::AID-JBM1043>3.0.CO;2-S
   Duerig TW, 1996, BIO-MED MATER ENG, V6, P255
   Eiselt P, 2000, BIOMATERIALS, V21, P1921, DOI 10.1016/S0142-9612(00)00033-8
   Elisseeff J, 1999, P NATL ACAD SCI USA, V96, P3104, DOI 10.1073/pnas.96.6.3104
   Fuchs KH, 2002, ENDOSCOPY, V34, P154, DOI 10.1055/s-2002-19857
   GUO JF, 1989, CONNECT TISSUE RES, V19, P277, DOI 10.3109/03008208909043901
   Halberstadt C, 2002, TISSUE ENG, V8, P309, DOI 10.1089/107632702753725067
   HAUSELMANN HJ, 1994, J CELL SCI, V107, P17
   Kim SS, 1999, TRANSPLANTATION, V67, P227, DOI 10.1097/00007890-199901270-00007
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee H, 2002, TRANSPLANTATION, V73, P1589, DOI 10.1097/00007890-200205270-00011
   Lee KY, 2000, MACROMOLECULES, V33, P97, DOI 10.1021/ma991286z
   Lee KY, 2000, MACROMOLECULES, V33, P4291, DOI 10.1021/ma9921347
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lowman AM, 1999, J PHARM SCI, V88, P933, DOI 10.1021/js980337n
   Lu SX, 1999, J CONTROL RELEASE, V57, P291, DOI 10.1016/S0168-3659(98)00125-4
   Marler JJ, 2000, PLAST RECONSTR SURG, V105, P2049, DOI 10.1097/00006534-200005000-00020
   Mongia NK, 1996, J BIOMAT SCI-POLYM E, V7, P1055, DOI 10.1163/156856296X00543
   OSADA Y, 1995, NATURE, V376, P219, DOI 10.1038/376219a0
   PAIGE KT, 1996, PLAST RECONSTR SURG, V97, P167
   Passaretti D, 2001, TISSUE ENG, V7, P805, DOI 10.1089/107632701753337744
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Shapiro L, 1997, BIOMATERIALS, V18, P583, DOI 10.1016/S0142-9612(96)00181-0
   Suzuki K, 2000, J BIOMED MATER RES, V49, P528, DOI 10.1002/(SICI)1097-4636(20000315)49:4<528::AID-JBM11>3.0.CO;2-1
   Uyama S, 2001, TRANSPLANTATION, V71, P1226, DOI 10.1097/00007890-200105150-00008
NR 33
TC 62
Z9 68
U1 0
U2 21
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0041-1337
J9 TRANSPLANTATION
JI Transplantation
PD JUN 27
PY 2004
VL 77
IS 12
BP 1798
EP 1803
DI 10.1097/01.tp.0000131152.71117.0e
PG 6
WC Immunology; Surgery; Transplantation
SC Immunology; Surgery; Transplantation
GA 832XC
UT WOS:000222300000004
PM 15223894
DA 2018-10-19
ER

PT J
AU Ferruti, P
   Grigolini, M
   Ranucci, E
AF Ferruti, P
   Grigolini, M
   Ranucci, E
TI PHEMA hydrogels obtained by a novel low-heat curing procedure with a
   potential for in situ preparation
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE curing of polymers; functionalization of polymers; hydrogels; in situ
   polymerization; methacryloylating agent
ID TISSUE-REPAIR; METHACRYLATE; PROSTHESES; POLYMERS; IMPLANT; DISC
AB In this work, we report on poly(2-hydroxethyl methacrylate) (PHEMA) hydrogels obtained by a low heat curing reaction. These materials are suitable for in situ preparation and therefore endowed with a potential for several biomedical applications. The novel procedure adopted involves as the first step the synthesis of a soluble oligomeric PHEMA precursor containing polymerizable functions as side substituents. As the second step, the precursor is dissolved in equal amounts of 2-hydroxyethyl methacrylate (HEMA) and water, to form a viscous but still injectable syrup. A low temperature water soluble initiator is then added. The curing reaction starts promptly and is completed within a few minutes. During the entire process the internal temperature never rises above 40degreesC. Preliminary mechanical characterizations performed on the hydrogels in their water-swollen state and diffusion tests in absorption/desorption experiments clearly indicated that on all respects the novel hydrogels are comparable with conventional PHEMA hydrogels obtained according to literature from HEMA in the presence of divinyl crosslinkers. However, the much shorter curing time combined with the far lower curing temperature endow the new hydrogels with a higher potential in view of specific surgical requirements, and particularly for in situ preparation.
C1 Dipartimento Chim Organ & Ind, I-20123 Milan, Italy.
RP Ferruti, P (reprint author), Dipartimento Chim Organ & Ind, Via Venezia 21, I-20123 Milan, Italy.
EM elisabetta.ranucci@unimi.it
RI Ranucci, Elisabetta/J-3899-2015
OI Ranucci, Elisabetta/0000-0002-6402-2650; Ferruti,
   Paolo/0000-0002-5404-440X
CR Ambrosio L, 1996, J MATER SCI-MATER M, V7, P251, DOI 10.1007/BF00058561
   Bao QB, 1996, BIOMATERIALS, V17, P1157, DOI 10.1016/0142-9612(96)84936-2
   Bavaresco VP, 2000, ARTIF ORGANS, V24, P202, DOI 10.1046/j.1525-1594.2000.06518.x
   Cappello J, 1998, J CONTROL RELEASE, V53, P105, DOI 10.1016/S0168-3659(97)00243-5
   Cellesi F, 2002, MACROMOL CHEM PHYSIC, V203, P1466, DOI 10.1002/1521-3935(200207)203:10/11<1466::AID-MACP1466>3.0.CO;2-P
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   DAVIS PA, 1991, HIGH PERFORMANCE BIO, P343
   Halstenberg S, 2002, BIOMACROMOLECULES, V3, P710, DOI 10.1021/bm015629o
   Hicks CR, 1999, BRIT J OPHTHALMOL, V83, P616, DOI 10.1136/bjo.83.5.616
   Khan AJ, 1999, J CATARACT REFR SURG, V25, P1404, DOI 10.1016/S0886-3350(99)00199-6
   KOLARIK K, 1981, J BIOMED MATER RES, V15, P147
   Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lesny P, 2002, J CHEM NEUROANAT, V23, P243, DOI 10.1016/S0891-0618(02)00011-X
   Lindblad MS, 2001, MACROMOL RAPID COMM, V22, P962
   LUTOLF MP, 2003, ADV MATER, V11, P888
   NETTI PA, 1993, BIOMATERIALS, V14, P1098, DOI 10.1016/0142-9612(93)90211-J
   Park YD, 2003, BIOMATERIALS, V24, P893, DOI 10.1016/S0142-9612(02)00420-9
   Ranucci E, 2003, MACROMOL BIOSCI, V3, P742, DOI 10.1002/mabi.200350036
   Ranucci E, 1999, MACROMOL RAPID COMM, V20, P1
   Vernon B, 2003, J BIOMED MATER RES A, V64A, P447, DOI 10.1002/jbm.a.10369
NR 21
TC 4
Z9 5
U1 0
U2 7
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD JUN 25
PY 2004
VL 4
IS 6
BP 591
EP 600
DI 10.1002/mabi.200300130
PG 10
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 834VX
UT WOS:000222440100007
PM 15468253
DA 2018-10-19
ER

PT J
AU Brousmiche, DW
   Serin, JM
   Frechet, JMJ
   He, GS
   Lin, TC
   Chung, SJ
   Prasad, PN
   Kannan, R
   Tan, LS
AF Brousmiche, DW
   Serin, JM
   Frechet, JMJ
   He, GS
   Lin, TC
   Chung, SJ
   Prasad, PN
   Kannan, R
   Tan, LS
TI Fluorescence resonance energy transfer in novel multiphoton absorbing
   dendritic structures
SO JOURNAL OF PHYSICAL CHEMISTRY B
LA English
DT Article
ID ABSORPTION CROSS-SECTION; OPTICAL-DATA STORAGE; 2-PHOTON ABSORPTION;
   2-PHOTON-ABSORBING CHROMOPHORES; LASING PROPERTIES; ORGANIC MATERIALS;
   DYE-SOLUTION; MICROFABRICATION; SPECTROSCOPY; MOLECULES
AB A series of small dendritic structures containing one of two efficient multiphoton absorbing dyes at the periphery and a nile red derivative at the core have been synthesized. These molecules display efficient ( > 96%) fluorescence resonance energy transfer (FRET) from the periphery to the core on selective excitation of the two-photon absorbing chromophore by either UV (linear absorption) or high-intensity IR (nonlinear absorption) radiation. In addition, a significant increase in core emission is observed on excitation of the peripheral chromophores, compared to direct excitation of the core. This "antenna effect" essentially doubles between increasing dendrimer generations within a series. The combination of the ability of the peripheral chromophores to absorb high-intensity IR radiation, coupled with a very efficient energy transfer process and a significant increase in the fluorescence of the acceptor chromophore, makes these molecules potentially useful for a variety of applications, including optical power limiting and biomedical imaging.
C1 Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.
   SUNY Buffalo, Inst Lasers Photon & Biophoton, Berkeley, CA 94720 USA.
   Lawrence Berkeley Natl Lab, Div Sci Mat, Berkeley, CA 94720 USA.
   MLBP, AFRL, Polymer Branch, Wright Patterson AFB, OH 45433 USA.
RP Frechet, JMJ (reprint author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.
EM frechet@cchem.berkeley.edu
RI Tan, Loon-Seng/F-6985-2012
OI Tan, Loon-Seng/0000-0002-2134-9290; Frechet, Jean/0000-0001-6419-0163
CR Adronov A, 2000, CHEM MATER, V12, P2838, DOI 10.1021/cm000586o
   Adronov A, 2000, J AM CHEM SOC, V122, P1175, DOI 10.1021/ja993272e
   Belfield KD, 2002, CHEM MATER, V14, P3663, DOI 10.1021/cm0107981
   Belfield KD, 2000, J ORG CHEM, V65, P4475, DOI 10.1021/jo991950+
   Bhawalkar J. D., 1997, J CLIN MED SURG, V37, P510
   Bhawalkar JD, 1996, REP PROG PHYS, V59, P1041, DOI 10.1088/0034-4885/59/9/001
   BIRGE RR, 1979, J CHEM PHYS, V70, P165, DOI 10.1063/1.437217
   Briggs M. S. J., 1997, J CHEM SOC P1, V7, P1051
   Brousmiche DW, 2003, J AM CHEM SOC, V125, P1448, DOI 10.1021/ja0288688
   Chung SJ, 1999, J PHYS CHEM B, V103, P10741, DOI 10.1021/jp992846z
   Chung SJ, 2001, CHEM MATER, V13, P4071, DOI 10.1021/cm010151g
   Cumpston BH, 1999, NATURE, V398, P51
   DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027
   Drobizhev M, 2001, OPT LETT, V26, P1081, DOI 10.1364/OL.26.001081
   Fakis M, 2000, CHEM PHYS LETT, V323, P111, DOI 10.1016/S0009-2614(00)00494-2
   Fisher WG, 1997, PHOTOCHEM PHOTOBIOL, V66, P141, DOI 10.1111/j.1751-1097.1997.tb08636.x
   Frederiksen PK, 2001, J AM CHEM SOC, V123, P1215, DOI 10.1021/ja003468a
   Gil L, 1999, BIOORGAN MED CHEM, V7, P901, DOI 10.1016/S0968-0896(99)00045-0
   Gilat SL, 1999, ANGEW CHEM INT EDIT, V38, P1422, DOI 10.1002/(SICI)1521-3773(19990517)38:10<1422::AID-ANIE1422>3.0.CO;2-V
   Goppert-Mayer M, 1931, ANN PHYS-BERLIN, V9, P273
   HE GS, 1995, OPT LETT, V20, P1524, DOI 10.1364/OL.20.001524
   He GS, 1997, J APPL PHYS, V81, P2529, DOI 10.1063/1.364303
   HE GS, 1995, OPT LETT, V20, P2393, DOI 10.1364/OL.20.002393
   HE GS, 2003, J OPT LETT, V28, P768
   Joshi MP, 1998, OPT LETT, V23, P1742, DOI 10.1364/OL.23.001742
   Kannan R, 2001, CHEM MATER, V13, P1896, DOI 10.1021/cm000747o
   Kim OK, 2000, CHEM MATER, V12, P284, DOI 10.1021/cm990662r
   Lee WH, 2001, J AM CHEM SOC, V123, P10658, DOI 10.1021/ja004226d
   Lei H, 2001, CHEM PHYS LETT, V333, P387, DOI 10.1016/S0009-2614(00)01381-6
   MCCLAIN WM, 1974, ACCOUNTS CHEM RES, V7, P129, DOI 10.1021/ar50077a001
   MUGNIER J, 1985, J LUMIN, V33, P273, DOI 10.1016/0022-2313(85)90004-3
   Ohkuma S, 2002, J PHOTOPOLYM SCI TEC, V15, P23, DOI 10.2494/photopolymer.15.23
   Pan GL, 2001, CHEM COMMUN, P1744, DOI 10.1039/b102876f
   PARTHENOPOULOS DA, 1989, SCIENCE, V245, P843, DOI 10.1126/science.245.4920.843
   PETICOLA.WL, 1967, ANNU REV PHYS CHEM, V18, P233, DOI 10.1146/annurev.pc.18.100167.001313
   Pudavar HE, 1999, APPL PHYS LETT, V74, P1338, DOI 10.1063/1.123543
   Reinhardt BA, 1998, CHEM MATER, V10, P1863, DOI 10.1021/cm980036e
   Serin JM, 2002, CHEM COMMUN, P2605, DOI 10.1039/b207905d
   Serin JM, 2002, J AM CHEM SOC, V124, P11848, DOI 10.1021/ja027564i
   Shen YZ, 2000, APPL PHYS LETT, V76, P1, DOI 10.1063/1.125637
   So PTC, 2000, ANNU REV BIOMED ENG, V2, P399, DOI 10.1146/annurev.bioeng.2.1.399
   Spangler CW, 1999, J MATER CHEM, V9, P2013, DOI 10.1039/a902802a
   Tan LS, 2003, P SOC PHOTO-OPT INS, V4797, P171, DOI 10.1117/12.453273
   Tang XJ, 2002, CHEM PHYS LETT, V356, P573, DOI 10.1016/S0009-2614(02)00416-5
   Wang C, 2001, OPT COMMUN, V192, P315, DOI 10.1016/S0030-4018(01)01166-X
   Wang XM, 2001, J MATER CHEM, V11, P1600, DOI 10.1039/b009769l
   Zhou GY, 2002, APPL OPTICS, V41, P1120, DOI 10.1364/AO.41.001120
   Zhou WH, 2002, SCIENCE, V296, P1106, DOI 10.1126/science.296.5570.1106
   Zhou YF, 2000, SOLID STATE COMMUN, V116, P605, DOI 10.1016/S0038-1098(00)00387-2
NR 49
TC 73
Z9 73
U1 0
U2 12
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1520-6106
J9 J PHYS CHEM B
JI J. Phys. Chem. B
PD JUN 24
PY 2004
VL 108
IS 25
BP 8592
EP 8600
DI 10.1021/jp049948w
PG 9
WC Chemistry, Physical
SC Chemistry
GA 830MI
UT WOS:000222125900014
DA 2018-10-19
ER

PT J
AU Feddes, B
   Wolke, JGC
   Vredenberg, AM
   Jansen, JA
AF Feddes, B
   Wolke, JGC
   Vredenberg, AM
   Jansen, JA
TI Adhesion of calcium phosphate ceramic on polyethylene (PE) and
   polytetrafluoroethylene (PTFE)
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE adhesion test; radio frequency (RF); magnetron; sputtering;
   polyethylene; calcium phosphate ceramic
ID MAGNETRON SPUTTERING DEPOSITION; SURFACE MODIFICATION;
   ULTRAVIOLET-IRRADIATION; THIN-FILMS; POLYMERS; COATINGS
AB Calcium phosphate (CaP) ceramic coatings are often used on biomedical implants for its osteoinductive properties. In this work, the adhesion of r.f. magnetron sputter deposited CaP ceramic on PE and PTFE was studied by tensile and interface elongation tests. Both untreated and oxygen plasma pretreated substrates were used. The adhesion of CaP to PE was found to be good. In tensile tests, the coated material was glued to the pull rods using an epoxy adhesive. Usually, the epoxy failed instead of the CaP-PE interface. Moreover, the interfacial plane of the CaP coated PE could be extended to twice its normal size without the delamination of the coating. No significant difference was found between the untreated and plasma pretreated material. Additional experiments were performed to clarify what mechanism is responsible for the good adhesion of CaP to PE. Good adhesion is the result of a bombardment by energetic oxygen ions that originate from the sputtering target. The absence of this bombardment causes a lower number of chemical bonds between the polymer and the coating, and therefore the delamination of the coating. The PTFE showed a different behavior. The locus of failure in the tensile tests was within the PTFE. No significant difference was found whether or not a plasma pre-treatment was given. UV light induced damage of the PTFE is the most likely reason for the cohesive failure. The UV light is emitted from the plasma and is transmitted by the CaP coating. (C) 2003 Elsevier B.V. All rights reserved.
C1 Univ Nijmegen, Med Ctr, Coll Dent Sci, Dept Biomat, NL-6500 HB Nijmegen, Netherlands.
   Univ Utrecht, Debye Inst, Sect Interface Phys, NL-3508 TA Utrecht, Netherlands.
RP Jansen, JA (reprint author), Univ Nijmegen, Med Ctr, Coll Dent Sci, Dept Biomat, POB 9101, NL-6500 HB Nijmegen, Netherlands.
EM j.jansen@dent.umcn.nl
RI Institute (DINS), Debye/G-7730-2014; Jansen, John/H-8055-2014; Wolke,
   J.G.C./L-4768-2015
CR BAGLIN JEE, 1989, NUCL INSTRUM METH B, V39, P764, DOI 10.1016/0168-583X(89)90892-6
   BODO P, 1986, J APPL PHYS, V60, P1161, DOI 10.1063/1.337361
   CHANG CA, 1987, APPL PHYS LETT, V51, P103, DOI 10.1063/1.98637
   CHAPIRO A, 1988, NUCL INSTRUM METH B, V32, P111, DOI 10.1016/0168-583X(88)90191-7
   de Groot K, 1983, BIOCERAMICS CALCIUM
   Dong H, 1999, SURF COAT TECH, V111, P29, DOI 10.1016/S0257-8972(98)00698-7
   Durand AM, 1997, VIDE, V53, P242
   Feddes B, 2003, J APPL PHYS, V93, P9503, DOI 10.1063/1.1576894
   Feddes B, 2003, J APPL PHYS, V93, P662, DOI 10.1063/1.1525857
   Feddes B, 2003, J VAC SCI TECHNOL A, V21, P363, DOI 10.1116/1.1535176
   FEDDES B, UNPUB SURF COAT TECH
   FEDDES B, IN PRESS BIOMATERIAL
   Fujinami Y, 1998, MATER CHEM PHYS, V54, P102, DOI 10.1016/S0254-0584(98)00094-7
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hontsu S, 1998, JPN J APPL PHYS 2, V37, pL1169, DOI 10.1143/JJAP.37.L1169
   Jansen J A, 1993, Clin Oral Implants Res, V4, P28, DOI 10.1034/j.1600-0501.1993.040104.x
   Koh SK, 1997, MATER RES SOC SYMP P, V438, P523
   LEE EH, 1994, J MATER RES, V9, P1043, DOI 10.1557/JMR.1994.1043
   LISTON EM, 1993, J ADHES SCI TECHNOL, V7, P1091, DOI 10.1163/156856193X00600
   MATIENZO LJ, 1994, J VAC SCI TECHNOL A, V12, P2662, DOI 10.1116/1.579086
   Noh I, 1997, J POLYM SCI POL CHEM, V35, P1499
   PAWEL JE, 1990, NUCL INSTRUM METH B, V46, P392, DOI 10.1016/0168-583X(90)90735-D
   Ratchev BA, 1995, NUCL INSTRUM METH B, V106, P68, DOI 10.1016/0168-583X(95)00681-8
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   TANAHASHI M, 1994, J AM CERAM SOC, V77, P2805, DOI 10.1111/j.1151-2916.1994.tb04508.x
   van Dijk K, 1998, J BIOMED MATER RES, V41, P624, DOI 10.1002/(SICI)1097-4636(19980915)41:4<624::AID-JBM15>3.0.CO;2-E
   Van Dijk K., 1995, Journal of Biomedical Materials Research, V29, P269
   Weast R. C., 1968, HDB CHEM PHYS
NR 28
TC 14
Z9 16
U1 0
U2 16
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD JUN 22
PY 2004
VL 184
IS 2-3
BP 247
EP 254
DI 10.1016/j.surfcoat.2003.10.013
PG 8
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 829JJ
UT WOS:000222044000017
DA 2018-10-19
ER

PT J
AU Ohgoe, Y
   Hirakuri, KK
   Tsuchimoto, K
   Friedbacher, G
   Miyashita, O
AF Ohgoe, Y
   Hirakuri, KK
   Tsuchimoto, K
   Friedbacher, G
   Miyashita, O
TI Uniform deposition of diamond-like carbon films on polymeric materials
   for biomedical applications
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE diamond-like carbon; chemical vapor deposition; biomaterials; IR
   spectroscopy; electron spectroscopy for chemical analysis; scanning
   electron microscopy observation
ID SOURCE ION-IMPLANTATION; PLASMA; SURFACE
AB Diamond-like carbon (DLC) films are interesting in biomedical application for the improvement of the histocompatibility, blood compatibility and durability of diaphragms in artificial hearts. In order to achieve uniform deposition of DLC films on hemispherical polymer diaphragms used in artificial hearts to prevent inter-diffusion of driving fluid (silicone oil) and blood, coating has been performed by chemical vapor deposition using improved electrodes. The chemical and physical properties of the produced films as well as their durability have been investigated with infrared spectroscopy and electron spectroscopy for chemical analysis before and after the driving operation of the diaphragm. The uniformity of the films has been compared with DLC films obtained with conventional electrodes showing that the uniformity could be improved, thus obtaining DLC films with good durability and excellent adhesion properties as required for biomedical application. (C) 2003 Elsevier B.V. All rights reserved.
C1 Tokyo Denki Univ, Fac Sci & Engn, Dept Elect & Comp Engn, Hatoyama, Saitama 35003, Japan.
   Aisin Cosmos Res & Dev Co Ltd, Kariya, Aichi 4488650, Japan.
   Tech Univ Vienna, Inst Chem Technol & Analyt, Div Analyt Chem, A-1060 Vienna, Austria.
RP Ohgoe, Y (reprint author), Tokyo Denki Univ, Fac Sci & Engn, Dept Elect & Comp Engn, Hatoyama, Saitama 35003, Japan.
EM yas@ff.f.dendai.ac.jp
CR Alanazi A, 2000, ASAIO J, V46, P440, DOI 10.1097/00002480-200007000-00014
   Alanazi A, 2000, ARTIF ORGANS, V24, P624, DOI 10.1046/j.1525-1594.2000.06576.x
   BERG S, 1979, THIN SOLID FILMS, V58, P117, DOI 10.1016/0040-6090(79)90220-7
   CONRAD JR, 1989, J APPL PHYS, V65, P1707, DOI 10.1063/1.342942
   CONRAD JR, 1987, J APPL PHYS, V62, P4591, DOI 10.1063/1.339055
   Cooke A. F., 1978, Engineering in Medicine, V7, P66
   DESCOEUDRES A, 2003, PLASMA SOURCES SCI T, V152, P12
   FABER JJ, 1967, J APPL PHYSIOL, V22, P793
   Hirakuri KK, 1997, THIN SOLID FILMS, V302, P5, DOI 10.1016/S0040-6090(97)00022-9
   HOLLAND L, 1975, THIN SOLID FILMS, V27, P185, DOI 10.1016/0040-6090(75)90026-7
   HOLLAND L, 1977, J VAC SCI TECHNOL, V14, P4
   KOBAYASHI K, 1988, THIN SOLID FILMS, V158, P233, DOI 10.1016/0040-6090(88)90025-9
   Komatsu Y, 1999, DIAM RELAT MATER, V8, P2018, DOI 10.1016/S0925-9635(99)00138-7
   MARTON D, 1994, PHYS REV LETT, V73, P10353
   Miyagawa S, 2000, SURF COAT TECH, V128, P260, DOI 10.1016/S0257-8972(00)00588-0
   Munson CP, 1996, SURF COAT TECH, V84, P528, DOI 10.1016/S0257-8972(95)02836-6
   MUTSUKURA N, 1992, J APPL PHYS, V72, P43, DOI 10.1063/1.352145
   OHGOE Y, 2002, TANSO, V202, P71
   VORONKIN MA, 1994, DIAM RELAT MATER, V4, P5, DOI 10.1016/0925-9635(94)90061-2
   WANG HS, 1994, SURF COAT TECH, V66, P525, DOI 10.1016/0257-8972(94)90062-0
   Watanabe T, 2003, DIAM RELAT MATER, V12, P105, DOI 10.1016/S0925-9635(03)00010-4
   WEISSMANTEL C, 1982, THIN SOLID FILMS, V96, P31, DOI 10.1016/0040-6090(82)90210-3
NR 22
TC 31
Z9 34
U1 0
U2 18
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD JUN 22
PY 2004
VL 184
IS 2-3
BP 263
EP 269
DI 10.1016/j.surfcoat.2003.10.009
PG 7
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 829JJ
UT WOS:000222044000019
DA 2018-10-19
ER

PT J
AU Siegers, C
   Biesalski, M
   Haag, R
AF Siegers, C
   Biesalski, M
   Haag, R
TI Self-assembled monolayers of dendritic polyglycerol derivatives on gold
   that resist the adsorption of proteins
SO CHEMISTRY-A EUROPEAN JOURNAL
LA English
DT Article
DE biocompatible materials; dendrimers; polymers; proteins; surface
   chemistry
ID THIOCTIC ACID; HYPERBRANCHED POLYGLYCEROLS; MOLECULAR-CONFORMATION;
   THIN-FILMS; SURFACES; ARCHITECTURES; ATTACHMENT; POLYETHER; ADHESION;
   ANTIGEN
AB Highly protein-resistant, self-assembled monolayers (SAMs) of dendritic polyglycerols (PGs) on gold can easily be obtained by simple chemical modification of these readily available polymers with a surface-active disulfide linker group. Several disulfide-functionalized PGs were synthesized by N,N'-dicyclohexylcarbodiimide-mediated ester coupling of thioctic acid. Monolayers of the disulfide-functionalized PG derivatives spontaneously form on a semitransparent gold surface and effectively prevent the adsorption of proteins, as demonstrated by surface plasmon resonance (SPR) kinetic measurements. A structure-activity relationship relating the polymer architecture to its ability to effectuate protein resistance has been derived from results of different surface characterization techniques (SPR, attenuated total reflectance infrared (ATR-IR), and contact-angle measurements). Dendritic PGs combine the characteristic structural features of several highly protein-resistant surfaces: a highly flexible aliphatic polyether, hydrophilic surface groups, and a highly branched architecture. PG monolayers are as protein resistant as poly(ethylene glycol) (PEG) SAMs and are significantly better than dextran-coated surfaces, which are currently used as the background for SPR spectroscopy. Due to the higher thermal and oxidative stability of the bulk PG as compared to the PEG and the easy accessibility of these materials, dendritic polyglycerols are novel and promising candidates as surface coatings for biomedical applications.
C1 Univ Freiburg, Inst Makromol Chem, D-79104 Freiburg, Germany.
   Freiburger Mat Forschungszentrum, D-79104 Freiburg, Germany.
   Univ Freiburg, Inst Mikrosyst Tech, D-79110 Freiburg, Germany.
RP Haag, R (reprint author), Univ Dortmund, Otto Hahn Str 6, D-44227 Dortmund, Germany.
EM rainer.haag@uni-dortmund.de
CR ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   BAIER RE, 1984, J BIOMED MATER RES, V18, P337, DOI 10.1002/jbm.820180404
   Berggren C, 1997, ANAL CHEM, V69, P3651, DOI 10.1021/ac970203e
   Chapman RG, 2001, LANGMUIR, V17, P1225, DOI 10.1021/la001222d
   Chapman RG, 2000, J AM CHEM SOC, V122, P8303, DOI 10.1021/ja000774f
   Chapman RG, 2000, LANGMUIR, V16, P6927, DOI 10.1021/la9915791
   Dong YZ, 2003, LANGMUIR, V19, P8922, DOI 10.1021/la0261141
   Dong YZ, 2000, ANAL CHEM, V72, P2371, DOI 10.1021/ac991450g
   DUAN CM, 1995, MIKROCHIM ACTA, V117, P195, DOI 10.1007/BF01244890
   Falbe J, 1995, ROMPP CHEM LEXIKON
   Frazier RA, 2000, BIOMATERIALS, V21, P957, DOI 10.1016/S0142-9612(99)00270-7
   FRENTZEN M, 1988, DEUT ZAHNAERZTL Z, V43, P719
   Frey H, 2002, REV MOL BIOTECHNOL, V90, P257, DOI DOI 10.1016/S1389-0352(01)00063-0
   GOODMAN SL, 1990, J COLLOID INTERF SCI, V139, P561, DOI 10.1016/0021-9797(90)90129-C
   GORDIENOK NI, 1986, RUSS J APPL CHEM, V59, P1441
   Haag R, 2000, MACROMOLECULES, V33, P8158, DOI 10.1021/ma000831p
   Haag R, 2000, J AM CHEM SOC, V122, P2954, DOI 10.1021/ja994363e
   Haag R., 2002, [No title captured], Patent No. [DE10211664A1, 10211664]
   Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z
   Harris J. M., 1997, POLYETHYLENE GLYCOL
   Holland NB, 1998, NATURE, V392, P799
   JENKINS SH, 1988, ANAL BIOCHEM, V168, P292, DOI 10.1016/0003-2697(88)90321-1
   Jung LS, 2000, J PHYS CHEM B, V104, P11168, DOI 10.1021/jp001649t
   Knoll W, 1998, ANNU REV PHYS CHEM, V49, P569, DOI 10.1146/annurev.physchem.49.1.569
   KOMP A, UNPUB
   Lehmann T, 1999, MACROMOL SYMP, V142, P1, DOI 10.1002/masy.19991420103
   Luk YY, 2000, LANGMUIR, V16, P9604, DOI 10.1021/la0004653
   Madoz J, 1997, J AM CHEM SOC, V119, P1043, DOI 10.1021/ja963465r
   MATSUURA H, 1985, J MOL STRUCT, V126, P251, DOI 10.1016/0022-2860(85)80118-6
   Metzke M, 2003, J AM CHEM SOC, V125, P7760, DOI 10.1021/ja0349507
   MRKSICH M, 1995, LANGMUIR, V11, P4383, DOI 10.1021/la00011a034
   NAGAOKA S, 1984, POLYM BIOMATERIALS, P361
   OSTERBERG E, 1995, J BIOMED MATER RES, V29, P741, DOI 10.1002/jbm.820290610
   OSTERBERG E, 1993, COLLOID SURFACE A, V77, P159, DOI 10.1016/0927-7757(93)80112-R
   Ostuni E, 2001, LANGMUIR, V17, P6336, DOI 10.1021/la010552a
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   PALEGROSDEMANGE C, 1991, J AM CHEM SOC, V113, P12, DOI 10.1021/ja00001a002
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   RABINOW BE, 1994, J BIOMAT SCI-POLYM E, V6, P91, DOI 10.1163/156856295X00788
   Raether H., 1988, SURFACE PLASMONS SMO
   SADANA A, 1992, CHEM REV, V92, P1799, DOI 10.1021/cr00016a006
   SCHLENOFF JB, 1995, MACROMOLECULES, V28, P4280
   SCHLETTWEIN D, 1994, CHEM MATER, V6, P3, DOI 10.1021/cm00037a001
   Sigal GB, 1998, J AM CHEM SOC, V120, P3464, DOI 10.1021/ja970819l
   Sunder A, 1999, MACROMOLECULES, V32, P4240, DOI 10.1021/ma990090w
   Sunder A, 2000, ADV MATER, V12, P235, DOI 10.1002/(SICI)1521-4095(200002)12:3<235::AID-ADMA235>3.3.CO;2-P
   Sunder A, 2000, MACROMOLECULES, V33, P253, DOI 10.1021/ma9915881
   SUNDER A, 1998, Patent No. 19947631
   Tomizaki K, 2002, J ORG CHEM, V67, P6519, DOI 10.1021/jo0258002
   Wang RLC, 1997, J PHYS CHEM B, V101, P9767, DOI 10.1021/jp9716952
   Wang Y, 1998, J PHYS CHEM B, V102, P9922, DOI 10.1021/jp982824x
NR 51
TC 199
Z9 201
U1 3
U2 64
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0947-6539
J9 CHEM-EUR J
JI Chem.-Eur. J.
PD JUN 7
PY 2004
VL 10
IS 11
BP 2831
EP 2838
DI 10.1002/chem.200306073
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA 828JJ
UT WOS:000221969300022
PM 15195314
DA 2018-10-19
ER

PT J
AU Choi, HM
   Bide, M
   Phaneuf, M
   Quist, W
   LoGerfo, F
AF Choi, HM
   Bide, M
   Phaneuf, M
   Quist, W
   LoGerfo, F
TI Dyeing of wool with antibiotics to develop novel infection resistance
   materials for extracorporeal end use
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE wool; doxycycline; ciprofloxacin; biomaterials; absorption; FTIR
ID DACRON; CIPROFLOXACIN; SPECTROSCOPY; TECHNOLOGY; NYLON; FTIR
AB Two antibiotics, doxycycline (Doxy) and ciprofloxacin (Cipro), were applied under a variety of conditions to wool and to hydrolyzed wool at 40degreesC. Nylon was used as a synthetic control. Sorption of Doxy was much higher in wool than in nylon, whereas sorption of Cipro was similar in both fibers. FTIR spectroscopy confirmed that a drastic increase in sorption of antibiotics by hydrolyzed wool was attributed to an increase in polar functional groups by peptide scission and in oxidized sulfur groups by cystine oxidation. Both sorption and zone of inhibition (ZOI) values were improved by hydrolysis of wool. Wool hydrolyzed for 20 or 40 min at 40degreesC and dyed with Doxy at 45degreesC for 3.5 h maintained around 30 mm of ZOI after 24 h of challenge by a simulated flow of blood. Wool hydrolyzed for 60 min at 40degreesC and dyed with Cipro at 45degreesC for 3.5 h also maintained its antibiotic activity for an extended time. For the most part, ZOI values for nylon dyed by both antibiotics were zero within 24 h. This technique produced infection-resistant biomaterials of potential use in extra-corporeal biomedical and biological applications. (C) 2004 Wiley Periodicals, Inc.
C1 Soongsil Univ, Sch Text, Seoul, South Korea.
   Univ Rhode Isl, Dept Text, Kingston, RI 02881 USA.
   Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.
RP Choi, HM (reprint author), Soongsil Univ, Sch Text, Seoul, South Korea.
EM hchoi@ssu.ac.kr
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   ASAI M, 1955, J PHYS CHEM-US, V59, P322, DOI 10.1021/j150526a011
   Benavides S, 2002, ANN PHARMACOTHER, V36, P334
   BIDE M, 1993, TEXT CHEM COLOR, V25, P15
   BIDE M, 2001, ACS SYM SER, V792, P125
   BIDE M, 2002, 2002 AATCC INT C EXH
   BOCKER R, 1980, J CHROMATOGR, V187, P439, DOI 10.1016/S0021-9673(00)80479-3
   BURKINSHAW SM, 1990, CHEM APPL DYES, P365
   Carter EA, 1996, TEXT RES J, V66, P787, DOI 10.1177/004051759606601207
   CHANKOVA D, 1996, PROBL INF PARASIT DI, V23, P6
   CHOI H, IN PRESS TEXT RES J
   Cooper SJ, 2001, POLYMER, V42, P10119, DOI 10.1016/S0032-3861(01)00566-3
   Diz M, 1997, TEXT RES J, V67, P486, DOI 10.1177/004051759706700703
   Erra P, 1997, TEXT RES J, V67, P397, DOI 10.1177/004051759706700602
   FOX CL, 1986, Patent No. 4563485
   GLASBY JS, 1992, ENCY ANTIBIOTICS, P243
   HARVEY R, 1981, ANN SURG, P642
   HARVEY RA, 1984, AM J SURG, V147, P205, DOI 10.1016/0002-9610(84)90089-8
   HARVEY RA, 1982, SURGERY, V92, P504
   HAVERICH A, 1992, J VASC SURG, V15, P187, DOI 10.1016/0741-5214(92)70027-I
   Lin J, 2001, POLYMER, V42, P7903, DOI 10.1016/S0032-3861(01)00272-5
   MOHAMMED A, 1995, SMALL RUMINANT RES, V16, P191, DOI 10.1016/0921-4488(95)00617-T
   MURTY EM, 1990, POLYM ENG SCI, V30, P1595, DOI 10.1002/pen.760302407
   PETERS RH, 1963, TEXTILE CHEM, V1, P302
   Phaneuf MD, 2001, BIOMATERIALS, V22, P463, DOI 10.1016/S0142-9612(00)00202-7
   PHANEUF MD, 1995, J APPL BIOMATER, V6, P289, DOI 10.1002/jab.770060410
   PHANEUF MD, 1993, J BIOMED MATER RES, V27, P233, DOI 10.1002/jbm.820270213
   Rao C. N. R, 1963, CHEM APPL INFRARED S, P175
   SHALABY SW, 1985, HIGH TECHNOLOGY FI A, P87
   Torniainen K, 1996, INT J PHARM, V132, P53, DOI 10.1016/0378-5173(95)04332-2
   Yuan CQ, 2001, AATCC REV, V1, P35
NR 31
TC 11
Z9 11
U1 0
U2 5
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD JUN 5
PY 2004
VL 92
IS 5
BP 3343
EP 3354
DI 10.1002/app.20332
PG 12
WC Polymer Science
SC Polymer Science
GA 811GC
UT WOS:000220759400072
DA 2018-10-19
ER

PT J
AU Opdahl, A
   Koffas, TS
   Amitay-Sadovsky, E
   Kim, J
   Somorjai, GA
AF Opdahl, A
   Koffas, TS
   Amitay-Sadovsky, E
   Kim, J
   Somorjai, GA
TI Characterization of polymer surface structure and surface mechanical
   behaviour by sum frequency generation surface vibrational spectroscopy
   and atomic force microscopy
SO JOURNAL OF PHYSICS-CONDENSED MATTER
LA English
DT Review
ID HYDROGEL CONTACT-LENSES; POLYSTYRENE SURFACE; SIDE BRANCHES; SFG;
   INTERFACES; WATER; FILMS; CONFORMATION; CATALYSIS; ALIGNMENT
AB Sum frequency generation (SFG) vibrational spectroscopy and atomic force microscopy (AFM) have been used to study polymer surface structure and surface mechanical behaviour, specifically to study the relationships between the surface properties of polymers and their bulk compositions and the environment to which the polymer is exposed. The combination of SFG surface vibrational spectroscopy and AFM has been used to study surface segregation behaviour of polyolefin blends at the polymer/air and polymer/solid interfaces. SFG surface vibrational spectroscopy and AFM experiments have also been performed to characterize the properties of polymer/liquid and polymer/polymer interfaces, focusing on hydrogel materials. A method was developed to study the surface properties of hydrogel contact lens materials at various hydration conditions. Finally, the effect of mechanical stretching on the surface composition and surface mechanical behaviour of phase-separated polyurethanes, used in biomedical implant devices, has been studied by both SFG surface vibrational spectroscopy and AFM.
C1 Univ Calif Berkeley, Dept Chem, Berkeley & Mat Sci Div, Lawrence Berkeley Lab, Berkeley, CA 94720 USA.
   Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA.
RP Opdahl, A (reprint author), Univ Calif Berkeley, Dept Chem, Berkeley & Mat Sci Div, Lawrence Berkeley Lab, Berkeley, CA 94720 USA.
EM somorjai@socrates.berkeley.edu
CR AKMAL N, 1998, POLYM SENSORS THEORY
   Amitay-Sadovsky E, 2003, J PHYS CHEM B, V107, P6377, DOI 10.1021/jp030169+
   Amitay-Sadovsky E, 2002, J APPL PHYS, V91, P375, DOI 10.1063/1.1417990
   Aoike T, 2001, LANGMUIR, V17, P2153, DOI 10.1021/la001326o
   Briggman KA, 2001, J PHYS CHEM B, V105, P2785, DOI 10.1021/jp0037495
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chen CY, 2002, MACROMOLECULES, V35, P9130, DOI 10.1021/ma020614j
   Chen Z, 2002, ANNU REV PHYS CHEM, V53, P437, DOI 10.1146/annurev.physchem.53.091801.115126
   Davis KA, 2002, CRIT REV THER DRUG, V19, P385, DOI 10.1615/CritRevTherDrugCarrierSyst.v19.i45.30
   Dreesen L, 2001, CHEM PHYS LETT, V333, P327, DOI 10.1016/S0009-2614(00)01383-X
   EISENBERG D, 1986, NATURE, V319, P199, DOI 10.1038/319199a0
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   FONTYN M, 1991, COLLOID SURFACE, V54, P349, DOI 10.1016/0166-6622(91)80073-W
   Gautam KS, 2000, PHYS REV LETT, V85, P3854, DOI 10.1103/PhysRevLett.85.3854
   Goodwin J. W., 1995, COLLOIDAL POLYM PART
   HIROSE C, 1992, APPL SPECTROSC, V46, P1051, DOI 10.1366/0003702924124385
   Horbett T. A., 1995, PROTEINS INTERFACES, VII
   Iler R, 1979, CHEM SILICA
   ISRAELACHVILI J, 1992, J VAC SCI TECHNOL A, V10, P2961, DOI 10.1116/1.577894
   Ito H., 1994, POLYM MAT MICROELECT
   Karp JM, 2003, MRS BULL, V28, P301, DOI 10.1557/mrs2003.85
   Kawaguchi H, 2000, PROG POLYM SCI, V25, P1171, DOI 10.1016/S0079-6700(00)00024-1
   Kim J, 2003, LANGMUIR, V19, P9551, DOI 10.1021/la035496n
   Kim SH, 2002, BIOMATERIALS, V23, P1657, DOI 10.1016/S0142-9612(01)00292-7
   Koffas TS, 2003, LANGMUIR, V19, P3453, DOI 10.1021/la026719x
   Kralik M, 2001, J MOL CATAL A-CHEM, V177, P113, DOI 10.1016/S1381-1169(01)00313-2
   Lin DT, 2001, BIOMATERIALS, V22, P1521, DOI 10.1016/S0142-9612(00)00308-2
   Lopez-Alemany A, 2002, J BIOMED MATER RES, V63, P319, DOI 10.1002/jbm.10186
   McConville P, 2001, POLYMER, V42, P3559, DOI 10.1016/S0032-3861(00)00714-X
   Miranda PB, 1999, J PHYS CHEM B, V103, P3292, DOI 10.1021/jp9843757
   MORI Y, 1982, T AM SOC ART INT ORG, V28, P459
   MULLER N, 1990, ACCOUNTS CHEM RES, V23, P23, DOI 10.1021/ar00169a005
   Oh-e M, 2002, APPL PHYS LETT, V80, P784, DOI 10.1063/1.1435069
   Opdahl A, 2003, J BIOMED MATER RES A, V67A, P350, DOI 10.1002/jbm.a.10054
   Opdahl A, 2002, MACROMOLECULES, V35, P4387, DOI 10.1021/ma011773q
   Opdahl A, 2002, LANGMUIR, V18, P9409, DOI 10.1021/la020537l
   Opdahl A, 2002, J PHYS CHEM B, V106, P5212, DOI 10.1021/jp013741a
   OPDAHL A, 2003, IN PRESS J POLYM S B
   PRITCHARD N, 1995, OPHTHAL PHYSL OPT, V15, P281, DOI 10.1046/j.1475-1313.1995.9500004w.x
   Shen Y. R., 1984, PRINCIPLES NONLINEAR
   Sinniah SK, 1996, J AM CHEM SOC, V118, P8925, DOI 10.1021/ja961295c
   STANNERS CD, 1995, CHEM PHYS LETT, V232, P407, DOI 10.1016/0009-2614(94)01362-Y
   STERN T, 1995, BIOMATERIALS, V16, P17, DOI 10.1016/0142-9612(95)91091-C
   Tanford C., 1991, HYDROPHOBIC EFFECT F
   Wang H, 2002, MACROMOLECULES, V35, P2799, DOI 10.1021/ma0116699
   Wang J, 2002, J AM CHEM SOC, V124, P7016, DOI 10.1021/ja012387r
   Wang J, 2001, J PHYS CHEM B, V105, P12118, DOI 10.1021/jp013161d
   Ward R.S., 1984, POLYURETHANES BIOMED
   Wei X, 2000, PHYS REV E, V62, P5160, DOI 10.1103/PhysRevE.62.5160
   Wicks Z. W., 1992, ORGANIC COATINGS SCI
   Wulff G, 2002, CHEM REV, V102, P1, DOI 10.1021/cr980039a
   Zhang D, 2000, LANGMUIR, V16, P4528, DOI 10.1021/1a991353i
   Zhang D, 1997, CHEM PHYS LETT, V281, P394, DOI 10.1016/S0009-2614(97)01311-0
   Zhang D, 1998, J PHYS CHEM B, V102, P6225, DOI 10.1021/jp981550a
   Zhang XY, 2001, J AM CHEM SOC, V123, P6736, DOI 10.1021/ja015960f
   Zhuang X, 1999, PHYS REV B, V59, P12632, DOI 10.1103/PhysRevB.59.12632
NR 56
TC 22
Z9 24
U1 3
U2 27
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 0953-8984
J9 J PHYS-CONDENS MAT
JI J. Phys.-Condes. Matter
PD JUN 2
PY 2004
VL 16
IS 21
BP R659
EP R677
AR PII S0953-8984(04)59532-2
DI 10.1088/0953-8984/16/21/RO2
PG 19
WC Physics, Condensed Matter
SC Physics
GA 830CX
UT WOS:000222100300003
DA 2018-10-19
ER

PT J
AU Dunand, DC
AF Dunand, DC
TI Processing of titanium foams
SO ADVANCED ENGINEERING MATERIALS
LA English
DT Review
ID ARGON-FILLED PORES; POROUS TITANIUM; MECHANICAL-PROPERTIES;
   TRANSFORMATION SUPERPLASTICITY; SANDWICH STRUCTURES; IMPLANT MATERIAL;
   CREEP EXPANSION; THERMAL HISTORY; METAL FOAMS; ALLOY
AB Because of their excellent mechanical properties, low density and biocompatibility, titanium foams are attractive for structural and biomedical applications. This paper.. reviews current techniques for, titanium foam processing, which are all based on powder-metallurgy because of the extreme reactivity of liquid titanium. A first group of processes is based on powder sintering with or without place-holder or scaffolds. A second group relies on expansion of pressurized pores created during prior powder densification.
C1 Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA.
RP Dunand, DC (reprint author), Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA.
EM dunand@northwestern.edu
RI Dunand, David/B-7515-2009
OI Dunand, David/0000-0001-5476-7379
CR Andersen O, 2000, ADV ENG MATER, V2, P192, DOI 10.1002/(SICI)1527-2648(200004)2:4<192::AID-ADEM192>3.0.CO;2-#
   Asaoka K, 2003, MATER SCI FORUM, V426-4, P3079, DOI 10.4028/www.scientific.net/MSF.426-432.3079
   ASAOKA K, 1985, J BIOMED MATER RES, V19, P699, DOI 10.1002/jbm.820190609
   Ashby M.F., 2000, METAL FOAMS DESIGN G
   Assad M, 2002, BIO-MED MATER ENG, V12, P225
   Banhart J, 2000, JOM-J MIN MET MAT S, V52, P22, DOI 10.1007/s11837-000-0062-8
   Banhart J, 2001, PROG MATER SCI, V46, P559, DOI 10.1016/S0079-6425(00)00002-5
   Banhart J, 2003, MRS BULL, V28, P290, DOI 10.1557/mrs2003.83
   Bram M, 2000, ADV ENG MATER, V2, P196, DOI 10.1002/(SICI)1527-2648(200004)2:4<196::AID-ADEM196>3.0.CO;2-K
   Cirincione R, 2002, PROCESSSING AND PROPERTIES OF LIGHTWEIGHT CELLULAR METALS AND STRUCTURES, P189
   Davis NG, 2001, J MATER RES, V16, P1508, DOI 10.1557/JMR.2001.0210
   Degischer H-P, 2002, HDB CELLULAR METALS
   Donachie M., 1998, ADV MATER PROCESS, V7, P63
   Donachie M.J., 1988, TITANIUM TECHNICAL G
   Dunand DC, 1996, ACTA MATER, V44, P1063, DOI 10.1016/1359-6454(95)00224-3
   Dunand DC, 1998, MATER RES SOC SYMP P, V521, P231, DOI 10.1557/PROC-521-231
   Elzey DM, 1999, METALL MATER TRANS A, V30, P2689, DOI 10.1007/s11661-999-0309-0
   Elzey DM, 2001, ACTA MATER, V49, P849, DOI 10.1016/S1359-6454(00)00395-5
   Frary M, 2002, METALL MATER TRANS A, V33, P1669, DOI 10.1007/s11661-002-0176-4
   GREENWOOD GW, 1965, PROC R SOC LON SER-A, V283, P403, DOI 10.1098/rspa.1965.0029
   Guo ZX, 2000, MATER SCI TECH SER, V16, P776, DOI 10.1179/026708300101508423
   Hurysz KM, 1998, MATER RES SOC SYMP P, V521, P191, DOI 10.1557/PROC-521-191
   Jee CSY, 2000, METALL MATER TRANS B, V31, P1345, DOI 10.1007/s11663-000-0021-3
   Kearns M. W., 1987, MET MAT, V3, P85
   KEARNS MW, 1988, INT J POWDER METALL, V24, P59
   KOSTORNOV AG, 1990, SOV POWDER METALL+, V29, P804, DOI 10.1007/BF00793541
   KOSTORNOV AG, 1986, SOV POWDER METALL+, V25, P909, DOI 10.1007/BF00795323
   KUPP P, 2002, PROCESSING PROPERTIE, P61
   Lagoudas DC, 2002, J INTEL MAT SYST STR, V13, P837, DOI 10.1177/104538902032790
   LI H, IN PRESS MAT T
   Li JP, 2003, KEY ENG MAT, V240-2, P547, DOI 10.4028/www.scientific.net/KEM.240-242.547
   Li JP, 2002, KEY ENG MAT, V218-2, P51, DOI 10.4028/www.scientific.net/KEM.218-220.51
   Li YH, 2002, J ALLOY COMPD, V345, P271, DOI 10.1016/S0925-8388(02)00412-7
   MARTIN RL, 1992, METAL POWDER REPORT, P30
   MCNAMARA BP, 1995, KEY ENG MAT, V99-1, P309, DOI 10.4028/www.scientific.net/KEM.99-100.309
   MURRAY GAW, 1981, J BONE JOINT SURG BR, V63, P138
   Murray NGD, 2003, COMPOS SCI TECHNOL, V63, P2311, DOI 10.1016/S0266-3538(03)00264-1
   Murray NGD, 2004, ACTA MATER, V52, P2279, DOI 10.1016/j.actamat.2004.01.019
   Murray NGD, 2004, ACTA MATER, V52, P2269, DOI 10.1016/j.actamat.2004.01.039
   Murray NGD, 2003, SCRIPTA MATER, V49, P879, DOI 10.1016/S1359-6462(03)00438-X
   NILLES JL, 1974, J BIOMED MATER RES, V8, P319, DOI 10.1002/jbm.820080411
   Oh IH, 2003, MATER TRANS, V44, P657, DOI 10.2320/matertrans.44.657
   Oh IH, 2003, SCRIPTA MATER, V49, P1197, DOI 10.1016/j.scriptamat.2003.08.018
   Oh IH, 2002, MATER TRANS, V43, P443, DOI 10.2320/matertrans.43.443
   Queheillalt DT, 2000, METALL MATER TRANS A, V31, P261, DOI 10.1007/s11661-000-0070-x
   Rausch G, 2000, MATERIALWISS WERKST, V31, P412, DOI 10.1002/1521-4052(200006)31:6<412::AID-MAWE412>3.3.CO;2-2
   Rausch G, 2002, HDB CELLULAR METALS, P21
   Ricceri R, 2003, INT J POWDER METALL, V39, P53
   Ricceri R, 2001, INT J POWDER METALL, V37, P61
   Schuh C, 2000, ACTA MATER, V48, P1639, DOI 10.1016/S1359-6454(00)00018-5
   Schuh C, 2001, SCRIPTA MATER, V45, P631, DOI 10.1016/S1359-6462(01)01072-7
   Schuh C, 2001, J MATER RES, V16, P865, DOI 10.1557/JMR.2001.0115
   Schwartz DS, 1998, MATER RES SOC SYMP P, V521, P225, DOI 10.1557/PROC-521-225
   Simske SJ, 1997, MATER SCI FORUM, V250, P151, DOI 10.4028/www.scientific.net/MSF.250.151
   Sypeck DJ, 1998, MATER RES SOC SYMP P, V521, P205, DOI 10.1557/PROC-521-205
   TAYLOR N, 1993, ACTA METALL MATER, V41, P955, DOI 10.1016/0956-7151(93)90030-V
   Thelen S, 2004, J BIOMED MATER RES A, V69A, P601, DOI 10.1002/jbm.a.20100
   Thieme M, 2001, J MATER SCI-MATER M, V12, P225, DOI 10.1023/A:1008958914818
   TUCHINSKIY L, 2003, MAT PROCESSES MED DE, P1
   Vancheeswaran R, 2001, METALL MATER TRANS A, V32, P1813, DOI 10.1007/s11661-001-0157-z
   Wen CE, 2002, J MATER RES, V17, P2633, DOI 10.1557/JMR.2002.0382
   Wen CE, 2002, J MATER SCI-MATER M, V13, P397, DOI 10.1023/A:1014344819558
   Wen CE, 2001, SCRIPTA MATER, V45, P1147, DOI 10.1016/S1359-6462(01)01132-0
   WHEELER KR, 1983, C TIT ALL SURG IMPL, P241
NR 64
TC 221
Z9 228
U1 8
U2 86
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1438-1656
J9 ADV ENG MATER
JI Adv. Eng. Mater.
PD JUN
PY 2004
VL 6
IS 6
BP 369
EP 376
DI 10.1002/adem.200405576
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA 836RM
UT WOS:000222573300006
DA 2018-10-19
ER

PT J
AU Combes, RD
AF Combes, RD
TI The use of human cells in biomedical research and testing
SO ATLA-ALTERNATIVES TO LABORATORY ANIMALS
LA English
DT Article; Proceedings Paper
CT 4th World Congress on Alternatives and Animal Use in the Life Sciences
CY AUG 11-15, 2002
CL New Orleans, LA
DE biomedical research; cultured human cells; human cells; human research
   tissue banks
ID HUMAN TISSUE; PREDICTING TOXICITY; ALTERNATIVE METHODS; RECOMMENDATIONS;
   SYSTEMS; ESTABLISHMENT; AVAILABILITY; VALIDATION; LINES; DRUG
AB The ability to use human cells in biomedical research and testing has the obvious advantage over the use of laboratory animals that the need for species extrapolation is obviated, due to the presence of more-relevant morphological, physiological and biochemical properties, including receptors. Moreover, human cells exhibit the same advantages as animal cells in culture in that different cell types can be used, From different tissues, with a wide range of techniques, to investigate a wide variety of biological phenomena in tissue culture. Human cells can also be grown as organotypic cultures to facilitate the extrapolation from cells to whole organisms. Human cell lines have been available for many years on an ad hoc basis from individual researchers, and also from recognised sources, such as the European Collection of Animal Cell Cultures (ECACC) and, in the USA, the Human Cell Culture Centre (HCCC). Such cells have usually been derived from tumours and this has restricted the variety of types of cells available. This problem has been addressed by using primary human cells that can be obtained from a variety of sources, such as cadavers, diseased tissue, skin strips, peripheral blood, buccal cavity smears, hair follicles and surgical waste from biopsy material that is unsuitable for transplantation purposes. However, primary human cells need to be obtained, processed, distributed and handled in a safe and ethical manner. They also have to be made available at the correct time to researchers very shortly after they become available. It is only comparatively recently that the safe and controlled acquisition of surgical waste and non-transplantable human tissues has become feasible with the establishment of several human tissue banks. Recently, the formation of a UK and European centralised network for human tissue supply has been initiated. The problems of short longevity and loss of specialisation in culture are being approached by: a) cell immortalisation to generate a cell type possessing the properties of both primary cells and cell lines; b) the inhibition of intracellular activities resulting in oxidative stress; and c) the use of stem cells, both of embryonic and adult origin.
C1 FRAME, Nottingham NG1 4EE, England.
RP Combes, RD (reprint author), FRAME, Russell & Burch House,96-98 N Sherwood St, Nottingham NG1 4EE, England.
EM bob@frame.org.uk
CR ALEXANDRE E, 2002, CELL TISSUE BANKING, V3, P133
   Anderson R, 1999, TOXICOL IN VITRO, V13, P729, DOI 10.1016/S0887-2333(99)00051-X
   Anderson R, 1998, ATLA-ALTERN LAB ANIM, V26, P763
   Anderson R, 2001, ATLA-ALTERN LAB ANIM, V29, P125
   ARAKISASAKI K, 1995, INVEST OPHTH VIS SCI, V36, P614
   Bach PH, 1996, ATLA-ALTERN LAB ANIM, V24, P893
   BLAAUBOER BJ, 2004, UNPUB ATLA
   Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660
   Clothier R, 2000, ATLA-ALTERN LAB ANIM, V28, P293
   CLOTHIER RH, 1995, ATLA-ALTERN LAB ANIM, V23, P75
   Coecke S, 1999, ATLA-ALTERN LAB ANIM, V27, P579
   COMBES RD, 1995, PESTIC SCI, V45, P179, DOI 10.1002/ps.2780450213
   Dearden JC, 1997, ATLA-ALTERN LAB ANIM, V25, P223
   Janusch A, 1997, ATLA-ALTERN LAB ANIM, V25, P411
   Kinsner A., 2001, Cell and Tissue Banking, V2, P165, DOI 10.1023/A:1020196504392
   Ouellette MM, 2000, HUM MOL GENET, V9, P403, DOI 10.1093/hmg/9.3.403
   Pfaller W, 2001, Altern Lab Anim, V29, P393
   PFEIFER AMA, 1993, P NATL ACAD SCI USA, V90, P5123, DOI 10.1073/pnas.90.11.5123
   Todd M, 1998, ATLA-ALTERN LAB ANIM, V26, P13
   van de Sandt J, 1999, ATLA-ALTERN LAB ANIM, V27, P723
   WARD R, 1993, J ANAT, V182, P151
   Ward RK, 1997, TOXICOL IN VITRO, V11, P761, DOI 10.1016/S0887-2333(97)00025-8
   WARD RK, 1997, TOXICOLOGY ECOTOXICO, V4, P38
   Wiebel FJ, 1997, ATLA-ALTERN LAB ANIM, V25, P625
   Womack C, 2000, ATLA-ALTERN LAB ANIM, V28, P259
   WORTH AP, 2002, ATLA S1, V30, P1
   Zeilinger K, 2002, ATLA-ALTERN LAB ANIM, V30, P525
NR 27
TC 11
Z9 12
U1 0
U2 4
PU FRAME
PI NOTTINGHAM
PA RUSSELL & BURCH HOUSE 96-98 NORTH SHERWOOD ST, NOTTINGHAM NG1 4EE,
   NOTTS, ENGLAND
SN 0261-1929
J9 ATLA-ALTERN LAB ANIM
JI ATLA-Altern. Lab. Anim.
PD JUN
PY 2004
VL 32
SU 1A
BP 43
EP 49
PG 7
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 833QB
UT WOS:000222352100006
PM 23577433
DA 2018-10-19
ER

PT J
AU Zimmermann, J
   Loontjens, T
   Scholtens, BJR
   Mulhaupt, R
AF Zimmermann, J
   Loontjens, T
   Scholtens, BJR
   Mulhaupt, R
TI The formation of poly(ester-urea) networks in the absence of isocyanate
   monomers
SO BIOMATERIALS
LA English
DT Article
DE poly(ester-urea); N,N ' carbonylbis (caprolactam); cell adhesion;
   polymer network; degradation
ID IN-VITRO; BEHAVIOR; GROWTH
AB The polymerization of N,N' carbonylbis (caprolactam) (CBC) and polyol in the presence of alcoholate as catalyst produced crosslinked poly(ester-urea)s via ring opening addition reaction. In contrast to conventional synthetic routes, the use of non-toxic CBC eliminates the need for toxic isocyanate-based monomers. The structure of the molecules resulting from model reactions was confirmed using FT-IR and H-1- and C-13-NMR spectroscopy. Poly(ester-urea) networks exhibit rubber-like mechanical properties and high-temperature stability. Cell adhesion and cell growth on the polymers evidenced the high biocompatibility of the material. Degradation of the poly(ester-urea)s was investigated at 70degreesC in neutral and basic aqueous solution. The degradation depends on the swelling behavior of the samples. Mechanical properties, good biocompatibility, and degradation behavior of the CBC/polyolbased polymers make them interesting materials for biomedical applications. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Freiburg, Inst Makromol Chem, D-79104 Freiburg, Germany.
   Univ Freiburg, FMF, D-79104 Freiburg, Germany.
   DSM Res & Patents, NL-6160 MD Geleen, Netherlands.
RP Mulhaupt, R (reprint author), Univ Freiburg, Inst Makromol Chem, Stefan Meier Str 21-31, D-79104 Freiburg, Germany.
EM mulhaupt@uni-freiburg.de
CR Abraham GA, 1998, J APPL POLYM SCI, V69, P2159, DOI 10.1002/(SICI)1097-4628(19980912)69:11<2159::AID-APP7>3.0.CO;2-F
   Abraham GA, 1997, J APPL POLYM SCI, V65, P1193, DOI 10.1002/(SICI)1097-4628(19970808)65:6<1193::AID-APP15>3.0.CO;2-V
   BRUIN P, 1988, MAKROMOL CHEM-RAPID, V9, P589
   Gugala Z, 2000, J BIOMED MATER RES, V49, P183, DOI 10.1002/(SICI)1097-4636(200002)49:2<183::AID-JBM5>3.0.CO;2-D
   Kartvelishvili T, 1997, MACROMOL CHEM PHYSIC, V198, P1921, DOI 10.1002/macp.1997.021980620
   Kobashi T, 1999, CELL TRANSPLANT, V8, P477, DOI 10.1177/096368979900800503
   Mandal TK, 2000, EUR J PHARM BIOPHARM, V50, P337, DOI 10.1016/S0939-6411(00)00124-7
   MCGILL DB, 1974, NEW ENGL J MED, V291, P278, DOI 10.1056/NEJM197408082910604
   MCKAY AF, 1958, J AM CHEM SOC, V80, P1510, DOI 10.1021/ja01539a058
   MEYER HR, 1956, KUNSTSTOFFE PLASTICS, V3, P160
   Pegoretti A, 1998, J APPL POLYM SCI, V70, P577, DOI 10.1002/(SICI)1097-4628(19981017)70:3<577::AID-APP20>3.0.CO;2-X
   Zhang JY, 2000, BIOMATERIALS, V21, P1247, DOI 10.1016/S0142-9612(00)00005-3
   ZILG C, 2000, THESIS ALBERT LUDWIG, P171
NR 13
TC 28
Z9 28
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2004
VL 25
IS 14
BP 2713
EP 2719
DI 10.1016/j.biomaterials.2003.09.110
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 776TG
UT WOS:000189133000002
PM 14962550
OA Green Published
DA 2018-10-19
ER

PT J
AU Ho, D
   Chu, B
   Schmidt, JJ
   Brooks, EK
   Montemagno, CD
AF Ho, D
   Chu, B
   Schmidt, JJ
   Brooks, EK
   Montemagno, CD
TI Hybrid protein-polymer biomimetic membranes
SO IEEE TRANSACTIONS ON NANOTECHNOLOGY
LA English
DT Article
DE biomedical engineering; biomedical materials; biomedical transducers;
   biomembranes; detectors; microelectromechanical devices; proteins;
   quantum dot
ID TRIBLOCK COPOLYMER MEMBRANES; RECONSTITUTION; VOLTAGE
AB Protein-functionalized polymers retain dramatically increased stability over lipid membranes and the unique ability to be deposited on solid substrates in the ABA complex. Furthermore, since these polymers can mimic hydrophilic/hydrophobic biological environments in a single molecular chain, direct adsorption of protein-functionalized biomembrane films is enabled, which is a significant advantage over conventional lipid systems. Following the demonstration of protein mutagenesis and nanoscale biomimetic membrane fabrication, monolayer arrays of pore proteins have been deposited onto silicon wafers for applications in sensing nanomolecules such as conjugated quantum dots and colloidal gold beads. Furthermore, we have characterized monolayer surface properties of custom tailored polymers with varied block length for biomimetic membrane applications, as well as developed a multiwell microelectromechanical-system-based membrane testing platform for enhanced versatility in film deposition. We have successfully demonstrated the reconstitution of a genetically engineered OmpF porin in block copolymer-based biomembranes, fabrication of large-area hybrid protein-polymer Langmuir-Blodgett films, as well as protein insertion via macromolecule detection using protein-polymer active materials with the goal of buildup toward a multicomponent microsystem while preserving inherent molecular function.
C1 Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90049 USA.
RP Ho, D (reprint author), Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90049 USA.
EM deanh@seas.ucla.edu
CR Alvarez O., 1986, ION CHANNEL RECONSTI, P115
   Hong Q, 2001, BIOCHEM SOC T, V29, P578, DOI 10.1042/BST0290578
   Meier W, 2000, ANGEW CHEM INT EDIT, V39, P4599, DOI 10.1002/1521-3773(20001215)39:24<4599::AID-ANIE4599>3.0.CO;2-Y
   MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561
   Muller DJ, 1999, J MOL BIOL, V285, P1347, DOI 10.1006/jmbi.1998.2359
   Nardin C, 2000, LANGMUIR, V16, P7708, DOI 10.1021/la000204t
   Pantoja R, 2001, BIOPHYS J, V81, P2389, DOI 10.1016/S0006-3495(01)75885-7
   Saint N, 1996, J BIOL CHEM, V271, P20676, DOI 10.1074/jbc.271.34.20676
   Winterhalter M, 1995, ELECTROMANIPULATION, P137
NR 9
TC 24
Z9 24
U1 1
U2 19
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 1536-125X
J9 IEEE T NANOTECHNOL
JI IEEE Trans. Nanotechnol.
PD JUN
PY 2004
VL 3
IS 2
BP 256
EP 263
DI 10.1109/tnano.2004.828530
PG 8
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology;
   Materials Science, Multidisciplinary; Physics, Applied
SC Engineering; Science & Technology - Other Topics; Materials Science;
   Physics
GA 827KZ
UT WOS:000221899800006
DA 2018-10-19
ER

PT J
AU Gall, K
   Kreiner, P
   Turner, D
   Hulse, M
AF Gall, K
   Kreiner, P
   Turner, D
   Hulse, M
TI Shape-memory polymers for microelectromechanical systems
SO JOURNAL OF MICROELECTROMECHANICAL SYSTEMS
LA English
DT Article
DE indentation; microfludic; polymer; shape memory; soft lithograph
ID MARTENSITE START TEMPERATURES; TRANSFORMATION STRESS LEVELS; THIN-FILM;
   BIOMEDICAL APPLICATIONS; SOFT LITHOGRAPHY; FABRICATION; NITI; MEMS;
   BEHAVIOR; DESIGN
AB This paper investigates the use of shape-memory polymer thin films in microelectromechanical systems (MEMS). shape-memory polymers possess the capacity to recover large-strain deformations by the application of heat and are candidates for small-scale transduction. The key advantages of shape-memory polymers are their low material/fabrication cost coupled with their simplicity of integration/operation. In the present study, shape-memory polymers are spin coated onto a standard Si wafer and polymerized by thermal annealing. The thermomechanics of strain storage and recovery in the polymer films are studied using instrumented microindentation. The sharp microindents demonstrate full recovery at all load levels, establishing the feasibility of microscale actuation. The microindentation response of the polymer film is shown to depend on temperature and the cooling cycle during indentation. In turn, the subsequent recovery behavior of an indent depends on the thermal history during indentation. Indents performed at higher temperatures are larger in size, but have smaller stored strain energy compared to indents performed at low temperature. The larger stored strain energy in low temperature indents results in lower shape recovery temperatures. The effects of indentation temperature and load are systematically investigated to provide a framework for the use of shape-memory polymers in microsystems. Application of shape-memory polymers is demonstrated through the development of an active microfluidic reservoir. The reservoir was created by indentation at the end of a microfluidic channel and was activated by local heating. The collapse of the filled reservoir caused the motion of fluid down the microfluidic channel.
C1 Univ Colorado, Dept Mech Engn, Boulder, CO 80309 USA.
RP Gall, K (reprint author), Univ Colorado, Dept Mech Engn, Boulder, CO 80309 USA.
EM Kenneth.Gall@Colorado.edu
CR Arias F, 2001, J MICROELECTROMECH S, V10, P107, DOI 10.1109/84.911098
   Bao LR, 2002, J VAC SCI TECHNOL B, V20, P2881, DOI 10.1116/1.1526355
   Benard WL, 1998, J MICROELECTROMECH S, V7, P245, DOI 10.1109/84.679390
   El Feninat F, 2002, ADV ENG MATER, V4, P91, DOI 10.1002/1527-2648(200203)4:3<91::AID-ADEM91>3.0.CO;2-B
   Gall K, 2001, ACTA MATER, V49, P3205, DOI 10.1016/S1359-6454(01)00223-3
   Gall K, 1999, J ENG MATER-T ASME, V121, P28, DOI 10.1115/1.2815995
   Gall K, 1999, J ENG MATER-T ASME, V121, P19, DOI 10.1115/1.2815993
   Gall K, 2000, J INTEL MAT SYST STR, V11, P877, DOI 10.1106/EJGR-EWNM-6CLX-3X2M
   Gall K, 2002, ACTA MATER, V50, P5115, DOI 10.1016/S1359-6454(02)00368-3
   HAY JL, 2003, ASM HDB, V8
   Huang XY, 2003, NAT MATER, V2, P307, DOI 10.1038/nmat884
   Jackson WC, 2001, J VAC SCI TECHNOL B, V19, P596, DOI 10.1116/1.1350840
   Jameson R, 2003, MICROELECTRON ENG, V67-8, P930, DOI 10.1016/S0167-9317(03)00156-4
   JARDINE AP, 1994, MATER CHARACT, V32, P169
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   King WP, 2002, J MICROELECTROMECH S, V11, P765, DOI 10.1109/JMEMS.2002.803283
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lendlein A, 2001, P NATL ACAD SCI USA, V98, P842, DOI 10.1073/pnas.031571398
   Liu CD, 2002, MACROMOLECULES, V35, P9868, DOI 10.1021/ma021141j
   Liu YP, 2003, SMART MATER STRUCT, V12, P947, DOI 10.1088/0964-1726/12/6/012
   Maitland DJ, 2002, LASER SURG MED, V30, P1
   Metcalfe A, 2003, BIOMATERIALS, V24, P491, DOI 10.1016/S0142-9612(02)00362-9
   Metzger MF, 2002, BIOMED MICRODEVICES, V4, P89, DOI 10.1023/A:1014674912979
   Muralt P, 1997, INTEGR FERROELECTR, V17, P297, DOI 10.1080/10584589708013004
   NI W, APP PHYS LETT, V80, P3310
   OTA S, 1981, RADIAT PHYS CHEM, V18, P81, DOI 10.1016/0146-5724(81)90066-2
   Otsuka K., 1998, SHAPE MEMORY MAT
   OUELLETTE J, 2003, IND PHYS         AUG, P14
   Pfeiffer K, 2003, MICROELECTRON ENG, V67-8, P266, DOI 10.1016/S0167-9317(03)00079-0
   POLLA DL, 1995, INTEGR FERROELECTR, V7, P359, DOI 10.1080/10584589508220246
   Polla DL, 1998, ANNU REV MATER SCI, V28, P563, DOI 10.1146/annurev.matsci.28.1.563
   Roberts DC, 2003, J MICROELECTROMECH S, V12, P81, DOI 10.1109/JMEMS.2002.807471
   Roch I, 2003, J MICROMECH MICROENG, V13, P330, DOI 10.1088/0960-1317/13/2/323
   Scheer HC, 1998, J VAC SCI TECHNOL B, V16, P3917, DOI 10.1116/1.590436
   Schift H, 1999, MICROELECTRON ENG, V46, P121, DOI 10.1016/S0167-9317(99)00030-1
   Schulz H, 2000, J VAC SCI TECHNOL B, V18, P1861, DOI 10.1116/1.1305331
   SILLION B, 2002, ACT CHIMIQUE, V3, P182
   Wang LP, 2003, J MICROELECTROMECH S, V12, P433, DOI 10.1109/JMEMS.2003.811749
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
   Wolf RH, 1995, J MICROELECTROMECH S, V4, P206, DOI 10.1109/84.475547
NR 40
TC 125
Z9 128
U1 2
U2 59
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 1057-7157
J9 J MICROELECTROMECH S
JI J. Microelectromech. Syst.
PD JUN
PY 2004
VL 13
IS 3
BP 472
EP 483
DI 10.1109/JMEMS.2004.828727
PG 12
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology;
   Instruments & Instrumentation; Physics, Applied
SC Engineering; Science & Technology - Other Topics; Instruments &
   Instrumentation; Physics
GA 826RH
UT WOS:000221845700010
DA 2018-10-19
ER

PT J
AU Wang, ZL
AF Wang, Zhong Lin
TI Nanostructures of zinc oxide
SO MATERIALS TODAY
LA English
DT Article
AB Zinc oxide (ZnO) is a unique material that exhibits semiconducting, piezoelectric, and pyroelectric multiple properties. Using a solid-vapor phase thermal sublimation technique, nanocombs, nanorings, nanohelixes/nanosprings, nanobows, nanobelts, nanowires, and nanocages of ZnO have been synthesized under specific growth conditions. These unique nanostructures unambiguously demonstrate that ZnO is probably the richest family of nanostructures among all materials, both in structures and properties. The nanostructures could have novel applications in optoelectronics, sensors, transducers, and biomedical science because it is bio-safe.
C1 Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.
RP Wang, ZL (reprint author), Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.
EM zhong.wang@mse.gatech.edu
FU Defense Advanced Projects Research Agency; National Science Foundation;
   NASA
FX Thanks to Y. Ding, P. X. Gao, W. L. Hughes, X. Y. Kong, C. Ma, D. Moore,
   Z. W. Pan, C. J. Summers, X. D. Wang, and Y. Zhang for helpful
   discussion and their contributions to the work reviewed in this article.
   We acknowledge generous support by the Defense Advanced Projects
   Research Agency, National Science Foundation, and NASA.
CR Arnold MS, 2003, J PHYS CHEM B, V107, P659, DOI 10.1021/jp0271054
   Bai XD, 2003, NANO LETT, V3, P1147, DOI 10.1021/nl034342p
   Bai XD, 2003, APPL PHYS LETT, V82, P4806, DOI 10.1063/1.1587878
   Comini E, 2002, APPL PHYS LETT, V81, P1869, DOI 10.1063/1.1504867
   Gao PX, 2002, J PHYS CHEM B, V106, P12653, DOI 10.1021/jp0265485
   Gao PX, 2004, APPL PHYS LETT, V84, P2883, DOI 10.1063/1.1702137
   Gao PX, 2003, NANO LETT, V3, P1315, DOI 10.1021/nl034548q
   Gao PX, 2003, J AM CHEM SOC, V125, P11299, DOI 10.1021/ja035569p
   Harnack O, 2003, NANO LETT, V3, P1097, DOI 10.1021/nl034240z
   Huang ZP, 2003, APPL PHYS LETT, V82, P460, DOI 10.1063/1.1539299
   Hughes WL, 2003, APPL PHYS LETT, V82, P2886, DOI 10.1063/1.1570497
   Kong XY, 2004, SCIENCE, V303, P1348, DOI 10.1126/science.1092356
   Kong XY, 2003, NANO LETT, V3, P1625, DOI 10.1021/nl034463p
   Liu CH, 2003, ADV MATER, V15, P838, DOI 10.1002/adma.200304430
   Pan ZW, 2001, SCIENCE, V291, P1947, DOI 10.1126/science.1058120
   Park WI, 2002, APPL PHYS LETT, V80, P4232, DOI 10.1063/1.1482800
   Shi L, 2004, APPL PHYS LETT, V84, P2638, DOI 10.1063/1.1697622
   Wang X. D., 2004, J PHYS CH B IN PRESS
   Wang X. D., 2004, ADV MAT IN PRESS
   Wang XD, 2004, NANO LETT, V4, P423, DOI 10.1021/nl035102c
   Wang Z. L., 1998, FUNCTIONAL SMART MAT
   Yang PD, 2002, ADV FUNCT MATER, V12, P323, DOI 10.1002/1616-3028(20020517)12:5<323::AID-ADFM323>3.0.CO;2-G
   Zhao QX, 2003, APPL PHYS LETT, V83, P165, DOI 10.1063/1.1591069
NR 23
TC 932
Z9 960
U1 18
U2 195
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1369-7021
EI 1873-4103
J9 MATER TODAY
JI Mater. Today
PD JUN
PY 2004
VL 7
IS 6
BP 26
EP 33
DI 10.1016/S1369-7021(04)00286-X
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA V32DK
UT WOS:000208931700030
OA Other Gold
DA 2018-10-19
ER

PT J
AU Berry, E
   Handley, JW
   Fitzgerald, AJ
   Merchant, WJ
   Boyle, RD
   Zinov'ev, NN
   Miles, RE
   Chamberlain, JM
   Smith, MA
AF Berry, E
   Handley, JW
   Fitzgerald, AJ
   Merchant, WJ
   Boyle, RD
   Zinov'ev, NN
   Miles, RE
   Chamberlain, JM
   Smith, MA
TI Multispectral classification techniques for terahertz pulsed imaging: an
   example in histopathology
SO MEDICAL ENGINEERING & PHYSICS
LA English
DT Article
DE terahertz pulsed imaging; multispectral classification; clustering;
   histopathology; basal cell carcinoma; melanoma
ID TIME-DOMAIN SPECTROSCOPY; TISSUE; BEAMS
AB Terahertz pulsed imaging is a spectroscopic imaging modality using pulses of electromagnetic radiation (100 GHz-10 THz), and there has been recent interest in studying biomedical specimens. It is usual to display parametric images derived from the measured pulses. In this work, classification was achieved by applying multispectral clustering techniques to sets of parametric images. It was hypothesised that adequate information for clustering was carried in a small number of parametric images, providing these were weighted by complementary physical properties. Materials prepared for histopathological examination were chosen because their condition remained stable during long imaging periods and because their dehydrated state led to greater penetration of the radiation. Two specimens were examined in this pilot study, one of basal cell carcinoma and one of melanoma. Unsupervised ISODATA classification using three selected parametric terahertz pulsed images was compared qualitatively with k-means classification using the shape of the whole time series, and with conventional stained microscope slides. There was good qualitative agreement between the classifications. Classifications were consistent with the morphological appearances expected, but further work is required to determine if tumour discrimination is possible. The results have implications for the future development of the technique as the need for only a small number of features could lead to considerably reduced acquisition times. (C) 2004 IPEM. Published by Elsevier Ltd. All rights reserved.
C1 Univ Leeds, Gen Infirm, Acad Unit Med Phys, Leeds LS1 3EX, W Yorkshire, England.
   Univ Leeds, Sch Comp, Leeds LS2 9JT, W Yorkshire, England.
   Leeds Teaching Hosp, Dept Histopathol, NHS Trust, Leeds LS1 3EX, W Yorkshire, England.
   Univ Leeds, Sch Elect & Elect Engn, Leeds LS2 9JT, W Yorkshire, England.
RP Berry, E (reprint author), Univ Leeds, Gen Infirm, Acad Unit Med Phys, Wellcome Wing,Great George St, Leeds LS1 3EX, W Yorkshire, England.
EM e.berry@leeds.ac.uk
CR AUSTON DH, 1988, IEEE J QUANTUM ELECT, V24, P184, DOI 10.1109/3.114
   Berry E, 2003, PROC SPIE, V5030, P459, DOI 10.1117/12.479993
   Dorney TD, 2001, J OPT SOC AM A, V18, P1562, DOI 10.1364/JOSAA.18.001562
   Duda R. O., 1973, PATTERN CLASSIFICATI
   Duvillaret L, 1999, APPL OPTICS, V38, P409, DOI 10.1364/AO.38.000409
   Ferguson B, 2002, MICROELECTRON J, V33, P1043, DOI 10.1016/S0026-2692(02)00109-X
   Fitzgerald AJ, 2002, PHYS MED BIOL, V47, P3865, DOI 10.1088/0031-9155/47/21/326
   GRISCHKOWSKY D, 1990, J OPT SOC AM B, V7, P2006, DOI 10.1364/JOSAB.7.002006
   Grischkowsky D. R., 2003, SENSING TERAHERTZ RA, P1
   Hecht E, 1974, OPTICS
   HU BB, 1995, OPT LETT, V20, P1716, DOI 10.1364/OL.20.001716
   IEEE, 1999, STAND SAF LEV RESP H
   Kindt JT, 1996, J PHYS CHEM-US, V100, P10373, DOI 10.1021/jp960141g
   Knobloch P, 2002, PHYS MED BIOL, V47, P3875, DOI 10.1088/0031-9155/47/21/327
   Loffler T, 2002, PHYS MED BIOL, V47, P3847, DOI 10.1088/0031-9155/47/21/324
   Loffler T, 2001, OPT EXPRESS, V9, P616
   Lundervold A, 2000, MED IMAGE ANAL, V4, P123, DOI 10.1016/S1361-8415(00)00009-8
   Mittleman D., 2003, SENSING TERAHERTZ RA, P117, DOI 10.1007/978-3-540-45601-8
   Mittleman DM, 1999, APPL PHYS B-LASERS O, V68, P1085, DOI 10.1007/s003400050750
   Smye SW, 2001, PHYS MED BIOL, V46, pR101, DOI 10.1088/0031-9155/46/9/201
   Vinitski S, 1997, MAGNET RESON MED, V37, P457, DOI 10.1002/mrm.1910370325
   Wu Q, 1996, APPL PHYS LETT, V69, P1026, DOI 10.1063/1.116920
NR 22
TC 33
Z9 33
U1 0
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1350-4533
J9 MED ENG PHYS
JI Med. Eng. Phys.
PD JUN
PY 2004
VL 26
IS 5
BP 423
EP 430
DI 10.1016/j.medengphy.2004.02.011
PG 8
WC Engineering, Biomedical
SC Engineering
GA 825SM
UT WOS:000221778600007
PM 15147750
DA 2018-10-19
ER

PT J
AU McHargue, CJ
AF McHargue, CJ
TI Radiation effects in insulators: past, present, future
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM
   INTERACTIONS WITH MATERIALS AND ATOMS
LA English
DT Article; Proceedings Paper
CT 12th International Conference on Radiation Effects in Insulators
CY AUG 31-SEP 05, 2003
CL Gramado, BRAZIL
SP UFRGS, FAPERGS, CNPQ, FINEP, Elsevier, High Voltage Engn Europa BV
AB Interest in the structure and chemical and physical properties of irradiated ionic crystals in the 1960s and 1970s lead to the initiation of this series of conferences with REM at Arco, Lago di Garda (Italy) in 1981. The early programs focused on treatment of collisional events in insulators (mainly from ions) and the physical and chemical properties of defects. Studies were about evenly distributed among halides, oxides, glasses and organic polymers. Radiation effects in nuclear waste materials and "hot" chemistry were important subjects during the mid to late 1980s but interest in these areas has decreased.
   In recent years, the addition of laser-induced effects has grown and the interest in polymers has focused on tailoring surfaces for specific applications, e.g. biomedical. Researches on covalent-bonded materials (SiC and diamond), complex oxides (spinels, etc.) and nanoclusters have become more prevalent. Theoretical and modeling treatments have moved from treatment of single collision events to molecular dynamics modeling of events associated with cascades.
   Many fundamental questions remain that will be studied by increasingly improved experimental techniques and modeling. The modeling studies will progress from describing events that occur during the first few picoseconds to description of microstructural developments. There should be renewed interest in secondary effects such as the influence of electronic excitation on defect diffusion and stability. The future of ion beam produced nanoclusters rests upon a demonstration of its ability to satisfy the demands of some unique application. (C) 2004 Elsevier B.V. All rights reserved.
C1 Univ Tennessee, Ctr Mat Proc, Knoxville, TN 37996 USA.
RP McHargue, CJ (reprint author), Univ Tennessee, Ctr Mat Proc, 100 Eastbrook Hall, Knoxville, TN 37996 USA.
EM crl@utk.edu
CR ALVES E, 2002, NUCL INSTR METH B, V191
   ARNOLD GW, 1984, NUCL INSTR METH, V1
   BELSON J, 1986, RAD EFF, V97
   Corrales LR, 2003, CURR OPIN SOLID ST M, V7, P35, DOI 10.1016/S1359-0286(03)00016-0
   DAVIES J, 1990, NUCL INSTR METH B, V46
   FOTI G, 1996, NUCL INSTR METH B, V116
   GOTZ G, 1992, NUCL INSTR METH B, V65
   IOTH N, 1994, NUCL INSTR METH B, V91
   MANNING I, 1974, COMPUT PHYS COMMUN, V7, P85, DOI 10.1016/0010-4655(74)90043-5
   MAZZOLDI P, 1982, RAD EFF, V64
   MCHARGUE CJ, 1998, NUCL INSTR METH B, V141
   Mie G, 1908, ANN PHYS-BERLIN, V25, P377
   MOLLER W, 2003, NUCL INSTR METH B, V202
   PEREZ A, 1980, SITE CHARACTERIZATIO
   ROESSLER K, 1988, NUCL INSTRUM METH B, V32, P519, DOI 10.1016/0168-583X(88)90265-0
   SIENDENTOPF H, 2005, Z PHYS, V6, P855
   THEVENARD P, 1988, NUCL INSTR METH B, V32
   WESCH W, 2000, NUCL INSTR METH B, V166
   Ziegler J. F., 1985, STOPPING RANGE IONS
NR 19
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-583X
J9 NUCL INSTRUM METH B
JI Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms
PD JUN
PY 2004
VL 218
BP 1
EP 8
DI 10.1016/j.nimb.2003.12.065
PG 8
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Atomic, Molecular & Chemical; Physics, Nuclear
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA 822SR
UT WOS:000221561000002
DA 2018-10-19
ER

PT J
AU Jones, AN
   Ahmed, W
   Hassan, IU
   Sein, H
   Rego, CA
AF Jones, AN
   Ahmed, W
   Hassan, IU
   Sein, H
   Rego, CA
TI Pulsed biased growth of nanocrystalline diamond by hot filament chemical
   vapour deposition
SO SURFACE ENGINEERING
LA English
DT Article
DE diamond growth; diamond characterisation; bias enhanced nucleation;
   nanocrystalline; biocompatibility; CVD
ID MICROWAVE-PLASMA; FILMS; CVD; NUCLEATION
AB For many industrial applications such as biomedical instruments, optical devices and microelectromechanical systems, the control of the film structure, crystallinity and morphology is of critical importance. The crystallite size, orientation and surface roughness have a profound effect oil the mechanical, optical and electrical properties of the films and therefore the final product performance. In order to reduce the crystallite size and surface roughness, inert gases were added to the methane and hydrogen mixture during chemical vapour deposition of nanocrystalline diamond films. In addition, the results oil the influence of pulsed biasing Oil tire morphology of these films are reported Bias voltages in the range -300-0 V were investigated Increasing the bias voltage significantly alters tire crystallite size and morphology of the deposited films. Raman spectroscopy, SEM and atomic force microscopy were used to characterise the nanocrystalline diamond films. (C) 2004 IoM Communications Ltd. Published by Maney for the Institute of Materials, Minerals and Mining.
C1 Manchester Metropolitan Univ, Dept Chem & Mat, Surface Coatings & Characterisat Res Grp, Manchester M1 5GD, Lancs, England.
RP Jones, AN (reprint author), Manchester Metropolitan Univ, Dept Chem & Mat, Surface Coatings & Characterisat Res Grp, Manchester M1 5GD, Lancs, England.
EM Ahmed@unzmu.ac.uk
RI Jones, Abbie/A-2763-2012
OI Jones, Abbie/0000-0002-1350-4617; Ahmed, Waqar/0000-0003-4152-5172
CR Ahmed W, 2000, VACUUM, V56, P153, DOI 10.1016/S0042-207X(99)00147-5
   Ali N, 2003, VACUUM, V71, P445, DOI 10.1016/S0042-207X(03)00003-4
   ANGUS JC, 1988, SCIENCE, V241, P913, DOI 10.1126/science.241.4868.913
   ANGUS JC, 1975, SURF SCI, V50, P157, DOI 10.1016/0039-6028(75)90180-6
   Chiang MJ, 2001, DIAM RELAT MATER, V10, P1470, DOI 10.1016/S0925-9635(00)00579-3
   Erdemir A, 1999, SURF COAT TECH, V120, P565, DOI 10.1016/S0257-8972(99)00443-0
   Hassan IU, 1999, THIN SOLID FILMS, V355, P134, DOI 10.1016/S0040-6090(99)00500-3
   Sharda T, 2000, DIAM RELAT MATER, V9, P1331, DOI 10.1016/S0925-9635(00)00247-8
   Sharda T, 2002, THIN SOLID FILMS, V406, P70, DOI 10.1016/S0040-6090(01)01774-6
   Sharda T, 2001, DIAM RELAT MATER, V10, P1592, DOI 10.1016/S0925-9635(01)00415-0
   Shim JY, 2001, DIAM RELAT MATER, V10, P847, DOI 10.1016/S0925-9635(01)00378-8
   Stockel R, 1996, DIAM RELAT MATER, V5, P321, DOI 10.1016/0925-9635(95)00355-X
   Yang TS, 2001, DIAM RELAT MATER, V10, P2161, DOI 10.1016/S0925-9635(01)00495-2
   Zaitsev A.M., OPTICAL PROPERTIES D
NR 14
TC 1
Z9 1
U1 0
U2 2
PU MANEY PUBLISHING
PI LEEDS
PA HUDSON RD, LEEDS LS9 7DL, ENGLAND
SN 0267-0844
J9 SURF ENG
JI Surf. Eng.
PD JUN
PY 2004
VL 20
IS 3
BP 181
EP 185
DI 10.1179/026708404225010720
PG 5
WC Materials Science, Coatings & Films
SC Materials Science
GA 840NV
UT WOS:000222866700007
DA 2018-10-19
ER

PT J
AU Chen, SQ
   Zhu, ZQ
   Zhu, JZ
   Zhang, JA
   Shi, YL
   Ke, Y
   Wang, WM
   Wang, XH
   Feng, XA
   Luo, LQ
   Li, S
AF Chen, SQ
   Zhu, ZQ
   Zhu, JZ
   Zhang, JA
   Shi, YL
   Ke, Y
   Wang, WM
   Wang, XH
   Feng, XA
   Luo, LQ
   Li, S
TI Hydroxyapatite coating on porous silicon substrate obtained by
   precipitation process
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE hydroxyapatite coating; porous silicon; bioactivity; biocompatible
ID SOL-GEL SYNTHESIS; ELECTROPHORETIC DEPOSITION; OPTICAL-PROPERTIES;
   CALCIUM-PHOSPHATE; THIN-FILMS; TITANIUM; POWDERS; SENSORS; STRESS;
   BODIES
AB Hydroxyapatite Ca-10(PO4)(6)(OH)(2) (HAP) is known as a bioactive and biocompatible material, HAP coatings were used to improve the biocompatible of substrate by many researcher, In this work, HAP thin films on porous silicon (PS) substrates have been prepared by aqueous precipitation method with rapid thermal annealing (RTA) processes. The HAP films had been prepared under the annealing temperature ranging from 300 to 1000 degreesC. By the measurement of X-ray diffraction (XRD), it was found that for the crystallinity optimization, the heat-treatment at 850-950 degreesC for I h would be favorable. Atomic force microscopy (AFM) and scanning electron microscope (SEM) measurements reveal a dense and smooth surface of the HAP film, and tightly adherence of the coating on porous silicon substrate after sintered. Thus, by this method, porous silicon could be increased its bioactivity and so that could be used in the biomedical area. (C) 2004 Elsevier B.V. All rights reserved.
C1 E China Normal Univ, Dept Elect Engn, Shanghai 200062, Peoples R China.
RP Zhu, ZQ (reprint author), E China Normal Univ, Dept Elect Engn, 3663 Zhongshan N Rd, Shanghai 200062, Peoples R China.
EM sophorate@163.com; zqzhu@ee.ecnu.edu.cn
CR Baratto C, 2002, SENSORS, V2, P121, DOI 10.3390/s20300121
   Bengtsson M, 2000, PHYS STATUS SOLIDI A, V182, P533, DOI 10.1002/1521-396X(200011)182:1<533::AID-PSSA533>3.0.CO;2-W
   Berndt C. C., 1990, Materials Forum, V14, P161
   Bisi O, 2000, SURF SCI REP, V38, P1, DOI 10.1016/S0167-5729(99)00012-6
   Carvalho FLS, 1999, J NON-CRYST SOLIDS, V247, P64, DOI 10.1016/S0022-3093(99)00033-2
   Chan S, 2001, MAT SCI ENG C-BIO S, V15, P277, DOI 10.1016/S0928-4931(01)00219-3
   Chen CH, 1999, SOLID STATE COMMUN, V111, P681, DOI 10.1016/S0038-1098(99)00271-9
   Craciun V, 1999, APPL SURF SCI, V138, P587, DOI 10.1016/S0169-4332(98)00457-7
   Fernandez-Pradas JM, 2002, APPL SURF SCI, V195, P31, DOI 10.1016/S0169-4332(02)00002-8
   FUJISHIRO Y, 1995, J COLLOID INTERF SCI, V173, P119, DOI 10.1006/jcis.1995.1304
   GRUNING U, 1995, THIN SOLID FILMS, V255, P135, DOI 10.1016/0040-6090(94)05638-T
   GUANGLIANG X, 2001, CERAMIC, V152, P32
   Guipont V, 2002, MAT SCI ENG A-STRUCT, V325, P9, DOI 10.1016/S0921-5093(01)01414-9
   Hing KA, 1999, J MATER SCI-MATER M, V10, P135, DOI 10.1023/A:1008929305897
   Hsieh MF, 2002, MATER CHEM PHYS, V74, P245, DOI 10.1016/S0254-0584(01)00474-6
   Hwang K, 1999, SURF COAT TECH, V115, P172, DOI 10.1016/S0257-8972(99)00174-7
   Kim HS, 2002, APPL PHYS LETT, V80, P2287, DOI 10.1063/1.1465130
   KWEH SWK, 1999, J MATER PROCESS TECH, V89, P373
   Layrolle P, 1998, J AM CERAM SOC, V81, P1421
   Liu CS, 2001, BIOMATERIALS, V22, P301, DOI 10.1016/S0142-9612(00)00166-6
   Liu DM, 1998, CERAM INT, V24, P441, DOI 10.1016/S0272-8842(97)00033-3
   Liu DM, 2001, BIOMATERIALS, V22, P1721, DOI 10.1016/S0142-9612(00)00332-X
   Liua D.M., 2002, BIOMATERIALS, V23, P1227
   Liua DM, 2002, BIOMATERIALS, V23, P1679
   Lopatin CM, 1998, THIN SOLID FILMS, V326, P227, DOI 10.1016/S0040-6090(98)00531-8
   Lu YP, 2003, APPL SURF SCI, V206, P345, DOI 10.1016/S0169-4332(02)01308-9
   Luth H, 2000, MAT SCI ENG B-SOLID, V69, P104, DOI 10.1016/S0921-5107(99)00275-5
   Ma J, 2003, BIOMATERIALS, V24, P3505, DOI 10.1016/S0142-9612(03)00203-5
   Manso-Silvan M, 2003, J EUR CERAM SOC, V23, P243, DOI 10.1016/S0955-2219(02)00187-5
   McGinnis SP, 2000, THIN SOLID FILMS, V365, P1, DOI 10.1016/S0040-6090(00)00729-X
   Metikos-Hukovic M, 2003, SURF COAT TECH, V165, P40, DOI 10.1016/S0257-8972(02)00732-6
   Milella E, 2001, BIOMATERIALS, V22, P1425, DOI 10.1016/S0142-9612(00)00300-8
   Nelea V, 2000, APPL SURF SCI, V168, P127, DOI 10.1016/S0169-4332(00)00616-4
   Park E, 1999, MATER LETT, V40, P228, DOI 10.1016/S0167-577X(99)00080-4
   Reddy RRK, 2001, BIOSENS BIOELECTRON, V16, P313, DOI 10.1016/S0956-5663(01)00129-4
   Rodriguez-Lorenzo LM, 2004, MATER RES BULL, V39, P83, DOI 10.1016/j.materresbull.2003.09.014
   Rodriguez-Lorenzo LM, 2001, BIOMATERIALS, V22, P583, DOI 10.1016/S0142-9612(00)00218-0
   Setzu S, 2000, MAT SCI ENG B-SOLID, V69, P34, DOI 10.1016/S0921-5107(99)00261-5
   Shi W, 2002, MAT SCI ENG A-STRUCT, V337, P104, DOI 10.1016/S0921-5093(02)00003-5
   Wang C, 2002, MATER LETT, V57, P99, DOI 10.1016/S0167-577X(02)00706-1
   Wei M, 1999, J BIOMED MATER RES, V45, P11, DOI 10.1002/(SICI)1097-4636(199904)45:1<11::AID-JBM2>3.0.CO;2-7
   Weng WJ, 1998, J MATER SCI-MATER M, V9, P159, DOI 10.1023/A:1008819703551
   Yang YC, 2001, BIOMATERIALS, V22, P1827, DOI 10.1016/S0142-9612(00)00364-1
   YUA LG, 2003, BIOMATERIALS, V24, P2695
   Zhitomirsky I, 2000, MATER LETT, V42, P262, DOI 10.1016/S0167-577X(99)00197-4
NR 45
TC 16
Z9 21
U1 1
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD MAY 31
PY 2004
VL 230
IS 1-4
BP 418
EP 424
DI 10.1016/j.apsusc.2004.03.203
PG 7
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 828IX
UT WOS:000221968100053
DA 2018-10-19
ER

PT J
AU Zhang, Y
   Lawn, B
AF Zhang, Y
   Lawn, B
TI Long-term strength of ceramics for biomedical applications
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE bilayers; brittle coatings; crack velocity; critical loads; dental
   crowns; lifetime; fracture
ID BRITTLE COATINGS; LAYER STRUCTURES; DENTAL CERAMICS; STATIC FATIGUE;
   DAMAGE MODES; CONTACT; FRACTURE; SPHERES; DESIGN; LOADS
AB The influence of slow crack growth on the initiation of radial cracks at the lower surfaces of ceramic layers bonded to polymeric substrates is studied, with particular relevance to biomechanical systems, e.g., dental crowns and hip replacement prostheses. Critical loads are measured as a function of loading rate (dynamic fatigue) for model bilayers fabricated by epoxy-bonding selected clinical ceramics to polycarbonate bases. Radial crack initiation is observed in situ by viewing from below the transparent base during loading. Declines in the critical loads with diminishing load rate are consistent with slow crack growth of intrinsic flaws prior to radial crack pop in. A simple fracture mechanics relation incorporating a crack velocity function is used to analyze the data. Extrapolation beyond the data range enables long-lifetime (10 yr) estimates of sustainable loads. The procedure provides a basis for ranking ceramic types, and in particular for eliminating vulnerable candidate materials, for use in biomechanical systems. While slow crack growth is an important factor in failure, other mechanisms could operate in concert and even dominate under severe testing conditions, especially under cyclic loading. (C) 2004 Wiley Periodicals, Inc.
C1 Natl Inst Stand & Technol, Mat Sci & Engn Lab, Gaithersburg, MD 20899 USA.
RP Lawn, B (reprint author), Natl Inst Stand & Technol, Mat Sci & Engn Lab, Gaithersburg, MD 20899 USA.
EM brian.lawn@nist.gov
FU NIDCR NIH HHS [P01DE10976]
CR Chai H, 1999, J MATER RES, V14, P3805
   Deng Y, 2002, J BIOMED MATER RES, V63, P137, DOI 10.1002/jbm.10091
   Holand W, 2000, J BIOMED MATER RES, V53, P297, DOI 10.1002/1097-4636(2000)53:4<297::AID-JBM3>3.0.CO;2-G
   Jung YG, 2000, J DENT RES, V79, P722, DOI 10.1177/00220345000790020501
   Jung YG, 1999, J DENT RES, V78, P887, DOI 10.1177/00220345990780040901
   Kelly JR, 1999, J PROSTHET DENT, V81, P652, DOI 10.1016/S0022-3913(99)70103-4
   Kelly JR, 1997, ANNU REV MATER SCI, V27, P443, DOI 10.1146/annurev.matsci.27.1.443
   Kim DK, 1999, ACTA MATER, V47, P4711, DOI 10.1016/S1359-6454(99)00246-3
   Kim HW, 2001, J AM CERAM SOC, V84, P2377
   Lakshminarayanan R, 1996, J AM CERAM SOC, V79, P79, DOI 10.1111/j.1151-2916.1996.tb07883.x
   Lawn B.R., 1993, FRACTURE BRITTLE SOL
   Lawn BR, 1998, J AM CERAM SOC, V81, P1977, DOI 10.1111/j.1151-2916.1998.tb02580.x
   LAWN BR, 1994, SCIENCE, V263, P1114, DOI 10.1126/science.263.5150.1114
   Lawn BR, 2002, CURR OPIN SOLID ST M, V6, P229, DOI 10.1016/S1359-0286(02)00016-5
   Lawn BR, 2000, ADV ENG MATER, V2, P745, DOI 10.1002/1527-2648(200011)2:11<745::AID-ADEM745>3.0.CO;2-E
   Lawn BR, 2001, J PROSTHET DENT, V86, P495, DOI 10.1067/mpr.2001.119581
   Lawn BR, 2002, J MATER RES, V17, P3019, DOI 10.1557/JMR.2002.0440
   Lee CS, 2002, J AM CERAM SOC, V85, P2019, DOI 10.1111/j.1151-2916.2002.tb00398.x
   Lohbauer U, 2002, J BIOMED MATER RES, V63, P780, DOI 10.1002/jbm.10468
   Miranda P, 2003, ACTA MATER, V51, P4347, DOI 10.1016/S1359-6454(03)00290-8
   Miranda P, 2001, ACTA MATER, V49, P3719, DOI 10.1016/S1359-6454(01)00280-4
   Rhee YW, 2001, J AM CERAM SOC, V84, P1066, DOI 10.1111/j.1151-2916.2001.tb00791.x
   Wiederhorn S. M., FRACTURE MECH CERAMI, P613
   WIEDERHORN SM, 1970, J AM CERAM SOC, V53, P543, DOI 10.1111/j.1151-2916.1970.tb15962.x
   WIEDERHORN SM, 1972, J AM CERAM SOC, V55, P81, DOI 10.1111/j.1151-2916.1972.tb11215.x
   Willmann G, 2001, ADV ENG MATER, V3, P135, DOI 10.1002/1527-2648(200103)3:3<135::AID-ADEM135>3.3.CO;2-2
NR 26
TC 54
Z9 57
U1 0
U2 3
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD MAY 15
PY 2004
VL 69B
IS 2
BP 166
EP 172
DI 10.1002/jbm.b.20039
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 818XQ
UT WOS:000221278200008
PM 15116406
OA Green Published
DA 2018-10-19
ER

PT J
AU Peitl, O
   Orefice, RL
   Hench, LL
   Brennan, AB
AF Peitl, O
   Orefice, RL
   Hench, LL
   Brennan, AB
TI Effect of the crystallization of bioactive glass reinforcing agents on
   the mechanical properties of polymer composites
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE composites; glass-ceramic particles; crystallization
ID CERAMICS
AB Polymer composites based on the introduction of bioactive materials into polymer matrices can combine mechanical with bioactive properties suitable for many potential biomedical applications. In this work, glass-ceramics derived from the crystallization of bioactive glasses were tested as reinforcing agents in polymer composites. The kinetics of crystallization of soda-lime silica glasses containing phosphorous was studied to define conditions for obtaining glass-ceramics having different microstructures. This type of glass can be used in biomedical applications due to its ability to bind to bone (bioactive behavior). Evaluation of the mechanical properties of glass-ceramic bodies derived from bioactive glasses has allowed us to determine the relationship between microstructure and properties. A particular microstructure capable of leading to fine grained glass-ceramics with enhanced properties was then reproduced in bioactive glass particles. Thus, bioactive glass particles were crystallized to different levels and used as reinforcing agents in polymer (polysulfone) composites. Mechanical properties of composites were evaluated using a four-point bending test. Glass-ceramic reinforced composites showed higher elastic modulus than glass reinforced composites. Therefore, crystallization of silicate glasses used as reinforcing agents in polymer matrices is a possible way to enhance the mechanical properties of composites. Polymer composites having bioactive glass-ceramic particles display some mechanical properties comparable to human cortical bone. (C) 2004 Elsevier B.V. All rights reserved.
C1 Univ Fed Minas Gerais, Dept Met & Mat Engn, Lab Polymer & Composite Engn, LEPCom, BR-30160030 Belo Horizonte, MG, Brazil.
   Univ Fed Sao Carlos, BR-13560 Sao Carlos, SP, Brazil.
   Univ London Imperial Coll Sci Technol & Med, Dept Mat Sci, London, England.
   Univ Florida, Dept Mat Sci & Engn, Gainesville, FL 32611 USA.
RP Orefice, RL (reprint author), Univ Fed Minas Gerais, Dept Met & Mat Engn, Lab Polymer & Composite Engn, LEPCom, Rue Espirito Santo 35,2 Andar, BR-30160030 Belo Horizonte, MG, Brazil.
EM opeitl@power.ufscar.br; rorefice@demet.ufmg.br
RI Brennan, Anthony/C-8552-2009; Orefice, Rodrigo/N-8055-2018
OI Brennan, Anthony/0000-0002-0431-8425; Orefice,
   Rodrigo/0000-0002-6046-4056
CR DEHOFF RT, 1961, T METALL SOC AIME, V221, P975
   FAN Z, 1994, J MATER SCI, V29, P141, DOI 10.1007/BF00356585
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hench LL, 2000, CURR ORTHOPAED, V14, P7, DOI 10.1054/cuor.1999.0074
   Holand W, 1997, J NON-CRYST SOLIDS, V219, P192, DOI 10.1016/S0022-3093(97)00329-3
   KALININA AM, 1980, J NON-CRYST SOLIDS, V38-9, P723, DOI 10.1016/0022-3093(80)90522-0
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   MALLICK RK, 1993, FIBER REINFORCED COM
   Orefice RL, 2001, J BIOMED MATER RES, V55, P460, DOI 10.1002/1097-4636(20010615)55:4<460::AID-JBM1037>3.0.CO;2-3
   OREFICE RL, 1995, BIOCERAMICS, V8, P409
   Peitl O, 1996, J BIOMED MATER RES, V30, P509
   Peitl O, 2001, J NON-CRYST SOLIDS, V292, P115, DOI 10.1016/S0022-3093(01)00822-5
   Wang M, 2000, MATER LETT, V44, P119, DOI 10.1016/S0167-577X(00)00026-4
   Wang M, 2003, BIOMATERIALS, V24, P2133, DOI 10.1016/S0142-9612(03)00037-1
NR 14
TC 21
Z9 22
U1 0
U2 5
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD MAY 15
PY 2004
VL 372
IS 1-2
BP 245
EP 251
DI 10.1016/j.msea.2004.01.011
PG 7
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 821TC
UT WOS:000221484600029
DA 2018-10-19
ER

PT J
AU Tolvanen, M
   Vihinen, M
AF Tolvanen, M
   Vihinen, M
TI Virtual bioinformatics distance learning suite
SO BIOCHEMISTRY AND MOLECULAR BIOLOGY EDUCATION
LA English
DT Article
DE bioinformatics education; computer-aided education; sequence analysis;
   functional genomics
AB Distance learning as a computer-aided concept allows students to take courses from anywhere at any time. In bioinformatics, computers are needed to collect, store, process, and analyze massive amounts of biological and biomedical data. We have applied the concept of distance learning in virtual bioinformatics to provide university course material over the Internet. Currently, we provide two fully computer-based courses, "Introduction to Bioinformatics" and "Bioinformatics in Functional Genomics." Here we will discuss the application of distance learning in bioinformatics training and our experiences gained during the 3 years that we have run the courses, with about 400 students from a number of universities. The courses are available at bioinf.uta.fi.
C1 Univ Tampere, Inst Med Technol, FI-33014 Tampere, Finland.
   Tampere Univ Hosp, Res Unit, FI-33520 Tampere, Finland.
RP Vihinen, M (reprint author), Univ Tampere, Inst Med Technol, FI-33014 Tampere, Finland.
EM mauno.vihinen@uta.fi
RI Vihinen, Mauno/A-8452-2012
OI Vihinen, Mauno/0000-0002-9614-7976
CR Altman RB, 1998, BIOINFORMATICS, V14, P549, DOI 10.1093/bioinformatics/14.7.549
   Lim YP, 2003, BIOCHEM MOL BIOL EDU, V31, P20, DOI 10.1002/bmb.2003.494031010160
   MABEY JE, 2001, CAL LABORATE, V6, P13
   Pearson WR, 2001, BIOINFORMATICS, V17, P761, DOI 10.1093/bioinformatics/17.9.761
   WICKWARE P, 2001, NATUREJOBS, V413, P6
   2003, S STAR BIOINFORMATIC
   MANCHESTER DISTANCE
   2002, ENGLISH FINNISH ENGL
NR 8
TC 8
Z9 8
U1 0
U2 2
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 1470-8175
J9 BIOCHEM MOL BIOL EDU
JI Biochem. Mol. Biol. Educ.
PD MAY-JUN
PY 2004
VL 32
IS 3
BP 156
EP 160
DI 10.1002/bmb.2004.494032030336
PG 5
WC Biochemistry & Molecular Biology; Education, Scientific Disciplines
SC Biochemistry & Molecular Biology; Education & Educational Research
GA 826FA
UT WOS:000221813500004
PM 21706714
OA Bronze
DA 2018-10-19
ER

PT J
AU Levy, I
   Paldi, T
   Shoseyov, O
AF Levy, I
   Paldi, T
   Shoseyov, O
TI Engineering a bifunctional starch-cellulose cross-bridge protein
SO BIOMATERIALS
LA English
DT Article
DE starch-binding domain; cellulose-binding domain; cross-bridging
ID CARBOHYDRATE-BINDING MODULE; WOUND DRESSING MATERIALS; ESCHERICHIA-COLI;
   IN-VITRO; PSEUDOMONAS XYLANASE; ASPERGILLUS-NIGER; HYBRID ENZYMES;
   ALPHA-AMYLASE; DOMAIN; FUSION
AB Biodegradable starch- and cellulose-based polymers have a range of properties which make them suitable for use in a wide array of biomedical applications ranging from bone replacement to engineering of tissue scaffolds and drug delivery systems. A novel polysaccharide cross-bridging protein was designed which was comprised of a cellulose-binding domain from Clostridium cellulovorans (CBDclos) and a starch-binding domain from Aspergillus niger B1 (SBDAsp). The two genes were fused in-frame via a synthetic elastin gene to construct a Cellulose/Starch Cross bridging Protein (CSCP). Recombinant CSCP was expressed in Escherichia coli, and successfully refolded from inclusion bodies. CSCP demonstrated cross-bridging ability in different model systems composed of insoluble or soluble starch and cellulose. The aspect that different carbohydrate-binding module maintain their binding capacity over a wide range of conditions, without the need for chemical reactions, makes them attractive domains for designing new classes of chimeric polysaccharide-binding domains which demonstrate potential for use in a wide range of biomaterials. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Hebrew Univ Jerusalem, Inst Plant Sci & Genet Agr, Fac Agr Food & Environm Qual Sci, IL-76100 Rehovot, Israel.
RP Shoseyov, O (reprint author), Hebrew Univ Jerusalem, Inst Plant Sci & Genet Agr, Fac Agr Food & Environm Qual Sci, POB 12, IL-76100 Rehovot, Israel.
EM shoseyov@agri.huji.ac.il
CR Arai R, 2001, PROTEIN ENG, V14, P529, DOI 10.1093/protein/14.8.529
   Bayer EA, 1998, J STRUCT BIOL, V124, P221, DOI 10.1006/jsbi.1998.4065
   Beguin P, 1999, CURR OPIN BIOTECH, V10, P336, DOI 10.1016/S0958-1669(99)80061-5
   Betre H, 2002, BIOMACROMOLECULES, V3, P910, DOI 10.1021/bm0255037
   Bolam DN, 1998, BIOCHEM J, V331, P775, DOI 10.1042/bj3310775
   Bourne Y, 2001, CURR OPIN STRUC BIOL, V11, P593, DOI 10.1016/S0959-440X(00)00253-0
   BULOW L, 1991, TRENDS BIOTECHNOL, V9, P226, DOI 10.1016/0167-7799(91)90075-S
   DIN N, 1991, BIO-TECHNOL, V9, P1096, DOI 10.1038/nbt1191-1096
   DOI RH, 1994, CRIT REV MICROBIOL, V20, P87, DOI 10.3109/10408419409113548
   Duarte MG, 1997, J MATER SCI-MATER M, V8, P321, DOI 10.1023/A:1018568513662
   Elvira C, 2002, BIOMATERIALS, V23, P1955, DOI 10.1016/S0142-9612(01)00322-2
   Espigares I, 2002, BIOMATERIALS, V23, P1883, DOI 10.1016/S0142-9612(01)00315-5
   FONTANA JD, 1990, APPL BIOCHEM BIOTECH, V24-5, P253, DOI 10.1007/BF02920250
   George RA, 2002, PROTEIN ENG, V15, P871, DOI 10.1093/protein/15.11.871
   GILKES NR, 1991, MICROBIOL REV, V55, P303
   Gill J, 1999, BIOCHEM J, V342, P473, DOI 10.1042/0264-6021:3420473
   Gokhale RS, 2000, CURR OPIN CHEM BIOL, V4, P22, DOI 10.1016/S1367-5931(99)00046-0
   GOLDSTEIN MA, 1993, J BACTERIOL, V175, P5762
   Gustavsson M, 2001, PROTEIN ENG, V14, P711, DOI 10.1093/protein/14.9.711
   HARSH DC, 1991, J CONTROL RELEASE, V17, P175, DOI 10.1016/0168-3659(91)90057-K
   Hoenich NA, 2000, BIOMATERIALS, V21, P317, DOI 10.1016/S0142-9612(99)00196-9
   Jervis EJ, 1997, J BIOL CHEM, V272, P24016, DOI 10.1074/jbc.272.38.24016
   KETOLA H, 1999, PAPER MAKING CHEM, P269
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Leonor IB, 2003, BIOMATERIALS, V24, P579, DOI 10.1016/S0142-9612(02)00371-X
   Levy I, 2002, CELLULOSE, V9, P91, DOI 10.1023/A:1015848701029
   Levy I, 2002, BIOTECHNOL ADV, V20, P191, DOI 10.1016/S0734-9750(02)00006-X
   Levy I, 2002, BIOMOL ENG, V19, P17, DOI 10.1016/S1389-0344(02)00007-2
   Marques AP, 2002, BIOMATERIALS, V23, P1471, DOI 10.1016/S0142-9612(01)00272-1
   MATTHEW IR, 1995, BIOMATERIALS, V16, P275, DOI 10.1016/0142-9612(95)93254-B
   McPherson DT, 1996, PROTEIN EXPRES PURIF, V7, P51, DOI 10.1006/prep.1996.0008
   Mendes SC, 2001, BIOMATERIALS, V22, P2057, DOI 10.1016/S0142-9612(00)00395-1
   Meyer DE, 1999, NAT BIOTECHNOL, V17, P1112, DOI 10.1038/15100
   Michailova V, 2001, INT J PHARM, V222, P7, DOI 10.1016/S0378-5173(01)00706-2
   Moseley R, 2003, BIOMATERIALS, V24, P1549, DOI 10.1016/S0142-9612(02)00540-9
   Nixon AE, 1998, TRENDS BIOTECHNOL, V16, P258, DOI 10.1016/S0167-7799(98)01204-9
   Notenboom V, 2001, BIOCHEMISTRY-US, V40, P6248, DOI 10.1021/bi0101704
   Ohdan K, 2000, APPL ENVIRON MICROB, V66, P3058, DOI 10.1128/AEM.66.7.3058-3064.2000
   Paldi T, 2003, BIOCHEM J, V372, P905, DOI 10.1042/BJ20021527
   Raghothama S, 2000, BIOCHEMISTRY-US, V39, P978, DOI 10.1021/bi992163+
   Receveur V, 2002, J BIOL CHEM, V277, P40887, DOI 10.1074/jbc.M205404200
   Risbud MV, 2001, J BIOMED MATER RES, V54, P436, DOI 10.1002/1097-4636(20010305)54:3<436::AID-JBM180>3.3.CO;2-#
   Roberts J. C., 1996, CHEM PAPER
   Sambrook J, 1989, MOL CLONING LAB MANU
   Sauer J, 2001, BIOCHEMISTRY-US, V40, P9336, DOI 10.1021/bi010515i
   SCHARF SJ, 1990, PCR PROTOCOLS GUIDE, P84
   Seo HS, 2000, APPL ENVIRON MICROB, V66, P2484, DOI 10.1128/AEM.66.6.2484-2490.2000
   SHOSEYOV O, 1992, P NATL ACAD SCI USA, V89, P3483, DOI 10.1073/pnas.89.8.3483
   Shpigel E, 1999, BIOTECHNOL BIOENG, V65, P17, DOI 10.1002/(SICI)1097-0290(19991005)65:1<17::AID-BIT3>3.0.CO;2-Y
   SHPIGEL E, 1998, PROTEIN EXPRES PURIF, V14, P1085
   Simpson PJ, 2002, BIOCHEMISTRY-US, V41, P5712, DOI 10.1021/bi012093i
   Simpson PJ, 2000, J BIOL CHEM, V275, P41137, DOI 10.1074/jbc.M006948200
   SRISODSUK M, 1993, J BIOL CHEM, V268, P20756
   STUDIER FW, 1990, METHOD ENZYMOL, V185, P30
   SWILLENS S, 1995, MOL PHARMACOL, V47, P1197
   Tibbot BK, 2000, J PROTEIN CHEM, V19, P663, DOI 10.1023/A:1007148202270
   Tomme P, 1995, Adv Microb Physiol, V37, P1, DOI 10.1016/S0065-2911(08)60143-5
   Tormo J, 1996, EMBO J, V15, P5739, DOI 10.1002/j.1460-2075.1996.tb00960.x
   Tsuji SY, 2001, BIOCHEMISTRY-US, V40, P2317, DOI 10.1021/bi002462v
   Urry DW, 1999, TRENDS BIOTECHNOL, V17, P249, DOI 10.1016/S0167-7799(99)01306-2
   URRY DW, 1996, PROTEIN BASED MAT, P133
   WHITLOW M, 1993, PROTEIN ENG, V6, P989, DOI 10.1093/protein/6.8.989
NR 62
TC 23
Z9 24
U1 1
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2004
VL 25
IS 10
BP 1841
EP 1849
DI 10.1016/j.biomaterials.2003.08.041
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 770CQ
UT WOS:000188706000013
PM 14738848
DA 2018-10-19
ER

PT J
AU Ji, J
   Zhu, HG
   Shen, JC
AF Ji, J
   Zhu, HG
   Shen, JC
TI Surface tailoring of poly(DL-lactic acid) by ligand-tethered amphiphilic
   polymer for promoting chondrocyte attachment and growth
SO BIOMATERIALS
LA English
DT Article
DE poly(DL-lactic acid) (PDL-LA); PEO-PPO-PEO amphiphilic copolymer; amino
   acid; tissue engineering; chondrocyte
ID POLY(ETHYLENE GLYCOL); POLYETHYLENE OXIDE; BIOMATERIALS; COPOLYMERS;
   PEPTIDES; IMMOBILIZATION; PROLIFERATION; ADHESION; HYDROGEL; ASSAY
AB The ligand-tethered poly(ethylene oxide-propylene oxide-ethylene oxide) (PEO-PPO-PEO) triblock copolymer was explored to engineer poly(DL-lactic acid) (PDL-LA) material to promote cell attachment and growth. The PEO-PPO-PEO was activated by methyl sulfonyl chloride and the amino acid, and peptide were attached. By blending the PDL-LA with the ligand-tethered PEO-PPO-PEO derivatives, the surface of modified PDL-LA film was investigated by ATR-FTIR, XPS and contact angle. The chondrocytes test on different PDL-LA films indicated that the PEO-PPO-PEO amino acid and RGD derivatives modified PDL-LA films could promote chondrocyte attachment and growth. This simple surface treatment method may have potentials for tissue engineering and other biomedical applications. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Zhejiang Univ, Dept Polymer Sci & Engn, Hangzhou 310027, Peoples R China.
RP Ji, J (reprint author), Zhejiang Univ, Dept Polymer Sci & Engn, Hangzhou 310027, Peoples R China.
EM jianji@mail.hz.zj.cn
RI Zhu, Huiguang/A-8591-2010
OI Ji, Jian/0000-0001-9870-4038
CR Andreopoulos AG, 1999, J MATER SCI-MATER M, V10, P29, DOI 10.1023/A:1008887910068
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Babensee JE, 1998, ADV DRUG DELIVER REV, V33, P111, DOI 10.1016/S0169-409X(98)00023-4
   Bancel S, 1996, BIOTECHNOL PROGR, V12, P398, DOI 10.1021/bp960023a
   Benson RS, 2002, NUCL INSTRUM METH B, V191, P752, DOI 10.1016/S0168-583X(02)00647-X
   Bisson I, 2002, BIOMATERIALS, V23, P3149, DOI 10.1016/S0142-9612(02)00061-3
   BLUM RN, 1992, J GEN INTERN MED, V7, P140, DOI 10.1007/BF02598002
   Brown KC, 2000, CURR OPIN CHEM BIOL, V4, P16, DOI 10.1016/S1367-5931(99)00045-9
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   DELGADO C, 1990, BIOTECHNOL APPL BIOC, V12, P119
   Drumright RE, 2000, ADV MATER, V12, P1841, DOI 10.1002/1521-4095(200012)12:23<1841::AID-ADMA1841>3.0.CO;2-E
   HAYASHI T, 1971, BIOCHIM BIOPHYS ACTA, V251, P208, DOI 10.1016/0005-2795(71)90104-8
   Holmes TC, 2002, TRENDS BIOTECHNOL, V20, P16, DOI 10.1016/S0167-7799(01)01840-6
   Irvine DJ, 1998, J BIOMED MATER RES, V40, P498, DOI 10.1002/(SICI)1097-4636(19980605)40:3<498::AID-JBM21>3.0.CO;2-E
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P159, DOI 10.1016/0021-9797(91)90044-9
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Klagsbrun M, 1979, Methods Enzymol, V58, P560
   Lebaron RG, 2000, TISSUE ENG, V6, P85, DOI 10.1089/107632700320720
   Li JT, 1996, BIOCONJUGATE CHEM, V7, P592, DOI 10.1021/bc960048v
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Nagasaki Y, 1998, MACROMOLECULES, V31, P1473, DOI 10.1021/ma971294k
   NILSSON K, 1984, METHOD ENZYMOL, V104, P56
   OKUDA M, 1994, INT ARCH ALLERGY IMM, V104, P6, DOI 10.1159/000236735
   Otsuka H, 2000, BIOMACROMOLECULES, V1, P39, DOI 10.1021/bm990005s
   Risbud MV, 2001, J BIOMED MATER RES, V57, P300, DOI 10.1002/1097-4636(200111)57:2<300::AID-JBM1171>3.0.CO;2-Q
   Salem AK, 2001, BIOMACROMOLECULES, V2, P575, DOI 10.1021/bm010030+
   Sechriest VF, 2000, J BIOMED MATER RES, V49, P534, DOI 10.1002/(SICI)1097-4636(20000315)49:4<534::AID-JBM12>3.0.CO;2-#
   Starcher B, 2001, ANAL BIOCHEM, V292, P125, DOI 10.1006/abio.2001.5050
   Tessmar JK, 2002, BIOMACROMOLECULES, V3, P194, DOI 10.1021/bn015608u
   Ydens I, 2000, MACROMOLECULES, V33, P6713, DOI 10.1021/ma0002803
   ZALIPSKY S, 1995, BIOCONJUGATE CHEM, V6, P150, DOI 10.1021/bc00032a002
   Zund G, 1999, EUR J CARDIO-THORAC, V15, P519, DOI 10.1016/S1010-7940(99)00068-8
NR 33
TC 37
Z9 39
U1 2
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2004
VL 25
IS 10
BP 1859
EP 1867
DI 10.1016/j.biometerials.2003.08.031
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 770CQ
UT WOS:000188706000015
PM 14738850
DA 2018-10-19
ER

PT J
AU Speranza, G
   Gottardi, G
   Pederzolli, C
   Lunelli, L
   Canteri, R
   Pasquardini, L
   Carli, E
   Lui, A
   Maniglio, D
   Brugnara, M
   Anderle, M
AF Speranza, G
   Gottardi, G
   Pederzolli, C
   Lunelli, L
   Canteri, R
   Pasquardini, L
   Carli, E
   Lui, A
   Maniglio, D
   Brugnara, M
   Anderle, M
TI Role of chemical interactions in bacterial adhesion to polymer surfaces
SO BIOMATERIALS
LA English
DT Article
DE bacterial adhesion; acid-base interactions; XPS; Tof-SIMS; SEM; contact
   angle
ID STAPHYLOCOCCUS-EPIDERMIDIS; BIOFILM FORMATION; BIOMEDICAL POLYMERS;
   MICROBIAL ADHESION; IONIC-STRENGTH; HYDROPHOBICITY; PREVENTION;
   INFECTIONS; CATHETERS; GROWTH
AB Development of biomaterial-related infections is attracting an increasing interest due to the significant percentage of implant failure in the hospital care. Recent literature puts in evidence the dependence of the infection risk on the different biomaterials used, because of the different interactions between material surface and micro-organisms. Despite this, the mechanisms underlying the adhesion of bacteria to the biomaterial surface are still unclear. Aim of this work is to study the initial events of the processes responsible for the bacterial adhesion on polymers in order to prevent the development of bacterial infections and the consequent failure and replacement of biomedical devices. Electrostatic and Lifshitz-van der Waals forces are usually considered responsible for the interactions at the biomaterial interface. A new term that involves Lewis acid-base interactions is here introduced to better describe the bacterial adhesion to the polymer surface. Two requirements are needed to test this hypothesis: the development of an ideal polymeric surface in terms of chemical and morphological properties and the choice of a specific bacterial strain to be utilized as "probe". Experiments were worked out using an Escherichia coli (Gram-) strain that represent one of the principal isolates from infected biomaterial implants and its adhesion was investigated on polymers having different acid/basic character. The findings indicate that the bacterial adhesion is influenced by the chemical properties of the polymeric surface. These results may be interpreted taking into account a mechanism in which the acid/base (Lewis) interaction plays an important role. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Ist Ric Sci & Tecnol, ITC, I-38050 Trent, Italy.
   Univ Trent, Dept Mat Engn & Ind Technol, Trent, Italy.
RP Speranza, G (reprint author), Ist Ric Sci & Tecnol, ITC, Sommarive Str 18, I-38050 Trent, Italy.
EM speranza@itc.it
RI Gottardi, Gloria/E-5334-2010; Speranza, Giorgio/G-6275-2011; Maniglio,
   Devid/C-4187-2014
OI Gottardi, Gloria/0000-0002-3472-8572; Speranza,
   Giorgio/0000-0003-1478-0995; Maniglio, Devid/0000-0002-1653-861X;
   Canteri, Roberto/0000-0002-0895-8884
CR An YH, 2000, HDB BACTERIAL ADHESI
   Barton AJ, 1996, J BIOMED MATER RES, V30, P403, DOI 10.1002/(SICI)1097-4636(199603)30:3<403::AID-JBM15>3.0.CO;2-K
   Beamson G., 1992, HIGH RESOLUTION XPS
   Boonaert CJP, 2001, COLLOID SURFACE B, V22, P171, DOI 10.1016/S0927-7765(01)00196-5
   Boonaert CJP, 2000, APPL ENVIRON MICROB, V66, P2548, DOI 10.1128/AEM.66.6.2548-2554.2000
   Briandet R, 1999, APPL ENVIRON MICROB, V65, P5328
   BRUNISMA GM, 2002, BIOMATERIALS, V22, P3217
   BUNT CR, 1993, INT J PHARMACEUT, V99, P93, DOI 10.1016/0378-5173(93)90350-O
   CARLEN A, 2000, BIOMATERIALS, V22, P481
   CHANG CC, 1992, J BIOMED MATER RES, V26, P197, DOI 10.1002/jbm.820260206
   Cunliffe D, 1999, APPL ENVIRON MICROB, V65, P4995
   Della Volpe C, 2000, J ADHES SCI TECHNOL, V14, P235, DOI 10.1163/156856100742546
   Della Volpe C., 2002, COLLOID SURF A, V206, P46
   Della Volpe C, 2000, J ADHES SCI TECHNOL, V14, P239
   DELLAVOLLPE C, IN PRESS J ADHES SCI
   DELLAVOLPE C, 2002, ENCY SURFACE COLLOID, V1
   DiTizio V, 1998, BIOMATERIALS, V19, P1877, DOI 10.1016/S0142-9612(98)00096-9
   Francois P, 1996, BIOMATERIALS, V17, P667, DOI 10.1016/0142-9612(96)86736-6
   GARBASSI F, 2000, POLYM SURFACES
   GOOD RJ, 1991, FUNDAMENTALS ADHESIO, pCH3
   Gottenbos B, 2000, J BIOMED MATER RES, V50, P208, DOI 10.1002/(SICI)1097-4636(200005)50:2<208::AID-JBM16>3.0.CO;2-D
   Gottenbos B, 2001, J ANTIMICROB CHEMOTH, V48, P7, DOI 10.1093/jac/48.1.7
   GRISTINA AG, 1993, INT J ARTIF ORGANS, V16, P755
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Hendricks SK, 2000, J BIOMED MATER RES, V50, P160, DOI 10.1002/(SICI)1097-4636(200005)50:2<160::AID-JBM10>3.0.CO;2-M
   Higashi JM, 1998, J BIOMED MATER RES, V39, P341, DOI 10.1002/(SICI)1097-4636(19980305)39:3<341::AID-JBM1>3.0.CO;2-J
   JANSEN B, 1995, J IND MICROBIOL, V15, P391, DOI 10.1007/BF01569996
   JARVIS NL, 1964, CONTACT ANGLE WETTAB
   Jones DS, 1996, INT J PHARM, V131, P83, DOI 10.1016/0378-5173(95)04368-3
   Kiaie D., 1995, J BIOMED MATER RES, V29, P729
   Klueh U, 2000, J BIOMED MATER RES, V53, P621, DOI 10.1002/1097-4636(2000)53:6<621::AID-JBM2>3.0.CO;2-Q
   Maruyama N, 1998, THIN SOLID FILMS, V327, P854, DOI 10.1016/S0040-6090(98)00777-9
   Morra M, 1997, J BIOMAT SCI-POLYM E, V9, P55, DOI 10.1163/156856297X00263
   Morra M, 1996, J BIOMED MATER RES, V31, P149
   Otto K, 1999, J BACTERIOL, V181, P5210
   PAGE B, 1993, INT J ONCOL, V3, P473
   Park KD, 1998, BIOMATERIALS, V19, P851, DOI 10.1016/S0142-9612(97)00245-7
   REID G, 1994, COLLOID SURFACE B, V2, P377
   Tsibouklis J, 1999, BIOMATERIALS, V20, P1229, DOI 10.1016/S0142-9612(99)00023-X
   WANG IW, 1995, J BIOMED MATER RES, V29, P485, DOI 10.1002/jbm.820290408
   WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9
   Yousefi Rad A, 1998, J Biomater Sci Polym Ed, V9, P915, DOI 10.1163/156856298X00244
NR 42
TC 126
Z9 132
U1 2
U2 42
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2004
VL 25
IS 11
BP 2029
EP 2037
DI 10.1016/j.biomaterials.2003.08.061
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 771QB
UT WOS:000188796600007
PM 14741617
DA 2018-10-19
ER

PT J
AU Yuan, YL
   Ai, F
   Zang, XP
   Zhuang, W
   Shen, J
   Lin, SC
AF Yuan, YL
   Ai, F
   Zang, XP
   Zhuang, W
   Shen, J
   Lin, SC
TI Polyurethane vascular catheter surface grafted with zwitterionic
   sulfobetaine monomer activated by ozone
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE ozonization; graft copolymerization; PUVC-g-PDMMSA; platelet adhesion
ID BLOOD COMPATIBILITY; POLY(ETHER URETHANE); PLATELET-ADHESION
AB Polyurethane (PU) is a conventional biomedical material with favorable biocompatibility and excellent mechanical properties and widely used in making vascular catheter, but its anti thrombogenic property is not good enough to make it as a more demanding applicable biomaterial. Surface modification is an effective way to improve the hemocompatibility for biomaterials. The purpose of present study was to use ozonization method to modify the surface of PU vascular catheter slice to improve its antithrombogenicity by grafting N,N-dimethyl-N-methacrytoxyethyl-N-(3-sulfopropyl) ammonium (DMMSA), a zwitterionic sulfobetaine monomer. PU vascular catheter (PUVC) grafted with DMMSA (PUVC-g-PDMMSA) was characterized by ATR-FTIR and XPS. ATR-FTIR and XPS investigation confirmed the graft polymerization. The blood compatibility of the grafted films was evaluated by platelet rich plasma (PRP) platelet adhesion study and scanning electron microscopy (SEM) was used to observe the morphology of platelet using PU vascular catheter (PUVC) as the reference. No platelet adhesion was observed for the grafted PUVC slice incubated with PRP at 37degreesC for 120 min. It is significant that this new zwitterionic sulfobetaine grafted PUVC have improved antithrobogenicity. It is effective that the inner surface of vascular catheter with inner diameter in only 3 mm can be grafted with PDMMSA by using ozonization method. (C) 2004 Elsevier B.V. All rights reserved.
C1 Nanjing Univ, Ctr Res Surface & Interface Chem Engn & Techol, Nanjing 210093, Peoples R China.
   Nanjing Normal Univ, Coll Chem & Environm Sci, Nanjing 210097, Peoples R China.
RP Lin, SC (reprint author), Nanjing Univ, Ctr Res Surface & Interface Chem Engn & Techol, Nanjing 210093, Peoples R China.
EM sicong_lin@yahoo.com
CR AI F, 2002, ACTA POLYM SIN, V4, P535
   Dickinson RB, 1997, J BIOMED MATER RES, V36, P152, DOI 10.1002/(SICI)1097-4636(199708)36:2<152::AID-JBM3>3.0.CO;2-J
   FOUGNOT C, 1984, MACROMOLECULAR BIOMA
   FUJIMOTO K, 1993, J POLYM SCI POL CHEM, V31, P1035, DOI 10.1002/pola.1993.080310426
   HORNING EC, 1955, ORGANIC SYNTHESES CO, V3, pP415
   Lee JH, 2000, BIOMATERIALS, V21, P683, DOI 10.1016/S0142-9612(99)00197-0
   Lee JH, 1998, J BIOMED MATER RES, V40, P314, DOI 10.1002/(SICI)1097-4636(199805)40:2<314::AID-JBM17>3.0.CO;2-L
   Lelah M. D., 1986, POLYURETHANES MED
   LELAH MD, 1985, J COLLOID INTERF SCI, V104, P422, DOI 10.1016/0021-9797(85)90051-7
   Li YJ, 1997, J BIOMATER APPL, V12, P167, DOI 10.1177/088532829701200205
   Lin SC, 1998, POLYM B, V1, P1
   NEILL TO, 1972, J POLYM SCI POL CHEM, V10, P569
   PENN LS, 1994, POLYM ADVAN TECHNOL, V5, P809
   THOMPSON AR, 1983, MANUAL HEMOSTASIS TH
   Tsuruta T., 1993, BIOMEDICAL APPL POLY
   TYLER BJ, 1992, J BIOMED MATER RES, V26, P273, DOI 10.1002/jbm.820260302
   Uyama Y, 1998, ADV POLYM SCI, V137, P1
   WANG CH, 1997, ACTA POLYM SIN, V1, P114
   Yuan J, 2003, CHEM J CHINESE U, V24, P916
   Yuan YL, 2003, COLLOID SURFACE B, V29, P247, DOI 10.1016/S0927-7765(02)00210-2
   Zhang J, 2003, COLLOID SURFACE B, V28, P1
   ZHANG J, 2003, BIOINTERFACES, V30, P249
NR 22
TC 74
Z9 81
U1 6
U2 47
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD MAY 1
PY 2004
VL 35
IS 1
BP 1
EP 5
DI 10.1016/j.colsurfb.2004.01.005
PG 5
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 823RA
UT WOS:000221629500001
PM 15261048
DA 2018-10-19
ER

PT J
AU Kidd, KR
   Williams, SK
AF Kidd, KR
   Williams, SK
TI Laminin-5-enriched extracellular matrix accelerates angiogenesis and
   neovascularization in association with ePTFE
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE ePTFE; angiogenesis; extracellular matrix; laminin-5
ID FIBROBLAST GROWTH-FACTOR; EXPANDED POLYTETRAFLUOROETHYLENE GRAFTS;
   ENCAPSULATES SUBCUTANEOUS IMPLANTS; ENDOTHELIAL-CELL PROLIFERATION;
   HEPARINIZED COLLAGEN MATRICES; VASCULAR GRAFTS; INFLAMMATORY RESPONSE;
   GEOMETRIC CONTROL; HOST RESPONSE; IN-VIVO
AB The performance of biomedical implant devices is often limited by inappropriate tissue responses associated with synthetic materials used in device construction. Adverse healing responses, in particular the lack of an extensive vascular supply in the peri-implant tissue, are believed to lead to the ultimate failure of many of these medical devices. Accelerated formation of new blood vessels in the peri-implant tissue and within porous polymeric implants is hypothesized to improve the performance of such biomedical implant devices. The current study evaluated the use of cell-mediated, extracellular matrix modification of expanded polytetrafluoroethylene (ePTFE) to increase vessel growth in peri-implant tissue and within the pores of the implants. Discs of ePTFE were modified through cell-mediated matrix deposition using epithelial and endothelial cell lines with variable deposition of collagen types, fibronectin, and laminin types. Cell matrix-modified discs, Matrigel-coated discs, and nonmodified discs were implanted in both the adipose and subcutaneous tissues of the rat. Following a 5-week implant period, samples were removed and evaluated histologically and morphometrically for the presence of blood vessels in the peri-implant tissue and within the pores of-the polymer as well as for the presence of activated macrophages and monocytes. A significantly increased presence of activated macrophages and monocytes was associated only with the samples modified with the matrix from a human microvessel endothelial cell line. Increased vessel density was identified in association with those ePTFE samples modified with either the 804-G, HaCaT, or Pi-4 cell matrices, all of which have extracellular matrices enriched in the protein laminin-5. (C) 2004 Wiley Periodicals, Inc.
C1 Univ Arizona, Biomed Engn Program, Tucson, AZ 85724 USA.
RP Williams, SK (reprint author), Univ Arizona, Biomed Engn Program, Tucson, AZ 85724 USA.
EM skwill@u.arizona.edu
FU NHLBI NIH HHS [HL63873]
CR Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   Black MM, 1995, J MED ENG TECHNOL, V19, P151, DOI 10.3109/03091909509009986
   BRAUKER JH, 1995, J BIOMED MATER RES, V29, P1517, DOI 10.1002/jbm.820291208
   Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   DAVIS GE, 1995, EXP CELL RES, V216, P113, DOI 10.1006/excr.1995.1015
   DeVos P, 1997, TRANSPLANTATION, V63, P824, DOI 10.1097/00007890-199703270-00006
   DIDISHEIM P, 1993, CARDIOVASC PATHOL, V2, pS1
   Dike LE, 1999, IN VITRO CELL DEV-AN, V35, P441
   FOLKMAN J, 1992, J BIOL CHEM, V267, P10931
   Fujiwara H, 2001, J BIOL CHEM, V276, P17550, DOI 10.1074/jbc.M010155200
   GARRIDO T, 1995, BRIT J CANCER, V71, P770, DOI 10.1038/bjc.1995.149
   Gerritsen M, 2000, DIABETES CARE, V23, P143, DOI 10.2337/diacare.23.2.143
   Giordano FJ, 2001, CURR OPIN GENET DEV, V11, P35, DOI 10.1016/S0959-437X(00)00153-2
   GREENHALGH RM, 1990, ACTA CHIR SCAND, P249
   GREISLER HP, 1987, J VASC SURG, V5, P393, DOI 10.1067/mva.1987.avs0050393
   GREISLER HP, 1992, SURGERY, V112, P244
   Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7
   Homan SM, 1998, J CELL SCI, V111, P2717
   Hunt JA, 1997, BIOMATERIALS, V18, P1449, DOI 10.1016/S0142-9612(97)00091-4
   INGBER DE, 1989, CELL, V58, P803, DOI 10.1016/0092-8674(89)90928-8
   Jones JCR, 1998, BIOESSAYS, V20, P488, DOI 10.1002/(SICI)1521-1878(199806)20:6<488::AID-BIES7>3.3.CO;2-9
   Kao WYJ, 2001, BIOMATERIALS, V22, P2901, DOI 10.1016/S0142-9612(01)00037-0
   Kidd KR, 2002, J BIOMED MATER RES, V59, P366, DOI 10.1002/jbm.1253
   Kikkawa Y, 1996, IN VITRO CELL DEV-AN, V32, P46
   Kikkawa Y, 1998, J BIOL CHEM, V273, P15854, DOI 10.1074/jbc.273.25.15854
   Kikkawa Y, 2000, J CELL SCI, V113, P869
   KLEIN S, 1993, MOL BIOL CELL, V4, P973
   KLEINMAN HK, 1982, BIOCHEMISTRY-US, V21, P6188, DOI 10.1021/bi00267a025
   Kortesmaa J, 2000, J BIOL CHEM, V275, P14853, DOI 10.1074/jbc.275.20.14853
   KOVEKER GB, 1991, SURGERY, V109, P313
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LINDNER V, 1990, J CLIN INVEST, V85, P2004, DOI 10.1172/JCI114665
   Marois Y, 2000, ARTIF ORGANS, V24, P533, DOI 10.1046/j.1525-1594.2000.06547.x
   Merzkirch C, 2001, ANAT REC, V263, P379, DOI 10.1002/ar.1118
   MILLER KM, 1989, J BIOMED MATER RES, V23, P911, DOI 10.1002/jbm.820230808
   PASSANITI A, 1992, LAB INVEST, V67, P519
   Pepper MS, 2001, ARTERIOSCL THROM VAS, V21, P1104, DOI 10.1161/hq0701.093685
   Pepper MS, 1996, CURR TOP MICROBIOL, V213, P31
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   RATNR BD, 1987, J BIOMED MATER RES-A, V21, P59
   Rongish BJ, 1996, J MOL CELL CARDIOL, V28, P2203, DOI 10.1006/jmcc.1996.0212
   Sanders JE, 2000, J BIOMED MATER RES, V52, P231, DOI 10.1002/1097-4636(200010)52:1<231::AID-JBM29>3.0.CO;2-E
   Sharkawy AA, 1997, J BIOMED MATER RES, V37, P401
   Sharkawy AA, 1998, J BIOMED MATER RES, V40, P586, DOI 10.1002/(SICI)1097-4636(19980615)40:4<586::AID-JBM10>3.0.CO;2-E
   Shireman PK, 2000, J VASC SURG, V31, P936, DOI 10.1067/mva.2000.106420
   SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410
   Tassiopoulos AK, 2000, J BIOMAT SCI-POLYM E, V11, P1275, DOI 10.1163/156856200744200
   Udipi K, 2000, J BIOMED MATER RES, V51, P549, DOI 10.1002/1097-4636(20000915)51:4<549::AID-JBM2>3.0.CO;2-Z
   Updike SJ, 2000, DIABETES CARE, V23, P208, DOI 10.2337/diacare.23.2.208
   VOHRA R, 1991, BRIT J SURG, V78, P417, DOI 10.1002/bjs.1800780411
   VOLDER JGR, 1974, T AM SOC ART INT ORG, VB 20, P521
   Wagner S, 2000, NEUROSCI LETT, V284, P105, DOI 10.1016/S0304-3940(00)00987-3
   Wagner S, 1997, STROKE, V28, P858, DOI 10.1161/01.STR.28.4.858
   WESOLOWSKI SA, 1961, SURGERY, V50, P91
   Williams SK, 1997, J BIOMED MATER RES, V35, P473
   WILLIAMS SK, 1994, J VASC SURG, V19, P916, DOI 10.1016/S0741-5214(94)70019-2
   WILLIAMS SK, 1991, J ELECTRON MICR TECH, V19, P439, DOI 10.1002/jemt.1060190406
   Wissink MJB, 2000, THROMB HAEMOSTASIS, V84, P325
   Wissink MJB, 2000, J CONTROL RELEASE, V64, P103, DOI 10.1016/S0168-3659(99)00145-5
   Wissink MJB, 2000, J CONTROL RELEASE, V67, P141, DOI 10.1016/S0168-3659(00)00202-9
NR 61
TC 23
Z9 23
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY 1
PY 2004
VL 69A
IS 2
BP 294
EP 304
DI 10.1002/jbm.a.20133
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 812ST
UT WOS:000220859900011
PM 15058002
DA 2018-10-19
ER

PT J
AU Desroches, R
   Smith, B
AF Desroches, R
   Smith, B
TI Shape memory alloys in seismic resistant design and retrofit: A critical
   review of their potential and limitations
SO JOURNAL OF EARTHQUAKE ENGINEERING
LA English
DT Review
DE seismic, shape memory alloys; nitinol; retrofit
ID DAMPING CHARACTERISTICS; CYCLIC DEFORMATION; BEHAVIOR; NITI; WIRES
AB Shape memory alloys (SMAs) are a class of materials that have unique properties, including Young's modulus-temperature relations, shape memory effects, superelastic effects, and high damping characteristics. These unique properties, which have led to numerous applications in the biomedical and aerospace industries, are currently being evaluated for applications in the area of seismic resistant design and retrofit. This paper provides a critical review of the state-of-the-art in the use of shape memory alloys for applications in seismic resistant design. The paper reviews the general characteristics of shape memory alloys and highlights the factors affecting their properties. A review of current studies show that the superelastic and high-damping characteristics of SMAs result in applications in bridges and buildings that show significant promise. The barriers to the expanded use of SMAs include the high cost, lack of clear understanding of thermo-mechanical processing, dependency of properties on temperature, and difficulty in machining.
C1 Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30332 USA.
RP Desroches, R (reprint author), Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30332 USA.
RI DesRoches, Reginald/F-5875-2011
CR ADACHI Y, 1999, P SPIE SMART STRUCTU
   Aiken ID, 1990, UCBEERC9003
   BERNARDINI D, 1999, II169176 MANSIDE
   BRADY P, 1995, ASEE ANN C P
   Buehler W, 1961, 6175 NOLTR
   CASTELLANO M, 2001, P SPIE SMART STRUCT
   CHANG LC, 1951, T AM I MIN MET ENG, V191, P47
   Chute D., 1990, ENG ASPECTS SHAPE ME, P420
   CLARK PW, 1995, P PASSIVE DAMPING SA
   CROCI G, 2001, STRUTURAL ENG INT
   DAVOODI H, 1997, P 16 CAN CONGR APPL
   DEROCHES R, 2003, IN PRESS ASCE J STRU
   DESROCHES R, 2001, ENG STRUCT, V24, P325
   Dolce M, 2001, INT J MECH SCI, V43, P2657, DOI 10.1016/S0020-7403(01)00050-9
   DOLCE M, 1999, II105134 MANSIDE
   Duerig T, 1999, MAT SCI ENG A-STRUCT, V273, P149, DOI 10.1016/S0921-5093(99)00294-4
   DUERIG T, 1997, MED PLASTICS BIOMATE
   EATON JP, 1999, THESIS WORCESTER POL
   FRIEND C, 1999, P 1 EUR C SHAP MEM S, P115
   Higashino M., 1996, 2 INT WORKSH STRUCT, P221
   INANDI J, 1994, 1 WORLD C STRUCT CON, P127
   Indirli M., 2001, P SPIE SMART STRUCTU
   JACKSON CM, 1972, NASA SP, V5110
   KAOUNIDES L, 1995, FT MANAGEMENT REPORT
   KOLOMYTSEV, 1998, 28 S UIA MAY 13 15
   KOVEL Y, 1995, J PHYS IV, V5, P397
   KRUMME R, 1995, P SPIE INT SOC OPT E
   LIN HC, 1993, METALL TRANS A, V24, P2189, DOI 10.1007/BF02648593
   Liu Y, 1999, MAT SCI ENG A-STRUCT, V273, P673, DOI 10.1016/S0921-5093(99)00347-0
   Liu Y, 1997, J PHYS 6, V7, pC5
   MANSIDE, 1998, MEM ALL NEW STRUCT V
   Miyazaki S., 1990, ENG ASPECTS SHAPE ME, P394
   OCEL J, 2002, P 7 US NAT C EARTHQ
   OHI K, 2001, NSF JSPS US JAP SEM
   OLEARY JP, 1990, ENG ASPECTS SHAPE ME, P477
   PICORNELL C, 1994, METALL MATER TRANS A, V25, P687, DOI 10.1007/BF02665445
   Piedboeuf MC, 1998, J SOUND VIB, V214, P885, DOI 10.1006/jsvi.1998.1578
   Sachdeva R, 1990, ENG ASPECTS SHAPE ME, P452
   SCHETKY L, 1999, SMST 99, P248
   Sehitoglu H, 2001, MAT SCI ENG A-STRUCT, V314, P67, DOI 10.1016/S0921-5093(00)01924-9
   SERNEELS A, 1999, P 1 EUR C SHAP MEM S, P6
   SHERNGELL H, 1999, MAT SCI ENG A-STRUCT, V273, P400
   STRNADEL B, 1995, MAT SCI ENG A-STRUCT, V202, P148, DOI 10.1016/0921-5093(95)09801-1
   SWEENEY S, 1995, WIND SEISMIC EFFECTS
   TOBUSHI H, 1992, JSME INT J I-SOLID M, V35, P271, DOI 10.1299/jsmea1988.35.3_271
   Tobushi H, 1996, SMART MATER STRUCT, V5, P788, DOI 10.1088/0964-1726/5/6/008
   VALENTE C, 1999, II177192 MANSIDE
   Van Humbeeck J, 1999, MAT SCI ENG A-STRUCT, V273, P134, DOI 10.1016/S0921-5093(99)00293-2
   WHITTAKER A, 1995, 22 US ARM CORPS ENG
   Wilde K, 2000, ENG STRUCT, V22, P222, DOI 10.1016/S0141-0296(98)00097-2
   Wolons D, 1998, J INTEL MAT SYST STR, V9, P116, DOI 10.1177/1045389X9800900205
   Xie ZL, 1998, ACTA MATER, V46, P1989, DOI 10.1016/S1359-6454(97)00379-0
   Zhao C, 2001, ADV MATER PROCESS, P33
NR 53
TC 72
Z9 73
U1 3
U2 24
PU IMPERIAL COLLEGE PRESS
PI LONDON
PA 57 SHELTON ST, COVENT GARDEN, LONDON WC2H 9HE, ENGLAND
SN 1363-2469
J9 J EARTHQ ENG
JI J. EARTHQU. ENG.
PD MAY
PY 2004
VL 8
IS 3
BP 415
EP 429
DI 10.1142/S1363246904001298
PG 15
WC Engineering, Civil; Engineering, Geological; Geosciences,
   Multidisciplinary
SC Engineering; Geology
GA 814MJ
UT WOS:000220978500004
DA 2018-10-19
ER

PT J
AU Kuckelhaus, S
   Reis, SC
   Carneiro, MF
   Tedesco, AC
   Oliveira, DM
   Lima, ECD
   Morais, PC
   Azevedo, RB
   Lacava, ZGM
AF Kuckelhaus, S
   Reis, SC
   Carneiro, MF
   Tedesco, AC
   Oliveira, DM
   Lima, ECD
   Morais, PC
   Azevedo, RB
   Lacava, ZGM
TI In vivo investigation of cobalt ferrite-based magnetic fluid and
   magnetoliposomes using morphological tests
SO JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS
LA English
DT Article; Proceedings Paper
CT International Conference on Magnetism (ICM 2003)
CY JUL 27-AUG 01, 2003
CL Rome, ITALY
DE magnetic fluid; liposome; cobalt; citrate; biocompatibility
ID TOXICITY
AB Morphological studies were carried out after endovenous injection of a magnetic fluid and magnetoliposome samples, all containing cobalt ferrite magnetic nanoparticles (MNPs). Twenty four hours after injection, the three investigated samples presented differences concerning blood clearance, phagocytosis susceptibility, and MNP cluster size and amount. Our data suggest that the samples investigated are biocompatible and could be used as material basis for biomedical applications. Further, differences observed in the in vivo tests support application of the samples for different biomedical purposes. (C) 2004 Elsevier B.V. All rights reserved.
C1 Univ Brasilia, Inst Ciencias Biol, Depto Genet & Morfol, BR-70910900 Brasilia, DF, Brazil.
   USP, FFCLRP, BR-14040901 Ribeirao Preto, SP, Brazil.
   Univ Fed Goias, Inst Quim, BR-74001970 Goiania, Go, Brazil.
   Univ Brasilia, Inst Fis Nucl Fis Aplicada, BR-70919970 Brasilia, DF, Brazil.
RP Lacava, ZGM (reprint author), Univ Brasilia, Inst Ciencias Biol, Depto Genet & Morfol, BR-70910900 Brasilia, DF, Brazil.
EM zulmira@unb.br
RI Azevedo, Ricardo/D-6273-2012; Tedesco, Antonio/B-7584-2012
OI Tedesco, Antonio/0000-0003-4198-9321
CR Ayala-Fierro F, 1999, J TOXICOL ENV HEAL A, V56, P571, DOI 10.1080/009841099157908
   Bulte JWM, 1999, J MAGN MAGN MATER, V194, P204, DOI 10.1016/S0304-8853(98)00556-3
   DECUYPER M, 1988, EUR BIOPHYS J BIOPHY, V15, P311, DOI 10.1007/BF00256482
   DECUYPER M, 1993, J MAGN MAGN MATER, V122, P340, DOI 10.1016/0304-8853(93)91105-G
   Garcia VAP, 2002, EUR CELLS MATER, V3, P154
   Jordan A, 1997, INT J HYPERTHER, V13, P587, DOI 10.3109/02656739709023559
   Kuckelhaus S, 2003, J APPL PHYS, V93, P6707, DOI 10.1063/1.1558665
   Lacava LM, 2003, J APPL PHYS, V93, P7563, DOI 10.1063/1.1540178
   Lacava ZGM, 1999, J MAGN MAGN MATER, V194, P90, DOI 10.1016/S0304-8853(98)00583-6
   Lacava ZGM, 1999, J MAGN MAGN MATER, V201, P431, DOI 10.1016/S0304-8853(99)00002-5
   Morais PC, 2001, J MAGN MAGN MATER, V225, P37, DOI 10.1016/S0304-8853(00)01225-7
NR 11
TC 25
Z9 26
U1 1
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-8853
J9 J MAGN MAGN MATER
JI J. Magn. Magn. Mater.
PD MAY
PY 2004
VL 272
SI SI
BP 2402
EP 2403
DI 10.1016/j.jmmm.2003.12.1218
PN 3
PG 2
WC Materials Science, Multidisciplinary; Physics, Condensed Matter
SC Materials Science; Physics
GA 831ZU
UT WOS:000222236800320
DA 2018-10-19
ER

PT J
AU Rodriguez-Lorenzo, LM
   Gross, KA
AF Rodriguez-Lorenzo, LM
   Gross, KA
TI Encapsulation of hydroxyapatite microspheres with fluorapatite using a
   diffusion process
SO JOURNAL OF THE AMERICAN CERAMIC SOCIETY
LA English
DT Article
ID FLUORIDE UPTAKE; ADSORPTION; ENAMEL; BONE
AB Modification of hydroxyapatite surfaces can improve the properties of biomedical devices. The objective of this work was to encapsulate hydroxyapatite particles with a fluorapatite layer. A suspension of hydroxyapatite microspheres was prepared in a solution at different pH and treated with ammonium fluoride. pH, calcium, and fluoride were monitored in real time and particles subjected to fluoride analysis. After addition of fluoride, it was found that more material is released from the particle surface at low pH conditions, but leads to a high fluoride uptake from solution. Low solution fluoride levels produce a fluorapatite layer, but higher fluoride levels produce calcium fluoride.
C1 Monash Univ, Sch Phys & Mat Engn, Clayton, Vic, Australia.
RP Gross, KA (reprint author), Monash Univ, Sch Phys & Mat Engn, Clayton, Vic, Australia.
EM karlis.gross@spme.monash.edu.au
RI Rodriguez-Lorenzo, Luis/A-1090-2008; Gross, Karlis/G-2793-2010
OI Rodriguez-Lorenzo, Luis/0000-0002-4816-1087; 
CR BONFIELD W, 1988, BIOCERAMICS MATERIAL, V523, P173
   Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023
   CHANDER S, 1985, COLLOID SURFACE, V13, P137
   Chow LC, 1998, CALCIUM PHOSPHATES B, P67
   DASARATHY H, 1993, J BIOMED MATER RES, V27, P477, DOI 10.1002/jbm.820270408
   DEGROOT K, 1983, BIOCERAMICS CALCIUM, P100
   Demos LL, 2001, AUST DENT J, V46, P80, DOI 10.1111/j.1834-7819.2001.tb00561.x
   DRIESSENS FCM, 1980, Z NATURFORSCH C, V35, P357
   Elliott JC, 1994, STUDIES INORGANIC CH, V18
   *INT CTR DIFFR DAT, 1999, 2433 INT CTR DIFFR D
   *INT CTR DIFFR DAT, 1999, 35816 INT CTR DIFFR
   Jha LJ, 1997, J MATER SCI-MATER M, V8, P185, DOI 10.1023/A:1018531505484
   KRESAK M, 1977, J COLLOID INTERF SCI, V59, P283, DOI 10.1016/0021-9797(77)90010-8
   LARSEN MJ, 1977, SCAND J DENT RES, V85, P327
   Leach S. A., 1959, BRIT DENT J, V106, P133
   Leamy P, 1998, J BIOMED MATER RES, V42, P458, DOI 10.1002/(SICI)1097-4636(19981205)42:3<458::AID-JBM16>3.0.CO;2-C
   Legeros R.Z., 1991, MONOGRAPHS ORAL SCI, V15
   LIN J, 1981, COLLOID SURFACE, V3, P357, DOI 10.1016/0166-6622(81)80062-5
   Liu Y, 1997, J COLLOID INTERF SCI, V186, P102, DOI 10.1006/jcis.1996.4621
   Liu Y, 1996, J CRYST GROWTH, V165, P116, DOI 10.1016/0022-0248(95)00981-7
   MCCANN HG, 1953, J BIOL CHEM, V201, P247
   MORENO EC, 1974, NATURE, V247, P64, DOI 10.1038/247064a0
   Murata H, 1996, CARIES RES, V30, P465, DOI 10.1159/000262361
   NELSON NG, 1970, J DENT RES, V49, P1541
   Okazaki M, 1999, BIOMATERIALS, V20, P1303, DOI 10.1016/S0142-9612(99)00030-7
   OKAZAKI M, 1992, BIOMATERIALS, V13, P749, DOI 10.1016/0142-9612(92)90012-D
   REY C, 1998, CALCIUM PHOSPHATES B, P217
   Scherrer WN, 1983, ADV XRAY ANAL, V26, P141
   SINGER L, 1968, ANAL CHEM, V40, P613, DOI 10.1021/ac60259a017
   SPINELLI MA, 1971, ARCH ORAL BIOL, V16, P187, DOI 10.1016/0003-9969(71)90106-3
   TENCATE JM, 1991, CRIT REV ORAL BIOL M, V2, P283, DOI 10.1177/10454411910020030101
   TODDA H, 1995, BOMATERIALS, V16, P945
   VEERBECK G, 1990, J CRYST GROWTH, V104, P820
NR 33
TC 1
Z9 1
U1 0
U2 3
PU AMER CERAMIC SOC
PI WESTERVILLE
PA 735 CERAMIC PLACE, PO BOX 6136, WESTERVILLE, OH 43086-6136 USA
SN 0002-7820
J9 J AM CERAM SOC
JI J. Am. Ceram. Soc.
PD MAY
PY 2004
VL 87
IS 5
BP 814
EP 818
DI 10.1111/j.1551-2916.2004.00814.x
PG 5
WC Materials Science, Ceramics
SC Materials Science
GA 826DA
UT WOS:000221808100007
DA 2018-10-19
ER

PT J
AU Lee, H
   Kim, HB
   Lee, CW
   Im, TG
   Jeong, JI
   Ahn, S
AF Lee, H
   Kim, HB
   Lee, CW
   Im, TG
   Jeong, JI
   Ahn, S
TI Characterization of a platinum electrode by using unbalanced magnetic
   field sputter for implantable biomedical applications
SO JOURNAL OF THE KOREAN PHYSICAL SOCIETY
LA English
DT Article; Proceedings Paper
CT 30th International Conference on Plasma Science
CY JUN 02-05, 2003
CL Jeju Isl, SOUTH KOREA
SP IEEE PSAC
DE platinum(Pt); unbalanced magnetic field (UBM); biocompatible
ID THIN-FILMS; ELECTROPLATING BATHS; PLASMA; DEPOSITION
AB Platinum (Pt) is a biocompatible material which exhibits strong thermal and electrical conductivity due to its high melting point and good durability. Thus, it is used commonly in bio-electrodes and bio-chips. In this study, a tungsten (W) wire was coated with a platinum film and was analyzed for its mechanical and biocompatibility properties. The platinum film was deposited by magnetron sputtering with an UnBalanced Magnetic (UBM) field system, The experiment was performed under a variety of conditions by changing the deposition temperature, the bias voltage, the magnetic field and the deposition time in order to deduce the optimum conditions. We examined the exfoliation and the sedimentation states of the anode and the cathode by using microscope and an electron probe microanalysis (EPMA) for the electro-chemical corrosion test using the Hank's solution. The film showed a very low impurity level, and the surface and the cross section of the film appeared elaborate. No sedimentation appeared in the film, and the crystallization in the (110), the (200), the (220) and the (222) directions observed. However, at a high current density (800 mA/cm(2)), sedimentation was observed in the corrosion test.
C1 Solco Biomed Co Ltd, Inst Biomed, Pyungteak 451852, South Korea.
   Res Inst Ind Sci & Technol, Pohang 790330, South Korea.
   Seoul Natl Univ, Coll Nat Sci, Seoul 151742, South Korea.
RP Lee, H (reprint author), Solco Biomed Co Ltd, Inst Biomed, Pyungteak 451852, South Korea.
EM hoonlee@solco.co.kr
CR Chou CK, 1997, BIOELECTROMAGNETICS, V18, P14, DOI 10.1002/(SICI)1521-186X(1997)18:1<14::AID-BEM4>3.3.CO;2-O
   Farooq M, 2002, J KOREAN PHYS SOC, V40, P511
   Gregory AJ, 1995, J ELECTROANAL CHEM, V399, P105, DOI 10.1016/0022-0728(95)04283-0
   GREGORY AJ, 1993, J ELECTROANAL CHEM, V348, P211, DOI 10.1016/0022-0728(93)80133-3
   Kim HW, 2003, J KOREAN PHYS SOC, V42, P667
   Kim SH, 2003, J KOREAN PHYS SOC, V42, P196
   Suzuki Y, 1997, NUCL INSTRUM METH B, V121, P107, DOI 10.1016/S0168-583X(96)00645-3
   Thompson MP, 2002, SENSOR ACTUAT A-PHYS, V101, P358, DOI 10.1016/S0924-4247(02)00267-4
NR 8
TC 3
Z9 3
U1 0
U2 0
PU KOREAN PHYSICAL SOC
PI SEOUL
PA 635-4, YUKSAM-DONG, KANGNAM-KU, SEOUL 135-703, SOUTH KOREA
SN 0374-4884
J9 J KOREAN PHYS SOC
JI J. Korean Phys. Soc.
PD MAY
PY 2004
VL 44
IS 5
BP 1173
EP 1176
PN 1
PG 4
WC Physics, Multidisciplinary
SC Physics
GA 821LC
UT WOS:000221461000030
DA 2018-10-19
ER

PT J
AU Lallas, CD
   Preminger, GM
   Pearle, MS
   Leveillee, RJ
   Lingeman, JE
   Schwope, JP
   Pietrow, PK
   Auge, BK
AF Lallas, CD
   Preminger, GM
   Pearle, MS
   Leveillee, RJ
   Lingeman, JE
   Schwope, JP
   Pietrow, PK
   Auge, BK
TI Internet based multi-institutional clinical research: A convenient and
   secure option
SO JOURNAL OF UROLOGY
LA English
DT Article
DE Internet; biomedical research; clinical trials; cooperative behavior;
   data collection
ID DATA-ACQUISITION; TRIALS; MULTICENTER; WEB; SURGERY; CARE
AB Purpose: As randomized, prospective trials have become an integral part of clinical research, multi-institutional, collaborative research has become a necessity. However, it may be cumbersome for participants at remote facilities to participate because the submission and compilation of data and results are at times lengthy processes. Internet based clinical studies have been found to be a rapid, easily accessible, safe and secure method of performing multi-institutional trials.
   Materials and Methods: The Internet was used at geographically distant medical centers to enroll patients into a multi-institutional, prospective, randomized trial for the management of lower pole renal calculi. The Clinical Research Web-based Information Center secure computer web based program (Simplified Clinical Data Systems, Amherst, New Hampshire) was established to input preliminary demographic and clinical data, randomize patients, and collect treatment and followup information without paper chart documentation. The primary investigators in the study were sent a questionnaire to determine the ease of use of this Internet based program. The results were tabulated.
   Results: A total of 112 patients from 21 participating institutions were randomized into the secure web site for inclusion into a lower pole renal stone clinical trial. Of the investigators 64% responded to the questionnaire. The majority of those having enrolled patients into the study reported no difficulties or only minimal difficulties in navigating the web site. Moreover, investigators from remote locations throughout North America described the improved convenience, rapid transmission of information, and ability to review and update patient data as benefits of enrolling patients using the Internet. The Internet based system also permits the prompt compilation of data at the host research site for performing interim data assessments and eventually the final analysis.
   Conclusions: A web based data collection center allows for large, multi-institutional trials to be done with unprecedented accuracy and efficiency. Through centralization of data capture, and real-time study monitoring and data analysis the system removes these responsibilities from those at individual test sites, permitting investigators to concentrate instead on other aspects of the study and its progress. State-of-the-art security protects all information to ensure confidentiality. The Internet may prove to be an invaluable tool in the future of clinical research.
C1 Natl Naval Med Res Inst, Dept Urol, San Diego, CA 92134 USA.
   Duke Univ, Med Ctr, Dept Surg, Div Urol, Durham, NC 27710 USA.
   Univ Texas, Dept Urol, Dallas, TX 75230 USA.
   Univ Miami, Dept Urol, Miami, FL 33152 USA.
   Methodist Hosp Indiana Inc, Dept Urol, Indianapolis, IN USA.
   Boston Sci Corp, Natick, MA USA.
   Univ Kansas, Med Ctr, Dept Urol, Kansas City, KS 66103 USA.
RP Auge, BK (reprint author), Natl Naval Med Res Inst, Dept Urol, 34730 Bob Wilson Dr,Bldg 3,Suite 200, San Diego, CA 92134 USA.
EM bkauge@nmcsd.med.navy.mil
RI Preminger, Glenn/B-3990-2011
OI Preminger, Glenn/0000-0003-4287-602X
CR Albala DM, 2001, J UROLOGY, V166, P2072, DOI 10.1016/S0022-5347(05)65508-5
   Dorman K, 2000, OBSTET GYNECOL, V96, P636, DOI 10.1016/S0029-7844(00)00978-9
   FDA, 1999, COMP SYST US CLIN TR
   Kelly MA, 1997, INT J MED INFORM, V47, P91, DOI 10.1016/S1386-5056(97)00091-9
   Kuchenbecker J, 2001, TELEMED J E-HEALTH, V7, P73, DOI 10.1089/153056201300093976
   Marks RG, 2001, STAT MED, V20, P2683, DOI 10.1002/sim.736
   Marshall W W, 2000, JAMA, V284, P1843, DOI 10.1001/jama.284.14.1843
   Mezzana P, 2002, PLAST RECONSTR SURG, V109, P1658, DOI 10.1097/00006534-200204150-00027
   Miravitlles M, 2002, ARCH BRONCONEUMOL, V38, P427, DOI 10.1016/S0300-2896(02)75256-3
   Mross K, 2001, ONKOLOGIE, V24, P24, DOI 10.1159/000055162
   Rangel SJ, 2002, J PEDIATR SURG, V37, P990, DOI 10.1053/jpsu.2002.33826
   Santoro E, 1999, CONTROL CLIN TRIALS, V20, P194, DOI 10.1016/S0197-2456(98)00060-9
   Unutzer J, 2002, PSYCHIATR SERV, V53, P671, DOI 10.1176/appi.ps.53.6.671
NR 13
TC 25
Z9 25
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD MAY
PY 2004
VL 171
IS 5
BP 1880
EP 1885
DI 10.1097/01.ju.0000120221.39184.3c
PG 6
WC Urology & Nephrology
SC Urology & Nephrology
GA 812XS
UT WOS:000220872800032
PM 15076298
DA 2018-10-19
ER

PT J
AU Li, L
   Leigh, JS
AF Li, L
   Leigh, JS
TI Quantifying arbitrary magnetic susceptibility distributions with MR
SO MAGNETIC RESONANCE IN MEDICINE
LA English
DT Article
DE magnetic susceptibility; spherical mean value; magnetic resonance;
   inverse problem; quantitative susceptibility imaging
ID SUSCEPTOMETRY; OBJECTS; BRAIN; NMR
AB Magnetic susceptibility, as a physical property of materials, plays important roles in many physical, chemical, engineering, and medical applications. Its quantification becomes of significant interest when MRI becomes a commonly used technique in biomedical applications. A general method is presented here for quantifying arbitrary magnetic susceptibility distributions in a localized region on the basis of first principles of magnetic induction field distributions in space. A proof of the concept was demonstrated by computer simulations. The study establishes the methodological basis for quantitative magnetic susceptibility imaging with MR. (C) 2004 Wiley-Liss, Inc.
C1 Univ Penn, Dept Radiol, Stellar Chance Labs 6100, MMRRCC, Philadelphia, PA 19104 USA.
RP Li, L (reprint author), Univ Penn, Dept Radiol, Stellar Chance Labs 6100, MMRRCC, B1, Philadelphia, PA 19104 USA.
EM lin@mail.mmrrcc.upenn.edu
RI Li, Lin/D-1157-2009
OI Li, Lin/0000-0001-9447-7982
FU NCRR NIH HHS [RR 02305]
CR Bartzokis G, 1999, MAGN RESON IMAGING, V17, P213, DOI 10.1016/S0730-725X(98)00155-6
   Beuf O, 1996, J MAGN RESON SER B, V112, P111, DOI 10.1006/jmrb.1996.0120
   BRITTENHAM G, 2002, BLOOD, V101, P15
   CHU SCK, 1990, MAGN RESON MED, V13, P239
   Craik D., 1995, MAGNETISM PRINCIPLES
   HOLT RW, 1994, JMRI-J MAGN RESON IM, V4, P809, DOI 10.1002/jmri.1880040612
   Hopkins JA, 1997, MAGNET RESON MED, V37, P494, DOI 10.1002/mrm.1910370404
   Jackson JD, 1998, CLASSICAL ELECTRODYN, P184
   Li L, 2003, MED PHYS, V30, P449, DOI 10.1118/1.1543574
   Li L, 2002, AM J PHYS, V70, P1029, DOI 10.1119/1.1491264
   Li L, 2001, MAGNET RESON MED, V46, P907
   NOBLE B, 1969, APPL LINEAR ALGEBRA
   Press W., 1992, NUMERICAL RECIPES C, P59
   RO YM, 1995, MAGNET RESON MED, V33, P521, DOI 10.1002/mrm.1910330410
   Schenck JF, 1996, MED PHYS, V23, P815, DOI 10.1118/1.597854
   SEPULVEDA NG, 1994, IEEE T MAGN, V30, P5062, DOI 10.1109/20.334296
   Wang ZYJ, 1999, J MAGN RESON, V140, P477, DOI 10.1006/jmre.1999.1873
   WEISSKOFF RM, 1992, MAGNET RESON MED, V24, P375, DOI 10.1002/mrm.1910240219
   YOUNG IR, 1987, J COMPUT ASSIST TOMO, V11, P2, DOI 10.1097/00004728-198701000-00002
NR 19
TC 76
Z9 79
U1 0
U2 7
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0740-3194
J9 MAGNET RESON MED
JI Magn. Reson. Med.
PD MAY
PY 2004
VL 51
IS 5
BP 1077
EP 1082
DI 10.1002/mrm.20054
PG 6
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 818IO
UT WOS:000221239000028
PM 15122694
OA Bronze
DA 2018-10-19
ER

PT J
AU Karabanova, LV
   Mikhalovska, SV
   Sergeeva, LM
   Meikle, ST
   Helias, M
   Lloyd, A
AF Karabanova, LV
   Mikhalovska, SV
   Sergeeva, LM
   Meikle, ST
   Helias, M
   Lloyd, A
TI Semi-interpenetrating polymer networks based on polyurethane and
   poly(vinyl pyrrolidone) obtained by photopolymerization:
   Structure-property relationships and bacterial adhesion
SO POLYMER ENGINEERING AND SCIENCE
LA English
DT Article
ID THERMODYNAMIC STATE; TEMPERATURE TRANSITIONS; SPECTROSCOPY;
   PECULIARITIES; METHACRYLATE
AB A range of semi-interpenetrating polymer networks (semi-IPNs) based on polyurethane (PU) and poly(vinyl pyrrolidone) (PVP) have been synthesized and characterized with respect to their thermodynamic characteristics, morphology, mechanical properties, surface properties, water sorption and bacterial adhesion. The free energies of mixing of PU and PVP in semi-IPNs have been determined by the vapor sorption method and were shown to be positive for all compositions. The surface properties of semi-IPNs were investigated using the dynamic contact angle analysis. It was shown that the advancing contact angle changes from 83.1degrees to 65.3degrees with increasing PVP from 7.05% to 57.38%. Scanning electron microscopy demonstrated that the semi-IPNs are two-phase systems with incomplete phase separation. The mechanical properties reflect the changes in structure of semi-IPNs with increasing of amounts of PVP in the system. Incorporation of PVP into the semi-IPN with PU restricts the ability of PVP to sorb water. As infection is likely to be caused by bacterial adherence to biomedical implants, the bacterial adhesion data suggests that the semi-IPNs with PVP content below 22.52% may be useful for biomedical material applications.
C1 Inst Macromol Chem, UA-02660 Kiev, Ukraine.
   Univ Brighton, Sch Pharm & Biomol Sci, Biomed Mat Res Grp, Brighton BN2 4GJ, E Sussex, England.
RP Karabanova, LV (reprint author), Inst Macromol Chem, Kharkov Rd 48, UA-02660 Kiev, Ukraine.
OI Meikle, Steven/0000-0002-3846-5001
CR Andrade J. D., 1985, SURFACE INTERFACIAL, P249
   ANDRADE JD, 1979, J POLYM SCI POL SYM, P313
   Bershtein VA, 1999, J POLYM SCI POL PHYS, V37, P429, DOI 10.1002/(SICI)1099-0488(19990301)37:5<429::AID-POLB3>3.0.CO;2-E
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   GUPTA N, 1994, POLYM INT, V35, P109, DOI 10.1002/pi.1994.210350201
   HSIEH KH, 1990, J MEMBRANE SCI, V49, P341, DOI 10.1016/S0376-7388(00)80647-X
   Kanapitsas A, 1998, POLYM GELS NETW, V6, P83, DOI 10.1016/S0966-7822(97)00018-X
   Karabanova L, 1998, J APPL POLYM SCI, V68, P161, DOI 10.1002/(SICI)1097-4628(19980404)68:1<161::AID-APP18>3.0.CO;2-3
   Karabanova LV, 2001, J APPL POLYM SCI, V80, P852, DOI 10.1002/1097-4628(20010509)80:6<852::AID-APP1163>3.0.CO;2-Y
   Lehah M. D., 1986, POLYURETHANE MED SUR, P158
   Lipatov Y. S., 1989, ADV INTERPENETRATING, P261
   Lipatov Y. S., 1994, ADV INTERPENETRATING, P191
   LIPATOV YS, 1990, J MACROMOL SCI R M C, VC30, P209
   LIPATOV YS, 1994, POLYM INT, V34, P7, DOI 10.1002/pi.1994.210340102
   LIPATOV YS, 1992, POLYMER, V33, P361, DOI 10.1016/0032-3861(92)90994-8
   LIPATOV YS, 1992, POLYM INT, V28, P99, DOI 10.1002/pi.4990280202
   LIPATOV YS, 1995, POLYM REINFORCEMENT, P286
   LIPATOV YS, 1979, INTERPENETRATING POL
   Lloyd AW, 2001, BIOMATERIALS, V22, P769, DOI 10.1016/S0142-9612(00)00237-4
   Lowe AB, 2000, J BIOMED MATER RES, V52, P88, DOI 10.1002/1097-4636(200010)52:1<88::AID-JBM11>3.0.CO;2-#
   Nielsen L. E., 1974, MECH PROPERTIES POLY
   OHTSUKA Y, 1973, APPL PHYS LETT, V23, P247, DOI 10.1063/1.1654876
   PAYNTER RW, 1987, BIOMATERIALS, V8, P94, DOI 10.1016/0142-9612(87)90096-2
   SPERLIG LH, 1994, ADV INTERPENETRATING, P1
   SPERLING LH, 1997, IPNS WORLD SCI ENG, P16
   SZYCHER M, 1984, T SOC BIOMATER, V7, P24
   Tager A. A., 1977, VYSOKOMOL SOEDIN, V19, P1654
   Thoma R J, 1987, J Biomater Appl, V1, P449
NR 28
TC 16
Z9 16
U1 0
U2 3
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0032-3888
J9 POLYM ENG SCI
JI Polym. Eng. Sci.
PD MAY
PY 2004
VL 44
IS 5
BP 940
EP 947
DI 10.1002/pen.20085
PG 8
WC Engineering, Chemical; Polymer Science
SC Engineering; Polymer Science
GA 833KD
UT WOS:000222335300012
DA 2018-10-19
ER

PT J
AU Satoh, T
   Hayakawa, H
   Nagahata, M
   Teramoto, A
   Abe, K
AF Satoh, T
   Hayakawa, H
   Nagahata, M
   Teramoto, A
   Abe, K
TI The basic research on physiological property of functionalized
   hyaluronan (II) : Effect of sulfated hyaluronan on histamine release
   from the mast cell
SO SEN-I GAKKAISHI
LA English
DT Article
ID POLYELECTROLYTE COMPLEX PEC; FIBROBLAST HPLF FUNCTION; HEPARIN
AB Hyaluronan (HA) is one of polysaccharides in living body that is found widely in connective tissue of the mammals. It has no sulfate group but high molecular weight in comparison with other glycosaminoglycans (GAGs). We synthesized sulfated HA (S-HA) with various degrees of substitution (D.S.) in order to give HA new biological functions, since GAGs with sulfate groups interact with various biocomponents to express some specific biofunctions. Moreover in order to develop biomedical polymers, immunological response against artificial polymer matrices must be evaluated. So we measured histamine release from the mast cell and discussed the effect of S-HA on the immunological response. It was confirmed that they could be used as biomedical materials with immunological safety. And S-HA inhibited the histamine release that was induced by compound 48/80 from the mast cell. The inhibitory effect of S-HA was seemed to be due to such various factors as D.S., molecular weight, substitution site of the sulfate group and the structure of a polysaccharide chain.
C1 Shinshu Univ, Fac Text Sci & Technol, Ueda, Nagano 3868567, Japan.
RP Satoh, T (reprint author), Shinshu Univ, Fac Text Sci & Technol, 3-15-1 Tokida, Ueda, Nagano 3868567, Japan.
CR AIBA S, 1987, BIOMATERIALS, V8, P481, DOI 10.1016/0142-9612(87)90086-X
   ANDEREGG G, 1954, HELV CHIM ACTA, V37, P113, DOI 10.1002/hlca.19540370114
   GHOSH TK, 1988, J BIOL CHEM, V263, P11075
   GLEICH GJ, 1986, MAST CELL DIFFERENTI, P347
   Hamano T, 1998, J BIOMED MATER RES, V41, P257, DOI 10.1002/(SICI)1097-4636(199808)41:2<257::AID-JBM11>3.0.CO;2-I
   Hamano T, 1998, J BIOMAT SCI-POLYM E, V9, P985, DOI 10.1163/156856298X00299
   Hamano T, 1998, J BIOMED MATER RES, V41, P270, DOI 10.1002/(SICI)1097-4636(199808)41:2<270::AID-JBM12>3.3.CO;2-B
   JALKANEN M, 1991, RECEPTORS EXTRACELLU, P1
   Kikuchi T, 1996, INT J TISSUE REACT, V18, P87
   MATSUDA H, 1990, J IMMUNOL, V144, P259
   Meade CJ, 2001, LIFE SCI, V69, P1225, DOI 10.1016/S0024-3205(01)01231-0
   Niitsuma A, 1996, GEN PHARMACOL, V27, P123, DOI 10.1016/0306-3623(95)00082-8
   NINOMIYA Y, 1979, J BIOCHEM-TOKYO, V86, P111
   OKUNO T, 1990, J IMMUNOL, V136, P4652
   SAKAKIBARA Y, 1994, CLIN ORTHOP RELAT R, P282
   SEARS P, 1991, P NATL ACAD SCI USA, V96, P12086
   SHORE PA, 1959, J PHARMACOL EXP THER, V127, P182
   STEAD RH, 1987, P NATL ACAD SCI USA, V84, P2975, DOI 10.1073/pnas.84.9.2975
   TONES MA, 1989, FEBS LETT, V252, P105, DOI 10.1016/0014-5793(89)80898-1
   TSUCHIDA E, 1982, ADV POLYM SCI, V45, P21
   YURT RW, 1977, J BIOL CHEM, V252, P518
NR 21
TC 0
Z9 0
U1 0
U2 1
PU SOC FIBER SCIENCE TECHNOLOGY
PI TOKYO
PA KAMIOSAKI 3-3-9-208, SHINAGAWA-KU, TOKYO, 141-0025, JAPAN
SN 0037-9875
J9 SEN-I GAKKAISHI
JI Sen-I Gakkaishi
PD MAY
PY 2004
VL 60
IS 5
BP 137
EP 143
PG 7
WC Materials Science, Textiles; Polymer Science
SC Materials Science; Polymer Science
GA 837KD
UT WOS:000222627700005
DA 2018-10-19
ER

PT J
AU Lund, E
   Gustafsson, H
   Danilczuk, M
   Sastry, MD
   Lund, A
AF Lund, E
   Gustafsson, H
   Danilczuk, M
   Sastry, MD
   Lund, A
TI Compounds of Li-6 and natural Li for EPR dosimetry in photon/neutron
   mixed radiation fields
SO SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY
LA English
DT Article; Proceedings Paper
CT 8th International Workshop on Electron Magnetic Resonance of Disordered
   Systems
CY JUN 07-16, 2003
CL Sofia, BULGARIA
DE EPR dosimetry; Li-6; Li-7; photon/neutron fields
ID LITHIUM FORMATE; ALANINE
AB Formates and dithionates of Li-6, enriched and Li-7 in natural composition of Li offer a possibility to measure the absorbed dose from photons and thermal neutrons in a mixed radiation field for instance at a boron neutron capture therapy (BNCT) facility. Tests with formates and dithionates of enriched 6Li and lithium compounds with natural composition have been performed at the BNCT facility at Studsvik, Sweden. Irradiations have been performed at 3 cm depth in a Perspex phantom in a fluence rate of thermal neutrons 1.8 x 10(9) n cm(-2) s(-1). The compounds were also irradiated in a pure X-ray field from a 4 MV linear accelerator at 5 cm depth in a phantom with accurately determined absorbed doses. The signal intensity and shape was investigated within 3 h after the irradiation. A single line spectrum attributed to the CO2- radical was observed after irradiation of lithium formate. An increase in line width occurring after neutron irradiation in comparison with photon irradiation of the Li-6 sample was attributed to dipolar broadening between CO2- radicals trapped in the tracks of the alpha particles. A spectrum due to the SO3- radical anion was observed after irradiation of lithium dithionate. The signal amplitude increased using the Li-6 in place of the Li with natural composition of isotopes, in studies with low energy X-ray irradiation. Due to the decreased line width, caused by the difference in g(N) and I between the isotopes, the sensitivity with Li-6 dithionate may be enhanced by an order of magnitude compared to alanine dosimetry. After comprehensive examination of the different combinations of compounds with different amounts of Li-6 and Li-7 regarding dosimetry, radiation chemistry and EPR properties these dosimeter material might be used for dose determinations at BNCT treatments and for biomedical experiments. Interesting properties of the radical formation might be visible due to the large difference in ionization density of neutrons compared to photons. (C) 2003 Elsevier B.V. All rights reserved.
C1 IMV, Fac Hlth Sci, Dept Radiat Phys, SE-58185 Linkoping, Sweden.
   Linkoping Univ, IFM, Chem Phys Lab, SE-58183 Linkoping, Sweden.
   Inst Nucl Chem & Technol, PL-03195 Warsaw, Poland.
RP Lund, E (reprint author), IMV, Fac Hlth Sci, Dept Radiat Phys, SE-58185 Linkoping, Sweden.
EM eva.lund@imv.liv.se
CR af Rosenschold PMM, 2003, MED PHYS, V30, P1569, DOI 10.1118/1.1580484
   Bogushevich SE, 2000, APPL RADIAT ISOTOPES, V52, P1217, DOI 10.1016/S0969-8043(00)00074-9
   Brauer G., 1954, HDB PRAPARATIVEN ANO
   BRUSTOLON M, 1994, APPL MAGN RESON, V7, P405, DOI 10.1007/BF03162621
   CHANTRY GW, 1962, MOL PHYS, V5, P233, DOI 10.1080/00268976200100251
   Coderre JA, 1999, RADIAT RES, V151, P1, DOI 10.2307/3579742
   GUSTAFSSON H, 2001, LITHIFMEX910
   Ikeya M, 2000, APPL RADIAT ISOTOPES, V52, P1209, DOI 10.1016/S0969-8043(00)00073-7
   Ikeya M., 1993, NEW APPL ELECT SPIN
   KANSIKAS J, 1989, ACTA CRYSTALLOGR C, V45, P187, DOI 10.1107/S0108270188010327
   KEIZER PN, 1991, J CHEM SOC FARADAY T, V87, P3147, DOI 10.1039/ft9918703147
   KOMAGUCHI K, EMARDIS C GRAD SCH E, P739
   Lund A, 2002, SPECTROCHIM ACTA A, V58, P1301, DOI 10.1016/S1386-1425(01)00719-3
   MAHGOUB AS, 1994, J MATER CHEM, V4, P223, DOI 10.1039/jm9940400223
   MAHGOUB ASA, 1983, RADIAT PHYS CHEM, V21, P527, DOI 10.1016/0146-5724(83)90008-0
   OLSSON S, 2001, 701 ESR
   Regulla D, 2000, APPL RADIAT ISOTOPES, V52, P1023, DOI 10.1016/S0969-8043(00)00043-9
   SUPE AA, 1986, LATVIJAS PSR ZINATNU, V4, P433
   TELLGREN R, 1974, FERROELECTRICS, V6, P191
   Vestad TA, 2003, APPL RADIAT ISOTOPES, V59, P181, DOI 10.1016/S0969-8043(03)00165-9
NR 20
TC 22
Z9 22
U1 1
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1386-1425
J9 SPECTROCHIM ACTA A
JI Spectroc. Acta Pt. A-Molec. Biomolec. Spectr.
PD MAY
PY 2004
VL 60
IS 6
BP 1319
EP 1326
DI 10.1016/j.saa.2003.10.029
PG 8
WC Spectroscopy
SC Spectroscopy
GA 822ZB
UT WOS:000221578400011
PM 15134730
DA 2018-10-19
ER

PT J
AU Tan, JL
   Liu, W
   Nelson, CM
   Raghavan, S
   Chen, CS
AF Tan, JL
   Liu, W
   Nelson, CM
   Raghavan, S
   Chen, CS
TI Simple approach to micropattern cells on common culture substrates by
   tuning substrate wettability
SO TISSUE ENGINEERING
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; ENDOTHELIAL-CELLS; BLOCK-COPOLYMERS;
   ELASTOMERIC MEMBRANES; NEURONAL NETWORKS; GEOMETRIC CONTROL;
   MAMMALIAN-CELLS; SURFACES; PROTEINS; POLYMER
AB The ability to spatially control cell adhesion and multicellular organization is critical to many biomedical and tissue-engineering applications. This work describes a straightforward method to micropattern cells onto glass, silicone rubber, and polystyrene using commercially available reagents. An elastomeric polydimethylsiloxane stamp is used to contact-transfer extracellular matrix protein onto a surface followed by blocking cell adhesion in the surrounding regions by the physisorption of Pluronic surfactants. Using self-assembled monolayers of alkanethiols on gold as model surfaces to control surface wettability, we found that protein printing was most effective at intermediate to highly wetting surfaces whereas Pluronic adsorption occurred at intermediate to low wetting surfaces. Within a regimen of intermediate wettability both techniques were applied in conjunction to restrict cell adhesion to specified patterns. Adjusting the wettability of common tissue culture substrates to the same intermediate range again allowed the micropatterning of cells, suggesting that this approach is likely to be generally applicable to many types of materials. This technique therefore may allow for wider adoption of cell patterning.
C1 Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA.
   Johns Hopkins Univ, Dept Oncol, Baltimore, MD USA.
RP Chen, CS (reprint author), Johns Hopkins Univ, Dept Biomed Engn, 720 Rutland Ave,Traylor 718, Baltimore, MD 21205 USA.
EM cchen@bme.jhu.edu
FU NIBIB NIH HHS [EB00262]
CR Adams ML, 2003, J PHARM SCI, V92, P1343, DOI 10.1002/jps.10397
   Ahmed F, 2001, LANGMUIR, V17, P537, DOI 10.1021/la001305u
   AMIJI M, 1992, BIOMATERIALS, V13, P682, DOI 10.1016/0142-9612(92)90128-B
   BAIN CD, 1989, J AM CHEM SOC, V111, P7155, DOI 10.1021/ja00200a039
   Bernard A, 1998, LANGMUIR, V14, P2225, DOI 10.1021/la980037l
   Bhatia SN, 1999, BIOMED MICRODEVICES, V2, P131, DOI 10.1023/A:1009949704750
   Bhatia SN, 1999, FASEB J, V13, P1883
   Bohner M, 2002, MACROMOLECULES, V35, P6724, DOI 10.1021/ma0103324
   Branch DW, 1998, MED BIOL ENG COMPUT, V36, P135, DOI 10.1007/BF02522871
   CARTER SB, 1967, EXP CELL RES, V48, P189, DOI 10.1016/0014-4827(67)90298-4
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Dike LE, 1999, IN VITRO CELL DEV-AN, V35, P441
   DRELICH J, 2000, APPARENT MICROSCOPIC
   Duffy DC, 1999, ADV MATER, V11, P546, DOI 10.1002/(SICI)1521-4095(199905)11:7<546::AID-ADMA546>3.0.CO;2-E
   DULCEY CS, 1991, SCIENCE, V252, P551, DOI 10.1126/science.2020853
   Folch A, 1998, BIOTECHNOL PROGR, V14, P388, DOI 10.1021/bp980037b
   Folch A, 2000, ANNU REV BIOMED ENG, V2, P227, DOI 10.1146/annurev.bioeng.2.1.227
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   Frangos SG, 2001, ENDOTHELIUM-NEW YORK, V8, P1
   GROSS GW, 1995, BIOSENS BIOELECTRON, V10, P553, DOI 10.1016/0956-5663(95)96931-N
   HAMMARBACK JA, 1988, DEV BIOL, V126, P29, DOI 10.1016/0012-1606(88)90235-7
   Healy KE, 1996, BIOMATERIALS, V17, P195, DOI 10.1016/0142-9612(96)85764-4
   Hyun JH, 2003, ADV MATER, V15, P576, DOI 10.1002/adma.200304496
   JACKMAN RJ, 1995, SCIENCE, V269, P664, DOI 10.1126/science.7624795
   James CD, 1998, LANGMUIR, V14, P741, DOI 10.1021/la9710482
   KLEINFELD D, 1988, J NEUROSCI, V8, P4098
   Lahann J, 2002, LANGMUIR, V18, P3632, DOI 10.1021/la011464t
   Liu VA, 2002, J BIOMED MATER RES, V60, P126, DOI 10.1002/jbm.10005
   MATSUSHIMA N, 1990, MOKUZAI GAKKAISHI, V36, P559
   McGurk SL, 1999, LANGMUIR, V15, P5136, DOI 10.1021/la981788q
   Nelson CM, 2003, LANGMUIR, V19, P1493, DOI 10.1021/la026178b
   Ostuni E, 2000, LANGMUIR, V16, P7811, DOI 10.1021/la000382m
   Patel N, 1998, FASEB J, V12, P1447
   PRASAD KN, 1979, J COLLOID INTERF SCI, V69, P225, DOI 10.1016/0021-9797(79)90151-6
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   Roberts C, 1998, J AM CHEM SOC, V120, P6548, DOI 10.1021/ja972467o
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   SPARGO BJ, 1994, P NATL ACAD SCI USA, V91, P11070, DOI 10.1073/pnas.91.23.11070
   STRANICK SJ, 1994, J PHYS CHEM-US, V98, P7636, DOI 10.1021/j100082a040
   Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100
   Tan JL, 2002, LANGMUIR, V18, P519, DOI 10.1021/la011351+
   Tan W, 2003, TISSUE ENG, V9, P255, DOI 10.1089/107632703764664729
   Thomas CH, 2002, P NATL ACAD SCI USA, V99, P1972, DOI 10.1073/pnas.032668799
   TIEN J, 2002, METHODS TISSUE ENG, P113
   Xia YN, 1996, ADV MATER, V8, P1015, DOI 10.1002/adma.19960081217
   XIA YN, 1995, ADV MATER, V7, P471, DOI 10.1002/adma.19950070513
NR 46
TC 151
Z9 155
U1 2
U2 33
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD MAY
PY 2004
VL 10
IS 5-6
BP 865
EP 872
DI 10.1089/1076327041348365
PG 8
WC Cell & Tissue Engineering
SC Cell Biology
GA 836DC
UT WOS:000222534500022
PM 15265304
DA 2018-10-19
ER

PT J
AU Nelea, V
   Morosanu, C
   Iliescu, M
   Mihailescu, IN
AF Nelea, V
   Morosanu, C
   Iliescu, M
   Mihailescu, IN
TI Hydroxyapatite thin films grown by pulsed laser deposition and
   radio-frequency magnetron sputtering: comparative study
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE hydroxyapatite thin films; pulsed laser deposition; radio-frequency
   magnetron sputtering; biomedical materials
ID CALCIUM-PHOSPHATE COATINGS; BEAM-ASSISTED DEPOSITION;
   MECHANICAL-PROPERTIES; TRANSFORMATION; TEMPERATURE; DISSOLUTION;
   PRESSURE; ABLATION; LAYERS
AB Hydroxyapatite (HA) thin films for applications in the biomedical field were grown by pulsed laser deposition (PLD) and radio-frequency magnetron sputtering (RF-MS) techniques. The depositions were performed from pure hydroxyapatite targets on Ti-5Al-2.5Fe (TiAlFe) alloys substrates. In order to prevent the HA film penetration by Ti atoms or ions diffused from the Ti-based alloy during and after deposition, the substrates were pre-coated with a thin buffer layer of TiN. In both cases, TiN was introduced by reactive PLD from TiN targets in low-pressure N-2. The PLD films were grown in vacuum onto room temperature substrates. The RF-MS films were deposited in low-pressure argon on substrates heated at 550 degreesC. The initially amorphous PLD thin films were annealed at 550 degreesC for 1 h in ambient air in order to restore the initial crystalline structure of HA target. The thickness of the PLD and RF-MS films were similar to1 mum and similar to350 nm, respectively. All films were structurally studied by scanning electron microscopy (SEM), grazing incidence X-ray diffraction (GIXRD), energy dispersive X-ray spectrometry (EDS) and white light confocal microscopy (WLCM). The mechanical properties of the films were tested by Berkovich nano-indentation. Both PLD and RF-MS films mostly contain HA phase and exhibit good mechanical characteristics. Peaks of CaO were noticed as secondary phase in the GIXRD patterns only for RF-MS films. By its turn, the sputtered films were smoother as compared to the ones deposited by PLD (50 nm versus 250 nm average roughness). The R-F-MS films were harder, more mechanically resistant and have a higher Young modulus. (C) 2004 Elsevier B.V. All rights reserved.
C1 Natl Inst Lasers Plasma & Radiat Phys, Lasers Dept, Bucharest 76900, Romania.
   Inst Natl Sci Appl, Lab Ingn Surfaces, F-67084 Strasbourg, France.
   Natl Inst Mat Phys, R-76900 Bucharest, Romania.
   Inst Phys & Chim Mat, Grp Surfaces Interfaces, F-67037 Strasbourg, France.
RP Mihailescu, IN (reprint author), Natl Inst Lasers Plasma & Radiat Phys, Lasers Dept, POB MG-36, Bucharest 76900, Romania.
EM mihailes@ifin.nipne.ro
RI Mihailescu, Ion/A-5403-2011
CR Arias JL, 1997, J MATER SCI-MATER M, V8, P873, DOI 10.1023/A:1018553821781
   Bauerle D., 1996, LASER PROCESSING CHE
   Campbell PA, 1996, J VAC SCI TECHNOL B, V14, P1167, DOI 10.1116/1.588422
   Chai CS, 1999, J MATER SCI-MATER M, V10, P465, DOI 10.1023/A:1008992807888
   Chen JY, 1997, J BIOMED MATER RES, V34, P15, DOI 10.1002/(SICI)1097-4636(199701)34:1<15::AID-JBM3>3.0.CO;2-Q
   Choi JM, 2000, BIOMATERIALS, V21, P469, DOI 10.1016/S0142-9612(99)00186-6
   Cleries L, 2000, BIOMATERIALS, V21, P967, DOI 10.1016/S0142-9612(99)00240-9
   Cohen - Sabban J., 1999, MESURES, V179, P85
   COTELL CM, 1994, PULSED LASER DEPOSIT, P549
   Cui FZ, 1997, J MATER SCI-MATER M, V8, P403, DOI 10.1023/A:1018597320022
   de Groot K, 1983, BIOCERAMICS CALCIUM
   DUCHEYNE P, 1993, J BIOMED MATER RES, V27, P25, DOI 10.1002/jbm.820270105
   Elliot J.C., 1994, STRUCTURE CHEM APATI
   Feng CF, 1999, SCRIPTA MATER, V42, P103, DOI 10.1016/S1359-6462(99)00321-8
   Fernandez-Pradas JM, 1998, THIN SOLID FILMS, V317, P393, DOI 10.1016/S0040-6090(97)00629-9
   Gross KA, 1998, J BIOMED MATER RES, V39, P580, DOI 10.1002/(SICI)1097-4636(19980315)39:4<580::AID-JBM12>3.3.CO;2-Y
   Gyorgy E, 2004, THIN SOLID FILMS, V446, P178, DOI 10.1016/j.tsf.2003.09.071
   Gyorgy E, 2002, APPL SURF SCI, V195, P270, DOI 10.1016/S0169-4332(02)00561-5
   Hwang K, 1999, SURF COAT TECH, V115, P172, DOI 10.1016/S0257-8972(99)00174-7
   Li XD, 1997, BIOMATERIALS, V18, P1487, DOI 10.1016/S0142-9612(97)00085-9
   Lopatin CM, 1998, THIN SOLID FILMS, V326, P227, DOI 10.1016/S0040-6090(98)00531-8
   Luo ZS, 1999, J BIOMED MATER RES, V46, P80, DOI 10.1002/(SICI)1097-4636(199907)46:1<80::AID-JBM9>3.0.CO;2-9
   Mihailescu IN, 2002, P SOC PHOTO-OPT INS, V4762, P64, DOI 10.1117/12.478666
   MIHAILESCU IN, 1999, SPRINGER SERIES OPTI, P201
   Nelea V, 2002, APPL SURF SCI, V186, P483, DOI 10.1016/S0169-4332(01)00754-1
   Nelea V, 2000, APPL SURF SCI, V168, P127, DOI 10.1016/S0169-4332(00)00616-4
   Nieh TG, 2001, J MATER RES, V16, P3238, DOI 10.1557/JMR.2001.0446
   Oh KT, 1998, SURF COAT TECH, V110, P4, DOI 10.1016/S0257-8972(98)00537-4
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   SARDIN G, 1994, HYDROXYAPATITE AND RELATED MATERIALS, P225
   Socol G, 2004, BIOMATERIALS, V25, P2539, DOI 10.1016/j.biomaterials.2003.09.044
   Tsui YC, 1998, BIOMATERIALS, V19, P2015, DOI 10.1016/S0142-9612(98)00103-3
   vanDijk K, 1995, SURF COAT TECH, V76, P206, DOI 10.1016/02578-9729(50)25901-
   vanDijk K, 1996, BIOMATERIALS, V17, P405, DOI 10.1016/0142-9612(96)89656-6
   Wolke JGC, 1997, BIOMATERIALS, V18, P483, DOI 10.1016/S0142-9612(96)00164-0
   Zeng HT, 2000, BIOMATERIALS, V21, P23, DOI 10.1016/S0142-9612(99)00128-3
   Zeng HT, 2000, J BIOMED MATER RES, V50, P239, DOI 10.1002/(SICI)1097-4636(200005)50:2<239::AID-JBM19>3.0.CO;2-V
NR 37
TC 92
Z9 98
U1 3
U2 41
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD APR 30
PY 2004
VL 228
IS 1-4
BP 346
EP 356
DI 10.1016/j.apsusc.2004.01.029
PG 11
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 820DL
UT WOS:000221367000048
DA 2018-10-19
ER

PT J
AU Etim, A
   Zhou, GH
   Wen, XY
   Liu, H
   Ruotti, V
   Twigger, S
   Jin, WH
   Matysiak, B
   Mathis, J
   Tonellato, PJ
   Datta, MW
AF Etim, A
   Zhou, GH
   Wen, XY
   Liu, H
   Ruotti, V
   Twigger, S
   Jin, WH
   Matysiak, B
   Mathis, J
   Tonellato, PJ
   Datta, MW
TI ChromSorter PC: A database of chromosomal regions associated with human
   prostate cancer
SO BMC GENOMICS
LA English
DT Article
AB Background: Our increasing use of genetic and genomic strategies to understand human prostate cancer means that we need access to simplified and integrated information present in the associated biomedical literature. In particular, microarray gene expression studies and associated genetic mapping studies in prostate cancer would benefit from a generalized understanding of the prior work associated with this disease. This would allow us to focus subsequent laboratory studies to genomic regions already related to prostate cancer by other scientific methods. We have developed a database of prostate cancer related chromosomal information from the existing biomedical literature. The input material was based on a broad literature search with subsequent hand annotation of information relevant to prostate cancer.
   Description: The database was then analyzed for identifiable trends in the whole scale literature. We have used this database, named ChromSorter PC, to present graphical summaries of chromosomal regions associated with prostate cancer broken down by age, ethnicity and experimental method. In addition we have placed the database information on the human genome using the Generic Genome Browser tool that allows the visualization of the data with respect to user generated datasets.
   Conclusions: We have used this database as an additional dataset for the filtering of genes identified through genetics and genomics studies as warranting follow-up validation studies. We would like to make this dataset publicly available for use by other groups. Using the Genome Browser allows for the graphical analysis of the associated data http://www.prostategenomics.org/datamining/chrom-sorter_pc.html. Additional material from the database can be obtained by contacting the authors (mdatta@ mcw.edu).
C1 Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA.
   Med Coll Wisconsin, Human & Mol Genet Ctr, Bioinformat Program, Milwaukee, WI 53226 USA.
   Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA.
RP Datta, MW (reprint author), Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA.
EM aetim@mcw.edu; guohui@rocketmail.com; xwen@mcw.edu; hliu@mcw.edu;
   vruotti@mcw.edu; simont@mcw.edu; weihong@mcw.edu; bmatysia@mcw.edu;
   jmathis@mcw.edu; tone@mcw.edu; mdatta@mcw.edu
FU NCI NIH HHS [R21 CA098032, R21CA098032]; NHLBI NIH HHS [R01 HL064541]
NR 0
TC 1
Z9 2
U1 0
U2 2
PU BIOMED CENTRAL LTD
PI LONDON
PA MIDDLESEX HOUSE, 34-42 CLEVELAND ST, LONDON W1T 4LB, ENGLAND
SN 1471-2164
J9 BMC GENOMICS
JI BMC Genomics
PD APR 28
PY 2004
VL 5
AR 27
DI 10.1186/1471-2164-5-27
PG 11
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA 824OU
UT WOS:000221696700001
PM 15113398
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Rudraiah, N
   Ng, CO
AF Rudraiah, N
   Ng, CO
TI A model for manufacture of nano-sized smart materials free from
   impurities
SO CURRENT SCIENCE
LA English
DT Review
ID RAYLEIGH-TAYLOR INSTABILITY; NONUNIFORM TEMPERATURE-GRADIENT; FINITE
   THICKNESS; SURFACE-TENSION; ELECTRIC-FIELD; MAGNETIC-FIELD;
   POROUS-MEDIUM; CONVECTION; LAYER; ACCELERATION
AB The importance of nano-sized smart materials in structural engineering, biomedical engineering, and in military applications is discussed. It is shown that the solidification of poorly conducting alloys involved in the manufacture of these materials gives rise to surface and convective instabilities. Different types of surface and convective instabilities are briefly discussed. These instabilities produce a mushy zone regarded as dendrites of nano-sized crystals. These dendrites arising from instabilities are regarded as impurities. To manufacture nano-sized smart materials free from impurities, it is essential to control both surface and convective instabilities. We discuss here briefly, different types of convective and surface instabilities in a poorly conducting fluid. We also discuss different mechanisms of control of these instabilities. Different analytical and numerical techniques used to investigate these instabilities under different boundary conditions are discussed. In this review the moment method is explained to find the condition for the onset of convection, and porous lining is used to suppress the growth rate of surface instability. This is useful in the manufacture of nano-sized smart materials free from impurities. Different methods to obtain the required basic equations and the corresponding boundary conditions are briefly discussed.
C1 Natl Res Inst Appl Math, Bangalore 560070, Karnataka, India.
   Bangalore Univ, Dept Math, UGC, CAS Fluid Mech, Bangalore 560001, Karnataka, India.
   Univ Hong Kong, Dept Mech Engn, Hong Kong, Hong Kong, Peoples R China.
RP Rudraiah, N (reprint author), Natl Res Inst Appl Math, 492G,7th Cross,7th Block W, Bangalore 560070, Karnataka, India.
EM nrudraiah@hotmail.com
RI Ng, Chiu-On/B-9205-2009
OI Ng, Chiu-On/0000-0002-3142-6691
CR BABCHIN AJ, 1983, PHYS FLUIDS, V26, P3159, DOI 10.1063/1.864083
   BEAVERS GS, 1967, J FLUID MECH, V30, P197, DOI 10.1017/S0022112067001375
   BETTI R, 1995, PHYS PLASMAS, V2, P3844, DOI 10.1063/1.871083
   Chandrasekhar S., 1961, HYDRODYNAMICS HYDROM
   HEMALATHA, 2001, THESIS BANGALORE U
   KANUER JP, 2000, PHYS PLASMAS, V7, P338
   Kaviany M., 1991, PRINCIPLES HEAT TRAN
   KILKENNY JD, 1994, PHYS PLASMAS, V1, P1374
   LEE C, 1972, PHYS FLUIDS, V15, P789, DOI 10.1063/1.1693986
   LEE CO, 1974, P 5 INT HEAT TRANSF, V3, P173
   LINDL J, 1995, PHYS PLASMAS, V2, P3933, DOI 10.1063/1.871025
   LING RY, 1990, FERROELECTRICS, V102, P215
   MIKAELIAN KO, 1990, PHYS FLUIDS A-FLUID, V2, P592, DOI 10.1063/1.857759
   NAGASHREE MS, 2001, THESIS BANGALORE U
   NAIR P, 2001, THESIS BANGALORE U
   NEUMANN RE, 1990, CROSS FERROELECTRICS, V102, P259
   Nield D. A., 1999, CONVECTION POROUS ME
   PEARSON JRA, 1958, J FLUID MECH, V4, P489, DOI 10.1017/S0022112058000616
   Plouraboue F, 2002, PHYS FLUIDS, V14, P922, DOI 10.1063/1.1446884
   RADHAKRISHNA, 2001, THESIS BANGALORE U
   RICHTMYER RD, 1960, COMMUN PUR APPL MATH, V13, P297, DOI 10.1002/cpa.3160130207
   RUDRAIAH N, 1984, INT J HEAT MASS TRAN, V27, P1825, DOI 10.1016/0017-9310(84)90164-9
   Rudraiah N., 1976, Vignana Bharathi, V2, P30
   Rudraiah N, 1997, P INDIAN AS-MATH SCI, V107, P213, DOI 10.1007/BF02837730
   Rudraiah N, 2003, ACTA MECH, V166, P217, DOI 10.1007/s00707-003-0018-5
   Rudraiah N, 1997, CURR SCI INDIA, V72, P391
   Rudraiah N, 2003, J POROUS MEDIA, V6, P1
   RUDRAIAH N, 1985, J FLUID ENG-T ASME, V107, P322, DOI 10.1115/1.3242486
   RUDRAIAH N, 1982, P INDIAN AS-MATH SCI, V91, P17, DOI 10.1007/BF02837258
   RUDRAIAH N, 1984, ARAB J SCI ENG, V9, P153
   RUDRAIAH N, 1985, INT J HEAT MASS TRAN, V28, P1621, DOI 10.1016/0017-9310(85)90264-9
   RUDRAIAH N, 1986, ACTA MECH, V61, P37, DOI 10.1007/BF01176361
   RUDRAIAH N, 1986, INDIAN J TECHNOL, V24, P279
   RUDRAIAH N, 1996, INT C POR MED THEIR, V30
   Rudraiah N., 2003, MODELLING NANO SMART
   RUDRAIAH N, 2004, LASER PART BEAM, V22, P1
   RUDRAIAH N, 2003, 2 IAEA TECHN COMM M, V43, P1
   RUDRAIAH N, 1997, INDIAN J PURE APPL M, V26, P969
   RUDRAIAH N, 2000, J AEROSPACE SCI TECH, V48, P517
   RUDRAIAH N, 1988, P CAN C CONT MECH AP
   RUDRAIAH N, 1998, NATL ACAD SCI LETT, V21
   RUDRAIAH N, 1998, ACTA MECH, V27, P235
   RUDRAIAH N, 1981, ASTRON SOC JAPAN, V33, P721
   RUDRAIAH N, 1974, ASTRON SOC JPN, V26, P221
   RUDRAIAH N, 1984, P INT C THEOR APPL M
   RUDRAIAH N, 2003, IJAME, V8
   SETHURAM HR, 2001, THESIS BANGALORE U
   Smorodin BL, 2000, J ELECTROSTAT, V48, P261, DOI 10.1016/S0304-3886(99)00074-1
   TAKABE H, 1985, PHYS FLUIDS, V28, P3676, DOI 10.1063/1.865099
   TURNBULL RJ, 1968, PHYS FLUIDS, V11, P2597, DOI 10.1063/1.1691865
NR 50
TC 8
Z9 8
U1 0
U2 6
PU CURRENT SCIENCE ASSN
PI BANGALORE
PA C V RAMAN AVENUE, PO BOX 8005, BANGALORE 560 080, INDIA
SN 0011-3891
J9 CURR SCI INDIA
JI Curr. Sci.
PD APR 25
PY 2004
VL 86
IS 8
BP 1076
EP 1091
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 818FI
UT WOS:000221230600018
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Zhou, YL
   Niinomi, M
   Akahori, T
AF Zhou, YL
   Niinomi, M
   Akahori, T
TI Effects of Ta content on Young's modulus and tensile properties of
   binary Ti-Ta alloys for biomedical applications
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE Young's modulus; microstructure; Ti-Ta alloy; solution treatment;
   tensile property; biomedical implant material
ID MECHANICAL-PROPERTIES; TITANIUM-ALLOYS; MARTENSITIC TRANSFORMATIONS;
   CAST-IRON; NB ALLOYS; MO ALLOYS; BIOCOMPATIBILITY; TANTALUM;
   TI-29NB-13TA-4.6ZR; IMPLANTS
AB The effects of Ta content on the microstructures, dynamic Young's modulus and tensile properties of the quenched Ti-Ta alloys were investigated for biomedical applications. The microstructures were examined using a scanning electron microscopy (SEM) and an X-ray diffraction (XRD) analysis. The results indicate that the microstructures of the quenched binary Ti-Ta alloys are sensitive to Ta content. The Ti-Ta alloys exhibit lamellar HCP martensite (alpha') structure at a Ta content below 20%, needle-like orthorhombic martensite (alpha") structure at a Ta content between 30-50%. metastable beta + alpha" structure at a Ta content of 60%, and single metastable structure at a Ta content above 60%. The dynamic Young's modulus and tensile properties of the binary Ti-Ta alloys depend strongly on Ta content. Ti-30% Ta and 70% Ta alloys have much lower modulus and a good combination of high strength and low modulus among all the studied Ii-Ta alloys. They have the great potential to become new candidates for biomedical applications. (C) 2004 Elsevier B.V. All rights reserved.
C1 Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418580, Japan.
RP Zhou, YL (reprint author), Toyohashi Univ Technol, Dept Prod Syst Engn, 1-1 Hibarigaoku Cho, Toyohashi, Aichi 4418580, Japan.
EM shuu@sp-mac4.tutpse.ac.jp
RI Niinomi, Mitsuo/B-5965-2011
CR BAGARIATSKII IA, 1959, TECH PHYS, P1014
   Boccaccini AR, 1997, Z METALLKD, V88, P23
   Bothe R., 1940, SURG GYNECOL OBSTET, V71, P598
   Burke GL, 1940, CAN MED ASSOC J, V43, P125
   BYWATER KA, 1972, PHILOS MAG, V25, P1249, DOI 10.1080/14786437208223852
   Collings E. W., 1984, PHYS METALLURGY TITA
   Cui Z., 2000, METALLOGRAPHY HEAT T
   DAVIS R, 1979, J MATER SCI, V14, P712
   DESOUZA KA, 2003, MATER LETT, V4280, P1
   Dieter G. E., 1976, MECH METALLURGY
   Dobromyslov AV, 2001, SCRIPTA MATER, V44, P905, DOI 10.1016/S1359-6462(00)00694-1
   ENTWISTLE KM, 1960, PHYS EXAMINATION MET, P487
   FAN ZY, 1993, SCRIPTA METALL MATER, V29, P1427, DOI 10.1016/0956-716X(93)90331-L
   Fedotov S G, 1986, PHYS MET METALLOGR, V62, P109
   Hao YL, 2003, METALL MATER TRANS A, V34A, P1007, DOI 10.1007/s11661-003-0230-x
   Hao YL, 2002, METALL MATER TRANS A, V33, P3137, DOI 10.1007/s11661-002-0299-7
   Ho WF, 1999, BIOMATERIALS, V20, P2115, DOI 10.1016/S0142-9612(99)00114-3
   HUNT M, 1991, MATER ENG, V108, P27
   LEDBETTER H, 1992, Z METALLKD, V83, P195
   Lee CM, 2002, J ORAL REHABIL, V29, P314, DOI 10.1046/j.1365-2842.2002.00825.x
   LEE YT, 1990, MAT SCI ENG A-STRUCT, V128, P77, DOI 10.1016/0921-5093(90)90097-M
   LEVENTHAL GS, 1951, J BONE JOINT SURG AM, V33-A, P473, DOI 10.2106/00004623-195133020-00021
   LOPATA SL, 1965, T METALL SOC AIME, V233, P288
   MACK DJ, 1946, T AM I MIN MET ENG, V166, P68
   Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1
   MOFFAT DL, 1988, METALL TRANS A, V19, P1677, DOI 10.1007/BF02645135
   Murray J. L., 1987, PHASE DIAGRAM BINARY
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Perl D., 1980, SCIENCE, V208, P297
   Prigent H, 1998, J BIOMED MATER RES, V39, P200, DOI 10.1002/(SICI)1097-4636(199802)39:2<200::AID-JBM5>3.0.CO;2-T
   SOLAR RJ, 1979, J BIOMED MATER RES, V13, P217, DOI 10.1002/jbm.820130206
   Song Y, 1999, MAT SCI ENG A-STRUCT, V260, P269, DOI 10.1016/S0921-5093(98)00886-7
   Steinemann S. G., 1980, EVALUATION BIOMATERI, P1
   SUMNER DR, 1992, CLIN ORTHOP RELAT R, P202
   Trillo EA, 2001, J MATER SCI-MATER M, V12, P283, DOI 10.1023/A:1011210101895
   Wang K, 1996, MAT SCI ENG A-STRUCT, V213, P134, DOI 10.1016/0921-5093(96)10243-4
   WILLIAMS DF, 1981, FUNDAMENTAL ASPECTS, P3
NR 38
TC 172
Z9 183
U1 2
U2 62
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD APR 25
PY 2004
VL 371
IS 1-2
BP 283
EP 290
DI 10.1016/j.msea.2003.12.011
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 818IL
UT WOS:000221238700038
DA 2018-10-19
ER

PT J
AU Kabir, A
   Hamlet, C
   Yoo, KS
   Newkome, GR
   Malik, A
AF Kabir, A
   Hamlet, C
   Yoo, KS
   Newkome, GR
   Malik, A
TI Capillary microextraction on sol-gel dendrimer coatings
SO JOURNAL OF CHROMATOGRAPHY A
LA English
DT Article
DE capillary microextraction; sol-gel dendrimer coating; sol-gel;
   solid-phase microextraction; aldehydes; ketones; phenols; alcohols;
   polynuclear aromatic hydrocarbons
ID PHASE MICROEXTRACTION; GAS-CHROMATOGRAPHY; STATIONARY PHASES;
   CARBONYL-COMPOUNDS; DRINKING-WATER; FIBERS; MACROMOLECULES;
   DERIVATIZATION; TECHNOLOGY; POLYMERS
AB Sol-gel capillary microextraction (CME) is a new direction in the solventless sample preparation for the preconcentration of trace analytes, and presents significant interest in environmental, pharmaceutical, petrochemical, biomedical, agricultural, food, flavor, and a host of other important areas. It utilizes advanced material properties of organic-inorganic hybrid sol-gel polymers to perform efficient extraction and preconcentration of target compounds from a wide variety of matrices. In the present work, a novel benzyl-terminated dendron-based sol-gel coating was developed for CME. A detailed investigation was conducted to evaluate the performance of the newly developed sol-gel dendrimer coatings to perform solventless extraction of a wide range of polar and nonpolar analytes. The characteristic branched architecture of dendrons makes them structurally superior extraction media compared with their traditional linear polymeric counterparts. Sol-gel chemistry was used to chemically immobilize dendritic macromolecules on fused silica capillary inner surface. Due to the strong chemical bonding with the capillary inner walls, sol-gel dendron coatings showed excellent thermal and solvent stability in capillary microextraction in hyphenation with chromatographic analysis. Efficient extraction of a wide range of analytes from their aqueous solutions was accomplished using sol-gel dendron coated fused silica capillaries. Low parts per trillion level detection limits were achieved in CME-GC for both polar and nonpolar analytes including polyaromatic hydrocarbons (PAHs), aldehydes, ketones, phenols, and alcohols. (C) 2004 Elsevier B.V. All rights reserved.
C1 Univ S Florida, Dept Chem, Tampa, FL 33620 USA.
   Univ Akron, Inst Polymer Sci, Dept Chem, Akron, OH 44325 USA.
RP Malik, A (reprint author), Univ S Florida, Dept Chem, 4202 E Fowler Ave, Tampa, FL 33620 USA.
EM Malik@chumal.cas.usf.edu
RI Kabir, Abuzar/D-1504-2011; Newkome, George/P-3093-2018
OI Newkome, George/0000-0001-6019-5071; Kabir, Abuzar/0000-0002-3740-8857
CR ALBRECHT M, 1998, J CHEM SOC CHEM COMM, V9, P1003
   AMDUR MO, 1991, CASARETT DOULLS TOXI, P866
   ARTHUR CL, 1990, ANAL CHEM, V62, P2145, DOI 10.1021/ac00218a019
   Bao ML, 1998, J CHROMATOGR A, V809, P75, DOI 10.1016/S0021-9673(98)00188-5
   Bartak P, 1997, J CHROMATOGR A, V767, P171, DOI 10.1016/S0021-9673(96)01090-4
   Belardi R.G., 1989, WATER POLLUT RES J C, V24, P179
   Bigham S, 2002, ANAL CHEM, V74, P752, DOI 10.1021/ac0109523
   Blomberg L. G., 1990, J MICROCOLUMN SEP, V2, P62
   BUCHHOLZ KD, 1994, ANAL CHEM, V66, P160, DOI 10.1021/ac00073a027
   BYORSETH A, 1985, HDB POLYCYCLIC AROMA, V2, P1
   Cancho B, 2002, J CHROMATOGR A, V943, P1, DOI 10.1016/S0021-9673(01)01437-6
   Chao HC, 2002, J SEP SCI, V25, P345, DOI 10.1002/1615-9314(20020401)25:5/6<345::AID-JSSC345>3.0.CO;2-5
   Chong SL, 1997, ANAL CHEM, V69, P3889, DOI 10.1021/ac9703360
   CHORUS I, 1992, WATER SCI TECHNOL, V25, P251
   Clark TJ, 1997, J CHROMATOGR SCI, V35, P209, DOI 10.1093/chromsci/35.5.209
   Doong R, 2000, J CHROMATOGR A, V879, P177, DOI 10.1016/S0021-9673(00)00347-2
   *EPA, 1984, 604 EPA, P58
   Fresenius W., 1988, WATER ANAL PRACTICAL
   *GEN PUBL CORP, 1985, MAT SAF DAT SHEET PH
   Hayes JD, 1997, J CHROMATOGR B, V695, P3, DOI 10.1016/S0378-4347(97)00134-5
   KATAOKA H, 2002, JPN J FORENSIC TOXIC, V20, P251
   KIEBER RJ, 1990, ENVIRON SCI TECHNOL, V24, P1477, DOI 10.1021/es00080a003
   KUZDZAL SA, 1994, J CHEM SOC CHEM COMM, P2139, DOI 10.1039/c39940002139
   Lee MR, 1998, J CHROMATOGR A, V806, P317, DOI 10.1016/S0021-9673(98)00075-2
   LEIKAUF GD, 1992, ENV TOXICANTS HUMAN, P299
   Malik A., 1999, APPL SOLID PHASE MIC, P73
   MALIK A, 2002, COMPREHENSIVE ANAL C, P1023
   Mani V., 1999, APPL SOLID PHASE MIC, P57
   Mathews BT, 2001, CHROMATOGRAPHIA, V53, P147
   McElhanon JR, 1998, J AM CHEM SOC, V120, P1647, DOI 10.1021/ja970150i
   MILLS OE, 1998, J ACS S SER, V705, P85
   MISRA MK, 1999, STAR HYPERBRANCHED P
   Moder M, 1997, FRESEN J ANAL CHEM, V357, P326, DOI 10.1007/s002160050162
   MOORE JW, 1984, PHENOLS ORGANIC CHEM
   Muijselaar P, 1995, J HIGH RES CHROMATOG, V18, P121
   Mullett WM, 2001, ANAL CHEM, V73, P2383, DOI 10.1021/ac0100502
   NEWKOME GR, 1985, J ORG CHEM, V50, P2003, DOI 10.1021/jo00211a052
   Newkome GR, 2001, TETRAHEDRON LETT, V42, P7537, DOI 10.1016/S0040-4039(01)01642-2
   NEWKOME GR, 1993, MACROMOLECULES, V26, P2394, DOI 10.1021/ma00061a041
   NEWKOME GR, 2001, DENDRIMERS DENDRON C
   Palmer CP, 1997, J CHROMATOGR A, V792, P105, DOI 10.1016/S0021-9673(97)00870-4
   Pollak KW, 1998, CHEM MATER, V10, P30, DOI 10.1021/cm970312+
   POTTER DW, 1994, ENVIRON SCI TECHNOL, V28, P298, DOI 10.1021/es00051a017
   ROWE WD, 1983, EVALUATION METHODS E
   Shende C, 2003, ANAL CHEM, V75, P3518, DOI 10.1021/ac0207224
   Stevens MP, 1999, POLYM CHEM
   TOMALIA DA, 1985, POLYM J, V17, P117, DOI 10.1295/polymj.17.117
   TOMALIA DA, 1990, ANGEW CHEM INT EDIT, V29, P138, DOI 10.1002/anie.199001381
   Wang DX, 1997, ANAL CHEM, V69, P4566, DOI 10.1021/ac970614v
   Wang PW, 1996, ADV MATER, V8, P237, DOI 10.1002/adma.19960080311
   Wang ZY, 2000, J CHROMATOGR A, V893, P157, DOI 10.1016/S0021-9673(00)00692-0
   WOOLEY KL, 1994, POLYMER, V35, P4489, DOI 10.1016/0032-3861(94)90793-5
   Wu JC, 2001, J CHROMATOGR A, V909, P37, DOI 10.1016/S0021-9673(00)01025-6
   Zeng ZR, 2001, ANAL CHEM, V73, P2429, DOI 10.1021/ac0012750
   Zeng ZR, 2001, J CHROMATOGR A, V934, P51, DOI 10.1016/S0021-9673(01)01303-6
   ZHANG ZY, 1994, ANAL CHEM, V66, pA844, DOI 10.1021/ac00089a001
NR 56
TC 57
Z9 57
U1 0
U2 23
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0021-9673
J9 J CHROMATOGR A
JI J. Chromatogr. A
PD APR 23
PY 2004
VL 1034
IS 1-2
BP 1
EP 11
DI 10.1016/j.chroma.2004.02.019
PG 11
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 808NS
UT WOS:000220576400001
PM 15116909
DA 2018-10-19
ER

PT J
AU Vandermeulen, GWM
   Klok, HA
AF Vandermeulen, GWM
   Klok, HA
TI Peptide/protein hybrid materials: Enhanced control of structure and
   improved performance through conjugation of biological and synthetic
   polymers
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Review
DE biomaterials; peptides; proteins; structure-property relations;
   supramolecular structures
ID ACID) BLOCK-COPOLYMER; POLYION COMPLEX MICELLES; POLY(ETHYLENE GLYCOL);
   POLYPEPTIDE BLOCK; AQUEOUS-MEDIUM; CELL-ADHESION; RGD-PEPTIDE;
   BETA-SHEETS; POLY(LACTIC ACID-CO-LYSINE); SENSITIVE STABILIZATION
AB The conjugation peptides/proteins and synthetic polymers is a useful strategy to overcome some of the limitations related to the use of the individual components. This review will highlight two aspects: enhanced structural control at the nanometer level and improved performance, in particular with respect to biomedical applications. In the former case, peptide sequences are mainly used to mediate I self-assembly of synthetic polymers. In the latter case, conjugation of an appropriate synthetic polymer to a pharmaceutically active peptide/protein can, for example, prevent premature enzymatic degradation and enhance blood circulation times, which is therapeutically advantageous.
C1 Ecole Polytech Fed Lausanne, Inst Mat, Lab Polymeres, CH-1015 Lausanne, Switzerland.
   Max Planck Inst Polymer Res, D-55128 Mainz, Germany.
RP Klok, HA (reprint author), Ecole Polytech Fed Lausanne, Inst Mat, Lab Polymeres, Batiment MX-D, CH-1015 Lausanne, Switzerland.
EM Harm-Anton.Klok@epfl.ch
CR Aoyagi T, 1999, COLLOID SURFACE B, V16, P237, DOI 10.1016/S0927-7765(99)00074-0
   Ayres L, 2003, MACROMOLECULES, V36, P5967, DOI 10.1021/ma025727h
   Baldwin SP, 1998, ADV DRUG DELIVER REV, V33, P71, DOI 10.1016/S0169-409X(98)00021-0
   BARRERA DA, 1993, J AM CHEM SOC, V115, P11010, DOI 10.1021/ja00076a077
   BARRERA DA, 1995, MACROMOLECULES, V28, P425, DOI 10.1021/ma00106a004
   BERNDT P, 1995, J AM CHEM SOC, V117, P9515, DOI 10.1021/ja00142a019
   BILLOT JP, 1977, MAKROMOL CHEM, V178, P1641
   BILLOT JP, 1976, MAKROMOL CHEM, V177, P1889
   Brodsky B, 1995, FASEB J, V9, P1537
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Burkoth TS, 1999, J AM CHEM SOC, V121, P7429, DOI 10.1021/ja991233x
   Burkoth TS, 1998, J AM CHEM SOC, V120, P7655, DOI 10.1021/ja980566b
   Cammas S, 1996, MACROMOLECULES, V29, P3227, DOI 10.1021/ma951025z
   Checot F., 2002, ANGEW CHEM INT EDIT, V41, P1340
   Cho CS, 1999, KOREA POLYM J, V7, P203
   CIMA LG, 1993, CHEM ENG PROG, V6, P46
   Cook AD, 1997, J BIOMED MATER RES, V35, P513
   Dai WG, 1996, BIOTECHNOL BIOENG, V50, P349, DOI 10.1002/(SICI)1097-0290(19960520)50:4<349::AID-BIT1>3.3.CO;2-D
   Davis FF, 2002, ADV DRUG DELIVER REV, V54, P457, DOI 10.1016/S0169-409X(02)00021-2
   Diwan M, 2001, J CONTROL RELEASE, V73, P233, DOI 10.1016/S0168-3659(01)00292-9
   DOUY A, 1977, POLYM ENG SCI, V17, P523, DOI 10.1002/pen.760170807
   DOUY A, 1982, POLYMER, V23, P1039, DOI 10.1016/0032-3861(82)90405-0
   Duncan R, 1996, STP PHARMA SCI, V6, P237
   Duncan R, 2003, NAT REV DRUG DISCOV, V2, P347, DOI 10.1038/nrd1088
   DUNCAN R, 1999, PHARM SCI TECHNOL TO, V2, P441, DOI DOI 10.1016/S1461-5347(99)00211-4
   Dvorak M, 1999, J CONTROL RELEASE, V60, P321, DOI 10.1016/S0168-3659(99)00087-5
   Edwards DA, 1997, SCIENCE, V276, P1868, DOI 10.1126/science.276.5320.1868
   Elbert DL, 1998, J BIOMED MATER RES, V42, P55, DOI 10.1002/(SICI)1097-4636(199810)42:1<55::AID-JBM8>3.0.CO;2-N
   Elbert DL, 1998, CHEM BIOL, V5, P177, DOI 10.1016/S1074-5521(98)90062-X
   FLANAGAN PA, 1992, J CONTROL RELEASE, V18, P25, DOI 10.1016/0168-3659(92)90208-9
   FOSTER JA, 1973, J BIOL CHEM, V248, P2876
   Francis GE, 1998, INT J HEMATOL, V68, P1
   Gallot B, 1996, PROG POLYM SCI, V21, P1035, DOI 10.1016/S0079-6700(96)00010-X
   Gore T, 2001, LANGMUIR, V17, P5352, DOI 10.1021/la010223i
   GRAY WR, 1973, NATURE, V246, P461, DOI 10.1038/246461a0
   Griffith LG, 1998, BIOMATERIALS, V19, P979, DOI 10.1016/S0142-9612(97)00185-3
   Groth T, 1995, ATLA-ALTERN LAB ANIM, V23, P790
   Guijarro JI, 1998, P NATL ACAD SCI USA, V95, P4224, DOI 10.1073/pnas.95.8.4224
   Han DK, 1996, MACROMOLECULES, V29, P5233, DOI 10.1021/ma9601070
   Harada A, 1998, MACROMOLECULES, V31, P288, DOI 10.1021/ma971277v
   Harada A, 1996, MACROMOLECULES, V29, P6183, DOI 10.1021/ma960487p
   Harada A, 1999, SCIENCE, V283, P65, DOI 10.1126/science.283.5398.65
   HARADA A, 1995, MACROMOLECULES, V28, P5294, DOI 10.1021/ma00119a019
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   HERSHFIELD MS, 1987, NEW ENGL J MED, V316, P589, DOI 10.1056/NEJM198703053161005
   HO DH, 1986, DRUG METAB DISPOS, V14, P349
   HO SP, 1994, ADV MATER, V6, P130, DOI 10.1002/adma.19940060205
   HODGES RS, 1972, COLD SPRING HARB SYM, V37, P299
   Irvine DJ, 2001, BIOMACROMOLECULES, V2, P85, DOI 10.1021/bm005584b
   Iwai K, 1984, CANCER RES, V44, P2114
   Jen AC, 1996, BIOTECHNOL BIOENG, V50, P357, DOI 10.1002/(SICI)1097-0290(19960520)50:4<357::AID-BIT2>3.0.CO;2-K
   Jo S, 2001, BIOMACROMOLECULES, V2, P255, DOI 10.1021/bm000107e
   Johnson-Saliba M, 2001, CURR DRUG TARGETS, V2, P371, DOI 10.2174/1389450013348245
   Kakizawa Y, 1999, J AM CHEM SOC, V121, P11247, DOI 10.1021/ja993057y
   Kakizawa Y, 2002, ADV DRUG DELIVER REV, V54, P203, DOI 10.1016/S0169-409X(02)00017-0
   Kakizawa Y, 2001, BIOMACROMOLECULES, V2, P491, DOI 10.1021/bm000142I
   Kataoka K, 1998, MACROMOLECULES, V31, P6071, DOI 10.1021/ma971838i
   Katayose S, 1998, J PHARM SCI, V87, P160, DOI 10.1021/js970304s
   Katayose S, 1997, BIOCONJUGATE CHEM, V8, P702, DOI 10.1021/bc9701306
   KIN HB, 1992, BIOMATERIALS, V13, P905
   Klee D, 1999, ADV POLYM SCI, V149, P1
   Klok HA, 2001, ADV MATER, V13, P1217, DOI 10.1002/1521-4095(200108)13:16<1217::AID-ADMA1217>3.0.CO;2-D
   Klok HA, 2000, MACROMOLECULES, V33, P7819, DOI 10.1021/ma0009606
   Kochendoerfer GG, 2003, SCIENCE, V299, P884, DOI 10.1126/science.1079085
   Koga T, 2003, CHEM-EUR J, V9, P1146, DOI 10.1002/chem.200390132
   Koga T, 2002, CHEM COMMUN, P242, DOI 10.1039/b109574a
   Kopecek J, 2001, J CONTROL RELEASE, V74, P147, DOI 10.1016/S0168-3659(01)00330-3
   Kopecek J, 2001, MACROMOL SYMP, V174, P31, DOI 10.1002/1521-3900(200109)174:1<31::AID-MASY31>3.0.CO;2-6
   Kuhl PR, 1996, NAT MED, V2, P1022, DOI 10.1038/nm0996-1022
   Kukula H, 2002, J AM CHEM SOC, V124, P1658, DOI 10.1021/ja012091l
   Kwok KY, 1999, J PHARM SCI, V88, P996, DOI 10.1021/js990072s
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lecommandoux S, 2001, MACROMOLECULES, V34, P9100, DOI 10.1021/ma010940j
   LIN HB, 1992, J BIOMAT SCI-POLYM E, V3, P217, DOI 10.1163/156856292X00132
   Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/S0968-0004(96)10052-9
   Maeda H, 2001, ADV ENZYME REGUL, V41, P189, DOI 10.1016/S0065-2571(00)00013-3
   Maeda M, 1998, BIOCHEM BIOPH RES CO, V248, P485, DOI 10.1006/bbrc.1998.9018
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   MILES AJ, 1994, J BIOL CHEM, V269, P30939
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   Nishiyama N, 1999, LANGMUIR, V15, P377, DOI 10.1021/la980572l
   Pechar M, 2002, MACROMOL BIOSCI, V2, P199, DOI 10.1002/1616-5195(200206)2:5<199::AID-MABI199>3.0.CO;2-2
   PERLY B, 1974, CR ACAD SCI C CHIM, V279, P1109
   PERLY B, 1976, MAKROMOL CHEM, V177, P2569
   PETERSON CM, 2001, ADV EXP MED BIOL, V519, P101
   RAMACHANDRAN GN, 1988, INT J PEPT PROT RES, V31, P1
   Rathore O, 2001, J AM CHEM SOC, V123, P5231, DOI 10.1021/ja004030d
   Rathore O, 2001, MACROMOLECULES, V34, P1477, DOI 10.1021/ma001553x
   Rathore O, 2000, J POLYM SCI POL CHEM, V38, P352, DOI 10.1002/(SICI)1099-0518(20000115)38:2<352::AID-POLA10>3.0.CO;2-P
   Roberts MJ, 2002, ADV DRUG DELIVER REV, V54, P459, DOI 10.1016/S0169-409X(02)00022-4
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   SAIKI I, 1993, JPN J CANCER RES, V84, P558, DOI 10.1111/j.1349-7006.1993.tb00176.x
   Sakiyama-Elbert SE, 2001, ANN REV MATER RES, V31, P183, DOI 10.1146/annurev.matsci.31.1.183
   Schlaad H, 2002, POLYMER, V43, P5321, DOI 10.1016/S0032-3861(02)00360-9
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Shakesheff KM, 1998, J BIOMAT SCI-POLYM E, V9, P507, DOI 10.1163/156856298X00596
   SODEK J, 1972, P NATL ACAD SCI USA, V69, P3800, DOI 10.1073/pnas.69.12.3800
   Stile RA, 2001, BIOMACROMOLECULES, V2, P185, DOI 10.1021/bm0000945
   Tang A, 2001, J CONTROL RELEASE, V72, P57, DOI 10.1016/S0168-3659(01)00262-0
   Thiyagarajan P, 2000, J APPL CRYSTALLOGR, V33, P535, DOI 10.1107/S0021889899014387
   Urry D. W., 1997, PROTEIN BASED MAT
   Urry DW, 1998, BIOTECHNOL BIOENG, V58, P175, DOI 10.1002/(SICI)1097-0290(19980420)58:2/3<175::AID-BIT10>3.0.CO;2-C
   Urry DW, 1997, J PHYS CHEM B, V101, P11007, DOI 10.1021/jp972167t
   Vandermeulen GWM, 2003, MACROMOLECULES, V36, P4107, DOI 10.1021/ma034124i
   VANDERMEULEN GWM, 2004, IN PRESS CHEMPHYSCHE
   VandeVondele S, 2003, BIOTECHNOL BIOENG, V82, P784, DOI 10.1002/bit.10625
   Veronese FM, 2001, BIOMATERIALS, V22, P405, DOI 10.1016/S0142-9612(00)00193-9
   Wang C, 1999, NATURE, V397, P417, DOI 10.1038/17092
   Wang C, 2001, BIOMACROMOLECULES, V2, P912, DOI 10.1021/bm0155322
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
   Winblade ND, 2000, BIOMACROMOLECULES, V1, P523, DOI 10.1021/bm000040v
   Winningham MJ, 1997, MACROMOLECULES, V30, P862, DOI 10.1021/ma960804s
   YOKOYAMA M, 1990, J CONTROL RELEASE, V11, P269
   Yokoyama M, 1999, J DRUG TARGET, V7, P171, DOI 10.3109/10611869909085500
   Yu YC, 1998, J AM CHEM SOC, V120, P9979, DOI 10.1021/ja981654z
   Yu YC, 1996, J AM CHEM SOC, V118, P12515, DOI 10.1021/ja9627656
   ZALIPSKY S, 1995, ADV DRUG DELIVER REV, V16, P157, DOI 10.1016/0169-409X(95)00023-Z
NR 118
TC 186
Z9 190
U1 2
U2 70
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD APR 19
PY 2004
VL 4
IS 4
BP 383
EP 398
DI 10.1002/mabi.200300079
PG 16
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 817II
UT WOS:000221170800001
PM 15468229
DA 2018-10-19
ER

PT J
AU Carlsson, HE
   Hagelin, J
   Hau, J
AF Carlsson, HE
   Hagelin, J
   Hau, J
TI Implementation of the 'Three Rs' in biomedical research
SO VETERINARY RECORD
LA English
DT Article
ID LABORATORY-ANIMALS; SCIENTIFIC PAPERS; EXPERIMENTATION
AB A systematic sample of 2800 articles published between 1970 and 2000 in 14 major biomedical journals was analysed to assess the implementation of the 'Three Rs' (replacement, reduction and refinement) in biomedical research. During this period the total number of articles published annually by the journals more than doubled, but the proportion of studies using animals decreased by 30 per cent. There was a significant increase, from 21 per cent to 35 per cent, in the proportion of animal studies which made use of untreated euthanased animals as donors of biological materials, a gradual decrease in the number of chronic studies on animals, and a 50 per cent decrease in the average number of animals used per published paper. There was an improvement in the reporting of the specification of the animals' husbandry, conditions of care and environment. Parameters of importance for the evaluation of the scientific quality of the research and the welfare of the animals were generally poorly reported, but the proportion of papers with adequate information on most of the parameters analysed increased between 1970 and 2000.
C1 Uppsala Univ, Div Comparat Med, Dept Neurosci, SE-75123 Uppsala, Sweden.
RP Carlsson, HE (reprint author), Uppsala Univ, Div Comparat Med, Dept Neurosci, BMC Box 572, SE-75123 Uppsala, Sweden.
RI Hau, Jann/C-8692-2012
OI Hau, Jann/0000-0001-8586-5705
CR Alder M, 2002, VET REC, V151, P221
   BIGGERS JD, 1958, NATURE, V182, P77, DOI 10.1038/182077a0
   Boisvert DPJ, 1997, DEV AN VET, V27, P399
   CHANCE MRA, 1957, COLLECTED PAPERS LAB, V6, P59
   CLOUGH G, 1982, BIOL REV, V57, P487, DOI 10.1111/j.1469-185X.1982.tb00705.x
   *EUR COMM, 1986, OFFICIAL J L, V358, P1
   FESTING MFW, 1995, STAT TOXICOLOGY, P1
   Granados-Zuniga J, 1997, REV BIOL TROP, V45, P979
   Hagelin J, 2003, LAB ANIM-UK, V37, P10, DOI 10.1258/002367703762226656
   Hagelin J, 2002, ANTHROZOOS, V15, P251, DOI 10.2752/089279302786992540
   Hagelin J, 1999, LANCET, V353, P1191, DOI 10.1016/S0140-6736(05)74419-6
   Hendriksen C. F. M., 1999, HUMANE ENDPOINTS ANI
   *HOUS LORD, 2002, SEL COMM AN SCI PROC
   LANG CM, 1976, FED PROC, V35, P1123
   Milstien J, 1996, DEV BIOL STAND, V86, P31
   NEWTON MW, 1978, ADV VET SCI COMP MED, V22, P1
   OBRINK KJ, 1996, FORSOKSDJURSVETENSKA, P197
   Roberts I, 2002, BRIT MED J, V324, P474, DOI 10.1136/bmj.324.7335.474
   Russell W. M. S., 1959, PRINCIPLES HUMAN EXP
   SCHOBERBENDIXEN S, 1997, ALTEX ALTERNATIVEN T, V14, P99
   Smith JA, 1997, LAB ANIM, V31, P312, DOI 10.1258/002367797780596176
   Stokstad E, 1999, SCIENCE, V286, P1068, DOI 10.1126/science.286.5442.1068
   Turner JZ, 1998, PUBLIC UNDERST SCI, V7, P27, DOI 10.1088/0963-6625/7/1/003
NR 23
TC 12
Z9 14
U1 1
U2 9
PU BRITISH VETERINARY ASSOC
PI LONDON
PA 7 MANSFIELD ST, LONDON W1M 0AT, ENGLAND
SN 0042-4900
J9 VET REC
JI Vet. Rec.
PD APR 10
PY 2004
VL 154
IS 15
BP 467
EP 470
DI 10.1136/vr.154.15.467
PG 4
WC Veterinary Sciences
SC Veterinary Sciences
GA 819HI
UT WOS:000221305400017
PM 15143737
DA 2018-10-19
ER

PT J
AU Lee, GB
   Huang, FC
   Lee, CY
   Miau, JJ
AF Lee, GB
   Huang, FC
   Lee, CY
   Miau, JJ
TI A new fabrication process for a flexible skin with temperature sensor
   array and its applications
SO ACTA MECHANICA SINICA
LA English
DT Article; Proceedings Paper
CT International Conference on Mico and Nano Systems (ICMNS 2002)
CY AUG 11-14, 2002
CL KUNMING, PEOPLES R CHINA
DE MEMS; flexible skin; temperature sensors; TCR; polyimide
ID TECHNOLOGY; POLYMERASE; DNA
AB This paper reports a novel technique for fabrication of a flexible skin with a temperature sensor array (40 x 1 sensors). A simplified MEMS technology using platinum resistors as sensing materials, which are sandwiched between two polyimide layers as flexible substrates is developed. The two polyimide layers are deposited on top of a thin aluminum layer, which serves as a sacrificial layer such that the flexible skin can be released by metal etching and peeled off easily. The flexible skin with a temperature sensor array has a high mechanical flexibility and can be handily attached on a highly curved surface to detect tiny temperature distribution inside a small area. The sensor array shows a linear output and has a sensitivity of 7.5 mV/degreesC (prior to amplifiers) at a drive current of 1 mA. To demonstrate its applications, two examples have been demonstrated, including measurement of temperature distribution around a micro heater of a micro PCR (polymerase chain reaction) chip for DNA amplification and detection of separation point for flow over a circular cylinder. The development of the flexible skin with a temperature sensor array may be crucial for measuring temperature distribution on any curved surface in the fields of aerodynamics, space exploration, auto making and biomedical applications etc.
C1 Natl Cheng Kung Univ, Dept Engn Sci, Tainan 701, Taiwan.
   Natl Cheng Kung Univ, Inst Aeronaut & Astronaut, Tainan 701, Taiwan.
RP Lee, GB (reprint author), Natl Cheng Kung Univ, Dept Engn Sci, Tainan 701, Taiwan.
EM gwobin@mail.ncku.edu.tw
RI Lee, Gwo-Bin/D-3032-2012
OI Lee, Gwo-Bin/0000-0001-6910-9133
CR ANTHONY RJ, 2001, AIAA20010553 P 39 AE
   BANG C, 1996, P AFOSR CONTR GRANT
   BARTH PW, 1985, IEEE T ELECTRON DEV, V32, P1202, DOI 10.1109/T-ED.1985.22101
   BEEBE DJ, 1994, SENSOR ACTUAT A-PHYS, V44, P57, DOI 10.1016/0924-4247(93)00775-Y
   Jiang FK, 2000, SENSOR ACTUAT A-PHYS, V79, P194, DOI 10.1016/S0924-4247(99)00277-0
   Jiang FK, 1997, PROC IEEE MICR ELECT, P465, DOI 10.1109/MEMSYS.1997.581894
   Kovacs G.T.A., 2000, MICROMACHINED TRANSD
   Lee GB, 2000, J AIRCRAFT, V37, P697, DOI 10.2514/2.2655
   Lee GB, 2002, J CHIN INST ENG, V25, P619, DOI 10.1080/02533839.2002.9670736
   Lin CH, 2002, INT J NONLINEAR SCI, V3, P177
   Liu RH, 1998, P ANN INT IEEE EMBS, V20, P1841, DOI 10.1109/IEMBS.1998.746950
   Madou MJ, 1997, FUNDAMENTALS MICROFA
   MULLIS KB, 1987, METHOD ENZYMOL, V155, P335
   SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875
NR 14
TC 4
Z9 8
U1 4
U2 20
PU CHINESE JOURNAL MECHANICS PRESS
PI BEIJING
PA 15 ZHONG-GUAN-CUN ST, BEIJING 100080, PEOPLES R CHINA
SN 0567-7718
J9 ACTA MECH SINICA
JI Acta Mech. Sin.
PD APR
PY 2004
VL 20
IS 2
BP 140
EP 145
PG 6
WC Engineering, Mechanical; Mechanics
SC Engineering; Mechanics
GA 822EH
UT WOS:000221518600005
DA 2018-10-19
ER

PT J
AU Dorner-Reisel, A
   Schurer, C
   Muller, E
AF Dorner-Reisel, A
   Schurer, C
   Muller, E
TI The wear resistance of diamond-like carbon coated and uncoated Co28Cr6Mo
   knee prostheses
SO DIAMOND AND RELATED MATERIALS
LA English
DT Article; Proceedings Paper
CT 14th European Conference on Diamond, Diamond-like Materials, Carbon
   Nanotubes, Nitrides and Silicon Carbide
CY SEP 08-12, 2003
CL Salzburg, AUSTRIA
SP AIXTRON AG, Elsevier Ltd, Iplas Innovat Plasma, Jobin Yvon GbmH, KINIK, Renishaw Plc, Roth & Rau, Seki Technotron, UralAlmazInvest Co
DE biomedical applications; diamond-like carbon; tribology;
   biocompatibility
ID POLYETHYLENE; UHMWPE; DEBRIS
AB Diamond-like carbon (DLC) coatings were deposited on medical grade Co28Cr6Mo femoral segments for knee joint prostheses by plasma decomposition of the gaseous hydrocarbon methane. In dependence on the DLC-coating thickness (0.8, 2.7 and 4.5 mum), the wear of the polymeric UHMW-PE (UHMW-PE: ultra high molecular weight polyethylene) counter face was increasing. In comparison with an uncoated Co28Cr6Mo femur, the surface modification with 0.8 and 2.7 mum thick DLCs resulted in improved wear resistance. A 4.5 mum thick DLC coating led to a strong decrease of the wear resistance of the UHMW-PE counter face. A possible reason for this phenomenon may be changes in the heat transfer. The heat transfer may be reduced due to lower fraction of defects, like pinholes, in thicker DLC coatings. Starting from a certain temperature level at the surface of the polymeric inlays, structural changes could be expected, causing a higher materials loss. Furthermore, in comparison with the uncoated Co28Cr6Mo femoral components, the release of metallic wear products is reduced due to the coverage of the metallic alloy with the DLCs. Hereby, an improved biocompatibility is expected. (C) 2003 Elsevier B.V. All rights reserved.
C1 Bergakad Freiberg, Inst Ceram Mat, D-9200 Freiberg, Germany.
RP Dorner-Reisel, A (reprint author), Bergakad Freiberg, Inst Ceram Mat, D-9200 Freiberg, Germany.
EM domer@mailtuba.tu-freiberg.de
CR Allen M, 1996, J BONE JOINT SURG BR, V78B, P32
   Chandrasekaran M, 2001, WEAR, V250, P237, DOI 10.1016/S0043-1648(01)00646-9
   Costa L, 2001, BIOMATERIALS, V22, P307, DOI 10.1016/S0142-9612(00)00182-4
   DOENERREISEL A, IN PRESS THIN SOLID
   Dorner A, 2001, WEAR, V249, P489, DOI 10.1016/S0043-1648(01)00587-7
   Dorner-Reisel A, 2003, DIAM RELAT MATER, V12, P1030, DOI 10.1016/S0925-9635(02)00293-5
   Hahn DW, 1996, J BIOMED MATER RES, V31, P355
   Jacobs J.J., 1996, CLIN ORTHOP RELAT R, V329, P5256
   Jordan ND, 2001, J BIOMED MATER RES, V55, P158
   KOIZUMI M, 1998, 44 ANN M ORTH RES SO, P811
   Peters K, 2002, BIOMATERIALS, V23, P3413, DOI 10.1016/S0142-9612(02)00042-X
   SCHMALZRIED TP, 1994, J APPL BIOMATER, V5, P185, DOI 10.1002/jab.770050302
   Schmitt S, 2000, SCRIPTA MATER, V43, P523, DOI 10.1016/S1359-6462(00)00461-9
NR 13
TC 17
Z9 20
U1 1
U2 4
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-9635
J9 DIAM RELAT MATER
JI Diam. Relat. Mat.
PD APR-AUG
PY 2004
VL 13
IS 4-8
BP 823
EP 827
DI 10.1016/j.diamond.2003.11.080
PG 5
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 824MQ
UT WOS:000221691100054
DA 2018-10-19
ER

PT J
AU Smietana, M
   Smidt, J
   Dudek, M
   Niedzielski, P
AF Smietana, M
   Smidt, J
   Dudek, M
   Niedzielski, P
TI Optical properties of diamond-like cladding for optical fibres
SO DIAMOND AND RELATED MATERIALS
LA English
DT Article; Proceedings Paper
CT 14th European Conference on Diamond, Diamond-like Materials, Carbon
   Nanotubes, Nitrides and Silicon Carbide
CY SEP 08-12, 2003
CL Salzburg, AUSTRIA
SP AIXTRON AG, Elsevier Ltd, Iplas Innovat Plasma, Jobin Yvon GbmH, KINIK, Renishaw Plc, Roth & Rau, Seki Technotron, UralAlmazInvest Co
DE diamond-like carbon; plasma CVD; optical properties characterization;
   sensors
ID CARBON COATINGS; BIOMEDICAL APPLICATIONS; LAYERS
AB This article presents a novel application of DLC layers: cladding material for silica optical fibre's core. The coats were successfully obtained using the radio frequency plasma chemical vapour deposition (RF PCVD) method. A technological subject of depositing diamond-like carbon layers onto dielectric substrates is also raised. An original way of placing samples in a plasma reactor and a process taken in order to get a desirable effect were worked out. Different values of optical fibre transmission, which depend on the RF PCVD process parameters, can be observed. Obtained coats can be characterized by good adhesion and stability. Scanning electron microscopy (SEM) and atomic force microscopy (AFM) images of the deposited DLC layer were made. A partly uncoated optical fibre, covered by the DLC layer, can act as a sensing head. The experiments prove very high sensitivity to humidity depending on a length of the uncoated section and deposition process parameters. (C) 2003 Elsevier B.V. All rights reserved.
C1 Warsaw Univ Technol, Inst Micro & Optoelect, PL-00665 Warsaw, Poland.
   Tech Univ Lodz, Inst Mat Sci & Engn, PL-90924 Lodz, Poland.
RP Smietana, M (reprint author), Warsaw Univ Technol, Inst Micro & Optoelect, Koszykowa 75, PL-00665 Warsaw, Poland.
EM msmietan@elka.pw.edu.pl
RI Dudek, Mariusz/O-1242-2018
OI Dudek, Mariusz/0000-0003-4213-7673; Niedzielski,
   Piotr/0000-0002-6966-9154
CR Abderrahmane S, 2001, SENSOR ACTUAT B-CHEM, V75, P1, DOI 10.1016/S0925-4005(00)00677-8
   ADBERMALEK F, 1997, P 11 EUR C SOL STAT, P1529
   ALALUF M, 1995, THIN SOLID FILMS, V256, P1, DOI 10.1016/0040-6090(95)80024-7
   BUTTER R, 1995, DIAM RELAT MATER, V4, P857, DOI 10.1016/0925-9635(94)05280-8
   Coad EJ, 1996, DIAM RELAT MATER, V5, P640, DOI 10.1016/0925-9635(95)00403-3
   DLUZNIEWSKI M, DIAMOND96
   GRANT DM, 1992, DIAM RELAT MATER, V1, P727, DOI 10.1016/0925-9635(92)90198-W
   Grill A, 2003, DIAM RELAT MATER, V12, P166, DOI 10.1016/S0925-9635(03)00018-9
   Langer M, 1997, NATO ASI 3 HIGH TECH, V38, P211
   LETTINGTON AH, 1992, DIAM RELAT MATER, V1, P805, DOI 10.1016/0925-9635(92)90104-V
   MITURA E, 1994, DIAM RELAT MATER, V3, P896, DOI 10.1016/0925-9635(94)90295-X
   MITURA E, 1994, DIAM RELAT MATER, V3, P868, DOI 10.1016/0925-9635(94)90288-7
   MITURA S, 1991, MATER SCI MONOG, V73, P795
   Robertson J, 2003, DIAM RELAT MATER, V12, P79, DOI 10.1016/S0925-9635(03)00006-2
   SZMIDT J, 1994, DIAM RELAT MATER, V3, P849, DOI 10.1016/0925-9635(94)90283-6
NR 15
TC 32
Z9 36
U1 1
U2 12
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-9635
J9 DIAM RELAT MATER
JI Diam. Relat. Mat.
PD APR-AUG
PY 2004
VL 13
IS 4-8
BP 954
EP 957
DI 10.1016/j.diamond.2003.12.003
PG 4
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 824MQ
UT WOS:000221691100080
DA 2018-10-19
ER

PT J
AU Okpalugo, TIT
   Ogwu, AA
   Maguire, PD
   McLaughlin, JAD
   Hirst, DG
AF Okpalugo, TIT
   Ogwu, AA
   Maguire, PD
   McLaughlin, JAD
   Hirst, DG
TI In-vitro blood compatibility of a-C : H : Si and a-C : H thin films
SO DIAMOND AND RELATED MATERIALS
LA English
DT Article; Proceedings Paper
CT 14th European Conference on Diamond, Diamond-like Materials, Carbon
   Nanotubes, Nitrides and Silicon Carbide
CY SEP 08-12, 2003
CL Salzburg, AUSTRIA
SP AIXTRON AG, Elsevier Ltd, Iplas Innovat Plasma, Jobin Yvon GbmH, KINIK, Renishaw Plc, Roth & Rau, Seki Technotron, UralAlmazInvest Co
DE blood compatibility; cell adhesion; silicon doping; surface bond energy
AB Carbon-based materials, for example pyrolytic carbon, have been successfully applied as artificial clinical heart valve coatings but due to ease of availability, processing, increased hardness, corrosion and scratch resistance, DLC has recently attracted attention for biomedical applications. Although often cited as having bio-compatible properties there has been little systematic study of DLC and how film structure may affect such properties. RF PECVD a-C:H and Si-doped a-C:H:Si films were deposited and in-vitro blood compatibility (haemocompatibility) investigated by the use of human microvascular endothelial cells (HMEC) on one end of the scale and platelets on the other, in order to assess the potential of DLC in biomedicine and surgical applications. Increased electronic conduction, decreased work function and decreased surface bond energy (with a high dispersive component) in the absence of graphitisation improved the blood compatibility of a-C:H and a-C:H:Si thin films. Changes in the nanostructure, surface energy and electrical properties was observed with silicon doping while thermal annealing also altered the electrical properties, reduced intrinsic compressive stress and at higher temperatures (> 400 degreesC) induced graphitisation. Increased HMEC adhesion (approx. 6x) and/or decreased platelets aggregation (approx. 6x) is associated with lower resistivity, work function and surface energy in the thin films where there is no graphitisation. Graphitisation, however, despite the lower resistivity and work function, leads to lower HMEC adhesion and increased platelets aggregation. Si-doped a-C:H coatings deposited under optimal conditions are a significant factor in developing haemocompatible medical implants and devices. (C) 2003 Elsevier B.V. All rights reserved.
C1 Univ Ulster, Sch Elect & Mech Engn, NIBEC, Belfast BT37 0QB, Antrim, North Ireland.
   Univ Paisley, Thin Film Ctr, Paisley PA1 2BE, Renfrew, Scotland.
   Univ Ulster, Ctr Mol Biosci, Coleraine BT52 1SA, Londonderry, North Ireland.
RP Maguire, PD (reprint author), Univ Ulster, Sch Elect & Mech Engn, NIBEC, Shore Rd, Belfast BT37 0QB, Antrim, North Ireland.
EM pd.maguire@ulst.ac.uk
RI MAGUIRE, Paul/D-1568-2009
OI MAGUIRE, PAUL/0000-0002-2725-4647; McLaughlin, James/0000-0001-6026-8971
CR [Anonymous], 10993 ISO
   Baikie ID, 1998, REV SCI INSTRUM, V69, P3902, DOI 10.1063/1.1149197
   Gordan J. L., 1986, BLOOD SURFACE INTERA, P5
   Magill DP, 2001, J VAC SCI TECHNOL A, V19, P2456, DOI 10.1116/1.1387078
   Maguire PD, 2001, DIAM RELAT MATER, V10, P216, DOI 10.1016/S0925-9635(00)00470-2
   MARTINO BC, 1997, DIAM RELAT MATER, V6, P559
   MONCADA S, 1982, PATHOBIOLOGY ENDOTHE, P253
   OGWU AA, UNPUB APPL PHYS A
   OKPALUGO TIT, 2003, IN PRESS BIOMATERIAL
   WILCOX DC, 1996, GREER IMAGETOOL UTHS
NR 10
TC 41
Z9 42
U1 0
U2 7
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-9635
J9 DIAM RELAT MATER
JI Diam. Relat. Mat.
PD APR-AUG
PY 2004
VL 13
IS 4-8
BP 1088
EP 1092
DI 10.1016/j.diamond.2003.10.064
PG 5
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 824MQ
UT WOS:000221691100106
DA 2018-10-19
ER

PT J
AU Bibby, JK
   Mummery, PM
   Bubb, N
   Wood, DJ
AF Bibby, JK
   Mummery, PM
   Bubb, N
   Wood, DJ
TI Novel bioactive coatings for biomedical applications deposited by
   electrophoretic deposition
SO GLASS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 7th International Symposium on Crystallisation in Glasses and Liquids
CY JUL 06-09, 2003
CL Univ Sheffield, Sheffield, ENGLAND
HO Univ Sheffield
ID HYDROXYAPATITE COATINGS; GLASS-CERAMICS; SURFACE; INTERFACE
AB There are thousands of implant operations every year that give significant pain relief to patients. Even small improvements can reduce the need for further revision surgery. Improving the bonding of an implant, by using a bioactive coating, increases the rate of fixture of the implant, reducing the healing time The original artificial bioactive coatings, calcium phosphates and hydroxyapatite, were absorbed quickly by the body. This leaves the substrate bare, resulting in loosening of the implant. Hench developed bioactive glass ceramics in the 1970s that were longer lasting and bonded to hone. Due to the low fracture toughness ( of these glass ceramics, these materials are used for non-load hearing components, or more commonly, as coatings. This paper shows that fluorapatite-mullite coatings can be successfully deposited as a glass ceramic. Initial bioactivity tests using SBF show that this coaling is biologically active.
C1 Univ Manchester, Inst Sci & Technol, Ctr Mat Sci, Manchester M1 7HS, Lancs, England.
   Leeds Dent Inst, Div Restorat Dent, Leeds LS2 9LU, W Yorkshire, England.
RP Bibby, JK (reprint author), Univ Manchester, Inst Sci & Technol, Ctr Mat Sci, Grosvenor St, Manchester M1 7HS, Lancs, England.
EM jennifer_bibby@hotmail.com
CR Bao Y, 2002, J MATER SCI-MATER M, V13, P639, DOI 10.1023/A:1015773322821
   BREME J, 1995, BIOMATERIALS, V16, P239, DOI 10.1016/0142-9612(95)92123-N
   de Sena LA, 2002, J BIOMED MATER RES, V60, P1
   GAM MS, 1994, IND CERAM, V14, P163
   Gomez-Vega JM, 1999, J BIOMED MATER RES, V46, P549, DOI 10.1002/(SICI)1097-4636(19990915)46:4<549::AID-JBM13>3.0.CO;2-M
   Gomez-Vega JM, 2000, ADV MATER, V12, P894, DOI 10.1002/1521-4095(200006)12:12<894::AID-ADMA894>3.0.CO;2-4
   GREENSPAN DC, 1999, MED DIAGNOSTIC I MAR
   HENCH LL, 1993, INTRO BIOCERAMICS
   HILL R, 1995, J MATER SCI-MATER M, V6, P311, DOI 10.1007/BF00120298
   Jallot E, 2000, SURF INTERFACE ANAL, V29, P314, DOI 10.1002/(SICI)1096-9918(200005)29:5<314::AID-SIA871>3.3.CO;2-C
   JANA C, 1995, GLASTECH BER-GLASS, V68, P117
   KOKUBO T, 1999, MAT SCI FORUM, V293
   Manso M, 2000, BIOMATERIALS, V21, P1755, DOI 10.1016/S0142-9612(00)00061-2
   Massaro C, 2001, J BIOMED MATER RES, V58, P651, DOI 10.1002/jbm.1065
   MCDONALD DE, 2001, J BIOMED MATER RES, V54, P480
   Nobre MAL, 2001, MATER LETT, V50, P115, DOI 10.1016/S0167-577X(00)00426-2
   PEITL C, 2001, J NONCRYST SOLIDS, V292, P116
   Stoch A, 2001, J MOL STRUCT, V596, P191, DOI 10.1016/S0022-2860(01)00716-5
   Sun LM, 2001, J BIOMED MATER RES, V58, P570, DOI 10.1002/jbm.1056.abs
   TOMSIA AP, 1999, ACTA MAT, V47, P4221
   VERNE E, IN PRESS J EUR CERAM
   Yue RF, 1998, APPL SURF SCI, V126, P255, DOI 10.1016/S0169-4332(97)00407-8
NR 22
TC 8
Z9 8
U1 0
U2 0
PU SOC GLASS TECHNOLOGY
PI SHEFFIELD
PA 9 CHURCHILL WAY, SHEFFIELD S35 2PY, CHAPELTOWN, ENGLAND
SN 0017-1050
J9 GLASS TECHNOL
JI Glass Technol.
PD APR
PY 2004
VL 45
IS 2
BP 80
EP 83
PG 4
WC Materials Science, Ceramics
SC Materials Science
GA 835ZZ
UT WOS:000222525800011
DA 2018-10-19
ER

PT J
AU Voskerician, G
   Shawgo, RS
   Hiltner, PA
   Anderson, JM
   Cima, MJ
   Langer, R
AF Voskerician, G
   Shawgo, RS
   Hiltner, PA
   Anderson, JM
   Cima, MJ
   Langer, R
TI In vivo inflammatory and wound healing effects of gold electrode
   voltammetry for MEMS micro-reservoir drug delivery device
SO IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING
LA English
DT Article
DE bioelectric phenomena; biomedical materials; electrochemical process;
   microelectromechanical devices
ID ELECTRICAL-STIMULATION
AB The in vivo biocompatibility and biofouling of gold electrodes for a microelectromechanical systems drug delivery device were investigated in a rodent model. The role of the applied voltage and gold electrolysis products in modulating the inflammatory response (biocompatibility), and the temporal adhesion of cellular populations onto macroscopic gold film electrodes (biofouling) were analyzed in reference to two controls, devices to which voltage was not applied (uncorroded) or voltage was applied to inert platinum electrodes (electrical controls). Voltammetry was applied to the gold surfaces once (day 4, 7, 14, 21, 28, 35, 42, or 49), while voltage of identical magnitude was applied to the electrical controls. An inflammatory response characterized by a rapid decrease of leukocyte concentration to control levels was observed 48 h following voltage application with no significant cell concentration difference (p > 0.05) between the corroded devices and electrical controls. The histological evaluation of the direct implant fibrous capsule showed comparable thickness of voltage applied and control specimens. The gold corrosion peak current showed no significant difference (p > 0.05) among peak values at all time points. It was concluded that gold electrode corrosion was biocompatible and its electrochemical performance was not hindered by fibrous capsule formation.
C1 Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.
   Case Western Reserve Univ, Dept Macromol Sci, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Inst Pathol, Dept Biomed Engn, Cleveland, OH 44106 USA.
   MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
RP Voskerician, G (reprint author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
EM gxv4@po.cwru.edu
FU NIAID NIH HHS [1 R24 AI47739-01]
CR Best S, 1996, GOLD BULL, V29, P87, DOI DOI 10.1007/BF03214741
   Cho MR, 2000, ANN BIOMED ENG, V28, P234, DOI 10.1114/1.263
   Gentzkow G D, 1991, Clin Podiatr Med Surg, V8, P827
   GENTZKOW GD, 1993, J DERMATOL SURG ONC, V19, P753, DOI 10.1111/j.1524-4725.1993.tb00420.x
   Jones D., 1996, PRINCIPLES PREVENTIO
   KAO WJ, 1999, HDB BIOMATERIALS EVA, P659
   KISZA A, 1973, B ACAD POL SCI-CHIM, V21, P37
   Merchant B, 1998, BIOLOGICALS, V26, P49, DOI 10.1006/biol.1997.0123
   MILLER KM, 1989, J BIOMED MATER RES, V23, P1007, DOI 10.1002/jbm.820230904
   *OUT RES, HSC COMP PROGR VERS
   REICH J, 1990 INT C TISS REP
   ROSENBERG AD, 2001, THESIS MIT CAMBRIDGE
   Santini JT, 1999, NATURE, V397, P335
   Shive MS, 1999, J BIOMED MATER RES, V46, P511, DOI 10.1002/(SICI)1097-4636(19990915)46:4<511::AID-JBM9>3.0.CO;2-M
   Suggs LJ, 1999, J BIOMED MATER RES, V46, P22, DOI 10.1002/(SICI)1097-4636(199907)46:1<22::AID-JBM3>3.0.CO;2-R
   VOSKERICIAN G, IN PRESS BIOMATERIAL
   Weiss DS, 1989, J INVEST DERMATOL, P92
NR 17
TC 22
Z9 23
U1 0
U2 11
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 0018-9294
J9 IEEE T BIO-MED ENG
JI IEEE Trans. Biomed. Eng.
PD APR
PY 2004
VL 51
IS 4
BP 627
EP 635
DI 10.1109/TBME.2003.821034
PG 9
WC Engineering, Biomedical
SC Engineering
GA 805HJ
UT WOS:000220357100008
PM 15072217
DA 2018-10-19
ER

PT J
AU Hassed, CS
AF Hassed, CS
TI Bringing holism into mainstream biomedical education
SO JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE
LA English
DT Article
AB Introducing holism and complementary medicine into mainstream medical education provides many scientific, philosophical, and personal challenges. The growth of new knowledge always necessitates venturing into areas, which are, by definition, unknown, hence arise potential clashes of ideology, knowledge, evidence, interpretation, language, and personality. This paper outlines some of the experience and progress made at Monash University Victoria, Australia, in teaching this material in undergraduate medical education. The Monash medical course has always been known for its commitment to an integrated curriculum, a holistic perspective, and the personal development of its students. Some of the points of integration in the core curriculum already achieved include health enhancement and mindfulness-based stress management programs right from first year, lectures and forums on complementary medicine, integration of this material into weekly case-based teaching, and health promotion and mind-body medicine. For very interested students, electives provide an opportunity to explore subjects in more depth. Experience has taught us that it is as important to learn how to deliver the message as it is to refine its content. This presents challenges that are as much personal as they are intellectual. Areas of particular importance are the academic environment, language, diplomacy, style, relevance, and evidence. In this process, building relationships, collegiality, patience, objectivity, impartiality, and humor are helpful.
C1 Monash Univ, Dept Gen Practice, Melbourne, Vic 3165, Australia.
RP Hassed, CS (reprint author), Monash Univ, Dept Gen Practice, 867 Ctr Rd, Melbourne, Vic 3165, Australia.
EM craig.hassed@med.monash.edu.au
CR Astin JA, 1998, JAMA-J AM MED ASSOC, V279, P1548, DOI 10.1001/jama.279.19.1548
NR 1
TC 13
Z9 13
U1 0
U2 8
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538 USA
SN 1075-5535
J9 J ALTERN COMPLEM MED
JI J. Altern. Complement Med.
PD APR
PY 2004
VL 10
IS 2
BP 405
EP 407
DI 10.1089/107555304323062428
PG 3
WC Integrative & Complementary Medicine
SC Integrative & Complementary Medicine
GA 814VL
UT WOS:000221002100026
PM 15165424
DA 2018-10-19
ER

PT J
AU Matheson, LA
   Santerre, JP
   Labow, RS
AF Matheson, LA
   Santerre, JP
   Labow, RS
TI Changes in macrophage function and morphology due to biomedical
   polyurethane surfaces undergoing biodegradation
SO JOURNAL OF CELLULAR PHYSIOLOGY
LA English
DT Article
ID MONOCYTE-DERIVED MACROPHAGES; MULTINUCLEATED GIANT-CELLS; CHOLESTEROL
   ESTERASE; IN-VITRO; POLYETHYLENE; PHAGOCYTOSIS; CHEMISTRY; MEMBRANE;
   CYTOSKELETAL; ACTIVATION
AB Monocytes are recruited to the material surface of an implanted biomedical device recognizing it as a foreign body. Differentiation into macrophages subsequently occurs followed by fusion to form foreign body giant cells (FBGCs). Consequently, implants can become degraded, cause chronic inflammation or become isolated by fibrous encapsulation. In this study, a relationship between material surface chemistry and the FBGC response was demonstrated by seeding mature monocyte-derived macrophages (MDMs) on polycarbonate-based polyurethanes that differed in their chemical structures (synthesized with poly(1,6-hexyl 1,2-ethyl carbonate) diol, and either C-hexane diisocyanate and butanediol (BD) (referred to as HDI) or 4,4'-methylene bisphenyl diisocyanate and C-14-BD (referred to as MDI)) and material degradation assessed. At 48 h of cell-material interaction, the FBGC attached to HDI were more multinucleated (73%) compared to MDI or the polystyrene (PS) control (21 and 36%, respectively). There was a fivefold increase in the synthesis and secretion of a protein with an approximate molecular weight of 48 kDa and a pl of 6.1 (determined by two-dimensional gel electrophoresis) only from cells seeded on HDI. Immunoprecipitation confirmed that MSE and CE were synthesized and secreted de novo. Immunoblotting also showed an increase in se creted monocyte-specific esterase (MSE) and cholesterol esterase (CE) from cells seeded on HDI relative to PS and MDl. Significantly more radiolabel (C-14) release and esterase activity were elicited by MDMs on HDI than MDI (P < 0.05). The material that was more degradable (HDI), elicited greater protein synthesis and esterase secretion as well as more multi nucleated MDMs than MDI, suggesting that the material surface chemistry modulates the function of MDM at the site of an inflammatory response to an implanted device. (C) 2003 Wiley-Liss, Inc..
C1 Univ Ottawa, Inst Heart, Ottawa, ON K1Y 4W7, Canada.
   Univ Toronto, Fac Dent, Toronto, ON, Canada.
   Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.
RP Labow, RS (reprint author), Univ Ottawa, Inst Heart, 40 Ruskin St, Ottawa, ON K1Y 4W7, Canada.
EM rlabow@ottawaheart.ca
CR Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008
   Belanger MC, 2000, ARTIF ORGANS, V24, P879, DOI 10.1046/j.1525-1594.2000.06504.x
   Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732
   Boynton EL, 2000, J BIOMED MATER RES, V52, P239, DOI 10.1002/1097-4636(200011)52:2<239::AID-JBM1>3.0.CO;2-R
   BOZDECH MJ, 1981, J EXP MED, V153, P182, DOI 10.1084/jem.153.1.182
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   CANNON GJ, 1992, J CELL SCI, V101, P907
   Crenshaw HC, 1996, EXP CELL RES, V227, P285, DOI 10.1006/excr.1996.0278
   DeFife KM, 1999, J HISTOCHEM CYTOCHEM, V47, P65, DOI 10.1177/002215549904700107
   Garcia-Garcia E, 2002, J LEUKOCYTE BIOL, V72, P1092
   HUANG Y, 1991, J BIOL CHEM, V266, P6720
   Jacob SS, 2002, MOL CELL BIOCHEM, V233, P9, DOI 10.1023/A:1015593232347
   Jenney CR, 1999, J BIOMED MATER RES, V46, P11, DOI 10.1002/(SICI)1097-4636(199907)46:1<11::AID-JBM2>3.3.CO;2-P
   Kao WJ, 2001, J BIOMED MATER RES, V55, P79, DOI 10.1002/1097-4636(200104)55:1<79::AID-JBM110>3.3.CO;2-Q
   Korossis SA, 2000, BIO-MED MATER ENG, V10, P83
   Labow RS, 2001, BIOMATERIALS, V22, P3025, DOI 10.1016/S0142-9612(01)00049-7
   Labow RS, 2002, BIOMATERIALS, V23, P3969, DOI 10.1016/S0142-9612(02)00137-0
   LABOW RS, 1994, J BIOMAT SCI-POLYM E, V6, P169, DOI 10.1163/156856294X00293
   Labow RS, 1998, J BIOMED MATER RES, V39, P469, DOI 10.1002/(SICI)1097-4636(19980305)39:3<469::AID-JBM18>3.0.CO;2-5
   Labow RS, 2001, J BIOMED MATER RES, V54, P189, DOI 10.1002/1097-4636(200102)54:2<189::AID-JBM5>3.0.CO;2-8
   Li F, 1997, J BIOL CHEM, V272, P28666, DOI 10.1074/jbc.272.45.28666
   MARCHISIO PC, 1987, EXP CELL RES, V169, P202, DOI 10.1016/0014-4827(87)90238-2
   Matheson LA, 2002, J BIOMED MATER RES, V61, P505, DOI 10.1002/jbm.10286
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   OFARRELL PH, 1975, J BIOL CHEM, V250, P4007
   Rao KMK, 2001, J LEUKOCYTE BIOL, V69, P3
   Reinhard G, 2002, BRIT J CANCER, V86, P1529, DOI 10.1038/sj/bjc/6600316
   Rosengart MR, 2000, SHOCK, V13, P183, DOI 10.1097/00024382-200003000-00003
   Saad B, 2000, J BIOMAT SCI-POLYM E, V11, P787, DOI 10.1163/156856200744011
   Santerre JP, 1997, J BIOMED MATER RES, V36, P223
   Satoh T, 1998, ANNU REV PHARMACOL, V38, P257, DOI 10.1146/annurev.pharmtox.38.1.257
   SKARLATOS SI, 1992, J TISS CULT METH, V14, P113
   SMETANA K, 1987, EXP MOL PATHOL, V46, P258, DOI 10.1016/0014-4800(87)90048-7
   STOKES K, 1995, J BIOMATER APPL, V9, P321, DOI 10.1177/088532829500900402
   Tanaka H, 1999, J BIOCHEM, V125, P883, DOI 10.1093/oxfordjournals.jbchem.a022364
   Tang YW, 2002, J BIOMAT SCI-POLYM E, V13, P463, DOI 10.1163/156856202320253965
   Tang YW, 2001, J BIOMED MATER RES, V57, P597, DOI 10.1002/1097-4636(20011215)57:4<597::AID-JBM1207>3.0.CO;2-T
   Tiwari A, 2002, CARDIOVASC SURG, V10, P191, DOI 10.1016/S0967-2109(02)00004-2
   Uphoff CC, 2000, LEUKEMIA LYMPHOMA, V39, P257, DOI 10.3109/10428190009065825
   VIGNERY A, 1989, J HISTOCHEM CYTOCHEM, V37, P1265, DOI 10.1177/37.8.2546991
   WERB Z, 1989, AM J PATHOL, V134, P661
   WOLTER JR, 1983, OPHTHALMIC SURG LAS, V14, P839
   Xing S, 2002, J BIOMED MATER RES, V61, P619, DOI 10.1002/jbm.10078
   Xing S, 2002, BIOMATERIALS, V23, P3595, DOI 10.1016/S0142-9612(02)00088-1
   Yang ML, 2001, BIOMACROMOLECULES, V2, P134, DOI 10.1021/bm000087g
   Zdrahala RJ, 1999, J BIOMATER APPL, V14, P67, DOI 10.1177/088532829901400104
NR 46
TC 57
Z9 57
U1 0
U2 14
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9541
J9 J CELL PHYSIOL
JI J. Cell. Physiol.
PD APR
PY 2004
VL 199
IS 1
BP 8
EP 19
DI 10.1002/jcp.10412
PG 12
WC Cell Biology; Physiology
SC Cell Biology; Physiology
GA 773EQ
UT WOS:000188885100002
PM 14978730
DA 2018-10-19
ER

PT J
AU Costa, SA
   Reis, RL
AF Costa, SA
   Reis, RL
TI Immobilisation of catalase on the surface of biodegradable starch-based
   polymers as a way to change its surface characteristics
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 18th European Conference on Biomaterials
CY OCT 01-04, 2003
CL Stuttgart, GERMANY
ID COVALENT IMMOBILIZATION; MECHANICAL-PROPERTIES; HYDROGEN-PEROXIDE;
   IN-VITRO; SCAFFOLDS; POLYETHYLENEIMINE; ACID); STABILIZATION;
   OPTIMIZATION; CHYMOTRYPSIN
AB In this study, a specific enzyme catalase was immobilised onto the surface of two different biodegradable materials, starch cellulose acetate (SCA) and starch polycrapolactone (SPCL) blends. This immobilisation was achieved by several different routes, mainly by covalent binding and an adsorption method using as activation agents epichlorohydrin, cyanogen bromide (CNBr), and aminopropyltriethoxysilane. The effect of the coupling pH of the enzyme-support reaction was determined in terms of activity recovery (%). The catalase immobilised on SCA showed higher activity recovery (%) for all the methods used as compared with results obtained with SPCL. The immobilisation process using epichlorohydrin as an activation agent and polyethylenimine as a spacer-arm enhanced the stability and the half-lives at pH 7.0, 30 degreesC, for immobilised catalase on both SCA and SPCL. The half-lives were respectively, 1162 and 870 h compared with other treatments and free enzyme (480 h). The free glycerol present in the immobilisation medium was also a factor that contributed toward the better performance regarding the long-term stability at 30 degreesC and neutral pH. The extension of the morphological modifications on the surface of the materials was observed by scanning electron microscopy. In general, the results indicated that the chemical modification with epichlorohydrin could provide a simple and rather efficient technique to modify the starch-based materials' surface that might be useful in several biomedical applications. (C) 2004 Kluwer Academic Publishers.
C1 3Bs Res Grp, P-4710057 Braga, Portugal.
   Univ Minho, Dept Polymer Engn, P-4800058 Guimaraes, Portugal.
RP Costa, SA (reprint author), 3Bs Res Grp, Campus Gualtar, P-4710057 Braga, Portugal.
EM silgia@adep.uminho.pt
RI Reis, Rui L./A-8938-2008; Aparecida da Costa, Silgia/M-5901-2015; Group,
   3Bs/E-4374-2012
OI Reis, Rui L./0000-0002-4295-6129; Aparecida da Costa,
   Silgia/0000-0001-8331-538X; Group, 3Bs/0000-0002-5195-3456
CR Aebi H.E., 1983, METHODS ENZYME ANAL, V3, P273
   AKERTEK E, 1995, APPL BIOCHEM BIOTECH, V50, P291, DOI 10.1007/BF02788099
   AKOGOL S, 2001, J MOL CATAL B-ENZYM, V15, P197
   Albayrak N, 2002, BIOTECHNOL PROGR, V18, P240, DOI 10.1021/bp010167b
   Alves CM, 2003, J MATER SCI-MATER M, V14, P157, DOI 10.1023/A:1022023930825
   ARICA MY, 1995, BIOMATERIALS, V16, P761, DOI 10.1016/0142-9612(95)99638-3
   BAHULEKAR R, 1991, ENZYME MICROB TECH, V13, P858, DOI 10.1016/0141-0229(91)90101-F
   BICKERSTAFF GF, 1987, ENZYME IND MED
   Bilkova Z, 1999, J CHROMATOGR A, V852, P141, DOI 10.1016/S0021-9673(99)00234-4
   Broz ME, 2003, BIOMATERIALS, V24, P4181, DOI 10.1016/S0142-9612(03)00314-4
   Castro GR, 2000, ENZYME MICROB TECH, V27, P143, DOI 10.1016/S0141-0229(00)00197-6
   Cetinus SA, 2003, ENZYME MICROB TECH, V32, P889, DOI 10.1016/S0141-0229(03)00065-6
   Chae HJ, 1998, APPL BIOCHEM BIOTECH, V73, P195, DOI 10.1007/BF02785655
   Chung I, 2003, EUR POLYM J, V39, P1817
   Costa SA, 2002, ENZYME MICROB TECH, V30, P387, DOI 10.1016/S0141-0229(01)00505-1
   Costa SA, 2001, ENZYME MICROB TECH, V28, P815, DOI 10.1016/S0141-0229(01)00335-0
   DUNG NA, 1995, RADIAT PHYS CHEM, V46, P1037, DOI 10.1016/0969-806X(95)00316-P
   DYBKO A, 1997, SENSOR ACTUAT B-CHEM, V38, P207
   Eldin MSM, 2000, J MOL CATAL B-ENZYM, V10, P445
   Emerson D, 1996, BIOTECHNOL TECH, V10, P673
   Gomes ME, 2001, BIOMATERIALS, V22, P883, DOI 10.1016/S0142-9612(00)00211-8
   Gomes ME, 2002, MAT SCI ENG C-BIO S, V20, P19, DOI 10.1016/S0928-4931(02)00008-5
   Goth L, 2001, BLOOD CELL MOL DIS, V27, P512, DOI 10.1006/bcmd.2001.0415
   Goth L, 2001, CLIN CHIM ACTA, V311, P161, DOI 10.1016/S0009-8981(01)00609-X
   GREENWALD RA, 1990, FREE RADICAL BIO MED, V8, P201, DOI 10.1016/0891-5849(90)90092-W
   Hacker M, 2003, BIOMATERIALS, V24, P4459, DOI 10.1016/S0142-9612(03)00346-6
   HARTMEIR W, 1986, IMMOBILISED BIOCATAL, P206
   Johnson P, 2002, COMP BIOCHEM PHYS C, V133, P493, DOI 10.1016/S1532-0456(02)00120-5
   Jurado LA, 2003, J CHROMATOGR A, V984, P9, DOI 10.1016/S0021-9673(02)01770-3
   Koneracka M, 1999, J MAGN MAGN MATER, V201, P427, DOI 10.1016/S0304-8853(99)00005-0
   Kotze AC, 2003, INT J PARASITOL, V33, P393, DOI 10.1016/S0020-7519(03)00012-2
   Marolia KZ, 1999, J BIOCHEM BIOPH METH, V39, P115, DOI 10.1016/S0165-022X(98)00021-9
   Matsumoto M, 1997, J CHEM TECHNOL BIOT, V70, P188, DOI 10.1002/(SICI)1097-4660(199710)70:2<188::AID-JCTB745>3.0.CO;2-X
   Oliveira AL, 2003, BIOMATERIALS, V24, P2575, DOI 10.1016/S0142-9612(03)00060-7
   Oliveira AL, 1999, J MATER SCI-MATER M, V10, P827, DOI 10.1023/A:1008900428325
   Oliveira P.C., 2000, BIOCH ENG J, V5, P63
   Ostrovidova GU, 2003, MAT SCI ENG C-BIO S, V23, P377, DOI 10.1016/S0928-4931(02)00307-7
   Petro M, 1996, BIOTECHNOL BIOENG, V49, P355, DOI 10.1002/(SICI)1097-0290(19960220)49:4<355::AID-BIT1>3.0.CO;2-O
   Quirk RA, 2001, BIOMATERIALS, V22, P865, DOI 10.1016/S0142-9612(00)00250-7
   Rocha JMS, 1998, J BIOTECHNOL, V66, P61, DOI 10.1016/S0168-1656(98)00157-6
   Salgado AJ, 2002, MAT SCI ENG C-BIO S, V20, P27, DOI 10.1016/S0928-4931(02)00009-7
   SHULZ B, 1999, J MOL CATAL B-ENZYM, V7, P85
   SOARES CMF, 2001, APPL BIOCHEM BIOTECH, V91, P1
   SOLAS MT, 1994, J BIOTECHNOL, V33, P63, DOI 10.1016/0168-1656(94)90099-X
   SOUZA SF, 2001, PROCESS BIOCHEM, V36, P677
   Subramanian A, 1999, ENZYME MICROB TECH, V24, P26, DOI 10.1016/S0141-0229(98)00084-2
   SWAISGOOD HE, 1991, APPL BIOPROCESSING F
   Torres R, 2002, BIOTECHNOL PROGR, V18, P1221, DOI 10.1021/bp020082q
   Yang Y, 2003, NUCL INSTRUM METH B, V207, P165, DOI 10.1016/S0168-583X(03)00456-7
   Yang Z, 1996, ENZYME MICROB TECH, V18, P82, DOI 10.1016/0141-0229(95)00073-9
   Zamocky M, 2001, FEBS LETT, V492, P177, DOI 10.1016/S0014-5793(01)02237-2
   Zhao HQ, 2003, BLOOD CELL MOL DIS, V30, P90, DOI 10.1016/S1079-9796(03)00012-3
   Zhou SB, 2003, BIOMATERIALS, V24, P3563, DOI 10.1016/S0142-9612(03)00207-2
   Zhu YB, 2002, BIOMATERIALS, V23, P4889, DOI 10.1016/S0142-9612(02)00247-8
   Zuwei M, 2002, EUR POLYM J, V38, P2279
NR 55
TC 14
Z9 16
U1 1
U2 18
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2004
VL 15
IS 4
BP 335
EP 342
DI 10.1023/B:JMSM.0000021098.75103.3a
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 805XN
UT WOS:000220399100008
PM 15332596
DA 2018-10-19
ER

PT J
AU Heijkants, RGJC
   Van Calck, RV
   De Groot, JH
   Pennings, AJ
   Schouten, AJ
   Van Tienen, TG
   Ramrattan, N
   Buma, P
   Veth, RPH
AF Heijkants, RGJC
   Van Calck, RV
   De Groot, JH
   Pennings, AJ
   Schouten, AJ
   Van Tienen, TG
   Ramrattan, N
   Buma, P
   Veth, RPH
TI Design, synthesis and properties of a degradable polyurethane scaffold
   for meniscus regeneration
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 18th European Conference on Biomaterials
CY OCT 01-04, 2003
CL Stuttgart, GERMANY
ID BIOMEDICAL POLYURETHANE; REPAIR; ULTRASTRUCTURE; DOGS
AB Longitudinal lesions in menisci are among the most frequent orthopedic problems of the knee. Repair by simple techniques is only limited to the vascular part of the meniscus. For repair of the avascular part of the meniscus a scaffold, which will assist the body in the formation of new meniscus cell tissue, might be applicable. In this study a biomedical segmented polyurethane with poly(epsilon-caprolactone) as soft segment and 1,4-butanediisocyanate and 1,4-butanediol as uniform hard segments has been synthesised. The material has a micro phase separated morphology and excellent mechanical properties. A porous scaffold was prepared via a combination of liquid-liquid phase separation and salt leaching. The foams prepared combined a very high interconnectivity and porosity with the desired compression modulus. After six months of implantation in the knees of beagles full ingrowth with cells was obtained and it was found that meniscus like tissue had been formed in the scaffold. Moreover, compression behaviour appeared to be comparable to native meniscus tissue. (C) 2004 Kluwer Academic Publishers.
C1 Univ Groningen, Fac Math & Nat Sci, Dept Polymer Chem, NL-9747 AG Groningen, Netherlands.
   Univ Med Ctr, Orthopaed Res Lab, NL-6500 HB Nijmegen, Netherlands.
RP Schouten, AJ (reprint author), Univ Groningen, Fac Math & Nat Sci, Dept Polymer Chem, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.
EM A.J.Schouten@chem.rug.nl
RI Buma, P./H-8019-2014; Buma, Pieter/C-9828-2013
CR deGroot JH, 1997, POLYM BULL, V38, P211, DOI 10.1007/s002890050040
   deGroot JH, 1997, BIOMATERIALS, V18, P613, DOI 10.1016/S0142-9612(96)00169-X
   DEGROOT JH, 1990, COLLOID POLYM SCI, V268, P1071
   GHADIALLY FN, 1978, J ANAT, V125, P499
   GORIS A, 1968, ANN PHARM FR, V24, P781
   Goris R J, 1987, Free Radic Res Commun, V3, P13, DOI 10.3109/10715768709069764
   GORIS RJA, 1985, UNFALLCHIRURG, V88, P330
   KLOMPMAKER J, 1991, BIOMATERIALS, V12, P810, DOI 10.1016/0142-9612(91)90066-J
   KLOMPMAKER J, 1992, J ORTHOP RES, V10, P359, DOI 10.1002/jor.1100100308
   MARCHANT RE, 1987, POLYMER, V28, P2032, DOI 10.1016/0032-3861(87)90037-1
   MCDEVITT CA, 1990, CLIN ORTHOP RELAT R, P8
   MILES MJ, 1988, DEV CRYSTALLINE POLY, V2, P233
   Spaans CJ, 1998, J MATER SCI-MATER M, V9, P675, DOI 10.1023/A:1008922128455
   TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533
   Tienen TG, 2003, BIOMATERIALS, V24, P2541, DOI 10.1016/S0142-9612(03)00053-X
   VANTIENEN TG, 2003, IN PRESS GEN ORTHOP
   WEBBER RJ, 1985, J ORTHOPAED RES, V3, P171
NR 17
TC 75
Z9 79
U1 5
U2 33
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2004
VL 15
IS 4
BP 423
EP 427
DI 10.1023/B:JMSM.0000021114.39595.1e
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 805XN
UT WOS:000220399100023
PM 15332611
DA 2018-10-19
ER

PT J
AU Lyon, J
   Giuse, NB
   Williams, A
   Koonce, T
   Walden, R
AF Lyon, J
   Giuse, NB
   Williams, A
   Koonce, T
   Walden, R
TI A model for training the new bioinformationist
SO JOURNAL OF THE MEDICAL LIBRARY ASSOCIATION
LA English
DT Article
ID INFORMATICS CONSULT SERVICE; SCHOOL OBJECTIVES PROJECT;
   MEDICAL-LIBRARIES; HEALTH; EDUCATION; GENETICS
AB Objectives: The objectives were to examine the effectiveness of a curriculum designed to increase bioinformatics competencies of librarians with diverse backgrounds and to identify demographic factors that may affect the learning process.
   Methods: Sixteen professional staff participated in a 12-week training course consisting of 5 distinct modules: molecular biology, genetic analysis, biotechnology, research literature, and databases. Participants completed a 120-question pretest and an 88-question posttest designed to evaluate the effectiveness of the training.
   Results: Training was deemed successful as all participants scored higher on the posttest than the pretest. Data analysis was conducted in relation to participant background. Holding a biology degree did not seem to affect posttest results. Years of experience, however, had an impact on final scores in the databases section, as senior team members had greater difficulty learning the material.
   Discussion: As the need for specialized information in the area of molecular biology and genetics becomes more central for the effectiveness of organizations, it is crucial for libraries to quickly align with those needs by having a clear vision for increasing the skills and competencies of their staff in this subject area. This paper describes an effective model for learning that was developed and tested by the Eskind Biomedical Library.
C1 Vanderbilt Univ, Med Ctr, Res Informat Consult Serv, Eskind Biomed Lib, Nashville, TN 37232 USA.
   Vanderbilt Univ, Med Ctr, Dept Biomed Informat, Nashville, TN 37232 USA.
RP Lyon, J (reprint author), Vanderbilt Univ, Med Ctr, Res Informat Consult Serv, Eskind Biomed Lib, 2009 Garland Ave, Nashville, TN 37232 USA.
EM Jennifer.Lyon@Vanderbilt.edu; Nunzia.Giuse@Vanderbilt.edu;
   Annette.Williams@Vanderbilt.edu; Taneya.Koonce@Vanderbilt.edu;
   Rachel.Walden@Vanderbilt.edu
RI Giuse, Nunzia/N-2032-2016; Lyon, Jennifer/B-6126-2011
OI Giuse, Nunzia/0000-0002-7644-9803; Lyon, Jennifer/0000-0001-9740-1270;
   Koonce, Taneya Y/0000-0002-4014-467X
CR ALPI K, 2003, ISSUES SCI TECHNOL L, P37
   Anderson MB, 1999, ACAD MED, V74, P13
   Delwiche Frances A., 2001, Medical Reference Services Quarterly, V20, P33, DOI 10.1300/J115v20n02_04
   Florance V, 2002, J MED LIBR ASSOC, V90, P49
   Friedman CP, 1999, ACAD MED, V74, P130
   Giuse N B, 1998, Bull Med Libr Assoc, V86, P412
   Giuse N B, 1999, Bull Med Libr Assoc, V87, P26
   Giuse NB, 1997, J AM MED INFORM ASSN, V4, P57, DOI 10.1136/jamia.1997.0040057
   Giuse NB, 1996, B MED LIBR ASSOC, V84, P534
   Huber JT, 1999, B MED LIBR ASSOC, V87, P74
   Jerome RN, 2001, B MED LIBR ASSOC, V89, P177
   KNOWLES M, 2003, SELF DIRECTED LEARNI
   Lynch C, 1999, B MED LIBR ASSOC, V87, P408
   LYON J, 2003, P SPEC LIB ASS 9I AN, P22
   Lyon Jennifer, 2003, Medical Reference Services Quarterly, V22, P67, DOI 10.1300/J115v22n01_07
   Owen David J., 1995, Science and Technology Libraries, V15, P3
   PROUD VK, 1989, AM J HUM GENET, V44, P597
   Stead WW, 1998, B MED LIBR ASSOC, V86, P26
   Tennant MR, 2002, J MED LIBR ASSOC, V90, P181
   Williams MD, 2001, B MED LIBR ASSOC, V89, P185
   Yarfitz S, 2000, B MED LIBR ASSOC, V88, P36
NR 21
TC 18
Z9 19
U1 0
U2 3
PU MEDICAL LIBRARY ASSOC
PI CHICAGO
PA 65 EAST WACKER PLACE, STE 1900, CHICAGO, IL 60601-7298 USA
SN 1536-5050
J9 J MED LIBR ASSOC
JI J. Med. Libr. Assoc.
PD APR
PY 2004
VL 92
IS 2
BP 188
EP 195
PG 8
WC Information Science & Library Science
SC Information Science & Library Science
GA 811NF
UT WOS:000220777900008
PM 15098047
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Van Loo, PLP
   de Weerd, HAV
   Van Zutphen, LFM
   Baumans, V
AF Van Loo, PLP
   de Weerd, HAV
   Van Zutphen, LFM
   Baumans, V
TI Preference for social contact versus environmental enrichment in male
   laboratory mice
SO LABORATORY ANIMALS
LA English
DT Article
DE aggression; enrichment; nesting material; male mice; preference; social
   contact
ID MUS-MUSCULUS L; NESTING MATERIAL; AGGRESSIVE-BEHAVIOR; HOUSING
   CONDITIONS; MOUSE; MODULATION; MOTIVATION; DECREASES; RATS
AB Due to their aggressive nature, male mice are less frequently used than female mice in biomedical research. When aggressive males are being used, individual housing is common practice. The question arises whether this is an acceptable housing for a social species. The present study was designed to gain more insight into the nature of inter-male social contact and into the potential of a form of environmental enrichment (nesting material) to compensate for the lack of social contact. In a series of tests, we analysed whether male mice of different ages preferred to spend time (1) near a familiar cage mate versus an empty cage, or (2) near to a familiar cage mate versus direct contact with nesting material (tissues). Dwelling time in each of the test cages and sleeping sites was recorded, as was the behaviour of the test mice. Results indicated that when other conditions were similar, male mice preferred to sleep in close proximity to their familiar cage mate. Furthermore, the need to engage in active social behaviour increased with age. Tissues were used to a large extent for sleeping and sleep-related behaviour. it is concluded that single housing in order to avoid aggression between male mice is a solution with evident negative consequences for the animals. When individual housing is inevitable due to excessive aggressive behaviour, the presence of nesting material could partly compensate for the deprivation of social contact.
C1 Univ Utrecht, Dept Lab Anim Sci, NL-3508 TD Utrecht, Netherlands.
   Univ Newcastle Upon Tyne, Dept Agr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   Karolinska Inst, S-17177 Stockholm, Sweden.
RP Van Loo, PLP (reprint author), Univ Utrecht, Dept Lab Anim Sci, POB 80166, NL-3508 TD Utrecht, Netherlands.
EM PL.P.vanloo@las.vet.uu.nl
CR BISAZZA A, 1981, Bollettino di Zoologia, V48, P157
   BLOM HJM, 1992, APPL ANIM BEHAV SCI, V35, P67, DOI 10.1016/0168-1591(92)90017-6
   BRAIN P, 1975, LIFE SCI, V16, P187, DOI 10.1016/0024-3205(75)90017-X
   BRAIN PF, 1990, BIOL J LINN SOC, V41, P257, DOI 10.1111/j.1095-8312.1990.tb00834.x
   CLAASSSEN V, 1994, TECHNIQUES BEHAV NEU, V12, P225
   *COMM INF DIS MIC, 1991, INF DIS MIC RATS, P195
   *COUNC EUR, 1997, RES ACC CAR LAB AN
   FRASER D, 1996, LAB ANIMAL, V25, P27
   GARTNER K, 1968, DTSCH TIERARZTLICHE, V2, P97
   HASEMAN JK, 1994, FUND APPL TOXICOL, V23, P44, DOI 10.1006/faat.1994.1077
   HATCH AM, 1965, TOXICOL APPL PHARM, V7, P737, DOI 10.1016/0041-008X(65)90132-8
   Hol T, 1999, BEHAV BRAIN RES, V100, P91, DOI 10.1016/S0166-4328(98)00116-8
   HUGHES BO, 1988, ANIM BEHAV, V36, P1696, DOI 10.1016/S0003-3472(88)80110-6
   HURST JL, 1993, ANIM BEHAV, V45, P997, DOI 10.1006/anbe.1993.1117
   Kudryavtseva NN, 2000, AGGRESSIVE BEHAV, V26, P241, DOI 10.1002/(SICI)1098-2337(2000)26:3<241::AID-AB4>3.0.CO;2-J
   Kudryavtseva NN, 2000, AGGRESSIVE BEHAV, V26, P386, DOI 10.1002/1098-2337(2000)26:5<386::AID-AB4>3.0.CO;2-#
   KUDRYAVTSEVA NN, 1994, BEHAV PROCESS, V32, P297, DOI 10.1016/0376-6357(94)90049-3
   KUDRYAVTSEVA NN, 1991, AGGRESSIVE BEHAV, V17, P285, DOI 10.1002/1098-2337(1991)17:5<285::AID-AB2480170505>3.0.CO;2-P
   *LAB AN SCI ASS, 1998, LASA TASK FORC M 12, V12
   Loo P. L. P. van, 2001, Journal of Applied Animal Welfare Science, V4, P91, DOI 10.1207/S15327604JAWS0402_1
   *MOUS GEN DAT, 2001, MOUS GEN INF WEB SIT
   PARMIGIANI S, 1989, AGGRESSIVE BEHAV, V15, P191, DOI 10.1002/1098-2337(1989)15:3<191::AID-AB2480150302>3.0.CO;2-U
   POOLE TB, 1976, ANIM BEHAV, V24, P476, DOI 10.1016/S0003-3472(76)80056-5
   POOLE TB, 1973, ANIM BEHAV, V21, P788, DOI 10.1016/S0003-3472(73)80105-8
   Rodent Refinement Working Party, 1998, LAB ANIM, V32, P233
   ROPER TJ, 1973, ANIM BEHAV, V21, P733, DOI 10.1016/S0003-3472(73)80099-5
   Sherwin CM, 1996, APPL ANIM BEHAV SCI, V48, P203, DOI 10.1016/0168-1591(96)01027-1
   Sherwin CM, 1997, LAB ANIM, V31, P125, DOI 10.1258/002367797780600134
   Van de Weerd HA, 1998, APPL ANIM BEHAV SCI, V55, P369, DOI 10.1016/S0168-1591(97)00043-9
   Van Loo PLP, 2001, PHYSIOL BEHAV, V72, P675, DOI 10.1016/S0031-9384(01)00425-5
   Van Loo PLP, 2000, ANIM WELFARE, V9, P281
   VandeWeerd HA, 1997, LAB ANIM, V31, P133, DOI 10.1258/002367797780600152
   VANDEWEERD HA, 1994, J EXP ANIM SCI, V36, P117
   Varlinskaya EI, 1999, PHYSIOL BEHAV, V67, P475, DOI 10.1016/S0031-9384(98)00285-6
NR 34
TC 60
Z9 61
U1 3
U2 25
PU ROYAL SOC MEDICINE PRESS LTD
PI LONDON
PA 1 WIMPOLE STREET, LONDON W1G 0AE, ENGLAND
SN 0023-6772
J9 LAB ANIM-UK
JI Lab. Anim.
PD APR
PY 2004
VL 38
IS 2
BP 178
EP 188
DI 10.1258/002367704322968867
PG 11
WC Veterinary Sciences; Zoology
SC Veterinary Sciences; Zoology
GA 816AR
UT WOS:000221083300009
PM 15070458
OA Bronze
DA 2018-10-19
ER

PT J
AU Kim, HY
   Ohmatsu, Y
   Kim, JI
   Hosoda, H
   Miyazaki, S
AF Kim, HY
   Ohmatsu, Y
   Kim, JI
   Hosoda, H
   Miyazaki, S
TI Mechanical properties and shape memory behavior of Ti-Mo-Ga alloys
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE shape memory alloy; superelasticity; biomaterial; smart material;
   titanium based alloy
ID MARTENSITIC TRANSFORMATIONS
AB Mechanical properties and shape memory behavior of Ti-Mo-Ga alloys were investigated in order to develop Ni-free biomedical shape memory alloys. The Ti-Mo-Ga alloys were fabricated by arc melting method. The ingots were cold-rolled tip to 95% reduction in thickness. The cold-rolled specimens were heat treated in the temperature range 673-1273K for 60s-3.6ks. The martensitic transformation temperature decreased with increase in Mo and Ga content. The maximum shape recovery strain was obtained in a solution treated Ti-6 at%Mo-3 at%Ga alloy. Mechanical properties and shape memory behavior strongly depend on heat treatment condition in the Ti-6 at%Mo-3 at%Ga. Premature failure was observed in specimens heat treated in the temperature range 673-773 K. Ultimate tensile strength decreased and fracture strain increased with increasing heat treatment temperature. Shape memory effect was obtained in specimens heat treated in the temperature range 1073-1273 K. The shape memory effect was due to the stress induced martensitic transformation yielding tensile deformation and the reverse transformation upon heating after unloading. The martensitic transformation start temperature increased and the yield stress decreased with increasing heat treatment temperature and time. Stable superclastic behavior was obtained in a Ti-7 at%Mo-4 at%Ga alloy at room temperature by cyclic tensile tests. The recovery strain exceeding 4% was achieved in the pre-strained Ti-7 at%Mo-4 at%Ga alloy.
C1 Univ Tsukuba, Inst Sci Mat, Tsukuba, Ibaraki 3058573, Japan.
   Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 2268503, Japan.
RP Miyazaki, S (reprint author), Univ Tsukuba, Inst Sci Mat, Tsukuba, Ibaraki 3058573, Japan.
EM miyazaki@ims.tsukuba.ac.jp
RI Miyazaki, Shuichi/A-3113-2012; Kim, Hee Young/F-6065-2011
OI Miyazaki, Shuichi/0000-0003-3849-4176; Kim, Hee
   Young/0000-0003-1981-6678
CR Ahmed T, 1996, J MATER SCI, V31, P4267, DOI 10.1007/BF00356449
   Baker C., 1971, Metal Science Journal, V5, P92
   DAVIS R, 1979, ACTA METALL MATER, V27, P1041, DOI 10.1016/0001-6160(79)90192-5
   DAVIS R, 1979, J MATER SCI, V14, P712
   DUERIG TW, 1982, ACTA METALL MATER, V30, P2161, DOI 10.1016/0001-6160(82)90137-7
   Grosdidier T, 2000, MAT SCI ENG A-STRUCT, V291, P218, DOI 10.1016/S0921-5093(00)00921-7
   Ho WF, 1999, BIOMATERIALS, V20, P2115, DOI 10.1016/S0142-9612(99)00114-3
   Hosoda H, 2003, MATER SCI FORUM, V426-4, P3121, DOI 10.4028/www.scientific.net/MSF.426-432.3121
   Hosoda H, 2001, T MRS J, V26, P243
   Hosoda H, 2001, T MRS J, V26, P235
   MIYAZAKI S, 1989, ISIJ INT, V29, P353, DOI 10.2355/isijinternational.29.353
   MIYAZAKI S, 1990, ENG ASPECTS SHAPE ME, P452
   Nitta K, 2001, STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY, P25
   Ohmatsu Y, 2001, 4 PAC RIM INT C ADV, P1627
   OSHIDA Y, 1991, CORROSION ENG, V40, P1009
   Shabalovskaya S., 1994, P 1 INT C SHAP MEM S, P209
NR 16
TC 99
Z9 103
U1 0
U2 25
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD APR
PY 2004
VL 45
IS 4
BP 1090
EP 1095
DI 10.2320/matertrans.45.1090
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 819KX
UT WOS:000221314900021
OA Bronze
DA 2018-10-19
ER

PT J
AU He, G
   Hagiwara, M
AF He, G
   Hagiwara, M
TI Ti-Cu-M(Fe,Cr,Co)-Sn-Ta(Nb) alloys with potential for biomedical
   applications
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE titanium alloy; nanostructure; mechanical properties; biomaterials;
   microstructure
ID NANOSTRUCTURE-DENDRITE COMPOSITE; ENHANCED PLASTICITY; MATERIALS SCIENCE
AB A group of multicomponent Ti-Cu-Ni(Cr, Fe, Co)-Sn-Ta(Nb) alloys were investigated in terms of the microstructure and the mechanical properties. A composite microstructure with a micrometer-sized dendritic bcc-beta-Ti(RM) (RM = Nb, Ta) phase dispersed in a matrix was obtained. The TEM observation on the Ti60Cu14Ni12Sn4Ta10 alloy shows that the matrix is composed of a nano/ultrafine bcc-phase with the size of 50-100 nm which is isolated by a tetragonal-phase. The designed Ti alloy exhibit very high yield strength (1050-1472 MPa) and relative lower Young's modulus (67-105 GPa). Such combined properties, not easily achievable in previous Ti alloys, make these new designed Ti alloys promising candidates as biomedical materials.
C1 Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan.
RP He, G (reprint author), Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan.
CR Eckert J, 2003, MATER TRANS, V44, P1999, DOI 10.2320/matertrans.44.1999
   GLEITER H, 1992, ADV MATER, V4, P474, DOI 10.1002/adma.19920040704
   GRIMME P, 1992, METALLURGY, V46, P365
   HALL EO, 1951, P PHYS SOC LOND B, V64, P747, DOI 10.1088/0370-1301/64/9/303
   He G, 2003, BIOMATERIALS, V24, P5115, DOI 10.1016/S0142-9612(03)00440-X
   He G, 2003, ACTA MATER, V51, P5223, DOI [10.1016/S1359-6454(03)00386-0, 10.1016/s1359-6454(03000386-0]
   He G, 2002, J MATER RES, V17, P3015, DOI 10.1557/JMR.2002.0439
   He G, 2003, NAT MATER, V2, P33, DOI 10.1038/nmat792
   INOUE A, 1995, MATER T JIM, V36, P866, DOI 10.2320/matertrans1989.36.866
   Lee BH, 2003, BIOMATERIALS, V24, P2257, DOI 10.1016/S0142-9612(03)00034-6
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   MASSALSKI TB, 1992, BINARY ALLOY PHASE D, P1485
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Noort R. V, 1987, J MATER SCI, V22, P3801, DOI DOI 10.1007/BF01133326
   PETCH NJ, 1953, J IRON STEEL I, V174, P25
   Valiev R, 2002, NATURE, V419, P887, DOI 10.1038/419887a
NR 17
TC 8
Z9 8
U1 0
U2 3
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD APR
PY 2004
VL 45
IS 4
BP 1120
EP 1123
DI 10.2320/matertrans.45.1120
PG 4
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 819KX
UT WOS:000221314900026
OA Bronze
DA 2018-10-19
ER

PT J
AU Bram, M
   Laptev, A
   Buchkremer, HP
   Stover, D
AF Bram, M
   Laptev, A
   Buchkremer, HP
   Stover, D
TI Near-net-shape manufacturing of highly porous titanium parts for
   biomedical applications
SO MATERIALWISSENSCHAFT UND WERKSTOFFTECHNIK
LA English
DT Article
DE titanium; porous; implant; green machining; near-net-shape
ID STAINLESS-STEEL
AB The production of highly porous titanium parts is attractive for biomedical applications. Preferrentially, these parts are produced by powdermetallurgical means using suitable spacer materials. Porosities up to 75 % and well defined pore sizes in the range of 0.1 to 2.0 mm. are achieved adjusting the amount and the particle size of the spacer material. Up to now, near-net-shape manufacturing of highly porous parts was hindered by the plastic deformation of the sintered network during machining leading to a partial or complete closing of the open porosity. A new manufacturing route is presented, where the shaping is already done in the unsintered state starting from pressed compacts. The stability of the compacts was found to be sufficient to machine the compacts without additional binders. The manufacturing route was successfully applied to the prototype of an acetabular cup. Additionally, some investigations are presented characterizing the highly porous titanium.
C1 Forschungszentrum Julich GmbH, Inst Werkstoffe & Verfahren Energietech 1, D-52425 Julich, Germany.
RP Bram, M (reprint author), Forschungszentrum Julich GmbH, Inst Werkstoffe & Verfahren Energietech 1, Postfach 1913, D-52425 Julich, Germany.
EM m.bram@fz-juelich.de
OI Laptev, Alexander/0000-0001-9077-5747; Bram, Martin/0000-0002-1203-2777
CR [Anonymous], 1999, 58322 ISO
   ASHMAN A, 1977, J PROSTHET DENT, V37, P657, DOI 10.1016/0022-3913(77)90216-5
   Bram M, 2000, ADV ENG MATER, V2, P196, DOI 10.1002/(SICI)1527-2648(200004)2:4<196::AID-ADEM196>3.0.CO;2-K
   Bram M, 2000, MATERIALWISS WERKST, V31, P497, DOI 10.1002/1521-4052(200006)31:6<497::AID-MAWE497>3.3.CO;2-O
   BRAM M, 2001, CELLULAR METALS MATA, P215
   BREME J, 1996, TITAN TITANLEGIERUNG, P205
   KAMPMANN C, 2003, ADV ENG MATER, V5, P441
   LI JP, 2003, P BIOCERAMICS 15 KEY, V240, P547
   TENCER E, 1994, BIOMECHANICS ORTHOPE, P31
   WEN CE, 2002, J MATER SCI-MATER M, V13, P412
NR 10
TC 5
Z9 5
U1 1
U2 5
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0933-5137
J9 MATERIALWISS WERKST
JI Materialwiss. Werkstofftech.
PD APR
PY 2004
VL 35
IS 4
BP 213
EP 218
DI 10.1002/mawe.200400731
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 815AQ
UT WOS:000221015600008
DA 2018-10-19
ER

PT J
AU Tadic, D
   Beckmann, F
   Donath, T
   Epple, M
AF Tadic, D
   Beckmann, F
   Donath, T
   Epple, M
TI Comparison of different methods for the preparation of porous bone
   substitution materials and structural investigations by synchrotron
   mu-computer tomography
SO MATERIALWISSENSCHAFT UND WERKSTOFFTECHNIK
LA English
DT Article
DE bone substitution materials; microtomography; synchrotron radiation;
   calcium phosphate
ID MICROTOMOGRAPHY; IMPLANTS; BIOMATERIALS; RADIATION; PHOSPHATE; INGROWTH
AB The preparation of porous biomaterials for bone substitution is an important clinical issue in current biomedical technology because the ingrowth of bone can only occur if a suitable number of sufficiently large pores is available. Different procedures are compared here: The combined chemical-thermal treatment of bovine and human cancellous bone, the calcination of bovine cancellous bone, mechanical hole-drilling, and the extraction of porogens (in this case: salt crystals). The inner structure and the porosity of all samples were studied using high-resolution synchrotron mu-computer tomography.
C1 Univ Duisberg Essen, Inst Inorgan Chem, D-45117 Essen, Germany.
   GKSS Forschungszentrum Geesthacht GmbH, Mat Res Inst, D-21494 Geesthacht, Germany.
RP Epple, M (reprint author), Univ Duisberg Essen, Inst Inorgan Chem, D-45117 Essen, Germany.
EM matthias.epple@uni-essen.de
RI Beckmann, Felix/E-1940-2016
OI Beckmann, Felix/0000-0002-2266-9173
CR Beckmann F, 1999, P SOC PHOTO-OPT INS, V3772, P179, DOI 10.1117/12.363719
   BOHNER M, 2001, EUR SPINE J, V10, P114
   Bonse U, 1996, PROG BIOPHYS MOL BIO, V65, P133, DOI 10.1016/S0079-6107(96)00011-9
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   Fajardo RJ, 2002, AM J PHYS ANTHROPOL, V118, P1, DOI 10.1002/ajpa.10086
   Fajardo RJ, 2001, AM J PHYS ANTHROPOL, V115, P327, DOI 10.1002/ajpa.1089
   Greenwald AS, 2001, J BONE JOINT SURG AM, V83A, P98, DOI 10.2106/00004623-200100022-00007
   Jaecques SVN, 2004, BIOMATERIALS, V25, P1683, DOI 10.1016/S0142-9612(03)00516-7
   LeGeros R. Z., 1991, CALCIUM PHOSPHATES O
   Schnettler R, 2003, BIOMATERIALS, V24, P4603, DOI 10.1016/S0142-9612(03)00354-5
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Tadic D, 2004, BIOMATERIALS, V25, P3335, DOI 10.1016/j.biomaterials.2003.10.007
   Tadic D, 2003, BIOMATERIALS, V24, P4565, DOI 10.1016/S0142-9612(03)00281-3
   Tadic D, 2002, BIOMATERIALS, V23, P2553, DOI 10.1016/S0142-9612(01)00390-8
   TADIC D, 2004, BIOMATERIALS, V24, P987
   Trentz OA, 2003, BIOMATERIALS, V24, P3417, DOI 10.1016/S0142-9612(03)00205-9
   Weiss P, 2003, BIOMATERIALS, V24, P4591, DOI 10.1016/S0142-9612(03)00335-1
   Zerbo IR, 2001, CLIN ORAL IMPLAN RES, V12, P379, DOI 10.1034/j.1600-0501.2001.012004379.x
NR 18
TC 26
Z9 26
U1 0
U2 3
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0933-5137
J9 MATERIALWISS WERKST
JI Materialwiss. Werkstofftech.
PD APR
PY 2004
VL 35
IS 4
BP 240
EP 244
DI 10.1002/mawe.200400730
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 815AQ
UT WOS:000221015600013
DA 2018-10-19
ER

PT J
AU Mirtaheri, P
   Grimnes, S
   Martinsen, OG
   Tonnessen, TI
AF Mirtaheri, P
   Grimnes, S
   Martinsen, OG
   Tonnessen, TI
TI A new biomedical sensor for measuring PCO2
SO PHYSIOLOGICAL MEASUREMENT
LA English
DT Article
DE biomedical sensor; ischemia; PCO2; gas measuring; conductivity
ID BIOLOGICAL-MATERIALS; ELECTRODES; ISCHEMIA; IMPEDANCE; CONDUCTIVITY;
   SURFACE
AB Measuring PCO2 (partial pressure of carbon dioxide) in an organ can enable early detection of ischemia. However, there are few clinical applicable solutions for measuring PCO2. Based upon the requirement for clinical applications, a conductivity based PCO2 sensor is proposed. A conductivity based PCO2 sensor measures conductance in an aqueous solution separated from the measured object by a gas-permeable membrane. A bridge design with two cavities is favored for such a sensor. A planar and a cylindrical macro prototype based upon the bridge design were studied. The design criteria were based on the contribution from the electrode polarization, stray capacitances, contact area with the sample and design ability to miniaturize the sensor. The cylindrical sensor is favored because of its large contact area and advantages for miniaturization. Further investigation has to be done to confirm the functionality of such a design in a miniaturized form and its clinical performance.
C1 Rikshosp Univ Hosp, Intervent Ctr, Oslo, Norway.
   Univ Oslo, Dept Phys, N-0316 Oslo, Norway.
   Rikshosp Univ Hosp, Dept Anesthesiol, Oslo, Norway.
   Rikshosp Univ Hosp, Dept Clin & Biomed Engn, Oslo, Norway.
RP Mirtaheri, P (reprint author), Rikshosp Univ Hosp, Intervent Ctr, Oslo, Norway.
RI Martinsen, Orjan/M-4459-2014
OI Martinsen, Orjan/0000-0003-1632-4352
CR Arquint P., 1994, INTEGRATED BLOOD GAS
   Baker JM, 1996, AGRON J, V88, P675, DOI 10.2134/agronj1996.00021962008800040029x
   BLACK J, 1999, BIOL PERFORMANCE MAT, P10
   Butler J., 1982, CARBON DIOXIDE EQUIL
   Cunningham R. E., 1980, DIFFUSION GASES PORO
   DETEMPLE P, 1998, MED DEVICE TECHNOL, V11, P18
   FOSTER KR, 1989, CRIT REV BIOMED ENG, V17, P25
   GEDDES LA, 1971, MED BIOL ENG, V9, P511, DOI 10.1007/BF02474708
   Goldberg W., 1997, DESIGN SOLUTIONS USI
   Grimnes S, 2000, BIOIMPEDANCE BIOELEC
   Hoffman WE, 1999, SURG NEUROL, V51, P654, DOI 10.1016/S0090-3019(99)00011-7
   HONG XJ, 1996, BLOOD GAS NEWS, V5, P3
   JACOBS P, 1995, MED BIOL ENG COMPUT, V33, P802, DOI 10.1007/BF02523012
   KEMPEN LHJ, 1975, RESPIR PHYSL, V24, P89
   KORYTA J, 1993, PRINCIPLES ELECTROCH, P29
   Kvarstein G, 2004, CRIT CARE MED, V32, P232, DOI 10.1097/01.CCM.0000104948.41544.FC
   LIS K, 1979, PFLUG ARCH EUR J PHY, V381, P289, DOI 10.1007/BF00583262
   Niggemann M, 1999, MICROSYST TECHNOL, V6, P48, DOI 10.1007/s005420050174
   NUNN JF, 1993, NUNNS APPL RESP PHYS
   ONARAL B, 1982, MED BIOL ENG COMPUT, V20, P299, DOI 10.1007/BF02442796
   RAGHEB T, 1990, MED BIOL ENG COMPUT, V28, P182, DOI 10.1007/BF02441775
   Rolfe P, 1995, Acta Anaesthesiol Scand Suppl, V104, P61
   SCHWAN HP, 1968, REV SCI INSTRUM, V39, P481, DOI 10.1063/1.1683413
   SCHWAN HP, 1968, ANN NY ACAD SCI, V148, P191, DOI 10.1111/j.1749-6632.1968.tb20349.x
   SEVERINGHAUS JW, 1958, J APPL PHYSIOL, V13, P515
   SIGGAARDANDERSEN O, 1995, ACTA ANAESTH SCAND, V39, P7, DOI 10.1111/j.1399-6576.1995.tb04250.x
   STOW RW, 1957, ARCH PHYS MED REHAB, V7, P646
   Tonnessen TI, 1996, ACTA ANAESTH SCAND, V40, P510, DOI 10.1111/j.1399-6576.1996.tb04481.x
   Tonnessen TI, 1997, ACTA ANAESTH SCAND, V41, P659
   VARLAN AR, 1997, SENSOR ACTUAT B-CHEM, V55, P309
NR 30
TC 12
Z9 12
U1 0
U2 8
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0967-3334
EI 1361-6579
J9 PHYSIOL MEAS
JI Physiol. Meas.
PD APR
PY 2004
VL 25
IS 2
BP 421
EP 436
AR PII S0967-3334(04)70867-9
DI 10.1088/0967-3334/25/2/002
PG 16
WC Biophysics; Engineering, Biomedical; Physiology
SC Biophysics; Engineering; Physiology
GA 815XM
UT WOS:000221075000004
PM 15132308
DA 2018-10-19
ER

PT J
AU Choi, HM
   Bide, M
   Phaneuf, M
   Quist, W
   Logerfo, F
AF Choi, HM
   Bide, M
   Phaneuf, M
   Quist, W
   Logerfo, F
TI Antibiotic treatment of silk to produce novel infection-resistant
   biomaterials
SO TEXTILE RESEARCH JOURNAL
LA English
DT Article
ID BOMBYX-MORI SILK; FIBROIN; TRANSITION; DACRON
AB Dye-like applications of antibiotics to silk produce infection-resistant materials for potential use in biomedical applications. Two antibiotics, doxycycline (doxy) and ciprofloxacin (cipro), are applied under a variety of conditions to silk and to silk that has previously been hydrolyzed at 40degreesC for 20, 40, and 60 minutes. FTIR spectroscopic analyses indicate that the drastically increased sorption of antibiotics by hydrolyzed silk is attributable to both chemical and conformational changes that occur with the hydrolysis. The high sorption of doxy by hydrolyzed silk does not necessarily yield a more infection-resistant material, as determined by a zone of inhibition test. Conversely, the same hydrolysis considerably increases both the sorption of cipro and the zone of inhibition of cipro-treated silk dyed at 65 and 85degreesC.
C1 Soongsil Univ, Sch Text, Seoul, South Korea.
   Univ Rhode Isl, Dept Text, Kingston, RI 02881 USA.
   Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.
RP Choi, HM (reprint author), Soongsil Univ, Sch Text, Seoul, South Korea.
EM hchoi@ssu.ac.kr
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   ASAI M, 1955, J PHYS CHEM-US, V59, P322, DOI 10.1021/j150526a011
   Benavides S, 2002, ANN PHARMACOTHER, V36, P334
   BHAT NV, 1980, J APPL POLYM SCI, V25, P921, DOI 10.1002/app.1980.070250518
   BIDE M, 1993, TEXT CHEM COLOR, V25, P15
   BIDE M, 2002, AATCC INT C EXH CHAR
   BIDE M, 2001, ACS SYM SER, V792, P125
   BOCKER R, 1980, J CHROMATOGR, V187, P439, DOI 10.1016/S0021-9673(00)80479-3
   Chen X, 2001, BIOPHYS CHEM, V89, P25, DOI 10.1016/S0301-4622(00)00213-1
   Chen X, 2001, POLYMER, V42, P9969, DOI 10.1016/S0032-3861(01)00541-9
   Erra P, 1997, TEXT RES J, V67, P397, DOI 10.1177/004051759706700602
   Fawaz F, 1997, INT J PHARM, V154, P191, DOI 10.1016/S0378-5173(97)00138-5
   FOX CL, 1986, Patent No. 4563485
   GLASBY JS, 1992, ENCY ANTIBIOTICS, P243
   GRECO RS, 1985, ARCH SURG-CHICAGO, V120, P71
   Gu JW, 2002, MAT SCI ENG C-BIO S, V20, P199, DOI 10.1016/S0928-4931(02)00033-4
   HARVEY RA, 1984, AM J SURG, V147, P205, DOI 10.1016/0002-9610(84)90089-8
   HARVEY RA, 1982, SURGERY, V92, P504
   HAVERICH A, 1992, J VASC SURG, V15, P187, DOI 10.1016/0741-5214(92)70027-I
   MAGOSHI J, 1977, J APPL POLYM SCI, V21, P2405, DOI 10.1002/app.1977.070210909
   PETERS RH, 1963, TEXTILE CHEM, V1, P302
   Robson RM, 1999, INT J BIOL MACROMOL, V24, P145, DOI 10.1016/S0141-8130(98)00081-6
   Torniainen K, 1996, INT J PHARM, V132, P53, DOI 10.1016/0378-5173(95)04332-2
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   Yuan CQ, 2001, AATCC REV, V1, P35
   Zhang YQ, 2002, BIOTECHNOL ADV, V20, P91, DOI 10.1016/S0734-9750(02)00003-4
NR 26
TC 11
Z9 11
U1 0
U2 1
PU TEXTILE RESEARCH INST
PI PRINCETON
PA PO BOX 625, PRINCETON, NJ 08540 USA
SN 0040-5175
J9 TEXT RES J
JI Text. Res. J.
PD APR
PY 2004
VL 74
IS 4
BP 333
EP 342
DI 10.1177/004051750407400409
PG 10
WC Materials Science, Textiles
SC Materials Science
GA 810WH
UT WOS:000220733900009
DA 2018-10-19
ER

PT J
AU Loir, AS
   Garrelie, F
   Donnet, C
   Belin, M
   Forest, B
   Rogemond, F
   Laporte, P
AF Loir, AS
   Garrelie, F
   Donnet, C
   Belin, M
   Forest, B
   Rogemond, F
   Laporte, P
TI Deposition of tetrahedral diamond-like carbon thin films by femtosecond
   laser ablation for applications of hip joints
SO THIN SOLID FILMS
LA English
DT Article; Proceedings Paper
CT EMRS 2003 Spring Conference
CY JUN 10-11, 2003
CL Strasbourg, FRANCE
DE diamond-like carbon (DLC); pulsed laser deposition (PLD); 316L stainless
   steel; Hip joints
ID AMORPHOUS-CARBON; NANOCRYSTALLINE DIAMOND; MECHANICAL-PROPERTIES;
   COATINGS; ADHESION
AB Tetrahedral diamond-like carbon films (ta-C) were deposited by femtosecond pulsed laser deposition (PLD) on various substrates, including 316L stainless steel and ultra high molecular weight polyethylene, in perspective to extend the wear resistance of materials used in hip joints. Usually films are deposited by plasma enhanced chemical vapor deposition or by PLD, principally performed with laser pulse duration in the nanosecond range. In the present study, DLC films were deposited by femtosecond laser ablation in high vacuum conditions at room temperature. The 800 nm, 150 fs laser pulses are generated by a mode-locked Ti:Sapphire laser, including an amplification stage. The fluence ranges from 1 to 6 J/cm(2). Sputter cleaning of the substrates in an argon atmosphere prior carbon deposition was widely investigated; the adhesion of the films onto the stainless steel substrates was then considerably enhanced by removing the contamination and oxidized top-coats. The adhesion properties of films deposited in various conditions on 316L stainless steel substrates were studied by tensile tests. The films exhibit high wear resistance (in the 10(-8) mm(3) N-1 m(-1) range) with moderate hardness (in the 20-30 GPa range), which may be favorable for the accommodation motion between contacting surfaces in a hip joint. The capacity of these films to satisfy the biomedical demand is discussed. (C) 2003 Elsevier B.V. All rights reserved.
C1 Univ St Etienne, CNRS, UMR 5516, Lab Traitement Signal & Instrumentat, F-42000 St Etienne, France.
   Ecole Cent Lyon, CNRS, UMR 5513, Lab Tirbol & Dynam Syst, F-69134 Ecully, France.
   Ecole Natl Super Mines, Dept Mecan Phys & Interfaces, CNRS, URA 84,Ctr Sci Mat & Struct, F-42023 St Etienne, France.
RP Loir, AS (reprint author), Univ St Etienne, CNRS, UMR 5516, Lab Traitement Signal & Instrumentat, 10 Rue Barrouis,Batiment F, F-42000 St Etienne, France.
EM anne.sophie.loir@univ-st-etienne.fr
RI LOIR, Anne-Sophie/J-4041-2012
OI LOIR, Anne-Sophie/0000-0001-9169-1545
CR Bonelli M, 2000, EUROPHYS LETT, V50, P501, DOI 10.1209/epl/i2000-00297-5
   Bulir J, 1997, THIN SOLID FILMS, V292, P318, DOI 10.1016/S0040-6090(96)08951-1
   Chrisey D., 1994, PULSED LASER DEPOSIT
   Garrelie F, 2003, SURF COAT TECH, V163, P306, DOI 10.1016/S0257-8972(02)00481-4
   Garrelie F, 2002, PROC SPIE, V4760, P301, DOI 10.1117/12.482098
   Grill A, 2003, DIAM RELAT MATER, V12, P166, DOI 10.1016/S0925-9635(03)00018-9
   Hou QR, 1999, APPL PHYS A-MATER, V68, P343, DOI 10.1007/s003390050900
   Loir AS, 2003, APPL SURF SCI, V208, P553, DOI 10.1016/S0169-4332(02)01380-6
   Matsuyama N, 2001, J APPL PHYS, V89, P1938, DOI 10.1063/1.1334640
   Morshed MM, 2003, SURF COAT TECH, V174, P579, DOI 10.1016/S0257-8972(03)00701-1
   Morshed MM, 2003, SURF COAT TECH, V163, P541, DOI 10.1016/S0257-8972(02)00619-9
   NEMANICH RJ, 1988, J VAC SCI TECHNOL A, V6, P1783, DOI 10.1116/1.575297
   PAPPAS DL, 1992, J APPL PHYS, V71, P5675, DOI 10.1063/1.350501
   Podgornik B, 2001, DIAM RELAT MATER, V10, P2232, DOI 10.1016/S0925-9635(01)00514-3
   Robertson J, 2002, MAT SCI ENG R, V37, P129, DOI 10.1016/S0927-796X(02)00005-0
   Schwan J, 1996, J APPL PHYS, V79, P1416, DOI 10.1063/1.360979
   Sharda T, 2001, DIAM RELAT MATER, V10, P1592, DOI 10.1016/S0925-9635(01)00415-0
   Sharma AK, 2000, MAT SCI ENG B-SOLID, V77, P139, DOI 10.1016/S0921-5107(00)00434-7
   SHI X, 1997, PHILOS MAG B, V76, P351
   Shim KS, 2000, APPL SURF SCI, V154, P482, DOI 10.1016/S0169-4332(99)00401-8
   STAMBOULI V, 1990, SURF COAT TECH, V43-4, P137, DOI 10.1016/0257-8972(90)90068-N
   Tiainen VM, 2001, DIAM RELAT MATER, V10, P153, DOI 10.1016/S0925-9635(00)00462-3
   Tsui YY, 2000, SURF COAT TECH, V126, P96, DOI 10.1016/S0257-8972(99)00642-8
   Voevodin AA, 1996, SURF COAT TECH, V82, P199, DOI 10.1016/0257-8972(95)02734-3
   Wei Q, 2001, SURF COAT TECH, V146, P250, DOI 10.1016/S0257-8972(01)01394-9
NR 25
TC 22
Z9 24
U1 0
U2 8
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0040-6090
J9 THIN SOLID FILMS
JI Thin Solid Films
PD APR 1
PY 2004
VL 453
SI SI
BP 531
EP 536
DI 10.1016/j.tsf.2003.11.135
PG 6
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 807ON
UT WOS:000220510900101
DA 2018-10-19
ER

PT J
AU Lewin, PA
AF Lewin, PA
TI Quo vadis medical ultrasound?
SO ULTRASONICS
LA English
DT Article; Proceedings Paper
CT Ultrasonics International 2003 Meetng
CY JUN 30-JUL 03, 2003
CL Granada, SPAIN
DE ultrasound imaging; diagnostic and therapeutic ultrasound; biomedical
   ultrasonics; ultrasound imaging transducers
ID FOCUSED ULTRASOUND; RADIATION FORCE; FLOW; ELASTOGRAPHY
AB The last three decades of development in diagnostic ultrasound imaging and technology are briefly reviewed and the impact of the crucial link between the two apparently independent research efforts, which eventually facilitated implementation of harmonic imaging modality is explored. These two efforts included the experiments with piezoelectric PVDF polymer material and studies of the interaction between ultrasound energy and biological tissue. Harmonic imaging and its subsequent improvements revolutionized the diagnostic power of clinical ultrasound and brought along images of unparalleled resolution, close to that of magnetic resonance imaging (MRI) quality. The nonlinear propagation effects and their implications for both diagnostic and therapeutic applications of ultrasound are also briefly addressed. In diagnostic applications, the impact of these effects on image resolution and tissue characterization is reviewed; in therapeutic applications, the influence of nonlinear propagation effects on highly localized tissue ablation and cauterization is examined. Next, the most likely developments and future trends in clinical ultrasound technology, including 3D and 4D imaging, distant palpation, image enhancement using contrast agents, monitoring, and merger of diagnostic and therapeutic applications by e.g. introducing ultrasonically controlled targeted drug delivery are reviewed. Finally, a possible competition from other imaging modalities is discussed. (C) 2004 Elsevier B.V. All rights reserved.
C1 Drexel Univ, Sch Biomed Engn, Sci & Hlth Syst, Philadelphia, PA 19104 USA.
   Drexel Univ, Sch Biomed Engn, Dept Elect & Comp Engn, Philadelphia, PA 19104 USA.
RP Lewin, PA (reprint author), Drexel Univ, Sch Biomed Engn, Sci & Hlth Syst, 3141 Chestnut St,MS Biomed 7-727, Philadelphia, PA 19104 USA.
EM lewin@ece.drexel.edu
CR Bao SP, 1998, CANCER RES, V58, P219
   Behar V, 2003, ULTRASONICS, V41, P377, DOI [10.1016/S0041-624X(03)00105-7, 10.1016/S0041-642X(03)00105-7]
   Behar V, 2003, ULTRASONICS, V41, P385, DOI 10.1016/S0041-642X(03)00106-9
   BIBIBRA H, 1999, ECHOCARDIOGR-J CARD, V16, P733
   Cherin E, 1998, ULTRASOUND MED BIOL, V24, P341, DOI 10.1016/S0301-5629(97)00289-5
   ENTREKIN R, 1999, MEDICA MUNDI, V43
   Fatemi M, 1999, ULTRASONIC IMAGING, V21, P147, DOI 10.1177/016173469902100205
   Fenster A, 1996, IEEE ENG MED BIOL, V15, P41, DOI 10.1109/51.544511
   Fleischer AC, 2000, J ULTRAS MED, V19, P55, DOI 10.7863/jum.2000.19.1.55
   Forsberg F, 2000, ULTRASONICS, V38, P110, DOI 10.1016/S0041-624X(99)00149-3
   FORSBERG F, 1996, ULTRASONOGRAPHY
   Foster FS, 2000, IEEE T ULTRASON FERR, V47, P1363, DOI 10.1109/58.883525
   FOWLES JB, 2000, CATEGORICAL COURSE D
   Gavrilov LR, 1996, ULTRASOUND MED BIOL, V22, P179, DOI 10.1016/0301-5629(96)83782-3
   Haider B, 1998, IEEE T ULTRASON FERR, V45, P98, DOI 10.1109/58.646915
   Jensen JA, 1998, IEEE T ULTRASON FERR, V45, P837, DOI 10.1109/58.677749
   Jin XC, 2001, IEEE T ULTRASON FERR, V48, P750, DOI 10.1109/58.920706
   Jordan WD, 1999, CARDIOVASC SURG, V7, P33, DOI 10.1016/S0967-2109(98)00097-0
   Knapik DA, 2000, IEEE T ULTRASON FERR, V47, P1540, DOI 10.1109/58.883543
   Konofagou E, 2001, PHYS MED BIOL, V46, P2967, DOI 10.1088/0031-9155/46/11/314
   Kruse D, 2000, ULTRASOUND MED BIOL, V26, pS16, DOI 10.1016/S0301-5629(00)00154-X
   Nelson TR, 1998, ULTRASOUND MED BIOL, V24, P1243, DOI 10.1016/S0301-5629(98)00043-X
   Nightingale KR, 2001, J ACOUST SOC AM, V110, P625, DOI 10.1121/1.1378344
   ODONNELL M, 1992, IEEE T ULTRASON FERR, V39, P341, DOI 10.1109/58.143168
   Ophir J, 1999, P I MECH ENG H, V213, P203, DOI 10.1243/0954411991534933
   Sarvazyan AP, 1998, ULTRASOUND MED BIOL, V24, P1419, DOI 10.1016/S0301-5629(98)00110-0
   Silverman RH, 2001, J ULTRAS MED, V20, P979
   ter Haar G, 2000, ULTRASOUND MED BIOL, V26, pS51, DOI 10.1016/S0301-5629(00)00164-2
   Varghese T, 1998, IEEE T ULTRASON FERR, V45, P65, DOI 10.1109/58.646912
   VILKOMMERSON DL, 1999, IEEE ULTRASONICS S E, V1459, P1464
   Wei K, 2001, J AM COLL CARDIOL, V37, P1135, DOI 10.1016/S0735-1097(00)01210-9
   NEWS MAGAZINES MEDIC
   NEWS MAGAZINES
   2000, ULTRASOUND MED BIOL, V26, pS1
NR 34
TC 21
Z9 22
U1 1
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0041-624X
J9 ULTRASONICS
JI Ultrasonics
PD APR
PY 2004
VL 42
IS 1-9
BP 1
EP 7
DI 10.1016/j.ultras.2004.01.077
PG 7
WC Acoustics; Radiology, Nuclear Medicine & Medical Imaging
SC Acoustics; Radiology, Nuclear Medicine & Medical Imaging
GA 812DP
UT WOS:000220820500002
PM 15047254
DA 2018-10-19
ER

PT J
AU van Nostrum, CF
   Veldhuis, TFJ
   Bos, GW
   Hennink, WE
AF van Nostrum, CF
   Veldhuis, TFJ
   Bos, GW
   Hennink, WE
TI Tuning the degradation rate of poly(2-hydroxypropyl
   methacrylamide)-graft-oligo(lactic acid) stereocomplex hydrogels
SO MACROMOLECULES
LA English
DT Article
ID GRAFT-COPOLYMERS; BIOMEDICAL APPLICATIONS; RADICAL POLYMERIZATION;
   TRIBLOCK-COPOLYMERS; STEREO-COMPLEXATION; STRUCTURAL CONTROL; DEXTRAN
   HYDROGELS; POLY(L-LACTIDE); OLIGOMERS; DESIGN
AB The degradation time of stereocomplex hydrogels based on poly(2-hydroxypropyl methacrylamide) (pHPMAm) with oligo(lactic acid) side chains of opposite chirality can be tailored from approximately 1 week to almost 3 months under physiological conditions by adjusting the grafting density and the side chain terminus. The polymers were prepared by free radical copolymerization of HPDAAmoligo(lactic acid) macromonomers and HPMAm. The viscoelasticity and degradation time of hydrogels formed by mixing aqueous solutions of two polymers containing side chains of opposite chirality increased with increasing grafting density. Gels based on polymers with side chains having acetyl chain ends degraded slower than those containing hydroxyl-terminating side chains, because of a change in the hydrolysis mechanism from slow random chain scission to more rapid chain end scission (backbiting), respectively. The ease of preparation and the possibility of tuning the degradation rate over a wide range make these pHPMAm-based hydrogels ideal materials for the controlled release of, e.g., therapeutic proteins.
C1 Univ Utrecht, Dept Pharmaceut, Utreat Inst Pharmaceut Sci, NL-3508 TB Utrecht, Netherlands.
RP van Nostrum, CF (reprint author), Univ Utrecht, Dept Pharmaceut, Utreat Inst Pharmaceut Sci, POB 80082, NL-3508 TB Utrecht, Netherlands.
EM C.F.vanNostrum@pharm.uu.nl
RI van Nostrum, Cornelus/I-9445-2016
CR de Jong SJ, 2000, MACROMOLECULES, V33, P3680, DOI 10.1021/ma992067g
   de Jong SJ, 2002, J APPL POLYM SCI, V86, P289, DOI 10.1002/app.10954
   de Jong SJ, 2001, POLYMER, V42, P2795, DOI 10.1016/S0032-3861(00)00646-7
   de Jong SJ, 2001, J CONTROL RELEASE, V71, P261, DOI 10.1016/S0168-3659(01)00228-0
   de Jong SJ, 1998, MACROMOLECULES, V31, P6397, DOI 10.1021/ma980553i
   Eguiburu JL, 1996, POLYMER, V37, P3615, DOI 10.1016/0032-3861(96)00184-X
   Fujiwara T, 2001, MACROMOL BIOSCI, V1, P204, DOI 10.1002/1616-5195(20010701)1:5<204::AID-MABI204>3.3.CO;2-8
   Grijpma DW, 2001, J CONTROL RELEASE, V72, P247
   Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/S0169-409X(01)00240-X
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   IKADA Y, 1987, MACROMOLECULES, V20, P904, DOI 10.1021/ma00170a034
   Kopecek J, 2000, EUR J PHARM BIOPHARM, V50, P61, DOI 10.1016/S0939-6411(00)00075-8
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lim DW, 2000, J APPL POLYM SCI, V75, P1615, DOI 10.1002/(SICI)1097-4628(20000328)75:13<1615::AID-APP7>3.0.CO;2-L
   Lim DW, 2000, MACROMOL RAPID COMM, V21, P464, DOI 10.1002/(SICI)1521-3927(20000501)21:8<464::AID-MARC464>3.0.CO;2-#
   Neradovic D, 2001, MACROMOLECULES, V34, P7589, DOI 10.1021/ma011198q
   OKIHARA T, 1991, J MACROMOL SCI PHYS, VB30, P119, DOI 10.1080/00222349108245788
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   Shinoda H, 2001, MACROMOLECULES, V34, P6243, DOI 10.1021/ma0105791
   Shinoda H, 2001, MACROMOLECULES, V34, P3186, DOI 10.1021/ma001943j
   Slager J, 2003, ADV DRUG DELIVER REV, V55, P549, DOI 10.1016/S0169-409X(03)00042-5
   VANNOSTRUM CF, UNPUB
   VANNOSTRUM CF, 2003, ACS S SERIES, V846
NR 23
TC 19
Z9 19
U1 1
U2 11
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD MAR 23
PY 2004
VL 37
IS 6
BP 2113
EP 2118
DI 10.1021/ma035534+
PG 6
WC Polymer Science
SC Polymer Science
GA 804GY
UT WOS:000220288400019
DA 2018-10-19
ER

PT J
AU van der Walt, TN
   Vermeulen, C
AF van der Walt, TN
   Vermeulen, C
TI Thick targets for the production of some radionuclides and the chemical
   processing of these targets at iThemba LABS
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS
   SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT
LA English
DT Article; Proceedings Paper
CT 21st World Conference of the
   International-Nuclear-Target-Development-Society
CY NOV 04-08, 2002
CL Argonne, IL
SP Int Nuclear Target Dev Soc
DE cyclotron; radionuclides; ion exchange chromatography; PET;
   radiopharmaceuticals
AB iThemba Laboratory for Accelerated Based Sciences is a multi-disciplinary research centre, operated by the National Research Foundation. It provides national accelerator and ancillary facilities for research and training in physical, biomedical, chemical and material sciences, research in, and the treatment of, cancer with energetic neutrons and protons. Radionuclides are produced for use in research and industry, and to prepare various radiopharmaceuticals for diagnostic imaging at nuclear medicine centers. (C) 2004 Elsevier B.V. All rights reserved.
C1 IThemba LABS, ZA-71290 Somerset W, South Africa.
RP van der Walt, TN (reprint author), IThemba LABS, POB 722, ZA-71290 Somerset W, South Africa.
EM nico@tlabs.ac.za; etienne@tlabs.ac.za
RI Vermeulen, Christiaan/C-5059-2013
OI Vermeulen, Christiaan/0000-0002-6723-8983
CR du Raan H, 2000, MED PHYS, V27, P1523, DOI 10.1118/1.599018
   Fassbender M, 1999, RADIOCHIM ACTA, V87, P87
   HAASBROEK FJ, 1991, SYNTHESIS APPL ISOTO
   Kastleiner S, 2002, APPL RADIAT ISOTOPES, V56, P685, DOI 10.1016/S0969-8043(01)00267-6
   NAIDOO C, 2002, J RADIOANAL CHEM, V2, P221
   NAIDOO C, 2001, APPL RADIAT ISOTOPES, P1
   NORTIER FM, 1991, SYNTHESIS APPL ISOTO
   Phillips DR, 2000, RADIOCHIM ACTA, V88, P149, DOI 10.1524/ract.2000.88.3-4.149
   STEYN GF, 1992, NUCL INSTRUM METH A, V316, P128, DOI 10.1016/0168-9002(92)90894-A
   VANDERWALT TN, 1994, SYNTHESIS APPL ISOTO
NR 10
TC 8
Z9 8
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-9002
J9 NUCL INSTRUM METH A
JI Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc.
   Equip.
PD MAR 21
PY 2004
VL 521
IS 1
BP 171
EP 175
DI 10.1016/j.nima.2003.11.410
PG 5
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Nuclear; Physics, Particles & Fields
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA 808UG
UT WOS:000220593400022
DA 2018-10-19
ER

PT J
AU Tanaka, M
   Mochizuki, A
AF Tanaka, M
   Mochizuki, A
TI Effect of water structure on blood compatibility - thermal analysis of
   water in poly(meth)acrylate
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE blood compatible materials; poly(2-methoxyethyl acrylate); water
   structure; freezing bound water; cold crystallization
ID SELF-ASSEMBLED MONOLAYERS; PROTEIN ADSORPTION; CARDIOPULMONARY BYPASS;
   POLY(2-METHOXYETHYLACRYLATE) PMEA; BIOMEDICAL APPLICATIONS; IR
   SPECTROSCOPY; POLYMER; SURFACE; RESISTANCE; SOLVATION
AB The purpose of this study is to clarify the main factor causing excellent blood compatibility of poly(2-methoxyethyl acrylate)(PMEA) by the comparison between PMEA and seven PMEA analogous polymers. The polymers have a typical functional group as ester side chains such as methoxyethyl, hydroxyethyl, phenoxyethyl, and alkyl groups. The properties of the polymers relating to water were investigated in terms of contact angle, equilibrium water content (EWC), and thermal analysis by differential scanning calorimetry. The water in PMEA could be classified into three types: nonfreezing water, freezing bound water, and free water while the water in the analogous polymers was classified into just two types: free and nonfreezing waters, regardless of the chemical structure of the side chain. The surface property represented by the contact angle of water corresponded to the content of the bound water (nonfreezing water + freezing bound water). The platelet compatibility in vitro did not depend on the contents of these waters, or on the contact angle. On the basis of the results of this work and the previous work on the platelet compatibility of poly(MEA-co-HEMA) (Tanaka et al. Biomacromolecules 2002;3;36-41), the main factor causing the excellent compatibility of PMEA is discussed. (C) 2004 Wiley Periodicals, Inc.
C1 Hokkaido Univ, Res Inst Elect Sci, Mol Device Lab, Kita Ku, Sapporo, Hokkaido 0600812, Japan.
   JST, PRESTO, Sapporo, Hokkaido 0600812, Japan.
   Terumo Co Ltd, Kofu Factory, Yamanashi 4093853, Japan.
RP Tanaka, M (reprint author), Hokkaido Univ, Res Inst Elect Sci, Mol Device Lab, Kita Ku, N12W6, Sapporo, Hokkaido 0600812, Japan.
EM tanaka@poly.es.hokudai.ac.jp
OI Mochizuki, Akira/0000-0001-8104-7764; Tanaka, Masaru/0000-0002-1115-2080
CR ANDRADE JD, 1973, T AM SOC ART INT ORG, V19, P1
   Anzai T., 2000, JPN J ARTIF ORGANS, V29, P73
   Bajpai AK, 2002, J BIOMAT SCI-POLYM E, V13, P237, DOI 10.1163/156856202320176501
   BAYKUT D, 2001, EUR J MED RES, V30, P297
   BRUCK SD, 1973, J BIOMED MATER RES, V7, P387, DOI 10.1002/jbm.820070503
   De Bartolo L, 2002, BIOMATERIALS, V23, P2485, DOI 10.1016/S0142-9612(01)00383-0
   Feldman K, 1999, J AM CHEM SOC, V121, P10134, DOI 10.1021/ja991049b
   Gracia C, 1980, T AM SOC INTERN ORGA, V26, P294
   Greenfield Benjamin L, 2002, J Extra Corpor Technol, V34, P267
   Harris J. M., 1992, POLYETHYLENE GLYCOL
   HAZLEWOO.CF, 1969, NATURE, V222, P747, DOI 10.1038/222747a0
   HORBETT TA, 1995, ACS S SERIES, V302
   Ichikawa K, 2001, J POLYM SCI POL PHYS, V39, P2175, DOI 10.1002/polb.1191
   Ide M, 2003, LANGMUIR, V19, P429, DOI 10.1021/1a020617p
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   Israelachvili J, 1996, NATURE, V379, P219, DOI 10.1038/379219a0
   Iwasaki Y, 2000, J BIOMED MATER RES, V52, P701, DOI 10.1002/1097-4636(20001215)52:4<701::AID-JBM15>3.3.CO;2-Y
   Kataoka K, 1998, J BIOMAT SCI-POLYM E, V9, P111, DOI 10.1163/156856298X00460
   Kitano H, 2001, J COLLOID INTERF SCI, V242, P133, DOI 10.1006/jcis.2001.7785
   KUNTZ ID, 1969, SCIENCE, V163, P1329, DOI 10.1126/science.163.3873.1329
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   LINDON JN, 1986, BLOOD, V68, P355
   LING GN, 1983, PHYSIOL CHEM PHYS M, V15, P407
   LU DR, 1991, J BIOMAT SCI-POLYM E, V3, P127, DOI 10.1163/156856291X00232
   MORI Y, 1982, T AM SOC ART INT ORG, V28, P459
   Morra M, 2001, WATER BIOMATERIAL SU
   Mueller XM, 2002, INT J ARTIF ORGANS, V25, P223
   OKANO T, 1981, J BIOMED MATER RES, V15, P393, DOI 10.1002/jbm.820150310
   Pal SK, 2002, P NATL ACAD SCI USA, V99, P1763, DOI 10.1073/pnas.042697899
   PEPPAS NA, 1987, HYDROGEL MED PHARM, V2
   RATHNER BD, 2000, J BIOMAT SCI-POLYM E, V11, P1107
   Ratner BD, 1979, J POLYM SCI POLYM S, V66, P363
   Rubens FD, 2002, J BIOMAT SCI-POLYM E, V13, P485, DOI 10.1163/156856202320253974
   Saito N, 2000, ARTIF ORGANS, V24, P547, DOI 10.1046/j.1525-1594.2000.06520.x
   Schwendel D, 2001, LANGMUIR, V17, P5717, DOI 10.1021/la010576h
   Sefton MV, 2000, J BIOMAT SCI-POLYM E, V11, P1165
   Severian D., 2002, POLYM BIOMATERIALS
   Suhara H, 2001, ANN THORAC SURG, V71, P1603, DOI 10.1016/S0003-4975(01)02466-3
   Tanaka M, 2000, POLYM INT, V49, P1709, DOI 10.1002/1097-0126(200012)49:12<1709::AID-PI601>3.0.CO;2-L
   Tanaka M, 2000, BIOMATERIALS, V21, P1471, DOI 10.1016/S0142-9612(00)00031-4
   Tanaka M., 2000, Japanese Journal of Artificial Organs, V29, P209
   Tanaka M, 2002, BIOMACROMOLECULES, V3, P36, DOI 10.1021/bm010072y
   Tanaka M, 2002, COLLOID SURFACE A, V203, P195, DOI 10.1016/S0927-7757(01)01100-1
   Tanaka M, 2001, COLLOID SURFACE A, V193, P145, DOI 10.1016/S0927-7757(01)00682-3
   Tsuruta T, 1996, ADV POLYM SCI, V126, P1
   UEDAIRA H, 1980, WATER METAL CATIONS, P47
   Vogler EA, 1999, J BIOMAT SCI-POLYM E, V10, P1015, DOI 10.1163/156856299X00667
   Wang RLC, 1997, J PHYS CHEM B, V101, P9767, DOI 10.1021/jp9716952
   Wolfgang G. G., 1992, ACS S SERIES, V489
   YAMADANOSAKA A, 1990, J APPL POLYM SCI, V39, P2443, DOI 10.1002/app.1990.070391117
NR 50
TC 109
Z9 109
U1 2
U2 32
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN 0021-9304
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR 15
PY 2004
VL 68A
IS 4
BP 684
EP 695
DI 10.1002/jbm.a.20088
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 779CG
UT WOS:000189277600009
PM 14986323
DA 2018-10-19
ER

PT J
AU Ding, B
   Kimura, E
   Sato, T
   Fujita, S
   Shiratori, S
AF Ding, B
   Kimura, E
   Sato, T
   Fujita, S
   Shiratori, S
TI Fabrication of blend biodegradable nanofibrous nonwoven mats via
   multi-jet electrospinning
SO POLYMER
LA English
DT Article
DE multi-jet electrospinning; blend nanofibrous mats; dispersibility
ID CELLULOSE-ACETATE; BENDING INSTABILITY; POLYMER NANOFIBERS; FIBER MATS;
   MORPHOLOGY; MEMBRANES; BEHAVIOR
AB A series of blend biodegradable nanofibrous mats comprising poly(vinyl alcohol) (PVA) and cellulose acetate (CA) were prepared via multi-jet electrospinning. A relative high voltage (20 kV) was used to supply the power for multi-jet electrospinning. The weight ratio of PVA/CA in blend nanofibrous mats can be controlled by changing the number ratio of jets of PVA/CA. Moreover, the real composition of PVA and CA in blend nanofibrous mats was determined by immersing the blend nanofibrous mats into water to remove the PVA component. Morphology, dispersibility, and mechanical properties of blend nanofibrous mats were examined by field emission scanning electron microscopy (FE-SEM), Fourier transform infrared (FT-IR) spectroscopy, wide-angle X-ray diffraction (WAXD), and tensile test. The results showed that the blend nanofibrous mats have good dispersibility. Additionally, the mechanical properties of blend nanofibrous mats were largely influenced by the weight ratio of PVA/CA in blends. Potential applications of the blend nanofibrous mats include filters and biomedical materials. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Keio Univ, Grad Sch Sci & Technol, Yokohama, Kanagawa 2238522, Japan.
   Shiratori Nanotechnol Co Ltd, Kawasaki, Kanagawa 2120054, Japan.
RP Shiratori, S (reprint author), Keio Univ, Grad Sch Sci & Technol, Yokohama, Kanagawa 2238522, Japan.
EM binding@appi.keio.ac.jp; shiratori@appi.keio.ac.jp
RI Shiratori, Seimei/B-7882-2015
CR Deitzel JM, 2001, POLYMER, V42, P261, DOI 10.1016/S0032-3861(00)00250-0
   Ding B, 2002, J POLYM SCI POL PHYS, V40, P1261, DOI 10.1002/polb.10191
   Ding B, 2003, NANOTECHNOLOGY, V14, P532, DOI 10.1088/0957-4484/14/5/309
   Dror Y, 2003, LANGMUIR, V19, P7012, DOI 10.1021/la034234i
   Gupta P, 2003, POLYMER, V44, P6353, DOI 10.1016/S0032-3861(03)00616-5
   HE CH, 2003, J POLYM DEGRAD STAB, V81, P117
   Kenawy ER, 2002, J CONTROL RELEASE, V81, P57, DOI 10.1016/S0168-3659(02)00041-X
   Ko F, 2003, ADV MATER, V15, P1161, DOI 10.1002/adma.200304955
   Lee KH, 2003, J POLYM SCI POL PHYS, V41, P1256, DOI 10.1002/polb.10482
   Liu HQ, 2002, J POLYM SCI POL PHYS, V40, P2119, DOI 10.1002/polb.10261
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   Norris ID, 2000, SYNTHETIC MET, V114, P109, DOI 10.1016/S0379-6779(00)00217-4
   Reneker DH, 2000, J APPL PHYS, V87, P4531, DOI 10.1063/1.373532
   Reneker DH, 1996, NANOTECHNOLOGY, V7, P216, DOI 10.1088/0957-4484/7/3/009
   Ryu JH, 2001, CHEM-EUR J, V7, P1525, DOI 10.1002/1521-3765(20010401)7:7<1525::AID-CHEM1525>3.0.CO;2-U
   Schreuder-Gibson H, 2002, J ADV MATER-COVINA, V34, P44
   Shao CL, 2003, MATER LETT, V57, P1579, DOI 10.1016/S0167-577X(02)01036-4
   Shin YM, 2001, POLYMER, V42, P9955, DOI 10.1016/S0032-3861(01)00540-7
   Sun ZC, 2003, ADV MATER, V15, P1929, DOI 10.1002/adma.200305136
   Theron A, 2001, NANOTECHNOLOGY, V12, P384, DOI 10.1088/0957-4484/12/3/329
   Tsai PP, 2002, J ELECTROSTAT, V54, P333, DOI 10.1016/S0304-3886(01)00160-7
   Wang XY, 2002, NANO LETT, V2, P1273, DOI 10.1021/nl020216u
   Yarin AL, 2001, J APPL PHYS, V89, P3018, DOI 10.1063/1.1333035
   Yu YH, 2003, POLYMER, V44, P3553, DOI 10.1016/S0032-3861(03)00062-4
   Zhou Q, 2003, POLYMER, V44, P1733, DOI 10.1016/S0032-3861(02)00748-6
NR 25
TC 263
Z9 275
U1 9
U2 142
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
J9 POLYMER
JI Polymer
PD MAR 15
PY 2004
VL 45
IS 6
BP 1895
EP 1902
DI 10.1016/j.polymer.2004.01.026
PG 8
WC Polymer Science
SC Polymer Science
GA 777ZQ
UT WOS:000189214700019
DA 2018-10-19
ER

PT J
AU Chatterjee, J
   Haik, Y
   Chen, CJ
AF Chatterjee, J
   Haik, Y
   Chen, CJ
TI pH-reversible magnetic gel with a biodegradable polymer
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE magnetic polymers; gels; biodegradable; nanocomposites
ID DRUG DELIVERY
AB Polymer gels that react to external stimuli, such as pH, temperature, and electromagnetic fields, are an important class of materials. Such materials have pharmaceutical, industrial, and biomedical applications. Our intention in this study was to synthesize a stimuli-responsive polymer gel with a biodegradable polymer. However, the chemical crosslinker, divinyl sulfone, which is most widely used for the crosslinking of this type of material, is highly toxic in nature. To overcome this problem, a reversible magnetic gel was synthesized with hydroxy propyl cellulose (HPC) and maghemite at pH 13 without with a chemical crosslinker. With a decrease in pH from 13 to 9, the gel formed a homogeneous dispersion of HPC particles with maghemite in it. This process was a reversible physical gelation where the crosslinks of the network had a physical origin (in this case, hydrogen bonding) and, therefore, were sensitive to variations in pH. When this physically prepared gel was compared with the chemically crosslinked one, no significant differences in structural properties were noted. At higher pH values, the gel was formed due to weak intermolecular hydrogen bonding, as observed by the broadening of the IR band in both the magnetic and nonmagnetic gels. Transmission electron micrographs also showed no significant difference in the gel morphology. Differential scanning calorimetry showed an increase in melting temperature for the gel sample compared to that of pure HPC. (C) 2004 Wiley Periodicals, Inc.
C1 Florida A&M Univ Florida State Univ Coll Engn, Biomagnet Engn Lab, Tallahassee, FL 32310 USA.
RP Haik, Y (reprint author), Florida A&M Univ Florida State Univ Coll Engn, Biomagnet Engn Lab, 2525 Pottsdamer St, Tallahassee, FL 32310 USA.
EM haik@eng.fsu.edu
CR BRONSTED H, 1992, ACS SYM SER, P285
   CHATTERJEE J, IN PRESS J MAG MAGN
   CHATTERJEE J, 2002, INT C PART ORL FL AP
   DONG LC, 1990, J CONTROL RELEASE, V13, P21, DOI 10.1016/0168-3659(90)90071-Z
   DONG LC, 1991, J CONTROL RELEASE, V15, P141, DOI 10.1016/0168-3659(91)90072-L
   GUTOWSKA A, 1994, MACROMOLECULES, V27, P4167, DOI 10.1021/ma00093a018
   HOFFMAN A S, 1986, Journal of Controlled Release, V4, P213
   Holtz JH, 1997, NATURE, V389, P829
   KISHI R, 1991, POLYMER GELS, P205
   OKANO T, 1991, POLYMER GELS, P299
   Roland B., 1991, CARBOHYD POLYM, V16, P399
   Sebti I, 2002, CARBOHYD POLYM, V49, P139, DOI 10.1016/S0144-8617(01)00315-0
   Shojaei A H, 1998, J Pharm Pharm Sci, V1, P15
   SOCRATES G, 1980, INFRARED CHARACTERIS, P46
   TANAKA T, 1982, SCIENCE, V218, P467, DOI 10.1126/science.218.4571.467
   Zrinyi M, 1997, POLYM GELS NETW, V5, P415, DOI 10.1016/S0966-7822(97)00010-5
NR 16
TC 14
Z9 16
U1 0
U2 16
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD MAR 5
PY 2004
VL 91
IS 5
BP 3337
EP 3341
DI 10.1002/app.13545
PG 5
WC Polymer Science
SC Polymer Science
GA 770DR
UT WOS:000188708400073
DA 2018-10-19
ER

PT J
AU DeLongchamp, DM
   Hammond, PT
AF DeLongchamp, DM
   Hammond, PT
TI High-contrast electrochromism and controllable dissolution of assembled
   Prussian blue/polymer nanocomposites
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
ID MIXED-VALENCE HEXACYANIDES; LAYER POLYMER-FILMS; THIN-FILMS; METAL
   HEXACYANOFERRATE; MULTILAYER CAPSULES; MODIFIED ELECTRODES; BLUE;
   OXIDATION; POLYANILINE; REDUCTION
AB To maintain the momentum and impact of the field, assembled materials systems must increasingly incorporate broad functionality ality to meet real-world applications. Here we describe nanocomposite films of specially synthesized inorganic Prussian blue (PB) (PB) nanoparticles and linear poly(ethylene imine) (LPEI) that possess the unusual functional combination of high-performance electrochromism for displays and controllable dissolution for drug delivery. Fabrication using layer-by-layer (LBL) assembly was followed by spectroelectrochemical characterization, allowing a full composition determination rarely achieved for LBL films. The electrochromic performance of thick LPEI/PB nanocomposites most relevant to applications surpassed that or inorganic PB films with competitive switching speed and superior contrast. Oxidation beyond the primary electrochromic transition removes nanoparticle ionization and can controllably dissolve the films. Because PB is non-toxic we suggest this mechanism for controlled in-vivo drug delivery. The performance and multifunctional quality of these nanocomposites promise a strong impact on flexible displays, electrochromic windows, and even biomedical devices.
C1 MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
   NIST, Elect Mat Grp, Div Polymers, Gaithersburg, MD 20899 USA.
RP DeLongchamp, DM (reprint author), MIT, Dept Chem Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
EM hammond@mit.edu
CR Antipov AA, 2001, J PHYS CHEM B, V105, P2281, DOI 10.1021/jp002184+
   Bharathi S, 2001, LANGMUIR, V17, P7468, DOI 10.1021/la011053c
   BUSER HJ, 1977, INORG CHEM, V16, P2704, DOI 10.1021/ic50177a008
   CARPENTER MK, 1990, J ELECTROCHEM SOC, V137, P2464, DOI 10.1149/1.2086962
   Caruso F, 2000, LANGMUIR, V16, P1485, DOI 10.1021/la991161n
   Chen SM, 2002, J ELECTROANAL CHEM, V521, P29, DOI 10.1016/S0022-0728(02)00677-0
   Cho J, 2003, MACROMOLECULES, V36, P2845, DOI 10.1021/ma021049n
   Dagani R, 2003, CHEM ENG NEWS, V81, P25, DOI 10.1021/cen-v081n001.p025
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   DeLongchamp D, 2001, ADV MATER, V13, P1455, DOI 10.1002/1521-4095(200110)13:19<1455::AID-ADMA1455>3.0.CO;2-7
   DeLongchamp DM, 2003, CHEM MATER, V15, P1165, DOI 10.1021/cm020945a
   DeLongchamp DM, 2003, CHEM MATER, V15, P1575, DOI 10.1021/cm021045x
   DELONGCHAMP DM, 2003, POLYM PREPR AM CHEM, V44, P649
   Dubas ST, 2001, J AM CHEM SOC, V123, P5368, DOI 10.1021/ja015774+
   DUEK EAR, 1993, ADV MATER, V5, P650, DOI 10.1002/adma.19930050912
   ELLIS D, 1981, J PHYS CHEM-US, V85, P1225, DOI 10.1021/j150609a026
   FERLAY S, 1995, NATURE, V378, P701, DOI 10.1038/378701a0
   Garjonyte R, 2000, BIOSENS BIOELECTRON, V15, P445, DOI 10.1016/S0956-5663(00)00101-9
   HABIB MA, 1992, J ELECTROCHEM SOC, V139, P2155, DOI 10.1149/1.2221194
   HABIB MA, 1991, J APPL ELECTROCHEM, V21, P203, DOI 10.1007/BF01052571
   ITAYA K, 1982, J APPL PHYS, V53, P804, DOI 10.1063/1.329997
   Jaiswal A, 2003, J COLLOID INTERF SCI, V261, P330, DOI 10.1016/S0021-9797(03)00054-7
   JELLE BP, 1993, ELECTROCHIM ACTA, V38, P1497, DOI 10.1016/0013-4686(93)80281-4
   Kulesza PJ, 2001, ELECTROCHIM ACTA, V46, P4065, DOI 10.1016/S0013-4686(01)00687-9
   Li JP, 2002, CHINESE J CHEM, V20, P1038
   LIN C, 1991, J ELECTROANAL CHEM, V300, P325, DOI 10.1016/0022-0728(91)85403-C
   Millward RC, 2001, CHEM COMMUN, P1994, DOI 10.1039/b106616c
   Monk P.M.S., 1995, ELECTROCHROMISM FUND
   Moriguchi I, 2002, CHEM LETT, P310, DOI 10.1246/cl.2002.310
   Mortimer RJ, 1997, CHEM SOC REV, V26, P147, DOI 10.1039/cs9972600147
   NEFF VD, 1978, J ELECTROCHEM SOC, V125, P886, DOI 10.1149/1.2131575
   PEARCE J, 1994, FOOD CHEM TOXICOL, V32, P577, DOI 10.1016/0278-6915(94)90116-3
   PEERCE PJ, 1980, J ELECTROANAL CHEM, V114, P89, DOI 10.1016/S0022-0728(80)80438-4
   Pyrasch M, 2001, LANGMUIR, V17, P7706, DOI 10.1021/la0104424
   RAJAN KP, 1982, J PHYS CHEM-US, V86, P4361, DOI 10.1021/j100219a017
   Ravaine S, 1998, LANGMUIR, V14, P6347, DOI 10.1021/la9808014
   ROBIN MB, 1962, INORG CHEM, V1, P337, DOI 10.1021/ic50002a028
   Santini JT, 1999, NATURE, V397, P335
   Sato O, 1996, SCIENCE, V271, P49, DOI 10.1126/science.271.5245.49
   Somani PR, 2003, MATER CHEM PHYS, V77, P117, DOI 10.1016/S0254-0584(01)00575-2
   Sukhishvili SA, 2002, MACROMOLECULES, V35, P301, DOI 10.1021/ma011346c
   Vazquez E, 2002, J AM CHEM SOC, V124, P13992, DOI 10.1021/ja026405w
   Vittal R, 1999, J ELECTROCHEM SOC, V146, P786, DOI 10.1149/1.1391682
   Zhou DM, 1996, J ELECTROANAL CHEM, V408, P219, DOI 10.1016/0022-0728(95)04522-8
NR 44
TC 254
Z9 257
U1 21
U2 184
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-301X
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD MAR
PY 2004
VL 14
IS 3
BP 224
EP 232
DI 10.1002/adfm.200304507
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 807KS
UT WOS:000220501000003
DA 2018-10-19
ER

PT J
AU Adar, E
AF Adar, E
TI SaRAD: a simple and robust abbreviation dictionary
SO BIOINFORMATICS
LA English
DT Article
ID ARTICLES; GENE
AB Motivation: Due to recent interest in the use of textual material to augment traditional experiments it has become necessary to automatically cluster, classify and filter natural language information.
   Results: The Simple and Robust Abbreviation Dictionary (SaRAD) provides an easy to implement, high performance tool for the construction of a biomedical symbol dictionary. The algorithms, applied to the MEDLINE document set, result in a high quality dictionary and toolset to disambiguate abbreviation symbols automatically.
C1 HP Labs, Palo Alto, CA 94304 USA.
RP Adar, E (reprint author), HP Labs, 1501 Page Mill Rd, Palo Alto, CA 94304 USA.
EM eytan@hpl.hp.com
CR Adamic LA, 2002, CSB2002: IEEE COMPUTER SOCIETY BIOINFORMATICS CONFERENCE, P109, DOI 10.1109/CSB.2002.1039334
   BAEZAYATES R, 1999, MODERN INFORMATION R
   Blaschke C, 1999, Proc Int Conf Intell Syst Mol Biol, P60
   BOWDEN PR, COMPUTERM 98, P43
   BOWDEN PR, 1999, AUTOMATIC GLOSSARY C
   BOWDEN PR, 2000, 17 INT C ENGL LANG R
   CHANG JS, 2001, P 3 INT S NONTH PLAS, P274
   Chang JT, 2002, J AM MED INFORM ASSN, V9, P612, DOI 10.1197/jamia.M1139
   CHANG JT, NLP BIOINFORMATICS
   Fuchs P, 2002, AUDIOL NEURO-OTOL, V7, P40, DOI 10.1159/000046862
   GUSFIELD D, 1997, ALGORITHMS STRINGS T, P227
   Jenssen TK, 2001, NAT GENET, V28, P21, DOI 10.1038/88213
   Krauthammer M, 2000, GENE, V259, P245, DOI 10.1016/S0378-1119(00)00431-5
   LARKEY LS, 2000, P 5 ACM INT C DIG LI, P205
   LIU H, 2002, P AM MED INF ASS S 2
   PARK Y, 2001, P 2001 C EMP METH NA
   PORTER MF, 1980, PROGRAM-AUTOM LIBR, V14, P130, DOI 10.1108/eb046814
   Pustejovsky J, 2001, MEDINFO, V10, P371
   SCHWARTZ AS, 2003, P 2003 PAC S BIOC
   TAGHVA K, 1995, 9503 TR U NEV
   Yandell MD, 2002, NAT REV GENET, V3, P601, DOI 10.1038/nrg861
   YEATES S, 2000, DAT COMPR C, P582
   YEATES S, 1999, P 3 NZ COMP SCI RES, P117
   Yoshida M, 2000, BIOINFORMATICS, V16, P169, DOI 10.1093/bioinformatics/16.2.169
   Yu H, 2002, J AM MED INFORM ASSN, V9, P262, DOI 10.1197/jamia.M0913
NR 25
TC 25
Z9 28
U1 0
U2 3
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1367-4803
EI 1460-2059
J9 BIOINFORMATICS
JI Bioinformatics
PD MAR 1
PY 2004
VL 20
IS 4
BP 527
EP 533
DI 10.1093/bioinformatics/btg439
PG 7
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Computer Science, Interdisciplinary Applications; Mathematical &
   Computational Biology; Statistics & Probability
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Computer Science; Mathematical & Computational Biology; Mathematics
GA 800WQ
UT WOS:000220058800011
PM 14990448
OA Bronze
DA 2018-10-19
ER

PT J
AU Juhasz, JA
   Best, SM
   Brooks, R
   Kawashita, M
   Miyata, N
   Kokubo, T
   Nakamura, T
   Bonfield, W
AF Juhasz, JA
   Best, SM
   Brooks, R
   Kawashita, M
   Miyata, N
   Kokubo, T
   Nakamura, T
   Bonfield, W
TI Mechanical properties of glass-ceramic A-W-polyethylene composites:
   effect of filler content and particle size
SO BIOMATERIALS
LA English
DT Article
DE composite; polyethylene; glass-ceramic; mechanical properties
ID HYDROXYAPATITE REINFORCED POLYETHYLENE; APATITE
AB Composites which comprise a bioactive filler and ductile polymer matrix are desirable as implant materials since both their biological and mechanical properties can be tailored for a given application. In the present study three-point bending was used to characterise biomedical materials composed of glass-ceramic apatite-wollastonite (A-W) particulate reinforced polyethylene (PE) (denoted as AWPEX). The effects of filler volume fraction, varied from 10 to 50 vol%, and average particle size, 4.4 and 6.7 mum, on the bending strength, yield strength, mode of fracture, Young's modulus and strain to failure were investigated. HAPEX(TM), a commercially used composite of hydroxyapatite and polyethylene, with a 40 vol% filler content, was used for comparison. Increasing the filler content caused an increase in Young's modulus, yield strength and bending strength, and a decreased strain to failure. When filler particle size was increased, the Young's modulus, yield and bending strengths were found to be slightly reduced. A transition in fracture behaviour from ductile to brittle behaviour was observed in samples containing between 30 and 40 vol% filler. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Cambridge, Dept Mat Sci & Met, Cambridge CB2 3QZ, England.
   Addenbrookes Hosp, Orthopaed Res Unit, Cambridge CB2 2QQ, England.
   Kyoto Univ, Grad Sch Engn, Dept Chem Mat, Kyoto 6068501, Japan.
   Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Kyoto 6068501, Japan.
RP Juhasz, JA (reprint author), Univ Cambridge, Dept Mat Sci & Met, Pembroke St, Cambridge CB2 3QZ, England.
RI Kawashita, Masakazu/E-6632-2016
OI Kawashita, Masakazu/0000-0002-4329-9001
CR Altman DG, 1991, PRACTICAL STAT MED R
   Bonfield W, 1988, Ann N Y Acad Sci, V523, P173, DOI 10.1111/j.1749-6632.1988.tb38510.x
   BONFIELD W, 1988, COMPSITES MED APPL E, P17
   BONFIELD W, 1984, Patent No. 2085461
   BONFIELD W, 1986, BIOL BIOMECHANICAL P, P153
   Bonfield W., 1991, US Patent, Patent No. 5017627
   Dowling N. E., 1993, MECH BEHAV MAT ENG M, P570
   FRIEDRICH K, 1981, J MATER SCI, V16, P2167, DOI 10.1007/BF00542377
   HENCH LL, 1982, BIOMATERIALS INTER 4, P62
   HUANG YL, 1988, J MATER SCI, V23, P2348
   KOKUBO T, 1991, BIOMATERIALS, V12, P155, DOI 10.1016/0142-9612(91)90194-F
   KOKUBO T, 1985, J MATER SCI, V20, P2001, DOI 10.1007/BF01112282
   Kokubo T., 1982, Bulletin of the Institute for Chemical Research, Kyoto University, V60, P260
   KOKUBO T, 1987, J MATER SCI, V22, P4067, DOI 10.1007/BF01133359
   LIU DM, 1994, J MATER SCI-MATER M, V5, P7, DOI 10.1007/BF00121146
   NAKAMURA T, 1985, J BIOMED MATER RES, V19, P685, DOI 10.1002/jbm.820190608
   Nazhat SN, 2000, J MATER SCI-MATER M, V11, P621, DOI 10.1023/A:1008957729512
   Okuno K., 1974, J CELL PLAST, V10, P237
   Ravaglioli A, 1989, BIOCERAMICS, V1, P13
   TANNER KE, 1994, BRIT CERAM T, V93, P104
   Wang M, 1998, BIOMATERIALS, V19, P2357, DOI 10.1016/S0142-9612(98)00154-9
   WANG M, 1994, BRIT CERAM T, V93, P91
   Wang M., 1996, BIOCERAMICS, V9, P387
   WANG M, 1997, BIOCERAMICS, V10, P15
   YAMAMURO T, 1995, BIOCERAMICS, V8, P123
   YAMAMURO T, 1990, HDB BIOACTIVE CERAMI, V1, P335
   YAMAMURO T, 1993, INTRO BIOCERAMICS, P89
NR 27
TC 79
Z9 83
U1 1
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2004
VL 25
IS 6
BP 949
EP 955
DI 10.1016/j.biomaterials.2003.07.005
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 748GF
UT WOS:000186853600001
PM 14615158
DA 2018-10-19
ER

PT J
AU Jones, DS
   Garvin, CP
   Gorman, SP
AF Jones, DS
   Garvin, CP
   Gorman, SP
TI Relationship between biomedical catheter surface properties and
   lubricity as determined using textural analysis and multiple regression
   analysis
SO BIOMATERIALS
LA English
DT Article
DE lubricity; catheters; dynamic contact angle analysis; microrugosity;
   textural analysis; agar; multiple regression
ID IN-VITRO; FRICTION; ADHESION; DEVICES; ENERGY
AB In this study, the surface properties of and work required to remove 12 commercially available and developmental catheters from a model biological medium (agar), a measure of catheter lubricity, were characterised and the relationships between these properties were examined using multiple regression and correlation analysis. The work required for removal of catheter sections (7 cm) from a model biological medium (1% w/w agar) were examined using tensile analysis. The water wettability of the catheters were characterised using dynamic contact angle analysis, whereas surface roughness was determined using atomic force microscopy. Significant differences in the ease of removal were observed between the various catheters, with the silicone-based materials generally exhibiting the greatest ease of removal. Similarly, the catheters exhibited a range of advancing and receding contact angles that were dependent on the chemical nature of each catheter. Finally, whilst the microrugosities of the various catheters differed, no specific relationship to the chemical nature of the biomaterial was apparent. Using multiple regression analysis, the relationship between ease of removal, receding contact angle and surface roughness was defined as: Work done (N mm) 17.18 + 0.055 Rugosity (nm)-0.52 Receding contact angle (degrees) (r = 0.49). Interestingly, whilst the relationship between ease of removal and surface roughness was significant (r = 0.48, p = 0.0005), in which catheter lubricity increased as the surface roughness decreased, this was not the case with the relationship between ease of removal and receding contact angle (r = -0.18, p > 0.05). This study has therefore uniquely defined the contributions of each of these surface properties to catheter lubricity. Accordingly, in the design of urethral catheters. it is recommended that due consideration should be directed towards biomaterial surface roughness to ensure maximal ease of catheter removal. Furthermore, using the method described in this study, differences in the lubricity of the various catheters were observed that may be apparent in their clinical use. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Queens Univ Belfast, Sch Pharm, Ctr Med Biol, Med Devices Unit, Belfast BT9 7BL, Antrim, North Ireland.
RP Jones, DS (reprint author), Queens Univ Belfast, Sch Pharm, Ctr Med Biol, Med Devices Unit, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.
CR AKADA Y, 1993, LUBRICATING POLYM SU
   Andrade J. D., 1985, SURFACE INTERFACIAL, P249
   COX AJ, 1987, BIOMATERIALS, V8, P500, DOI 10.1016/0142-9612(87)90089-5
   FERREIROS CM, 1989, FEMS MICROBIOL LETT, V60, P89, DOI 10.1016/0378-1097(89)90083-9
   GOLD P, 1985, Patent No. 4534363
   Gorman SP, 1997, BIOMATERIALS, V18, P1379, DOI 10.1016/S0142-9612(97)00070-7
   GORMAN SP, 1993, J MED MICROBIOL, V38, P411, DOI 10.1099/00222615-38-6-411
   Gorman SP, 2003, MED IMPLICATIONS BIO, P136
   GROSCH KA, 1963, PROC R SOC LON SER-A, V274, P21, DOI 10.1098/rspa.1963.0112
   HEILMAN MS, 1978, Patent No. 4080706
   Jones DS, 1997, BIOMATERIALS, V18, P503, DOI 10.1016/S0142-9612(96)00170-6
   Jones DS, 1997, PHARMACEUT RES, V14, P450, DOI 10.1023/A:1012091231023
   Jones DS, 2001, J MATER SCI-MATER M, V12, P15, DOI 10.1023/A:1026744732504
   KiremitciGumusderelioglu M, 1996, BIOMATERIALS, V17, P443, DOI 10.1016/0142-9612(96)89662-1
   LAPORTE RJ, 1997, HYDROPHILLIC POLYM C
   Marmieri G, 1996, J BIOMED MATER RES, V33, P29, DOI 10.1002/(SICI)1097-4636(199621)33:1<29::AID-JBM5>3.3.CO;2-M
   McGovern JG, 1997, INT J PHARM, V149, P251, DOI 10.1016/S0378-5173(97)04883-7
   NAGAOKA S, 1990, BIOMATERIALS, V11, P419, DOI 10.1016/0142-9612(90)90098-B
   Polderman KH, 2002, INTENS CARE MED, V28, P1, DOI 10.1007/s00134-001-1154-9
   Pomfret I J, 1996, Br J Nurs, V5, P245
   RAMSAY JWA, 1986, BRIT J UROL, V58, P70, DOI 10.1111/j.1464-410X.1986.tb05431.x
   Rosen M, 1992, HDB PERCUTANEOUS CEN
   Tunney MM, 1999, METHOD ENZYMOL, V310, P558
   UYAMA Y, 1991, BIOMATERIALS, V12, P71, DOI 10.1016/0142-9612(91)90135-W
   WEERKAMP AH, 1988, J DENT RES, V67, P1483, DOI 10.1177/00220345880670120801
NR 25
TC 24
Z9 26
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAR-APR
PY 2004
VL 25
IS 7-8
BP 1421
EP 1428
DI 10.1016/j.biomaterials.2003.08.01
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 753PJ
UT WOS:000187239500031
PM 14643617
DA 2018-10-19
ER

PT J
AU Coyle, F
AF Coyle, F
TI 'Safe space' as counter-space: women, environmental illness and
   'corporeal chaos'
SO CANADIAN GEOGRAPHER-GEOGRAPHE CANADIEN
LA English
DT Review
ID MULTIPLE CHEMICAL SENSITIVITIES; MEDICAL GEOGRAPHY; THERAPEUTIC
   LANDSCAPES; CASE-DEFINITION; PLACE; BODY; HEALTH; FEAR; POLITICS;
   INVITATION
AB Women constitute a disproportionate 80 percent of people diagnosed with environmental illness (El), a contentious condition in which patients react adversely to everyday chemicals in the environment at levels politically conceived to be 'safe'. Whilst the diverse range of somatic symptoms constitutes a biomedical anomaly, in this paper I present an alternative means of conceiving environmentally ill bodies. Women (and environmental health practitioners at the Environmental Health Centre, Nova Scotia) have begun to view their bodies as complex systems that have been nudged into a state of 'corporeal chaos, in which minute quantities of chemicals trigger disproportionate somatic symptoms. This chaos extends into 'corporeal space' [Moss and Dyck (1999a)] as the diagnosis of environmental illness is experienced simultaneously through both material and discursive bodies. This diagnosis also carries with it a means to mitigate corporeal chaos through a series of body- and environment-based modifications that replace risky bodies with 'safe space'. As a discursive construct, safe space is associated with an absence of chemicals, and in order to mitigate chaos, should ideally be stable, predictable, controllable and communicative. I finalise this paper with some examples of body modifications and illustrate how safe space materialises in the home environment.
C1 Lincoln Univ, Agribusiness & Econ Res Unit, Canterbury, New Zealand.
RP Coyle, F (reprint author), Lincoln Univ, Agribusiness & Econ Res Unit, POB 84, Canterbury, New Zealand.
EM leadora2000@yahoo.com
OI Coyle, Fiona/0000-0002-8000-3636
CR APRR H, 1995, MAPPING SUBJECT GEOG, P199
   ASHFORD NA, 1992, NATL RES COUNCIL MUL
   Bankey R., 2001, GENDER PLACE CULT, V8, P37
   Baxter J., 1999, GEOGR ANN B, V81, P91, DOI DOI 10.1111/J.0435-3684.1999.00051.X
   BELL IR, 1992, BIOL PSYCHIAT, V32, P218, DOI 10.1016/0006-3223(92)90105-9
   Bondi L, 2003, ENVIRON PLANN A, V35, P853, DOI 10.1068/a35135
   BRIGGS J, 1989, TURBULENT MIRROR
   BUCHWALD D, 1994, ARCH INTERN MED, V154, P2049, DOI 10.1001/archinte.154.18.2049
   BUTLER R, 1999, MIND BODY SPACES GEO
   Chouinard V, 1999, EMBODIED GEOGRAPHIES, P142
   Coveney P., 1995, FRONTIERS COMPLEXITY
   Cox J. Charles, 1911, SANCTUARIES SANCTUAR
   COYLE FJ, 2002, THESIS CARLETON U OT
   Crawford C., 1994, NO SAFE PLACE LEGACY
   CULLEN MR, 1992, TOXICOL IND HEALTH, V8, P15
   CULLEN MR, 1987, OCCUPATIONAL MED STA, V2, P656
   CULLEN MR, 1992, PUBLIC HLTH PREVENTI, P459
   Davidson J, 2000, AREA, V32, P31, DOI 10.1111/j.1475-4762.2000.tb00112.x
   Davidson J, 2000, SOCIOL HEALTH ILL, V22, P640, DOI 10.1111/1467-9566.00224
   Davidson J, 2001, GENDER PLACE CULT, V8, P283, DOI 10.1080/09663690120067357
   DORN M, 1994, PROF GEOGR, V46, P106, DOI 10.1111/j.0033-0124.1994.00106.x
   DOUGLAS M, 1965, PURITY DANGER
   DUNN C, 1996, SOC SCI MED, V40, P307
   DYCK I, 1995, SOC SCI MED, V40, P307, DOI 10.1016/0277-9536(94)E0091-6
   DYCK I, 1998, PUTTING HLTH PLACE L
   Dyck I, 1999, MIND BODY SPACES GEO, P119
   ECALMER P, 1997, MISTREATMENT ELDERLY
   EYLES J, 1993, HEALTH PLACE, V1, P5
   Eyles J, 1997, HEALTH PLACE, V3, P1, DOI 10.1016/S1353-8292(96)00031-7
   Galey K., 1995, INT REV VICTIMOLOGY, V4, P63
   Garvin T, 2001, SOC SCI MED, V53, P1175, DOI 10.1016/S0277-9536(00)00418-4
   Gesler W. M., 1998, PUTTING HLTH PLACE L, P17
   GESLER WM, 1992, SOC SCI MED, V34, P735, DOI 10.1016/0277-9536(92)90360-3
   GESLER WM, 1993, ENVIRON PLANN D, V11, P171, DOI 10.1068/d110171
   GIBSON P, 1993, WOMEN THER, V14, P171
   Gibson PR, 1998, RES NURS HEALTH, V21, P103, DOI 10.1002/(SICI)1098-240X(199804)21:2<103::AID-NUR2>3.0.CO;2-N
   Gibson PR, 1997, FEM PSYCHOL, V7, P475, DOI 10.1177/0959353597074003
   Giddens A, 1990, CONSEQUENCES MODERNI
   GOLD SJ, 1991, VISUAL SOCIOLOGY, V6, P9
   Grosz Elizabeth, 1995, SPACE TIME PERVERSIO
   GUBERMAN C, 1985, NO SAFE PLACE VIOLEN
   Harper D, 1988, AM SOCIOL, V19, P54, DOI DOI 10.1007/BF02692374
   Havens L. L, 1989, SAFE PLACE LAYING GR
   Hayles N. Katherine, 1991, CHAOS ORDER COMPLEX
   Hayles N. Katherine, 1990, CHAOS BOUND
   HEUSER C, 1992, MULTIPLE CHEM SENSIT
   Kearns G., 1998, PUTTING HLTH PLACE L, P36
   KEARNS RA, 1994, PROF GEOGR, V46, P111, DOI 10.1111/j.0033-0124.1994.00111.x
   KEARNS RA, 1993, SOC SCI MED, V37, P711, DOI 10.1016/0277-9536(93)90364-A
   KEARNS RA, 1995, PROG HUM GEOG, V19, P251, DOI 10.1177/030913259501900206
   KEARNS RA, 1993, PROF GEOGR, V45, P139, DOI 10.1111/j.0033-0124.1993.00139.x
   KIPEN H, 1992, TOXICOL IND HEALTH, V8, P125
   Koskela H, 2000, GEOFORUM, V31, P269, DOI 10.1016/S0016-7185(99)00033-0
   Kroll-Smith S., 1997, BODIES PROTEST ENV I
   KROLLSMITH S, 1993, SOCIOL SPECTRUM, V13, P7, DOI 10.1080/02732173.1993.9982015
   Lyon M, 1997, BODY SOC, V3, P83, DOI [10.1177/1357034X97003001006, DOI 10.1177/1357034X97003001006]
   MACLEOD L, 1989, CITY WOMEN NO SAFE P
   MARTIN E, 1990, MED ANTHROPOL Q, V4, P410, DOI 10.1525/maq.1990.4.4.02a00030
   MARTIN E, 1999, REVISIONING WOMEN HL
   Martin E, 1994, FLEXIBLE BODIES TRAC
   MARTIN E, 1998, MAKING REALITY NATUR
   MEGGS WJ, 1993, ENVIRON HEALTH PERSP, V101, P234, DOI 10.2307/3431548
   MEISSNER SJ, 1998, PSYCHOANALYSIS CONT, V21, P113
   MILNE C, 1999, GLOBE MAIL HLTH S
   Moeller D., 1992, ENV HLTH
   MORROW L, 1993, STREETCAR NAMED DESI
   Moss P, 1996, ENVIRON PLANN D, V14, P737, DOI 10.1068/d140737
   Moss P, 1997, SOC SCI MED, V45, P23, DOI 10.1016/S0277-9536(96)00305-X
   Moss P., 1999, ANTIPODE, V31, P372, DOI DOI 10.1111/1467-8330.00110
   MOSS P, 1999, EMBODIED GEOGRAPHIES, P157
   Murphy M, 2000, CONFIGURATIONS, V8, P87
   NETHERCOTT JR, 1993, ARCH ENVIRON HEALTH, V48, P19, DOI 10.1080/00039896.1993.9938389
   Norman Jr W. R., 1991, VISUAL ANTHR, V4, P193
   *NRC, 1992, MULT CHEM SENS ADD B, V6
   Pain R, 2002, GEOFORUM, V33, P105, DOI 10.1016/S0016-7185(01)00025-2
   Pain R, 2000, PROG HUM GEOG, V24, P365, DOI 10.1191/030913200701540474
   Pain R. H., 1995, NO EC REV, V24, P96
   Pain RH, 1997, T I BRIT GEOGR, V22, P231
   Parr H, 1998, AREA, V30, P28, DOI 10.1111/j.1475-4762.1998.tb00045.x
   Parr H, 1999, ENVIRON PLANN D, V17, P673, DOI 10.1068/d170673
   PARR H, 1999, MIND BODY SPACES GEO
   PAULSEN M, 1993, UTNE READER, P81
   PROSSER J, 1998, IMAGE BASED RES SOUR, P60
   Prosser Jon, 1996, VISUAL SOCIOLOGY, V11, P25, DOI DOI 10.1080/14725869608583763
   RANDOLPH TG, 1965, ANN ALLERGY, V23, P11
   Randolph TG, 1962, HUMAN ECOLOGY SUSCEP, p148pp
   REA WJ, 1992, CHEM SENSITIVITY, V1
   ROGERS SA, 1990, TIRED TOXIC BLUEPRIN
   Shriver TE, 1998, SOCIOL INQ, V68, P458, DOI 10.1111/j.1475-682X.1998.tb00480.x
   Sibley D., 1995, GEOGRAPHIES EXCLUSIO
   Snyder E. E., 1990, Journal of Sport Management, V4, P21
   SPARKS PJ, 1994, J OCCUP ENVIRON MED, V36, P718
   Thrift N, 1999, THEOR CULT SOC, V16, P31, DOI 10.1177/02632769922050610
   TOMOKO K, 1998, CREATING SAFE SPACE
   Valentine G, 1997, J RURAL STUD, V13, P137, DOI 10.1016/S0743-0167(97)83094-X
   Valentine Gill, 1995, MAPPING DESIRE GEOGR
   VANLOON J, 1998, APOCALYPSE SPACE CUL, V2, P127
   Wakefield S, 2000, SOC SCI MED, V50, P1139, DOI 10.1016/S0277-9536(99)00361-5
   Wakefield SEL, 2001, HEALTH PLACE, V7, P163, DOI 10.1016/S1353-8292(01)00006-5
   WIELANDBURSTON J, 1992, CHAOS ORDER WORLD PY
   Williams A, 1998, SOC SCI MED, V46, P1193, DOI 10.1016/S0277-9536(97)10048-X
   Winnicott D. W., 1971, PLAYING REALITY
NR 102
TC 11
Z9 11
U1 0
U2 7
PU CANADIAN ASSN GEOGRAPHERS
PI MONTREAL
PA MCGILL UNIV, BURNSIDE HALL, 805 SHERBROKKE ST., WEST, MONTREAL, QUEBEC
   H3A 2K6, CANADA
SN 0008-3658
J9 CAN GEOGR-GEOGR CAN
JI Can. Geogr.-Geogr. Can.
PD SPR
PY 2004
VL 48
IS 1
BP 62
EP 75
DI 10.1111/j.1085-9489.2004.01e08.x
PG 14
WC Geography
SC Geography
GA 779VN
UT WOS:000189322400006
DA 2018-10-19
ER

PT J
AU Vlad, S
AF Vlad, S
TI Hydrolytic stability of some thermoplastic poly(ether-urethane-urea)s
SO HIGH PERFORMANCE POLYMERS
LA English
DT Article
DE thermoplastic poly(ether-urethane-urea); hydrolytic stability;
   biomedical application
ID POLYURETHANE BLOCK COPOLYMERS; SEPARATION KINETICS; HEART-VALVE;
   ELASTOMERS; URETHANES; SERIES
AB Two thermoplastic poly(ether-urethane-urea)s were synthesized from isophorone diisocyanate, hexamethylene diamine, and polyethylene glycol as macrodiol. The molecular weight of the macrodiol was 2000 g mol(-1). The polymers have been characterized by means of transmission electron microscopy, H-1-NMR, infrared spectroscopy, and other techniques. The hydrolytic stability of these materials was investigated under in vitro condition using Ringer's solution and phosphate-buffered saline. The stability of these series was compared with a poly(ether-urethane) prepared from isophorone diisocyanate, polyethylene glycol and 1,4-butanediol. The in vitro study revealed possible use of poly(ether-urethane-urea)s for long-terrn biomedical applications.
C1 Inst Macromol Chem, Iasi 6600, Romania.
RP Vlad, S (reprint author), Inst Macromol Chem, Aleea Grigore Ghica Voda 41-A, Iasi 6600, Romania.
EM vladus@icmpp.tuiasi.ro
RI Vlad, Stelian/C-3430-2011
OI Vlad, Stelian/0000-0002-5895-438X
CR BERNACCA GM, 1995, BIOMATERIALS, V16, P279, DOI 10.1016/0142-9612(95)93255-C
   Bernacca GM, 1996, J HEART VALVE DIS, V5, P538
   CHANG YJP, 1975, J POLYM SCI POL PHYS, V13, P455, DOI 10.1002/pol.1975.180130302
   CHU B, 1992, MACROMOLECULES, V25, P5724, DOI 10.1021/ma00047a025
   Coury A J, 1988, J Biomater Appl, V3, P130, DOI 10.1177/088532828800300202
   FERGUSON J, 1987, EUR POLYM J, V8, P385
   HUN SL, 1989, MACROMOLECULES, V22, P1100
   KAZMIERCZAK ME, 1989, J POLYM SCI POL PHYS, V27, P2189, DOI 10.1002/polb.1989.090271103
   KAZMIERCZAK ME, 1989, J POLYM SCI POL PHYS, V27, P2173, DOI 10.1002/polb.1989.090271102
   KIM BK, 1992, COLLOID POLYM SCI, V270, P956, DOI 10.1007/BF00655964
   KOBERSTEIN JT, 1992, MACROMOLECULES, V25, P6205, DOI 10.1021/ma00049a018
   KOBERSTEIN JT, 1986, J POLYM SCI POL PHYS, V24, P2487, DOI 10.1002/polb.1986.090241107
   KOLFF WJ, 1989, ANN THORAC SURG, V48, P598
   Lelah M. D., 1986, POLYURETHANES MED, P23
   LI YJ, 1992, MACROMOLECULES, V25, P1737, DOI 10.1021/ma00032a018
   MARCONI W, 1995, BIOMATERIALS, V16, P449, DOI 10.1016/0142-9612(95)98817-X
   MARCONI W, 1994, MACROMOL CHEM PHYS, V195, P875, DOI 10.1002/macp.1994.021950306
   Mark HF, 1996, ENCY POLYM SCI TECHN, V4, P331
   PETROVIC ZS, 1991, PROG POLYM SCI, V16, P695, DOI 10.1016/0079-6700(91)90011-9
   PLANK H, 1987, POLYURETHANE BIOMEDI, P197
   Schollenberger C. S., 1971, J ELASTOPLAST, V3, P28, DOI DOI 10.1177/009524437100300103
   SREENIVASAN K, 1991, EUR POLYM J, V27, P811, DOI 10.1016/0014-3057(91)90014-F
   STOKES K, 1990, Journal of Biomaterials Science Polymer Edition, V1, P207
   Stokes K, 1987, J Biomater Appl, V1, P411
   STOKES K, 1982, BIOMATERIALS, V3, P225, DOI 10.1016/0142-9612(82)90024-2
   Stokes K B, 1988, J Biomater Appl, V3, P228, DOI 10.1177/088532828800300205
   STRIZINAR I, 1992, J BIOMED MATER RES, V26, P577
   TAKAHARA A, 1988, ARTIFICIAL HEART, V2, P1095
   VANBOGART JWC, 1981, POLYMER, V22, P1428, DOI 10.1016/0032-3861(81)90250-0
   WILKES GL, 1975, J POLYM SCI POL LETT, V13, P321, DOI 10.1002/pol.1975.130130601
NR 30
TC 4
Z9 4
U1 0
U2 5
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0954-0083
J9 HIGH PERFORM POLYM
JI High Perform. Polym.
PD MAR
PY 2004
VL 16
IS 1
BP 81
EP 88
DI 10.1177/0954008304038963
PG 8
WC Polymer Science
SC Polymer Science
GA 802QV
UT WOS:000220178900006
DA 2018-10-19
ER

PT J
AU Gupta, AK
   Wells, S
AF Gupta, AK
   Wells, S
TI Surface-modified superparamagnetic nanoparticles for drug delivery:
   Preparation, characterization, and cytotoxicity studies
SO IEEE TRANSACTIONS ON NANOBIOSCIENCE
LA English
DT Article
DE biological cells; drug delivery systems; magnetic materials;
   nanotechnology
ID MAGNETITE NANOPARTICLES; IRON-OXIDES; SIZE; SYSTEM; AGENT
AB Superparamagnetic iron oxide nanoparticles have been used for many years as magnetic resonance imaging (MRI) contrast agents or in drug delivery applications. In this study, a novel approach to prepare magnetic polymeric nanoparticles with magnetic core and polymeric shell using inverse microemulsion polymerization process is reported. Poly (ethyleneglycol) (PEG)-modified superparamagnetic iron oxide nanoparticles with specific shape and size have been prepared inside the aqueous cores of AOT/n-Hexane reverse micelles and characterized by various pbysicochemical means such as transmission electron microscopy (TEM), infrared spectroscopy, atomic force microscopy (AFM), vibrating sample magnetometry (VSM), and ultraviolet/visible spectroscopy. The inverse microemulsion polymerization of a polymerizable derivative of PEG and a cross-linking agent resulted in a stable hydrophilic polymeric shell of the nanoparticles. The results taken together from TEM and AFM studies showed that the particles are spherical in shape with core-shell structure. The average size of the PEG-modified nanoparticles was found to be around 40-50 nm with narrow size distribution. The magnetic measurement studies revealed the superparamagnetic behavior of the nanoparticles with saturation magnetization values between 45-50 electromagnetic units per gram. The cytotoxicity profile of the nanoparticles on human dermal fibroblasts as measured by standard 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay showed that the particles are nontoxic and may be useful for various in vivo and in vitro biomedical applications.
C1 Univ Glasgow, Inst Biomed & Life Sci, Ctr Cell Engn, Glasgow G12 8QQ, Lanark, Scotland.
RP Gupta, AK (reprint author), Univ Glasgow, Inst Biomed & Life Sci, Ctr Cell Engn, Glasgow G12 8QQ, Lanark, Scotland.
EM akgupta25@hotmail.com
CR AMIMJI M, 1992, BIOMATERIALS, V13, P682
   Chouly C, 1996, J MICROENCAPSUL, V13, P245, DOI 10.3109/02652049609026013
   Dresco PA, 1999, LANGMUIR, V15, P1945, DOI 10.1021/la980971g
   DUNN J, 1994, PROF ENG, V7, P10
   Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3
   Golander C. G., 1992, POLYETHYLENE GLYCOL, P221, DOI DOI 10.1007/978-1-4899-0703-5_15.
   GRANQVIST CG, 1976, J APPL PHYS, V47, P2200, DOI 10.1063/1.322870
   GUPTA PK, 1989, LIFE SCI, V44, P175, DOI 10.1016/0024-3205(89)90593-6
   HOU MJ, 1988, J COLLOID INTERF SCI, V123, P398, DOI 10.1016/0021-9797(88)90261-5
   KENT TA, 1990, MAGNET RESON MED, V13, P434, DOI 10.1002/mrm.1910130310
   Kim DK, 2001, J MAGN MAGN MATER, V225, P30, DOI 10.1016/S0304-8853(00)01224-5
   MOBE G, 1983, J COLLOID INTERF SCI, V93, P293
   Mosmann T, 1993, J IMMUNOL METHODS, V95, P55
   Munshi N, 1997, J COLLOID INTERF SCI, V190, P387, DOI 10.1006/jcis.1997.4889
   Reimer P, 1996, RADIOLOGE, V36, P153, DOI 10.1007/s001170050053
   STOLNIK S, 1995, ADV DRUG DELIVER REV, V16, P195, DOI 10.1016/0169-409X(95)00025-3
   STORM G, 1995, ADV DRUG DELIVER REV, V17, P31, DOI 10.1016/0169-409X(95)00039-A
   WEISSLEDER R, 1994, RADIOLOGY, V191, P225, DOI 10.1148/radiology.191.1.8134576
   WEISSLEDER R, 1994, RADIOLOGY, V193, P593, DOI 10.1148/radiology.193.3.7972790
   WEISSLEDER R, 1992, RADIOLOGY, V182, P381, DOI 10.1148/radiology.182.2.1732953
   WEISSLEDER R, 1995, ADV DRUG DELIVER REV, V16, P321, DOI 10.1016/0169-409X(95)00033-4
   Zaitsev VS, 1999, J COLLOID INTERF SCI, V212, P49, DOI 10.1006/jcis.1998.5993
   Zhang Y, 2002, BIOMATERIALS, V23, P1553, DOI 10.1016/S0142-9612(01)00267-8
NR 23
TC 387
Z9 410
U1 8
U2 182
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 1536-1241
J9 IEEE T NANOBIOSCI
JI IEEE Trans. Nanobiosci.
PD MAR
PY 2004
VL 3
IS 1
BP 66
EP 73
DI 10.1109/TNB.2003.820277
PG 8
WC Biochemical Research Methods; Nanoscience & Nanotechnology
SC Biochemistry & Molecular Biology; Science & Technology - Other Topics
GA 808ST
UT WOS:000220589500013
PM 15382647
DA 2018-10-19
ER

PT J
AU Esudero, ML
   Munoz-Morris, MA
   Garcia-Alonso, MC
   Fernandez-Escalante, E
AF Esudero, ML
   Munoz-Morris, MA
   Garcia-Alonso, MC
   Fernandez-Escalante, E
TI In vitro evaluation of a gamma-TiAl intermetallic for potential
   endoprothesic applications
SO INTERMETALLICS
LA English
DT Article
DE titanium aluminides; based on TiAl; corrosion; trace element analysis;
   electron microscopy, scanning; biomedical applications
ID CATHODIC STRIPPING VOLTAMMETRY; TITANIUM ALUMINIDES; ALLOYS; CORROSION;
   WATER; PROTECTION; RESISTANCE; OXIDATION; BEHAVIOR; METAL
AB In vitro properties of a new gamma-based TiAl intermetallic have been evaluated in the as-received state and after carrying out surface modifications by oxidation under two different heat treatments, namely 700 degreesC, 24 It and 1000 degreesC, I h. Cathodic stripping voltammetry was used to determine the concentration of Ti and Al elements released into a solution simulating the body fluids (Ringer's solution) after six months immersion. Electrochemical techniques were used to measure the corrosion resistance and the susceptibility to pitting corrosion. The results confirmed that the best material is the TiAl intermetallic pre-oxidised at 700 degreesC, since it produces a much lower concentration of Al and Ti ions and also exhibits the lowest passive current densities. The latter are one order of magnitude lower than those of the as-received intermetallic alloy and after pre-oxidation at 1000 degreesC and two orders of magnitude lower than that obtained from a conventional Ti6Al4V currently used as biomaterial. (C) 2004 Elsevier Ltd. All rights reserved.
C1 CSIC, CENIM, Dept Met Phys, E-28040 Madrid, Spain.
   CSIC, CENIM, Dept Mat Engn Degradat & Durabil, E-28040 Madrid, Spain.
RP Munoz-Morris, MA (reprint author), CSIC, CENIM, Dept Met Phys, Avenida Gregorio Amo 8, E-28040 Madrid, Spain.
EM mmunoz@cenim.csic.es
RI Garcia-Alonso, Maria Cristina/K-3779-2014
OI Garcia-Alonso, Maria Cristina/0000-0003-0275-4626; Munoz, Maria
   Antonia/0000-0002-9410-098X
CR Bloyce A, 1998, SURF COAT TECH, V107, P125, DOI 10.1016/S0257-8972(98)00580-5
   Brady MP, 1996, JOM-J MIN MET MAT S, V48, P46, DOI 10.1007/BF03223244
   Dimiduk DM, 1999, MAT SCI ENG A-STRUCT, V263, P281, DOI 10.1016/S0921-5093(98)01158-7
   Doorn PF, 1998, J BIOMED MATER RES, V42, P103, DOI 10.1002/(SICI)1097-4636(199810)42:1<103::AID-JBM13>3.0.CO;2-M
   Escudero ML, 2003, SCRIPTA MATER, V48, P1549, DOI 10.1016/S1359-6462(03)00090-3
   Gil I, 2001, INTERMETALLICS, V9, P373, DOI 10.1016/S0966-9795(01)00014-0
   Gurappa I, 2003, INTERMETALLICS, V11, P867, DOI 10.1016/S0966-9795(03)00094-3
   Hallab NJ, 2000, J BIOMED MATER RES, V49, P353, DOI 10.1002/(SICI)1097-4636(20000305)49:3<353::AID-JBM8>3.0.CO;2-T
   KIM YW, 1994, JOM-J MIN MET MAT S, V46, P30
   KIM YW, 1992, ACTA METALL MATER, V40, P1121, DOI 10.1016/0956-7151(92)90411-7
   Lang FQ, 2003, INTERMETALLICS, V11, P129, DOI 10.1016/S0966-9795(02)00192-9
   LI H, 1989, ANAL CHIM ACTA, V221, P269, DOI 10.1016/S0003-2670(00)81963-7
   MORRIS MA, 1994, SCRIPTA METALL MATER, V31, P449, DOI 10.1016/0956-716X(94)90017-5
   MUNOZMORRIS MA, 1997, MATER SCI ENG, V124, P1
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Schmitz-Niederau M, 1999, OXID MET, V52, P225, DOI 10.1023/A:1018839511102
   VAN DEN BERG CMG, 1986, ANAL CHIM ACTA, V188, P177, DOI 10.1016/S0003-2670(00)86041-9
   YOKOI K, 1991, ANAL CHIM ACTA, V245, P167, DOI 10.1016/S0003-2670(00)80217-2
NR 18
TC 20
Z9 20
U1 1
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0966-9795
J9 INTERMETALLICS
JI Intermetallics
PD MAR
PY 2004
VL 12
IS 3
BP 253
EP 260
DI 10.1016/j.intermet.2003.10.004
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary; Metallurgy &
   Metallurgical Engineering
SC Chemistry; Materials Science; Metallurgy & Metallurgical Engineering
GA 778FR
UT WOS:000189229300002
DA 2018-10-19
ER

PT J
AU Naitoh, M
   Katsumata, A
   Mitsuya, S
   Kamemoto, H
   Ariji, E
AF Naitoh, M
   Katsumata, A
   Mitsuya, S
   Kamemoto, H
   Ariji, E
TI Measurement of mandibles with microfocus X-ray computerized tomography
   and compact computerized tomography for dental use
SO INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS
LA English
DT Article
DE biomedical technology assessment; compact computerized tomography;
   dental radiography; microfocus x-ray computerized tomography; trabecular
   bone patterns
ID MICROCOMPUTED TOMOGRAPHY; IMPLANTS
AB Purpose; The trabecular bone patterns in jaws and tooth structure were analyzed using microfocus x-ray computerized tomography (micro-CT), and the usefulness of this method was reported. This study was performed to clarify the accuracy of micro-CT and to determine whether micro-CT could replace bone slice segments as a means for assessment of the accuracy of medical radiography units. In addition, the accuracy of compact CT for dental use (compact CT) was evaluated using the same method. Materials and Methods: Three dried hemimandibles were used in this study. Images of mandibular interdental alveolar bone in the premolar and molar regions were obtained using micro-CT and compact CT Measurement of the mandibular shape at 6 sites using micro-CT images and at 4 sites using compact CT images was performed, and then the values of the micro-CT and compact CT were compared with those of bone slice segments. Results: The accuracy of mandibular measurement and the ratios of agreement for micro-CT were significantly higher than those for compact CT Moreover, the coefficient of correlation of the rate of trabecular bone between compact CT images and bone slice segment images was 0.916. Discussion: The significant difference in mandibular measurement betwen micro-CT and compact CT was considered to be related to pixel size. Conclusion: Micro-CT can replace bone slice segments for assessment of the accuracy of medical radiography units. In addition, compact CT can be used for imaging diagnosis in dental implant treatment. It is suggested that the ratio of trabecular bone could be used to evaluate the bone density.
C1 Aichi Gakuin Univ, Sch Dent, Dept Oral & Maxillofacial Radiol, Chikusa Ku, Nagoya, Aichi 4648651, Japan.
   Asahi Univ, Sch Dent, Dept Oral Radiol, Gifu, Japan.
   Asahi Univ, Sch Dent, Dept Oral Radiol, Gifu, Japan.
   Aichi Gakuin Univ, Dent Hosp, Oral Implant Clin, Nagoya, Aichi 464, Japan.
RP Naitoh, M (reprint author), Aichi Gakuin Univ, Sch Dent, Dept Oral & Maxillofacial Radiol, Chikusa Ku, 2-11 Suemori Dori, Nagoya, Aichi 4648651, Japan.
EM mune@dpc.aichi-gakuin.ac.jp
OI Katsumata, Akitoshi/0000-0001-5281-5234; Ariji,
   Eiichiro/0000-0002-5245-5395
CR Bou Serhal C, 2001, Clin Oral Implants Res, V12, P230
   Bou Serhal C, 2000, Clin Oral Implants Res, V11, P242
   Dowker SEP, 1997, ORAL SURG ORAL MED O, V83, P510, DOI 10.1016/S1079-2104(97)90155-4
   Ekestubbe A, 1997, DENTOMAXILLOFAC RAD, V26, P206, DOI 10.1038/sj.dmfr.4600249
   HOLLENDER L, 1992, ADV OSSEOINTEGRATION, P80
   Ide Yoshinobu, 2000, Acta Anatomica Nipponica, V75, P357
   Ito K, 2001, CLIN ORAL IMPLAN RES, V12, P539, DOI 10.1034/j.1600-0501.2001.120516.x
   Ito M, 1998, BONE, V23, P163, DOI 10.1016/S8756-3282(98)00083-0
   KLINGE B, 1989, International Journal of Oral and Maxillofacial Implants, V4, P327
   KOBAYASHI K, 2001, 5 WORLD C OR IMPL JA
   MONOV G, 2002, CLIN ORAL IMPLAN RES, V13, P28
   Muller R, 1998, BONE, V23, P59, DOI 10.1016/S8756-3282(98)00068-4
   NAITOH M, 1999, J JAP SOC ORAL IMPLA, V12, P246
   PETRIKOWSKI CG, 1989, J PROSTHET DENT, V61, P59, DOI 10.1016/0022-3913(89)90110-8
   Potter BJ, 1997, ORAL SURG ORAL MED O, V84, P436, DOI 10.1016/S1079-2104(97)90045-7
   Sennerby L, 2001, CLIN ORAL IMPLAN RES, V12, P91, DOI 10.1034/j.1600-0501.2001.012001091.x
   Shibata Takashi, 1999, Acta Anatomica Nipponica, V74, P545
   Sonic M, 1994, INT J ORAL MAXILLOF, V9, P455
   TODD AD, 1993, J PERIODONTOL, V64, P1243, DOI 10.1902/jop.1993.64.12.1243
   Uchiyama T, 1997, CALCIFIED TISSUE INT, V61, P493, DOI 10.1007/s002239900373
   Wyatt CCL, 1998, INT J PROSTHODONT, V11, P442
NR 21
TC 42
Z9 46
U1 0
U2 6
PU QUINTESSENCE PUBL CO INC
PI CAROL STREAM
PA 551 NORTH KIMBERLY DR, CAROL STREAM, IL 60188-1881 USA
SN 0882-2786
J9 INT J ORAL MAX IMPL
JI Int. J. Oral Maxillofac. Implants
PD MAR-APR
PY 2004
VL 19
IS 2
BP 239
EP 246
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 810VR
UT WOS:000220732300011
PM 15101596
DA 2018-10-19
ER

PT J
AU Rossomacha, E
   Hoemann, CD
   Shive, MS
AF Rossomacha, E
   Hoemann, CD
   Shive, MS
TI Simple methods for staining chitosan in biotechnological applications
SO JOURNAL OF HISTOTECHNOLOGY
LA English
DT Article
DE chitin; Fast Green; Safranin-O; cibacron brilliant Red-3BA; tissue
   repair; drug delivery; blood clots
AB Chitosan is a naturally abundant cationic polysaccharide with unique physicochemical properties resulting in its use in a vast array of biomedical applications, including wound repair, drug delivery, and tissue engineering. However, despite numerous and diverse studies investigating its use, there have been no detailed reports describing specific staining methods for cell culture and histopathological studies using chitosan based materials. Here, we describe methods for staining chitosan in both cell culture and within paraffin sections. Procedural models used included identifying chitosan within in vitro whole blood clots, and culture wells, and in vivo chitosan hydrogel implants in multiple anatomical sites. First, a staining process for identifying chitosan was optimized using 0.03% Cibacron Brilliant Red-3BA. A second sensitive and versatile method using 0.01% Fast Green in conjunction with the known Safranin-O Method was demonstrated and may prove to be a key advancement in the histological study of chitosan-based biotechnological products. The method described here is broadly applicable to histological in situ detection of chitosan scaffolds of multiple deacetylation level and of variable fabrication.
C1 Biosyntech Canada Inc, Laval, PQ, Canada.
   Ecole Polytech, Dept Chem Engn, Montreal, PQ H3C 3A7, Canada.
RP Rossomacha, E (reprint author), 475 Armand Frappier Blvd, Laval, PQ H7V 4B3, Canada.
OI Hoemann, Caroline/0000-0003-3750-7879
CR Chenite A, 2001, CARBOHYD POLYM, V46, P39, DOI 10.1016/S0144-8617(00)00281-2
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   CHENITE A, Patent No. 6344488
   GOROVSKY MA, 1970, ANAL BIOCHEM, V35, P359, DOI 10.1016/0003-2697(70)90196-X
   Hoekstra A, 1998, BIOMATERIALS, V19, P1467, DOI 10.1016/S0142-9612(98)00060-X
   HOEMANN CD, 2003, 3 ANN ENG TISS GROWT
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   LILLIE RD, 1976, HISTOPATHOLOGIC TECH
   Mattioli-Belmonte M, 1999, CARBOHYD POLYM, V40, P23, DOI 10.1016/S0144-8617(99)00028-4
   Muzzarelli R. A. A., 1993, CHITIN ENZYMOLOGY
   Muzzarelli RAA, 1998, ANAL BIOCHEM, V260, P255, DOI 10.1006/abio.1998.2705
   Ono K, 2001, SURGERY, V130, P844, DOI 10.1067/msy.2001.117197
   Ruel-Gariepy E, 2004, EUR J PHARM BIOPHARM, V57, P53, DOI 10.1016/S0939-6411(03)00095-X
   SHIGEMASA Y, 1995, BIOTECHNOL GENET ENG, V13, P383
   Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841
   VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270
NR 16
TC 16
Z9 17
U1 1
U2 7
PU NATL SOC HISTOTECHNOLOGY
PI BOWIE
PA 4201 NORTHVIEW DR, STE 502, BOWIE, MD 20716-1073 USA
SN 0147-8885
J9 J HISTOTECHNOL
JI J. Histotechnol.
PD MAR
PY 2004
VL 27
IS 1
BP 31
EP 36
DI 10.1179/his.2004.27.1.31
PG 6
WC Cell Biology
SC Cell Biology
GA 809HT
UT WOS:000220628500004
DA 2018-10-19
ER

PT J
AU Sproule, TL
   Lee, JA
   Li, HB
   Lannutti, JJ
   Tomasko, DL
AF Sproule, TL
   Lee, JA
   Li, HB
   Lannutti, JJ
   Tomasko, DL
TI Bioactive polymer surfaces via supercritical fluids
SO JOURNAL OF SUPERCRITICAL FLUIDS
LA English
DT Article
DE supercritical carbon dioxide; polymethylmethacrylate; swelling;
   impregnation; biomaterials; fluorescent protein
ID CARBON-DIOXIDE; INACTIVATION; MIXTURES
AB Supercritical CO2 (scCO(2)) can reversibly swell thermoplastic polymers. We use this phenomenon to enhance the impregnation of a fluorescently-labeled protein into a polymethylmethacrylate (PMMA) matrix. Exposure to scCO(2) provides simultaneous sterilization and foamed morphologies similar to those found in both hard and soft tissues in vivo. This combination of enhanced diffusion, foaming, and sterilization can conceivably be exploited to produce or modify a variety of biomedical materials. In the current study, efforts were made to control the scCO(2)-induced foaming in PMMA. Fundamental information regarding solid state swelling (via laser dilatometry) and foaming (via microfocus X-ray computed tomography) were used to explore the interactions between process variables. This is the first application of laser dilatometry to measure scCO(2) swelling of and desorption from a polymer in situ. scCO(2) at 40degreesC was also used to impregnate PMMA with a fluorescently-labeled protein, a rhodamine-labeled antibody to immunoglobin. Protein impregnation was verified using confocal microscopy. (C) 2003 Elsevier B.V All rights reserved.
C1 Ohio State Univ, Dept Chem Engn, Koffolt Lab 125, Columbus, OH 43210 USA.
   Ohio State Univ, Dept Mat Sci & Engn, Columbus, OH 43210 USA.
RP Tomasko, DL (reprint author), Ohio State Univ, Dept Chem Engn, Koffolt Lab 125, 140 W 19th Ave, Columbus, OH 43210 USA.
EM tomasko.1@osu.edu
CR BERENS AR, 1992, J APPL POLYM SCI, V46, P231, DOI 10.1002/app.1992.070460204
   CASTOR TP, 1999, Patent No. 5877005
   Chang SH, 1998, J SUPERCRIT FLUID, V13, P113, DOI 10.1016/S0896-8446(98)00042-4
   Cooper AI, 2000, J MATER CHEM, V10, P207, DOI 10.1039/a906486i
   COOPER AI, 2001, ADV MATER, V13, P1114
   Dillow AK, 1999, P NATL ACAD SCI USA, V96, P10344, DOI 10.1073/pnas.96.18.10344
   DURRILL PL, 1966, AICHE J, V12, P1147, DOI 10.1002/aic.690120619
   Fages J, 1998, ASAIO J, V44, P289
   KAMIYA Y, 1998, MACROMOLECULES, V31, P477
   Kazarian S. G., 2000, POLYM SCI SER C, V42, P78, DOI DOI 10.1080/03602549909351647
   Kazarian SG, 2002, INT J PHARM, V232, P81, DOI 10.1016/S0378-5173(01)00905-X
   Kazarian SG, 1999, CHEMTECH, V29, P36
   Kazarian SG, 1996, J AM CHEM SOC, V118, P1729, DOI 10.1021/ja950416q
   KISZKA MB, 1988, J APPL POLYM SCI, V36, P583, DOI 10.1002/app.1988.070360311
   LIAU IS, 1985, SUPERCRITICAL FLUID, P415
   Lu PZK, 2000, J AM CERAM SOC, V83, P2536
   Ratner B. D., 1996, BIOMATERIALS SCI, P165
   SAIDGALIYEV E, 2000, IND ENG CHEM RES, V39, P4896
   von Schnitzler J, 1999, J SUPERCRIT FLUID, V16, P81, DOI 10.1016/S0896-8446(99)00020-0
   WANG Y, 2001, IND ENG CHEM RES, V41, P1780
   West BL, 1998, J APPL POLYM SCI, V69, P911, DOI 10.1002/(SICI)1097-4628(19980801)69:5<911::AID-APP10>3.0.CO;2-R
   WISSINGER RG, 1987, J POLYM SCI POL PHYS, V25, P2497, DOI 10.1002/polb.1987.090251206
NR 22
TC 46
Z9 50
U1 0
U2 17
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0896-8446
J9 J SUPERCRIT FLUID
JI J. Supercrit. Fluids
PD MAR
PY 2004
VL 28
IS 2-3
BP 241
EP 248
DI 10.1016/S0896-8446(03)00044-5
PG 8
WC Chemistry, Physical; Engineering, Chemical
SC Chemistry; Engineering
GA 801ES
UT WOS:000220079800008
DA 2018-10-19
ER

PT J
AU Mandel, NS
   Henderson, JD
   Hung, LY
   Wille, DF
   Wiessner, JH
AF Mandel, NS
   Henderson, JD
   Hung, LY
   Wille, DF
   Wiessner, JH
TI A porcine model of calcium oxalate kidney stone disease
SO JOURNAL OF UROLOGY
LA English
DT Article
DE kidney; kidney calculi; swine; calcium oxalate; diet
ID RENAL EPITHELIAL-CELLS; PIG
AB Purpose: The pig has been extensively used in biomedical research because of the similarities in organ structure and function to humans. It is desirable to have an animal model of oxaluria and urolithiasis with physiological, anatomical and nutritional characteristics that more closely resemble those of man. In this study we determined if feeding pigs trans-4-hydroxy-L-proline (HP) increased urine oxalate levels and if it would serve as a model for human hyperoxaluria and stone disease.
   Materials and Methods: Male Yorkshire-Durox cross-bred pigs were fed HP for up to 20 days. Urine was periodically collected and analyzed for oxalate levels and the presence of crystalluria. After 20 days of feeding the kidneys were removed and examined grossly and microscopically for indications of injury, crystal deposition and stone formation.
   Results: Feeding pigs 10% HP (weight per weight HP/food) produced hyperoxaluria, which reached a maximum and leveled off by day 6. Urine oxalate remained near this level until the study ended at 20 days regardless of the further increase in HP to 20% of the weight of the food. When the kidneys were removed and grossly examined, calcium oxalate encrustations were observed on multiple papillary tips. Histopathological observation of the papillary tissue showed tissue injury and crystal deposition.
   Conclusions: Pigs fed HP have hyperoxaluria and calcium oxalate crystalluria, and calcium oxalate papillary deposits form that may be precursors of kidney stones. The use of the pig as a model of human hyperoxaluria and stone formation should prove ideal for studies of these human diseases.
C1 Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA.
   Med Coll Wisconsin, Dept Surg, Milwaukee, WI 53226 USA.
   Zablocki Vet Affairs Med Ctr, Dept Vet Affairs, Milwaukee, WI USA.
RP Mandel, NS (reprint author), Vet Affairs Med Ctr, Res Serv 151, 5000 W Natl Ave, Milwaukee, WI 53295 USA.
FU NIDDK NIH HHS [R21-DK062739-01]; PHS HHS [R01-30579]
CR ASSIMOS DG, 1986, SWINE BIOL RES, V1, P399
   BORDEN T. A., 1966, INVEST UROL, V4, P125
   Bushinsky DA, 2002, KIDNEY INT, V61, P975, DOI 10.1046/j.1523-1755.2002.00190.x
   Jonassen JA, 1999, J AM SOC NEPHROL, V10, pS446
   KHAN SR, 1985, SCAN ELECTRON MICROS, P759
   KHAN SR, 1989, UROLITHIASIS, P117
   Paterson RF, 2002, J ENDOUROL, V16, P543, DOI 10.1089/089277902320913215
   SACHS DH, 1994, VET IMMUNOL IMMUNOP, V43, P185, DOI 10.1016/0165-2427(94)90135-X
   TERRIS JM, 1986, SWINE BIOL RES, V1, P1673
   Wiessner JH, 1999, J AM SOC NEPHROL, V10, pS441
NR 10
TC 27
Z9 29
U1 0
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-5347
J9 J UROLOGY
JI J. Urol.
PD MAR
PY 2004
VL 171
IS 3
BP 1301
EP 1303
DI 10.1097/01.ju.0000110101.41653.bb
PG 3
WC Urology & Nephrology
SC Urology & Nephrology
GA 774DU
UT WOS:000188965100084
PM 14767337
DA 2018-10-19
ER

PT J
AU Lukaszczyk, J
   Benecki, L
   Jaszcz, K
   Smiga, M
AF Lukaszczyk, J
   Benecki, L
   Jaszcz, K
   Smiga, M
TI Versatility of potential biomedical use of functional polysuccinates
SO MACROMOLECULAR SYMPOSIA
LA English
DT Article; Proceedings Paper
CT 2nd International Symposium on React 2003
CY SEP 28-OCT 01, 2003
CL Dresden, GERMANY
SP Deutsch Forsch Geminsch, Sachsisches Staatsminister Wissensch & Kunst, Deutsch Akad Austauschdienst, Tech Univ Dresden, Parr Instrument Deutschland Gmbh, DSM, Geleen, Buchi Autoklaven & Reaktorsyst GmbH
DE biodegradable biomaterials; drug carriers; functional polysuccinates
ID POLYESTER RESINS; GLUTARIC ANHYDRIDE; ALLYL ETHERS
AB Polysuccinates with pendant allyl groups (PSAGE) were synthesized by melt copolymerization of succinic anhydride with allyl glycidyl ether and eventually other glycidyl ethers. It was found that PSAGE could be crosslinked by radical copolymerization with methyl methacrylate. Oxidized PSAGE considered as multifunctional epoxy resin was cured with use of glutaric anhydride to form solid material susceptible to hydrolytic degradation to water-soluble non-toxic products. Comb-like amphiphilic polysuccinates containing both pendant poly(oxyethylene) chains and epoxy groups have been synthesized as well and checked for their solubility in water. Properties of PSAGE-type polymers suggests their potential use as biomaterials and polymeric drug carries.
C1 Silesian Tech Univ, Dept Phys Chem & Technol Polymers, PL-44100 Gliwice, Poland.
RP Lukaszczyk, J (reprint author), Silesian Tech Univ, Dept Phys Chem & Technol Polymers, Ul M Strzody 9, PL-44100 Gliwice, Poland.
RI Smiga-Matuszowicz, Monika/R-9838-2018
OI Smiga-Matuszowicz, Monika/0000-0003-4651-5619; Jaszcz,
   Katarzyna/0000-0003-4883-8278
CR [Anonymous], 58332001 ISOFDIS
   BENDIX D, 1998, POLYM DEGRAD STABIL, V59, P12
   Bevington JC, 2001, J MACROMOL SCI PURE, V38, P981, DOI 10.1081/MA-100105960
   CHUNG H, 2003, EUR POLYM J, V39, P1817
   FURUKAWA S, 1980, FEBS LETT, V121, P239, DOI 10.1016/0014-5793(80)80351-6
   KOHN DH, 1992, MAT SCI TECHNOLOGY, V14
   Lukaszczyk J, 2002, MACROMOL CHEM PHYSIC, V203, P301, DOI 10.1002/1521-3935(20020101)203:2<301::AID-MACP301>3.0.CO;2-6
   Lukaszczyk J, 2002, POLYM ADVAN TECHNOL, V13, P871, DOI 10.1002/pat.281
   Lukaszczyk J, 2000, REACT FUNCT POLYM, V43, P25, DOI 10.1016/S1381-5148(98)00090-X
   ODIAN G, 1981, PRINCIPLES POLYM, P251
   Rokicki G, 1998, J APPL POLYM SCI, V70, P2031, DOI 10.1002/(SICI)1097-4628(19981205)70:10<2031::AID-APP19>3.3.CO;2-W
   ROSE S, 1991, CHEM LIFE
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   TIMMER MD, 2000, BIOMATERIALS, V21, P2395
   TRAENCKENER HJ, 1982, ANGEW MAKROMOL CHEM, V108, P619
   Uyama H, 2003, BIOMACROMOLECULES, V4, P211, DOI 10.1021/bm0256092
NR 16
TC 4
Z9 4
U1 0
U2 1
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1022-1360
J9 MACROMOL SYMP
JI Macromol. Symp.
PD MAR
PY 2004
VL 210
BP 457
EP 464
DI 10.1002/masy.200450651
PG 8
WC Polymer Science
SC Polymer Science
GA 821DC
UT WOS:000221439100052
DA 2018-10-19
ER

PT J
AU Laptev, A
   Bram, M
   Buchkremer, HP
   Stover, D
AF Laptev, A
   Bram, M
   Buchkremer, HP
   Stover, D
TI Study of production route for titanium parts combining very high
   porosity and complex shape
SO POWDER METALLURGY
LA English
DT Article
DE porous titanium; metal foam; pore forming; near net shape
ID MECHANICAL-PROPERTIES; STAINLESS-STEEL
AB The production of highly porous titanium parts of complex shape by powder metallurgical technology is described. Well defined porosity and pore sizes were achieved using a pore forming additive. This additive also enhances the strength of unsintered compacts, allowing machining in the green state. The requirements of the initial powders and pecularities of each production step are discussed in detail. The microstructure of porous materials and examples of net shape parts are given, aiming preferentially at biomedical applications. The impurities of the obtained titanium parts are compared with the requirements of the ISO standard for titanium implants.
C1 Forschoungzentrum Julich GmbH, Inst Werkstoffe & Verfahren Energietech, D-52425 Julich, Germany.
   Donbass State Engn Acad, UA-84313 Kramatorsk, Ukraine.
RP Laptev, A (reprint author), Forschoungzentrum Julich GmbH, Inst Werkstoffe & Verfahren Energietech, D-52425 Julich, Germany.
EM m.bram@fz-juelich.de
OI Laptev, Alexander/0000-0001-9077-5747
CR Azevedo CRF, 2003, J ALLOY COMPD, V353, P217, DOI 10.1016/S0925-8388(02)01297-5
   Bram M, 2000, ADV ENG MATER, V2, P196, DOI 10.1002/(SICI)1527-2648(200004)2:4<196::AID-ADEM196>3.0.CO;2-K
   Bram M, 2000, MATERIALWISS WERKST, V31, P497, DOI 10.1002/1521-4052(200006)31:6<497::AID-MAWE497>3.3.CO;2-O
   BRAM M, 2001, CELLULAR METALS MATA, P215
   BRAM M, 2000, PM2000 WORLD C POWD, P1131
   BREME J, 1996, ITTAN TITANLEGIERUNG, P205
   BUCHKREMER HP, 1998, Patent No. 19726961
   Davis NG, 2001, J MATER RES, V16, P1508, DOI 10.1557/JMR.2001.0210
   GERMAN RM, 1996, SINTERING THEORY PRA, P550
   Hausner H. H., 1982, HDB POWDER METALLURG
   ILYUSCHENKO A, 2001, P 15 INT PLANS SEM, V3, P248
   *ISO, 58322 ISO
   LIDE DR, 1994, CRC HDB CHEM PHYS, P37
   Rausch G, 2000, MATERIALWISS WERKST, V31, P412, DOI 10.1002/1521-4052(200006)31:6<412::AID-MAWE412>3.3.CO;2-2
   SCHATT W, 1997, POWEDER METALLURGY P, P353
   Wen CE, 2002, J MATER SCI-MATER M, V13, P397, DOI 10.1023/A:1014344819558
   WHEELER KR, 1974, Patent No. 3852045
   WINTERMANTEL E, 1996, BIOKOMPATIBLE WERKST, V159, P162
NR 18
TC 72
Z9 74
U1 3
U2 11
PU MANEY PUBLISHING
PI LEEDS
PA HUDSON RD, LEEDS LS9 7DL, ENGLAND
SN 0032-5899
J9 POWDER METALL
JI Powder Metall.
PD MAR
PY 2004
VL 47
IS 1
BP 85
EP 92
DI 10.1179/003258904225015536
PG 8
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 813IN
UT WOS:000220900900026
DA 2018-10-19
ER

PT J
AU Dabhade, RV
   Bodas, DS
   Gangal, SA
AF Dabhade, RV
   Bodas, DS
   Gangal, SA
TI Plasma-treated polymer as humidity sensing material - a feasibility
   study
SO SENSORS AND ACTUATORS B-CHEMICAL
LA English
DT Article
DE PMMA; humidity sensing; plasma treatment
ID THIN-FILMS; SENSOR; PMMA
AB Plasma treatment of polymers (surface modification) has been carried out for a long time namely for adhesion improvement and biomedical applications, as it is known to improve the wettability (increase in hydrophilicity) of the polymer surface. It was noted that although extensive work in this area has been carried out, no literature is available on the possible use of plasma-treated/modified polymers for use as humidity sensors. With this in mind, work has been carried out to study the possible use of plasma surface treatment of polymers for humidity sensing. In this communication, we report to the best of our knowledge for the first time humidity sensing by argon plasma-treated polymer namely PMMA with encouraging results. The argon plasma-treated PMMA was characterized by FTIR, XPS, SEM, and contact angle measurements. A capacitive RH sensor was fabricated using the argon plasma-treated PMMA as the dielectric for relative humidity sensing. The sensors fabricated from argon plasma-treated PMMA showed improvement in their sensitivity in 0-40% RH range. (C) 2003 Elsevier B.V. All rights reserved.
C1 Univ Poona, Dept Elect Sci, Pune 411007, Maharashtra, India.
RP Gangal, SA (reprint author), Univ Poona, Dept Elect Sci, Pune 411007, Maharashtra, India.
EM sag@electronics.unipune.ernet.in
CR Anchisini R, 1996, SENSOR ACTUAT B-CHEM, V35, P99, DOI 10.1016/S0925-4005(97)80037-8
   France RM, 1997, J CHEM SOC FARADAY T, V93, P3173, DOI 10.1039/a702311a
   LISTON EM, 1994, PLASMA SURFACE MODIF
   Maddanimath T, 2002, SENSOR ACTUAT B-CHEM, V81, P141, DOI 10.1016/S0925-4005(01)00944-3
   Matsuguchi M, 1998, SENSOR ACTUAT B-CHEM, V49, P179, DOI 10.1016/S0925-4005(98)00117-8
   MATSUGUCHI M, 1991, J ELECTROCHEM SOC, V138, P1862, DOI 10.1149/1.2085886
   Perez JMM, 1997, SENSOR ACTUAT B-CHEM, V42, P27, DOI 10.1016/S0925-4005(97)80308-5
   RALSTON ARK, 1994, SENSOR ACTUAT B-CHEM, V22, P139, DOI 10.1016/0925-4005(94)87013-6
   SAKAI Y, 1993, SENSOR ACTUAT B-CHEM, V13, P82, DOI 10.1016/0925-4005(93)85329-9
   Sakai Y, 1996, SENSOR ACTUAT B-CHEM, V35, P85, DOI 10.1016/S0925-4005(96)02019-9
   Schroth A, 1996, SENSOR ACTUAT B-CHEM, V34, P301, DOI 10.1016/S0925-4005(96)01936-3
   Schulz U, 2001, SURF COAT TECH, V142, P507, DOI 10.1016/S0257-8972(01)01202-6
   SILVERSTEEN RM, 2002, SPECTROSCOPIC IDENTI
   VARGO TG, 1989, J POLYM SCI POL CHEM, V27, P1267, DOI 10.1002/pola.1989.080270413
   WEXLER A, 1965, HUMIDITY MOISTURE ME, V1, P219
NR 15
TC 31
Z9 31
U1 1
U2 10
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-4005
J9 SENSOR ACTUAT B-CHEM
JI Sens. Actuator B-Chem.
PD MAR 1
PY 2004
VL 98
IS 1
BP 37
EP 40
DI 10.1016/j.snb.2003.08.020
PG 4
WC Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation
SC Chemistry; Electrochemistry; Instruments & Instrumentation
GA 801ZB
UT WOS:000220132700006
DA 2018-10-19
ER

PT J
AU Salgado, AJ
   Coutinho, OP
   Reis, RL
AF Salgado, AJ
   Coutinho, OP
   Reis, RL
TI Novel starch-based scaffolds for bone tissue engineering: Cytotoxicity,
   cell culture, and protein expression
SO TISSUE ENGINEERING
LA English
DT Article
ID BIODEGRADABLE POLYMER SCAFFOLDS; MORPHOLOGY; LINE; DIFFERENTIATION;
   PROLIFERATION; DEXAMETHASONE; REGENERATION; DEGRADATION; TECHNOLOGY;
   DESIGN
AB Starch-based biomaterials and scaffolds have been proposed for several biomedical applications. In the present work new scaffolds based on a 50150 (wt%) blend of corn starch/ethylene-vinyl alcohol (SEVA-C) were studied. These scaffolds were processed by a melt-based technology, which has been used before with other starch-based materials but never with SEVA-C. Scanning electron microscopy (SEM) observation showed that the developed porous structures were 60% porous with pore size between 200 and 900 mum and a reasonable degree of interconnectivity. Moreover, scaffolds presented a compressive modulus of 117.50 +/- 3.7 MPa and a compressive strength of 20.8 +/- 2.4 MPa. Cytotoxicity evaluation was performed according to ISO/EN 10993 part 5 guidelines, and revealed that the developed scaffolds were nontoxic and did not inhibit cell growth. Direct contact assays were also carried out by use of a cell line of human osteoblast-like cells (SaOS-2). Cells were seeded (3 X 101 per scaffold) and allowed to grow for 4 weeks at 37degreesC, in a humidified atmosphere containing 5% CO2. Total protein assay showed that the cells were able to grow for the 4 weeks of the experiment. These data were further confirmed by SEM. Moreover, a cell viability assay (NITS test) demonstrated that cells were perfectly viable after the 4 weeks of culture, showing the adequacy of the developed structure in supporting them. Finally, Western blot analysis revealed that osteopontin was being actively expressed by the cells, which, in association with collagen deposition observed by SEM, seems to indicate that bone extracellular matrix was being deposited. Consequently it is believed that starch-based scaffolds should be considered as an alternative for bone tissue-engineering applications in the near future.
C1 Univ Minho, Res Grp Biomat Biodegradables Biomimet B3, P-4710057 Braga, Portugal.
   Univ Minho, Dept Biol, P-4710057 Braga, Portugal.
   Univ Minho, Dept Polymer Engn, Guimareaes, Portugal.
RP Salgado, AJ (reprint author), Univ Minho, Res Grp Biomat Biodegradables Biomimet B3, Campus Gualtar, P-4710057 Braga, Portugal.
EM asalgado@dep.uminho.pt
RI Reis, Rui L./A-8938-2008; Coutinho, Olga/K-7155-2013; Salgado,
   Antonio/J-4129-2013; Group, 3Bs/E-4374-2012
OI Reis, Rui L./0000-0002-4295-6129; Salgado, Antonio/0000-0003-3806-9823;
   Group, 3Bs/0000-0002-5195-3456; Coutinho, Olga/0000-0002-0647-080X
CR [Anonymous], 1992, 10993 ISO
   CORY AH, 1991, CANCER COMMUN, V3, P207
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   Freed LE, 1998, ADV DRUG DELIVER REV, V33, P15, DOI 10.1016/S0169-409X(98)00017-9
   Gomes ME, 2001, BIOMATERIALS, V22, P883, DOI 10.1016/S0142-9612(00)00211-8
   Gomes ME, 2002, MAT SCI ENG C-BIO S, V20, P19, DOI 10.1016/S0928-4931(02)00008-5
   Horbett TA, 1998, J BIOMAT SCI-POLYM E, V9, P1071, DOI 10.1163/156856298X00334
   Hulley PA, 1998, ENDOCRINOLOGY, V139, P2423, DOI 10.1210/en.139.5.2423
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Malafaya PB, 2001, J BIOMAT SCI-POLYM E, V12, P1227, DOI 10.1163/156856201753395761
   Maquet V, 1997, MATER SCI FORUM, V250, P15, DOI 10.4028/www.scientific.net/MSF.250.15
   Melican MC, 2001, J BIOMED MATER RES, V55, P194, DOI 10.1002/1097-4636(200105)55:2<194::AID-JBM1006>3.0.CO;2-K
   Mendes SC, 2001, BIOMATERIALS, V22, P2057, DOI 10.1016/S0142-9612(00)00395-1
   Noshi T, 2000, J BIOMED MATER RES, V52, P621
   Ogston N, 2002, STEROIDS, V67, P895, DOI 10.1016/S0039-128X(02)00054-5
   Ohgushi H, 1999, J BIOMED MATER RES, V48, P913, DOI 10.1002/(SICI)1097-4636(1999)48:6<913::AID-JBM22>3.0.CO;2-0
   OHGUSHI H, 1993, J BIOMED MATER RES, V27, P1401, DOI 10.1002/jbm.820271107
   Pereira CS, 1998, J MATER SCI-MATER M, V9, P825, DOI 10.1023/A:1008944127971
   Perka C, 2000, BIOMATERIALS, V21, P1145, DOI 10.1016/S0142-9612(99)00280-X
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Reis R.L., 2000, J APPL MED POLYM, V4, P1
   REIS RL, 1998, J APPL MED POLYM, V2, P49
   REIS RL, 2001, BIOL BIOMIMETIC MAT, P8810
   Salgado AJ, 2002, MAT SCI ENG C-BIO S, V20, P27, DOI 10.1016/S0928-4931(02)00009-7
   Salih V, 2000, J MATER SCI-MATER M, V11, P615, DOI 10.1023/A:1008901612674
   Shea LD, 2000, TISSUE ENG, V6, P605, DOI 10.1089/10763270050199550
   Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101
   STEELE JG, 1999, BONE ENG, P225
   Temenoff J.S., 1999, BONE ENG, P454
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Thomson RC, 1999, BIOMATERIALS, V20, P2007, DOI 10.1016/S0142-9612(99)00103-9
   Vacanti CA, 2001, NEW ENGL J MED, V344, P1511, DOI 10.1056/NEJM200105173442004
   Washburn NR, 2002, J BIOMED MATER RES, V60, P20, DOI 10.1002/jbm.10049
   Whang K, 1999, TISSUE ENG, V5, P35, DOI 10.1089/ten.1999.5.35
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
NR 36
TC 88
Z9 88
U1 0
U2 13
PU MARY ANN LIEBERT INC PUBL
PI LARCHMONT
PA 2 MADISON AVENUE, LARCHMONT, NY 10538 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD MAR-APR
PY 2004
VL 10
IS 3-4
BP 465
EP 474
DI 10.1089/107632704323061825
PG 10
WC Cell & Tissue Engineering
SC Cell Biology
GA 816JA
UT WOS:000221105000016
PM 15165463
DA 2018-10-19
ER

PT J
AU Friedman, M
AF Friedman, M
TI Applications of the ninhydrin reaction for analysis of amino acids,
   peptides, and proteins to agricultural and biomedical sciences
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Review
DE ninhydrin; Ruhemann's purple; amino acids; peptides; proteins; analysis;
   food chemistry; protein chemistry; clinical chemistry; histochemistry;
   fo; rensic science; microbiology; medicine; nutrition; pharmacology;
   plant science; toxicology; proteolysis; cereal proteins; keratin
   proteins; milk proteins; soy proteins; whey proteins; protein-tannin
   complexes; cheeses; fruits; vegetables
ID ION-EXCHANGE CHROMATOGRAPHY; PERFORMANCE LIQUID-CHROMATOGRAPHY;
   BETA-UNSATURATED COMPOUNDS; THIN-LAYER CHROMATOGRAPHY; QUANTITATIVE
   COLORIMETRIC ASSAY; FLUORESCENT TERNARY PRODUCTS; TRIKETOHYDRINDENE
   HYDRATE; LATENT FINGERPRINTS; FOOD PROTEINS; SPECTROPHOTOMETRIC
   DETERMINATION
AB The reaction of ninhydrin with primary amino groups to form the purple dye now called Ruhemann's purple (RIP) was discovered by Siegfried Ruhemann in 1910. In addition, imines such as pipecolic acid and proline, the guanidino group of arginine, the amide groups of asparagine, the indole ring of tryptophan, the sulfhydryl group of cysteine, amino groups of cytosine and guanine, and cyanide ions also react with ninhydrin to form various chromophores of analytical interest. Since its discovery, extensive efforts have been made to apply manual and automated ninhydrin reactions as well as ninhydrin spray reagents to the detection, isolation, and analysis of numerous compounds of interest across a broad spectrum of disciplines. These include agricultural, biochemical, clinical, environmental, food, forensic, histochemical, microbiological, medical, nutritional, plant, and protein sciences. This reaction is unique among chromogenic reactions in that at pH 5.5 it results in the formation of the same soluble chromophore by all primary amines which react, be they amines, amino acids, peptides, proteins, and even ammonia. Because the chromophore is not chemically bound to the protein or other insoluble material, it is not lost when the insoluble substrate is removed by centrifugation or filtration after the reaction is completed. The visible color of the chromophore is distinctive and is generally not affected by the yellow colors present in many food, plant, and tissue extracts. Adaptations of the classical ninhydrin reaction to specialized needs; in analytical chemistry and biochemistry include the use of acid, alkaline, and fluorogenic ninhydrin reagents. To cross-fertilize information among several disciplines wherein an interest in the ninhydrin reaction has developed, and to enhance its utility, this review attempts to integrate and correlate the widely scattered literature on ninhydrin reactions of a variety of structurally different compounds. Specifically covered are the following aspects: historical perspective, chemistry and mechanisms, applications, and research needs. A better understanding of these multifaceted ninhydrin, reactions provide a scientific basis for further improvements of this important analytical technique.
C1 USDA ARS, Western Reg Res Ctr, Albany, CA 94710 USA.
RP Friedman, M (reprint author), USDA ARS, Western Reg Res Ctr, 800 Buchanan St, Albany, CA 94710 USA.
EM mfried@pw.usda.gov
OI Friedman, Mendel/0000-0003-2582-7517
CR Abdellatef HE, 2003, J PHARMACEUT BIOMED, V31, P209, DOI 10.1016/S0731-7085(02)00572-1
   ABDERHALDEN E, 1911, Z PHYSL CHEM, V72, P37
   ABDERHALDEN E, 1913, Z PHYSL CH, V85, P143
   AHOKAS H, 1989, CEREAL CHEM, V66, P135
   Al-Shabanah OA, 2000, LIFE SCI, V67, P559, DOI 10.1016/S0024-3205(00)00645-7
   BECKWITH AC, 1975, J AGR FOOD CHEM, V23, P194, DOI 10.1021/jf60198a015
   Bell EA, 2003, J AGR FOOD CHEM, V51, P2854, DOI 10.1021/jf020880w
   BENSON JV, 1972, ANAL BIOCHEM, V50, P477, DOI 10.1016/0003-2697(72)90057-7
   BOPPANA VK, 1990, J CHROMATOGR, V507, P79, DOI 10.1016/S0021-9673(01)84183-2
   Boschin G, 2003, J DAIRY SCI, V86, P2283, DOI 10.3168/jds.S0022-0302(03)73820-X
   BOTTOM CB, 1979, BIOCHEM EDUC, V6, P4
   Briddon A, 1998, AMINO ACIDS, V15, P235, DOI 10.1007/BF01318862
   BRODERICK GA, 1980, J DAIRY SCI, V63, P64, DOI 10.3168/jds.S0022-0302(80)82888-8
   BRODERICK GA, 1975, PROTEIN NUTRITIONA 2, P211
   CANDIANO G, 1989, PREP BIOCHEM, V19, P193, DOI 10.1080/10826068908544909
   CARRASCO P, 1988, PHYSIOL PLANTARUM, V72, P610, DOI 10.1111/j.1399-3054.1988.tb09171.x
   CASHMAN PJ, 1979, J FORENSIC SCI SOC, V19, P137, DOI 10.1016/S0015-7368(79)71264-3
   CAVINS JF, 1967, BIOCHEMISTRY-US, V6, P3766, DOI 10.1021/bi00864a021
   CAVINS JF, 1970, ANAL BIOCHEM, V35, P489, DOI 10.1016/0003-2697(70)90211-3
   CAVINS JF, 1968, CEREAL CHEM, V45, P172
   CHAPLIN MF, 1976, BIOCHEM J, V155, P457, DOI 10.1042/bj1550457
   Chauffe L, 1977, Adv Exp Med Biol, V86A, P415
   CHEN G, 1987, J DAIRY SCI, V70, P1211, DOI 10.3168/jds.S0022-0302(87)80133-9
   CHEN GJ, 1991, J ANIM SCI, V69, P2196
   CHINARD FP, 1952, J BIOL CHEM, V199, P91
   CONCON JM, 1975, PROTEIN NUTRITION QU, P311
   CONGER KA, 1978, J HISTOCHEM CYTOCHEM, V26, P423, DOI 10.1177/26.6.78939
   COOPER C, 2001, METHOD MOL BIOL, P265
   DAVIES RL, 1972, J CHROMATOGR, V71, P564
   de Jonge R, 2003, J APPL MICROBIOL, V94, P625
   DENT CE, 1948, BIOCHEM J, V43, P169, DOI 10.1042/bj0430169
   DHOOGE R, 1992, J NEUROL SCI, V112, P96, DOI 10.1016/0022-510X(92)90138-B
   DOI E, 1981, ANAL BIOCHEM, V118, P173, DOI 10.1016/0003-2697(81)90175-5
   DORLAND L, 1990, CLIN CHIM ACTA, V188, P221, DOI 10.1016/0009-8981(90)90203-5
   EGGUM BO, 1989, ABSORPTION UTILIZATI, V3, P265
   EVERSE KE, 1986, J FORENSIC SCI, V31, P446
   Exline DL, 2003, J FORENSIC SCI, V48, P1047
   Ezeagu IE, 2002, FOOD CHEM, V78, P105, DOI 10.1016/S0308-8146(02)00105-X
   FELDHOFF RC, 1984, J CHROMATOGR, V311, P267, DOI 10.1016/S0378-4347(00)84720-9
   Finley J W, 1977, Adv Exp Med Biol, V86B, P123
   FINLEY JW, 1973, CEREAL CHEM, V50, P101
   FOLKERTSMA B, 1992, J DAIRY RES, V59, P217, DOI 10.1017/S0022029900030466
   Folkertsma B, 1996, INT DAIRY J, V6, P1117, DOI 10.1016/0958-6946(95)00066-6
   Fontaine J, 2000, J AOAC INT, V83, P771
   Friedman M, 1996, J AGR FOOD CHEM, V44, P631, DOI 10.1021/jf950394r
   Friedman M, 2003, J AGR FOOD CHEM, V51, P4504, DOI 10.1021/jf030204+
   FRIEDMAN M, 1970, J BIOL CHEM, V245, P3868
   FRIEDMAN M, 1980, ANAL BIOCHEM, V106, P27, DOI 10.1016/0003-2697(80)90114-1
   FRIEDMAN M, 1970, BIOCHIM BIOPHYS ACTA, V207, P361, DOI 10.1016/0005-2795(70)90028-0
   FRIEDMAN M, 1974, BIOORG CHEM, V3, P267, DOI 10.1016/0045-2068(74)90017-0
   Friedman M, 1999, J AGR FOOD CHEM, V47, P3457, DOI 10.1021/jf990080u
   FRIEDMAN M, 1984, J FOOD SCI, V49, P1282, DOI 10.1111/j.1365-2621.1984.tb14970.x
   FRIEDMAN M, 1980, ENVIRON SCI TECHNOL, V14, P1145, DOI 10.1021/es60169a003
   FRIEDMAN M, 1967, CAN J CHEMISTRY, V45, P2271, DOI 10.1139/v67-369
   FRIEDMAN M, 1971, MICROCHEM J, V16, P204, DOI 10.1016/0026-265X(71)90110-X
   FRIEDMAN M, 1981, J CHROMATOGR, V219, P343, DOI 10.1016/S0021-9673(00)87949-2
   FRIEDMAN M, 1973, ANAL BIOCHEM, V54, P333, DOI 10.1016/0003-2697(73)90361-8
   FRIEDMAN M, 1971, J AGR FOOD CHEM, V19, P626, DOI 10.1021/jf60176a010
   FRIEDMAN M, 1979, NUTR REP INT, V19, P437
   FRIEDMAN M, 1979, J AGR FOOD CHEM, V27, P331, DOI 10.1021/jf60222a001
   Friedman M, 1996, J AGR FOOD CHEM, V44, P6, DOI 10.1021/jf9400167
   FRIEDMAN M, 1966, J ORG CHEM, V31, P2888, DOI 10.1021/jo01347a036
   FRIEDMAN M, 1965, J AM CHEM SOC, V87, P3672, DOI 10.1021/ja01094a025
   FRIEDMAN M, 1995, J AGR FOOD CHEM, V43, P69, DOI 10.1021/jf00049a014
   Friedman M, 1978, Adv Exp Med Biol, V105, P131
   Friedman M., 1982, Diabetes, V31, P5
   FRIEDMAN M, 1984, J FOOD SCI, V49, P10, DOI 10.1111/j.1365-2621.1984.tb13656.x
   FRIEDMAN M, 1988, J AGR FOOD CHEM, V36, P1079, DOI 10.1021/jf00083a042
   FRIEDMAN M, 1968, J ORG CHEM, V33, P154, DOI 10.1021/jo01265a028
   FRIEDMAN M, 1986, J AGR FOOD CHEM, V34, P497, DOI 10.1021/jf00069a032
   FRIEDMAN M, 1973, ANAL BIOCHEM, V51, P280, DOI 10.1016/0003-2697(73)90476-4
   FRIEDMAN M, 1973, P485
   FRIEDMAN M, 1990, J AGR FOOD CHEM, V38, P2011, DOI 10.1021/jf00101a005
   FRIEDMAN M, 1970, TEXT RES J, V40, P1073, DOI 10.1177/004051757004001205
   FRIEDMAN M, 1974, INT J PEPT PROT RES, V6, P183
   FRIEDMAN M, 1979, ANAL BIOCHEM, V98, P293, DOI 10.1016/0003-2697(79)90144-1
   FRIEDMAN M, 1967, J AM CHEM SOC, V89, P4709, DOI 10.1021/ja00994a025
   FRIEDMAN M, 1982, J AGR FOOD CHEM, V30, P72, DOI 10.1021/jf00109a015
   Friedman M, 2001, J PROTEIN CHEM, V20, P431, DOI 10.1023/A:1012558530359
   Friedman M, 2001, J AGR FOOD CHEM, V49, P1069, DOI 10.1021/jf0009246
   Friedman M, 1999, J AGR FOOD CHEM, V47, P1295, DOI 10.1021/jf981000+
   FRIEDMAN M, 1964, J AM CHEM SOC, V86, P3735, DOI 10.1021/ja01072a025
   FRIEDMAN M, 1966, BIOCHEMISTRY-US, V5, P478, DOI 10.1021/bi00866a012
   Friedman M, 1984, PROGR TRYPTOPHAN SER, P119
   FRIEDMAN M, 1975, PROTEIN NUTRITIONA 1, P521
   FRIEDMAN M, 1977, PROTEIN CROSSLINKING, V86, P1
   FRIEDMAN M, 1978, NUTR IMPROVEMENT FOO, P882
   FRIEDMAN M, 1977, FOOD PROTEINS, P465
   FRIEDMAN M, 1990, UNPUB REACTIONS FRUI
   FRIEDMAN M, 1970, PROTEIN CROSS LINKIN, P545
   FRIEDMAN M, 1980, P 6 INT WOOL TEXT RE, V5, P323
   FRIEDMAN M, 1971, J APPL POLYM SCI, V18, P297
   FRIEDMAN M, 1978, FLAME RETARDANT POLY, P229
   Frutos P, 2000, J PHARMACEUT BIOMED, V21, P1149, DOI 10.1016/S0731-7085(99)00192-2
   FUKUDA M, 1979, HISTOCHEMISTRY, V63, P35, DOI 10.1007/BF00508010
   Fukuda S, 1996, CIENC TECNOL ALIMENT, V16, P52
   GAITONDE MK, 1970, BIOCHEM J, V117, P907, DOI 10.1042/bj1170907
   GAITONDE MK, 1967, BIOCHEM J, V104, P627, DOI 10.1042/bj1040627
   GARCIABUSTOS JF, 1984, BIOCHEM BIOPH RES CO, V119, P779, DOI 10.1016/S0006-291X(84)80318-6
   GARDNER MLG, 1984, ANAL BIOCHEM, V141, P429, DOI 10.1016/0003-2697(84)90066-6
   GOLDMAN WE, 1982, INFECT IMMUN, V36, P782
   Grangeasse C, 1999, BIOTECHNIQUES, V27, P62, DOI 10.2144/99271bm12
   GRASSMANN W, 1934, ANAL CHEM, V6, P288
   GRIFFIN M, 1984, MOL CELL BIOCHEM, V58, P37, DOI 10.1007/BF00240603
   Griswold KE, 1997, J DAIRY SCI, V80, P167, DOI 10.3168/jds.S0022-0302(97)75924-1
   HAAGSMA N, 1979, J CHROMATOGR, V168, P550, DOI 10.1016/0021-9673(79)80032-1
   Harding VJ, 1916, J BIOL CHEM, V25, P319
   Harding VJ, 1916, J BIOL CHEM, V25, P337
   Heesing A, 1970, Justus Liebigs Ann Chem, V735, P72, DOI 10.1002/jlac.19707350112
   HIRS CHW, 1954, J BIOL CHEM, V211, P941
   HOLMES EJ, 1968, J HISTOCHEM CYTOCHEM, V16, P428, DOI 10.1177/16.6.428
   HSIEH CL, 1995, ANAL BIOCHEM, V224, P187, DOI 10.1006/abio.1995.1027
   HUAIGONG W, 1988, CHEM J CLIN U, V9, P732
   HURST PL, 1995, FOOD CHEM, V53, P467, DOI 10.1016/0308-8146(95)99843-O
   Hurst PL, 1998, FOOD CHEM, V61, P381, DOI 10.1016/S0308-8146(97)00031-9
   HUTZLER J, 1983, CLIN CHIM ACTA, V128, P75, DOI 10.1016/0009-8981(83)90057-8
   IWASE H, 1995, J CHROMATOGR B, V663, P15, DOI 10.1016/0378-4347(94)00439-C
   Jeannotte ME, 2003, INFECT IMMUN, V71, P4657, DOI 10.1128/IAI.71.8.4657-4663.2003
   JOOSTEN HMLJ, 1986, J CHROMATOGR, V356, P311, DOI 10.1016/S0021-9673(00)91491-2
   Jorns A, 1997, J ENDOCRINOL, V155, P283, DOI 10.1677/joe.0.1550283
   JOULLIE MM, 1991, TETRAHEDRON, V47, P8791, DOI 10.1016/S0040-4020(01)80997-2
   KABIRUD D, 2000, J CHEM A, V39, P1019
   KABIRUDDIN JKJ, 1999, J COLLOID INTERF SCI, V215, P9
   KALAN EB, 1965, ANAL BIOCHEM, V12, P488, DOI 10.1016/0003-2697(65)90215-0
   KANG SM, 1989, PLANT PHYSIOL, V91, P1232, DOI 10.1104/pp.91.3.1232
   KAS J, 1982, SB VYS SK CHEM TECHN, VE53, P67
   KATO T, 1986, J JPN SOC HORTIC SCI, V55, P169
   Kaupp G, 2002, CHEM-EUR J, V8, P594, DOI 10.1002/1521-3765(20020201)8:3<594::AID-CHEM594>3.0.CO;2-5
   Khramov V A, 2002, Stomatologiia (Mosk), V81, P10
   Kim MS, 2002, TOXICOL APPL PHARM, V183, P55, DOI 10.1006/taap.2002.9456
   Kleinman MH, 2003, PHOTOCHEM PHOTOBIOL, V77, P10, DOI 10.1562/0031-8655(2003)077<0010:TSON>2.0.CO;2
   KLOTZ AV, 1991, ARCH BIOCHEM BIOPHYS, V291, P113, DOI 10.1016/0003-9861(91)90112-V
   KOKKINI G, 1980, BLOOD, V56, P701
   KREMPF M, 1990, SCI ALIMENT, V10, P671
   Krzek J, 2001, J PHARMACEUT BIOMED, V24, P629, DOI 10.1016/S0731-7085(00)00438-6
   KUBO H, 1987, ANAL BIOCHEM, V162, P219, DOI 10.1016/0003-2697(87)90030-3
   KUBO H, 1989, BUNSEKI KAGAKU, V38, P215
   KUHN R, 1951, CHEM BER-RECL, V84, P91, DOI 10.1002/cber.19510840115
   LABER B, 1989, ANAL BIOCHEM, V181, P297, DOI 10.1016/0003-2697(89)90246-7
   LAMOTHE PJ, 1973, ANAL CHEM, V45, P1906, DOI 10.1021/ac60333a021
   LAMOTHE PJ, 1972, ANAL CHEM, V44, P821, DOI 10.1021/ac60312a003
   LANGNER HJ, 1969, J CHROMATOGR, V45, P142, DOI 10.1016/S0021-9673(01)86194-X
   LaPorte GM, 2003, J FORENSIC SCI, V48, P658
   Laskar S, 2001, AMINO ACIDS, V21, P201, DOI 10.1007/s007260170027
   LeBoucher J, 1997, CLIN CHEM, V43, P1421
   LENZEN S, 1992, N-S ARCH PHARMACOL, V346, P532
   LIARDON R, 1987, J AGR FOOD CHEM, V35, P661, DOI 10.1021/jf00077a007
   Ma ZW, 2003, J BIOMED MATER RES B, V67B, P610, DOI 10.1002/jbm.b.10049
   Macchi FD, 2000, METH MOL B, V159, P9
   MACFADYEN DA, 1950, J BIOL CHEM, V186, P13
   MACFADYEN DA, 1950, J BIOL CHEM, V186, P1
   MACGREGOR JT, 1980, ENVIRON MUTAGEN, V2, P405, DOI 10.1002/em.2860020311
   MAGNE C, 1992, ANAL BIOCHEM, V200, P115, DOI 10.1016/0003-2697(92)90285-F
   MAKKAR HPS, 1987, ANAL BIOCHEM, V166, P435, DOI 10.1016/0003-2697(87)90596-3
   MALININ GI, 1991, J HISTOCHEM CYTOCHEM, V39, P707, DOI 10.1177/39.5.2016517
   Markandeya N, 2002, INT J LEPROSY, V70, P125
   MARKS D, 1987, J SCI FOOD AGR, V38, P255, DOI 10.1002/jsfa.2740380309
   MARKS DL, 1985, ANAL BIOCHEM, V147, P136, DOI 10.1016/0003-2697(85)90019-3
   Martinez LG, 2002, J PHARMACEUT BIOMED, V29, P405
   MASON V C, 1976, Zeitschrift fuer Tierphysiologie Tierernaehrung und Futtermittelkunde, V36, P221
   MCCALDIN DJ, 1960, CHEM REV, V60, P39, DOI 10.1021/cr60203a004
   MCGRATH R, 1972, ANAL BIOCHEM, V49, P95, DOI 10.1016/0003-2697(72)90245-X
   MENCKE AJ, 1987, METHOD ENZYMOL, V138, P409
   MENEFEE E, 1985, J PROTEIN CHEM, V4, P333, DOI 10.1007/BF01025498
   MERTZ ET, 1974, CEREAL CHEM, V51, P304
   MOLNARPERL I, 1989, ANAL BIOCHEM, V177, P16, DOI 10.1016/0003-2697(89)90005-5
   Mondini C, 2003, J ENVIRON QUAL, V32, P2379, DOI 10.2134/jeq2003.2379
   MOORE S, 1954, J BIOL CHEM, V211, P907
   MOORE S, 1948, J BIOL CHEM, V176, P367
   MOORE S, 1968, J BIOL CHEM, V243, P6281
   MORRELL RS, 1944, J CHEM SOC, P46
   MORRIS GK, 1985, J CLIN MICROBIOL, V22, P714
   Moulin M, 2002, ANAL BIOCHEM, V308, P320, DOI 10.1016/S0003-2697(02)00202-6
   Nagaraja P, 2002, ANAL SCI, V18, P1027, DOI 10.2116/analsci.18.1027
   NAKAGAWA M, 1979, CHAGYO KENKYU HOKOKU, P56
   NIKA H, 1984, J CHROMATOGR, V297, P261, DOI 10.1016/S0021-9673(01)89047-6
   OKA Y, 1984, J NUTR SCI VITAMINOL, V30, P27
   OSTE RE, 1991, ADV EXP MED BIOL, V289, P371
   PAPAZOVA P, 1977, PHARMAZIE, V32, P486
   Paul RG, 1998, BIOCHEM J, V330, P1241, DOI 10.1042/bj3301241
   Pavia M, 2000, J DAIRY SCI, V83, P1441, DOI 10.3168/jds.S0022-0302(00)75014-4
   PEARCE KN, 1988, J FOOD SCI, V53, P432, DOI 10.1111/j.1365-2621.1988.tb07723.x
   Perrone P, 1998, PHYTOCHEMISTRY, V49, P1879, DOI 10.1016/S0031-9422(98)00370-7
   Picton SF, 2002, DIABETES METAB, V28, pS70
   PIEZ KA, 1960, ANAL BIOCHEM, V1, P187, DOI 10.1016/0003-2697(60)90045-2
   PINTERSZAKACS M, 1990, J AGR FOOD CHEM, V38, P720, DOI 10.1021/jf00093a028
   PROTA G, 1973, TETRAHEDRON, V29, P4271, DOI 10.1016/0040-4020(73)80269-8
   Quilliam Michael A., 1998, Natural Toxins, V6, P147, DOI 10.1002/(SICI)1522-7189(199805/08)6:3/4<147::AID-NT8>3.0.CO;2-#
   QUINN JR, 1974, ANAL BIOCHEM, V58, P609, DOI 10.1016/0003-2697(74)90230-9
   Qureshi S, 2000, INVEST NEW DRUG, V18, P221, DOI 10.1023/A:1006465504723
   Rahman Nafisur, 2003, Farmaco (Lausanne), V58, P1045, DOI 10.1016/S0014-827X(03)00184-8
   Ramminger U, 2001, J FORENSIC SCI, V46, P288
   RERAT A, 1987, REPROD NUTR DEV, V27, P955, DOI 10.1051/rnd:19870708
   RHODES AP, 1979, J AGR FOOD CHEM, V27, P1266, DOI 10.1021/jf60226a034
   RODRIGUEZ GP, 1984, J CHROMATOGR, V308, P65, DOI 10.1016/0378-4347(84)80196-6
   ROSEN H, 1957, ARCH BIOCHEM BIOPHYS, V67, P10, DOI 10.1016/0003-9861(57)90241-2
   RUBIN MB, 1975, CHEM REV, V75, P177, DOI 10.1021/cr60294a002
   Ruhemann S, 1910, J CHEM SOC, V97, P1438, DOI 10.1039/ct9109701438
   Ruhemann S, 1911, J CHEM SOC, V99, P1306, DOI 10.1039/ct9119901306
   Ruhemann S, 1911, J CHEM SOC, V99, P1486, DOI 10.1039/ct9119901486
   Ruhemann S, 1910, J CHEM SOC, V97, P2025, DOI 10.1039/ct9109702025
   RYAN EA, 1980, J CHROMATOGR, V195, P127, DOI 10.1016/S0021-9673(00)81550-2
   SAMEJIMA K, 1971, ANAL BIOCHEM, V42, P237, DOI 10.1016/0003-2697(71)90031-5
   SAMEJIMA K, 1971, ANAL BIOCHEM, V42, P222, DOI 10.1016/0003-2697(71)90030-3
   SARWAR G, 1985, J ASSOC OFF ANA CHEM, V68, P52
   SARWAR G, 1983, J FOOD SCI, V48, P526, DOI 10.1111/j.1365-2621.1983.tb10781.x
   Schertz TD, 2001, J ORG CHEM, V66, P7596, DOI 10.1021/jo0102720
   SCHILLING ED, 1963, ANAL BIOCHEM, V5, P1, DOI 10.1016/0003-2697(63)90051-4
   SCHONBERG A, 1978, TETRAHEDRON, V34, P1285
   SCHRAM E, 1953, ANAL CHIM ACTA, V9, P149, DOI 10.1016/S0003-2670(01)80747-9
   Schwarz L, 2002, J FORENSIC SCI, V47, P1274
   Schwimmer S., 1972, Flavour Industry, V3, P137
   SCHWIMMER S, 1981, SOURCE BOOK FOOD ENZ, P967
   SCOTT DB, 1987, J BACTERIOL, V169, P278, DOI 10.1128/jb.169.1.278-282.1987
   SEKKAT M, 1989, J PHARMACEUT BIOMED, V7, P883, DOI 10.1016/0731-7085(89)80010-X
   SHAPIRO R, 1968, J AM CHEM SOC, V90, P474, DOI 10.1021/ja01004a045
   SHAPIRO R, 1966, BIOCHEMISTRY-US, V5, P2799, DOI 10.1021/bi00873a004
   SHENG SJ, 1993, ANAL BIOCHEM, V211, P242, DOI 10.1006/abio.1993.1264
   SHUKLA Y, 1994, FOOD CHEM TOXICOL, V32, P651, DOI 10.1016/0278-6915(94)90009-4
   SLOBODIAN E, 1962, SCIENCE, V135, P441, DOI 10.1126/science.135.3502.441
   SMITH GA, 1984, J FOOD SCI, V49, P817, DOI 10.1111/j.1365-2621.1984.tb13219.x
   SNOW JT, 1975, BIOCHEM BIOPH RES CO, V64, P441, DOI 10.1016/0006-291X(75)90272-7
   SODEK L, 1975, J AGR FOOD CHEM, V23, P1147, DOI 10.1021/jf60202a024
   SREEKRISHNA K, 1980, ANAL BIOCHEM, V103, P55, DOI 10.1016/0003-2697(80)90235-3
   Starcher B, 2001, ANAL BIOCHEM, V292, P125, DOI 10.1006/abio.2001.5050
   STOILOVIC M, 1986, J FORENSIC SCI, V31, P432
   Taha EA, 2003, CHEM PHARM BULL, V51, P1444, DOI 10.1248/cpb.51.1444
   TAKAHASHI K, 1976, J BIOCHEM, V80, P1173, DOI 10.1093/oxfordjournals.jbchem.a131373
   TAYLOR IEP, 1970, J CHROMATOGR, V50, P331, DOI 10.1016/S0021-9673(00)97955-X
   THOMPSON J, 1988, J BIOL CHEM, V263, P2064
   THOMPSON JF, 1959, ANAL CHEM, V31, P1031, DOI 10.1021/ac60150a023
   Tiedge M, 1997, BBA-PROTEIN STRUCT M, V1337, P175, DOI 10.1016/S0167-4838(96)00162-8
   TROLL W, 1953, J BIOL CHEM, V200, P803
   Tschen J S, 1989, Proc Natl Sci Counc Repub China B, V13, P258
   van den Bosch E, 2003, INT J BIOL MACROMOL, V32, P129, DOI 10.1016/S0141-8130(03)00046-1
   Van Slyke DD, 1943, J BIOL CHEM, V150, P471
   VANDALEN JP, 1971, HISTOCHEMISTRY, V26, P183
   VISSER S, 1986, ANAL BIOCHEM, V153, P235, DOI 10.1016/0003-2697(86)90087-4
   WARD LC, 1978, ANAL BIOCHEM, V88, P598, DOI 10.1016/0003-2697(78)90461-X
   WEST R, 1965, J CHEM EDUC, V42, P386, DOI 10.1021/ed042p386
   WHITFIELD RE, 1972, TEXT RES J, V42, P344, DOI 10.1177/004051757204200608
   Wiesner S, 2001, J FORENSIC SCI, V46, P1082
   Wimalasena R, 2003, BIOMED CHROMATOGR, V17, P165, DOI 10.1002/bmc.234
   WORK E, 1957, BIOCHEM J, V67, P416, DOI 10.1042/bj0670416
   YAMADA H, 1991, ANAL BIOCHEM, V198, P1, DOI 10.1016/0003-2697(91)90496-G
   YAMADA K, 1990, J HISTOCHEM CYTOCHEM, V38, P985, DOI 10.1177/38.7.2355178
   YAO K, 1992, J CHROMATOGR-BIOMED, V581, P11, DOI 10.1016/0378-4347(92)80442-S
   YAO K, 1990, ACTA MED OKAYAMA, V44, P65
   YEMM EW, 1955, ANALYST, V80, P209, DOI 10.1039/an9558000209
   YUFEROV VP, 1970, BIOCHIM BIOPHYS ACTA, V200, P160, DOI 10.1016/0005-2795(70)90054-1
   YUFEROV VP, 1968, BIOFIZIKA, V13, P1119
   YUFEROV VP, 1971, USP BIOL KHIM, V12, P62
   ZACHARIUS RM, 1962, J CHROMATOGR, V7, P51, DOI 10.1016/S0021-9673(01)86378-0
   ZACHARIUS RM, 1976, J CHROMATOGR, V125, P421, DOI 10.1016/S0021-9673(00)83373-7
   ZAHNLEY JC, 1973, BIOCHEM J, V135, P59, DOI 10.1042/bj1350059
   Zdebska E, 1999, ANAL BIOCHEM, V275, P171, DOI 10.1006/abio.1999.4294
   Zhan CG, 2002, J AM CHEM SOC, V124, P2744, DOI 10.1021/ja0113394
   ZORRILLA HL, 1979, CROP SCI, V19, P659
NR 258
TC 214
Z9 220
U1 17
U2 304
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
EI 1520-5118
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD FEB 11
PY 2004
VL 52
IS 3
BP 385
EP 406
DI 10.1021/jf030490p
PG 22
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
SC Agriculture; Chemistry; Food Science & Technology
GA 772FH
UT WOS:000188830300001
PM 14759124
DA 2018-10-19
ER

PT J
AU Leoni, L
   Desai, TA
AF Leoni, L
   Desai, TA
TI Micromachined biocapsules for cell-based sensing and delivery
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE nanotechnology; microfabrication; silicon; immunoisolation; cell-based
   delivery
ID SINGLE-FILE DIFFUSION; PC12 CELLS; IMMUNOISOLATION; SILICON; TRANSPORT;
   MEMBRANES; ISLETS
AB In recent years, rapid advancements have been made in the biomedical applications of micro- and nanotechnology. While the focus of such technology has primarily been on in vitro analytical and diagnostic tools, more recently, in vivo therapeutic and sensing applications have gained attention. The long-term integration of cells with inorganic materials provides the basis for novel delivery and sensing platforms. Our recent work has focused on the ability to maintain cells long term in nanoporous silicon-based microenvironments. This paper describes the creation of monodisperse, nanoporous, biocompatible, silicon membranes as a platform for the delivery of cells. Studies described herein focus on the interaction of silicon-based substrates with cells of interest in terms of viability, proliferation, and functionality. Such microfabricated nanoporous membranes can be used both in vitro for cell-based assays and in vivo for immunoisolation and drug delivery applications. (C) 2003 Elsevier B.V. All rights reserved.
C1 Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
   Univ Illinois, Dept Bioengn, Chicago, IL 60607 USA.
RP Desai, TA (reprint author), Boston Univ, Dept Biomed Engn, 44 Cummington St, Boston, MA 02215 USA.
EM tdesai@bu.edu
CR AEBISCHER P, 1994, EXP NEUROL, V126, P151, DOI 10.1006/exnr.1994.1053
   AITYAN SK, 1986, GEN PHYSIOL BIOPHYS, V5, P351
   AITYAN SK, 1988, GEN PHYSIOL BIOPHYS, V7, P591
   Campbell C E, 1989, J Invest Surg, V2, P51, DOI 10.3109/08941938909016503
   Chu W., 1996, SPIE P MICRO NANOFAB, V2978, P111
   COLTON CK, 1995, CELL TRANSPLANT, V4, P415, DOI 10.1016/0963-6897(95)00025-S
   COLTON CK, 1991, T ASME, V113, P152
   DESAI T, 1998, THESIS U CALIFORNIA
   Desai TA, 2000, BIOMOL ENG, V17, P23, DOI 10.1016/S1389-0344(00)00063-0
   Desai TA, 1998, BIOTECHNOL BIOENG, V57, P118, DOI 10.1002/(SICI)1097-0290(19980105)57:1<118::AID-BIT14>3.0.CO;2-G
   Desai TA, 1999, J MEMBRANE SCI, V159, P221, DOI 10.1016/S0376-7388(99)00062-9
   DESAI TA, 1999, J BIOMED MICRODEVICE, V1, P131
   Ferrari M, 1996, MATER RES SOC SYMP P, V414, P101
   Hahn K, 1996, PHYS REV LETT, V76, P2762, DOI 10.1103/PhysRevLett.76.2762
   HANSFORD DJ, 1999, THESIS U CALIFORNIA
   HERNANDEZ JA, 1994, BIOPHYS J, V67, P996, DOI 10.1016/S0006-3495(94)80565-X
   Iwata H, 1995, TRANSPLANT P, V27, P3224
   IWATA H, 1994, J BIOMED MATER RES, V28, P1003, DOI 10.1002/jbm.820280905
   Kovacs GTA, 1998, P IEEE, V86, P1536, DOI 10.1109/5.704259
   Lanza RP, 1996, NAT BIOTECHNOL, V14, P1107, DOI 10.1038/nbt0996-1107
   Leoni L, 2002, BIOMED MICRODEVICES, V4, P131, DOI 10.1023/A:1014639332543
   LEONI L, 2001, IEEE T BIOMED ENG, V48, P11
   LEONI L, 2003, THESIS U ILLINOIS
   Polla DL, 2000, ANNU REV BIOMED ENG, V2, P551, DOI 10.1146/annurev.bioeng.2.1.551
   Roberts T, 1996, BIOMATERIALS, V17, P267, DOI 10.1016/0142-9612(96)85564-5
   SAGEN J, 1993, J NEUROSCI, V13, P2415
   Storrs R, 2001, ANN NY ACAD SCI, V944, P252
   Suzuki K, 1998, CELL TRANSPLANT, V7, P47, DOI 10.1016/S0963-6897(97)00114-0
   SZE M, 1994, SEMICONDUCTOR SENSOR
   Wei QH, 2000, SCIENCE, V287, P625, DOI 10.1126/science.287.5453.625
   WINN SR, 1994, P NATL ACAD SCI USA, V91, P2324, DOI 10.1073/pnas.91.6.2324
NR 31
TC 57
Z9 63
U1 0
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD FEB 10
PY 2004
VL 56
IS 2
BP 211
EP 229
DI 10.1016/j.addr.2003.08.014
PG 19
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 771GU
UT WOS:000188777900007
PM 14741117
DA 2018-10-19
ER

PT J
AU Cui, YJ
   Zhao, M
   Tang, XZ
   Luo, YP
AF Cui, YJ
   Zhao, M
   Tang, XZ
   Luo, YP
TI Novel micro-crosslinked poly(organophosphazenes) with improved
   mechanical properties and controllable degradation rate as potential
   biodegradable matrix
SO BIOMATERIALS
LA English
DT Article
DE polyphosphazenes; biodegradation; mechanical properties; crosslinked
ID POLY<(AMINO ACID ESTER)PHOSPHAZENES>; SKELETAL TISSUE REGENERATION;
   BIOMEDICAL APPLICATIONS; CONTROLLED-RELEASE; SIDE-GROUPS;
   POLYPHOSPHAZENES; BLENDS; POLYMERS
AB As biodegradable materials, linear polyphosphazenes undergo rapid hydrolysis degradation but exhibit poor mechanical properties. Blending with biodegradable polyesters or inorganic particles strengthen their mechanical properties but give rise to slower degradation rate. To balance the mechanical properties and the degradation rate, micro-crosslinked polyphosphazenes were synthesized in this study. Their glass transition temperatures, mechanical properties, and in vitro degradation behavior were investigated. 2-Hydroxyethyl methacrylate (HEMA) was firstly attached to the side chain along with glycine ethyl ester to prepare co-substituted poly(organophosphazene) with pendant ethenyl substituents. The co-substituted poly(organophosphazene) was blended with HEMA or acrylic acid (AA) followed by a free radical polymerization to prepare micro-crosslinked poly(organophosphazenes). The resulting crosslinked polymers showed two separate glass transition temperatures depending on the HEMA or AA feed. Incorporation of crosslinking affected the mechanical properties positively. Crosslinked poly(organophosphazenes) showed an approximately 11-17 fold increase in terms of modulus of elasticity when compared to the linear counterpart. In vitro degradation tests indicated that HEMA-crosslinked polymers hydrolyzed at a retarded rate while AA-crosslinked polymers hydrolyzed at a moderate rate compared to linear polymers. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Shanghai Jiao Tong Univ, Sch Chem & Chem Technol, Shanghai 200240, Peoples R China.
RP Tang, XZ (reprint author), Shanghai Jiao Tong Univ, Sch Chem & Chem Technol, Shanghai 200240, Peoples R China.
CR Aldini NN, 2000, INT ORTHOP, V24, P121
   ALEXANDER KA, 1998, BIOMATERIALS, V19, P109
   ALLCOCK HR, 1994, MACROMOLECULES, V27, P1, DOI 10.1021/ma00079a001
   ALLCOCK HR, 1977, MACROMOLECULES, V10, P824, DOI 10.1021/ma60058a020
   ALLCOCK HR, 1994, BIOMATERIALS, V15, P563, DOI 10.1016/0142-9612(94)90205-4
   ALLCOCK HR, 1977, ANGEW CHEM INT EDIT, V16, P147, DOI 10.1002/anie.197701471
   ALLCOCK HR, 1965, J AM CHEM SOC, V87, P4216, DOI 10.1021/ja01096a056
   ALLCOCK HR, 1982, INORG CHEM, V21, P515, DOI 10.1021/ic00132a009
   Allcock HR, 1996, MACROMOLECULES, V29, P2721, DOI 10.1021/ma9501398
   ALLCOCK HR, 1994, MACROMOLECULES, V27, P1071, DOI 10.1021/ma00083a001
   ALLCOCK HR, 1992, CHEM MATER, V4, P1182, DOI 10.1021/cm00024a015
   ALLCOCK HR, 1992, SCIENCE, V255, P1106, DOI 10.1126/science.255.5048.1106
   Ambrosio AMA, 2002, BIOMATERIALS, V23, P1667, DOI 10.1016/S0142-9612(01)00293-9
   CROMMEN J, 1993, J CONTROL RELEASE, V24, P167, DOI 10.1016/0168-3659(93)90176-6
   Hoffman A. S., 2002, ADV DRUG DELIVERY RE, V43, P3, DOI DOI 10.1016/S0169-409X(01)00239-3
   Ibim SEM, 1997, BIOMATERIALS, V18, P1565, DOI 10.1016/S0142-9612(97)00099-9
   Ibim SM, 1996, J CONTROL RELEASE, V40, P31, DOI 10.1016/0168-3659(95)00136-0
   LAURENCIN CT, 1987, J BIOMED MATER RES, V21, P1231, DOI 10.1002/jbm.820211006
   LAURENCIN CT, 1993, J BIOMED MATER RES, V27, P963, DOI 10.1002/jbm.820270716
   Laurencin CT, 1996, J BIOMED MATER RES, V30, P133, DOI 10.1002/(SICI)1097-4636(199602)30:2<133::AID-JBM1>3.0.CO;2-S
   Lemmouchi Y, 1998, J BIOACT COMPAT POL, V13, P4, DOI 10.1177/088391159801300102
   NEILSON RH, 1988, CHEM REV, V88, P541, DOI 10.1021/cr00085a005
   Qiu LY, 2000, POLYM INT, V49, P1283, DOI 10.1002/1097-0126(200011)49:11<1283::AID-PI471>3.0.CO;2-D
   Reed CS, 1996, CHEM MATER, V8, P440, DOI 10.1021/cm9503644
   Schacht E, 1996, BIOTECHNOL BIOENG, V52, P102, DOI 10.1002/(SICI)1097-0290(19961005)52:1<102::AID-BIT10>3.3.CO;2-B
   SMETANA K, 1987, J BIOMED MATER RES, V21, P1247, DOI 10.1002/jbm.820211007
NR 26
TC 23
Z9 27
U1 4
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2004
VL 25
IS 3
BP 451
EP 457
DI 10.1016/S0142-9612(03)00532-5
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 746CA
UT WOS:000186727900009
PM 14585693
DA 2018-10-19
ER

PT J
AU Sionkowska, A
   Wisniewski, M
   Skopinska, J
   Kennedy, CJ
   Wess, TJ
AF Sionkowska, A
   Wisniewski, M
   Skopinska, J
   Kennedy, CJ
   Wess, TJ
TI Molecular interactions in collagen and chitosan blends
SO BIOMATERIALS
LA English
DT Article
DE collagen; chitosan; FTIR; XRD; structure; viscometry; gelatin
ID BIOARTIFICIAL POLYMERIC MATERIALS; PRINCIPAL COMPONENTS-ANALYSIS;
   PHYSICOCHEMICAL CHARACTERISTICS; PROPRANOLOL HYDROCHLORIDE;
   MECHANICAL-PROPERTIES; COMPOSITE MEMBRANES; TISSUE; BIOMATERIALS;
   SCAFFOLDS; SAMPLES
AB Molecular interactions between collagen and chitosan (CC) have the potential to produce biocomposites with novel properties. We have characterised the molecular interactions in CC complexes by viscometry, wide angle X-ray scattering and Fourier transform infrared spectroscopy. It was found that CC are miscible at the molecular level and exhibit interactions between the components;, X-ray diffraction of CC blends indicate that the collagen helix structure is lost in CC films with increasing chitosan content. Non-linear viscometic behaviour with decreasing chitosan content is interpreted as evidence of a third structural phase formed as a complex of CC. The blending of collagen with chitosan gives the possibility of producing new bespoke materials for potential biomedical applications. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Nicholas Copernicus Univ, Fac Chem, PL-87100 Torun, Poland.
   Univ Stirling, Dept Biol Sci, Ctr Extracellular Matrix Biol, Stirling FK9 4LA, Scotland.
RP Wess, TJ (reprint author), Cardiff Univ, Dept Opt & Vis Sci, Redwood Bldg,King Edward 7 Ave,Cathays Pk, Cardiff CF10 3NB, S Glam, Wales.
EM tjw3@stir.ac.uk
RI Kennedy, Craig/H-8826-2012; Skopinska-Wisniewska, Joanna/O-6445-2015;
   Sionkowska, Alina/I-5599-2014
OI Kennedy, Craig/0000-0001-7788-5095
CR Basilevsky A., 1994, STAT FACTOR ANAL REL
   Boik RJ, 1998, J MULTIVARIATE ANAL, V67, P244, DOI 10.1006/jmva.1998.1766
   Brodsky-Doyle B, 1975, BIOPOLYMERS, V14, P937
   Candel MJJM, 2001, QUAL QUANT, V35, P91, DOI 10.1023/A:1004873031561
   Cascone MG, 1997, POLYM INT, V43, P55
   Chen XG, 2002, BIOMATERIALS, V23, P4609, DOI 10.1016/S0142-9612(02)00207-7
   Everitt B S, 1992, APPL MULTIVARIATE DA
   GARP T, 1999, HDB MICROANALYSIS PA, P211
   GIUSTI P, 1994, BIOMATERIALS, V15, P1229, DOI 10.1016/0142-9612(94)90274-7
   Hirano S, 2000, BIOMATERIALS, V21, P997, DOI 10.1016/S0142-9612(99)00258-6
   JACKSON M, 1995, BBA-MOL BASIS DIS, V1270, P1, DOI 10.1016/0925-4439(94)00056-V
   Kalukin AR, 2000, IEEE T NUCL SCI, V47, P1729, DOI 10.1109/23.890998
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Leffler CC, 2000, INT J PHARM, V194, P229, DOI 10.1016/S0378-5173(99)00383-X
   Machado AAS, 2002, J THERM ANAL CALORIM, V67, P491
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   MUZZARELLI R, 1988, BIOMATERIALS, V9, P247, DOI 10.1016/0142-9612(88)90092-0
   Nettles DL, 2002, TISSUE ENG, V8, P1009, DOI 10.1089/107632702320934100
   OGAWA K, 1991, AGR BIOL CHEM TOKYO, V55, P2375, DOI 10.1080/00021369.1991.10870939
   Onishi H, 1999, BIOMATERIALS, V20, P175, DOI 10.1016/S0142-9612(98)00159-8
   Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720
   PINGPING Z, 1997, EUR POLYM J, V33, P411
   RENUGOPALAKRISHNAN V, 1989, MACROMOLECULES, V22, P4121, DOI 10.1021/ma00200a054
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Shanmugasundaram N, 2001, BIOMATERIALS, V22, P1943, DOI 10.1016/S0142-9612(00)00220-9
   Silverman BW, 1996, ANN STAT, V24, P1
   Struszczyk MH, 2002, POLIMERY-W, V47, P396
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   SUSI H, 1971, J AM LEATHER CHEM AS, V66, P508
   Taravel MN, 1996, BIOMATERIALS, V17, P451, DOI 10.1016/0142-9612(96)89663-3
   TARAVEL MN, 1995, BIOMATERIALS, V16, P865, DOI 10.1016/0142-9612(95)94149-F
   TARAVEL MN, 1993, BIOMATERIALS, V14, P930, DOI 10.1016/0142-9612(93)90135-O
   THACHARODI D, 1995, INT J PHARM, V120, P115, DOI 10.1016/0378-5173(94)00423-3
   Thacharodi D, 1996, INT J PHARM, V134, P239, DOI 10.1016/0378-5173(96)04453-5
   WARREN JR, 1969, J AM CHEM ASS, V64, P4
   WEINER S, 1980, NATURE, V287, P820, DOI 10.1038/287820a0
   Wess TJ, 2001, ARCHAEOMETRY, V43, P117, DOI 10.1111/1475-4754.00007
NR 37
TC 280
Z9 297
U1 3
U2 87
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2004
VL 25
IS 5
BP 795
EP 801
DI 10.1016/S0142-9612(03)00595-7
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 748GD
UT WOS:000186853400005
PM 14609668
DA 2018-10-19
ER

PT J
AU Bujan, J
   Garcia-Honduvilla, N
   Bellon, JM
AF Bujan, J
   Garcia-Honduvilla, N
   Bellon, JM
TI Engineering conduits to resemble natural vascular tissue
SO BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY
LA English
DT Review
DE endothelial-cell seeding; expanded polytetrafluoroethylene (ePTFE);
   scaffold; tissue engineering; vascular prostheses
ID IN-VITRO ENDOTHELIALIZATION; DACRON ARTERIAL GRAFTS; MARROW STROMAL
   CELLS; EXPANDED POLYTETRAFLUOROETHYLENE; INTIMAL HYPERPLASIA; PROSTHETIC
   GRAFTS; PULMONARY-ARTERY; EPTFE GRAFTS; PLATELET-AGGREGATION;
   CLINICAL-EXPERIENCE
AB Research on the use of biomaterials as vascular substitutes has been dominated in the past by studies focusing on the properties of the materials used. These need to be resistant to protein absorption and should allow cell colonization and integration of the biomaterial within recipient tissue. Despite promising perspectives related both to the appearance of new synthetic materials with biomedical applications and to developments in arterial replacement techniques, there are still many unresolved problems. These include the appearance of occlusive phenomena when using medium- or small-calibre arterial substitutes, and the lack of growth and adaptability of the biomaterial to changes in the host. Notwithstanding, the tissue-engineering techniques developed in recent decades have vastly improved prosthetic behaviour at the blood/ biomaterial interface. There is also no doubt that developments in engineered arterial grafts made of natural biomaterials colonized with cells harvested from the recipient patient are drawing us closer and closer to achieving the living graft.
C1 Univ Alcala de Henares, Fac Med, Dept Med Specialties, Madrid, Spain.
   Univ Alcala de Henares, Fac Med, Dept Surg, Madrid, Spain.
RP Bujan, J (reprint author), Univ Alcala de Henares, Fac Med, Dept Med Specialties, Madrid, Spain.
EM mjulia.bujan@uah.es
OI BELLON, JUAN M./0000-0002-6071-5011; bujan, Julia/0000-0003-2419-2476;
   Garcia Honduvilla, Natalio/0000-0003-0904-6198
CR AKIYAMA SK, 1987, ADV ENZYMOL RAMB, V59, P1
   ALLEN BT, 1984, J VASC SURG, V1, P224, DOI 10.1067/mva.1984.avs0010224
   Almeida JI, 1998, J VASC SURG, V27, P896, DOI 10.1016/S0741-5214(98)70270-8
   Ambrosio AMA, 2002, BIOMATERIALS, V23, P1667, DOI 10.1016/S0142-9612(01)00293-9
   Arts CHP, 2002, EUR J VASC ENDOVASC, V23, P29, DOI 10.1053/ejvs.2001.1532
   Bader A, 1998, EUR J CARDIO-THORAC, V14, P279, DOI 10.1016/S1010-7940(98)00171-7
   Bader A, 2000, TRANSPLANTATION, V70, P7
   BADYLAK SF, 1998, BIOMATER SCI POLYM E, V8, P863
   BARRENA EG, 2000, BIOMATERIALS AQUI AH, P31
   Bellon J M, 1993, Ann Vasc Surg, V7, P549, DOI 10.1007/BF02000149
   Bellon JM, 1997, EUR J VASC ENDOVASC, V13, P142, DOI 10.1016/S1078-5884(97)80010-X
   BELLON JM, 1992, CIR ESPAN, V51, P25
   BENGTSSON LA, 1995, ANN THORAC SURG, V60, pS365, DOI 10.1016/0003-4975(95)00316-D
   Bonassar LJ, 1998, J CELL BIOCHEM, P297, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<297::AID-JCB36>3.0.CO;2-6
   Bos GW, 1999, THROMB HAEMOSTASIS, V82, P1757
   Brockbank KGM, 2000, TRANSPLANT P, V32, P3, DOI 10.1016/S0041-1345(99)00851-9
   Bujan J, 1998, J BIOMED MATER RES, V39, P32, DOI 10.1002/(SICI)1097-4636(199801)39:1<32::AID-JBM5>3.0.CO;2-J
   BUJAN J, 1999, PATOL VASC, V5, P9
   BUJAN J, 1997, ANGIOLOGIA, V3, P111
   CAMPBELL LB, 1988, EUR J VASCULAR SURG, V2, P365
   Chakfe N, 2003, EUR J VASC ENDOVASC, V25, P360, DOI 10.1053/ejvs.2002.1790
   CIMA LG, 1993, CHEM ENG PROG    JUN, P46
   Clarke DR, 2001, ANN THORAC SURG, V71, pS433, DOI 10.1016/S0003-4975(01)02556-5
   Coito A J, 1996, Ann Transplant, V1, P14
   Coito A J, 2000, Dev Immunol, V7, P239, DOI 10.1155/2000/98187
   COURTMAN DW, 1994, J BIOMED MATER RES, V28, P655, DOI 10.1002/jbm.820280602
   Courtman DW, 2001, J BIOMED MATER RES, V55, P576, DOI 10.1002/1097-4636(20010615)55:4<576::AID-JBM1051>3.0.CO;2-9
   COURTMAN DW, 1999, P SOC BIOM 25 ANN M
   Curtil A, 1997, J HEART VALVE DIS, V6, P296
   CURTIS ASG, 1984, J CELLS CI, V86, P9
   DAHM M, 1990, J THORAC CARDIOV SUR, V99, P1082
   Dardik H, 1999, Semin Vasc Surg, V12, P1
   DEBAKEY ME, 1964, ARCH SURG-CHICAGO, V89, P757
   Falkenback D, 2000, EUR J VASC ENDOVASC, V19, P468, DOI 10.1053/ejvs.1999.1075
   Fauza DO, 2001, J PEDIATR SURG, V36, P146, DOI 10.1053/jpsu.2001.20034
   FLETCHER JP, 1990, AUST NZ J SURG, V60, P801, DOI 10.1111/j.1445-2197.1990.tb07477.x
   GALLARDO A, 2000, BIOMATERIALS AQUI AH, P45
   GARCIAHONDUVILL.N, 2002, ANGIOLOGIA, V54, P270
   GARCIAHONDUVILL.N, 1995, ARTIF ORGANS, V19, P144
   GARCIAHONDUVILL.N, 2000, PATOL VASC, V6, P203
   GIMBRONE MA, 1976, PROG HEMOST THROMB, V31, P1
   Goissis G, 2000, ARTIF ORGANS, V24, P217, DOI 10.1046/j.1525-1594.2000.06537.x
   GOLDEN MA, 1990, J VASC SURG, V11, P838, DOI 10.1067/mva.1990.18047
   GRAHAM L, 1987, ENDOTHELIALISATION V, P57
   GRAHAM LM, 1991, J BIOMED MATER RES, V25, P525, DOI 10.1002/jbm.820250409
   GRAHAM LM, 1982, SURGERY, V91, P550
   GREISLER HP, 1990, ARCH SURG-CHICAGO, V125, P1622
   HARRISON JH, 1958, AM J SURG, V95, P3, DOI 10.1016/0002-9610(58)90735-9
   Hazama K, 1999, J SURG RES, V81, P174, DOI 10.1006/jsre.1998.5497
   Hernandez D.J., 1994, SOCIAL POLICY REPORT, V8, P1
   HERNANDO A, 1995, EUR J VASC ENDOVASC, V10, P387, DOI 10.1016/S1078-5884(05)80077-2
   HERRING M, 1978, SURGERY, V84, P498
   HERRING M, 1994, J VASC SURG, V20, P650, DOI 10.1016/0741-5214(94)90291-7
   Hoerstrup SP, 2002, ANN THORAC SURG, V74, P46, DOI 10.1016/S0003-4975(02)03649-4
   Hoerstrup SP, 2001, EUR J CARDIO-THORAC, V20, P164, DOI 10.1016/S1010-7940(01)00706-0
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   HUBBELL JA, 1995, CHEM ENG NEWS   0313, P42
   HUSSAIN S, 1989, J VASC SURG, V9, P656, DOI 10.1067/mva.1989.vs0090656
   IMANISHI Y, 1988, J MACROMOL SCI CHEM, VA25, P555, DOI 10.1080/00222338808053384
   JACKSON RL, 1991, PHYSIOL REV, V71, P481
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   JORGEHERRERO E, 1991, BIOMATERIALS, V12, P683, DOI 10.1016/0142-9612(91)90117-S
   Kadner A, 2002, EUR J CARDIO-THORAC, V21, P1055, DOI 10.1016/S1010-7940(02)00079-9
   Kao WYJ, 2000, BIOMATERIALS, V21, P2295, DOI 10.1016/S0142-9612(00)00156-3
   KATZ MH, 1991, J AM ACAD DERMATOL, V25, P1054, DOI 10.1016/0190-9622(91)70306-M
   Kaviani A, 2001, J PEDIATR SURG, V36, P1662, DOI 10.1053/jpsu.2001.27945
   Kaviani A, 2002, J PEDIATR SURG, V37, P995, DOI 10.1053/jpsu.2002.33828
   KEMPCZINSKI RF, 1985, J VASC SURG, V2, P424, DOI 10.1067/mva.1985.avs0020424
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   KIRKPATRICK CJ, 1990, PATHOBIOLOGY, V58, P221
   KRIJGSMAN B, 1995, EUR J VASC ENDOVASC, V10, P387, DOI 10.1016/S1078-5884(05)80076-0
   LALKA SG, 1989, ANN VASC SURG, V3, P187
   Lamm P, 1999, J THORAC CARDIOV SUR, V117, P1217, DOI 10.1016/S0022-5223(99)70264-3
   Langer RS, 1999, SCI AM, V280, P86, DOI 10.1038/scientificamerican0499-86
   Laube HR, 2000, J THORAC CARDIOV SUR, V120, P134, DOI 10.1067/mtc.2000.106327
   Lemson MS, 2000, EUR J VASC ENDOVASC, V19, P336, DOI 10.1053/ejvs.1999.1040
   Liechty KW, 2000, NAT MED, V6, P1282
   LIVESEY S, 1999, MAT RES SOC S P SER, V530
   LOGERFO FW, 1983, ANN SURG, V197, P479, DOI 10.1097/00000658-198304000-00018
   MACKENZIE DC, 1960, BRIT J SURG, V48, P212, DOI 10.1002/bjs.18004820827
   Madden R, 2002, AM J KIDNEY DIS, V40, P1240, DOI 10.1053/ajkd.2002.36892
   MALONE JM, 1984, J VASC SURG, V1, P181, DOI 10.1067/mva.1984.avs0010181
   MANSFIELD P B, 1970, Review of Surgery, V27, P291
   Marois Y, 1999, ASAIO J, V45, P272, DOI 10.1097/00002480-199907000-00005
   Meinhart JG, 2001, ANN THORAC SURG, V71, pS327, DOI 10.1016/S0003-4975(01)02555-3
   Mikucki S A, 1999, Semin Vasc Surg, V12, P18
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Niu S, 1991, ASAIO Trans, V37, pM441
   Noishiki Y, 1989, ASAIO Trans, V35, P267, DOI 10.1097/00002480-198907000-00030
   NUWAYSER ES, 1973, ASAIO T, V19, P168
   OBLATH RW, 1978, SURGERY, V84, P37
   PALMER RMJ, 1988, NATURE, V333, P664, DOI 10.1038/333664a0
   Park JC, 2001, YONSEI MED J, V42, P304, DOI 10.3349/ymj.2001.42.3.304
   PARK PK, 1990, J VASC SURG, V11, P468, DOI 10.1067/mva.1990.17242
   Pascual G, 2002, EUR J VASC ENDOVASC, V24, P23, DOI 10.1053/ejvs.2002.1663
   Patterson R B, 1989, Ann Vasc Surg, V3, P160, DOI 10.1016/S0890-5096(06)62010-4
   Phaneuf MD, 2001, BIOMATERIALS, V22, P463, DOI 10.1016/S0142-9612(00)00202-7
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   PREVEL CD, 1994, MICROSURG, V15, P586, DOI 10.1002/micr.1920150812
   Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71
   RAMALANJAONA GR, 1986, J SURG RES, V41, P479, DOI 10.1016/0022-4804(86)90165-4
   Roeder R, 1999, J BIOMED MATER RES, V47, P65, DOI 10.1002/(SICI)1097-4636(199910)47:1<65::AID-JBM9>3.0.CO;2-F
   ROSENMAN JE, 1985, J VASC SURG, V2, P778, DOI 10.1067/mva.1985.avs0020778
   SANDUSKY GE, 1992, AM J PATHOL, V140, P317
   SanRoman J, 1996, J BIOMED MATER RES, V32, P19, DOI 10.1002/(SICI)1097-4636(199609)32:1<19::AID-JBM3>3.0.CO;2-S
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   SCHMITZRIXEN T, 1988, J VASC SURG, V7, P82, DOI 10.1067/mva.1988.avs0070082
   SCHNEIDER PA, 1989, J VASC SURG, V23, P183
   SEEGER JM, 1988, J VASC SURG, V8, P476
   SHAREFKIN JB, 1982, SURGERY, V92, P385
   Shinoka T, 1998, J THORAC CARDIOV SUR, V115, P536, DOI 10.1016/S0022-5223(98)70315-0
   Shum-Tim D, 1999, ANN THORAC SURG, V68, P2298, DOI 10.1016/S0003-4975(99)01055-3
   Siegel G, 2001, BIOSENS BIOELECTRON, V16, P895, DOI 10.1016/S0956-5663(01)00235-4
   SOYER T, 1972, SURGERY, V72, P864
   Sparks SR, 2002, ANN VASC SURG, V16, P73, DOI 10.1007/s10016-001-0133-5
   STANSBY G, 1994, CARDIOVASC SURG, V2, P254
   STERPETTI AV, 1988, J VASC SURG, V7, P677, DOI 10.1067/mva.1988.avs0070677
   Stock UA, 2000, J THORAC CARDIOV SUR, V120, P1158, DOI 10.1067/mtc.2000.109539
   SZILAGYI DE, 1982, J CARDIOVASC SURG, V23, P183
   Takasaki K., 1989, REV MATH PHYS, V1, P1
   Teebken OE, 2000, EUR J VASC ENDOVASC, V19, P381, DOI 10.1053/ejvs.1999.1004
   Teebken OE, 2002, EUR J VASC ENDOVASC, V23, P475, DOI 10.1006/ejvs.2002.1654
   Thomson JJ, 1900, PHYS Z, V1, P20
   Tiwari A, 2003, EUR J VASC ENDOVASC, V25, P325, DOI 10.1053/ejvs.2002.1854
   Tiwari A, 2002, FASEB J, V16, DOI 10.1096/fj.01-0826com
   Tsukagoshi T, 1999, J RECONSTR MICROSURG, V15, P127, DOI 10.1055/s-2007-1000083
   Uchida K, 2000, BIOMATERIALS, V21, P923, DOI 10.1016/S0142-9612(99)00260-4
   VANDERLEI B, 1991, INT ANGIOL, V10, P202
   VANHINSBERGH VWM, 1990, BLOOD, V75, P1490
   Vinard E, 1999, ANN VASC SURG, V13, P141, DOI 10.1007/s100169900232
   Vohra R K, 1990, Eur J Vasc Surg, V4, P33, DOI 10.1016/S0950-821X(05)80036-2
   VOHRA RK, 1990, ARTIF ORGANS, V14, P41
   VOORHEES AB, 1952, ANN SURG, V135, P332, DOI 10.1097/00000658-195203000-00006
   Walles T, 2003, INT J ARTIF ORGANS, V26, P225
   Walluscheck KP, 1996, EUR J VASC ENDOVASC, V12, P321, DOI 10.1016/S1078-5884(96)80251-6
   WILLIAMS SK, 1991, J ELECTRON MICR TECH, V19, P439, DOI 10.1002/jemt.1060190406
   Wilson G J, 1993, ASAIO J, V39, pM526
   WILSON GJ, 1995, ANN THORAC SURG, V60, pS353, DOI 10.1016/0003-4975(95)98967-Y
   Wissink MJB, 2001, BIOMATERIALS, V22, P151, DOI 10.1016/S0142-9612(00)00164-2
   Xue L, 2003, J VASC SURG, V37, P472, DOI 10.1067/mva.2003.88
   Yoda R, 1998, J BIOMAT SCI-POLYM E, V9, P561, DOI 10.1163/156856298X00046
   Zdrahala RJ, 1996, J BIOMATER APPL, V10, P309, DOI 10.1177/088532829601000402
NR 143
TC 25
Z9 26
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0885-4513
EI 1470-8744
J9 BIOTECHNOL APPL BIOC
JI Biotechnol. Appl. Biochem.
PD FEB
PY 2004
VL 39
BP 17
EP 27
DI 10.1042/BA20030111
PN 1
PG 11
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 773MH
UT WOS:000188927200003
PM 14535843
DA 2018-10-19
ER

PT J
AU Laymon, CM
   Harrison, RL
   Kohlmyer, SG
   Miyaoka, RS
   Lewellen, TK
AF Laymon, CM
   Harrison, RL
   Kohlmyer, SG
   Miyaoka, RS
   Lewellen, TK
TI Charicterization of single and multiple scatter from matter and activity
   distributions outside the FOV in 3-D PET
SO IEEE TRANSACTIONS ON NUCLEAR SCIENCE
LA English
DT Article
DE biomedical image processing; biomedical imaging; positron emission
   tomography (PET); scattering
ID FIELD-OF-VIEW; ENERGY THRESHOLD; 3D PET
AB Operation of PET in 3-D mode, without internal septa results in increased sensitivity but at the cost of increased scatter fraction. Significant amounts of scattered events in 3-D PET either originate from activity outside the FOV (OFOV) or scatter from matter outside the FOV, complicating scatter correction methods. We performed 3-D PET simulations with scanner geometry based on the GE Advance with several phantom geometries designed to characterize all scatter with particular attention to that from outside the FOV. Scatter from OFOV matter was deduced by performing simulations with matter and activity within the FOV only (short phantom). Studies were repeated with phantoms with identical characteristics inside the FOV but with additional OFOV material (long phantom) but no activity outside the FOV. The incremental effect of OFOV activity was then determined by repeating the long phantom studies with additional activity. Scatter was also classified as single or multiple. In summary, the data allow extraction of yields from unscattered and all types of scattered events. The effect of source position, both within and external to the FOV, on scatter was determined by performing a series of simulations with point sources and techniques similar to those described above. The effect of energy,discriminator setting (with BGO detectors) was also studied and data sets were generated for five settings from 300 to 425 keV. Using a Zubal phantom with the lungs and heart in the FOV and the abdomen outside the FOV and with a 300 keV discriminator, we find a total scatter fraction of 57%. Of the total scatter, 7.4% comes from OFOV matter, and 24% from OFOV activity. If the discriminator is increased to 425 keV the scatter fraction drops to 36%. OFOV scatter, particularly from OFOV activity, becomes relatively less important with the OFOV matter contribution dropping to 5.3% and OFOV activity contribution to 17%. Additionally, the spatial distributions of scatter from external matter and external activity were found to be different.
C1 Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15213 USA.
   Univ Washington, Seattle, WA 98195 USA.
   GE Med Syst, Waukesha, WI 53188 USA.
RP Laymon, CM (reprint author), Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15213 USA.
EM CML14@pitt.edu
CR Adam LE, 1999, PHYS MED BIOL, V44, P2879, DOI 10.1088/0031-9155/44/12/302
   BENTOURKIA M, 1999, P 1999 MED IM C SEAT, V2, P958
   DAUBEWITHERSPOO.ME, 1998, P IEEE NUCL SCI S ME, V2, P1237
   Kohlmyer SG, 1999, IEEE T NUCL SCI, V46, P2141, DOI 10.1109/23.819296
   Lewellen TK, 1999, IEEE T NUCL SCI, V46, P1129, DOI 10.1109/23.790846
   Lewellen TK, 1998, MED SCI SER, P77
   Ollinger JM, 1996, PHYS MED BIOL, V41, P153, DOI 10.1088/0031-9155/41/1/012
   SOSSI V, 1995, IEEE T NUCL SCI, V42, P1157, DOI 10.1109/23.467733
   Spinks TJ, 1998, PHYS MED BIOL, V43, P895, DOI 10.1088/0031-9155/43/4/017
   Watson CC, 1997, IEEE T NUCL SCI, V44, P90, DOI 10.1109/23.554831
   ZUBAL IG, 1994, MED PHYS, V21, P299, DOI 10.1118/1.597290
NR 11
TC 5
Z9 5
U1 0
U2 4
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 0018-9499
J9 IEEE T NUCL SCI
JI IEEE Trans. Nucl. Sci.
PD FEB
PY 2004
VL 51
IS 1
BP 10
EP 15
DI 10.1109/TNS.2004.823340
PN 1
PG 6
WC Engineering, Electrical & Electronic; Nuclear Science & Technology
SC Engineering; Nuclear Science & Technology
GA 813BR
UT WOS:000220883100002
DA 2018-10-19
ER

PT J
AU Altpeter, H
   Bevis, MJ
   Grijpma, DW
   Feijen, J
AF Altpeter, H
   Bevis, MJ
   Grijpma, DW
   Feijen, J
TI Non-conventional injection molding of poly(lactide) and
   poly(epsilon-caprolactone) intended for orthopedic applications
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID EPSILON-CAPROLACTONE; ENHANCEMENT
AB Biodegradable polymers such as poly(lactide) (PLA) and poly(epsilon-caprolactone) (PCL) are increasingly used in biomedical applications as temporary implants. However, melt processing of these materials in particular of PLA is difficult due to the temperature sensitivity. Within this study, PLA and PCL were injection molded conventionally and by using the process shear controled orientation in injection molding (SCORIM) in order to investigate the effect of processing parameters on the physical properties of the moldings. Therefore, flexural testing, differential scanning calorimetry (DSC), wide-angle X-ray diffraction (WAXD), molecular weight (MW) and orientation measurements were performed.
   PLA showed high sensitivity to melt temperature. In the case of amorphous poly(DL-lactide), the molecular weight and subsequently the ductility is substantially reduced by processing at higher melt temperatures. In the case of crystallizable poly(L-lactide), higher melt temperatures and shear induced by the SCORIM process resulted in enhanced crystallinity, which compromised the mechanical properties. Generally, SCORIM processing improved the mechanical properties, in particular the ductility, by orientating the molecular structure. PCL was shown to be less sensitive to shear and temperature than PLA. Stress at yield and stiffness are more improved by SCORIM processing. However, the processing temperature in combination with the grade used proved to be influential for the mechanical properties of resulting moldings. (C) 2004 Kluwer Academic Publishers.
C1 Brunel Univ, Wolfson Ctr Mat Proc, Uxbridge UB8 3PH, Middx, England.
   Univ Twente, Fac Chem Technol, Dept Polymer Chem & Biomat, NL-7500 AE Enschede, Netherlands.
RP Altpeter, H (reprint author), Brunel Univ, Wolfson Ctr Mat Proc, Uxbridge UB8 3PH, Middx, England.
CR ALLAN PS, 1987, PLAST RUB PROC APPL, V7, P3
   ALLAN PS, Patent No. 2170140
   ANDREOPOULOS AG, 1994, J ELASTOM PLAST, V26, P308, DOI 10.1177/009524439402600401
   BERGSMA JE, 1998, J CRANIO MAXILLOFAC, V26, P17
   Corden TJ, 2000, BIOMATERIALS, V21, P713, DOI 10.1016/S0142-9612(99)00236-7
   GURAV N, 1994, J MATER SCI-MATER M, V3, P784
   Ikada Y, 1996, J BIOMED MATER RES, V30, P553
   Kalay G, 1999, J APPL POLYM SCI, V73, P2473, DOI 10.1002/(SICI)1097-4628(19990919)73:12<2473::AID-APP16>3.3.CO;2-F
   Kalay G, 1997, KUNSTST-PLAST EUR, V87, P768
   Lowry KJ, 1997, J BIOMED MATER RES, V36, P536
   Nakamura T, 1998, J BIOMED MATER RES, V42, P475, DOI 10.1002/(SICI)1097-4636(19981215)42:4<475::AID-JBM1>3.0.CO;2-B
   Reis RL, 1997, ADV POLYM TECH, V16, P263, DOI 10.1002/(SICI)1098-2329(199711)16:4<263::AID-ADV2>3.0.CO;2-T
   ROSS PJ, 1988, TAGUSHI TECHNIQUES Q
   Sinclair RG, 1996, J MACROMOL SCI PURE, VA33, P585, DOI 10.1080/10601329608010880
   SOUSA RA, 2000, J APPL POLYM SCI, V77, P1300
   Tormala P, 1998, P I MECH ENG H, V212, P101, DOI 10.1243/0954411981533872
   VERT M, 1995, J MACROMOL SCI PURE, V32, P4
   von Oepen R, 1992, Clin Mater, V10, P21, DOI 10.1016/0267-6605(92)90080-D
NR 18
TC 18
Z9 19
U1 0
U2 9
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2004
VL 15
IS 2
BP 175
EP 184
DI 10.1023/B:JMSM.0000011820.64572.a5
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 762XA
UT WOS:000188006700012
PM 15330053
DA 2018-10-19
ER

PT J
AU Trouet, C
AF Trouet, C
TI New European guidelines for the use of stored human biological materials
   in biomedical research
SO JOURNAL OF MEDICAL ETHICS
LA English
DT Article
AB The increasing possibilities for using tissue for research and development in genetics and biotechnology have made stored human biological materials more important than ever. Using stored human biological materials raises many legal and ethical questions. On an international level however, the use of these materials has not been regulated in a detailed manner so far. The Council of Europe recently declassified the text of the proposal for an instrument on the use of archived human biological materials in biomedical research for public consultation. The purpose of this paper is to comment on this document regarding its primary goal, which is to protect the rights and fundamental freedoms of the individual whose biological materials could be included in a research project. The guidelines offer good basic protection for sources of identifiable human biological materials but, surprisingly, offer no protection to sources of anonymous or anonymised materials.
RP Trouet, C (reprint author), Kapucijnenvoer 35, B-3000 Leuven, Belgium.
EM Caroline.Trouet@med.kuleuven.ac.be
CR ANNAS GJ, 1993, JAMA-J AM MED ASSOC, V270, P2347
   BOEL E, 1997, HUMAN BIO BANKS ETHI, P107
   CLAYTON EW, 1997, HUMAN DNA LAW POLICY, P294
   CLAYTON EW, 1997, HUMAN DNA LAW POLICY, P298
   *COUNC EUR, 1998, ETH REV BIOM RES EUR
   DANIELS LB, 1990, CALIFORNIA W SCH LAW, P210
   DEHERT P, 1998, ARTIKEL 8 EVRM BELGI, P75
   GASSNER UM, 2001, MEDIZINRECHT, V19, P553
   GULWIRTH S, 1993, WAARHEIDSAANSPRAKEN, P23
   HARRIS DJ, 1995, LAW EUROPEAN CONVENT, P306
   HERMITTE MA, 1993, BIOETHIQUE DROITS HO, P50
   JONSSON L, 2001, USE HUMAN BIO BANKS, P4
   Knoppers B, 1999, COMMERCIALIZATION GE, P1
   LABRUSSERIOU C, 1997, PRODUIRE HOMME QUEL, P196
   LAWRENCE SC, 1998, STORED TISSUE SAMPLE, P113
   LEENEN HJJ, 2000, HDB GEZONDHEIDSRECHT, V1, P36
   LOUCAIDES LG, 1991, BRIT YB INT LAW 1990, P178
   LOUCAIDES LG, 1991, BRIT YB INT LAW 1990, P176
   *MRC UK, 2001, HUM TISS BIOL SAMPL
   *OFF PARL EV CHOIX, 1994, 94654 OFF PARL EV CH, P34
   PHILLIPS JA, 1995, AM J HUM GENET, V57, P1499
   *ROYAL COLL PATH, 2001, TRANS GUID FAC CHANG
   *STEER COMM BIOETH, 2002, PROP INSTR US ARCH H
   WARBRICK C, 1998, EUROPEAN HUMAN RIGHT, P33
   Wertz D C, 1999, Community Genet, V2, P51, DOI 10.1159/000016187
   WINICKOFF D, 2000, J BIOLAW BUS, V4, P11
   ZIEMELE I, 2002, BALTIC YB INT LAW, V2, P11
NR 27
TC 26
Z9 26
U1 0
U2 0
PU B M J PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0306-6800
J9 J MED ETHICS
JI J. Med. Ethics
PD FEB 1
PY 2004
VL 30
IS 1
BP 99
EP 103
DI 10.1136/jme.2003.003467
PG 5
WC Ethics; Medical Ethics; Social Issues; Social Sciences, Biomedical
SC Social Sciences - Other Topics; Medical Ethics; Social Issues;
   Biomedical Social Sciences
GA 772TG
UT WOS:000188856900021
PM 14872085
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Shih, IL
   Van, YT
   Shen, MH
AF Shih, IL
   Van, YT
   Shen, MH
TI Biomedical applications of chemically and microbiologically synthesized
   poly(glutamic acid) and poly(lysine)
SO MINI-REVIEWS IN MEDICINAL CHEMISTRY
LA English
DT Review
DE poly-alpha-glutamic acid; poly-alpha-lysine; poly-gamma-glutamic acid;
   poly-epsilon-lysine; biosynthesis; biomedical applications
ID POLY-L-LYSINE; POLYRIBOINOSINIC-POLYRIBOCYTIDYLIC ACID;
   INTERMEDIATE-DRUG CARRIER; BACILLUS-SUBTILIS NATTO; GAMMA-POLYGLUTAMIC
   ACID; GLUTAMIC-ACID; POLY(GAMMA-GLUTAMIC ACID); GENE-THERAPY;
   POLY(L-GLUTAMIC ACID); STREPTOMYCES-ALBULUS
AB This review article deals with the synthesis, physiochemical properties, and potential biomedical applications of two homo-poly amino acids. Poly-alpha-glutamic acid (alpha-PGA) and poly-alpha-lysine (alpha-PL) were synthesized by chemical synthesis, poly-gamma-glutamic acid (gamma-PGA) and poly-epsilon-lysine (epsilon-PL) were naturally occurring bio-materials that were produced by microbial fermentation. Poly(glutamic acid) (PGA) and poly(lysine) (PL) are water soluble, biodegradable, edible and nontoxic toward humans and the environment. As a result, they are suitable for various applications and have recently attracted considerable interest of the chemical industry. The distinguished features of PGA and PL also make them promising candidates for biomedical applications. The applications of PGA and PL in the areas of biomedical materials. drug delivery carriers and biological adhesives have been studied extensively and will be discussed in this review.
C1 Da Yeh Univ, Dept Environm Engn, Da Tsuen 51505, Chang Hwa, Taiwan.
RP Shih, IL (reprint author), Da Yeh Univ, Dept Environm Engn, 112,Shan Jiau Rd, Da Tsuen 51505, Chang Hwa, Taiwan.
EM ils@mail.dyu.edu.tw
CR Asayama S, 1998, BIOCONJUGATE CHEM, V9, P476, DOI 10.1021/bc970213m
   Ashiuchi M, 2001, APPL MICROBIOL BIOT, V57, P764, DOI 10.1007/s00253-001-0848-9
   Avichezer D, 1998, REACT FUNCT POLYM, V36, P59, DOI 10.1016/S1381-5148(97)00121-1
   BATZ HG, 1974, MAKROMOL CHEM, V175, P2229
   BECKER RR, 1952, J AM CHEM SOC, V74, P38, DOI 10.1021/ja01121a010
   BEHR JP, 1993, ACCOUNTS CHEM RES, V26, P274, DOI 10.1021/ar00029a008
   BENISHAI D, 1952, J ORG CHEM, V17, P1564, DOI 10.1021/jo50012a002
   BLOCK L, 1983, POLY GAMA BENZYL L G
   Bogdanov AA, 1996, BIOCONJUGATE CHEM, V7, P144, DOI 10.1021/bc950089b
   BORST HG, 1982, J THORAC CARDIOV SUR, V84, P548
   Bovarnick M, 1942, J BIOL CHEM, V145, P415
   CALBRESI P, 1975, PHARMACOL BASIS THER, P1268
   CHAMPNEY K, 1976, CLIN RES, V24, P451
   CHENG C, 1989, AGR BIOL CHEM TOKYO, V53, P2369, DOI 10.1080/00021369.1989.10869686
   CHIO JS, 2000, NUCLEIC ACIDS RES, V122, P474
   CHIOU HC, 1994, NUCLEIC ACIDS RES, V22, P5439, DOI 10.1093/nar/22.24.5439
   Choi JS, 2000, J AM CHEM SOC, V122, P474, DOI 10.1021/ja9931473
   Choi YH, 1998, BIOCONJUGATE CHEM, V9, P708, DOI 10.1021/bc980017v
   Cromwick AM, 1996, BIOTECHNOL BIOENG, V50, P222, DOI 10.1002/(SICI)1097-0290(19960420)50:2<222::AID-BIT10>3.0.CO;2-P
   CROMWICK AM, 1995, INT J BIOL MACROMOL, V16, P265
   Dekie L, 2000, J CONTROL RELEASE, V65, P187, DOI 10.1016/S0168-3659(99)00235-7
   Deming TJ, 1997, NATURE, V390, P386, DOI 10.1038/37084
   DEVITA V, 1970, P AM ASSOC CANC RES, V11, P21
   DORUDI S, 1993, BRIT J SURG, V80, P566, DOI 10.1002/bjs.1800800507
   EDDE B, 1990, SCIENCE, V247, P83, DOI 10.1126/science.1967194
   EWEL CH, 1992, CANCER RES, V52, P3005
   FIELD AK, 1967, P NATL ACAD SCI USA, V58, P1004, DOI 10.1073/pnas.58.3.1004
   Frankel M, 1944, J AM CHEM SOC, V66, P763, DOI 10.1021/ja01233a031
   FRIEDMANN T, 1972, SCIENCE, V175, P949, DOI 10.1126/science.175.4025.949
   FUJII H, 1963, J AGR CHEM SOC JPN, V37, P407
   FULLER WD, 1976, BIOPOLYMERS, V15, P1869, DOI 10.1002/bip.1976.360150922
   GALUN E, 1990, HEPATOLOGY, V11, P578, DOI 10.1002/hep.1840110409
   GILBOA E, 1986, BIOTECHNIQUES, V4, P504
   GILBOIN H, 1970, SCIENCE, V107, P205
   GIOVANELLA BC, 1989, SCIENCE, V246, P1046, DOI 10.1126/science.2555920
   GIOVANELLA BC, 1991, CANCER RES, V51, P3052
   GOFF BA, 1991, CANCER RES, V51, P4761
   GOTO A, 1992, BIOSCI BIOTECH BIOCH, V56, P1031, DOI 10.1271/bbb.56.1031
   GREENFIELD RS, 1989, ANTIBODY IMMUNOCONJ, V2, P201
   HANANIA EG, 1995, AM J MED, V99, P537, DOI 10.1016/S0002-9343(99)80232-0
   HARA T, 1982, AGR BIOL CHEM TOKYO, V46, P2275, DOI 10.1080/00021369.1982.10865430
   Hashida M, 1998, J CONTROL RELEASE, V53, P301, DOI 10.1016/S0168-3659(97)00263-0
   Hiraki J, 1998, SEIBUTSU-KOGAKU KAIS, V76, P487
   Hirayama C, 1999, J CHROMATOGR B, V721, P187, DOI 10.1016/S0378-4347(98)00479-4
   HOES CJT, 1993, J CONTROL RELEASE, V23, P37, DOI 10.1016/0168-3659(93)90069-H
   HOLMES FA, 1995, TAXANE ANTICANCER AG, P31
   HOUSEWRIGHT RD, 1962, BACTERIA, V3, P389
   Hurwitz E., 1980, J APPL BIOCHEM, V2, P25
   IDELSON M, 1958, J AM CHEM SOC, V80, P4631, DOI 10.1021/ja01550a056
   Ito Y, 1996, BIOSCI BIOTECH BIOCH, V60, P1239, DOI 10.1271/bbb.60.1239
   IVAOVICS G, 1937, ZIMMUNITATSFORSCH, V90, P304
   JIANG XT, 1996, ACTA PHARMACOL SINIC, V31, P632
   KABANOV AV, 1995, BIOCONJUGATE CHEM, V6, P7, DOI 10.1021/bc00031a002
   Kahar P, 2002, J BIOSCI BIOENG, V93, P274, DOI 10.1263/jbb.93.274
   Kahar P, 2001, J BIOSCI BIOENG, V91, P190, DOI 10.1263/jbb.91.190
   KALCHALSKI E, 1958, ADV PROTEIN CHEM, V13, P243
   Kambourova M, 2001, APPL ENVIRON MICROB, V67, P1004, DOI 10.1128/AEM.67.2.1004-1007.2001
   KATAKAI R, 1985, J ORG CHEM, V50, P715, DOI 10.1021/jo00205a039
   KATO Y, 1984, J MED CHEM, V27, P1602, DOI 10.1021/jm00378a013
   KATO Y, 1984, CANCER RES, V44, P25
   Ko YH, 1998, BIOTECHNOL BIOENG, V57, P430, DOI 10.1002/(SICI)1097-0290(19980220)57:4<430::AID-BIT6>3.0.CO;2-N
   KUBOTA H, 1993, BIOSCI BIOTECH BIOCH, V57, P1212, DOI 10.1271/bbb.57.1212
   Kunioka M, 1997, APPL MICROBIOL BIOT, V47, P469, DOI 10.1007/s002530050958
   LAEMMLI UK, 1975, P NATL ACAD SCI USA, V72, P4288, DOI 10.1073/pnas.72.11.4288
   LAMPKIN BC, 1985, CANCER RES, V45, P5904
   LEDLEY FD, 1995, HUM GENE THER, V6, P1129, DOI 10.1089/hum.1995.6.9-1129
   LEONARD CG, 1958, J BACTERIOL, V76, P499
   LEVY HB, 1985, J BIOL RESP MODIF, V4, P475
   LEVY HB, 1975, J INFECT DIS, V132, P434, DOI 10.1093/infdis/132.4.434
   LEVY HB, 1969, P NATL ACAD SCI USA, V62, P357, DOI 10.1073/pnas.62.2.357
   Li C, 1998, CANCER RES, V58, P2404
   Li C, 2002, ADV DRUG DELIVER REV, V54, P695, DOI 10.1016/S0169-409X(02)00045-5
   Li C, 1999, CLIN CANCER RES, V5, P891
   Machluf M, 2000, WORLD J UROL, V18, P80, DOI 10.1007/s003450050014
   MACHULUF M, 1999, P ANN M AM UR ASS DA
   Markland P, 1999, INT J PHARM, V178, P183, DOI 10.1016/S0378-5173(98)00373-1
   Maruyama A, 1997, BIOCONJUGATE CHEM, V8, P735, DOI 10.1021/bc9701048
   Moromoto Y, 1984, J PHARMACOBIO-DYNAM, V7, P688
   MULLIGAN RC, 1993, SCIENCE, V260, P926, DOI 10.1126/science.8493530
   Murao S, 1969, KOBUNSHI, V16, P1204
   NITCCKI DE, 1971, CHEM BIOCH AMINO ACI, V1, P87
   Ogawa Y, 1997, BIOSCI BIOTECH BIOCH, V61, P1684, DOI 10.1271/bbb.61.1684
   Okada N, 1997, BIOCHEM BIOPH RES CO, V230, P524, DOI 10.1006/bbrc.1996.5996
   Oppermann-Sanio FB, 2002, NATURWISSENSCHAFTEN, V89, P11, DOI 10.1007/s00114-001-0280-0
   Otani Y, 1996, J BIOMED MATER RES, V31, P157
   Otani Y, 1998, BIOMATERIALS, V19, P2167, DOI 10.1016/S0142-9612(98)00123-9
   PALACIOS P, 1991, J BIOCHEM BIOPH METH, V23, P67, DOI 10.1016/0165-022X(91)90051-W
   Perez-Camero G, 1999, BIOTECHNOL BIOENG, V63, P110, DOI 10.1002/(SICI)1097-0290(19990405)63:1<110::AID-BIT11>3.0.CO;2-T
   ROOS CF, 1984, INT J PHARM, V22, P75, DOI 10.1016/0378-5173(84)90047-4
   ROSENFELD MA, 1991, SCIENCE, V252, P431, DOI 10.1126/science.2017680
   ROWINSKY EK, 1995, NEW ENGL J MED, V332, P1004, DOI 10.1056/NEJM199504133321507
   ROWLAND GF, 1975, NATURE, V255, P487, DOI 10.1038/255487a0
   RYSER HJP, 1978, P NATL ACAD SCI USA, V75, P3867, DOI 10.1073/pnas.75.8.3867
   RYSER HJP, 1980, CANCER, V45, P1207, DOI 10.1002/1097-0142(19800315)45:5+<1207::AID-CNCR2820451327>3.0.CO;2-M
   SEKINE T, 2000, J BIOMED MATER RES, V35, P305
   SHEN C, 1981, P FED AM SOC EXP BIO, V49, P642
   SHEN WC, 1981, LIFE SCI, V28, P1209, DOI 10.1016/0024-3205(81)90445-8
   SHEN WC, 1978, P NATL ACAD SCI USA, V75, P1872, DOI 10.1073/pnas.75.4.1872
   SHEN WC, 1979, MOL PHARMACOL, V16, P614
   Shih IL, 2002, ENZYME MICROB TECH, V31, P213, DOI 10.1016/S0141-0229(02)00103-5
   Shih IL, 2001, BIORESOURCE TECHNOL, V79, P207, DOI 10.1016/S0960-8524(01)00074-8
   SHIMA S, 1981, AGR BIOL CHEM TOKYO, V45, P2497, DOI 10.1080/00021369.1981.10864929
   SHIMA S, 1977, AGR BIOL CHEM TOKYO, V41, P1807, DOI 10.1080/00021369.1977.10862764
   SHIMA S, 1984, J ANTIBIOT, V37, P1449, DOI 10.7164/antibiotics.37.1449
   SHIMA S, 1981, AGR BIOL CHEM TOKYO, V45, P2503, DOI 10.1080/00021369.1981.10864930
   SHIMA S, 1983, J AGR CHEM SOC JPN, V57, P221, DOI 10.1271/nogeikagaku1924.57.221
   Singer JW, 2000, ANN NY ACAD SCI, V922, P136
   Singer JW, 2001, J CONTROL RELEASE, V74, P243, DOI 10.1016/S0168-3659(01)00323-6
   Spotnitz W. D., 1996, SURG ADHESIVES SEALA, P3
   Suye S, 1998, BIOTECHNOL APPL BIOC, V27, P245
   TEMIN HM, 1990, HUM GENE THER, V10, P4329
   THORNE CB, 1954, J BACTERIOL, V68, P307
   TORIUMI D, 1996, SURG ADHESIVES SEALA, P61
   TROY FA, 1973, J BIOL CHEM, V248, P305
   TROY FA, 1982, PEPTIDES ANTIBIOTICS
   TSUKADA Y, 1984, JNCI-J NATL CANCER I, V73, P721
   Van Heeswijk WAR, 1985, J CONTROL RELEASE, V1, P301
   VEGA J, 2002, 5 INT S POL THER LAB, P63
   WOLFERT MA, 1996, HUM GENE THER, V7, P213
   WONG JP, 1995, ANTIMICROB AGENTS CH, V39, P2574, DOI 10.1128/AAC.39.11.2574
   WORTHINGTON M, 1973, P SOC EXP BIOL MED, V143, P638
   Yoon SH, 2000, BIOTECHNOL LETT, V22, P585, DOI 10.1023/A:1005625026623
   YOUNG CW, 1971, MED CLIN N AM, V55, P721, DOI 10.1016/S0025-7125(16)32513-5
   Zauner W, 1998, ADV DRUG DELIVER REV, V30, P97, DOI 10.1016/S0169-409X(97)00110-5
   Zou YY, 2001, INT J ONCOL, V18, P331
   ZUNINO F, 1989, J CONTROL RELEASE, V10, P65, DOI 10.1016/0168-3659(89)90018-7
NR 126
TC 76
Z9 85
U1 4
U2 51
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1389-5575
J9 MINI-REV MED CHEM
JI Mini-Rev. Med. Chem.
PD FEB
PY 2004
VL 4
IS 2
BP 179
EP 188
DI 10.2174/1389557043487420
PG 10
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA 890BL
UT WOS:000226486600005
PM 14965290
DA 2018-10-19
ER

PT B
AU Dong, HS
AF Dong, HS
BE Xu, Y
   Shao, Z
   Gao, N
TI Towards long-life replacement joint prostheses - A surface engineering
   approach
SO 14TH CONGRESS OF INTERNATIONAL FEDERATION FOR HEAT TREATMENT AND SURFACE
   ENGINEERING, VOLS 1 and 2, PROCEEDINGS
LA English
DT Proceedings Paper
CT 14th Congress of the
   International-Federation-for-Heat-Treatment-and-Surface-Engineering
CY OCT 26-28, 2004
CL Shanghai, PEOPLES R CHINA
SP Int Federat Heat Treatmant & Surface Engn, Chinese Mech Engn Soc, Chinese Heat Treatment Soc, Shanghai Jiao Tong Univ, Shanghai Elect Grp Corp
DE joint prostheses; surface engineering; biomaterials; plasma surface
   alloying; ion beam; ceramic conversion
ID WEAR; RESISTANCE
AB How to improve the wear resistance of bearing surfaces, hereby achieving long life of orthopaedic joint prostheses has long been a technical challenge with much fundamental interest and social and economic impacts. Surface engineering has been emerging as one of the most promising technologies to improve the tribological properties of biomedical materials. A current area of research within the Birmingham Surface Engineering Group has been directed at developing novel surface engineering technologies for biomedical materials towards long-life joint prostheses. Following a brief introduction, the author reports their recent progress in the surface engineering of biomedical materials particular for joint prosthesis. The potential of these innovative surface engineering technologies in enhancing the performance of oral and maxillofacial implants and surgical devices is also discussed.
C1 Univ Birmingham, Dept Met & Mat, Birmingham B15 2TT, W Midlands, England.
RP Dong, HS (reprint author), Univ Birmingham, Dept Met & Mat, Birmingham B15 2TT, W Midlands, England.
CR Dong H, 2000, WEAR, V238, P131, DOI 10.1016/S0043-1648(99)00359-2
   DONG H, 2001, Patent No. 6210807
   Fisher J, 2004, J MATER SCI-MATER M, V15, P225, DOI 10.1023/B:JMSM.0000015482.24542.76
   JONES AHS, 2000, C FRICT LUBR WEAR AR
   LACOMBE P, 1982, TITANIUM TITANIUM AL, V2, P874
   Li XY, 2001, WEAR, V250, P553, DOI 10.1016/S0043-1648(01)00637-8
   MALCHAU H, 1996, P 63 ANN M AM AC ORT
   Raimondi MT, 2000, BIOMATERIALS, V21, P907
   Shi W, 2004, J MATER SCI, V39, P3183, DOI 10.1023/B:JMSC.0000025854.49913.4a
   Sun Y, 1999, SURF ENG, V15, P49, DOI 10.1179/026708499322911647
   Thaiwatthana S, 2003, SURF ENG, V19, P211, DOI 10.1179/026708403225006203
   Zhang Z.L., 1985, SURF ENG, V1, P131, DOI DOI 10.1179/SUR.1985.1.2.131
NR 12
TC 1
Z9 1
U1 0
U2 2
PU TRANSACTIONS MATERIALS & HEAT TREATMENT
PI BEIJING
PA NO 18 XUEQING RD, BEIJING, 100083, PEOPLES R CHINA
PY 2004
BP 1287
EP 1290
PG 4
WC Engineering, Mechanical; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Engineering; Materials Science; Metallurgy & Metallurgical Engineering
GA BCC83
UT WOS:000228664200300
DA 2018-10-19
ER

PT B
AU Krishnaswamy, A
   Baranoski, GVG
AF Krishnaswamy, A
   Baranoski, GVG
BE Gaudiot, JL
   Pilla, ML
   Navaux, POA
   Song, SW
TI Combining a shared-memory high performance computer and a heterogeneous
   cluster for the simulation of light interaction with human skin
SO 16TH SYMPOSIUM ON COMPUTER ARCHITECTURE AND HIGH PERFORMANCE COMPUTING,
   PROCEEDINGS
LA English
DT Proceedings Paper
CT 16th Symposium on Computer Architecture and High Performance Computing
CY OCT 27-29, 2004
CL Iguassu Falls, BRAZIL
SP Brazilian Comp Soc, IEEE Comp Soc, Int Federat Informat Proc, Fed Univ Rio Grande do Sul, Univ Sao Paulo
AB When light interacts with human skin, a complex and involved process begins as the light is absorbed and propagated by cells, fibers and other microscopic materials. This interaction happens countless times each day and its accurate simulation is essential to biomedical and computer graphics applications. Simulating this interaction is computationally intensive, yet highly suitable to parallelization. This paper describes the use of both a shared-memory high performance computer and a heterogeneous cluster to accelerate these simulations. With a description of the parallel software used, we present results to show the performance gains from using such a hybrid approach.
C1 Univ Waterloo, Sch Comp Sci, Nat Phenomena Simulat Grp, Waterloo, ON N2L 3G1, Canada.
RP Krishnaswamy, A (reprint author), Univ Waterloo, Sch Comp Sci, Nat Phenomena Simulat Grp, Waterloo, ON N2L 3G1, Canada.
CR ANDERSON RR, 1981, J INVEST DERMATOL, V77, P13, DOI 10.1111/1523-1747.ep12479191
   BARANOSKI GVG, 2003, CS200345 U WAT SCH C
   BRULS WAG, 1984, PHOTOCHEM PHOTOBIOL, V40, P231, DOI 10.1111/j.1751-1097.1984.tb04581.x
   GLASSNER A, 1995, PRINCIPLES DIGITAL I
   Gropp W., 1999, USING MPI PORTABLE P
   Jacques S. L., 1996, OSA TOPS ADV OPTICAL, V2, P364
   KRISHNASWAMY A, 2004, IN PRDESS COMPUTER G
   REINHARD E, 1999, THESIS U BRISTOL BRI
   Shirley P., 2000, REALISTIC RAY TRACIN
   Su YX, 2002, P SOC PHOTO-OPT INS, V4916, P299, DOI 10.1117/12.482974
   TUCHIN V, 1997, PHYSICS USPEKHI, V40
   Tuchin V, 2000, TISSUE OPTICS LIGHT
   Wang C., 1999, Journal of Graphics Tools, V4, P39
NR 13
TC 2
Z9 2
U1 0
U2 0
PU IEEE COMPUTER SOC
PI LOS ALAMITOS
PA 10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1264 USA
BN 0-7695-2240-8
PY 2004
BP 166
EP 171
DI 10.1109/SBAC-PAD.2004.13
PG 6
WC Computer Science, Hardware & Architecture; Computer Science, Theory &
   Methods
SC Computer Science
GA BBF41
UT WOS:000225222600021
DA 2018-10-19
ER

PT B
AU Wechsler, D
AF Wechsler, D
GP IEEE
TI Nanobiotechnology meets medical technology: Prospects and demands
SO 2004 4TH IEEE CONFERENCE ON NANOTECHNOLOGY
LA English
DT Proceedings Paper
CT 4th IEEE Conference on Nanotechnology
CY AUG 16-19, 2004
CL Munich, GERMANY
SP IEEE
DE anotechnology; biomedical materials; membranes; drug delivery systems;
   control systems
ID NANOPARTICLES
AB Nanobiotechnology bridges the technological gaps between physics, chemistry and biology on the nanoscale. This leads to many innovative approaches which will result in new methods and products for both, technological and medical-pharmaceutical applications. This report discusses the following question how can nanobiotechnology contribute to and combined with medical technology
   inactive, biocompatible and functionalised surfaces are important for the further development of many applied medical systems like bone implants, stents and also membranes for apheresis. Furthermore nanoparticles are good candidates for establishing new therapeutic applications. They are considered and some are already applied as drug delivery systems and contrast agents. It is argued that coated nanoparticles functionalised with target molecules and interacting with a ternal devices offer real perspectives for medical applications which come close to the more or less realistic visions connected with nanobots.
C1 VDI Technol Zentrum GmbH, D-40239 Dusseldorf, Germany.
RP Wechsler, D (reprint author), VDI Technol Zentrum GmbH, Graf Recke Str 84, D-40239 Dusseldorf, Germany.
CR Berry CC, 2003, J PHYS D APPL PHYS, V36, pR198, DOI 10.1088/0022-3727/36/13/203
   CATLEDGE SA, 2002, ANOSCI ANOTECH, V2, P1
   GOULD P, 2004, MAT TODAY        FEB, P36
   O'Neal DP, 2004, CANCER LETT, V209, P171, DOI 10.1016/j.canlet.2004.02.004
   Steiniger SCJ, 2004, INT J CANCER, V109, P759, DOI 10.1002/ijc.20048
   WAGNER V, 2004, VDI TECHNOLOGIEZENTR
NR 6
TC 0
Z9 0
U1 0
U2 5
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 0-7803-8536-5
PY 2004
BP 230
EP 232
PG 3
WC Instruments & Instrumentation; Materials Science, Multidisciplinary
SC Instruments & Instrumentation; Materials Science
GA BBL92
UT WOS:000226085100076
DA 2018-10-19
ER

EF